Citrus Sinensis ID: 014736

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------42
Protein Sequence
MRESSEPSKPWRPFTSKCCSAEGQIIFGNLSRCKTSRSDFSKNIAPMPSFRRLSFSDLSRSSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMAVSCGQWPATQKSTRNGVSPKATRGGNVRKSAPVTQNRKR
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccEEEEEEEcccccccccccEEEEEEcccccccHHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEcccccHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccHHHHHHHHHHccccccccccccccHHHHHccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHccccccccEEcHHHHHHHHccccHHHccccccccEEEEEEEccccccccccEEEEEEEEccccccccHHHHHHHHHHHHccccccEEEEEEEEccccEEEEEEEcccccHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEcccHccEEEcccccccHcHccccccccccccccEEEEEcccccHccHHHHHHcEEcHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHccccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mressepskpwrpftskccsaegqiifgnlsrcktsrsdfskniapmpsfrrlsfsdlsrssstrinedlahtfgpdlydFQLSELRAITQNfssnyllgeggfgtvhkgyiddDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVyefmprgslenhLFKRisvslpwgtrLKIAIGAAKGLAflhgaenpviyrdfktsnilldsdftaklsdfglakmgpegsnthvttrvmgtygyaapeyistghlttksdVYSFGVVLLELLTgrrsmdklrpkseqnlvdwakpylrssrrlryivdprlagqysvkGAKEMAVLALQCisvnpkdrpKMAAVVATLESLLNLKDMAvscgqwpatqkstrngvspkatrggnvrksapvtqnrkr
Flexible Loop (DISEMBL)
mressepskpwrpftskCCSAEGQIIFGNLSRCKTSrsdfskniapmpsfrrlsfsdLSRSSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLakmgpegsnthvtTRVMGTYGYAAPEYISTghlttksdVYSFGVVLLELLtgrrsmdklrpkseqnlvdwakpylrssrrlryivdprLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMAVSCGQwpatqkstrngvspkatrggnvrksapvtqnrkr
Low Complexity Region (SEG)
MRESSEPSKPWRPFTSKCCSAEGQIIFGNLSRCKTSRSDFSKNIAPMPsfrrlsfsdlsrsssTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMAVSCGQWPATQKSTRNGVSPKATRGGNVRKSAPVTQNRKR
Disordered region (IsUnstruct)
*************FTSKCCSAEGQIIFGNLSRC***********************************DLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR************NLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMAVSCGQW*********************************
Disordered Region (DISOPRED)
******************CSA*G*******************************************************YDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL**********************************************
Disordered Region (DISEMBL)
*************FTSKCCSAEGQIIFGNLSRCKTSRSDFSKNIAPMPSFRRLSFSDLSRSSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMAVSCGQWPA*******************************
Disordered Region (DISPRO)
***************************************************************************PDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN********************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MRESSEPSKPWRPFTSKCCSAEGQIIFGNLSRCKTSRSDFSKNIAPMPSFRRLSFSDLSRSSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMAVSCGQWPATQKSTRNGVSPKATRGGNVRKSAPVTQNRKR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	419	2.2.26 [Sep-21-2011]
Q8GXZ3	410	Serine/threonine-protein	no	no	0.787	0.804	0.661	1e-125
Q9LFP7	493	Probable receptor-like pr	no	no	0.766	0.651	0.621	1e-113
Q9CAH1	450	Putative receptor-like pr	no	no	0.778	0.724	0.600	1e-112
Q9SRH7	490	Receptor-like serine/thre	no	no	0.720	0.616	0.631	1e-109
P43293	389	Probable serine/threonine	no	no	0.708	0.763	0.625	1e-108
P46573	412	Protein kinase APK1B, chl	no	no	0.723	0.735	0.613	1e-106
Q9FM85	408	Probable receptor-like pr	no	no	0.747	0.767	0.592	1e-106
Q06548	410	Protein kinase APK1A, chl	no	no	0.711	0.726	0.611	1e-105
O49840	426	Protein kinase 2B, chloro	no	no	0.778	0.765	0.576	1e-105
O49839	426	Protein kinase 2A, chloro	no	no	0.711	0.699	0.611	1e-103

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  448 bits (1152), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 219/331 (66%), Positives = 256/331 (77%), Gaps = 1/331 (0%)

Query: 54  SFSDLSRSSSTRINEDLAHTFG-PDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYI 112
           S SDLS  S+ R  +D         +  F L EL  IT++F  +Y+LGEGGFGTV+KGYI
Sbjct: 29  SVSDLSDPSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYI 88

Query: 113 DDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLV 172
           DD+LR GLK+  VAVK+L+ EGLQGHREWL EV FLGQLRHP+LV+LIGYCCED+ RLLV
Sbjct: 89  DDNLRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLV 148

Query: 173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD 232
           YEFM RGSLENHLF++ +  L W  R+ IA+GAAKGLAFLH AE PVIYRDFKTSNILLD
Sbjct: 149 YEFMLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLD 208

Query: 233 SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLE 292
           SD+TAKLSDFGLAK GP+G  THV+TRVMGTYGYAAPEY+ TGHLT +SDVYSFGVVLLE
Sbjct: 209 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE 268

Query: 293 LLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQC 352
           +LTGR+S+DK RP  EQNLVDWA+P L   R+L  I+DPRL  QYSV+ A++   LA  C
Sbjct: 269 MLTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYC 328

Query: 353 ISVNPKDRPKMAAVVATLESLLNLKDMAVSC 383
           +S NPK RP M+ VV TLE L    D  + C
Sbjct: 329 LSQNPKARPLMSDVVETLEPLQCTGDALIPC 359

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  408 bits (1048), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 204/328 (62%), Positives = 252/328 (76%), Gaps = 7/328 (2%)

Query: 59  SRSSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQ 118
           S SS+  I+E+L       L  F  ++L+  T+NF    LLGEGGFG V KG+I+++   
Sbjct: 110 SSSSTPVISEEL--NISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTA 167

Query: 119 GLK---AQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEF 175
            +K      VAVK L+ +GLQGH+EWLAE+ FLG L HP+LV+L+GYC ED++RLLVYEF
Sbjct: 168 PVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEF 227

Query: 176 MPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG-AENPVIYRDFKTSNILLDSD 234
           MPRGSLENHLF+R S+ LPW  R+KIA+GAAKGL+FLH  A  PVIYRDFKTSNILLD+D
Sbjct: 228 MPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDAD 286

Query: 235 FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELL 294
           + AKLSDFGLAK  P+   THV+TRVMGTYGYAAPEY+ TGHLT+KSDVYSFGVVLLE+L
Sbjct: 287 YNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 346

Query: 295 TGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCIS 354
           TGRRSMDK RP  E NLV+WA+P+L   RR   ++DPRL G +S+KGA+++  LA QC+S
Sbjct: 347 TGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLS 406

Query: 355 VNPKDRPKMAAVVATLESLLNLKDMAVS 382
            +PK RPKM+ VV  L+ L +LKDMA S
Sbjct: 407 RDPKIRPKMSDVVEALKPLPHLKDMASS 434

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAH1|Y1725_ARATH Putative receptor-like protein kinase At1g72540 OS=Arabidopsis thaliana GN=At1g72540 PE=2 SV=1

 Score =  407 bits (1045), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 197/328 (60%), Positives = 250/328 (76%), Gaps = 2/328 (0%)

Query: 52  RLSFSDLSRSSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGY 111
           R+  SD S +S+  +N D +++F  +++ F   EL+ ITQ FS    LGEGGFG V+KG+
Sbjct: 45  RVYMSDFS-NSTISLN-DFSNSFFINIHIFTYEELKTITQGFSKYNFLGEGGFGEVYKGF 102

Query: 112 IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLL 171
           +DD L+ GLK Q VAVK L  EG QGHREWLAEVI LGQL+HPHLV L+GYCCED+ERLL
Sbjct: 103 VDDSLKTGLKDQPVAVKALKREGGQGHREWLAEVIILGQLKHPHLVNLVGYCCEDDERLL 162

Query: 172 VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL 231
           VYE+M RG+LE+HLF++   +LPW TR+KI +GAAKGL FLH  E PVIYRDFK SNILL
Sbjct: 163 VYEYMERGNLEDHLFQKYGGALPWLTRVKILLGAAKGLEFLHKQEKPVIYRDFKPSNILL 222

Query: 232 DSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLL 291
            SDF++KLSDFGLA  G E  +++ T  VMGT GYAAPEYIS G+LTT SDV+SFGVVLL
Sbjct: 223 SSDFSSKLSDFGLATDGSEEEDSNFTKSVMGTEGYAAPEYISAGNLTTMSDVFSFGVVLL 282

Query: 292 ELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQ 351
           E+LT R++++K R +  +NLV+WA+P L+   +L  I+DP L G+YSV+G ++ A LA Q
Sbjct: 283 EMLTARKAVEKYRAQRGRNLVEWARPMLKDPNKLERIIDPSLEGKYSVEGIRKAAALAYQ 342

Query: 352 CISVNPKDRPKMAAVVATLESLLNLKDM 379
           C+S NPK RP M  VV TLE +L+LKD+
Sbjct: 343 CLSHNPKSRPTMTTVVKTLEPILDLKDI 370

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  396 bits (1017), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 194/307 (63%), Positives = 239/307 (77%), Gaps = 5/307 (1%)

Query: 78  LYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLK---AQAVAVKLLDIEG 134
           L  F   +L+  T+NF    LLGEGGFG V KG+++++    +K      VAVK L+ +G
Sbjct: 121 LKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDG 180

Query: 135 LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLP 194
           LQGH+EWLAE+ +LG L HP+LV+L+GYC ED++RLLVYEFMPRGSLENHLF+R S+ LP
Sbjct: 181 LQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLP 239

Query: 195 WGTRLKIAIGAAKGLAFLHG-AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN 253
           W  R+KIA+GAAKGL+FLH  A  PVIYRDFKTSNILLD ++ AKLSDFGLAK  P+   
Sbjct: 240 WSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGK 299

Query: 254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
           THV+TRVMGTYGYAAPEY+ TGHLT+KSDVYSFGVVLLE+LTGRRSMDK RP  E NLV+
Sbjct: 300 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 359

Query: 314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           WA+P+L   RR   ++DPRL G +SVKGA+++  LA QC+S + K RPKM+ VV  L+ L
Sbjct: 360 WARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPL 419

Query: 374 LNLKDMA 380
            +LKDMA
Sbjct: 420 PHLKDMA 426

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  391 bits (1004), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 189/302 (62%), Positives = 237/302 (78%), Gaps = 5/302 (1%)

Query: 77  DLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLK---AQAVAVKLLDIE 133
           +L +F LSEL++ T+NF  + ++GEGGFG V KG+ID+      K      +AVK L+ E
Sbjct: 52  NLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQE 111

Query: 134 GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSL 193
           G QGHREWLAE+ +LGQL HP+LV+LIGYC E+E RLLVYEFM RGSLENHLF+R +   
Sbjct: 112 GFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQ 171

Query: 194 P--WGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG 251
           P  W TR+++A+GAA+GLAFLH A+  VIYRDFK SNILLDS++ AKLSDFGLA+ GP G
Sbjct: 172 PLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMG 231

Query: 252 SNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNL 311
            N+HV+TRVMGT GYAAPEY++TGHL+ KSDVYSFGVVLLELL+GRR++DK +P  E NL
Sbjct: 232 DNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNL 291

Query: 312 VDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
           VDWA+PYL + RRL  ++DPRL GQYS+  A ++AVLAL CIS++ K RP M  +V T+E
Sbjct: 292 VDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTME 351

Query: 372 SL 373
            L
Sbjct: 352 EL 353

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  387 bits (993), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 189/308 (61%), Positives = 236/308 (76%), Gaps = 5/308 (1%)

Query: 76  PDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLK---AQAVAVKLLDI 132
           P+L  F  +EL+A T+NF  + +LGEGGFG+V KG+ID+      K      +AVK L+ 
Sbjct: 52  PNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQ 111

Query: 133 EGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS 192
           +G QGH+EWLAEV +LGQ  HP+LV+LIGYC EDE RLLVYEFMPRGSLENHLF+R S  
Sbjct: 112 DGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYF 171

Query: 193 LP--WGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE 250
            P  W  RLK+A+GAAKGLAFLH AE  VIYRDFKTSNILLDS++ AKLSDFGLAK GP 
Sbjct: 172 QPLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPT 231

Query: 251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQN 310
           G  +HV+TR+MGTYGYAAPEY++TGHLTTKSDVYS+GVVLLE+L+GRR++DK RP  EQ 
Sbjct: 232 GDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQK 291

Query: 311 LVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL 370
           LV+WA+P L + R+L  ++D RL  QYS++ A ++A LAL+C++   K RP M  VV+ L
Sbjct: 292 LVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHL 351

Query: 371 ESLLNLKD 378
           E +  L +
Sbjct: 352 EHIQTLNE 359

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1

 Score =  385 bits (988), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 189/319 (59%), Positives = 237/319 (74%), Gaps = 6/319 (1%)

Query: 78  LYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDL--RQGLKAQAVAVKLLDIEG- 134
           L  F   EL+ IT NF  + +LG GGFG+V+KG+I +DL  ++  +   VAVK+ D +  
Sbjct: 61  LIAFTYEELKNITSNFRQDRVLGGGGFGSVYKGFIKEDLGDQEVPEPLPVAVKVHDGDNS 120

Query: 135 LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLP 194
            QGHREWLAEVIFLGQL HP+LV+LIGYCCED  R+L+YE+M RGS+EN+LF R+ + L 
Sbjct: 121 FQGHREWLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRVLLPLS 180

Query: 195 WGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT 254
           W  R+KIA GAAKGLAFLH A+ PVIYRDFKTSNILLD D+ AKLSDFGLAK GP G  +
Sbjct: 181 WAIRMKIAFGAAKGLAFLHEAKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDKS 240

Query: 255 HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW 314
           HV+TR+MGTYGYAAPEYI TGHLT  SDVYSFGVVLLELLTGR+S+DK RP  EQNL+DW
Sbjct: 241 HVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLIDW 300

Query: 315 AKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           A P L+  +++  IVDP++  +Y VK  ++ A+LA  C++ NPK RP M  +V +LE L 
Sbjct: 301 ALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQ 360

Query: 375 NLKDMAVSCGQWPATQKST 393
             ++ A+     P  QK+ 
Sbjct: 361 ATEEEALLV---PPVQKAV 376

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  382 bits (981), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 189/309 (61%), Positives = 238/309 (77%), Gaps = 11/309 (3%)

Query: 76  PDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQ------AVAVKL 129
           P+L  F  +EL++ T+NF  + +LGEGGFG V KG+ID+   + L A        +AVK 
Sbjct: 51  PNLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDE---KSLTASRPGTGLVIAVKK 107

Query: 130 LDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKR- 188
           L+ +G QGH+EWLAEV +LGQ  H HLV+LIGYC EDE RLLVYEFMPRGSLENHLF+R 
Sbjct: 108 LNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRG 167

Query: 189 -ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM 247
                L W  RLK+A+GAAKGLAFLH +E  VIYRDFKTSNILLDS++ AKLSDFGLAK 
Sbjct: 168 LYFQPLSWKLRLKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKD 227

Query: 248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKS 307
           GP G  +HV+TRVMGT+GYAAPEY++TGHLTTKSDVYSFGVVLLELL+GRR++DK RP  
Sbjct: 228 GPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSG 287

Query: 308 EQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
           E+NLV+WAKPYL + R++  ++D RL  QYS++ A ++A L+L+C++   K RP M+ VV
Sbjct: 288 ERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVV 347

Query: 368 ATLESLLNL 376
           + LE + +L
Sbjct: 348 SHLEHIQSL 356

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  382 bits (980), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 196/340 (57%), Positives = 241/340 (70%), Gaps = 14/340 (4%)

Query: 76  PDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA---VAVKLLDI 132
           P+L  F  +EL+  T+NF  + LLGEGGFG V KG+ID       K  +   VAVK L  
Sbjct: 66  PNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKT 125

Query: 133 EGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS 192
           EG QGH+EWL EV +LGQL HP+LV+L+GYC E E RLLVYEFMP+GSLENHLF+R +  
Sbjct: 126 EGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGAQP 185

Query: 193 LPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS 252
           L W  R+K+AIGAAKGL FLH A++ VIYRDFK +NILLD++F +KLSDFGLAK GP G 
Sbjct: 186 LTWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGD 245

Query: 253 NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV 312
            THV+T+VMGT+GYAAPEY++TG LT KSDVYSFGVVLLELL+GRR++DK +   EQ+LV
Sbjct: 246 KTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLV 305

Query: 313 DWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES 372
           DWA PYL   R+L  I+D RL GQY  KGA   A LALQC++ + K RPKM+ V+A L+ 
Sbjct: 306 DWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQ 365

Query: 373 LLNLKDMAVSCGQWPATQKSTRNGV--SPKATRGGNVRKS 410
           L + K         P T    R     SP+ + G  V+KS
Sbjct: 366 LESTK---------PGTGVGNRQAQIDSPRGSNGSIVQKS 396

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1

 Score =  375 bits (964), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 184/301 (61%), Positives = 225/301 (74%), Gaps = 3/301 (0%)

Query: 76  PDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA---VAVKLLDI 132
           P+L  F  +EL+  T+NF  + LLGEGGFG V KG+ID       +  +   VAVK L  
Sbjct: 69  PNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKP 128

Query: 133 EGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS 192
           EG QGH+EWL EV +LGQL HP+LV L+GYC E E RLLVYEFMP+GSLENHLF+R +  
Sbjct: 129 EGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGAQP 188

Query: 193 LPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS 252
           L W  R+K+A+GAAKGL FLH A++ VIYRDFK +NILLD+DF AKLSDFGLAK GP G 
Sbjct: 189 LTWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGD 248

Query: 253 NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV 312
           NTHV+T+V+GT+GYAAPEY++TG LT KSDVYSFGVVLLEL++GRR+MD     +E +LV
Sbjct: 249 NTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLV 308

Query: 313 DWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES 372
           DWA PYL   R+L  I+D +L GQY  KGA   A LALQC++ + K RPKM+ V+ TLE 
Sbjct: 309 DWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQ 368

Query: 373 L 373
           L
Sbjct: 369 L 369

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	419
359474773	424	PREDICTED: serine/threonine-protein kina	0.952	0.941	0.854	0.0
224071475	420	predicted protein [Populus trichocarpa]	0.990	0.988	0.827	0.0
255557737	421	receptor serine-threonine protein kinase	0.985	0.980	0.839	0.0
224138420	422	predicted protein [Populus trichocarpa]	0.985	0.978	0.828	0.0
147772215	415	hypothetical protein VITISV_022341 [Viti	0.945	0.954	0.849	0.0
356495262	420	PREDICTED: serine/threonine-protein kina	0.971	0.969	0.823	0.0
358248006	420	serine/threonine-protein kinase At5g0102	0.947	0.945	0.846	0.0
357484535	420	Protein kinase 2B [Medicago truncatula]	0.980	0.978	0.808	0.0
449462547	419	PREDICTED: serine/threonine-protein kina	0.945	0.945	0.809	0.0
15220535	424	protein kinase-like protein [Arabidopsis	0.957	0.945	0.767	0.0

>gi|359474773|ref|XP_002265959.2| PREDICTED: serine/threonine-protein kinase At5g01020-like [Vitis vinifera] gi|296085496|emb|CBI29228.3| unnamed protein product [Vitis vinifera]

 Score =  708 bits (1828), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 341/399 (85%), Positives = 372/399 (93%)

Query: 8   SKPWRPFTSKCCSAEGQIIFGNLSRCKTSRSDFSKNIAPMPSFRRLSFSDLSRSSSTRIN 67
           SKPWRPFT+ CCSAE   + GN SRC+ SRS+FSKNIAP+PSFRRLSFSDLSRSSSTR+N
Sbjct: 4   SKPWRPFTANCCSAEDHTVLGNFSRCRPSRSEFSKNIAPLPSFRRLSFSDLSRSSSTRVN 63

Query: 68  EDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAV 127
           EDLA +FGP+L+DFQLSELRAITQNFSSN+ LGEGGFGTVHKGYID++LRQGLKAQAVAV
Sbjct: 64  EDLAQSFGPELHDFQLSELRAITQNFSSNFFLGEGGFGTVHKGYIDENLRQGLKAQAVAV 123

Query: 128 KLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK 187
           KLLDIEGLQGHREWLAEVIFLGQLRHP+LV+LIGYCCED+ERLLVYEFMPRGSLENHLFK
Sbjct: 124 KLLDIEGLQGHREWLAEVIFLGQLRHPNLVKLIGYCCEDDERLLVYEFMPRGSLENHLFK 183

Query: 188 RISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM 247
           R+SVSLPWGTRLKIA+GAAKGLAFLHGAE PVIYRDFKTSN+LLDSDFTAKLSDFGLAKM
Sbjct: 184 RLSVSLPWGTRLKIAVGAAKGLAFLHGAEQPVIYRDFKTSNVLLDSDFTAKLSDFGLAKM 243

Query: 248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKS 307
           GPEGS +HVTTRVMGT+GYAAPEY+STGHLTTKSDVYSFGVVLLE+LTGRRSMDK RPK+
Sbjct: 244 GPEGSKSHVTTRVMGTFGYAAPEYVSTGHLTTKSDVYSFGVVLLEMLTGRRSMDKSRPKN 303

Query: 308 EQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
           EQNLVDW KPYL SSRRLRYI+DPRLAGQYSVKGAKE+A+LALQCIS NPKDRP+M  VV
Sbjct: 304 EQNLVDWTKPYLTSSRRLRYIMDPRLAGQYSVKGAKEIALLALQCISSNPKDRPRMPGVV 363

Query: 368 ATLESLLNLKDMAVSCGQWPATQKSTRNGVSPKATRGGN 406
            TLE L +L+DMAV+CGQWPAT KSTRNG + K  R  N
Sbjct: 364 ETLEGLQHLRDMAVTCGQWPATPKSTRNGAAVKGRRENN 402

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224071475|ref|XP_002303478.1| predicted protein [Populus trichocarpa] gi|222840910|gb|EEE78457.1| predicted protein [Populus trichocarpa]

 Score =  706 bits (1821), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 350/423 (82%), Positives = 387/423 (91%), Gaps = 8/423 (1%)

Query: 1   MRESSEPSKPWRPFTSKCCSAEGQIIFGNLSRCKTSRSDFSKNIAPMPSFRRLSFSDLSR 60
           MRESS   KPWRPFT+ CCS E Q  FGN SRC+TS+SD SK+IAP+PSFRRLSFSDLSR
Sbjct: 1   MRESS---KPWRPFTANCCSVEDQAFFGNYSRCRTSKSDVSKSIAPLPSFRRLSFSDLSR 57

Query: 61  SSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGL 120
           SSS RINEDLA TFGPDL+DFQLSELRAIT NFSS++LLGEGGFGTVHKGY+D++LRQGL
Sbjct: 58  SSSIRINEDLAQTFGPDLFDFQLSELRAITHNFSSSFLLGEGGFGTVHKGYVDNNLRQGL 117

Query: 121 KAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGS 180
           KAQAVAVKLLD+EGLQGHREWLAEVIFLGQLRH +LV+L+GYCCE+EERLLVYEFMPRGS
Sbjct: 118 KAQAVAVKLLDMEGLQGHREWLAEVIFLGQLRHSNLVKLLGYCCEEEERLLVYEFMPRGS 177

Query: 181 LENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS 240
           LENHLFKR+SVSLPWGTRLKIA GAAKGLAFLHGAE PVIYRDFKTSN+LLDSDFTAKLS
Sbjct: 178 LENHLFKRLSVSLPWGTRLKIATGAAKGLAFLHGAEKPVIYRDFKTSNVLLDSDFTAKLS 237

Query: 241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSM 300
           DFGLAKMGPEGS THVTTRVMGTYGYAAPEY+STGHLTT+SDVYSFGVVLLELLTGRR+ 
Sbjct: 238 DFGLAKMGPEGSETHVTTRVMGTYGYAAPEYVSTGHLTTQSDVYSFGVVLLELLTGRRAT 297

Query: 301 DKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDR 360
           D+ RPKSEQN++DWAKPYL SSRRLR I+DPRLAGQYSVKGAK MA+LALQCIS+NP+DR
Sbjct: 298 DRSRPKSEQNIIDWAKPYLTSSRRLRCIMDPRLAGQYSVKGAKHMALLALQCISLNPRDR 357

Query: 361 PKMAAVVATLESLLNLKDMAVSCGQWPATQKST-RNGVSPKA---TRGGNVRKSAPVTQN 416
           PKM ++V TLE+L + KDMAVSCGQW A+ KST RNGVSP+    +RG + RKSAPVT +
Sbjct: 358 PKMPSIVETLEALQHYKDMAVSCGQWQASPKSTARNGVSPRGRLESRGASYRKSAPVT-S 416

Query: 417 RKR 419
           RKR
Sbjct: 417 RKR 419

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255557737|ref|XP_002519898.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223540944|gb|EEF42502.1| receptor serine-threonine protein kinase, putative [Ricinus communis]

 Score =  704 bits (1818), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 351/418 (83%), Positives = 387/418 (92%), Gaps = 5/418 (1%)

Query: 6   EPSKPWRPFTSKCCSAEGQIIFGNLSRCKTSRSDFSKNIAPMPSFRRLSFSDLSRSSSTR 65
           + SK W+PFT+ CCSAE Q I GN SRCK S+SDFSKN+AP+PSFRRLSFSDLSRSSS R
Sbjct: 3   DSSKQWKPFTANCCSAEDQTILGNFSRCKPSKSDFSKNLAPLPSFRRLSFSDLSRSSSLR 62

Query: 66  INEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAV 125
           INED+A + GPDL+DFQLSEL+AITQNFSSNYLLGEGGFGTVHKGYID++LRQGLKAQAV
Sbjct: 63  INEDIAQSLGPDLFDFQLSELKAITQNFSSNYLLGEGGFGTVHKGYIDENLRQGLKAQAV 122

Query: 126 AVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHL 185
           AVKLLDIEGLQGHREWLAEVIFLGQLRHP+LV+LIGYCCEDEERLLVYEFMPRGSLENHL
Sbjct: 123 AVKLLDIEGLQGHREWLAEVIFLGQLRHPNLVKLIGYCCEDEERLLVYEFMPRGSLENHL 182

Query: 186 FKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA 245
           FKR+SVSLPWGTRLKIAIGAAKG+AFLHGAENPVIYRDFKTSN+LLDSDFTAKLSDFGLA
Sbjct: 183 FKRVSVSLPWGTRLKIAIGAAKGVAFLHGAENPVIYRDFKTSNVLLDSDFTAKLSDFGLA 242

Query: 246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRP 305
           KMGPEGS+THVTTRVMGTYGYAAPEY+STGHLTTKSDVYSFGVVLLELLTGRR+MDK RP
Sbjct: 243 KMGPEGSDTHVTTRVMGTYGYAAPEYVSTGHLTTKSDVYSFGVVLLELLTGRRAMDKCRP 302

Query: 306 KSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAA 365
           KSEQNL+DWAKPYL SSRRLRYI+DPRLAGQYSVKGAK++A+LALQCIS+NPKDRPKM A
Sbjct: 303 KSEQNLIDWAKPYLTSSRRLRYIMDPRLAGQYSVKGAKQVALLALQCISMNPKDRPKMPA 362

Query: 366 VVATLESLLNLKDMAVSCGQWPATQKSTRN-GVSPK----ATRGGNVRKSAPVTQNRK 418
           +V TLE+L   KDMAVSCGQWP + KS RN GVS +     +R  + +KS+PVTQ++K
Sbjct: 363 IVETLEALQTYKDMAVSCGQWPPSPKSKRNIGVSNQSRSLESRSSSYKKSSPVTQSKK 420

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224138420|ref|XP_002326598.1| predicted protein [Populus trichocarpa] gi|222833920|gb|EEE72397.1| predicted protein [Populus trichocarpa]

 Score =  698 bits (1802), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 347/419 (82%), Positives = 381/419 (90%), Gaps = 6/419 (1%)

Query: 6   EPSKPWRPFTSK-CCSAEGQIIFGNLSRCKTSRSDFSKNI-APMPSFRRLSFSDLSRSSS 63
           E S+PWRPFT+K CCS E Q  FGN SRC+TS+SD SKNI AP PSFRRLSFSDLSRSSS
Sbjct: 3   ESSQPWRPFTAKYCCSVEDQTFFGNFSRCRTSKSDISKNINAPAPSFRRLSFSDLSRSSS 62

Query: 64  TRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQ 123
           TRINE+LA +FGPDL+DFQLSELRAITQNFSSN+LLGEGGFGTVHKGY+DD+LRQGLKAQ
Sbjct: 63  TRINEELAQSFGPDLFDFQLSELRAITQNFSSNFLLGEGGFGTVHKGYVDDNLRQGLKAQ 122

Query: 124 AVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLEN 183
           AVAVKLLDIEGLQGHREWLAEVIFLGQLRHP+LV+LIGYCCE+EERLLVYEFMPRGSLEN
Sbjct: 123 AVAVKLLDIEGLQGHREWLAEVIFLGQLRHPNLVKLIGYCCEEEERLLVYEFMPRGSLEN 182

Query: 184 HLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFG 243
           HLFKRISVSLPW TRLKIAIGAAKGLAFLHGAE PVIYRDFKTSN+LLDSDFT KLSDFG
Sbjct: 183 HLFKRISVSLPWSTRLKIAIGAAKGLAFLHGAEKPVIYRDFKTSNVLLDSDFTVKLSDFG 242

Query: 244 LAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKL 303
           LAKMGPEGS+THVTTRVMGTYGYAAPEY+STGHLTTKSDV+SFGVVLLELLTGRR+ DK 
Sbjct: 243 LAKMGPEGSDTHVTTRVMGTYGYAAPEYVSTGHLTTKSDVFSFGVVLLELLTGRRATDKS 302

Query: 304 RPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKM 363
           RPK EQN++DWAKPYL SSRRLR I+DPRLAGQYSVKGAK+MA+LA QC+S+NPKDRPKM
Sbjct: 303 RPKREQNIIDWAKPYLTSSRRLRCIIDPRLAGQYSVKGAKQMALLARQCVSLNPKDRPKM 362

Query: 364 AAVVATLESLLNLKDMAVSCGQWPATQKS-TRNGVSPKAT---RGGNVRKSAPVTQNRK 418
            ++V TLE+L + KDMAV+CGQ  A+ KS TRNGVS       RG + RKSAPVT ++K
Sbjct: 363 PSIVETLEALQHYKDMAVACGQSQASTKSATRNGVSSGGRLEGRGASYRKSAPVTSSKK 421

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147772215|emb|CAN69043.1| hypothetical protein VITISV_022341 [Vitis vinifera]

 Score =  698 bits (1801), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/399 (84%), Positives = 370/399 (92%), Gaps = 3/399 (0%)

Query: 8   SKPWRPFTSKCCSAEGQIIFGNLSRCKTSRSDFSKNIAPMPSFRRLSFSDLSRSSSTRIN 67
           SKPWRPFT+ CCSAE   + GN SRC+ SRS+FSKNIAP+PSFRRLSFSDLSRSSSTR+N
Sbjct: 4   SKPWRPFTANCCSAEDHTVLGNFSRCRPSRSEFSKNIAPLPSFRRLSFSDLSRSSSTRVN 63

Query: 68  EDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAV 127
           EDLA +FGP+L+DFQLSELRAITQNFSSN+ LGEGGFGTVHKGYID++LRQGLKAQAVAV
Sbjct: 64  EDLAQSFGPELHDFQLSELRAITQNFSSNFFLGEGGFGTVHKGYIDENLRQGLKAQAVAV 123

Query: 128 KLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK 187
           KLLDIEGLQGHREWLAEVIFLGQLRHP+LV+LIGYCCED+ERLLVYEFMPRGSLENHLFK
Sbjct: 124 KLLDIEGLQGHREWLAEVIFLGQLRHPNLVKLIGYCCEDDERLLVYEFMPRGSLENHLFK 183

Query: 188 RISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM 247
              +SLPWGTRLKIA+GAAKGLAFLHGAE PVIYRDFKTSN+LLDSDFTAKLSDFGLAKM
Sbjct: 184 ---MSLPWGTRLKIAVGAAKGLAFLHGAEQPVIYRDFKTSNVLLDSDFTAKLSDFGLAKM 240

Query: 248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKS 307
           GPEGS +HVTTRVMGT+GYAAPEY+STGHLTTKSDVYSFGVVLLE+LTGRRSMDK RPK+
Sbjct: 241 GPEGSKSHVTTRVMGTFGYAAPEYVSTGHLTTKSDVYSFGVVLLEMLTGRRSMDKSRPKN 300

Query: 308 EQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
           EQNLVDWAKPYL SSRRLRYI+DPRLAGQYSVKGAKE+A+LALQCIS NPKDRP+M  VV
Sbjct: 301 EQNLVDWAKPYLTSSRRLRYIMDPRLAGQYSVKGAKEIALLALQCISSNPKDRPRMPGVV 360

Query: 368 ATLESLLNLKDMAVSCGQWPATQKSTRNGVSPKATRGGN 406
            TLE L +L+DMAV+CGQWPAT KSTRNG + K  R  N
Sbjct: 361 ETLEGLQHLRDMAVTCGQWPATPKSTRNGAAVKGRRENN 399

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356495262|ref|XP_003516498.1| PREDICTED: serine/threonine-protein kinase At5g01020-like [Glycine max]

 Score =  691 bits (1782), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 341/414 (82%), Positives = 371/414 (89%), Gaps = 7/414 (1%)

Query: 6   EPSKPWRPFTSKCCSAEGQIIFGNLSRCKTSRSDFSKNIAPMPSFRRLSFSDLSRSSSTR 65
           +PSKPWRPFT+ CCS E Q IF N SRCK SRSD SKNIAP+PSFRRLSFSDLSRSSSTR
Sbjct: 3   QPSKPWRPFTANCCSTEDQTIFKNFSRCKPSRSDLSKNIAPLPSFRRLSFSDLSRSSSTR 62

Query: 66  INEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAV 125
           INEDLA +FG DL+DFQLSELRAITQNFSSN+LLGEGGFGTVHKGYIDD+LR GLKAQ V
Sbjct: 63  INEDLAQSFGSDLFDFQLSELRAITQNFSSNFLLGEGGFGTVHKGYIDDNLRLGLKAQPV 122

Query: 126 AVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHL 185
           AVKLLDIEGLQGHREWLAEVIFLGQLRHP+LV+LIGYCCEDEERLLVYEFMPRGSLENHL
Sbjct: 123 AVKLLDIEGLQGHREWLAEVIFLGQLRHPNLVKLIGYCCEDEERLLVYEFMPRGSLENHL 182

Query: 186 FKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA 245
           F+R++ SLPWGTRLKIA GAAKGL+FLHGAE PVIYRDFKTSN+LLDS+FTAKLSDFGLA
Sbjct: 183 FRRLT-SLPWGTRLKIATGAAKGLSFLHGAEKPVIYRDFKTSNVLLDSEFTAKLSDFGLA 241

Query: 246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRP 305
           KMGPEGSNTHV+TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRR+ DK RP
Sbjct: 242 KMGPEGSNTHVSTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRATDKTRP 301

Query: 306 KSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAA 365
           K+EQNLVDW+KPYL SSRRLRYI+DPRL+GQYSVKGAKEMA LALQCIS+NPKDRP+M  
Sbjct: 302 KTEQNLVDWSKPYLSSSRRLRYIMDPRLSGQYSVKGAKEMAHLALQCISLNPKDRPRMPT 361

Query: 366 VVATLESLLNLKDMAVSCGQWPATQKSTRNGVSP------KATRGGNVRKSAPV 413
           +V TLE L   KDMAV+ G WP + KST+N VS       KA  G N ++ +PV
Sbjct: 362 IVETLEGLQQYKDMAVTSGHWPVSPKSTKNRVSNNNKVNVKARAGANHKQPSPV 415

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|358248006|ref|NP_001240045.1| serine/threonine-protein kinase At5g01020-like [Glycine max] gi|223452448|gb|ACM89551.1| protein kinase [Glycine max]

 Score =  686 bits (1771), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 337/398 (84%), Positives = 363/398 (91%), Gaps = 1/398 (0%)

Query: 1   MRESSEPSKPWRPFTSKCCSAEGQIIFGNLSRCKTSRSDFSKNIAPMPSFRRLSFSDLSR 60
           M++ S  SKPWRPFT+ CCS E Q IF N SRCK SRSD SKNIAP+PSFRRLSFSDLSR
Sbjct: 1   MKQPSSKSKPWRPFTANCCSTEDQTIFKNFSRCKPSRSDLSKNIAPLPSFRRLSFSDLSR 60

Query: 61  SSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGL 120
           SSSTRINEDLA +FG DL+DFQL ELRAITQNFSSN+LLGEGGFGTVHKGYIDD+LR GL
Sbjct: 61  SSSTRINEDLAQSFGSDLFDFQLIELRAITQNFSSNFLLGEGGFGTVHKGYIDDNLRLGL 120

Query: 121 KAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGS 180
           KAQ VAVKLLDIEGLQGHREWLAEVIFLGQLRHP+LV+LIGYCCEDEERLLVYEFMPRGS
Sbjct: 121 KAQPVAVKLLDIEGLQGHREWLAEVIFLGQLRHPNLVKLIGYCCEDEERLLVYEFMPRGS 180

Query: 181 LENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS 240
           LENHLF+R++ SLPWGTRLKIA GAAKGL+FLHGAE PVIYRDFKTSN+LLDSDFTAKLS
Sbjct: 181 LENHLFRRLT-SLPWGTRLKIATGAAKGLSFLHGAEKPVIYRDFKTSNVLLDSDFTAKLS 239

Query: 241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSM 300
           DFGLAKMGPEGSNTHV+TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRR+ 
Sbjct: 240 DFGLAKMGPEGSNTHVSTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRAT 299

Query: 301 DKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDR 360
           DK RPK+EQNLVDW+KPYL SSRRLRYI+DPRLAGQYSVKGAKEMA LALQCIS+NPKDR
Sbjct: 300 DKTRPKTEQNLVDWSKPYLSSSRRLRYIMDPRLAGQYSVKGAKEMAHLALQCISLNPKDR 359

Query: 361 PKMAAVVATLESLLNLKDMAVSCGQWPATQKSTRNGVS 398
           P+M  +V TLE L   KDMAV+ G WP + KST+N VS
Sbjct: 360 PRMPTIVETLEGLQQYKDMAVTSGHWPVSSKSTKNRVS 397

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357484535|ref|XP_003612555.1| Protein kinase 2B [Medicago truncatula] gi|355513890|gb|AES95513.1| Protein kinase 2B [Medicago truncatula]

 Score =  681 bits (1758), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 337/417 (80%), Positives = 369/417 (88%), Gaps = 6/417 (1%)

Query: 1   MRESSEPSKPWRPFTSKCCSAEGQIIFGNLSRCKTSRSDFSKNIAPMPSFRRLSFSDLSR 60
           M+E S  SKPWRPFTS CC+ E Q I  N S+CK SRSD+SKNIAP+PSFRRLSFSDLSR
Sbjct: 1   MKEPSN-SKPWRPFTSNCCTTENQTILRNFSKCKPSRSDYSKNIAPLPSFRRLSFSDLSR 59

Query: 61  SSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGL 120
           SSSTRINEDLA +FG DL+DFQLSELRAITQNFSSN+LLGEGGFGTVHKGY DD+ RQGL
Sbjct: 60  SSSTRINEDLALSFGSDLFDFQLSELRAITQNFSSNFLLGEGGFGTVHKGYFDDNFRQGL 119

Query: 121 KAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGS 180
           KAQ VAVKLLDIEGLQGHREWLAEVIFLGQLRHP+LV+LIGYCCEDEERLLVYEFMPRGS
Sbjct: 120 KAQPVAVKLLDIEGLQGHREWLAEVIFLGQLRHPNLVKLIGYCCEDEERLLVYEFMPRGS 179

Query: 181 LENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS 240
           LENHLF+R++ SLPW TR+KIAIGAAKGL+FLHGAE PVIYRDFKTSN+LLDSDFTAKLS
Sbjct: 180 LENHLFRRLT-SLPWATRIKIAIGAAKGLSFLHGAEKPVIYRDFKTSNVLLDSDFTAKLS 238

Query: 241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSM 300
           DFGLAKMGPEGS +HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRR+ 
Sbjct: 239 DFGLAKMGPEGSKSHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRAT 298

Query: 301 DKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDR 360
           DK RPK+EQN+VDW KPYL SSRRLRYI+DPRLAGQYSVKGAKE+A LALQCIS++PKDR
Sbjct: 299 DKTRPKTEQNIVDWTKPYLSSSRRLRYIMDPRLAGQYSVKGAKEIAHLALQCISLHPKDR 358

Query: 361 PKMAAVVATLESLLNLKDMAVSCGQWPATQKSTRNGVSPKATRGG----NVRKSAPV 413
           P+MA +V TLESL   KDMAV+ G WP + KST+N  S    +      N +K APV
Sbjct: 359 PRMAMIVETLESLEQFKDMAVTSGHWPISSKSTKNVSSNNKVKARAISVNQKKQAPV 415

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449462547|ref|XP_004149002.1| PREDICTED: serine/threonine-protein kinase At5g01020-like [Cucumis sativus] gi|449515025|ref|XP_004164550.1| PREDICTED: serine/threonine-protein kinase At5g01020-like [Cucumis sativus]

 Score =  657 bits (1694), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 322/398 (80%), Positives = 356/398 (89%), Gaps = 2/398 (0%)

Query: 6   EPSKPWRPFTSKCCSAEGQIIFGNLSRCKTSRSDFSKNIAPMPSFRRLSFSDLSRSSSTR 65
           E +K WRPFT+ CCSA+ Q  FGN SRC+ +RSDFSKNIAP+PSFRRLSFSDLSRSSS R
Sbjct: 3   ESTKTWRPFTANCCSADDQTAFGNFSRCRPNRSDFSKNIAPLPSFRRLSFSDLSRSSSMR 62

Query: 66  INEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAV 125
           +NEDLA +FG DL+DFQLSELRA+TQNFSSN+LLGEGGFG VHKGY+D++ R GL+AQAV
Sbjct: 63  LNEDLAASFGGDLFDFQLSELRAVTQNFSSNFLLGEGGFGRVHKGYVDENFRTGLRAQAV 122

Query: 126 AVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHL 185
           AVKLLD +GLQGHREWLAEV+FLGQLRHP+LV+LIGYCCE+EERLLVYEF+PRGSLENHL
Sbjct: 123 AVKLLDNQGLQGHREWLAEVVFLGQLRHPNLVKLIGYCCEEEERLLVYEFLPRGSLENHL 182

Query: 186 FKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA 245
           FKR+SVSLPW TRLKIAIGAAKGL FLHGAE PVIYRDFKTSN+LLDSDFTAKLSDFGLA
Sbjct: 183 FKRLSVSLPWSTRLKIAIGAAKGLDFLHGAEKPVIYRDFKTSNVLLDSDFTAKLSDFGLA 242

Query: 246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRP 305
           KMGPEGS+THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRR+MDK R 
Sbjct: 243 KMGPEGSDTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRAMDKSRA 302

Query: 306 KSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAA 365
           K++QNLVDWAKPYL SSRRL  I+DPRL GQYSVKGAK MA LALQ  S+NPKDRP+M A
Sbjct: 303 KNDQNLVDWAKPYLSSSRRLHCIMDPRLCGQYSVKGAKGMASLALQSTSLNPKDRPRMPA 362

Query: 366 VVATLESLLNLKDMAVSCGQWPATQ--KSTRNGVSPKA 401
           +V  LE+LL  KDMAV+ G W A+   K  RNGVS KA
Sbjct: 363 IVEALENLLQFKDMAVTSGHWSASASPKHARNGVSAKA 400

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15220535|ref|NP_176353.1| protein kinase-like protein [Arabidopsis thaliana] gi|4585873|gb|AAD25546.1|AC005850_3 Putative protein kinase [Arabidopsis thaliana] gi|17381261|gb|AAL36049.1| At1g61590/T25B24_6 [Arabidopsis thaliana] gi|20453381|gb|AAM19929.1| At1g61590/T25B24_6 [Arabidopsis thaliana] gi|332195739|gb|AEE33860.1| protein kinase-like protein [Arabidopsis thaliana]

 Score =  653 bits (1685), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 311/405 (76%), Positives = 355/405 (87%), Gaps = 4/405 (0%)

Query: 11  WRPFTSKCCSAEGQIIFGNLSRCKTSRSDFSKN-IAPMPSFRRLSFSDLSRSSSTRINED 69
           W+PF S CCS + Q +FGNLSRC+ SRS+FSKN + P+PSFRRLSF+DLSRSSS RINED
Sbjct: 16  WKPFASNCCSVDDQTVFGNLSRCRPSRSEFSKNHLGPLPSFRRLSFADLSRSSSARINED 75

Query: 70  LAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKL 129
           LA T G DL DFQ+ EL+ ITQ+FS NYLLGEGGFG V+KGY+DD LRQ LKAQ VAVKL
Sbjct: 76  LAQTLGADLVDFQMCELKMITQSFSGNYLLGEGGFGKVYKGYVDDYLRQSLKAQPVAVKL 135

Query: 130 LDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRI 189
           LDIEGLQGHREWL+EVIFLGQL+HP+LV+LIGYCCE+EER+L+YEFMPRGSLENHLF+RI
Sbjct: 136 LDIEGLQGHREWLSEVIFLGQLKHPNLVKLIGYCCEEEERVLIYEFMPRGSLENHLFRRI 195

Query: 190 SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP 249
           S+SLPW TRLKIA+ AAKGLAFLH  E+P+IYRDFKTSNILLDSDFTAKLSDFGLAKMGP
Sbjct: 196 SLSLPWATRLKIAVAAAKGLAFLHDLESPIIYRDFKTSNILLDSDFTAKLSDFGLAKMGP 255

Query: 250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQ 309
           EGS +HVTTRVMGTYGYAAPEY+STGHLTTKSDVYS+GVVLLELLTGRR+ +K RPK++Q
Sbjct: 256 EGSKSHVTTRVMGTYGYAAPEYVSTGHLTTKSDVYSYGVVLLELLTGRRATEKSRPKNQQ 315

Query: 310 NLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT 369
           N++DW+KPYL SSRRLR ++DPRLAGQYSVK AK+ A+LALQC+S NPKDRPKM AVV  
Sbjct: 316 NIIDWSKPYLTSSRRLRCVMDPRLAGQYSVKAAKDTALLALQCVSPNPKDRPKMLAVVEA 375

Query: 370 LESLLNLKDMAVSCGQWPATQKSTRNGVSPKATRGGNV--RKSAP 412
           LESL++ KDMAVS G WP + KS    VSPK  RG +   RKSAP
Sbjct: 376 LESLIHYKDMAVSSGHWPLSPKSQGGKVSPK-VRGDHRSGRKSAP 419

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	419
TAIR|locus:2200863	424	AT1G61590 [Arabidopsis thalian	0.973	0.962	0.725	5.7e-162
TAIR|locus:2064712	462	RIPK "RPM1-induced protein kin	0.821	0.744	0.668	1.6e-118
TAIR|locus:2150019	410	AT5G01020 [Arabidopsis thalian	0.756	0.773	0.675	5.2e-113
TAIR|locus:2057770	424	ARSK1 "root-specific kinase 1"	0.735	0.726	0.666	4.8e-110
TAIR|locus:2157101	494	AT5G35580 [Arabidopsis thalian	0.823	0.698	0.612	1e-109
TAIR|locus:2095517	453	AT3G28690 [Arabidopsis thalian	0.785	0.726	0.595	4.7e-103
TAIR|locus:2147805	493	AT5G15080 [Arabidopsis thalian	0.823	0.699	0.586	1.3e-102
TAIR|locus:2100282	490	AT3G01300 [Arabidopsis thalian	0.797	0.681	0.593	4.9e-101
TAIR|locus:2030185	450	AT1G72540 [Arabidopsis thalian	0.742	0.691	0.614	6.2e-101
TAIR|locus:2060167	442	AT2G07180 [Arabidopsis thalian	0.730	0.692	0.602	9.4e-98

TAIR|locus:2200863 AT1G61590 [Arabidopsis thaliana (taxid:3702)]

 Score = 1577 (560.2 bits), Expect = 5.7e-162, P = 5.7e-162
 Identities = 299/412 (72%), Positives = 344/412 (83%)

Query:     4 SSEPSKPWRPFTSKCCSAEGQIIFGNLSRCKTSRSDFSKN-IAPMPXXXXXXXXXXXXXX 62
             S++ S  W+PF S CCS + Q +FGNLSRC+ SRS+FSKN + P+P              
Sbjct:     9 STKSSPLWKPFASNCCSVDDQTVFGNLSRCRPSRSEFSKNHLGPLPSFRRLSFADLSRSS 68

Query:    63 XTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKA 122
               RINEDLA T G DL DFQ+ EL+ ITQ+FS NYLLGEGGFG V+KGY+DD LRQ LKA
Sbjct:    69 SARINEDLAQTLGADLVDFQMCELKMITQSFSGNYLLGEGGFGKVYKGYVDDYLRQSLKA 128

Query:   123 QAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLE 182
             Q VAVKLLDIEGLQGHREWL+EVIFLGQL+HP+LV+LIGYCCE+EER+L+YEFMPRGSLE
Sbjct:   129 QPVAVKLLDIEGLQGHREWLSEVIFLGQLKHPNLVKLIGYCCEEEERVLIYEFMPRGSLE 188

Query:   183 NHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF 242
             NHLF+RIS+SLPW TRLKIA+ AAKGLAFLH  E+P+IYRDFKTSNILLDSDFTAKLSDF
Sbjct:   189 NHLFRRISLSLPWATRLKIAVAAAKGLAFLHDLESPIIYRDFKTSNILLDSDFTAKLSDF 248

Query:   243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDK 302
             GLAKMGPEGS +HVTTRVMGTYGYAAPEY+STGHLTTKSDVYS+GVVLLELLTGRR+ +K
Sbjct:   249 GLAKMGPEGSKSHVTTRVMGTYGYAAPEYVSTGHLTTKSDVYSYGVVLLELLTGRRATEK 308

Query:   303 LRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK 362
              RPK++QN++DW+KPYL SSRRLR ++DPRLAGQYSVK AK+ A+LALQC+S NPKDRPK
Sbjct:   309 SRPKNQQNIIDWSKPYLTSSRRLRCVMDPRLAGQYSVKAAKDTALLALQCVSPNPKDRPK 368

Query:   363 MAAVVATLESLLNLKDMAVSCGQWPATQKSTRNGVSPKATRGGNV--RKSAP 412
             M AVV  LESL++ KDMAVS G WP + KS    VSPK  RG +   RKSAP
Sbjct:   369 MLAVVEALESLIHYKDMAVSSGHWPLSPKSQGGKVSPKV-RGDHRSGRKSAP 419

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2064712 RIPK "RPM1-induced protein kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 1167 (415.9 bits), Expect = 1.6e-118, P = 1.6e-118
 Identities = 232/347 (66%), Positives = 270/347 (77%)

Query:    66 INEDLAHTF-GPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA 124
             ++EDL+ +  G DL+ F L+EL+ ITQ+FSS   LGEGGFG VHKG+IDD LR GLKAQ 
Sbjct:    59 LSEDLSISLAGSDLHVFTLAELKVITQSFSSTNFLGEGGFGPVHKGFIDDKLRPGLKAQP 118

Query:   125 VAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENH 184
             VAVKLLD+EGLQGHREWL EV+FLGQL+H +LV+LIGYCCE+E R LVYEFMPRGSLEN 
Sbjct:   119 VAVKLLDLEGLQGHREWLTEVMFLGQLKHKNLVKLIGYCCEEEHRTLVYEFMPRGSLENQ 178

Query:   185 LFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL 244
             LF+R S SLPW TR+KIA GAA GL FLH AENPVIYRDFK SNILLDSD+TAKLSDFGL
Sbjct:   179 LFRRYSASLPWSTRMKIAHGAATGLQFLHEAENPVIYRDFKASNILLDSDYTAKLSDFGL 238

Query:   245 AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLR 304
             AK GPEG +THV+TRVMGT GYAAPEYI TGHLT +SDVYSFGVVLLELLTGRRS+DK R
Sbjct:   239 AKDGPEGDDTHVSTRVMGTQGYAAPEYIMTGHLTARSDVYSFGVVLLELLTGRRSVDKKR 298

Query:   305 PKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMA 364
                EQNLVDWA+P L   R+L  I+DPRL GQYS  GA++ A LA QC+S  PK+RP M+
Sbjct:   299 SSREQNLVDWARPMLNDPRKLSRIMDPRLEGQYSETGARKAATLAYQCLSHRPKNRPCMS 358

Query:   365 AVVATLESLLNLKDMAVSCGQWPATQKSTRNGVSPKATRGGNVRKSA 411
             AVV+ L  L +  D+ +  G +  T  +T +        G   RKS+
Sbjct:   359 AVVSILNDLKDYNDIPM--GTFTYTVPNTPDNKEDDGRVGNKPRKSS 403

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)]

 Score = 1115 (397.6 bits), Expect = 5.2e-113, P = 5.2e-113
 Identities = 214/317 (67%), Positives = 248/317 (78%)

Query:    81 FQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE 140
             F L EL  IT++F  +Y+LGEGGFGTV+KGYIDD+LR GLK+  VAVK+L+ EGLQGHRE
Sbjct:    57 FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHRE 116

Query:   141 WLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK 200
             WL EV FLGQLRHP+LV+LIGYCCED+ RLLVYEFM RGSLENHLF++ +  L W  R+ 
Sbjct:   117 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSRRMM 176

Query:   201 IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRV 260
             IA+GAAKGLAFLH AE PVIYRDFKTSNILLDSD+TAKLSDFGLAK GP+G  THV+TRV
Sbjct:   177 IALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 236

Query:   261 MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR 320
             MGTYGYAAPEY+ TGHLT +SDVYSFGVVLLE+LTGR+S+DK RP  EQNLVDWA+P L 
Sbjct:   237 MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLN 296

Query:   321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMA 380
               R+L  I+DPRL  QYSV+ A++   LA  C+S NPK RP M+ VV TLE L    D  
Sbjct:   297 DKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCTGDAL 356

Query:   381 VSCGQWPATQKSTRNGV 397
             + C    A       GV
Sbjct:   357 IPCATTTAGAAFAMGGV 373

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0009086 "methionine biosynthetic process" evidence=RCA

GO:0032880 "regulation of protein localization" evidence=RCA

TAIR|locus:2057770 ARSK1 "root-specific kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1087 (387.7 bits), Expect = 4.8e-110, P = 4.8e-110
 Identities = 206/309 (66%), Positives = 252/309 (81%)

Query:    66 INEDLAHTF-GPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA 124
             + +DL+H+F    L  F LSELR IT NFS + +LGEGGFG V+KG+IDD ++ G++AQ 
Sbjct:    60 VMDDLSHSFTSQKLRLFTLSELRVITHNFSRSNMLGEGGFGPVYKGFIDDKVKPGIEAQP 119

Query:   125 VAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENH 184
             VAVK LD+ G QGHREWLAE++FLGQL + HLV+LIG+CCE+E+R+LVYE+MPRGSLEN 
Sbjct:   120 VAVKALDLHGHQGHREWLAEILFLGQLSNKHLVKLIGFCCEEEQRVLVYEYMPRGSLENQ 179

Query:   185 LFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL 244
             LF+R S+++ WG R+KIA+GAAKGLAFLH AE PVIYRDFKTSNILLDSD+ AKLSDFGL
Sbjct:   180 LFRRNSLAMAWGIRMKIALGAAKGLAFLHEAEKPVIYRDFKTSNILLDSDYNAKLSDFGL 239

Query:   245 AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLR 304
             AK GPEG +THVTTRVMGT GYAAPEYI TGHLTT +DVYSFGVVLLEL+TG+RSMD  R
Sbjct:   240 AKDGPEGEHTHVTTRVMGTQGYAAPEYIMTGHLTTMNDVYSFGVVLLELITGKRSMDNTR 299

Query:   305 PKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMA 364
              + EQ+LV+WA+P LR  R+L  I+DPRLA Q+  + A+  A LA +C+S +PK RP M 
Sbjct:   300 TRREQSLVEWARPMLRDQRKLERIIDPRLANQHKTEAAQVAASLAYKCLSQHPKYRPTMC 359

Query:   365 AVVATLESL 373
              VV  LES+
Sbjct:   360 EVVKVLESI 368

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2157101 AT5G35580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1084 (386.6 bits), Expect = 1.0e-109, P = 1.0e-109
 Identities = 212/346 (61%), Positives = 259/346 (74%)

Query:    34 KTSRSDFSKNIAPMPXXXXXXXXXXXXXXXTRINEDLAHTF-GPDLYDFQLSELRAITQN 92
             KT + D  + I                   T ++EDL+ +  G DL+ F  +ELR ITQ+
Sbjct:    16 KTKKDDGERVITKQKSFLGLSILDISNPSSTTLSEDLSISLAGSDLHVFTQAELRVITQS 75

Query:    93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR 152
             FSS+  LGEGGFG VHKG+IDD LR GLKAQ VAVKLLD++GLQGHRE++ EV+ LG+L+
Sbjct:    76 FSSSNFLGEGGFGPVHKGFIDDKLRPGLKAQPVAVKLLDLDGLQGHREFMTEVMCLGKLK 135

Query:   153 HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
             HP+LV+LIGYCCE+  RLLVYEFMPRGSLE+ LF+R S+ LPW TRL IA  AAKGL FL
Sbjct:   136 HPNLVKLIGYCCEEAHRLLVYEFMPRGSLESQLFRRCSLPLPWTTRLNIAYEAAKGLQFL 195

Query:   213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
             H AE P+IYRDFK SNILLDSD+TAKLSDFGLAK GP+G +THV+TRVMGT GYAAPEYI
Sbjct:   196 HEAEKPIIYRDFKASNILLDSDYTAKLSDFGLAKDGPQGDDTHVSTRVMGTQGYAAPEYI 255

Query:   273 STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR 332
              TGHLT KSDVYSFGVVLLELLTGR+S+D  R   ++ LV+WA+P L  +R+L  I+DPR
Sbjct:   256 MTGHLTAKSDVYSFGVVLLELLTGRKSVDIARSSRKETLVEWARPMLNDARKLGRIMDPR 315

Query:   333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKD 378
             L  QYS  GA++ A LA QC+   PK RP ++ VV+ L+ + + KD
Sbjct:   316 LEDQYSETGARKAATLAYQCLRYRPKTRPDISTVVSVLQDIKDYKD 361

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)]

 Score = 1021 (364.5 bits), Expect = 4.7e-103, P = 4.7e-103
 Identities = 200/336 (59%), Positives = 251/336 (74%)

Query:    81 FQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLK---AQAVAVKLLDIEGLQG 137
             F  ++L+  T+NF    LLGEGGFG V KG+I+++    +K      VAVK L+ +GLQG
Sbjct:    91 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQG 150

Query:   138 HREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGT 197
             H+EWLAE+ FLG L HP LV+L+GYC E+++RLLVYEFMPRGSLENHLF+R ++ LPW  
Sbjct:   151 HKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLENHLFRR-TLPLPWSV 209

Query:   198 RLKIAIGAAKGLAFLHG-AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV 256
             R+KIA+GAAKGLAFLH  AE PVIYRDFKTSNILLD ++ AKLSDFGLAK  P+   +HV
Sbjct:   210 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEKKSHV 269

Query:   257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK 316
             +TRVMGTYGYAAPEY+ TGHLTTKSDVYSFGVVLLE+LTGRRS+DK RP  EQNLV+W +
Sbjct:   270 STRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSRPNGEQNLVEWVR 329

Query:   317 PYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL 376
             P+L   +R   ++DPRL G YS+KGA++   +A QC++ + K RPKM+ VV  L+ L NL
Sbjct:   330 PHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMSEVVEALKPLPNL 389

Query:   377 KDMAVSCGQWPATQKSTRNGVSPKATRGGNVRKSAP 412
             KD A S   +   Q   +NGV  +   GG V ++ P
Sbjct:   390 KDFASSSSSFQTMQPVAKNGVRTQG--GGFVSRNGP 423

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)]

 Score = 1017 (363.1 bits), Expect = 1.3e-102, P = 1.3e-102
 Identities = 207/353 (58%), Positives = 258/353 (73%)

Query:    66 INEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLK---A 122
             I+E+L       L  F  ++L+  T+NF    LLGEGGFG V KG+I+++    +K    
Sbjct:   117 ISEEL--NISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTG 174

Query:   123 QAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLE 182
               VAVK L+ +GLQGH+EWLAE+ FLG L HP+LV+L+GYC ED++RLLVYEFMPRGSLE
Sbjct:   175 LTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 234

Query:   183 NHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG-AENPVIYRDFKTSNILLDSDFTAKLSD 241
             NHLF+R S+ LPW  R+KIA+GAAKGL+FLH  A  PVIYRDFKTSNILLD+D+ AKLSD
Sbjct:   235 NHLFRR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSD 293

Query:   242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMD 301
             FGLAK  P+   THV+TRVMGTYGYAAPEY+ TGHLT+KSDVYSFGVVLLE+LTGRRSMD
Sbjct:   294 FGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 353

Query:   302 KLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP 361
             K RP  E NLV+WA+P+L   RR   ++DPRL G +S+KGA+++  LA QC+S +PK RP
Sbjct:   354 KNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRP 413

Query:   362 KMAAVVATLESLLNLKDMAVSCGQWPATQ-KSTRNGVSPKATRGGNVRKSAPV 413
             KM+ VV  L+ L +LKDMA S   +   Q +  +NG       G    +  PV
Sbjct:   414 KMSDVVEALKPLPHLKDMASSSYYFQTMQAERLKNGSGRSQGFGSRNGQHQPV 466

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)]

 Score = 1002 (357.8 bits), Expect = 4.9e-101, P = 4.9e-101
 Identities = 203/342 (59%), Positives = 252/342 (73%)

Query:    78 LYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLK---AQAVAVKLLDIEG 134
             L  F   +L+  T+NF    LLGEGGFG V KG+++++    +K      VAVK L+ +G
Sbjct:   121 LKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDG 180

Query:   135 LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLP 194
             LQGH+EWLAE+ +LG L HP+LV+L+GYC ED++RLLVYEFMPRGSLENHLF+R S+ LP
Sbjct:   181 LQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLP 239

Query:   195 WGTRLKIAIGAAKGLAFLHG-AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN 253
             W  R+KIA+GAAKGL+FLH  A  PVIYRDFKTSNILLD ++ AKLSDFGLAK  P+   
Sbjct:   240 WSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGK 299

Query:   254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
             THV+TRVMGTYGYAAPEY+ TGHLT+KSDVYSFGVVLLE+LTGRRSMDK RP  E NLV+
Sbjct:   300 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 359

Query:   314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
             WA+P+L   RR   ++DPRL G +SVKGA+++  LA QC+S + K RPKM+ VV  L+ L
Sbjct:   360 WARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPL 419

Query:   374 LNLKDMAVSCGQWPATQKSTR--NGVSPKATRGGNVRKSAPV 413
              +LKDMA S   +  T ++ R   G    + RG   R   PV
Sbjct:   420 PHLKDMA-SASYYFQTMQAERLKAGSGSGSGRGFGSRNGQPV 460

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2030185 AT1G72540 [Arabidopsis thaliana (taxid:3702)]

 Score = 1001 (357.4 bits), Expect = 6.2e-101, P = 6.2e-101
 Identities = 191/311 (61%), Positives = 240/311 (77%)

Query:    69 DLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK 128
             D +++F  +++ F   EL+ ITQ FS    LGEGGFG V+KG++DD L+ GLK Q VAVK
Sbjct:    60 DFSNSFFINIHIFTYEELKTITQGFSKYNFLGEGGFGEVYKGFVDDSLKTGLKDQPVAVK 119

Query:   129 LLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKR 188
              L  EG QGHREWLAEVI LGQL+HPHLV L+GYCCED+ERLLVYE+M RG+LE+HLF++
Sbjct:   120 ALKREGGQGHREWLAEVIILGQLKHPHLVNLVGYCCEDDERLLVYEYMERGNLEDHLFQK 179

Query:   189 ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG 248
                +LPW TR+KI +GAAKGL FLH  E PVIYRDFK SNILL SDF++KLSDFGLA  G
Sbjct:   180 YGGALPWLTRVKILLGAAKGLEFLHKQEKPVIYRDFKPSNILLSSDFSSKLSDFGLATDG 239

Query:   249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSE 308
              E  +++ T  VMGT GYAAPEYIS G+LTT SDV+SFGVVLLE+LT R++++K R +  
Sbjct:   240 SEEEDSNFTKSVMGTEGYAAPEYISAGNLTTMSDVFSFGVVLLEMLTARKAVEKYRAQRG 299

Query:   309 QNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA 368
             +NLV+WA+P L+   +L  I+DP L G+YSV+G ++ A LA QC+S NPK RP M  VV 
Sbjct:   300 RNLVEWARPMLKDPNKLERIIDPSLEGKYSVEGIRKAAALAYQCLSHNPKSRPTMTTVVK 359

Query:   369 TLESLLNLKDM 379
             TLE +L+LKD+
Sbjct:   360 TLEPILDLKDI 370

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2060167 AT2G07180 [Arabidopsis thaliana (taxid:3702)]

 Score = 971 (346.9 bits), Expect = 9.4e-98, P = 9.4e-98
 Identities = 185/307 (60%), Positives = 230/307 (74%)

Query:    68 EDLAHTFGPDLYD-FQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVA 126
             +DL    G +  D F   E++  T+ F  +Y+LGEGGFG V+KG ID+ +R G K+  VA
Sbjct:    64 KDLQSNPGYENVDIFTYEEMKIATKQFRPDYILGEGGFGVVYKGVIDESVRVGFKSTKVA 123

Query:   127 VKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLF 186
             +K L+ EG QG REWLAEV +LGQL HP+LV+LIGYCCED+ RLLVYE+M  GSLE HLF
Sbjct:   124 IKELNPEGFQGDREWLAEVNYLGQLSHPNLVKLIGYCCEDDHRLLVYEYMAMGSLEKHLF 183

Query:   187 KRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK 246
             +R+  +L W  R+KIA+ AAKGLAFLHGAE  +IYRD KT+NILLD  + AKLSDFGLAK
Sbjct:   184 RRVGCTLTWTKRMKIALDAAKGLAFLHGAERSIIYRDLKTANILLDEGYNAKLSDFGLAK 243

Query:   247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPK 306
              GP G  THV+TRVMGTYGYAAPEY+ TGHLT++SDVY FGV+LLE+L G+R+MDK R  
Sbjct:   244 DGPRGDQTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYGFGVLLLEMLLGKRAMDKSRAC 303

Query:   307 SEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
              E NLV+WA+P L  +++L  I+DPR+ GQY  K   ++A LA QC+S NPK RP M  V
Sbjct:   304 REHNLVEWARPLLNHNKKLLRIIDPRMDGQYGTKALMKVAGLAYQCLSQNPKGRPLMNHV 363

Query:   367 VATLESL 373
             V  LE+L
Sbjct:   364 VEVLETL 370

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00030778 hypothetical protein (420 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	419
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-58
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-58
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-56
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-53
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-52
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-49
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-47
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-38
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-38
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-33
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-31
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-30
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-29
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-28
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-28
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-28
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-27
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-27
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-27
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-27
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-26
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-26
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-25
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-25
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-25
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-24
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-24
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-24
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-24
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-24
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-23
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-23
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-23
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-23
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	9e-23
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-21
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-21
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-21
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-21
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-21
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-20
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-20
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-20
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-20
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-19
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-19
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-19
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-19
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-19
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-19
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-18
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-18
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-18
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-18
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-17
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-17
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	9e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-16
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-16
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-15
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-15
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-15
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-15
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-14
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	9e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-13
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-13
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-13
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-13
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-13
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-11
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-09
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	8e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-07
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	9e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.001
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.002

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  191 bits (489), Expect = 1e-58
 Identities = 87/274 (31%), Positives = 131/274 (47%), Gaps = 24/274 (8%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK-LLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LGEG FG V+KG +    +   K   VAVK L +    Q   E+L E   + +L HP++V
Sbjct: 7   LGEGAFGEVYKGTLKG--KGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +L+G C E+E  ++V E+MP G L ++L K     L     L  A+  A+G+ +L     
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--SK 122

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
             I+RD    N L+  +   K+SDFGL++   +     V         + APE +  G  
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPESLKEGKF 181

Query: 278 TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL-RYIVDPRLAGQ 336
           T+KSDV+SFGV+L E+ T         P    +  +    YL+   RL +    P     
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEE-----PYPGMSNAE-VLEYLKKGYRLPKPPNCP----- 230

Query: 337 YSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL 370
                  E+  L LQC + +P+DRP  + +V  L
Sbjct: 231 ------PELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  190 bits (485), Expect = 5e-58
 Identities = 86/273 (31%), Positives = 130/273 (47%), Gaps = 23/273 (8%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK-LLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LGEG FG V+KG +    + G K   VAVK L +    Q   E+L E   + +L HP++V
Sbjct: 7   LGEGAFGEVYKGKLKG--KGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +L+G C E+E   +V E+M  G L ++L K     L     L  A+  A+G+ +L     
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-LSLSDLLSFALQIARGMEYLE--SK 121

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
             I+RD    N L+  +   K+SDFGL++   +               + APE +  G  
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPESLKEGKF 180

Query: 278 TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQY 337
           T+KSDV+SFGV+L E+ T         P    +  +    YL++  RL     P+     
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLEYLKNGYRL-----PQPP--- 226

Query: 338 SVKGAKEMAVLALQCISVNPKDRPKMAAVVATL 370
                 E+  L LQC + +P+DRP  + +V  L
Sbjct: 227 --NCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  185 bits (473), Expect = 3e-56
 Identities = 85/280 (30%), Positives = 126/280 (45%), Gaps = 36/280 (12%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGHREWLAEVIFLGQLRHPHLV 157
           LGEG FG V+KG +  D         VAVK L      +   E+L E   + +L HP++V
Sbjct: 7   LGEGAFGEVYKGTLKGD--GEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHL-FKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           RL+G C + E   +V E+MP G L + L      ++L     L++A+  AKG+ +L    
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE--S 120

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT------RVMGTYGYAAPE 270
              ++RD    N L+  +   K+SDFGL++   E              + M      APE
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM------APE 174

Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
            +  G  T+KSDV+SFGV+L E+ T         P    +  +     L    RL     
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLELLEDGYRLPR--- 225

Query: 331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL 370
           P            E+  L LQC + +P+DRP  + +V  L
Sbjct: 226 PENCPD-------ELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  175 bits (446), Expect = 7e-53
 Identities = 73/198 (36%), Positives = 107/198 (54%), Gaps = 14/198 (7%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHLV 157
           LGEGGFGTV+        ++      VA+K++  E      E  L E+  L +L HP++V
Sbjct: 1   LGEGGFGTVYLARDKKTGKK------VAIKIIKKEDSSSLLEELLREIEILKKLNHPNIV 54

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +L G   ++    LV E+   GSL++ L K     L     L+I +   +GL +LH   N
Sbjct: 55  KLYGVFEDENHLYLVMEYCEGGSLKDLL-KENEGKLSEDEILRILLQILEGLEYLH--SN 111

Query: 218 PVIYRDFKTSNILLDSD-FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI-STG 275
            +I+RD K  NILLDSD    KL+DFGL+K+     +      ++GT  Y APE +   G
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLLGKG 169

Query: 276 HLTTKSDVYSFGVVLLEL 293
           + + KSD++S GV+L EL
Sbjct: 170 YYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  175 bits (447), Expect = 2e-52
 Identities = 92/287 (32%), Positives = 132/287 (45%), Gaps = 41/287 (14%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LGEG FG V+KG +        K   VAVK L +    +  +++L E   + +L HP++V
Sbjct: 3   LGEGAFGEVYKGKLKGK---DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISV-------SLPWGTRLKIAIGAAKGLA 210
           RL+G C E+E   LV E+M  G L ++L K   V       +L     L  AI  AKG+ 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT------RVMGTY 264
           +L       ++RD    N L+  D   K+SDFGL++   +       T      R M   
Sbjct: 120 YLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM--- 174

Query: 265 GYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
              APE +  G  T+KSDV+SFGV+L E+ T   +     P    +  +    YLR   R
Sbjct: 175 ---APESLKDGIFTSKSDVWSFGVLLWEIFTLGAT-----PYPGLSNEE-VLEYLRKGYR 225

Query: 325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
           L     P            E+  L L C  ++P+DRP  + +V  LE
Sbjct: 226 LP---KPEYCPD-------ELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  167 bits (424), Expect = 4e-49
 Identities = 94/282 (33%), Positives = 137/282 (48%), Gaps = 37/282 (13%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHL 156
           LG G FGTV+K             + VAVK+L       +  +    E+  L +L HP++
Sbjct: 7   LGSGSFGTVYKAKHKGT------GKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           VRLI    + +   LV E+   G L ++L +     L      KIA+   +GL +LH   
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLEYLH--S 116

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG- 275
           N +I+RD K  NILLD +   K++DFGLAK     S++ +TT V GT  Y APE +  G 
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGN 174

Query: 276 HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAG 335
               K DV+S GV+L ELLTG+       P S +N++D         + +R I+ P L  
Sbjct: 175 GYGPKVDVWSLGVILYELLTGK------PPFSGENILD-------QLQLIRRILGPPLEF 221

Query: 336 --QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
                  G++E   L  +C++ +P  RP       T E +L 
Sbjct: 222 DEPKWSSGSEEAKDLIKKCLNKDPSKRP-------TAEEILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  161 bits (411), Expect = 3e-47
 Identities = 70/201 (34%), Positives = 102/201 (50%), Gaps = 14/201 (6%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHL 156
            LGEG FG V+      D + G     VA+K++  + ++  RE  L E+  L +L+HP++
Sbjct: 6   KLGEGSFGKVYLAR---DKKTGKL---VAIKVIKKKKIKKDRERILREIKILKKLKHPNI 59

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           VRL     ++++  LV E+   G L + L KR  +S                L +LH   
Sbjct: 60  VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE--ARFYLRQILSALEYLH--S 115

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH 276
             +++RD K  NILLD D   KL+DFGLA+         +TT V GT  Y APE +    
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVLLGKG 172

Query: 277 LTTKSDVYSFGVVLLELLTGR 297
                D++S GV+L ELLTG+
Sbjct: 173 YGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  138 bits (350), Expect = 3e-38
 Identities = 68/207 (32%), Positives = 111/207 (53%), Gaps = 12/207 (5%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G+GGFG V+K       R G   + VA+K++ +E  +   + + E+  L + +HP++V+
Sbjct: 8   IGKGGFGEVYKAR---HKRTG---KEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
             G   + +E  +V EF   GSL++ L K  + +L       +     KGL +LH   N 
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLH--SNG 118

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
           +I+RD K +NILL SD   KL DFGL+    + S+T     ++GT  + APE I+     
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPYD 175

Query: 279 TKSDVYSFGVVLLELLTGRRSMDKLRP 305
            K+D++S G+  +EL  G+    +L P
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELPP 202

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  137 bits (347), Expect = 8e-38
 Identities = 66/210 (31%), Positives = 105/210 (50%), Gaps = 24/210 (11%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH--REWLAEVIFLGQLRHPH 155
           LLG G FG+V+      D   G   + +AVK +++ G           E+  L  L+HP+
Sbjct: 7   LLGRGSFGSVYLAL---DKDTG---ELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 156 LVRLIGYCCEDEER-LLVY-EFMPRGSLENHL--FKRISVSLPWGTRLKIAIGAA---KG 208
           +VR  G   ++E+  L ++ E++  GSL + L  F ++   +       I        +G
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV-------IRKYTRQILEG 113

Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LA+LH   N +++RD K +NIL+DSD   KL+DFG AK   +      T  V GT  + A
Sbjct: 114 LAYLH--SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171

Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLTGRR 298
           PE I        +D++S G  ++E+ TG+ 
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  124 bits (314), Expect = 6e-33
 Identities = 89/289 (30%), Positives = 131/289 (45%), Gaps = 29/289 (10%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHLV 157
           LGEG FG V     D  L      Q VAVK L+  G + HR ++  E+  L  L H ++V
Sbjct: 12  LGEGHFGKVELCRYDP-LGDNTGEQ-VAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 158 RLIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +  G C +   R   L+ E++P GSL ++L +R    +     L  +    KG+ +L   
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQICKGMDYLG-- 126

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT--RVMGTYGYAAPEYIS 273
               I+RD    NIL++S+   K+SDFGLAK+ PE  + +          + Y APE + 
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLR 185

Query: 274 TGHLTTKSDVYSFGVVLLELLT-GRRS-------MDKLRPKSEQNLVDWAKPYLRSSRRL 325
           T   ++ SDV+SFGV L EL T G  S       +  +     Q +V      L+   RL
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERL 245

Query: 326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                PR           E+  L   C    P+DRP  A ++  ++ L 
Sbjct: 246 -----PRPPSCPD-----EVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  121 bits (305), Expect = 8e-32
 Identities = 69/197 (35%), Positives = 103/197 (52%), Gaps = 11/197 (5%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V +G   + +R       VA+K+L  + L   +++  EV  L +LRH HL+ 
Sbjct: 14  LGSGYFGEVWEGLWKNRVR-------VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L   C   E   ++ E M +GSL   L       LP  + + +A   A+G+A+L   E  
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE--EQN 124

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
            I+RD    NIL+  D   K++DFGLA++  E        ++   Y + APE  S G  +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFS 182

Query: 279 TKSDVYSFGVVLLELLT 295
           TKSDV+SFG++L E+ T
Sbjct: 183 TKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  120 bits (303), Expect = 2e-31
 Identities = 71/209 (33%), Positives = 108/209 (51%), Gaps = 28/209 (13%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPH 155
           L+G G FG V+KG    +L  G     VA+K + +E +  +  +  + E+  L  L+HP+
Sbjct: 7   LIGRGAFGVVYKGL---NLETG---DFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 156 LVRLIGYCCEDEERL-LVYEFMPRGSLENHL--FKRISVSLPWGTRLKIAIGAA---KGL 209
           +V+ IG   E  + L ++ E+   GSL   +  F     SL       +A+      +GL
Sbjct: 61  IVKYIG-SIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-------VAVYVYQVLQGL 112

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAA 268
           A+LH  E  VI+RD K +NIL   D   KL+DFG+A K+     +      V+GT  + A
Sbjct: 113 AYLH--EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGTPYWMA 167

Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE I     +T SD++S G  ++ELLTG 
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  119 bits (300), Expect = 3e-31
 Identities = 80/286 (27%), Positives = 128/286 (44%), Gaps = 52/286 (18%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
            +G+G FG V  G          + Q VAVK L  +     + +LAE   +  LRHP+LV
Sbjct: 13  TIGKGEFGDVMLGD--------YRGQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLV 63

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +L+G   +     +V E+M +GSL ++L  R    +    +L  A+   +G+ +L   E 
Sbjct: 64  QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE--EK 121

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
             ++RD    N+L+  D  AK+SDFGLAK   E S    + ++     + APE +     
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKL--PVKWTAPEALREKKF 176

Query: 278 TTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQ 336
           +TKSDV+SFG++L E+ + GR                   PY R    L+ +V       
Sbjct: 177 STKSDVWSFGILLWEIYSFGR------------------VPYPRIP--LKDVVP------ 210

Query: 337 YSVKGAK---------EMAVLALQCISVNPKDRPKMAAVVATLESL 373
           +  KG +         E+  +   C  ++P  RP    +   L  +
Sbjct: 211 HVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  119 bits (298), Expect = 4e-30
 Identities = 81/284 (28%), Positives = 126/284 (44%), Gaps = 29/284 (10%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIFLGQLRHP 154
            LGEG FG V+              + VA+K+L  +     +E    L E+  L  L HP
Sbjct: 7   KLGEGSFGEVYLAR---------DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 155 -HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRIS-VSLPWGTRLKIAIGAAKGLAFL 212
            ++V+L  +  ++    LV E++  GSLE+ L K      L     L I       L +L
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 213 HGAENPVIYRDFKTSNILLDSD-FTAKLSDFGLAKM----GPEGSNTHVTTRVMGTYGYA 267
           H     +I+RD K  NILLD D    KL DFGLAK+    G   S   + +  +GT GY 
Sbjct: 118 H--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 268 APEYI---STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
           APE +   S  + ++ SD++S G+ L ELLTG    +  +  S  +           +  
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT-LKIILELPTPS 234

Query: 325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA 368
           L   + P      S   +     L  + ++ +PK+R   ++ ++
Sbjct: 235 LASPLSPSNPELISKAASD----LLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  115 bits (291), Expect = 9e-30
 Identities = 68/269 (25%), Positives = 114/269 (42%), Gaps = 33/269 (12%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HREWLAEVIFLGQLRHPH 155
            +G+G FG V+      D +         +K +D+  +      + L EV  L +L HP+
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKL------YVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 156 LVRLIGYCCEDEERLL-VYEFMPRGSLENHLFKRIS--VSLPWGTRLKIAIGAAKGLAFL 212
           +++      E++ +L  V E+   G L   + K+       P    L   +     L +L
Sbjct: 61  IIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119

Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
           H     +++RD K  NI L S+   KL DFG++K+    S   +   V+GT  Y +PE  
Sbjct: 120 H--SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPELC 175

Query: 273 STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR 332
                  KSD++S G VL EL T +   +    ++   L            + +Y   P 
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFEG---ENLLELA-------LKILKGQY---PP 222

Query: 333 LAGQYSVKGAKEMAVLALQCISVNPKDRP 361
           +  QYS     E+  L    +  +P++RP
Sbjct: 223 IPSQYS----SELRNLVSSLLQKDPEERP 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 2e-29
 Identities = 93/290 (32%), Positives = 132/290 (45%), Gaps = 58/290 (20%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LG G FG+V KG     L +  K   VAVK L       G +E+L E   + QL HP +V
Sbjct: 3   LGHGNFGSVVKGVY---LMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV 59

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKR--ISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           RLIG  C+ E  +LV E  P G L  +L KR  I VS       ++A   A G+A+L   
Sbjct: 60  RLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVS----DLKELAHQVAMGMAYLE-- 112

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTY--GYAAPEYI 272
               ++RD    N+LL +   AK+SDFG+++ +G    + +      G +   + APE I
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA--GSDYYRATTAGRWPLKWYAPECI 170

Query: 273 STGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPY-----------LR 320
           + G  ++KSDV+S+GV L E  + G                  AKPY           L 
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYG------------------AKPYGEMKGAEVIAMLE 212

Query: 321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL 370
           S  RL     PR          +E+  + L C    P+DRP  + + +T 
Sbjct: 213 SGERL-----PRPEE-----CPQEIYSIMLSCWKYRPEDRPTFSELESTF 252

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 2e-28
 Identities = 65/222 (29%), Positives = 108/222 (48%), Gaps = 20/222 (9%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQ-AVAVK-LLDIEGLQGHREWLAEVIFLGQLRHPHL 156
           LG G FGTV+KG    +     K +  VA+K L +    + ++E L E   +  + HPH+
Sbjct: 15  LGSGAFGTVYKGVWIPEGE---KVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHV 71

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RISVS--LPWGTRLKIAIGAAKGLAF 211
           VRL+G C    +  L+ + MP G L +++      I     L W  ++      AKG+++
Sbjct: 72  VRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSY 124

Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEY 271
           L   E  +++RD    N+L+ +    K++DFGLAK+       +          + A E 
Sbjct: 125 LE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 272 ISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLV 312
           I     T KSDV+S+GV + EL+T G +  + +      +L+
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 3e-28
 Identities = 79/285 (27%), Positives = 136/285 (47%), Gaps = 39/285 (13%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHLV 157
           +G G FG V +G +    ++ +    VA+K L        R ++L E   +GQ  HP+++
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEID---VAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           RL G   +    +++ E+M  GSL+  L +        G  + +  G A G+ +L  +E 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFL-RENDGKFTVGQLVGMLRGIASGMKYL--SEM 125

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG------YAAPEY 271
             ++RD    NIL++S+   K+SDFGL++   E S    TT+     G      + APE 
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSR-RLEDSEATYTTK-----GGKIPIRWTAPEA 179

Query: 272 ISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
           I+    T+ SDV+SFG+V+ E+++ G R    +   S Q+++      +    RL   +D
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM---SNQDVIK----AVEDGYRLPPPMD 232

Query: 331 -PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
            P    Q           L L C   +  +RP  + +V+TL+ ++
Sbjct: 233 CPSALYQ-----------LMLDCWQKDRNERPTFSQIVSTLDKMI 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  110 bits (277), Expect = 6e-28
 Identities = 76/284 (26%), Positives = 132/284 (46%), Gaps = 43/284 (15%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHL 156
            +G+G FG V+KG +  +         VAVK          +  +L E   L Q  HP++
Sbjct: 2   KIGKGNFGDVYKGVLKGNTE-------VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNI 54

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           V+LIG C + +   +V E +P GSL   L K+    L     L++++ AA G+ +L  ++
Sbjct: 55  VKLIGVCVQKQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLE-SK 112

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH 276
           N  I+RD    N L+  +   K+SDFG+++    G  T           + APE ++ G 
Sbjct: 113 N-CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171

Query: 277 LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR-SSRRLRYIVD----- 330
            T++SDV+S+G++L E  +   +                 PY   S+++ R  ++     
Sbjct: 172 YTSESDVWSYGILLWETFSLGDT-----------------PYPGMSNQQTRERIESGYRM 214

Query: 331 --PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES 372
             P+L         +E+  L LQC + +P++RP  + +   L+ 
Sbjct: 215 PAPQLC-------PEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  110 bits (276), Expect = 8e-28
 Identities = 70/278 (25%), Positives = 120/278 (43%), Gaps = 29/278 (10%)

Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HREWLAEVIFLG 149
           +F     +G+G FG V K     D       +  A+K +D+  +      E + E   L 
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKAD------KRVYAMKQIDLSKMNRREREEAIDEARVLA 54

Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
           +L   +++R      +  +  +V E+   G L   L  +    LP     +  I    GL
Sbjct: 55  KLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGL 114

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
           A LH     +++RD K+ N+ LD+    K+ D G+AK+     NT+    ++GT  Y +P
Sbjct: 115 AHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSP 170

Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
           E         KSDV++ GVVL E  TG+   D     ++  L+           R  +  
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA---NNQGALI-------LKIIRGVF-- 218

Query: 330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
            P ++  YS    +++A L  QC++ + + RP    ++
Sbjct: 219 -PPVSQMYS----QQLAQLIDQCLTKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  109 bits (276), Expect = 1e-27
 Identities = 75/208 (36%), Positives = 100/208 (48%), Gaps = 27/208 (12%)

Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIFLGQL 151
           LG+G FG V     K   D         +  A+K+L  + +   +E    L E   L ++
Sbjct: 1   LGKGSFGKVLLVRKK---DTG-------KLYAMKVLKKKKIIKRKEVEHTLTERNILSRI 50

Query: 152 RHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA-IGAAKGL 209
            HP +V+L  Y  + EE+L LV E+ P G L +HL K    S     R   A I  A  L
Sbjct: 51  NHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER-ARFYAAEIVLA--L 106

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
            +LH     +IYRD K  NILLD+D   KL+DFGLAK      +   T    GT  Y AP
Sbjct: 107 EYLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPEYLAP 162

Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGR 297
           E +         D +S GV+L E+LTG+
Sbjct: 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  115 bits (290), Expect = 1e-27
 Identities = 77/240 (32%), Positives = 119/240 (49%), Gaps = 21/240 (8%)

Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           +G+L+HP++V+LIG C  ++   L++E+     +E      +  +L W  R KIAIG AK
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEY-----IEGKNLSEVLRNLSWERRRKIAIGIAK 791

Query: 208 GLAFLHGAENP-VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
            L FLH   +P V+  +     I++D      L      ++   G     T   + +  Y
Sbjct: 792 ALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISS-AY 844

Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQN--LVDWAKPYLRSSRR 324
            APE   T  +T KSD+Y FG++L+ELLTG+   D    +   +  +V+WA+ Y  S   
Sbjct: 845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPAD---AEFGVHGSIVEWAR-YCYSDCH 900

Query: 325 LRYIVDPRLAGQYSVKGAK--EMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMAVS 382
           L   +DP + G  SV   +  E+  LAL C + +P  RP    V+ TLES        V+
Sbjct: 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCVT 960

Length = 968

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 4e-27
 Identities = 83/290 (28%), Positives = 127/290 (43%), Gaps = 35/290 (12%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLAEVIFLGQLRHP 154
           +LGEG FG+V +G +  D    LK   VAVK + ++    + E   +L+E   +    HP
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLK---VAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHP 61

Query: 155 HLVRLIGYCCEDEER------LLVYEFMPRGSLENHLFK-RI---SVSLPWGTRLKIAIG 204
           ++++LIG C E          +++  FM  G L + L   R+      LP  T LK  + 
Sbjct: 62  NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121

Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY 264
            A G+ +L  +    I+RD    N +L  D T  ++DFGL+K    G             
Sbjct: 122 IALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 265 GYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
            + A E ++    T+KSDV++FGV + E+ T  R            + D    YLR   R
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYD----YLRHGNR 233

Query: 325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           L+   D             E+  L   C   +PKDRP    +   LE++L
Sbjct: 234 LKQPED----------CLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 5e-27
 Identities = 81/291 (27%), Positives = 129/291 (44%), Gaps = 44/291 (15%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LG+G FG V++G     + +G     VA+K + +   ++   E+L E   + +    H+V
Sbjct: 14  LGQGSFGMVYEGLAKG-VVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKR-----ISVSLPWGTRLKI---AIGAAKGL 209
           RL+G     +  L+V E M +G L+++L  R      +  L   T  K    A   A G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
           A+L  A    ++RD    N ++  D T K+ DFG+ +   E        + +    + AP
Sbjct: 133 AYL--AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRY 327
           E +  G  TTKSDV+SFGVVL E+ T           +EQ       PY  L +   L++
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT----------LAEQ-------PYQGLSNEEVLKF 233

Query: 328 IVD------PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES 372
           ++D      P             +  L   C   NPK RP    +V++L+ 
Sbjct: 234 VIDGGHLDLPENCPDK-------LLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  106 bits (266), Expect = 3e-26
 Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 18/210 (8%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLV 157
           LGEG FG V+KG +     + L A +VA+K L      +  +E+  E   +  L+HP++V
Sbjct: 13  LGEGAFGKVYKGELTG-PNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKR--------------ISVSLPWGTRLKIAI 203
            L+G C +++   +++E++  G L   L +               +  SL     L IAI
Sbjct: 72  CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT 263
             A G+ +L  + +  ++RD    N L+    T K+SDFGL++         V ++ +  
Sbjct: 132 QIAAGMEYL--SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 264 YGYAAPEYISTGHLTTKSDVYSFGVVLLEL 293
             +  PE I  G  TT+SD++SFGVVL E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 3e-26
 Identities = 69/203 (33%), Positives = 100/203 (49%), Gaps = 18/203 (8%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  G  +   +       VAVK L   G      +L E   + +LRH  LV+
Sbjct: 14  LGAGQFGEVWMGTWNGTTK-------VAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQ 65

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L   C E+E   +V E+M +GSL + L       L     + +A   A+G+A+L      
Sbjct: 66  LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE--SRN 123

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT---YGYAAPEYISTG 275
            I+RD    NIL+  +   K++DFGLA++     +   T R  G      + APE  + G
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARL---IEDDEYTAR-EGAKFPIKWTAPEAANYG 179

Query: 276 HLTTKSDVYSFGVVLLELLT-GR 297
             T KSDV+SFG++L E++T GR
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  105 bits (264), Expect = 4e-26
 Identities = 82/284 (28%), Positives = 119/284 (41%), Gaps = 41/284 (14%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-HREWLAEVIFLGQLRHPHL 156
            LG+G FG V +G   +    G K   VAVK L  + L     ++L E   +  L H +L
Sbjct: 2   KLGDGSFGVVRRG---EWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL 58

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           +RL G        ++V E  P GSL + L K         T    A+  A G+ +L    
Sbjct: 59  IRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE--S 115

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT---RVMGTYGYAAPEYIS 273
              I+RD    NILL SD   K+ DFGL +  P+  + +V     +V   + + APE + 
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLR 173

Query: 274 TGHLTTKSDVYSFGVVLLELLT-------GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR 326
           T   +  SDV+ FGV L E+ T       G      L+       +D         +   
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK------KID---------KEGE 218

Query: 327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL 370
            +  P    Q       ++  + LQC + NP DRP  AA+   L
Sbjct: 219 RLERPEACPQ-------DIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  105 bits (265), Expect = 4e-26
 Identities = 80/269 (29%), Positives = 123/269 (45%), Gaps = 32/269 (11%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLV 157
           LG G  G V K             + +AVK + +E      ++ L E+  L +   P++V
Sbjct: 9   LGAGNSGVVSKVLHRPT------GKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIV 62

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
              G    + +  +  E+M  GSL+  + K +   +P     KIA+   KGL +LH    
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            +I+RD K SNIL++S    KL DFG++    +  N+   T V GT  Y APE I     
Sbjct: 122 -IIHRDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFV-GTSSYMAPERIQGNDY 176

Query: 278 TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD---PRL- 333
           + KSD++S G+ L+EL TGR                   P       L+YIV+   PRL 
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPP-----------ENDPPDGIFELLQYIVNEPPPRLP 225

Query: 334 AGQYSVKGAKEMAVLALQCISVNPKDRPK 362
           +G++S     +       C+  +P++RP 
Sbjct: 226 SGKFS----PDFQDFVNLCLIKDPRERPS 250

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  105 bits (263), Expect = 1e-25
 Identities = 92/295 (31%), Positives = 133/295 (45%), Gaps = 24/295 (8%)

Query: 93  FSSNYL-----LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVI 146
           F   YL     LGEG FG V   Y  D    G   + VAVK L  E  Q +   W  E+ 
Sbjct: 1   FHKRYLKKIRVLGEGHFGKVSL-YCYDPANDG-TGEMVAVKTLKRECGQQNTSGWKKEIN 58

Query: 147 FLGQLRHPHLVRLIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIG 204
            L  L H ++V+  G C E   +   L+ E++P GSL ++L K   ++L     L  A  
Sbjct: 59  ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNL--AQLLLFAQQ 115

Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM--- 261
             +G+A+LH      I+RD    N+LLD+D   K+ DFGLAK  PEG   H   RV    
Sbjct: 116 ICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG---HEYYRVREDG 170

Query: 262 -GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR 320
                + A E +     +  SDV+SFGV L ELLT   S      K E+ +    K    
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI--GPKQGQM 228

Query: 321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           +  RL  +++  +         +E+ +L   C     K RP   +++  L+ + +
Sbjct: 229 TVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  104 bits (261), Expect = 1e-25
 Identities = 80/275 (29%), Positives = 130/275 (47%), Gaps = 34/275 (12%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG V  GY  +        + VA+K +  EG     +++ E   + +L HP LV+
Sbjct: 12  IGSGQFGLVWLGYWLEK-------RKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQ 63

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G C E     LV+EFM  G L ++L  +        T L + +   +G+A+L    + 
Sbjct: 64  LYGVCTERSPICLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLE--SSN 120

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT---YGYAAPEYISTG 275
           VI+RD    N L+  +   K+SDFG+ +   +   T  T    GT     +++PE  S  
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFS 176

Query: 276 HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAG 335
             ++KSDV+SFGV++ E+ +  ++  + R  SE  +V+     + +  RL     PRLA 
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVE----TINAGFRL---YKPRLAS 227

Query: 336 QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL 370
           Q   +       L   C    P+DRP  + ++  L
Sbjct: 228 QSVYE-------LMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  104 bits (260), Expect = 2e-25
 Identities = 93/290 (32%), Positives = 134/290 (46%), Gaps = 42/290 (14%)

Query: 98  LLGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLLD-IEGLQGHREWLAEVIFLGQLRHPH 155
           ++G+G FG V+ G  ID D ++       AVK L+ I  L+   ++L E I +    HP+
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQK----IHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPN 57

Query: 156 LVRLIGYCCEDE-ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIG----AAKGLA 210
           ++ L+G C   E   L+V  +M  G L N  F R     P    +K  IG     AKG+ 
Sbjct: 58  VLSLLGICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNP---TVKDLIGFGLQVAKGME 112

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAA 268
           +L  A    ++RD    N +LD  FT K++DFGLA+     E  + H  T       + A
Sbjct: 113 YL--ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170

Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR-- 326
            E + T   TTKSDV+SFGV+L EL+T         P  + +  D    YL   RRL   
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVDSFDITV-YLLQGRRLLQP 224

Query: 327 -YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            Y  DP     Y V          L C    P+ RP  + +V+ +E + +
Sbjct: 225 EYCPDP----LYEV---------MLSCWHPKPEMRPTFSELVSRIEQIFS 261

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  104 bits (262), Expect = 2e-25
 Identities = 83/289 (28%), Positives = 131/289 (45%), Gaps = 42/289 (14%)

Query: 99  LGEGGFGTVH-------KGYIDDDLRQGLKAQA---VAVKLL----DIEGLQGHREWLAE 144
           LGEG FG VH       + + +    +   A A   VAVK+L         +   ++L E
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE---DFLKE 69

Query: 145 VIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRI---------SVSLPW 195
           V  L +L  P++ RL+G C  D    ++ E+M  G L   L K +         S SL +
Sbjct: 70  VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129

Query: 196 GTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH 255
            T L +A   A G+ +L       ++RD  T N L+  ++T K++DFG+++         
Sbjct: 130 STLLYMATQIASGMRYL--ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYR 187

Query: 256 VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSE---QNLV 312
           V  R      + A E +  G  TTKSDV++FGV L E+LT    + + +P      Q ++
Sbjct: 188 VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT----LCREQPYEHLTDQQVI 243

Query: 313 DWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP 361
           + A  + R   R  Y+  P           K++  L L+C   + +DRP
Sbjct: 244 ENAGHFFRDDGRQIYLPRPPNC-------PKDIYELMLECWRRDEEDRP 285

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  103 bits (259), Expect = 2e-25
 Identities = 83/277 (29%), Positives = 126/277 (45%), Gaps = 36/277 (12%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  GY +           VA+K L  +G      +LAE   + QL+HP LVR
Sbjct: 14  LGAGQFGEVWMGYYNGH-------TKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVR 65

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     + E   ++ E+M  GSL + L     + L     + +A   A+G+AF+      
Sbjct: 66  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE--RKN 122

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +NIL+      K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGT 179

Query: 277 LTTKSDVYSFGVVLLELLT-GRRSMDKLR-PKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
            T KSDV+SFG++L E++T GR     +  P+  QNL            R   +  P   
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-----------ERGYRMPRPDNC 228

Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
            +       E+  L   C    P++RP    + + LE
Sbjct: 229 PE-------ELYELMRLCWKEKPEERPTFEYLRSVLE 258

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  102 bits (256), Expect = 1e-24
 Identities = 65/228 (28%), Positives = 98/228 (42%), Gaps = 44/228 (19%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-------QGHREWLAEVIFLGQ 150
           ++GEG F TV      +  ++       A+K+LD   L           E       L +
Sbjct: 8   IIGEGSFSTVVLAKEKETNKE------YAIKILDKRQLIKEKKVKYVKIEKEV----LTR 57

Query: 151 L-RHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA-IGAAK 207
           L  HP +++L  Y  +DEE L  V E+ P G L  ++ K  S+     TR   A I    
Sbjct: 58  LNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRFYAAEI--LL 113

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVM----- 261
            L +LH     +I+RD K  NILLD D   K++DFG AK + P  S              
Sbjct: 114 ALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 262 ------------GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
                       GT  Y +PE ++       SD+++ G ++ ++LTG+
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  101 bits (254), Expect = 1e-24
 Identities = 75/274 (27%), Positives = 124/274 (45%), Gaps = 45/274 (16%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA---EVIFLGQLRHPH 155
           LG+G  G V+K       R     +  A+K + ++G +  R+ L    + +   +   P+
Sbjct: 9   LGQGSSGVVYKV------RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE--SPY 60

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK-IAIGAAKGLAFLHG 214
           +V+  G   ++ E  +V E+M  GSL + L K   +  P    L  IA    KGL +LH 
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPV---LAYIARQILKGLDYLHT 117

Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM---GPEGSNTHVTTRVMGTYGYAAPEY 271
             + +I+RD K SN+L++S    K++DFG++K+     +  NT V     GT  Y +PE 
Sbjct: 118 KRH-IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPER 171

Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD- 330
           I     +  +D++S G+ LLE   G+       P        + +        ++ I D 
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGK------FPFLPPGQPSFFE-------LMQAICDG 218

Query: 331 --PRL-AGQYSVKGAKEMAVLALQCISVNPKDRP 361
             P L A ++S     E       C+  +PK RP
Sbjct: 219 PPPSLPAEEFS----PEFRDFISACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  101 bits (254), Expect = 2e-24
 Identities = 85/306 (27%), Positives = 144/306 (47%), Gaps = 46/306 (15%)

Query: 99  LGEGGFGTVHKGYIDD-----------DLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVI 146
           LGEG FG VH   + +           ++R+G +   VAVK+L  +  +  R ++L EV 
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG-RPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 147 FLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRI--------------SVS 192
            L +L+ P+++RL+G C +++   ++ E+M  G L   L                  +  
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 193 LP---WGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP 249
           LP   + + L +A+  A G+ +L  +    ++RD  T N L+  + T K++DFG+++   
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL--SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSE- 308
            G    +  R +    + A E I  G  TT SDV++FGV L E+L     + K +P  E 
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL----MLCKEQPYGEL 245

Query: 309 --QNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
             + +++ A  + R   R  Y+  P    Q    G  E   L LQC S + ++RP  + +
Sbjct: 246 TDEQVIENAGEFFRDQGRQVYLFRPPPCPQ----GLYE---LMLQCWSRDCRERPSFSDI 298

Query: 367 VATLES 372
            A L  
Sbjct: 299 HAFLTE 304

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score =  101 bits (252), Expect = 3e-24
 Identities = 74/241 (30%), Positives = 122/241 (50%), Gaps = 27/241 (11%)

Query: 81  FQLSELRAITQNFSSNYLLGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLL-DIEGLQGH 138
            + +ELR +        LLG G FGTVHKG +I +     +K   VA+K + D  G Q  
Sbjct: 4   LKETELRKLK-------LLGSGVFGTVHKGIWIPEG--DSIKI-PVAIKTIQDRSGRQTF 53

Query: 139 REWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK-RISVS----L 193
           +E    ++ +G L H ++VRL+G  C      LV +  P GSL +H+ + R S+     L
Sbjct: 54  QEITDHMLAMGSLDHAYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLL 112

Query: 194 PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN 253
            W  ++      AKG+ +L   E+ +++R+    NILL SD   +++DFG+A +      
Sbjct: 113 NWCVQI------AKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164

Query: 254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLV 312
            +  +       + A E I  G  T +SDV+S+GV + E+++ G      +RP    +L+
Sbjct: 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224

Query: 313 D 313
           +
Sbjct: 225 E 225

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  100 bits (250), Expect = 5e-24
 Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 11/199 (5%)

Query: 98  LLGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPH 155
            +GEG FG V++G Y+     +  K  AVAVK          RE +L E   + Q  HPH
Sbjct: 13  CIGEGQFGDVYQGVYMS---PENEKI-AVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +V+LIG    +    +V E  P G L ++L      SL   + +  +   +  LA+L   
Sbjct: 69  IVKLIG-VITENPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESK 126

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
               ++RD    N+L+ S    KL DFGL++   + S     ++      + APE I+  
Sbjct: 127 R--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFR 183

Query: 276 HLTTKSDVYSFGVVLLELL 294
             T+ SDV+ FGV + E+L
Sbjct: 184 RFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 99.4 bits (248), Expect = 7e-24
 Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 26/205 (12%)

Query: 99  LGEGGFGTVHKGY----IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG VH G     ID           VA+K++  EG     +++ E   + +L HP
Sbjct: 12  LGSGQFGVVHLGKWRGKID-----------VAIKMIR-EGAMSEDDFIEEAKVMMKLSHP 59

Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
           +LV+L G C +     +V E+M  G L N+L +R    L     L +     + + +L  
Sbjct: 60  NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLE- 117

Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT---YGYAAPEY 271
             N  I+RD    N L+  D   K+SDFGLA+   +   T       GT     +A PE 
Sbjct: 118 -SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEV 172

Query: 272 ISTGHLTTKSDVYSFGVVLLELLTG 296
                 ++KSDV+SFGV++ E+ + 
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 99.3 bits (247), Expect = 7e-24
 Identities = 66/209 (31%), Positives = 109/209 (52%), Gaps = 25/209 (11%)

Query: 99  LGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLL--DIEGLQGHREWLAEVIFLGQLRHPH 155
           +GEG FG V +G Y           Q VAVK +  D+      + +L E   + +L H +
Sbjct: 14  IGEGEFGAVLQGEYT---------GQKVAVKNIKCDVTA----QAFLEETAVMTKLHHKN 60

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LVRL+G    +    +V E M +G+L N L  R    +     L+ ++  A+G+ +L   
Sbjct: 61  LVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK 119

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +++RD    NIL+  D  AK+SDFGLA++G  G +    +++     + APE +   
Sbjct: 120 K--LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD---NSKL--PVKWTAPEALKHK 172

Query: 276 HLTTKSDVYSFGVVLLELLT-GRRSMDKL 303
             ++KSDV+S+GV+L E+ + GR    K+
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 99.7 bits (248), Expect = 1e-23
 Identities = 81/286 (28%), Positives = 139/286 (48%), Gaps = 37/286 (12%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQA---------VAVKLLDIEGLQGHR-EWLAEVIFL 148
           LGEG FG VH    +  L + L   A         VAVK+L  +  +  R ++L E+  +
Sbjct: 13  LGEGQFGEVHLCEAEG-LAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKR-------ISVSLPWGTR--- 198
            +L++P+++RL+G C  D+   ++ E+M  G L   L +R        + ++P  +    
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT 258
           L +A+  A G+ +L  A    ++RD  T N L+ + +T K++DFG+++    G    +  
Sbjct: 132 LYMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189

Query: 259 RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKS---EQNLVDWA 315
           R +    + A E I  G  TT SDV++FGV L E+ T    + K +P S   ++ +++  
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT----LCKEQPYSLLSDEQVIENT 245

Query: 316 KPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP 361
             + R+  R  Y+    L      K       L ++C S + KDRP
Sbjct: 246 GEFFRNQGRQIYLSQTPLCPSPVFK-------LMMRCWSRDIKDRP 284

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 99.4 bits (248), Expect = 1e-23
 Identities = 79/277 (28%), Positives = 119/277 (42%), Gaps = 39/277 (14%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LGEG  G+V K  +    +      A+     D       ++ L E+      + P++V+
Sbjct: 9   LGEGAGGSVTKCRL----KNTGMIFALKTITTD-PNPDLQKQILRELEINKSCKSPYIVK 63

Query: 159 LIGYCCEDEERLL--VYEFMPRGSLENHLFKRISVSLPWGTR------LKIAIGAAKGLA 210
             G   ++    +    E+   GSL++ ++K++      G R       KIA    KGL+
Sbjct: 64  YYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKV---KKRGGRIGEKVLGKIAESVLKGLS 119

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           +LH     +I+RD K SNILL      KL DFG++    E  N+   T   GT  Y APE
Sbjct: 120 YLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG---ELVNSLAGTFT-GTSFYMAPE 173

Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
            I     +  SDV+S G+ LLE+   R       P+ E  L     P       L YIV+
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLG----PI----ELLSYIVN 222

Query: 331 ---PRLAGQYS--VKGAKEMAVLALQCISVNPKDRPK 362
              P L  +    +K ++E      QC+  +P  RP 
Sbjct: 223 MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT 259

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 98.5 bits (245), Expect = 1e-23
 Identities = 73/201 (36%), Positives = 110/201 (54%), Gaps = 19/201 (9%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G+G FG V  G    D R G K   VAVK   I+     + +LAE   + QLRH +LV+
Sbjct: 14  IGKGEFGDVMLG----DYR-GNK---VAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQ 63

Query: 159 LIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           L+G   E++  L +V E+M +GSL ++L  R    L     LK ++   + + +L    N
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA--N 121

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
             ++RD    N+L+  D  AK+SDFGL K   E S+T  T ++     + APE +     
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKF 176

Query: 278 TTKSDVYSFGVVLLELLT-GR 297
           +TKSDV+SFG++L E+ + GR
Sbjct: 177 STKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 97.9 bits (245), Expect = 3e-23
 Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 23/206 (11%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL----DIEGLQGHREWLAEVIFLGQLRHP 154
           LGEG +G V+K     D + G   + VA+K +    + EG+      L E+  L +L+HP
Sbjct: 7   LGEGTYGVVYKAR---DKKTG---EIVALKKIRLDNEEEGIP--STALREISLLKELKHP 58

Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
           ++V+L+     + +  LV+E+     L+ +L  +    L       I     +GLA+ H 
Sbjct: 59  NIVKLLDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIKSIMYQLLRGLAYCH- 115

Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAAPEYI 272
             + +++RD K  NIL++ D   KL+DFGLA+    P  + TH    V+ T  Y APE +
Sbjct: 116 -SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH---EVV-TLWYRAPEIL 170

Query: 273 -STGHLTTKSDVYSFGVVLLELLTGR 297
             + H +T  D++S G +  E++TG+
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 97.6 bits (243), Expect = 4e-23
 Identities = 70/211 (33%), Positives = 103/211 (48%), Gaps = 17/211 (8%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHL 156
            LG G FG V++G   D L  G     VAVK L      Q  +E+L E   +    HP++
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFK-RISVSLPWGTRLK----IAIGAAKGLAF 211
           V+L+G C  +E + ++ E M  G L ++L   R+    P    LK    I +  AKG  +
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 212 LHGAENPVIYRDFKTSNILL-----DSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG- 265
           L   +   I+RD    N L+     D+D   K+ DFGLA+      + +      G    
Sbjct: 122 LE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--DIYKSDYYRKEGEGLLPV 177

Query: 266 -YAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
            + APE +  G  TT+SDV+SFGV++ E+LT
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 97.0 bits (242), Expect = 6e-23
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 37/217 (17%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HREWLAEVIFLGQLRHPHL 156
           +G G FG V+      +L  G   + +AVK + I+       +E   E+  L  L+HP+L
Sbjct: 8   IGGGTFGKVYTAV---NLDTG---ELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNL 61

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLEN----------HLFKRISVSLPWGTRLKIAIGAA 206
           V+  G     E+  +  E+   G+LE           H+ +  ++ L             
Sbjct: 62  VKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL------------L 109

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT--RVMGTY 264
           +GLA+LH   + +++RD K +NI LD +   KL DFG A      + T       + GT 
Sbjct: 110 EGLAYLH--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTP 167

Query: 265 GYAAPEYISTGHLTTK---SDVYSFGVVLLELLTGRR 298
            Y APE I+ G        +D++S G V+LE+ TG+R
Sbjct: 168 AYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 97.1 bits (242), Expect = 7e-23
 Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 16/210 (7%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LGEG FG V  G       +  K   VAVK L +       +++  E   L   +H ++V
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKEL-VAVKTLKETASNDARKDFEREAELLTNFQHENIV 71

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHL------FKRISVSLPWGTRL------KIAIGA 205
           +  G C E +  ++V+E+M  G L   L         +         L      +IA+  
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
           A G+ +L  A    ++RD  T N L+  D   K+ DFG+++         V    M    
Sbjct: 132 ASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189

Query: 266 YAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
           +  PE I     TT+SDV+SFGVVL E+ T
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 97.3 bits (242), Expect = 7e-23
 Identities = 79/292 (27%), Positives = 134/292 (45%), Gaps = 30/292 (10%)

Query: 99  LGEGGFGTVH-------KGYIDDDLRQGLKAQA---VAVKLLDIEGLQGHR-EWLAEVIF 147
           LGEG FG VH       + ++D D    +       VAVK+L  +  +  R ++L E+  
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSL---------ENHLFKRISVSLPWGTR 198
           + +L+ P+++RL+  C   +   ++ E+M  G L         +    K   V++ + T 
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT 258
           + +A   A G+ +L       ++RD  T N L+  ++T K++DFG+++    G    +  
Sbjct: 133 IFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG 190

Query: 259 RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY 318
           R +    + + E I  G  TT SDV++FGV L E+LT  +     +   EQ +++    +
Sbjct: 191 RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-VIENTGEF 249

Query: 319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL 370
            R   R  Y+  P L      K       L L C   N K+RP    + ATL
Sbjct: 250 FRDQGRQVYLPKPALCPDSLYK-------LMLSCWRRNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 96.9 bits (242), Expect = 8e-23
 Identities = 80/301 (26%), Positives = 124/301 (41%), Gaps = 66/301 (21%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +GEG  G V+K     D   G   + VA+K + +   Q     + E++ +   +HP++V 
Sbjct: 27  IGEGASGEVYKAT---DRATG---KEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVD 79

Query: 159 LIGYCCEDEERLLVYEFMPRGSL----ENHLFKRISVSLPWGTRLKIAIGAA------KG 208
                   +E  +V E+M  GSL      +             R+     A       +G
Sbjct: 80  YYDSYLVGDELWVVMEYMDGGSLTDIITQNFV-----------RMNEPQIAYVCREVLQG 128

Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGSNTHVTTRVMGTYGYA 267
           L +LH     VI+RD K+ NILL  D + KL+DFG  A++  E S  +    V+GT  + 
Sbjct: 129 LEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN---SVVGTPYWM 183

Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS--RRL 325
           APE I       K D++S G++ +E+  G        P           PYLR    R L
Sbjct: 184 APEVIKRKDYGPKVDIWSLGIMCIEMAEG-------EP-----------PYLREPPLRAL 225

Query: 326 RYIVD---PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMAVS 382
             I     P L  +   K + E      +C+  +P+ RP       + E LL    +  +
Sbjct: 226 FLITTKGIPPL--KNPEKWSPEFKDFLNKCLVKDPEKRP-------SAEELLQHPFLKKA 276

Query: 383 C 383
           C
Sbjct: 277 C 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 96.3 bits (240), Expect = 8e-23
 Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 14/201 (6%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V +G  ++          VAVK L   G    +++LAE   + +LRHP L++
Sbjct: 14  LGAGQFGEVWEGLWNN-------TTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQ 65

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L   C  +E   +V E M  GSL  +L      +L     + +A   A G+A+L  A+N 
Sbjct: 66  LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE-AQN- 123

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS-NTHVTTRVMGTYGYAAPEYISTGHL 277
            I+RD    N+L+  +   K++DFGLA++  E         +      + APE       
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRF 181

Query: 278 TTKSDVYSFGVVLLELLT-GR 297
           + KSDV+SFG++L E++T GR
Sbjct: 182 SIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 97.3 bits (243), Expect = 9e-23
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 22/208 (10%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-------DIEGLQGHREWLAEVIFLGQ 150
            LGEG +  V+K       R     + VA+K +         +G+  +   L E+  L +
Sbjct: 7   KLGEGTYAVVYKA------RDKETGRIVAIKKIKLGERKEAKDGI--NFTALREIKLLQE 58

Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
           L+HP+++ L+          LV+EFM    LE  + K  S+ L         +   +GL 
Sbjct: 59  LKHPNIIGLLDVFGHKSNINLVFEFME-TDLE-KVIKDKSIVLTPADIKSYMLMTLRGLE 116

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           +LH   N +++RD K +N+L+ SD   KL+DFGLA+      N  +T +V+ T  Y APE
Sbjct: 117 YLH--SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS-PNRKMTHQVV-TRWYRAPE 172

Query: 271 YI-STGHLTTKSDVYSFGVVLLELLTGR 297
            +    H     D++S G +  ELL   
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 96.3 bits (240), Expect = 9e-23
 Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 41/217 (18%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGH---REWLAEVIFLGQLR 152
           LLG G FG+V++G   DD          AVK   L  +G  G    ++   E+  L +L+
Sbjct: 7   LLGSGSFGSVYEGLNLDD------GDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 153 HPHLVRLIGYCCEDEERLLVY-EFMPRGSLENHL-----FKRISVSLPWGTRLKIAIGAA 206
           HP++V+ +G    +E+ L ++ E +P GSL   L     F    + L   TR  +     
Sbjct: 61  HPNIVQYLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLY--TRQIL----- 112

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM----- 261
            GL +LH      ++RD K +NIL+D++   KL+DFG+AK         V          
Sbjct: 113 LGLEYLHD--RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFK 162

Query: 262 GTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
           G+  + APE I   G     +D++S G  +LE+ TG+
Sbjct: 163 GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 20/212 (9%)

Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIFL 148
           +F    ++G+G FG V        +++    +  A+K +           R  L E   L
Sbjct: 1   HFELLRVIGKGAFGKVCI------VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRIL 54

Query: 149 GQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA-A 206
            +L HP LV L  Y  +DEE + LV + +  G L  HL +++  S     ++K  I    
Sbjct: 55  QELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS---EEQVKFWICEIV 110

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
             L +LH     +I+RD K  NILLD      ++DF +A      +    TT   GT GY
Sbjct: 111 LALEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGY 165

Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLELLTGRR 298
            APE +     +   D +S GV   E L G+R
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 95.3 bits (237), Expect = 2e-22
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 12/198 (6%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G +G V++G      +  L    VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 14  LGGGQYGEVYEGVWK---KYSL---TVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 66

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +L   +  
Sbjct: 67  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 124

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT-HVTTRVMGTYGYAAPEYISTGHL 277
            I+RD    N L+  +   K++DFGL+++    + T H   +      + APE ++    
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKF 182

Query: 278 TTKSDVYSFGVVLLELLT 295
           + KSDV++FGV+L E+ T
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 94.4 bits (235), Expect = 5e-22
 Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 55/292 (18%)

Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHRE-WLAEVIFLG 149
           +F     LG+G +G+V+K      +++    Q  A+K +D+  + Q  RE  + E+  L 
Sbjct: 1   DFKVLKKLGKGSYGSVYK------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILA 54

Query: 150 QLRHPHLVR-----LIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRL--KI 201
            + HP+++      L G       +L +V E+ P G L   + KR         +   +I
Sbjct: 55  SVNHPNIISYKEAFLDG------NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108

Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
            I   +GL  LH  E  +++RD K++NILL ++   K+ D G++K+  +     +    +
Sbjct: 109 FIQLLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQI 162

Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR-----RSMDKLRPKSEQNLVDWAK 316
           GT  Y APE       + KSD++S G +L E+ T       RSM  LR K          
Sbjct: 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK---------- 212

Query: 317 PYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA 368
                 +R +Y   P +   YS    +++       + V PK RP    ++A
Sbjct: 213 -----VQRGKY---PPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 93.4 bits (232), Expect = 1e-21
 Identities = 71/219 (32%), Positives = 117/219 (53%), Gaps = 24/219 (10%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLA---EVIFLGQL 151
           +LG+G +GTV+ G  +    QG   Q +AVK ++++    L   +E+     EV  L  L
Sbjct: 7   VLGKGAYGTVYCGLTN----QG---QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59

Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +H ++V+ +G C +D    +  EF+P GS+ + L  R    LP     K       G+A+
Sbjct: 60  KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-NRFG-PLPEPVFCKYTKQILDGVAY 117

Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK----MGPEGSNTHVTTRVMGTYGYA 267
           LH   N V++RD K +N++L  +   KL DFG A+    +G  G+++++   + GT  + 
Sbjct: 118 LH--NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175

Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGR---RSMDKL 303
           APE I+      KSD++S G  + E+ TG+    SMD+L
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL 214

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 93.0 bits (231), Expect = 2e-21
 Identities = 77/290 (26%), Positives = 136/290 (46%), Gaps = 44/290 (15%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQ-GLKAQAVAVKLLDIEGLQGH--REWLAEVIFLGQLRHP 154
           ++G G FG V +G     L+  G +   VA+K L   G      R++L+E   +GQ  HP
Sbjct: 11  VIGAGEFGEVCRGR----LKLPGKREIFVAIKTLKS-GYTEKQRRDFLSEASIMGQFDHP 65

Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHL------FKRISVSLPWGTRLKIAIGAAKG 208
           +++ L G   +    +++ EFM  G+L++ L      F  I +       + +  G A G
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-------VGMLRGIAAG 118

Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG---TYG 265
           + +L  +E   ++RD    NIL++S+   K+SDFGL++   + ++    T  +G      
Sbjct: 119 MKYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176

Query: 266 YAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
           + APE I+    T+ SDV+S+G+V+ E+++ G R    +  +   N ++           
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ---------- 226

Query: 325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                D RL        A  +  L L C   +   RPK   +V+TL+ ++
Sbjct: 227 -----DYRLPPPMDCPTA--LHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 93.1 bits (231), Expect = 2e-21
 Identities = 81/285 (28%), Positives = 137/285 (48%), Gaps = 36/285 (12%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHL 156
           ++G G FG V +G +      G K  AVA+K L     +  R ++L+E   +GQ  H ++
Sbjct: 12  VIGAGEFGEVFRGILK---MPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           +RL G   + +  +++ E+M  G+L+ +L         +   + +  G A G+ +L  ++
Sbjct: 69  IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY-QLVGMLRGIAAGMKYL--SD 125

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKM---GPEGSNTHVTTRVMGTYGYAAPEYIS 273
              ++RD    NIL++S+   K+SDFGL+++    PEG  T+ T+       + APE I+
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG--TYTTSGGKIPIRWTAPEAIA 183

Query: 274 TGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR--LRYIVD 330
               T+ SDV+SFG+V+ E+++ G R                  PY   S    ++ I D
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGER------------------PYWDMSNHEVMKAIND 225

Query: 331 P-RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
             RL        A  +  L LQC   +   RP+   +V  L+ LL
Sbjct: 226 GFRLPAPMDCPSA--VYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 92.8 bits (231), Expect = 2e-21
 Identities = 85/292 (29%), Positives = 122/292 (41%), Gaps = 48/292 (16%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLAEVIFLGQLRHPHLV 157
           +G G    V+              + VA+K +D+E  Q    E   EV  + Q  HP++V
Sbjct: 9   IGVGATAVVYAAICLP------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV 62

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG--------TRLKIAIGAAKGL 209
           +        +E  LV  ++  GSL   + K    S P G        T LK      KGL
Sbjct: 63  KYYTSFVVGDELWLVMPYLSGGSLL-DIMKS---SYPRGGLDEAIIATVLK---EVLKGL 115

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR--VMGTYGYA 267
            +LH   N  I+RD K  NILL  D + K++DFG++    +G +     R   +GT  + 
Sbjct: 116 EYLH--SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173

Query: 268 APEYISTGH-LTTKSDVYSFGVVLLELLTGRRSMDKLRP-KSEQNLVDWAKPYLRSSRRL 325
           APE +   H    K+D++SFG+  +EL TG     K  P K     +    P L +    
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADY 233

Query: 326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK 377
                     +YS K  ++M  L LQ    +P  RP       T E LL  K
Sbjct: 234 ---------KKYS-KSFRKMISLCLQ---KDPSKRP-------TAEELLKHK 265

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 93.1 bits (231), Expect = 2e-21
 Identities = 86/304 (28%), Positives = 131/304 (43%), Gaps = 52/304 (17%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQA----VAVKLLDIEGLQGH-REWLAEVIFLGQLRH 153
           LGEG FG V K          LK +A    VAVK+L         R+ L+E   L Q+ H
Sbjct: 8   LGEGEFGKVVKATAFR-----LKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNH 62

Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISV---------------------- 191
           PH+++L G C +D   LL+ E+   GSL + L +   V                      
Sbjct: 63  PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122

Query: 192 SLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG 251
           +L  G  +  A   ++G+ +L  AE  +++RD    N+L+      K+SDFGL++   E 
Sbjct: 123 ALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 252 SNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQN 310
            +    ++      + A E +     TT+SDV+SFGV+L E++T G      + P   + 
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP---ER 237

Query: 311 LVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL 370
           L +  K   R  R       P          ++EM  L L C    P  RP  A +   L
Sbjct: 238 LFNLLKTGYRMER-------PE-------NCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283

Query: 371 ESLL 374
           E ++
Sbjct: 284 EKMM 287

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 92.3 bits (230), Expect = 3e-21
 Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 21/211 (9%)

Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ 150
           + F     LGEG +G+V+K             Q VA+K++ +E     +E + E+  L Q
Sbjct: 3   EVFDILEKLGEGSYGSVYKA------IHKETGQVVAIKVVPVEE--DLQEIIKEISILKQ 54

Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI---GAAK 207
              P++V+  G   ++ +  +V E+   GS+ + + K  + +L   T  +IA       K
Sbjct: 55  CDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV-SDIMKITNKTL---TEEEIAAILYQTLK 110

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGY 266
           GL +LH   N  I+RD K  NILL+ +  AKL+DFG++ ++    +     T V+GT  +
Sbjct: 111 GLEYLH--SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNT-VIGTPFW 165

Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
            APE I       K+D++S G+  +E+  G+
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 92.4 bits (229), Expect = 3e-21
 Identities = 83/290 (28%), Positives = 130/290 (44%), Gaps = 38/290 (13%)

Query: 99  LGEGGFGTVHKGYIDDD---LRQGLKAQAVAV-KLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LGEG FG+V +G ++ D   L+  +K   +A+    ++E      ++L+E + + +  HP
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME------DFLSEAVCMKEFDHP 60

Query: 155 HLVRLIGYCCEDEER------LLVYEFMPRGSLENHL-FKRIS---VSLPWGTRLKIAIG 204
           +++RLIG C +  E       +++  FM  G L + L + R+      LP    +K    
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY 264
            A G+ +L  +    I+RD    N +L+ +    ++DFGL+K    G             
Sbjct: 121 IASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178

Query: 265 GYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
            + A E ++    TTKSDV+SFGV + E+ T  R            + D    YLR   R
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIAT--RGQTPYPGVENSEIYD----YLRQGNR 232

Query: 325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           L+   D  L G YS         L   C  +NPKDRP    +   LE  L
Sbjct: 233 LKQPPDC-LDGLYS---------LMSSCWLLNPKDRPSFETLRCELEKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 92.8 bits (230), Expect = 3e-21
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 22/214 (10%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLK-AQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHL 156
           LGE  FG ++KG++      G+  AQ VA+K L DI   Q   E+  E   + +L HP++
Sbjct: 13  LGECAFGKIYKGHL---YLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI 69

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKR---------------ISVSLPWGTRLKI 201
           V L+G   +++   +++E++ +G L   L  R               +  SL  G  L I
Sbjct: 70  VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129

Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
           AI  A G+ +L  + +  +++D    NIL+      K+SD GL++         V  + +
Sbjct: 130 AIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
               +  PE I  G  ++ SD++SFGVVL E+ +
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 91.9 bits (229), Expect = 4e-21
 Identities = 73/281 (25%), Positives = 123/281 (43%), Gaps = 48/281 (17%)

Query: 97  YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWL-AEVIFLGQLRHP 154
             +G+G FGTV K      +R+    + +  K +D   +    ++ L +EV  L +L+HP
Sbjct: 6   ETIGKGSFGTVRK------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHP 59

Query: 155 HLVRLIGYCCEDEERLL--VYEFMPRGSLENHL------FKRISVSLPWGTRLKIAIGAA 206
           ++VR      +   + L  V E+   G L   +       K I     W    ++ +   
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA-- 117

Query: 207 KGLAFLHGAENP---VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS---NTHVTTRV 260
             L   H   +P   V++RD K +NI LD++   KL DFGLAK+    S    T+V    
Sbjct: 118 --LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV---- 171

Query: 261 MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR 320
            GT  Y +PE ++      KSD++S G ++ EL         L P         A+  L+
Sbjct: 172 -GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCA-------LSPPFT------ARNQLQ 217

Query: 321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP 361
            + +++     R+  +YS     E+  +    ++V+P  RP
Sbjct: 218 LASKIKEGKFRRIPYRYS----SELNEVIKSMLNVDPDKRP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 91.8 bits (229), Expect = 6e-21
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 50/221 (22%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW------LAEVIFLGQLR 152
           +GEG +G V+K     + + G   + VA+K + +E    + +       + E+  L +LR
Sbjct: 7   IGEGTYGQVYKA---RNKKTG---ELVALKKIRME----NEKEGFPITAIREIKLLQKLR 56

Query: 153 HPHLVRLIGYCCEDEER--LLVYEFMP---RGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           HP++VRL        +    +V+E+M     G L++   K                   K
Sbjct: 57  HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-------------FTESQIK 103

Query: 208 --------GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTT 258
                   GL +LH   N +++RD K SNIL+++D   KL+DFGLA       S  + T 
Sbjct: 104 CYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY-TN 160

Query: 259 RVMGTYGYAAPEYI--STGHLTTKSDVYSFGVVLLELLTGR 297
           RV+ T  Y  PE +  +T     + D++S G +L EL  G+
Sbjct: 161 RVI-TLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 91.1 bits (226), Expect = 9e-21
 Identities = 82/267 (30%), Positives = 130/267 (48%), Gaps = 34/267 (12%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G  GTV+K Y         +  AV V  LDI  ++  ++ ++E+  L +   P+++ 
Sbjct: 9   LGHGNGGTVYKAYH----LLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIG 63

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
             G    +    +  EFM  GSL+  ++++I    P     +IA+   KGL +L   +  
Sbjct: 64  FYGAFFVENRISICTEFMDGGSLD--VYRKI----PEHVLGRIAVAVVKGLTYLWSLK-- 115

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
           +++RD K SN+L+++    KL DFG++    +  N+   T V GT  Y APE IS     
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYV-GTNAYMAPERISGEQYG 171

Query: 279 TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD---PRL-A 334
             SDV+S G+  +EL  GR       P+ ++N     +  L   + L+ IVD   P L  
Sbjct: 172 IHSDVWSLGISFMELALGRFPY----PQIQKN-----QGSLMPLQLLQCIVDEDPPVLPV 222

Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRP 361
           GQ+S K    +     QC+   PK+RP
Sbjct: 223 GQFSEKFVHFIT----QCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 90.4 bits (224), Expect = 1e-20
 Identities = 69/201 (34%), Positives = 103/201 (51%), Gaps = 20/201 (9%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQ-AVAVKLL----DIEGLQGHREWLAEVIFLGQLRH 153
           LG G FGTV KG       +  K++  VAVK+L    +   L+   E L E   + QL +
Sbjct: 3   LGSGNFGTVKKGMY-----KMKKSEKTVAVKILKNDNNDPALKD--ELLREANVMQQLDN 55

Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
           P++VR+IG  CE E  +LV E    G L   L K   V+    T L   +  + G+ +L 
Sbjct: 56  PYIVRMIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQV--SMGMKYLE 112

Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEY 271
             E   ++RD    N+LL +   AK+SDFGL+K      N +   +  G +   + APE 
Sbjct: 113 --ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN-YYKAKTHGKWPVKWYAPEC 169

Query: 272 ISTGHLTTKSDVYSFGVVLLE 292
           ++    ++KSDV+SFGV++ E
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 89.9 bits (223), Expect = 2e-20
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 16/208 (7%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVKLLDIEGLQGHREWLA--EVIFLGQLRHP 154
           ++G G FG VH       L +    Q  V +K + +E +       A  E   L  L HP
Sbjct: 7   VVGRGAFGIVH-------LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59

Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
           +++       ED+  ++V E+ P G+L  ++ KR +  L   T L   +     LA  H 
Sbjct: 60  NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL--LALHHV 117

Query: 215 AENPVIYRDFKTSNILLDSDFTA-KLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
               +++RD KT NILLD      K+ DFG++K+    S +   T V+GT  Y +PE   
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYISPELCE 174

Query: 274 TGHLTTKSDVYSFGVVLLELLTGRRSMD 301
                 KSD+++ G VL EL + +R+ +
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 14/202 (6%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HREWLAEVIFLGQLRHPHL 156
           +GEG  G V K     D   G   + VA+K + +  L+G    + L E+  L   +HP++
Sbjct: 8   IGEGAHGIVFKAK---DRETG---ETVALKKVALRRLEGGIPNQALREIKALQACQHPYV 61

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           V+L+         +LV E+MP   L   L +     LP            KG+A++H   
Sbjct: 62  VKLLDVFPHGSGFVLVMEYMPS-DLSEVL-RDEERPLPEAQVKSYMRMLLKGVAYMHA-- 117

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI-STG 275
           N +++RD K +N+L+ +D   K++DFGLA++  E      + +V  T  Y APE +    
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGAR 176

Query: 276 HLTTKSDVYSFGVVLLELLTGR 297
                 D+++ G +  ELL G 
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 90.2 bits (224), Expect = 2e-20
 Identities = 82/292 (28%), Positives = 130/292 (44%), Gaps = 35/292 (11%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
            LG+G FG+V     D    Q    + VAVK L     +  R++  E+  L  L+H ++V
Sbjct: 11  QLGKGNFGSVELCRYDP--LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 158 RLIGYCCEDEER--LLVYEFMPRGSLENHLFK---RISVSLPWGTRLKIAIGAAKGLAFL 212
           +  G C     R   LV E++P GSL ++L K   R+         L  A    KG+ +L
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR----KLLLYASQICKGMEYL 124

Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT--YGYAAPE 270
                  ++RD  T NIL++S+   K+ DFGL K+ P+    +       +  + Y APE
Sbjct: 125 --GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APE 181

Query: 271 YISTGHLTTKSDVYSFGVVLLELLT--------GRRSMDKLRP-KSEQNLVDWAKPYLRS 321
            ++    +  SDV+SFGVVL EL T            M  +   K  Q +V      L++
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241

Query: 322 SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           + RL     P   G        E+  +  +C + +P  RP  + +   +E++
Sbjct: 242 NGRL-----PAPPG-----CPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 90.1 bits (224), Expect = 3e-20
 Identities = 74/285 (25%), Positives = 114/285 (40%), Gaps = 36/285 (12%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK-LLDIEGLQG-HREWLAEVIFLGQLRHPH 155
           ++GEG +G V K       R     + VA+K   + E  +   +  L EV  L QLRH +
Sbjct: 8   VVGEGAYGVVLK------CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +V L           LV+E++ R  LE  L +     LP            + +A+ H  
Sbjct: 62  IVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAIAYCHS- 118

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
            + +I+RD K  NIL+      KL DFG A+       + +T  V  T  Y APE +   
Sbjct: 119 -HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGD 176

Query: 276 HLTTKS-DVYSFGVVLLELLTGR------RSMDKLR---------PKSEQNLVDWAKPYL 319
               K  DV++ G ++ ELL G         +D+L          P S Q L   + P  
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS-SNPRF 235

Query: 320 RSSRRLRYI-VDPR--LAGQYSVKGAKEMAVLALQCISVNPKDRP 361
                + +        L  +Y  K +         C+ ++PK+R 
Sbjct: 236 ---AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 88.9 bits (220), Expect = 5e-20
 Identities = 75/285 (26%), Positives = 135/285 (47%), Gaps = 34/285 (11%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHLV 157
           LG+G FG V++G     ++   + + VA+K ++       R E+L E   + +    H+V
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFK-------RISVSLPWGTRL-KIAIGAAKGL 209
           RL+G   + +  L++ E M RG L+++L             + P   ++ ++A   A G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
           A+L+   N  ++RD    N ++  DFT K+ DFG+ +   E        + +    + +P
Sbjct: 133 AYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRY 327
           E +  G  TT SDV+SFGVVL E+ T           +EQ       PY  + + + LR+
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQGMSNEQVLRF 233

Query: 328 IVDPRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLE 371
           +++  L  +       +M   L   C   NPK RP    ++++++
Sbjct: 234 VMEGGLLDK--PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 88.1 bits (218), Expect = 7e-20
 Identities = 62/199 (31%), Positives = 104/199 (52%), Gaps = 12/199 (6%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHL 156
           LLG+G FG V KG + D          VAVK    +  Q  + ++L+E   L Q  HP++
Sbjct: 2   LLGKGNFGEVFKGTLKDK-------TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNI 54

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           V+LIG C + +   +V E +P G   + L K+    L     +K A+ AA G+A+L    
Sbjct: 55  VKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYLESKN 113

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH 276
              I+RD    N L+  +   K+SDFG+++   +G  +    + +    + APE ++ G 
Sbjct: 114 --CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGR 170

Query: 277 LTTKSDVYSFGVVLLELLT 295
            +++SDV+S+G++L E  +
Sbjct: 171 YSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 88.7 bits (220), Expect = 8e-20
 Identities = 62/224 (27%), Positives = 94/224 (41%), Gaps = 36/224 (16%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLV 157
           +G+G FG V +      L        VAVK+L  E       ++  E   + +  HP++V
Sbjct: 13  IGQGAFGRVFQARAPG-LLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKR------------ISVSLPWGTR------- 198
           +L+G C   +   L++E+M  G L   L  R             S               
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 199 -LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL------AKMGPEG 251
            L IA   A G+A+L  +E   ++RD  T N L+  +   K++DFGL      A      
Sbjct: 132 QLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 252 SNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
            N  +  R M       PE I     TT+SDV+++GVVL E+ +
Sbjct: 190 ENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 88.3 bits (219), Expect = 9e-20
 Identities = 68/209 (32%), Positives = 96/209 (45%), Gaps = 18/209 (8%)

Query: 99  LGEGGFGTVHKG---YIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V++G     D D         VAVK L +    Q   ++L E + + +  H 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDA----VELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69

Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK-RISVSLPWGTR----LKIAIGAAKGL 209
           ++VRLIG   E   R ++ E M  G L++ L + R     P        L  A   AKG 
Sbjct: 70  NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129

Query: 210 AFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
            +L   EN  I+RD    N LL        AK++DFG+A+     S      R M    +
Sbjct: 130 KYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187

Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLELLT 295
             PE    G  T+K+DV+SFGV+L E+ +
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 87.6 bits (217), Expect = 1e-19
 Identities = 79/288 (27%), Positives = 138/288 (47%), Gaps = 42/288 (14%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHL 156
           ++G G FG V  G +      G +   VA+K L     +  R ++L+E   +GQ  HP++
Sbjct: 11  VIGAGEFGEVCSGRLK---LPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RISVSLPWGTRLKIAIGAAKGLAFLH 213
           + L G   + +  ++V E+M  GSL+  L K   + +V    G    +  G A G+ +L 
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVG----MLRGIASGMKYL- 122

Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM---GPEGSNTHVTTRVMGTYGYAAPE 270
            ++   ++RD    NIL++S+   K+SDFGL+++    PE + T    ++     + APE
Sbjct: 123 -SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTAPE 179

Query: 271 YISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR--LRY 327
            I+    T+ SDV+S+G+V+ E+++ G R                  PY   S +  ++ 
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGER------------------PYWEMSNQDVIKA 221

Query: 328 IVDP-RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           I +  RL        A  +  L L C   +  +RPK   +V+ L+ L+
Sbjct: 222 IEEGYRLPAPMDCPAA--LHQLMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 86.9 bits (215), Expect = 2e-19
 Identities = 68/214 (31%), Positives = 111/214 (51%), Gaps = 21/214 (9%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHLV 157
           LG G FG V KG      +Q      VA+K+L  E  +  R E + E   + QL +P++V
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQ----IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV 58

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKR---ISVSLPWGTRLKIAIGAAKGLAFLHG 214
           R+IG  CE E  +LV E    G L   L  +   I+VS      +++    + G+ +L G
Sbjct: 59  RMIG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVS----NVVELMHQVSMGMKYLEG 113

Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTY--GYAAPEY 271
                ++RD    N+LL +   AK+SDFGL+K +G + S  +   R  G +   + APE 
Sbjct: 114 KN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS--YYKARSAGKWPLKWYAPEC 169

Query: 272 ISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLR 304
           I+    +++SDV+S+G+ + E  + G++   K++
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 87.2 bits (217), Expect = 2e-19
 Identities = 70/210 (33%), Positives = 99/210 (47%), Gaps = 36/210 (17%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLAEVIFLGQLRHPH 155
           LG G FG V        +R     +  A+K+L    +   ++    L E   L  +RHP 
Sbjct: 9   LGTGSFGRVML------VRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62

Query: 156 LVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK---GLAF 211
           LV L G   +D+  L LV E++P G L +HL K      P          AA+    L +
Sbjct: 63  LVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVAR-----FYAAQVVLALEY 116

Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM---GTYGYAA 268
           LH  +  ++YRD K  N+LLDSD   K++DFG AK         V  R     GT  Y A
Sbjct: 117 LHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTLCGTPEYLA 166

Query: 269 PEYI-STGHLTTKS-DVYSFGVVLLELLTG 296
           PE I S G+   K+ D ++ G+++ E+L G
Sbjct: 167 PEIILSKGY--GKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 86.6 bits (214), Expect = 2e-19
 Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 15/199 (7%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  GY ++  +       VAVK L   G    + +L E   +  L+H  LVR
Sbjct: 14  LGAGQFGEVWMGYYNNSTK-------VAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVR 65

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     ++E   ++ E+M +GSL + L       +     +  +   A+G+A++      
Sbjct: 66  LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--RKN 123

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +N+L+      K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGS 180

Query: 277 LTTKSDVYSFGVVLLELLT 295
            T KSDV+SFG++L E++T
Sbjct: 181 FTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.4 bits (214), Expect = 3e-19
 Identities = 69/213 (32%), Positives = 110/213 (51%), Gaps = 22/213 (10%)

Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH--REWLA---EVI 146
           N+    LLG+G FG V+  Y  D  R+      +AVK +  +       +E  A   E+ 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRE------LAVKQVPFDPDSPETKKEVNALECEIQ 56

Query: 147 FLGQLRHPHLVRLIGYCCEDEERLLVY-EFMPRGSLENHL--FKRISVSLPWGTRLKIAI 203
            L  L+H  +V+  G C  D+E L ++ E+MP GS+++ L  +  ++ ++   TR K   
Sbjct: 57  LLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV---TR-KYTR 111

Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMG 262
              +G+ +LH   N +++RD K +NIL DS    KL DFG +K +    S+      V G
Sbjct: 112 QILEGVEYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG 169

Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
           T  + +PE IS      K+DV+S G  ++E+LT
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 87.0 bits (215), Expect = 3e-19
 Identities = 65/210 (30%), Positives = 91/210 (43%), Gaps = 16/210 (7%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LGEG FG V      + L +  K   VAVK L        +++  E   L  L+H H+VR
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDK-MLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 159 LIGYCCEDEERLLVYEFMPRGSL---------ENHLFKRISVS----LPWGTRLKIAIGA 205
             G C E    L+V+E+M  G L         +  +           L  G  L IA   
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
           A G+ +L       ++RD  T N L+      K+ DFG+++         V  R M    
Sbjct: 132 ASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 266 YAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
           +  PE I     TT+SD++SFGVVL E+ T
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 87.0 bits (215), Expect = 3e-19
 Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 33/218 (15%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHL 156
           ++GEG FG V +  I  D   GLK  A    L +      HR++  E+  L +L  HP++
Sbjct: 9   VIGEGNFGQVIRAMIKKD---GLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 157 VRLIGYCCEDEERLLVY---EFMPRGSLENHLFK-RISVSLPWGTR-------------L 199
           + L+G C   E R  +Y   E+ P G+L + L K R+  + P   +             L
Sbjct: 66  INLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122

Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
           + A   A G+ +L  +E   I+RD    N+L+  +  +K++DFGL++    G   +V  +
Sbjct: 123 QFASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYV-KK 175

Query: 260 VMGTYG--YAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
            MG     + A E ++    TTKSDV+SFGV+L E+++
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 87.4 bits (217), Expect = 4e-19
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 30/211 (14%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---------DIEGLQGHREWLAEVIFL 148
           +LG+G FG V               +  AVK+L         D+E     +      +  
Sbjct: 2   VLGKGSFGKVLLA------ELKGTDELYAVKVLKKDVILQDDDVECTMTEKR-----VLA 50

Query: 149 GQLRHPHLVRLIGYCC-EDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAA 206
              +HP L +L  + C + ++RL  V E++  G L  H+ +      P        I   
Sbjct: 51  LAGKHPFLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI--V 106

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
            GL FLH  E  +IYRD K  N+LLDS+   K++DFG+ K G  G  T  T+   GT  Y
Sbjct: 107 LGLQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDY 162

Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
            APE +S        D ++ GV+L E+L G+
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 85.8 bits (213), Expect = 5e-19
 Identities = 59/164 (35%), Positives = 86/164 (52%), Gaps = 16/164 (9%)

Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLK 200
           L E   L Q + P++V+L  Y  + ++ L LV E++P G L   L + +        R+ 
Sbjct: 41  LTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDVARIY 98

Query: 201 IA-IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV--- 256
           IA I  A  L +LH   N +I+RD K  NIL+DS+   KL+DFGL+K+G      ++   
Sbjct: 99  IAEIVLA--LEYLH--SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154

Query: 257 ---TTRVMGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTG 296
                R++GT  Y APE I   GH +   D +S G +L E L G
Sbjct: 155 EKEDKRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.1 bits (214), Expect = 5e-19
 Identities = 77/274 (28%), Positives = 118/274 (43%), Gaps = 48/274 (17%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-EVIFLGQLRHPHL 156
            +G+G FG V+K     D R     Q VA+K++D+E  +   E +  E+ FL Q R P++
Sbjct: 8   CIGKGSFGEVYKAI---DKRTN---QVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYI 61

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI---GAAKGLAFLH 213
            +  G   +  +  ++ E+   GS    L K   +         IA        GL +LH
Sbjct: 62  TKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPGKLDET-----YIAFILREVLLGLEYLH 115

Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR---VMGTYGYAAPE 270
             E   I+RD K +NILL  +   KL+DFG++     G  T   ++    +GT  + APE
Sbjct: 116 --EEGKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPE 168

Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
            I       K+D++S G+  +EL  G   +  L P                 R L  I  
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM----------------RVLFLIPK 212

Query: 331 ---PRLAGQYSVKGAKEMAVLALQCISVNPKDRP 361
              P L G    K  K+       C++ +PK+RP
Sbjct: 213 NNPPSLEGNKFSKPFKDFVS---LCLNKDPKERP 243

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 6e-19
 Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 33/211 (15%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW------LAEVIFLGQLR 152
           +GEG +G V+K     D   G   + VA+K +                 L E+  L +L 
Sbjct: 7   IGEGTYGVVYKAR---DKLTG---EIVAIKKI----KLRFESEGIPKTALREIKLLKELN 56

Query: 153 HPHLVRLIGYCCEDEERLLVYEFMPRGSLEN--HLFKRISVSLPWGTRLKIAIGAAKGLA 210
           HP++++L+       +  LV+EFM      +   L K     LP            +GLA
Sbjct: 57  HPNIIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM--GPEGSNTH-VTTRVMGTYGYA 267
           F H   + +++RD K  N+L++++   KL+DFGLA+    P    TH V TR      Y 
Sbjct: 113 FCH--SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYR 165

Query: 268 APEYIST-GHLTTKSDVYSFGVVLLELLTGR 297
           APE +      +T  D++S G +  ELL+ R
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 86.2 bits (213), Expect = 7e-19
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 27/215 (12%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHL 156
           ++GEG FG V K  I  D   GL+  A   ++ +      HR++  E+  L +L  HP++
Sbjct: 14  VIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFK--------------RISVSLPWGTRLKIA 202
           + L+G C       L  E+ P G+L + L K                + +L     L  A
Sbjct: 71  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
              A+G+ +L  ++   I+RD    NIL+  ++ AK++DFGL++    G   +V  + MG
Sbjct: 131 ADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV-KKTMG 183

Query: 263 TYG--YAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                + A E ++    TT SDV+S+GV+L E+++
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 85.7 bits (212), Expect = 7e-19
 Identities = 78/296 (26%), Positives = 129/296 (43%), Gaps = 37/296 (12%)

Query: 93  FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL--DIEGLQGHREWLAEVIFLGQ 150
           F+   +LG+G FG+V +  +  +       Q VAVK+L  DI       E+L E   + +
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSF---QKVAVKMLKADIFSSSDIEEFLREAACMKE 57

Query: 151 LRHPHLVRLIGYCCEDEER------LLVYEFMPRGSLENHLF-KRIS---VSLPWGTRLK 200
             HP++++LIG       +      +++  FM  G L   L   RI     +LP  T ++
Sbjct: 58  FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117

Query: 201 IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRV 260
             I  A G+ +L  +    I+RD    N +L+ + T  ++DFGL+K    G         
Sbjct: 118 FMIDIASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175

Query: 261 MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK--PY 318
                + A E ++    TT SDV++FGV + E++T        R ++    V+ ++   Y
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT--------RGQTPYAGVENSEIYNY 227

Query: 319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           L    RL+   D            +++  L  QC S  PK RP    +   LE + 
Sbjct: 228 LIKGNRLKQPPD----------CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 27/215 (12%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHL 156
           ++GEG FG V K  I  D   GL+  A   ++ +      HR++  E+  L +L  HP++
Sbjct: 2   VIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFK-RISVSLPWGTR-------------LKIA 202
           + L+G C       L  E+ P G+L + L K R+  + P                 L  A
Sbjct: 59  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
              A+G+ +L  ++   I+RD    NIL+  ++ AK++DFGL++    G   +V  + MG
Sbjct: 119 ADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV-KKTMG 171

Query: 263 TYG--YAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                + A E ++    TT SDV+S+GV+L E+++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 65/219 (29%), Positives = 114/219 (52%), Gaps = 10/219 (4%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQ-AVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPH 155
           +LG G FGTV+KG     + +G   +  VA+K+L +  G + + E++ E + +  + HPH
Sbjct: 14  VLGSGAFGTVYKGIW---VPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPH 70

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LVRL+G C     + LV + MP G L +++ +    ++     L   +  AKG+ +L   
Sbjct: 71  LVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLE-- 126

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           E  +++RD    N+L+ S    K++DFGLA++       +          + A E I   
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186

Query: 276 HLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVD 313
             T +SDV+S+GV + EL+T G +  D +  +   +L++
Sbjct: 187 KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 88.0 bits (218), Expect = 1e-18
 Identities = 54/190 (28%), Positives = 90/190 (47%), Gaps = 16/190 (8%)

Query: 123 QAVAVKLLDIEGLQGHRE---WLAEVIFLGQLRHPHLVRLIGY-CCEDEERLLVYEFMPR 178
             VA+KLL  +  +   +   +  E     +L HP++V L+            V+E++P 
Sbjct: 4   HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63

Query: 179 GSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL---DSDF 235
            +L   L      +LP G   ++ +     LA  H     +++RD K  NI++       
Sbjct: 64  RTLREVL--AADGALPAGETGRLMLQVLDALACAH--NQGIVHRDLKPQNIMVSQTGVRP 119

Query: 236 TAKLSDFGLAKMGPEGSNTHV-----TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVL 290
            AK+ DFG+  + P   +  V     TT V+GT  Y APE +    +T  SD+Y++G++ 
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179

Query: 291 LELLTGRRSM 300
           LE LTG+R +
Sbjct: 180 LECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 81/307 (26%), Positives = 126/307 (41%), Gaps = 50/307 (16%)

Query: 81  FQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQG 137
           F  S L+ IT        LG G FG V          +G +   V VK L     E LQ 
Sbjct: 2   FPRSNLQEITT-------LGRGEFGEVFLAKAKGIEEEGGE-TLVLVKALQKTKDENLQ- 52

Query: 138 HREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSL---- 193
             E+  E+    +L H ++VRL+G C E E   ++ E+   G L+  L  R + S     
Sbjct: 53  -SEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFL--RATKSKDEKL 109

Query: 194 ---PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE 250
              P  T+ K+A+     L   H +    ++RD    N L+ S    K+S   L+K    
Sbjct: 110 KPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVY 168

Query: 251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT------GRRSMDKLR 304
            S  +     +    + APE +     +TKSDV+SFGV++ E+ T         S +++ 
Sbjct: 169 NSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL 228

Query: 305 PKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMA 364
            + +   ++   P    SR  +                     L  +C +VNPKDRP  +
Sbjct: 229 NRLQAGKLELPVPEGCPSRLYK---------------------LMTRCWAVNPKDRPSFS 267

Query: 365 AVVATLE 371
            +V+ L 
Sbjct: 268 ELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 77/273 (28%), Positives = 124/273 (45%), Gaps = 30/273 (10%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG VH G      R  +K   VA+K ++ EG     +++ E   + +L HP LV+
Sbjct: 12  LGSGQFGVVHLG----KWRAQIK---VAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQ 63

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G C + +   +V EFM  G L N+L +R    L     L +     +G+ +L    N 
Sbjct: 64  LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLE--RNS 120

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
            I+RD    N L+ S    K+SDFG+ +   +   T  ++       ++ PE  +    +
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYS 179

Query: 279 TKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQY 337
           +KSDV+SFGV++ E+ T G+   +K   KS   +V+      R  R       P+LA   
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEK---KSNYEVVEMISRGFRLYR-------PKLASMT 229

Query: 338 SVKGAKEMAVLALQCISVNPKDRPKMAAVVATL 370
             +       +   C    P+ RP  A ++  +
Sbjct: 230 VYE-------VMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 83/287 (28%), Positives = 134/287 (46%), Gaps = 55/287 (19%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL-AEVIFLGQLRHPHLV 157
           +GEG  G V    I  D   G   + VAVK +D+   Q  RE L  EV+ +   +HP++V
Sbjct: 27  IGEGSTGIV---CIATDKSTG---RQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIV 79

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------IAIGAAKGLAF 211
            +       +E  +V EF+  G+L + +           TR+       + +   K L+F
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIATVCLAVLKALSF 130

Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGSNTHVTTR--VMGTYGYAA 268
           LH     VI+RD K+ +ILL SD   KLSDFG  A++  E     V  R  ++GT  + A
Sbjct: 131 LHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-----VPRRKSLVGTPYWMA 183

Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI 328
           PE IS     T+ D++S G++++E++ G           E    +  +P L++ +R+R  
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDG-----------EPPYFN--EPPLQAMKRIRDN 230

Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           + P+L  +   K +  +     + +  +P  R       AT   LLN
Sbjct: 231 LPPKL--KNLHKVSPRLRSFLDRMLVRDPAQR-------ATAAELLN 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 84.1 bits (208), Expect = 4e-18
 Identities = 74/206 (35%), Positives = 98/206 (47%), Gaps = 32/206 (15%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIFLGQLRHPH 155
           +G G FG V   Y   D+R     + VA+K +   G Q + +W   + EV FL QLRHP+
Sbjct: 23  IGHGSFGAV---YFARDVRTN---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGS----LENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
            +   G    +    LV E+   GS    LE H      V +       I  GA +GLA+
Sbjct: 77  TIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIA-----AICHGALQGLAY 130

Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM-GPEGSNTHVTTRVMGTYGYAAPE 270
           LH  E   I+RD K  NILL    T KL+DFG A +  P  +N+ V     GT  + APE
Sbjct: 131 LHSHER--IHRDIKAGNILLTEPGTVKLADFGSASLVSP--ANSFV-----GTPYWMAPE 181

Query: 271 YI---STGHLTTKSDVYSFGVVLLEL 293
            I     G    K DV+S G+  +EL
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 83.2 bits (205), Expect = 5e-18
 Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 16/202 (7%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 14  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 65

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +GSL + L   +   L     + +A   A G+A++      
Sbjct: 66  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 122

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD + +NIL+  +   K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGR 179

Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL T  R
Sbjct: 180 FTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 83.5 bits (206), Expect = 5e-18
 Identities = 64/224 (28%), Positives = 101/224 (45%), Gaps = 22/224 (9%)

Query: 99  LGEGGFGTVHKGYIDD--DLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHL 156
           LGEG FG V   ++ +  +L        VAVK L    L   +++  E   L  L+H H+
Sbjct: 13  LGEGAFGKV---FLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLF--------------KRISVSLPWGTRLKIA 202
           V+  G C + +  ++V+E+M  G L   L               ++    L     L IA
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
              A G+ +L  A    ++RD  T N L+ ++   K+ DFG+++         V    M 
Sbjct: 130 SQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP 305
              +  PE I     TT+SDV+SFGV+L E+ T G++   +L  
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 231

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 83.5 bits (206), Expect = 5e-18
 Identities = 80/288 (27%), Positives = 132/288 (45%), Gaps = 32/288 (11%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLV 157
           LG+G FG V++G    D+ +G     VAVK ++    L+   E+L E   +      H+V
Sbjct: 14  LGQGSFGMVYEG-NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFK-RISVSLPWGT-------RLKIAIGAAKGL 209
           RL+G   + +  L+V E M  G L+++L   R       G         +++A   A G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
           A+L+  +   ++RD    N ++  DFT K+ DFG+ +   E        + +    + AP
Sbjct: 133 AYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRY 327
           E +  G  TT SD++SFGVVL E+ +           +EQ       PY  L + + L++
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQ-------PYQGLSNEQVLKF 233

Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           ++D     Q      + +  L   C   NPK RP    +V  L+  L+
Sbjct: 234 VMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 82.6 bits (204), Expect = 7e-18
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 19/209 (9%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG V  G     +    KA+ V  +L           +L EV    +L HP++++
Sbjct: 3   IGNGWFGKVLLGEAHRGMS---KARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFK-RISVSLPWGTRL--KIAIGAAKGLAFLHGA 215
            +G C E    LLV EF P G L+N+L   R  V+      +  ++A   A GL +LH  
Sbjct: 60  CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-- 117

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGT-YGYAAPEYIS 273
           +   I+ D    N  L +D + K+ D+GLA +  PE  + ++T         + APE + 
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPE--DYYITKDCHAVPLRWLAPELVE 175

Query: 274 TGH-------LTTKSDVYSFGVVLLELLT 295
                      T KS+++S GV + EL T
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 82.7 bits (204), Expect = 8e-18
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 13/205 (6%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHL 156
           +LG G FG + +G +    ++ L    VA+  L      +  R +LAE + LGQ  H ++
Sbjct: 12  ILGTGRFGELCRGCLKLPSKREL---PVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNI 68

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           VRL G        ++V E+M  G+L++ L ++    L  G  + +  G A G+ +L  +E
Sbjct: 69  VRLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQLMGMLPGLASGMKYL--SE 125

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG--YAAPEYIST 274
              +++      +L++SD   K+S F       E  +  + T + G     +AAPE I  
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182

Query: 275 GHLTTKSDVYSFGVVLLELLT-GRR 298
            H ++ SDV+SFG+V+ E+++ G R
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 14/200 (7%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-HREWLAEVIFLGQLRHPHLV 157
           LG G  G+V K      ++       +A K++ I       ++ L E+  + + R P++V
Sbjct: 13  LGAGNGGSVSK------VKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIV 66

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
              G    +    +  EFM  GSL+     +    +P     KIA+   +GL +L+   +
Sbjct: 67  SFYGAFLNENNICMCMEFMDCGSLDRIY--KKGGPIPVEILGKIAVAVVEGLTYLYN-VH 123

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            +++RD K SNIL++S    KL DFG++    E  N+   T V GT  Y +PE I  G  
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSG---ELINSIADTFV-GTSTYMSPERIQGGKY 179

Query: 278 TTKSDVYSFGVVLLELLTGR 297
           T KSDV+S G+ ++EL  G+
Sbjct: 180 TVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 67/203 (33%), Positives = 95/203 (46%), Gaps = 13/203 (6%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGL-KAQA---VAVKLLDIEGLQGHREWL-AEVIFLGQL-R 152
           LG G FG V +         GL K+ A   VAVK+L        RE L +E+  +  L  
Sbjct: 43  LGAGAFGKVVEA-----TAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN 97

Query: 153 HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
           H ++V L+G C      L++ E+   G L N L ++    L     L  +   AKG+AFL
Sbjct: 98  HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157

Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
             A    I+RD    N+LL      K+ DFGLA+     SN  V         + APE I
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215

Query: 273 STGHLTTKSDVYSFGVVLLELLT 295
                T +SDV+S+G++L E+ +
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 66/202 (32%), Positives = 99/202 (49%), Gaps = 16/202 (7%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  G  + + +       VAVK L   G      +L E   + +LRH  LV+
Sbjct: 14  LGNGQFGEVWMGTWNGNTK-------VAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQ 65

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +GSL + L      +L     + +A   A G+A++      
Sbjct: 66  LYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN-- 122

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD +++NIL+      K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGR 179

Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL+T  R
Sbjct: 180 FTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 72/274 (26%), Positives = 121/274 (44%), Gaps = 33/274 (12%)

Query: 99  LGEGGFG--TVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHP 154
           LG+G FG  T+++   DD L        V  K +++  L  +  R+ L E++ L  L+HP
Sbjct: 8   LGKGAFGEATLYRRTEDDSL--------VVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59

Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
           +++    +  +D   L+  E+   G+L + + ++          L         ++++H 
Sbjct: 60  NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH- 118

Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +++RD KT NI L      KL DFG++K+   GS   +   V+GT  Y +PE    
Sbjct: 119 -KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQG 175

Query: 275 GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
                KSD+++ G VL ELLT +R+ D   P    NLV           +  Y       
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNP---LNLVV-------KIVQGNYTPVV--- 222

Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA 368
             YS     E+  L    +  +P+ RP    V+ 
Sbjct: 223 SVYS----SELISLVHSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 84/289 (29%), Positives = 122/289 (42%), Gaps = 29/289 (10%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL-AEVIFLGQLRHPHLV 157
           LGEG FG V     D         + VAVK L  E    H   L  E+  L  L H ++V
Sbjct: 12  LGEGHFGKVELCRYDP--EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 158 RLIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +  G C ED      L+ EF+P GSL+ +L +  +  +    +LK A+   KG+ +L G+
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYL-GS 127

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM--GPEGSNTHVTTRVMGTYGYAAPEYIS 273
               ++RD    N+L++S+   K+ DFGL K     +   T         + Y APE + 
Sbjct: 128 RQ-YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLI 185

Query: 274 TGHLTTKSDVYSFGVVLLELLTGRRS--------MDKLRPKSEQNLVDWAKPYLRSSRRL 325
                  SDV+SFGV L ELLT   S        +  + P   Q  V      L   +RL
Sbjct: 186 QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL 245

Query: 326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                PR          +E+  L  +C    P  R     ++   E++L
Sbjct: 246 -----PRPP-----NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 74/291 (25%), Positives = 125/291 (42%), Gaps = 53/291 (18%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-------DIEGLQGHREWLAEVIFLGQ 150
           L+G G +G V++G            + VA+K++       D+  +Q       EV  L Q
Sbjct: 8   LIGRGAYGAVYRGK------HVPTGRVVALKIINLDTPDDDVSDIQ------REVALLSQ 55

Query: 151 LRH---PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           LR    P++ +  G   +     ++ E+   GS+   L K   ++  + + +   +  A 
Sbjct: 56  LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVA- 113

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L ++H  +  VI+RD K +NIL+ +    KL DFG+A +  + S+   T   +GT  + 
Sbjct: 114 -LKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWM 168

Query: 268 APEYISTGHL-TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR 326
           APE I+ G    TK+D++S G+ + E+ TG      +       L+  +KP         
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP--------- 219

Query: 327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK 377
               PRL      K  +E       C+   PK+R        + E LL  K
Sbjct: 220 ----PRLEDNGYSKLLREFVAA---CLDEEPKER-------LSAEELLKSK 256

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 81.7 bits (201), Expect = 2e-17
 Identities = 70/213 (32%), Positives = 108/213 (50%), Gaps = 16/213 (7%)

Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA---EVIFL 148
           N+    LLG+G FG V+  Y D D  + L A+ V     D E  +  +E  A   E+  L
Sbjct: 3   NWRRGKLLGQGAFGRVYLCY-DVDTGRELAAKQVQ---FDPESPETSKEVSALECEIQLL 58

Query: 149 GQLRHPHLVRLIGYCCED--EERLLVY-EFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
             L+H  +V+  G C  D  E+ L ++ E+MP GS+++ L  +   +L      K     
Sbjct: 59  KNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQI 115

Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR-VMGTY 264
            +G+++LH   N +++RD K +NIL DS    KL DFG +K       +    R V GT 
Sbjct: 116 LEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTP 173

Query: 265 GYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
            + +PE IS      K+DV+S G  ++E+LT +
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 80.9 bits (199), Expect = 3e-17
 Identities = 66/202 (32%), Positives = 98/202 (48%), Gaps = 16/202 (7%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   +       VA+K L   G      +L E   + +LRH  LV 
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-------VAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVP 65

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V EFM +GSL + L +     L     + +A   A G+A++      
Sbjct: 66  LYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN-- 122

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +NIL+  +   K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGR 179

Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL+T  R
Sbjct: 180 FTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 81.1 bits (200), Expect = 3e-17
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 21/210 (10%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQG-LKA--QAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
            LG G F +    Y   D++ G L A  Q   V+    E  +       E+  + +L HP
Sbjct: 7   QLGTGAFSSC---YQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63

Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK----RISVSLPWGTRLKIAIGAAKGLA 210
           H++R++G  CED    L  E+M  GS+ + L K    + +V + +  +L       +GL+
Sbjct: 64  HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLS 117

Query: 211 FLHGAENPVIYRDFKTSNILLDSD-FTAKLSDFGLA-KMGPEGSNT-HVTTRVMGTYGYA 267
           +LH  EN +I+RD K +N+L+DS     +++DFG A ++  +G+       +++GT  + 
Sbjct: 118 YLH--ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175

Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           APE +         DV+S G V++E+ T +
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 81.0 bits (200), Expect = 3e-17
 Identities = 59/203 (29%), Positives = 86/203 (42%), Gaps = 16/203 (7%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           LG+GGFG V    +          +  A K LD   ++  +G +  L E   L ++    
Sbjct: 1   LGKGGFGEVCACQVKA------TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF 54

Query: 156 LVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
           +V L  Y  E ++ L LV   M  G L+ H++       P    +  A     GL  LH 
Sbjct: 55  IVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH- 112

Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  ++YRD K  N+LLD     ++SD GLA     G          GT GY APE +  
Sbjct: 113 -QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQG 168

Query: 275 GHLTTKSDVYSFGVVLLELLTGR 297
                  D ++ G  L E++ GR
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 80.9 bits (199), Expect = 4e-17
 Identities = 73/265 (27%), Positives = 121/265 (45%), Gaps = 33/265 (12%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-EVIFLGQLRHPHLV 157
           +G+G FG V KG ID+  ++      VA+K++D+E  +   E +  E+  L Q   P++ 
Sbjct: 12  IGKGSFGEVFKG-IDNRTQK-----VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G   +D +  ++ E++  GS  + L           T L+  +   KGL +LH  + 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEKK 122

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT-TRVMGTYGYAAPEYISTGH 276
             I+RD K +N+LL      KL+DFG+A    + ++T +     +GT  + APE I    
Sbjct: 123 --IHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 277 LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQ 336
             +K+D++S G+  +EL  G     +L P     L+    P             P L G 
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTLEGN 224

Query: 337 YSVKGAKEMAVLALQCISVNPKDRP 361
           YS    K +      C++  P  RP
Sbjct: 225 YS----KPLKEFVEACLNKEPSFRP 245

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 4e-17
 Identities = 67/215 (31%), Positives = 99/215 (46%), Gaps = 30/215 (13%)

Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQG----LKAQAV--AVKLLDIEGLQGHREWLAE 144
            +      +G G FG VH      D        LK  A+   ++L   + +   +  L E
Sbjct: 1   DDLERIKTVGTGTFGRVHL---VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKE 57

Query: 145 VIFLGQLRHPHLVRLIGYCCEDEERLL--VYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           V       HP ++RL  +  E ++R L  + E++P G L ++L  R S      T L  A
Sbjct: 58  V------SHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYA 107

Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
                 L +LH  E  ++YRD K  NILLD +   KL+DFG AK   + + T     + G
Sbjct: 108 SEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-----LCG 160

Query: 263 TYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTG 296
           T  Y APE I S GH     D ++ G+++ E+L G
Sbjct: 161 TPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 80.0 bits (198), Expect = 6e-17
 Identities = 69/204 (33%), Positives = 89/204 (43%), Gaps = 20/204 (9%)

Query: 99  LGEGGFGTVHK-GYIDDDLRQGLKAQAVAVKLLDI--EGLQGHREWLAEVIFLGQLRHPH 155
           LG GGFG V        +    LK     VK   I   G Q H    +E   L +  HP 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKC----VKKRHIVETGQQEH--IFSEKEILEECNHPF 54

Query: 156 LVRLIGYCC-EDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
           +V+L  Y   +D++ + ++ E+   G L   L  R      +  R  IA        +LH
Sbjct: 55  IVKL--YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD-EYTARFYIA-CVVLAFEYLH 110

Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
                +IYRD K  N+LLDS+   KL DFG AK    G  T       GT  Y APE I 
Sbjct: 111 --NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIIL 165

Query: 274 TGHLTTKSDVYSFGVVLLELLTGR 297
                   D +S G++L ELLTGR
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 80.1 bits (197), Expect = 7e-17
 Identities = 74/265 (27%), Positives = 120/265 (45%), Gaps = 33/265 (12%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-EVIFLGQLRHPHLV 157
           +G+G FG V+KG ID+  ++      VA+K++D+E  +   E +  E+  L Q   P++ 
Sbjct: 12  IGKGSFGEVYKG-IDNRTKE-----VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           R  G   +  +  ++ E++  GS  + L           T L+  +   KGL +LH    
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL---KGLDYLHSERK 122

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRV-MGTYGYAAPEYISTGH 276
             I+RD K +N+LL      KL+DFG+A    + ++T +     +GT  + APE I    
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 277 LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQ 336
              K+D++S G+  +EL  G      L P     L+    P             P L GQ
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLEGQ 224

Query: 337 YSVKGAKEMAVLALQCISVNPKDRP 361
           YS    K        C++ +P+ RP
Sbjct: 225 YS----KPFKEFVEACLNKDPRFRP 245

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 79.8 bits (197), Expect = 7e-17
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 24/208 (11%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V+K         GL A   A K++ IE  +   +++ E+  L + +HP++V 
Sbjct: 13  LGDGAFGKVYKAQ---HKETGLFA---AAKIIQIESEEELEDFMVEIDILSECKHPNIVG 66

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG-TRLKIAI---GAAKGLAFLHG 214
           L      + +  ++ EF   G+L++     I + L  G T  +I        + L FLH 
Sbjct: 67  LYEAYFYENKLWILIEFCDGGALDS-----IMLELERGLTEPQIRYVCRQMLEALNFLH- 120

Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
             + VI+RD K  NILL  D   KL+DFG++           T   +GT  + APE ++ 
Sbjct: 121 -SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVAC 177

Query: 275 GHLTT-----KSDVYSFGVVLLELLTGR 297
                     K+D++S G+ L+EL    
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 79.3 bits (195), Expect = 9e-17
 Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 32/275 (11%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V     +       K   VAVK +   G      +LAE   +  L+H  LV+
Sbjct: 14  LGAGQFGEVWMATYN-------KHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVK 65

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     + E   ++ EFM +GSL + L        P    +  +   A+G+AF+   +  
Sbjct: 66  LHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRN 122

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +NIL+ +    K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGS 179

Query: 277 LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQ 336
            T KSDV+SFG++L+E++T  R      P    +  +  +   R  R  R    P     
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRI-----PYPGMSNPEVIRALERGYRMPRPENCP----- 229

Query: 337 YSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
                 +E+  + ++C    P++RP    + + L+
Sbjct: 230 ------EELYNIMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 69/286 (24%), Positives = 129/286 (45%), Gaps = 54/286 (18%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI---------EGLQGHREWL-AEVIF 147
           L+G+G +G V   Y+  ++  G   + +AVK +++            +   + L +E+  
Sbjct: 8   LIGKGTYGRV---YLALNVTTG---EMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61

Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSL----------ENHLFKRISVSLPWGT 197
           L  L H ++V+ +G+   +E   +  E++P GS+          E  L +  +  +    
Sbjct: 62  LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV---- 117

Query: 198 RLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT 257
                    +GLA+LH     +++RD K  N+L+D+D   K+SDFG++K   +  +    
Sbjct: 118 --------LEGLAYLH--SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN 167

Query: 258 TRVMGTYGYAAPEYISTGH--LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA 315
             + G+  + APE I +     + K D++S G V+LE+  GR      RP S++  +  A
Sbjct: 168 MSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSDEEAIA-A 220

Query: 316 KPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP 361
              L + R       P +    S+  +         C ++NP +RP
Sbjct: 221 MFKLGNKRSA-----PPIPPDVSMNLSPVALDFLNACFTINPDNRP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 80.0 bits (197), Expect = 1e-16
 Identities = 76/284 (26%), Positives = 134/284 (47%), Gaps = 37/284 (13%)

Query: 93  FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQL 151
           F    +LG G FGTV+KG    +  + +K   VA+K L +    + ++E L E   +  +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPE-GEKVKI-PVAIKELREATSPKANKEILDEAYVMASV 66

Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RISVS--LPWGTRLKIAIGAA 206
            +PH+ RL+G C     +L + + MP G L +++ +    I     L W  ++      A
Sbjct: 67  DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------A 119

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYG 265
           KG+ +L   E  +++RD    N+L+ +    K++DFGLAK +G +    H     +    
Sbjct: 120 KGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV-PIK 176

Query: 266 YAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
           + A E I     T +SDV+S+GV + EL+T G +  D + P SE + +      L    R
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSI------LEKGER 229

Query: 325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA 368
           L     P +          ++ ++ ++C  ++   RPK   ++ 
Sbjct: 230 LP---QPPIC-------TIDVYMIMVKCWMIDADSRPKFRELII 263

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 62/208 (29%), Positives = 89/208 (42%), Gaps = 14/208 (6%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LGEG FG V      +   +  K   VAVK L        +++  E   L  L+H H+V+
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKI-LVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKR-----------ISVSLPWGTRLKIAIGAAK 207
             G C E +  ++V+E+M  G L   L                  L     L IA   A 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+ +L  A    ++RD  T N L+  +   K+ DFG+++         V    M    + 
Sbjct: 132 GMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLT 295
            PE I     TT+SDV+S GVVL E+ T
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 58/199 (29%), Positives = 103/199 (51%), Gaps = 15/199 (7%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G+G  GTV   Y   D+  G   Q VA+K ++++        + E++ + + +HP++V 
Sbjct: 27  IGQGASGTV---YTAIDVATG---QEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
            +      +E  +V E++  GSL + +       +  G    +     + L FLH   N 
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHS--NQ 135

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
           VI+RD K+ NILL  D + KL+DFG  A++ PE S     + ++GT  + APE ++    
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAY 192

Query: 278 TTKSDVYSFGVVLLELLTG 296
             K D++S G++ +E++ G
Sbjct: 193 GPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 79/299 (26%), Positives = 122/299 (40%), Gaps = 47/299 (15%)

Query: 98  LLGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVI-------FLG 149
            LGEG FG V K   +  D     +   VAVK+L  +      + L++++        +G
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPN--ETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIG 73

Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKR------ISVSLPWGTRLKI-- 201
           +  H +++ L+G C ++    +V E+   G+L + L  R       S   P      +  
Sbjct: 74  K--HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 202 ------AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH 255
                 A   A+G+ FL  A    I+RD    N+L+  D   K++DFGLA+         
Sbjct: 132 KDLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR 189

Query: 256 VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA 315
            TT       + APE +     T +SDV+SFGV+L E+ T   S     P  E  L    
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LFK-- 245

Query: 316 KPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
              L+   R+     P+   Q       E+  L   C    P  RP    +V  L+ +L
Sbjct: 246 --LLKEGYRME---KPQNCTQ-------ELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 16/201 (7%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHLV 157
           LG G  G V K      +        +A KL+ +E     R + + E+  L +   P++V
Sbjct: 9   LGAGNGGVVTK------VLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
              G    D E  +  E M  GSL+  L K+    +P     KI+I   +GL +L   ++
Sbjct: 63  GFYGAFYSDGEISICMEHMDGGSLDQVL-KKAG-RIPENILGKISIAVLRGLTYLR-EKH 119

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG-SNTHVTTRVMGTYGYAAPEYISTGH 276
            +++RD K SNIL++S    KL DFG++    +  +N+ V TR      Y +PE +   H
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQGTH 174

Query: 277 LTTKSDVYSFGVVLLELLTGR 297
            T +SD++S G+ L+E+  GR
Sbjct: 175 YTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 17/210 (8%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA----EVIFLGQLRH 153
           L+G G FG+V+ G ++    + +  + V +  +        R  L     E+  L +L+H
Sbjct: 7   LIGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65

Query: 154 PHLVRLIGYCCEDEERLLVY-EFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
            ++V+ +G    D + L ++ E++P GS+   L    +            I   KGL +L
Sbjct: 66  ENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI--LKGLNYL 122

Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR-----VMGTYGYA 267
           H     +I+RD K +NIL+D+    K+SDFG++K   E ++    T      + G+  + 
Sbjct: 123 HNRG--IIHRDIKGANILVDNKGGIKISDFGISKK-LEANSLSTKTNGARPSLQGSVFWM 179

Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           APE +     T K+D++S G +++E+LTG+
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 74/279 (26%), Positives = 117/279 (41%), Gaps = 37/279 (13%)

Query: 90  TQNFSSNYLLGEGGFGTVHKGY-IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFL 148
             NF     +G+G F  V+K   + D     LK     V++ ++   +  ++ L E+  L
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKK----VQIFEMMDAKARQDCLKEIDLL 56

Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHL--FKRISVSLPWGTRLKIAIGAA 206
            QL HP++++ +    E+ E  +V E    G L   +  FK+    +P  T  K  +   
Sbjct: 57  KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
             L  +H     +++RD K +N+ + +    KL D GL +     S T     ++GT  Y
Sbjct: 117 SALEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYY 172

Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLEL--LTGRRSMDKLRPKSEQNLVDWAK-------- 316
            +PE I       KSD++S G +L E+  L      DK+      NL    K        
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEKCDYP 226

Query: 317 --PYLRSSRRLRYIV------DP--RLAGQYSVKGAKEM 345
             P    S  LR +V      DP  R    Y ++ AKEM
Sbjct: 227 PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 56/167 (33%), Positives = 84/167 (50%), Gaps = 25/167 (14%)

Query: 144 EVIFLGQLR-HPHLVRLIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLK 200
           E++FL +L  HP++V+L+     + ++   LV+E+M     E  L   I  ++     L+
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANI-----LE 105

Query: 201 ------IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM---GPEG 251
                 I     K L ++H     VI+RD K SNILL+SD   KL+DFGLA+      E 
Sbjct: 106 DVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163

Query: 252 SNTHVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
               V T  + T  Y APE +      TK  D++S G +L E+L G+
Sbjct: 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 5e-16
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 24/215 (11%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G +G V+K     D+  G   + VA+K++ +E          E+  L + RHP++V 
Sbjct: 11  IGSGTYGDVYKAR---DIATG---ELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI---GAAKGLAFLHGA 215
             G     ++  +V E+   GSL++ +++     L     L+IA       KGLA+LH  
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLS---ELQIAYVCRETLKGLAYLH-- 118

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR--VMGTYGYAAPEYI- 272
           E   I+RD K +NILL  D   KL+DFG++    + + T +  R   +GT  + APE   
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVSA---QLTAT-IAKRKSFIGTPYWMAPEVAA 174

Query: 273 --STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRP 305
               G    K D+++ G+  +EL   +  M  L P
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDLHP 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 77.5 bits (191), Expect = 5e-16
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 36/213 (16%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLAEVIFLGQLRHPHLV 157
           LGEG + TV+KG      R     + VA+K + ++  +G     + E+  + +L+H ++V
Sbjct: 8   LGEGTYATVYKG------RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 158 RLIGYCCEDEERLLVYEFM------------PRGSLENHLFKRISVSLPWGTRLKIAIGA 205
           RL      + + +LV+E+M             RG+L+ +  K  +  L            
Sbjct: 62  RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL------------ 109

Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
            KG+AF H  EN V++RD K  N+L++     KL+DFGLA+      NT     V  T  
Sbjct: 110 LKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLW 165

Query: 266 YAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           Y AP+  + +   +T  D++S G ++ E++TGR
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 77.8 bits (191), Expect = 5e-16
 Identities = 66/207 (31%), Positives = 96/207 (46%), Gaps = 34/207 (16%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIFLGQLRHPH 155
           +G G FG V   Y   D+R     + VA+K +   G Q + +W   + EV FL +LRHP+
Sbjct: 23  IGHGSFGAV---YFARDVRNS---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGS---LENHL--FKRISVSLPWGTRLKIAIGAAKGLA 210
            ++  G    +    LV E+    +   LE H    + + ++        +  GA +GLA
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-------AVTHGALQGLA 129

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAP 269
           +LH   + +I+RD K  NILL      KL DFG A  M P           +GT  + AP
Sbjct: 130 YLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-------FVGTPYWMAP 180

Query: 270 EYI---STGHLTTKSDVYSFGVVLLEL 293
           E I     G    K DV+S G+  +EL
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 77.5 bits (191), Expect = 7e-16
 Identities = 68/204 (33%), Positives = 95/204 (46%), Gaps = 20/204 (9%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAE-VIFLGQLRHP 154
           +G+G FG V         +     +  AVK+L  + +   +E    +AE  + L  ++HP
Sbjct: 3   IGKGSFGKVLLA------KHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHP 56

Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKI-AIGAAKGLAFL 212
            LV L  Y  +  ++L  V +++  G L  HL +  S   P   R +  A   A  L +L
Sbjct: 57  FLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP---RARFYAAEIASALGYL 112

Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
           H     +IYRD K  NILLDS     L+DFGL K G E S T  T+   GT  Y APE +
Sbjct: 113 HSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVL 168

Query: 273 STGHLTTKSDVYSFGVVLLELLTG 296
                    D +  G VL E+L G
Sbjct: 169 RKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 77.4 bits (191), Expect = 7e-16
 Identities = 67/225 (29%), Positives = 103/225 (45%), Gaps = 42/225 (18%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI----EGLQGHREWLAEVIFLGQLRHP 154
           LGEG FG V+K       RQ    + VA+K + +    +G       L E+  L +L+HP
Sbjct: 16  LGEGTFGEVYKA------RQIKTGRVVALKKILMHNEKDGF--PITALREIKILKKLKHP 67

Query: 155 HLVRLIGYCCE-----DEERLLVYEFMP------RGSLENHLFKRISVSLPWGTRLK-IA 202
           ++V LI    E       +R  VY   P       G LEN     + ++     ++K   
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN---PSVKLTES---QIKCYM 121

Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK---------MGPEGSN 253
           +   +G+ +LH  EN +++RD K +NIL+D+    K++DFGLA+          G  G  
Sbjct: 122 LQLLEGINYLH--ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179

Query: 254 THVTTRVMGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
           T   T ++ T  Y  PE +      TT  D++  G V  E+ T R
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 76.5 bits (188), Expect = 9e-16
 Identities = 72/281 (25%), Positives = 127/281 (45%), Gaps = 44/281 (15%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQ-AVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LG G FG V  G          + Q  VA+K++  EG     E++ E   + +L H  LV
Sbjct: 12  LGTGQFGVVKYG--------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLV 62

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHL---FKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
           +L G C +     +V E+M  G L N+L    KR   S      L++     +G+A+L  
Sbjct: 63  QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPS----QLLEMCKDVCEGMAYLES 118

Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT---YGYAAPEY 271
            +   I+RD    N L+D     K+SDFGL++   +       T  +G+     ++ PE 
Sbjct: 119 KQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEV 172

Query: 272 ISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
           +     ++KSDV++FGV++ E+ + G+   ++    +    V+     LR  R       
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF---NNSETVEKVSQGLRLYR------- 222

Query: 331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
           P LA       ++++  +   C     ++RP    +++++E
Sbjct: 223 PHLA-------SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 69/206 (33%), Positives = 94/206 (45%), Gaps = 32/206 (15%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIFLGQLRHPH 155
           +G G FG V+              + VAVK +   G Q + +W   + EV FL QL+HP+
Sbjct: 29  IGHGSFGAVYFA------TNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGS----LENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
            +   G   ++    LV E+   GS    LE H      V +       I  GA +GLA+
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA-----AITHGALQGLAY 136

Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAPE 270
           LH   + +I+RD K  NILL      KL+DFG A K  P  S        +GT  + APE
Sbjct: 137 LH--SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS-------FVGTPYWMAPE 187

Query: 271 YI---STGHLTTKSDVYSFGVVLLEL 293
            I     G    K DV+S G+  +EL
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 29/280 (10%)

Query: 92  NFSSNYLLGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ 150
           NF     +G G F  V++   + D +   LK     V++ D+   +   + + E+  L Q
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKK----VQIFDLMDAKARADCIKEIDLLKQ 58

Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHL--FKRISVSLPWGTRLKIAIGAAKG 208
           L HP++++      ED E  +V E    G L   +  FK+    +P  T  K  +     
Sbjct: 59  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118

Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           L  +H     V++RD K +N+ + +    KL D GL +     S T     ++GT  Y +
Sbjct: 119 LEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMS 174

Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLTGRRSM--DKLRPKSEQNLVDWAKPYLRSSRRLR 326
           PE I       KSD++S G +L E+   +     DK+      NL    K   +      
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEQCD---- 224

Query: 327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
               P  +  YS    +E+  L   CI+ +P+ RP +  V
Sbjct: 225 --YPPLPSDHYS----EELRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 68/216 (31%), Positives = 106/216 (49%), Gaps = 26/216 (12%)

Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA---EVIFL 148
           N+    LLG G FG V+  Y D D  + L  + V     D +  +  +E  A   E+  L
Sbjct: 3   NWRLGKLLGRGAFGEVYLCY-DADTGRELAVKQVP---FDPDSQETSKEVNALECEIQLL 58

Query: 149 GQLRHPHLVRLIGYCCED--EERLLVY-EFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
             LRH  +V+  G C  D  E++L ++ E+MP GS+++ L  +   +L      +     
Sbjct: 59  KNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQI 115

Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK------MGPEGSNTHVTTR 259
            +G+++LH   N +++RD K +NIL DS    KL DFG +K      M   G  +     
Sbjct: 116 LQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS----- 168

Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
           V GT  + +PE IS      K+DV+S    ++E+LT
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 76.3 bits (187), Expect = 1e-15
 Identities = 60/221 (27%), Positives = 112/221 (50%), Gaps = 21/221 (9%)

Query: 83  LSELRAIT------QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ 136
           L +LR+I       + ++    +G+G  GTV   Y   D+  G   Q VA++ ++++   
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTV---YTAMDVATG---QEVAIRQMNLQQQP 59

Query: 137 GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG 196
                + E++ + + ++P++V  +      +E  +V E++  GSL + +       +  G
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEG 116

Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGSNTH 255
               +     + L FLH   N VI+RD K+ NILL  D + KL+DFG  A++ PE S   
Sbjct: 117 QIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172

Query: 256 VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
             + ++GT  + APE ++      K D++S G++ +E++ G
Sbjct: 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 60/203 (29%), Positives = 90/203 (44%), Gaps = 16/203 (7%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ---GHREWLAEVIFLGQLRHPH 155
           LG+GGFG V    + +        +  A K LD + L+   G +  L E   L ++  P 
Sbjct: 1   LGKGGFGEVCAVQVKN------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPF 54

Query: 156 LVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
           +V L  Y  E +  L LV   M  G L+ H++      L     +  +     G+  LH 
Sbjct: 55  IVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH- 112

Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
               ++YRD K  N+LLD     +LSD GLA    +G      T+  GT GY APE +  
Sbjct: 113 -SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKE 168

Query: 275 GHLTTKSDVYSFGVVLLELLTGR 297
              +   D ++ G  + E++ GR
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 75.9 bits (186), Expect = 2e-15
 Identities = 61/221 (27%), Positives = 112/221 (50%), Gaps = 21/221 (9%)

Query: 83  LSELRAIT------QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ 136
           L +LR+I       + ++    +G+G  GTV   Y   D+  G   Q VA+K ++++   
Sbjct: 5   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTV---YTAIDIATG---QEVAIKQMNLQQQP 58

Query: 137 GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG 196
                + E++ + + ++P++V  +      +E  +V E++  GSL + +       +  G
Sbjct: 59  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEG 115

Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGSNTH 255
               +     + L FLH   N VI+RD K+ NILL  D + KL+DFG  A++ PE S   
Sbjct: 116 QIAAVCRECLQALDFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 171

Query: 256 VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
             + ++GT  + APE ++      K D++S G++ +E++ G
Sbjct: 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 70/205 (34%), Positives = 97/205 (47%), Gaps = 20/205 (9%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEV-IFLGQLRH 153
           ++G+G FG V         ++ L  +  AVK+L  + +   +E    +AE  + L  ++H
Sbjct: 2   VIGKGSFGKVLLA------KRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKH 55

Query: 154 PHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA-AKGLAF 211
           P LV L  Y  +  E+L  V +F+  G L  HL +  S   P   R +      A  L +
Sbjct: 56  PFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP---RARFYAAEIASALGY 111

Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEY 271
           LH     ++YRD K  NILLDS     L+DFGL K G   S+T  TT   GT  Y APE 
Sbjct: 112 LHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEV 167

Query: 272 ISTGHLTTKSDVYSFGVVLLELLTG 296
           I         D +  G VL E+L G
Sbjct: 168 IRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 71/229 (31%), Positives = 102/229 (44%), Gaps = 39/229 (17%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHL 156
           ++GEG +G V+K       R     Q VA+K++DI       E   E   L +   HP++
Sbjct: 13  VIGEGTYGKVYKA------RHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNI 65

Query: 157 VRLIG------YCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------IAIG 204
               G          D++  LV E    GS+ + L K +      G RLK      I   
Sbjct: 66  ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGL---RKKGKRLKEEWIAYILRE 121

Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM--GPEGS-NTHVTTRVM 261
             +GLA+LH  EN VI+RD K  NILL  +   KL DFG++       G  NT +     
Sbjct: 122 TLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI----- 174

Query: 262 GTYGYAAPEYIS-----TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRP 305
           GT  + APE I+           +SDV+S G+  +EL  G+  +  + P
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 52/151 (34%), Positives = 74/151 (49%), Gaps = 16/151 (10%)

Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL- 212
           P++V+  GY   D +  +  E M   +  + L KRI   +P     K+ +   K L +L 
Sbjct: 74  PYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131

Query: 213 --HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
             HG    VI+RD K SNILLD+    KL DFG++    + S     TR  G   Y APE
Sbjct: 132 EKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVD-SKAK--TRSAGCAAYMAPE 184

Query: 271 YI----STGHLTTKSDVYSFGVVLLELLTGR 297
            I           ++DV+S G+ L+EL TG+
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 16/201 (7%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHLV 157
           LG G  G V K      ++       +A KL+ +E     R + + E+  L +   P++V
Sbjct: 13  LGAGNGGVVTK------VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
              G    D E  +  E M  GSL+  L  + +  +P     K++I   +GLA+L   ++
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLR-EKH 123

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAPEYISTGH 276
            +++RD K SNIL++S    KL DFG++ ++    +N+ V TR      Y +PE +   H
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQGTH 178

Query: 277 LTTKSDVYSFGVVLLELLTGR 297
            + +SD++S G+ L+EL  GR
Sbjct: 179 YSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 54/157 (34%), Positives = 76/157 (48%), Gaps = 17/157 (10%)

Query: 146 IFL--GQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKI- 201
           IF      RHP LV L   C + E+ +  V E+   G L  H+   +  S P   R    
Sbjct: 52  IFETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDV-FSEP---RAVFY 106

Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTR 259
           A     GL +LH  EN ++YRD K  N+LLD++   K++DFGL K  MG        T+ 
Sbjct: 107 AACVVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR----TST 160

Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
             GT  + APE ++    T   D +  GV++ E+L G
Sbjct: 161 FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 41/225 (18%)

Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFLG 149
           NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L 
Sbjct: 1   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 54

Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFM-----------PRGSLENHLFKRISVSLPWGTR 198
           +L HP++V+L+     + +  LV+EF+           P   +   L K     L     
Sbjct: 55  ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQL----- 109

Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MG-PEGSNTHV 256
                   +GLAF H   + V++RD K  N+L++++   KL+DFGLA+  G P  + TH 
Sbjct: 110 -------LQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 160

Query: 257 TTRVMGTYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGRRSM 300
                 T  Y APE  +   + +T  D++S G +  E++T RR++
Sbjct: 161 VV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 74/265 (27%), Positives = 122/265 (46%), Gaps = 33/265 (12%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-EVIFLGQLRHPHLV 157
           +G+G FG V KG ID+  +Q      VA+K++D+E  +   E +  E+  L Q   P++ 
Sbjct: 12  IGKGSFGEVFKG-IDNRTQQ-----VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G   +  +  ++ E++  GS  + L           T LK  +   KGL +LH  + 
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSEKK 122

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRV-MGTYGYAAPEYISTGH 276
             I+RD K +N+LL      KL+DFG+A    + ++T +     +GT  + APE I    
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIQQSA 177

Query: 277 LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQ 336
             +K+D++S G+  +EL  G      + P     L+    P             P L G+
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-------------PTLTGE 224

Query: 337 YSVKGAKEMAVLALQCISVNPKDRP 361
           +S K  KE       C++ +P  RP
Sbjct: 225 FS-KPFKEFID---ACLNKDPSFRP 245

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 55/165 (33%), Positives = 81/165 (49%), Gaps = 10/165 (6%)

Query: 153 HPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           HP LV L   C + E RL  V EF+  G L  H+ ++    LP       +   +  L F
Sbjct: 55  HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNF 111

Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEY 271
           LH  E  +IYRD K  N+LLD++   KL+D+G+ K G    +T  T+   GT  Y APE 
Sbjct: 112 LH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYIAPEI 167

Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMD--KLRPKSEQNLVDW 314
           +         D ++ GV++ E++ GR   D   +    +QN  D+
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY 212

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 75.9 bits (186), Expect = 3e-15
 Identities = 72/244 (29%), Positives = 111/244 (45%), Gaps = 39/244 (15%)

Query: 59  SRSSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQ 118
           SR+ S + + ++A  F  +  +   ++LR I          G G FG V   Y   D+R 
Sbjct: 4   SRAGSLK-DPEIAELFFKEDPEKLFTDLREI----------GHGSFGAV---YFARDVR- 48

Query: 119 GLKAQAVAVKLLDIEGLQGHREW---LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEF 175
               + VA+K +   G Q + +W   + EV FL +++HP+ +   G    +    LV E+
Sbjct: 49  --TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106

Query: 176 MPRGS---LENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD 232
               +   LE H      V +       I  GA +GLA+LH   + +I+RD K  NILL 
Sbjct: 107 CLGSASDLLEVHKKPLQEVEIA-----AITHGALQGLAYLH--SHNMIHRDIKAGNILLT 159

Query: 233 SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI---STGHLTTKSDVYSFGVV 289
                KL+DFG A +    ++       +GT  + APE I     G    K DV+S G+ 
Sbjct: 160 EPGQVKLADFGSASIASPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 213

Query: 290 LLEL 293
            +EL
Sbjct: 214 CIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 55/199 (27%), Positives = 103/199 (51%), Gaps = 15/199 (7%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G+G  GTV   +   D+  G   Q VA+K ++++        + E++ + +L++P++V 
Sbjct: 27  IGQGASGTV---FTAIDVATG---QEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
            +      +E  +V E++  GSL + +       +       +     + L FLH   N 
Sbjct: 81  FLDSFLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHA--NQ 135

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
           VI+RD K+ N+LL  D + KL+DFG  A++ PE S     + ++GT  + APE ++    
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAY 192

Query: 278 TTKSDVYSFGVVLLELLTG 296
             K D++S G++ +E++ G
Sbjct: 193 GPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 18/212 (8%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LGE  FG V+KG++      G + QAVA+K L D        E+  E +   +L+HP++V
Sbjct: 13  LGEDRFGKVYKGHLFGT-APGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKR--------------ISVSLPWGTRLKIAI 203
            L+G   +++   +++ +     L   L  R              +  +L     + I  
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT 263
             A G+ FL  + + V+++D  T N+L+      K+SD GL +         +    +  
Sbjct: 132 QIAAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 264 YGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
             + +PE I  G  +  SD++S+GVVL E+ +
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 79/289 (27%), Positives = 125/289 (43%), Gaps = 50/289 (17%)

Query: 99  LGEGGFGTVHKGYI----DDDLRQGLKAQAVAVKLLDIEGLQGHREWLA--EVI-FLGQL 151
           LG+G F  ++KG +    D D+    +  +V +K+L       HR+ LA  E    + QL
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG----SDHRDSLAFFETASLMSQL 58

Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK-RISVSLPWGTRLKIAIGAAKGLA 210
            H HLV+L G C  DE  ++V E++  G L+  L + + +VSL W  +L +A   A  L 
Sbjct: 59  SHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALH 115

Query: 211 FLHGAENPVIYRDFKTSNILL--DSDFT-----AKLSDFGLAKMGPEGSNTHVTTRVMGT 263
           +L   +  +++ +    NIL+             KLSD G+       S      R+   
Sbjct: 116 YLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI--- 168

Query: 264 YGYAAPEYISTGH--LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS 321
             + APE I  G   LT  +D +SFG  LLE+ +            E+ L         S
Sbjct: 169 -PWIAPECIRNGQASLTIAADKWSFGTTLLEICSN----------GEEPL----STLSSS 213

Query: 322 SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL 370
            +   Y    +   +  +    E+A L  QC + +P  RP   A++  L
Sbjct: 214 EKERFY----QDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 68/276 (24%), Positives = 113/276 (40%), Gaps = 28/276 (10%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK-LLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           +G G FG V  G +  D         VAVK   +        ++L E   L Q  HP++V
Sbjct: 3   IGRGNFGEVFSGRLRAD------NTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 56

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           RLIG C + +   +V E +  G     L +     L     +++   AA G+ +L     
Sbjct: 57  RLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKH- 114

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
             I+RD    N L+      K+SDFG+++   +G              + APE ++ G  
Sbjct: 115 -CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173

Query: 278 TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR-SSRRLRYIVDPRLAGQ 336
           +++SDV+SFG++L E  +                   A PY   S+++ R  ++  +   
Sbjct: 174 SSESDVWSFGILLWEAFSLG-----------------AVPYANLSNQQTREAIEQGVRLP 216

Query: 337 YSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES 372
                   +  L  +C   +P  RP  + V   L+S
Sbjct: 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 74.7 bits (183), Expect = 5e-15
 Identities = 74/284 (26%), Positives = 135/284 (47%), Gaps = 37/284 (13%)

Query: 98  LLGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPH 155
           +LG G FGTV+KG +I D   + +K   VA+K+L +    + ++E L E   +  +  P+
Sbjct: 14  VLGSGAFGTVYKGIWIPDG--ENVKI-PVAIKVLRENTSPKANKEILDEAYVMAGVGSPY 70

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RISVSLPWGTR--LKIAIGAAKGLA 210
           + RL+G C     +L V + MP G L +++ +   RI      G++  L   +  AKG++
Sbjct: 71  VCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRI------GSQDLLNWCVQIAKGMS 123

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           +L   E  +++RD    N+L+ S    K++DFGLA++       +          + A E
Sbjct: 124 YLE--EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181

Query: 271 YISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
            I     T +SDV+S+GV + EL+T G +  D +  +   +L       L    RL    
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL-------LEKGERLP--- 231

Query: 330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
            P +          ++ ++ ++C  ++ + RP+   +V     +
Sbjct: 232 QPPIC-------TIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 74.9 bits (184), Expect = 6e-15
 Identities = 68/211 (32%), Positives = 95/211 (45%), Gaps = 32/211 (15%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---------DIEGLQGHREWLAEVIFL 148
           +LG+G FG V    + +        +  AVK+L         D+E     +  L+    L
Sbjct: 2   VLGKGSFGKVMLARLKES------GRLYAVKVLKKDVILQDDDVECTMTEKRILS----L 51

Query: 149 GQLRHPHLVRLIGYCC-EDEERLL-VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAA 206
            +  HP L +L  YCC +  +RL  V EF+  G L  H+ K               I +A
Sbjct: 52  AR-NHPFLTQL--YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA 108

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM-GTYG 265
             L FLH  +  +IYRD K  N+LLD +   KL+DFG+ K   EG     TT    GT  
Sbjct: 109 --LMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPD 161

Query: 266 YAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           Y APE +         D ++ GV+L E+L G
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 64/211 (30%), Positives = 88/211 (41%), Gaps = 30/211 (14%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---------DIEGLQGHREWLAEVIFL 148
           +LG+G FG V    +          +  A+K L         D+E     R  LA    L
Sbjct: 2   VLGKGSFGKVMLAELKG------TNEFFAIKALKKDVVLEDDDVECTMVERRVLA----L 51

Query: 149 GQLRHPHLVRLIGYCC-EDEERLL-VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAA 206
               HP L  L  +C  + +E L  V E++  G L  H+                 I   
Sbjct: 52  AW-EHPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEI--I 106

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
            GL FLH  +  +IYRD K  N+LLD D   K++DFG+ K    G      +   GT  Y
Sbjct: 107 CGLQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162

Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
            APE +         D +SFGV+L E+L G+
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 77/292 (26%), Positives = 128/292 (43%), Gaps = 40/292 (13%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK-LLDIEGLQGHREW-LAEVIFLGQLRHPH 155
           L+GEG +G V K       +     Q VA+K  L+ E  +  ++  + E+  L QLRH +
Sbjct: 8   LVGEGSYGMVMK------CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LV LI      +   LV+EF+    L++   ++    L      K      +G+ F H  
Sbjct: 62  LVNLIEVFRRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVRKYLFQILRGIEFCH-- 117

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM--GPEGSNT-HVTTRVMGTYGYAAPEYI 272
            + +I+RD K  NIL+      KL DFG A+    P    T +V TR      Y APE +
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPELL 172

Query: 273 STGHLTTKS-DVYSFGVVLLELLTGR----------------RSMDKLRPKSEQNLVDWA 315
                  ++ D+++ G ++ E+LTG                 + +  L P+  Q +    
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPR-HQEIFQ-- 229

Query: 316 KPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
           K  L +  RL  + +     +   K +  +  LA QC+ ++P DRP  + ++
Sbjct: 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 32/208 (15%)

Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIFLGQL 151
           LG G FG V    HKG            +  A+K L   +I  ++  +    E   L +L
Sbjct: 26  LGTGSFGRVRIAKHKG----------TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75

Query: 152 RHPHLVRLI-GYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            HP +V ++  +  +DE R+  + EF+  G L  HL  R +   P    +     A   L
Sbjct: 76  SHPFIVNMMCSF--QDENRVYFLLEFVVGGELFTHL--RKAGRFP--NDVAKFYHAELVL 129

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
           AF +     +IYRD K  N+LLD+    K++DFG AK  P+ + T     + GT  Y AP
Sbjct: 130 AFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGTPEYLAP 184

Query: 270 EYI-STGHLTTKSDVYSFGVVLLELLTG 296
           E I S GH     D ++ GV+L E + G
Sbjct: 185 EVIQSKGH-GKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 72/209 (34%), Positives = 103/209 (49%), Gaps = 27/209 (12%)

Query: 98  LLGEGGFGTVH--KGYIDDDLRQGLKAQAV----AVKLLDIEGLQGHREWLAEVIFLGQL 151
           +LG+G FG V   +     D  Q L A  V     +K+ D    +  R+ LAEV      
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQ-LYAMKVLKKATLKVRDRVRTKMERDILAEV------ 55

Query: 152 RHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTR-LKIAIGA-AKG 208
            HP +V+L  Y  + E +L L+ +F+  G L    F R+S  + +    +K  +   A  
Sbjct: 56  NHPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALA 110

Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           L  LH     +IYRD K  NILLD +   KL+DFGL+K   +           GT  Y A
Sbjct: 111 LDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMA 166

Query: 269 PEYIS-TGHLTTKSDVYSFGVVLLELLTG 296
           PE ++  GH T  +D +SFGV++ E+LTG
Sbjct: 167 PEVVNRRGH-TQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 70/234 (29%), Positives = 102/234 (43%), Gaps = 39/234 (16%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFLGQLRHPHL 156
           +GEG +G V K       R     Q VA+K  +   +     +  L E+  L QL+HP+L
Sbjct: 9   IGEGSYGVVFK------CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNL 62

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           V LI       +  LV+E+    ++ N L K     +P     KI     + + F H  +
Sbjct: 63  VNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH--K 118

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKM--GPEGSNT-HVTTRVMGTYGYAAPEYIS 273
           +  I+RD K  NIL+      KL DFG A++  GP    T +V TR      Y APE + 
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPELL- 172

Query: 274 TGHLT--TKSDVYSFGVVLLELLTG----------------RRSMDKLRPKSEQ 309
            G        DV++ G V  ELLTG                R+++  L P+ +Q
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 226

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 69/237 (29%), Positives = 106/237 (44%), Gaps = 56/237 (23%)

Query: 85  ELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---- 140
             R++T  F     +GEG +G V++     D   G   + VA+K + ++      E    
Sbjct: 2   RCRSVT-EFEKLNRIGEGTYGIVYRA---RDTTSG---EIVALKKVRMD-----NERDGI 49

Query: 141 ---WLAEVIFLGQLRHPHLVRL---------------IGYCCEDEERLLVYEFMPRGSLE 182
               L E+  L  LRHP++V L               + YC +D   LL  + MP    E
Sbjct: 50  PISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPTPFSE 107

Query: 183 NHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF 242
           + + K + + L             +GL +LH  EN +I+RD K SN+LL      K++DF
Sbjct: 108 SQV-KCLMLQL------------LRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADF 152

Query: 243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYI--STGHLTTKSDVYSFGVVLLELLTGR 297
           GLA+    G      T  + T  Y APE +   T + TT  D+++ G +L ELL  +
Sbjct: 153 GLART--YGLPAKPMTPKVVTLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 68/213 (31%), Positives = 103/213 (48%), Gaps = 16/213 (7%)

Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA---EVIFL 148
           N+    LLG+G FG V+  Y  D  R+     AV     D E  +  +E  A   E+  L
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRE----LAVKQVQFDPESPETSKEVNALECEIQLL 58

Query: 149 GQLRHPHLVRLIGYCCEDEERLL--VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAA 206
             L H  +V+  G   +  ER L    E MP GS+++ L  +   +L      K      
Sbjct: 59  KNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQIL 116

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE--GSNTHVTTRVMGTY 264
           +G+++LH   N +++RD K +NIL DS    KL DFG +K       S T + + V GT 
Sbjct: 117 EGVSYLH--SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTP 173

Query: 265 GYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
            + +PE IS      K+D++S G  ++E+LT +
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 71.8 bits (176), Expect = 3e-14
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 34/214 (15%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           +LG+G +G V+      DL   ++   +A+K +     +  +    E+     L+H ++V
Sbjct: 15  VLGKGTYGIVYAA---RDLSTQVR---IAIKEIPERDSRYVQPLHEEIALHSYLKHRNIV 68

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG-------TRLKIAIGAAKGLA 210
           + +G   E+    +  E +P GSL   L  +      WG       T +       +GL 
Sbjct: 69  QYLGSDSENGFFKIFMEQVPGGSLSALLRSK------WGPLKDNEQTIIFYTKQILEGLK 122

Query: 211 FLHGAENPVIYRDFKTSNILLDS-DFTAKLSDFG----LAKMGPEGSNTHVTTRVMGTYG 265
           +LH  +N +++RD K  N+L+++     K+SDFG    LA + P       T    GT  
Sbjct: 123 YLH--DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CTETFTGTLQ 174

Query: 266 YAAPEYISTGH--LTTKSDVYSFGVVLLELLTGR 297
           Y APE I  G       +D++S G  ++E+ TG+
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 67/238 (28%), Positives = 114/238 (47%), Gaps = 27/238 (11%)

Query: 96  NYL-LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           NY+ +GEG  G V         R+    + VAVK++D+   Q       EV+ +   +H 
Sbjct: 25  NYIKIGEGSTGIVCIA------REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQ 78

Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI---GAAKGLAF 211
           ++V +       EE  ++ EF+  G+L +       VS       +IA       + L +
Sbjct: 79  NVVEMYKSYLVGEELWVLMEFLQGGALTD------IVSQTRLNEEQIATVCESVLQALCY 132

Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGSNTHVTTR--VMGTYGYAA 268
           LH     VI+RD K+ +ILL  D   KLSDFG  A++  +     V  R  ++GT  + A
Sbjct: 133 LHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD-----VPKRKSLVGTPYWMA 185

Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRP-KSEQNLVDWAKPYLRSSRRL 325
           PE IS     T+ D++S G++++E++ G        P ++ + L D   P L+++ ++
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKI 243

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 67/225 (29%), Positives = 101/225 (44%), Gaps = 16/225 (7%)

Query: 93  FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLG 149
           F    +LG+GGFG V    +          +  A K L+   I+  +G    L E   L 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVR------ATGKMYACKKLEKKRIKKRKGESMALNEKQILE 55

Query: 150 QLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
           ++    +V L  Y  E ++ L LV   M  G L+ H++         G  +  A     G
Sbjct: 56  KVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114

Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           L  LH  +  ++YRD K  NILLD     ++SD GLA   PEG    +  RV GT GY A
Sbjct: 115 LEDLH--QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMA 169

Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
           PE +     T   D ++ G +L E++ G+    + + K ++  V+
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 71.7 bits (176), Expect = 5e-14
 Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 25/208 (12%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA--EVIFLGQLRHPHL 156
           +GEG +G V+KG      R     Q VA+K + +E  +      A  E+  L +L+HP++
Sbjct: 8   IGEGTYGVVYKG------RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAA------KGLA 210
           V L     ++    L++EF+   S++    K+   SLP G  +   +  +      +G+ 
Sbjct: 62  VCLQDVLMQESRLYLIFEFL---SMD---LKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           F H     V++RD K  N+L+D+    KL+DFGLA+    G    V T  + T  Y APE
Sbjct: 116 FCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPE 171

Query: 271 -YISTGHLTTKSDVYSFGVVLLELLTGR 297
             + +   +T  D++S G +  E+ T +
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 71.5 bits (176), Expect = 5e-14
 Identities = 66/219 (30%), Positives = 99/219 (45%), Gaps = 48/219 (21%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI----EGLQGHREWLAEVIFLGQLR- 152
            +GEG +GTV+K     DL  G   + VA+K + +    EG+      L E+  L QL  
Sbjct: 6   EIGEGAYGTVYKA---RDLNTG---RFVALKKVRVPLSEEGIP--LSTLREIALLKQLES 57

Query: 153 --HPHLVRLIGYC--CEDEERL---LVYEFM-----------PRGSLENHLFKRISVSLP 194
             HP++VRL+  C     +  L   LV+E +           P+  L     K +   L 
Sbjct: 58  FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL- 116

Query: 195 WGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT 254
                       +G+ FLH   + +++RD K  NIL+ SD   K++DFGLA++    S  
Sbjct: 117 -----------LRGVDFLH--SHRIVHRDLKPQNILVTSDGQVKIADFGLARI---YSFE 160

Query: 255 HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLEL 293
              T V+ T  Y APE +      T  D++S G +  EL
Sbjct: 161 MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 71.7 bits (176), Expect = 5e-14
 Identities = 54/151 (35%), Positives = 77/151 (50%), Gaps = 15/151 (9%)

Query: 152 RHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
           R P LV L  Y  + + +L L+ +++  G L  HL++R   +    + +++ I     LA
Sbjct: 63  RCPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE---SEVRVYIAEIV-LA 117

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAA 268
             H  +  +IYRD K  NILLDS+    L+DFGL+K  +  E    +      GT  Y A
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMA 174

Query: 269 PEYI---STGHLTTKSDVYSFGVVLLELLTG 296
           PE I   S GH     D +S GV+  ELLTG
Sbjct: 175 PEVIRGGSGGH-DKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 58/185 (31%), Positives = 87/185 (47%), Gaps = 13/185 (7%)

Query: 131 DIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRI 189
           DI+ +Q  +      +F     +P LV L   C +   RL LV E++  G L  H+ ++ 
Sbjct: 38  DIDWVQTEKH-----VFEQASSNPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQ- 90

Query: 190 SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP 249
              LP       A      L FLH  E  +IYRD K  N+LLD+D   KL+D+G+ K G 
Sbjct: 91  -RKLPEEHARFYAAEICIALNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL 147

Query: 250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQ 309
              +T  T+   GT  Y APE +         D ++ GV++ E++ GR   D +    + 
Sbjct: 148 GPGDT--TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM 205

Query: 310 NLVDW 314
           N  D+
Sbjct: 206 NTEDY 210

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 71.1 bits (174), Expect = 6e-14
 Identities = 64/274 (23%), Positives = 120/274 (43%), Gaps = 34/274 (12%)

Query: 99  LGEGGFGTVH--KGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA--EVIFLGQLRHP 154
           +GEG FG ++  K   D        ++   +K +D+  +    +  +  EVI L +++HP
Sbjct: 8   IGEGSFGKIYLAKAKSD--------SEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59

Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
           ++V       E+    +V E+   G L   + ++  V       L   +  + GL  +H 
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH- 118

Query: 215 AENPVIYRDFKTSNILLDSD-FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
            +  +++RD K+ NI L  +   AKL DFG+A+      +  +    +GT  Y +PE   
Sbjct: 119 -DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEICQ 175

Query: 274 TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL 333
                 K+D++S G VL EL T +   +     +   LV      L+  +     + P  
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEG---NNLHQLV------LKICQGYFAPISPNF 226

Query: 334 AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
                   ++++  L  Q   V+P+DRP + +++
Sbjct: 227 --------SRDLRSLISQLFKVSPRDRPSITSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 71.7 bits (176), Expect = 8e-14
 Identities = 67/219 (30%), Positives = 97/219 (44%), Gaps = 32/219 (14%)

Query: 96  NYL--LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---------DIEGLQGHREWLAE 144
           N+L  LG+G FG V         R+G   +  A+K+L         D+E        + E
Sbjct: 3   NFLMVLGKGSFGKVMLAE-----RKGTD-ELYAIKILKKDVIIQDDDVECT------MVE 50

Query: 145 VIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
              L     P  +  +  C +  +RL  V E++  G L  H+ +      P        I
Sbjct: 51  KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEI 110

Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM-G 262
             A GL FLH     +IYRD K  N++LD++   K++DFG+ K   E      TTR   G
Sbjct: 111 --AIGLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFCG 163

Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMD 301
           T  Y APE I+        D ++FGV+L E+L G+   D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 71.4 bits (176), Expect = 8e-14
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 48/223 (21%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK-LLDI-EGLQGHREWLAEVIFLGQLRHPH 155
            +G G +G V       D R G K   VA+K + ++ + L   +  L E+  L  LRH +
Sbjct: 7   PIGSGAYGVVCSAV---DKRTGRK---VAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60

Query: 156 LVRLI-----GYCCEDEERLLVYEFMP---------RGSLENHLFKRISVSLPWGTRLKI 201
           ++ L+         +  +  +V E M             L +   +     +        
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQI-------- 112

Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNT-----H 255
                +GL +LH A   VI+RD K SNIL++S+   K+ DFGLA+ + P+         +
Sbjct: 113 ----LRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166

Query: 256 VTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
           V TR      Y APE + +    TK+ D++S G +  ELLT +
Sbjct: 167 VVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 71.2 bits (174), Expect = 9e-14
 Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 25/211 (11%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI----EGLQGHREWLAEVIFLGQLR-- 152
           +GEG +G V K     DL+ G   + VA+K + +    EG+      + EV  L  L   
Sbjct: 9   IGEGAYGKVFKA---RDLKNG--GRFVALKRVRVQTGEEGMP--LSTIREVAVLRHLETF 61

Query: 153 -HPHLVRLIGYCC----EDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAA 206
            HP++VRL   C     + E +L LV+E + +  L  +L K     +P  T   +     
Sbjct: 62  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL 120

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +GL FLH   + V++RD K  NIL+ S    KL+DFGLA++    S     T V+ T  Y
Sbjct: 121 RGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWY 175

Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
            APE +      T  D++S G +  E+   +
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 66/207 (31%), Positives = 97/207 (46%), Gaps = 24/207 (11%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG------LQGHREWLAEVIFLGQLR 152
           +G G +GTV+K     D   G     VA+K + ++       L   RE +A +  L    
Sbjct: 8   IGVGAYGTVYKA---RDPHSG---HFVALKSVRVQTNEDGLPLSTVRE-VALLKRLEAFD 60

Query: 153 HPHLVRLIGYCCE---DEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           HP++VRL+  C     D E    LV+E + +  L  +L K     LP  T   +     +
Sbjct: 61  HPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLR 119

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           GL FLH   N +++RD K  NIL+ S    KL+DFGLA++    S     T V+ T  Y 
Sbjct: 120 GLDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWYR 174

Query: 268 APEYISTGHLTTKSDVYSFGVVLLELL 294
           APE +      T  D++S G +  E+ 
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 66/208 (31%), Positives = 92/208 (44%), Gaps = 25/208 (12%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLAEVIFLGQLRHP 154
           LLG+G FG V        +R+    +  A+K+L  E +    E    L E   L   RHP
Sbjct: 2   LLGKGTFGKVIL------VREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHP 55

Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLP----WGTRLKIAIGAAKGL 209
            L  L  Y  +  +RL  V E+   G L  HL +    S      +G  +  A+G     
Sbjct: 56  FLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG----- 109

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
            +LH  +  V+YRD K  N++LD D   K++DFGL K G     T       GT  Y AP
Sbjct: 110 -YLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAP 164

Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGR 297
           E +         D +  GVV+ E++ GR
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 69/250 (27%), Positives = 116/250 (46%), Gaps = 44/250 (17%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +GEG  G V    I  +   G   + VAVK +D+   Q       EV+ +    H ++V 
Sbjct: 30  IGEGSTGIV---CIATEKHTG---KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVD 83

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------IAIGAAKGLAFL 212
           +       +E  +V EF+  G+L + +           TR+       + +   + L++L
Sbjct: 84  MYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIATVCLSVLRALSYL 134

Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGSNTHVTTR--VMGTYGYAAP 269
           H     VI+RD K+ +ILL SD   KLSDFG  A++  E     V  R  ++GT  + AP
Sbjct: 135 H--NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE-----VPKRKSLVGTPYWMAP 187

Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
           E IS     T+ D++S G++++E++ G                 + +P L++ RR+R  +
Sbjct: 188 EVISRLPYGTEVDIWSLGIMVIEMIDGEPPY-------------FNEPPLQAMRRIRDNL 234

Query: 330 DPRLAGQYSV 339
            PR+   + V
Sbjct: 235 PPRVKDSHKV 244

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 54/147 (36%), Positives = 68/147 (46%), Gaps = 10/147 (6%)

Query: 153 HPHLVRLIGYCC--EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
           HP L  L  YC     E    V E++  G L  H+       LP  T     I    GL 
Sbjct: 55  HPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEI--ICGLQ 110

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           FLH     ++YRD K  NILLD+D   K++DFG+ K    G     T    GT  Y APE
Sbjct: 111 FLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPE 166

Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGR 297
            +      T  D +SFGV+L E+L G+
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 70.9 bits (173), Expect = 1e-13
 Identities = 68/204 (33%), Positives = 94/204 (46%), Gaps = 17/204 (8%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLAEVIFLGQLRHP 154
           LLG+G FG V        +R+    +  A+K+L  E +    E    L E   L   RHP
Sbjct: 2   LLGKGTFGKVIL------VREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP 55

Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            L  L  Y  + ++RL  V E++  G L  HL  R  V     TR   A      L +LH
Sbjct: 56  FLTSL-KYSFQTKDRLCFVMEYVNGGELFFHL-SRERVFSEDRTRFYGA-EIVSALDYLH 112

Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
             +  ++YRD K  N++LD D   K++DFGL K G   + T  T    GT  Y APE + 
Sbjct: 113 SGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLE 168

Query: 274 TGHLTTKSDVYSFGVVLLELLTGR 297
                   D +  GVV+ E++ GR
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 15/206 (7%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG V  G ++        AQ V  +L     +Q   ++L E      L+H +L++
Sbjct: 3   IGNGWFGKVILGEVNSGYT---PAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHL-FKRISVSL-PWGTRL-KIAIGAAKGLAFLHGA 215
            +G C E    LLV EF P G L+ +L   R +  + P  T L ++A   A GL  LH  
Sbjct: 60  CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH-- 117

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +N  I+ D    N LL +D T K+ D+GL+    +        ++     + APE +   
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177

Query: 276 H-------LTTKSDVYSFGVVLLELL 294
           H        T +S+V+S GV + EL 
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 36/214 (16%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---------DIEGLQGHREWLAEVIFL 148
           +LG+G FG V          +G   +  A+K+L         D++     +  LA     
Sbjct: 2   VLGKGSFGKVMLAE-----LKG-TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA--- 52

Query: 149 GQLRHPHLVRLIGYCC-EDEERLL-VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAA 206
              +HP L  L  +CC + ++RL  V E++  G L   + +      P     +    AA
Sbjct: 53  --AKHPFLTAL--HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP-----RSRFYAA 103

Query: 207 K---GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT 263
           +    L FLH   + VIYRD K  NILLD++   KL+DFG+ K G     T  TT   GT
Sbjct: 104 EVTLALMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGT 159

Query: 264 YGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
             Y APE +         D ++ GV++ E++ G+
Sbjct: 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 68/205 (33%), Positives = 93/205 (45%), Gaps = 20/205 (9%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEV-IFLGQLRH 153
           ++G+G FG V       D          AVK+L  + +   +E    +AE  + L  L+H
Sbjct: 2   VIGKGSFGKVLLAKRKSD------GSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKH 55

Query: 154 PHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKI-AIGAAKGLAF 211
           P LV L  Y  +  E+L  V +++  G L  HL +      P   R +  A   A  + +
Sbjct: 56  PFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP---RARFYAAEVASAIGY 111

Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEY 271
           LH     +IYRD K  NILLDS     L+DFGL K G E   T  T+   GT  Y APE 
Sbjct: 112 LHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEV 167

Query: 272 ISTGHLTTKSDVYSFGVVLLELLTG 296
           +         D +  G VL E+L G
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 70/253 (27%), Positives = 119/253 (47%), Gaps = 17/253 (6%)

Query: 125 VAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLEN 183
           +A KL+ +E     R + + E+  L +   P++V   G    D E  +  E M  GSL+ 
Sbjct: 33  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 92

Query: 184 HLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFG 243
            L K  +  +P     K++I   KGL +L   ++ +++RD K SNIL++S    KL DFG
Sbjct: 93  VLKK--AGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFG 149

Query: 244 LA-KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDK 302
           ++ ++    +N+ V TR      Y +PE +   H + +SD++S G+ L+E+  GR  +  
Sbjct: 150 VSGQLIDSMANSFVGTR-----SYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204

Query: 303 LRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQ----YSVKGAKEMAVLALQCISVNPK 358
             P +++  + +  P             PR  G+    Y       MA+  L    VN +
Sbjct: 205 --PDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVN-E 261

Query: 359 DRPKMAAVVATLE 371
             PK+ + V   E
Sbjct: 262 PPPKLPSGVFGAE 274

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 54/173 (31%), Positives = 83/173 (47%), Gaps = 35/173 (20%)

Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS--NTHVT 257
           KIA+   K L +LH   + VI+RD K SN+L++ +   KL DFG++     G   ++   
Sbjct: 107 KIAVSIVKALEYLHSKLS-VIHRDVKPSNVLINRNGQVKLCDFGIS-----GYLVDSVAK 160

Query: 258 TRVMGTYGYAAPEYI----STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
           T   G   Y APE I    +      KSDV+S G+ ++EL TGR   D            
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS----------- 209

Query: 314 WAKPYLRSSRRLRYIVD---PRL-AGQYSVKGAKEMAVLALQCISVNPKDRPK 362
           W  P+    ++L+ +V+   P+L A ++S     E      +C+  N K+RP 
Sbjct: 210 WKTPF----QQLKQVVEEPSPQLPAEKFSP----EFQDFVNKCLKKNYKERPN 254

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 70.5 bits (172), Expect = 2e-13
 Identities = 55/172 (31%), Positives = 82/172 (47%), Gaps = 13/172 (7%)

Query: 131 DIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLL-VYEFMPRGSLENHLFKRI 189
           DI+ +Q  +      +F     HP LV L   C + E RL  V E++  G L  H+ ++ 
Sbjct: 38  DIDWVQTEKH-----VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQR 91

Query: 190 SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP 249
            +           I  A  L +LH  E  +IYRD K  N+LLDS+   KL+D+G+ K G 
Sbjct: 92  KLPEEHARFYSAEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147

Query: 250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMD 301
              +T  T+   GT  Y APE +         D ++ GV++ E++ GR   D
Sbjct: 148 RPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 68/282 (24%), Positives = 119/282 (42%), Gaps = 33/282 (11%)

Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK---LLDIEGLQGHREWLAEVIFL 148
           NF     +G G F  V++          L  + VA+K   + ++   +  ++ + E+  L
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCL------LDRKPVALKKVQIFEMMDAKARQDCVKEIDLL 56

Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHL--FKRISVSLPWGTRLKIAIGAA 206
            QL HP++++ +    ED E  +V E    G L   +  FK+    +P  T  K  +   
Sbjct: 57  KQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC 116

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
             +  +H     V++RD K +N+ + +    KL D GL +     S T     ++GT  Y
Sbjct: 117 SAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYY 172

Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLEL--LTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
            +PE I       KSD++S G +L E+  L      DK+      NL           ++
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NL-------FSLCQK 219

Query: 325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
           +     P L  ++  +  +E+  +   CI  +P  RP +  V
Sbjct: 220 IEQCDYPPLPTEHYSEKLRELVSM---CIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 76/272 (27%), Positives = 119/272 (43%), Gaps = 30/272 (11%)

Query: 93  FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLG 149
           F    +LG+GGFG V    +          +  A K L+   I+  +G    L E   L 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVR------ATGKMYACKKLEKKRIKKRKGEAMALNEKRILE 55

Query: 150 QLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
           ++    +V L  Y  E ++ L LV   M  G L+ H++   +        +  A     G
Sbjct: 56  KVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG 114

Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           L  L      ++YRD K  NILLD     ++SD GLA   PEG    V  RV GT GY A
Sbjct: 115 LEDLQ--RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMA 169

Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI 328
           PE I+    T   D +  G ++ E++ G+    K + + ++  VD         RR++  
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---------RRVKED 220

Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDR 360
            +     +YS K +++   +    ++ NPK+R
Sbjct: 221 QE-----EYSEKFSEDAKSICRMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 67/204 (32%), Positives = 93/204 (45%), Gaps = 16/204 (7%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLAEVIFLGQLRHP 154
           LLG+G FG V        +++    +  A+K+L  E +    E    L E   L   RHP
Sbjct: 2   LLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 55

Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            L  L  Y  +  +RL  V E+   G L  HL +    S          I +A  L +LH
Sbjct: 56  FLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYLH 112

Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
            +E  V+YRD K  N++LD D   K++DFGL K G +   T  T    GT  Y APE + 
Sbjct: 113 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLE 169

Query: 274 TGHLTTKSDVYSFGVVLLELLTGR 297
                   D +  GVV+ E++ GR
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 68.7 bits (168), Expect = 3e-13
 Identities = 70/281 (24%), Positives = 121/281 (43%), Gaps = 49/281 (17%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HREWLAEVIFLGQLRHPHL 156
           +GEG FG        +D +Q        +K ++I  +      E   EV  L  ++HP++
Sbjct: 8   IGEGSFGKAILVKSKEDGKQ------YVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS----------LPWGTRLKIAIGAA 206
           V+      E+    +V ++   G L    +K+I+            L W  ++       
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDL----YKKINAQRGVLFPEDQILDWFVQI------- 110

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
             LA  H  +  +++RD K+ NI L  D T KL DFG+A++    S   +    +GT  Y
Sbjct: 111 -CLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYY 167

Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR 326
            +PE         KSD+++ G VL E+ T + + +     + +NLV      +R S    
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA---GNMKNLV---LKIIRGSY--- 218

Query: 327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
               P ++  YS     ++  L  Q    NP+DRP + +++
Sbjct: 219 ----PPVSSHYSY----DLRNLVSQLFKRNPRDRPSVNSIL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 70.3 bits (172), Expect = 5e-13
 Identities = 49/156 (31%), Positives = 70/156 (44%), Gaps = 23/156 (14%)

Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LA  H     +I+RD K++NILL S+   KL DFG +KM     +  V     GT  Y A
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213

Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI 328
           PE       + K+D++S GV+L ELLT +R  D                       +  +
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD--------------------GENMEEV 253

Query: 329 VDPRLAGQYSV---KGAKEMAVLALQCISVNPKDRP 361
           +   LAG+Y       + EM  +    +S +PK RP
Sbjct: 254 MHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRP 289

Length = 496

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 52/162 (32%), Positives = 76/162 (46%), Gaps = 9/162 (5%)

Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLK 200
           + E   L     P  +  +  C +  +RL  V E++  G L  H+ +      P      
Sbjct: 48  MVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYA 107

Query: 201 IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRV 260
             I  + GL FLH     +IYRD K  N++LDS+   K++DFG+ K   E     VTTR 
Sbjct: 108 AEI--SVGLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRT 160

Query: 261 M-GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMD 301
             GT  Y APE I+        D +++GV+L E+L G+   D
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 75/290 (25%), Positives = 127/290 (43%), Gaps = 46/290 (15%)

Query: 98  LLGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRH 153
           LL EG FG +  G  ID+      K + V VK +  +    +Q     L E   L  L H
Sbjct: 13  LLQEGTFGRIFYGILIDEK---PGKEEEVFVKTV-KDHASEIQVTL-LLQESCLLYGLSH 67

Query: 154 PHLVRLIGYCCEDEERLLV-YEFMPRGSLENHLFKRISVSLPWGTRLK------IAIGAA 206
            +++ ++  C ED E   V Y +M  G+L+  L +           L       +AI  A
Sbjct: 68  QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPE-----GSNTHVTTRV 260
            G+++LH     VI++D    N ++D +   K++D  L++ + P      G N +   + 
Sbjct: 128 CGMSYLHKRG--VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKW 185

Query: 261 MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR 320
           M      A E +     ++ SDV+SFGV+L EL+T  ++     P  E +  + A  YL+
Sbjct: 186 M------ALESLVNKEYSSASDVWSFGVLLWELMTLGQT-----PYVEIDPFEMAA-YLK 233

Query: 321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL 370
              RL             +    E+  +   C +++P++RP  + +V  L
Sbjct: 234 DGYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 69.4 bits (170), Expect = 6e-13
 Identities = 66/233 (28%), Positives = 103/233 (44%), Gaps = 41/233 (17%)

Query: 82  QLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD-IEGLQGHRE 140
           ++++LR   ++F    ++G G FG V        +R     Q  A+KLL   E ++    
Sbjct: 34  KITKLRMKAEDFDVIKVIGRGAFGEVQL------VRHKSSKQVYAMKLLSKFEMIKR--- 84

Query: 141 WLAEVIFLGQLRH-------PHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVS 192
             ++  F  + R          +V+L  Y  +D++ L +V E+MP G L N L     + 
Sbjct: 85  --SDSAFFWEERDIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIP 140

Query: 193 LPWG----TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KM 247
             W       + +A+ A   + F+H        RD K  N+LLD     KL+DFG   KM
Sbjct: 141 EKWARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKM 192

Query: 248 GPEGSNTHVTTRVMGTYGYAAPEYIST----GHLTTKSDVYSFGVVLLELLTG 296
              G      T V GT  Y +PE + +    G+   + D +S GV L E+L G
Sbjct: 193 DANGM-VRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 68.8 bits (168), Expect = 6e-13
 Identities = 67/201 (33%), Positives = 92/201 (45%), Gaps = 15/201 (7%)

Query: 99  LGEGGFGTVHKGYIDDDLR-QGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           +G+G FG V +    D  R   LK     ++   I         LAE   L Q+  P +V
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKT----IRKAHIVSRSEVTHTLAERTVLAQVNCPFIV 56

Query: 158 RLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
            L  +  +  E+L LV  F+  G L +HL +     L   +R +    A    A  +  +
Sbjct: 57  PL-KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDL---SRARFYT-AELLCALENLHK 111

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH 276
             VIYRD K  NILLD      L DFGL K+     +   T    GT  Y APE +  GH
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNM--KDDDKTNTFCGTPEYLAPELLL-GH 168

Query: 277 LTTKS-DVYSFGVVLLELLTG 296
             TK+ D ++ GV+L E+LTG
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 68.3 bits (167), Expect = 6e-13
 Identities = 68/290 (23%), Positives = 124/290 (42%), Gaps = 50/290 (17%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH---------------REWL 142
            LG G FG V+K          ++ +     LL ++ +  H                + +
Sbjct: 7   HLGSGAFGCVYK----------VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIV 56

Query: 143 AEVIFLG-QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHL--FKRISVSLPWGTRL 199
           +EV  +  QLRHP++VR      E++   +V + +    L  H    K            
Sbjct: 57  SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116

Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
            I +     L +LH  E  +++RD   +NI+L  D    ++DFGLAK   +   + +T+ 
Sbjct: 117 NIFVQMVLALRYLH-KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKLTS- 172

Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPK-SEQNLVDWAKPY 318
           V+GT  Y+ PE +       K+DV++FG +L +       M  L+P     N++  A   
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQ-------MCTLQPPFYSTNMLSLA--- 222

Query: 319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA 368
              ++ +  + +P   G YS    +++  +   C++ + + RP +  V A
Sbjct: 223 ---TKIVEAVYEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQVSA 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 22/203 (10%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V+K     +   G  A   A K+++ +  +   +++ E+  L    HP++V+
Sbjct: 20  LGDGAFGKVYKA---KNKETGALA---AAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L+G    D +  ++ EF P G+++  + + +   L       I     + L +LH  +  
Sbjct: 74  LLGAFYWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVICRQMLEALQYLHSMK-- 130

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR---VMGTYGYAAPEYISTG 275
           +I+RD K  N+LL  D   KL+DFG++       N     R    +GT  + APE +   
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVS-----AKNVKTLQRRDSFIGTPYWMAPEVVMCE 185

Query: 276 HLTT-----KSDVYSFGVVLLEL 293
            +       K+D++S G+ L+E+
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 67.9 bits (166), Expect = 6e-13
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 39/283 (13%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQA--VAVKLLDIEGLQGHREWLAEVIF-----LGQL 151
           LG+G F  + KG I  ++    +     V +K+LD    + HR + +E  F     + QL
Sbjct: 3   LGQGTFTKIFKG-IRREVGDYGELHKTEVLLKVLD----KSHRNY-SESFFEAASMMSQL 56

Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRIS-VSLPWGTRLKIAIGAAKGLA 210
            H HLV   G C   +E ++V E++  GSL+ +L K  + +++ W  +L++A   A  L 
Sbjct: 57  SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALH 114

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT--YGYAA 268
           FL   +  + + +    N+LL  +   K  +    K+   G +  V  + +      +  
Sbjct: 115 FLE--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVP 172

Query: 269 PEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
           PE I    +L+  +D +SFG  L E+ +G                D     L S ++L++
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSG---------------GDKPLSALDSQKKLQF 217

Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL 370
             D     Q       E+A L  QC+   P  RP   A++  L
Sbjct: 218 YEDRH---QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 68.8 bits (168), Expect = 7e-13
 Identities = 51/145 (35%), Positives = 66/145 (45%), Gaps = 6/145 (4%)

Query: 153 HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
           +P L  L       E    V EF+  G L  H+  +    L   T     I    GL FL
Sbjct: 55  NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC--GLQFL 112

Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
           H     +IYRD K  N++LD D   K++DFG+ K    G N   T    GT  Y APE +
Sbjct: 113 H--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEIL 168

Query: 273 STGHLTTKSDVYSFGVVLLELLTGR 297
                T   D +SFGV+L E+L G+
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 19/205 (9%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLAEVIFLGQLRHP 154
           LLG+G FG V        +R+    +  A+K+L  E +    E    + E   L   RHP
Sbjct: 2   LLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 55

Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            L  L  Y  +  +RL  V E+   G L  HL +    +          I +A  L +LH
Sbjct: 56  FLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYLH 112

Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM-GTYGYAAPEYI 272
             +  V+YRD K  N++LD D   K++DFGL K   EG +   T +   GT  Y APE +
Sbjct: 113 SRD--VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVL 167

Query: 273 STGHLTTKSDVYSFGVVLLELLTGR 297
                    D +  GVV+ E++ GR
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 68.1 bits (166), Expect = 9e-13
 Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 19/214 (8%)

Query: 99  LGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLAEVIFLGQL-RHPH 155
           LGEG FG V     I  D  +  +   VAVK+L  +  +    + ++E+  +  + +H +
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR--------------LKI 201
           ++ L+G C +D    ++ E+  +G+L  +L  R    + +                 +  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
           A   A+G+ +L  A    I+RD    N+L+  D   K++DFGLA+          TT   
Sbjct: 146 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 203

Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
               + APE +     T +SDV+SFGV+L E+ T
Sbjct: 204 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 67.9 bits (167), Expect = 9e-13
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 41/215 (19%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW-----LAEVIFLGQL-R 152
           LG+G FG+V+        R     + VA+K +     +    W     L EV  L +L  
Sbjct: 7   LGDGTFGSVYLA------RNKETGELVAIKKM----KKKFYSWEECMNLREVKSLRKLNE 56

Query: 153 HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLF----KRISVSLPWGTRLKIAIGAAKG 208
           HP++V+L     E++E   V+E+M     E +L+     R            I     +G
Sbjct: 57  HPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQG 111

Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK----MGPEGSNTHVTTRVMGTY 264
           LA +H  ++   +RD K  N+L+      K++DFGLA+      P     +V+TR     
Sbjct: 112 LAHIH--KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--YTDYVSTR----- 162

Query: 265 GYAAPEYI--STGHLTTKSDVYSFGVVLLELLTGR 297
            Y APE +  ST   ++  D+++ G ++ EL T R
Sbjct: 163 WYRAPEILLRST-SYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 8/92 (8%)

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +GL ++H A   +I+RD K SNI ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 129 RGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 181

Query: 267 AAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
            APE + +  H     D++S G ++ ELLTG+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 68/228 (29%), Positives = 103/228 (45%), Gaps = 22/228 (9%)

Query: 93  FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLG 149
           F    +LG+GGFG V    +          +  A K L+   I+  +G    L E   L 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVR------ATGKMYACKRLEKKRIKKRKGESMALNEKQILE 55

Query: 150 QLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK- 207
           ++    +V L  Y  E ++ L LV   M  G L+ H++   ++  P     +    AA+ 
Sbjct: 56  KVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIY---NMGNPGFEEERALFYAAEI 111

Query: 208 --GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
             GL  LH      +YRD K  NILLD     ++SD GLA   PEG +  +  RV GT G
Sbjct: 112 LCGLEDLH--RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVG 166

Query: 266 YAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
           Y APE ++    T   D +  G ++ E++ G+      + K ++  VD
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 36/93 (38%), Positives = 57/93 (61%), Gaps = 4/93 (4%)

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGSNTHVTTRVMGTYG 265
           +GL ++H A   V++RD K SN+LL+++   K+ DFGLA++  PE  +T   T  + T  
Sbjct: 117 RGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 266 YAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
           Y APE +      TK+ D++S G +L E+L+ R
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 42/216 (19%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL----DIEGLQGHREWLAEVIFLGQLRHP 154
           +GEG +G V+K     D   G   + VA+K +    + EG+      + E+  L +L HP
Sbjct: 7   IGEGTYGVVYKA---RDKLTG---EIVALKKIRLETEDEGVPSTA--IREISLLKELNHP 58

Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAA-------- 206
           ++VRL+     + +  LV+EF+      +   K+   S P        +           
Sbjct: 59  NIVRLLDVVHSENKLYLVFEFL------DLDLKKYMDSSP-----LTGLDPPLIKSYLYQ 107

Query: 207 --KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MG-PEGSNTHVTTRVMG 262
             +G+A+ H   + V++RD K  N+L+D +   KL+DFGLA+  G P  + TH       
Sbjct: 108 LLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV---- 161

Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           T  Y APE  + +   +T  D++S G +  E++  R
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 19/214 (8%)

Query: 99  LGEGGFG-TVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL--RHPH 155
           LGEG FG  V    I  D  +  K   VAVK+L  +        L   + + ++  +H +
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKR--------------ISVSLPWGTRLKI 201
           ++ L+G C +D    ++ E+  +G+L  +L  R                  L +   +  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
           A   A+G+ +L  A    I+RD    N+L+  D   K++DFGLA+          TT   
Sbjct: 140 AYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGR 197

Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
               + APE +     T +SDV+SFGV+L E+ T
Sbjct: 198 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 45/177 (25%), Positives = 75/177 (42%), Gaps = 17/177 (9%)

Query: 146 IFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIG 204
           I + Q   P++ +L  Y  + ++ L LV E++  G   + +     +   W    +    
Sbjct: 49  IMMIQGESPYVAKLY-YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAE 105

Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY 264
              G+  LH     +I+RD K  N+L+D     KL+DFGL++ G          + +GT 
Sbjct: 106 VVLGVEDLHQ--RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTP 157

Query: 265 GYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRR-----SMDKLRPKSEQNLVDWAK 316
            Y APE I        SD +S G V+ E L G       + D +        ++W +
Sbjct: 158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE 214

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 72/280 (25%), Positives = 124/280 (44%), Gaps = 41/280 (14%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLAEVIFLGQLRHPHLV 157
           LG+G +G+V+K      +        +A+K + +E  +    + + E+  L +   P++V
Sbjct: 9   LGKGNYGSVYK------VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIV 62

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-LPWGTRLKIAIGAAKGLAFLHGAE 216
              G    +    +  E+M  GSL+      ++   +P     +I     KGL FL    
Sbjct: 63  DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           N +I+RD K +N+L++ +   KL DFG++  +    + T++     G   Y APE I +G
Sbjct: 123 N-IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSG 176

Query: 276 HL------TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
                   T +SDV+S G+ +LE+  GR       P++  N+            +L  IV
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYP---PETYANIFA----------QLSAIV 223

Query: 330 D---PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
           D   P L   YS      +A    +C++  P  RP  A +
Sbjct: 224 DGDPPTLPSGYSDDAQDFVA----KCLNKIPNRRPTYAQL 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 22/203 (10%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V+K     +   G+ A   A K++D +  +   +++ E+  L    HP++V+
Sbjct: 13  LGDGAFGKVYKA---QNKETGVLA---AAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 66

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L+     +    ++ EF   G+++  + + +   L       +     + L +LH  EN 
Sbjct: 67  LLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLH--ENK 123

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR---VMGTYGYAAPEYI--- 272
           +I+RD K  NIL   D   KL+DFG++       NT    R    +GT  + APE +   
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 273 --STGHLTTKSDVYSFGVVLLEL 293
                    K+DV+S G+ L+E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 58/187 (31%), Positives = 78/187 (41%), Gaps = 43/187 (22%)

Query: 143 AEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPW----GT 197
           AE   L     P +V+L  Y  +DEE L LV E+MP G L N L ++             
Sbjct: 50  AERDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA 108

Query: 198 RLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT--- 254
            L +A+ +   L F+H        RD K  NIL+D+D   KL+DFGL K   +  +    
Sbjct: 109 ELVLALDSVHKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160

Query: 255 -------------------HVTTRVM-----GTYGYAAPE-YISTGHLTTKSDVYSFGVV 289
                              H   RV      GT  Y APE    T +   + D +S GV+
Sbjct: 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVI 219

Query: 290 LLELLTG 296
           L E+L G
Sbjct: 220 LYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 36/93 (38%), Positives = 55/93 (59%), Gaps = 6/93 (6%)

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +GL +LH A   +++RD K  N+L++S+   K+ DFGLA++     + H+T  V+  Y Y
Sbjct: 114 RGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-Y 170

Query: 267 AAPEYISTG--HLTTKSDVYSFGVVLLELLTGR 297
            APE I  G  H T+  D++S G +  ELL  R
Sbjct: 171 RAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 73/267 (27%), Positives = 117/267 (43%), Gaps = 30/267 (11%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHP 154
           +LG+GGFG V    +          +  A K L+   I+  +G    L E   L ++   
Sbjct: 7   VLGKGGFGEVCACQVR------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60

Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            +V L  Y  E ++ L LV   M  G L+ H++   +        +  A     GL  LH
Sbjct: 61  FVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119

Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
             E  ++YRD K  NILLD     ++SD GLA   PEG    +  RV GT GY APE + 
Sbjct: 120 -RER-IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVVK 174

Query: 274 TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL 333
               T   D +  G ++ E++ G+    + + K ++  V+         RR++   +   
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE---------RRVKEDQE--- 222

Query: 334 AGQYSVKGAKEMAVLALQCISVNPKDR 360
             +YS K ++    +  Q ++ +P  R
Sbjct: 223 --EYSEKFSEAARSICRQLLTKDPGFR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 66/255 (25%), Positives = 113/255 (44%), Gaps = 35/255 (13%)

Query: 91  QNFSSNYL-LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLG 149
           + +  N++ +GEG  G V    +          + VAVK +D+   Q       EV+ + 
Sbjct: 19  RTYLDNFIKIGEGSTGIVCIATVKS------SGKLVAVKKMDLRKQQRRELLFNEVVIMR 72

Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------IAI 203
             +H ++V +       +E  +V EF+  G+L + +           TR+       + +
Sbjct: 73  DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCL 123

Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR--VM 261
              K L+ LH     VI+RD K+ +ILL  D   KLSDFG         +  V  R  ++
Sbjct: 124 AVLKALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ----VSKEVPRRKSLV 177

Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRP-KSEQNLVDWAKPYLR 320
           GT  + APE IS      + D++S G++++E++ G        P K+ + + D   P L+
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLK 237

Query: 321 SSRRLRYIVDPRLAG 335
           +  +    V P L G
Sbjct: 238 NLHK----VSPSLKG 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 65.8 bits (160), Expect = 7e-12
 Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 26/219 (11%)

Query: 92  NFSSNYLLGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA---E 144
           +F+   +LG+G FG V     KG  D+     +  + V ++  D+E     +  LA   +
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK 59

Query: 145 VIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
             FL QL           C +  +RL  V E++  G L   + +      P        I
Sbjct: 60  PPFLTQLHS---------CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEI 110

Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM-G 262
             A GL FLH     +IYRD K  N++LDS+   K++DFG+ K   E     VTT+   G
Sbjct: 111 --AIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCG 163

Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMD 301
           T  Y APE I+        D ++FGV+L E+L G+   +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 65.0 bits (158), Expect = 8e-12
 Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 37/226 (16%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRH- 153
           ++G GGFG V+        R+    +  A+K LD   I+  QG    L E I L  +   
Sbjct: 1   IIGRGGFGEVY------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 54

Query: 154 --PHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK--- 207
             P +V  + Y     ++L  + + M  G L  HL +    S       ++   AA+   
Sbjct: 55  DCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-----EAEMRFYAAEIIL 108

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA----KMGPEGSNTHVTTRVMGT 263
           GL  +H     V+YRD K +NILLD     ++SD GLA    K  P  S        +GT
Sbjct: 109 GLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGT 158

Query: 264 YGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSE 308
           +GY APE +  G    + +D +S G +L +LL G     + + K +
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 27/218 (12%)

Query: 99  LGEGGFGTV--HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL----- 151
           LGEG FG V   + Y  D  R   +   VAVK+L           LA++I   +L     
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPD-QTVTVAVKMLKDNATDKD---LADLISEMELMKLIG 75

Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSL---PWGTRL--------- 199
           +H +++ L+G C ++    ++ E+  +G+L   L  R           T++         
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 200 --KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT 257
               A   A+G+ +L       I+RD    N+L+  D   K++DFGLA+   +      T
Sbjct: 136 LVSCAYQVARGMEYL--ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193

Query: 258 TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
           +       + APE +     T +SDV+SFG+++ E+ T
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 66/216 (30%), Positives = 96/216 (44%), Gaps = 23/216 (10%)

Query: 92  NFSSNYLLGEGGFGTVH-----KGYIDDDL--RQGLKAQAVAVKLLDIEGLQGHREWLAE 144
           NF    +LG G +G V       G+    L   + LK   +  K    E  +  R+ L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 145 VIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           +      + P LV L  Y  + + +L L+ +++  G L  HL +R          ++I  
Sbjct: 61  I-----RQSPFLVTL-HYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYS 111

Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT 263
           G    LA  H  +  +IYRD K  NILLDS+    L+DFGL+K   E       +   GT
Sbjct: 112 GEIV-LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGT 169

Query: 264 YGYAAPEYIS---TGHLTTKSDVYSFGVVLLELLTG 296
             Y AP+ +     GH     D +S GV++ ELLTG
Sbjct: 170 IEYMAPDIVRGGDGGH-DKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 33/168 (19%)

Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLEN-HLFKRISVSLPWGTRLKIA 202
           E+  L  + HP++V+       + E  ++ EFM  GSLE  H+     ++        +A
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-------DVA 174

Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-----MGPEGSNTHVT 257
                G+A+LH     +++RD K SN+L++S    K++DFG+++     M P  S+    
Sbjct: 175 RQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---- 228

Query: 258 TRVMGTYGYAAPEYIST--------GHLTTKSDVYSFGVVLLELLTGR 297
              +GT  Y +PE I+T        G+     D++S GV +LE   GR
Sbjct: 229 ---VGTIAYMSPERINTDLNHGAYDGY---AGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 77/263 (29%), Positives = 114/263 (43%), Gaps = 45/263 (17%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQG-------LKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ 150
           +LG+GG+G V +         G       LK   +     D    +  R  L  V     
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV----- 57

Query: 151 LRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            +HP +V LI Y  +   +L L+ E++  G L  HL +R  + +       ++      L
Sbjct: 58  -KHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHL-EREGIFMEDTACFYLS---EISL 111

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGSNTHVTTRVMGTYGYAA 268
           A  H  +  +IYRD K  NILLD+    KL+DFGL K    EG+ TH      GT  Y A
Sbjct: 112 ALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMA 168

Query: 269 PEYIS-TGHLTTKSDVYSFGVVLLELLTG---------RRSMDKLRPKSEQNLVDWAKPY 318
           PE +  +GH     D +S G ++ ++LTG         ++++DK+  K + NL     PY
Sbjct: 169 PEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL-KGKLNL----PPY 222

Query: 319 LRSSRR------LRYIVDPRLAG 335
           L    R      L+     RL  
Sbjct: 223 LTPEARDLLKKLLKRNPSSRLGA 245

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 35/91 (38%), Positives = 54/91 (59%), Gaps = 5/91 (5%)

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+A LH  +N +++RD KTSN+LL++    K+ DFGLA+    GS     T+++ T  Y 
Sbjct: 118 GVAHLH--DNWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLWYR 173

Query: 268 APE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           APE  +     +T  D++S G +  ELLT +
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 3e-11
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 33/216 (15%)

Query: 100 GEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-----EVIFLGQLRHP 154
           G G +G V+K    +    G   +  A+K    +G +     ++     E+  L +L+H 
Sbjct: 9   GRGTYGRVYKAKRKN----GKDGKEYAIKK--FKGDKEQYTGISQSACREIALLRELKHE 62

Query: 155 HLVRLIGYCCEDEERL--LVYEFMPRGSLENHLFKRI-------SVSLPWGTRLKIAIGA 205
           ++V L+    E  ++   L++++      E+ L++ I        VS+P      +    
Sbjct: 63  NVVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117

Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDF----TAKLSDFGLAKMGPEGSNTHVT-TRV 260
             G+ +LH   N V++RD K +NIL+  +       K+ D GLA++             V
Sbjct: 118 LNGVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 261 MGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLT 295
           + T  Y APE +    H T   D+++ G +  ELLT
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 39/215 (18%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL----DIEGLQGHREWLAEVIFLGQLRHP 154
           +GEG +GTV K    +        + VA+K +    D EG+      L E+  L +L+H 
Sbjct: 8   IGEGTYGTVFKAKNRET------HEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHK 59

Query: 155 HLVRLIGYCCEDEERLLVYEFMP----------RGSLENHLFKRISVSLPWGTRLKIAIG 204
           ++VRL      D++  LV+E+             G ++  + K     L           
Sbjct: 60  NIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL----------- 108

Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY 264
             KGLAF H   + V++RD K  N+L++ +   KL+DFGLA+    G      +  + T 
Sbjct: 109 -LKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVTL 163

Query: 265 GYAAPEYISTGHL-TTKSDVYSFGVVLLELLTGRR 298
            Y  P+ +    L +T  D++S G +  EL    R
Sbjct: 164 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 52/148 (35%), Positives = 76/148 (51%), Gaps = 14/148 (9%)

Query: 154 PHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
           P LV L  Y  + E +L L+ +++  G +  HL++R + S      ++   G    LA  
Sbjct: 65  PFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS---EDEVRFYSGEII-LALE 119

Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAAPE 270
           H  +  ++YRD K  NILLDS+    L+DFGL+K  +  E   T+      GT  Y APE
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY---SFCGTIEYMAPE 176

Query: 271 YI--STGHLTTKSDVYSFGVVLLELLTG 296
            I    GH     D +S G+++ ELLTG
Sbjct: 177 IIRGKGGH-GKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 23/216 (10%)

Query: 99  LGEGGFGTVHKGY---IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL--RH 153
           LGEG FG V       ID D  +  +A  VAVK+L  +  +     L   + + ++  +H
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPK--EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80

Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG---TRL----------- 199
            +++ L+G C +D    ++ E+  +G+L  +L  R    + +     R+           
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
                 A+G+ +L  A    I+RD    N+L+  +   K++DFGLA+          TT 
Sbjct: 141 SCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198

Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 16/165 (9%)

Query: 155 HLVRLIGY---CCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
           +++++ G+     +D  RL L+ E+  RG L   L K   +S    T+L +AI   KGL 
Sbjct: 79  NILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFK--TKLDMAIDCCKGLY 136

Query: 211 FLHGAEN-PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
            L+   N P  Y++  + + L+  ++  K+   GL K+       +V   V     Y + 
Sbjct: 137 NLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSY 189

Query: 270 EYIST--GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV 312
           + ++      T K D+YS GVVL E+ TG+   + L  K   +L+
Sbjct: 190 KMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI 234

Length = 283

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 18/204 (8%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLAEV-IFLGQLRH 153
           ++G+G FG V         R   + +  AVK+L  + +   +E    ++E  + L  ++H
Sbjct: 2   VIGKGSFGKVLLA------RHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 55

Query: 154 PHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
           P LV L  +  +  ++L  V +++  G L  HL +      P        I +A  L +L
Sbjct: 56  PFLVGL-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA--LGYL 112

Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
           H     ++YRD K  NILLDS     L+DFGL K   E + T  T+   GT  Y APE +
Sbjct: 113 HSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVL 168

Query: 273 STGHLTTKSDVYSFGVVLLELLTG 296
                    D +  G VL E+L G
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 14/201 (6%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHLV 157
           LGEG + TV KG      R  L    VA+K + +E  +G     + EV  L  L+H ++V
Sbjct: 14  LGEGTYATVFKG------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
            L      D+   LV+E++ +  L+ ++    ++      ++ +     +GLA+ H    
Sbjct: 68  TLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL-YQILRGLAYCH--RR 123

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE-YISTGH 276
            V++RD K  N+L++     KL+DFGLA+     + T+    V  T  Y  P+  + +  
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSE 181

Query: 277 LTTKSDVYSFGVVLLELLTGR 297
            +T+ D++  G +  E+ +GR
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 66/229 (28%), Positives = 101/229 (44%), Gaps = 37/229 (16%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRH- 153
           ++G GGFG V+        R+    +  A+K LD   I+  QG    L E I L  +   
Sbjct: 1   IIGRGGFGEVY------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 54

Query: 154 --PHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK--- 207
             P +V  + Y     ++L  + + M  G L  HL +    S       ++   A +   
Sbjct: 55  DCPFIV-CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFS-----EKEMRFYATEIIL 108

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA----KMGPEGSNTHVTTRVMGT 263
           GL  +H     V+YRD K +NILLD     ++SD GLA    K  P  S        +GT
Sbjct: 109 GLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGT 158

Query: 264 YGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNL 311
           +GY APE +  G    + +D +S G +L +LL G     + + K +  +
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 62.0 bits (151), Expect = 8e-11
 Identities = 46/135 (34%), Positives = 64/135 (47%), Gaps = 13/135 (9%)

Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS--NTHVT 257
           KIA+   K L +L   E  +I+RD K SNILLD +   KL DFG++     G   ++   
Sbjct: 111 KIAVATVKALNYLK-EELKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAK 164

Query: 258 TRVMGTYGYAAPEYISTGHLT---TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQ--NLV 312
           TR  G   Y APE I          +SDV+S G+ L E+ TG+    K     +Q   +V
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV 224

Query: 313 DWAKPYLRSSRRLRY 327
               P L +S    +
Sbjct: 225 KGDPPILSNSEEREF 239

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 36/218 (16%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW-----LAEVIFLGQLRH 153
           +GEG +G V+K       R     + VA+K + ++     +E      + E+  L QL H
Sbjct: 15  IGEGTYGQVYKA------RDKDTGELVALKKVRLDN---EKEGFPITAIREIKILRQLNH 65

Query: 154 PHLVRLIGYCCEDEERL----------LVYEFMPR---GSLENHLFKRISVSLPWGTRLK 200
            ++V L     + ++ L          LV+E+M     G LE+ L     V         
Sbjct: 66  RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-----VHFSEDHIKS 120

Query: 201 IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRV 260
                 +GL + H  +   ++RD K SNILL++    KL+DFGLA++     +   T +V
Sbjct: 121 FMKQLLEGLNYCH--KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 261 MGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
           + T  Y  PE +        + DV+S G +L EL T +
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 47/132 (35%), Positives = 62/132 (46%), Gaps = 7/132 (5%)

Query: 166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFK 225
           D +  LV ++M  G L  HL K    S     R K  I A   LA  H  +  ++YRD K
Sbjct: 68  DSDLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFYI-AELVLALEHLHKYDIVYRDLK 123

Query: 226 TSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKS-DVY 284
             NILLD+     L DFGL+K     ++   T    GT  Y APE +      TK  D +
Sbjct: 124 PENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFW 181

Query: 285 SFGVVLLELLTG 296
           S GV++ E+  G
Sbjct: 182 SLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 71/305 (23%), Positives = 115/305 (37%), Gaps = 79/305 (25%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK-----LLDIEGLQGHREWLAEVIFLGQLR 152
           L+G+GG G V+  Y   D     +   VA+K     L +   L   + +L E      L 
Sbjct: 9   LIGKGGMGEVYLAY---DPVCSRR---VALKKIREDLSENPLL--KKRFLREAKIAADLI 60

Query: 153 HPHLVRLIGYCCEDEERLLVYEFMP--RGSLENHLFKRI----SVSLPW------GTRLK 200
           HP +V +   C + +    VY  MP   G     L K +    S+S         G  L 
Sbjct: 61  HPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117

Query: 201 IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM------------- 247
           I       + ++H     V++RD K  NILL       + D+G A               
Sbjct: 118 IFHKICATIEYVH--SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175

Query: 248 ---GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT--------- 295
                  S+  +  +++GT  Y APE +     +  +D+Y+ GV+L ++LT         
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235

Query: 296 GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISV 355
           GR+   +    S   +     PY       R I  P    Q           +A++ ++V
Sbjct: 236 GRKISYRDVILSPIEVA----PY-------REI--PPFLSQ-----------IAMKALAV 271

Query: 356 NPKDR 360
           +P +R
Sbjct: 272 DPAER 276

Length = 932

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 22/225 (9%)

Query: 144 EVIFLGQLRHPHLVRLI-GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           E   L QL+HP++V     +  ED    +V  F   G L + L ++    LP    ++  
Sbjct: 49  EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108

Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           +  A  L +LH  E  +++RD KT N+ L      K+ D G+A++  E      +T ++G
Sbjct: 109 VQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIARV-LENQCDMAST-LIG 164

Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS 322
           T  Y +PE  S      KSDV++ G  + E+ T + + +    K   +LV     Y    
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA---KDMNSLV-----YRIIE 216

Query: 323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
            +L     P +   YS     E+  L    +S  P+ RP + +++
Sbjct: 217 GKL-----PPMPKDYS----PELGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)

Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 20  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 70

Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 71  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 128

Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 129 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 181

Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 182 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 73/294 (24%), Positives = 126/294 (42%), Gaps = 45/294 (15%)

Query: 94  SSNYL----LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-HREWLAEVIFL 148
           +++YL    LGEG + TV+KG         +  Q VA+K++ ++  +G     + E   L
Sbjct: 4   ATSYLNLEKLGEGSYATVYKGI------SRINGQLVALKVISMKTEEGVPFTAIREASLL 57

Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
             L+H ++V L       E    V+E+M    L  ++ +      P+  RL       +G
Sbjct: 58  KGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRG 115

Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LA++HG    +++RD K  N+L+      KL+DFGLA+     S T+ +  V  T  Y  
Sbjct: 116 LAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRP 171

Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA------------ 315
           P+  +     ++  D++  G + +E+L G+ +   +    EQ    W             
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231

Query: 316 -------KP--YLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDR 360
                  KP  +L    +   +V  RL+     +       LA Q + + PKDR
Sbjct: 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAED------LASQMLMMFPKDR 279

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 40/225 (17%)

Query: 80  DFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQ 136
           DFQ+     +TQ       +G+GG+G V      D        + VA+K +    +  L 
Sbjct: 2   DFQI-----LTQ-------VGQGGYGQVFLAKKKD------TGEIVALKRMKKSLLFKLN 43

Query: 137 GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLP- 194
             R  L E   L   +   LV+L+ Y  +D+E L L  E++P G     L     +S   
Sbjct: 44  EVRHVLTERDILTTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH 102

Query: 195 ---WGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG 251
              +   +  A+ A   L ++H        RD K  N L+D+    KL+DFGL+K     
Sbjct: 103 ARFYMAEMFEAVDALHELGYIH--------RDLKPENFLIDASGHIKLTDFGLSKGIVTY 154

Query: 252 SNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           +N+     V+G+  Y APE +         D +S G +L E L G
Sbjct: 155 ANS-----VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 45/158 (28%), Positives = 69/158 (43%), Gaps = 7/158 (4%)

Query: 144 EVIFLGQLRHPHLVRLI-GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           E+  L  + H  ++ LI  Y      +  V   MP+   +   +   S  LP    + I 
Sbjct: 136 EIDILKTISHRAIINLIHAY----RWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQ 191

Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
               + LA+LHG    +I+RD KT NI LD    A L DFG A       +T       G
Sbjct: 192 RRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249

Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSM 300
           T    +PE ++      K+D++S G+VL E+     ++
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 60.7 bits (147), Expect = 4e-10
 Identities = 47/181 (25%), Positives = 78/181 (43%), Gaps = 11/181 (6%)

Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMP--RGSLENHLFKRISVSLPWGTRL 199
           L E + L  + HP ++R+           +V   +P     L  +L KR S  LP    L
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKR-SRPLPIDQAL 160

Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
            I     +GL +LH     +I+RD KT NI ++      + D G A+             
Sbjct: 161 IIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL---G 215

Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYL 319
           + GT    APE ++     +K+D++S G+VL E+L    ++ +  P + +  V     +L
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL 275

Query: 320 R 320
            
Sbjct: 276 L 276

Length = 357

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 13/106 (12%)

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK---MGPEGSNTHVTTRVMGTY 264
           GL ++H A   V++RD K  N+L+++D   K+ DFGLA+     P  +   +T  V  T 
Sbjct: 117 GLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-ATR 173

Query: 265 GYAAPEYISTGHLTTKS-DVYSFGVVLLELL------TGRRSMDKL 303
            Y APE + +    TK+ DV+S G +L ELL       G+  +D+L
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQL 219

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 59.7 bits (144), Expect = 5e-10
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 20/219 (9%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHLV 157
           LGEG + TV KG      R  L    VA+K + +E  +G     + EV  L  L+H ++V
Sbjct: 13  LGEGTYATVFKG------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISV--SLPWGTRLKIAI-GAAKGLAFLHG 214
            L      +    LV+E+     L++ L + +    +L     +KI +    +GL++ H 
Sbjct: 67  TLHDIIHTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH- 120

Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE-YIS 273
            +  +++RD K  N+L++     KL+DFGLA+     + T+    V  T  Y  P+  + 
Sbjct: 121 -KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 177

Query: 274 TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV 312
           +   +T  D++  G +L E+ TGR        K E +L+
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 13/202 (6%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREW-LAEVIFLGQLRHPH 155
           ++GEG +G V K       R     + VA+K   D E  +  +E  L E+  L  L+  +
Sbjct: 8   VVGEGAYGVVLK------CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +V L        +  LV+E++ +  LE  L + +   +P            K + + H  
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIKAIHWCH-- 117

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +N +++RD K  N+L+  +   KL DFG A+   EGSN + T  V  T  Y +PE +   
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPELLLGA 176

Query: 276 HLTTKSDVYSFGVVLLELLTGR 297
                 D++S G +L EL  G+
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 56/207 (27%), Positives = 87/207 (42%), Gaps = 23/207 (11%)

Query: 166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFK 225
           D++ LL+ E+   G L   + +R+   LP+       +     LA        +++RD K
Sbjct: 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLK 196

Query: 226 TSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYS 285
           ++NI L      KL DFG +K   +  +  V +   GT  Y APE       + K+D++S
Sbjct: 197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWS 256

Query: 286 FGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYS---VKGA 342
            GV+L ELLT  R                  P+   S+  R I+   L G+Y       +
Sbjct: 257 LGVILYELLTLHR------------------PFKGPSQ--REIMQQVLYGKYDPFPCPVS 296

Query: 343 KEMAVLALQCISVNPKDRPKMAAVVAT 369
             M  L    +S NP  RP    ++ T
Sbjct: 297 SGMKALLDPLLSKNPALRPTTQQLLHT 323

Length = 478

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 14/201 (6%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHLV 157
           LGEG + TV+KG      R  L    VA+K + +E  +G     + EV  L  L+H ++V
Sbjct: 14  LGEGTYATVYKG------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
            L      ++   LV+E++ +  L+ +L    +       +L +     +GL + H    
Sbjct: 68  TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCH--RR 123

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE-YISTGH 276
            V++RD K  N+L++     KL+DFGLA+     + T+    V  T  Y  P+  + +  
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTD 181

Query: 277 LTTKSDVYSFGVVLLELLTGR 297
            +T+ D++  G +  E+ TGR
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 59.5 bits (144), Expect = 6e-10
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 19/206 (9%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPH 155
           LG+GGFG V         +     +  A K L+ + L   +G+   + E   L ++ H  
Sbjct: 1   LGKGGFGEVSA------CQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSR 53

Query: 156 LVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK---GLAF 211
            +  + Y  + +  L LV   M  G L  H++  +    P     +     A+   GL  
Sbjct: 54  FIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYN-VDEENPGFPEPRACFYTAQIISGLEH 112

Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEY 271
           LH  +  +IYRD K  N+LLD+D   ++SD GLA    +G +   T    GT G+ APE 
Sbjct: 113 LH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPEL 168

Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGR 297
           +         D ++ GV L E++  R
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 66/229 (28%), Positives = 100/229 (43%), Gaps = 33/229 (14%)

Query: 82  QLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD----IEGLQG 137
           ++ +LR   +++    ++G G FG V        +R     +  A+KLL     I+    
Sbjct: 34  KIRDLRMKAEDYEVVKVIGRGAFGEVQL------VRHKSTRKVYAMKLLSKFEMIKRSDS 87

Query: 138 HREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWG 196
              W  E   +     P +V+L  Y  +D+  L +V E+MP G L N L     V   W 
Sbjct: 88  AFFW-EERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWA 144

Query: 197 ----TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEG 251
                 + +A+ A   + F+H        RD K  N+LLD     KL+DFG   KM  EG
Sbjct: 145 RFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196

Query: 252 SNTHVTTRVMGTYGYAAPEYIST----GHLTTKSDVYSFGVVLLELLTG 296
                T   +GT  Y +PE + +    G+   + D +S GV L E+L G
Sbjct: 197 MVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 29/217 (13%)

Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL------DIEGLQGHREWL 142
           IT  +     +G G FG V      D L      Q VA+K +       +   + +RE  
Sbjct: 8   ITNRYVDLQPVGMGAFGLVCSAR--DQLT----GQNVAIKKIMKPFSTPVLAKRTYRE-- 59

Query: 143 AEVIFLGQLRHPHLVRLIG-YCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKI 201
             +  L  LRH +++ L   +    E+   V E +  G+  + L     +   +      
Sbjct: 60  --LKLLKHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLY 115

Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
            I   +GL ++H A   V++RD K SNIL++ +   K+ DFGLA++       +V+TR  
Sbjct: 116 QI--LRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY- 170

Query: 262 GTYGYAAPEYISTGH-LTTKSDVYSFGVVLLELLTGR 297
               Y APE + T      + D++S G +  E+L G+
Sbjct: 171 ----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 58.8 bits (142), Expect = 7e-10
 Identities = 66/272 (24%), Positives = 112/272 (41%), Gaps = 28/272 (10%)

Query: 98  LLGEGGFG-TVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHL 156
           ++GEG FG  +   +++ D +  +K   +      +E  +       E + L +++HP++
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR------KEAVLLAKMKHPNI 60

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           V        D    +V E+   G L   +  +     P  T L+  +    G+  +H  E
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH--E 118

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH 276
             V++RD K+ NI L  +   KL DFG A++         T   +GT  Y  PE      
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMP 176

Query: 277 LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQ 336
              KSD++S G +L EL T +      +  S +NL+          +  +    P L   
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHP---FQANSWKNLI---------LKVCQGSYKP-LPSH 223

Query: 337 YSVKGAKEMAVLALQCISVNPKDRPKMAAVVA 368
           YS     E+  L  Q    NP+ RP    +++
Sbjct: 224 YSY----ELRSLIKQMFKRNPRSRPSATTILS 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 57/211 (27%), Positives = 103/211 (48%), Gaps = 31/211 (14%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI----EGLQGHREWLAEVIFLGQLRHP 154
           +GEG +G V+K       R  +  + +A+K + +    EG+      + E+  L +++H 
Sbjct: 10  IGEGTYGVVYKA------RDRVTNETIALKKIRLEQEDEGVPSTA--IREISLLKEMQHG 61

Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA----IGAAKGLA 210
           ++VRL      ++   LV+E+     L+  L K +  S  +    ++         +G+A
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAK-MG-PEGSNTHVTTRVMGTYGYA 267
           + H   + V++RD K  N+L+D    A KL+DFGLA+  G P  + TH       T  Y 
Sbjct: 117 YCH--SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYR 170

Query: 268 APE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           APE  + + H +T  D++S G +  E++  +
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 59.6 bits (145), Expect = 8e-10
 Identities = 36/98 (36%), Positives = 54/98 (55%), Gaps = 8/98 (8%)

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM---GPEGSNTHVTTRVMGT 263
           +GL ++H A   VI+RD K SN+L++ D   ++ DFG+A+     P      +T  V  T
Sbjct: 118 RGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV-AT 174

Query: 264 YGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGRRSM 300
             Y APE + S    TT  D++S G +  E+L GRR +
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 58.8 bits (142), Expect = 9e-10
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 16/201 (7%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA--EVIFLGQLRHPHL 156
           LG+G FGTV   Y+  D +   + +   +K + +  L  +    A  E   L +L HP +
Sbjct: 8   LGKGSFGTV---YLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHL--FKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
           V+      E +   ++ E+     L+  L   K    +L      +  I    G+ ++H 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH- 123

Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAAPEYI 272
            +  +++RD K  NI L ++   K+ DFG+++  MG    +  + T   GT  Y +PE +
Sbjct: 124 -QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMG----SCDLATTFTGTPYYMSPEAL 177

Query: 273 STGHLTTKSDVYSFGVVLLEL 293
                 +KSD++S G +L E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 59.0 bits (142), Expect = 9e-10
 Identities = 67/263 (25%), Positives = 114/263 (43%), Gaps = 27/263 (10%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHL 156
           L+G G +G V+KG      R     Q  A+K++D+ G +   E   E+  L +   H ++
Sbjct: 13  LVGNGTYGQVYKG------RHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNI 65

Query: 157 VRLIGYCCE------DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
               G   +      D++  LV EF   GS+ + +      +L       I     +GL+
Sbjct: 66  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
            LH  ++ VI+RD K  N+LL  +   KL DFG++           T   +GT  + APE
Sbjct: 126 HLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPE 181

Query: 271 YISTGH-----LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW-AKPYLRS--- 321
            I+           KSD++S G+  +E+  G   +  + P     L+     P L+S   
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW 241

Query: 322 SRRLRYIVDPRLAGQYSVKGAKE 344
           S++ +  ++  L   +S +   E
Sbjct: 242 SKKFQSFIESCLVKNHSQRPTTE 264

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 36/213 (16%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL------DIEGLQGHREWLAEVIFLGQLR 152
           +G G +GTV       D R G K   VA+K L      ++   + +RE    +  L  ++
Sbjct: 23  VGSGAYGTVCSAL---DRRTGAK---VAIKKLYRPFQSELFAKRAYRE----LRLLKHMK 72

Query: 153 HPHLVRLIGYCCEDE------ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI-GA 205
           H +++ L+     D       +  LV  FM  G+    L K   +S     R++  +   
Sbjct: 73  HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLS---EDRIQFLVYQM 127

Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
            KGL ++H A   +I+RD K  N+ ++ D   K+ DFGLA+        +V TR      
Sbjct: 128 LKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180

Query: 266 YAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
           Y APE I +  H T   D++S G ++ E+LTG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 46/218 (21%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFLGQLRHPHL 156
           +G G +G+V   Y D  LRQ      VAVK L    + L   R    E+  L  ++H ++
Sbjct: 23  VGSGAYGSVCSAY-DTRLRQ-----KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRIS-VSLPWGTRLKIAIGAAK-------- 207
           + L+              F P  S+EN  F  +  V+   G  L   +   K        
Sbjct: 77  IGLLDV------------FTPATSIEN--FNEVYLVTNLMGADLNNIVKCQKLSDEHVQF 122

Query: 208 -------GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRV 260
                  GL ++H A   +I+RD K SN+ ++ D   ++ DFGLA+   +    +V TR 
Sbjct: 123 LIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR- 179

Query: 261 MGTYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
                Y APE  ++  H     D++S G ++ ELL G+
Sbjct: 180 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 68/239 (28%), Positives = 94/239 (39%), Gaps = 56/239 (23%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAV-AVKLLD----IEGLQGHREWLAEVIFLGQLR 152
           LLG+G  G V        L +      + A+K+LD    I+  +  R  L E   L  L 
Sbjct: 8   LLGKGDVGRVF-------LVRLKGTGKLFALKVLDKKEMIKRNKVKRV-LTEQEILATLD 59

Query: 153 HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIG---AAK-- 207
           HP L  L      +    LV ++ P G L   L +R       G  L   +    AA+  
Sbjct: 60  HPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQP-----GKCLSEEVARFYAAEVL 113

Query: 208 -GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM--------------GPEGS 252
             L +LH     ++YRD K  NILL       LSDF L+K               G   S
Sbjct: 114 LALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171

Query: 253 NTH----------VTTRVM---GTYGYAAPEYIS-TGHLTTKSDVYSFGVVLLELLTGR 297
           + +           + R     GT  Y APE IS  GH  +  D ++ G++L E+L G 
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 24/206 (11%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-----EVIFLGQLRH 153
           LGEG + TV+KG      R  L  Q VA+K + +E    H E        E   L  L+H
Sbjct: 13  LGEGSYATVYKG------RSKLTGQLVALKEIRLE----HEEGAPFTAIREASLLKDLKH 62

Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            ++V L       +   LV+E++    L+ ++            RL       +GLA+ H
Sbjct: 63  ANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRL-FLFQLLRGLAYCH 120

Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI- 272
                V++RD K  N+L+      KL+DFGLA+     S T+    V  T  Y  P+ + 
Sbjct: 121 QRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLL 176

Query: 273 -STGHLTTKSDVYSFGVVLLELLTGR 297
            ST + +T  D++  G +  E+ TGR
Sbjct: 177 GSTEY-STSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 72/290 (24%), Positives = 123/290 (42%), Gaps = 55/290 (18%)

Query: 99  LGEGGFGTVHKGYI------DDDLRQGLKAQAVAVKLLDIEGLQGHRE----WLAEVIFL 148
           LG G    ++ G +      +DD     K   V +K+LD      HR+    +      +
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLD----PSHRDISLAFFETASMM 58

Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISV-SLPWGTRLKIAIGAAK 207
            Q+ H H+V L G C  D E ++V EF+  G L+  + ++  V + PW  + K+A   A 
Sbjct: 59  RQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLAS 116

Query: 208 GLAFLHGAENPVIYRDFKTSNILL-----DSDFTA--KLSDFGLAKMGPEGSNTHVTTR- 259
            L++L   +  +++ +  T NILL     D +     KLSD G+           V +R 
Sbjct: 117 ALSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--------ITVLSRQ 166

Query: 260 -VMGTYGYAAPEYIS-TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP 317
             +    + APE +  + +L+  +D +SFG  L E+           P  ++ L +  + 
Sbjct: 167 ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEI-----PLKDKTLAEKERF 221

Query: 318 YLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
           Y         +V P           KE+A L   C++ +P  RP   A++
Sbjct: 222 YEGQCM----LVTP---------SCKELADLMTHCMNYDPNQRPFFRAIM 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 62/229 (27%), Positives = 98/229 (42%), Gaps = 33/229 (14%)

Query: 82  QLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD----IEGLQG 137
           ++ +L+   +++    ++G G FG V        +R     +  A+KLL     I+    
Sbjct: 34  KIRKLQMKAEDYDVVKVIGRGAFGEVQL------VRHKSSQKVYAMKLLSKFEMIKRSDS 87

Query: 138 HREWLAEVIFLGQLRHPHLVRLIGYCC-EDEERL-LVYEFMPRGSLENHLFKRISVSLPW 195
              W  E   +     P +V+L  +C  +D++ L +V E+MP G L N L     V   W
Sbjct: 88  AFFW-EERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKW 143

Query: 196 G----TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG 251
                  + +A+ A   +  +H        RD K  N+LLD     KL+DFG      E 
Sbjct: 144 AKFYTAEVVLALDAIHSMGLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDET 195

Query: 252 SNTHVTTRVMGTYGYAAPEYIST----GHLTTKSDVYSFGVVLLELLTG 296
                 T V GT  Y +PE + +    G+   + D +S GV L E+L G
Sbjct: 196 GMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 31/214 (14%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFLGQLRHPHL 156
           +G+G FG V K       R     Q VA+K  L++ E        L E+  L  L+H ++
Sbjct: 20  IGQGTFGEVFKA------RHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENV 73

Query: 157 VRLIGYC-----CEDEER---LLVYEFMPR---GSLENHLFKRISVSLPWGTRLKIAIGA 205
           V LI  C       +  +    LV+EF      G L N   K +  +L    ++   +  
Sbjct: 74  VNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKML-- 128

Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK---MGPEGSNTHVTTRVMG 262
             GL ++H   N +++RD K +NIL+  D   KL+DFGLA+   +         T RV+ 
Sbjct: 129 LNGLYYIH--RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV- 185

Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLT 295
           T  Y  PE  +         D++  G ++ E+ T
Sbjct: 186 TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 31/216 (14%)

Query: 91  QNFSSNYLLGEGGFGTV------HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAE 144
           ++F+    LG G FG V      ++ +    +++  K++ +  K +D           +E
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD--------HVFSE 81

Query: 145 VIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIG 204
              L  + HP  V L G   ++    LV EF+  G  E   F R +   P    +     
Sbjct: 82  RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGG--EFFTFLRRNKRFP--NDVGCFYA 137

Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR---VM 261
           A   L F +     ++YRD K  N+LLD D   K++DFG AK+        V TR   + 
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTLC 189

Query: 262 GTYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTG 296
           GT  Y APE  ++ GH    +D ++ G+ + E+L G
Sbjct: 190 GTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 5/90 (5%)

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 184

Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           APE I         D++S G ++ E++ G 
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 52/187 (27%), Positives = 83/187 (44%), Gaps = 36/187 (19%)

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT-TRVMGTYG 265
           + L ++H A   V +RD K  NIL ++D   K+ DFGLA++    + T +  T  + T  
Sbjct: 114 RALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 266 YAAPEYIST--GHLTTKSDVYSFGVVLLELLTGR---------RSMDKL-----RPKSEQ 309
           Y APE   +     T   D++S G +  E+LTG+           +D +      P  E 
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231

Query: 310 -----NLVDWAKPYLRSSRRLRYIVDPRLAGQYSVK--GAKEMAVLALQ-CISVNPKDRP 361
                N  + A+ YL S R        +    +S K   A  +A+  L+  ++ +PKDRP
Sbjct: 232 ISRVRN--EKARRYLSSMR-------KKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP 282

Query: 362 KMAAVVA 368
                +A
Sbjct: 283 TAEEALA 289

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 11/95 (11%)

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN---THVTTRVMGT 263
           +GL ++H A   V++RD K SN+LL+++   K+ DFGLA+   E  +    +V TR    
Sbjct: 119 RGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR---- 172

Query: 264 YGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
             Y APE + +    TT  DV+S G +  ELL  +
Sbjct: 173 -WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 29/94 (30%), Positives = 54/94 (57%), Gaps = 5/94 (5%)

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDS-DFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTY 264
           +GL ++H A   V++RD K +N+ +++ D   K+ DFGLA+ + P  S+    +  + T 
Sbjct: 125 RGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 265 GYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
            Y +P  + S  + T   D+++ G +  E+LTG+
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 57.4 bits (138), Expect = 4e-09
 Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 14/213 (6%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHLV 157
           LGEG + TV+KG      +  +  + VA+K++ ++  +G     + E   L  L+H ++V
Sbjct: 13  LGEGSYATVYKG------KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
            L       E   LV+E++    L  ++ K      P   +L +     +GL+++H  + 
Sbjct: 67  LLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL-FQLLRGLSYIH--QR 122

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE-YISTGH 276
            +++RD K  N+L+      KL+DFGLA+     S+T+    V  T  Y  P+  + +  
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGSTE 180

Query: 277 LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQ 309
            +T  D++  G + +E++ G  +   ++   +Q
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 57.2 bits (138), Expect = 5e-09
 Identities = 54/175 (30%), Positives = 80/175 (45%), Gaps = 29/175 (16%)

Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK---MGPE---GSNTHVTTR 259
           A+G+ FL  A    I+RD    NILL  +   K+ DFGLA+     P+     +  +  +
Sbjct: 183 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240

Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYL 319
            M      APE I     TT+SDV+SFGV+L E+ +   S     P     + +     L
Sbjct: 241 WM------APESIFDKVYTTQSDVWSFGVLLWEIFSLGAS-----PYPGVQIDEEFCRRL 289

Query: 320 RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           +   R+R       A +Y+     E+  + L C   NP+DRP  + +V  L  LL
Sbjct: 290 KEGTRMR-------APEYA---TPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 56.9 bits (137), Expect = 6e-09
 Identities = 52/169 (30%), Positives = 76/169 (44%), Gaps = 17/169 (10%)

Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
           A+G+ FL  A    I+RD    NILL  +   K+ DFGLA+   +  +            
Sbjct: 184 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241

Query: 266 YAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL 325
           + APE I     TT+SDV+SFGV+L E+ +   S     P     + +     L+   R+
Sbjct: 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS-----PYPGVQINEEFCQRLKDGTRM 296

Query: 326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           R    P  A         E+  + L C   +PK+RP  +A+V  L  LL
Sbjct: 297 R---APENA-------TPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 56.7 bits (137), Expect = 6e-09
 Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 34/224 (15%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGHREW----------LAEVIF 147
           LGEG +G V K Y   D   G       VK+++I   +   R+           L E+  
Sbjct: 17  LGEGTYGKVEKAY---DTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +++H +++ L+    E +   LV + M    L+  + ++I ++      + + I    
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQI--LN 130

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-------------KMGPEGSNT 254
           GL  LH      ++RD   +NI ++S    K++DFGLA             K        
Sbjct: 131 GLNVLHKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 255 HVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
            +T++V+ T  Y APE +        + D++S G +  ELLTG+
Sbjct: 189 EMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 56.4 bits (136), Expect = 7e-09
 Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 8/92 (8%)

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
            GL ++H A   +I+RD K  N+ ++ D   K+ DFGLA+        +V TR      Y
Sbjct: 128 CGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WY 180

Query: 267 AAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
            APE I +  H     D++S G ++ E+LTG+
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 56.2 bits (135), Expect = 8e-09
 Identities = 64/240 (26%), Positives = 102/240 (42%), Gaps = 23/240 (9%)

Query: 78  LYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG 137
           L D  LS LR     F    ++G G +G V+KG      R     Q  A+K++D+   + 
Sbjct: 3   LDDIDLSALRDPAGIFELVEVVGNGTYGQVYKG------RHVKTGQLAAIKVMDVTEDE- 55

Query: 138 HREWLAEVIFLGQL-RHPHLVRLIGYCCE------DEERLLVYEFMPRGSLENHLFKRIS 190
             E   E+  L +   H ++    G   +      D++  LV EF   GS+ + +     
Sbjct: 56  EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG 115

Query: 191 VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE 250
            +L       I     +GLA LH   + VI+RD K  N+LL  +   KL DFG++     
Sbjct: 116 NALKEDWIAYICREILRGLAHLHA--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173

Query: 251 GSNTHVTTRVMGTYGYAAPEYISTGH-----LTTKSDVYSFGVVLLELLTGRRSMDKLRP 305
                 T   +GT  + APE I+           +SD++S G+  +E+  G   +  + P
Sbjct: 174 TVGRRNT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 36/217 (16%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKL----LDIEGLQGHREWLAEVIFLGQLRH- 153
           +GEG +G V+K     D   G   + VA+K     +D EG+      L E+  L  L   
Sbjct: 9   IGEGTYGKVYKA---RDKNTG---KLVALKKTRLEMDEEGIPPTA--LREISLLQMLSES 60

Query: 154 PHLVRLIGYCCEDEER-------LLVYEFMPRGSLENHL---FKRISVSLPWGTRLKIAI 203
            ++VRL+    E  E         LV+E++    L+  +    +     LP  T      
Sbjct: 61  IYIVRLL--DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMY 117

Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAKMG--PEGSNTHVTTRV 260
              KG+A  H   + V++RD K  N+L+D      K++D GL +    P  S TH     
Sbjct: 118 QLLKGVAHCHK--HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-- 173

Query: 261 MGTYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTG 296
             T  Y APE  + + H +T  D++S G +  E+   
Sbjct: 174 --TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 6/157 (3%)

Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           E   L  + HP +++L G    ++   L+   +PR   + + +     ++     L I  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIER 189

Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT 263
              + + +LH  EN +I+RD K  NI ++      L DFG A   P   N +      GT
Sbjct: 190 SVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYYGWAGT 246

Query: 264 YGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSM 300
               APE ++        D++S G+VL E+ T   S+
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 2/101 (1%)

Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT 258
           L+ +   A+G+ FL  A    I+RD    N+LL     AK+ DFGLA+     SN  V  
Sbjct: 215 LRFSSQVAQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272

Query: 259 RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRS 299
                  + APE I     T +SDV+S+G++L E+ +  +S
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 70/230 (30%), Positives = 100/230 (43%), Gaps = 44/230 (19%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD-IEGLQGHREWLAEVIFLGQL-RHPHL 156
           +G+G +G V+K     D          AVK+LD I  +    E  AE   L  L  HP++
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLA------AVKILDPISDVDEEIE--AEYNILQSLPNHPNV 81

Query: 157 VRLIGYC-----CEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI------GA 205
           V+  G           +  LV E    GS+   L K +   L  G RL  A+      GA
Sbjct: 82  VKFYGMFYKADKLVGGQLWLVLELCNGGSV-TELVKGL---LICGQRLDEAMISYILYGA 137

Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRV----- 260
             GL  LH   N +I+RD K +NILL ++   KL DFG+       S    +TR+     
Sbjct: 138 LLGLQHLH--NNRIIHRDVKGNNILLTTEGGVKLVDFGV-------SAQLTSTRLRRNTS 188

Query: 261 MGTYGYAAPEYISTGH-----LTTKSDVYSFGVVLLELLTGRRSMDKLRP 305
           +GT  + APE I+           + DV+S G+  +EL  G   +  + P
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 35/89 (39%), Positives = 50/89 (56%), Gaps = 5/89 (5%)

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+     +N  +T  V+  Y Y 
Sbjct: 135 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTPYVVTRY-YR 189

Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           APE I         D++S G ++ EL+ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 34/90 (37%), Positives = 47/90 (52%), Gaps = 2/90 (2%)

Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
           AKG++FL  A    I+RD    NILL      K+ DFGLA+     SN  V         
Sbjct: 224 AKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281

Query: 266 YAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
           + APE I     T +SDV+S+G++L E+ +
Sbjct: 282 WMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 71/225 (31%), Positives = 102/225 (45%), Gaps = 34/225 (15%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD-IEGLQGHREWLAEVIFLGQLR-HPHL 156
           +G+G +G V K     + + G KA   AVK+LD I  +    E  AE   L  L  HP++
Sbjct: 26  IGKGTYGKVFKVL---NKKNGSKA---AVKILDPIHDIDEEIE--AEYNILKALSDHPNV 77

Query: 157 VRLIG-YCCED----EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------IAIGA 205
           V+  G Y  +D    ++  LV E    GS+ + L K     L  G R++      I   A
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTD-LVKGF---LKRGERMEEPIIAYILHEA 133

Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
             GL  LH   N  I+RD K +NILL ++   KL DFG++      S        +GT  
Sbjct: 134 LMGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPF 189

Query: 266 YAAPEYISTGH-----LTTKSDVYSFGVVLLELLTGRRSMDKLRP 305
           + APE I+           + DV+S G+  +EL  G   +  L P
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 51/169 (30%), Positives = 72/169 (42%), Gaps = 17/169 (10%)

Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
           AKG+ FL  A    I+RD    NILL  +   K+ DFGLA+   +  +            
Sbjct: 189 AKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246

Query: 266 YAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL 325
           + APE I     T +SDV+SFGV+L E+ +   S     P     + +     L+   R+
Sbjct: 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRRLKEGTRM 301

Query: 326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           R       A  Y+     EM    L C    P  RP  + +V  L +LL
Sbjct: 302 R-------APDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 68/257 (26%), Positives = 102/257 (39%), Gaps = 75/257 (29%)

Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD----IEGLQ-GH----REWL 142
           +F S  ++G G FG V        +++       A+K L     +E  Q  H    R+ L
Sbjct: 2   DFESIKVIGRGAFGEVRL------VQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDIL 55

Query: 143 AEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKI 201
           AE        +P +V+L  Y  +DE  L L+ E++P G +   L K+ + +    TR  I
Sbjct: 56  AEA------DNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-ETRFYI 107

Query: 202 -----AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK---------- 246
                AI +   L ++H        RD K  N+LLD+    KLSDFGL            
Sbjct: 108 AETILAIDSIHKLGYIH--------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159

Query: 247 ----MGPEGSNTHVTTR----------------------VMGTYGYAAPE-YISTGHLTT 279
                    SN                             +GT  Y APE ++ TG+   
Sbjct: 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NK 218

Query: 280 KSDVYSFGVVLLELLTG 296
           + D +S GV++ E+L G
Sbjct: 219 ECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 53.9 bits (129), Expect = 6e-08
 Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 5/90 (5%)

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192

Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           APE I         D++S G ++ E++ G 
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 52.9 bits (127), Expect = 6e-08
 Identities = 38/148 (25%), Positives = 62/148 (41%), Gaps = 17/148 (11%)

Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLP----WGTRLKIAIGAAKGL 209
           P++V L  Y   ++   LV +    G L +H+ K +++       W   + +A+ A    
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
             LH     ++ RD   +NILLD     +L+ F       +  +      +     Y AP
Sbjct: 101 --LH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151

Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGR 297
           E       T   D +S G +L ELLTG+
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 53.7 bits (129), Expect = 7e-08
 Identities = 50/190 (26%), Positives = 86/190 (45%), Gaps = 31/190 (16%)

Query: 162 YCCEDEERL-LVYEFMPRG---SLENHLFKRISVSLP--WGTRLKIAIGAAKGLAFLHGA 215
           Y  +D++ L LV E+ P G   SL N    +    +   +   L +AI +   + ++H  
Sbjct: 68  YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH-- 125

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFG-LAKMGPEGSNTHVTTRV-MGTYGYAAPEYIS 273
                 RD K  N+L+D     KL+DFG  A++    +N  V +++ +GT  Y APE ++
Sbjct: 126 ------RDIKPENVLIDRTGHIKLADFGSAARL---TANKMVNSKLPVGTPDYIAPEVLT 176

Query: 274 TGHLTTKS------DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
           T +   K       D +S GV+  E++ GR       P  E          +   R L++
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGR------SPFHEGTSAKTYNNIMNFQRFLKF 230

Query: 328 IVDPRLAGQY 337
             DP+++  +
Sbjct: 231 PEDPKVSSDF 240

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 53.6 bits (128), Expect = 7e-08
 Identities = 39/108 (36%), Positives = 56/108 (51%), Gaps = 11/108 (10%)

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 131 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 185

Query: 268 APEYISTGHLTTKSDVYSFGVVLLE------LLTGRRSMDKLRPKSEQ 309
           APE I         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 37/123 (30%), Positives = 54/123 (43%), Gaps = 2/123 (1%)

Query: 173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD 232
           Y+      ++N L    S  L     L      A+G+ FL  A    ++RD    N+LL 
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL--ASKNCVHRDLAARNVLLA 271

Query: 233 SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLE 292
                K+ DFGLA+     SN            + APE I     TT SDV+S+G++L E
Sbjct: 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWE 331

Query: 293 LLT 295
           + +
Sbjct: 332 IFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 23/159 (14%)

Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHL-----FKRISVSLPWGTRLKIAIGA 205
           L+HP++++ +G C E    LLV+E+   G L+++L      +R S  L      ++A   
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLL---LLQRMACEI 108

Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG-SNTHVTT--RVMG 262
           A G+  +H  ++  ++ D    N  L SD T K+ D+G+   GP      ++ T      
Sbjct: 109 AAGVTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGI---GPSRYKEDYIETEDDKCV 163

Query: 263 TYGYAAPEYISTGH-------LTTKSDVYSFGVVLLELL 294
              + APE +   H        T  S+V++ GV L EL 
Sbjct: 164 PLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 24/212 (11%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G +G V+K    D    G   +  A+K   IEG         E+  L +L+HP+++ 
Sbjct: 9   VGRGTYGHVYKAKRKD----GKDDRDYALK--QIEGTGISMSACREIALLRELKHPNVIS 62

Query: 159 L--IGYCCEDEERLLVYEFMPRGSLENHLFKRIS------VSLPWGTRLKIAIGAAKGLA 210
           L  +     D +  L++++          F R S      V LP G    +      G+ 
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFT----AKLSDFGLAKM--GPEGSNTHVTTRVMGTY 264
           +LH   N V++RD K +NIL+  +       K++D G A++   P      +   V+ T+
Sbjct: 123 YLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 179

Query: 265 GYAAPEYI-STGHLTTKSDVYSFGVVLLELLT 295
            Y APE +    H T   D+++ G +  ELLT
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 55/226 (24%), Positives = 103/226 (45%), Gaps = 23/226 (10%)

Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVI 146
           R   ++F     +G G +G V+K       R     +  A+K++ +E  +       E+I
Sbjct: 5   RNPQEDFELIQRIGSGTYGDVYKA------RNVNTGELAAIKVIKLEPGEDFAVVQQEII 58

Query: 147 FLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLEN--HLFKRISVS-LPWGTRLKIAI 203
            +   +H ++V   G     ++  +  EF   GSL++  H+   +S S + + +R  +  
Sbjct: 59  MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-- 116

Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR-VMG 262
              +GL +LH      ++RD K +NILL  +   KL+DFG++    + + T    +  +G
Sbjct: 117 ---QGLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSA---QITATIAKRKSFIG 168

Query: 263 TYGYAAPEYIST---GHLTTKSDVYSFGVVLLELLTGRRSMDKLRP 305
           T  + APE  +    G      D+++ G+  +EL   +  M  L P
Sbjct: 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 51.1 bits (123), Expect = 4e-07
 Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 35/210 (16%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-----DIEGLQGHREWLAEVIFLGQLR- 152
           +GEG F  V K       + G   +  A+K +      +E  Q +   L E+  L +L  
Sbjct: 7   IGEGTFSEVLKA---QSRKTG---KYYAIKCMKKHFKSLE--QVNN--LREIQALRRLSP 56

Query: 153 HPHLVRLIGYCCEDEE--RL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
           HP+++RLI     D +  RL LV+E M   +L   +  R    LP            K L
Sbjct: 57  HPNILRLIE-VLFDRKTGRLALVFELM-DMNLYELIKGRKR-PLPEKRVKSYMYQLLKSL 113

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT---TRVMGTYGY 266
             +H   N + +RD K  NIL+  D   KL+DFG  +        +     T  + T  Y
Sbjct: 114 DHMHR--NGIFHRDIKPENILIKDD-ILKLADFGSCR------GIYSKPPYTEYISTRWY 164

Query: 267 AAPEYIST-GHLTTKSDVYSFGVVLLELLT 295
            APE + T G+   K D+++ G V  E+L+
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.4 bits (121), Expect = 6e-07
 Identities = 46/185 (24%), Positives = 70/185 (37%), Gaps = 19/185 (10%)

Query: 125 VAVKLLDIEGLQGHREWL---AEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSL 181
           VAVK ++++      +      E+I   QL+HP+++  +     D E  +V   M  GS 
Sbjct: 28  VAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86

Query: 182 ENHLFKRISVSLPWGTRLKIAI---GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAK 238
           E+ L       LP    L IA         L ++H      I+R  K S+ILL  D    
Sbjct: 87  EDLLKTHFPEGLP---ELAIAFILKDVLNALDYIH--SKGFIHRSVKASHILLSGDGKVV 141

Query: 239 LSDFGLAKMGPEGSNTHVTTRVMGTYG-----YAAPEYISTGHL--TTKSDVYSFGVVLL 291
           LS    +    +                    + +PE +         KSD+YS G+   
Sbjct: 142 LSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITAC 201

Query: 292 ELLTG 296
           EL  G
Sbjct: 202 ELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 32/90 (35%), Positives = 44/90 (48%), Gaps = 2/90 (2%)

Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
           A G+ FL  A    ++RD    N+L+      K+ DFGLA+     SN            
Sbjct: 249 ANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306

Query: 266 YAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
           + APE I     TT SDV+SFG++L E+ T
Sbjct: 307 WMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 47/151 (31%), Positives = 69/151 (45%), Gaps = 21/151 (13%)

Query: 162 YCCEDEERLL--VYEFMPRGSLENHLFKRISVSLPWGT-RLKIAIGAAKGLAFLHGAENP 218
           +C  + +R L  V E++  G     L K I  +LP    R+  A      L +LH     
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCAT-LLKNIG-ALPVDMARMYFA-ETVLALEYLHNYG-- 121

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV-------TTR------VMGTYG 265
           +++RD K  N+L+ S    KL+DFGL+K+G     T++        TR      V GT  
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181

Query: 266 YAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           Y APE I         D ++ G++L E L G
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 25/215 (11%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G +G V+K       R     +  AVK++ +E          E+  + + +H ++V 
Sbjct: 17  VGSGTYGDVYKA------RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70

Query: 159 LIGYCCEDEERLLVYEFMPRGSLEN--HLFKRISVSLPWGTRLKIAI---GAAKGLAFLH 213
             G     E+  +  E+   GSL++  H+   +S        L+IA       +GLA+LH
Sbjct: 71  YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLS-------ELQIAYVCRETLQGLAYLH 123

Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
                 ++RD K +NILL  +   KL+DFG+A      +        +GT  + APE  +
Sbjct: 124 SKGK--MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAA 179

Query: 274 ---TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRP 305
               G      D+++ G+  +EL   +  M  L P
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 67/260 (25%), Positives = 110/260 (42%), Gaps = 47/260 (18%)

Query: 125 VAVKLLDIEGLQGHREWLAEVIF-----LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRG 179
           V +K+LD      HR+ +A   F     + Q+ H HL  + G C    E ++V EF+  G
Sbjct: 47  VVLKVLD----PSHRD-IALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHG 101

Query: 180 SLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL-------- 231
            L+    ++    +P   ++ +A   A  L++L   +  +++ +    NILL        
Sbjct: 102 PLDV-CLRKEKGRVPVAWKITVAQQLASALSYLE--DKNLVHGNVCAKNILLARLGLAEG 158

Query: 232 DSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI-STGHLTTKSDVYSFGVVL 290
            S F  KLSD G++      S      R+     + APE +     L+T +D +SFG  L
Sbjct: 159 TSPFI-KLSDPGVSFTAL--SREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTL 211

Query: 291 LELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLAL 350
           LE+        K R  SE+      + Y +  R    + +P           KE+A L  
Sbjct: 212 LEICFDGEVPLKERTPSEKE-----RFYEKKHR----LPEP---------SCKELATLIS 253

Query: 351 QCISVNPKDRPKMAAVVATL 370
           QC++  P  RP    ++  L
Sbjct: 254 QCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 64/257 (24%), Positives = 99/257 (38%), Gaps = 82/257 (31%)

Query: 99  LGEGGFGTV--------HKGYIDDDLRQG---LKAQAVAVKLLDIEGLQGHREWLAEVIF 147
           +G G FG V        +  Y    LR+    ++ QA  VK          R+ LAE   
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVK--------AERDILAEA-- 58

Query: 148 LGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKR----ISVSLPWGTRLKIA 202
                +  +V+L  Y  +D++ L  V +++P G + + L +       ++  +   L  A
Sbjct: 59  ----DNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCA 113

Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL------------------ 244
           I +   + F+H        RD K  NIL+D D   KL+DFGL                  
Sbjct: 114 IESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDH 165

Query: 245 -----------------AKMGP-EGSNTHVTTRVM-----GTYGYAAPEYIS-TGHLTTK 280
                             ++ P E        R +     GT  Y APE +  TG+ T  
Sbjct: 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQL 224

Query: 281 SDVYSFGVVLLELLTGR 297
            D +S GV+L E+L G+
Sbjct: 225 CDWWSVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 24/212 (11%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G +G V+K    D    G   +  A+K   IEG         E+  L +L+HP+++ 
Sbjct: 9   VGRGTYGHVYKAKRKD----GKDEKEYALK--QIEGTGISMSACREIALLRELKHPNVIA 62

Query: 159 L--IGYCCEDEERLLVYEFMPRGSLENHLFKRIS------VSLPWGTRLKIAIGAAKGLA 210
           L  +     D +  L++++          F R S      + LP      +      G+ 
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFT----AKLSDFGLAKM--GPEGSNTHVTTRVMGTY 264
           +LH   N V++RD K +NIL+  +       K++D G A++   P      +   V+ T+
Sbjct: 123 YLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 179

Query: 265 GYAAPEYI-STGHLTTKSDVYSFGVVLLELLT 295
            Y APE +    H T   D+++ G +  ELLT
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 47/174 (27%), Positives = 70/174 (40%), Gaps = 48/174 (27%)

Query: 162 YCCEDEERL-LVYEFMPRGSLENHLFKRISVSLP----WGTRLKIAIGAAKGLAFLHGAE 216
           Y  +D+  L L+ EF+P G +   L K+ ++S      +     +AI A   L F+H   
Sbjct: 68  YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH--- 124

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT---------------------- 254
                RD K  N+LLD+    KLSDFGL     +   T                      
Sbjct: 125 -----RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSK 179

Query: 255 -----------HVTTRVMGTYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTG 296
                       +    +GT  Y APE ++ TG+     D +S GV++ E+L G
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (112), Expect = 9e-06
 Identities = 71/264 (26%), Positives = 99/264 (37%), Gaps = 78/264 (29%)

Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAV-AVK-LLDIEGLQGHREWLAEVI-- 146
           ++F +  ++G+G FG V        L Q      + A+K LL  E  +  ++ LA V   
Sbjct: 1   EDFHTVKVIGKGAFGEVR-------LVQKKDTGKIYAMKTLLKSEMFK--KDQLAHVKAE 51

Query: 147 --FLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA- 202
              L +   P +V L  Y  +D + L L+ EF+P G L   L K  + S    TR  +A 
Sbjct: 52  RDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV-TRFYMAE 109

Query: 203 ----IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL-------------- 244
               I A   L F+H        RD K  NIL+D     KLSDFGL              
Sbjct: 110 CVLAIEAVHKLGFIH--------RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161

Query: 245 -------AKMGPEGSNTHV-------------------TTRVM-----GTYGYAAPEYIS 273
                   K   +  N+                       R+M     GT  Y APE I 
Sbjct: 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IF 220

Query: 274 TGH-LTTKSDVYSFGVVLLELLTG 296
                  + D +S G ++ E L G
Sbjct: 221 LQQGYGQECDWWSLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 24/148 (16%)

Query: 162 YCCEDEERL-LVYEFMPRGSLENHLFK---RISVSLP--WGTRLKIAIGAAKGLAFLHGA 215
           Y  +DE  L LV ++   G L   L K   R+   +   +   + +AI +   L ++H  
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH-- 125

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFG-LAKMGPEGSNTHVTTRV-MGTYGYAAPEYI- 272
                 RD K  N+LLD +   +L+DFG   ++  +G+   V + V +GT  Y +PE + 
Sbjct: 126 ------RDIKPDNVLLDKNGHIRLADFGSCLRLLADGT---VQSNVAVGTPDYISPEILQ 176

Query: 273 ----STGHLTTKSDVYSFGVVLLELLTG 296
                 G    + D +S GV + E+L G
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 57/225 (25%), Positives = 86/225 (38%), Gaps = 64/225 (28%)

Query: 143 AEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLP------W 195
           AE   L +  +  +V+L  Y  +D++ L  V +++P G + + L  R+ V  P      +
Sbjct: 50  AERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMS-LLIRMEV-FPEVLARFY 106

Query: 196 GTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA---------- 245
              L +AI +   + F+H        RD K  NIL+D D   KL+DFGL           
Sbjct: 107 IAELTLAIESVHKMGFIH--------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158

Query: 246 -----------KMGPEG-----SNTHVTTRVM-------------------GTYGYAAPE 270
                       M P       SN     R+                    GT  Y APE
Sbjct: 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPE 218

Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQ-NLVDW 314
            +     T   D +S GV+L E+L G+       P   Q  +++W
Sbjct: 219 VLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 65/250 (26%), Positives = 100/250 (40%), Gaps = 62/250 (24%)

Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD----IEGLQ-GHREWLAEV 145
           ++F S  ++G G FG V      D           A+K+L     +E  Q GH    AE 
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKD------TGHVYAMKILRKADMLEKEQVGHIR--AER 52

Query: 146 IFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLP----WGTRLK 200
             L +     +V++  Y  +D+  L L+ EF+P G +   L K+ +++      +     
Sbjct: 53  DILVEADSLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV 111

Query: 201 IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT------ 254
           +AI +   L F+H        RD K  N+LLDS    KLSDFGL     +   T      
Sbjct: 112 LAIDSIHQLGFIH--------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNL 163

Query: 255 ---------------------------HVTTRVMGTYGYAAPE-YISTGHLTTKSDVYSF 286
                                       +    +GT  Y APE ++ TG+     D +S 
Sbjct: 164 NHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSL 222

Query: 287 GVVLLELLTG 296
           GV++ E+L G
Sbjct: 223 GVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 59/198 (29%), Positives = 86/198 (43%), Gaps = 28/198 (14%)

Query: 125 VAVKLLDIEGL-QGHREWLA-EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLE 182
           V V++ D+E   + H + L  EV+     RHP+++             ++  FM  GS  
Sbjct: 28  VTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGS-A 86

Query: 183 NHLFKRISVSLPWGTRL----KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAK 238
           N L K      P G        I  GA +GL +LH  +N  I+R+ K S+IL+  D    
Sbjct: 87  NSLLKTY---FPEGMSEALIGNILFGALRGLNYLH--QNGYIHRNIKASHILISGDGLVS 141

Query: 239 LSDFG-LAKMGPEGSNTHV-------TTRVMGTYGYAAPEYIS---TGHLTTKSDVYSFG 287
           LS    L  +   G    V       +T V+    + +PE +     G+   KSD+YS G
Sbjct: 142 LSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYGY-NVKSDIYSVG 197

Query: 288 VVLLELLTGRRS-MDKLR 304
           +   EL TGR    D LR
Sbjct: 198 ITACELATGRVPFQDMLR 215

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 28/83 (33%), Positives = 44/83 (53%), Gaps = 8/83 (9%)

Query: 220 IYRDFKTSNILLDSDFTAKLSDFG-LAKMGPEGSNTHVTTRVMGTYGYAAPEYIST---- 274
           ++RD K  N+LLD +   +L+DFG   KM  +G  T  ++  +GT  Y +PE +      
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVAVGTPDYISPEILQAMEDG 181

Query: 275 -GHLTTKSDVYSFGVVLLELLTG 296
            G    + D +S GV + E+L G
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 42.2 bits (99), Expect = 3e-04
 Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 2/82 (2%)

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           ++HG    +I+RD KT N+L++      L DFG A       +T     + GT    APE
Sbjct: 275 YIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPE 332

Query: 271 YISTGHLTTKSDVYSFGVVLLE 292
            ++    T   D++S G+V+ E
Sbjct: 333 VLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 24/148 (16%)

Query: 162 YCCEDEERL-LVYEFMPRGSLENHLFKRISVSLP------WGTRLKIAIGAAKGLAFLHG 214
           Y  +DE  L LV ++   G L   L  +    LP      +   + IAI +   L ++H 
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH- 125

Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFG-LAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
                  RD K  NIL+D +   +L+DFG   K+  +G  T  ++  +GT  Y +PE + 
Sbjct: 126 -------RDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPEILQ 176

Query: 274 T-----GHLTTKSDVYSFGVVLLELLTG 296
                 G    + D +S GV + E+L G
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 50/223 (22%), Positives = 88/223 (39%), Gaps = 60/223 (26%)

Query: 143 AEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFK----RISVSLPWGT 197
           AE   L +  +  +VRL  Y  +D++ L  V +++P G + + L +       ++  +  
Sbjct: 50  AERDILAEADNEWVVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA 108

Query: 198 RLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA------------ 245
            L  A+ +   + F+H        RD K  NIL+D D   KL+DFGL             
Sbjct: 109 ELTCAVESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160

Query: 246 ---------------------------KMGP---EGSNTH---VTTRVMGTYGYAAPEYI 272
                                      ++ P     +  H   +   ++GT  Y APE +
Sbjct: 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL 220

Query: 273 STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRP-KSEQNLVDW 314
                T   D +S GV+L E+L G+       P +++  +++W
Sbjct: 221 LRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 25/77 (32%), Positives = 40/77 (51%), Gaps = 1/77 (1%)

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
           +I+RD K  NI L+ D    L DFG A M  E          +GT    +PE ++     
Sbjct: 288 LIHRDIKLENIFLNCDGKIVLGDFGTA-MPFEKEREAFDYGWVGTVATNSPEILAGDGYC 346

Query: 279 TKSDVYSFGVVLLELLT 295
             +D++S G++LL++L+
Sbjct: 347 EITDIWSCGLILLDMLS 363

Length = 501

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	419
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.85
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.84
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.83
smart00090	237	RIO RIO-like kinase.	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.64
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.58
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.54
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.52
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.46
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.45
KOG1243	690	consensus Protein kinase [General function predict	99.41
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.36
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.34
KOG3087	229	consensus Serine/threonine protein kinase [General	99.34
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.33
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.28
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.26
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.15
COG4248	637	Uncharacterized protein with protein kinase and he	99.14
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.04
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.97
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.89
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.86
PRK09902	216	hypothetical protein; Provisional	98.86
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.85
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.71
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.64
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.63
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.53
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.46
PF01636	239	APH: Phosphotransferase enzyme family This family	98.45
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.41
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.37
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.35
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.34
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.3
PLN02876	822	acyl-CoA dehydrogenase	98.26
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.17
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.06
PRK05231	319	homoserine kinase; Provisional	97.99
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.98
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.98
PRK10593	297	hypothetical protein; Provisional	97.98
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.97
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.93
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.81
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.77
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.66
PLN02236	344	choline kinase	97.45
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.3
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.3
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.21
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.08
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.98
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.93
KOG2270	520	consensus Serine/threonine protein kinase involved	96.87
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.82
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.8
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.78
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.73
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.7
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.65
PLN02756	418	S-methyl-5-thioribose kinase	96.56
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.56
PTZ00384	383	choline kinase; Provisional	96.34
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	96.26
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.1
PTZ00296	442	choline kinase; Provisional	95.93
PRK12396	409	5-methylribose kinase; Reviewed	95.83
PRK11768	325	serine/threonine protein kinase; Provisional	95.74

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-53  Score=410.47  Aligned_cols=248  Identities=25%  Similarity=0.396  Sum_probs=214.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC---CcccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE---GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .+|...++||+|||+.||.++      +..+|+.||+|++.+.   .....+.+.+||+|.+.|+|||||+++++|++.+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~------~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~   91 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEAR------DLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN   91 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEE------EcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence            579999999999999999995      4456899999999764   3345678899999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      +.|||+|+|..++|.+++.++  +.+++.+++.++.||+.||.|||  +++|+|||||..|+||+++.+|||+|||||..
T Consensus        92 nVYivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH--~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~  167 (592)
T KOG0575|consen   92 NVYIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLH--SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQ  167 (592)
T ss_pred             ceEEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHH--hcCceecccchhheeecCcCcEEecccceeee
Confidence            999999999999999999855  78999999999999999999999  67799999999999999999999999999998


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      +.....  ...+.||||.|+|||++.....+..+||||+|||+|.||.|++||+...-.+..+.+...          + 
T Consensus       168 le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~----------~-  234 (592)
T KOG0575|consen  168 LEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN----------E-  234 (592)
T ss_pred             ecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc----------C-
Confidence            764432  245689999999999999999999999999999999999999999875433322222111          0 


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                             -.++...+.++.+||.++|+.||.+|||+++|+.
T Consensus       235 -------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  235 -------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             -------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                   1233456788999999999999999999999986

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-52  Score=399.15  Aligned_cols=291  Identities=60%  Similarity=1.000  Sum_probs=251.3

Q ss_pred             CCcCCCHHHHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccc
Q 014736           77 DLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHL  156 (419)
Q Consensus        77 ~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI  156 (419)
                      ....|...++..++++|...++||+|+||.||+|...+       +..||||.+.........+|.+|+++|.+++|||+
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nl  133 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNL  133 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCc
Confidence            55678999999999999999999999999999998765       36799998876543215669999999999999999


Q ss_pred             cceeeEEEeCC-eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeecCCCCCcEEEcCC
Q 014736          157 VRLIGYCCEDE-ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA-ENPVIYRDFKTSNILLDSD  234 (419)
Q Consensus       157 v~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~  234 (419)
                      |+++|||.+.+ +.+||+||+.+|+|.++|.......++|..+++|+.++|.||+|||.. ...|||||||+.|||||++
T Consensus       134 v~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~  213 (361)
T KOG1187|consen  134 VKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED  213 (361)
T ss_pred             ccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence            99999999998 599999999999999999876433789999999999999999999973 3469999999999999999


Q ss_pred             CcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHh
Q 014736          235 FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW  314 (419)
Q Consensus       235 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  314 (419)
                      +.+||+|||+|+..... .........||.+|+|||++..+..+.++|||||||++.||++|+.+.+...+......++|
T Consensus       214 ~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w  292 (361)
T KOG1187|consen  214 FNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW  292 (361)
T ss_pred             CCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence            99999999999765441 11111111699999999999999999999999999999999999999988776667778999


Q ss_pred             hhHHhhcccccccccccccC-CCCCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          315 AKPYLRSSRRLRYIVDPRLA-GQYSV-KGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~-~~~~~-~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                      ..+.+... .+..++|+.+. ..+.. .....+..+..+|++.+|++||+|.+|+++|+.+...
T Consensus       293 ~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  293 AKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            98877666 88899999987 66664 5777899999999999999999999999999766544

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-53  Score=388.89  Aligned_cols=255  Identities=25%  Similarity=0.409  Sum_probs=209.7

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc-------HHHHHHHHHHHcCCCcccccce
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-------HREWLAEVIFLGQLRHPHLVRL  159 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~~  159 (419)
                      +.+.+.|.+.+.||+|+||.|-+|+      +..+++.||||+++......       .....+|+++|++|+|||||++
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~------e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~  241 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAY------EKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRI  241 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEE------EcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEE
Confidence            3467789999999999999999996      45668999999997543221       2335689999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC---Cc
Q 014736          160 IGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD---FT  236 (419)
Q Consensus       160 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~---~~  236 (419)
                      +++|+..+..||||||++||+|.+++..+  +.+.+..-+.+++|++.|+.|||  ++||+||||||+|||+..+   ..
T Consensus       242 ~d~f~~~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH--~~GI~HRDiKPeNILl~~~~e~~l  317 (475)
T KOG0615|consen  242 KDFFEVPDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLH--SQGIIHRDIKPENILLSNDAEDCL  317 (475)
T ss_pred             eeeeecCCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHH--HcCcccccCCcceEEeccCCcceE
Confidence            99999999999999999999999999877  56777777999999999999999  7889999999999999876   67


Q ss_pred             EEEeccCccccCCCCCCceeeecccccccccccccccCCCC---CchhhHHHHHHHHHHHHcCCCCCCCCCCcc-chhHH
Q 014736          237 AKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL---TTKSDVYSFGVVLLELLTGRRSMDKLRPKS-EQNLV  312 (419)
Q Consensus       237 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~  312 (419)
                      +||+|||+|+....   ...+.++|||+.|.|||++.+..+   ..++|+||+||+||-+|+|.+||....... ....+
T Consensus       318 lKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI  394 (475)
T KOG0615|consen  318 LKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI  394 (475)
T ss_pred             EEecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH
Confidence            99999999998653   335677899999999999976543   348899999999999999999998755433 22222


Q ss_pred             HhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          313 DWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .        .+++.  +.+    .....++++..+||.+||..||++|||+.|+++
T Consensus       395 ~--------~G~y~--f~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  395 L--------KGRYA--FGP----LQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             h--------cCccc--ccC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            1        11111  111    223457899999999999999999999999986

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-51  Score=376.05  Aligned_cols=251  Identities=29%  Similarity=0.419  Sum_probs=209.2

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC-CcccHHHHHHHHHHHcCCCcccccceeeEEEeCCe-e
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE-R  169 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~  169 (419)
                      +.+.++.||+|..|+||++      .|+.+++.+|+|++... +....+++.+|+++++..+||+||.+||.|..++. .
T Consensus        80 dle~~~~lG~G~gG~V~kv------~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i  153 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKV------RHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI  153 (364)
T ss_pred             HhhhhhhcccCCCcEEEEE------EEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence            3444567999999999999      46667899999999544 33446789999999999999999999999999994 9


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      +|+||||++|+|.+++...  +.+++.....++.++++||.|||. +++||||||||+||||+..|.|||||||.+..+.
T Consensus       154 sI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~-~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv  230 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHE-ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV  230 (364)
T ss_pred             EeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh-ccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence            9999999999999998765  679999999999999999999994 2679999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--ccchhHHHhhhHHhhccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRP--KSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ..    ....++||..|||||.+.+..|+.++||||||+.++||.+|+.||....+  .....+..++   ...      
T Consensus       231 nS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---v~~------  297 (364)
T KOG0581|consen  231 NS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---VDE------  297 (364)
T ss_pred             hh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---hcC------
Confidence            44    34567899999999999999999999999999999999999999987522  1122222221   110      


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       ..+.+...   .+++++++++..||++||.+||++.|+++
T Consensus       298 -ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  298 -PPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             -CCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             11222222   36789999999999999999999999987

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6e-52  Score=381.58  Aligned_cols=248  Identities=30%  Similarity=0.460  Sum_probs=205.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC--CcccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .+|.+.+.||+|+||+||+|++      +.++..||||.+.+.  ..+..+-+..|+.+|+.++|||||.+++++..++.
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h------~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~   83 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRH------KKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF   83 (429)
T ss_pred             ccceehhhccCcceEEEEEeEe------ccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence            5788888999999999999954      445689999999876  34455668899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC------CcEEEecc
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD------FTAKLSDF  242 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~------~~~kl~Df  242 (419)
                      +|||||||.||+|.+|+..+  +.+++..++.++.||+.||++||  +++||||||||+||||+.+      -.+||+||
T Consensus        84 i~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~--~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF  159 (429)
T KOG0595|consen   84 IYLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLH--ENNIIHRDLKPQNILLSTTARNDTSPVLKIADF  159 (429)
T ss_pred             EEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence            99999999999999999887  68999999999999999999999  7889999999999999875      46899999


Q ss_pred             CccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       243 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      |+|+.+..+.   ...+.||++.|||||++..+.|+.|+|+||+|+|+|+|++|+.||+.....+...       +....
T Consensus       160 GfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~-------~~~k~  229 (429)
T KOG0595|consen  160 GFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL-------YIKKG  229 (429)
T ss_pred             chhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-------HHhcc
Confidence            9999887554   3456899999999999999999999999999999999999999999765543222       11111


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV  366 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~ei  366 (419)
                      .        .+....+...+..+.+|+...++.+|.+|-+..+-
T Consensus       230 ~--------~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~  265 (429)
T KOG0595|consen  230 N--------EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDF  265 (429)
T ss_pred             c--------cccCchhhhccCchhhhhhHHHhcCccccCchHHh
Confidence            1        11222333344556677778888888877665544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=6e-52  Score=378.33  Aligned_cols=242  Identities=27%  Similarity=0.348  Sum_probs=205.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++.++||+|+||+||.++.+      .+++.||+|++++..   ....+...+|..+|..++||+||+++..|.+.+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~------dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~   98 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKK------DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE   98 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEc------ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC
Confidence            57999999999999999999644      567899999997653   234677889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ++|||+||+.||.|.-+|++.  ..+++..+..++.+|+.||.|||  ++|||||||||+|||||.+|+++|+||||++.
T Consensus        99 kLylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH--~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~  174 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLH--SKGIIYRDLKPENILLDEQGHIKLTDFGLCKE  174 (357)
T ss_pred             eEEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHH--hCCeeeccCCHHHeeecCCCcEEEeccccchh
Confidence            999999999999999999876  67899999999999999999999  77899999999999999999999999999996


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      .....  ..+..+|||+.|||||++.+..|+.++|+||||+++|||++|.+||...+.....+.+..      ..     
T Consensus       175 ~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~------~k-----  241 (357)
T KOG0598|consen  175 DLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK------GK-----  241 (357)
T ss_pred             cccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc------Cc-----
Confidence            43332  234558999999999999999999999999999999999999999987654332222211      00     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP  361 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP  361 (419)
                            ...++...+.++++|+.++|..||++|.
T Consensus       242 ------~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 ------LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ------CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence                  0112223567899999999999999995

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.6e-52  Score=363.60  Aligned_cols=258  Identities=25%  Similarity=0.369  Sum_probs=207.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceee-EEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIG-YCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~-~~~~~~  167 (419)
                      .+|.+.++||+|+||.||++.      +..+++.+|.|.++....  +..+.+..|+.+|++|+|||||++++ .|.++.
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~------~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQ------CLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             HHHHHHHHHcCCcchheEEee------eccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            357777889999999999994      566788999999975433  44567899999999999999999998 555555


Q ss_pred             e-eEEEEEecCCCChhhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCcEEEcCCCcEEEecc
Q 014736          168 E-RLLVYEFMPRGSLENHLFK--RISVSLPWGTRLKIAIGAAKGLAFLHGAENP--VIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       168 ~-~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                      . ++||||||.+|+|...+..  .....+++..+++++.|++.||..+|+.-..  |+||||||.||+|+.+|.|||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence            4 8999999999999998853  4456799999999999999999999973244  999999999999999999999999


Q ss_pred             CccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       243 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      |+++++....  ......+|||.||+||++.+.+|+.++||||+||++|||..-++||.+.+-      ...... ....
T Consensus       173 GL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~L~~K-I~qg  243 (375)
T KOG0591|consen  173 GLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LSLCKK-IEQG  243 (375)
T ss_pred             hhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HHHHHH-HHcC
Confidence            9999876543  234557899999999999999999999999999999999999999987532      111111 1111


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES  372 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~  372 (419)
                               ..........+.++..||..|+..||+.||+...++..+..
T Consensus       244 ---------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  244 ---------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             ---------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                     11111124567899999999999999999996555554443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-49  Score=378.50  Aligned_cols=256  Identities=36%  Similarity=0.585  Sum_probs=211.6

Q ss_pred             CCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc--HHHHHHHHHHHcCCCcccccceeeEEEeCC-eeE
Q 014736           94 SSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HREWLAEVIFLGQLRHPHLVRLIGYCCEDE-ERL  170 (419)
Q Consensus        94 ~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~  170 (419)
                      .+.+.||+|+||+||+|.|.+.       ..||+|++.......  .+.|.+|+.+|.+++|||||+++|++.+.. .++
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~-------~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~  116 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGT-------DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC  116 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCc-------eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence            3444599999999999988652       229999997653322  568999999999999999999999998887 799


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-eeecCCCCCcEEEcCCC-cEEEeccCccccC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP-VIYRDFKTSNILLDSDF-TAKLSDFGLAKMG  248 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~  248 (419)
                      +||||+++|+|.+++.......+++..++.++.+|+.||.|||  +++ |||||||++||||+.++ .+||+|||+++..
T Consensus       117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH--~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~  194 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH--SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK  194 (362)
T ss_pred             EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh--cCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence            9999999999999998755578999999999999999999999  566 99999999999999998 9999999999865


Q ss_pred             CCCCCceeeeccccccccccccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYIS--TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ....  ...+...||+.|||||++.  ...|+.++||||||+++|||+||+.||....+......+      .       
T Consensus       195 ~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v------~-------  259 (362)
T KOG0192|consen  195 VISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV------V-------  259 (362)
T ss_pred             cccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH------H-------
Confidence            4332  1233367999999999998  568999999999999999999999999987652111111      1       


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                         .......++..+++.+..|+.+||..||..||++.+|+..|+.+...
T Consensus       260 ---~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  260 ---VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             ---hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence               01112233334678899999999999999999999999999988764

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-50  Score=381.01  Aligned_cols=253  Identities=26%  Similarity=0.337  Sum_probs=212.8

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC---CcccHHHHHHHHHHHcCC-CcccccceeeEE
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE---GLQGHREWLAEVIFLGQL-RHPHLVRLIGYC  163 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  163 (419)
                      .--++|.+++.||.|+|++|++|+.      ..+++.||||++.+.   .....+-+..|-++|.+| .||.|++++..|
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~------~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF  143 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLARE------KATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF  143 (604)
T ss_pred             CChhhcchhheeccccceeEEEeee------cCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence            3346899999999999999999954      446789999999754   223344566788999999 799999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccC
Q 014736          164 CEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFG  243 (419)
Q Consensus       164 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  243 (419)
                      .++..+|+|+||+++|+|.++|.+.  +.+++..++.++.||+.||+|||  ++|||||||||+|||||+|+++||+|||
T Consensus       144 QD~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH--~~GIIHRDlKPENILLd~dmhikITDFG  219 (604)
T KOG0592|consen  144 QDEESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLH--SNGIIHRDLKPENILLDKDGHIKITDFG  219 (604)
T ss_pred             ecccceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeEcCCCcEEEeecc
Confidence            9999999999999999999999887  78899999999999999999999  7889999999999999999999999999


Q ss_pred             ccccCCCCCCc-----------eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHH
Q 014736          244 LAKMGPEGSNT-----------HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV  312 (419)
Q Consensus       244 la~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~  312 (419)
                      .|+.+......           .....++||..|++||++.....+..+|||+||||+|+|+.|.+||.+.++.-....+
T Consensus       220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI  299 (604)
T KOG0592|consen  220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI  299 (604)
T ss_pred             ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence            99976543322           0114489999999999999999999999999999999999999999987643322222


Q ss_pred             HhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          313 DWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ..          +        .=.|+...++.+.+|+.++|..||.+|+++.+|.+
T Consensus       300 ~~----------l--------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  300 QA----------L--------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HH----------h--------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            11          1        11234445588999999999999999999998875

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-49  Score=350.24  Aligned_cols=237  Identities=28%  Similarity=0.384  Sum_probs=205.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|+.++.||.|+||+|.+++      ++.++..||+|++++..   ..+.++..+|..+|+.+.||+++++++.|.+.+
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr------~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~  117 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVR------EKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS  117 (355)
T ss_pred             hhhhheeeeccCccceEEEEE------EccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence            568888899999999999994      45568899999997653   355677889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      .+||||||++||.|..++++.  +.+++..++.++.||+.||+|||  .++|++|||||+|||+|.+|.+||+|||+|+.
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH--~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~  193 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLH--SLDIIYRDLKPENLLLDQNGHIKITDFGFAKR  193 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHH--hcCeeeccCChHHeeeccCCcEEEEeccceEE
Confidence            999999999999999999876  67899999999999999999999  56699999999999999999999999999997


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      +...     +.+.|||+.|+|||+++...|+.++|+|||||++|||+.|.+||....+....+.+               
T Consensus       194 v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI---------------  253 (355)
T KOG0616|consen  194 VSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI---------------  253 (355)
T ss_pred             ecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH---------------
Confidence            6543     45689999999999999999999999999999999999999999876653222211               


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDR  360 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~R  360 (419)
                       +...+  .|+...+.++.+|+..+|+.|-.+|
T Consensus       254 -~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  254 -LEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -HhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence             11111  3455567889999999999999999

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.1e-48  Score=346.67  Aligned_cols=266  Identities=25%  Similarity=0.307  Sum_probs=209.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      +.|+.+.++|+|+||+||+|      +++.+|+.||||++--...  ...+-.++|+++|++|+|+|+|.++++|.....
T Consensus         2 ekYE~LgkvGEGSYGvV~KC------rnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk   75 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKC------RNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK   75 (396)
T ss_pred             cHHhhhhccccCcceEEEEe------ccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce
Confidence            35777888999999999999      5677899999999954322  223557899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      ++||+|||+.. +.+-|... ...++...+..++.|++.|+.|+|  ++++|||||||+||||+.+|.+||||||+|+.+
T Consensus        76 lhLVFE~~dhT-vL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cH--k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L  151 (396)
T KOG0593|consen   76 LHLVFEYCDHT-VLHELERY-PNGVPSELVKKYLYQLLKAIHFCH--KNNCIHRDIKPENILITQNGVVKLCDFGFARTL  151 (396)
T ss_pred             eEEEeeecchH-HHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhh--hcCeecccCChhheEEecCCcEEeccchhhHhh
Confidence            99999999664 44445443 356888999999999999999999  677999999999999999999999999999987


Q ss_pred             CCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh--------hHHh
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA--------KPYL  319 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~--------~~~~  319 (419)
                      ...  ....+.++.|..|.|||.+.+ ..|+..+||||+||++.||++|.+-|.+.++-+....+...        ...+
T Consensus       152 ~~p--gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF  229 (396)
T KOG0593|consen  152 SAP--GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF  229 (396)
T ss_pred             cCC--cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh
Confidence            632  223566788999999999877 78999999999999999999999999988766554433222        1122


Q ss_pred             hcccccccccccccCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          320 RSSRRLRYIVDPRLAG-----QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~-----~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .....+..+.-|....     .--+..+.-+.+|+..||..||.+|++.++++.
T Consensus       230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            2222222222222111     111234568999999999999999999999973

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-47  Score=368.31  Aligned_cols=250  Identities=26%  Similarity=0.384  Sum_probs=206.8

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC----Cc-ccHHHHHHHHHHHcCCC-cccccceeeE
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE----GL-QGHREWLAEVIFLGQLR-HPHLVRLIGY  162 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~  162 (419)
                      ...+|.+.+.||+|+||.|++|.      +..+++.||+|+++..    .. ...+.+.+|+.+++.++ ||||++++++
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~------~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev   88 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAK------HRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV   88 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEee------eccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE
Confidence            34689999999999999999995      4455789999987654    11 22445668999999998 9999999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-CcEEEec
Q 014736          163 CCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD-FTAKLSD  241 (419)
Q Consensus       163 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~-~~~kl~D  241 (419)
                      +.....+|+||||+.||+|.+++.+.  +.+.+..+..+++|++.|++|||  .+||+||||||+|||++.+ +++||+|
T Consensus        89 ~~t~~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H--~~gi~HRDLK~ENilld~~~~~~Kl~D  164 (370)
T KOG0583|consen   89 FATPTKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCH--SRGIVHRDLKPENILLDGNEGNLKLSD  164 (370)
T ss_pred             EecCCeEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHH--hCCEeeCCCCHHHEEecCCCCCEEEec
Confidence            99999999999999999999999884  67888999999999999999999  6789999999999999999 9999999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccCCC-CC-chhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHh
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH-LT-TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYL  319 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  319 (419)
                      ||++....  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+..........+      .
T Consensus       165 FG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki------~  236 (370)
T KOG0583|consen  165 FGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI------R  236 (370)
T ss_pred             cccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH------h
Confidence            99999763  1222345678999999999998877 86 7899999999999999999999973321111110      0


Q ss_pred             hcccccccccccccCCCCCHHH-HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          320 RSSRRLRYIVDPRLAGQYSVKG-AKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~~~~~~~-~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       ..   .        -.++... +.++.+|+.+||..||.+|+++.+|++
T Consensus       237 -~~---~--------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  237 -KG---E--------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             -cC---C--------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence             00   0        0122223 688999999999999999999999983

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.5e-47  Score=363.36  Aligned_cols=253  Identities=23%  Similarity=0.320  Sum_probs=208.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      .++|.++++||+|+||.||+|.      .+.+|+.+|+|++++..   ..+++.++.|-.+|...++|+||++|..|.+.
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLar------Kk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~  213 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLAR------KKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK  213 (550)
T ss_pred             cccchhheeeccccceeEEEEE------EccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence            4589999999999999999994      55678999999998764   34567788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +++||||||++||++..+|.+.  ..+++..+..++.+++.||+.||  +.|+|||||||+|+|||..|++||+||||+.
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH--~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIH--QLGYIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHH--HcCcccccCChhheeecCCCCEeeccccccc
Confidence            9999999999999999999877  78999999999999999999999  7889999999999999999999999999985


Q ss_pred             cCCCC----------------------CCc------ee-----------------eecccccccccccccccCCCCCchh
Q 014736          247 MGPEG----------------------SNT------HV-----------------TTRVMGTYGYAAPEYISTGHLTTKS  281 (419)
Q Consensus       247 ~~~~~----------------------~~~------~~-----------------~~~~~gt~~y~aPE~~~~~~~~~~~  281 (419)
                      -+...                      ...      ..                 ....+|||.|||||++.+..|+..+
T Consensus       290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c  369 (550)
T KOG0605|consen  290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC  369 (550)
T ss_pred             hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence            32110                      000      00                 0124799999999999999999999


Q ss_pred             hHHHHHHHHHHHHcCCCCCCCCCCccchh-HHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 014736          282 DVYSFGVVLLELLTGRRSMDKLRPKSEQN-LVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDR  360 (419)
Q Consensus       282 DiwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~R  360 (419)
                      |+||||||+||||.|-+||....+.+.-. ++.|...               +...-....+.++.+||.+||. ||.+|
T Consensus       370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------l~fP~~~~~s~eA~DLI~rll~-d~~~R  433 (550)
T KOG0605|consen  370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------LKFPEEVDLSDEAKDLITRLLC-DPENR  433 (550)
T ss_pred             cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------ccCCCcCcccHHHHHHHHHHhc-CHHHh
Confidence            99999999999999999999877655332 2333211               1111222345899999999999 99999


Q ss_pred             CC---HHHHHH
Q 014736          361 PK---MAAVVA  368 (419)
Q Consensus       361 Ps---~~eil~  368 (419)
                      ..   ++||.+
T Consensus       434 LG~~G~~EIK~  444 (550)
T KOG0605|consen  434 LGSKGAEEIKK  444 (550)
T ss_pred             cCcccHHHHhc
Confidence            65   555543

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-47  Score=362.20  Aligned_cols=255  Identities=33%  Similarity=0.476  Sum_probs=214.0

Q ss_pred             CCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEE
Q 014736           94 SSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVY  173 (419)
Q Consensus        94 ~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  173 (419)
                      ..++.||+|.||.||+|.+++.       ..||+|.+... ....+.|.+|+++|++|+|+|||++++++..++.+||||
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~~-------~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNGS-------TKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcCC-------CcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            3445699999999999998774       36999998754 334578899999999999999999999999989999999


Q ss_pred             EecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCC
Q 014736          174 EFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN  253 (419)
Q Consensus       174 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  253 (419)
                      ||++.|+|.++|.......+.....+.++.|||+||+||+  .+++|||||...||||+++..+||+|||+|+...+...
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe--s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y  358 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE--SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY  358 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH--hCCccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence            9999999999999866778899999999999999999999  56699999999999999999999999999995444433


Q ss_pred             ceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       254 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                      . ......-...|.|||.+..+.++.++|||||||+||||+| |+.||.+....+....+       ..+.+        
T Consensus       359 ~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l-------e~GyR--------  422 (468)
T KOG0197|consen  359 T-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL-------ERGYR--------  422 (468)
T ss_pred             e-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH-------hccCc--------
Confidence            2 2222334678999999999999999999999999999999 89999877644322222       12222        


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                        -..+..++.++.+|+..||..+|++|||++.+...|+.+...
T Consensus       423 --lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  423 --LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence              234556789999999999999999999999999999887653

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=366.86  Aligned_cols=250  Identities=25%  Similarity=0.389  Sum_probs=214.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ..|....+||+|.-|.||.|.      +..+++.||||.+........+-+++|+.+|+..+|+|||++++.|...+.+|
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~------~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW  346 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVAR------KISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELW  346 (550)
T ss_pred             hhhcchhhhccccccceeeee------eccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence            358888899999999999995      45567889999999887777788899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||++||+|.+.+...   .+++.++..|+++++.||+|||  .+||+|||||.+|||++.+|.+||+|||++..+..
T Consensus       347 VVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH--~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLH--ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             EEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHH--hcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            999999999999998765   5889999999999999999999  78899999999999999999999999999987665


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD  330 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (419)
                      ...  .....+||++|||||++....|++++||||||++++||+-|++||-...+.....++.       ..+       
T Consensus       422 ~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-------~ng-------  485 (550)
T KOG0578|consen  422 EQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------TNG-------  485 (550)
T ss_pred             ccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-------hcC-------
Confidence            543  3556789999999999999999999999999999999999999998644322211111       111       


Q ss_pred             cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       331 ~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       ...-..+...+.++.+++.+||+.|+.+|+++.|+|+
T Consensus       486 -~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  486 -TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             -CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence             1122334556789999999999999999999999987

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-47  Score=353.23  Aligned_cols=259  Identities=28%  Similarity=0.412  Sum_probs=206.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCC--e
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE--E  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~  168 (419)
                      .++...+.||+|+||.||++...+      ++...|||.+...+....+.+.+|+.+|.+++|||||+.+|......  .
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~------~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~   90 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKK------TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDE   90 (313)
T ss_pred             chhhhhccccCccceEEEEEEecC------CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence            356677889999999999996543      37889999998764434667889999999999999999999754444  6


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCcEEEeccCcccc
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS-DFTAKLSDFGLAKM  247 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~  247 (419)
                      ++++|||+.+|+|.+++.+... .+++..++.+.+||++||.|||  .+|||||||||+||||+. ++.+||+|||+++.
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH--s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH--SKGIVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH--hCCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence            8999999999999999988755 7999999999999999999999  778999999999999999 79999999999987


Q ss_pred             CCC-CCCceeeecccccccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          248 GPE-GSNTHVTTRVMGTYGYAAPEYISTGH-LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       248 ~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      ... ...........||+.|||||++..+. ...++|||||||++.||+||+.||....  .   ...+......     
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~--~---~~~~~~~ig~-----  237 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF--E---EAEALLLIGR-----  237 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc--c---hHHHHHHHhc-----
Confidence            653 11112233467999999999998543 3459999999999999999999998641  1   1111111100     


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                          .. ....++...+.++.+++.+|+..||.+|||++++++...-.
T Consensus       238 ----~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~  280 (313)
T KOG0198|consen  238 ----ED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK  280 (313)
T ss_pred             ----cC-CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence                01 11145556788999999999999999999999998864433

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-48  Score=361.91  Aligned_cols=267  Identities=23%  Similarity=0.310  Sum_probs=212.7

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHH--HHHHHHHcCCC-cccccceeeEEE
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW--LAEVIFLGQLR-HPHLVRLIGYCC  164 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~-hpnIv~~~~~~~  164 (419)
                      .+-++|.++++||.|+||.||+|+      ...+++.||||.++..- ..+++.  ++|+..|++|+ |||||++.+++.
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~------~~~~~~~VAIK~MK~Kf-~s~ee~~nLREvksL~kln~hpniikL~Evi~   79 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAK------SKETGELVAIKKMKKKF-YSWEECMNLREVKSLRKLNPHPNIIKLKEVIR   79 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEee------ecCCCceeeHHHHHhhh-ccHHHHHHHHHHHHHHhcCCCCcchhhHHHhh
Confidence            445789999999999999999995      34457889999997542 224443  57999999998 999999999998


Q ss_pred             eCC-eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccC
Q 014736          165 EDE-ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFG  243 (419)
Q Consensus       165 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  243 (419)
                      +.+ .+|+||||| ..+|++.+..+ +..+++..+..|+.||++||+|+|  ++|+.|||+||+|||+..+..+||+|||
T Consensus        80 d~~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH--k~GfFHRDlKPENiLi~~~~~iKiaDFG  155 (538)
T KOG0661|consen   80 DNDRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH--KHGFFHRDLKPENILISGNDVIKIADFG  155 (538)
T ss_pred             ccCceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH--hcCcccccCChhheEecccceeEecccc
Confidence            888 999999999 67999999887 788999999999999999999999  8899999999999999999999999999


Q ss_pred             ccccCCCCCCceeeeccccccccccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH----
Q 014736          244 LAKMGPEGSNTHVTTRVMGTYGYAAPEYIS-TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY----  318 (419)
Q Consensus       244 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----  318 (419)
                      +|+.......   .+.++.|..|+|||++. .+.|+.+.|+||+|||++|+.+-++-|.+.+..++...+-.+...    
T Consensus       156 LARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~  232 (538)
T KOG0661|consen  156 LAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKD  232 (538)
T ss_pred             cccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccc
Confidence            9997654432   45677899999999874 578999999999999999999999999987765544332111100    


Q ss_pred             -------hhcccc--cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          319 -------LRSSRR--LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       319 -------~~~~~~--~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                             +.....  +.....-.+..-+ ..++.++.+|+.+||++||.+|||+.|.++.
T Consensus       233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  233 SWPEGYNLASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             cchhHHHHHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                   000000  1111111111112 3378899999999999999999999999874

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-46  Score=347.54  Aligned_cols=262  Identities=25%  Similarity=0.327  Sum_probs=214.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc-HHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-HREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      +.|++..+||.|.-++||+|+      ...+++.||||+++.+.... ...+.+|+..|+.++||||++++..|..+..+
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~------c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L   99 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLAR------CIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL   99 (516)
T ss_pred             cceeEEEEEeccceeEeeeee------ecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence            578999999999999999995      44557899999998775544 47889999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+||.||.+|++.+.+.......+.+..+..|.++++.||.|||  .+|.||||||+.||||+.+|.|||+|||.+..+.
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH--~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH--QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH--hcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            99999999999999999888888999999999999999999999  8899999999999999999999999999876554


Q ss_pred             CCC-Cceee-ecccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          250 EGS-NTHVT-TRVMGTYGYAAPEYIST--GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       250 ~~~-~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      ... ..... ..+.||++|||||++..  ..|+.|+||||||++..||.+|..||....+....-....        +..
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--------n~p  249 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--------NDP  249 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--------CCC
Confidence            433 22222 56789999999999643  5799999999999999999999999998766442211110        000


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ....-..+...-....+..++.++..||++||++|||++++++
T Consensus       250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            0000001111122334568999999999999999999999984

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.5e-46  Score=360.83  Aligned_cols=267  Identities=28%  Similarity=0.420  Sum_probs=208.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCC-CcccccceeeEEEeC-
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQL-RHPHLVRLIGYCCED-  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~-  166 (419)
                      .++|.+.++||+|+||.||+|.+... .....++.||+|++..... .....+.+|+.+|..+ +||||+++++++... 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGI-DKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEecc-CCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            36799999999999999999975321 1234457899999874322 2346788999999999 899999999988764 


Q ss_pred             CeeEEEEEecCCCChhhhhhhcc---------------------------------------------------------
Q 014736          167 EERLLVYEFMPRGSLENHLFKRI---------------------------------------------------------  189 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------------  189 (419)
                      +..++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            46899999999999999986532                                                         


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccc
Q 014736          190 ---SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY  266 (419)
Q Consensus       190 ---~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  266 (419)
                         ...+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++...............++..|
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHH--HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence               124677888999999999999999  678999999999999999999999999999865333222122234467889


Q ss_pred             cccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHH
Q 014736          267 AAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEM  345 (419)
Q Consensus       267 ~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l  345 (419)
                      +|||++.+..++.++|||||||++|||++ |..||........  ..    ........          ...+...+.++
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~----~~~~~~~~----------~~~~~~~~~~l  306 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FC----QRLKDGTR----------MRAPENATPEI  306 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HH----HHHhcCCC----------CCCCCCCCHHH
Confidence            99999999999999999999999999997 9999976443211  11    01111110          01122345789


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          346 AVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       346 ~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      .+|+.+||+.||.+|||+.+|++.|+.++.
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-47  Score=357.33  Aligned_cols=270  Identities=23%  Similarity=0.279  Sum_probs=210.7

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEE
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCC  164 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  164 (419)
                      ..-.+.|+.+.+||+|+||.||+|      ++..+++.||+|++.....  .-..-..+||.||++|+||||+++.+...
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkA------r~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt  186 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKA------RDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVT  186 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEe------eecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEE
Confidence            344456788888999999999999      4666789999999987653  23455678999999999999999999887


Q ss_pred             eC--CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEecc
Q 014736          165 ED--EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       165 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                      +.  +.+|||+|||+ -+|..++... .-.+++.++..++.||+.||+|||  .+||+|||||..|||||.+|.+||+||
T Consensus       187 ~~~~~siYlVFeYMd-hDL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH--~~gvlHRDIK~SNiLidn~G~LKiaDF  262 (560)
T KOG0600|consen  187 SKLSGSIYLVFEYMD-HDLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCH--SRGVLHRDIKGSNILIDNNGVLKIADF  262 (560)
T ss_pred             ecCCceEEEEEeccc-chhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHh--hcCeeeccccccceEEcCCCCEEeccc
Confidence            76  68999999994 4787776543 357899999999999999999999  788999999999999999999999999


Q ss_pred             CccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH----
Q 014736          243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP----  317 (419)
Q Consensus       243 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~----  317 (419)
                      |||+++....... .+..+-|..|.|||++.+ ..|+.++|+||+||||.||+.|++.|.+....++...+-....    
T Consensus       263 GLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e  341 (560)
T KOG0600|consen  263 GLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTE  341 (560)
T ss_pred             cceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCCh
Confidence            9999876654433 444568999999999877 5799999999999999999999999998766554444321110    


Q ss_pred             -HhhcccccccccccccCCCC-------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          318 -YLRSSRRLRYIVDPRLAGQY-------SVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       318 -~~~~~~~~~~~~~~~l~~~~-------~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       ++. ..++.....-.....|       -...+....+|+..+|..||.+|.|+.++++
T Consensus       342 ~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  342 DYWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             hccc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence             000 0011100000001111       1234677899999999999999999999875

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-47  Score=367.43  Aligned_cols=245  Identities=27%  Similarity=0.383  Sum_probs=207.6

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCC-CcccccceeeEE
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQL-RHPHLVRLIGYC  163 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  163 (419)
                      ...++|.++++||+|.||+|++|..+.      +++.||||++++..   ..+++..+.|..|+... +||.+++++.+|
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~------~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f  438 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKG------TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF  438 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcC------CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc
Confidence            345789999999999999999996544      56899999998763   34567788888888777 599999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccC
Q 014736          164 CEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFG  243 (419)
Q Consensus       164 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  243 (419)
                      ...+++|+||||+.||++..+...   ..+++..+..++..|+.||+|||  ++||||||||.+|||||.+|.+||+|||
T Consensus       439 QT~~~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH--~~~IIYRDlKLdNiLLD~eGh~kiADFG  513 (694)
T KOG0694|consen  439 QTKEHLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLH--ENGIIYRDLKLDNLLLDTEGHVKIADFG  513 (694)
T ss_pred             ccCCeEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHH--hcCceeeecchhheEEcccCcEEecccc
Confidence            999999999999999996555433   47999999999999999999999  8889999999999999999999999999


Q ss_pred             ccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccc
Q 014736          244 LAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSR  323 (419)
Q Consensus       244 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  323 (419)
                      +++......  ..++++|||+.|||||++.+..|+.++|+|||||+|||||.|+.||.+.+.++..+.+...        
T Consensus       514 lcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d--------  583 (694)
T KOG0694|consen  514 LCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND--------  583 (694)
T ss_pred             cccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------
Confidence            999754322  2467899999999999999999999999999999999999999999976654433322110        


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014736          324 RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKM  363 (419)
Q Consensus       324 ~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~  363 (419)
                                .-.|+.-.+.+..+|+.++|..||++|.-+
T Consensus       584 ----------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  584 ----------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ----------CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                      113556678899999999999999999765

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-47  Score=326.34  Aligned_cols=249  Identities=25%  Similarity=0.364  Sum_probs=213.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++++.||+|.||.||+|+      .+.++..||+|++.+++.   ...+.+.+|++|-..|+||||+++|++|.++.
T Consensus        22 ~dfeigr~LgkgkFG~vYlar------ekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~   95 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAR------EKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK   95 (281)
T ss_pred             hhccccccccCCccccEeEee------eccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence            579999999999999999995      455678899999976543   33467889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..||++||..+|+|...|.......+++.....++.|+|.|+.|+|  .+++|||||||+|+|++.++.+||+|||.+..
T Consensus        96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h--~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~  173 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH--LKRVIHRDIKPENLLLGSAGELKIADFGWSVH  173 (281)
T ss_pred             eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc--cCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence            9999999999999999999777788999999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ....    .....|||..|.+||...+..++..+|+|++|++.||++.|.+||......+....+.          ..  
T Consensus       174 ~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~----------k~--  237 (281)
T KOG0580|consen  174 APSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR----------KV--  237 (281)
T ss_pred             cCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH----------Hc--
Confidence            4422    2456789999999999999999999999999999999999999998655222111111          11  


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                            .-.++..++.++.++|.+|+.++|.+|.+..++++.
T Consensus       238 ------~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  238 ------DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ------cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                  112345567899999999999999999999999874

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.3e-47  Score=360.60  Aligned_cols=247  Identities=29%  Similarity=0.420  Sum_probs=211.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|-+.+.||+|+||.||+|+      .+.+.+.||+|.+.+...  ++.+.+.+|++|++.++|||||.++++|+...+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgr------rK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~   75 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGR------RKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH   75 (808)
T ss_pred             cchhHHHHhcCCccceeeecc------cccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce
Confidence            467888889999999999995      455678999999987644  345678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      +++|+||+.| +|..++...  ..++++.+..++.+++.||.|||  +++|+|||+||.|||++.+|.+|+||||+|+..
T Consensus        76 ~~vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLh--s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   76 LWVVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLH--SNRILHRDMKPQNILLEKGGTLKLCDFGLARAM  150 (808)
T ss_pred             EEEEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH--hcCcccccCCcceeeecCCCceeechhhhhhhc
Confidence            9999999966 999999876  78999999999999999999999  677999999999999999999999999999975


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ..  +..+.+...||+.|||||++.++.|+..+|+||||||+|||+.|++||-....      .+.......        
T Consensus       151 ~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------~~Lv~~I~~--------  214 (808)
T KOG0597|consen  151 ST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------TQLVKSILK--------  214 (808)
T ss_pred             cc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------HHHHHHHhc--------
Confidence            44  45567778899999999999999999999999999999999999999975321      111111111        


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       |+.   .++...+..+..++..+|.+||.+|.+..+++.
T Consensus       215 -d~v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  215 -DPV---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             -CCC---CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence             111   234467789999999999999999999999985

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.4e-47  Score=347.25  Aligned_cols=253  Identities=22%  Similarity=0.355  Sum_probs=215.3

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccH---HHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH---REWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      +..+|++.+.||+|.||.|-+|+      +...++.||||.+++....+.   -.+.+|++||..|+||||+.+|++|++
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~------e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN  124 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAY------EHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN  124 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehh------hccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC
Confidence            34678899999999999999995      445689999999987654443   457789999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      .+.+.|||||..+|.|++|+.++  +.+++.++..+++||+.|+.|+|  +++++|||||.+|||+|.|+++||+|||++
T Consensus       125 kdKIvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCH--knrVvHRDLKLENILLD~N~NiKIADFGLS  200 (668)
T KOG0611|consen  125 KDKIVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCH--KNRVVHRDLKLENILLDQNNNIKIADFGLS  200 (668)
T ss_pred             CceEEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHh--hccceecccchhheeecCCCCeeeeccchh
Confidence            99999999999999999999887  78999999999999999999999  888999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL-TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      ..+..+.   ..+++||++.|.+||++++.+| ++.+|.|||||+||-|+.|..||++.........+       .++ .
T Consensus       201 Nly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI-------s~G-a  269 (668)
T KOG0611|consen  201 NLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI-------SRG-A  269 (668)
T ss_pred             hhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh-------hcc-c
Confidence            8876554   3567899999999999999988 58999999999999999999999986533211111       011 1


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                                 .+.+..+.++.-||++||..||++|.|+.+|....+--
T Consensus       270 -----------YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  270 -----------YREPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             -----------ccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                       11223345788999999999999999999999876643

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-46  Score=364.08  Aligned_cols=247  Identities=25%  Similarity=0.376  Sum_probs=209.7

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      -|++++-||+|+-|.|-+|      ++..+|+.+|||++.+...   .....+.+|+-+|+.+.||||+++|+++++..+
T Consensus        13 pwkLgkTLG~Gstg~vrla------kh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~   86 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLA------KHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH   86 (786)
T ss_pred             ceeccccccCCCCceehhh------hcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence            3677888999999999999      5778899999999976521   223457789999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      +|+|+||++||.|++++..+  +.+++.++..++.||+.|+.|||  ..+|+||||||+|+|||..+++||+|||+|...
T Consensus        87 lylvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH--~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe  162 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCH--AFNICHRDLKPENLLLDVKNNIKIADFGMASLE  162 (786)
T ss_pred             EEEEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHh--hhcceeccCCchhhhhhcccCEeeeccceeecc
Confidence            99999999999999999887  78999999999999999999999  566999999999999999999999999999875


Q ss_pred             CCCCCceeeecccccccccccccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLT-TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ..+.   ...+.||++.|.+||++.+..|+ .++||||+|||||.||+|++||+..+   ...++..++     .+    
T Consensus       163 ~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LLlKV~-----~G----  227 (786)
T KOG0588|consen  163 VPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLLLKVQ-----RG----  227 (786)
T ss_pred             cCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHHHHHH-----cC----
Confidence            4443   35567899999999999999885 78999999999999999999998432   222222111     01    


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                            .-..+..++.++++||.+||..||.+|.|+++|++.
T Consensus       228 ------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  228 ------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             ------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence                  112345667899999999999999999999999874

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-46  Score=358.43  Aligned_cols=266  Identities=29%  Similarity=0.470  Sum_probs=213.4

Q ss_pred             HHHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceee
Q 014736           84 SELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIG  161 (419)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~  161 (419)
                      .+.++..+++.+...||+|.||+||+|.|.++         ||||+++....  ...+.|.+|+.+|++-+|.||+-+.|
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---------VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG  455 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---------VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMG  455 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccccc---------eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeeh
Confidence            44555666778888999999999999999875         99999987654  34678999999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          162 YCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       162 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                      ++..... .||+.+|+|.+|+.++.-.. ..+.....++|++||++||.|||  .++|||||||..|||+.++++|||+|
T Consensus       456 ~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLH--AK~IIHrDLKSnNIFl~~~~kVkIgD  531 (678)
T KOG0193|consen  456 ACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLH--AKNIIHRDLKSNNIFLHEDLKVKIGD  531 (678)
T ss_pred             hhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhh--hhhhhhhhccccceEEccCCcEEEec
Confidence            9988777 99999999999999986543 46888899999999999999999  56699999999999999999999999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST---GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      |||+..-..-..........|...|||||++..   .+|++.+||||||+++|||++|..||.......    +.|..  
T Consensus       532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq----IifmV--  605 (678)
T KOG0193|consen  532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ----IIFMV--  605 (678)
T ss_pred             ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh----eEEEe--
Confidence            999975332222222333458889999999953   578999999999999999999999998332221    11111  


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                        ..+.+.    +.+ -.....+++++.+|+..||..++++||.+.+|+..|+.++.
T Consensus       606 --GrG~l~----pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  606 --GRGYLM----PDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             --cccccC----ccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence              111000    111 12234578899999999999999999999999998887766

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=7.3e-46  Score=323.34  Aligned_cols=266  Identities=25%  Similarity=0.335  Sum_probs=210.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc--HHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|...++||+|.||.||+|+      +..+++.||||++...+..+  ....++|++.|+.++|+||+.++++|...+.
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~------d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~   75 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKAR------DTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN   75 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEE------ecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence            467888899999999999995      55678999999998654332  3467899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      +.||+||+ ..+|...+..+ ...++...+..++.+++.||+|||  .+.|+||||||+|+|++.+|.+||+|||+|+.+
T Consensus        76 l~lVfEfm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H--~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f  151 (318)
T KOG0659|consen   76 LSLVFEFM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCH--SKWILHRDLKPNNLLISSDGQLKIADFGLARFF  151 (318)
T ss_pred             eEEEEEec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHH--hhhhhcccCCccceEEcCCCcEEeecccchhcc
Confidence            99999999 66999988765 346788899999999999999999  677999999999999999999999999999987


Q ss_pred             CCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH----------
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP----------  317 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~----------  317 (419)
                      .......  +..+-|..|.|||.+.+ ..|+..+|+||+|||+.||+-|.+-|.+.++-++...+-.+..          
T Consensus       152 ~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~  229 (318)
T KOG0659|consen  152 GSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM  229 (318)
T ss_pred             CCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence            6554432  22367899999998865 6799999999999999999999998887665544333311110          


Q ss_pred             -HhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          318 -YLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       318 -~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                       .+.+...+...-.+.+.. .-..++.++.+|+..||..||.+|.+++|++++
T Consensus       230 ~~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  230 TSLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence             011111122111122222 333456677999999999999999999999763

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-45  Score=343.06  Aligned_cols=264  Identities=25%  Similarity=0.326  Sum_probs=208.2

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--------------ccHHHHHHHHHHHcCCC
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--------------QGHREWLAEVIFLGQLR  152 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~  152 (419)
                      ....++|++++.||+|.||.|-+|+      +...++.||||++.+...              ...+...+||.+|++++
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar------~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~  166 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLAR------DEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH  166 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEe------ecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence            4556889999999999999999995      455688999999965322              12356889999999999


Q ss_pred             cccccceeeEEEe--CCeeEEEEEecCCCChhhhhhhccCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcE
Q 014736          153 HPHLVRLIGYCCE--DEERLLVYEFMPRGSLENHLFKRISVS-LPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNI  229 (419)
Q Consensus       153 hpnIv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NI  229 (419)
                      |||||+++++..+  .+.+|||+|||..|.+...-.   .+. +.+.+++++++.++.||+|||  .+|||||||||.|+
T Consensus       167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH--~QgiiHRDIKPsNL  241 (576)
T KOG0585|consen  167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLH--YQGIIHRDIKPSNL  241 (576)
T ss_pred             CcCeeEEEEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHH--hcCeeccccchhhe
Confidence            9999999999876  468999999999887754332   234 889999999999999999999  67799999999999


Q ss_pred             EEcCCCcEEEeccCccccCCCCCC---ceeeecccccccccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCC
Q 014736          230 LLDSDFTAKLSDFGLAKMGPEGSN---THVTTRVMGTYGYAAPEYISTGH----LTTKSDVYSFGVVLLELLTGRRSMDK  302 (419)
Q Consensus       230 ll~~~~~~kl~DfGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~pf~~  302 (419)
                      ||+++|.|||+|||.+..+..+..   ........||+.|+|||...++.    .+.+.||||+||+||+|+.|+.||-.
T Consensus       242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~  321 (576)
T KOG0585|consen  242 LLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD  321 (576)
T ss_pred             EEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence            999999999999999987643321   11233467999999999986632    35789999999999999999999976


Q ss_pred             CCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          303 LRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                      ......                ++.++...+...-.++..+++.+||.+||.+||++|.++.+|....+-.....
T Consensus       322 ~~~~~l----------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  322 DFELEL----------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD  380 (576)
T ss_pred             chHHHH----------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence            432221                11223333333333456788999999999999999999999977666554433

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-45  Score=338.71  Aligned_cols=254  Identities=26%  Similarity=0.301  Sum_probs=209.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc---HHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG---HREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++++.||+|.-|+||++...+      ++..+|+|++.+.....   ..+...|-+||..++||.++.+|..|+.+.
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~  150 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRG------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK  150 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecC------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence            456777889999999999997654      34789999998765433   345667999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+|||||.||+|...++++....+++..++.++.+++.||+|||  ..|||+|||||+||||.++|+|.|+||.|+..
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH--mlGivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH--MLGIVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH--hhceeeccCCcceeEEecCCcEEeeecccccc
Confidence            9999999999999999999998899999999999999999999999  67799999999999999999999999998753


Q ss_pred             CCC---------------------------------CCCc---------------------eeeeccccccccccccccc
Q 014736          248 GPE---------------------------------GSNT---------------------HVTTRVMGTYGYAAPEYIS  273 (419)
Q Consensus       248 ~~~---------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~  273 (419)
                      ...                                 ....                     .....++||-.|+|||++.
T Consensus       229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~  308 (459)
T KOG0610|consen  229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR  308 (459)
T ss_pred             CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence            211                                 0000                     0112368999999999999


Q ss_pred             CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcc
Q 014736          274 TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCI  353 (419)
Q Consensus       274 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l  353 (419)
                      +...+.++|+|+|||++||||.|..||.+.........+                +...+...-....+..+.+||+++|
T Consensus       309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI----------------v~~~l~Fp~~~~vs~~akDLIr~LL  372 (459)
T KOG0610|consen  309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI----------------VGQPLKFPEEPEVSSAAKDLIRKLL  372 (459)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH----------------hcCCCcCCCCCcchhHHHHHHHHHh
Confidence            999999999999999999999999999987654433222                2222222223356788999999999


Q ss_pred             cCCCCCCCC----HHHHHH
Q 014736          354 SVNPKDRPK----MAAVVA  368 (419)
Q Consensus       354 ~~dP~~RPs----~~eil~  368 (419)
                      .+||++|..    +.||-+
T Consensus       373 vKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  373 VKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             ccChhhhhccccchHHhhc
Confidence            999999988    666654

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-46  Score=348.21  Aligned_cols=249  Identities=26%  Similarity=0.375  Sum_probs=210.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-cHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ..|+...+||+|.||.||+|.      +..+++.||+|+++.+... .++++..|+.+|.+++++||.++|+.|..+..+
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~------d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L   86 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAI------DNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL   86 (467)
T ss_pred             cccccchhccccccceeeeee------eccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence            357777889999999999995      4456789999999876543 467888999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      +++||||.||++.+.+...  ..+.+..+..++++++.|+.|||  ..+.+|||||+.|||+..+|.+||+|||.+....
T Consensus        87 wiiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH--~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   87 WIIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLH--SEKKIHRDIKAANILLSESGDVKLADFGVAGQLT  162 (467)
T ss_pred             HHHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhh--hcceecccccccceeEeccCcEEEEecceeeeee
Confidence            9999999999999998654  34477788889999999999999  5669999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      .....  ..+++||+.|||||++.+..|+.++||||||++.|||++|.+||....+....                 .++
T Consensus       163 ~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl-----------------flI  223 (467)
T KOG0201|consen  163 NTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL-----------------FLI  223 (467)
T ss_pred             chhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-----------------Eec
Confidence            54332  35688999999999999889999999999999999999999999987653321                 122


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .+.....+...++..+.+++..||.+||+.||++.++++
T Consensus       224 pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  224 PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            222222333355678999999999999999999999985

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.6e-44  Score=343.13  Aligned_cols=270  Identities=27%  Similarity=0.446  Sum_probs=208.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCccc----------ccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccc
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLR----------QGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVR  158 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~----------~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~  158 (419)
                      .++|.+.++||+|+||.||+|.+.+...          ....+..||+|++..... .....+.+|+.++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578999999999999999998654211          123445799999976432 33467899999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEecCCCChhhhhhhcc-----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 014736          159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRI-----------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIY  221 (419)
Q Consensus       159 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH  221 (419)
                      +++++.+.+..++||||+.+++|.+++....                 ...+++..++.++.||+.||.|||  +.||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~ivH  161 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS--SLNFVH  161 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH--HCCccc
Confidence            9999999999999999999999999885432                 124677888999999999999999  677999


Q ss_pred             cCCCCCcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc--CCCC
Q 014736          222 RDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT--GRRS  299 (419)
Q Consensus       222 ~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~p  299 (419)
                      |||||+|||++.++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|+|++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986544433333344556889999999988899999999999999999987  5667


Q ss_pred             CCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          300 MDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       300 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                      |.......   ........+......       .....+..++..+.+|+.+||+.||.+|||+.+|.+.|+
T Consensus       242 ~~~~~~~~---~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDEQ---VIENAGEFFRDQGRQ-------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHHH---HHHHHHHHhhhcccc-------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            76543222   222221111111100       001112234678999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.5e-44  Score=340.29  Aligned_cols=252  Identities=27%  Similarity=0.399  Sum_probs=203.7

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .|+..+.||+|+||.||+|...      .+++.||+|++.....   .....+.+|+.++..++|+||+++++++.+++.
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~   74 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVR------ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEe------cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCe
Confidence            3777889999999999999643      3468899999865432   223457889999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .++||||+.+|+|.+++.......+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++...
T Consensus        75 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~  152 (285)
T cd05631          75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ--RERIVYRDLKPENILLDDRGHIRISDLGLAVQI  152 (285)
T ss_pred             EEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence            999999999999998886654456889999999999999999999  678999999999999999999999999999865


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      .....   .....||..|+|||++.+..++.++|||||||++|+|++|+.||...........+.   ....        
T Consensus       153 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~--------  218 (285)
T cd05631         153 PEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---RRVK--------  218 (285)
T ss_pred             CCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---HHhh--------
Confidence            43221   233569999999999999999999999999999999999999998654322111111   0000        


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK-----MAAVVA  368 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs-----~~eil~  368 (419)
                         .....++...+.++.+|+.+||+.||.+||+     ++++++
T Consensus       219 ---~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         219 ---EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ---cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence               0011233345678999999999999999997     777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-45  Score=344.95  Aligned_cols=245  Identities=25%  Similarity=0.326  Sum_probs=201.8

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|.+.+.||+|+||.||+|...      .+++.||+|++.....   .....+.+|+.+++.++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   74 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDR------ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR   74 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEc------CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC
Confidence            46889999999999999999643      3468899999965322   23456888999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+.+++|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~  150 (291)
T cd05612          75 FLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLH--SKEIVYRDLKPENILLDKEGHIKLTDFGFAKK  150 (291)
T ss_pred             eEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence            999999999999999998765  56888999999999999999999  67899999999999999999999999999986


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ....     .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+      ....     
T Consensus       151 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i------~~~~-----  214 (291)
T cd05612         151 LRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI------LAGK-----  214 (291)
T ss_pred             ccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC-----
Confidence            5432     12346999999999999999999999999999999999999999765432111111      0000     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK-----MAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs-----~~eil~  368 (419)
                             ..++...+..+.+|+.+||+.||.+||+     ++++++
T Consensus       215 -------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         215 -------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             -------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence                   0122334568999999999999999995     777765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.8e-45  Score=354.44  Aligned_cols=265  Identities=26%  Similarity=0.391  Sum_probs=208.5

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCC-CcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~  168 (419)
                      ++|.+.+.||+|+||.||+|.+... ......+.||+|++..... .....+.+|+.+++.+ +|+||+++++++...+.
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGL-GKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecC-CcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            4788999999999999999976432 1233456799999975432 2345688999999999 89999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhcc-----------------------------------------------------------
Q 014736          169 RLLVYEFMPRGSLENHLFKRI-----------------------------------------------------------  189 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  189 (419)
                      .++||||+.+|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999885431                                                           


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCceeeecc
Q 014736          190 ---------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRV  260 (419)
Q Consensus       190 ---------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  260 (419)
                               ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++..............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA--SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                     124677888999999999999999  678999999999999999999999999999865443322222233


Q ss_pred             cccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCH
Q 014736          261 MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSV  339 (419)
Q Consensus       261 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  339 (419)
                      .++..|+|||++.+..++.++|||||||++|+|++ |+.||........  ...    .....          .....+.
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~----~~~~~----------~~~~~~~  338 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYK----MVKRG----------YQMSRPD  338 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHH----HHHcc----------cCccCCC
Confidence            45678999999988999999999999999999997 9999976433211  100    00000          0011112


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 014736          340 KGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL  374 (419)
Q Consensus       340 ~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~  374 (419)
                      ..+.++.+++.+||+.||.+|||+.+|++.|+++.
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            23578999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-44  Score=353.74  Aligned_cols=265  Identities=28%  Similarity=0.384  Sum_probs=207.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCC-CcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  167 (419)
                      .++|++.+.||+|+||.||+|.+... ....++..||||++.... ....+.+.+|+.+|..+ +||||+++++++...+
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~-~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGL-FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEecc-ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            35788999999999999999975321 123346789999997543 23345788999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhcc----------------------------------------------------------
Q 014736          168 ERLLVYEFMPRGSLENHLFKRI----------------------------------------------------------  189 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  189 (419)
                      ..++||||+++|+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999986432                                                          


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCc
Q 014736          190 ---------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT  254 (419)
Q Consensus       190 ---------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  254 (419)
                                     ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++.........
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           124678888999999999999999  678999999999999999999999999999865443322


Q ss_pred             eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccccccccc
Q 014736          255 HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL  333 (419)
Q Consensus       255 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  333 (419)
                      .......++..|+|||++.+..++.++|||||||++|+|++ |..||.......  .....    ......         
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~----~~~~~~---------  335 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM----IKEGYR---------  335 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH----HHhCcc---------
Confidence            22223345678999999999999999999999999999998 889987643221  11111    111100         


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          334 AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       334 ~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                       ...+...+.++.+|+.+||+.||++||++.+|++.|++.
T Consensus       336 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 -MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence             011122356899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.4e-45  Score=325.86  Aligned_cols=266  Identities=22%  Similarity=0.254  Sum_probs=207.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc--HHHHHHHHHHHcCCCcccccceeeEEEeC--
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HREWLAEVIFLGQLRHPHLVRLIGYCCED--  166 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--  166 (419)
                      ++|..++.|++|+||.||+|      +++.+++.||+|.++.+....  --.-++||.+|.+++|||||.+.++....  
T Consensus        76 ~efe~lnrI~EGtyGiVYRa------kdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~  149 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRA------KDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM  149 (419)
T ss_pred             HHHHHHhhcccCcceeEEEe------ccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence            45777788999999999999      566778999999998764321  12346899999999999999999887543  


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +.+|||||||+ -+|...+..- ...+...++..++.|++.|++|||  ++.|+|||||++|+|++..|.+||+|||+|+
T Consensus       150 d~iy~VMe~~E-hDLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH--~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR  225 (419)
T KOG0663|consen  150 DKIYIVMEYVE-HDLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLH--DNWILHRDLKTSNLLLSHKGILKIADFGLAR  225 (419)
T ss_pred             ceeeeeHHHHH-hhHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHh--hceeEecccchhheeeccCCcEEecccchhh
Confidence            57999999995 5888887654 367889999999999999999999  8899999999999999999999999999999


Q ss_pred             cCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhc----
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS----  321 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----  321 (419)
                      .+....  ...+..+-|..|.|||++.+ ..|+.+.|+||+|||+.||+++++-|.+....++.+.+-.....-..    
T Consensus       226 ~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp  303 (419)
T KOG0663|consen  226 EYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP  303 (419)
T ss_pred             hhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence            876542  23556778999999999876 57999999999999999999999999887665544433211111000    


Q ss_pred             -c--------cccccccccccCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          322 -S--------RRLRYIVDPRLAGQYSVK-GAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       322 -~--------~~~~~~~~~~l~~~~~~~-~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       .        -.+.......+.+.|... .++.-.+|+..+|..||.+|.|+++.++
T Consensus       304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence             0        001111111222333333 5678899999999999999999998875

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.6e-44  Score=344.83  Aligned_cols=265  Identities=26%  Similarity=0.379  Sum_probs=205.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|++.+.||+|+||.||+|...      .++..||+|++..... .....+.+|+++|++++||||+++++++..++.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHK------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE   77 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEEC------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            368999999999999999999643      4567899999976532 234678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .++||||+++++|.+++...  ..+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++...
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  154 (331)
T cd06649          78 ISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (331)
T ss_pred             EEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhh-cCCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence            99999999999999998765  468889999999999999999994 246999999999999999999999999998765


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc----
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR----  324 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----  324 (419)
                      ....    .....||..|+|||++.+..++.++|||||||++|+|++|+.||.............  .+.......    
T Consensus       155 ~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~  228 (331)
T cd06649         155 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDGEEGEPHS  228 (331)
T ss_pred             cccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--ccccccccCCccc
Confidence            3322    233569999999999999999999999999999999999999997543221111000  000000000    


Q ss_pred             ----------------------------cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          325 ----------------------------LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       325 ----------------------------~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                                                  ...+.............+.++.+|+.+||+.||++|||+.+|++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                        000000000011112346789999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.3e-44  Score=346.66  Aligned_cols=242  Identities=26%  Similarity=0.344  Sum_probs=197.5

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVY  173 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  173 (419)
                      ++||+|+||.||+|..      ..+++.||+|++....   ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05571           1 KLLGKGTFGKVILVRE------KATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCeEEEEEEE------CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEE
Confidence            3699999999999964      3457889999997532   223456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCC
Q 014736          174 EFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN  253 (419)
Q Consensus       174 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  253 (419)
                      ||+.+++|.+++...  ..+++..+..++.||+.||+|||  ++||+||||||+|||++.++.+||+|||+++.......
T Consensus        75 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH--~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~  150 (323)
T cd05571          75 EYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA  150 (323)
T ss_pred             eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC
Confidence            999999999998765  56889999999999999999999  67799999999999999999999999999875322211


Q ss_pred             ceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccccccc
Q 014736          254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL  333 (419)
Q Consensus       254 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  333 (419)
                        .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......   .....   ...  .         
T Consensus       151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~~---~~~--~---------  211 (323)
T cd05571         151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELI---LME--E---------  211 (323)
T ss_pred             --cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHHH---HcC--C---------
Confidence              1234569999999999999999999999999999999999999997543211   11100   000  0         


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014736          334 AGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVA  368 (419)
Q Consensus       334 ~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~  368 (419)
                       ..++...+.++.+|+.+||+.||++||     ++.++++
T Consensus       212 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         212 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence             122334567899999999999999999     7998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-45  Score=330.34  Aligned_cols=265  Identities=25%  Similarity=0.345  Sum_probs=210.2

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEec--cCCcccHHHHHHHHHHHcCCCcccccceeeEEEe-
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE-  165 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-  165 (419)
                      +...|..++.||+|+||.|..|+.      ..+++.||||++.  .......++..+|+.+|+.++|+||+.+++++.. 
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~------~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~   93 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKD------KRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPP   93 (359)
T ss_pred             ccceecccccccCcceeeEEEEEE------cCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccc
Confidence            345677788999999999999964      4457899999997  4455566788999999999999999999999865 


Q ss_pred             ----CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          166 ----DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       166 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                          -+..|+|+|+| +.+|...+...  ..++...+..+++||+.||+|+||  .+|+||||||.|+|++.+..+||+|
T Consensus        94 ~~~~f~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHS--AnViHRDLKPsNll~n~~c~lKI~D  168 (359)
T KOG0660|consen   94 SRDKFNDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHS--ANVIHRDLKPSNLLLNADCDLKICD  168 (359)
T ss_pred             cccccceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhc--ccccccccchhheeeccCCCEEecc
Confidence                35689999999 78999998765  558999999999999999999995  5599999999999999999999999


Q ss_pred             cCccccCCCCCCceeeeccccccccccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh-----
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS-TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA-----  315 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~-----  315 (419)
                      ||+|+...........+..+-|..|.|||++. ...|+.+.||||+|||+.|||+|++-|.+...-.+...+...     
T Consensus       169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS  248 (359)
T ss_pred             ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence            99999875543333456778899999999874 578999999999999999999999999887654443333211     


Q ss_pred             ------------hHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          316 ------------KPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       316 ------------~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                                  .+++....   ......+...+ +.....+.+|+.+||..||.+|+|++|.++
T Consensus       249 ~e~l~~i~s~~ar~yi~slp---~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  249 EEDLQKIRSEKARPYIKSLP---QIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHHHhccHHHHHHHHhCC---CCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                        11111100   00001111112 255678999999999999999999999986

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.6e-45  Score=345.72  Aligned_cols=252  Identities=27%  Similarity=0.375  Sum_probs=215.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--cHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|..++++|+|+||.++++.      ++...+.|++|.+......  ..+..++|+.++++++|||||.+++.|.+++.
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvr------hk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~   77 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVR------HKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ   77 (426)
T ss_pred             chhhhhhhcCccccchhhhhh------hccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCc
Confidence            578889999999999999984      5555678999999876543  34467889999999999999999999999888


Q ss_pred             -eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          169 -RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       169 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                       ++|||+||+||+|.+.+.+.....+++..+..|+.|++.|+.|||  ++.|+|||||+.|||++.++.|||+|||+|+.
T Consensus        78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH--~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~  155 (426)
T KOG0589|consen   78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH--ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKI  155 (426)
T ss_pred             eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH--hhhhhcccchhhhhhccccCceeecchhhhhh
Confidence             999999999999999998877778999999999999999999999  77799999999999999999999999999998


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      .....  .......||+.||.||++.+.+|+.++|||||||++|||++-+++|...+-..   ++..+.           
T Consensus       156 l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki~-----------  219 (426)
T KOG0589|consen  156 LNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKIN-----------  219 (426)
T ss_pred             cCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHHh-----------
Confidence            66553  12345679999999999999999999999999999999999999998764322   221110           


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                         .......+...+.++..|+..||+.+|..||++.+++..
T Consensus       220 ---~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  220 ---RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ---hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence               111223455567899999999999999999999999976

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.7e-44  Score=345.36  Aligned_cols=245  Identities=26%  Similarity=0.351  Sum_probs=201.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|.+.+.||+|+||.||+|...      .+++.||+|++....   ......+.+|+.+++.++||||+++++++.+++
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   91 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHK------GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN   91 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEEC------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence            57889999999999999999654      346889999996432   233466889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+.+++|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  167 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLH--SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK  167 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence            999999999999999998765  56788899999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      .....     ....||+.|+|||++.+..++.++|||||||++|+|++|..||........   ..   ....  ...  
T Consensus       168 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~---~i~~--~~~--  232 (329)
T PTZ00263        168 VPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI---YE---KILA--GRL--  232 (329)
T ss_pred             cCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH---HH---HHhc--CCc--
Confidence            54322     234699999999999999999999999999999999999999975432111   11   1000  000  


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK-----MAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs-----~~eil~  368 (419)
                              .++...+.++.+|+.+||+.||.+|++     +.+++.
T Consensus       233 --------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        233 --------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             --------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                    112224567999999999999999987     677764

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=340.74  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=215.9

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc--HHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      +..-|.+.+-||+|.|+.|-+|      ++-.+|+.||||++.+.....  ..+++.|+..|+.++|||||++|++....
T Consensus        16 IAGLYDLekTlG~GHFAVVKLA------rHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ   89 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLA------RHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ   89 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhh------hhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc
Confidence            3455788888999999999998      688899999999998776544  35788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCcEEEeccCcc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS-DFTAKLSDFGLA  245 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla  245 (419)
                      ..+|||+|+=++|+|++||.++. ..+.+..+.+++.||+.|+.|+|  +..+|||||||+||.+.+ -|.|||.|||++
T Consensus        90 TKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCH--qLHVVHRDLKPENVVFFEKlGlVKLTDFGFS  166 (864)
T KOG4717|consen   90 TKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCH--QLHVVHRDLKPENVVFFEKLGLVKLTDFGFS  166 (864)
T ss_pred             ceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHh--hhhhhcccCCcceeEEeeecCceEeeecccc
Confidence            99999999999999999998764 46888999999999999999999  455999999999998765 588999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT-TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      ..+..+..   .+..||+..|.|||++.+..|+ +++||||||||||-|+||++||...++.+....+.           
T Consensus       167 Nkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm-----------  232 (864)
T KOG4717|consen  167 NKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM-----------  232 (864)
T ss_pred             ccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh-----------
Confidence            88777654   4567899999999999999997 68999999999999999999999876654433332           


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                           |  ..-..+...+.++++||..||..||++|.+.++|..
T Consensus       233 -----D--CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  233 -----D--CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -----c--ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence                 1  112346677899999999999999999999999975

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=9.7e-44  Score=333.97  Aligned_cols=263  Identities=28%  Similarity=0.466  Sum_probs=211.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|++.+.||+|+||.||+|...... .......|++|.+..... .....+.+|+.++..++||||+++++++.+.+..
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPN-ERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCC-CCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            46888899999999999999765431 133456899999875432 2345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 014736          170 LLVYEFMPRGSLENHLFKRIS--------------VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF  235 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~  235 (419)
                      +++|||+++++|.+++.....              ..+++..++.++.|++.||.|||  ++|++|+||||+||+++.++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS--SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccccceEEEcCCC
Confidence            999999999999999865421              45788889999999999999999  67899999999999999999


Q ss_pred             cEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHh
Q 014736          236 TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDW  314 (419)
Q Consensus       236 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~  314 (419)
                      .++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||........   ...
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~---~~~  238 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV---IEM  238 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH
Confidence            999999999986544333223334457889999999988899999999999999999998 9999976543221   111


Q ss_pred             hhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          315 AKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                      ..    .          ......+..++.++.+|+.+||+.||.+||++.+|++.|+++
T Consensus       239 i~----~----------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         239 IR----S----------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HH----c----------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            10    0          011122345568899999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-43  Score=334.05  Aligned_cols=246  Identities=21%  Similarity=0.338  Sum_probs=199.9

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc---HHHHHHHHHHHcCCCcccccceeeEEEe----CCee
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG---HREWLAEVIFLGQLRHPHLVRLIGYCCE----DEER  169 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~  169 (419)
                      ..||+|++|.||+|...        ++.||||.+.......   .+.+.+|+.+|.+++||||+++++++.+    ....
T Consensus        26 ~~i~~g~~~~v~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~   97 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN--------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL   97 (283)
T ss_pred             eEEeeCCceEEEEEEEC--------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCce
Confidence            57999999999999653        5789999997653333   4667899999999999999999999877    3478


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+.+|+|.+++.+.  ..+++.....++.|++.||.|||. ..+++||||||+|||++.++.+||+|||+++...
T Consensus        98 ~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988         98 SLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYK-YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             EEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHh-cCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            9999999999999999765  568888999999999999999994 2468999999999999999999999999998643


Q ss_pred             CCCCceeeecccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYIST--GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ...     ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||...........+      .....    
T Consensus       175 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i------~~~~~----  239 (283)
T PHA02988        175 SPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI------INKNN----  239 (283)
T ss_pred             ccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HhcCC----
Confidence            322     22458899999999976  68999999999999999999999999865432211111      10110    


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL  374 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~  374 (419)
                            ....+..++.++.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       240 ------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        240 ------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             ------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence                  11122345678999999999999999999999999998764

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-44  Score=346.89  Aligned_cols=254  Identities=23%  Similarity=0.266  Sum_probs=205.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|.+.+.||+|+||.||+|...      .+++.||+|++....   ......+.+|+.++..++||||+++++++.+.+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~   74 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKK------DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE   74 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEEC------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC
Confidence            36899999999999999999654      346789999997542   233456888999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+++++|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~  150 (333)
T cd05600          75 YLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALH--ELGYIHRDLKPENFLIDASGHIKLTDFGLSKG  150 (333)
T ss_pred             EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence            999999999999999998655  46888999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ...     ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+..      ....   
T Consensus       151 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~------~~~~---  216 (333)
T cd05600         151 IVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY------WKET---  216 (333)
T ss_pred             ccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh------cccc---
Confidence            543     12345699999999999999999999999999999999999999986543222111110      0000   


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                       .............+.++.+|+.+||..+|.+||++.++++.
T Consensus       217 -~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         217 -LQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             -ccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence             00000000112346789999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=322.36  Aligned_cols=252  Identities=25%  Similarity=0.353  Sum_probs=206.5

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      +.++|.+.++||+|.|+.||++      .+..+|+.+|+|+++....  .+.+++.+|+.|.+.|+|||||++.+.+..+
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc------~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~   82 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRC------VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE   82 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHH------HhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc
Confidence            4567888889999999999998      4666788999999875432  3567888999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC---CcEEEeccC
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD---FTAKLSDFG  243 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG  243 (419)
                      +..|||+|++.|++|..-+-.+  .-+++..+-.+++||++||.|+|  .+||||||+||+|+|+...   .-+||+|||
T Consensus        83 ~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH--~n~IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   83 SFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCH--SNGIVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             ceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeeeeccCCCceeecccc
Confidence            9999999999999998777665  45677788899999999999999  7889999999999999543   459999999


Q ss_pred             ccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccc
Q 014736          244 LAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSR  323 (419)
Q Consensus       244 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  323 (419)
                      +|..+..+   .......|||.|||||++...+|+..+|||+.|||||-||.|.+||.+.........+.        .+
T Consensus       159 vAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~--------~g  227 (355)
T KOG0033|consen  159 LAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK--------AG  227 (355)
T ss_pred             eEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh--------cc
Confidence            99987733   23455789999999999999999999999999999999999999998643222111111        00


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 014736          324 RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV  367 (419)
Q Consensus       324 ~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil  367 (419)
                        ...++    ..+-..++++..+|+++||..||.+|.|+.|.+
T Consensus       228 --~yd~~----~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL  265 (355)
T KOG0033|consen  228 --AYDYP----SPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL  265 (355)
T ss_pred             --ccCCC----CcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence              01111    223345678899999999999999999999987

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.8e-43  Score=340.08  Aligned_cols=255  Identities=26%  Similarity=0.323  Sum_probs=201.6

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC----cccHHHHHHHHHHHcCC-CcccccceeeEEEeC
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG----LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCED  166 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  166 (419)
                      +|++.+.||+|+||.||+|....   ...+++.||+|++....    ....+.+.+|+.++..+ +|+||+++++++..+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVT---GHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE   77 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcc---cCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC
Confidence            48889999999999999996532   23457899999986432    12345677899999999 599999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..++||||+.+|+|.+++..+  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++
T Consensus        78 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          78 AKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLH--KLGIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            9999999999999999998765  56889999999999999999999  6789999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      ........ ......||..|+|||++.+. .++.++|||||||++|+|++|..||...........+.  .....     
T Consensus       154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~~-----  225 (332)
T cd05614         154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRILK-----  225 (332)
T ss_pred             cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHhc-----
Confidence            65333221 12345799999999999765 47899999999999999999999997543322211111  11110     


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVA  368 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~  368 (419)
                         .++    .++...+.++.+++.+||+.||++||     +++++++
T Consensus       226 ---~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 ---CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ---CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence               011    22233567899999999999999999     7777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.5e-44  Score=335.15  Aligned_cols=267  Identities=23%  Similarity=0.267  Sum_probs=202.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|.+.+.||+|+||.||+|...      .+++.||+|++.....  .....+.+|+.+++.++||||+++++++..++.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHK------ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK   74 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEEC------CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence            46899999999999999999654      3467899999875422  234567889999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||+.++.|..+...  ...+++..++.++.||+.||.|||  .+||+||||||+||+++.++.+||+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  150 (287)
T cd07848          75 LYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCH--KNDIVHRDIKPENLLISHNDVLKLCDFGFARNL  150 (287)
T ss_pred             EEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence            9999999988766554332  246889999999999999999999  677999999999999999999999999999875


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh--------HHhh
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK--------PYLR  320 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--------~~~~  320 (419)
                      ...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+....        ..+.
T Consensus       151 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07848         151 SEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY  229 (287)
T ss_pred             cccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence            433221 1223568999999999988899999999999999999999999998654322111111000        0000


Q ss_pred             ccccccccccccc------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          321 SSRRLRYIVDPRL------AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       321 ~~~~~~~~~~~~l------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ..........+..      ...+....+.++.+|+.+||+.||++|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000000      01112235678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-45  Score=344.85  Aligned_cols=240  Identities=28%  Similarity=0.453  Sum_probs=202.1

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEe
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  175 (419)
                      ++-||.|+-|.||+|..+        ++.||||+++.-..       .+|+-|++|+|+||+.+.|+|....-++|||||
T Consensus       129 LeWlGSGaQGAVF~Grl~--------netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf  193 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--------NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF  193 (904)
T ss_pred             hhhhccCcccceeeeecc--------CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence            446999999999999755        46799998863211       378889999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCce
Q 014736          176 MPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH  255 (419)
Q Consensus       176 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  255 (419)
                      |..|.|.+.|...  ..+.......|..+||.||.|||.++  |||||||.-||||..+..|||+|||.++...+.   .
T Consensus       194 Ca~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---S  266 (904)
T KOG4721|consen  194 CAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---S  266 (904)
T ss_pred             cccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhhh---h
Confidence            9999999999776  56788888999999999999999544  999999999999999999999999999875544   2


Q ss_pred             eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCC
Q 014736          256 VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAG  335 (419)
Q Consensus       256 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  335 (419)
                      .+..++||..|||||++...+.+.++|||||||+|||||||..||.......    +.|-            .-...|.-
T Consensus       267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIwG------------VGsNsL~L  330 (904)
T KOG4721|consen  267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWG------------VGSNSLHL  330 (904)
T ss_pred             hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEEe------------ccCCcccc
Confidence            3456889999999999999999999999999999999999999998643221    1111            11122333


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          336 QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       336 ~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                      ..+..+++.+.-|+++||+-.|.+||++++|+..|+-.
T Consensus       331 pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  331 PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            45677889999999999999999999999999988743

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.4e-43  Score=347.71  Aligned_cols=267  Identities=26%  Similarity=0.382  Sum_probs=210.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCC-cccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLR-HPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~  167 (419)
                      .++|.++++||+|+||.||+|..... .....+..||||++..... ...+.+.+|+++|+.+. ||||+++++++.+.+
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~-~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGL-SRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEccc-CCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            56899999999999999999975432 1233456799999975433 23467899999999996 999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhcc----------------------------------------------------------
Q 014736          168 ERLLVYEFMPRGSLENHLFKRI----------------------------------------------------------  189 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  189 (419)
                      ..||||||+++|+|.+++....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999999886431                                                          


Q ss_pred             ------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 014736          190 ------------------------------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS  233 (419)
Q Consensus       190 ------------------------------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~  233 (419)
                                                          ...+++..++.++.||+.||.|||  .++|+|+||||+|||++.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivH~dikp~Nill~~  272 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA--SKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChHhEEEeC
Confidence                                                124677888999999999999999  678999999999999999


Q ss_pred             CCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHH
Q 014736          234 DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLV  312 (419)
Q Consensus       234 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~  312 (419)
                      ++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||........  ..
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~~  350 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--FY  350 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--HH
Confidence            99999999999986543322222233457788999999988899999999999999999997 9999875432111  00


Q ss_pred             HhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          313 DWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      .    .....          .....+...+.++.+++.+||+.||++||++.+|.++|..++.
T Consensus       351 ~----~~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         351 N----KIKSG----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             H----HHhcC----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            0    00011          0011223456789999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=8.5e-44  Score=341.74  Aligned_cols=243  Identities=26%  Similarity=0.342  Sum_probs=197.7

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVY  173 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  173 (419)
                      +.||+|+||.||+|..      ..+++.||+|++....   ......+.+|+.+++.++||||+++++++...+..|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   74 (328)
T cd05593           1 KLLGKGTFGKVILVRE------KASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVM   74 (328)
T ss_pred             CeeeeCCCEEEEEEEE------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEE
Confidence            3699999999999954      3457889999997532   233457788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCC
Q 014736          174 EFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN  253 (419)
Q Consensus       174 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  253 (419)
                      ||+++|+|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++.......
T Consensus        75 Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~  150 (328)
T cd05593          75 EYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLH--SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA  150 (328)
T ss_pred             eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc
Confidence            999999999888654  56889999999999999999999  67899999999999999999999999999875322211


Q ss_pred             ceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccccccc
Q 014736          254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL  333 (419)
Q Consensus       254 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  333 (419)
                        .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+      ...        .   
T Consensus       151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~------~~~--------~---  211 (328)
T cd05593         151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LME--------D---  211 (328)
T ss_pred             --ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh------ccC--------C---
Confidence              123457999999999999899999999999999999999999999754322111110      000        0   


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014736          334 AGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVAT  369 (419)
Q Consensus       334 ~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~~  369 (419)
                       ..++...+.++.+|+.+||+.||++|+     ++.++++.
T Consensus       212 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         212 -IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             -ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence             112334567899999999999999997     89988753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.4e-44  Score=341.09  Aligned_cols=242  Identities=26%  Similarity=0.335  Sum_probs=196.9

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVY  173 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  173 (419)
                      +.||+|+||.||+|..      ..+++.||+|++....   ......+.+|+.+++.++||||++++++|...+..|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05595           1 KLLGKGTFGKVILVRE------KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCEEEEEEEE------CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEE
Confidence            3699999999999954      3457889999997532   223456778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCC
Q 014736          174 EFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN  253 (419)
Q Consensus       174 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  253 (419)
                      ||+++++|..++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++........
T Consensus        75 E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  150 (323)
T cd05595          75 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  150 (323)
T ss_pred             eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC
Confidence            999999999888655  46889999999999999999999  67899999999999999999999999999875322211


Q ss_pred             ceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccccccc
Q 014736          254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL  333 (419)
Q Consensus       254 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  333 (419)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+      ....           
T Consensus       151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~------~~~~-----------  211 (323)
T cd05595         151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LMEE-----------  211 (323)
T ss_pred             --ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------hcCC-----------
Confidence              123356999999999999999999999999999999999999999764332111111      0000           


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014736          334 AGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVA  368 (419)
Q Consensus       334 ~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~  368 (419)
                       ..++...+.++.+|+.+||+.||++|+     ++.++++
T Consensus       212 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         212 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence             012234567899999999999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.5e-43  Score=328.46  Aligned_cols=259  Identities=25%  Similarity=0.408  Sum_probs=207.5

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|++.+.||+|+||.||+|.++..   ...+..||+|.+..... .....+.+|+.++++++||||+++++++...+..
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~---~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLP---SKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecC---CCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            5688999999999999999976532   23467899999975432 3345788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+++++|.+++... ...+++..++.++.||+.||+|||  ++|++||||||+|||++.++.++|+|||.+....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH--~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLS--EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--HCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            9999999999999998764 246889999999999999999999  7789999999999999999999999999876532


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ..... ......++..|+|||++.+..++.++|||||||++|||++ |..||.......   .....    ....     
T Consensus       159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----~~~~-----  225 (266)
T cd05064         159 SEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAV----EDGF-----  225 (266)
T ss_pred             ccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----HCCC-----
Confidence            22111 1112335678999999999999999999999999999875 999997654322   11111    0110     


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                           ....+..++..+.+++.+||+.+|.+||++++|++.|.++
T Consensus       226 -----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         226 -----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                 0112234567899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-43  Score=356.83  Aligned_cols=253  Identities=22%  Similarity=0.277  Sum_probs=205.4

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEE
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLL  171 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  171 (419)
                      .|.+.+.||+|+||.||+|....     ..++.||+|.+..........+.+|+.+|+.++|||||++++++..++..||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~-----~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGS-----DPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcC-----CCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence            48899999999999999996432     1256789998765555555677889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          172 VYEFMPRGSLENHLFKRI--SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       172 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ||||+++|+|.+++....  ...+++..+..++.||+.||.|||  .+||+||||||+|||++.++.+||+|||+++...
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH--SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--hCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            999999999999886432  346788899999999999999999  6789999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      ...........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ...   ....  +..    
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~---~~~~--~~~----  288 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQ---QVLY--GKY----  288 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHh--CCC----
Confidence            4433233445679999999999999999999999999999999999999997543211   111   1000  000    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                           ..++...+.++.+|+.+||..||++||++.+++.
T Consensus       289 -----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        289 -----DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -----CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                 0122334578999999999999999999999874

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.3e-43  Score=330.76  Aligned_cols=262  Identities=27%  Similarity=0.418  Sum_probs=209.5

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-cHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|.+.+.||+|+||.||+|...+. .....++.||+|.+...... ....+.+|+++|+.++|+||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHL-EPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccc-cCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            4688888999999999999976542 22344678999999755433 456889999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhcc------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcE
Q 014736          170 LLVYEFMPRGSLENHLFKRI------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA  237 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~  237 (419)
                      ++||||+++++|.+++....            ...+++..+..++.|++.||.|||  ++|++||||||+||+++.++.+
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA--SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh--hCCeeccccccceEEEcCCCeE
Confidence            99999999999999986542            234778889999999999999999  6789999999999999999999


Q ss_pred             EEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhh
Q 014736          238 KLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAK  316 (419)
Q Consensus       238 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  316 (419)
                      ||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.......   ......
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~~  238 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECIT  238 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH
Confidence            9999999975433322222233446788999999999999999999999999999998 999987644322   111111


Q ss_pred             HHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 014736          317 PYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES  372 (419)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~  372 (419)
                           .+.         ....+...+.++.+++.+||+.||++||++.||++.|++
T Consensus       239 -----~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         239 -----QGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             -----cCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                 000         011122346789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.4e-43  Score=334.18  Aligned_cols=266  Identities=23%  Similarity=0.314  Sum_probs=200.5

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|.+.++||+|+||.||+|...      .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+++..
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSK------LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCL   78 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEEC------CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            46999999999999999999643      4568899999975432 2345677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+. ++|.+++... ...+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++...
T Consensus        79 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          79 TLVFEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCH--KRKILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             EEEEeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            99999996 5899888654 235788899999999999999999  6789999999999999999999999999997543


Q ss_pred             CCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh--------HHhh
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK--------PYLR  320 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--------~~~~  320 (419)
                      ....  ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....        +...
T Consensus       155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07871         155 VPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT  232 (288)
T ss_pred             CCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence            2221  1223458999999998865 568999999999999999999999997654332221111000        0000


Q ss_pred             cccccccccccccCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          321 SSRRLRYIVDPRLAG----QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       321 ~~~~~~~~~~~~l~~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ....+.....+....    ......+.++.+|+.+||+.||.+|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000000000011000    001124578899999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.5e-43  Score=341.16  Aligned_cols=266  Identities=27%  Similarity=0.400  Sum_probs=208.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCC-CcccccceeeEEEe-CC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQL-RHPHLVRLIGYCCE-DE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~-~~  167 (419)
                      ++|++.++||+|+||.||+|...+. ....+++.||+|++..... .....+.+|+.++.++ +|+||+++++++.. +.
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~-~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGI-EKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHhhhhcccccCcCceEEecccccc-ccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            4789999999999999999975442 2344568999999875432 2345678899999999 79999999998764 45


Q ss_pred             eeEEEEEecCCCChhhhhhhccC---------------------------------------------------------
Q 014736          168 ERLLVYEFMPRGSLENHLFKRIS---------------------------------------------------------  190 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  190 (419)
                      ..+++|||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            68899999999999998854321                                                         


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccc
Q 014736          191 --VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA  268 (419)
Q Consensus       191 --~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a  268 (419)
                        ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.++|+|||++................++..|+|
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH--~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence              25788899999999999999999  77899999999999999999999999999987543322222233456778999


Q ss_pred             cccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHH
Q 014736          269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAV  347 (419)
Q Consensus       269 PE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~  347 (419)
                      ||++.+..++.++|||||||++|||++ |..||......+.  ..    .......          ....+...+.++.+
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~----~~~~~~~----------~~~~~~~~~~~~~~  307 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FC----RRLKEGT----------RMRAPEYATPEIYS  307 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HH----HHHhccC----------CCCCCccCCHHHHH
Confidence            999999999999999999999999998 9999976433211  10    0111110          00112234578999


Q ss_pred             HHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          348 LALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       348 li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      ++.+||+.+|++||++.+|++.|..++.
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=9.5e-43  Score=337.92  Aligned_cols=248  Identities=24%  Similarity=0.319  Sum_probs=193.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|..+++||+|+||.||+|...      .+++.||||++..... .....+.+|+++++.++|+||+++++++..++..
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  147 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHR------PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI  147 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEEC------CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence            34566778999999999999643      3467899999965432 2346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+||||+++++|.+..      ...+..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++....
T Consensus       148 ~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        148 QVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             EEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            9999999999986532      3456678899999999999999  6789999999999999999999999999998654


Q ss_pred             CCCCceeeecccccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYIST-----GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      ....  ......||..|+|||++..     ...+.++|||||||++|||++|+.||...............   . ..  
T Consensus       220 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~-~~--  291 (353)
T PLN00034        220 QTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---C-MS--  291 (353)
T ss_pred             cccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---h-cc--
Confidence            3221  1233569999999998743     33456899999999999999999999843322211111100   0 00  


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                              .........+.++.+||.+||+.||++||++.+|++
T Consensus       292 --------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        292 --------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             --------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    011122345678999999999999999999999987

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=340.18  Aligned_cols=254  Identities=25%  Similarity=0.308  Sum_probs=213.7

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc---cHHHHHHHHHHHcCCC-cccccceeeE
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ---GHREWLAEVIFLGQLR-HPHLVRLIGY  162 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-hpnIv~~~~~  162 (419)
                      ..+...|.+.+.||+|.||.||++.      +..+++.+|+|++.+....   ....+.+|+.+|+++. |||||.++++
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~------~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~  104 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCR------EKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA  104 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEE------ecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            3445689999999999999999995      4445899999999766443   3468889999999998 9999999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC----CcEE
Q 014736          163 CCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD----FTAK  238 (419)
Q Consensus       163 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~----~~~k  238 (419)
                      |++....++|||+|.||.|.+.+...   .+++..+..++.||+.++.|||  ..||+||||||+|+|+...    +.+|
T Consensus       105 ~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH--~~gvvHrDlKpEN~L~~~~~~~~~~ik  179 (382)
T KOG0032|consen  105 FEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLH--SLGVVHRDLKPENLLLASKDEGSGRIK  179 (382)
T ss_pred             EEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCHHHeeeccccCCCCcEE
Confidence            99999999999999999999999877   3999999999999999999999  6779999999999999643    4799


Q ss_pred             EeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          239 LSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       239 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      ++|||++.....   .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||...........+.     
T Consensus       180 ~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~-----  251 (382)
T KOG0032|consen  180 LIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL-----  251 (382)
T ss_pred             EeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH-----
Confidence            999999998665   224566789999999999998999999999999999999999999998765433222111     


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                         ...+      .+...+-...+..+.+++..||..||.+|+|+.++++
T Consensus       252 ---~~~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  252 ---RGDF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             ---cCCC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence               1111      1222333455788999999999999999999999988

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.6e-43  Score=331.03  Aligned_cols=265  Identities=27%  Similarity=0.412  Sum_probs=213.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      .+|.+.+.||+|+||.||+|.+... ........+++|.+..........+.+|+++++.++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNL-SPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeecc-CCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            4588889999999999999975442 123445679999987655555577889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc
Q 014736          171 LVYEFMPRGSLENHLFKRI--------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT  236 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~  236 (419)
                      +||||+++++|.+++....              ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA--SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEEccCCc
Confidence            9999999999999986542              234788999999999999999999  778999999999999999999


Q ss_pred             EEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhh
Q 014736          237 AKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWA  315 (419)
Q Consensus       237 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~  315 (419)
                      ++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.......   .....
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~  238 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIECI  238 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH
Confidence            99999999976544332222333457889999999988999999999999999999998 999987654322   11111


Q ss_pred             hHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          316 KPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                          .... .         .......+.++.+++.+||+.||.+||++.+|+++|+++..
T Consensus       239 ----~~~~-~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         239 ----TQGR-V---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             ----hCCC-C---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence                0110 0         01122345789999999999999999999999999999855

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=9.1e-44  Score=342.88  Aligned_cols=246  Identities=24%  Similarity=0.301  Sum_probs=201.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|.+.+.||+|+||.||+|.....     .+..||+|++....   ......+.+|+.+++.++||||+++++++.+.+
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNE-----DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECC-----CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            5789999999999999999975432     23579999986432   233467888999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+.+|+|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQ--SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            999999999999999999765  56889999999999999999999  67899999999999999999999999999986


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ....     .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+      ....     
T Consensus       181 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i------~~~~-----  244 (340)
T PTZ00426        181 VDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI------LEGI-----  244 (340)
T ss_pred             cCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH------hcCC-----
Confidence            5332     22356999999999999888999999999999999999999999764322111110      0000     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~  368 (419)
                             ..++...+.++.+++.+||+.||.+|+     +++++++
T Consensus       245 -------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        245 -------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             -------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence                   012233456789999999999999995     7888765

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.4e-43  Score=330.05  Aligned_cols=265  Identities=28%  Similarity=0.414  Sum_probs=212.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|.+.+.||+|+||.||++..... .....+..+|+|.+..........+.+|++++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~-~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNL-CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccC-CCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            5789999999999999999975432 122345679999987655555677899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhcc-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEE
Q 014736          171 LVYEFMPRGSLENHLFKRI-----------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKL  239 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  239 (419)
                      +||||+++++|.+++....           ...+++..++.++.|++.||+|||  ++|++||||||+|||++.++.+||
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH--~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEEccCCcEEe
Confidence            9999999999999986432           134889999999999999999999  778999999999999999999999


Q ss_pred             eccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHH
Q 014736          240 SDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       240 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      +|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......   .....   
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~i---  235 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECI---  235 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---
Confidence            99999986543322222233446788999999988899999999999999999998 899987654322   11111   


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                       .... .     .    ..+...+.++.+|+.+||+.||.+|||+.+|++.|+++..
T Consensus       236 -~~~~-~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         236 -TQGR-V-----L----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             -HcCC-c-----C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence             0110 0     0    0112245679999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-44  Score=339.57  Aligned_cols=240  Identities=27%  Similarity=0.313  Sum_probs=194.5

Q ss_pred             ecccCceEEEEEEEcCcccccccccEEEEEEeccC---CcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEe
Q 014736           99 LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE---GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        99 lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  175 (419)
                      ||+|+||.||+|...      .+++.||+|++...   .......+.+|+.++.+++||||+++++++.+.+..|+||||
T Consensus         1 lg~G~~g~Vy~~~~~------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   74 (312)
T cd05585           1 IGKGSFGKVMQVRKR------DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAF   74 (312)
T ss_pred             CCcCCCeEEEEEEEC------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcC
Confidence            799999999999643      34678999998643   223446678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCce
Q 014736          176 MPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH  255 (419)
Q Consensus       176 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  255 (419)
                      +++|+|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++......  .
T Consensus        75 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~  148 (312)
T cd05585          75 INGGELFHHLQRE--GRFDLSRARFYTAELLCALENLH--KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--D  148 (312)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--C
Confidence            9999999998765  56889999999999999999999  6779999999999999999999999999998543222  1


Q ss_pred             eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCC
Q 014736          256 VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAG  335 (419)
Q Consensus       256 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  335 (419)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      ........            ..
T Consensus       149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~~------------~~  210 (312)
T cd05585         149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQE------------PL  210 (312)
T ss_pred             ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHcC------------CC
Confidence            2334579999999999999999999999999999999999999997543211      11111110            01


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 014736          336 QYSVKGAKEMAVLALQCISVNPKDRPK---MAAVVA  368 (419)
Q Consensus       336 ~~~~~~~~~l~~li~~~l~~dP~~RPs---~~eil~  368 (419)
                      .++...+.++.+|+.+||..||.+||+   +.+++.
T Consensus       211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            223345678999999999999999986   455543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.8e-44  Score=359.82  Aligned_cols=266  Identities=30%  Similarity=0.457  Sum_probs=224.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-cHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .+....+.||+|.||+||+|...+. ........||||.++..... ...+|.+|+++|..|+|||||+++|+|.+++.+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l-~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGL-LPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCC-CCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            3556677899999999999987653 23455678999999866554 678999999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccC--------C----CCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcE
Q 014736          170 LLVYEFMPRGSLENHLFKRIS--------V----SLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA  237 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~--------~----~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~  237 (419)
                      +||+|||..|+|.+||..+..        .    .++..+.+.|+.|||.||.||-+  +.+|||||...|+||.++..|
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~--~~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS--HHFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CcccccchhhhhceeccceEE
Confidence            999999999999999975431        2    26778999999999999999994  559999999999999999999


Q ss_pred             EEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhh
Q 014736          238 KLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAK  316 (419)
Q Consensus       238 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  316 (419)
                      ||+|||+++.....++.+....-.-..+||+||.|..+.|+.++|||||||+|||+++ |+.||.+...++....+.   
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~---  719 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR---  719 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH---
Confidence            9999999998776666665544556789999999999999999999999999999999 999998876544322221   


Q ss_pred             HHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          317 PYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                          .         ..+ -..+..++.++..|+..||+.+|++||+++||-..|......
T Consensus       720 ----~---------g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  720 ----A---------GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             ----c---------CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                1         112 245667889999999999999999999999999999987664

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.4e-43  Score=336.31  Aligned_cols=245  Identities=26%  Similarity=0.371  Sum_probs=195.0

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHH---cCCCcccccceeeEEEeC
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFL---GQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~hpnIv~~~~~~~~~  166 (419)
                      |++.+.||+|+||.||+|...      .+++.||+|++....   ....+.+.+|+.++   +.++||||+++++++.+.
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~   74 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYK------KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE   74 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEEC------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC
Confidence            677889999999999999643      346889999997432   22334566666554   567899999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..|+||||+.+++|..++..   ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++.
T Consensus        75 ~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH--~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05589          75 DHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK  149 (324)
T ss_pred             CEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEECCCCcEEeCcccCCc
Confidence            999999999999999888754   36899999999999999999999  6789999999999999999999999999987


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ......  ......+|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+      ....    
T Consensus       150 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i------~~~~----  217 (324)
T cd05589         150 EGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI------VNDE----  217 (324)
T ss_pred             cCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC----
Confidence            532221  1233467999999999999999999999999999999999999999765322111111      0000    


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVA  368 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~  368 (419)
                              ..++...+.++.+++.+||+.||.+||     ++.++++
T Consensus       218 --------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         218 --------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             --------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                    012233467899999999999999999     5666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.4e-43  Score=338.25  Aligned_cols=266  Identities=27%  Similarity=0.357  Sum_probs=203.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|++.++||+|+||.||+|...      .++..+|+|++..... .....+.+|+++++.++|+||++++++|.+++.
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHK------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE   77 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEEC------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCE
Confidence            468999999999999999999643      3467899999875432 234568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .++||||+.+++|.+++...  ..+++..+..++.|++.||.|||+ .++|+|+||||+|||++.++.+||+|||++...
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~-~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          78 ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            99999999999999998764  468888999999999999999994 246999999999999999999999999998754


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh----hHH------
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA----KPY------  318 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~----~~~------  318 (419)
                      ....    .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...............    ...      
T Consensus       155 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (333)
T cd06650         155 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR  230 (333)
T ss_pred             hhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence            3321    23356899999999999889999999999999999999999999754332111100000    000      


Q ss_pred             ----------hh-cc-------cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 ----------LR-SS-------RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 ----------~~-~~-------~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                                .. ..       .....+.............+.++.+|+.+||+.||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                      00 00       0000000000000001123567999999999999999999999976

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-44  Score=308.50  Aligned_cols=265  Identities=24%  Similarity=0.352  Sum_probs=211.8

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeC--
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCED--  166 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--  166 (419)
                      ..++|++.+.||+|||+-||++.      +..+++.||+|++......+.+..++|++..++++|||+++++++...+  
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~------~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~   92 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVK------GLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK   92 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeec------ccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence            35789999999999999999984      5667889999999887777888999999999999999999998876443  


Q ss_pred             ---CeeEEEEEecCCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          167 ---EERLLVYEFMPRGSLENHLFKRI--SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       167 ---~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                         ...||+++|+..|+|.+.+....  ...+++.+.+.|+.+|++||++||.....++||||||.|||+.+.+.++|.|
T Consensus        93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D  172 (302)
T KOG2345|consen   93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD  172 (302)
T ss_pred             cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence               35899999999999999987543  2358999999999999999999996555599999999999999999999999


Q ss_pred             cCccccCCCCCCce-------eeeccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhH
Q 014736          242 FGLAKMGPEGSNTH-------VTTRVMGTYGYAAPEYIS---TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNL  311 (419)
Q Consensus       242 fGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  311 (419)
                      ||.+....-.....       .......|..|.|||.+.   +...+.++|||||||++|+||.|..||+..-.      
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~------  246 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ------  246 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh------
Confidence            99987543221111       011235788999999985   45678999999999999999999999985432      


Q ss_pred             HHhhhHHhhccccccccc-ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 014736          312 VDWAKPYLRSSRRLRYIV-DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL  374 (419)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~  374 (419)
                               .++.+...+ .......-....++.+.+|+.+||+.||.+||++.+++..++.+.
T Consensus       247 ---------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  247 ---------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ---------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                     111111111 111111112236788999999999999999999999999998775

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=354.80  Aligned_cols=261  Identities=24%  Similarity=0.299  Sum_probs=213.9

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-cccccceeeE-EEe-
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-HPHLVRLIGY-CCE-  165 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~-~~~-  165 (419)
                      -..++++.++|.+|||+.||+|....      .+..||+|++-..+....+.+.+|+++|++|+ |+|||.+++. ... 
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~  108 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVK------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR  108 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecC------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence            34578889999999999999996544      23789999987777777888999999999997 9999999993 221 


Q ss_pred             --C---CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 014736          166 --D---EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS  240 (419)
Q Consensus       166 --~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  240 (419)
                        +   -.++|+||||.||.|.+++..+....|++.++++|+.++++|+.+||.+...|||||||-|||||+.+|..|||
T Consensus       109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence              1   24689999999999999999888788999999999999999999999988899999999999999999999999


Q ss_pred             ccCccccCCCCCCcee-------eecccccccccccccc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchh
Q 014736          241 DFGLAKMGPEGSNTHV-------TTRVMGTYGYAAPEYI---STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQN  310 (419)
Q Consensus       241 DfGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  310 (419)
                      |||.|.-.........       .-...-|+.|+|||.+   .+..+++|+|||+|||+||-|+....||+......   
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la---  265 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA---  265 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---
Confidence            9999874322221100       0112468999999987   57889999999999999999999999998653221   


Q ss_pred             HHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          311 LVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                                       +++....-.-.+.++..+.+||..||+.||.+||++-+|+..+..+.+
T Consensus       266 -----------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  266 -----------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             -----------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                             112222222234678899999999999999999999999999988866

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.1e-43  Score=333.71  Aligned_cols=264  Identities=25%  Similarity=0.384  Sum_probs=208.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .+|++.+.||+|+||.||+|.+..+  .......||+|++.... ....+++.+|+.+++.++||||+++++++... ..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecC--CCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            4689999999999999999986542  12224569999987543 23456788999999999999999999998764 57


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++|+||+.+|+|.+++.... ..+++..++.++.||+.||+|||  ++||+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH--~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH--hcCeeccccchhheEecCCCcEEEcccccccccc
Confidence            89999999999999987642 45788899999999999999999  6779999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ............++..|+|||++.+..++.++||||||+++|||++ |..||..........       .......    
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-------~~~~~~~----  229 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEKGER----  229 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HHhCCCC----
Confidence            4333222222335678999999999999999999999999999998 999997643221111       1111110    


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                            ...+..++.++.+++.+||..||.+||++.+++..|..+....
T Consensus       230 ------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         230 ------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             ------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence                  0111223467899999999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.7e-43  Score=342.99  Aligned_cols=255  Identities=24%  Similarity=0.303  Sum_probs=198.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++.+.||+|+||+||+|..      ..+++.||+|++....   ......+.+|+.++..++|+||+++++.+.+..
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~   74 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQK------KDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL   74 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEE------CCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            4789999999999999999954      3457889999997532   223456788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||++||+|.+++.+.  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH--~~givHrDlKp~NILi~~~~~vkL~DFGla~~  150 (363)
T cd05628          75 NLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIH--QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTG  150 (363)
T ss_pred             eEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence            999999999999999999765  57899999999999999999999  67899999999999999999999999999875


Q ss_pred             CCCCCCc---------------------------------eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHH
Q 014736          248 GPEGSNT---------------------------------HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELL  294 (419)
Q Consensus       248 ~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  294 (419)
                      .......                                 ......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell  230 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH
Confidence            4321100                                 0012357999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHccc--CCCCCCCCHHHHHHH
Q 014736          295 TGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCIS--VNPKDRPKMAAVVAT  369 (419)
Q Consensus       295 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~--~dP~~RPs~~eil~~  369 (419)
                      +|..||...........+      ......+  .+.+      ....+.++.+++.+++.  .++..||++++|++.
T Consensus       231 ~G~~Pf~~~~~~~~~~~i------~~~~~~~--~~p~------~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         231 IGYPPFCSETPQETYKKV------MNWKETL--IFPP------EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             hCCCCCCCCCHHHHHHHH------HcCcCcc--cCCC------cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            999999765432211111      0000000  0000      11245678899988664  233356899999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-44  Score=316.23  Aligned_cols=263  Identities=24%  Similarity=0.367  Sum_probs=211.4

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc----cc----HHHHHHHHHHHcCC-Ccccc
Q 014736           86 LRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL----QG----HREWLAEVIFLGQL-RHPHL  156 (419)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~----~~----~~~~~~E~~~l~~l-~hpnI  156 (419)
                      -+.+.+.|.-.+.||.|..+.|-++      .++.+++.+|+|++.....    ..    .+.-..|+.||+++ .||+|
T Consensus        12 a~~fy~~y~pkeilgrgvss~vrRc------i~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~I   85 (411)
T KOG0599|consen   12 AKGFYAKYEPKEILGRGVSSVVRRC------IHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYI   85 (411)
T ss_pred             HhhHHhhcChHHHhcccchhhhhhh------hhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcE
Confidence            3455677888899999999999998      4556688899999864321    11    23456799999998 59999


Q ss_pred             cceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc
Q 014736          157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT  236 (419)
Q Consensus       157 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~  236 (419)
                      +++.++|+.+...++|+|.|+.|.|.|+|...  -.++++....|++|+++|++|||  .++||||||||+|||++++.+
T Consensus        86 I~l~D~yes~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylH--a~~IVHRDLKpENILlddn~~  161 (411)
T KOG0599|consen   86 IDLQDVYESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLH--ARNIVHRDLKPENILLDDNMN  161 (411)
T ss_pred             EEeeeeccCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHH--HhhhhhcccChhheeeccccc
Confidence            99999999999999999999999999999877  67899999999999999999999  666999999999999999999


Q ss_pred             EEEeccCccccCCCCCCceeeecccccccccccccccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchh
Q 014736          237 AKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST------GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQN  310 (419)
Q Consensus       237 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  310 (419)
                      +||+|||++..+..+..   ....|||++|+|||.+..      ..|+..+|+|++|||+|-||.|.+||......-...
T Consensus       162 i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR  238 (411)
T KOG0599|consen  162 IKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLR  238 (411)
T ss_pred             eEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHH
Confidence            99999999998877764   456789999999999853      468999999999999999999999997543211111


Q ss_pred             HHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhhc
Q 014736          311 LVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA--TLESLLN  375 (419)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~--~L~~l~~  375 (419)
                      .+.        .++..      +...--.+.+.+..+||.+||+.||.+|.|++|+++  ++..+..
T Consensus       239 ~Im--------eGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~  291 (411)
T KOG0599|consen  239 MIM--------EGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ  291 (411)
T ss_pred             HHH--------hcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence            111        01110      011111345678999999999999999999999987  3444444

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.7e-43  Score=327.44  Aligned_cols=263  Identities=25%  Similarity=0.412  Sum_probs=206.8

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ..++|++.+.||+|+||.||+|.+.... ....+..||+|++.... .....++.+|+.+++.++|+||+++++++....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVV-KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCC-CCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            4578999999999999999999765432 22345779999986432 233456889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccC--------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEE
Q 014736          168 ERLLVYEFMPRGSLENHLFKRIS--------VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKL  239 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  239 (419)
                      ..++||||+.+++|.+++.....        ..+++..++.++.|++.||.|||  ++|++|+||||+||+++.++.++|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCcchheEEEcCCCCEEE
Confidence            99999999999999999865321        23567788999999999999999  678999999999999999999999


Q ss_pred             eccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHH
Q 014736          240 SDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       240 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      +|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......   .....   
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~~---  234 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRFV---  234 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---
Confidence            99999876543332222222346788999999988899999999999999999999 788987653321   11111   


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                       .... .         ...+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus       235 -~~~~-~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         235 -MEGG-L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             -HcCC-c---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence             0100 0         0112234568999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-42  Score=322.90  Aligned_cols=260  Identities=27%  Similarity=0.469  Sum_probs=209.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|++.+.||+|+||.||+|.+...   ......||+|++..... .....+.+|+.+++.++||||+++++++...+..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~---~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLP---GKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccC---CCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            5789999999999999999987542   12346799999875432 2346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+++++|.+++.... ..+++..++.++.|++.||.|||  ++||+|+||||+|||++.++.++|+|||++....
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          81 MIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            99999999999999986643 36889999999999999999999  6889999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   .....    .....    
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~----  226 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAV----EDGYR----  226 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHH----HcCCC----
Confidence            3222222222345678999999988899999999999999999998 999986543221   11111    01000    


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                            ...+...+..+.+|+.+||+.+|++||++.+|++.|.++
T Consensus       227 ------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         227 ------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  011223457899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.7e-43  Score=342.16  Aligned_cols=261  Identities=20%  Similarity=0.225  Sum_probs=197.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ..+|.+.+.||+|+||.||+|..      ..+++.||+|...      ...+.+|+++|+.++||||++++++|......
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d------~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~  158 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACID------NKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFT  158 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEE------CCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence            35799999999999999999954      4457889999754      23467899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++|||++ +++|..++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++....
T Consensus       159 ~lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH--~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        159 CLILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             EEEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence            9999999 57898888665  46889999999999999999999  6789999999999999999999999999997533


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccch----hHHHhhhHHhh-----
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQ----NLVDWAKPYLR-----  320 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----~~~~~~~~~~~-----  320 (419)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|..||.........    ..+........     
T Consensus       234 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~  312 (391)
T PHA03212        234 DINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE  312 (391)
T ss_pred             cccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence            2211 1123457999999999999999999999999999999999999887543221100    00000000000     


Q ss_pred             ----ccccccccc---------ccccCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          321 ----SSRRLRYIV---------DPRLAGQ--YSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       321 ----~~~~~~~~~---------~~~l~~~--~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                          ....+....         .+.....  .....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                000000000         0000000  01134668999999999999999999999985

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.1e-43  Score=325.73  Aligned_cols=256  Identities=32%  Similarity=0.525  Sum_probs=211.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ..+|.+.++||.|+||.||+|...+       ++.+++|++..........+.+|+.+++.++|+||+++++++.+.+..
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   77 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPV   77 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCe
Confidence            4578889999999999999997543       467999999876655567888999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+++++|.+++.......+++..+..++.||+.||.|||  ++|++|+||||+||+++.++.+||+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE--EQNSIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence            99999999999999998765667899999999999999999999  7789999999999999999999999999998654


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      .....  .....++..|+|||++....++.++||||||+++|+|++ |+.||.......   ......    .       
T Consensus       156 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~~----~-------  219 (261)
T cd05148         156 EDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQIT----A-------  219 (261)
T ss_pred             Ccccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHH----h-------
Confidence            32211  123346778999999988899999999999999999998 899997644211   111111    0       


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                         ......+...+.++.+++.+||+.||++|||+.++++.|+.+
T Consensus       220 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         220 ---GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ---CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence               001112234567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1e-42  Score=327.21  Aligned_cols=261  Identities=27%  Similarity=0.424  Sum_probs=206.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|++.+.||+|+||.||+|....  .....++.|++|.+..... .....+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~--~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYL--PGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEec--CCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            467888999999999999997532  1233567899999974332 3346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhcc---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 014736          170 LLVYEFMPRGSLENHLFKRI---------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD  234 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~  234 (419)
                      |+||||+.+++|.+++....               ...+++..++.++.|++.||.|||  ++|++|+||||+|||++.+
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS--SHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hcCeehhccccceEEEcCC
Confidence            99999999999999985331               234778888999999999999999  7789999999999999999


Q ss_pred             CcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHH
Q 014736          235 FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVD  313 (419)
Q Consensus       235 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~  313 (419)
                      +.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.......   ...
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~~  237 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VIE  237 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH
Confidence            9999999999986544332222333456778999999988889999999999999999998 999987643221   111


Q ss_pred             hhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 014736          314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES  372 (419)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~  372 (419)
                      ..    ....          ....+..++.++.+++.+||+.||.+||++.+|++.|.+
T Consensus       238 ~~----~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 MV----RKRQ----------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HH----HcCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11    0110          001222345789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3e-43  Score=344.82  Aligned_cols=254  Identities=24%  Similarity=0.244  Sum_probs=198.9

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .|.+++.||+|+||+||+|..      ..+++.||+|++....   ......+.+|+.+++.++|+||+++++++.+.+.
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~------~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~   75 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACK------VDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN   75 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEE------CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE
Confidence            588899999999999999964      3457889999997542   2334568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||++||+|.+++...  ..+++..+..++.||+.||.|||  ..||+||||||+||||+.++.+||+|||++..+
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH--~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          76 LYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVH--KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            99999999999999998765  46888899999999999999999  678999999999999999999999999997643


Q ss_pred             CCCCCc---------------------------------------------eeeecccccccccccccccCCCCCchhhH
Q 014736          249 PEGSNT---------------------------------------------HVTTRVMGTYGYAAPEYISTGHLTTKSDV  283 (419)
Q Consensus       249 ~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  283 (419)
                      ......                                             ......+||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (381)
T cd05626         152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW  231 (381)
T ss_pred             ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce
Confidence            110000                                             00123579999999999998899999999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcc--cCCCCCCC
Q 014736          284 YSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCI--SVNPKDRP  361 (419)
Q Consensus       284 wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l--~~dP~~RP  361 (419)
                      |||||++|||++|..||...........+      ......+        ........+.++.+|+.+|+  ..++..|+
T Consensus       232 wSlG~il~elltG~~Pf~~~~~~~~~~~i------~~~~~~~--------~~~~~~~~s~~~~dli~~ll~~~~~~~~R~  297 (381)
T cd05626         232 WSVGVILFEMLVGQPPFLAPTPTETQLKV------INWENTL--------HIPPQVKLSPEAVDLITKLCCSAEERLGRN  297 (381)
T ss_pred             eehhhHHHHHHhCCCCCcCCCHHHHHHHH------Hcccccc--------CCCCCCCCCHHHHHHHHHHccCcccccCCC
Confidence            99999999999999999865432211111      0000000        00111124578999999854  55566699


Q ss_pred             CHHHHHHH
Q 014736          362 KMAAVVAT  369 (419)
Q Consensus       362 s~~eil~~  369 (419)
                      ++.+|++.
T Consensus       298 ~~~~~l~h  305 (381)
T cd05626         298 GADDIKAH  305 (381)
T ss_pred             CHHHHhcC
Confidence            99999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.2e-42  Score=330.14  Aligned_cols=265  Identities=22%  Similarity=0.312  Sum_probs=198.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|.+.+.||+|+||.||+|..      ..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   77 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKS------KVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKET   77 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEE------CCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCe
Confidence            36899999999999999999964      34578899999975432 223467789999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .++||||+ +++|.+++... ...+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++...
T Consensus        78 ~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  153 (303)
T cd07869          78 LTLVFEYV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIH--QRYILHRDLKPQNLLISDTGELKLADFGLARAK  153 (303)
T ss_pred             EEEEEECC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECCCCcceec
Confidence            99999999 56888887654 345788899999999999999999  677999999999999999999999999998754


Q ss_pred             CCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccc----
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSR----  323 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----  323 (419)
                      .....  ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......  ..+...........    
T Consensus       154 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~  229 (303)
T cd07869         154 SVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTW  229 (303)
T ss_pred             cCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhc
Confidence            32211  1233468999999999865 468999999999999999999999998653211  11111110000000    


Q ss_pred             ----cccccc--------ccccCCCCC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          324 ----RLRYIV--------DPRLAGQYS-VKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       324 ----~~~~~~--------~~~l~~~~~-~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                          ......        ...+...+. ...+.++.+|+.+||+.||++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                000000        000000000 012357889999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=9.8e-43  Score=323.82  Aligned_cols=256  Identities=25%  Similarity=0.403  Sum_probs=208.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      .+|.+.+.||+|+||.||+|.+.+      .++.||+|++... ......+.+|+++++.++|+||+++++++..++..+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~------~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEec------CCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence            457888899999999999997543      3578999998744 334567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+++++|.+++.......+++..++.++.|++.||.|||  ++|++||||||+||+++.++.+||+|||++.....
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            9999999999999997765567899999999999999999999  67899999999999999999999999999986543


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      .... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   .....    ..        
T Consensus       157 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~----~~--------  220 (263)
T cd05052         157 DTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELL----EK--------  220 (263)
T ss_pred             ceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----HC--------
Confidence            3211 1112234668999999988999999999999999999998 999987543221   11110    00        


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                        ......+...+.++.+++.+||+.||++||++.++++.|+.+
T Consensus       221 --~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         221 --GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             --CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence              011122334567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.3e-43  Score=330.22  Aligned_cols=266  Identities=25%  Similarity=0.317  Sum_probs=198.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCC---CcccccceeeEEEe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQL---RHPHLVRLIGYCCE  165 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~  165 (419)
                      ++|++.+.||+|+||.||+|....     ..++.||+|++.....  .....+.+|+.+++.+   +||||+++++++..
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~   75 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLK-----NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   75 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcC-----CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEec
Confidence            479999999999999999996422     2357899999865432  2234566677776655   69999999998852


Q ss_pred             -----CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 014736          166 -----DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS  240 (419)
Q Consensus       166 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  240 (419)
                           ....++||||+. ++|.+++.......+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+
T Consensus        76 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--~~~iiH~dlkp~Nil~~~~~~~kl~  152 (290)
T cd07862          76 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLA  152 (290)
T ss_pred             ccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEEcCCCCEEEc
Confidence                 456899999995 69999987665566899999999999999999999  6789999999999999999999999


Q ss_pred             ccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhh
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR  320 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  320 (419)
                      |||++.......   ......||..|+|||++.+..++.++|||||||++|+|++|++||...........+....... 
T Consensus       153 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~-  228 (290)
T cd07862         153 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP-  228 (290)
T ss_pred             cccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC-
Confidence            999998654331   2234568999999999988899999999999999999999999998754432211111000000 


Q ss_pred             cccccc-------ccccccc---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          321 SSRRLR-------YIVDPRL---AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       321 ~~~~~~-------~~~~~~l---~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ......       ..+....   ........+..+.+|+.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000000       0000000   00111234677899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5e-43  Score=335.75  Aligned_cols=245  Identities=27%  Similarity=0.344  Sum_probs=197.2

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCC----cccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG----LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      ++||+|+||.||+++...+   ...++.||+|++....    ......+.+|+.+|+.++||||+++++++..++..|+|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~---~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   78 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTG---ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLI   78 (323)
T ss_pred             ceeeecCCeEEEEEEEccc---CCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEE
Confidence            5799999999999975331   2457889999987432    12334577899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      |||+.+++|.+++...  ..+.+..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++......
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          79 LEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLH--QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             EeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            9999999999998765  56788888999999999999999  6779999999999999999999999999987533222


Q ss_pred             CceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........   .   .......          
T Consensus       155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~---~---~~~~~~~----------  216 (323)
T cd05584         155 T--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT---I---DKILKGK----------  216 (323)
T ss_pred             C--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH---H---HHHHcCC----------
Confidence            1  12335699999999999988899999999999999999999999976432211   1   1111000          


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVA  368 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~  368 (419)
                        ..++...+.++.+|+.+||+.||++||     ++.++++
T Consensus       217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence              012233457899999999999999999     7888876

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.6e-43  Score=339.52  Aligned_cols=244  Identities=26%  Similarity=0.334  Sum_probs=196.9

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVY  173 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  173 (419)
                      +.||+|+||.||+|..      ..+++.||+|++....   ......+.+|++++..++||||+++++++...+..|+||
T Consensus         1 ~~lG~G~~g~V~~~~~------~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~   74 (325)
T cd05594           1 KLLGKGTFGKVILVKE------KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM   74 (325)
T ss_pred             CeeeeCCCEEEEEEEE------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEE
Confidence            3699999999999953      3457899999997532   223456778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCC
Q 014736          174 EFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN  253 (419)
Q Consensus       174 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  253 (419)
                      ||+.+++|..++...  ..+++..+..++.||+.||.|||+ .+||+||||||+|||++.++.+||+|||+++.......
T Consensus        75 E~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~-~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~  151 (325)
T cd05594          75 EYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  151 (325)
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence            999999999888655  468899999999999999999994 26799999999999999999999999999875322211


Q ss_pred             ceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccccccc
Q 014736          254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL  333 (419)
Q Consensus       254 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  333 (419)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.      ..        .   
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~------~~--------~---  212 (325)
T cd05594         152 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------ME--------E---  212 (325)
T ss_pred             --ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh------cC--------C---
Confidence              1233569999999999999999999999999999999999999997643221111110      00        0   


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014736          334 AGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVAT  369 (419)
Q Consensus       334 ~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~~  369 (419)
                       ..++...+.++.+|+.+||+.||++|+     ++.++++.
T Consensus       213 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         213 -IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence             012233457899999999999999996     89998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=344.86  Aligned_cols=253  Identities=23%  Similarity=0.272  Sum_probs=200.8

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++.++||+|+||.||+|..      ..+++.||||++....   ......+.+|+.+|..++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~   74 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQK------KDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN   74 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEE------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence            4789999999999999999964      3457889999997532   233456788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+.+|+|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  150 (364)
T cd05599          75 YLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIH--KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTG  150 (364)
T ss_pred             eEEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEeeccccee
Confidence            999999999999999998765  46899999999999999999999  67799999999999999999999999999875


Q ss_pred             CCCCCCce------------------------------------eeecccccccccccccccCCCCCchhhHHHHHHHHH
Q 014736          248 GPEGSNTH------------------------------------VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLL  291 (419)
Q Consensus       248 ~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  291 (419)
                      ........                                    .....+||+.|+|||++.+..++.++|||||||++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  230 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY  230 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHH
Confidence            43211100                                    011246999999999999999999999999999999


Q ss_pred             HHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 014736          292 ELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK---MAAVVA  368 (419)
Q Consensus       292 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs---~~eil~  368 (419)
                      +|++|..||..........      ........+        ........++++.+||.+||. +|.+|++   +.++++
T Consensus       231 el~~G~~Pf~~~~~~~~~~------~i~~~~~~~--------~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         231 EMLVGYPPFCSDNPQETYR------KIINWKETL--------QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HhhcCCCCCCCCCHHHHHH------HHHcCCCcc--------CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999999997654321111      111000000        000111345789999999996 9999997   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.3e-42  Score=329.74  Aligned_cols=265  Identities=26%  Similarity=0.363  Sum_probs=210.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCC-CcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  167 (419)
                      .++|.+.+.||+|+||.||+|..... .....+..||+|++..... ...+.+.+|+.+++++ +|+||+++++++...+
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGL-SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecC-CCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            35799999999999999999975432 2234466899999875432 3345788999999999 7999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+.+++|.+++.......+++..+..++.|++.||.|||  +++|+|+||||+|||++.++.++|+|||++..
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            9999999999999999997654445899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ..............++..|+|||++.+..++.++|||||||++|+|++ |..||.........  ...    .....   
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~~----~~~~~---  261 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YKL----IKEGY---  261 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HHH----HHcCC---
Confidence            544332222223446788999999988999999999999999999998 99998764432111  110    00100   


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                             ....+...+.++.+++.+||..+|++||++.++++.|+++
T Consensus       262 -------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 -------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                   0011123356899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1e-42  Score=323.17  Aligned_cols=255  Identities=26%  Similarity=0.428  Sum_probs=206.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|++.++||+|+||.||+|...+       +..||+|.+.... ...+.+.+|+.+++.++|+||+++++++...+..+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~-------~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNN-------STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecC-------CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            578899999999999999997543       3569999886543 23567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      ++|||+.+++|.+++.......+++..++.++.|++.||.|||  +++++|+||||+||+++.++.++|+|||++.....
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--RKNYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            9999999999999997765567888999999999999999999  67799999999999999999999999999987543


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      .... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.......   ......    ....     
T Consensus       156 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~----~~~~-----  222 (261)
T cd05072         156 NEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQ----RGYR-----  222 (261)
T ss_pred             Ccee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHH----cCCC-----
Confidence            3221 1222346778999999988889999999999999999998 999997543221   111110    1000     


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                       .    ......+.++.+++.+||..+|++||++++|++.|+.+
T Consensus       223 -~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         223 -M----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -C----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence             0    11123456799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.7e-43  Score=353.15  Aligned_cols=258  Identities=26%  Similarity=0.325  Sum_probs=206.1

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEE
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCC  164 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  164 (419)
                      +...++|.+.++||+|+||.||+|..      ..+++.||||++.....  .....+.+|+.++..++|+||+++++.+.
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~------~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~  101 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKR------VSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFA  101 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEE------cCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence            44457999999999999999999964      34478899999975432  33456788999999999999999988775


Q ss_pred             eCC--------eeEEEEEecCCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 014736          165 EDE--------ERLLVYEFMPRGSLENHLFKRI--SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD  234 (419)
Q Consensus       165 ~~~--------~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~  234 (419)
                      ..+        .+++||||+.+|+|.+++..+.  ...+++..+..++.|++.||.|||  .+||+||||||+|||++.+
T Consensus       102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH--~~~IiHrDLKP~NILl~~~  179 (496)
T PTZ00283        102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH--SKHMIHRDIKSANILLCSN  179 (496)
T ss_pred             cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEeCC
Confidence            432        3689999999999999986532  346888999999999999999999  6789999999999999999


Q ss_pred             CcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHh
Q 014736          235 FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW  314 (419)
Q Consensus       235 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  314 (419)
                      +.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ..  
T Consensus       180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---~~--  254 (496)
T PTZ00283        180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---VM--  254 (496)
T ss_pred             CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HH--
Confidence            9999999999987544333333345679999999999999999999999999999999999999997543211   11  


Q ss_pred             hhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          315 AKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                       ......           .....+...+.++.+|+.+||+.||.+||++.++++.
T Consensus       255 -~~~~~~-----------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        255 -HKTLAG-----------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             -HHHhcC-----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence             111100           0111233456789999999999999999999999863

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.2e-43  Score=335.81  Aligned_cols=242  Identities=26%  Similarity=0.363  Sum_probs=195.5

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCc-ccccceeeEEEeCC
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRH-PHLVRLIGYCCEDE  167 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~  167 (419)
                      +|++.+.||+|+||.||+|...+      +++.||+|++....   ....+.+..|..++..++| ++|+++++++.+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKG------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   74 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Confidence            58889999999999999996443      46789999997532   2344667889999999976 56888999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||  .+||+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05587          75 RLYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE  150 (324)
T ss_pred             EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence            999999999999999988765  46888999999999999999999  67899999999999999999999999999875


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   .....   ...      
T Consensus       151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i---~~~------  216 (324)
T cd05587         151 NIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQSI---MEH------  216 (324)
T ss_pred             cCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHH---HcC------
Confidence            322221  1234569999999999999999999999999999999999999997643221   11110   000      


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKM  363 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~  363 (419)
                            ...++...+.++.+++.+||..||.+|++.
T Consensus       217 ------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         217 ------NVSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                  012233456789999999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.9e-42  Score=326.56  Aligned_cols=264  Identities=30%  Similarity=0.434  Sum_probs=208.2

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      +|.+.+.||+|+||.||+|..... ........+++|.+..... .....+.+|+.+++.++||||+++++.+..++..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRL-KGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecC-CCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            477888999999999999976432 1223346799998865432 23467889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhcc----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCc
Q 014736          171 LVYEFMPRGSLENHLFKRI----------------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSN  228 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~N  228 (419)
                      ++|||+.+++|.+++....                      ...+++..++.++.|++.||.|||  ++||+||||||+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~ivH~dikp~n  157 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA--EMKLVHRDLAARN  157 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH--HCCeehhhhhhhe
Confidence            9999999999999876421                      134778899999999999999999  7789999999999


Q ss_pred             EEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcc
Q 014736          229 ILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKS  307 (419)
Q Consensus       229 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  307 (419)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....+..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999986543322111223346778999999988899999999999999999998 999997654322


Q ss_pred             chhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          308 EQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                         .....    ...          .....+...+.++.+++.+||+.+|++||++.+|++.|+++..
T Consensus       238 ---~~~~~----~~~----------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 ---LFNLL----KTG----------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             ---HHHHH----hCC----------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence               11111    110          0111123345789999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7e-43  Score=336.66  Aligned_cols=266  Identities=23%  Similarity=0.341  Sum_probs=197.1

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC--CcccHHHHHHHHHHHcCCCcccccceeeEEEeC---
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCED---  166 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---  166 (419)
                      +|++.++||+|+||.||+|..      ..+++.||+|++...  .......+.+|+++++.++||||+++++++...   
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   74 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAID------THTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR   74 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEE------CCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence            588899999999999999964      345788999998643  223345688999999999999999999988543   


Q ss_pred             --CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCc
Q 014736          167 --EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL  244 (419)
Q Consensus       167 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  244 (419)
                        ...|+||||+ +++|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~kL~Dfg~  149 (338)
T cd07859          75 EFKDIYVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIH--TANVFHRDLKPKNILANADCKLKICDFGL  149 (338)
T ss_pred             CCceEEEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCcEEEccCcc
Confidence              2579999999 57899988655  46889999999999999999999  67799999999999999999999999999


Q ss_pred             cccCCCCCCc-eeeecccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh-----
Q 014736          245 AKMGPEGSNT-HVTTRVMGTYGYAAPEYIST--GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK-----  316 (419)
Q Consensus       245 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-----  316 (419)
                      ++........ .......||..|+|||++.+  ..++.++|||||||++|+|++|++||...........+....     
T Consensus       150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  229 (338)
T cd07859         150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP  229 (338)
T ss_pred             ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9864332211 11234569999999999865  678999999999999999999999997654322111100000     


Q ss_pred             ---HHhhcc--cccccccccccCCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          317 ---PYLRSS--RRLRYIVDPRLAGQY---SVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       317 ---~~~~~~--~~~~~~~~~~l~~~~---~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                         ......  ......+.......+   ....+.++.+++.+||+.||++|||++++++
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence               000000  000000000000000   1123567899999999999999999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.9e-42  Score=324.93  Aligned_cols=262  Identities=27%  Similarity=0.414  Sum_probs=208.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|...++||+|+||.||+|..... .....+..+++|.+..........+.+|+++++.++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNL-LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecC-CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            5678889999999999999975432 223446689999987665555678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccC-------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcE
Q 014736          171 LVYEFMPRGSLENHLFKRIS-------------VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA  237 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~  237 (419)
                      ++|||+.+++|.+++.....             ..+++..++.++.||+.||.|||  ++|++|+||||+|||+++++.+
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA--SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH--HCCeecccccHhhEEEcCCCCE
Confidence            99999999999999865421             24788899999999999999999  7789999999999999999999


Q ss_pred             EEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhh
Q 014736          238 KLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAK  316 (419)
Q Consensus       238 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  316 (419)
                      ||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |.+||............    
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~----  237 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI----  237 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH----
Confidence            9999999875543322222223345788999999988999999999999999999998 89998654332211111    


Q ss_pred             HHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 014736          317 PYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES  372 (419)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~  372 (419)
                         .....          ...+..++..+.+|+.+||+.||.+||++.+|++.|++
T Consensus       238 ---~~~~~----------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         238 ---TQGRE----------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             ---HcCcc----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence               01000          01112345679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-43  Score=327.87  Aligned_cols=252  Identities=27%  Similarity=0.379  Sum_probs=202.6

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      +|++.++||+|+||.||++...      .+++.||+|++.....   .....+.+|+.+++.++|+||+++++.+.+.+.
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVR------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEc------CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe
Confidence            4788899999999999999643      3468899999865322   223457789999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .++||||+.+++|.+++.......+++..+..++.|++.||.|||  ++||+||||||+||++++++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05605          75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH--RERIVYRDLKPENILLDDYGHIRISDLGLAVEI  152 (285)
T ss_pred             EEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence            999999999999999887654557899999999999999999999  677999999999999999999999999999865


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      .....   .....|+..|+|||++.+..++.++|||||||++|+|++|..||...........+.   .....       
T Consensus       153 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~---~~~~~-------  219 (285)
T cd05605         153 PEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE---RRVKE-------  219 (285)
T ss_pred             CCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH---HHhhh-------
Confidence            43221   223468999999999998899999999999999999999999998644322111111   00000       


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVA  368 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~  368 (419)
                          ....++...+..+.+|+.+||..||.+||     ++.++++
T Consensus       220 ----~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         220 ----DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ----cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence                01122334567899999999999999999     7777755

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.1e-43  Score=325.83  Aligned_cols=255  Identities=36%  Similarity=0.572  Sum_probs=200.0

Q ss_pred             CCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEE
Q 014736           95 SNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVY  173 (419)
Q Consensus        95 ~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  173 (419)
                      +.+.||.|.||.||+|.+..  .....+..|+||++..... .....+.+|++++++++||||+++++++...+..++||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~--~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQ--KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEES--TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEc--ccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccc
Confidence            35679999999999999874  2345568899999965432 34678999999999999999999999999888899999


Q ss_pred             EecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCC
Q 014736          174 EFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN  253 (419)
Q Consensus       174 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  253 (419)
                      ||+++|+|.+++.......+++..+..++.||+.||.|||  +++++|+||++.|||++.++.+||+|||++........
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh--~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH--SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH--HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccc
Confidence            9999999999998875677899999999999999999999  56799999999999999999999999999987643333


Q ss_pred             ceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       254 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                      ........+...|+|||.+....++.++||||||+++|||++ |+.||.......   .....    ......       
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~~~----~~~~~~-------  224 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIEKL----KQGQRL-------  224 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHHHH----HTTEET-------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccc----cccccc-------
Confidence            333333457788999999988889999999999999999999 788887653221   11111    111111       


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL  370 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L  370 (419)
                         ..+..++..+.+++.+||..||++||++.+|++.|
T Consensus       225 ---~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 ---PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ---TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ---eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence               11223457799999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=342.89  Aligned_cols=254  Identities=26%  Similarity=0.310  Sum_probs=205.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|.+.+.||+|+||.||+|...      .+++.||+|++....   ......+.+|+.++..++|+||+++++++.+++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDK------DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE   74 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEEC------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC
Confidence            47899999999999999999643      357889999997542   234567888999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+.+++|.+++...  ..+++..++.++.||+.||.|||  .+||+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~  150 (350)
T cd05573          75 HLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVH--KLGFIHRDIKPDNILIDADGHIKLADFGLCKK  150 (350)
T ss_pred             eEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence            999999999999999999766  67889999999999999999999  67899999999999999999999999999986


Q ss_pred             CCCCCC---------------------------ceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 014736          248 GPEGSN---------------------------THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSM  300 (419)
Q Consensus       248 ~~~~~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf  300 (419)
                      ......                           ........||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf  230 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF  230 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC
Confidence            544320                           01122356999999999999999999999999999999999999999


Q ss_pred             CCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 014736          301 DKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK-MAAVVAT  369 (419)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs-~~eil~~  369 (419)
                      ...........+      ......+        .-......+.++.+||.+||. ||.+||+ +.++++.
T Consensus       231 ~~~~~~~~~~~i------~~~~~~~--------~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         231 YSDTLQETYNKI------INWKESL--------RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCHHHHHHHH------hccCCcc--------cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            865432211111      0000000        000111146789999999997 9999999 9999873

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8.1e-43  Score=333.25  Aligned_cols=241  Identities=27%  Similarity=0.366  Sum_probs=191.9

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcC-CCcccccceeeEEEeCCeeEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQ-LRHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      ++||+|+||.||+|...      .+++.||+|++....   ......+..|..++.. .+||||+++++++...+..|+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv   74 (316)
T cd05592           1 KVLGKGSFGKVMLAELK------GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEEC------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence            36999999999999654      346789999997532   2233455667777765 4899999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      |||++||+|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH--~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  150 (316)
T cd05592          75 MEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE  150 (316)
T ss_pred             EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC
Confidence            9999999999988765  46889999999999999999999  6789999999999999999999999999997543322


Q ss_pred             CceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                        ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ...   .....           
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~---~i~~~-----------  211 (316)
T cd05592         151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFD---SILND-----------  211 (316)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHcC-----------
Confidence              12334579999999999999899999999999999999999999998643211   111   00000           


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMA-AVV  367 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~-eil  367 (419)
                       ...++...+.++.+|+.+||+.||.+||++. +++
T Consensus       212 -~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         212 -RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence             0112333467899999999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.3e-43  Score=320.11  Aligned_cols=266  Identities=23%  Similarity=0.259  Sum_probs=203.5

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--cHHHHHHHHHHHcCCCccc-ccceeeEEEeCC-
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--GHREWLAEVIFLGQLRHPH-LVRLIGYCCEDE-  167 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~-  167 (419)
                      .|..+++||+|+||+||+|.      ...+|+.||+|++......  .-....+|+.+|+.++|+| ||.+++++..++ 
T Consensus        12 ~~~~~eklGeGtyg~Vykar------~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~   85 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKAR------SKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN   85 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEE------EecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence            45555679999999999995      5556799999999866432  2345678999999999999 999999998877 


Q ss_pred             -----eeEEEEEecCCCChhhhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 014736          168 -----ERLLVYEFMPRGSLENHLFKRIS--VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS  240 (419)
Q Consensus       168 -----~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  240 (419)
                           .+++|+||+ ..+|..++.....  ..++...++.++.||+.||+|||  .++|+||||||+||||+.+|.+||+
T Consensus        86 ~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H--~~~IlHRDLKPQNlLi~~~G~lKla  162 (323)
T KOG0594|consen   86 HRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH--SHGILHRDLKPQNLLISSSGVLKLA  162 (323)
T ss_pred             ccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCcceEEECCCCcEeee
Confidence                 899999999 7799999977643  35777889999999999999999  6779999999999999999999999


Q ss_pred             ccCccccCCCCCCceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHh
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYL  319 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  319 (419)
                      |||+|+.......  ..+..++|..|.|||++.+. .|+...||||+|||++||+++++-|.+....+....+-......
T Consensus       163 DFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP  240 (323)
T KOG0594|consen  163 DFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP  240 (323)
T ss_pred             ccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence            9999996543332  23456689999999999876 89999999999999999999999998876533322221110000


Q ss_pred             hcccccccc---------ccccc-CCCCCHH---HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          320 RSSRRLRYI---------VDPRL-AGQYSVK---GAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       320 ~~~~~~~~~---------~~~~l-~~~~~~~---~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                       +...+...         +.... ...+...   ...+..+++.+||+.+|.+|.|+..+++.
T Consensus       241 -~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  241 -NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             -CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence             00000000         00000 0011111   12478999999999999999999999875

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.9e-43  Score=344.30  Aligned_cols=252  Identities=25%  Similarity=0.261  Sum_probs=197.6

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      +|+++++||+|+||.||+|..      ..+++.||+|++....   ......+.+|+.++++++|+||+++++.+.+.+.
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~------~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~   75 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARK------VDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN   75 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEE------CCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE
Confidence            588899999999999999964      3457889999997532   2334568889999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++..+
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH--~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          76 LYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            99999999999999998765  46788899999999999999999  677999999999999999999999999997532


Q ss_pred             CCCCC---------------------------------------------ceeeecccccccccccccccCCCCCchhhH
Q 014736          249 PEGSN---------------------------------------------THVTTRVMGTYGYAAPEYISTGHLTTKSDV  283 (419)
Q Consensus       249 ~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  283 (419)
                      .....                                             .......+||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (382)
T cd05625         152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  231 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeE
Confidence            11000                                             000123469999999999999999999999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-
Q 014736          284 YSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK-  362 (419)
Q Consensus       284 wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs-  362 (419)
                      |||||++|||++|+.||....+......+      .....        .+........+.++.+++.+|+ .+|.+|++ 
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~~~~i------~~~~~--------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~  296 (382)
T cd05625         232 WSVGVILYEMLVGQPPFLAQTPLETQMKV------INWQT--------SLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK  296 (382)
T ss_pred             EechHHHHHHHhCCCCCCCCCHHHHHHHH------HccCC--------CcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC
Confidence            99999999999999999865432211111      00000        0011111234577899998876 59999987 


Q ss_pred             --HHHHHH
Q 014736          363 --MAAVVA  368 (419)
Q Consensus       363 --~~eil~  368 (419)
                        +.++++
T Consensus       297 ~~~~ei~~  304 (382)
T cd05625         297 NGADEIKA  304 (382)
T ss_pred             CCHHHHhc
Confidence              887765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.8e-42  Score=339.89  Aligned_cols=267  Identities=24%  Similarity=0.356  Sum_probs=209.7

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-cHHHHHHHHHHHcCCC-cccccceeeEEEeC
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQLR-HPHLVRLIGYCCED  166 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~  166 (419)
                      -.++|.+.++||+|+||.||+|.+.+. .+...++.||+|++...... ....+.+|+.+|..+. ||||+++++++...
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~-~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGL-SHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCC-CCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            345688889999999999999987642 23345678999999754322 2456889999999997 99999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccC--------------------------------------------------------
Q 014736          167 EERLLVYEFMPRGSLENHLFKRIS--------------------------------------------------------  190 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------  190 (419)
                      +..++||||+.+|+|.+++.....                                                        
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            999999999999999999864321                                                        


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 014736          191 ----------------------------------------VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNIL  230 (419)
Q Consensus       191 ----------------------------------------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIl  230 (419)
                                                              ..+++..++.++.||+.||.|||  +++|+||||||+|||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrdlkp~NiL  271 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA--SKNCVHRDLAARNVL  271 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCcCcccCCcceEE
Confidence                                                    13566778899999999999999  678999999999999


Q ss_pred             EcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccch
Q 014736          231 LDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQ  309 (419)
Q Consensus       231 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~  309 (419)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.........
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence            99999999999999986533222111223457889999999988889999999999999999998 88998754322110


Q ss_pred             hHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 014736          310 NLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL  374 (419)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~  374 (419)
                        .    ......          .....+..++.++.+|+.+||..+|.+||++.+|++.|+.++
T Consensus       352 --~----~~~~~~----------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         352 --Y----NAIKRG----------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             --H----HHHHcC----------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence              0    001111          011122334678999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.6e-42  Score=324.44  Aligned_cols=275  Identities=30%  Similarity=0.416  Sum_probs=207.6

Q ss_pred             cCC-CCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeC--
Q 014736           91 QNF-SSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCED--  166 (419)
Q Consensus        91 ~~y-~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--  166 (419)
                      ++| .+.+.||+|+||+||++....  .....++.||+|.+..... .....+.+|+++|+.++||||+++++++...  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDP--ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEcc--ccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            345 888999999999999876532  2334567899999975432 2356788999999999999999999987653  


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      ...++||||+.+++|.+++...   .+++..++.++.|++.||.|||  ++||+|+||||+|||++.++.++|+|||++.
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLH--SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHH--HCCeeccccChheEEEcCCCcEEEeeccccc
Confidence            4689999999999999998654   5899999999999999999999  6789999999999999999999999999998


Q ss_pred             cCCCCCCcee-eecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          247 MGPEGSNTHV-TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       247 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      .......... .....++..|+|||.+.+..++.++||||||+++|+|++|..||....... ........... ....+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~-~~~~~  233 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQM-TVVRL  233 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhccccccc-chhhh
Confidence            6544322111 122345677999999988899999999999999999999999986543211 01110000000 00000


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL  374 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~  374 (419)
                      ....+.......+...+.++.+++.+||+.+|++|||+++|+++|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            0111111111223445678999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.9e-43  Score=334.31  Aligned_cols=237  Identities=27%  Similarity=0.364  Sum_probs=191.8

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCC-CcccccceeeEEEeCCeeEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      ++||+|+||.||+|...      .+++.||+|++....   ......+..|..++..+ +||||+++++++.+.+..|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv   74 (320)
T cd05590           1 RVLGKGSFGKVMLARLK------ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFV   74 (320)
T ss_pred             CeeeeCCCeEEEEEEEc------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEE
Confidence            36999999999999644      346789999987432   23445677888888776 699999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH--~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~  150 (320)
T cd05590          75 MEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG  150 (320)
T ss_pred             EcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC
Confidence            9999999999988765  56889999999999999999999  6789999999999999999999999999987532221


Q ss_pred             CceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........   ..   ......          
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~---~i~~~~----------  212 (320)
T cd05590         151 K--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---FE---AILNDE----------  212 (320)
T ss_pred             C--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HH---HHhcCC----------
Confidence            1  23345799999999999999999999999999999999999999986542211   11   111000          


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKM  363 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~  363 (419)
                        ..++...+.++.+|+.+||+.||.+||++
T Consensus       213 --~~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         213 --VVYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence              01222346789999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-42  Score=319.83  Aligned_cols=256  Identities=29%  Similarity=0.427  Sum_probs=206.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .++|++.+.||+|+||.||+|....       ++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN-------TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI   76 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC-------CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence            4578999999999999999997433       3579999987543 2356788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+.+++|.+++.......+++..+..++.|++.||.|||  ++|++|+||||+||+++.++.++|+|||++....
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  154 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE--AQNYIHRDLAARNVLVGENNICKVADFGLARVIK  154 (261)
T ss_pred             eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence            99999999999999997765456899999999999999999999  7789999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ..... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||........   ...    .....     
T Consensus       155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~----~~~~~-----  221 (261)
T cd05068         155 EDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV---LQQ----VDQGY-----  221 (261)
T ss_pred             CCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHH----HHcCC-----
Confidence            32211 1111223457999999988899999999999999999999 9999975432211   110    00100     


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                           ....+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       222 -----~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         222 -----RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             -----CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                 0012223457899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-43  Score=343.81  Aligned_cols=254  Identities=22%  Similarity=0.258  Sum_probs=198.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|.+.++||+|+||.||+|..      ..+++.||||++....   ......+.+|+++++.++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~   74 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQK------KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ   74 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEE------CCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            4788999999999999999954      3457889999986432   223456788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||++||+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH--~~givHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          75 YLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVH--KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             eeEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence            999999999999999998765  56888899999999999999999  67799999999999999999999999999863


Q ss_pred             CCCCCCc---------------------------------------------eeeecccccccccccccccCCCCCchhh
Q 014736          248 GPEGSNT---------------------------------------------HVTTRVMGTYGYAAPEYISTGHLTTKSD  282 (419)
Q Consensus       248 ~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D  282 (419)
                      +......                                             ......+||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  230 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD  230 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCcee
Confidence            3211000                                             0001246999999999999999999999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCC--
Q 014736          283 VYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDR--  360 (419)
Q Consensus       283 iwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~R--  360 (419)
                      ||||||++|||++|..||...........+      ......+.      +.  -....+.++.+|+.+||. +|.+|  
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~~~~~~i------~~~~~~~~------~p--~~~~~s~~~~dli~~lL~-~~~~r~~  295 (377)
T cd05629         231 WWSLGAIMFECLIGWPPFCSENSHETYRKI------INWRETLY------FP--DDIHLSVEAEDLIRRLIT-NAENRLG  295 (377)
T ss_pred             eEecchhhhhhhcCCCCCCCCCHHHHHHHH------HccCCccC------CC--CCCCCCHHHHHHHHHHhc-CHhhcCC
Confidence            999999999999999999764432111110      00000000      00  011245789999999997 66665  


Q ss_pred             -CCHHHHHHH
Q 014736          361 -PKMAAVVAT  369 (419)
Q Consensus       361 -Ps~~eil~~  369 (419)
                       +++.+++..
T Consensus       296 r~~~~~~l~h  305 (377)
T cd05629         296 RGGAHEIKSH  305 (377)
T ss_pred             CCCHHHHhcC
Confidence             599998864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.6e-42  Score=333.17  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=195.6

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCC-CcccccceeeEEEeCCeeEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      ++||+|+||.||+|...      .+++.||+|++....   ......+..|..++..+ +||||+++++++.+.+..|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv   74 (329)
T cd05588           1 RVIGRGSYAKVLLVELK------KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeEeeCCCeEEEEEEEC------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEE
Confidence            36999999999999644      346889999997532   22345677899999888 699999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      |||+++|+|.+++...  ..+++..++.++.||+.||.|||  .+||+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  150 (329)
T cd05588          75 IEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG  150 (329)
T ss_pred             EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC
Confidence            9999999999888655  57899999999999999999999  6789999999999999999999999999987432211


Q ss_pred             CceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcc--chhHHHhhhHHhhcccccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKS--EQNLVDWAKPYLRSSRRLRYIVD  330 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  330 (419)
                      .  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||+......  ......+.......         
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------  219 (329)
T cd05588         151 D--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             C--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------
Confidence            1  2234579999999999999999999999999999999999999997533221  11111111111110         


Q ss_pred             cccCCCCCHHHHHHHHHHHHHcccCCCCCCCC------HHHHHH
Q 014736          331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPK------MAAVVA  368 (419)
Q Consensus       331 ~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs------~~eil~  368 (419)
                      ..  ..++...+.++.+++.+||+.||.+|++      +.++++
T Consensus       220 ~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         220 KQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            00  0122334578999999999999999997      566653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.3e-42  Score=328.09  Aligned_cols=266  Identities=26%  Similarity=0.383  Sum_probs=210.9

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCC-CcccccceeeEEEeC
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCED  166 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  166 (419)
                      ..++|++.+.||+|+||.||+|...... .......+|+|.+.... ......+.+|+.++..+ +|+||+++++++..+
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~-~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLD-NPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCC-CCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            3457889999999999999999765431 12345689999987542 23345688999999999 799999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhc--------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 014736          167 EERLLVYEFMPRGSLENHLFKR--------------ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD  232 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~  232 (419)
                      +..+++|||+.+++|.+++..+              ....+++..++.++.|++.||.|||  ++||+||||||+|||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA--SKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCccccccceeeEEEc
Confidence            9999999999999999998642              2346888899999999999999999  67899999999999999


Q ss_pred             CCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhH
Q 014736          233 SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNL  311 (419)
Q Consensus       233 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~  311 (419)
                      .++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||...........
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  246 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  246 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            999999999999987554332222222345678999999988899999999999999999998 9999875433221111


Q ss_pred             HHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 014736          312 VDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL  374 (419)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~  374 (419)
                      .       ....          ....+...+.++.+|+.+||..||++|||+.++++.|+.+.
T Consensus       247 ~-------~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         247 L-------KEGY----------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             H-------HcCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            1       0100          01122334578999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3e-43  Score=344.36  Aligned_cols=254  Identities=24%  Similarity=0.230  Sum_probs=199.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .+|++++.||+|+||.||+|..      ..+++.||+|++....   ......+.+|+.+|+.++|+||+++++.+.+++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~   74 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRK------VDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD   74 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEE------CCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            3689999999999999999954      3447889999986432   223456788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          75 NLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            999999999999999998765  46788889999999999999999  67899999999999999999999999999753


Q ss_pred             CCCCCC-----------------------------------------ceeeecccccccccccccccCCCCCchhhHHHH
Q 014736          248 GPEGSN-----------------------------------------THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSF  286 (419)
Q Consensus       248 ~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  286 (419)
                      +.....                                         .......+||+.|+|||++.+..++.++|||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  230 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  230 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence            211000                                         000123579999999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC---CH
Q 014736          287 GVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP---KM  363 (419)
Q Consensus       287 G~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP---s~  363 (419)
                      ||++|+|++|+.||...........+.      .....        +........+.++.++|.+|+ .+|.+|+   ++
T Consensus       231 Gvilyell~G~~Pf~~~~~~~~~~~i~------~~~~~--------~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~  295 (376)
T cd05598         231 GVILYEMLVGQPPFLADTPAETQLKVI------NWETT--------LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGA  295 (376)
T ss_pred             cceeeehhhCCCCCCCCCHHHHHHHHh------ccCcc--------ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence            999999999999998654322111110      00000        000111234567889999976 5999999   88


Q ss_pred             HHHHHH
Q 014736          364 AAVVAT  369 (419)
Q Consensus       364 ~eil~~  369 (419)
                      .++++.
T Consensus       296 ~ell~h  301 (376)
T cd05598         296 DEIKAH  301 (376)
T ss_pred             HHHhCC
Confidence            988754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-43  Score=338.87  Aligned_cols=267  Identities=32%  Similarity=0.470  Sum_probs=215.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC---CcccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE---GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      .++..+.++||+|+||.||+|.+...  .......||+|.....   ......+|++|.+++++++|||||++||+....
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~--~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~  233 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLK--NGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE  233 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEec--CCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence            44556678999999999999987652  1111223999999853   245678899999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      ..+++|||+|.||+|.++|.+... .++..+...++.+.+.||+|||  .+++|||||-..|+|++.++.+||+|||+++
T Consensus       234 ~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh--~k~~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  234 EPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLH--SKNCIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             CccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHH--HCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence            999999999999999999987733 6899999999999999999999  5669999999999999999999999999988


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      ....  .........-...|+|||.+..+.|+.++|||||||++||+++ |..||.+....+....+.            
T Consensus       311 ~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~------------  376 (474)
T KOG0194|consen  311 AGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV------------  376 (474)
T ss_pred             CCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH------------
Confidence            6431  1111111224678999999999999999999999999999999 888998765443222110            


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCccc
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDM  379 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~~  379 (419)
                          ........+...+.++..++.+||..+|++||+|.++.+.|+.+......
T Consensus       377 ----~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  377 ----KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             ----hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence                11122233445678899999999999999999999999999999876554

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.5e-42  Score=326.03  Aligned_cols=261  Identities=24%  Similarity=0.380  Sum_probs=206.4

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-cHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      +|.+.+.||+|+||.||+|...+. .....++.||+|++...... ....+.+|+.++..++||||+++++++......+
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGT-APGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecC-CCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            466677899999999999976543 12334578999999754332 2456888999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc
Q 014736          171 LVYEFMPRGSLENHLFKRI--------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT  236 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~  236 (419)
                      +++||+.+++|.+++....              ...+++..+..++.|++.||.|||  ++||+||||||+|||+++++.
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH--~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS--SHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HcCccccccchhheEecCCCc
Confidence            9999999999999985321              234778889999999999999999  678999999999999999999


Q ss_pred             EEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhh
Q 014736          237 AKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWA  315 (419)
Q Consensus       237 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~  315 (419)
                      +||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||.......   .....
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~i  239 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VIEMI  239 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH
Confidence            99999999886544333222334456789999999988889999999999999999998 888887643221   11111


Q ss_pred             hHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 014736          316 KPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES  372 (419)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~  372 (419)
                      .    ...          ...++..++.++.+|+.+||+.+|.+||++.+|+..|+.
T Consensus       240 ~----~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         240 R----NRQ----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             H----cCC----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            0    110          112233456789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=9.9e-43  Score=332.64  Aligned_cols=241  Identities=28%  Similarity=0.371  Sum_probs=192.5

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcC-CCcccccceeeEEEeCCeeEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQ-LRHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      ++||+|+||.||+|...      .+++.||+|++....   ......+..|..++.. ++||||+++++++.+.+..|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   74 (316)
T cd05620           1 KVLGKGSFGKVLLAELK------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEEC------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEE
Confidence            46999999999999644      357889999997532   2234556678888765 4899999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      |||+.+++|..++...  ..+++..+..++.||+.||+|||  ++||+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05620          75 MEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLH--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD  150 (316)
T ss_pred             ECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC
Confidence            9999999999988765  56888899999999999999999  6789999999999999999999999999987432222


Q ss_pred             CceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                      .  ......||..|+|||++.+..++.++|||||||++|+|++|..||.......   ......    ..       .+ 
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~~~~----~~-------~~-  213 (316)
T cd05620         151 N--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFESIR----VD-------TP-  213 (316)
T ss_pred             C--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hC-------CC-
Confidence            1  2344679999999999999999999999999999999999999997543211   111100    00       01 


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMA-AVV  367 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~-eil  367 (419)
                         .++...+.++.+|+.+||+.||++||++. +++
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         214 ---HYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence               12223457899999999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9.4e-43  Score=333.89  Aligned_cols=242  Identities=26%  Similarity=0.340  Sum_probs=195.3

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCC-CcccccceeeEEEeCC
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDE  167 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  167 (419)
                      +|.+.+.||+|+||.||+|...      .+++.||+|++....   ......+..|..++..+ +|++|+++++++...+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERK------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD   74 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEEC------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC
Confidence            5888999999999999999644      346789999987542   22334566788888777 5899999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~  150 (323)
T cd05616          75 RLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence            999999999999999988665  46888999999999999999999  67899999999999999999999999999875


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .....   ...      
T Consensus       151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~~i---~~~------  216 (323)
T cd05616         151 NMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSI---MEH------  216 (323)
T ss_pred             cCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHHHH---HhC------
Confidence            332211  1234579999999999999999999999999999999999999997644321   11111   000      


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKM  363 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~  363 (419)
                            ...++...+.++.+|+.+||+.||.+|++.
T Consensus       217 ------~~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         217 ------NVAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ------CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                  012233456789999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=8.7e-43  Score=333.83  Aligned_cols=242  Identities=27%  Similarity=0.363  Sum_probs=194.5

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCC-CcccccceeeEEEeCCeeEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      ++||+|+||.||+|...      .+++.||+|++....   ......+..|.+++..+ +||||+++++++.+.+..|+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv   74 (321)
T cd05591           1 KVLGKGSFGKVMLAELK------GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFV   74 (321)
T ss_pred             CccccCCCeEEEEEEEC------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEE
Confidence            36999999999999643      346789999987532   23345677888888765 799999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      |||+++++|..++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~  150 (321)
T cd05591          75 MEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG  150 (321)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC
Confidence            9999999999988665  56888999999999999999999  6789999999999999999999999999987543222


Q ss_pred             CceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ....   .....          
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~~---i~~~~----------  212 (321)
T cd05591         151 V--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFES---ILHDD----------  212 (321)
T ss_pred             c--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHHH---HHcCC----------
Confidence            1  1234569999999999999999999999999999999999999998654221   1111   11000          


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHH
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRP-------KMAAVVA  368 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RP-------s~~eil~  368 (419)
                        ..++...+.++.+|+.+||+.||++||       ++.++++
T Consensus       213 --~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         213 --VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             --CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence              011222457899999999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.8e-42  Score=317.60  Aligned_cols=249  Identities=25%  Similarity=0.407  Sum_probs=197.2

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEe
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  175 (419)
                      ++||+|+||.||+|....      +++.||+|.+.... ......+.+|+++++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   74 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRA------DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL   74 (252)
T ss_pred             CccCcccCccEEEEEEec------CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEee
Confidence            369999999999996543      36789999876432 23346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCce
Q 014736          176 MPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH  255 (419)
Q Consensus       176 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  255 (419)
                      +.+++|.+++... ...+++..++.++.|++.||.|||  ++||+|+||||+|||++.++.+||+|||++..........
T Consensus        75 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  151 (252)
T cd05084          75 VQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLE--SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS  151 (252)
T ss_pred             ccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEEEcCCCcEEECccccCcccccccccc
Confidence            9999999998654 245789999999999999999999  7789999999999999999999999999987543321111


Q ss_pred             eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccccccccC
Q 014736          256 VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA  334 (419)
Q Consensus       256 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  334 (419)
                      ......++..|+|||.+.++.++.++||||||+++|+|++ |..||............       ..          ...
T Consensus       152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~-------~~----------~~~  214 (252)
T cd05084         152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-------EQ----------GVR  214 (252)
T ss_pred             cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH-------Hc----------CCC
Confidence            1111123457999999988899999999999999999998 88888754322111111       00          011


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       335 ~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                      ...+...+..+.+|+.+||+.+|++|||+.+|++.|+
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            1222344678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.8e-42  Score=326.82  Aligned_cols=268  Identities=25%  Similarity=0.396  Sum_probs=211.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcc-cccccccEEEEEEeccCC-cccHHHHHHHHHHHcCC-CcccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDL-RQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~-~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  166 (419)
                      .++|.+.+.||+|+||.||+|.+.... .....+..||+|++.... ......+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467889999999999999999753211 122345679999987442 23456788999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRI--------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD  232 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~  232 (419)
                      ...|+||||+.+++|.+++....              ...+++..++.++.||+.||.|||  ++||+||||||+||+++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~givH~dlkp~Nili~  171 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA--SQKCIHRDLAARNVLVT  171 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH--HCCeeecccccceEEEc
Confidence            99999999999999999987642              134678889999999999999999  67899999999999999


Q ss_pred             CCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhH
Q 014736          233 SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNL  311 (419)
Q Consensus       233 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~  311 (419)
                      .++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.......   .
T Consensus       172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~  248 (304)
T cd05101         172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---L  248 (304)
T ss_pred             CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---H
Confidence            999999999999986644332222233446778999999988889999999999999999998 788886543221   1


Q ss_pred             HHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          312 VDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                      ..    .......          ...+..++.++.+|+.+||+.+|++||++.+|++.|.+++..
T Consensus       249 ~~----~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         249 FK----LLKEGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             HH----HHHcCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            11    1111100          011234567899999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3e-42  Score=328.00  Aligned_cols=268  Identities=25%  Similarity=0.389  Sum_probs=210.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCccc-ccccccEEEEEEeccCC-cccHHHHHHHHHHHcCC-CcccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLR-QGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  166 (419)
                      .++|.+.+.||+|+||.||+|...+... .......+|+|++.... ......+.+|+++++.+ +|+||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3579999999999999999997643211 12234679999997542 23345788899999999 799999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRIS--------------VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD  232 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~  232 (419)
                      +..|+||||+.+++|.+++.....              ..+++..++.++.|++.||+|||  ++|++||||||+|||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~Nill~  174 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVT  174 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHHheEEc
Confidence            999999999999999999976421              24788899999999999999999  77899999999999999


Q ss_pred             CCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhH
Q 014736          233 SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNL  311 (419)
Q Consensus       233 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~  311 (419)
                      .++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||...........
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~  254 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL  254 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence            999999999999876543222111222234578999999988899999999999999999998 8888865432111111


Q ss_pred             HHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          312 VDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                             .....          ....+...+.++.+|+.+||..+|++||++.+|++.|+.+...
T Consensus       255 -------~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         255 -------LKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             -------HHcCC----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence                   11110          0112234467899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2e-42  Score=330.55  Aligned_cols=241  Identities=28%  Similarity=0.383  Sum_probs=192.4

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcC-CCcccccceeeEEEeCCeeEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQ-LRHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      +.||+|+||.||+|...      .+++.||+|++....   ......+..|..++.. ++||||+++++++.+.+..|+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   74 (316)
T cd05619           1 KMLGKGSFGKVFLAELK------GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFV   74 (316)
T ss_pred             CeeeeCCCEEEEEEEEC------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEE
Confidence            36999999999999644      346789999997542   2234456678888775 4899999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH--~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05619          75 MEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD  150 (316)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC
Confidence            9999999999998764  46888899999999999999999  6789999999999999999999999999987532222


Q ss_pred             CceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                      .  ......||..|+|||++.+..++.++|||||||++|+|++|..||.......   .....    ...       .+ 
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i----~~~-------~~-  213 (316)
T cd05619         151 A--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSI----RMD-------NP-  213 (316)
T ss_pred             C--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHH----HhC-------CC-
Confidence            1  1234569999999999999999999999999999999999999997643221   11111    000       01 


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMA-AVV  367 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~-eil  367 (419)
                         .++...+.++.+|+.+||+.||++||++. +++
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         214 ---CYPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             ---CCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence               11223457799999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.6e-42  Score=317.92  Aligned_cols=251  Identities=27%  Similarity=0.438  Sum_probs=201.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|++.+.||+|+||.||+|.+++       +..+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-------~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-------QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY   75 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-------CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEE
Confidence            458888999999999999997643       3569999886432 33567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+++|+|.+++.... ..+++..++.++.|++.||.|||  ++||+|+||||+||+++.++.+||+|||+++....
T Consensus        76 iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          76 IVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLE--RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            9999999999999886542 35889999999999999999999  77899999999999999999999999999986533


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      .... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||.......   ......    .....    
T Consensus       153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i~----~~~~~----  220 (256)
T cd05114         153 DEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMIS----RGFRL----  220 (256)
T ss_pred             Ccee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----CCCCC----
Confidence            2211 1122335678999999988899999999999999999999 899997643221   111111    11000    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL  370 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L  370 (419)
                            ..+...+.++.+|+.+||+.+|++||++.++++.|
T Consensus       221 ------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         221 ------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                  01112346799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-42  Score=323.14  Aligned_cols=262  Identities=27%  Similarity=0.420  Sum_probs=208.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|.+.+.||+|+||.||+|...... ....+..||+|.+.... ......+.+|+.++..++|+||+++++++.....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVV-KGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccC-CCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            467899999999999999999875431 13445789999986543 2334578899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccC--------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 014736          169 RLLVYEFMPRGSLENHLFKRIS--------VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS  240 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  240 (419)
                      .++||||+++++|.+++.....        ..+++..++.++.|++.||.|||  +++++|+||||+|||++.++.+||+
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA--AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccChheEEEcCCCCEEEC
Confidence            9999999999999999865321        23678889999999999999999  7789999999999999999999999


Q ss_pred             ccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHh
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYL  319 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  319 (419)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||............       
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~-------  234 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV-------  234 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH-------
Confidence            9999886544332222233457889999999988889999999999999999998 99999754432211111       


Q ss_pred             hcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          320 RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                      .....          ...+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus       235 ~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         235 IDGGH----------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             hcCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            11100          0112234678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.6e-42  Score=331.60  Aligned_cols=244  Identities=25%  Similarity=0.361  Sum_probs=191.9

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCC-CcccccceeeEEEeCCeeEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      +.||+|+||.||+|...      .+++.||+|++....   ......+.+|+.++.++ +||||+++++++...+..|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   74 (329)
T cd05618           1 RVIGRGSYAKVLLVRLK------KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeeeeCCCeEEEEEEEC------CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEE
Confidence            46999999999999643      346789999997542   23345677888888776 799999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      |||+++++|..++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~  150 (329)
T cd05618          75 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  150 (329)
T ss_pred             EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC
Confidence            9999999999888655  56899999999999999999999  6779999999999999999999999999987532221


Q ss_pred             CceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcc--chhHHHhhhHHhhcccccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKS--EQNLVDWAKPYLRSSRRLRYIVD  330 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  330 (419)
                      .  ......||..|+|||++.+..++.++|||||||++|+|++|..||.......  ......+........        
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--------  220 (329)
T cd05618         151 D--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------  220 (329)
T ss_pred             C--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--------
Confidence            1  1234579999999999999999999999999999999999999996432211  111111111111000        


Q ss_pred             cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014736          331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKM  363 (419)
Q Consensus       331 ~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~  363 (419)
                         ...++...+.++.+|+.+||+.||++||++
T Consensus       221 ---~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         221 ---QIRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence               011233456789999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.8e-42  Score=331.90  Aligned_cols=238  Identities=28%  Similarity=0.351  Sum_probs=189.8

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHH-HHcCCCcccccceeeEEEeCCeeEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVI-FLGQLRHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      +.||+|+||+||+|...      .+++.||+|++.....   .....+..|.. +++.++||||+++++++.+.+..|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv   74 (323)
T cd05575           1 KVIGKGSFGKVLLAKHK------ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFV   74 (323)
T ss_pred             CeeeeCCCeEEEEEEEC------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEE
Confidence            36999999999999643      4578899999975321   22344555555 56789999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      |||+.+++|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (323)
T cd05575          75 LDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS  150 (323)
T ss_pred             EcCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC
Confidence            9999999999988765  56888999999999999999999  6789999999999999999999999999987532222


Q ss_pred             CceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|..||........   .   .......          
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~---~~i~~~~----------  212 (323)
T cd05575         151 --KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM---Y---DNILNKP----------  212 (323)
T ss_pred             --CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH---H---HHHHcCC----------
Confidence              123345799999999999999999999999999999999999999976432111   1   1111000          


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMA  364 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~  364 (419)
                        .......+.++.+++.+||+.||.+||++.
T Consensus       213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         213 --LRLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence              011223467899999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=7.6e-42  Score=322.23  Aligned_cols=267  Identities=27%  Similarity=0.408  Sum_probs=208.4

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ..++|.+.++||+|+||.||+|...+.. ....+..||+|.+..... .....+.+|+.+++.++|+||+++++++.+.+
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDII-KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccC-CCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            3568999999999999999999765421 223356799999864432 23346788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhcc--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEE
Q 014736          168 ERLLVYEFMPRGSLENHLFKRI--------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKL  239 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  239 (419)
                      ..|+||||+.+|+|.+++....        ....++..+..++.|++.||.|||  ++||+||||||+|||++.++.++|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999996532        123456778899999999999999  678999999999999999999999


Q ss_pred             eccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHH
Q 014736          240 SDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       240 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      +|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.......   ....    
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~----  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKF----  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----
Confidence            99999886543322222223345778999999988899999999999999999998 788987543221   1111    


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      .......          ..+...+.++.+++.+||+.||++|||+.++++.|++.+.
T Consensus       234 ~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  280 (288)
T cd05061         234 VMDGGYL----------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH  280 (288)
T ss_pred             HHcCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence            1111100          1122335789999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-42  Score=319.09  Aligned_cols=259  Identities=29%  Similarity=0.468  Sum_probs=203.9

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe--
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE--  168 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--  168 (419)
                      |.+.+.||+|+||.||+|.+..+   ...+..||+|++.....  .....+.+|+.+++.++|+||+++++++.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQD---DGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecC---CCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            56788999999999999976542   22357899999875432  334678899999999999999999998866544  


Q ss_pred             ----eEEEEEecCCCChhhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 014736          169 ----RLLVYEFMPRGSLENHLFKRI----SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS  240 (419)
Q Consensus       169 ----~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  240 (419)
                          .+++|||+++++|..++....    ...+++..+..++.|++.||.|||  +++++||||||+||++++++.+||+
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~  155 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS--NRNFIHRDLAARNCMLREDMTVCVA  155 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH--hCCeeccccchheEEECCCCeEEEC
Confidence                799999999999999885432    246888999999999999999999  6789999999999999999999999


Q ss_pred             ccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHh
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYL  319 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  319 (419)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ...+.    
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~----  228 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL----  228 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----
Confidence            9999986544332222222335678999999988899999999999999999999 889987543211   11111    


Q ss_pred             hcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          320 RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                      ....          ....+..++.++.+++.+||+.||++||++.+|++.|..+
T Consensus       229 ~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 RHGN----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HcCC----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0110          0112234567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2e-42  Score=330.91  Aligned_cols=242  Identities=28%  Similarity=0.378  Sum_probs=195.0

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCC-CcccccceeeEEEeCCeeEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      +.||+|+||.||+|...      .+++.||+|++....   ......+.+|..++..+ +||||+++++++.+.+..|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv   74 (318)
T cd05570           1 KVLGKGSFGKVLLAELK------GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFV   74 (318)
T ss_pred             CeeeeCCCeEEEEEEEC------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence            36999999999999654      346789999997532   23345677888988877 699999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      |||+.+++|..++.+.  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  150 (318)
T cd05570          75 MEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG  150 (318)
T ss_pred             EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC
Confidence            9999999999988665  56899999999999999999999  6779999999999999999999999999987532221


Q ss_pred             CceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                      .  .....+||..|+|||++.+..++.++|||||||++|+|++|+.||........   ..   ... ..          
T Consensus       151 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~---~~---~i~-~~----------  211 (318)
T cd05570         151 V--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL---FQ---SIL-ED----------  211 (318)
T ss_pred             C--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH---HH---HHH-cC----------
Confidence            1  12335699999999999999999999999999999999999999975432111   11   000 00          


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKM-----AAVVA  368 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~-----~eil~  368 (419)
                       ...++...+.++.+|+.+||+.||.+||++     .++++
T Consensus       212 -~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         212 -EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             -CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence             001223346789999999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.7e-42  Score=320.74  Aligned_cols=262  Identities=27%  Similarity=0.419  Sum_probs=204.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|++.+.||+|+||.||+|.+..+  .......+++|.+..... ....++..|+.++..++||||+++++++. +...
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~   83 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPE--GDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL   83 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCC--CCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence            4688889999999999999976442  111223588888864322 23356778888999999999999999875 4567


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++++||+.+|+|.+++... ...+++..++.++.||+.||.|||  ++|++|+||||+|||++.++.+||+|||+++...
T Consensus        84 ~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            8999999999999998654 246889999999999999999999  6779999999999999999999999999998654


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ............++..|+|||++.++.++.++||||||+++|||++ |..||...........+       ......   
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-------~~~~~~---  230 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-------EKGERL---  230 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HCCCcC---
Confidence            4332222233457788999999988899999999999999999998 99999765432211111       111110   


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                             ..+..++.++.+++.+||..||.+|||+.++++.|..+..
T Consensus       231 -------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         231 -------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                   0011234578899999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-42  Score=331.58  Aligned_cols=242  Identities=28%  Similarity=0.334  Sum_probs=195.4

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYE  174 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  174 (419)
                      +.||+|+||.||++....   ....++.||+|++.....  .....+.+|+++|++++||||+++++++.+++..|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~---~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKIT---GPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEec---cCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            579999999999986432   234578999999975422  233456789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCc
Q 014736          175 FMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT  254 (419)
Q Consensus       175 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  254 (419)
                      |+.+++|.+++.+.  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++........ 
T Consensus        79 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-  153 (318)
T cd05582          79 FLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-  153 (318)
T ss_pred             CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence            99999999998665  56899999999999999999999  67799999999999999999999999999886443321 


Q ss_pred             eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccC
Q 014736          255 HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA  334 (419)
Q Consensus       255 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  334 (419)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........   ...   .....            
T Consensus       154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~---i~~~~------------  214 (318)
T cd05582         154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---MTM---ILKAK------------  214 (318)
T ss_pred             -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---HHH---HHcCC------------
Confidence             23345799999999999888899999999999999999999999976432211   110   00000            


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 014736          335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAA  365 (419)
Q Consensus       335 ~~~~~~~~~~l~~li~~~l~~dP~~RPs~~e  365 (419)
                      ..++...+.++.+|+.+||+.||++||++.+
T Consensus       215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            0122334578999999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.4e-42  Score=321.46  Aligned_cols=249  Identities=25%  Similarity=0.361  Sum_probs=196.5

Q ss_pred             ecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEe
Q 014736           99 LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        99 lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  175 (419)
                      ||+|+||.||++...      .+++.||+|.+.....   .....+..|+++++.++||||+++++++.++...|+||||
T Consensus         1 lg~G~~g~Vy~~~~~------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05607           1 LGKGGFGEVCAVQVK------NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSL   74 (277)
T ss_pred             CCCCCceEEEEEEEc------cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEec
Confidence            799999999999643      3478899999864322   1234456799999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCce
Q 014736          176 MPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH  255 (419)
Q Consensus       176 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  255 (419)
                      +.|++|.+++.......+++..+..++.||+.||.|||  ++||+||||||+|||++.++.++|+|||++.......   
T Consensus        75 ~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---  149 (277)
T cd05607          75 MNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH--SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---  149 (277)
T ss_pred             CCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---
Confidence            99999999887665556889999999999999999999  6789999999999999999999999999988654332   


Q ss_pred             eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCC
Q 014736          256 VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAG  335 (419)
Q Consensus       256 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  335 (419)
                      ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.........  .........          .... 
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~----------~~~~-  216 (277)
T cd05607         150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTLE----------DEVK-  216 (277)
T ss_pred             eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhhc----------cccc-
Confidence            123346899999999998888999999999999999999999999754322111  111111000          0000 


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          336 QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       336 ~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                      ......+.++.+|+.+||+.||++||++.++++.+.
T Consensus       217 ~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         217 FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            001134578999999999999999999987764433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.5e-43  Score=340.64  Aligned_cols=273  Identities=25%  Similarity=0.306  Sum_probs=211.7

Q ss_pred             CCHHHHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-c-----c
Q 014736           81 FQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-H-----P  154 (419)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----p  154 (419)
                      |....-+.+.-+|.+.++||+|+||.|.+|+.      ..+++.||||+++... .-..+...|+.+|..|+ |     -
T Consensus       176 Y~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d------~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~  248 (586)
T KOG0667|consen  176 YQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYD------HKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKY  248 (586)
T ss_pred             eeEEecceeEEEEEEEEEecccccceeEEEEe------cCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCe
Confidence            33333455566899999999999999999964      4567999999998542 23445567999998886 4     4


Q ss_pred             cccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 014736          155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD  234 (419)
Q Consensus       155 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~  234 (419)
                      |||+++++|...+++|||+|.+ +-+|.+++..+.-..++...++.++.||+.||.+||  +.||||+|||||||||.+-
T Consensus       249 n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~--~l~IIHcDLKPENILL~~~  325 (586)
T KOG0667|consen  249 NIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH--ELGIIHCDLKPENILLKDP  325 (586)
T ss_pred             eEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCChhheeeccC
Confidence            8999999999999999999999 789999999887778999999999999999999999  7889999999999999764


Q ss_pred             --CcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHH
Q 014736          235 --FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV  312 (419)
Q Consensus       235 --~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~  312 (419)
                        ..|||+|||.+......-.     ..+.+..|.|||++.+.+|+.+.|+||||||++||++|.+-|.+.+..+....+
T Consensus       326 ~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I  400 (586)
T KOG0667|consen  326 KRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARI  400 (586)
T ss_pred             CcCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHH
Confidence              4699999999997554432     456788899999999999999999999999999999999989877655443222


Q ss_pred             Hhh---------------hHHhhc-cccccccc-------------------------cc----ccCCCCCHHHHHHHHH
Q 014736          313 DWA---------------KPYLRS-SRRLRYIV-------------------------DP----RLAGQYSVKGAKEMAV  347 (419)
Q Consensus       313 ~~~---------------~~~~~~-~~~~~~~~-------------------------~~----~l~~~~~~~~~~~l~~  347 (419)
                      ...               ..++.. ........                         -+    .+...........+.+
T Consensus       401 ~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~d  480 (586)
T KOG0667|consen  401 IEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFID  480 (586)
T ss_pred             HHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHH
Confidence            111               011111 00000000                         00    0011112234567899


Q ss_pred             HHHHcccCCCCCCCCHHHHHH
Q 014736          348 LALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       348 li~~~l~~dP~~RPs~~eil~  368 (419)
                      ++.+||.+||.+|+|..++++
T Consensus       481 flk~~L~~dP~~R~tp~qal~  501 (586)
T KOG0667|consen  481 FLKRCLEWDPAERITPAQALN  501 (586)
T ss_pred             HHHHHhccCchhcCCHHHHhc
Confidence            999999999999999999987

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8e-42  Score=343.35  Aligned_cols=267  Identities=21%  Similarity=0.293  Sum_probs=193.7

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC------cccccce
Q 014736           86 LRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR------HPHLVRL  159 (419)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~~  159 (419)
                      +....++|.+.++||+|+||+||+|+..      ..++.||||+++... .....+..|+.++..++      |.+|+++
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~------~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i  196 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDR------KRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKI  196 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEc------CCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeee
Confidence            3445678999999999999999999643      346789999996432 12234455666666554      4568899


Q ss_pred             eeEEEeC-CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC---
Q 014736          160 IGYCCED-EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF---  235 (419)
Q Consensus       160 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~---  235 (419)
                      +++|..+ .+.++|||++ |++|.+++.+.  ..+++..+..++.||+.||.|||+ +.|||||||||+|||++.++   
T Consensus       197 ~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~-~~gIiHrDlKP~NILl~~~~~~~  272 (467)
T PTZ00284        197 QRYFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHT-ELHLMHTDLKPENILMETSDTVV  272 (467)
T ss_pred             EEEEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh-cCCeecCCCCHHHEEEecCCccc
Confidence            9988765 5788999998 88999988765  568899999999999999999994 24799999999999998765   


Q ss_pred             -------------cEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 014736          236 -------------TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDK  302 (419)
Q Consensus       236 -------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  302 (419)
                                   .+||+|||++......     ....+||+.|+|||++.+..|+.++|||||||++|||++|++||+.
T Consensus       273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        273 DPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             ccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                         4999999988642221     2346799999999999999999999999999999999999999987


Q ss_pred             CCCccchhHHHhhh-----------------HHhhcccccccccccc-c----C-CCC-CHHHHHHHHHHHHHcccCCCC
Q 014736          303 LRPKSEQNLVDWAK-----------------PYLRSSRRLRYIVDPR-L----A-GQY-SVKGAKEMAVLALQCISVNPK  358 (419)
Q Consensus       303 ~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~-l----~-~~~-~~~~~~~l~~li~~~l~~dP~  358 (419)
                      .........+....                 .++.....+....++. +    . ... .......+.+||.+||+.||.
T Consensus       348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~  427 (467)
T PTZ00284        348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ  427 (467)
T ss_pred             CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence            55432222211110                 0000000000000000 0    0 000 001245688999999999999


Q ss_pred             CCCCHHHHHH
Q 014736          359 DRPKMAAVVA  368 (419)
Q Consensus       359 ~RPs~~eil~  368 (419)
                      +|||+.|+++
T Consensus       428 ~R~ta~e~L~  437 (467)
T PTZ00284        428 KRLNARQMTT  437 (467)
T ss_pred             hCCCHHHHhc
Confidence            9999999987

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.9e-43  Score=336.29  Aligned_cols=253  Identities=22%  Similarity=0.255  Sum_probs=201.5

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|.+.+.||+|+||.||+|..      ..+++.||+|++.....   .....+.+|+.+++.++|+||+++++++.+.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~   74 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVRE------KATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD   74 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEE------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence            4688999999999999999954      34578899999975422   23456788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+++++|.+++.+. ...+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH--~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~  151 (330)
T cd05601          75 NLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVH--QMGYVHRDIKPENVLIDRTGHIKLADFGSAAR  151 (330)
T ss_pred             eEEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeEcccCchHheEECCCCCEEeccCCCCeE
Confidence            999999999999999998664 246889999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCceeeeccccccccccccccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYIS------TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS  321 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  321 (419)
                      ....... ......||+.|+|||++.      ...++.++|||||||++|+|++|..||..........      .....
T Consensus       152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------~i~~~  224 (330)
T cd05601         152 LTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN------NIMNF  224 (330)
T ss_pred             CCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH------HHHcC
Confidence            5443222 223346999999999986      4568899999999999999999999997643321111      11100


Q ss_pred             ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          322 SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       322 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ...        +.-......+.++.+|+.+||+ +|.+||++.++++
T Consensus       225 ~~~--------~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         225 QRF--------LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCc--------cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            000        0001112346789999999998 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-42  Score=338.96  Aligned_cols=254  Identities=22%  Similarity=0.243  Sum_probs=200.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      .++|.+.++||+|+||.||+|...      .+++.||+|++....   ......+.+|+.+++.++||||+++++++.++
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~  115 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHK------SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD  115 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEEC------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            457999999999999999999643      457889999996432   22344577899999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..|+||||++||+|.+++...   .+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++.
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEcCCCCEEEEecccee
Confidence            9999999999999999988653   5788889999999999999999  6789999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTG----HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      ........ .....+||+.|+|||++.+.    .++.++|||||||++|||++|..||..........      ......
T Consensus       191 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------~i~~~~  263 (370)
T cd05596         191 KMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS------KIMDHK  263 (370)
T ss_pred             eccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHH------HHHcCC
Confidence            65332211 12345699999999998643    47899999999999999999999998644221111      111100


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKD--RPKMAAVVAT  369 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~--RPs~~eil~~  369 (419)
                      ..        +.-......+.++.+|+.+||+.+|.+  |+++.++++.
T Consensus       264 ~~--------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         264 NS--------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             Cc--------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            00        000111134678999999999999998  9999999763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=8.1e-42  Score=323.51  Aligned_cols=265  Identities=27%  Similarity=0.403  Sum_probs=206.8

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC-CcccHHHHHHHHHHHcCC-CcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~  168 (419)
                      ++|++.++||+|+||.||+|...++    .....+++|.+... .....+.+.+|+.++.++ +||||+++++++.+.+.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKD----GLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCC----CCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            5788999999999999999976542    11234788887642 223446788999999999 79999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 014736          169 RLLVYEFMPRGSLENHLFKRI--------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD  234 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~  234 (419)
                      .|+||||+++++|.+++....              ...+++..++.++.|++.||+|||  ++||+||||||+|||++.+
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~  155 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS--EKQFIHRDLAARNVLVGEN  155 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCcCCcceEEECCC
Confidence            999999999999999986532              134788899999999999999999  6789999999999999999


Q ss_pred             CcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHH
Q 014736          235 FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVD  313 (419)
Q Consensus       235 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~  313 (419)
                      +.+||+|||++.......   .......+..|+|||++.+..++.++|||||||++|+|++ |..||.......   ...
T Consensus       156 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~  229 (297)
T cd05089         156 LASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYE  229 (297)
T ss_pred             CeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH
Confidence            999999999986422111   1111223557999999988899999999999999999997 999997654321   111


Q ss_pred             hhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCccccc
Q 014736          314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMAV  381 (419)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~~~~  381 (419)
                      ..    ..          ......+..++.++.+|+.+||+.+|.+||++.+|++.|..+........
T Consensus       230 ~~----~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~  283 (297)
T cd05089         230 KL----PQ----------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV  283 (297)
T ss_pred             HH----hc----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence            00    00          00111223345789999999999999999999999999999887654433

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.1e-41  Score=317.99  Aligned_cols=258  Identities=29%  Similarity=0.478  Sum_probs=199.9

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEeC----
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCED----  166 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----  166 (419)
                      |.+.++||+|+||.||+|.+...    .....||+|.+....  ....+.+.+|+.+++.++|+||+++++++...    
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~----~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQD----DSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE   76 (272)
T ss_pred             CccccccCcccCceEEEeEEccC----CCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc
Confidence            45678899999999999976442    112469999887542  33456788999999999999999999977432    


Q ss_pred             --CeeEEEEEecCCCChhhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 014736          167 --EERLLVYEFMPRGSLENHLFKR----ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS  240 (419)
Q Consensus       167 --~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  240 (419)
                        ...+++|||+.+|+|.+++...    ....+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+
T Consensus        77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~  154 (272)
T cd05075          77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS--SKSFIHRDLAARNCMLNENMNVCVA  154 (272)
T ss_pred             CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhheEEcCCCCEEEC
Confidence              2468999999999999887432    1234788999999999999999999  6789999999999999999999999


Q ss_pred             ccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHh
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYL  319 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  319 (419)
                      |||+++...............++..|++||++.+..++.++||||||+++|+|++ |..||.......   ...    ..
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~----~~  227 (272)
T cd05075         155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYD----YL  227 (272)
T ss_pred             CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HH
Confidence            9999987544332111222346778999999998999999999999999999999 889997543221   111    11


Q ss_pred             hcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          320 RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                      ......          ......+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       228 ~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         228 RQGNRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HcCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111110          11223456799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.2e-41  Score=316.54  Aligned_cols=255  Identities=28%  Similarity=0.432  Sum_probs=204.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|++.++||+|+||.||+|.+.++       ..||+|++..... ....+.+|+.+++.++|+||+++++++. ....+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-------~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~   76 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-------TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY   76 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-------ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence            5799999999999999999965432       3599999975332 3467889999999999999999999874 45689


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+.+++|.+++.......+++..+..++.|++.||.|||  +++++|+||||+||+++.++.++|+|||++.....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIED  154 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence            9999999999999997654456789999999999999999999  67899999999999999999999999999976543


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      .... ......++..|+|||++.+..++.++||||||+++|+|++ |..||............       ....      
T Consensus       155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~-------~~~~------  220 (262)
T cd05071         155 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-------ERGY------  220 (262)
T ss_pred             cccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH-------hcCC------
Confidence            3221 1122346778999999988899999999999999999999 88888754322111110       0000      


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL  374 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~  374 (419)
                          ........+..+.+|+.+||+.||++||++.++++.|+...
T Consensus       221 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         221 ----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             ----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence                01122345678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6.1e-42  Score=330.94  Aligned_cols=266  Identities=28%  Similarity=0.402  Sum_probs=205.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCC-CcccccceeeEEEeC-C
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQL-RHPHLVRLIGYCCED-E  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~-~  167 (419)
                      ++|++.++||+|+||.||+|.+... ....+++.||||++..... .....+.+|+.+|.++ +|+||+++++++... .
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccC-CccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            5799999999999999999975431 2345678899999975432 2345688999999999 689999999988654 4


Q ss_pred             eeEEEEEecCCCChhhhhhhcc----------------------------------------------------------
Q 014736          168 ERLLVYEFMPRGSLENHLFKRI----------------------------------------------------------  189 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  189 (419)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999986431                                                          


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCceeeecccc
Q 014736          190 -------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG  262 (419)
Q Consensus       190 -------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g  262 (419)
                             ...+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++................+
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                   123577788899999999999999  67899999999999999999999999999986533322112222345


Q ss_pred             cccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHH
Q 014736          263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKG  341 (419)
Q Consensus       263 t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  341 (419)
                      +..|+|||++.+..++.++||||||+++|+|++ |..||........  ...    ........          ..+...
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~----~~~~~~~~----------~~~~~~  307 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR----RLKEGTRM----------RAPDYT  307 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHH----HHhccCCC----------CCCCCC
Confidence            678999999988899999999999999999997 9999876432211  110    01111100          011123


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          342 AKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       342 ~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      +.++.+++.+||+.||++|||+.+|++.|+.++.
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            4679999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.8e-42  Score=321.77  Aligned_cols=246  Identities=25%  Similarity=0.373  Sum_probs=195.4

Q ss_pred             ecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEe
Q 014736           99 LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        99 lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  175 (419)
                      ||+|+||+||+|..      ..+++.||+|++.....   .....+..|+.+++.++|+||+++.+++......|+||||
T Consensus         1 lg~G~~g~Vy~~~~------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   74 (280)
T cd05608           1 LGKGGFGEVSACQM------RATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTI   74 (280)
T ss_pred             CCCCCceeEEEEEE------ccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeC
Confidence            79999999999954      34568899999865422   2235677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCC
Q 014736          176 MPRGSLENHLFKR--ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN  253 (419)
Q Consensus       176 ~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  253 (419)
                      +++|+|.+++...  ....+++..++.++.||+.||.|||  ++||+||||||+||+++.++.++|+|||++........
T Consensus        75 ~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  152 (280)
T cd05608          75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS  152 (280)
T ss_pred             CCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence            9999999887542  2346889999999999999999999  67899999999999999999999999999976543322


Q ss_pred             ceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccccccc
Q 014736          254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL  333 (419)
Q Consensus       254 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  333 (419)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............  ....          ...  
T Consensus       153 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~----------~~~--  216 (280)
T cd05608         153 --KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQRI----------LND--  216 (280)
T ss_pred             --cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH--HHhh----------ccc--
Confidence              123356899999999999999999999999999999999999999764322111110  0000          000  


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014736          334 AGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVA  368 (419)
Q Consensus       334 ~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~  368 (419)
                      ...++...+.++.+++.+||+.||++||     +++++++
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         217 SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            0122334567899999999999999999     6666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-42  Score=323.15  Aligned_cols=269  Identities=27%  Similarity=0.431  Sum_probs=205.8

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCccc--------ccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLR--------QGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIG  161 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~--------~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~  161 (419)
                      ++|++.+.||+|+||.||+|...+...        .......||+|++..... .....+.+|++++++++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            579999999999999999987543210        112234699999875422 23457889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCChhhhhhhccC----------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 014736          162 YCCEDEERLLVYEFMPRGSLENHLFKRIS----------VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL  231 (419)
Q Consensus       162 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll  231 (419)
                      ++...+..++||||+.+++|.+++.....          ..+++..++.++.|++.||.|||  ++|++|+||||+||++
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Nill  162 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA--SLNFVHRDLATRNCLV  162 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH--hcCeeccccChhhEEE
Confidence            99999999999999999999999864321          23678889999999999999999  6789999999999999


Q ss_pred             cCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCccch
Q 014736          232 DSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT--GRRSMDKLRPKSEQ  309 (419)
Q Consensus       232 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~~~~~~~~  309 (419)
                      +.++.+||+|||++................++..|+|||++.++.++.++||||||+++|+|++  |..||.......  
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~--  240 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ--  240 (295)
T ss_pred             cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH--
Confidence            9999999999999986544332222233446788999999988899999999999999999988  667776544322  


Q ss_pred             hHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          310 NLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                       .+.....+.......       .....+...+..+.+|+.+||+.||++||++.+|++.|+
T Consensus       241 -~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 -VIENTGEFFRNQGRQ-------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             -HHHHHHHhhhhcccc-------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence             111111111111100       001112234578999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=9.3e-42  Score=322.62  Aligned_cols=270  Identities=30%  Similarity=0.446  Sum_probs=210.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcc----------cccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccc
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDL----------RQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVR  158 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~----------~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~  158 (419)
                      .++|++.+.||+|+||.||+|...+..          ........||+|++..... .....+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            357899999999999999999765421          1122446799999875532 34567889999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEecCCCChhhhhhhcc---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcE
Q 014736          159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRI---------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNI  229 (419)
Q Consensus       159 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NI  229 (419)
                      +++++..++..+++|||+.+++|.+++....         ...+++..++.++.|++.||.|||  ++||+|+||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH--~~~i~H~dlkp~Ni  161 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE--SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH--HcCccccccchhce
Confidence            9999999999999999999999999987653         125789999999999999999999  67799999999999


Q ss_pred             EEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCcc
Q 014736          230 LLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT--GRRSMDKLRPKS  307 (419)
Q Consensus       230 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~~~~~~  307 (419)
                      +++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            999999999999999986544433333344557789999999988889999999999999999998  677776543211


Q ss_pred             chhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          308 EQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                         ........+....       .......+...+.++.+|+.+||+.||.+|||+.+|++.|+
T Consensus       242 ---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         242 ---VIENAGHFFRDDG-------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ---HHHHHHhcccccc-------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence               1111111111100       00111122334578999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.8e-43  Score=320.07  Aligned_cols=269  Identities=23%  Similarity=0.292  Sum_probs=204.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCC---
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE---  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---  167 (419)
                      -.|...+++|.|+||.||.|.+..+      .+.||||++-.+..    .-.+|+++|+.++|||||++.-+|....   
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~------~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d   93 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRET------EEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESD   93 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCC------CceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCc
Confidence            4577888999999999999987653      67899999864432    2235999999999999999998886532   


Q ss_pred             --eeEEEEEecCCCChhhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-CcEEEecc
Q 014736          168 --ERLLVYEFMPRGSLENHLFK--RISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD-FTAKLSDF  242 (419)
Q Consensus       168 --~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df  242 (419)
                        ...+||||+ ..+|.+.+..  +.+..++.-.++-+..||++||.|||  ..||+||||||.|+|+|.+ |.+|||||
T Consensus        94 ~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh--~~~IcHRDIKPqNlLvD~~tg~LKicDF  170 (364)
T KOG0658|consen   94 EVYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH--SHGICHRDIKPQNLLVDPDTGVLKICDF  170 (364)
T ss_pred             hhHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH--hcCcccCCCChheEEEcCCCCeEEeccC
Confidence              345899999 5589888864  22457888889999999999999999  5779999999999999986 99999999


Q ss_pred             CccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHh--
Q 014736          243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYL--  319 (419)
Q Consensus       243 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--  319 (419)
                      |.|+.+..+...   .....|..|+|||.+.+ .+|+.+.||||.||++.||+-|++-|.+.+..++...+.......  
T Consensus       171 GSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~  247 (364)
T KOG0658|consen  171 GSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR  247 (364)
T ss_pred             CcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence            999987665543   33457899999999866 689999999999999999999999999866554433332111100  


Q ss_pred             -------hc--ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhhc
Q 014736          320 -------RS--SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA--TLESLLN  375 (419)
Q Consensus       320 -------~~--~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~--~L~~l~~  375 (419)
                             .+  .-....+....+...+....++++.+|+.++|..+|.+|.++.|++.  .++.+..
T Consensus       248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence                   00  00111111111112245667889999999999999999999999985  3554443

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-41  Score=333.37  Aligned_cols=268  Identities=21%  Similarity=0.205  Sum_probs=203.8

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .+..+|.+++.||+|+||.||+|...+    ...++.||+|.+...     ..+.+|+.+|+.++||||+++++++....
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~----~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~  159 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHG----DEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKS  159 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcC----CccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence            345689999999999999999996533    234678999988643     23457999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+|||++ +++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.++|+|||++..
T Consensus       160 ~~~lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH--~~givHrDlkp~Nill~~~~~~~l~DfG~a~~  234 (392)
T PHA03207        160 TVCMVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLH--GRGIIHRDVKTENIFLDEPENAVLGDFGAACK  234 (392)
T ss_pred             EEEEEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEcCCCCEEEccCccccc
Confidence            999999999 57898888443  57899999999999999999999  67899999999999999999999999999976


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc-cccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS-RRLR  326 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~  326 (419)
                      ..............||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+......+... ..+.
T Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~  314 (392)
T PHA03207        235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP  314 (392)
T ss_pred             cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence            554433323334679999999999999999999999999999999999999997655433211111111000000 0000


Q ss_pred             c-----------ccccccCCCC-------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          327 Y-----------IVDPRLAGQY-------SVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       327 ~-----------~~~~~l~~~~-------~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      .           .........+       ....+.++.++|.+||..||++||++.+++..
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0           0000000000       01234678899999999999999999999874

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=9.6e-42  Score=319.65  Aligned_cols=262  Identities=28%  Similarity=0.391  Sum_probs=205.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|.+.+.||+|+||.||+|.+.+.. .......|++|.+..... .....+.+|+.+++.++|+||+++++++.+.+.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~-~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRD-GDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCC-CCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            357899999999999999999765421 112467899998864432 234568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC---cEEEe
Q 014736          169 RLLVYEFMPRGSLENHLFKRIS-----VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF---TAKLS  240 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~---~~kl~  240 (419)
                      .++||||+.+++|.+++.....     ..+++..++.++.||+.||.|||  .++++|+||||+||+++.++   .+||+
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchheEEEeccCCCcceEec
Confidence            9999999999999999866432     25788999999999999999999  67799999999999998765   59999


Q ss_pred             ccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHh
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYL  319 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  319 (419)
                      |||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||...........+       
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~-------  234 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-------  234 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------
Confidence            9999986533222111122234568999999988999999999999999999997 99999764432211111       


Q ss_pred             hcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          320 RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                      ....          ...++...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       235 ~~~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 TGGG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HcCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            0110          11123344678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=7.6e-42  Score=318.36  Aligned_cols=256  Identities=24%  Similarity=0.329  Sum_probs=202.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .++|++.+.||+|+||.||+|...      .+++.||+|++..........+.+|+.+++.++||||+++++++...+..
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~------~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~   81 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNL------HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL   81 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEEC------CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence            357999999999999999999643      34678999999765545556788899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+||||+.+++|.+++...  ..+++..+..++.|++.||.|||  ++||+|+||||+||+++.++.++|+|||++....
T Consensus        82 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          82 WICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLH--SKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            9999999999999988654  46788999999999999999999  6789999999999999999999999999998653


Q ss_pred             CCCCceeeeccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYIS---TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ....  ......|+..|+|||.+.   ...++.++|||||||++|+|++|+.||....+.......        ....+ 
T Consensus       158 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--------~~~~~-  226 (267)
T cd06646         158 ATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--------SKSNF-  226 (267)
T ss_pred             cccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--------ecCCC-
Confidence            2211  122345889999999884   445788999999999999999999998654322111000        00000 


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL  370 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L  370 (419)
                        ..+.+.  .....+.++.+++.+||+.+|++||++++|++.|
T Consensus       227 --~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         227 --QPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             --CCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence              001111  1123457899999999999999999999998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.6e-42  Score=329.01  Aligned_cols=244  Identities=25%  Similarity=0.346  Sum_probs=193.9

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCC-CcccccceeeEEEeCCeeEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      ++||+|+||.||+|...      ..++.||+|++....   ......+.+|+.++.++ +||||+++++++.+.+..|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   74 (327)
T cd05617           1 RVIGRGSYAKVLLVRLK------KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLV   74 (327)
T ss_pred             CeeeeCCCeEEEEEEEC------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEE
Confidence            36999999999999644      346789999997542   22345678899998888 699999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      |||+++++|..++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  150 (327)
T cd05617          75 IEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG  150 (327)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC
Confidence            9999999999888654  56899999999999999999999  6789999999999999999999999999987532221


Q ss_pred             CceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                      .  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.............+........          
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------  218 (327)
T cd05617         151 D--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK----------  218 (327)
T ss_pred             C--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC----------
Confidence            1  2334679999999999999999999999999999999999999997544332222221111111100          


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKM  363 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~  363 (419)
                       ...++...+..+.+++.+||+.||.+|+++
T Consensus       219 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         219 -PIRIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             -CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence             011233345778999999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=316.06  Aligned_cols=250  Identities=26%  Similarity=0.340  Sum_probs=209.2

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      .-++|..+++||+|.||.|.++      +.+.+++.||+|+++++..   ....+-+.|-.+|+..+||.+..+...|..
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~------rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt  239 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILC------REKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT  239 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEE------eecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence            3467889999999999999998      5677899999999986643   334456678999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      .+++++||||..||.|.-+|.+.  ..+++...+.+...|+.||.|||  .++||+||||.+|+|+|.+|++||+|||++
T Consensus       240 ~drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLH--s~~ivYRDlKLENLlLDkDGHIKitDFGLC  315 (516)
T KOG0690|consen  240 QDRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLH--SRNIVYRDLKLENLLLDKDGHIKITDFGLC  315 (516)
T ss_pred             CceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhh--hCCeeeeechhhhheeccCCceEeeecccc
Confidence            99999999999999999888665  57888899999999999999999  577999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      +....  ....+..+|||+.|+|||++....|+.++|+|.+||++|||+||++||..........++...          
T Consensus       316 KE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e----------  383 (516)
T KOG0690|consen  316 KEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME----------  383 (516)
T ss_pred             hhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh----------
Confidence            85322  223456799999999999999999999999999999999999999999876544333332110          


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVA  368 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~  368 (419)
                            .  -.|+...++++..|+..+|.+||.+|.     .+.||.+
T Consensus       384 ------d--~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  384 ------D--LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             ------h--ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence                  0  134556678999999999999999995     3555543

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.3e-42  Score=338.62  Aligned_cols=256  Identities=22%  Similarity=0.247  Sum_probs=200.4

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC---CcccHHHHHHHHHHHcCCCcccccceeeEEE
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE---GLQGHREWLAEVIFLGQLRHPHLVRLIGYCC  164 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  164 (419)
                      ...++|++.+.||+|+||.||+|...      .+++.||+|++...   .......+.+|+.+++.++||||+++++++.
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~  113 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHK------SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ  113 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEEC------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            33468999999999999999999643      45688999998642   1223456778999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCc
Q 014736          165 EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL  244 (419)
Q Consensus       165 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  244 (419)
                      +++..|+||||+++|+|.+++...   .+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH--~~~IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         114 DDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIH--SMGLIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEECCCCCEEEEeccc
Confidence            999999999999999999998653   5788899999999999999999  67799999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccccccccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhh
Q 014736          245 AKMGPEGSNTHVTTRVMGTYGYAAPEYISTG----HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR  320 (419)
Q Consensus       245 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  320 (419)
                      +......... .....+||+.|+|||++.+.    .++.++|||||||++|+|++|+.||.........      .....
T Consensus       189 a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------~~i~~  261 (370)
T cd05621         189 CMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------SKIMD  261 (370)
T ss_pred             ceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH------HHHHh
Confidence            9865432211 12345799999999998654    3789999999999999999999999765322111      11111


Q ss_pred             cccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 014736          321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKD--RPKMAAVVAT  369 (419)
Q Consensus       321 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~--RPs~~eil~~  369 (419)
                      ....+        ........+..+.+++.+||..++.+  |+++.++++.
T Consensus       262 ~~~~~--------~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         262 HKNSL--------NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCccc--------CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            11000        00111234678999999999866654  8899998874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3e-42  Score=343.12  Aligned_cols=268  Identities=21%  Similarity=0.296  Sum_probs=197.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeC---
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCED---  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---  166 (419)
                      .++|.+.++||+|+||.||+|...      .+++.||||++....    ....+|+.+|+.++||||+++++++...   
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~  134 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICI------DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFK  134 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEEC------CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence            457999999999999999999643      346789999885432    2344699999999999999999887432   


Q ss_pred             -----CeeEEEEEecCCCChhhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-cEE
Q 014736          167 -----EERLLVYEFMPRGSLENHLFK--RISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-TAK  238 (419)
Q Consensus       167 -----~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~-~~k  238 (419)
                           ..+++||||+. ++|.+++..  .....+++..++.++.||+.||.|||  .+||+||||||+|||++.++ .+|
T Consensus       135 ~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH--~~~IiHrDLKp~NILl~~~~~~vk  211 (440)
T PTZ00036        135 KNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTHTLK  211 (440)
T ss_pred             cCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCcCHHHEEEcCCCCcee
Confidence                 24679999995 578777643  23356889999999999999999999  67799999999999999765 699


Q ss_pred             EeccCccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh-
Q 014736          239 LSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK-  316 (419)
Q Consensus       239 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-  316 (419)
                      |+|||+++.......   .....||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.........+.... 
T Consensus       212 L~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~  288 (440)
T PTZ00036        212 LCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG  288 (440)
T ss_pred             eeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            999999986543322   223568999999999865 469999999999999999999999998654322211111000 


Q ss_pred             -H----Hhhccc-----ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhh
Q 014736          317 -P----YLRSSR-----RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA--TLESL  373 (419)
Q Consensus       317 -~----~~~~~~-----~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~--~L~~l  373 (419)
                       +    ......     .+.......+...++...+.++.+||.+||+.||.+|||+.++++  ++..+
T Consensus       289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence             0    000000     000011111222233345678999999999999999999999985  45544

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.9e-42  Score=332.13  Aligned_cols=243  Identities=26%  Similarity=0.316  Sum_probs=191.5

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHH-HHcCCCcccccceeeEEEeCCeeEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVI-FLGQLRHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      +.||+|+||.||+|...      .+++.||+|++.....   .....+..|.. +++.++||||+++++++...+..|+|
T Consensus         1 ~~lg~G~fg~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv   74 (325)
T cd05602           1 KVIGKGSFGKVLLARHK------AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV   74 (325)
T ss_pred             CeeeeCCCeEEEEEEEC------CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEE
Confidence            36999999999999644      3467899999974321   22234444544 56788999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      |||+.+++|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH--~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~  150 (325)
T cd05602          75 LDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  150 (325)
T ss_pred             EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC
Confidence            9999999999998765  56778888999999999999999  6789999999999999999999999999987533221


Q ss_pred             CceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                      .  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........   ...   .....          
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~---i~~~~----------  212 (325)
T cd05602         151 G--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YDN---ILNKP----------  212 (325)
T ss_pred             C--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HHH---HHhCC----------
Confidence            1  23345799999999999999999999999999999999999999975432211   111   11000          


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                        ..+....+.++.+++.+||+.||.+|+++.+.+..
T Consensus       213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         213 --LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             --cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence              01223456789999999999999999998754443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.6e-41  Score=316.03  Aligned_cols=259  Identities=23%  Similarity=0.343  Sum_probs=206.8

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|.+.+.||+|+||.||+|+..      .+++.||+|.+....   ......+.+|+++++.++||||+++++++.+.+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCL------LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN   75 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEe------CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence            47899999999999999999643      346789999886432   233456889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          168 ERLLVYEFMPRGSLENHLFKR--ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      ..++||||+++++|.+++...  ....+++..+..++.|++.||.|||  ++|++|+||||+||+++.++.++|+|||++
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~nil~~~~~~~~l~d~g~~  153 (267)
T cd08228          76 ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCCHHHEEEcCCCCEEECccccc
Confidence            999999999999999888542  2345788899999999999999999  678999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      ........  ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....... .....   . ....   
T Consensus       154 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~---~-~~~~---  223 (267)
T cd08228         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQ---K-IEQC---  223 (267)
T ss_pred             eeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHH---H-HhcC---
Confidence            86543221  1123458899999999988889999999999999999999999986432211 11111   1 0000   


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                            ..........+..+.+++.+||..+|++||++.+|++.|+.+
T Consensus       224 ------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         224 ------DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             ------CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence                  011111234557899999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=315.61  Aligned_cols=253  Identities=26%  Similarity=0.340  Sum_probs=203.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-----ccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-----QGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      ++|.+.+.||+|+||.||+|...      .+++.||+|.+.....     .....+.+|++++++++||||+++++++.+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~------~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   75 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDV------DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD   75 (263)
T ss_pred             CcccccceecCCCceEEEEEEEc------CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc
Confidence            47899999999999999999643      3467899999864422     123567889999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      ++..++||||+++++|.+++...  ..+++..+..++.|++.||.|||  +.||+|+||+|+||+++.++.++|+|||++
T Consensus        76 ~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nilv~~~~~~~l~dfg~~  151 (263)
T cd06625          76 DETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGAS  151 (263)
T ss_pred             CCeEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence            99999999999999999998765  46788899999999999999999  678999999999999999999999999998


Q ss_pred             ccCCCCCCcee-eecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          246 KMGPEGSNTHV-TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       246 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      ........... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||........   ...   ...    
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~---~~~----  221 (263)
T cd06625         152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---IFK---IAT----  221 (263)
T ss_pred             eeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---HHH---Hhc----
Confidence            76433221111 1234588899999999998899999999999999999999999975432111   000   000    


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                            ......++...+.++.+++.+||..+|.+|||+.++++.
T Consensus       222 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         222 ------QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ------cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                  001112333456789999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=9.7e-42  Score=315.97  Aligned_cols=251  Identities=24%  Similarity=0.402  Sum_probs=201.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|++.+.||+|+||.||+|.+.+       +..+|+|.+.... .....+.+|+.+++.++||||+++++++......+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-------~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-------QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY   75 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-------CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence            468888999999999999996543       2459999887443 33567899999999999999999999999888999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+.+++|.+++.... ..+++..++.++.||+.||.|||  ++|++|+||||.||+++.++.+||+|||+++....
T Consensus        76 lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          76 IVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLE--SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             EEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            9999999999999987643 36889999999999999999999  77899999999999999999999999999886543


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      .... ......++..|++||++.+..++.++||||||+++|+|++ |..||.......   .....    .....     
T Consensus       153 ~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~-----  219 (256)
T cd05113         153 DEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKV----SQGLR-----  219 (256)
T ss_pred             Ccee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----hcCCC-----
Confidence            3211 1112335678999999988889999999999999999998 999997554321   11111    01100     


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL  370 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L  370 (419)
                           ...+...+..+.+++.+||+.||.+||++.+|++.|
T Consensus       220 -----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         220 -----LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence                 011112357899999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.3e-41  Score=324.78  Aligned_cols=266  Identities=24%  Similarity=0.396  Sum_probs=208.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCccc-ccccccEEEEEEeccCC-cccHHHHHHHHHHHcCC-CcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLR-QGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  167 (419)
                      ++|.+.++||+|+||.||+|...+... .......+|+|++.... ......+.+|+.+++.+ +||||+++++++.+.+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            578899999999999999997533211 12335679999987542 23356788999999999 6999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 014736          168 ERLLVYEFMPRGSLENHLFKRI--------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS  233 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~  233 (419)
                      ..|++|||+.+++|.+++....              ...+++..+..++.||+.||.|||  ++|++||||||+|||++.
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~Nill~~  169 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--SRRCIHRDLAARNVLVTE  169 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH--HCCeeeccccceeEEEcC
Confidence            9999999999999999986532              134788899999999999999999  778999999999999999


Q ss_pred             CCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHH
Q 014736          234 DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLV  312 (419)
Q Consensus       234 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~  312 (419)
                      ++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||............
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~  249 (314)
T cd05099         170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL  249 (314)
T ss_pred             CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            99999999999986543222111222234567999999988899999999999999999999 88998754322211111


Q ss_pred             HhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          313 DWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                             .....          ...+..++.++.+|+.+||..+|++||++.++++.|.++..
T Consensus       250 -------~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         250 -------REGHR----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             -------HcCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence                   11100          01223345689999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.5e-42  Score=329.10  Aligned_cols=242  Identities=26%  Similarity=0.343  Sum_probs=194.9

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCC-cccccceeeEEEeCC
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLR-HPHLVRLIGYCCEDE  167 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~  167 (419)
                      +|...+.||+|+||.||+|...      .+++.||+|++....   ....+.+..|..++..+. |++|+++++++.+.+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERK------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD   74 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEEC------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC
Confidence            4778889999999999999643      357889999997532   233456778889888885 578889999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+++|+|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH--~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~  150 (323)
T cd05615          75 RLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEeccccccc
Confidence            999999999999999998765  56889999999999999999999  67899999999999999999999999999875


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ....   .....     
T Consensus       151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~---i~~~~-----  217 (323)
T cd05615         151 HMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQS---IMEHN-----  217 (323)
T ss_pred             cCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHH---HHhCC-----
Confidence            332211  1233569999999999999999999999999999999999999998653221   1111   11000     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKM  363 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~  363 (419)
                             ..++...+.++.+++.+||+.+|.+|++.
T Consensus       218 -------~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 -------VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -------CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                   11233445789999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.5e-42  Score=327.79  Aligned_cols=238  Identities=28%  Similarity=0.347  Sum_probs=188.7

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHH-HHcCCCcccccceeeEEEeCCeeEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVI-FLGQLRHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      ++||+|+||.||+|...      .+++.||+|++.....   .....+..|.. +++.++||||+++++++.+.+..|+|
T Consensus         1 ~~lg~G~~g~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv   74 (321)
T cd05603           1 KVIGKGSFGKVLLAKRK------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFV   74 (321)
T ss_pred             CeeeeCCCEEEEEEEEC------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEE
Confidence            36999999999999643      3468899999864321   22344555554 57889999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      |||+++++|..++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (321)
T cd05603          75 LDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE  150 (321)
T ss_pred             EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC
Confidence            9999999999888654  56888889999999999999999  6779999999999999999999999999987532221


Q ss_pred             CceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                        ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ...   .....          .
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~---~i~~~----------~  212 (321)
T cd05603         151 --ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYD---NILHK----------P  212 (321)
T ss_pred             --CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHH---HHhcC----------C
Confidence              12334579999999999998899999999999999999999999997643211   111   11000          0


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMA  364 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~  364 (419)
                        -.++...+.++.+++.+||+.||.+||++.
T Consensus       213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         213 --LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence              112233457899999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.1e-41  Score=316.13  Aligned_cols=255  Identities=29%  Similarity=0.458  Sum_probs=205.4

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ..++|.+.++||+|+||.||+|...+       ++.||+|.+..... ....+.+|+.+++.++|+||+++++++. .+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~-------~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~   74 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNG-------HTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEP   74 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCC-------CceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCC
Confidence            45689999999999999999996432       46799999875433 3567889999999999999999999874 467


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .+++|||+.+++|.+++.......+++..+..++.|++.||.|||  +.|++|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  152 (260)
T cd05067          75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE--RKNYIHRDLRAANILVSETLCCKIADFGLARLI  152 (260)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence            899999999999999987665567899999999999999999999  678999999999999999999999999999765


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ...... ......++..|+|||++....++.++||||||+++|+|++ |+.||........   ....    ....    
T Consensus       153 ~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~----~~~~----  220 (260)
T cd05067         153 EDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQNL----ERGY----  220 (260)
T ss_pred             CCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HHHH----HcCC----
Confidence            432211 1222346778999999988899999999999999999999 9999976542221   1110    0000    


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES  372 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~  372 (419)
                            ....+...+.++.+++.+||..+|++||+++++++.|+.
T Consensus       221 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         221 ------RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                  001122345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.6e-41  Score=315.00  Aligned_cols=254  Identities=29%  Similarity=0.446  Sum_probs=203.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .++|++.++||+|+||.||+|...+       +..+|+|.+..... ....+.+|+.++++++|+||+++++++. ....
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~-------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~   75 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNG-------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPI   75 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecC-------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCc
Confidence            3578899999999999999996543       35699999875433 3467889999999999999999999875 4568


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |++|||+.+++|.+++.......+++..++.++.|++.||.|||  ++|++|+||||+||+++.++.++|+|||++....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE--RMNYIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            99999999999999997655556899999999999999999999  6789999999999999999999999999998654


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ..... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.......   .....    ...      
T Consensus       154 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~------  219 (260)
T cd05070         154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQV----ERG------  219 (260)
T ss_pred             Ccccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----HcC------
Confidence            33211 1122335678999999988889999999999999999999 899997543211   11111    010      


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES  372 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~  372 (419)
                          .....+...+..+.+|+.+||..+|++|||+.++.+.|+.
T Consensus       220 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         220 ----YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ----CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                0111223445789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.6e-41  Score=318.36  Aligned_cols=263  Identities=26%  Similarity=0.396  Sum_probs=205.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|.+.++||+|+||+||+|.+..+.  ......||+|++..... .....+.+|+.++..++|+||+++++++.. ...
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~   83 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDG--ENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV   83 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCC--CccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence            57888999999999999999865431  11234589999875432 335678899999999999999999998865 457


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      +++|||+++|+|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH--~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          84 QLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLE--EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            8999999999999998654 246889999999999999999999  6789999999999999999999999999998664


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ...+    .......   
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~~~---  230 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDL----LEKGERL---  230 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCCCcC---
Confidence            3322211222235678999999988899999999999999999998 899987543221   1111    1111100   


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                             ..+...+.++.+++.+||..||++||++.++++.|..+...
T Consensus       231 -------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         231 -------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             -------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence                   11223456899999999999999999999999998877443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-41  Score=319.64  Aligned_cols=277  Identities=26%  Similarity=0.352  Sum_probs=205.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEe--CCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE--DEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~  168 (419)
                      ++|++.+.||+|+||.||+|....  .+...++.||+|.+........+.+.+|+++++.++||||+++++++..  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDP--LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecC--CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            578899999999999999997543  1344578899999976655556788999999999999999999998754  346


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .++||||+++++|.+++.+. ...+++..+..++.|++.||.|||  ++||+||||||+||+++.++.+||+|||++...
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH--~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLG--SKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            89999999999999998654 235889999999999999999999  778999999999999999999999999999876


Q ss_pred             CCCCCcee-eecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          249 PEGSNTHV-TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       249 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ........ .....++..|+|||++.+..++.++||||||+++|||++|..++........ ...............+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM-RMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhh-hhcccccccccchHHHHH
Confidence            44322111 1112344569999999888999999999999999999998876543221100 000000000000000000


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                      ..............+.++.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0000001112234567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.1e-42  Score=334.17  Aligned_cols=262  Identities=23%  Similarity=0.322  Sum_probs=199.6

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC--CcccHHHHHHHHHHHcCCCcccccceeeEEEeCC--
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE--  167 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--  167 (419)
                      +|.+.++||+|+||.||+|..      ..+++.||+|++...  .....+.+.+|+.+++.++|+||+++++++...+  
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   74 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTD------PRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID   74 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEE------CCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence            478899999999999999964      335788999998643  2233467889999999999999999999998776  


Q ss_pred             ---eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCc
Q 014736          168 ---ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL  244 (419)
Q Consensus       168 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  244 (419)
                         ..|+||||+. ++|.+++...  ..+++..+..++.||+.||.|||  .+||+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~  149 (372)
T cd07853          75 PFEEIYVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLH--SAGILHRDIKPGNLLVNSNCVLKICDFGL  149 (372)
T ss_pred             ccceEEEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChHHEEECCCCCEEeccccc
Confidence               7899999995 6888877554  56889999999999999999999  67799999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh--------
Q 014736          245 AKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA--------  315 (419)
Q Consensus       245 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~--------  315 (419)
                      +........ .......++..|+|||++.+ ..++.++|||||||++|||++|+.||....+......+...        
T Consensus       150 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~  228 (372)
T cd07853         150 ARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA  228 (372)
T ss_pred             eeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            986443221 12233458899999999876 45899999999999999999999999876543222111100        


Q ss_pred             --------hHHhhcccccccccccccC--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          316 --------KPYLRSSRRLRYIVDPRLA--GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       316 --------~~~~~~~~~~~~~~~~~l~--~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                              ...+.....    ..+...  .......++++.+|+.+||+.||++|||+.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         229 MRSACEGARAHILRGPH----KPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHhhHHHHHHHHhCCC----CCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                    000000000    000000  01122346789999999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-41  Score=313.85  Aligned_cols=250  Identities=30%  Similarity=0.491  Sum_probs=206.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|.+.+.||+|+||.||+|...        ++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+.+..+
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY   76 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence            57888999999999999999643        47799999976543 4678899999999999999999999999899999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+++++|.+++.......+++..+..++.|++.||.|||  .+|++|+||||+||+++.++.++|+|||++.....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~  154 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE--EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ  154 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence            9999999999999997765557899999999999999999999  77899999999999999999999999999986532


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      ...     ...++..|+|||++....++.++||||||+++|+|++ |..||.......   .....    ...       
T Consensus       155 ~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~----~~~-------  215 (256)
T cd05039         155 GQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHV----EKG-------  215 (256)
T ss_pred             ccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----hcC-------
Confidence            211     2235677999999988889999999999999999997 999997543221   11110    000       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                         .....+...+.++.+++.+||..+|++||++.+++++|+.+
T Consensus       216 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         216 ---YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ---CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence               01111223467899999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-41  Score=314.73  Aligned_cols=251  Identities=27%  Similarity=0.431  Sum_probs=200.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      .+|++.+.||+|+||.||+|.+..       +..+|+|++.... .....+.+|+++++.++|+||+++++++...+..|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~-------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG-------KIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIF   75 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC-------CccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceE
Confidence            357888899999999999996532       3569999986432 23457888999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+++++|.+++..+. ..+++..++.++.|++.||.|||  ++|++||||||+||+++.++.+||+|||+++....
T Consensus        76 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          76 IVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             EEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHhhEEECCCCcEEECCcccceeccc
Confidence            9999999999999987543 36889999999999999999999  67799999999999999999999999999876533


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      .... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||........   ....    ...       
T Consensus       153 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~----~~~-------  217 (256)
T cd05059         153 DQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VESV----SAG-------  217 (256)
T ss_pred             cccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HHHH----HcC-------
Confidence            2211 1111224567999999988999999999999999999999 8999976433221   1110    000       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL  370 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L  370 (419)
                         .....+...+.++.+++.+||..+|++|||+.++++.|
T Consensus       218 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         218 ---YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ---CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence               00111223467899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.1e-41  Score=320.72  Aligned_cols=252  Identities=27%  Similarity=0.420  Sum_probs=202.2

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc---cHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ---GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .|+..++||+|+||.||+|...      .+++.||+|.+......   ....+.+|+.+++.++|+||+.+++.+.+.+.
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~   74 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVR------ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEc------CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCE
Confidence            3677889999999999999644      34688999998654322   23457789999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .++||||+.+++|.+++.......+++..+..++.|++.||.|||  +.||+||||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05630          75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH--QERIVYRDLKPENILLDDHGHIRISDLGLAVHV  152 (285)
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence            999999999999999987655556899999999999999999999  677999999999999999999999999998764


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      .....   .....|+..|+|||++.+..++.++||||||+++|+|++|..||.............   .....       
T Consensus       153 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~~-------  219 (285)
T cd05630         153 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKE-------  219 (285)
T ss_pred             CCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhhh-------
Confidence            33221   123468999999999999999999999999999999999999998643321111111   00000       


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK-----MAAVVA  368 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs-----~~eil~  368 (419)
                          ....+....+.++.+|+.+||+.||.+|||     +.++++
T Consensus       220 ----~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         220 ----VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ----hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                001122334577999999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.6e-41  Score=316.05  Aligned_cols=260  Identities=25%  Similarity=0.349  Sum_probs=207.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .+|.+.+.||+|+||.||+|...      .+++.++||.+.....   ....++.+|+.+++.++|+||+++++++..++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~------~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCL------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN   75 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeec------CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC
Confidence            46888889999999999999643      3467899998864322   23457889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          168 ERLLVYEFMPRGSLENHLFKR--ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      ..+++|||+++++|.+++...  ....+++..++.++.||+.||.|||  ++|++|+||||+||+++.++.++|+|||++
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~dfg~~  153 (267)
T cd08229          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEECcchhh
Confidence            999999999999999988642  2346789999999999999999999  778999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      ........  ......|+..|+|||++.+..++.++|+||||+++|+|++|..||....... .   .....       +
T Consensus       154 ~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~---~~~~~-------~  220 (267)
T cd08229         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-Y---SLCKK-------I  220 (267)
T ss_pred             hccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-H---HHhhh-------h
Confidence            76543322  1223468899999999988889999999999999999999999996532211 1   11110       0


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL  374 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~  374 (419)
                      .....+.   ......+.++.+++.+||..||++|||+.+|++.++++.
T Consensus       221 ~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         221 EQCDYPP---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             hcCCCCC---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            0000011   111235678999999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.1e-41  Score=313.83  Aligned_cols=250  Identities=30%  Similarity=0.425  Sum_probs=198.6

Q ss_pred             eecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEe
Q 014736           98 LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        98 ~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  175 (419)
                      .||+|+||.||+|.+..    ..+++.+|+|++.....  ...+++.+|+.+++.++|+||+++++++. .+..++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~----~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~   76 (257)
T cd05116           2 ELGSGNFGTVKKGMYKM----KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMEL   76 (257)
T ss_pred             cCCCcCCcceEEeEEec----CCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEec
Confidence            58999999999997543    23467899999865432  23567889999999999999999999875 4567899999


Q ss_pred             cCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCce
Q 014736          176 MPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH  255 (419)
Q Consensus       176 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  255 (419)
                      +.+++|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||.||+++.++.+||+|||++..........
T Consensus        77 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          77 AELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLE--ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            9999999998654  46889999999999999999999  7789999999999999999999999999998654332211


Q ss_pred             e-eecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccccccccc
Q 014736          256 V-TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL  333 (419)
Q Consensus       256 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  333 (419)
                      . .....++..|+|||.+....++.++|||||||++|||++ |..||.......   ....    .....          
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~----i~~~~----------  215 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQM----IESGE----------  215 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHCCC----------
Confidence            1 122234678999999988889999999999999999998 999997653322   1111    11111          


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          334 AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       334 ~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                      ....+...+.++.+|+.+||+.||++||++.+|.+.|+..
T Consensus       216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            1112234567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.9e-41  Score=320.76  Aligned_cols=270  Identities=27%  Similarity=0.441  Sum_probs=205.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcc----------cccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccce
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDL----------RQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRL  159 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~----------~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~  159 (419)
                      ++|++.+.||+|+||.||++...+..          ........||+|++.... ......+.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            57999999999999999998654311          112234579999997543 2334678899999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCChhhhhhhccC---------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 014736          160 IGYCCEDEERLLVYEFMPRGSLENHLFKRIS---------VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNIL  230 (419)
Q Consensus       160 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIl  230 (419)
                      ++++..++..++||||+.+++|.+++.....         ..+++..+..++.|++.||.|||  ++|++|+||||+|||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dlkp~Nil  162 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS--SLNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCeecccCChheEE
Confidence            9999999999999999999999999865421         23667889999999999999999  677999999999999


Q ss_pred             EcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCccc
Q 014736          231 LDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT--GRRSMDKLRPKSE  308 (419)
Q Consensus       231 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~~~~~~~  308 (419)
                      ++.++.++|+|||++................++..|++||+..++.++.++|||||||++|||++  |..||........
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV  242 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence            99999999999999986544332222233345678999999888899999999999999999998  7788865433221


Q ss_pred             hhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 014736          309 QNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES  372 (419)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~  372 (419)
                         +.....++.......  .     ...+..++..+.+|+.+||+.||.+||++.+|++.|++
T Consensus       243 ---~~~~~~~~~~~~~~~--~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         243 ---IENTGEFFRDQGRQV--Y-----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             ---HHHHHHHHhhccccc--c-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence               111111111110000  0     01112345789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-41  Score=314.72  Aligned_cols=251  Identities=24%  Similarity=0.318  Sum_probs=203.9

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      +|.+.+.||+|+||.||++...      .+++.||+|.+.... ....+.+.+|+.+++.++|+||+++++.+.+++..|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   74 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHV------NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLY   74 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEc------CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEE
Confidence            4788899999999999999643      446889999986432 334567788999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      ++|||+++++|.+++.......+++..++.++.||+.||.|||  ++||+|+||||+||+++.++.++|+|||++.....
T Consensus        75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH--EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            9999999999999887655556888999999999999999999  77899999999999999999999999999876543


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD  330 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (419)
                      ...  ......|+..|+|||++.+..++.++|+||||+++|+|++|..||........   ..   ...  ....     
T Consensus       153 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~---~~~--~~~~-----  217 (255)
T cd08219         153 PGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---IL---KVC--QGSY-----  217 (255)
T ss_pred             ccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---HH---HHh--cCCC-----
Confidence            221  12335689999999999888899999999999999999999999975432111   10   000  0000     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       331 ~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                          ...+...+..+.+|+.+||+.||++||++.+|+..
T Consensus       218 ----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 ----KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ----CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                11223345679999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2e-41  Score=313.23  Aligned_cols=250  Identities=26%  Similarity=0.381  Sum_probs=205.0

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      +|.+.+.||+|+||.||+|....      +++.|++|.+....  ......+.+|+++++.++||||+++++++.+.+..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKA------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKL   74 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcC------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEE
Confidence            47788899999999999996543      46789999987542  33456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+||||+++++|.+++.......+++..+..++.|++.||.|||  ++|++|+||||+||+++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH--~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~  152 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS  152 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence            99999999999999998765567889999999999999999999  6789999999999999999999999999988654


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      ....  ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||.......   .....   . . .      
T Consensus       153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~---~-~-~------  216 (256)
T cd08529         153 DNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILKI---I-R-G------  216 (256)
T ss_pred             Cccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH---H-c-C------
Confidence            4322  1223468899999999999999999999999999999999999997554211   11110   0 0 0      


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                         .........+.++.+++.+||+.+|++||++.++++
T Consensus       217 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         217 ---VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             ---CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence               011122244578999999999999999999999976

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.4e-42  Score=331.36  Aligned_cols=243  Identities=28%  Similarity=0.340  Sum_probs=191.5

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHH-HHcCCCcccccceeeEEEeCCeeEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVI-FLGQLRHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      ++||+|+||.||+|..      ..+++.||+|++....   ......+..|.. +++.++||||+++++++...+..|+|
T Consensus         1 ~~lG~G~~g~V~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv   74 (325)
T cd05604           1 KVIGKGSFGKVLLAKR------KLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFV   74 (325)
T ss_pred             CceeeCCCeEEEEEEE------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEE
Confidence            3699999999999964      3457889999996432   223345555655 46779999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      |||+.+++|..++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH--~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~  150 (325)
T cd05604          75 LDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLH--SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS  150 (325)
T ss_pred             EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC
Confidence            9999999999888654  57889999999999999999999  6789999999999999999999999999987532221


Q ss_pred             CceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|..||........   .   ......          .
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~---~~~~~~----------~  212 (325)
T cd05604         151 D--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM---Y---DNILHK----------P  212 (325)
T ss_pred             C--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH---H---HHHHcC----------C
Confidence            1  22345799999999999999999999999999999999999999976432211   1   111100          0


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      +  ......+.++.+++.+||+.||.+||++.+.++.
T Consensus       213 ~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~  247 (325)
T cd05604         213 L--VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLE  247 (325)
T ss_pred             c--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence            0  1112345678999999999999999988644433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.1e-41  Score=324.91  Aligned_cols=269  Identities=25%  Similarity=0.384  Sum_probs=210.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccc-cccccEEEEEEeccCC-cccHHHHHHHHHHHcCC-CcccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQ-GLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  166 (419)
                      ..+|.+.+.||+|+||.||+|......+. ......||+|++.... ......+.+|+++++++ +|+||+++++++..+
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            45799999999999999999976432111 1234579999887542 23356788999999999 799999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRI--------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD  232 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~  232 (419)
                      +..+++|||+.+++|.+++....              ...+++..++.++.|++.||.|||  ++||+||||||+|||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~givH~dlkp~Nill~  168 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA--SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccceEEEc
Confidence            99999999999999999987532              134778888999999999999999  77899999999999999


Q ss_pred             CCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhH
Q 014736          233 SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNL  311 (419)
Q Consensus       233 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~  311 (419)
                      .++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||...........
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  248 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  248 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            999999999999986543322211222335578999999999999999999999999999998 8888875432211111


Q ss_pred             HHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          312 VDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                             .....          ....+...+.++.+|+.+||+.+|.+||++.++++.|.++....
T Consensus       249 -------~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         249 -------LKEGH----------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             -------HHcCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence                   11110          01112234568999999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.3e-42  Score=336.17  Aligned_cols=253  Identities=24%  Similarity=0.317  Sum_probs=198.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++.+.||+|+||.||+|...      .+++.||+|++....   ......+.+|+.++..++|+||+++++.+.+.+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   74 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKK------DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR   74 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEEC------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            36888999999999999999643      346889999996432   233456788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||++||+|.+++.+.  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH--~~givHrDLkp~NIli~~~~~vkL~DfG~~~~  150 (360)
T cd05627          75 NLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIH--QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTG  150 (360)
T ss_pred             EEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence            999999999999999998765  56889999999999999999999  67899999999999999999999999999875


Q ss_pred             CCCCCCc---------------------------------eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHH
Q 014736          248 GPEGSNT---------------------------------HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELL  294 (419)
Q Consensus       248 ~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  294 (419)
                      .......                                 ......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~  230 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence            4321100                                 0012346999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 014736          295 TGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK---MAAVVA  368 (419)
Q Consensus       295 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs---~~eil~  368 (419)
                      +|..||...........+      ......+  .+.+      ....+.++.+|+.+|+ .||.+|++   +.++++
T Consensus       231 tG~~Pf~~~~~~~~~~~i------~~~~~~~--~~p~------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         231 IGYPPFCSETPQETYRKV------MNWKETL--VFPP------EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             cCCCCCCCCCHHHHHHHH------HcCCCce--ecCC------CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            999999765432211111      0000000  0000      1124578999999987 49999985   555554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.1e-41  Score=322.36  Aligned_cols=266  Identities=27%  Similarity=0.360  Sum_probs=202.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|.+.+.||+|+||.||+|...      .++..+|+|.+..... .....+.+|++++.+++||||+++++++.+++..
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   74 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHR------PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEI   74 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEc------CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEE
Confidence            36899999999999999999643      3467899999875422 2345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||.|||+ ..+++|+||||+|||++.++.+||+|||++....
T Consensus        75 ~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (308)
T cd06615          75 SICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  151 (308)
T ss_pred             EEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-hCCEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence            9999999999999998765  568889999999999999999994 2479999999999999999999999999987543


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccc------
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSR------  323 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~------  323 (419)
                      ...    .....|+..|+|||++.+..++.++|+||||+++|+|++|..||.......................      
T Consensus       152 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (308)
T cd06615         152 DSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS  227 (308)
T ss_pred             ccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccccc
Confidence            321    2335689999999999888899999999999999999999999975432211111100000000000      


Q ss_pred             --------------ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          324 --------------RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       324 --------------~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                                    ..................+.++.+|+.+||..||++||++.+|++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                          0000000000000011245679999999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.3e-41  Score=320.26  Aligned_cols=265  Identities=26%  Similarity=0.320  Sum_probs=195.7

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCC---CcccccceeeEEEe-
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQL---RHPHLVRLIGYCCE-  165 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~-  165 (419)
                      +|++.+.||+|+||.||+|...      .+++.||+|.+.....  .....+.+|+.+++.+   +||||+++++++.. 
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~   74 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDP------HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS   74 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEEC------CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence            5888999999999999999643      4578899999875422  1223455677766655   79999999998864 


Q ss_pred             ----CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          166 ----DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       166 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                          ....++||||+. ++|.+++.......+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|
T Consensus        75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~~~~kl~d  151 (288)
T cd07863          75 RTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSGGQVKLAD  151 (288)
T ss_pred             cCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEECc
Confidence                245799999996 58988887655556899999999999999999999  67799999999999999999999999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhc
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS  321 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  321 (419)
                      ||++........   .....||..|+|||++.+..++.++|||||||++|+|++|.+||...........+.........
T Consensus       152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  228 (288)
T cd07863         152 FGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  228 (288)
T ss_pred             cCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence            999986543221   22346899999999998889999999999999999999999999765432211111000000000


Q ss_pred             ---cccc---ccccccc---cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          322 ---SRRL---RYIVDPR---LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       322 ---~~~~---~~~~~~~---l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                         ....   .....+.   .........+.++.+|+.+||+.||++|||+.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               0000   0000000   001112235678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.8e-41  Score=329.74  Aligned_cols=266  Identities=21%  Similarity=0.291  Sum_probs=197.9

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC--CcccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      .+.++|.+.+.||+|+||.||+|..      ..+++.||+|++...  .......+.+|+.+++.++||||+++++++..
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   91 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFD------TVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTP   91 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEE------cCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence            3457899999999999999999954      345788999999643  22335677899999999999999999999865


Q ss_pred             CC------eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEE
Q 014736          166 DE------ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKL  239 (419)
Q Consensus       166 ~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  239 (419)
                      .+      ..|+||||+. ++|.+.+.    ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||
T Consensus        92 ~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH--~~~ivHrDlkp~NIl~~~~~~~kl  164 (359)
T cd07876          92 QKSLEEFQDVYLVMELMD-ANLCQVIH----MELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKI  164 (359)
T ss_pred             CCCccccceeEEEEeCCC-cCHHHHHh----ccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEE
Confidence            43      5799999995 46666553    24788889999999999999999  678999999999999999999999


Q ss_pred             eccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHH-------
Q 014736          240 SDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV-------  312 (419)
Q Consensus       240 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~-------  312 (419)
                      +|||++.......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||............       
T Consensus       165 ~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  241 (359)
T cd07876         165 LDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP  241 (359)
T ss_pred             ecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999997543221   123356899999999999999999999999999999999999999865432111000       


Q ss_pred             ---------HhhhHHhhcccccc-----ccccccc---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          313 ---------DWAKPYLRSSRRLR-----YIVDPRL---AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       313 ---------~~~~~~~~~~~~~~-----~~~~~~l---~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                               .....+........     .......   ........+.++.+|+.+||+.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             cHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                     00000000000000     0000000   000111235678999999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.6e-42  Score=334.34  Aligned_cols=258  Identities=22%  Similarity=0.239  Sum_probs=200.7

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeE
Q 014736           86 LRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGY  162 (419)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~  162 (419)
                      .+...++|++.+.||+|+||.||+|...      .+++.||+|++....   ......+.+|+.+++.++||||++++++
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~  111 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHK------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA  111 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEEC------CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            3444578999999999999999999643      457889999986422   2234557789999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEecc
Q 014736          163 CCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       163 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                      +.+++..|+||||+++|+|.+++...   .+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+||
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         112 FQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             EEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999999988653   5788889999999999999999  678999999999999999999999999


Q ss_pred             CccccCCCCCCceeeecccccccccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG----HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       243 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      |++........ ......+||+.|+|||++.+.    .++.++|||||||++|+|++|..||.........      ...
T Consensus       187 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i  259 (371)
T cd05622         187 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKI  259 (371)
T ss_pred             CceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH------HHH
Confidence            99986543221 112345799999999998653    3889999999999999999999999864322111      111


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKD--RPKMAAVVAT  369 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~--RPs~~eil~~  369 (419)
                      ......+        ........+.++.+++.+||..++.+  |+++.+|++.
T Consensus       260 ~~~~~~~--------~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         260 MNHKNSL--------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             HcCCCcc--------cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            1110000        00111235678999999999854443  7899988874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.4e-41  Score=322.89  Aligned_cols=262  Identities=27%  Similarity=0.416  Sum_probs=204.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCC-CcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~  168 (419)
                      ++|.+.+.||+|+||.||+|.+..+    .....+++|.+.... ......+.+|++++.++ +|+||+++++++..++.
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~----~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~   82 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKD----GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   82 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccC----CceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence            4788899999999999999976432    112356777765322 23345788899999999 89999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 014736          169 RLLVYEFMPRGSLENHLFKRI--------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD  234 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~  234 (419)
                      .|+||||+++++|.+++....              ...+++..++.++.||+.||+|||  ++|++||||||+|||++.+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGEN  160 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEEecCC
Confidence            999999999999999986542              135788899999999999999999  7789999999999999999


Q ss_pred             CcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHH
Q 014736          235 FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVD  313 (419)
Q Consensus       235 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~  313 (419)
                      +.+||+|||++.......   ......++..|+|||++.+..++.++|||||||++|+|++ |..||.......   ...
T Consensus       161 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~  234 (303)
T cd05088         161 YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE  234 (303)
T ss_pred             CcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HHH
Confidence            999999999986422111   1111234667999999988889999999999999999998 999997543221   111


Q ss_pred             hhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCcc
Q 014736          314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKD  378 (419)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~  378 (419)
                      ..    ...          .....+...+.++.+|+.+||+.+|++||++.+++..|..++....
T Consensus       235 ~~----~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         235 KL----PQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             HH----hcC----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            00    000          0011122345679999999999999999999999999998877544

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.6e-41  Score=316.15  Aligned_cols=265  Identities=24%  Similarity=0.380  Sum_probs=209.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC-CcccHHHHHHHHHHHcCCCcccccceeeEEEe-CC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE-DE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~  167 (419)
                      .++|.+.+.||+|+||.||+|.+.+.  ....+..|++|++... .......+.+|+.+++.++|+||+++++++.. ..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~--~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDE--KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecC--CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            46788999999999999999986542  1223578999988643 23345678899999999999999999998766 46


Q ss_pred             eeEEEEEecCCCChhhhhhhccC------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          168 ERLLVYEFMPRGSLENHLFKRIS------VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                      ..++++||+.+++|.+++.....      ..+++..++.++.|++.||.|||  +++++|+||||+||+++.++.+||+|
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH--KRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCHhhEEEcCCCcEEECC
Confidence            78999999999999999865422      45889999999999999999999  77899999999999999999999999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhh
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLR  320 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  320 (419)
                      ||+++.+.............++..|+|||++.+..++.++||||||+++|++++ |+.||....+..   ...+.    .
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~  233 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYL----K  233 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHH----H
Confidence            999986544332222223446778999999988889999999999999999999 999997643321   11111    1


Q ss_pred             cccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       321 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      .....          .....++.++.+++.+||..||++|||+.++++.|..+..
T Consensus       234 ~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         234 DGYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             cCCCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            11000          1112245789999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.2e-41  Score=330.43  Aligned_cols=266  Identities=21%  Similarity=0.290  Sum_probs=198.9

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      .+.++|.+.+.||+|+||.||+|+.      ...++.||+|++....  ......+.+|+.+++.++||||+++++++..
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   87 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYD------AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP   87 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEe------cCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeec
Confidence            3457899999999999999999953      3456889999987542  2334667889999999999999999998864


Q ss_pred             C------CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEE
Q 014736          166 D------EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKL  239 (419)
Q Consensus       166 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  239 (419)
                      .      ...|+||||+. ++|.+.+..    .+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH--~~givHrDikp~Nill~~~~~~kl  160 (355)
T cd07874          88 QKSLEEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_pred             cccccccceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEECCCCCEEE
Confidence            4      35799999995 567766643    4788889999999999999999  778999999999999999999999


Q ss_pred             eccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHH-H-----
Q 014736          240 SDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV-D-----  313 (419)
Q Consensus       240 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~-~-----  313 (419)
                      +|||+++......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||............ .     
T Consensus       161 ~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (355)
T cd07874         161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  237 (355)
T ss_pred             eeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999998643321   123356899999999999999999999999999999999999999765422211100 0     


Q ss_pred             ----------hhhHHhhccccccccccccc--------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          314 ----------WAKPYLRSSRRLRYIVDPRL--------AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       314 ----------~~~~~~~~~~~~~~~~~~~l--------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                                ....+............+..        ........+.++.+|+.+||+.||++|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                      00001111000000000000        001122235678999999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.8e-41  Score=315.31  Aligned_cols=251  Identities=26%  Similarity=0.405  Sum_probs=198.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|.+.++||+|+||.||+|..      ..+++.||+|++.... ......+.+|++++++++||||+++++++...+..
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   74 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYH------LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRI   74 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEE------cCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEE
Confidence            3678889999999999999964      3456889999986542 23346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+++++|..+      ..+++..+..++.|++.||.|||  ++||+|+||||+|||++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~  146 (279)
T cd06619          75 SICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLW--SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV  146 (279)
T ss_pred             EEEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence            999999999998654      24678888999999999999999  7789999999999999999999999999997643


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhH-HHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNL-VDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  328 (419)
                      ...    .....|+..|+|||++.+..++.++|+||||+++|+|++|+.||........... ........ ...     
T Consensus       147 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~-----  216 (279)
T cd06619         147 NSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DED-----  216 (279)
T ss_pred             ccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccC-----
Confidence            322    2335689999999999999999999999999999999999999976433221110 11100000 000     


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                       .+.+   .....+.++.+++.+||+.||++||+++++++.
T Consensus       217 -~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         217 -PPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             -CCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             0011   112235679999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.5e-41  Score=313.31  Aligned_cols=261  Identities=26%  Similarity=0.439  Sum_probs=206.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|+..+.||+|+||.||+|....+   ......+++|.+.... ......+.+|+++++.++|+||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~---~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMP---GRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecC---CCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence            4688889999999999999976532   1223579999987542 33456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+||||+.+++|.+++... ...+++..+..++.|++.||.|||  +.|++|+||||+||+++.++.+||+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          82 MIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLS--DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999999999999998654 246889999999999999999999  6789999999999999999999999999998654


Q ss_pred             CCCCceee-ecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          250 EGSNTHVT-TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       250 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ........ .....+..|+|||++....++.++|||||||++|+|++ |..||.......   .....    ....    
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~i----~~~~----  227 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKAI----NDGF----  227 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHH----hcCC----
Confidence            33222111 11223457999999988889999999999999999997 999997543221   11111    0110    


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL  374 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~  374 (419)
                            ........+.++.+++.+||+.+|++||++.+|++.|++++
T Consensus       228 ------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         228 ------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence                  11112234578999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-42  Score=352.50  Aligned_cols=267  Identities=29%  Similarity=0.433  Sum_probs=219.5

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC-CcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++....+.||+|.||.||.|...+.... .....||+|.+... ..+...+|++|..+|+.++|||||+++|++.+....
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~-~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGS-VSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCC-ccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3456677899999999999987663221 11456999998754 445678899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhcc-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCc
Q 014736          170 LLVYEFMPRGSLENHLFKRI-----SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL  244 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  244 (419)
                      +|++|||+||+|..+|++..     ...++....+.++.+||+|+.||+  .+++|||||...|+||+....|||+|||+
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe--~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE--SKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH--hCCCcCcchhhhheeecccCcEEEcccch
Confidence            99999999999999997652     345778899999999999999999  66699999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccc
Q 014736          245 AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSR  323 (419)
Q Consensus       245 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  323 (419)
                      |+...............-...|||||.+..+.++.++|||||||++||+++ |..||......+....       +..++
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~-------~~~gg  921 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD-------VLEGG  921 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH-------HHhCC
Confidence            996555554444433344578999999999999999999999999999999 8999987654432211       11222


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          324 RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       324 ~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                      ++          ..+..++..+.+|+..||+.+|++||++..|++.+.++.+..
T Consensus       922 RL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  922 RL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             cc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence            32          235567888999999999999999999999999999887743

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.9e-41  Score=312.61  Aligned_cols=249  Identities=29%  Similarity=0.424  Sum_probs=201.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEE-eCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCC-EDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~  169 (419)
                      ++|.+.+.||+|+||.||+|...        +..|++|.+...  ...+.+.+|+.++++++|+||+++++++. .++..
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--------~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   75 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--------CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence            47888999999999999998543        467999998643  23467889999999999999999999764 45678


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |++|||+++++|.+++.......+++..++.++.|++.||.|||  .+|++||||||+||+++.++.+||+|||++....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  153 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  153 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeccccchheEEEcCCCcEEecCCccceecc
Confidence            99999999999999997765556889999999999999999999  6789999999999999999999999999987543


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ...     ....++..|+|||++.+..++.++|||||||++|+|++ |+.||.......   .....    ...      
T Consensus       154 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~----~~~------  215 (256)
T cd05082         154 STQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----EKG------  215 (256)
T ss_pred             ccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----hcC------
Confidence            321     12235678999999988899999999999999999997 999987543211   11111    000      


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                          ........++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       216 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         216 ----YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                01112233467899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-41  Score=312.32  Aligned_cols=255  Identities=30%  Similarity=0.468  Sum_probs=206.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .++|.+.++||+|+||.||+|...+       ++.||+|.+.... .....+.+|+.+++.++|+||+++++++......
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~-------~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNG-------TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI   76 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcC-------CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence            4689999999999999999997543       3569999987543 3456788999999999999999999999988999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+++++|.+++.......+++..+..++.|++.||.|||  ++|++|+||||+||+++.++.++|+|||++....
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh--~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE--SRNYIHRDLAARNILVGENLVCKIADFGLARLIE  154 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcchheEEEcCCCCEEECccccceecc
Confidence            99999999999999998765567899999999999999999999  7789999999999999999999999999988654


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ..... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.......   ......    ..  .   
T Consensus       155 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~----~~--~---  221 (261)
T cd05034         155 DDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQVE----RG--Y---  221 (261)
T ss_pred             chhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cC--C---
Confidence            32111 1112235568999999988899999999999999999998 999996543211   111110    00  0   


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES  372 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~  372 (419)
                           ....+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus       222 -----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 -----RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                 011122235789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=5.7e-41  Score=311.40  Aligned_cols=253  Identities=28%  Similarity=0.426  Sum_probs=202.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|.+...||+|+||.||+|...+       +..+|+|.+.... ...+.+.+|+.+++.++|+||+++++++. .+..+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~-------~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNG-------TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY   76 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcC-------CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence            568888999999999999996543       2358999886443 23467889999999999999999999875 45689


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      ++|||+.+++|.+++.......+++..+..++.|++.||.|||  ++|++|+||||+||++++++.++|+|||++.....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE--RMNYIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            9999999999999997765556889999999999999999999  77899999999999999999999999999976543


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      .... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.......   ......    ..       
T Consensus       155 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~-------  219 (260)
T cd05069         155 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVE----RG-------  219 (260)
T ss_pred             Cccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cC-------
Confidence            3221 1122346778999999988899999999999999999999 899997643221   111110    00       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES  372 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~  372 (419)
                         .....+...+..+.+++.+||..||.+||++++|++.|+.
T Consensus       220 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         220 ---YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ---CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               0011223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.8e-41  Score=317.98  Aligned_cols=251  Identities=27%  Similarity=0.396  Sum_probs=200.8

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      |+..++||+|+||+||+|.+.      .+++.||+|.+.....   .....+.+|+++|+.++|+||+.+++.+..++..
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~   75 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVR------ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDAL   75 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEC------CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEE
Confidence            667788999999999999644      3467899999865432   2234577899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+.+++|.+++.......+++..+..++.|++.||.|||  ++||+||||||+||+++.++.++|+|||++....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH--~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH--RENTVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            99999999999999887655557999999999999999999999  6789999999999999999999999999987643


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      ....   .....|+..|+|||++.+..++.++|+||||+++|+|++|..||...........+.  .. ....       
T Consensus       154 ~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~~-~~~~-------  220 (285)
T cd05632         154 EGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--RR-VLET-------  220 (285)
T ss_pred             CCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hh-hhcc-------
Confidence            3221   223468999999999988999999999999999999999999998653322111111  00 0000       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK-----MAAVVA  368 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs-----~~eil~  368 (419)
                          ...+....+.++.+|+.+||+.||++||+     +.+++.
T Consensus       221 ----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         221 ----EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ----ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                01122334567899999999999999999     666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.9e-41  Score=316.00  Aligned_cols=256  Identities=29%  Similarity=0.450  Sum_probs=202.0

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEe
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  175 (419)
                      +.||+|+||.||+|...+.......++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36999999999999876543223445689999886432 23456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhcc-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-----cEEEeccCcc
Q 014736          176 MPRGSLENHLFKRI-----SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-----TAKLSDFGLA  245 (419)
Q Consensus       176 ~~~g~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DfGla  245 (419)
                      +++++|.+++....     ...+++..++.++.|++.||.|||  +++++|+||||+||+++.++     .++|+|||++
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH--hCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            99999999986532     234788899999999999999999  67799999999999999887     8999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      ................++..|+|||++.++.++.++||||||+++|+|++ |..||.......   ....    ..... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~----~~~~~-  230 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQH----VTAGG-  230 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHH----HhcCC-
Confidence            76543332222223346788999999999999999999999999999998 999997543211   1111    11110 


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                               ....+...+..+.+++.+||..+|++||++.+|++.|.
T Consensus       231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                     01122345678999999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.4e-41  Score=319.09  Aligned_cols=251  Identities=23%  Similarity=0.362  Sum_probs=204.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ..+|++.+.||+|+||.||+|...      ..++.|++|.+..........+.+|+.+++.++|+||+++++.+......
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~   92 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDV------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEEC------CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence            357999999999999999999643      34678999999876656667788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+||||+++++|.+++.+.   .+++..+..++.|++.||.|||  +.||+|+||||+|||++.++.++|+|||++....
T Consensus        93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH--~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             EEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            9999999999999988543   5788899999999999999999  6779999999999999999999999999987643


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      ....  ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+...  .....    ...  .    
T Consensus       168 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~----~~~--~----  233 (296)
T cd06654         168 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIA----TNG--T----  233 (296)
T ss_pred             cccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHh----cCC--C----
Confidence            3221  12234688999999999888899999999999999999999999975432111  11000    000  0    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       +  ....+...+..+.+++.+||..||++||++.+|++
T Consensus       234 -~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         234 -P--ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             -C--CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence             0  00112345577999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.6e-41  Score=312.68  Aligned_cols=260  Identities=27%  Similarity=0.455  Sum_probs=206.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .+|++.+.||+|+||.||+|.+...   ......+|+|.+..... .....+.+|+.++++++||||+++++++..++..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~---~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLP---GKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecC---CCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            5788899999999999999975432   12345799999875432 2346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+||||+++++|.+++.... ..+++..+..++.|++.||.|||  ++|++|+||||+|||++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH--~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            99999999999999987542 45788999999999999999999  6789999999999999999999999999998754


Q ss_pred             CCCCceee-ecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          250 EGSNTHVT-TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       250 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ........ ....++..|+|||.+.+..++.++|+||||+++|++++ |..||.......   ......    ....   
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~----~~~~---  227 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIE----EGYR---  227 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHh----CCCc---
Confidence            43221111 12234568999999988899999999999999999886 999997654322   111111    1000   


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                             .......+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       228 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 -------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                   011223457899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4e-41  Score=313.91  Aligned_cols=260  Identities=26%  Similarity=0.466  Sum_probs=205.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC-CcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ..|++.+.||+|+||.||+|.+..+   ......||+|++... .......|..|+.+++.++||||+++++++.+++..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLP---GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecC---CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            3578889999999999999976543   122457999998754 233456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+.+++|.+++... ...+++..++.++.|++.||.|||  ++|++|+||||+||+++.++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH--~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          81 MIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999999988654 346889999999999999999999  6789999999999999999999999999987654


Q ss_pred             CCCCceeeec-c--cccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          250 EGSNTHVTTR-V--MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       250 ~~~~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      .......... .  ..+..|+|||.+.+..++.++|||||||++|||++ |..||.......   ...+..    .... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~----~~~~-  229 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIE----QDYR-  229 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHH----cCCc-
Confidence            3322111111 1  12457999999998999999999999999999886 999997644221   111111    0000 


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                               -..+..++..+.+++.+||+.+|.+||++.+|+..|+++
T Consensus       230 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         230 ---------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ---------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                     011223456789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.9e-41  Score=322.86  Aligned_cols=266  Identities=23%  Similarity=0.310  Sum_probs=200.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|.+.+.||+|+||.||+|+..      .+++.||+|.+..... .....+.+|+.+++.++||||+++++++..++..
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSK------LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSL   79 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEec------CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence            57899999999999999999643      3467899999875432 2234677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+. ++|.+++... ...+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++....
T Consensus        80 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          80 TLVFEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (309)
T ss_pred             EEEEeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence            99999996 5888887654 235788899999999999999999  6789999999999999999999999999987543


Q ss_pred             CCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh--------HHhh
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK--------PYLR  320 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--------~~~~  320 (419)
                      ....  ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+....        +...
T Consensus       156 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07872         156 VPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS  233 (309)
T ss_pred             CCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence            3221  1223458899999998865 568999999999999999999999998654433222111100        0000


Q ss_pred             cccccccccccccC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          321 SSRRLRYIVDPRLA----GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       321 ~~~~~~~~~~~~l~----~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ..........+...    .......+.++.+|+.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00000000000000    0011234678899999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.6e-41  Score=317.53  Aligned_cols=263  Identities=27%  Similarity=0.420  Sum_probs=205.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|++.+.||+|+||.||+|..... .....+..||+|++..... .....+.+|+.+++.++||||+++++++.++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGL-LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEccc-CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            35789999999999999999975431 1233567899999875432 234668899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhcc--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCc
Q 014736          169 RLLVYEFMPRGSLENHLFKRI--------------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSN  228 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~--------------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~N  228 (419)
                      .++||||+.+++|.+++....                    ...+++..++.++.|++.||.|||  .++++||||||.|
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH--~~~i~H~dl~p~n  160 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS--ERKFVHRDLATRN  160 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCeecccccHhh
Confidence            999999999999999986432                    124678888999999999999999  7789999999999


Q ss_pred             EEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcc
Q 014736          229 ILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKS  307 (419)
Q Consensus       229 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~  307 (419)
                      ||++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999875433222111222335677999999988899999999999999999997 888886543221


Q ss_pred             chhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 014736          308 EQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES  372 (419)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~  372 (419)
                         ....    ..... .        . ..+...+.++.+|+.+||+.||++|||+.||++.|++
T Consensus       241 ---~~~~----~~~~~-~--------~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 ---VIYY----VRDGN-V--------L-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ---HHHH----HhcCC-C--------C-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence               1111    11111 0        0 1122345789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=7.9e-41  Score=311.17  Aligned_cols=260  Identities=23%  Similarity=0.348  Sum_probs=207.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++.+.||+|+||.||+|...      .+++.||+|.++...   ......+.+|++++++++|+||+++++++.+.+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~   75 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICL------LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN   75 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEc------CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            57899999999999999999654      346789999886432   233567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          168 ERLLVYEFMPRGSLENHLFKR--ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      ..++||||+++++|.+++...  ....+++..++.++.|++.||.|||  +.||+|+||+|+||+++.++.++|+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~nil~~~~~~~~l~d~~~~  153 (267)
T cd08224          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH--hCCEecCCcChhhEEECCCCcEEEecccee
Confidence            999999999999999988643  2345788999999999999999999  678999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      .........  .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ......   ... .    
T Consensus       154 ~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~---~~~-~----  222 (267)
T cd08224         154 RFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK---KIE-K----  222 (267)
T ss_pred             eeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHh---hhh-c----
Confidence            765432211  22345889999999998888999999999999999999999998643311 111111   000 0    


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL  374 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~  374 (419)
                           ...........+.++.+++.+||..+|++||++.+|+++|+.+.
T Consensus       223 -----~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         223 -----CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -----CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                 00011111245678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-41  Score=309.84  Aligned_cols=253  Identities=33%  Similarity=0.513  Sum_probs=205.2

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc-HHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEe
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-HREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  175 (419)
                      +.||+|+||.||+|......   ..+..|++|++....... ...+.+|++++..++|+||+++++++......++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD---GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCC---CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence            36999999999999765421   336789999997654333 67888999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhcc-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          176 MPRGSLENHLFKRI-------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       176 ~~~g~L~~~l~~~~-------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      +++++|.+++....       ...+++..+..++.|++.||.|||  ++|++|+||||+||+++.++.+||+|||.+...
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH--cCCcccCccCcceEEECCCCcEEEccccccccc
Confidence            99999999987642       356899999999999999999999  678999999999999999999999999999876


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      .............++..|+|||.+....++.++||||||+++|+|++ |..||.......   ......    ...    
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~----~~~----  224 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYLR----KGY----  224 (262)
T ss_pred             ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH----cCC----
Confidence            55432222334557889999999988899999999999999999999 699998763221   111110    100    


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                            ....+...+.++.+++.+||..+|++|||+.++++.|+
T Consensus       225 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 ------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  11122334678999999999999999999999998773

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.3e-41  Score=314.66  Aligned_cols=261  Identities=26%  Similarity=0.368  Sum_probs=207.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-cHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|.+.+.||+|+||.||+|+.+.. ......+.|++|.+...... ....+.+|++++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGI-EEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccC-CcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            5788999999999999999987653 22345578999998754333 346788999999999999999999999998999


Q ss_pred             EEEEEecCCCChhhhhhhccC-------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEecc
Q 014736          170 LLVYEFMPRGSLENHLFKRIS-------VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                      ++||||+++++|.+++.....       ..+++..+..++.|++.||.|||  +++|+|+||||+||+++.++.++|+||
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS--NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh--hcCcccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999876531       15889999999999999999999  677999999999999999999999999


Q ss_pred             CccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhc
Q 014736          243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRS  321 (419)
Q Consensus       243 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  321 (419)
                      |++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   .....     .
T Consensus       162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~-----~  232 (275)
T cd05046         162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRL-----Q  232 (275)
T ss_pred             ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHH-----H
Confidence            998754322211 1222346778999999988889999999999999999998 888986543221   11111     0


Q ss_pred             ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          322 SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       322 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                      ...        +........+..+.+++.+||+.+|.+||++.++++.|.
T Consensus       233 ~~~--------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         233 AGK--------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             cCC--------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            000        011112234578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.4e-41  Score=334.17  Aligned_cols=263  Identities=22%  Similarity=0.232  Sum_probs=196.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ...|.+.+.||+|+||.||+|...      ..++.||||....      ..+.+|+.+|++++|+|||++++++..++..
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~------~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~  235 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHP------DYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLT  235 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEEC------CCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence            347999999999999999999644      3467899996432      3456799999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++|||++ .++|.+++.... ..+++..++.++.||+.||.|||  .+||+||||||+||||+.++.+||+|||+++...
T Consensus       236 ~lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH--~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~  311 (461)
T PHA03211        236 CLVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIH--GEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR  311 (461)
T ss_pred             EEEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence            9999999 578988886542 36899999999999999999999  6789999999999999999999999999998654


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccc-----hhHHHhhhHHhhcccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSE-----QNLVDWAKPYLRSSRR  324 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~  324 (419)
                      ............||..|+|||++.+..++.++|||||||++|||++|..++........     ................
T Consensus       312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~  391 (461)
T PHA03211        312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE  391 (461)
T ss_pred             cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence            43322223345799999999999999999999999999999999998766533221110     0111111000000000


Q ss_pred             cccc----------------cccc----cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          325 LRYI----------------VDPR----LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       325 ~~~~----------------~~~~----l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      +...                ..+.    .+..+ ...+.++.+||.+||+.||.+|||+.|+++.
T Consensus       392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRY-YKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CCCCcchHHHHHHHhhhhcccCCccCCcchhhh-ccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0000                0000    00000 1234578999999999999999999999873

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.6e-41  Score=314.38  Aligned_cols=252  Identities=34%  Similarity=0.496  Sum_probs=200.0

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHH--HHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR--EWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      |++.+.||+|+||+||+|...      .+++.||+|++.........  ...+|+.++++++||||+++++++.+....+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNK------KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLY   74 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEET------TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEEC------CCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccc
Confidence            567889999999999999644      45678999999876543322  3456999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+.+++|.+++...  ..+++..++.++.|++.||.+||  ++||+|+||||+||+++.++.++|+|||.+.....
T Consensus        75 ~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh--~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~  150 (260)
T PF00069_consen   75 IVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLH--SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE  150 (260)
T ss_dssp             EEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHH--HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS
T ss_pred             cccccccccccccccccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence            999999999999999843  57899999999999999999999  56799999999999999999999999999975411


Q ss_pred             CCCceeeeccccccccccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH-Hhhcccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYIS-TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP-YLRSSRRLRYI  328 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  328 (419)
                        .........++..|+|||++. +..++.++||||||+++|+|++|..||................. .....      
T Consensus       151 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~------  222 (260)
T PF00069_consen  151 --NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS------  222 (260)
T ss_dssp             --TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH------
T ss_pred             --cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc------
Confidence              112334566899999999998 78899999999999999999999999987622121111111100 00000      


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                         .   ........++.+++.+||+.||++||++.++++
T Consensus       223 ---~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  223 ---S---QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             ---T---TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ---c---cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0   000011378999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.3e-41  Score=310.79  Aligned_cols=253  Identities=31%  Similarity=0.461  Sum_probs=202.8

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEe
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  175 (419)
                      ++||+|+||.||+|.+...   ......||+|.+..... ...+.+.+|+.++++++|+||+++++++.. ...++||||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTS---GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecC---CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence            3689999999999987542   22334699999987655 456788999999999999999999999988 889999999


Q ss_pred             cCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCce
Q 014736          176 MPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH  255 (419)
Q Consensus       176 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  255 (419)
                      +++++|.+++.+.....+++..+..++.|++.||.|||  ++|++|+||||+||+++.++.+||+|||++..........
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE--SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH--hCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            99999999997764356889999999999999999999  7789999999999999999999999999998764432211


Q ss_pred             -eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccccccccc
Q 014736          256 -VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL  333 (419)
Q Consensus       256 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  333 (419)
                       ......++..|+|||++.+..++.++||||||+++|+|++ |..||...........+   .   .....         
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~---~---~~~~~---------  219 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI---D---KEGER---------  219 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H---hcCCc---------
Confidence             1123457789999999988899999999999999999998 99999754332211111   0   00000         


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          334 AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       334 ~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                       ...+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       220 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         220 -LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence             0112234578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.2e-41  Score=316.46  Aligned_cols=269  Identities=28%  Similarity=0.373  Sum_probs=206.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeC--C
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCED--E  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~  167 (419)
                      +.|.+.+.||+|+||.||+|....  .....++.||+|.+.... ......+.+|+.+++.++||||+++++++...  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDP--EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEcc--CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            347888999999999999997543  234557889999987543 23346788999999999999999999998775  5


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..++||||++|++|.+++.+.. ..+++..+..++.|++.||.|||  ++|++||||||+||+++.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH--~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccchheEEEcCCCCEEECCCccccc
Confidence            6899999999999999986542 35789999999999999999999  78899999999999999999999999999986


Q ss_pred             CCCCCCc-eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCc--------cchhHHHhhhHH
Q 014736          248 GPEGSNT-HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPK--------SEQNLVDWAKPY  318 (419)
Q Consensus       248 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~~~~~~~~  318 (419)
                      ....... .......++..|+|||++.+..++.++||||||+++|+|++++.|+......        ............
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            5443221 1122345777899999998888999999999999999999987664321100        000000000011


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL  374 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~  374 (419)
                      .....          .......++.++.+|+.+||+.||++||++.++++.|+.++
T Consensus       239 ~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         239 LEEGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             HHcCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence            11110          01112235678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.7e-41  Score=329.12  Aligned_cols=264  Identities=21%  Similarity=0.274  Sum_probs=197.7

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      +.++|.+.+.||+|+||.||+|+.      ...++.||||++....  ......+.+|+.+++.++||||+++++++...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~   95 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYD------AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ   95 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEE------CCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccc
Confidence            457899999999999999999964      3446789999997532  23346788999999999999999999987543


Q ss_pred             ------CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 014736          167 ------EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS  240 (419)
Q Consensus       167 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  240 (419)
                            ...|+||||+. ++|.+++..    .+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+
T Consensus        96 ~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~  168 (364)
T cd07875          96 KSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKIL  168 (364)
T ss_pred             ccccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEECCCCcEEEE
Confidence                  35799999995 577777643    4778889999999999999999  6789999999999999999999999


Q ss_pred             ccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHh------
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW------  314 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~------  314 (419)
                      |||+++......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||...........+..      
T Consensus       169 DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (364)
T cd07875         169 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC  245 (364)
T ss_pred             eCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999998643321   12335689999999999999999999999999999999999999976543221111100      


Q ss_pred             ----------hhHHhhccccccc-----cccccc---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          315 ----------AKPYLRSSRRLRY-----IVDPRL---AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       315 ----------~~~~~~~~~~~~~-----~~~~~l---~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                                ...+.........     .....+   ..........++.+||.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                      0000000000000     000000   00111123467899999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-41  Score=313.89  Aligned_cols=262  Identities=26%  Similarity=0.404  Sum_probs=207.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .+|.+.+.||+|+||.||+|.+..+.  ......+|+|.+..... .....+.+|+.++..++|+||+++++++.. ...
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~--~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEG--EKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCC--CCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            46888899999999999999865431  22234699998875543 334678899999999999999999999887 788


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||  ++|++|+||||+||+++.++.+||+|||++....
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH--~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999999987642 35889999999999999999999  6789999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ............++..|+|||.+....++.++|+||||+++|||++ |..||...........+       .....    
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~~----  229 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL-------EKGER----  229 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-------hCCCC----
Confidence            4332221222234678999999988899999999999999999998 99999765432211111       11100    


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                            ...+..++.++.+++.+||..||.+||++.++++.|..+..
T Consensus       230 ------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 ------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                  01122234678999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.1e-41  Score=315.04  Aligned_cols=253  Identities=26%  Similarity=0.365  Sum_probs=199.9

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-CcccccceeeEEEeC-
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHLVRLIGYCCED-  166 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~-  166 (419)
                      ....|++.+.||+|+||.||+|...      ..++.||+|++.... .....+.+|+.++..+ +|+||+++++++... 
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~------~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHV------KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   76 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEc------CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence            3467888889999999999999654      346789999997543 3446778899999998 699999999998753 


Q ss_pred             -----CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          167 -----EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       167 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                           ...|+||||+.+++|.+++.......+++..+..++.|++.||.|||  +++|+|+||||+||+++.++.++|+|
T Consensus        77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH--~~~ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHEEECCCCCEEEcc
Confidence                 46899999999999999987755567889999999999999999999  67799999999999999999999999


Q ss_pred             cCccccCCCCCCceeeeccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS-----TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK  316 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  316 (419)
                      ||++........  ......|+..|+|||++.     +..++.++|||||||++|+|++|..||............    
T Consensus       155 fg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~----  228 (272)
T cd06637         155 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----  228 (272)
T ss_pred             CCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH----
Confidence            999886433221  123456899999999985     346888999999999999999999999754322111100    


Q ss_pred             HHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          317 PYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                          .....        ........+.++.+|+.+||..||.+|||+.+|++
T Consensus       229 ----~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         229 ----PRNPA--------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             ----hcCCC--------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence                00000        00111234568999999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3e-41  Score=314.35  Aligned_cols=253  Identities=23%  Similarity=0.346  Sum_probs=200.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|.+.+.||+|+||.||+|...      .+++.||+|++..........+.+|+.+++.++||||+++++++...+..|
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNV------NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW   82 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEc------CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence            46777788999999999999643      346789999997665455567888999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+++++|.+++...  ..+++..++.++.|++.||.|||  ++|++|+||||+||+++.++.++|+|||++.....
T Consensus        83 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLH--SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             EEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            999999999999988655  56889999999999999999999  67899999999999999999999999999876533


Q ss_pred             CCCceeeeccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYIS---TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ...  ......|+..|+|||++.   ...++.++|+|||||++|+|++|..||....+........       . ...  
T Consensus       159 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~-------~-~~~--  226 (267)
T cd06645         159 TIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT-------K-SNF--  226 (267)
T ss_pred             ccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh-------c-cCC--
Confidence            211  123356899999999874   4568899999999999999999999986543221110000       0 000  


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       ..+....  ...++..+.+++.+||+.+|++||++.+|++
T Consensus       227 -~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         227 -QPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             -CCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence             0011110  1123467899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.4e-41  Score=349.85  Aligned_cols=255  Identities=25%  Similarity=0.378  Sum_probs=199.1

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      ...++|.+++.||+|+||+||+|...      ..++.||+|++.....  .....+..|+.+|+.|+|||||+++++|.+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk------~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d   83 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHK------RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN   83 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEEC------CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence            34578999999999999999999643      4567899999875432  234678899999999999999999998855


Q ss_pred             C--CeeEEEEEecCCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCeeecCCCCCcEEEcC---
Q 014736          166 D--EERLLVYEFMPRGSLENHLFKRI--SVSLPWGTRLKIAIGAAKGLAFLHGAE-----NPVIYRDFKTSNILLDS---  233 (419)
Q Consensus       166 ~--~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~-----~~ivH~Dlkp~NIll~~---  233 (419)
                      .  ..+||||||+.+++|.++|....  ...+++..++.|+.||+.||.|||+..     ++||||||||+||||+.   
T Consensus        84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~  163 (1021)
T PTZ00266         84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR  163 (1021)
T ss_pred             cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence            3  56899999999999999986532  246899999999999999999999533     56999999999999964   


Q ss_pred             --------------CCcEEEeccCccccCCCCCCceeeecccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCC
Q 014736          234 --------------DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST--GHLTTKSDVYSFGVVLLELLTGR  297 (419)
Q Consensus       234 --------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~  297 (419)
                                    .+.+||+|||++.......   ......||+.|+|||++.+  ..++.++||||||||||+|++|.
T Consensus       164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk  240 (1021)
T PTZ00266        164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK  240 (1021)
T ss_pred             ccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence                          3358999999998653322   1234569999999999854  45899999999999999999999


Q ss_pred             CCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          298 RSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       298 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .||.......  ..+.   . +...        +.+.   ....+.++.+||.+||+.+|.+||++.+++.
T Consensus       241 ~PF~~~~~~~--qli~---~-lk~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        241 TPFHKANNFS--QLIS---E-LKRG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCCcCCcHH--HHHH---H-HhcC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            9997543211  1111   0 1000        0000   1123578999999999999999999999984

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.5e-41  Score=312.17  Aligned_cols=256  Identities=27%  Similarity=0.393  Sum_probs=193.6

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEe
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  175 (419)
                      +.||+|+||.||+|.+.+    ..++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNS----GYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcC----CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence            359999999999997643    23356799998875432 2335788899999999999999999999998999999999


Q ss_pred             cCCCChhhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          176 MPRGSLENHLFKRI---SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       176 ~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      +++|+|.+++....   ....++..+..++.|++.||.|||  ++|++|+||||+||+++.++.+||+|||++.......
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            99999999986532   224566778899999999999999  6789999999999999999999999999997543322


Q ss_pred             CceeeecccccccccccccccCC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYISTG-------HLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      .........|+..|+|||++.+.       .++.++||||||+++|||++ |..||..........   ..  .  .. .
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~~--~--~~-~  226 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---YT--V--RE-Q  226 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---HH--h--hc-c
Confidence            21122234578889999998542       35789999999999999996 999997654322111   10  0  00 0


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                      ......+.+    ....++.+.+++.+|+ .+|++|||+.+|+..|.
T Consensus       227 ~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         227 QLKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cCCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            001111111    1223467889999998 68999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.2e-40  Score=308.95  Aligned_cols=251  Identities=27%  Similarity=0.417  Sum_probs=198.0

Q ss_pred             eecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEec
Q 014736           98 LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFM  176 (419)
Q Consensus        98 ~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  176 (419)
                      .||+|+||.||+|.+..    ...+..||+|++..... ...+.+.+|+.+++.++|+||+++++++. ....++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~----~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKM----RKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEec----CCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeC
Confidence            38999999999997542    12345799999975532 23456889999999999999999999875 45789999999


Q ss_pred             CCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCcee
Q 014736          177 PRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV  256 (419)
Q Consensus       177 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  256 (419)
                      ++++|.+++... ...+++..++.++.||+.||.|||  ++|++|+||||+|||++.++.+||+|||++...........
T Consensus        77 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          77 SGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLE--GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             CCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--hcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence            999999988653 346899999999999999999999  67899999999999999999999999999986543322111


Q ss_pred             -eecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccccccccC
Q 014736          257 -TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA  334 (419)
Q Consensus       257 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  334 (419)
                       .....++..|+|||++....++.++||||||+++|+|++ |..||...........+       ....          .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~----------~  216 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-------EQGK----------R  216 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-------HCCC----------C
Confidence             111224578999999988889999999999999999996 99999765432211111       1111          1


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       335 ~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                      ...+...+.++.+++.+||..||++||++.+|.+.|+.+
T Consensus       217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            122334567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.2e-41  Score=310.95  Aligned_cols=250  Identities=23%  Similarity=0.370  Sum_probs=200.8

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc---------cHHHHHHHHHHHcCCCcccccceeeE
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ---------GHREWLAEVIFLGQLRHPHLVRLIGY  162 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~hpnIv~~~~~  162 (419)
                      +|.+...||+|+||.||+|...      ..++.||+|.+......         ..+.+.+|+.++++++||||++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   74 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNA------SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGS   74 (267)
T ss_pred             CccccceeecCCCeEEEEEEec------CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            4778889999999999999643      34678999988654322         12457789999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEecc
Q 014736          163 CCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       163 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                      +.+.+..++||||+++++|.+++...  ..+++..+..++.|++.||.|||  ++|++|+||+|+||+++.++.++|+||
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH--~~~ivH~di~p~nil~~~~~~~~l~df  150 (267)
T cd06628          75 SLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLH--NRGIIHRDIKGANILVDNKGGIKISDF  150 (267)
T ss_pred             EEeCCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHH--hcCcccccCCHHHEEEcCCCCEEeccc
Confidence            99999999999999999999999765  56788899999999999999999  678999999999999999999999999


Q ss_pred             CccccCCCCCCc----eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          243 GLAKMGPEGSNT----HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       243 Gla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      |+++........    .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.......   .+.   . 
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~---~-  223 (267)
T cd06628         151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---AIF---K-  223 (267)
T ss_pred             CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---HHH---H-
Confidence            998865422111    11123458899999999988889999999999999999999999997643211   110   0 


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        ...        ......+...+.++.+++.+||+.||.+||++.+|++
T Consensus       224 --~~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         224 --IGE--------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             --Hhc--------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence              000        0111223345678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-41  Score=325.46  Aligned_cols=256  Identities=20%  Similarity=0.218  Sum_probs=197.5

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC---CcccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE---GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++.+.||+|+||.||+|...      .+++.||+|++...   .......+.+|+.++..++|+||+++++++.+++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMK------NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEEC------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            47899999999999999999643      34678999999642   2223456788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      +.|+||||+.+++|.+++.+. ...+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  151 (331)
T cd05597          75 NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVH--QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLR  151 (331)
T ss_pred             eEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--hCCeEECCCCHHHEEECCCCCEEEEECCceee
Confidence            999999999999999998653 346889999999999999999999  67799999999999999999999999999876


Q ss_pred             CCCCCCceeeecccccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYIST-----GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      ....... ......||+.|+|||++..     ..++.++|||||||++|+|++|+.||..........      ......
T Consensus       152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~------~i~~~~  224 (331)
T cd05597         152 LLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHK  224 (331)
T ss_pred             cCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH------HHHcCC
Confidence            5433221 1223469999999999863     457889999999999999999999997543221111      111111


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKD--RPKMAAVVAT  369 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~--RPs~~eil~~  369 (419)
                      ....      +. ......+.++.+++.+||..++.+  |+++.++++.
T Consensus       225 ~~~~------~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         225 EHFQ------FP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             Cccc------CC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            0000      00 111225678999999988654443  7899988864

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.7e-41  Score=323.35  Aligned_cols=256  Identities=19%  Similarity=0.226  Sum_probs=198.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|.+.++||+|+||.||++....      .++.||+|++....   ......+.+|+.++..++|+||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKN------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN   74 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            478999999999999999996543      46789999986421   122345778999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+.+|+|.+++.+. ...+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH--~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~  151 (332)
T cd05623          75 NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVH--QLHYVHRDIKPDNILMDMNGHIRLADFGSCLK  151 (332)
T ss_pred             EEEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEECCCCCEEEeecchhee
Confidence            999999999999999999753 246888899999999999999999  67799999999999999999999999999875


Q ss_pred             CCCCCCceeeeccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYIS-----TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      ...... ......+||+.|+|||++.     ...++.++|||||||++|||++|+.||...........      .....
T Consensus       152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~------i~~~~  224 (332)
T cd05623         152 LMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK------IMNHK  224 (332)
T ss_pred             cccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHH------HhCCC
Confidence            433222 1223356999999999985     35688999999999999999999999976432221111      11111


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKD--RPKMAAVVAT  369 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~--RPs~~eil~~  369 (419)
                      ....      . ......++.++.+|+.+||..++.+  |+++.++++.
T Consensus       225 ~~~~------~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         225 ERFQ------F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cccc------C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            0000      0 0111234678999999999765554  6889988765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-41  Score=309.50  Aligned_cols=253  Identities=34%  Similarity=0.504  Sum_probs=200.2

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEe
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  175 (419)
                      ++||+|+||.||+|++...   ......||+|.+..... .....+.+|+.+++.++|+||+++++++. .+..++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~---~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMK---SGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeecc---CCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence            4699999999999976442   11346899999975543 24567889999999999999999999875 4568999999


Q ss_pred             cCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCce
Q 014736          176 MPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH  255 (419)
Q Consensus       176 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  255 (419)
                      +.+++|.+++...  ..+++..+..++.|++.||.|||  .++++|+||||+|||++.++.+||+|||++..........
T Consensus        77 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          77 APLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLE--SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHh--hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            9999999999766  36889999999999999999999  6779999999999999999999999999998654433221


Q ss_pred             e-eecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccccccccc
Q 014736          256 V-TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL  333 (419)
Q Consensus       256 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  333 (419)
                      . .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .......    ....         
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~----~~~~---------  216 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLE----SGER---------  216 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH----cCCc---------
Confidence            1 111224567999999988899999999999999999998 99999765332   1111111    1100         


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 014736          334 AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL  374 (419)
Q Consensus       334 ~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~  374 (419)
                       ...+..++..+.+++.+||..+|++||++.+|++.|.++.
T Consensus       217 -~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         217 -LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence             0122234578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.7e-41  Score=348.92  Aligned_cols=262  Identities=21%  Similarity=0.313  Sum_probs=203.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++.++||+|+||.||+|+.      ..+++.||+|++.....   ...+++.+|+++++.++||||+++++++.+++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d------~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~   75 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYD------PVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD   75 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEE------CCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence            4799999999999999999964      33478899999975322   22457889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhcc---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEE
Q 014736          168 ERLLVYEFMPRGSLENHLFKRI---------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAK  238 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~k  238 (419)
                      ..|+||||++|++|.+++....         ....++..++.++.||+.||.|||  ++||+||||||+|||++.++.+|
T Consensus        76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH--s~GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH--SKGVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH--HCCccccCCchheEEEcCCCCEE
Confidence            9999999999999999886421         123456678899999999999999  67899999999999999999999


Q ss_pred             EeccCccccCCCCCC----------------ceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 014736          239 LSDFGLAKMGPEGSN----------------THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDK  302 (419)
Q Consensus       239 l~DfGla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  302 (419)
                      |+|||++........                .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            999999986521110                0011235699999999999999999999999999999999999999976


Q ss_pred             CCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhhc
Q 014736          303 LRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP-KMAAVVATLESLLN  375 (419)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-s~~eil~~L~~l~~  375 (419)
                      ......   .. . ...         ..+... ......+..+.+++.+||+.||++|+ +++++++.|+....
T Consensus       234 ~~~~ki---~~-~-~~i---------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        234 KKGRKI---SY-R-DVI---------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             cchhhh---hh-h-hhc---------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            332111   00 0 000         000000 00123457799999999999999995 67777778887755

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-40  Score=321.17  Aligned_cols=260  Identities=21%  Similarity=0.298  Sum_probs=192.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ..+|.+.+.||+|+||.||+|....      +++.||+|+....      ....|+.++++++|+||+++++++...+..
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  132 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPG------QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAIT  132 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECC------CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCee
Confidence            3579999999999999999996543      4678999975432      234689999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++|||++ .++|.+++... ...+++..++.++.||+.||.|||  .+||+||||||+|||++.++.+||+|||+++...
T Consensus       133 ~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        133 CMVLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLH--AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             EEEEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            9999999 56888887653 356899999999999999999999  6779999999999999999999999999997533


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhH--------HHhhhHHhhc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNL--------VDWAKPYLRS  321 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~--------~~~~~~~~~~  321 (419)
                      ...   ......||..|+|||++.+..++.++|||||||++|||+++..++....+......        ..........
T Consensus       209 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~  285 (357)
T PHA03209        209 VAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH  285 (357)
T ss_pred             cCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence            221   12335699999999999999999999999999999999986554432222211110        0000000000


Q ss_pred             ccccc---------cccc--ccc---CCCC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          322 SRRLR---------YIVD--PRL---AGQY----SVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       322 ~~~~~---------~~~~--~~l---~~~~----~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ...+.         ...+  ...   ...+    ....+.++.+||.+||+.||.+|||+.|+++
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence            00000         0000  000   0000    0123456778999999999999999999986

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.2e-41  Score=324.36  Aligned_cols=256  Identities=19%  Similarity=0.225  Sum_probs=198.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|.+.+.||+|+||.||++...      .+++.||+|++....   ......+.+|+.++..++|+||+++++++.+.+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~   74 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMK------HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEEC------CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            47899999999999999999643      346789999986421   223345778999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+.||+|.+++.+. ...+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH--~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~  151 (331)
T cd05624          75 YLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIH--QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLK  151 (331)
T ss_pred             EEEEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCchHHEEEcCCCCEEEEeccceee
Confidence            999999999999999999763 246888899999999999999999  67899999999999999999999999999976


Q ss_pred             CCCCCCceeeecccccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYIST-----GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      ....... ......||+.|+|||++.+     +.++.++|||||||++|+|++|+.||..........      ......
T Consensus       152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~  224 (331)
T cd05624         152 MNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHE  224 (331)
T ss_pred             ccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH------HHHcCC
Confidence            5433221 1233569999999999865     568899999999999999999999997543221111      111010


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKD--RPKMAAVVAT  369 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~--RPs~~eil~~  369 (419)
                      ...      .+. ......+.++.+++.+||..++++  |++++++++.
T Consensus       225 ~~~------~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         225 ERF------QFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             Ccc------cCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            000      000 111234678999999999876654  4678887653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.1e-40  Score=315.91  Aligned_cols=252  Identities=22%  Similarity=0.345  Sum_probs=205.3

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ..++|++.+.||+|+||.||+|...      ..++.||+|.+........+.+.+|+.+++.++|+||+++++++..++.
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDI------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE   90 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEEC------CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence            3468999999999999999999643      3467899999986655556778899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||+++++|.+++.+.   .+++..+..++.|++.||.|||  +.|++|+||||+|||++.++.++|+|||++...
T Consensus        91 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH--~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~  165 (297)
T cd06656          91 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (297)
T ss_pred             EEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence            99999999999999988643   5788899999999999999999  677999999999999999999999999998764


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      .....  ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....+.......      . ..      
T Consensus       166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~------~-~~------  230 (297)
T cd06656         166 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------A-TN------  230 (297)
T ss_pred             cCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee------c-cC------
Confidence            33321  122346889999999998888999999999999999999999999754332111000      0 00      


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        .......+...+..+.+++.+||..||++||++.+|++
T Consensus       231 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         231 --GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             --CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              00001122334577899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-40  Score=308.19  Aligned_cols=254  Identities=25%  Similarity=0.354  Sum_probs=205.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|.+.+.||+|+||.||+|....      +++.+++|++..........+.+|+.+++.++||||+++++++.+.+..|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   76 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIA------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW   76 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecC------CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence            578899999999999999996433      45789999998765556678899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      ++|||+.+++|.+++... ...+++..+..++.|++.||.|||  ++||+|+||||+||+++.++.+||+|||++.....
T Consensus        77 l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          77 IVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLH--ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            999999999999988654 246889999999999999999999  67899999999999999999999999999876543


Q ss_pred             CCCceeeecccccccccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTG---HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ...  ......++..|+|||.+.+.   .++.++|+||||+++|+|++|..||............  .      ...+. 
T Consensus       154 ~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~--~------~~~~~-  222 (262)
T cd06613         154 TIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI--S------KSNFP-  222 (262)
T ss_pred             hhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H------hccCC-
Confidence            221  12335688899999999776   8899999999999999999999999765432211110  0      00000 


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        ..  ........+.++.+++.+||..+|.+|||+.+|+.
T Consensus       223 --~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         223 --PP--KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             --Cc--cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              00  01123345678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.5e-41  Score=310.23  Aligned_cols=255  Identities=27%  Similarity=0.428  Sum_probs=204.7

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ..++|.+.++||+|+||.||+|...+       +..+++|.+.... .....+.+|+.+++.++|+||+++++++.+ ..
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~-------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~   74 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNK-------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EP   74 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecC-------CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CC
Confidence            34689999999999999999996433       3469999887432 235678899999999999999999999877 77


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .+++|||+++++|.+++.......+++..+..++.|++.||.|||  ++|++|+||||+||+++.++.+||+|||++...
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  152 (260)
T cd05073          75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARVI  152 (260)
T ss_pred             eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCCcceeec
Confidence            899999999999999997765566888899999999999999999  678999999999999999999999999999765


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ...... ......++..|+|||++....++.++|+||||+++|+|++ |..||........   ..+.    ....    
T Consensus       153 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~----~~~~----  220 (260)
T cd05073         153 EDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRAL----ERGY----  220 (260)
T ss_pred             cCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH----hCCC----
Confidence            433221 1222345678999999988889999999999999999998 9999975432211   1111    0100    


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES  372 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~  372 (419)
                            ........+.++.+++.+||+.+|++||++.++++.|+.
T Consensus       221 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         221 ------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                  001112345789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-43  Score=312.02  Aligned_cols=248  Identities=26%  Similarity=0.392  Sum_probs=210.5

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEE
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      |.++.+||+|+||.||+|      .++..|+.+|+|.+..+  .+.+++++|+.|+++.+.|++|++||.|..+..+++|
T Consensus        35 FDi~~KLGEGSYGSV~KA------IH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV  106 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKA------IHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV  106 (502)
T ss_pred             HHHHHHhcCCcchHHHHH------HHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence            455667999999999999      56667999999999754  4678999999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      ||||..|++.+.++.+ ++.+.+.++..+++..+.||+|||  ...-||||||..|||++.+|..||+|||.|..+.+..
T Consensus       107 MEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH--~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLH--DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM  183 (502)
T ss_pred             hhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHH--HHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence            9999999999998655 468999999999999999999999  4448999999999999999999999999998654432


Q ss_pred             CceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                      -  ......||+.|||||++..-.|+.++||||||++..||..|++||....+....-.+               ...+.
T Consensus       184 A--KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---------------PT~PP  246 (502)
T KOG0574|consen  184 A--KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---------------PTKPP  246 (502)
T ss_pred             H--hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec---------------cCCCC
Confidence            1  244578999999999999999999999999999999999999999876553321111               01122


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ....-+..++.++.++++.||-++|++|.|+.++++
T Consensus       247 PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  247 PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            222345678899999999999999999999998874

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.1e-40  Score=308.52  Aligned_cols=250  Identities=24%  Similarity=0.365  Sum_probs=201.5

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEe-CCe
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCE-DEE  168 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~  168 (419)
                      +|++.+.||+|+||.||++...      ..++.||+|.+.....  ...+.+.+|++++++++|+||+++++.+.. +..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHR------TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL   74 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEc------CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence            4888999999999999999643      3467899999865432  334568889999999999999999998764 446


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|++|||+++++|.+++.......+++..++.++.|++.||.|||  ++|++|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH--~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~  152 (257)
T cd08223          75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL  152 (257)
T ss_pred             EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCchhEEEecCCcEEEecccceEEe
Confidence            899999999999999997755566899999999999999999999  778999999999999999999999999998765


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      .....  ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.......   ..   ....  .+.+   
T Consensus       153 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~---~~---~~~~--~~~~---  219 (257)
T cd08223         153 ENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS---LV---YRII--EGKL---  219 (257)
T ss_pred             cccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---HH---HHHH--hcCC---
Confidence            33221  2234568999999999999999999999999999999999999997543211   11   0100  0000   


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                            ...+...+.++.+++.+||+.||++||++.++++
T Consensus       220 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         220 ------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                  1122345678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.4e-41  Score=325.00  Aligned_cols=264  Identities=22%  Similarity=0.289  Sum_probs=196.8

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEE
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCC  164 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  164 (419)
                      -.+.++|.+.+.||+|+||.||+|...      .+++.||+|++.....  .....+.+|+.+|+.++||||+++++++.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDT------RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFT   84 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEEC------CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhc
Confidence            345678999999999999999999643      3467899999875322  23456778999999999999999999875


Q ss_pred             eC------CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEE
Q 014736          165 ED------EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAK  238 (419)
Q Consensus       165 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~k  238 (419)
                      ..      ...|++|+++ +++|.+++..   ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+|
T Consensus        85 ~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrdikp~Nil~~~~~~~k  158 (343)
T cd07878          85 PATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIH--SAGIIHRDLKPSNVAVNEDCELR  158 (343)
T ss_pred             ccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecccCChhhEEECCCCCEE
Confidence            43      3568999998 8899887753   36899999999999999999999  67899999999999999999999


Q ss_pred             EeccCccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh-
Q 014736          239 LSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK-  316 (419)
Q Consensus       239 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-  316 (419)
                      |+|||++......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.... 
T Consensus       159 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  233 (343)
T cd07878         159 ILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVG  233 (343)
T ss_pred             EcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999999865432     233468999999999876 578999999999999999999999997643221111000000 


Q ss_pred             ----HHhhc-----c----cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          317 ----PYLRS-----S----RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       317 ----~~~~~-----~----~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                          .....     .    ..+.......+. .......+.+.+|+.+||..||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLK-KIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             CCCHHHHHhcchhhHHHHhhccccccchhHH-HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                00000     0    000000000000 000112456889999999999999999999986

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.1e-41  Score=314.76  Aligned_cols=268  Identities=28%  Similarity=0.383  Sum_probs=209.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-cHHHHHHHHHHHcCCCcccccceeeEEEe--CC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQLRHPHLVRLIGYCCE--DE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~  167 (419)
                      ++|.+.+.||+|+||.||+|.+...  +...++.||+|++...... ....+.+|+++++.++|+||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~--~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPL--GDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCC--CCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            4677888999999999999976542  2445788999999765443 45788999999999999999999999877  55


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..++||||+++++|.+++.... ..+++..+..++.|++.||+|||  ++|++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLG--SQRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            7899999999999999987652 25889999999999999999999  67899999999999999999999999999987


Q ss_pred             CCCCCCcee-eecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccch--------hHHHhhhHH
Q 014736          248 GPEGSNTHV-TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQ--------NLVDWAKPY  318 (419)
Q Consensus       248 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--------~~~~~~~~~  318 (419)
                      ......... .....++..|++||.+.+..++.++||||||+++|+|++|..|+.........        .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            653322111 11233566799999998889999999999999999999999998654322110        001000111


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                      ....          .....+..++.++.+|+.+||+.+|++||++.+|+++|+++
T Consensus       239 ~~~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKEG----------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHcC----------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111          11111223457899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.8e-40  Score=313.45  Aligned_cols=252  Identities=24%  Similarity=0.363  Sum_probs=201.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      +.|++.++||+|+||.||+|...      ..++.|++|++..........+.+|+.+++.++|+||+++++.+..++..|
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNK------ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW   85 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEEC------CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence            56889999999999999999643      346789999998765556678889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+++++|..++.+.. ..+++..+..++.|++.||.|||  ++|++||||||+||+++.++.++|+|||++.....
T Consensus        86 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLH--SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh--cCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            9999999999988775542 46889999999999999999999  67899999999999999999999999999875332


Q ss_pred             CCCceeeeccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYIS-----TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      ...  ......++..|+|||++.     ...++.++|||||||++|+|++|..||........  ...    .. ...  
T Consensus       163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~----~~-~~~--  231 (292)
T cd06644         163 TLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLK----IA-KSE--  231 (292)
T ss_pred             ccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHH----Hh-cCC--
Confidence            211  122345889999999984     34578899999999999999999999975432110  110    00 000  


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                          .+  ....+...+.++.+++.+||..||++||++.+|++
T Consensus       232 ----~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         232 ----PP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ----Cc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                00  00112234567999999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.1e-40  Score=315.56  Aligned_cols=250  Identities=22%  Similarity=0.377  Sum_probs=204.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      .+|++.+.||.|+||.||+|..      ..+++.|++|.+........+.+.+|+.+++.++|+||+++++++...+..|
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~------~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAID------VATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELF   92 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEE------cCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence            4689999999999999999954      3456889999997665555678889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+.+++|.+++...   .+++..+..++.|++.||.|||  ++|++|+||||+||+++.++.+||+|||++.....
T Consensus        93 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH--~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          93 VVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLH--ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            999999999999988643   5889999999999999999999  67799999999999999999999999999876443


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD  330 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (419)
                      ...  ......|+..|+|||.+.+..++.++|||||||++|+|++|..||............      . ... .     
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~------~-~~~-~-----  232 (296)
T cd06655         168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------A-TNG-T-----  232 (296)
T ss_pred             ccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------H-hcC-C-----
Confidence            321  123346889999999998888999999999999999999999999765432211110      0 000 0     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       331 ~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      +.  ...+...+..+.+++.+||..||++||++.+|+.
T Consensus       233 ~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         233 PE--LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cc--cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            00  0112334578999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=311.09  Aligned_cols=251  Identities=28%  Similarity=0.431  Sum_probs=196.0

Q ss_pred             eecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCC-CcccccceeeEEEeCCeeEEEEEe
Q 014736           98 LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        98 ~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~  175 (419)
                      +||+|+||.||+|.+.++    .....+++|.+.... ......+.+|++++.++ +||||+++++++...+..|+||||
T Consensus         2 ~lg~g~~g~v~~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   77 (270)
T cd05047           2 VIGEGNFGQVLKARIKKD----GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   77 (270)
T ss_pred             cCCCCCCceEEEEEEcCC----CCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence            599999999999976542    112357888886432 23446788999999999 799999999999999999999999


Q ss_pred             cCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          176 MPRGSLENHLFKRI--------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       176 ~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                      +++++|.+++....              ...+++..++.++.|++.||+|||  ++|++|+||||+|||++.++.+||+|
T Consensus        78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nili~~~~~~kl~d  155 (270)
T cd05047          78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIAD  155 (270)
T ss_pred             CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccccceEEEcCCCeEEECC
Confidence            99999999986542              124788899999999999999999  67899999999999999999999999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhh
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLR  320 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  320 (419)
                      ||++.......   .......+..|+|||++....++.++||||||+++|+|++ |..||.......   .....    .
T Consensus       156 fgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~----~  225 (270)
T cd05047         156 FGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL----P  225 (270)
T ss_pred             CCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHHH----h
Confidence            99986322111   1111224567999999988899999999999999999997 999996543211   11110    0


Q ss_pred             cccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 014736          321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL  374 (419)
Q Consensus       321 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~  374 (419)
                      ...          ....+...+.++.+|+.+||..||.+|||+.+++..|..++
T Consensus       226 ~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         226 QGY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCC----------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            000          00112234567999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=320.37  Aligned_cols=249  Identities=28%  Similarity=0.387  Sum_probs=211.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      +.|+.-++||+||||.||-+.      ...+|+-||.|.+.+...   ......++|-.+|.+++.+.||.+-..|+..+
T Consensus       185 n~F~~~RvlGkGGFGEV~acq------vraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd  258 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQ------VRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD  258 (591)
T ss_pred             cceeeeEEEecccccceeEEE------EecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence            468888999999999999985      445688899999865432   33456788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      .++|||..|.||+|.-+|.+.++..+++..++.++.+|+.||++||  +.+||+|||||+|||+|+.|+++|+|+|||..
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH--~~~iVYRDLKPeNILLDd~GhvRISDLGLAve  336 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH--RRRIVYRDLKPENILLDDHGHVRISDLGLAVE  336 (591)
T ss_pred             ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH--hcceeeccCChhheeeccCCCeEeeccceEEe
Confidence            9999999999999999999988889999999999999999999999  78899999999999999999999999999998


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      +..+...   ...+||.+|||||+++++.|+...|+|||||+||||+.|+.||.....+....-++.  ..         
T Consensus       337 i~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr--r~---------  402 (591)
T KOG0986|consen  337 IPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR--RT---------  402 (591)
T ss_pred             cCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH--HH---------
Confidence            7766542   223799999999999999999999999999999999999999987655443322211  00         


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMA  364 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~  364 (419)
                         ......|+...++++.+|+..+|.+||.+|....
T Consensus       403 ---~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  403 ---LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             ---hcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence               0112345667789999999999999999997654

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=8.7e-41  Score=319.32  Aligned_cols=200  Identities=26%  Similarity=0.388  Sum_probs=161.3

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEe--CCeeEEEE
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE--DEERLLVY  173 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~  173 (419)
                      .++||+|+||.||+|...+    ...++.||+|.+....  ....+.+|+.+|+.++||||+++++++..  +...|++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~----~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKD----GKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEcc----CCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence            4579999999999997543    2346789999987543  23457789999999999999999998854  45689999


Q ss_pred             EecCCCChhhhhhhcc-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE----cCCCcEEEecc
Q 014736          174 EFMPRGSLENHLFKRI-------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL----DSDFTAKLSDF  242 (419)
Q Consensus       174 e~~~~g~L~~~l~~~~-------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll----~~~~~~kl~Df  242 (419)
                      ||+ +++|.+++....       ...+++..+..++.||+.||.|||  ++||+||||||+|||+    +.++.+||+||
T Consensus        80 e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          80 DYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH--hCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            999 568888775321       235788899999999999999999  6789999999999999    45678999999


Q ss_pred             CccccCCCCCCc-eeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 014736          243 GLAKMGPEGSNT-HVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLR  304 (419)
Q Consensus       243 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~  304 (419)
                      |++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||....
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            999865433211 11234568999999999876 468999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.6e-40  Score=307.32  Aligned_cols=251  Identities=24%  Similarity=0.363  Sum_probs=204.9

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      +|+..++||.|+||.||.+...      .+++.+++|.+....  ......+.+|+.++++++|+||+++++++.+.+..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   74 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRT------EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL   74 (256)
T ss_pred             CceEeeEecccCCceEEEEEEc------CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE
Confidence            5888999999999999998543      456789999987543  33456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      +++|||+++++|.+++.......+++..+..++.|++.||.|||  +.|++|+||+|+||+++.++.+||+|||++....
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~  152 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH--KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG  152 (256)
T ss_pred             EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence            99999999999999997664556889999999999999999999  6779999999999999999999999999998654


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      ....  ......|+..|+|||++.+..++.++||||||+++|+|++|..||........   .   ....  .+..    
T Consensus       153 ~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~---~---~~~~--~~~~----  218 (256)
T cd08221         153 SEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL---V---VKIV--QGNY----  218 (256)
T ss_pred             cccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH---H---HHHH--cCCC----
Confidence            4331  22335689999999999888899999999999999999999999975432211   1   1100  0000    


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                          . ......+.++.+++.+||..+|.+||++.++++.
T Consensus       219 ----~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         219 ----T-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ----C-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                0 1113345789999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=318.10  Aligned_cols=254  Identities=25%  Similarity=0.309  Sum_probs=202.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc---cHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ---GHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|.+.+.||+|+||.||+|...+      +++.||+|.+......   ..+.+.+|+++++.++|+||+++++.+.++.
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   74 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKG------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET   74 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcC------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC
Confidence            368889999999999999996543      4688999999765332   3456889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+.+++|.+++.......+++..+..++.|++.||.|||  ++|++|+||||+||+++.++.++|+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  152 (316)
T cd05574          75 YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH--LLGIVYRDLKPENILLHESGHIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChHHeEEcCCCCEEEeecchhhc
Confidence            9999999999999999987655567899999999999999999999  67899999999999999999999999999875


Q ss_pred             CCCCCCc---------------------------eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 014736          248 GPEGSNT---------------------------HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSM  300 (419)
Q Consensus       248 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf  300 (419)
                      .......                           .......|+..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence            4322110                           0011346899999999998888999999999999999999999999


Q ss_pred             CCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 014736          301 DKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK----MAAVVA  368 (419)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs----~~eil~  368 (419)
                      ...........+      .          .....-......+.++.+++.+||+.||++||+    +.+++.
T Consensus       233 ~~~~~~~~~~~~------~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         233 KGSNRDETFSNI------L----------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCCchHHHHHHH------h----------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            765432111000      0          000000011115678999999999999999999    555554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.4e-40  Score=306.27  Aligned_cols=256  Identities=27%  Similarity=0.430  Sum_probs=196.1

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccC-CcccHHHHHHHHHHHcCCCcccccceeeEEE-eCCeeEEEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGHREWLAEVIFLGQLRHPHLVRLIGYCC-EDEERLLVYE  174 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~e  174 (419)
                      +.||+|+||.||+|.+.+.   ......||+|.+... .......+.+|+.+++.++||||+++++++. .++..++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDS---DGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecC---CCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence            3689999999999976432   223467999998543 2334567889999999999999999999775 4556899999


Q ss_pred             ecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCc
Q 014736          175 FMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT  254 (419)
Q Consensus       175 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  254 (419)
                      |+.+++|.+++.... ...++..+..++.||+.||.|||  +++++||||||+|||++.++.+||+|||++.........
T Consensus        78 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          78 YMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLA--SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            999999999986542 34667788899999999999999  678999999999999999999999999999754332211


Q ss_pred             e--eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCccchhHHHhhhHHhhccccccccccc
Q 014736          255 H--VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG-RRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDP  331 (419)
Q Consensus       255 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (419)
                      .  ......++..|+|||.+.+..++.++||||||+++|||++| .+||......   ......    .....      .
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~----~~~~~------~  221 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYL----LQGRR------L  221 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH----hcCCC------C
Confidence            1  11123467789999999888999999999999999999995 5666543221   111111    01100      0


Q ss_pred             ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          332 RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       332 ~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                          ..+...+..+.+++.+||..+|++||++.+|++.|+++..
T Consensus       222 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         222 ----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             ----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence                1112235679999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-40  Score=310.86  Aligned_cols=249  Identities=28%  Similarity=0.404  Sum_probs=203.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|.+.+.||.|+||.||+|...      .+++.||+|++.... ......+.+|+.+++.++|+||+++++++.++...
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDK------RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKL   74 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEEC------CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeE
Confidence            36888899999999999999654      346889999997553 33456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+|+||+.+++|.+++...   .+++..+..++.|++.||.|||  +++++|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  149 (274)
T cd06609          75 WIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLH--EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT  149 (274)
T ss_pred             EEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEcccccceeec
Confidence            9999999999999998654   7889999999999999999999  6779999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      ....  ......|+..|+|||++.+..++.++||||||+++|+|++|..||....+......+   .    ..      .
T Consensus       150 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~---~----~~------~  214 (274)
T cd06609         150 STMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI---P----KN------N  214 (274)
T ss_pred             cccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh---h----hc------C
Confidence            4321  123356888999999998888999999999999999999999999765422111000   0    00      0


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .+.+..   ...+.++.+++.+||..+|++||+++++++
T Consensus       215 ~~~~~~---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         215 PPSLEG---NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             CCCCcc---cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            011111   114567999999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3e-40  Score=304.51  Aligned_cols=246  Identities=28%  Similarity=0.469  Sum_probs=195.9

Q ss_pred             eecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-cHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEec
Q 014736           98 LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFM  176 (419)
Q Consensus        98 ~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  176 (419)
                      +||+|+||.||+|...+       +..||+|++...... ....+.+|+++++.++||||+++++++...+..++||||+
T Consensus         2 ~ig~g~~g~vy~~~~~~-------~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   74 (250)
T cd05085           2 LLGKGNFGEVFKGTLKD-------KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELV   74 (250)
T ss_pred             ccCCCCCceEEEEEecC-------CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECC
Confidence            69999999999996432       467999998754322 2346889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCcee
Q 014736          177 PRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV  256 (419)
Q Consensus       177 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  256 (419)
                      ++++|.+++.... ..+++..+..++.|++.||.|||  ++|++|+||||+||+++.++.+||+|||++......... .
T Consensus        75 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~  150 (250)
T cd05085          75 PGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-S  150 (250)
T ss_pred             CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccChheEEEcCCCeEEECCCccceeccccccc-c
Confidence            9999999886542 45788999999999999999999  778999999999999999999999999998754332211 1


Q ss_pred             eecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCC
Q 014736          257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAG  335 (419)
Q Consensus       257 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  335 (419)
                      .....++..|+|||++.+..++.++||||||+++|+|++ |..||........   ....    ...          ...
T Consensus       151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~~~~----~~~----------~~~  213 (250)
T cd05085         151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---REQV----EKG----------YRM  213 (250)
T ss_pred             CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHH----HcC----------CCC
Confidence            112234677999999988899999999999999999998 9999975432211   1100    000          011


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          336 QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       336 ~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                      ..+...+.++.+++.+||+.+|++||++.++++.|.
T Consensus       214 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         214 SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            122334678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.4e-40  Score=319.31  Aligned_cols=264  Identities=19%  Similarity=0.230  Sum_probs=196.0

Q ss_pred             CCCeeccc--CceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           95 SNYLLGEG--GFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        95 ~~~~lg~G--~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++++||+|  +|++||++..      ..+++.||+|.+.....  .....+.+|+.+++.++||||+++++++..++..|
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~   75 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARY------KPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW   75 (327)
T ss_pred             hhhhccccccceEEEEEEee------cccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEE
Confidence            45679999  7899999954      44578899999975432  23356778999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+++++|.+++.......+++..++.++.|++.||.|||  ++||+||||||+|||++.++.++++||+.+.....
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence            9999999999999997655556899999999999999999999  67799999999999999999999999986543221


Q ss_pred             CCC-ce----eeecccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhh---
Q 014736          251 GSN-TH----VTTRVMGTYGYAAPEYIST--GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR---  320 (419)
Q Consensus       251 ~~~-~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---  320 (419)
                      ... ..    ......++..|+|||++.+  ..++.++|||||||++|+|++|..||.........  .........   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~  231 (327)
T cd08227         154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLL  231 (327)
T ss_pred             ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHhcCCccccc
Confidence            111 00    1112346788999999865  46899999999999999999999999754321110  000000000   


Q ss_pred             c------------c------cc---------cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          321 S------------S------RR---------LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       321 ~------------~------~~---------~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .            .      ..         ............+....+.++.+|+.+||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            0            0      00         00000000011122345678999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.9e-40  Score=308.40  Aligned_cols=245  Identities=24%  Similarity=0.378  Sum_probs=191.7

Q ss_pred             eecccCceEEEEEEEcCccc------ccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEE
Q 014736           98 LLGEGGFGTVHKGYIDDDLR------QGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLL  171 (419)
Q Consensus        98 ~lg~G~fg~Vy~a~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  171 (419)
                      .||+|+||.||+|++.....      .......|++|++..........+.+|+.+++.++||||+++++++..+...++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l   81 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM   81 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence            58999999999998653211      112345689999876555555678889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc-------EEEeccCc
Q 014736          172 VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT-------AKLSDFGL  244 (419)
Q Consensus       172 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~-------~kl~DfGl  244 (419)
                      ||||+++++|..++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.       ++++|||+
T Consensus        82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          82 VEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             EEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhh--hCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            99999999998887643 245888999999999999999999  678999999999999987664       89999999


Q ss_pred             cccCCCCCCceeeeccccccccccccccc-CCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          245 AKMGPEGSNTHVTTRVMGTYGYAAPEYIS-TGHLTTKSDVYSFGVVLLELL-TGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       245 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      +......      ....++..|+|||++. +..++.++|||||||++|+|+ .|..||..........       +....
T Consensus       159 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------~~~~~  225 (262)
T cd05077         159 PITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-------FYEGQ  225 (262)
T ss_pred             CccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-------HHhcC
Confidence            8754322      2234788899999886 567899999999999999998 5888876543211100       00000


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL  370 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L  370 (419)
                        .          ........++.+|+.+||+.||.+||++.+|++.|
T Consensus       226 --~----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         226 --C----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             --c----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence              0          00111246789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.5e-40  Score=308.71  Aligned_cols=261  Identities=27%  Similarity=0.406  Sum_probs=206.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|.+.++||+|+||.||+|.+.+.   ......|++|...... ....+.+.+|+.+++.++||||+++++++.+ +..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~---~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSP---ENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecC---CCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            5688889999999999999976442   1223569999887554 3345678999999999999999999998865 567


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+||||+++++|.+++.... ..+++..++.++.|++.||.|||  ++|++|+||||+||+++.++.++|+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLE--SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence            89999999999999986642 35889999999999999999999  6789999999999999999999999999988654


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      .... .......++..|+|||.+....++.++||||||+++|+|++ |..||...........+       ......   
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-------~~~~~~---  227 (270)
T cd05056         159 DESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI-------ENGERL---  227 (270)
T ss_pred             cccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------HcCCcC---
Confidence            3321 11122234568999999988889999999999999999986 99999765432211111       011100   


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                             ..+...+.++.+++.+|+..+|.+|||+.++++.|.++...
T Consensus       228 -------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         228 -------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                   11233467899999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-40  Score=312.57  Aligned_cols=262  Identities=25%  Similarity=0.349  Sum_probs=205.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|++.+.||+|+||+||+|...      ..++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHI------PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI   78 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEc------CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEE
Confidence            46778889999999999999643      346789999886543 23356788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+++++|.+++...  ..+++..+..++.+++.||.|||+ ..+++|+||||+||+++.++.++|+|||++....
T Consensus        79 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             EEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH-hcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            9999999999999988664  468899999999999999999994 2479999999999999999999999999987542


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccc-----hhHHHhhhHHhhcccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSE-----QNLVDWAKPYLRSSRR  324 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~  324 (419)
                      ...    .....|+..|+|||++.+..++.++|||||||++|+|++|..||........     .....+......    
T Consensus       156 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----  227 (284)
T cd06620         156 NSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ----  227 (284)
T ss_pred             hhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh----
Confidence            221    2234689999999999888999999999999999999999999986543211     111111111110    


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                            ...........+.++.+|+.+||+.||.+||++.++++...-+..
T Consensus       228 ------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         228 ------EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             ------ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                  000000111255789999999999999999999999986443433

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-40  Score=305.18  Aligned_cols=248  Identities=29%  Similarity=0.469  Sum_probs=198.6

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-cHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEe
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  175 (419)
                      ++||+|+||.||+|...+       ++.|++|++...... ....+.+|++++++++|+||+++++++.+....++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~-------~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   73 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMEL   73 (251)
T ss_pred             CccccCCCceEEEEEEeC-------CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEc
Confidence            369999999999996432       578999998765433 456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCce
Q 014736          176 MPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH  255 (419)
Q Consensus       176 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  255 (419)
                      +.+++|.+++.... ..+++..+..++.+++.||.|||  +++++||||||+|||++.++.++|+|||++..........
T Consensus        74 ~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH--~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  150 (251)
T cd05041          74 VPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV  150 (251)
T ss_pred             CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee
Confidence            99999999986542 35788899999999999999999  7789999999999999999999999999998654322211


Q ss_pred             eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccccccccC
Q 014736          256 VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA  334 (419)
Q Consensus       256 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  334 (419)
                      ......++..|+|||.+.++.++.++|+||||+++|+|++ |..||...........+.       ..          ..
T Consensus       151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-------~~----------~~  213 (251)
T cd05041         151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-------SG----------YR  213 (251)
T ss_pred             ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-------cC----------CC
Confidence            1112234667999999988899999999999999999999 888887654322111110       00          00


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       335 ~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                      ...+...+.++.+++.+||..+|++||++.+|++.|+
T Consensus       214 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            1122334678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.2e-40  Score=308.95  Aligned_cols=255  Identities=26%  Similarity=0.365  Sum_probs=191.2

Q ss_pred             eecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEec
Q 014736           98 LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFM  176 (419)
Q Consensus        98 ~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  176 (419)
                      .||+|+||.||+|.....    .....+++|.+..... .....+.+|+.+++.++|+||+++++.+......|+||||+
T Consensus         2 ~lg~G~fg~v~~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRG----MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             cCCccCCceEEEEEEecC----CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence            599999999999975432    3346799998764432 23456889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCC
Q 014736          177 PRGSLENHLFKRIS---VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN  253 (419)
Q Consensus       177 ~~g~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  253 (419)
                      .+|+|.+++.....   ...++...+.++.||+.||+|||  ++||+||||||+|||++.++.+||+|||++........
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH--hcCEecccccHhheEecCCCcEEEeccccccccccchh
Confidence            99999999876432   23457778899999999999999  67799999999999999999999999999875333221


Q ss_pred             ceeeeccccccccccccccc-------CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          254 THVTTRVMGTYGYAAPEYIS-------TGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       254 ~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      ........++..|+|||++.       ...++.++|||||||++|||++ |..||........   ..   ..... .. 
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~---~~~~~-~~-  227 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV---LK---QVVRE-QD-  227 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH---HH---HHhhc-cC-
Confidence            11122234677899999874       3457889999999999999999 7888875432211   11   00000 00 


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                      .....    .......+..+.+++..|+ .||++|||+.+|++.|.
T Consensus       228 ~~~~~----~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         228 IKLPK----PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ccCCC----CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            00111    1223345577888999998 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.9e-40  Score=311.56  Aligned_cols=250  Identities=24%  Similarity=0.366  Sum_probs=199.0

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEE
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      |++.+.||+|+||.||+|...      ..+..+++|.+..........+.+|+++++.++|+||+++++++...+..|+|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNK------ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEEC------CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence            567788999999999999644      34578999998766555567788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      |||+.+++|..++.+. ...+++..+..++.|++.||.|||  +.|++|+||||+|||++.++.+||+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH--~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          81 IEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLH--ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence            9999999998887543 246889999999999999999999  6779999999999999999999999999987543221


Q ss_pred             Cceeeeccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYIS-----TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      .  ......|+..|+|||++.     +..++.++|||||||++|+|++|++||........  .....    ...     
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~----~~~-----  224 (282)
T cd06643         158 Q--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKIA----KSE-----  224 (282)
T ss_pred             c--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHHh----hcC-----
Confidence            1  123346899999999983     45678899999999999999999999976432111  11100    000     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        .+.  ...+..++.++.+|+.+||+.||.+||++.++++
T Consensus       225 --~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         225 --PPT--LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             --CCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              000  0112234578999999999999999999998865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.6e-41  Score=311.77  Aligned_cols=245  Identities=26%  Similarity=0.390  Sum_probs=192.9

Q ss_pred             eecccCceEEEEEEEcCcccc-cccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEec
Q 014736           98 LLGEGGFGTVHKGYIDDDLRQ-GLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFM  176 (419)
Q Consensus        98 ~lg~G~fg~Vy~a~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  176 (419)
                      .||+|+||.||+|........ ......|++|.+........+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   81 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV   81 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence            599999999999976543211 2345568999887555455567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc--------EEEeccCccccC
Q 014736          177 PRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT--------AKLSDFGLAKMG  248 (419)
Q Consensus       177 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DfGla~~~  248 (419)
                      .+|+|.+++.... ..+++..++.++.||+.||.|||  ++||+||||||+||+++.++.        ++++|||++...
T Consensus        82 ~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          82 KFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLE--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             CCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            9999999987652 36788899999999999999999  778999999999999987765        699999998754


Q ss_pred             CCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGR-RSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ...      ....++..|+|||++.+ ..++.++||||||+++|+|++|. .||........   .    ......    
T Consensus       159 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~----~~~~~~----  221 (258)
T cd05078         159 LPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---L----QFYEDR----  221 (258)
T ss_pred             CCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---H----HHHHcc----
Confidence            322      22457889999999976 45899999999999999999984 55554322111   1    011111    


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL  370 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L  370 (419)
                              ..++.....++.+|+.+||+.||++|||+++|++.|
T Consensus       222 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         222 --------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             --------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                    012222346799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.9e-40  Score=310.47  Aligned_cols=245  Identities=25%  Similarity=0.398  Sum_probs=190.9

Q ss_pred             eecccCceEEEEEEEcCcc------------------cccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccce
Q 014736           98 LLGEGGFGTVHKGYIDDDL------------------RQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRL  159 (419)
Q Consensus        98 ~lg~G~fg~Vy~a~~~~~~------------------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~  159 (419)
                      .||+|+||.||+|.+..+.                  ........|++|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            5999999999999753211                  1122334689999876544445678889999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC----
Q 014736          160 IGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF----  235 (419)
Q Consensus       160 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~----  235 (419)
                      ++++.++...++||||+++++|..++... ...+++..+..++.||+.||+|||  ++||+||||||+|||++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLE--DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--cCCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999999888653 346889999999999999999999  67899999999999997654    


Q ss_pred             ---cEEEeccCccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHH-cCCCCCCCCCCccchh
Q 014736          236 ---TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELL-TGRRSMDKLRPKSEQN  310 (419)
Q Consensus       236 ---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~~~~~  310 (419)
                         .+||+|||++......      ....++..|+|||++.+ ..++.++||||||+++|||+ +|..||..........
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  232 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER  232 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence               3899999988643221      12347788999998865 56899999999999999995 6999997654322111


Q ss_pred             HHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014736          311 LVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL  370 (419)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L  370 (419)
                      .       .....        .    .+.....++.+++.+||+.+|++|||+.+|++.|
T Consensus       233 ~-------~~~~~--------~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         233 F-------YEKKH--------R----LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             H-------HHhcc--------C----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            1       11100        0    1111235789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-41  Score=325.43  Aligned_cols=241  Identities=24%  Similarity=0.301  Sum_probs=187.3

Q ss_pred             ecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCC---CcccccceeeEEEeCCeeEEE
Q 014736           99 LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQL---RHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        99 lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      ||+|+||+||+|..      ..+++.||+|++.....   .....+..|..++..+   +||||+++++++.+.+..|+|
T Consensus         1 lG~G~~g~Vy~~~~------~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv   74 (330)
T cd05586           1 IGKGTFGQVYQVRK------KDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLV   74 (330)
T ss_pred             CCCCCceEEEEEEE------CCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEE
Confidence            79999999999954      44578899999864322   2233455677776554   699999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      |||+.+|+|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH--~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  150 (330)
T cd05586          75 TDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLH--KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN  150 (330)
T ss_pred             EcCCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC
Confidence            9999999999988765  56889999999999999999999  6779999999999999999999999999987533222


Q ss_pred             CceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDP  331 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (419)
                      .  .....+||..|+|||++.+. .++.++|||||||++|+|++|..||...........+      . . ...      
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i------~-~-~~~------  214 (330)
T cd05586         151 K--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI------A-F-GKV------  214 (330)
T ss_pred             C--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH------H-c-CCC------
Confidence            1  12345799999999998654 5899999999999999999999999764321111110      0 0 000      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 014736          332 RLAGQYSVKGAKEMAVLALQCISVNPKDRP----KMAAVVA  368 (419)
Q Consensus       332 ~l~~~~~~~~~~~l~~li~~~l~~dP~~RP----s~~eil~  368 (419)
                      .+.   ....+.++.+++.+||+.||.+||    ++.++++
T Consensus       215 ~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         215 RFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            000   112357889999999999999998    5666655

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.7e-40  Score=314.98  Aligned_cols=266  Identities=22%  Similarity=0.302  Sum_probs=199.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|.+.+.||+|+||.||+|...      .+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~   79 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSK------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   79 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEc------CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence            57899999999999999999643      3467899999875432 2335677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+. ++|.+++... ...+++..+..++.||+.||.|||  ++||+|+||||+|||++.++.++|+|||++....
T Consensus        80 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (301)
T ss_pred             EEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence            99999995 6898887654 346788899999999999999999  6789999999999999999999999999987543


Q ss_pred             CCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh--------HHhh
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK--------PYLR  320 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--------~~~~  320 (419)
                      ....  ......++..|+|||++.+ ..++.++||||||+++|+|++|++||................        +...
T Consensus       156 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         156 IPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  233 (301)
T ss_pred             CCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence            3221  1223357889999998865 457889999999999999999999998654322111110000        0000


Q ss_pred             cccccccccccccCC----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          321 SSRRLRYIVDPRLAG----QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       321 ~~~~~~~~~~~~l~~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ..........+....    ......+.++.+||.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000000000000    111234668899999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=312.91  Aligned_cols=253  Identities=26%  Similarity=0.411  Sum_probs=203.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|.+.+.||.|+||.||+|....      +++.||+|++..........+.+|+++++.++|+||+++++++......|
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKE------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW   78 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcC------CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence            468888899999999999996532      46789999998665556678889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+++++|.+++... ...+++..+..++.|++.||.|||  ++||+|+||||+||+++.++.++|+|||++.....
T Consensus        79 lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          79 ILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLH--SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             EEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            999999999999988654 246889999999999999999999  67899999999999999999999999999876433


Q ss_pred             CCCceeeeccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYIS-----TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      ...  ......|+..|+|||++.     ...++.++|+||||+++|+|++|..||........  ....    . ...  
T Consensus       156 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~----~-~~~--  224 (280)
T cd06611         156 TLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKI----L-KSE--  224 (280)
T ss_pred             ccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHH----h-cCC--
Confidence            221  123346899999999874     34578899999999999999999999976532211  1100    0 000  


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                          .+.+  ..+...+.++.+++.+||+.+|.+||++.+|++.
T Consensus       225 ----~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         225 ----PPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ----CCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                0000  1122345789999999999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.7e-40  Score=314.03  Aligned_cols=263  Identities=27%  Similarity=0.444  Sum_probs=204.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|+..+.||+|+||.||+|.+..+.  ......||+|.+..... .....+.+|+.+++.++||||+++++++... ..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEG--ETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCC--CcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            46788899999999999999765421  11234689998875433 2234688999999999999999999988654 56


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++++||+++|+|.+++... ...+++..++.++.|++.||.|||  ++||+|+||||+||+++.++.+||+|||+++...
T Consensus        84 ~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHh--hcCeeccccccceeeecCCCceEEcccccccccc
Confidence            7999999999999998654 235788899999999999999999  6789999999999999999999999999998654


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ............++..|+|||++.+..++.++||||||+++|||++ |+.||.......   ...+    .......   
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~~~---  230 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDL----LEKGERL---  230 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHCCCCC---
Confidence            3322212222345778999999988999999999999999999997 899997643211   1111    1111110   


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                             ..+..++..+.+++.+||..+|++||++.++++.|..+...
T Consensus       231 -------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         231 -------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                   01122346789999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.1e-40  Score=307.20  Aligned_cols=251  Identities=26%  Similarity=0.411  Sum_probs=199.8

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc------ccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL------QGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      +|.+.+.||+|+||.||+|...       +++.+|+|.+.....      .....+.+|+++++.++|+||+++++++.+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   73 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD   73 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec
Confidence            4788899999999999999632       357899999864321      123557889999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      .+..++||||+++++|.+++.+.  ..+++..+..++.|++.||.|||  +.+|+|+||+|+||+++.++.++|+|||++
T Consensus        74 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  149 (265)
T cd06631          74 DNTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLH--NNCVVHRDIKGNNVMLMPNGIIKLIDFGCA  149 (265)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHhEEECCCCeEEeccchhh
Confidence            99999999999999999999765  46788899999999999999999  677999999999999999999999999998


Q ss_pred             ccCCCCC----CceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhc
Q 014736          246 KMGPEGS----NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS  321 (419)
Q Consensus       246 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  321 (419)
                      .......    .........|+..|+|||++.+..++.++||||||+++|+|++|..||............      . .
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~-~  222 (265)
T cd06631         150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI------G-A  222 (265)
T ss_pred             HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh------h-h
Confidence            7542211    111122346899999999999888999999999999999999999999754321111000      0 0


Q ss_pred             ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          322 SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       322 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ..        ......+...+.++.+++.+||+.+|.+||++.++++
T Consensus       223 ~~--------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         223 HR--------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             cc--------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00        0011122335678999999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.2e-40  Score=306.31  Aligned_cols=247  Identities=31%  Similarity=0.488  Sum_probs=199.8

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|.+.+.||+|+||.||+|..        .++.||+|++....  ....+.+|+.+++.++||||+++++++..+ ..+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   74 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY   74 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence            4688999999999999999842        35679999986532  346788999999999999999999998654 479


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+.+++|.+++.......+++..++.++.|++.||.|||  ++|++||||||+||+++.++.+||+|||++.....
T Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~  152 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM  152 (254)
T ss_pred             EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence            9999999999999997765556889999999999999999999  78899999999999999999999999999876432


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      ..     .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||............       ....      
T Consensus       153 ~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~------  214 (254)
T cd05083         153 GV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV-------EKGY------  214 (254)
T ss_pred             cC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-------hCCC------
Confidence            21     12234567999999988899999999999999999997 99999765432211111       1110      


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES  372 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~  372 (419)
                          ........+.++.+++.+||+.+|++||++.+|++.|++
T Consensus       215 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         215 ----RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ----CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                001122345789999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=316.12  Aligned_cols=265  Identities=27%  Similarity=0.452  Sum_probs=219.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc-HHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-HREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .+...+.++||+|.||.|.+|....       +..||+|+++...... .++|.+|+++|.+|+|||||.++++|..++.
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg-------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP  609 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEG-------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP  609 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecC-------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence            4566788899999999999997554       4789999998765544 4889999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      +++|+||+++|+|.+++.++............|+.||+.||+||.+.+  +|||||.+.|+|+++++++||+|||+++-+
T Consensus       610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~l  687 (807)
T KOG1094|consen  610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNL  687 (807)
T ss_pred             hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCccccccc
Confidence            999999999999999998875444444556789999999999999655  999999999999999999999999999988


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT--GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ..+....+..+.+-...|||+|.+.-++++.++|+|+||+++||+++  ...||.......   .++-...++....   
T Consensus       688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~---  761 (807)
T KOG1094|consen  688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQG---  761 (807)
T ss_pred             ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCC---
Confidence            88888877778888899999999999999999999999999999865  678887654322   2322223222221   


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                          ....-..+.-++.++.+++.+||..+-.+||+++++-..|...
T Consensus       762 ----~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  762 ----RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ----cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                1112233456788999999999999999999999998887754

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-41  Score=325.02  Aligned_cols=248  Identities=24%  Similarity=0.341  Sum_probs=209.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc--HHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ..|.+...||+|.|+.|.+|+      +..++..||||++++.....  .+.+.+|+.+|..++|||||+++.+.+....
T Consensus        56 g~y~i~~tig~g~f~~V~La~------~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLAR------HILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT  129 (596)
T ss_pred             cceeeeeeeccceeEEEEeeE------ecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence            468899999999999999995      45567889999998775433  3568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      +|+||||+.+|.+++++.++  ..+.+..+..++.|++.|++|||  .++|||||||.+||||+.+.++||+|||++.++
T Consensus       130 lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH--~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCH--SKNIVHRDLKAENILLDENMNIKIADFGFSTFF  205 (596)
T ss_pred             eEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHh--hcceeccccchhhcccccccceeeeccccceee
Confidence            99999999999999999877  45666888999999999999999  667999999999999999999999999999987


Q ss_pred             CCCCCceeeecccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHL-TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ..+.   ....++|++.|.|||++.+..| ++.+|+||+|+++|.|++|.+||++.........+.        .+++  
T Consensus       206 ~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl--------~gk~--  272 (596)
T KOG0586|consen  206 DYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL--------RGKY--  272 (596)
T ss_pred             cccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe--------eeee--
Confidence            6443   3566899999999999998777 489999999999999999999999765443222110        0000  


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                              ..+...+.++.+||.++|..+|.+|+++++|++-
T Consensus       273 --------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  273 --------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             --------cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence                    1223345689999999999999999999999864

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.1e-40  Score=310.41  Aligned_cols=266  Identities=22%  Similarity=0.258  Sum_probs=198.0

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      +|++.+.||+|+||.||+|+..      .+++.||+|++.....  .....+.+|+.+++.++||||+++++++.+++..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNK------KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL   74 (285)
T ss_pred             CceEeeEecccCceEEEEEEEC------CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence            4788899999999999999643      3467899999865432  2346678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          170 LLVYEFMPRGSLENHLFKRIS-VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      |+||||+. ++|.+++..... ..+++..++.++.||+.||.|||  .+||+|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH--SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            99999996 689888765332 56889999999999999999999  678999999999999999999999999998754


Q ss_pred             CCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHH-Hhhh-------HHh
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV-DWAK-------PYL  319 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~-------~~~  319 (419)
                      ....  .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||............ ....       +..
T Consensus       152 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd07861         152 GIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV  229 (285)
T ss_pred             CCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence            3321  11223457889999998865 45789999999999999999999999764322111000 0000       000


Q ss_pred             hcccccccccccccC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          320 RSSRRLRYIVDPRLA---GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~---~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ...............   .......++++.+++.+||+.||.+|||+.+|++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000000000000000   0011224678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5e-40  Score=303.87  Aligned_cols=256  Identities=32%  Similarity=0.511  Sum_probs=204.5

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-cHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEE
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLL  171 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  171 (419)
                      |.+.+.||.|+||.||+|.+.+.  ....+..||+|++...... ....+..|+.++..++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGL--SGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCC--CCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            45678899999999999986553  1134588999999765433 56788899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCC
Q 014736          172 VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG  251 (419)
Q Consensus       172 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  251 (419)
                      +|||+++++|.+++.......+++..+..++.|++.||.|||  +.|++|+||||+||+++.++.++|+|||++......
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh--~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh--cCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999999987654333899999999999999999999  678999999999999999999999999999876544


Q ss_pred             CCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccccc
Q 014736          252 SNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD  330 (419)
Q Consensus       252 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (419)
                      ..... ....++..|+|||.+.+..++.++||||||+++|+|++ |.+||.......   .....    .....      
T Consensus       157 ~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~------  222 (258)
T smart00219      157 DYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEYL----KKGYR------  222 (258)
T ss_pred             ccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----hcCCC------
Confidence            22211 12237789999999988889999999999999999998 788887532211   11111    01100      


Q ss_pred             cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014736          331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL  370 (419)
Q Consensus       331 ~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L  370 (419)
                          .......+.++.+++.+||..||++|||+.++++.|
T Consensus       223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 ----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                011122567899999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.8e-40  Score=304.61  Aligned_cols=250  Identities=27%  Similarity=0.421  Sum_probs=204.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|++.+.||+|+||.||+|.+..      .++.|++|.+.....  ...+.+|+.+++.++|+||+++++++.+....|
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKE------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLW   74 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcC------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEE
Confidence            578899999999999999997543      357899999875432  678899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +++||+.+++|.+++... ...+++..+..++.|++.||.|||  +.+++|+||+|.||+++.++.++|+|||++.....
T Consensus        75 l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          75 IVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLH--SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             EEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            999999999999998653 246889999999999999999999  67799999999999999999999999999886544


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD  330 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (419)
                      ...  ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....+......+        ...     ..
T Consensus       152 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~--------~~~-----~~  216 (256)
T cd06612         152 TMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--------PNK-----PP  216 (256)
T ss_pred             Ccc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh--------ccC-----CC
Confidence            321  122345889999999998889999999999999999999999999864332211000        000     00


Q ss_pred             cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       331 ~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .  ....+...+.++.+++.+||+.||++|||+.+|++
T Consensus       217 ~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         217 P--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             C--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            0  01122334578999999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.8e-40  Score=307.58  Aligned_cols=249  Identities=24%  Similarity=0.357  Sum_probs=203.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ..|+..+.||+|+||.||+|...      ..++.||+|++.... ......+.+|+.+++.++|+||+++++++.++...
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDN------RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKL   77 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEc------cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            45777888999999999999643      346789999987543 23456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+||||+.+++|.+++..   ..+++..+..++.|++.||.|||  .++++|+||+|+||+++.++.++|+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh--~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~  152 (277)
T cd06640          78 WIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLH--SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             EEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence            999999999999998864   35788889999999999999999  6789999999999999999999999999997654


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      ....  ......++..|+|||++.+..++.++|+||||+++|+|++|..||....+.......                 
T Consensus       153 ~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-----------------  213 (277)
T cd06640         153 DTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-----------------  213 (277)
T ss_pred             CCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-----------------
Confidence            3221  122345888999999998888999999999999999999999999764432111000                 


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      ............+..+.+++.+||+.+|++||++.+++..
T Consensus       214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         214 PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            0111123344567889999999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-41  Score=325.11  Aligned_cols=245  Identities=27%  Similarity=0.390  Sum_probs=203.4

Q ss_pred             eecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEecC
Q 014736           98 LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMP  177 (419)
Q Consensus        98 ~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  177 (419)
                      +||+|.||+||.|+      +..+...+|||-+........+-+..||.+.+.|+|.|||+++|.+.+++++-|.||-++
T Consensus       582 VLGKGTYG~VYA~R------D~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVP  655 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAAR------DMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVP  655 (1226)
T ss_pred             EeecCceeEEEeec------cccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCC
Confidence            69999999999995      444567799999986666667788899999999999999999999999999999999999


Q ss_pred             CCChhhhhhhccCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCcEEEeccCccccCCCCCCc
Q 014736          178 RGSLENHLFKRISVSL--PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS-DFTAKLSDFGLAKMGPEGSNT  254 (419)
Q Consensus       178 ~g~L~~~l~~~~~~~~--~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~~  254 (419)
                      ||+|..++...- +++  .+.++-.+.+||++||+|||  ++.|||||||-+||||+. .|.+||+|||.++.+..-  .
T Consensus       656 GGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLH--en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--n  730 (1226)
T KOG4279|consen  656 GGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLH--ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--N  730 (1226)
T ss_pred             CCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhh--hcceeeccccCCcEEEeeccceEEecccccchhhccC--C
Confidence            999999997653 233  67788899999999999999  777999999999999975 689999999999876543  3


Q ss_pred             eeeecccccccccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          255 HVTTRVMGTYGYAAPEYISTG--HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       255 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                      ..+.++.||..|||||++..+  .|+.++|||||||++.||.||++||-........-   +....+            .
T Consensus       731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---FkVGmy------------K  795 (1226)
T KOG4279|consen  731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---FKVGMY------------K  795 (1226)
T ss_pred             ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---hhhcce------------e
Confidence            345668899999999999764  68999999999999999999999997653322110   000000            1


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .....+.+.+.++..+|.+|+.+||.+||++.+++.
T Consensus       796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            123567788999999999999999999999999975

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5e-40  Score=307.00  Aligned_cols=259  Identities=27%  Similarity=0.447  Sum_probs=201.4

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEeCC---
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE---  167 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---  167 (419)
                      |.+.+.||+|+||.||+|.+..   ...+++.||+|++....  ....+.+.+|+.+++.++||||+++++++....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~---~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKS---EDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeec---cCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            5677889999999999997653   23457889999986542  234567889999999999999999999886532   


Q ss_pred             ---eeEEEEEecCCCChhhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 014736          168 ---ERLLVYEFMPRGSLENHLFKRI----SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS  240 (419)
Q Consensus       168 ---~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  240 (419)
                         ..+++++|+.+++|.+++....    ...+++...+.++.||+.||+|||  ++||+||||||+||+++.++.+||+
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~nili~~~~~~kl~  155 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS--SKNFIHRDLAARNCMLNENMTVCVA  155 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccchhhEEEcCCCCEEEC
Confidence               2478899999999998874321    235788889999999999999999  6789999999999999999999999


Q ss_pred             ccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHh
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYL  319 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  319 (419)
                      |||+++...............++..|++||.+....++.++||||||+++|+|++ |.+||.......   ...+..   
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~---  229 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI---  229 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH---
Confidence            9999986543322222223346678999999988899999999999999999999 889887543211   111110   


Q ss_pred             hcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          320 RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                       .....          ..+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       230 -~~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 -KGNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -cCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             11100          11123456899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-40  Score=310.29  Aligned_cols=253  Identities=25%  Similarity=0.363  Sum_probs=200.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC-CcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|++.+.||+|+||.||+|...      ..++.||+|.+... .......+.+|+.++++++|+||+++++.+..++..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHR------PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAV   74 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEc------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeE
Confidence            36888899999999999999643      34688999988654 223346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          170 LLVYEFMPRGSLENHLFKRI-SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      |+||||+++++|..++.... ...+++..+..++.|++.||.|||. +.||+|+||||+||+++.++.+||+|||++...
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99999999999988886532 2368999999999999999999994 247999999999999999999999999998764


Q ss_pred             CCCCCceeeecccccccccccccccCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTG------HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      ....    .....|+..|+|||++.+.      .++.++|+|||||++|+|++|..||..............        
T Consensus       154 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~--------  221 (286)
T cd06622         154 VASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA--------  221 (286)
T ss_pred             cCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH--------
Confidence            3221    2234588899999998543      358899999999999999999999975432211111100        


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                           +... .....+...+.++.+|+.+||+.+|++||++.++++
T Consensus       222 -----~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         222 -----IVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             -----Hhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                 0000 011223346688999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.3e-40  Score=303.66  Aligned_cols=249  Identities=27%  Similarity=0.420  Sum_probs=202.8

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      +|.+.+.||+|+||.||+|....      +++.+|+|.+.....  .....+.+|+++++.++||||+++++.+...+..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKA------DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL   74 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcC------CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEE
Confidence            58888999999999999996543      468899999875432  3356788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-cEEEeccCccccC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-TAKLSDFGLAKMG  248 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~  248 (419)
                      ++||||+++++|.+++.......+++..+..++.|++.||.|||  ++|++|+||||+||+++.++ .+||+|||++...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH--TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999999999999998765556899999999999999999999  67899999999999998654 5899999999865


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      .....   .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.......   .....   ..  ..    
T Consensus       153 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~---~~--~~----  217 (256)
T cd08220         153 SSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKI---MS--GT----  217 (256)
T ss_pred             CCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHH---Hh--cC----
Confidence            44322   223458899999999988889999999999999999999999997653321   11110   00  00    


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                           ....+...+.++.+++.+||+.||.+|||+.++++
T Consensus       218 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         218 -----FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             -----CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                 01122234678999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-42  Score=327.98  Aligned_cols=251  Identities=24%  Similarity=0.374  Sum_probs=204.7

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEE
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLL  171 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  171 (419)
                      .|.++..||.|+||.||+|..+      .++-..|.|++........++++-||+||...+||+||++++.|..++.++|
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nk------et~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi  106 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNK------ETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI  106 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcc------cchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence            3556667999999999999543      3455678898887777778899999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCC
Q 014736          172 VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG  251 (419)
Q Consensus       172 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  251 (419)
                      +.|||.||-....+.... ..+++..+..+++|++.||.|||  +++|||||||..|||++.+|.++|+|||.+..... 
T Consensus       107 liEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LH--s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-  182 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLH--SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-  182 (1187)
T ss_pred             EEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHh--hcchhhhhccccceEEEecCcEeeecccccccchh-
Confidence            999999999888876653 46889999999999999999999  56699999999999999999999999999764221 


Q ss_pred             CCceeeeccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          252 SNTHVTTRVMGTYGYAAPEYIS-----TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       252 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                       .......++||++|||||+..     ..+|+.++||||||++|.||..+.+|....++....-.+  ..          
T Consensus       183 -t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi--aK----------  249 (1187)
T KOG0579|consen  183 -TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI--AK----------  249 (1187)
T ss_pred             -HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH--hh----------
Confidence             112234578999999999874     578999999999999999999999998766543211111  10          


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       .-.+.|  .-+..++..+.+++.+||.+||..||++.++++
T Consensus       250 -SePPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  250 -SEPPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             -cCCCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence             011111  124567788999999999999999999999974

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.5e-40  Score=304.45  Aligned_cols=257  Identities=26%  Similarity=0.370  Sum_probs=206.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|++.+.||.|+||+||+|....      .+..+++|++..... .....+.+|+++++.++|+||+++++.+...+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLP------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDEL   74 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcC------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEE
Confidence            478999999999999999996543      467899999875432 2457788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          170 LLVYEFMPRGSLENHLFKRIS-VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      |+|||++++++|.+++..... ..+++..+..++.|++.||.|||  ++|++|+||+|+||++++++.++|+|||++...
T Consensus        75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh--~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--SNGQIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            999999999999999976533 56889999999999999999999  778999999999999999999999999998765


Q ss_pred             CCCCCce--eeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          249 PEGSNTH--VTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       249 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      .......  ......|+..|+|||++... .++.++|+||||+++|+|++|+.||.........  .....    ..   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~--~~~~~----~~---  223 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL--MLTLQ----ND---  223 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH--HHHhc----CC---
Confidence            5443221  22345689999999998776 7899999999999999999999999765432211  11000    00   


Q ss_pred             ccccccccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          326 RYIVDPRLAGQ-YSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       326 ~~~~~~~l~~~-~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                          .+.+... .....+.++.+++.+||..||++||++.+|++
T Consensus       224 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         224 ----PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             ----CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                0011111 11245678999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.3e-40  Score=311.41  Aligned_cols=245  Identities=29%  Similarity=0.384  Sum_probs=200.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|.+.+.||+|+||.||+|....      .++.||+|++....   ......+.+|++++++++||||+++++++.+++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKG------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS   74 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC
Confidence            468899999999999999996543      46889999986532   233466889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+.+++|.+++...  ..+++..+..++.||+.||.|||  ++|++|+||+|.|||++.++.+||+|||++..
T Consensus        75 ~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~  150 (290)
T cd05580          75 NLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLH--SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR  150 (290)
T ss_pred             eEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence            999999999999999998766  57889999999999999999999  67899999999999999999999999999987


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ....     .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.......   ....   ....  .   
T Consensus       151 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~---~~~~--~---  214 (290)
T cd05580         151 VKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IYEK---ILEG--K---  214 (290)
T ss_pred             cCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HhcC--C---
Confidence            5443     223468999999999988889999999999999999999999997644211   1110   0000  0   


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~  368 (419)
                             ..++...+..+.+++.+||..||.+|+     +++++++
T Consensus       215 -------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         215 -------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             -------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence                   012223357899999999999999998     6666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.1e-40  Score=310.54  Aligned_cols=248  Identities=25%  Similarity=0.365  Sum_probs=200.4

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      .|...+.||+|+||.||+|....      .++.||+|.+.... ......+.+|+.+++.++|+||+++++++..++..|
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNR------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLW   78 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcC------CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceE
Confidence            45566779999999999996533      35789999987543 233457889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+.+++|.+++..   ..+++..+..++.|++.||.|||  ++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH--~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          79 IIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLH--SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             EEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh--cCCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence            99999999999998854   36788999999999999999999  67899999999999999999999999999876543


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD  330 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (419)
                      ...  ......|+..|+|||++.+..++.++||||||+++|+|++|..||....+...   ...    ..          
T Consensus       154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~----~~----------  214 (277)
T cd06642         154 TQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFL----IP----------  214 (277)
T ss_pred             cch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hhh----hh----------
Confidence            221  12234588999999999988999999999999999999999999875432211   100    00          


Q ss_pred             cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       331 ~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      ...........+.++.+++.+||+.+|.+||++.+|++.
T Consensus       215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         215 KNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             cCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            001112223346789999999999999999999999973

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.6e-40  Score=313.61  Aligned_cols=264  Identities=22%  Similarity=0.319  Sum_probs=188.1

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEe--CCeeEEEE
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE--DEERLLVY  173 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~  173 (419)
                      ..+||+|+||.||+|...+    ...+..||+|.+....  ....+.+|+.+++.++||||+++++++..  +...++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~----~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKD----GKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecC----CCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence            3579999999999997543    2345789999987543  23467789999999999999999998854  46789999


Q ss_pred             EecCCCChhhhhhhc-------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE----cCCCcEEEecc
Q 014736          174 EFMPRGSLENHLFKR-------ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL----DSDFTAKLSDF  242 (419)
Q Consensus       174 e~~~~g~L~~~l~~~-------~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll----~~~~~~kl~Df  242 (419)
                      ||+. ++|.+++...       ....+++..+..++.||+.||.|||  ++||+||||||+|||+    +.++.+||+||
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH--hCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9985 5787776422       1235788889999999999999999  6779999999999999    45678999999


Q ss_pred             CccccCCCCCCc-eeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccch------hHHHh
Q 014736          243 GLAKMGPEGSNT-HVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQ------NLVDW  314 (419)
Q Consensus       243 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~~~~~  314 (419)
                      |+++........ .......||..|+|||++.+ ..++.++|||||||++|||++|++||.........      .....
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR  236 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence            999865433221 11233568999999999876 45899999999999999999999999754322110      00000


Q ss_pred             hhHHhh--------c---c---cccccccc------ccc---CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          315 AKPYLR--------S---S---RRLRYIVD------PRL---AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       315 ~~~~~~--------~---~---~~~~~~~~------~~l---~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ....+.        .   .   ........      ..+   ...........+.+|+.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence            000000        0   0   00000000      000   00011122456889999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.7e-40  Score=304.44  Aligned_cols=254  Identities=24%  Similarity=0.393  Sum_probs=202.3

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc------ccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL------QGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      +|+..+.||+|+||.||+|..      ..+++.||+|++.....      .....+.+|+.+++.++|+||+++++++.+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~------~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   74 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARD------VKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE   74 (268)
T ss_pred             CccccceecCcCceEEEEEEE------cCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc
Confidence            478889999999999999953      34568899999875431      124578899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-cEEEeccCc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-TAKLSDFGL  244 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGl  244 (419)
                      .+..++||||+.+++|.+++.+.  ..+++..+..++.||+.||.|||  ++|++|+||+|+||+++.++ .++|+|||+
T Consensus        75 ~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH--~~~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          75 DSHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLH--ENQIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CCeEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            99999999999999999998764  46888999999999999999999  67899999999999998776 599999999


Q ss_pred             cccCCCCCCc--eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          245 AKMGPEGSNT--HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       245 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      +.........  .......|+..|+|||++.+..++.++||||||+++|+|++|..||...............   .   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~---  224 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI---A---  224 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHH---h---
Confidence            8765432111  1122346889999999998888999999999999999999999999754332211111100   0   


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                             ........+...+.++.+++.+||..+|.+||++.+++.
T Consensus       225 -------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         225 -------SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -------ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                   001112334456678999999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.6e-40  Score=304.34  Aligned_cols=250  Identities=25%  Similarity=0.368  Sum_probs=203.0

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      +|++.+.||+|+||.||++...      ..++.||+|.+....  ......+.+|+.+++.++|+||+++++++.+.+..
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSK------EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNL   74 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEc------CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE
Confidence            5888999999999999999643      346789999986542  23345788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+.+++|.+++.......+++..++.++.|++.||.|||  ++|++|+||+|+|||++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~  152 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN  152 (256)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence            99999999999999987654456788999999999999999999  6789999999999999999999999999997654


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      .....  .....|+..|+|||++.+..++.++|+||||+++|+|++|..||.......   ..   ..... . .     
T Consensus       153 ~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~~---~~~~~-~-~-----  217 (256)
T cd08218         153 STVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN---LV---LKIIR-G-S-----  217 (256)
T ss_pred             cchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH---HH---HHHhc-C-C-----
Confidence            33211  123458889999999988889999999999999999999999997532211   11   11100 0 0     


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                          ....+...+.++.+++.+||+.+|.+||++.+|++
T Consensus       218 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         218 ----YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ----CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                01122344678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=325.08  Aligned_cols=243  Identities=31%  Similarity=0.422  Sum_probs=199.1

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc---cHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ---GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      |.-++.||.|+||.||-|+      +..+.+.||||++...+..   .+.++++|+..|+++.|||+|.+.|+|..+...
T Consensus        28 f~dLrEIGHGSFGAVYfAr------d~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~Ta  101 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFAR------DVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTA  101 (948)
T ss_pred             HHHHHHhcCCccceeEEee------ccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchH
Confidence            5556679999999999995      4556789999999866543   357789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ||||||| -|+-.|++.-. .+++.+.++..|+.+.+.||.|||++  +.||||||..|||+++.|.|||+|||.|....
T Consensus       102 WLVMEYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~--~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~  177 (948)
T KOG0577|consen  102 WLVMEYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH--NRIHRDIKAGNILLSEPGLVKLADFGSASIMA  177 (948)
T ss_pred             HHHHHHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHh--hHHhhhccccceEecCCCeeeeccccchhhcC
Confidence            9999999 45666655322 35688889999999999999999954  49999999999999999999999999998654


Q ss_pred             CCCCceeeeccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYIS---TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ..      ..++|||+|||||++.   .+.|+-++||||||++..||.-.++|+...+.......+  +       .   
T Consensus       178 PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI--A-------Q---  239 (948)
T KOG0577|consen  178 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--A-------Q---  239 (948)
T ss_pred             ch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH--H-------h---
Confidence            43      3478999999999984   578999999999999999999999998765432211111  1       0   


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV  367 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil  367 (419)
                       .-.|.+.   ..+++..++.++..||++-|++|||.++++
T Consensus       240 -NesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll  276 (948)
T KOG0577|consen  240 -NESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELL  276 (948)
T ss_pred             -cCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence             1112222   456789999999999999999999999886

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.9e-40  Score=303.05  Aligned_cols=244  Identities=26%  Similarity=0.429  Sum_probs=191.9

Q ss_pred             CeecccCceEEEEEEEcCcccc----cccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQ----GLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      +.||+|+||.||+|...+....    ......+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            3699999999999987653211    222346888887654333 6788899999999999999999999987 778999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-------cEEEeccCcc
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-------TAKLSDFGLA  245 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~-------~~kl~DfGla  245 (419)
                      |||+.+++|.+++..... .+++..+..++.||+.||.|||  ++||+||||||+|||++.++       .+||+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh--hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            999999999999876532 6888999999999999999999  67899999999999999887       7999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccCC--CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTG--HLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      ......      ....++..|+|||++.+.  .++.++||||||+++|+|++ |..||............       ...
T Consensus       156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~-------~~~  222 (259)
T cd05037         156 ITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY-------QDQ  222 (259)
T ss_pred             cccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-------hcC
Confidence            864431      123467789999999776  78999999999999999999 57777665422111110       000


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL  370 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L  370 (419)
                      ..            .+......+.+++.+||..+|.+||++.+|++.|
T Consensus       223 ~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         223 HR------------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             CC------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            00            0001126799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=8.2e-40  Score=304.65  Aligned_cols=251  Identities=25%  Similarity=0.352  Sum_probs=196.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-----ccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-----QGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      .+|...+.||+|+||.||+|...      .++..|++|++.....     .....+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   75 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDV------DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD   75 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEc------CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc
Confidence            36889999999999999999643      3467899998864321     223567889999999999999999998875


Q ss_pred             --CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccC
Q 014736          166 --DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFG  243 (419)
Q Consensus       166 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  243 (419)
                        ....+++|||+++++|.+++...  ..+++...+.++.|++.||.|||  +.+|+|+||||+||+++.++.++|+|||
T Consensus        76 ~~~~~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH--~~~i~H~~l~p~nil~~~~~~~~l~dfg  151 (266)
T cd06651          76 RAEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLH--SNMIVHRDIKGANILRDSAGNVKLGDFG  151 (266)
T ss_pred             CCCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEEEccCC
Confidence              35788999999999999998765  45788889999999999999999  6779999999999999999999999999


Q ss_pred             ccccCCCCCCc-eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          244 LAKMGPEGSNT-HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       244 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      ++......... .......++..|+|||++.+..++.++|||||||++|+|++|+.||.......   .+   .....  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~---~~---~~~~~--  223 (266)
T cd06651         152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA---AI---FKIAT--  223 (266)
T ss_pred             CccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH---HH---HHHhc--
Confidence            98754322111 11123458899999999988889999999999999999999999997542211   01   00000  


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                              ......++...++.+.+++ +||..+|++||++++|++
T Consensus       224 --------~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         224 --------QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             --------CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                    0011223334556788888 688889999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.7e-40  Score=306.11  Aligned_cols=255  Identities=24%  Similarity=0.398  Sum_probs=199.4

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc----------ccHHHHHHHHHHHcCCCcccccceee
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL----------QGHREWLAEVIFLGQLRHPHLVRLIG  161 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~hpnIv~~~~  161 (419)
                      +|.+.+.||+|+||.||+|...      .+++.||+|.+.....          ...+.+.+|+.+++.++|+||+++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~------~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   75 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNV------TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLG   75 (272)
T ss_pred             ceeecceecccCceEEEEEeec------CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEE
Confidence            4778889999999999999643      3467899998853211          11245778999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          162 YCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       162 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                      ++...+..++||||+.+++|.+++.+.  ..+++..+..++.||+.||.|||  ++|++|+||+|+||+++.++.++|+|
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~~~nil~~~~~~~~l~d  151 (272)
T cd06629          76 FETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLH--SKGILHRDLKADNLLVDADGICKISD  151 (272)
T ss_pred             EeccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh--hCCeeecCCChhhEEEcCCCeEEEee
Confidence            999999999999999999999998765  56888899999999999999999  67899999999999999999999999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHh
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH--LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYL  319 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  319 (419)
                      ||++................|+..|+|||++....  ++.++|+||||+++|+|++|..||.......  ....    ..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~----~~  225 (272)
T cd06629         152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AMFK----LG  225 (272)
T ss_pred             ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HHHH----hh
Confidence            99998644322222223456889999999987654  8899999999999999999999996432211  0000    00


Q ss_pred             hcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          320 RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       . ...    ...+........+.++.+++.+||..+|++||++.+|++
T Consensus       226 -~-~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         226 -N-KRS----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             -c-ccc----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence             0 000    111111222345678999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.7e-39  Score=302.95  Aligned_cols=255  Identities=23%  Similarity=0.355  Sum_probs=189.8

Q ss_pred             eecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEec
Q 014736           98 LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFM  176 (419)
Q Consensus        98 ~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  176 (419)
                      .||+|+||.||+|.....    .....+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....|+||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTD----TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcC----CCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            599999999999965432    223457778776543 234567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCc
Q 014736          177 PRGSLENHLFKRI--SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT  254 (419)
Q Consensus       177 ~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  254 (419)
                      ++|+|.+++.+..  ....+...++.++.||+.||.|||  +.+++||||||+|||++.++.++|+|||++.........
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence            9999999987642  234566677899999999999999  677999999999999999999999999998643222111


Q ss_pred             eeeecccccccccccccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          255 HVTTRVMGTYGYAAPEYIST-------GHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       255 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      .......|+..|+|||++..       ..++.++||||||+++|||++ |..||.......   ....   ....  ...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~---~~~~--~~~  227 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VLNH---VIKD--QQV  227 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH---HHhh--ccc
Confidence            12233568899999998743       245789999999999999997 577886543221   1111   0100  011


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                      ...++.+.    ...+..+.+++..|| .+|++||++.+|++.|.
T Consensus       228 ~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         228 KLFKPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ccCCCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11122222    224567888999999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.1e-40  Score=312.34  Aligned_cols=257  Identities=23%  Similarity=0.292  Sum_probs=201.8

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|.+.+.||+|+||.||+|..      ...++.|++|.+.....   .....+.+|+++++.++||||+++++.+..++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~------~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRH------KETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR   74 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEE------CCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC
Confidence            3688899999999999999964      34467899999875432   23456788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..++||||++|++|.+++...  ..+++..+..++.|++.||.|||  ++|++|+||||+||+++.++.+||+|||+++.
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          75 HLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLH--NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            999999999999999999665  46889999999999999999999  67899999999999999999999999999874


Q ss_pred             CCCCCCc-------------eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHh
Q 014736          248 GPEGSNT-------------HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW  314 (419)
Q Consensus       248 ~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  314 (419)
                      .......             .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+.....   ... 
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~~~-  226 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFG-  226 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH-
Confidence            2111100             01112457889999999988899999999999999999999999997543221   111 


Q ss_pred             hhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 014736          315 AKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES  372 (419)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~  372 (419)
                        ......  .   ..+.    .....+.++.+++.+||+.||++||+..++.+.|+.
T Consensus       227 --~~~~~~--~---~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         227 --QVISDD--I---EWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             --HHHhcc--c---CCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence              000000  0   0000    011345789999999999999999997777766665

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=9.9e-40  Score=304.37  Aligned_cols=253  Identities=23%  Similarity=0.336  Sum_probs=199.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++++.....||+|+||.||+|...+      ++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..
T Consensus         7 ~~~~~~~~~lg~g~~g~v~~~~~~~------~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (268)
T cd06624           7 YDENGERVVLGKGTYGIVYAARDLS------TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF   80 (268)
T ss_pred             cccCCceEEEecCCceEEEEeEecC------CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence            4455556689999999999996433      4678999998766656667889999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCcEEEeccCccc
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSL--PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS-DFTAKLSDFGLAK  246 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~  246 (419)
                      ++||||+.+++|.+++.... ..+  ++..+..++.||+.||.|||  .+||+||||||+||+++. ++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          81 KIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLH--DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            99999999999999987542 233  77788899999999999999  678999999999999986 6789999999987


Q ss_pred             cCCCCCCceeeecccccccccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTG--HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      .......  ......|+..|+|||++...  .++.++||||||+++|+|++|..||........   ..+......    
T Consensus       158 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~----  228 (268)
T cd06624         158 RLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK----  228 (268)
T ss_pred             ecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc----
Confidence            6433221  12234588999999998654  378999999999999999999999975432111   111100000    


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                              ....++...++++.+++.+||+.+|++|||+.+|++
T Consensus       229 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         229 --------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             --------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                    011223345678999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.3e-40  Score=308.82  Aligned_cols=266  Identities=24%  Similarity=0.296  Sum_probs=200.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|++.+.||+|+||.||+|...      .+++.||+|++.....  ...+.+.+|+.+++.++|+||+++++++.....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   74 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNR------ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK   74 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEEC------CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence            46889999999999999999653      3467899998864422  233567889999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .++||||++++.|..++...  ..+++..++.++.||+.||.|||  ++|++|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (286)
T cd07847          75 LHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCH--KHNCIHRDVKPENILITKQGQIKLCDFGFARIL  150 (286)
T ss_pred             EEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCChhhEEEcCCCcEEECccccceec
Confidence            99999999988887766443  46899999999999999999999  677999999999999999999999999999875


Q ss_pred             CCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh-hH-------Hh
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA-KP-------YL  319 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~-------~~  319 (419)
                      .....  ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+....+....+... ..       .+
T Consensus       151 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07847         151 TGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF  228 (286)
T ss_pred             CCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            44321  1223457889999999865 56889999999999999999999999865533221111100 00       00


Q ss_pred             hcccccccccccccCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          320 RSSRRLRYIVDPRLAGQ-----YSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~~-----~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ...........+.....     .....+..+.+|+.+||+.+|++||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00000000000100000     01124678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.1e-40  Score=309.28  Aligned_cols=255  Identities=25%  Similarity=0.345  Sum_probs=199.7

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-CcccccceeeEEEe
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHLVRLIGYCCE  165 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  165 (419)
                      ......|++.+.||+|+||.||+|...      ..++.+|+|++.... .....+..|+.++.++ +|+||+++++++..
T Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~------~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636          12 RDPAGIFELVEVVGNGTYGQVYKGRHV------KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             cChhhhhhhheeeccCCCeEEEEEEEc------CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            334568899999999999999999643      346789999986543 2345677899999888 69999999999853


Q ss_pred             ------CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEE
Q 014736          166 ------DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKL  239 (419)
Q Consensus       166 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  239 (419)
                            ....|++|||+.+++|.+++.......+++..+..++.||+.||.|||  ++||+|+||||+||+++.++.++|
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~~ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH--AHKVIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEE
Confidence                  457899999999999999987765566888889999999999999999  677999999999999999999999


Q ss_pred             eccCccccCCCCCCceeeeccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHh
Q 014736          240 SDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS-----TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW  314 (419)
Q Consensus       240 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  314 (419)
                      +|||++........  ......|+..|+|||++.     ...++.++|||||||++|+|++|..||....+........ 
T Consensus       163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~-  239 (282)
T cd06636         163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP-  239 (282)
T ss_pred             eeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh-
Confidence            99999875432211  122356899999999885     3568889999999999999999999997543221111000 


Q ss_pred             hhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          315 AKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                            .         ..........++.++.+|+.+||+.||.+||++.+|++
T Consensus       240 ------~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         240 ------R---------NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ------h---------CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                  0         00001111234578999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.3e-40  Score=311.78  Aligned_cols=250  Identities=24%  Similarity=0.349  Sum_probs=199.3

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEE
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLL  171 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  171 (419)
                      .|.....||+|+||.||++..      ..++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..|+
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l   96 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATE------KHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV   96 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEE------CCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence            344445699999999999954      33467899999876555556678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCC
Q 014736          172 VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG  251 (419)
Q Consensus       172 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  251 (419)
                      ||||+++++|.+++..   ..+++..+..++.||+.||.|||  ++||+||||||+||+++.++.++|+|||++......
T Consensus        97 v~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (292)
T cd06658          97 VMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLH--NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE  171 (292)
T ss_pred             EEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence            9999999999998754   35788999999999999999999  677999999999999999999999999998754332


Q ss_pred             CCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccccc
Q 014736          252 SNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDP  331 (419)
Q Consensus       252 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (419)
                      ..  ......|+..|+|||.+.+..++.++||||||+++|||++|..||........   ......          ....
T Consensus       172 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~~~~----------~~~~  236 (292)
T cd06658         172 VP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---MRRIRD----------NLPP  236 (292)
T ss_pred             cc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh----------cCCC
Confidence            21  12234589999999999888899999999999999999999999975432211   100000          0111


Q ss_pred             ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          332 RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       332 ~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      .+..  ....+..+.+++.+||..||.+|||+.++++.
T Consensus       237 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         237 RVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1111  11235678999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=8.8e-40  Score=302.45  Aligned_cols=251  Identities=27%  Similarity=0.465  Sum_probs=199.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      .+|++.+.||+|+||.||+|.+..       +..+|+|.+.... .....+.+|++++++++||||+++++++......+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-------~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-------KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPIC   75 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-------CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceE
Confidence            367788899999999999996542       3579999886432 23467889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+.+++|.+++.... ..+++..++.++.|++.||.|||  +++++|+||||+||+++.++.++|+|||++.....
T Consensus        76 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          76 LVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLE--SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH--HCCccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            9999999999999886542 35788899999999999999999  67799999999999999999999999999876433


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      .... ......++..|+|||++.++.++.++||||||+++|||++ |..||.......   .....    .....   . 
T Consensus       153 ~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~~---~-  220 (256)
T cd05112         153 DQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETI----NAGFR---L-  220 (256)
T ss_pred             Cccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHH----hCCCC---C-
Confidence            2211 1112235678999999988899999999999999999998 999997543211   11110    00000   0 


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL  370 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L  370 (419)
                            ..+...+.++.+|+.+||+.+|++||++.++++.|
T Consensus       221 ------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         221 ------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                  01112357899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-40  Score=309.54  Aligned_cols=267  Identities=25%  Similarity=0.317  Sum_probs=201.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|++.+.||+|+||.||+|...+      +++.|++|++....  ......+.+|+++++.++|+||+++++++...+.
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKA------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR   74 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCC------CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCE
Confidence            368899999999999999996543      36789999986542  2234678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .++||||+.++.|..++...  ..+++..+..++.||+.||.|||  ++|++|+||+|+||+++.++.+||+|||++...
T Consensus        75 ~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~  150 (288)
T cd07833          75 LYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCH--SHNIIHRDIKPENILVSESGVLKLCDFGFARAL  150 (288)
T ss_pred             EEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence            99999999876666554433  45889999999999999999999  678999999999999999999999999999875


Q ss_pred             CCCCCceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH--------Hh
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP--------YL  319 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--------~~  319 (419)
                      ...... ......++..|+|||++.+. .++.++||||||+++|+|++|++||.................        .+
T Consensus       151 ~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07833         151 RARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF  229 (288)
T ss_pred             CCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence            544321 22335688999999999887 889999999999999999999999976433221111100000        00


Q ss_pred             hccccccc-----cccc-ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          320 RSSRRLRY-----IVDP-RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       320 ~~~~~~~~-----~~~~-~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ........     .... .....++...+.++.+|+.+||..+|++||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00000000     0000 0001122334788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.6e-40  Score=309.14  Aligned_cols=261  Identities=23%  Similarity=0.258  Sum_probs=196.2

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      +|++.+.||+|+||.||+|...      .+++.||+|.+.....  .....+.+|+.+++.++|+||+++++++.+.+..
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~------~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNR------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKL   74 (284)
T ss_pred             CceeEEEecccCCeEEEEEEEC------CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence            4888899999999999999643      3467899999865422  2235677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++|+||+. ++|.+++... ...+++..++.++.||+.||.|||  .+||+|+||||+||+++.++.+||+|||++....
T Consensus        75 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  150 (284)
T cd07839          75 TLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGLARAFG  150 (284)
T ss_pred             EEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence            99999995 5888877653 246899999999999999999999  6779999999999999999999999999998654


Q ss_pred             CCCCceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHh---------
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYL---------  319 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---------  319 (419)
                      ....  ......++..|+|||++.+. .++.++|||||||++|+|++|..||.......  ..........         
T Consensus       151 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~  226 (284)
T cd07839         151 IPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWP  226 (284)
T ss_pred             CCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhH
Confidence            3221  12234578899999998664 47899999999999999999988864332211  1111000000         


Q ss_pred             --hcccccccccccccC-----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          320 --RSSRRLRYIVDPRLA-----GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       320 --~~~~~~~~~~~~~l~-----~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        .......  .-+...     .......+.++.+|+.+||+.||.+|||+.++++
T Consensus       227 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         227 GVSKLPDYK--PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             Hhhhccccc--ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence              0000000  000000     1112235678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.9e-40  Score=311.35  Aligned_cols=249  Identities=24%  Similarity=0.365  Sum_probs=199.1

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEE
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      |.....||+|+||.||+|...      ..++.||+|++........+.+.+|+.++..++||||+++++++..++..|+|
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv   96 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREK------HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL   96 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEc------CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence            333446999999999999543      34678999999765555567788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      |||+++++|..++..   ..+++..++.++.|++.||.|||  ++|++|+||||+||+++.++.+||+|||++.......
T Consensus        97 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659          97 MEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLH--SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             EecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence            999999999987754   35789999999999999999999  6789999999999999999999999999987543322


Q ss_pred             CceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                      .  ......|+..|+|||++.+..++.++||||||+++|+|++|..||........   .....    ...      ...
T Consensus       172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~~----~~~------~~~  236 (297)
T cd06659         172 P--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRLR----DSP------PPK  236 (297)
T ss_pred             c--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHh----ccC------CCC
Confidence            1  12235689999999999888999999999999999999999999975432211   11100    000      000


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      .  ......+.++.+++.+||+.+|++||++.++++.
T Consensus       237 ~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         237 L--KNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             c--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0  1112345679999999999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.4e-39  Score=302.79  Aligned_cols=251  Identities=24%  Similarity=0.313  Sum_probs=197.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-----cccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-----LQGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      ++|++.++||+|+||.||+|...      .+++.||+|.+....     ....+.+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   75 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDA------DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD   75 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEc------CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc
Confidence            47889999999999999999644      346789999886432     1224577889999999999999999998876


Q ss_pred             C--CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccC
Q 014736          166 D--EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFG  243 (419)
Q Consensus       166 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  243 (419)
                      .  ..++++|||+++++|.+++.+.  ..+++..++.++.|++.||.|||  +.+++|+||||+||+++.++.++|+|||
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~l~Dfg  151 (265)
T cd06652          76 PMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLH--SNMIVHRDIKGANILRDSVGNVKLGDFG  151 (265)
T ss_pred             CCCceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEecCCCCEEECcCc
Confidence            3  4688999999999999998765  45788889999999999999999  6779999999999999999999999999


Q ss_pred             ccccCCCCCCc-eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          244 LAKMGPEGSNT-HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       244 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      ++......... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||........  ..    ... . 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~----~~~-~-  223 (265)
T cd06652         152 ASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IF----KIA-T-  223 (265)
T ss_pred             cccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HH----HHh-c-
Confidence            98764322111 112234588999999999888899999999999999999999999975422111  00    000 0 


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                              .......+...+..+.+++.+|+. +|++||++++|++
T Consensus       224 --------~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         224 --------QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             --------CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                    001112344556788999999994 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.7e-40  Score=308.86  Aligned_cols=258  Identities=26%  Similarity=0.335  Sum_probs=198.6

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-CcccccceeeEEE
Q 014736           86 LRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHLVRLIGYCC  164 (419)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  164 (419)
                      +....++|.+.+.||+|+||.||+|...      ..++.+|+|++.... .....+.+|+.+++.+ +|+||+++++++.
T Consensus        13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~------~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638          13 FPDPSDTWEIIETIGKGTYGKVFKVLNK------KNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             CCCcccceeeeeeeccCCCcEEEEEEEC------CCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            3455678999999999999999999643      346789999886432 2235677899999998 6999999999874


Q ss_pred             -----eCCeeEEEEEecCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcE
Q 014736          165 -----EDEERLLVYEFMPRGSLENHLFKR--ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA  237 (419)
Q Consensus       165 -----~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~  237 (419)
                           .++..++||||+++++|.+++...  ....+++..+..++.|++.||.|||  .++|+||||||+||+++.++.+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--VNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH--hCCccccCCCHHhEEECCCCCE
Confidence                 345789999999999999987542  2346788889999999999999999  6779999999999999999999


Q ss_pred             EEeccCccccCCCCCCceeeeccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHH
Q 014736          238 KLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS-----TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV  312 (419)
Q Consensus       238 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~  312 (419)
                      +|+|||++........  ......|+..|+|||++.     +..++.++|||||||++|+|++|+.||.........  .
T Consensus       164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~  239 (286)
T cd06638         164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--F  239 (286)
T ss_pred             EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--h
Confidence            9999999876533221  122345899999999875     345789999999999999999999999764321110  0


Q ss_pred             HhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          313 DWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      .       ....    ..+.+  ..+...+.++.+|+.+||+.||++|||+.+|++.
T Consensus       240 ~-------~~~~----~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         240 K-------IPRN----PPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             h-------cccc----CCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            0       0000    00000  0111234679999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.1e-39  Score=306.76  Aligned_cols=263  Identities=24%  Similarity=0.296  Sum_probs=200.8

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      +|.+.+.||+|+||.||+|....      +++.|++|++.....  .....+.+|+.++++++||||+++++++......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRE------TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF   74 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECC------CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence            58889999999999999996533      367899999976542  2346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+||||+ +++|.+++.... ..+++..++.++.||+.||.|||  ++|++|+||||+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~  150 (286)
T cd07832          75 VLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH--ANGIMHRDLKPANLLISADGVLKIADFGLARLFS  150 (286)
T ss_pred             EEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence            9999999 999999886543 56899999999999999999999  6779999999999999999999999999998754


Q ss_pred             CCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhc-------
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS-------  321 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------  321 (419)
                      .... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|.++|.........   ......+..       
T Consensus       151 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  226 (286)
T cd07832         151 EEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL---AIVFRTLGTPNEETWP  226 (286)
T ss_pred             CCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH---HHHHHHcCCCChHHHh
Confidence            4322 11223458999999999865 45689999999999999999998888654322111   111100000       


Q ss_pred             ----cccccccccccc----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          322 ----SRRLRYIVDPRL----AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       322 ----~~~~~~~~~~~l----~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                          ......+..+..    ........+.++.+++.+||+.||++||+++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                000000000000    00111234578999999999999999999999976

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-39  Score=300.91  Aligned_cols=248  Identities=28%  Similarity=0.426  Sum_probs=200.5

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-----ccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-----QGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      +|+..+.||+|+||.||+|....      +++.|++|.+.....     ...+.+.+|+.+++.++|+||+++++++.++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLD------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE   74 (258)
T ss_pred             CccccceeeecCCceEEEEEEcC------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC
Confidence            47788899999999999996542      367899999865432     2346788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      ...|++|||+++++|.+++.+.  ..+++..+..++.||+.||.|||  ..|++|+||+|+||+++.++.+||+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~  150 (258)
T cd06632          75 DNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLH--DRNTVHRDIKGANILVDTNGVVKLADFGMAK  150 (258)
T ss_pred             CeEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccCccce
Confidence            9999999999999999998765  45788899999999999999999  6779999999999999999999999999988


Q ss_pred             cCCCCCCceeeecccccccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGH-LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      ......   ......|+..|++||.+.... ++.++|+||||+++|+|++|+.||........  ....  .   .... 
T Consensus       151 ~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~~~--~---~~~~-  219 (258)
T cd06632         151 QVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VFKI--G---RSKE-  219 (258)
T ss_pred             eccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HHHH--H---hccc-
Confidence            654332   123456899999999987766 89999999999999999999999976542111  1100  0   0000 


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                              ...++...+.++.+++.+||+.+|.+||++.+++.
T Consensus       220 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         220 --------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             --------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                    01122334578999999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.7e-39  Score=306.98  Aligned_cols=251  Identities=23%  Similarity=0.362  Sum_probs=204.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|.+.+.||+|+||.||+|...      .+++.|++|.+........+.+.+|+.+++.++||||+++++++...+..|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   92 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDV------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW   92 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEc------CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence            57999999999999999999643      235789999987655555677889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +|+||+++++|.+++.+.   .+++..+..++.|++.||.|||  ++|++|+||||+||+++.++.++|+|||++.....
T Consensus        93 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH--~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             EEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            999999999999998653   5788899999999999999999  77899999999999999999999999999875443


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD  330 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (419)
                      ...  ......|+..|++||.+....++.++|+||||+++|+|++|..||.............       .        .
T Consensus       168 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~-------~--------~  230 (293)
T cd06647         168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------T--------N  230 (293)
T ss_pred             ccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh-------c--------C
Confidence            322  1233468899999999988889999999999999999999999997654322111000       0        0


Q ss_pred             cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       331 ~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      ...........+..+.+++.+||..+|++||++.+++..
T Consensus       231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         231 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000011122345679999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7e-40  Score=330.94  Aligned_cols=277  Identities=17%  Similarity=0.232  Sum_probs=190.8

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCccccc---------cccc----EEEEEEeccCCcccHHHHHHHHHHHcCCCc
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQG---------LKAQ----AVAVKLLDIEGLQGHREWLAEVIFLGQLRH  153 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~---------~~~~----~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  153 (419)
                      ..+.++|++++.||+|+||+||+|.+.......         ..+.    .++.|.+.. .......+.+|+.+|+.++|
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~H  222 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNH  222 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCC
Confidence            445689999999999999999998654321100         0001    111122211 11234567899999999999


Q ss_pred             ccccceeeEEEeCCeeEEEEEecCCCChhhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 014736          154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRI---SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNIL  230 (419)
Q Consensus       154 pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIl  230 (419)
                      +||+++++++...+..|+|++++ +++|.+++....   ........++.++.||+.||.|||  ++|||||||||+|||
T Consensus       223 pnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH--~~gIiHrDLKP~NIL  299 (501)
T PHA03210        223 ENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH--DKKLIHRDIKLENIF  299 (501)
T ss_pred             CCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEE
Confidence            99999999999999999999999 567887775432   122335567889999999999999  677999999999999


Q ss_pred             EcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCCCccch
Q 014736          231 LDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRS-MDKLRPKSEQ  309 (419)
Q Consensus       231 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~  309 (419)
                      ++.++.+||+|||++..+...... ......||..|+|||++.+..++.++|||||||++|||++|..+ |.........
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             ECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            999999999999999865433221 22345799999999999999999999999999999999998754 4332222211


Q ss_pred             hHHHhhhHHhhcccc-------ccccccc----ccCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          310 NLVDWAKPYLRSSRR-------LRYIVDP----RLAGQY-----SVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       310 ~~~~~~~~~~~~~~~-------~~~~~~~----~l~~~~-----~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ...............       +...++.    .....+     ....+.++.++|.+||+.||.+|||+.|+++
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            111111100000000       0000000    000000     0113456788999999999999999999986

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-40  Score=316.34  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=199.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC--CcccHHHHHHHHHHHcCCC-cccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQLR-HPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~  166 (419)
                      ...|+++++||+||.+.||++.-.+       ...||+|++...  +.+...-|.+|+..|.+|+ |.+||++++|-..+
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~-------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d  432 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSD-------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD  432 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCC-------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence            4568899999999999999985433       356888876533  3345677999999999995 99999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +.+||||||= .-+|..+|.++......| .++.+..|++.|+.++|  +.||||.||||.|+|+-. |.+||+|||+|.
T Consensus       433 ~~lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH--~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~  507 (677)
T KOG0596|consen  433 GYLYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIH--QHGIVHSDLKPANFLLVK-GRLKLIDFGIAN  507 (677)
T ss_pred             ceEEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHH--HhceeecCCCcccEEEEe-eeEEeeeechhc
Confidence            9999999985 669999998775443334 78899999999999999  788999999999999875 589999999999


Q ss_pred             cCCCCCCceeeecccccccccccccccCC-----------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTG-----------HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA  315 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~  315 (419)
                      ........-.....+||..||+||.+...           ..+.++||||||||||+|+.|+.||.....     .+   
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~~---  579 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----QI---  579 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----HH---
Confidence            87776665566678899999999988432           256789999999999999999999975421     11   


Q ss_pred             hHHhhcccccccccccccCCCCCHHH-HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          316 KPYLRSSRRLRYIVDPRLAGQYSVKG-AKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                             .++..+.++...-.|+..- ..++.++++.||+.||++||++.++|+
T Consensus       580 -------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  580 -------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             -------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                   1222334443322222211 223999999999999999999999986

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=306.78  Aligned_cols=264  Identities=24%  Similarity=0.311  Sum_probs=195.8

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|.+.+.||+|+||.||+|...      .+++.||+|.+..... .....+.+|+++++.++|+||+++++++.+++..
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSK------LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTL   78 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEc------CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeE
Confidence            57899999999999999999643      3467899999865432 2234567899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+. ++|.+++.... ..+++..+..++.|++.||.|||  ++||+|+||||+|||++.++.+||+|||+++...
T Consensus        79 ~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          79 TLVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCH--QRRVLHRDLKPQNLLISERGELKLADFGLARAKS  154 (291)
T ss_pred             EEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence            99999996 59999886543 36788999999999999999999  6789999999999999999999999999987543


Q ss_pred             CCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhc--cccc-
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS--SRRL-  325 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~-  325 (419)
                      ....  ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.........  ..........  .... 
T Consensus       155 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  230 (291)
T cd07844         155 VPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ--LHKIFRVLGTPTEETWP  230 (291)
T ss_pred             CCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHhcCCCChhhhh
Confidence            2211  1122346889999998865 56889999999999999999999999755421111  1000000000  0000 


Q ss_pred             -------------ccccccccCCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          326 -------------RYIVDPRLAGQY-SVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       326 -------------~~~~~~~l~~~~-~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                                   .......+.... ......++.+++.+||+.+|++|||+.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                         000000000000 0011267889999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-40  Score=293.79  Aligned_cols=257  Identities=24%  Similarity=0.303  Sum_probs=200.5

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-cccccceeeEEEeCCeeEEEEEe
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-HPHLVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~  175 (419)
                      +.||+|+|+.|-.+      ....++..||||++.+.......++.+|++++.+.+ |+||+.++++|+++..+|||||.
T Consensus        84 e~LGeGAyasVqtc------v~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK  157 (463)
T KOG0607|consen   84 ELLGEGAYASVQTC------VSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK  157 (463)
T ss_pred             HHhcCccceeeeee------eeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence            36999999999987      456678899999998776666788999999998885 99999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc---EEEeccCccccCCCCC
Q 014736          176 MPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT---AKLSDFGLAKMGPEGS  252 (419)
Q Consensus       176 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGla~~~~~~~  252 (419)
                      +.||.|..+|.++  .-+++.++..+.+.|+.||.|||  .+||.||||||+|||......   ||||||.+..-.....
T Consensus       158 m~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH--~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~  233 (463)
T KOG0607|consen  158 MRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLH--TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN  233 (463)
T ss_pred             ccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHh--hcCcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence            9999999999887  67889999999999999999999  888999999999999976544   8999998865322211


Q ss_pred             C-----ceeeeccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchh----HHHhhhHH
Q 014736          253 N-----THVTTRVMGTYGYAAPEYIS-----TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQN----LVDWAKPY  318 (419)
Q Consensus       253 ~-----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~----~~~~~~~~  318 (419)
                      .     +......+|+..|||||+..     ...|+.++|.||||||+|.||+|-+||.+....+-..    .-...+..
T Consensus       234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~  313 (463)
T KOG0607|consen  234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK  313 (463)
T ss_pred             CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH
Confidence            1     11223467999999999873     3579999999999999999999999998775543211    00000000


Q ss_pred             hhccccccccccccc--CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 LRSSRRLRYIVDPRL--AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l--~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      +     ++.+-+...  ...--..++.+..+|+..+|..|+.+|.++.+++.
T Consensus       314 L-----FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  314 L-----FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             H-----HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            0     000001000  00011246788999999999999999999998876

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.7e-39  Score=299.27  Aligned_cols=253  Identities=26%  Similarity=0.361  Sum_probs=207.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|.+.+.||+|++|.||+|...      .+++.|++|++..... .....+.+|+.++..++|+||+++++++...+..
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~------~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHK------PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEI   74 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEc------CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeE
Confidence            36888999999999999999644      3468899999976544 3457788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE-NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      ++||||+++++|.+++...  ..+++..++.++.|++.||.|||  + .|++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh--~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~  150 (264)
T cd06623          75 SIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL  150 (264)
T ss_pred             EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh--ccCCCccCCCCHHHEEECCCCCEEEccCccceec
Confidence            9999999999999999765  57899999999999999999999  6 78999999999999999999999999998865


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ......  .....++..|+|||.+.+..++.++|+||||+++|+|++|..||................    .       
T Consensus       151 ~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~-------  217 (264)
T cd06623         151 ENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----D-------  217 (264)
T ss_pred             ccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----c-------
Confidence            433322  123458899999999998899999999999999999999999997664322222221111    0       


Q ss_pred             cccccCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          329 VDPRLAGQYSVK-GAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       329 ~~~~l~~~~~~~-~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                        . .....+.. .+..+.+++.+||..+|++||++.++++.
T Consensus       218 --~-~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         218 --G-PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             --C-CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              0 00112222 56789999999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-39  Score=303.06  Aligned_cols=253  Identities=28%  Similarity=0.384  Sum_probs=199.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-CcccccceeeEEEeCC-
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDE-  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~-  167 (419)
                      .++|++.+.||+|+||.||+|...      .+++.+++|++..... ....+.+|+.+++++ +|+||+++++++.... 
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~------~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHK------KTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP   77 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEEC------CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence            478999999999999999999643      3467899999875543 346788999999998 6999999999997644 


Q ss_pred             -----eeEEEEEecCCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 014736          168 -----ERLLVYEFMPRGSLENHLFKRI--SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS  240 (419)
Q Consensus       168 -----~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  240 (419)
                           ..|+||||+++++|.+++....  ...+++..+..++.|++.||.|||  ++|++|+||+|+||+++.++.++|+
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH--~~~i~H~~l~p~ni~~~~~~~~~l~  155 (275)
T cd06608          78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLV  155 (275)
T ss_pred             CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHHHEEEccCCeEEEC
Confidence                 4899999999999999886543  457889999999999999999999  6779999999999999999999999


Q ss_pred             ccCccccCCCCCCceeeecccccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-----GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA  315 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~  315 (419)
                      |||++........  ......|+..|+|||++..     ..++.++||||||+++|+|++|..||........  ...  
T Consensus       156 d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~--  229 (275)
T cd06608         156 DFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFK--  229 (275)
T ss_pred             CCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHH--
Confidence            9999876433221  1233558999999998753     3477899999999999999999999975432111  110  


Q ss_pred             hHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          316 KPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        .. . .     ..+.+  ......++++.+|+.+||..||++|||+.++++
T Consensus       230 --~~-~-~-----~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         230 --IP-R-N-----PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             --hh-c-c-----CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence              00 0 0     00011  112235678999999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=311.29  Aligned_cols=267  Identities=28%  Similarity=0.436  Sum_probs=220.3

Q ss_pred             HHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEE
Q 014736           85 ELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYC  163 (419)
Q Consensus        85 ~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  163 (419)
                      .++...+.....++||.|.||.||+|...+.  .+...-.||||..+.+. ....+.|+.|..+|+.++|||||+++|+|
T Consensus       383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~--~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~  460 (974)
T KOG4257|consen  383 NYELRRELITLKRLIGEGQFGDVYKGVYTDP--EKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC  460 (974)
T ss_pred             cceeehhhccHHHhhcCCcccceeeeEeccc--ccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence            3344445667778899999999999987763  23445569999998753 34467899999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccC
Q 014736          164 CEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFG  243 (419)
Q Consensus       164 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  243 (419)
                      .+ ...+||||+++-|.|..||..+ ...++......++.||+.||.|||+  ..+|||||...|||+.....|||+|||
T Consensus       461 ~e-~P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeS--krfVHRDIAaRNiLVsSp~CVKLaDFG  536 (974)
T KOG4257|consen  461 VE-QPMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLES--KRFVHRDIAARNILVSSPQCVKLADFG  536 (974)
T ss_pred             ec-cceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHh--hchhhhhhhhhheeecCcceeeecccc
Confidence            65 5789999999999999999766 3468888889999999999999995  559999999999999999999999999


Q ss_pred             ccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          244 LAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       244 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      +++...+....... ...-...|||||-++-..++.++|||.|||++||++. |..||.+-...+....+       +++
T Consensus       537 LSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-------EnG  608 (974)
T KOG4257|consen  537 LSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-------ENG  608 (974)
T ss_pred             hhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-------cCC
Confidence            99988776655433 3335678999999999999999999999999999977 99999886554422221       122


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      .          +-..++.++..+..|..+||+.+|.+||++.+|...|..++.
T Consensus       609 e----------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  609 E----------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             C----------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            2          224566788999999999999999999999999999988876

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.3e-39  Score=300.54  Aligned_cols=252  Identities=24%  Similarity=0.351  Sum_probs=202.2

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEe--CC
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCE--DE  167 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~  167 (419)
                      +|.+.+.||.|+||.||+|...      .+++.||+|.+.....  ...+.+.+|+.+++.++|+||+++++++..  ..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRK------SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ   74 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeec------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence            4788899999999999999543      3467899999875432  334568889999999999999999998754  45


Q ss_pred             eeEEEEEecCCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhcC---CCCeeecCCCCCcEEEcCCCcEEEecc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRI--SVSLPWGTRLKIAIGAAKGLAFLHGA---ENPVIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~~~ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                      ..+++|||+++++|.+++....  ...+++..++.++.||+.||.|||..   +.+++|+||||+||+++.++.+||+||
T Consensus        75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~  154 (265)
T cd08217          75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF  154 (265)
T ss_pred             EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence            6899999999999999986532  35688999999999999999999944   566999999999999999999999999


Q ss_pred             CccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       243 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      |++........  ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||......   ......    .. 
T Consensus       155 g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~----~~-  224 (265)
T cd08217         155 GLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKI----KE-  224 (265)
T ss_pred             cccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHH----hc-
Confidence            99987654332  122346899999999998888999999999999999999999999865421   111111    00 


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                               ......+...+.++.+++.+||+.+|.+||++.+|++
T Consensus       225 ---------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         225 ---------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ---------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                     0111233345678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=5.8e-40  Score=308.70  Aligned_cols=266  Identities=25%  Similarity=0.325  Sum_probs=199.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--cHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|++.++||+|+||.||+|.+.+      .++.||+|++......  ..+.+.+|+++++.++||||+++++++..++.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKE------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR   74 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECC------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence            468889999999999999996543      3678999988643322  24567889999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||++++.|.++....  ..+++..++.++.||+.||.|||  +.|++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH--~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~  150 (286)
T cd07846          75 LYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL  150 (286)
T ss_pred             EEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence            99999999998888766543  45889999999999999999999  678999999999999999999999999998865


Q ss_pred             CCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh-hH-------Hh
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA-KP-------YL  319 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~-------~~  319 (419)
                      .....  ......++..|+|||++.+ ..++.++||||||+++|+|++|.+||...........+... ..       ..
T Consensus       151 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07846         151 AAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF  228 (286)
T ss_pred             cCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence            43321  2233558899999999865 45788999999999999999999999754322111111100 00       00


Q ss_pred             hcccccccccccccCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          320 RSSRRLRYIVDPRLAG-----QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~-----~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ...........+....     ......+..+.+|+.+||+.+|++||++.+|++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            0000000000000000     011234678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.4e-39  Score=306.54  Aligned_cols=265  Identities=25%  Similarity=0.309  Sum_probs=199.3

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-----cHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-----GHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      +|.+.+.||+|+||.||+|....      +++.||+|.+......     ....+..|+++++.++|+||+++++++.+.
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKE------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK   74 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECC------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC
Confidence            47888899999999999996543      3678999999755332     234567899999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||  .+||+|+||||+|||++.++.++|+|||++.
T Consensus        75 ~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nill~~~~~~~l~dfg~~~  150 (298)
T cd07841          75 SNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH--SNWILHRDLKPNNLLIASDGVLKLADFGLAR  150 (298)
T ss_pred             CEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCChhhEEEcCCCCEEEccceeee
Confidence            9999999999 999999987653 36899999999999999999999  6779999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh--H---Hhh
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK--P---YLR  320 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~---~~~  320 (419)
                      .......  ......++..|+|||.+.+ ..++.++|||||||++|+|++|.++|................  +   ...
T Consensus       151 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (298)
T cd07841         151 SFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP  228 (298)
T ss_pred             eccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence            6544321  1222346788999998854 567899999999999999999988887544322111110000  0   000


Q ss_pred             cccccccccccccC-----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          321 SSRRLRYIVDPRLA-----GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       321 ~~~~~~~~~~~~l~-----~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ..............     .......+.++.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            00000000000000     0111234678999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.7e-39  Score=301.50  Aligned_cols=255  Identities=24%  Similarity=0.370  Sum_probs=201.1

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC----------cccHHHHHHHHHHHcC-CCccccccee
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG----------LQGHREWLAEVIFLGQ-LRHPHLVRLI  160 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~hpnIv~~~  160 (419)
                      +|++.+.||+|+||.||+|....     ..++.+|+|.+....          ......+.+|+.++.+ ++|+||++++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~-----~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~   75 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKN-----NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYY   75 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcC-----CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEE
Confidence            47888899999999999997644     135789999885432          1223457788888865 7999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEE
Q 014736          161 GYCCEDEERLLVYEFMPRGSLENHLFKR--ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAK  238 (419)
Q Consensus       161 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~k  238 (419)
                      +++..++..++||||+++++|.+++...  ....+++..++.++.|++.||.|||+ ..|++|+||+|+||+++.++.++
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~i~H~dl~~~nil~~~~~~~~  154 (269)
T cd08528          76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK-EKRIVHRDLTPNNIMLGEDDKVT  154 (269)
T ss_pred             eeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc-CCceeecCCCHHHEEECCCCcEE
Confidence            9999999999999999999999987542  23468888999999999999999994 35799999999999999999999


Q ss_pred             EeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          239 LSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       239 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      |+|||++.......   ......|+..|++||.+.+..++.++|+||||+++|+|++|..||........   ..   ..
T Consensus       155 l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~---~~---~~  225 (269)
T cd08528         155 ITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL---AT---KI  225 (269)
T ss_pred             Eecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---HH---HH
Confidence            99999998654432   23345689999999999988899999999999999999999999975432111   11   00


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                      . .. ..    .+    ......+.++.+++.+||+.||++||++.++.+++.
T Consensus       226 ~-~~-~~----~~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         226 V-EA-VY----EP----LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             h-hc-cC----Cc----CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            0 00 00    00    011123578999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.5e-39  Score=302.30  Aligned_cols=252  Identities=27%  Similarity=0.390  Sum_probs=202.0

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      +|++.+.||+|+||.||+|...      .+++.|++|.+..... .....+.+|+++++.++||||+++++.+..++..+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   75 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHR------PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDIS   75 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEc------CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEE
Confidence            5777888999999999999643      3468899999876532 34467889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE-NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      +++||+.+++|.+++.... ..+++..+..++.|++.||.|||  . .|++|+||||+||+++.++.++|+|||.+....
T Consensus        76 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          76 ICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             EEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHc--CCCCeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            9999999999999987543 56888899999999999999999  5 789999999999999999999999999987543


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      ....    ....++..|+|||.+.+..++.++||||||+++|+|++|..||....... ..............       
T Consensus       153 ~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~-------  220 (265)
T cd06605         153 NSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEP-------  220 (265)
T ss_pred             HHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCC-------
Confidence            2211    11568899999999999999999999999999999999999997543211 11111111111000       


Q ss_pred             ccccCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          330 DPRLAGQYSVK-GAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       330 ~~~l~~~~~~~-~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .+    ..+.. .+.++.++|.+||..||++|||+.+++.
T Consensus       221 ~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         221 PP----RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CC----CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            01    11111 5678999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=7.6e-40  Score=303.32  Aligned_cols=248  Identities=25%  Similarity=0.318  Sum_probs=203.1

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      +|.+.+.||.|+||.||+|...      .+++.||+|++.....   ...+.+.+|++++++++||||+++++++.+...
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKR------DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN   74 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEc------cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe
Confidence            5888899999999999999643      3467899999975432   335678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .++||||+.+++|.+++...  ..+++..+..++.||+.||.|||  ++|++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~  150 (258)
T cd05578          75 MYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV  150 (258)
T ss_pred             EEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence            99999999999999998765  57889999999999999999999  678999999999999999999999999998865


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ....   ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.............    ....       
T Consensus       151 ~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~-------  216 (258)
T cd05578         151 TPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA----KQET-------  216 (258)
T ss_pred             CCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH----Hhcc-------
Confidence            4432   1233458899999999988889999999999999999999999998765431111111    0000       


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKM--AAVV  367 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~--~eil  367 (419)
                          ....++...+.++.+++.+||+.||.+||++  .+++
T Consensus       217 ----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 ----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                1112333456889999999999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.7e-39  Score=304.98  Aligned_cols=251  Identities=27%  Similarity=0.380  Sum_probs=193.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHH-HcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIF-LGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|++.+.||+|+||.||+|..      ..+++.||+|.+..... .....+..|+.+ ++.++||||+++++++..++.
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~   74 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRH------VPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGD   74 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEE------cCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc
Confidence            4688999999999999999964      34578999999875432 223455566665 566789999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          169 RLLVYEFMPRGSLENHLFKR--ISVSLPWGTRLKIAIGAAKGLAFLHGAEN-PVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~-~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      .|++|||++ ++|.+++...  ....+++..++.++.||+.||.|||  ++ +++||||||+|||++.++.+||+|||++
T Consensus        75 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~  151 (283)
T cd06617          75 VWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS  151 (283)
T ss_pred             EEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence            999999995 6888877543  2346889999999999999999999  55 7999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccccccccccccccC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYIST----GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS  321 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  321 (419)
                      .......   ......|+..|+|||++.+    ..++.++|+||||+++|+|++|+.||.......  ..+.   .....
T Consensus       152 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~---~~~~~  223 (283)
T cd06617         152 GYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--QQLK---QVVEE  223 (283)
T ss_pred             ccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--HHHH---HHHhc
Confidence            8653321   1223458899999998854    457889999999999999999999996432110  1110   00000


Q ss_pred             ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          322 SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       322 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                             ..+.+   .....+.++.+++.+||..+|++||++.+|++
T Consensus       224 -------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         224 -------PSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -------CCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   00000   11224578999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.9e-39  Score=300.76  Aligned_cols=249  Identities=25%  Similarity=0.375  Sum_probs=201.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      +-|++.+.||+|+||.||+|...      ..++.||+|++..... .....+.+|+.+++.++||||+++++++..++..
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   77 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDN------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL   77 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEEC------CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeE
Confidence            34778889999999999999643      3467899999865432 3346788899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+||||+.+++|.+++..   ..+++..+..++.|++.|+.|||  ++|++|+||||.||+++.++.++|+|||++....
T Consensus        78 ~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06641          78 WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT  152 (277)
T ss_pred             EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHc--cCCeecCCCCHHhEEECCCCCEEEeecccceecc
Confidence            999999999999998854   36789999999999999999999  7889999999999999999999999999987654


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      ....  ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||.......   .....    ...       
T Consensus       153 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~----~~~-------  216 (277)
T cd06641         153 DTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VLFLI----PKN-------  216 (277)
T ss_pred             cchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HHHHH----hcC-------
Confidence            3221  1223458889999999988889999999999999999999999997543211   11100    000       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                         .........+.++.+++.+||+.+|.+||++.+++..
T Consensus       217 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         217 ---NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ---CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence               0111223345789999999999999999999999884

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.7e-39  Score=305.25  Aligned_cols=265  Identities=24%  Similarity=0.315  Sum_probs=198.3

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      +|+..+.||.|+||.||+|...      .+++.||+|++.....  .....+.+|++++++++||||+++++++.+++..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNK------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL   74 (284)
T ss_pred             CceeeeeecCCCceEEEEEEEC------CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcE
Confidence            4888999999999999999643      3467899999875432  2335788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+. ++|.+++.......+++..+..++.|++.||+|||  .+|++|+||+|+||+++.++.+||+|||++....
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh--~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~  151 (284)
T cd07860          75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG  151 (284)
T ss_pred             EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence            99999995 68999887655567899999999999999999999  6789999999999999999999999999987643


Q ss_pred             CCCCceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhH-HHhhh-------HHhh
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNL-VDWAK-------PYLR  320 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-~~~~~-------~~~~  320 (419)
                      ....  ......++..|+|||++.+. .++.++||||||+++|+|++|+.||........... .....       +...
T Consensus       152 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07860         152 VPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT  229 (284)
T ss_pred             cCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence            3221  12233478899999988664 468899999999999999999999975432111100 00000       0000


Q ss_pred             c----ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          321 S----SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       321 ~----~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .    ...+.......+ .......+.++.++|.+||+.||.+||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         230 SLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0    000000000000 0011224567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.9e-39  Score=298.59  Aligned_cols=253  Identities=28%  Similarity=0.419  Sum_probs=201.5

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--cHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      +|.+.+.||+|+||.||+|....      .++.|++|.+......  ....+.+|+.+++.++|+||+++++++.+.+..
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLD------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV   74 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECC------CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE
Confidence            58888999999999999996433      4678999999765443  567889999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++|+||+++++|.+++...  ..+++..+..++.|++.||.|||  ++||+|+||+|+||+++.++.+||+|||++....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~  150 (264)
T cd06626          75 YIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLH--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK  150 (264)
T ss_pred             EEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence            9999999999999998765  45788899999999999999999  6779999999999999999999999999988754


Q ss_pred             CCCCcee--eecccccccccccccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          250 EGSNTHV--TTRVMGTYGYAAPEYISTGH---LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       250 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      .......  .....++..|+|||++.+..   ++.++||||||+++|+|++|+.||........   ..+..    ... 
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~---~~~~~----~~~-  222 (264)
T cd06626         151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ---IMFHV----GAG-  222 (264)
T ss_pred             CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH---HHHHH----hcC-
Confidence            4332211  11245788999999997766   88999999999999999999999975432111   10000    000 


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                          ..+.+.  .....+..+.+++.+||+.+|++||++.+++.
T Consensus       223 ----~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         223 ----HKPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ----CCCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                001111  01123677899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.6e-39  Score=302.04  Aligned_cols=258  Identities=25%  Similarity=0.311  Sum_probs=200.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeC--C
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCED--E  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~  167 (419)
                      ++|...+.||.|++|.||+|....      .++.+|+|.+..... .....+.+|+++++.++||||+++++++.+.  +
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   74 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKN------TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS   74 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECC------CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCC
Confidence            367888999999999999997543      468899999875433 3346788999999999999999999988654  4


Q ss_pred             eeEEEEEecCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          168 ERLLVYEFMPRGSLENHLFKR--ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      ..|+||||+++++|.+++...  ....+++..+..++.||+.||.|||  ..|++|+||+|.||+++.++.++|+|||++
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~  152 (287)
T cd06621          75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGVS  152 (287)
T ss_pred             eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEecCCeEEEeecccc
Confidence            689999999999999887542  2345788899999999999999999  677999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCc--cchhHHHhhhHHhhccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPK--SEQNLVDWAKPYLRSSR  323 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~  323 (419)
                      .......    .....++..|+|||.+.+..++.++||||||+++|+|++|..||......  .......+..    ...
T Consensus       153 ~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~  224 (287)
T cd06621         153 GELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----NMP  224 (287)
T ss_pred             ccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh----cCC
Confidence            7543322    12345788999999998899999999999999999999999999865331  1111111111    100


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          324 RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       324 ~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       ...+ ....  ......+.++.+++.+||..+|.+|||+.||++
T Consensus       225 -~~~~-~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         225 -NPEL-KDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             -chhh-ccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence             0000 0000  001234678999999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.9e-39  Score=302.65  Aligned_cols=249  Identities=25%  Similarity=0.368  Sum_probs=199.8

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEE
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLL  171 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  171 (419)
                      +|...+.||+|++|.||+|...      ..++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~   93 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDK------STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV   93 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEEC------CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEE
Confidence            4555678999999999999643      3467899999875554555678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCC
Q 014736          172 VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG  251 (419)
Q Consensus       172 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  251 (419)
                      ++||+.+++|.+++..   ..+++..+..++.|++.||.|||  ++||+||||+|+||+++.++.++|+|||++......
T Consensus        94 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~  168 (285)
T cd06648          94 VMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLH--AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE  168 (285)
T ss_pred             EEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence            9999999999998866   36888899999999999999999  678999999999999999999999999988754332


Q ss_pred             CCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccccc
Q 014736          252 SNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDP  331 (419)
Q Consensus       252 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (419)
                      ..  ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....+...   ..   ... .. .     .+
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~---~~---~~~-~~-~-----~~  233 (285)
T cd06648         169 VP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA---MK---RIR-DN-L-----PP  233 (285)
T ss_pred             Cc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH---HH---HHH-hc-C-----CC
Confidence            21  12234589999999999888899999999999999999999999975432111   11   000 00 0     00


Q ss_pred             ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          332 RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       332 ~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ...  .....+..+.+++.+||+.+|++||++.++++
T Consensus       234 ~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         234 KLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            110  11124568999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=8.5e-39  Score=301.76  Aligned_cols=267  Identities=23%  Similarity=0.308  Sum_probs=196.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-cHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|.+.+.||+|+||.||+|...      ..++.||+|++...... ....+.+|+.+++.++|+||+++++++..++.
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   77 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISR------INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKET   77 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEc------CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCe
Confidence            367999999999999999999643      34678999998654322 23467789999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||  .+||+|+||||+|||++.++.+||+|||+++..
T Consensus        78 ~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          78 LTFVFEYM-HTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIH--GQHILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             EEEEEecc-cCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEEcCCCcEEEecccccccc
Confidence            99999999 478877765432 45778888999999999999999  677999999999999999999999999998754


Q ss_pred             CCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh---HH------
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK---PY------  318 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~---~~------  318 (419)
                      .....  ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.........-...+..   +.      
T Consensus       154 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (291)
T cd07870         154 SIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG  231 (291)
T ss_pred             CCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence            32211  1223457889999999865 458899999999999999999999998654321110000000   00      


Q ss_pred             hhc-ccccccccccccCCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 LRS-SRRLRYIVDPRLAGQY-----SVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 ~~~-~~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ... ................     ....+.++.+++.+|+..||.+|||+.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000 0000000000000000     0012467899999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.7e-39  Score=304.27  Aligned_cols=259  Identities=27%  Similarity=0.343  Sum_probs=199.8

Q ss_pred             HHHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-CcccccceeeE
Q 014736           84 SELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHLVRLIGY  162 (419)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~  162 (419)
                      ..+....++|.+.+.||+|+||.||+|...      ..++.+|+|++.... .....+.+|+.+++++ +||||++++++
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~------~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~   87 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNK------KDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGM   87 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEEC------CCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence            344556788999999999999999999643      346789999986432 2235677899999988 79999999999


Q ss_pred             EEeC-----CeeEEEEEecCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 014736          163 CCED-----EERLLVYEFMPRGSLENHLFKR--ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF  235 (419)
Q Consensus       163 ~~~~-----~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~  235 (419)
                      +...     +..|+||||+++++|.+++...  ....+++..++.++.|++.||.|||  ++|++|+||||+||+++.++
T Consensus        88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~nili~~~~  165 (291)
T cd06639          88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH--NNRIIHRDVKGNNILLTTEG  165 (291)
T ss_pred             EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEEcCCC
Confidence            8754     3589999999999999988542  2346889999999999999999999  67899999999999999999


Q ss_pred             cEEEeccCccccCCCCCCceeeecccccccccccccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchh
Q 014736          236 TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG-----HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQN  310 (419)
Q Consensus       236 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  310 (419)
                      .+||+|||++.........  .....|+..|+|||++...     .++.++|||||||++|+|++|+.||........  
T Consensus       166 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--  241 (291)
T cd06639         166 GVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--  241 (291)
T ss_pred             CEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--
Confidence            9999999998864432211  1234588999999998543     368899999999999999999999976432111  


Q ss_pred             HHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          311 LVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .....     . ...     +.+  ........++.+|+.+||+.+|++||++.+|++
T Consensus       242 ~~~~~-----~-~~~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         242 LFKIP-----R-NPP-----PTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHHHh-----c-CCC-----CCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11100     0 000     000  112234467999999999999999999999976

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-39  Score=300.62  Aligned_cols=248  Identities=24%  Similarity=0.371  Sum_probs=198.6

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCC---cccccceeeEEEeCC
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLR---HPHLVRLIGYCCEDE  167 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~  167 (419)
                      .|++.+.||+|+||.||+|.+.      ..++.||+|.+.... ......+.+|+.+++.++   ||||+++++++.++.
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~   75 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHV------PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP   75 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEc------CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC
Confidence            4777889999999999999653      346789999987542 234567888999998886   999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..++||||+++++|.+++...   .+++..++.++.|++.||.|||  +.||+|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06917          76 RLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL  150 (277)
T ss_pred             EEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHHEEEcCCCCEEEccCCceee
Confidence            999999999999999988543   6889999999999999999999  77899999999999999999999999999987


Q ss_pred             CCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ......  ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||........   ....          .
T Consensus       151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~----------~  215 (277)
T cd06917         151 LNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MMLI----------P  215 (277)
T ss_pred             cCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hhcc----------c
Confidence            654332  1233468999999998865 4578999999999999999999999976432111   1000          0


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ....+.+..   ...+.++.+++.+||+.||++||++.+++.
T Consensus       216 ~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         216 KSKPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             cCCCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            000111111   114568999999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=295.26  Aligned_cols=255  Identities=23%  Similarity=0.260  Sum_probs=199.2

Q ss_pred             HhcCCCCC-CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-CcccccceeeEEEeC
Q 014736           89 ITQNFSSN-YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHLVRLIGYCCED  166 (419)
Q Consensus        89 ~~~~y~~~-~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  166 (419)
                      ++++|.+. ++||-|-.|.|..++      ++.+++.+|+|++.-     .....+|+++.-.. .|||||.++++|++.
T Consensus        59 itedY~is~qvLG~GinGkV~~C~------~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs  127 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCV------HKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENS  127 (400)
T ss_pred             chhhheehhhhhccccCCceEEEE------eccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence            45666654 479999999999985      556788999999862     34556788876554 599999999998653


Q ss_pred             ----CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCcEEE
Q 014736          167 ----EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKL  239 (419)
Q Consensus       167 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~---~~~~kl  239 (419)
                          ..+.+|||+++||.|+..+.++....+++.++..|+.||..|+.|||+  .+|.||||||+|+|...   |..+||
T Consensus       128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~--~nIAHRDlKpENLLyt~t~~na~lKL  205 (400)
T KOG0604|consen  128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS--MNIAHRDLKPENLLYTTTSPNAPLKL  205 (400)
T ss_pred             ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh--cchhhccCChhheeeecCCCCcceEe
Confidence                356789999999999999999988999999999999999999999995  55999999999999976   456999


Q ss_pred             eccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHh
Q 014736          240 SDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYL  319 (419)
Q Consensus       240 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  319 (419)
                      +|||+|+.-...   ......+.|++|.|||++....|+..+|+||+||++|.||+|-+||-.........-   .+...
T Consensus       206 tDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispg---Mk~rI  279 (400)
T KOG0604|consen  206 TDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKRRI  279 (400)
T ss_pred             cccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChh---HHhHh
Confidence            999999964332   124456789999999999999999999999999999999999999965433211000   00000


Q ss_pred             hcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          320 RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      ..+ .+      .+.+.--..++++..++|+.+|..+|.+|.|+.++++.
T Consensus       280 ~~g-qy------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  280 RTG-QY------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             hcc-Cc------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            000 00      01111124568899999999999999999999999863

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.8e-39  Score=312.70  Aligned_cols=265  Identities=22%  Similarity=0.295  Sum_probs=198.7

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC--CcccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      .+.++|++.+.||+|+||.||+|..      ..+++.||+|.+...  .......+.+|+.+++.++|+||++++++|..
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYD------TVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTP   86 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEE------CCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeecc
Confidence            3567899999999999999999954      345788999998643  22334567789999999999999999998864


Q ss_pred             C------CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEE
Q 014736          166 D------EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKL  239 (419)
Q Consensus       166 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  239 (419)
                      .      ...|+||||+ +++|.+.+...    ++...+..++.|++.||.|||  .+||+||||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH--~~gi~H~dlkp~Nil~~~~~~~kL  159 (353)
T cd07850          87 QKSLEEFQDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKI  159 (353)
T ss_pred             CCCccccCcEEEEEecc-CCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEEE
Confidence            3      3579999999 45888877533    788889999999999999999  678999999999999999999999


Q ss_pred             eccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHH------
Q 014736          240 SDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD------  313 (419)
Q Consensus       240 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~------  313 (419)
                      +|||++........   .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+.      
T Consensus       160 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  236 (353)
T cd07850         160 LDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP  236 (353)
T ss_pred             ccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99999986543221   223458899999999999999999999999999999999999997543221111000      


Q ss_pred             ----------hhhHHhhccc-----cccccccccc----CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          314 ----------WAKPYLRSSR-----RLRYIVDPRL----AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       314 ----------~~~~~~~~~~-----~~~~~~~~~l----~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                                ....+.....     .+.......+    ........+.++.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                      0000000000     0000000000    00112234667899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6.5e-39  Score=300.46  Aligned_cols=245  Identities=28%  Similarity=0.395  Sum_probs=194.8

Q ss_pred             ecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEe
Q 014736           99 LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        99 lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  175 (419)
                      ||+|+||+||+|...      .+++.||+|++.....   .....+.+|+++++.++||||+++++++...+..|+||||
T Consensus         1 lg~g~~g~vy~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05577           1 LGKGGFGEVCACQVK------ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTL   74 (277)
T ss_pred             CCCCCceeEEEEEEc------CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEec
Confidence            699999999999643      3467899999864322   2344567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCce
Q 014736          176 MPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH  255 (419)
Q Consensus       176 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  255 (419)
                      +++++|.+++.......+++..+..++.|++.||.|||  ..|++|+||+|+||+++.++.++|+|||++........  
T Consensus        75 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--  150 (277)
T cd05577          75 MNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--  150 (277)
T ss_pred             CCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--
Confidence            99999999997765557899999999999999999999  67899999999999999999999999999876543211  


Q ss_pred             eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCC
Q 014736          256 VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAG  335 (419)
Q Consensus       256 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  335 (419)
                       .....++..|+|||++.+..++.++||||||+++|+|++|+.||...........+..  ...            ....
T Consensus       151 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~------------~~~~  215 (277)
T cd05577         151 -IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--RTL------------EMAV  215 (277)
T ss_pred             -cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh--ccc------------cccc
Confidence             2234578899999999888899999999999999999999999976543221111110  000            0011


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014736          336 QYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVA  368 (419)
Q Consensus       336 ~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~  368 (419)
                      .++...+.++.+++.+||+.||.+||     ++.++++
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            22333467899999999999999999     5555653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-40  Score=319.53  Aligned_cols=271  Identities=28%  Similarity=0.398  Sum_probs=209.0

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCC------e
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE------E  168 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------~  168 (419)
                      .+.||+|+||.||+|      +++.+|+.||||.++... ....+...+|+++|++++|+|||+++++=++..      .
T Consensus        18 ~e~LG~Ga~g~V~rg------rnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRG------RNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             hhhhcCCccceeeee------cccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            345999999999999      577789999999998653 345677889999999999999999998755433      4


Q ss_pred             eEEEEEecCCCChhhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC--CC--cEEEeccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRI-SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS--DF--TAKLSDFG  243 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~--~~--~~kl~DfG  243 (419)
                      ..+|||||.||+|...|.+.. ...+++.+.+.++..+..||.|||  ++|||||||||.||++-.  +|  ..||+|||
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr--En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR--ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH--HcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            579999999999999997654 367999999999999999999999  899999999999999843  34  37999999


Q ss_pred             ccccCCCCCCceeeeccccccccccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHh---
Q 014736          244 LAKMGPEGSNTHVTTRVMGTYGYAAPEYIS-TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYL---  319 (419)
Q Consensus       244 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---  319 (419)
                      .|+...++.   ....++||..|++||+.. .+.|+..+|.|||||++|+++||..||...........+.|..-.-   
T Consensus       170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~  246 (732)
T KOG4250|consen  170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS  246 (732)
T ss_pred             ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence            999876655   456688999999999998 4899999999999999999999999997654432211111111000   


Q ss_pred             --------hcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHHhhhcCc
Q 014736          320 --------RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP--KMAAVVATLESLLNLK  377 (419)
Q Consensus       320 --------~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP--s~~eil~~L~~l~~~~  377 (419)
                              ...+.+.....-.............+-..+..+|..+|++|-  ...+....+..|++..
T Consensus       247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~  314 (732)
T KOG4250|consen  247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK  314 (732)
T ss_pred             ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence                    011111111111112333444556677888899999999998  8888888888877643

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-39  Score=305.60  Aligned_cols=270  Identities=21%  Similarity=0.263  Sum_probs=198.3

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeC--
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCED--  166 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--  166 (419)
                      +|.+.++||+|+||.||+|.....    ..++.||+|.+....   ......+.+|+.+++.++||||+++++++.+.  
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~----~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG----KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD   76 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC----CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCC
Confidence            478889999999999999975431    247889999997632   33346678899999999999999999999988  


Q ss_pred             CeeEEEEEecCCCChhhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC----CCcEEE
Q 014736          167 EERLLVYEFMPRGSLENHLFKRI---SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS----DFTAKL  239 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~----~~~~kl  239 (419)
                      ...++||||+. ++|.+++....   ...+++..++.++.||+.||.|||  +++|+||||||+|||++.    ++.+||
T Consensus        77 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~h~dlkp~Nil~~~~~~~~~~~kl  153 (316)
T cd07842          77 KSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKI  153 (316)
T ss_pred             ceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH--hCCEeeCCCCHHHEEEcCCCCccceEEE
Confidence            78999999995 57777664332   236788899999999999999999  677999999999999999    899999


Q ss_pred             eccCccccCCCCCCc-eeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccch------hH
Q 014736          240 SDFGLAKMGPEGSNT-HVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQ------NL  311 (419)
Q Consensus       240 ~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~~  311 (419)
                      +|||++......... .......++..|+|||++.+ ..++.++||||||+++|+|++|++||.........      ..
T Consensus       154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
T cd07842         154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ  233 (316)
T ss_pred             CCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence            999999865443221 11223467899999998765 46899999999999999999999999865443210      00


Q ss_pred             HHhhhHHhh-----------cccccccccccccCCCCC---------H--HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          312 VDWAKPYLR-----------SSRRLRYIVDPRLAGQYS---------V--KGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       312 ~~~~~~~~~-----------~~~~~~~~~~~~l~~~~~---------~--~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .......+.           .........+......++         .  ..+.++.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000000           000000000000000111         1  34567999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.5e-39  Score=304.85  Aligned_cols=255  Identities=26%  Similarity=0.354  Sum_probs=195.1

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCC-cccccceeeEEEeCCee
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLR-HPHLVRLIGYCCEDEER  169 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~  169 (419)
                      +|...+.||+|+||.||++..      ..+++.||+|.+..... .....+.+|+.++.++. |+||+++++++..++..
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~   78 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLH------KPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC   78 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEE------CCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence            455567799999999999954      34468899999875432 33457889999999996 99999999999999999


Q ss_pred             EEEEEecCCCChhhhh---hhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          170 LLVYEFMPRGSLENHL---FKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l---~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +++|||+. ++|.++.   .......+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.++|+|||++.
T Consensus        79 ~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  156 (288)
T cd06616          79 WICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGISG  156 (288)
T ss_pred             EEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-cCCeeccCCCHHHEEEccCCcEEEeecchhH
Confidence            99999984 4555433   33334578999999999999999999994 2479999999999999999999999999987


Q ss_pred             cCCCCCCceeeecccccccccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTG---HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSR  323 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  323 (419)
                      .......   .....|+..|+|||++.+.   .++.++|||||||++|+|++|+.||.....     ..........   
T Consensus       157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~---  225 (288)
T cd06616         157 QLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK---  225 (288)
T ss_pred             HhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC---
Confidence            5433221   1233588999999998765   689999999999999999999999975431     1111000000   


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          324 RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       324 ~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                          ...+.+........+.++.+|+.+||+.||.+|||+.+|++.
T Consensus       226 ----~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         226 ----GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             ----CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                001112222223456789999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1e-38  Score=294.75  Aligned_cols=250  Identities=24%  Similarity=0.368  Sum_probs=205.6

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      +|.+.+.||.|+||.||++....      +++.|++|++.....  .....+.+|+++++.++|+|++++++.+...+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~   74 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKS------DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL   74 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcC------CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence            57888999999999999996543      467899999976543  4456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          170 LLVYEFMPRGSLENHLFKRI--SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ++||||+++++|.+++....  ...+++..+..++.+++.||.|||  ++|++|+||+|+||+++.++.++|+|||++..
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~  152 (258)
T cd08215          75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV  152 (258)
T ss_pred             EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHHeEEcCCCcEEECCccceee
Confidence            99999999999999987653  367899999999999999999999  67899999999999999999999999999987


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      .....  .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||........   ..   ... . ..   
T Consensus       153 ~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~---~~~-~-~~---  219 (258)
T cd08215         153 LSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL---AL---KIL-K-GQ---  219 (258)
T ss_pred             cccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH---HH---HHh-c-CC---
Confidence            54433  123335689999999999888899999999999999999999999976542211   10   000 0 00   


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                            ....+...+.++.+++.+||..+|++||++.++++
T Consensus       220 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         220 ------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                  11122244578999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.7e-39  Score=297.53  Aligned_cols=250  Identities=24%  Similarity=0.413  Sum_probs=201.4

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      +|.+.+.||+|+||.||+|....      .+..||+|.+.....  ...+.+.+|+.+++.++|+||+++++.+..++..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~   74 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKS------DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRL   74 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcC------CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence            57888999999999999996543      467799999875422  3345678999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc-EEEeccCccccC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT-AKLSDFGLAKMG  248 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~-~kl~DfGla~~~  248 (419)
                      |+|+||+.+++|.+++.......+++..+..++.|++.||.|||  .++++|+||||.||++++++. +||+|||.+...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999999999999987765556889999999999999999999  677999999999999998864 699999999865


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      .....  ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.......   ..   .....  ...   
T Consensus       153 ~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~---~~~~~--~~~---  219 (257)
T cd08225         153 NDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ---LV---LKICQ--GYF---  219 (257)
T ss_pred             cCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HH---HHHhc--ccC---
Confidence            43321  1223458999999999988889999999999999999999999997543211   11   11110  000   


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                            .......+.++.+++.+||..+|++|||+.+|++
T Consensus       220 ------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         220 ------APISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                  0112234568999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.5e-40  Score=337.50  Aligned_cols=257  Identities=29%  Similarity=0.418  Sum_probs=193.5

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      .+...+|+.+.+||+||||.||++      +++..|+.||||++.... ......+.+|+.+|++|+|||||+++..+.+
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkV------RNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVE  548 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKV------RNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVE  548 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEE------eecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhc
Confidence            456778999999999999999999      677889999999997653 2334678899999999999999999865421


Q ss_pred             CC------------------------------------------------------------------------------
Q 014736          166 DE------------------------------------------------------------------------------  167 (419)
Q Consensus       166 ~~------------------------------------------------------------------------------  167 (419)
                      ..                                                                              
T Consensus       549 s~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~  628 (1351)
T KOG1035|consen  549 STAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGR  628 (1351)
T ss_pred             cCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccc
Confidence            00                                                                              


Q ss_pred             -----------------------------------------eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHH
Q 014736          168 -----------------------------------------ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAA  206 (419)
Q Consensus       168 -----------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~  206 (419)
                                                               .+||-||||+...|.+++.++.... .....+.++++|+
T Consensus       629 ~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIl  707 (1351)
T KOG1035|consen  629 NLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREIL  707 (1351)
T ss_pred             ccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHH
Confidence                                                     1189999998888888776652221 3567899999999


Q ss_pred             HHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC----------------CCCCceeeecccccccccccc
Q 014736          207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP----------------EGSNTHVTTRVMGTYGYAAPE  270 (419)
Q Consensus       207 ~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE  270 (419)
                      +||.|+|  +.|||||||||.|||++.++.|||+|||+|+...                .+......+..+||..|+|||
T Consensus       708 EGLaYIH--~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE  785 (1351)
T KOG1035|consen  708 EGLAYIH--DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE  785 (1351)
T ss_pred             HHHHHHH--hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence            9999999  7889999999999999999999999999998621                011111235578999999999


Q ss_pred             cccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHH
Q 014736          271 YISTG---HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAV  347 (419)
Q Consensus       271 ~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~  347 (419)
                      ++.+.   .|+.|+|+||||+|++||+.   ||.....  ....+.    .++ .+.+.     .. ..+......+-..
T Consensus       786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra~iL~----~LR-~g~iP-----~~-~~f~~~~~~~e~s  849 (1351)
T KOG1035|consen  786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME--RASILT----NLR-KGSIP-----EP-ADFFDPEHPEEAS  849 (1351)
T ss_pred             HhcccccccccchhhhHHHHHHHHHHhc---cCCchHH--HHHHHH----hcc-cCCCC-----CC-cccccccchHHHH
Confidence            99764   49999999999999999984   4553211  111110    011 11111     00 2233344456789


Q ss_pred             HHHHcccCCCCCCCCHHHHHH
Q 014736          348 LALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       348 li~~~l~~dP~~RPs~~eil~  368 (419)
                      +|.+|++.||.+|||+.|++.
T Consensus       850 lI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  850 LIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHhcCCCccCCCHHHHhh
Confidence            999999999999999999974

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-39  Score=301.31  Aligned_cols=264  Identities=22%  Similarity=0.271  Sum_probs=198.4

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      |++.+.||.|++|.||+|....      +++.||+|++.....  .....+.+|+++++.++|+||+++++++.+.+..|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~   74 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKL------TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLY   74 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcC------CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence            6778899999999999996533      468899999875432  23356888999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      ++|||+ +++|.+++.......+++..++.++.|++.||.|||  +++++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH--~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  151 (283)
T cd07835          75 LVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV  151 (283)
T ss_pred             EEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence            999999 568999987664456899999999999999999999  67899999999999999999999999999975433


Q ss_pred             CCCceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhH-HHhhh-------HHhhc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNL-VDWAK-------PYLRS  321 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-~~~~~-------~~~~~  321 (419)
                      ...  ......++..|+|||++.+. .++.++||||||+++|+|++|+.||........... .....       .....
T Consensus       152 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07835         152 PVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS  229 (283)
T ss_pred             Ccc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence            211  11223468899999988654 578999999999999999999999976533211100 00000       00000


Q ss_pred             ----ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          322 ----SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       322 ----~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                          ........... ........+.++.+++.+||+.||.+||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         230 LPDYKPTFPKWARQD-LSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             chhhhhhcccccccc-hhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                00000000000 01112334578999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1e-38  Score=301.83  Aligned_cols=261  Identities=16%  Similarity=0.178  Sum_probs=189.4

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccH-----------HHHHHHHHHHcCCCccccc
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-----------REWLAEVIFLGQLRHPHLV  157 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpnIv  157 (419)
                      ..++|.+.++||+|+||.||+|.+.++   ...+..+|+|+.........           .....++..+..++|+||+
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~---~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASD---HCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCC---cccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            346899999999999999999976543   11245677776543322111           1123344556778999999


Q ss_pred             ceeeEEEeCC----eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 014736          158 RLIGYCCEDE----ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS  233 (419)
Q Consensus       158 ~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~  233 (419)
                      ++++++....    ..+++|+++ ..++.+.+...  ...++..++.++.|++.||.|||  +++|+||||||+|||++.
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~iiHrDiKp~Nill~~  161 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIH--EHGISHGDIKPENIMVDG  161 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcC
Confidence            9998765543    347888887 45676665443  34577888999999999999999  677999999999999999


Q ss_pred             CCcEEEeccCccccCCCCCCc-----eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccc
Q 014736          234 DFTAKLSDFGLAKMGPEGSNT-----HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSE  308 (419)
Q Consensus       234 ~~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  308 (419)
                      ++.++|+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            999999999999865332211     111234699999999999999999999999999999999999999987632221


Q ss_pred             h-hH--HHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014736          309 Q-NL--VDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL  370 (419)
Q Consensus       309 ~-~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L  370 (419)
                      . ..  .++.....          ...+   .....++++.+++..|+..+|++||++.+|++.|
T Consensus       242 ~~~~~~~~~~~~~~----------~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        242 LIHAAKCDFIKRLH----------EGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHhHHHHHHHhh----------hhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            1 10  01111100          0000   1122357899999999999999999999999876

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.5e-38  Score=292.40  Aligned_cols=250  Identities=29%  Similarity=0.446  Sum_probs=204.0

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEE
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLL  171 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  171 (419)
                      +|...+.||+|++|.||+|....      .++.+++|++..........+.+|+++++.++|+||+++++++..+...++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   74 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKR------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWI   74 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECC------CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            47788899999999999996543      467899999987655556788999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCC
Q 014736          172 VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG  251 (419)
Q Consensus       172 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  251 (419)
                      ++||+++++|.+++.... ..+++..+..++.|++.||.|||  ++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        75 ~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          75 VMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             EEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh--cCCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            999999999999886643 46899999999999999999999  688999999999999999999999999999875543


Q ss_pred             CCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccccc
Q 014736          252 SNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDP  331 (419)
Q Consensus       252 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (419)
                      ..   .....|+..|++||.+.+..++.++|+||||+++|+|++|+.||............   .    . ....     
T Consensus       152 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~----~-~~~~-----  215 (253)
T cd05122         152 KA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI---A----T-NGPP-----  215 (253)
T ss_pred             cc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---H----h-cCCC-----
Confidence            31   23356889999999998888999999999999999999999999765322111110   0    0 0000     


Q ss_pred             ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          332 RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       332 ~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .+  ......+.++.+++.+||+.||++|||+.++++
T Consensus       216 ~~--~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         216 GL--RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             Cc--CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00  011113578999999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-40  Score=303.03  Aligned_cols=243  Identities=26%  Similarity=0.361  Sum_probs=202.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCC-CcccccceeeEEEe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQL-RHPHLVRLIGYCCE  165 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  165 (419)
                      ..+|.++.+||+|+||.|.+|.      .+.+.+.||||++++...   .+.+--+.|-++|... +-|.++.+..+|..
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLae------rkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT  421 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAE------RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT  421 (683)
T ss_pred             ecccceEEEeccCccceeeeec------ccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh
Confidence            4578999999999999999995      344568899999986532   2333345677788776 47899999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      -+++|+||||+.||+|--.+++.  +.+.+..+..++..|+.||-+||  ++|||+||||.+|||++.+|++||+|||++
T Consensus       422 mDRLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh--~kgIiYRDLKLDNvmLd~eGHiKi~DFGmc  497 (683)
T KOG0696|consen  422 MDRLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFGMC  497 (683)
T ss_pred             hhheeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhh--cCCeeeeeccccceEeccCCceEeeecccc
Confidence            99999999999999999988877  56778889999999999999999  788999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      +.-.....  .+..++||+.|+|||++..++|+.++|+||+||+|||||.|++||++....+....+             
T Consensus       498 KEni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI-------------  562 (683)
T KOG0696|consen  498 KENIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI-------------  562 (683)
T ss_pred             cccccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------------
Confidence            85433332  245689999999999999999999999999999999999999999986544322221             


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK  362 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs  362 (419)
                         .+.  .-.|+...+.|+.+++...|.++|.+|..
T Consensus       563 ---~eh--nvsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  563 ---MEH--NVSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ---HHc--cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence               111  12567778899999999999999999953

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.2e-39  Score=303.03  Aligned_cols=266  Identities=22%  Similarity=0.264  Sum_probs=199.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--cHHHHHHHHHHHcCCCcccccceeeEEEeC--
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--GHREWLAEVIFLGQLRHPHLVRLIGYCCED--  166 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--  166 (419)
                      ++|.+.+.||+|+||.||+|....      +++.+++|.+......  ....+.+|+.++++++||||+++++++...  
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   78 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKK------TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL   78 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECC------CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence            468888999999999999996543      4678999999754322  223567899999999999999999998877  


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..|+||||+. ++|.+++.... ..+++..++.++.||+.||+|||  ++|++|+||||+|||++.++.++|+|||++.
T Consensus        79 ~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nili~~~~~~~l~d~g~~~  154 (293)
T cd07843          79 DKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLH--DNWILHRDLKTSNLLLNNRGILKICDFGLAR  154 (293)
T ss_pred             CcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHHHEEECCCCcEEEeecCcee
Confidence            88999999996 59988886542 36899999999999999999999  6779999999999999999999999999988


Q ss_pred             cCCCCCCceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh--------hH
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA--------KP  317 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~--------~~  317 (419)
                      .......  ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+...        .+
T Consensus       155 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
T cd07843         155 EYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP  232 (293)
T ss_pred             eccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence            6544321  12234578899999988654 4689999999999999999999999765432211111000        00


Q ss_pred             Hhhc-----ccccccccccccCCCCCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          318 YLRS-----SRRLRYIVDPRLAGQYSVK-GAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       318 ~~~~-----~~~~~~~~~~~l~~~~~~~-~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .+..     ...........+...++.. .++.+.+++.+||+.||++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0000     0000000011111222222 4678999999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1e-38  Score=299.51  Aligned_cols=243  Identities=25%  Similarity=0.333  Sum_probs=187.8

Q ss_pred             eecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc---cHHHHHHHHHH---HcCCCcccccceeeEEEeCCeeEE
Q 014736           98 LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ---GHREWLAEVIF---LGQLRHPHLVRLIGYCCEDEERLL  171 (419)
Q Consensus        98 ~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~---l~~l~hpnIv~~~~~~~~~~~~~l  171 (419)
                      +||+|+||.||+|...      .+++.||+|.+......   ....+.+|..+   +...+|+||+.+++++..++..++
T Consensus         1 ~lg~G~~g~Vy~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l   74 (279)
T cd05633           1 IIGRGGFGEVYGCRKA------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCF   74 (279)
T ss_pred             CcccCCCeEEEEEEEC------CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEE
Confidence            4899999999999643      34678999998654221   12233444443   334579999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCC
Q 014736          172 VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG  251 (419)
Q Consensus       172 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  251 (419)
                      ||||+.+++|.+++...  ..+++..+..++.|++.||.|||  .+||+|+||||+|||++.++.++|+|||++......
T Consensus        75 v~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~  150 (279)
T cd05633          75 ILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (279)
T ss_pred             EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc
Confidence            99999999999988765  56899999999999999999999  677999999999999999999999999998754332


Q ss_pred             CCceeeeccccccccccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccc
Q 014736          252 SNTHVTTRVMGTYGYAAPEYIS-TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD  330 (419)
Q Consensus       252 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (419)
                      .    .....|+..|+|||.+. +..++.++|||||||++|+|++|..||...............   .           
T Consensus       151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~-----------  212 (279)
T cd05633         151 K----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---L-----------  212 (279)
T ss_pred             C----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---h-----------
Confidence            2    12245899999999986 456899999999999999999999999765432221111100   0           


Q ss_pred             cccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014736          331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVAT  369 (419)
Q Consensus       331 ~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~~  369 (419)
                       ......+...+.++.+++.+||..||.+||     ++.++++.
T Consensus       213 -~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         213 -TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             -cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence             001122334567899999999999999999     58888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.3e-38  Score=299.80  Aligned_cols=253  Identities=25%  Similarity=0.391  Sum_probs=204.8

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ..+.|+..+.||+|+||.||+|....      .++.|++|++..... ....+.+|+++++.++|+||+++++.+...+.
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   89 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRA------TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDE   89 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEcc------CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE
Confidence            45678888899999999999996542      357899999976544 46678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+|+||+++++|.+++.... ..+++..+..++.|++.||.|||  .+|++|+||+|+||+++.++.++|+|||++...
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH--~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  166 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH--SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL  166 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence            999999999999999997753 37899999999999999999999  688999999999999999999999999998754


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      .....  ......++..|++||++.+..++.++|+||||+++|+|++|..||....+.......  .     . ...   
T Consensus       167 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~--~-----~-~~~---  233 (286)
T cd06614         167 TKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI--T-----T-KGI---  233 (286)
T ss_pred             ccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H-----h-cCC---
Confidence            33221  122345788999999998888999999999999999999999999754332111100  0     0 000   


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        +.  ......++.++.+++.+||+.+|.+||++.+|++
T Consensus       234 --~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         234 --PP--LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             --CC--CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence              00  0111224578999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-40  Score=318.69  Aligned_cols=244  Identities=23%  Similarity=0.389  Sum_probs=192.8

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEecc---C-CcccHHHHHHHHHHHcCCCcccccceeeEEEeCCe--e
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI---E-GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE--R  169 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~---~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--~  169 (419)
                      ..+||+|+|-+||+|.+..      +|..||=-.++.   . .....++|..|+.+|+.|+|||||++|+++.+...  +
T Consensus        45 ~evLGrGafKtVYka~De~------~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i  118 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEE------EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI  118 (632)
T ss_pred             hhhcccccceeeeeccccc------cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence            3469999999999997543      344455333322   1 22345789999999999999999999999987665  7


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-CcEEEeccCccccC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD-FTAKLSDFGLAKMG  248 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla~~~  248 (419)
                      .+|+|++..|+|..|+.+.  +.+....++.|++||+.||.|||++...|||||||.+||||+.+ |.|||+|+|||...
T Consensus       119 n~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~  196 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL  196 (632)
T ss_pred             eeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence            8999999999999999877  66788899999999999999999999999999999999999875 89999999999975


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ....    ....+|||.|||||... ..|+..+||||||++++||+|+..||..-.....  ..   +..          
T Consensus       197 r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ--IY---KKV----------  256 (632)
T KOG0584|consen  197 RKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ--IY---KKV----------  256 (632)
T ss_pred             hccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH--HH---HHH----------
Confidence            4433    22367999999999984 8999999999999999999999999975433211  11   100          


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ........+..--.+++++||.+||.. ..+|||+.|+|.
T Consensus       257 ~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  257 TSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            001111112222246899999999999 999999999986

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1e-38  Score=301.75  Aligned_cols=267  Identities=21%  Similarity=0.269  Sum_probs=197.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|.+.+.||+|++|.||+|...      .+++.||+|.+.....  .....+.+|+++++.++|+||+++++++.+...
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDR------VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR   75 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEec------CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence            57889999999999999999643      3467899999865432  234567889999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCcEEEeccCcccc
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS-DFTAKLSDFGLAKM  247 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~  247 (419)
                      .|+||||+. ++|.+++.......+++..+..++.||+.||+|||  ++|++|+||+|+||+++. ++.+||+|||++..
T Consensus        76 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~  152 (294)
T PLN00009         76 LYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--SHRVLHRDLKPQNLLIDRRTNALKLADFGLARA  152 (294)
T ss_pred             EEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCcceEEEECCCCEEEEcccccccc
Confidence            999999994 68888876654455678888899999999999999  678999999999999985 56799999999975


Q ss_pred             CCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHH-Hhh-hH---Hhhc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV-DWA-KP---YLRS  321 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~-~~~-~~---~~~~  321 (419)
                      ......  ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||............ ... .+   .+..
T Consensus       153 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (294)
T PLN00009        153 FGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG  230 (294)
T ss_pred             cCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence            433211  1223457889999998865 46789999999999999999999999764332111110 000 00   0000


Q ss_pred             ccccccc---ccc---ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          322 SRRLRYI---VDP---RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       322 ~~~~~~~---~~~---~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ...+...   ...   ..........+.++.+++.+||+.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000000   000   0000012234677999999999999999999999986

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-40  Score=313.91  Aligned_cols=259  Identities=25%  Similarity=0.403  Sum_probs=215.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ..+....++||-|.||.||.|+|+..      .-.||||.++. +....++|+.|..+|+.++|||+|+++|+|..+..+
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKky------slTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeecc------ceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            34566778999999999999999764      24599999874 344578999999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |||+|||..|+|.+||.+-....++.-..+.++.||..||+||.  .+++|||||...|+|+.++..||++||||+++..
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE--kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH--HhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence            99999999999999998877777888888999999999999999  6779999999999999999999999999999865


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ...++. .....-...|.|||-+.-..++.++|||+|||+|||+.| |..||.+..-.....+       ++.+      
T Consensus       417 gDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~L-------LEkg------  482 (1157)
T KOG4278|consen  417 GDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGL-------LEKG------  482 (1157)
T ss_pred             CCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHH-------Hhcc------
Confidence            544332 222234568999999999999999999999999999988 8999987643221111       1121      


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                          ..-.-+..|++.+..|++.||+++|.+||++.||-+.|+.+..
T Consensus       483 ----yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  483 ----YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             ----ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence                2222344567889999999999999999999999888887643

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.8e-38  Score=293.16  Aligned_cols=252  Identities=29%  Similarity=0.391  Sum_probs=205.7

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeC--C
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCED--E  167 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~  167 (419)
                      +|...+.||+|++|.||+|....      +++.|++|++.....  .....+.+|+.++++++|+||+++++.+...  .
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKD------TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKN   74 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECC------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence            47788899999999999996543      467899999976543  3457788999999999999999999999988  8


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..+++|||+.+++|.+++...  ..+++..+..++.|++.||.|||  ++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh--~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~  150 (260)
T cd06606          75 TLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLH--SNGIVHRDIKGANILVDSDGVVKLADFGCAKR  150 (260)
T ss_pred             eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence            899999999999999998765  37899999999999999999999  67899999999999999999999999999987


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ..............++..|+|||.+.+..++.++||||||+++|+|++|..||.......  . ..  ....        
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~-~~--~~~~--------  217 (260)
T cd06606         151 LGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--A-AL--YKIG--------  217 (260)
T ss_pred             cccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--H-HH--Hhcc--------
Confidence            655432111233568899999999988889999999999999999999999998654110  0 00  0000        


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        ........+...+.++.+++.+||..||++||++.+++.
T Consensus       218 --~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         218 --SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             --ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence              001112233344688999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-39  Score=309.65  Aligned_cols=269  Identities=22%  Similarity=0.305  Sum_probs=197.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeC--
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCED--  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--  166 (419)
                      .++|.+.++||+|+||.||+|...      .+++.||+|++.... ......+.+|+.+++.++|+||+++++++...  
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   77 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHK------PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF   77 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEc------CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence            468999999999999999999643      446889999986432 23345678899999999999999999987654  


Q ss_pred             ---CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccC
Q 014736          167 ---EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFG  243 (419)
Q Consensus       167 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  243 (419)
                         ...|+||||+. ++|.+.+..   ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||
T Consensus        78 ~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH--~~~ivH~dlkp~Nill~~~~~~kl~dfg  151 (336)
T cd07849          78 ESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTNCDLKICDFG  151 (336)
T ss_pred             cccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCCEEECccc
Confidence               35799999995 588777644   36889999999999999999999  6779999999999999999999999999


Q ss_pred             ccccCCCCCCc-eeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhc
Q 014736          244 LAKMGPEGSNT-HVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS  321 (419)
Q Consensus       244 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  321 (419)
                      ++......... .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.........   ......+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~---~~~~~~~~~  228 (336)
T cd07849         152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL---NLILGVLGT  228 (336)
T ss_pred             ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCC
Confidence            98765332211 11223568999999998654 56899999999999999999999999754321111   000000000


Q ss_pred             --cccccccccc---------ccC-----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhh
Q 014736          322 --SRRLRYIVDP---------RLA-----GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT--LESL  373 (419)
Q Consensus       322 --~~~~~~~~~~---------~l~-----~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~--L~~l  373 (419)
                        ...+..+...         ...     .......+.++.+++.+||+.||.+|||+.++++.  |+..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence              0000000000         000     00111235679999999999999999999999875  5444

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-40  Score=323.61  Aligned_cols=265  Identities=26%  Similarity=0.443  Sum_probs=221.1

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEE
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLL  171 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  171 (419)
                      ..+.++||.|.||.|++|.++-.   ......||||.++.-. .+++.+|+.|..||-+++||||+++.|+........|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~p---gkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLP---GKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             eEEEEEEecccccceecccccCC---CCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            45778999999999999987643   3345689999998542 3456789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCC
Q 014736          172 VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG  251 (419)
Q Consensus       172 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  251 (419)
                      |.|||++|+|..||+.+. +.++..+..-+++.|+.||+||-  +.|+|||||...||||+.+..+|++|||+++.+.+.
T Consensus       708 iTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLs--dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLS--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             EhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHh--hcCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence            999999999999998875 45888888999999999999999  777999999999999999999999999999987655


Q ss_pred             CCceeeec-ccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          252 SNTHVTTR-VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       252 ~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      .....++. ..-...|.|||.+....++.++||||+|++|||.|+ |..||......+..+.++                
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe----------------  848 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE----------------  848 (996)
T ss_pred             CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH----------------
Confidence            42222211 123468999999999999999999999999999988 999998776544332221                


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCcccc
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMA  380 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~~~  380 (419)
                       ....-..+.+++..+.+|+..||++|-.+||.+.+|+..|+++......-
T Consensus       849 -~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL  898 (996)
T KOG0196|consen  849 -QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL  898 (996)
T ss_pred             -hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence             12222345678899999999999999999999999999999998765443

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.5e-38  Score=298.81  Aligned_cols=266  Identities=24%  Similarity=0.304  Sum_probs=199.2

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-cHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      +|++.+.||.|++|.||+|...      .+++.||+|++...... ....+.+|+.++++++|+||+++++++.+.+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   74 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNR------TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLM   74 (284)
T ss_pred             CceEeeeeccCCceEEEEEEEC------CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEE
Confidence            5888999999999999999643      34678999999765332 3456778999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          171 LVYEFMPRGSLENHLFKRI-SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      +||||+. ++|.+++.... ...+++..+..++.|++.||.|||  +.|++|+||||+||+++.++.++|+|||++....
T Consensus        75 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          75 LVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             EEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            9999996 58888886543 245899999999999999999999  6779999999999999999999999999997543


Q ss_pred             CCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHH-hh-hH------Hhh
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD-WA-KP------YLR  320 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~-~~-~~------~~~  320 (419)
                      ....  ......++..|++||++.+ ..++.++||||||+++|+|++|..||...........+. .. .+      .+.
T Consensus       152 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07836         152 IPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS  229 (284)
T ss_pred             CCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence            3211  1223457889999998865 457899999999999999999999998654322111110 00 00      000


Q ss_pred             ccccccccccc---ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          321 SSRRLRYIVDP---RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       321 ~~~~~~~~~~~---~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ....+......   .....+....+.++.+++.+||+.||.+||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000000000   0001111234678999999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.9e-38  Score=301.79  Aligned_cols=247  Identities=29%  Similarity=0.385  Sum_probs=196.5

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      +.|.+.+.||+|+||.||+|...      ..++.||+|++.....   .....+.+|+++++.++||||+++++++.+.+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~------~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~   88 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDV------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH   88 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEc------CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence            56888999999999999999643      3467899999864432   23356889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+. |+|.+++... ...+++..+..++.|++.||.|||  ..||+|+||+|+||+++.++.++|+|||++..
T Consensus        89 ~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH--~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~  164 (307)
T cd06607          89 TAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLH--SHERIHRDIKAGNILLTEPGTVKLADFGSASL  164 (307)
T ss_pred             eEEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcccEEECCCCCEEEeecCccee
Confidence            9999999995 6777776543 246889999999999999999999  67799999999999999999999999999875


Q ss_pred             CCCCCCceeeeccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYIS---TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      ....      ....|+..|+|||++.   ...++.++||||||+++|+|++|..||...........+      . ..  
T Consensus       165 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~------~-~~--  229 (307)
T cd06607         165 VSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------A-QN--  229 (307)
T ss_pred             cCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH------h-cC--
Confidence            4322      2245888999999874   456889999999999999999999999754322111000      0 00  


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                             .........++.++.+++.+||+.||++||++.+|+..
T Consensus       230 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         230 -------DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             -------CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                   00011122356789999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.2e-38  Score=303.52  Aligned_cols=267  Identities=23%  Similarity=0.267  Sum_probs=196.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--cHHHHHHHHHHHcCCCcccccceeeEEEeC-
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--GHREWLAEVIFLGQLRHPHLVRLIGYCCED-  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-  166 (419)
                      .++|++.+.||+|+||.||+|...      .+++.||+|++......  ....+.+|+.++++++|+||+++++++.+. 
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDT------TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH   79 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEEC------CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC
Confidence            357999999999999999999643      35788999998754322  123466799999999999999999998765 


Q ss_pred             -CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          167 -EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       167 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                       +..++||||+. ++|.+++... ...+++..+..++.||+.||.|||  +.|++||||||+||+++.++.+||+|||++
T Consensus        80 ~~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~kL~dfg~~  155 (309)
T cd07845          80 LDSIFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLA  155 (309)
T ss_pred             CCeEEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEECcccee
Confidence             56899999995 5888887653 256899999999999999999999  677999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH-------
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP-------  317 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-------  317 (419)
                      .........  .....++..|+|||++.+ ..++.++||||||+++|+|++|.+||...........+.....       
T Consensus       156 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07845         156 RTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW  233 (309)
T ss_pred             eecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            865433211  122346788999999865 5689999999999999999999999986544332211111000       


Q ss_pred             -Hhhcccccccc-cccccCCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          318 -YLRSSRRLRYI-VDPRLAGQY---SVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       318 -~~~~~~~~~~~-~~~~l~~~~---~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       .+......... .........   ....++++.++|.+||+.||++|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence             00000000000 000000000   0113677899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-38  Score=294.50  Aligned_cols=251  Identities=25%  Similarity=0.316  Sum_probs=198.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-----cccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-----LQGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      .+|.+.+.||+|+||.||+|...      .+++.||+|.+....     ......+.+|++++++++|+||+++++++.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   75 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDA------DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD   75 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEc------CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc
Confidence            47889999999999999999643      457889999875321     2234578889999999999999999999866


Q ss_pred             C--CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccC
Q 014736          166 D--EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFG  243 (419)
Q Consensus       166 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  243 (419)
                      .  +..+++|||+++++|.+++...  ..+++..+..++.|++.||.|||  ++|++|+||||+||+++.++.++|+|||
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~l~dfg  151 (264)
T cd06653          76 PEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLH--SNMIVHRDIKGANILRDSAGNVKLGDFG  151 (264)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEECccc
Confidence            4  4688999999999999998765  45788889999999999999999  6789999999999999999999999999


Q ss_pred             ccccCCCCCCc-eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          244 LAKMGPEGSNT-HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       244 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      ++......... .......|+..|+|||++.+..++.++|+|||||++|+|++|+.||.......  ....    ..   
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~----~~---  222 (264)
T cd06653         152 ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFK----IA---  222 (264)
T ss_pred             cccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HHHH----HH---
Confidence            99864322111 11123568999999999988889999999999999999999999997542211  1110    00   


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                             .......++...++++.+++.+||. +|.+||++.+++.
T Consensus       223 -------~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         223 -------TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             -------cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                   0111123344566889999999999 5799999998765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.4e-38  Score=295.50  Aligned_cols=243  Identities=28%  Similarity=0.343  Sum_probs=196.7

Q ss_pred             ecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEe
Q 014736           99 LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        99 lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  175 (419)
                      ||.|+||.||+|...      ..++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.++...|+||||
T Consensus         1 lg~g~~~~v~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   74 (262)
T cd05572           1 LGVGGFGRVELVKVK------SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEY   74 (262)
T ss_pred             CCCCCceEEEEEEEC------CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEec
Confidence            799999999999653      3468899999975432   2346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCce
Q 014736          176 MPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH  255 (419)
Q Consensus       176 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  255 (419)
                      +++++|.+++.+.  ..+++..+..++.||+.||.|||  ++|++|+||+|+||+++.++.++|+|||++.......   
T Consensus        75 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH--~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---  147 (262)
T cd05572          75 CLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---  147 (262)
T ss_pred             CCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---
Confidence            9999999999765  45888999999999999999999  6789999999999999999999999999998765432   


Q ss_pred             eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCC
Q 014736          256 VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAG  335 (419)
Q Consensus       256 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  335 (419)
                      ......|+..|++||.+.+..++.++|+||||+++|+|++|..||....... ....   ....          ......
T Consensus       148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~---~~~~----------~~~~~~  213 (262)
T cd05572         148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIY---NDIL----------KGNGKL  213 (262)
T ss_pred             ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHH---HHHh----------ccCCCC
Confidence            1223468899999999988889999999999999999999999998654311 1111   1100          000111


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 014736          336 QYSVKGAKEMAVLALQCISVNPKDRPK-----MAAVVA  368 (419)
Q Consensus       336 ~~~~~~~~~l~~li~~~l~~dP~~RPs-----~~eil~  368 (419)
                      .++...+.++.+++.+||+.+|++||+     +.|+++
T Consensus       214 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         214 EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            233334678999999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=291.48  Aligned_cols=248  Identities=30%  Similarity=0.443  Sum_probs=204.0

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      +|++.+.||+|++|.||+|...      ..++.|++|.+.....  .....+.+|++++++++|+|++++++++.+.+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNL------ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL   74 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEc------CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Confidence            5788899999999999999643      3457899999976654  3456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      +++|||+.+++|.+++...  ..+++..+..++.|++.||.|||  ++||+|+||||+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  150 (254)
T cd06627          75 YIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLH--EQGVIHRDIKAANILTTKDGVVKLADFGVATKLN  150 (254)
T ss_pred             EEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence            9999999999999998765  57899999999999999999999  6789999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      .....  .....++..|+|||.+.+..++.++||||||+++|+|++|..||.......    ..+...    ..      
T Consensus       151 ~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~~~~~~----~~------  214 (254)
T cd06627         151 DVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----ALFRIV----QD------  214 (254)
T ss_pred             CCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHh----cc------
Confidence            43321  223458899999999988888999999999999999999999997543211    111000    00      


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                         ....++...+.++.+++.+||..+|++||++.+++.
T Consensus       215 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         215 ---DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence               011223344678999999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.8e-38  Score=304.88  Aligned_cols=269  Identities=22%  Similarity=0.287  Sum_probs=196.0

Q ss_pred             eeccc--CceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEE
Q 014736           98 LLGEG--GFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVY  173 (419)
Q Consensus        98 ~lg~G--~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  173 (419)
                      .||+|  +||+||+|..      ...++.||+|++.....  ...+.+.+|+.+++.++||||++++++|..++..++||
T Consensus         5 ~ig~g~~~~~~v~~a~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~   78 (328)
T cd08226           5 EIGRGFCNLTSVYLARH------TPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVIS   78 (328)
T ss_pred             HhCCcccCceeEEEEEE------cCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEE
Confidence            46666  9999999954      34578999999875432  23467888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCC
Q 014736          174 EFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN  253 (419)
Q Consensus       174 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  253 (419)
                      ||+.+++|.+++.......+++..+..++.|++.||+|||  ++||+||||||+|||++.++.++++||+.+........
T Consensus        79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~  156 (328)
T cd08226          79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH--QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ  156 (328)
T ss_pred             ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence            9999999999988765556889999999999999999999  67899999999999999999999999986543221111


Q ss_pred             -cee----eecccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH--------
Q 014736          254 -THV----TTRVMGTYGYAAPEYIST--GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--------  318 (419)
Q Consensus       254 -~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------  318 (419)
                       ...    .....++..|+|||++.+  ..++.++|||||||++|+|++|..||.................+        
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence             000    011235667999999866  35789999999999999999999999765322110000000000        


Q ss_pred             -------------hh--------cccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhh
Q 014736          319 -------------LR--------SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA--TLESLL  374 (419)
Q Consensus       319 -------------~~--------~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~--~L~~l~  374 (419)
                                   ..        ............+.......++..+.+|+.+||+.||++|||+.++++  ++..+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~  315 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK  315 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence                         00        000000011111122223456788999999999999999999999985  344443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.2e-38  Score=297.22  Aligned_cols=259  Identities=24%  Similarity=0.281  Sum_probs=193.3

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCC-cccccceeeEEEeC--Ce
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLR-HPHLVRLIGYCCED--EE  168 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~--~~  168 (419)
                      |++.+.||+|+||.||+|...      .+++.||+|++..... .......+|+.++.++. |+||+++++++.+.  +.
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~------~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   74 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSR------KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGR   74 (282)
T ss_pred             CceEeeccccccceEEEEEEc------CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCc
Confidence            677889999999999999643      3467899999875422 22234557899898885 99999999999987  88


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .++||||+. ++|.+++.... ..+++..+..++.|++.||.|||  ++|++|+||||+||+++. +.+||+|||++...
T Consensus        75 ~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~  149 (282)
T cd07831          75 LALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMH--RNGIFHRDIKPENILIKD-DILKLADFGSCRGI  149 (282)
T ss_pred             EEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEcC-CCeEEEeccccccc
Confidence            999999995 58888876542 46899999999999999999999  678999999999999999 99999999999865


Q ss_pred             CCCCCceeeeccccccccccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHh--------
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYIS-TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYL--------  319 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--------  319 (419)
                      .....   .....++..|+|||++. ++.++.++|||||||++|+|++|..||......+.   +.......        
T Consensus       150 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~  223 (282)
T cd07831         150 YSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVL  223 (282)
T ss_pred             ccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHH
Confidence            43322   12345889999999764 45678999999999999999999999976543221   11111100        


Q ss_pred             ---hcccccccccccccC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          320 ---RSSRRLRYIVDPRLA---GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       320 ---~~~~~~~~~~~~~l~---~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                         ...............   .......+.++.+|+.+||+.+|++||++.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence               000000000000000   0011235688999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.3e-38  Score=300.87  Aligned_cols=264  Identities=23%  Similarity=0.252  Sum_probs=194.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCC-cccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLR-HPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~  167 (419)
                      ++|++.+.||+|+||.||+|...      .+++.||+|++.....  .....+.+|+.+++.+. |+||+++++++...+
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~------~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   74 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDK------NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE   74 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEEC------CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence            46889999999999999999653      3467899999865432  22356788999999995 699999999998766


Q ss_pred             e-----eEEEEEecCCCChhhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCcEE
Q 014736          168 E-----RLLVYEFMPRGSLENHLFKRI---SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS-DFTAK  238 (419)
Q Consensus       168 ~-----~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-~~~~k  238 (419)
                      .     .|+||||+++ +|.+++....   ...+++..++.++.||+.||.|||  .+||+||||||+||+++. ++.+|
T Consensus        75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dl~~~nil~~~~~~~~k  151 (295)
T cd07837          75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH--KHGVMHRDLKPQNLLVDKQKGLLK  151 (295)
T ss_pred             CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHHEEEecCCCeEE
Confidence            5     8999999975 8988876532   245789999999999999999999  678999999999999999 88999


Q ss_pred             EeccCccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH
Q 014736          239 LSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP  317 (419)
Q Consensus       239 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~  317 (419)
                      |+|||++.........  .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+   ..
T Consensus       152 l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~---~~  226 (295)
T cd07837         152 IADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI---FK  226 (295)
T ss_pred             EeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---HH
Confidence            9999998754332111  122346888999998855 46789999999999999999999999764332211100   00


Q ss_pred             Hhhccc--------cccccc-----ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          318 YLRSSR--------RLRYIV-----DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       318 ~~~~~~--------~~~~~~-----~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ......        .+....     .+..........+.++.++|.+||..||.+||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000000        000000     000000111235678999999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.1e-38  Score=307.41  Aligned_cols=269  Identities=26%  Similarity=0.347  Sum_probs=199.4

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC--CcccHHHHHHHHHHHcCC-CcccccceeeEEE
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQL-RHPHLVRLIGYCC  164 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  164 (419)
                      .+.++|.+.+.||+|+||.||+|...      ..++.+|+|.+...  .......+.+|+.+++++ +|+||+++++++.
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~   77 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDR------RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIK   77 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEc------CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeec
Confidence            35678999999999999999999643      34678999988542  223345677899999999 9999999999886


Q ss_pred             eC--CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEecc
Q 014736          165 ED--EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       165 ~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                      ..  ...|+||||+. ++|.+++...   .+++..+..++.||+.||.|||  ++||+|+||||+|||++.++.+||+||
T Consensus        78 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH--~~~i~H~dl~p~nill~~~~~~kl~d~  151 (337)
T cd07852          78 AENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH--SGNVIHRDLKPSNILLNSDCRVKLADF  151 (337)
T ss_pred             cCCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEEeec
Confidence            54  36899999996 5998887654   6788888999999999999999  678999999999999999999999999


Q ss_pred             CccccCCCCCCc---eeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh--
Q 014736          243 GLAKMGPEGSNT---HVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK--  316 (419)
Q Consensus       243 Gla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--  316 (419)
                      |++.........   .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||...........+....  
T Consensus       152 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~  231 (337)
T cd07852         152 GLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP  231 (337)
T ss_pred             cchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            999865443321   12334568999999998754 567899999999999999999999997654322111110000  


Q ss_pred             -----------HHhhcc-cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          317 -----------PYLRSS-RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       317 -----------~~~~~~-~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                                 ...... ..........+. ......+.++.+++.+||+.||++|||+.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         232 PSAEDIESIKSPFAATMLDSLPSRPRKPLD-ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CCHHHHHHHHhhhHHHhhhhcccccccchh-hhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                       000000 000000000000 1112256789999999999999999999999873

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-39  Score=280.61  Aligned_cols=248  Identities=27%  Similarity=0.408  Sum_probs=194.5

Q ss_pred             CCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCC-CcccccceeeEEEeCCeeEEE
Q 014736           95 SNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        95 ~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      ++..||.|+-|+|+++.      ...++...|||.+..... ...++++..+.++..- ++|+||+.+|+|..+...++.
T Consensus        96 ~l~dlGsGtcG~V~k~~------~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic  169 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMR------FRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC  169 (391)
T ss_pred             hHHhhcCCCccceEEEE------EcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence            34459999999999995      445678999999976643 3456677777776555 489999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      ||.| + ...+.|..+..+.+++..+-++...++.||.||-. ++||+|||+||+|||+|+.|++||||||++.++-+..
T Consensus       170 MelM-s-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  170 MELM-S-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHH-H-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            9998 3 34444555666789988888999999999999985 5789999999999999999999999999998754433


Q ss_pred             CceeeecccccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYIST---GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                         ..++..|-+.|||||.+..   ..|+.++||||||+.++||.||+.||.+...+  ...+..+   +.+       .
T Consensus       247 ---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkv---ln~-------e  311 (391)
T KOG0983|consen  247 ---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKV---LNE-------E  311 (391)
T ss_pred             ---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHH---Hhc-------C
Confidence               3455679999999999954   46899999999999999999999999874321  1111111   110       1


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .+.|...  ...++.+++++..||.+|+.+||.+.++++
T Consensus       312 PP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  312 PPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            1223222  225788999999999999999999999875

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.3e-39  Score=308.01  Aligned_cols=268  Identities=21%  Similarity=0.287  Sum_probs=199.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEe--
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCE--  165 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--  165 (419)
                      .++|.+.+.||+|+||.||+|...      .+++.||+|++....  ......+.+|+.+|+.++||||+++++++..  
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   77 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDT------RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG   77 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEc------CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC
Confidence            468999999999999999999643      446889999987542  2345677889999999999999999998753  


Q ss_pred             --CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccC
Q 014736          166 --DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFG  243 (419)
Q Consensus       166 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  243 (419)
                        ....|+||||+ +++|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+||+++.++.+||+|||
T Consensus        78 ~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~dfg  152 (334)
T cd07855          78 ADFKDVYVVMDLM-ESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIH--SANVIHRDLKPSNLLVNEDCELRIGDFG  152 (334)
T ss_pred             CCCceEEEEEehh-hhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEecccc
Confidence              35689999999 56898888654  45899999999999999999999  6789999999999999999999999999


Q ss_pred             ccccCCCCCCc--eeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH---
Q 014736          244 LAKMGPEGSNT--HVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP---  317 (419)
Q Consensus       244 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~---  317 (419)
                      ++.........  .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+.....   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~  232 (334)
T cd07855         153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS  232 (334)
T ss_pred             cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence            98764332211  11223568999999998855 5689999999999999999999999976543221111100000   


Q ss_pred             --Hhh--cccccccccc------cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          318 --YLR--SSRRLRYIVD------PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       318 --~~~--~~~~~~~~~~------~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        ...  ..........      ...........+.++.+++.+||+.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence              000  0000000000      00000111234678999999999999999999999887

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.6e-38  Score=300.86  Aligned_cols=268  Identities=24%  Similarity=0.298  Sum_probs=194.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCC-
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE-  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-  167 (419)
                      ++|.+.++||+|+||.||+|...      .+++.||+|.+.....  .....+.+|+.+++.++||||+++++++...+ 
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   85 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHK------KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT   85 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEEC------CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence            57999999999999999999643      3468899999864422  22345678999999999999999999987654 


Q ss_pred             -------eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 014736          168 -------ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS  240 (419)
Q Consensus       168 -------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  240 (419)
                             ..++||||+. ++|.+++... ...+++..++.++.||+.||.|||  ++|++|+||||+||+++.++.+||+
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~  161 (310)
T cd07865          86 PYNRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIH--RNKILHRDMKAANILITKDGILKLA  161 (310)
T ss_pred             cccCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEECCCCcEEEC
Confidence                   4599999995 5888877543 246899999999999999999999  6789999999999999999999999


Q ss_pred             ccCccccCCCCCCc--eeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH
Q 014736          241 DFGLAKMGPEGSNT--HVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP  317 (419)
Q Consensus       241 DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~  317 (419)
                      |||++.........  .......++..|+|||++.+. .++.++||||||+++|+|++|..||...........+.....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T cd07865         162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG  241 (310)
T ss_pred             cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999865433221  112234578899999988654 478899999999999999999999976543322222111100


Q ss_pred             Hh-----hcccccccccccccCCCC---------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          318 YL-----RSSRRLRYIVDPRLAGQY---------SVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       318 ~~-----~~~~~~~~~~~~~l~~~~---------~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ..     .............+....         .......+.+|+.+||..||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00     000000000000000000         0012356789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=313.26  Aligned_cols=241  Identities=27%  Similarity=0.321  Sum_probs=205.1

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC---CcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE---GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      +..+.-||-||||.|-++..++.      ...+|+|++++.   ...+.+++..|-+||...+.|.||++|..|.++.+.
T Consensus       422 l~~iaTLGvGgFGRVELV~~~~~------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv  495 (732)
T KOG0614|consen  422 LKRIATLGVGGFGRVELVKVNSQ------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV  495 (732)
T ss_pred             hhhhhhcccCccceEEEEEeccc------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence            44445699999999999876542      124777777543   445667888999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |++||-|-||.|+..|.++  +.+....+..++..+++|++|||  .+|||+|||||+|.+++.+|-+||.|||+|+...
T Consensus       496 YmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH--~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLH--RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             hhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHH--hcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            9999999999999999887  67888899999999999999999  6779999999999999999999999999999887


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      .+..   +.++|||+.|+|||++.+...+.++|.||||+++||||+|.+||.+..+....+.+..-...           
T Consensus       572 ~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~-----------  637 (732)
T KOG0614|consen  572 SGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK-----------  637 (732)
T ss_pred             cCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh-----------
Confidence            7664   45689999999999999999999999999999999999999999998776655544321111           


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK  362 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs  362 (419)
                           -.++..+.....+|+++++..+|.+|..
T Consensus       638 -----i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  638 -----IEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             -----hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence                 1344556778999999999999999976

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.5e-38  Score=298.94  Aligned_cols=244  Identities=24%  Similarity=0.368  Sum_probs=196.0

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEec
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFM  176 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~  176 (419)
                      .+||+|+||.||+|...      .+++.||+|++..........+.+|+.+++.++|+||+++++.+...+..++||||+
T Consensus        26 ~~lg~g~~g~v~~~~~~------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   99 (292)
T cd06657          26 IKIGEGSTGIVCIATVK------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL   99 (292)
T ss_pred             HHcCCCCCeEEEEEEEc------CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence            46999999999999643      346889999987554445567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCcee
Q 014736          177 PRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV  256 (419)
Q Consensus       177 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  256 (419)
                      ++++|.+++..   ..+++..+..++.|++.||+|||  ++|++|+||+|+||+++.++.++|+|||++........  .
T Consensus       100 ~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH--~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~  172 (292)
T cd06657         100 EGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R  172 (292)
T ss_pred             CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--c
Confidence            99999998754   35788899999999999999999  67899999999999999999999999999875433221  1


Q ss_pred             eecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCC
Q 014736          257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQ  336 (419)
Q Consensus       257 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  336 (419)
                      .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||............   ...          ....+.  
T Consensus       173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~---~~~----------~~~~~~--  237 (292)
T cd06657         173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDN----------LPPKLK--  237 (292)
T ss_pred             ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hhh----------CCcccC--
Confidence            23345889999999998888999999999999999999999999754322111111   000          001110  


Q ss_pred             CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          337 YSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       337 ~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .....+.++.+++.+||+.||.+||++.++++
T Consensus       238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            01123567899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-40  Score=333.23  Aligned_cols=259  Identities=22%  Similarity=0.233  Sum_probs=207.0

Q ss_pred             HHHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC---CcccHHHHHHHHHHHcCCCccccccee
Q 014736           84 SELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE---GLQGHREWLAEVIFLGQLRHPHLVRLI  160 (419)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~  160 (419)
                      .+++--.++|.++++||+|+||.|.+++      ++.+++.||+|++++.   ......-|..|-.+|..-+.+-|+.++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr------~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh  141 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVR------HKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLH  141 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEE------eeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHH
Confidence            3445556799999999999999999995      4556789999999763   234445688899999999999999999


Q ss_pred             eEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 014736          161 GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS  240 (419)
Q Consensus       161 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  240 (419)
                      ..|.++.++|+||||++||+|..++.+..  .+++..++.++..|+.||.-||  +.|+|||||||+|||||..|++||+
T Consensus       142 yAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH--~mgyVHRDiKPDNvLld~~GHikLA  217 (1317)
T KOG0612|consen  142 YAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH--SMGYVHRDIKPDNVLLDKSGHIKLA  217 (1317)
T ss_pred             HHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH--hccceeccCCcceeEecccCcEeec
Confidence            99999999999999999999999997763  7999999999999999999999  6779999999999999999999999


Q ss_pred             ccCccccCCCCCCceeeeccccccccccccccc----C-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS----T-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA  315 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~  315 (419)
                      |||.+-........ .....+|||.|++||++.    + +.|+..+|+||+||++|||+.|..||-...-      ++..
T Consensus       218 DFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl------veTY  290 (1317)
T KOG0612|consen  218 DFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL------VETY  290 (1317)
T ss_pred             cchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH------HHHH
Confidence            99998776544333 234567999999999984    3 6799999999999999999999999975322      1111


Q ss_pred             hHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 014736          316 KPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK---MAAVVA  368 (419)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs---~~eil~  368 (419)
                      .....-..        .+...-...++.++.+||.+.+. +|+.|..   +++|..
T Consensus       291 ~KIm~hk~--------~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  291 GKIMNHKE--------SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             HHHhchhh--------hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            11111111        11111124478899999999884 6888887   777753

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.8e-38  Score=293.23  Aligned_cols=248  Identities=25%  Similarity=0.355  Sum_probs=202.8

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      +|++.+.||+|+||.||++...      .+++.+++|.+.....  .....+.+|+.+++.++|+||+++++++.+....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRL------SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL   74 (256)
T ss_pred             CceEeeeecCCCceeEEEEEEC------CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence            4788899999999999999643      3467899999875432  3345778899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          170 LLVYEFMPRGSLENHLFKRI--SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      |+||||+++++|.+++....  ...+++..+..++.|++.||.|||  ++|++|+||+|.||+++.++.+||+|||++..
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh--~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~  152 (256)
T cd08530          75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISKV  152 (256)
T ss_pred             EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEEecCCcEEEeeccchhh
Confidence            99999999999999986632  246788899999999999999999  67899999999999999999999999999987


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      .....    .....|+..|++||.+.+..++.++|+||||+++|+|++|+.||...........+        ..     
T Consensus       153 ~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~--------~~-----  215 (256)
T cd08530         153 LKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV--------QR-----  215 (256)
T ss_pred             hccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------hc-----
Confidence            65441    22245889999999999989999999999999999999999999765432111100        00     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                          ......+...+.++.+++.+||..+|.+||++.++++
T Consensus       216 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         216 ----GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ----CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                0111223345678999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5e-38  Score=300.34  Aligned_cols=251  Identities=27%  Similarity=0.382  Sum_probs=197.8

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .|...+.||+|+||.||+|....      .++.||+|++.....   .....+.+|+.+++.++|+|++++++++.++..
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVR------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT   99 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcC------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe
Confidence            47778889999999999996433      467899999875422   234568889999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .++||||+. |+|.+.+... ...+++..+..++.|++.||.|||  ++||+|+||+|+||+++.++.++|+|||++...
T Consensus       100 ~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH--~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~  175 (317)
T cd06635         100 AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSASIA  175 (317)
T ss_pred             EEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence            999999996 5787776543 346889999999999999999999  778999999999999999999999999998754


Q ss_pred             CCCCCceeeeccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYIS---TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      ...      ....|+..|+|||++.   .+.++.++|||||||++|+|++|..||...........+      ....   
T Consensus       176 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~------~~~~---  240 (317)
T cd06635         176 SPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------AQNE---  240 (317)
T ss_pred             CCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH------Hhcc---
Confidence            322      2345889999999973   467899999999999999999999998754221111100      0000   


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL  374 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~  374 (419)
                             .........+..+.+|+.+||+.+|.+||++.+|++.+..+.
T Consensus       241 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         241 -------SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             -------CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                   000112234567999999999999999999999998665443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.8e-39  Score=308.20  Aligned_cols=270  Identities=23%  Similarity=0.324  Sum_probs=200.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC--CcccHHHHHHHHHHHcCCCcccccceeeEEEeC-
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCED-  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-  166 (419)
                      .++|.+.+.||+|+||+||+|..      ..+++.||+|.+...  .......+.+|+.+++.++|+||+++++++... 
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~   77 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKN------SETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPH   77 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEe------cCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccc
Confidence            46799999999999999999954      345788999998643  223345677899999999999999999987654 


Q ss_pred             ----CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEecc
Q 014736          167 ----EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       167 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                          ...|+||||+ +++|.+++...  ..+++..+..++.|++.||.|||  .++++|+||||+||+++.++.+||+||
T Consensus        78 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~~i~H~dlkp~Nil~~~~~~~kL~Df  152 (337)
T cd07858          78 REAFNDVYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIH--SANVLHRDLKPSNLLLNANCDLKICDF  152 (337)
T ss_pred             ccccCcEEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEECcC
Confidence                3579999999 57898888654  56899999999999999999999  677999999999999999999999999


Q ss_pred             CccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh-----
Q 014736          243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK-----  316 (419)
Q Consensus       243 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-----  316 (419)
                      |++.......  .......++..|+|||++.. ..++.++|||||||++|+|++|+.||................     
T Consensus       153 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  230 (337)
T cd07858         153 GLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE  230 (337)
T ss_pred             ccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            9998654332  11233458889999998764 568999999999999999999999997643211111100000     


Q ss_pred             ---HHhhcccc------cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhh
Q 014736          317 ---PYLRSSRR------LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT--LESL  373 (419)
Q Consensus       317 ---~~~~~~~~------~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~--L~~l  373 (419)
                         ........      ......... .......+.++.+++.+||+.+|++|||+.++++.  +..+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         231 EDLGFIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             HHhhhcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence               00000000      000000000 01112356789999999999999999999999875  5544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.5e-38  Score=294.46  Aligned_cols=242  Identities=24%  Similarity=0.333  Sum_probs=187.8

Q ss_pred             eecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc---cHHHHHHHH---HHHcCCCcccccceeeEEEeCCeeEE
Q 014736           98 LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ---GHREWLAEV---IFLGQLRHPHLVRLIGYCCEDEERLL  171 (419)
Q Consensus        98 ~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~---~~l~~l~hpnIv~~~~~~~~~~~~~l  171 (419)
                      +||+|+||.||+|...      .+++.||+|.+......   ....+..|.   .+++...||||+++++++.+.+..++
T Consensus         1 ~ig~g~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~   74 (278)
T cd05606           1 IIGRGGFGEVYGCRKA------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   74 (278)
T ss_pred             CcccCCCeEEEEEEEe------cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEE
Confidence            4899999999999543      34678999998754321   112233343   34455689999999999999999999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCC
Q 014736          172 VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG  251 (419)
Q Consensus       172 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  251 (419)
                      ||||+.|++|.+++...  ..+++..++.++.|++.||.|||  +++|+||||||+||+++.++.++|+|||++......
T Consensus        75 v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~  150 (278)
T cd05606          75 ILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (278)
T ss_pred             EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc
Confidence            99999999999988654  56899999999999999999999  677999999999999999999999999998754332


Q ss_pred             CCceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccc
Q 014736          252 SNTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD  330 (419)
Q Consensus       252 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (419)
                      .    .....|+..|+|||++.++ .++.++||||+|+++|+|++|..||...............     ..      ..
T Consensus       151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----~~------~~  215 (278)
T cd05606         151 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-----LT------MA  215 (278)
T ss_pred             C----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-----hc------cC
Confidence            1    1234689999999998754 6899999999999999999999999865332211111000     00      01


Q ss_pred             cccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014736          331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVA  368 (419)
Q Consensus       331 ~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~  368 (419)
                          ..++...+.++.+++.+||..+|.+||     ++.++++
T Consensus       216 ----~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         216 ----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ----CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence                112223467899999999999999999     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=8.7e-38  Score=291.38  Aligned_cols=249  Identities=21%  Similarity=0.256  Sum_probs=192.9

Q ss_pred             HHHHHhcCCCCCCee--cccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-Ccccccceee
Q 014736           85 ELRAITQNFSSNYLL--GEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHLVRLIG  161 (419)
Q Consensus        85 ~~~~~~~~y~~~~~l--g~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~  161 (419)
                      +.....++|.+.+.+  |+|+||.||++..      ..++..+|+|.+........     |+.....+ +|+||+++++
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~------~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~   76 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKH------KPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYY   76 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEE------cCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEE
Confidence            344455678887777  9999999999954      34467899999875432221     22222222 6999999999


Q ss_pred             EEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-cEEEe
Q 014736          162 YCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-TAKLS  240 (419)
Q Consensus       162 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~-~~kl~  240 (419)
                      .+...+..|+||||+++++|.+++...  ..+++..+..++.|++.||.|||  +.|++||||||+||+++.++ .++|+
T Consensus        77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~~l~  152 (267)
T PHA03390         77 SVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLH--KHNIIHNDIKLENVLYDRAKDRIYLC  152 (267)
T ss_pred             EEecCCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEEeCCCCeEEEe
Confidence            999999999999999999999998765  37899999999999999999999  67799999999999999998 99999


Q ss_pred             ccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhh
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR  320 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  320 (419)
                      |||++......      ....|+..|+|||++.+..++.++||||||+++|+|++|..||....... .....+....  
T Consensus       153 dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--  223 (267)
T PHA03390        153 DYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ--  223 (267)
T ss_pred             cCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh--
Confidence            99998764322      12358899999999998899999999999999999999999998543322 1111111110  


Q ss_pred             cccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 014736          321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK-MAAVVA  368 (419)
Q Consensus       321 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs-~~eil~  368 (419)
                       ..          ........+..+.++|.+||+.+|.+||+ ++++++
T Consensus       224 -~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        224 -QK----------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -cc----------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence             00          00112245678999999999999999996 588864

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-38  Score=292.75  Aligned_cols=244  Identities=23%  Similarity=0.261  Sum_probs=188.9

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc---cHHHHHHHHHH-HcCCCcccccceeeEEEeCCeeEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ---GHREWLAEVIF-LGQLRHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      +.||+|+||.||+|...      ..++.||+|.+......   ....+..|..+ ....+|+||+++++++..++..|+|
T Consensus         2 ~~l~~g~~~~v~~a~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   75 (260)
T cd05611           2 KPISKGAFGSVYLAKKR------STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLV   75 (260)
T ss_pred             ccCCcCCCeeEEEEEec------CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEE
Confidence            46999999999999643      34678999998754321   22334445444 4556899999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||  ..|++|+||+|.||+++.++.++|+|||++.....  
T Consensus        76 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--  149 (260)
T cd05611          76 MEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLH--QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--  149 (260)
T ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCcEEEeecccceeccc--
Confidence            9999999999998765  46888999999999999999999  67799999999999999999999999999875432  


Q ss_pred             CceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                          .....|+..|+|||.+.+..++.++||||||+++|+|++|..||...........      ......        .
T Consensus       150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~~~~--------~  211 (260)
T cd05611         150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN------ILSRRI--------N  211 (260)
T ss_pred             ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH------HHhccc--------C
Confidence                2234588899999999888899999999999999999999999975432211110      000000        0


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL  370 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L  370 (419)
                      ........++.++.+++.+||+.||++||++..+.+.|
T Consensus       212 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         212 WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            11111223467899999999999999999776555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1e-37  Score=340.10  Aligned_cols=266  Identities=30%  Similarity=0.484  Sum_probs=208.9

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           86 LRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      ...+...|...++||+|+||.||+|+..      ..++.||+|.+......    ...|++++++++|||||++++++.+
T Consensus       685 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~  754 (968)
T PLN00113        685 INDILSSLKEENVISRGKKGASYKGKSI------KNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS  754 (968)
T ss_pred             HHHHHhhCCcccEEccCCCeeEEEEEEC------CCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc
Confidence            3445567888999999999999999653      34678999998643321    1246888999999999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeecCCCCCcEEEcCCCcEEEeccCc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA-ENPVIYRDFKTSNILLDSDFTAKLSDFGL  244 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  244 (419)
                      .+..|+||||+++|+|.+++.     .++|..+..++.||+.||+|||.. .++|+||||||+||+++.++..++. ||.
T Consensus       755 ~~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~  828 (968)
T PLN00113        755 EKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL  828 (968)
T ss_pred             CCCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence            999999999999999999984     378999999999999999999954 5689999999999999999888775 665


Q ss_pred             cccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          245 AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       245 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      .......      ....||..|+|||++.+..++.++|||||||++|||++|+.||+.... .......|...... ...
T Consensus       829 ~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~-~~~  900 (968)
T PLN00113        829 PGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYS-DCH  900 (968)
T ss_pred             ccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcC-ccc
Confidence            5432111      123588999999999999999999999999999999999999964332 22344555443222 122


Q ss_pred             cccccccccCC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          325 LRYIVDPRLAG--QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       325 ~~~~~~~~l~~--~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      ....+++.+..  ........++.+++.+||+.||++||++.+|++.|+++..
T Consensus       901 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            33334444433  2344556678999999999999999999999999998855

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.3e-38  Score=298.16  Aligned_cols=250  Identities=26%  Similarity=0.375  Sum_probs=203.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCC-cccccceeeEEEeC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLR-HPHLVRLIGYCCED  166 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~  166 (419)
                      ++|.+.+.||+|+||.||+|....      +++.|++|++....   ......+.+|++++++++ |+||+++++++.+.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   74 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKE------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE   74 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcC------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC
Confidence            478899999999999999996543      47889999987532   223456788999999998 99999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..++||||+.+++|.+++.+.  ..+++..++.++.|++.||.|||  +.|++|+||+|+||+++.++.++|+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh--~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~  150 (280)
T cd05581          75 ENLYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLH--SKGIIHRDLKPENILLDKDMHIKITDFGTAK  150 (280)
T ss_pred             ceEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEecCCcccc
Confidence            9999999999999999999765  47899999999999999999999  6789999999999999999999999999988


Q ss_pred             cCCCCCCc------------------eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccc
Q 014736          247 MGPEGSNT------------------HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSE  308 (419)
Q Consensus       247 ~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  308 (419)
                      ........                  .......|+..|+|||++....++.++|+||||+++++|++|..||........
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  230 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT  230 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence            65443221                  122334688999999999888899999999999999999999999986542111


Q ss_pred             hhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 014736          309 QNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKM----AAVVA  368 (419)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~----~eil~  368 (419)
                         ..   ....            ....++...++.+.+++.+||+.+|.+||++    +++++
T Consensus       231 ---~~---~~~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         231 ---FQ---KILK------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ---HH---HHHh------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence               10   0000            1112233346789999999999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.3e-38  Score=293.83  Aligned_cols=247  Identities=26%  Similarity=0.355  Sum_probs=196.1

Q ss_pred             ecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEe
Q 014736           99 LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        99 lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  175 (419)
                      ||+|+||.||+|...      .+++.|++|++.....   .....+.+|+++++.++|+||+++++.+......|++|||
T Consensus         1 lg~g~~~~vy~~~~~------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   74 (265)
T cd05579           1 ISKGAYGRVFLAKKK------STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEY   74 (265)
T ss_pred             CCCCCceEEEEEEEC------CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEec
Confidence            689999999999654      3467899999975433   3456788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCC--
Q 014736          176 MPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN--  253 (419)
Q Consensus       176 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~--  253 (419)
                      +.+++|.+++.+.  ..+++..+..++.||+.||.|||  ++|++|+||+|+||+++.++.++|+|||++........  
T Consensus        75 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  150 (265)
T cd05579          75 LPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLH--SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN  150 (265)
T ss_pred             CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc
Confidence            9999999998765  36899999999999999999999  77899999999999999999999999999876443321  


Q ss_pred             ----ceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          254 ----THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       254 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                          ........++..|++||.+....++.++||||||+++|+|++|..||............      . . ....   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~-~-~~~~---  219 (265)
T cd05579         151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI------L-N-GKIE---  219 (265)
T ss_pred             cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------h-c-CCcC---
Confidence                11223356888999999998888999999999999999999999999765422111110      0 0 0000   


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                         ...  ....+.++.+++.+||+.+|.+|||+..+.+.|.
T Consensus       220 ---~~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         220 ---WPE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             ---CCc--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence               000  0113678999999999999999999965555444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-38  Score=296.25  Aligned_cols=265  Identities=24%  Similarity=0.291  Sum_probs=198.2

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEeC--Ce
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCED--EE  168 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~  168 (419)
                      |.+.+.||.|+||.||+|....      .++.+|+|.+....  ......+.+|+.+++.++|+||+++++++.+.  +.
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKK------TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS   74 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECC------CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence            6678899999999999996543      36789999998653  23345688999999999999999999999888  89


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .++||||+. ++|.+++.... ..+++..++.++.||+.||.|||  +.|++|+||||+||++++++.++|+|||++...
T Consensus        75 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH--~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~  150 (287)
T cd07840          75 IYMVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLH--SNGILHRDIKGSNILINNDGVLKLADFGLARPY  150 (287)
T ss_pred             EEEEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCcHHHeEEcCCCCEEEccccceeec
Confidence            999999996 58888876542 46889999999999999999999  678999999999999999999999999999866


Q ss_pred             CCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhh-----cc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR-----SS  322 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-----~~  322 (419)
                      ...... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+........     ..
T Consensus       151 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07840         151 TKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV  229 (287)
T ss_pred             cCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence            444321 1223357888999997754 4678999999999999999999999976543221111110000000     00


Q ss_pred             ccc--------ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          323 RRL--------RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       323 ~~~--------~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ..+        .......+...+...++.++.+++.+||..+|++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            000        0000000001111113678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-39  Score=311.44  Aligned_cols=255  Identities=29%  Similarity=0.439  Sum_probs=211.1

Q ss_pred             CCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-cHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEE
Q 014736           94 SSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        94 ~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      ...++||+|+||.|++|.|+..   ..+.-.||||.+...... ...+|++|+.+|.+|+|+|++++||+..+ ....||
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~p---sgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQP---SGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCC---CCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            3455799999999999999763   233457999999866554 56789999999999999999999999987 778999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      ||+++.|+|.+.|.+-....+.......++.|||.||.||.  .+++|||||...|+||.....|||+||||.+-+....
T Consensus       189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe--skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE--SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh--hhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            99999999999998855566777888899999999999999  5669999999999999999999999999999877665


Q ss_pred             Cceeee-cccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccccc
Q 014736          253 NTHVTT-RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD  330 (419)
Q Consensus       253 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (419)
                      ...++. ...-...|.|||.+....++.++|||+|||+||||++ |+.||.+.........++       .+..      
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-------~~er------  333 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-------AGER------  333 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-------cccc------
Confidence            544433 2234567999999999999999999999999999999 789998876544333322       1111      


Q ss_pred             cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       331 ~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                          -..++.+++++.+++.+||..+|++|||+..|.+.+-
T Consensus       334 ----LpRPk~csedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  334 ----LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             ----CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence                1235567899999999999999999999999975443

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=340.30  Aligned_cols=257  Identities=28%  Similarity=0.360  Sum_probs=205.1

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEE
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCC  164 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  164 (419)
                      ..++-++.-...||.|.||.||.|.      +..+|+..|+|-+....  ......+.+|+.+|..|+|||+|++||+=.
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtav------N~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAV------NLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV 1304 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEee------cCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee
Confidence            4445567778899999999999995      45568899999886432  233456778999999999999999999998


Q ss_pred             eCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCc
Q 014736          165 EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL  244 (419)
Q Consensus       165 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  244 (419)
                      ..+..+|.||||++|+|.+.+...  ...++.....+..|++.|+.|||  +.|||||||||+|||++.+|.+|++|||.
T Consensus      1305 HRekv~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH--~~gIVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLH--EHGIVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred             cHHHHHHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHH--hcCceecCCCccceeeecCCcEEeecccc
Confidence            899999999999999999988654  34556666788899999999999  78899999999999999999999999999


Q ss_pred             cccCCCCCCce--eeecccccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHh
Q 014736          245 AKMGPEGSNTH--VTTRVMGTYGYAAPEYIST---GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYL  319 (419)
Q Consensus       245 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  319 (419)
                      |..........  .....+||+.|||||++.+   ..-..++|||||||++.||+||+.||......       |+.-|-
T Consensus      1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~ 1453 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYH 1453 (1509)
T ss_pred             eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhH
Confidence            98765442111  1234689999999999965   34567999999999999999999999865431       221111


Q ss_pred             hcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          320 RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      ..         ..-..+++...+.+-.++|.+||..||++|.++.|+++.
T Consensus      1454 V~---------~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 VA---------AGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             Hh---------ccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            11         112235566688999999999999999999988877663

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.3e-39  Score=289.77  Aligned_cols=275  Identities=21%  Similarity=0.266  Sum_probs=201.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEe-C
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCE-D  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~  166 (419)
                      ...|+.+..||+|.||.||+|..+++  +....+.+|+|+++.+..  .-.....+|+.+++.++||||+.+..+|.. +
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~--n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNT--NDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccC--CcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            35799999999999999999965543  222245799999976532  123567789999999999999999999977 7


Q ss_pred             CeeEEEEEecCCCChhhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC----CcEEE
Q 014736          167 EERLLVYEFMPRGSLENHLFKRI---SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD----FTAKL  239 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~----~~~kl  239 (419)
                      ...+|++||.+ -+|++.|.-+.   ...++...+..|+.||+.|+.|||  ++-|+||||||.||||..+    |.|||
T Consensus       101 ~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH--~NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  101 KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH--SNWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh--hhheeeccCCcceEEEeccCCccCeeEe
Confidence            88999999994 58888875432   346888899999999999999999  7889999999999999888    89999


Q ss_pred             eccCccccCCCCCCce-eeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchh------H
Q 014736          240 SDFGLAKMGPEGSNTH-VTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQN------L  311 (419)
Q Consensus       240 ~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~------~  311 (419)
                      +|||+++.+...-... .....+-|..|.|||++.+ ..|+.+.|||++|||+.||++.++-|.+...+....      .
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            9999999876554332 1234567899999999876 579999999999999999999999997654322211      1


Q ss_pred             HHhhhHHh-----------hcccccccccccccCCCCCH-----------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          312 VDWAKPYL-----------RSSRRLRYIVDPRLAGQYSV-----------KGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       312 ~~~~~~~~-----------~~~~~~~~~~~~~l~~~~~~-----------~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      ++.+...+           .+.......+...-.+.+..           .-++...+|+.++|..||.+|.|+++.++.
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            11111111           00000000000000001110           013347899999999999999999998763

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=6.6e-38  Score=297.11  Aligned_cols=269  Identities=23%  Similarity=0.264  Sum_probs=198.6

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEE
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCC  164 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  164 (419)
                      +...++|++.+.||+|+||.||+|....      .++.||+|++.....  .....+.+|+++++.++||||+++++++.
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~   76 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKD------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVT   76 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECC------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheec
Confidence            3456789999999999999999997543      367899999975432  23356778999999999999999999887


Q ss_pred             eCC----------eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 014736          165 EDE----------ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD  234 (419)
Q Consensus       165 ~~~----------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~  234 (419)
                      +..          ..++||||+++ +|...+... ...+++..+..++.||+.||.|||  ++||+|+||||+||+++++
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nili~~~  152 (302)
T cd07864          77 DKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCH--KKNFLHRDIKCSNILLNNK  152 (302)
T ss_pred             CcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCC
Confidence            654          78999999965 777776544 346899999999999999999999  7789999999999999999


Q ss_pred             CcEEEeccCccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHH
Q 014736          235 FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD  313 (419)
Q Consensus       235 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  313 (419)
                      +.+||+|||++......... ......++..|+|||++.+ ..++.++|||||||++|+|++|++||...........+.
T Consensus       153 ~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~  231 (302)
T cd07864         153 GQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS  231 (302)
T ss_pred             CcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            99999999999865443321 1122346788999998854 457899999999999999999999997544322111111


Q ss_pred             hhhHHhhcccccccccc--------------cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          314 WAKPYLRSSRRLRYIVD--------------PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       314 ~~~~~~~~~~~~~~~~~--------------~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ...... .......+..              ..... .....+..+.+++.+||+.||.+||++.+|++
T Consensus       232 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         232 RLCGSP-CPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHhCCC-Chhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            100000 0000000000              00000 01124678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-38  Score=294.58  Aligned_cols=264  Identities=24%  Similarity=0.296  Sum_probs=199.6

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--cHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      |.+.+.||+|++|.||+|...      .+++.+++|.+......  ....+.+|+.+++.++|+||+++++++...+..+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDK------LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY   74 (283)
T ss_pred             CccceeeecCCCceEEEEEcC------CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence            567788999999999999643      34688999998754332  3467788999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+. ++|.+++.... ..+++..+..++.||+.||.|||  ++||+|+||||+||+++.++.++|+|||.+.....
T Consensus        75 ~v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~  150 (283)
T cd05118          75 LVFEFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH--SHGILHRDLKPENLLINTEGVLKLADFGLARSFGS  150 (283)
T ss_pred             EEEeccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHH--HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence            9999996 48888876642 57889999999999999999999  67799999999999999999999999999986644


Q ss_pred             CCCceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh--hHHhhccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA--KPYLRSSRRLRY  327 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~  327 (419)
                      ...  ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....+...  .+.......+..
T Consensus       151 ~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd05118         151 PVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS  228 (283)
T ss_pred             Ccc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence            331  12234578899999998776 7899999999999999999999999765432211111000  000000000000


Q ss_pred             -------ccc---cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          328 -------IVD---PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       328 -------~~~---~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                             ...   ...........+.++.+++.+||+.||.+||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                   000   00001112345788999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=7.8e-38  Score=301.30  Aligned_cols=264  Identities=23%  Similarity=0.308  Sum_probs=196.0

Q ss_pred             hcCCCC-CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc--------------HHHHHHHHHHHcCCCcc
Q 014736           90 TQNFSS-NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--------------HREWLAEVIFLGQLRHP  154 (419)
Q Consensus        90 ~~~y~~-~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hp  154 (419)
                      .++|.. .+.||+|+||.||+|...      ..++.||+|++.......              ...+.+|+++++.++|+
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   80 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDT------LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHE   80 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEEC------CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCc
Confidence            356654 567999999999999643      346889999986542221              12467899999999999


Q ss_pred             cccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 014736          155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD  234 (419)
Q Consensus       155 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~  234 (419)
                      ||+++++++..++..++||||+. ++|.+++...  ..+++.....++.|++.||.|||  +.||+|+||+|+||+++.+
T Consensus        81 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH--~~~i~H~dl~~~nill~~~  155 (335)
T PTZ00024         81 NIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLH--KWYFMHRDLSPANIFINSK  155 (335)
T ss_pred             ceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHHHeEECCC
Confidence            99999999999999999999995 6899988654  56888999999999999999999  6789999999999999999


Q ss_pred             CcEEEeccCccccCCCCCC------------ceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCC
Q 014736          235 FTAKLSDFGLAKMGPEGSN------------THVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMD  301 (419)
Q Consensus       235 ~~~kl~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~  301 (419)
                      +.++|+|||++........            ........++..|+|||.+.+. .++.++|||||||++|+|++|..||.
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~  235 (335)
T PTZ00024        156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP  235 (335)
T ss_pred             CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999999976541110            0111223468889999998664 47899999999999999999999997


Q ss_pred             CCCCccchhHHHhhhHHhhcccc--cc------------cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 014736          302 KLRPKSEQNLVDWAKPYLRSSRR--LR------------YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV  367 (419)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~--~~------------~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil  367 (419)
                      ........   ............  +.            ......+. ......+.++.+++.+||+.+|++||++++++
T Consensus       236 ~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l  311 (335)
T PTZ00024        236 GENEIDQL---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEAL  311 (335)
T ss_pred             CCCHHHHH---HHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence            65432211   111111100000  00            00000000 01122357799999999999999999999998


Q ss_pred             H
Q 014736          368 A  368 (419)
Q Consensus       368 ~  368 (419)
                      .
T Consensus       312 ~  312 (335)
T PTZ00024        312 K  312 (335)
T ss_pred             c
Confidence            6

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.3e-37  Score=296.95  Aligned_cols=260  Identities=20%  Similarity=0.249  Sum_probs=192.3

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccC--CcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYE  174 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  174 (419)
                      +.+|.|+++.||++        ..+++.||+|++...  .......+.+|+.+++.++|+||+++++++.+.+..+++||
T Consensus         8 ~~~~~~~~v~~~~~--------~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e   79 (314)
T cd08216           8 KCFEDLMIVHLAKH--------KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSP   79 (314)
T ss_pred             HhhcCCceEEEEEe--------cCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEe
Confidence            33444555555444        235788999999754  23445678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCc
Q 014736          175 FMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT  254 (419)
Q Consensus       175 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  254 (419)
                      |+.+++|.+++.......+++..+..++.|++.||.|||  +++|+|+||||+||+++.++.+||+|||.+.........
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH--~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~  157 (314)
T cd08216          80 LMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH--SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR  157 (314)
T ss_pred             ccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence            999999999998765567889999999999999999999  677999999999999999999999999988654322111


Q ss_pred             -----eeeecccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH---------
Q 014736          255 -----HVTTRVMGTYGYAAPEYIST--GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY---------  318 (419)
Q Consensus       255 -----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---------  318 (419)
                           .......++..|+|||++..  ..++.++|+|||||++|+|++|..||........  ..+.....         
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~  235 (314)
T cd08216         158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKST  235 (314)
T ss_pred             ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCc
Confidence                 11123457788999999865  4588999999999999999999999976432211  11100000         


Q ss_pred             -hhccccccc----cc----ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 -LRSSRRLRY----IV----DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 -~~~~~~~~~----~~----~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       .........    ..    ............+.++.+|+.+||..||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence             000000000    00    001111233445678999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-38  Score=303.96  Aligned_cols=273  Identities=24%  Similarity=0.296  Sum_probs=204.6

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEeCC--
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE--  167 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--  167 (419)
                      +|.+.+.||.|+||.||+|...      ..++.||+|++....  ....+.+.+|+.+++.++|+||+++++++....  
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDK------RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE   74 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeC------CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence            5888999999999999999643      346889999987543  334567889999999999999999999987765  


Q ss_pred             ---eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCc
Q 014736          168 ---ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL  244 (419)
Q Consensus       168 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  244 (419)
                         ..|+||||+. ++|.+++.+.  ..+++..++.++.||+.||.|||  .+||+|+||||+|||++.++.++|+|||+
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH--~~gi~H~dlkp~nili~~~~~~~L~dfg~  149 (330)
T cd07834          75 DFNDVYIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLH--SANVIHRDLKPSNILVNSNCDLKICDFGL  149 (330)
T ss_pred             cccceEEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEcccCc
Confidence               7899999996 5888888654  47899999999999999999999  67899999999999999999999999999


Q ss_pred             cccCCCCCCc-eeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhh--
Q 014736          245 AKMGPEGSNT-HVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR--  320 (419)
Q Consensus       245 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--  320 (419)
                      +......... .......++..|+|||++.+. .++.++|+||||+++|+|++|..||...........+........  
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  229 (330)
T cd07834         150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE  229 (330)
T ss_pred             eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence            9875544210 112334588999999999887 889999999999999999999999976653221111110000000  


Q ss_pred             -----cccccccccc------cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhhc
Q 014736          321 -----SSRRLRYIVD------PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA--TLESLLN  375 (419)
Q Consensus       321 -----~~~~~~~~~~------~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~--~L~~l~~  375 (419)
                           ..........      +.-........+.++.+++.+||+.+|.+||++.+++.  +++.+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                 0000000000      00000111224678999999999999999999999987  3555433

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.7e-38  Score=306.78  Aligned_cols=267  Identities=22%  Similarity=0.284  Sum_probs=196.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeC---
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCED---  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---  166 (419)
                      ..+|.+.+.||.|+||.||+|..      ..+++.||+|++........+.+.+|+++++.++||||+++++++...   
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~------~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~   77 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVD------SDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSD   77 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEE------CCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccc
Confidence            36899999999999999999964      345788999999776656667788999999999999999999876543   


Q ss_pred             -----------CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-C
Q 014736          167 -----------EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS-D  234 (419)
Q Consensus       167 -----------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-~  234 (419)
                                 ...|+||||+. ++|.+++..   ..+++..++.++.||+.||.|||  +.||+||||||+||+++. +
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH--~~givH~dikp~Nili~~~~  151 (342)
T cd07854          78 LTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIH--SANVLHRDLKPANVFINTED  151 (342)
T ss_pred             cccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEcCCC
Confidence                       35789999995 688887754   36889999999999999999999  678999999999999974 5


Q ss_pred             CcEEEeccCccccCCCCCCce-eeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHH
Q 014736          235 FTAKLSDFGLAKMGPEGSNTH-VTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV  312 (419)
Q Consensus       235 ~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~  312 (419)
                      +.+||+|||++.......... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||....+.......
T Consensus       152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~  231 (342)
T cd07854         152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI  231 (342)
T ss_pred             ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            678999999997643221111 1122357889999998654 56889999999999999999999999765432222111


Q ss_pred             HhhhHHhhc--cc----cccccc------ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          313 DWAKPYLRS--SR----RLRYIV------DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       313 ~~~~~~~~~--~~----~~~~~~------~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ....+....  ..    .+....      ............+.++.+|+.+||+.||.+|||+.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            110000000  00    000000      000000011234578999999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=8.8e-38  Score=294.42  Aligned_cols=260  Identities=27%  Similarity=0.319  Sum_probs=202.1

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC----cccHHHHHHHHHHHcCC-CcccccceeeEEEeC
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG----LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCED  166 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  166 (419)
                      +|.+.+.||+|+||.||+|.....   ...++.||+|++....    ......+.+|+.++.++ +|+||+++++.+..+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~---~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~   77 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGG---HDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD   77 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEecc---ccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC
Confidence            477888999999999999975432   2346789999986432    12335678899999999 599999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      ...++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  +.|++|+||||.||+++.++.++|+|||++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH--~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          78 TKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLH--QLGIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             CEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            9999999999999999998754  46888899999999999999999  6789999999999999999999999999987


Q ss_pred             cCCCCCCceeeecccccccccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGH--LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      ........ ......|+..|+|||.+.+..  .+.++||||||+++|+|++|..||.........  ..........   
T Consensus       154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~---  227 (288)
T cd05583         154 EFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRILKS---  227 (288)
T ss_pred             cccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHHHcc---
Confidence            65433221 122345899999999987654  788999999999999999999999643221111  1111111110   


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                           ..    ..+...+.++.+++.+||+.||++|||+.++.+.|+..
T Consensus       228 -----~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         228 -----KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             -----CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence                 01    12223456789999999999999999998887776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2e-37  Score=292.23  Aligned_cols=255  Identities=26%  Similarity=0.314  Sum_probs=197.5

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc----ccHHHHHHHHHHHcCC-CcccccceeeEEEeC
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL----QGHREWLAEVIFLGQL-RHPHLVRLIGYCCED  166 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  166 (419)
                      +|++.+.||+|+||.||+|.....   ..+++.||+|++.....    ...+.+.+|+.++.++ +|+||+++++++..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~---~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSG---HDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD   77 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccC---CCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC
Confidence            478889999999999999975421   23578899999864321    2345678899999999 599999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      ...|+||||+++++|.+++...  ..+++..+..++.||+.||.|||  ++|++||||+|+|||++.++.+||+|||++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          78 TKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             CeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            9999999999999999998765  46788899999999999999999  6789999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYIST--GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      ........ ......|+..|+|||.+..  ..++.++||||||+++|+|++|..||........  ...........   
T Consensus       154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~---  227 (290)
T cd05613         154 EFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS---  227 (290)
T ss_pred             eccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhcc---
Confidence            65432211 1223568999999999865  3478899999999999999999999974322111  11111111100   


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVA  368 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~  368 (419)
                               ...++...+..+.+++.+||+.||.+||     ++.+++.
T Consensus       228 ---------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 ---------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ---------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                     0112334567899999999999999997     5666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=292.25  Aligned_cols=263  Identities=25%  Similarity=0.304  Sum_probs=195.8

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--cHHHHHHHHHHHcCC---CcccccceeeEEEeCC
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--GHREWLAEVIFLGQL---RHPHLVRLIGYCCEDE  167 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~  167 (419)
                      |++.+.||+|+||.||+|....      +++.||+|++......  ....+.+|+.+++++   +|+||+++++++...+
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   74 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLN------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR   74 (287)
T ss_pred             CeEEEEecccCceEEEEEEECC------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence            6678899999999999997543      4678999999754222  234566787776555   6999999999998877


Q ss_pred             e-----eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEecc
Q 014736          168 E-----RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       168 ~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                      .     .+++|||+. ++|.+++.......+++..++.++.|++.||.|||  +++++|+||+|+||+++.++.+||+||
T Consensus        75 ~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH--~~~i~h~~l~~~nili~~~~~~~l~df  151 (287)
T cd07838          75 TDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH--SHRIVHRDLKPQNILVTSDGQVKIADF  151 (287)
T ss_pred             CCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCChhhEEEccCCCEEEecc
Confidence            6     899999996 58998887654456899999999999999999999  677999999999999999999999999


Q ss_pred             CccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHh-hhH-H-h
Q 014736          243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW-AKP-Y-L  319 (419)
Q Consensus       243 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~-~~~-~-~  319 (419)
                      |++........   .....++..|+|||++.+..++.++|+|||||++|+|++|.+||......+....+.. ... . .
T Consensus       152 g~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd07838         152 GLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE  228 (287)
T ss_pred             CcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChH
Confidence            99976543321   1223478899999999988999999999999999999999999976543221111100 000 0 0


Q ss_pred             --hc-----ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          320 --RS-----SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       320 --~~-----~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        ..     ........... ........+..+.+++.+||+.||.+||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         229 EWPRNVSLPRSSFPSYTPRS-FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hcCCCcccchhhcccccccc-hhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence              00     00000000000 01112245678899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3e-37  Score=294.43  Aligned_cols=244  Identities=29%  Similarity=0.395  Sum_probs=193.3

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      |...+.||+|+||.||+|+..      ..++.|++|++.....   .....+.+|+++++.++||||+++++++.+....
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNS------HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             hhcceeeccCCCeEEEEEEEC------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            667788999999999999643      3468899999875432   2335678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+||||+. ++|.+++... ...+++..+..++.||+.||.|||  ++|++|+||+|+||+++.++.+||+|||++....
T Consensus        97 ~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~  172 (313)
T cd06633          97 WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS  172 (313)
T ss_pred             EEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence            99999995 6787777543 246889999999999999999999  6789999999999999999999999999986432


Q ss_pred             CCCCceeeeccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYIS---TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      .      .....|+..|+|||++.   ...++.++||||||+++|+|++|..||.............       . ..  
T Consensus       173 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~-------~-~~--  236 (313)
T cd06633         173 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------Q-ND--  236 (313)
T ss_pred             C------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-------h-cC--
Confidence            2      12346889999999984   4668899999999999999999999987653222111110       0 00  


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                            .........+..+.+|+.+||+.+|.+||++.+++.
T Consensus       237 ------~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         237 ------SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             ------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  001111223467999999999999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-39  Score=303.48  Aligned_cols=245  Identities=25%  Similarity=0.352  Sum_probs=202.4

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEE
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVY  173 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  173 (419)
                      .++||+|.||+||-|      .+..+|+.||||++.+...  ++...+.+|+.||.+++||.||.+-..|+..+..++||
T Consensus       569 devLGSGQFG~VYgg------~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM  642 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGG------KHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM  642 (888)
T ss_pred             HhhccCCcceeeecc------eecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence            457999999999999      5677899999999986543  34567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC---CcEEEeccCccccCCC
Q 014736          174 EFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD---FTAKLSDFGLAKMGPE  250 (419)
Q Consensus       174 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla~~~~~  250 (419)
                      |.+ .|+..+.|.....+.+++.....++.||+.||.|||  .+||+|+||||+|||+...   .++||||||+|+...+
T Consensus       643 EKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH--~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE  719 (888)
T KOG4236|consen  643 EKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLH--FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE  719 (888)
T ss_pred             hhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh--hcceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence            999 556666666666678999989999999999999999  7889999999999999764   4699999999998765


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD  330 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (419)
                      ..   .....+||+.|+|||++..+.|+..-|+||+|||+|.-|+|..||....+  ..+.++          +...++.
T Consensus       720 ks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQ----------NAaFMyP  784 (888)
T KOG4236|consen  720 KS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQ----------NAAFMYP  784 (888)
T ss_pred             hh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhh----------ccccccC
Confidence            43   24456799999999999999999999999999999999999999975432  111221          1122222


Q ss_pred             cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       331 ~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      +..+    .+++.++.+||..+|+..-.+|.|.+.-+.
T Consensus       785 p~PW----~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  785 PNPW----SEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             CCch----hhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            3222    355678999999999999999999887653

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=291.92  Aligned_cols=262  Identities=25%  Similarity=0.352  Sum_probs=197.3

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCC-cccccceeeEEEeCCeeE
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLR-HPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~  170 (419)
                      |.+.+.||+|+||.||+|...+      +++.|++|.+..... .......+|+..+++++ |+||+++++++.+++..+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   74 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKE------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELY   74 (283)
T ss_pred             CeeheeeccCCceEEEEEEECC------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEE
Confidence            6678899999999999997543      357899999865422 22234557999999999 999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+ +++|.+++.......+++..++.++.|++.+|.|||  ++|++|+||+|.||+++.++.++|+|||++.....
T Consensus        75 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          75 FVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH--KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             EEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence            999999 889999887765457899999999999999999999  67899999999999999999999999999986543


Q ss_pred             CCCceeeeccccccccccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHH----------hhhHHh
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYIS-TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD----------WAKPYL  319 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~----------~~~~~~  319 (419)
                      ...   .....++..|+|||++. ...++.++|+||||+++++|++|++||.............          |.....
T Consensus       152 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07830         152 RPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK  228 (283)
T ss_pred             CCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence            221   12345888999999874 4567899999999999999999999997654322211110          000000


Q ss_pred             hcccccccccc----cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          320 RSSRRLRYIVD----PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       320 ~~~~~~~~~~~----~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       ........+.    ..+. ......+.++.+++.+||+.||++||++.|++.
T Consensus       229 -~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         229 -LASKLGFRFPQFAPTSLH-QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             -hhccccccccccccccHH-HHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence             0000000000    0000 011112577999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.6e-37  Score=298.20  Aligned_cols=265  Identities=23%  Similarity=0.299  Sum_probs=197.7

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEE
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCC  164 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  164 (419)
                      ..+.++|.+.+.||.|+||.||+|...      .+++.||+|.+....  ....+.+.+|+.+++.++||||++++++|.
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   79 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQ------LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFI   79 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEEC------CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEe
Confidence            346789999999999999999999643      457889999886432  223467788999999999999999999986


Q ss_pred             e-CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccC
Q 014736          165 E-DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFG  243 (419)
Q Consensus       165 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  243 (419)
                      . ....|+||||+ +++|.+++..   ..++...+..++.|++.||.|||  ++||+|+||+|.||+++.++.++|+|||
T Consensus        80 ~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH--~~~iiH~dl~p~Nili~~~~~~~l~dfg  153 (328)
T cd07856          80 SPLEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVH--SAGVVHRDLKPSNILINENCDLKICDFG  153 (328)
T ss_pred             cCCCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEeECCCCCEEeCccc
Confidence            5 56789999998 6789887754   35778888899999999999999  6779999999999999999999999999


Q ss_pred             ccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHH-h-------
Q 014736          244 LAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD-W-------  314 (419)
Q Consensus       244 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~-~-------  314 (419)
                      ++......     .....++..|+|||++.+ ..++.++||||||+++|+|++|..||...........+. .       
T Consensus       154 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  228 (328)
T cd07856         154 LARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD  228 (328)
T ss_pred             cccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            98754322     123457889999998765 578999999999999999999999997654311111100 0       


Q ss_pred             -hhHHhhcccccccccccccCCCCC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          315 -AKPYLRSSRRLRYIVDPRLAGQYS-----VKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       315 -~~~~~~~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                       ..... ..........-......+     ...+.++.+++.+||+.+|++||++.+++..
T Consensus       229 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         229 VINTIC-SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHhcc-chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             00000 000000000000001111     1245789999999999999999999998653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.9e-37  Score=298.27  Aligned_cols=267  Identities=22%  Similarity=0.256  Sum_probs=193.2

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC--CcccHHHHHHHHHHHcCC-CcccccceeeEEEeC--
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQL-RHPHLVRLIGYCCED--  166 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--  166 (419)
                      +|.+.+.||+|+||.||+|.....    ..+..||+|.+...  .....+.+.+|+.+++++ +||||+++++.+...  
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   76 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAET----SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG   76 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCC----CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence            478888999999999999975432    12678999998643  222345678899999999 599999999875432  


Q ss_pred             --CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCc
Q 014736          167 --EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL  244 (419)
Q Consensus       167 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  244 (419)
                        ...|+++||+ +++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+
T Consensus        77 ~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~givH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          77 NFNELYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIH--SANVLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             cCCcEEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence              4578899998 57899888654  56889999999999999999999  67899999999999999999999999999


Q ss_pred             cccCCCCCCc--eeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHh-------
Q 014736          245 AKMGPEGSNT--HVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW-------  314 (419)
Q Consensus       245 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~-------  314 (419)
                      +.........  .......|+..|+|||++.+ ..++.++||||||+++|+|++|..||...........+..       
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9865432211  11233568999999998765 5689999999999999999999999976442211110000       


Q ss_pred             ------hhHHhhc-ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          315 ------AKPYLRS-SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       315 ------~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                            ....... ...........+ .......+..+.+++.+||+.||++|||+.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcch-HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                  0000000 000000000000 0111123567999999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.9e-37  Score=293.40  Aligned_cols=253  Identities=25%  Similarity=0.390  Sum_probs=193.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCC-CcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~  168 (419)
                      ++|.+.+.||+|+||.||+|.+..      +++.||||.+..... .....+..|+.++.+. .|+||+++++++.+...
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKK------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECC------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            568889999999999999996543      367899999975432 2345566788766666 49999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||+ +++|.+++... ...+++..+..++.||+.||.|||+ .+||+||||+|+||+++.++.+||+|||++...
T Consensus        89 ~~~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~-~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          89 VFICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKE-KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             EEEEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-hCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            99999998 55777766543 3478889999999999999999994 247999999999999999999999999998765


Q ss_pred             CCCCCceeeecccccccccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGH----LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      .....   .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||......  .....   ......  
T Consensus       166 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~---~~~~~~--  235 (296)
T cd06618         166 VDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLT---KILQEE--  235 (296)
T ss_pred             cCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHH---HHhcCC--
Confidence            43221   12235788999999986543    889999999999999999999999753221  11111   001000  


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      .     +..  ......+.++.+|+.+||..||++||++.++++.
T Consensus       236 ~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         236 P-----PSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             C-----CCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0     000  0111245789999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-37  Score=297.94  Aligned_cols=268  Identities=22%  Similarity=0.312  Sum_probs=198.7

Q ss_pred             HHHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceee
Q 014736           84 SELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIG  161 (419)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~  161 (419)
                      ..+..+.++|.+.+.||+|+||.||+|..      ..+++.||+|++....  ....+.+.+|+.++++++|+||+++++
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~   83 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFD------TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD   83 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEE------cCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence            44566778999999999999999999954      3356889999987532  223456788999999999999999999


Q ss_pred             EEEeC------CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 014736          162 YCCED------EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF  235 (419)
Q Consensus       162 ~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~  235 (419)
                      ++...      ...|++++++ +++|.+++...   .+++..+..++.|++.||.|||  ++||+||||||+||+++.++
T Consensus        84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~  157 (345)
T cd07877          84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             eeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHHEEEcCCC
Confidence            88643      3467888887 88998877543   5889999999999999999999  67899999999999999999


Q ss_pred             cEEEeccCccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHh
Q 014736          236 TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW  314 (419)
Q Consensus       236 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  314 (419)
                      .+||+|||++......     .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..
T Consensus       158 ~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (345)
T cd07877         158 ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  232 (345)
T ss_pred             CEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999998864322     223458899999998866 5688999999999999999999999975433221111100


Q ss_pred             hh--------HHhhcc--c----ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          315 AK--------PYLRSS--R----RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       315 ~~--------~~~~~~--~----~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      ..        ......  .    .+.......+. ......+.++.+++.+||+.||.+||++.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            00        000000  0    00000000000 0011235678999999999999999999998864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.1e-37  Score=296.72  Aligned_cols=268  Identities=26%  Similarity=0.281  Sum_probs=194.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--cHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--GHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .++|.+.++||+|+||.||+|...      .+++.||+|++......  ....+.+|+++++.++|+||+++++++.+..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQI------KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERP   80 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEEC------CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence            468999999999999999999643      34678999998644322  2345678999999999999999999875433


Q ss_pred             --------eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEE
Q 014736          168 --------ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKL  239 (419)
Q Consensus       168 --------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  239 (419)
                              ..++||||+. ++|...+... ...+++..+..++.|++.||.|||  .+||+|+||||+||+++.++.++|
T Consensus        81 ~~~~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH--~~~i~H~dl~p~nil~~~~~~~~l  156 (311)
T cd07866          81 DKSKRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLH--ENHILHRDIKAANILIDNQGILKI  156 (311)
T ss_pred             ccccccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEE
Confidence                    4699999995 5777766543 346899999999999999999999  677999999999999999999999


Q ss_pred             eccCccccCCCCCCce---------eeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccch
Q 014736          240 SDFGLAKMGPEGSNTH---------VTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQ  309 (419)
Q Consensus       240 ~DfGla~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  309 (419)
                      +|||++..........         ..+...|++.|+|||++.+ ..++.++||||||+++|+|++|.+||.........
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~  236 (311)
T cd07866         157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL  236 (311)
T ss_pred             CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999997644322111         1123457888999998765 45889999999999999999999999765443222


Q ss_pred             hHHHhhhHH-----hhccccccccc--------ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          310 NLVDWAKPY-----LRSSRRLRYIV--------DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       310 ~~~~~~~~~-----~~~~~~~~~~~--------~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ..+......     ......+....        ...+... ......++.+++.+||+.||.+|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            111100000     00000000000        0000000 0122367899999999999999999998875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=307.97  Aligned_cols=242  Identities=25%  Similarity=0.286  Sum_probs=196.7

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcC-CCcccccceeeEEEeCC
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~  167 (419)
                      +++.|.+...+|.|+|+.|-.+.      +..+++.+++|++.....    .-.+|+.++.. -+||||+++.+++.+..
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~------~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~  389 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCE------SSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGK  389 (612)
T ss_pred             cchhhccccccCCCCccceeeee------ccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCc
Confidence            45678888889999999999984      455678899999976521    22246755544 47999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE-cCCCcEEEeccCccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL-DSDFTAKLSDFGLAK  246 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfGla~  246 (419)
                      +.|+|||++.|+.|.+.+....  .+. ..+..|+.+|+.|+.|||  .+|+|||||||+|||+ +..++++|+|||.++
T Consensus       390 ~~~~v~e~l~g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH--~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~  464 (612)
T KOG0603|consen  390 EIYLVMELLDGGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLH--EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWS  464 (612)
T ss_pred             eeeeeehhccccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHH--hcCeeecCCChhheeecCCCCcEEEEEechhh
Confidence            9999999999999988876552  222 677889999999999999  6889999999999999 688999999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      .....     ....+-|..|.|||++...+|++++||||||++||+||+|+.||.......  +..              
T Consensus       465 ~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~--ei~--------------  523 (612)
T KOG0603|consen  465 ELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI--EIH--------------  523 (612)
T ss_pred             hCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--HHH--------------
Confidence            75544     222357889999999999999999999999999999999999998765431  110              


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                         .....+.+...+++++.+|+.+||+.||.+|+++.++...
T Consensus       524 ---~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  524 ---TRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             ---HhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence               1112233446678999999999999999999999999763

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-37  Score=296.92  Aligned_cols=269  Identities=21%  Similarity=0.279  Sum_probs=199.2

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEE
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCC  164 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  164 (419)
                      ..+.++|.+.+.||+|+||.||+|...      .+++.||+|++.....  .....+.+|+.+++.++|+||+++++++.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDR------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFT   84 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEEC------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeec
Confidence            345678999999999999999999643      3468899999864322  22356789999999999999999999987


Q ss_pred             eCC------eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEE
Q 014736          165 EDE------ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAK  238 (419)
Q Consensus       165 ~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~k  238 (419)
                      .+.      ..++||||+ +++|.+++..   ..+++..++.++.||+.||.|||  ++||+||||||+||+++.++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH--~~gi~H~dlkp~Nill~~~~~~k  158 (343)
T cd07880          85 PDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIH--AAGIIHRDLKPGNLAVNEDCELK  158 (343)
T ss_pred             CCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEE
Confidence            654      458999999 7899888754   36889999999999999999999  67899999999999999999999


Q ss_pred             EeccCccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHH-H---
Q 014736          239 LSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV-D---  313 (419)
Q Consensus       239 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~-~---  313 (419)
                      |+|||++......     .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+ .   
T Consensus       159 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~  233 (343)
T cd07880         159 ILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG  233 (343)
T ss_pred             EeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999999864332     123457889999999865 45889999999999999999999999754321111000 0   


Q ss_pred             -----hhhHHhhc-c----cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhh
Q 014736          314 -----WAKPYLRS-S----RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA--TLESL  373 (419)
Q Consensus       314 -----~~~~~~~~-~----~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~--~L~~l  373 (419)
                           +....... .    ..+....... ........+.++.+++.+||+.||++|||+.+++.  .++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKD-FRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             CCCHHHHHhhcchhHHHHHHhccccCcch-HHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence                 00000000 0    0000000000 00111234567999999999999999999999984  44444

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.1e-37  Score=286.15  Aligned_cols=249  Identities=20%  Similarity=0.297  Sum_probs=193.8

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC---C--cccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE---G--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      +|.+.+.||+|+||.||++....      .+..+++|+++..   .  ......+..|+.+++.++||||+++++++.+.
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKK------AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER   74 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecC------CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC
Confidence            58888999999999999996543      2334555555421   1  12334566799999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCc
Q 014736          167 EERLLVYEFMPRGSLENHLFKR--ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL  244 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  244 (419)
                      ...++||||+++++|.+++...  ....+++..++.++.|++.||.|||  ++|++|+||||+||+++. +.++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~~l~~~nili~~-~~~~l~d~g~  151 (260)
T cd08222          75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--QRRILHRDLKAKNIFLKN-NLLKIGDFGV  151 (260)
T ss_pred             CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH--HcCccccCCChhheEeec-CCEeecccCc
Confidence            9999999999999999988642  2356889999999999999999999  678999999999999975 5699999999


Q ss_pred             cccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          245 AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       245 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      +........  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......   ...   .....    
T Consensus       152 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~---~~~~~----  219 (260)
T cd08222         152 SRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL---SVV---LRIVE----  219 (260)
T ss_pred             eeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHH---HHHHc----
Confidence            876543322  122345888999999998888999999999999999999999999643211   111   11000    


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                             ......+...+.++.+++.+||..||++||++.++++
T Consensus       220 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         220 -------GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -------CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                   0011123445678999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4e-37  Score=292.94  Aligned_cols=248  Identities=28%  Similarity=0.385  Sum_probs=194.5

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      +.|...+.||+|+||.||+|...      ..++.+++|.+.....   .....+.+|+++++.++|+|++++++++....
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   88 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDV------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH   88 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEc------CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence            34667788999999999999643      3467899999864322   23456788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..++||||+. ++|.+++... ...+++..+..++.|++.||.|||  +++++|+||||+||+++.++.++|+|||++..
T Consensus        89 ~~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  164 (308)
T cd06634          89 TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (308)
T ss_pred             eeEEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHhEEECCCCcEEECCccccee
Confidence            9999999995 6887776543 245788899999999999999999  67899999999999999999999999999876


Q ss_pred             CCCCCCceeeeccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYIS---TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      ....      ....|+..|+|||++.   ...++.++|||||||++|+|++|..||..........  ...     ... 
T Consensus       165 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~-----~~~-  230 (308)
T cd06634         165 MAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIA-----QNE-  230 (308)
T ss_pred             ecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--HHh-----hcC-
Confidence            4322      2345889999999874   3568889999999999999999999986543211111  000     000 


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL  370 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L  370 (419)
                              .........+..+.+|+.+||+.+|++||++.+++...
T Consensus       231 --------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         231 --------SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             --------CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence                    00011223457799999999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3e-37  Score=298.07  Aligned_cols=269  Identities=20%  Similarity=0.269  Sum_probs=196.4

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      +.++|.+.+.||+|+||.||+|...      .+++.||+|++....  ......+.+|+.+++.++|+||+++++++...
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~   86 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDK------RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSA   86 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeC------CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccc
Confidence            3578999999999999999999643      346889999986432  22235678899999999999999999998654


Q ss_pred             C------eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 014736          167 E------ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS  240 (419)
Q Consensus       167 ~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  240 (419)
                      .      ..|+||||+. .+|..++.    ..+++..+..++.|++.||.|||  .+||+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH--~~~i~H~dlkp~NIll~~~~~~kL~  159 (342)
T cd07879          87 VSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIH--SAGIIHRDLKPGNLAVNEDCELKIL  159 (342)
T ss_pred             ccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEe
Confidence            3      4689999995 47766542    35888999999999999999999  6779999999999999999999999


Q ss_pred             ccCccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh---
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK---  316 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~---  316 (419)
                      |||++......     .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+....   
T Consensus       160 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  234 (342)
T cd07879         160 DFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP  234 (342)
T ss_pred             eCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99998864322     123457889999999866 468999999999999999999999998644222111110000   


Q ss_pred             -----HHhhcc--cccccccccccCCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhhc
Q 014736          317 -----PYLRSS--RRLRYIVDPRLAGQY---SVKGAKEMAVLALQCISVNPKDRPKMAAVVA--TLESLLN  375 (419)
Q Consensus       317 -----~~~~~~--~~~~~~~~~~l~~~~---~~~~~~~l~~li~~~l~~dP~~RPs~~eil~--~L~~l~~  375 (419)
                           ......  ...............   ....+.++.+|+.+||+.||.+||++.+++.  .++.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                 000000  000000000000000   0124567899999999999999999999985  4666544

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-39  Score=291.92  Aligned_cols=267  Identities=23%  Similarity=0.332  Sum_probs=205.3

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-c-c----cccce
Q 014736           86 LRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-H-P----HLVRL  159 (419)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-p----nIv~~  159 (419)
                      ...+.++|.+...+|+|.||.|-.+++..      .+..||||+++.... -.+..+-|+++|.++. + |    -+|.+
T Consensus        84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~------~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m  156 (415)
T KOG0671|consen   84 GDILTNRYEIVDLLGEGTFGKVVECWDRE------TKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQM  156 (415)
T ss_pred             ccccccceehhhhhcCCcccceEEEeecC------CCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence            35568899999999999999999997543      268899999974422 2344556999999983 2 2    36888


Q ss_pred             eeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC------
Q 014736          160 IGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS------  233 (419)
Q Consensus       160 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~------  233 (419)
                      .+||+-.++.+||+|.+ |.+++++|.++...+++...++.+++|++++++|||  +++++|.||||+|||+..      
T Consensus       157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh--~~kl~HTDLKPENILfvss~~~~~  233 (415)
T KOG0671|consen  157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH--DLKLTHTDLKPENILFVSSEYFKT  233 (415)
T ss_pred             ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH--hcceeecCCChheEEEeccceEEE
Confidence            89999999999999999 889999999988889999999999999999999999  677999999999999831      


Q ss_pred             --------------CCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 014736          234 --------------DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRS  299 (419)
Q Consensus       234 --------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p  299 (419)
                                    +..|+|+|||.|+......     ...+.|..|.|||++.+..++..+||||+||||+||.+|..-
T Consensus       234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L  308 (415)
T KOG0671|consen  234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL  308 (415)
T ss_pred             eccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence                          3458999999999744432     445689999999999999999999999999999999999999


Q ss_pred             CCCCCCccchhHHHhh--------------hHHhhccccc-----------ccccccccC----CCCCHHHHHHHHHHHH
Q 014736          300 MDKLRPKSEQNLVDWA--------------KPYLRSSRRL-----------RYIVDPRLA----GQYSVKGAKEMAVLAL  350 (419)
Q Consensus       300 f~~~~~~~~~~~~~~~--------------~~~~~~~~~~-----------~~~~~~~l~----~~~~~~~~~~l~~li~  350 (419)
                      |......+.....+.+              ..++..+ .+           ....+....    -.-......++.+|++
T Consensus       309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~  387 (415)
T KOG0671|consen  309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR  387 (415)
T ss_pred             cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence            9877644422211111              1111111 11           011110000    0112334567999999


Q ss_pred             HcccCCCCCCCCHHHHHH
Q 014736          351 QCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       351 ~~l~~dP~~RPs~~eil~  368 (419)
                      +||..||.+|+|+.|++.
T Consensus       388 ~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  388 RMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHccCccccccHHHHhc
Confidence            999999999999999986

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-37  Score=288.09  Aligned_cols=264  Identities=25%  Similarity=0.290  Sum_probs=198.4

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      |+..+.||+|+||.||+|...      .+++.||+|++....  ......+..|+.+++.++|+||+++++++.+.+..+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   74 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDK------KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY   74 (282)
T ss_pred             CeeehcccccCcceEEEeeec------CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence            566788999999999999643      347889999998653  233467788999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+. ++|.+++.... ..+++..+..++.|++.||.|||  ++||+|+||+|+||+++.++.++|+|||++.....
T Consensus        75 ~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          75 LVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH--SHRILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             EEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            9999996 58999987642 46889999999999999999999  67899999999999999999999999999986543


Q ss_pred             CCCceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh--------hHHhhc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA--------KPYLRS  321 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~--------~~~~~~  321 (419)
                      ...  ......++..|+|||.+.+. .++.++||||||+++|+|++|.+||...........+...        ......
T Consensus       151 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07829         151 PLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK  228 (282)
T ss_pred             Ccc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence            321  12223467889999998766 8899999999999999999999999764422211111000        000000


Q ss_pred             ccccccccccccCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          322 SRRLRYIVDPRLAG---QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       322 ~~~~~~~~~~~l~~---~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ..............   ......+..+.+++.+||..||++||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00000000000000   001123578999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-37  Score=281.95  Aligned_cols=237  Identities=30%  Similarity=0.379  Sum_probs=192.9

Q ss_pred             ecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc---cHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEe
Q 014736           99 LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ---GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        99 lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  175 (419)
                      ||+|+||.||++...+      .++.|++|++......   ....+.+|+.+++.++|+||+++++.+..+...|+||||
T Consensus         1 lg~G~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   74 (250)
T cd05123           1 LGKGSFGKVLLVRKKD------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEY   74 (250)
T ss_pred             CCCCCceEEEEEEECC------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEec
Confidence            6999999999996543      4678999998754322   345788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCce
Q 014736          176 MPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH  255 (419)
Q Consensus       176 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  255 (419)
                      +.+++|.+++...  ..+++..+..++.|++.||.|||  +.+++|+||+|+||+++.++.++|+|||++........  
T Consensus        75 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh--~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--  148 (250)
T cd05123          75 APGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--  148 (250)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--
Confidence            9999999998765  46889999999999999999999  67899999999999999999999999999986544321  


Q ss_pred             eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCC
Q 014736          256 VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAG  335 (419)
Q Consensus       256 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  335 (419)
                      ......++..|++||.+.+...+.++|+||||+++|+|++|..||......   ......   ...            ..
T Consensus       149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~---~~~------------~~  210 (250)
T cd05123         149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIYEKI---LKD------------PL  210 (250)
T ss_pred             cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH---hcC------------CC
Confidence            123456889999999998888999999999999999999999999754321   111110   000            01


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 014736          336 QYSVKGAKEMAVLALQCISVNPKDRPKMAA  365 (419)
Q Consensus       336 ~~~~~~~~~l~~li~~~l~~dP~~RPs~~e  365 (419)
                      .++...+.++.+++.+||..||++||++.+
T Consensus       211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         211 RFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            122233678999999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6.7e-37  Score=318.62  Aligned_cols=146  Identities=26%  Similarity=0.325  Sum_probs=129.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|.+.++||+|+||.||+|...      ..++.||||++.....   .....+..|+.++..++|+||+++++++...+
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~------~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~   77 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKK------NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN   77 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEEC------CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence            57899999999999999999654      3468899999975432   22356788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +.||||||+.|++|.+++...  ..+++..++.++.||+.||.|||  .+|||||||||+||||+.++.+||+|||+++
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH--~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLH--RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999999998654  45788899999999999999999  6679999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-37  Score=299.96  Aligned_cols=264  Identities=22%  Similarity=0.285  Sum_probs=197.4

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      .+.++|.+.+.||+|+||.||+|....      +++.||+|++....  ......+.+|+.+++.++|+||+++++++..
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTK------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTP   85 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECC------CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhc
Confidence            346789999999999999999996543      46789999986432  2234567789999999999999999998866


Q ss_pred             CCe------eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEE
Q 014736          166 DEE------RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKL  239 (419)
Q Consensus       166 ~~~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  239 (419)
                      .+.      .++|+||+ +++|.+++..   ..+++..+..++.|++.||.|||  +.||+|+||||+||+++.++.++|
T Consensus        86 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH--~~gi~H~dlkp~Nill~~~~~~kL  159 (343)
T cd07851          86 ASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIH--SAGIIHRDLKPSNIAVNEDCELKI  159 (343)
T ss_pred             cccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEE
Confidence            554      89999999 7799998864   36899999999999999999999  678999999999999999999999


Q ss_pred             eccCccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH-
Q 014736          240 SDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP-  317 (419)
Q Consensus       240 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-  317 (419)
                      +|||++......     .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+..... 
T Consensus       160 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~  234 (343)
T cd07851         160 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT  234 (343)
T ss_pred             cccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence            999999865432     223457889999998855 4678999999999999999999999976543221111000000 


Q ss_pred             ----Hhhcc-----cccccccccccCCCC---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          318 ----YLRSS-----RRLRYIVDPRLAGQY---SVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       318 ----~~~~~-----~~~~~~~~~~l~~~~---~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                          .....     ..+...........+   ....+.++.+++.+||+.||++|||+.+|+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                00000     000000000000000   1123678999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-37  Score=286.92  Aligned_cols=268  Identities=28%  Similarity=0.405  Sum_probs=202.9

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcC--CCcccccceeeEEEeCC--
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ--LRHPHLVRLIGYCCEDE--  167 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~~--  167 (419)
                      ...+..+||+|.||.||+|.+.+        +.||||++...   ..+.|.+|-+|.+.  ++|+||+++++.-....  
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~~--------~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~  279 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLDN--------RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD  279 (534)
T ss_pred             chhhHHHhhcCccceeehhhccC--------ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence            34556679999999999996544        78999999753   45677778777665  58999999998765544  


Q ss_pred             --eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhc-------CCCCeeecCCCCCcEEEcCCCcEE
Q 014736          168 --ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG-------AENPVIYRDFKTSNILLDSDFTAK  238 (419)
Q Consensus       168 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-------~~~~ivH~Dlkp~NIll~~~~~~k  238 (419)
                        .++||++|.+.|+|.+||..+   .++|.....++..++.||+|||.       ++..|+|||||..||||..|+...
T Consensus       280 ~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc  356 (534)
T KOG3653|consen  280 RMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC  356 (534)
T ss_pred             ccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence              789999999999999999876   79999999999999999999995       457799999999999999999999


Q ss_pred             EeccCccccCCCCCCceeeecccccccccccccccCC-CCC-----chhhHHHHHHHHHHHHcCCCCCCCCCCccchh--
Q 014736          239 LSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG-HLT-----TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQN--  310 (419)
Q Consensus       239 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DiwslG~il~elltg~~pf~~~~~~~~~~--  310 (419)
                      |+|||+|..+..+......-..+||.+|||||++.+. ++.     .+.||||+|+++|||++...-+......+.+-  
T Consensus       357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf  436 (534)
T KOG3653|consen  357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF  436 (534)
T ss_pred             eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence            9999999988766555444457899999999999653 222     36899999999999999765553211111000  


Q ss_pred             --------HHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          311 --------LVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       311 --------~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                              .++..+.+....+....+.+....+    ....-+++.+..||+.|++-|.|+.=+.+++..+....
T Consensus       437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence                    0111111221222222222222221    23567899999999999999999999999999886654

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-37  Score=299.37  Aligned_cols=243  Identities=26%  Similarity=0.300  Sum_probs=193.5

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      |..++.||-|+||.|.++...+      +...||+|.+++.+.   .+......|-.||..-+.+-||++|..|.+.+.+
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvD------T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL  704 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVD------TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL  704 (1034)
T ss_pred             eEEEeeecccccceeEEEeecc------hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence            6777889999999999996444      357899999876532   3455677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+||||++||++-.+|.+.  +-+++..++.++.++.+|+++.|  +.|+|||||||+|||||.+|++||+||||++-+.
T Consensus       705 YFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVH--kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             EEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHH--hccceecccCccceEEccCCceeeeeccccccce
Confidence            9999999999999998876  67888899999999999999999  8889999999999999999999999999986321


Q ss_pred             ---------CCCCcee-------------------------------eecccccccccccccccCCCCCchhhHHHHHHH
Q 014736          250 ---------EGSNTHV-------------------------------TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVV  289 (419)
Q Consensus       250 ---------~~~~~~~-------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  289 (419)
                               .+.....                               .-..+||+.|+|||++....|+..||+||.|||
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi  860 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI  860 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence                     1110000                               012579999999999999999999999999999


Q ss_pred             HHHHHcCCCCCCCCCCccchhH-HHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 014736          290 LLELLTGRRSMDKLRPKSEQNL-VDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP  361 (419)
Q Consensus       290 l~elltg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP  361 (419)
                      ||||+.|++||....+.+.+.. +.|.           .    .|.-.+..+.+.++.+||.+++. +++.|.
T Consensus       861 l~em~~g~~pf~~~tp~~tq~kv~nw~-----------~----~l~~~~~~~ls~e~~~li~kLc~-sad~RL  917 (1034)
T KOG0608|consen  861 LYEMLVGQPPFLADTPGETQYKVINWR-----------N----FLHIPYQGNLSKEALDLIQKLCC-SADSRL  917 (1034)
T ss_pred             HHHHhhCCCCccCCCCCcceeeeeehh-----------h----ccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence            9999999999988776654432 2221           1    11222334456778888877553 455554

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=251.50  Aligned_cols=265  Identities=23%  Similarity=0.287  Sum_probs=199.7

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      +|...++||+|.||+||+|      ++..+.+.||+|.++....  ......++|+-+|+.++|.|||+++++...+..+
T Consensus         3 ~ydkmekigegtygtvfka------rn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkl   76 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKA------RNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL   76 (292)
T ss_pred             chHHHHhhcCCcceeeEec------ccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCcee
Confidence            4556678999999999999      4566789999999976533  2346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      -+|+||| .-+|..+... .++.++.+.+..++.|++.||.|+|+  +++.||||||.|.||+.+|.+||+|||+++.+.
T Consensus        77 tlvfe~c-dqdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchs--hnvlhrdlkpqnllin~ngelkladfglarafg  152 (292)
T KOG0662|consen   77 TLVFEFC-DQDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHS--HNVLHRDLKPQNLLINRNGELKLADFGLARAFG  152 (292)
T ss_pred             EEeHHHh-hHHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhh--hhhhhccCCcceEEeccCCcEEecccchhhhcC
Confidence            9999999 5688887644 35678889999999999999999995  559999999999999999999999999999754


Q ss_pred             CCCCceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccc--c
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR--L  325 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~  325 (419)
                      -.  .......+-|..|.+|.++.+. -|+...|+||.|||+.|+.. |++-|.+..-.+....+-|.........+  +
T Consensus       153 ip--vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~  230 (292)
T KOG0662|consen  153 IP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM  230 (292)
T ss_pred             Cc--eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence            32  2233445678999999998764 58899999999999999987 66667665444333333322211111111  0


Q ss_pred             ccccccccCCCC---------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          326 RYIVDPRLAGQY---------SVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       326 ~~~~~~~l~~~~---------~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      -.+-|-.....|         -+.....-++|++++|.-+|.+|.++++.++
T Consensus       231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            001110111111         1223345688999999999999999998765

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.3e-36  Score=275.68  Aligned_cols=221  Identities=23%  Similarity=0.237  Sum_probs=176.7

Q ss_pred             cCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEecCCCCh
Q 014736          102 GGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSL  181 (419)
Q Consensus       102 G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L  181 (419)
                      |.||.||++..      ..+++.||+|.+....     .+.+|...+....||||+++++++.+.+..++||||+.+++|
T Consensus         4 g~~~~v~~~~~------~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   72 (237)
T cd05576           4 GVIDKVLLVMD------TRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL   72 (237)
T ss_pred             cccceEEEEEE------ccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCH
Confidence            88999999954      4557889999997542     223355555556799999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCceeeeccc
Q 014736          182 ENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM  261 (419)
Q Consensus       182 ~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  261 (419)
                      .+++.+.  ..+++..+..++.|++.||.|||  ++||+||||||+||+++.++.++|+|||.+.......     ....
T Consensus        73 ~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~  143 (237)
T cd05576          73 WSHISKF--LNIPEECVKRWAAEMVVALDALH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEA  143 (237)
T ss_pred             HHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCC
Confidence            9998765  45889999999999999999999  7789999999999999999999999999876543321     2234


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHH
Q 014736          262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKG  341 (419)
Q Consensus       262 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  341 (419)
                      ++..|+|||.+.+..++.++|+||+|+++|+|++|..|+........            ..          .....+...
T Consensus       144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~----------~~~~~~~~~  201 (237)
T cd05576         144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------TH----------TTLNIPEWV  201 (237)
T ss_pred             cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------cc----------cccCCcccC
Confidence            67789999999888899999999999999999999988754211000            00          000122234


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHH
Q 014736          342 AKEMAVLALQCISVNPKDRPKMA  364 (419)
Q Consensus       342 ~~~l~~li~~~l~~dP~~RPs~~  364 (419)
                      +..+.+++.+||+.||++||++.
T Consensus       202 ~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         202 SEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             CHHHHHHHHHHccCCHHHhcCCC
Confidence            57799999999999999999963

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-38  Score=274.90  Aligned_cols=263  Identities=26%  Similarity=0.339  Sum_probs=199.7

Q ss_pred             CCcCCCHHHHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHc-CCCcc
Q 014736           77 DLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLG-QLRHP  154 (419)
Q Consensus        77 ~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~-~l~hp  154 (419)
                      ..+.|....++.+.       .||.|.||+|++-      .++..++..|||.+..... ...++++.|.+... .-++|
T Consensus        57 ~~~~F~~~~Lqdlg-------~iG~G~fG~V~KM------~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp  123 (361)
T KOG1006|consen   57 HLHTFTSDNLQDLG-------EIGNGAFGTVNKM------LHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCP  123 (361)
T ss_pred             cccccccchHHHHH-------HhcCCcchhhhhh------hcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCc
Confidence            45566666666654       4999999999986      5677899999999986644 45567888888654 45799


Q ss_pred             cccceeeEEEeCCeeEEEEEecCCCChhhhh---hhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 014736          155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHL---FKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL  231 (419)
Q Consensus       155 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l---~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll  231 (419)
                      |||++||....++..|+.||+| ..+|..+.   .......+++...-.|....+.||.||-. +..|||||+||+|||+
T Consensus       124 ~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~-~lkiIHRDvKPSNILl  201 (361)
T KOG1006|consen  124 NIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE-ELKIIHRDVKPSNILL  201 (361)
T ss_pred             HHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH-HhhhhhccCChhheEE
Confidence            9999999999999999999999 56665443   23334568888888899999999999974 4569999999999999


Q ss_pred             cCCCcEEEeccCccccCCCCCCceeeecccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccch
Q 014736          232 DSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST--GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQ  309 (419)
Q Consensus       232 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  309 (419)
                      +..|.+||||||++..+.+.-   ..+.-.|-..|||||.+..  ..|+.++||||||++|||+.||..|+.++...  .
T Consensus       202 dr~G~vKLCDFGIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv--f  276 (361)
T KOG1006|consen  202 DRHGDVKLCDFGICGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV--F  276 (361)
T ss_pred             ecCCCEeeecccchHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH--H
Confidence            999999999999987643321   2344568889999999953  46999999999999999999999999876431  1


Q ss_pred             hHHHhhhHHhhcccccccccccccC-CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          310 NLVDWAKPYLRSSRRLRYIVDPRLA-GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      +.+   ...  ..+..     +.+. ..-....+..+..++.-||.+|-..||.+.++.++
T Consensus       277 eql---~~V--v~gdp-----p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  277 EQL---CQV--VIGDP-----PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HHH---HHH--HcCCC-----CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            111   110  01111     1111 11123456789999999999999999999988764

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=271.85  Aligned_cols=249  Identities=25%  Similarity=0.347  Sum_probs=198.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCC-CcccccceeeEEEe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQL-RHPHLVRLIGYCCE  165 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  165 (419)
                      .++|.++++||+|+|+.|.++.      ...+.+.||+|+++++-.   .++.-...|-.+..+- +||.+|-+..+|..
T Consensus       249 l~df~ll~vigrgsyakvl~~~------~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVR------LKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccceeeeeecCcchhhhhhee------hcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            4689999999999999999984      455678999999976532   3344455676666665 69999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      +..+++|.||++||+|--++++.  ..++++.+..+...|..||.|||  ++|||+||||..|||+|..|.+||+|+|++
T Consensus       323 esrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh--~rgiiyrdlkldnvlldaeghikltdygmc  398 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMC  398 (593)
T ss_pred             cceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHh--hcCeeeeeccccceEEccCCceeecccchh
Confidence            99999999999999998887765  57999999999999999999999  889999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-ccchhHHHhhhHH-hhccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRP-KSEQNLVDWAKPY-LRSSR  323 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~~~~~~~~-~~~~~  323 (419)
                      +..-..  ...+..++||+.|+|||++.+..|+..+|+|+|||+++||+.|+.||+--.- ....+..++.... ++..-
T Consensus       399 ke~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi  476 (593)
T KOG0695|consen  399 KEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI  476 (593)
T ss_pred             hcCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence            863322  2346679999999999999999999999999999999999999999985421 1122222222111 11111


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC
Q 014736          324 RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK  362 (419)
Q Consensus       324 ~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs  362 (419)
                                  ..+...+-.+..+++..|.+||.+|..
T Consensus       477 ------------riprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  477 ------------RIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ------------cccceeehhhHHHHHHhhcCCcHHhcC
Confidence                        122233445778999999999999954

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-37  Score=283.76  Aligned_cols=259  Identities=25%  Similarity=0.368  Sum_probs=201.9

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-ccc------HHHHHHHHHHHcCCCccccccee
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQG------HREWLAEVIFLGQLRHPHLVRLI  160 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~------~~~~~~E~~~l~~l~hpnIv~~~  160 (419)
                      .+.++|-++++||+|||+.||+|++      ....+.||+|+-.... +.+      .+...+|..|.+.|+||.||++|
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFD------l~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlY  533 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFD------LTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLY  533 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcc------cchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeee
Confidence            3456788899999999999999963      4456889999875432 211      24567899999999999999999


Q ss_pred             eEEEe-CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCc
Q 014736          161 GYCCE-DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFT  236 (419)
Q Consensus       161 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~---~~~  236 (419)
                      ++|.- .+.++-|+|||+|-+|.-+|..+  ..+++.++..|+.||+.||.||......|||-||||.|||+-.   -|.
T Consensus       534 DyfslDtdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGe  611 (775)
T KOG1151|consen  534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGE  611 (775)
T ss_pred             eeeeeccccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccce
Confidence            99965 45678899999999999999776  6789999999999999999999988889999999999999954   478


Q ss_pred             EEEeccCccccCCCCCCce-----eeecccccccccccccccC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcc
Q 014736          237 AKLSDFGLAKMGPEGSNTH-----VTTRVMGTYGYAAPEYIST----GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKS  307 (419)
Q Consensus       237 ~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  307 (419)
                      +||+||||++.........     .+....||..|++||.+--    ..++.++||||+|||+|.++.|+.||....  .
T Consensus       612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq--s  689 (775)
T KOG1151|consen  612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ--S  689 (775)
T ss_pred             eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch--h
Confidence            9999999999876655443     3445789999999998743    357889999999999999999999997542  2


Q ss_pred             chhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 014736          308 EQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV  366 (419)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~ei  366 (419)
                      .++.++...-  -....        +.....+.++.++.++|++||+..-++|.+..++
T Consensus       690 QQdILqeNTI--lkAtE--------VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qL  738 (775)
T KOG1151|consen  690 QQDILQENTI--LKATE--------VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL  738 (775)
T ss_pred             HHHHHhhhch--hccee--------ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence            2222221110  01111        1111223456789999999999999999876655

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=299.58  Aligned_cols=253  Identities=25%  Similarity=0.345  Sum_probs=208.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-CcccccceeeEEEe---
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHLVRLIGYCCE---  165 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~---  165 (419)
                      ++-|+++..||+|.+|.||+++      +..+++..|+|+....... .+++..|.++|+.+ +|||++.++++|..   
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k------~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGR------HVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEe------eeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            3568889999999999999994      5566888999999866433 35566788999888 59999999999854   


Q ss_pred             --CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccC
Q 014736          166 --DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFG  243 (419)
Q Consensus       166 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  243 (419)
                        ++.+|||||||.||+..|++.......+.|..+..|++.++.|+.+||  ++.++|||||=.|||++.++.|||+|||
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH--~nkviHRDikG~NiLLT~e~~VKLvDFG  168 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH--NNKVIHRDIKGQNVLLTENAEVKLVDFG  168 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh--hcceeeecccCceEEEeccCcEEEeeee
Confidence              468999999999999999998777778999999999999999999999  7779999999999999999999999999


Q ss_pred             ccccCCCCCCceeeecccccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          244 LAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-----GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       244 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      ++..+.....  .....+||+.|||||++..     ..|+..+|+||||++..||.-|.+|+-...+....-.       
T Consensus       169 vSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~-------  239 (953)
T KOG0587|consen  169 VSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-------  239 (953)
T ss_pred             eeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc-------
Confidence            9886543322  2455789999999999964     3578899999999999999999999987654321111       


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        .      ..+|...-.-+..+++++.++|..||.+|..+||++.++++
T Consensus       240 --I------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  240 --I------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             --C------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence              1      11233333346778999999999999999999999998874

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-36  Score=277.76  Aligned_cols=271  Identities=28%  Similarity=0.425  Sum_probs=203.4

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcC--CCcccccceeeEE
Q 014736           86 LRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ--LRHPHLVRLIGYC  163 (419)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~  163 (419)
                      -+.+.++..+.+.||+|.||.||+|.|.+        +.||||++...   +...+.+|.+|.+.  |+|+||+.+++.-
T Consensus       206 QRTiarqI~L~e~IGkGRyGEVwrG~wrG--------e~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD  274 (513)
T KOG2052|consen  206 QRTIARQIVLQEIIGKGRFGEVWRGRWRG--------EDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAAD  274 (513)
T ss_pred             HHhhhheeEEEEEecCccccceeeccccC--------CceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhcc
Confidence            46777889999999999999999997764        67999999754   34567777777755  6999999998765


Q ss_pred             EeCC----eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhc------CCCCeeecCCCCCcEEEcC
Q 014736          164 CEDE----ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG------AENPVIYRDFKTSNILLDS  233 (419)
Q Consensus       164 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~------~~~~ivH~Dlkp~NIll~~  233 (419)
                      ..++    .++||++|.+.|+|+|||.+.   .++....++++..+|.||++||.      .+..|.|||||..||||..
T Consensus       275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk  351 (513)
T KOG2052|consen  275 NKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK  351 (513)
T ss_pred             ccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence            4433    689999999999999999874   78889999999999999999994      2567999999999999999


Q ss_pred             CCcEEEeccCccccCCCCCCc-e-eeecccccccccccccccCC----CC--CchhhHHHHHHHHHHHHcC---------
Q 014736          234 DFTAKLSDFGLAKMGPEGSNT-H-VTTRVMGTYGYAAPEYISTG----HL--TTKSDVYSFGVVLLELLTG---------  296 (419)
Q Consensus       234 ~~~~kl~DfGla~~~~~~~~~-~-~~~~~~gt~~y~aPE~~~~~----~~--~~~~DiwslG~il~elltg---------  296 (419)
                      ++.+.|+|+|||......... . ..+..+||..|||||++...    .+  -..+||||||+++||+...         
T Consensus       352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee  431 (513)
T KOG2052|consen  352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE  431 (513)
T ss_pred             CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence            999999999999875544221 1 12346799999999999542    12  2468999999999999763         


Q ss_pred             -CCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          297 -RRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       297 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                       ++||...-+.+.....  ....+ -.++++..++..   -.+......+.+|++.||..||.-|.|+--|-+.|.++.+
T Consensus       432 y~~Pyyd~Vp~DPs~ee--MrkVV-Cv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  432 YQLPYYDVVPSDPSFEE--MRKVV-CVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             hcCCcccCCCCCCCHHH--Hhcce-eecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence             2555544333221100  00000 011111111111   1234567789999999999999999999999999999876


Q ss_pred             C
Q 014736          376 L  376 (419)
Q Consensus       376 ~  376 (419)
                      .
T Consensus       506 ~  506 (513)
T KOG2052|consen  506 S  506 (513)
T ss_pred             C
Confidence            4

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=299.60  Aligned_cols=260  Identities=27%  Similarity=0.412  Sum_probs=215.9

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC-CcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEE
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLL  171 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  171 (419)
                      .+..++||+|+||+||+|.|-..  ...-+-+||+|++... ..+...++++|+.+|.+++|||++++++++.... +.|
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pe--ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPE--GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecC--CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            34466899999999999988664  2334568999998643 4445678999999999999999999999997665 789


Q ss_pred             EEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCC
Q 014736          172 VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG  251 (419)
Q Consensus       172 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  251 (419)
                      |++|++.|+|.++++.+ ...+-....+.|..||++||.|||  ++++|||||-..||||..-..+||.|||+++.....
T Consensus       775 vtq~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe--~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLE--EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH--hcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999999775 346777889999999999999999  777999999999999999999999999999987766


Q ss_pred             CCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccccc
Q 014736          252 SNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD  330 (419)
Q Consensus       252 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (419)
                      ..........-.+.|||-|.+....|+.++|||||||++||+|| |..|+++....+.-+++       +.+.++     
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll-------e~geRL-----  919 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL-------EKGERL-----  919 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-------hccccC-----
Confidence            55543333445678999999999999999999999999999999 99999987655433332       233322     


Q ss_pred             cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       331 ~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                           .-++.++.++..++.+||..|+..||+++++...+.....
T Consensus       920 -----sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  920 -----SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             -----CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence                 2345677899999999999999999999999998887654

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-35  Score=300.90  Aligned_cols=270  Identities=28%  Similarity=0.472  Sum_probs=213.2

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccc-cccccEEEEEEeccCC-cccHHHHHHHHHHHcCC-CcccccceeeEE
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQ-GLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQL-RHPHLVRLIGYC  163 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~  163 (419)
                      +.-.++..+.+.||+|.||.|++|........ ......||||.+.... ..+.+.+..|+++|+.+ +|+||+.++|++
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            33344556667999999999999987653222 1235689999997543 34567899999999998 599999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhhhcc------------C--CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcE
Q 014736          164 CEDEERLLVYEFMPRGSLENHLFKRI------------S--VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNI  229 (419)
Q Consensus       164 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------~--~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NI  229 (419)
                      ...+..++|+||+..|+|.+++....            .  ..++....+.++.||+.||+||+  +.++|||||-..||
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~--~~~~vHRDLAaRNV  449 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA--SVPCVHRDLAARNV  449 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh--hCCccchhhhhhhE
Confidence            99999999999999999999998764            0  13788899999999999999999  56699999999999


Q ss_pred             EEcCCCcEEEeccCccccCCCCCCceeeecccc--cccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCc
Q 014736          230 LLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG--TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPK  306 (419)
Q Consensus       230 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~  306 (419)
                      |+..+..+||+|||+|+............ ..|  ...|||||.+....|+.++||||||++||||++ |..||.+....
T Consensus       450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  450 LITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             EecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            99999999999999999655544433221 112  345999999999999999999999999999999 88999763311


Q ss_pred             cchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          307 SEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      .  ++.+    ++..+.++          ..+..+++++.++++.||+.+|++||++.++.+.|...+.
T Consensus       529 ~--~l~~----~l~~G~r~----------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  529 E--ELLE----FLKEGNRM----------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             H--HHHH----HHhcCCCC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            1  1121    22333222          2344557899999999999999999999999999998643

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-37  Score=267.77  Aligned_cols=267  Identities=25%  Similarity=0.328  Sum_probs=194.4

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--cHHHHHHHHHHHcCCCcccccceeeEEEe----
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--GHREWLAEVIFLGQLRHPHLVRLIGYCCE----  165 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----  165 (419)
                      .|.-..+||+|.||.||+|      +.+.+++.||+|++-.++..  --...++|+.+|..|+|+|++.+++.|..    
T Consensus        18 ~yek~~kigqGtfgeVFkA------r~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp   91 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKA------RSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP   91 (376)
T ss_pred             HHHHHHhcCCchHHHHHHH------hhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence            3444567999999999999      45666788999987543322  12456789999999999999999887743    


Q ss_pred             ----CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          166 ----DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       166 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                          ...+|+||++|+ -+|...+.+. ...++..++.+++.++++||.|+|  .+.|+|||+|++|+||+.+|.+||+|
T Consensus        92 ~~r~r~t~ylVf~~ce-hDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iH--r~kilHRDmKaaNvLIt~dgilklAD  167 (376)
T KOG0669|consen   92 TNRDRATFYLVFDFCE-HDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIH--RNKILHRDMKAANVLITKDGILKLAD  167 (376)
T ss_pred             cccccceeeeeHHHhh-hhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHH--HhhHHhhcccHhhEEEcCCceEEeec
Confidence                235899999994 5788777543 356888999999999999999999  55599999999999999999999999


Q ss_pred             cCccccCCCCCCce--eeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh--
Q 014736          242 FGLAKMGPEGSNTH--VTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK--  316 (419)
Q Consensus       242 fGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--  316 (419)
                      ||+++.+....+..  ..+..+-|..|.+||.+.+ ..|++..|||..|||+.||+++.+-|.+.........+....  
T Consensus       168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs  247 (376)
T KOG0669|consen  168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS  247 (376)
T ss_pred             cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence            99998665443322  1233456999999998866 679999999999999999999999888765443332221110  


Q ss_pred             ---HHhhcccc---ccccccccc-CCCCC--H------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          317 ---PYLRSSRR---LRYIVDPRL-AGQYS--V------KGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       317 ---~~~~~~~~---~~~~~~~~l-~~~~~--~------~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                         ..+.+...   ...+-.+.+ .+.+.  .      .-.++..+|+.++|..||.+|+++++++.
T Consensus       248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence               00001111   011100101 11111  0      11357899999999999999999999875

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=6e-34  Score=259.91  Aligned_cols=239  Identities=30%  Similarity=0.381  Sum_probs=192.6

Q ss_pred             CceEEEEEEEcCcccccccccEEEEEEeccCCccc-HHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEecCCCCh
Q 014736          103 GFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-HREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSL  181 (419)
Q Consensus       103 ~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L  181 (419)
                      +||.||+|...+      +++.+++|++....... ...+.+|++.+++++|+||+++++++......+++|||+.+++|
T Consensus         1 ~~g~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   74 (244)
T smart00220        1 SFGKVYLARDKK------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDL   74 (244)
T ss_pred             CceEEEEEEECC------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence            589999997543      46789999998665544 67889999999999999999999999999999999999999999


Q ss_pred             hhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCceeeeccc
Q 014736          182 ENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM  261 (419)
Q Consensus       182 ~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  261 (419)
                      .+++....  .+++..+..++.+++.++.|||  +.+++|+||+|.||+++.++.++|+|||.+.......   ......
T Consensus        75 ~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~  147 (244)
T smart00220       75 FDLLKKRG--RLSEDEARFYARQILSALEYLH--SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFV  147 (244)
T ss_pred             HHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH--HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---cccccc
Confidence            99987652  3788999999999999999999  6789999999999999999999999999998765432   223455


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHH
Q 014736          262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKG  341 (419)
Q Consensus       262 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  341 (419)
                      ++..|++||.+....++.++||||||+++|+|++|..||......  ........    ...        ..........
T Consensus       148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~----~~~--------~~~~~~~~~~  213 (244)
T smart00220      148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIG----KPK--------PPFPPPEWKI  213 (244)
T ss_pred             CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHh----ccC--------CCCccccccC
Confidence            888999999998888999999999999999999999999763211  11111110    000        0000000114


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          342 AKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       342 ~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      +.++.+++.+||..+|++||++.++++
T Consensus       214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      214 SPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             CHHHHHHHHHHccCCchhccCHHHHhh
Confidence            578999999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1e-34  Score=295.35  Aligned_cols=264  Identities=21%  Similarity=0.236  Sum_probs=169.5

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeE------
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGY------  162 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~------  162 (419)
                      ..++|.+.++||+|+||.||+|+..++.  ...+..||+|++.....  .+.+..|  .+....+.++..++..      
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~--~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQ--SKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCc--cccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence            4568999999999999999999765531  13367899998764322  1222221  1222222233222221      


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhhccCC------------------CCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 014736          163 CCEDEERLLVYEFMPRGSLENHLFKRISV------------------SLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDF  224 (419)
Q Consensus       163 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dl  224 (419)
                      ...+...++||||+.+++|.+++......                  ......+..++.||+.||.|||  ++||+||||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH--~~gIiHRDL  281 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH--STGIVHRDV  281 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH--HCCEEeCcC
Confidence            23556789999999999999988653210                  0112345679999999999999  678999999


Q ss_pred             CCCcEEEcC-CCcEEEeccCccccCCCCCCceeeecccccccccccccccCC----------------------CCCchh
Q 014736          225 KTSNILLDS-DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG----------------------HLTTKS  281 (419)
Q Consensus       225 kp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~  281 (419)
                      ||+|||++. ++.+||+|||+++....... .......|++.|+|||.+...                      .++.++
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            999999986 57899999999986543322 223446789999999965321                      245567


Q ss_pred             hHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc---cccccccc----cCCCC--CHHHHHHHHHHHHHc
Q 014736          282 DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR---LRYIVDPR----LAGQY--SVKGAKEMAVLALQC  352 (419)
Q Consensus       282 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~----l~~~~--~~~~~~~l~~li~~~  352 (419)
                      |||||||++|||+++..+++...       ......+......   +.....+.    +...+  .........+||.+|
T Consensus       361 DVwSlGviL~el~~~~~~~~~~~-------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m  433 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSNL-------IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM  433 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchHH-------HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence            99999999999999776644210       0000000000000   00000000    00000  001123456899999


Q ss_pred             ccCCCCCCCCHHHHHH
Q 014736          353 ISVNPKDRPKMAAVVA  368 (419)
Q Consensus       353 l~~dP~~RPs~~eil~  368 (419)
                      |+.||++|||+.++++
T Consensus       434 L~~dP~kR~ta~e~L~  449 (566)
T PLN03225        434 MRFKGRQRISAKAALA  449 (566)
T ss_pred             ccCCcccCCCHHHHhC
Confidence            9999999999999986

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.7e-34  Score=283.97  Aligned_cols=271  Identities=19%  Similarity=0.239  Sum_probs=182.8

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcc----------cccccccEEEEEEeccCCcccHHHH--------------HHH
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDL----------RQGLKAQAVAVKLLDIEGLQGHREW--------------LAE  144 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~----------~~~~~~~~vavK~~~~~~~~~~~~~--------------~~E  144 (419)
                      ..++|++.++||+|+||.||+|......          .....++.||||.+........++|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            3568999999999999999999753221          1234557899999875433323333              346


Q ss_pred             HHHHcCCCcccc-----cceeeEEEe--------CCeeEEEEEecCCCChhhhhhhcc----------------------
Q 014736          145 VIFLGQLRHPHL-----VRLIGYCCE--------DEERLLVYEFMPRGSLENHLFKRI----------------------  189 (419)
Q Consensus       145 ~~~l~~l~hpnI-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~----------------------  189 (419)
                      +.++.+++|.++     ++++++|..        .+..+|||||+.+++|.+++....                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            666777766544     667777643        356799999999999999886421                      


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCceeeeccccccccccc
Q 014736          190 SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP  269 (419)
Q Consensus       190 ~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP  269 (419)
                      ...+++..++.++.|++.+|.|||  .++|+||||||+|||++.++.+||+|||++.......... .....+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH--~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH--RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeCh
Confidence            112456778899999999999999  6779999999999999999999999999997543322111 1123358899999


Q ss_pred             ccccCCC--------------------CC--chhhHHHHHHHHHHHHcCCC-CCCCCCCccch-hHHHhhhHHhhccccc
Q 014736          270 EYISTGH--------------------LT--TKSDVYSFGVVLLELLTGRR-SMDKLRPKSEQ-NLVDWAKPYLRSSRRL  325 (419)
Q Consensus       270 E~~~~~~--------------------~~--~~~DiwslG~il~elltg~~-pf~~~~~~~~~-~~~~~~~~~~~~~~~~  325 (419)
                      |++....                    |+  .+.||||+||++|+|++|.. ||......... .........+..    
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~----  455 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM----  455 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh----
Confidence            9875322                    12  24799999999999999875 66543211100 000000000000    


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNP---KDRPKMAAVVA  368 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP---~~RPs~~eil~  368 (419)
                        .......-......+....+|+.+||..+|   .+|+|+.|+++
T Consensus       456 --~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        456 --YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             --hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence              000001111122346789999999999876   68999999976

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-34  Score=263.50  Aligned_cols=273  Identities=24%  Similarity=0.355  Sum_probs=221.4

Q ss_pred             CCHHHHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC-CcccHHHHHHHHHHHcCCCcccccce
Q 014736           81 FQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGHREWLAEVIFLGQLRHPHLVRL  159 (419)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~  159 (419)
                      -...++..-..+++...++-+|.||.||.|.|.+. ..-.+.+.|.+|.++.. ..-+...++.|-..|..+.|||+..+
T Consensus       274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eE-dt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V  352 (563)
T KOG1024|consen  274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREE-DTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSV  352 (563)
T ss_pred             hhHHhhhhhhhheechhhhhcCchhheeeeeeccc-CCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccce
Confidence            34455666667889999999999999999988764 22334566778877533 33445678899999999999999999


Q ss_pred             eeEEEeC-CeeEEEEEecCCCChhhhhhh------ccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 014736          160 IGYCCED-EERLLVYEFMPRGSLENHLFK------RISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD  232 (419)
Q Consensus       160 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~  232 (419)
                      .+++.++ ...+.++.+..-|+|..++..      .....++..+...++.|++.|++|||  ++|+||.||...|++|+
T Consensus       353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh--~~~ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH--NHGVIHKDIAARNCVID  430 (563)
T ss_pred             eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH--hcCcccchhhhhcceeh
Confidence            9988654 567888999999999999972      22344666677889999999999999  77799999999999999


Q ss_pred             CCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhH
Q 014736          233 SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNL  311 (419)
Q Consensus       233 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~  311 (419)
                      +..++||+|=.+++.+...+.............||+||.+....|+.++|+|||||++|||+| |+.|+....+.+....
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y  510 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY  510 (563)
T ss_pred             hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence            999999999999998877776655444556778999999999999999999999999999999 8999988776554332


Q ss_pred             HHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          312 VDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                      +       .++.++.          -+.++++++..++..||+.+|++||+++++...|...
T Consensus       511 l-------kdGyRla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  511 L-------KDGYRLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             H-------hccceec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            2       2333332          2345789999999999999999999999999988865

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-33  Score=263.19  Aligned_cols=264  Identities=23%  Similarity=0.313  Sum_probs=199.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-----c---ccccceeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-----H---PHLVRLIGY  162 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---pnIv~~~~~  162 (419)
                      .+|.+.++||.|.|++||+|++..      ..+.||+|+++.... -.+..+.||++|++++     |   ..||++++.
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq------~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~  150 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQ------NKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH  150 (590)
T ss_pred             ceEEEEEeccccccceeEEEeecc------CCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence            689999999999999999997544      467899999974422 2345678999998873     3   479999999


Q ss_pred             EEe----CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC----
Q 014736          163 CCE----DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD----  234 (419)
Q Consensus       163 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~----  234 (419)
                      |..    +.+.+||+|++ |.+|..+|.......++...+++|++||+.||.|||. +-||||.||||+|||+..+    
T Consensus       151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~-ecgIIHTDlKPENvLl~~~e~~~  228 (590)
T KOG1290|consen  151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR-ECGIIHTDLKPENVLLCSTEIDP  228 (590)
T ss_pred             ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH-hcCccccCCCcceeeeeccccch
Confidence            965    45899999999 9999999998888899999999999999999999996 5689999999999998100    


Q ss_pred             --------------------------------------------------------------------------------
Q 014736          235 --------------------------------------------------------------------------------  234 (419)
Q Consensus       235 --------------------------------------------------------------------------------  234 (419)
                                                                                                      
T Consensus       229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~  308 (590)
T KOG1290|consen  229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR  308 (590)
T ss_pred             hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 014736          235 --------------------------------------------------------------------------------  234 (419)
Q Consensus       235 --------------------------------------------------------------------------------  234 (419)
                                                                                                      
T Consensus       309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~  388 (590)
T KOG1290|consen  309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE  388 (590)
T ss_pred             CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence                                                                                            


Q ss_pred             --CcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccc---h
Q 014736          235 --FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSE---Q  309 (419)
Q Consensus       235 --~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~  309 (419)
                        -+|||+|||-|..+..     ..+.-+.|..|.|||++.+..|+..+||||++|++|||+||...|+.......   .
T Consensus       389 ~di~vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE  463 (590)
T KOG1290|consen  389 CDIRVKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDE  463 (590)
T ss_pred             cceeEEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence              0134444444443211     12223568889999999999999999999999999999999999976543321   1


Q ss_pred             hHH----H--------------hhhHHhhcccccccccccccCC---------CCCHHHHHHHHHHHHHcccCCCCCCCC
Q 014736          310 NLV----D--------------WAKPYLRSSRRLRYIVDPRLAG---------QYSVKGAKEMAVLALQCISVNPKDRPK  362 (419)
Q Consensus       310 ~~~----~--------------~~~~~~~~~~~~~~~~~~~l~~---------~~~~~~~~~l~~li~~~l~~dP~~RPs  362 (419)
                      +.+    +              +.+.++...+.++.+..-..+.         .++.+...++.+++.-||+.+|++|||
T Consensus       464 DHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t  543 (590)
T KOG1290|consen  464 DHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT  543 (590)
T ss_pred             HHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence            111    1              1123334444444333222221         245677889999999999999999999


Q ss_pred             HHHHHH
Q 014736          363 MAAVVA  368 (419)
Q Consensus       363 ~~eil~  368 (419)
                      +.+.++
T Consensus       544 A~~cl~  549 (590)
T KOG1290|consen  544 AAQCLK  549 (590)
T ss_pred             HHHHhc
Confidence            998875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=237.79  Aligned_cols=198  Identities=29%  Similarity=0.388  Sum_probs=163.5

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcC-CCcccccceeeEEEeCCeeEEEE
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQ-LRHPHLVRLIGYCCEDEERLLVY  173 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~~~~~~lv~  173 (419)
                      +..||+|++|.|-+-      ++..+|...|+|.+...- .+..+++++|+.+..+ ..+|.+|.+||.+..++..++.|
T Consensus        51 i~elGrGayG~vekm------rh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKM------RHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhcCCccchhhhe------eeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            345999999999775      677789999999997542 3345677888887655 47999999999999999999999


Q ss_pred             EecCCCChhhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCC
Q 014736          174 EFMPRGSLENHLFK--RISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG  251 (419)
Q Consensus       174 e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  251 (419)
                      |.| ..+|..+..+  .....+++...-+|+..++.||.|||+ +..+||||+||.||||+.+|+||+||||++..+.+.
T Consensus       125 E~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~-kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  125 ELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS-KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS  202 (282)
T ss_pred             HHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH-HhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence            999 6788766543  224678888889999999999999997 456999999999999999999999999999865443


Q ss_pred             CCceeeecccccccccccccccC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 014736          252 SNTHVTTRVMGTYGYAAPEYIST----GHLTTKSDVYSFGVVLLELLTGRRSMDKLR  304 (419)
Q Consensus       252 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~~pf~~~~  304 (419)
                      --   .+-..|-..|||||.+..    ..|+.++||||||+.++||.+++.||+.+.
T Consensus       203 iA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  203 IA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             hH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            21   222347788999999843    479999999999999999999999998764

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-34  Score=272.58  Aligned_cols=197  Identities=23%  Similarity=0.354  Sum_probs=168.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc--------HHHHHHHHHHHcCCC---cccccce
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--------HREWLAEVIFLGQLR---HPHLVRL  159 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~---hpnIv~~  159 (419)
                      .+|..++.||.|+||.|++|.++.      +...|+||.+.++..-.        .-.+-.|+.||..++   |+||+++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~------n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl  634 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKE------NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL  634 (772)
T ss_pred             ccceeeeeccccccceEEEeeecc------cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence            469999999999999999997554      35789999997653210        011335999999997   9999999


Q ss_pred             eeEEEeCCeeEEEEEec-CCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEE
Q 014736          160 IGYCCEDEERLLVYEFM-PRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAK  238 (419)
Q Consensus       160 ~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~k  238 (419)
                      +++|++++++||+||.. +|-+|+++|..+  ..+++.++..|++|++.|+++||  +.||||||||-+||.++.+|-+|
T Consensus       635 LdfFEddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh--~~~ivhrdikdenvivd~~g~~k  710 (772)
T KOG1152|consen  635 LDFFEDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLH--DQGIVHRDIKDENVIVDSNGFVK  710 (772)
T ss_pred             hheeecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccc--ccCceecccccccEEEecCCeEE
Confidence            99999999999999987 345899999776  67999999999999999999999  78899999999999999999999


Q ss_pred             EeccCccccCCCCCCceeeecccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCC
Q 014736          239 LSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL-TTKSDVYSFGVVLLELLTGRRSMD  301 (419)
Q Consensus       239 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~  301 (419)
                      |+|||.+.....+.    ...++||..|.|||++.+..| +..-|||++|++||-++....||-
T Consensus       711 lidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  711 LIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999998755543    334679999999999988777 577899999999999998888875

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-35  Score=255.05  Aligned_cols=267  Identities=21%  Similarity=0.307  Sum_probs=198.3

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC--CcccHHHHHHHHHHHcCCCcccccceeeEEEeC---
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCED---  166 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---  166 (419)
                      +..-.+.||-|+||.||.++      +...++.||+|++...  +...-+.+.+|+.+|.-++|.|++..+++..-.   
T Consensus        54 Di~PDRPIGYGAFGVVWsVT------DPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d  127 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVT------DPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS  127 (449)
T ss_pred             cCCCCCcccccceeEEEecc------CCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence            44556789999999999985      4455788999988643  333457789999999999999999998876433   


Q ss_pred             --CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCc
Q 014736          167 --EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL  244 (419)
Q Consensus       167 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  244 (419)
                        ..+|+++|++ ..+|...+-..  ..++...++-+.+||+.||+|||  ..||.||||||.|.|++.|..+||||||+
T Consensus       128 fFqEiYV~TELm-QSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLH--sA~ILHRDIKPGNLLVNSNCvLKICDFGL  202 (449)
T KOG0664|consen  128 FFQELYVLTELM-QSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLH--TANILHRDIKPGNLLVNSNCILKICDFGL  202 (449)
T ss_pred             HHHHHHHHHHHH-HhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHh--hcchhhccCCCccEEeccCceEEeccccc
Confidence              2468889998 66888887654  56777888999999999999999  55699999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh--------
Q 014736          245 AKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA--------  315 (419)
Q Consensus       245 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~--------  315 (419)
                      ++.-...... .++..+-|.+|.|||++.+ ..|+.+.||||+|||+.||+..+.-|....+-...+++...        
T Consensus       203 ARvee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~Ea  281 (449)
T KOG0664|consen  203 ARTWDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEA  281 (449)
T ss_pred             ccccchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHH
Confidence            9975444332 3445567999999999976 57999999999999999999999888877665544433211        


Q ss_pred             hHHhhccccccccc----ccccCCCC----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014736          316 KPYLRSSRRLRYIV----DPRLAGQY----SVKGAKEMAVLALQCISVNPKDRPKMAAVVATL  370 (419)
Q Consensus       316 ~~~~~~~~~~~~~~----~~~l~~~~----~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L  370 (419)
                      .....++.+..-+.    .+.+.--|    ......+...++..++..||++|.+..+.+..+
T Consensus       282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            01111111111000    11111111    112345678899999999999999988876543

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=5.6e-34  Score=268.95  Aligned_cols=270  Identities=24%  Similarity=0.232  Sum_probs=207.1

Q ss_pred             HHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC------cccccc
Q 014736           85 ELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR------HPHLVR  158 (419)
Q Consensus        85 ~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv~  158 (419)
                      ..+.+..+|.+....|+|-|++|.+|.      +...+..||||+|..... ..+.=+.|++||++|+      --|+++
T Consensus       426 igE~LD~RY~V~~~~GkGvFs~Vvra~------D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclr  498 (752)
T KOG0670|consen  426 IGELLDSRYEVQGYTGKGVFSTVVRAR------DQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLR  498 (752)
T ss_pred             hhhhhcceeEEEeccccceeeeeeecc------ccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence            346778899999999999999999994      455577999999985432 2344567999999995      348999


Q ss_pred             eeeEEEeCCeeEEEEEecCCCChhhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-Cc
Q 014736          159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRI-SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD-FT  236 (419)
Q Consensus       159 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~-~~  236 (419)
                      ++..|...+++|||+|-+ ..+|.+.|.+.+ +..+....+..++.|++.||..|-  +-||+|.||||.||||++. ..
T Consensus       499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK--~c~vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK--KCGVLHADIKPDNILVNESKNI  575 (752)
T ss_pred             HHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH--hcCeeecccCccceEeccCcce
Confidence            999999999999999998 889999997654 345778899999999999999999  5569999999999999986 46


Q ss_pred             EEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh
Q 014736          237 AKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK  316 (419)
Q Consensus       237 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  316 (419)
                      +||||||.|........    +.+.-+..|.|||++.+..|+...|+||+||+||||.||+..|.+........+..-..
T Consensus       576 LKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K  651 (752)
T KOG0670|consen  576 LKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK  651 (752)
T ss_pred             eeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence            89999999987655542    23345677999999999999999999999999999999999998876655443322111


Q ss_pred             HHh-----hccccccccccccc--------------------------------CCC--CC---HHHHHHHHHHHHHccc
Q 014736          317 PYL-----RSSRRLRYIVDPRL--------------------------------AGQ--YS---VKGAKEMAVLALQCIS  354 (419)
Q Consensus       317 ~~~-----~~~~~~~~~~~~~l--------------------------------~~~--~~---~~~~~~l~~li~~~l~  354 (419)
                      ..+     ..+.....-+|..+                                .+.  ++   ......+.+|+..||.
T Consensus       652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~  731 (752)
T KOG0670|consen  652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI  731 (752)
T ss_pred             CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence            111     11111111111100                                000  11   2346778999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 014736          355 VNPKDRPKMAAVVA  368 (419)
Q Consensus       355 ~dP~~RPs~~eil~  368 (419)
                      .||++|.|..+.|.
T Consensus       732 LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  732 LDPEKRITVNQALK  745 (752)
T ss_pred             cChhhcCCHHHHhc
Confidence            99999999998875

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=8.4e-34  Score=242.84  Aligned_cols=259  Identities=18%  Similarity=0.291  Sum_probs=195.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-cccccceeeEEEeC--
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-HPHLVRLIGYCCED--  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~--  166 (419)
                      .++|++.+++|+|.|+.||.|.      +..++++++||++++..   .+.+.+|+.||..|. ||||++++++..+.  
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~------~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGI------NITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPES  107 (338)
T ss_pred             cchHHHHHHHcCccHhhHhccc------ccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence            4678899999999999999994      45567889999998643   456778999999997 99999999998664  


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-CcEEEeccCcc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD-FTAKLSDFGLA  245 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla  245 (419)
                      ....||+||+.+.+.....     ..++...+..++.+++.||.|||  +.||+|||+||.|++||.. -.++|+|+|+|
T Consensus       108 ktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCH--S~GImHRDVKPhNvmIdh~~rkLrlIDWGLA  180 (338)
T KOG0668|consen  108 KTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCH--SMGIMHRDVKPHNVMIDHELRKLRLIDWGLA  180 (338)
T ss_pred             cCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHH--hcCcccccCCcceeeechhhceeeeeecchH
Confidence            4678999999888776654     35677789999999999999999  6779999999999999975 46999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh--------h
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA--------K  316 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~--------~  316 (419)
                      .+...+....+   .+.+..|--||++-. ..|+.+-|+|||||++..|+..+.||-.......+ ++..+        .
T Consensus       181 EFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ-LVkIakVLGt~el~  256 (338)
T KOG0668|consen  181 EFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVKIAKVLGTDELY  256 (338)
T ss_pred             hhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH-HHHHHHHhChHHHH
Confidence            98877655433   246778999998854 67899999999999999999999998655433322 11111        0


Q ss_pred             HHhh-----ccccccccccc---ccCCCC----C-HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          317 PYLR-----SSRRLRYIVDP---RLAGQY----S-VKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       317 ~~~~-----~~~~~~~~~~~---~l~~~~----~-~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .++.     ....+..++..   ..+..|    + --.++++.+|+.++|..|-++|+|+.|.+.
T Consensus       257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            1110     01111111110   001111    0 113578999999999999999999999876

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=279.76  Aligned_cols=243  Identities=28%  Similarity=0.378  Sum_probs=183.7

Q ss_pred             CCCCCeecccCceE-EEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-CcccccceeeEEEeCCeeE
Q 014736           93 FSSNYLLGEGGFGT-VHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        93 y~~~~~lg~G~fg~-Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~  170 (419)
                      |.-.+++|.|+-|+ ||+|...        ++.||||.+-.+   ......+|+..|+.- +|||||++|+.-.+....|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--------~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~Y  579 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--------GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLY  579 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--------CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEE
Confidence            44445689998875 7888654        478999988533   234556899999887 5999999999888889999


Q ss_pred             EEEEecCCCChhhhhhhccCCCC---CHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---C--CcEEEecc
Q 014736          171 LVYEFMPRGSLENHLFKRISVSL---PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---D--FTAKLSDF  242 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~---~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~---~--~~~kl~Df  242 (419)
                      |+.|.| ..+|.+++... ....   .....+.+..|++.||++||+.+  ||||||||.||||+.   +  ..++|+||
T Consensus       580 IalELC-~~sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDf  655 (903)
T KOG1027|consen  580 IALELC-ACSLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDF  655 (903)
T ss_pred             EEehHh-hhhHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccc
Confidence            999999 67999999764 1111   11345788999999999999654  999999999999976   3  46899999


Q ss_pred             CccccCCCCCCce-eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCccchhHHHhhhHHhh
Q 014736          243 GLAKMGPEGSNTH-VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG-RRSMDKLRPKSEQNLVDWAKPYLR  320 (419)
Q Consensus       243 Gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~  320 (419)
                      |+++....+.... ......||.+|+|||++....-+.++|||||||++|+.++| ..||......+ .+.+       .
T Consensus       656 glsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl-------~  727 (903)
T KOG1027|consen  656 GLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANIL-------T  727 (903)
T ss_pred             ccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhh-------c
Confidence            9999876654432 23456799999999999888888899999999999999996 89997543211 1111       0


Q ss_pred             cccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 014736          321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV  367 (419)
Q Consensus       321 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil  367 (419)
                      ....+..     +    ......++.+||.+|+.++|..||++.+|+
T Consensus       728 ~~~~L~~-----L----~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  728 GNYTLVH-----L----EPLPDCEAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             Cccceee-----e----ccCchHHHHHHHHHhcCCCcccCCCHHHHh
Confidence            1111100     0    000111899999999999999999999997

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.98  E-value=7.3e-33  Score=247.95  Aligned_cols=261  Identities=22%  Similarity=0.284  Sum_probs=195.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC--CcccHHHHHHHHHHHcCCCcccccceeeEEEeCC-
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE-  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-  167 (419)
                      .+|..++.+|.|.- .|..|      -+...++.||+|++...  +....++..+|+.++..++|+||++++.+|.-.. 
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a------~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~   89 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAA------FDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT   89 (369)
T ss_pred             eeeeeecccCCCCc-eEEec------chhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence            57788888999988 66666      34566789999988543  3344567788999999999999999999996543 


Q ss_pred             -----eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEecc
Q 014736          168 -----ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       168 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                           ..|+|||++ ..+|.+.+.    -.++-..+..++.|++.|++|||  ..||+||||||+||++..++.+||.||
T Consensus        90 l~~~~e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lh--s~~IihRdLkPsnivv~~~~~lKi~df  162 (369)
T KOG0665|consen   90 LEEFQEVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLH--SAGIIHRDLKPSNIVVNSDCTLKILDF  162 (369)
T ss_pred             HHHHHhHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHH--hcceeecccCcccceecchhheeeccc
Confidence                 569999999 778988876    24666788899999999999999  678999999999999999999999999


Q ss_pred             CccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHH----------
Q 014736          243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV----------  312 (419)
Q Consensus       243 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~----------  312 (419)
                      |+|+.....   ...+..+.|..|.|||++.+..|...+||||+||++.||++|+.-|.+...-+....+          
T Consensus       163 g~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~  239 (369)
T KOG0665|consen  163 GLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS  239 (369)
T ss_pred             hhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence            999863332   3566778999999999999988999999999999999999999988754322211111          


Q ss_pred             ------HhhhHHhhcccc-----ccccccccc-CC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          313 ------DWAKPYLRSSRR-----LRYIVDPRL-AG--QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       313 ------~~~~~~~~~~~~-----~~~~~~~~l-~~--~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                            .....+..+...     +...+...+ ..  ..+......+++|+.+||..||++|.+++++++
T Consensus       240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                  111111111100     011111000 00  011223456899999999999999999999876

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.5e-32  Score=239.24  Aligned_cols=260  Identities=22%  Similarity=0.328  Sum_probs=193.0

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-CcccccceeeE-EEe
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHLVRLIGY-CCE  165 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~-~~~  165 (419)
                      .+.+.|.+.+.||+|.||.+-+|      ++..++..+++|-+.... ....+|.+|+..--.| .|.||+.-|++ |..
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~------eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt   93 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLA------EHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT   93 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEee------eccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence            45578999999999999999999      456667889999997543 4568899999876666 48999998875 567


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC--CCcEEEeccC
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS--DFTAKLSDFG  243 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG  243 (419)
                      .+.++++|||++.|+|...+...   .+.+.....++.|+++||.|+|  ++++||||||.+||||-.  .-+|||||||
T Consensus        94 ~d~YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMH--sknlVHRdlK~eNiLif~~df~rvKlcDFG  168 (378)
T KOG1345|consen   94 SDAYVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMH--SKNLVHRDLKAENILIFDADFYRVKLCDFG  168 (378)
T ss_pred             CceEEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhh--ccchhhcccccceEEEecCCccEEEeeecc
Confidence            77888999999999998877553   5667788999999999999999  556999999999999943  3479999999


Q ss_pred             ccccCCCCCCceeeecccccccccccccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          244 LAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG-----HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       244 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      +.+.....     ......+..|.+||+....     ..++.+|||.||+|+|.+|||++||......+ .....|..-.
T Consensus       169 ~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~~~~w~  242 (378)
T KOG1345|consen  169 LTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWEWEQWL  242 (378)
T ss_pred             cccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHHHHHHh
Confidence            98853322     1122356779999976432     34678999999999999999999998543322 2222222211


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL  374 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~  374 (419)
                      ......+     |.....    .++.+..+.++-|..++++|--+.++.++-+..+
T Consensus       243 ~rk~~~~-----P~~F~~----fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w  289 (378)
T KOG1345|consen  243 KRKNPAL-----PKKFNP----FSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW  289 (378)
T ss_pred             cccCccC-----chhhcc----cCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence            1111111     122222    3466888999999999999977777766555443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-33  Score=271.40  Aligned_cols=253  Identities=24%  Similarity=0.338  Sum_probs=204.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .++|..+..+|.|+||.||+|      ++..+++..|+|+++.....+..-+..|+-+++..+|||||.+++.+...+.+
T Consensus        14 ~ddyellqrvgsgTygdvyKa------Rd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKA------RDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             ccchhheeeecCCcccchhhh------cccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCc
Confidence            367999999999999999999      56778899999999988777777788899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      +++||||.||+|.+..+-.  +.+++-++..+++..+.|++|||  ..|=+|||||-.|||+++.|.+||.|||.+-...
T Consensus        88 wicMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylh--s~gk~hRdiKGanilltd~gDvklaDfgvsaqit  163 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLH--SQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT  163 (829)
T ss_pred             EEEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhh--cCCcccccccccceeecccCceeecccCchhhhh
Confidence            9999999999999876443  67888888999999999999999  6669999999999999999999999999986533


Q ss_pred             CCCCceeeecccccccccccccc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYI---STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ..  ......+.||++|||||+.   ..+.|+..+|||++|+...|+-.-++|.....+.....        +.....+.
T Consensus       164 at--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~--------LmTkS~~q  233 (829)
T KOG0576|consen  164 AT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF--------LMTKSGFQ  233 (829)
T ss_pred             hh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH--------HhhccCCC
Confidence            22  1123457899999999987   46789999999999999999988888765443322111        11111111


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV  367 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil  367 (419)
                         .+.+.  -...+.+.+.++++.+|.++|++||+++.++
T Consensus       234 ---pp~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  234 ---PPTLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             ---CCccc--CCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence               01111  1224567899999999999999999998765

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1e-30  Score=232.71  Aligned_cols=211  Identities=36%  Similarity=0.551  Sum_probs=181.3

Q ss_pred             ecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-cHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEecC
Q 014736           99 LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMP  177 (419)
Q Consensus        99 lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~  177 (419)
                      ||+|.+|.||++...+      .++.+++|++...... ....+.+|+..++.++|++|+++++++......+++||++.
T Consensus         1 l~~g~~~~v~~~~~~~------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~   74 (215)
T cd00180           1 LGEGGFGTVYLARDKK------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCE   74 (215)
T ss_pred             CCcCCceEEEEEEecC------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCC
Confidence            6899999999996543      4678999999865432 34678899999999999999999999999899999999999


Q ss_pred             CCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCcEEEeccCccccCCCCCCcee
Q 014736          178 RGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS-DFTAKLSDFGLAKMGPEGSNTHV  256 (419)
Q Consensus       178 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~  256 (419)
                      +++|.+++.... ..++...+..++.+++.++.+||  ..|++|+||+|.||+++. ++.++|+|||.+........  .
T Consensus        75 ~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh--~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~  149 (215)
T cd00180          75 GGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLH--SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--L  149 (215)
T ss_pred             CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--h
Confidence            899999986542 35788899999999999999999  668999999999999999 89999999999986544321  1


Q ss_pred             eecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCC
Q 014736          257 TTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAG  335 (419)
Q Consensus       257 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  335 (419)
                      .....+...|++||.+... .++.+.|+|++|+++++|                                          
T Consensus       150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------  187 (215)
T cd00180         150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------  187 (215)
T ss_pred             hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence            2224478889999999777 888999999999999999                                          


Q ss_pred             CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          336 QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       336 ~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                             ..+.+++.+|++.||.+||++.++++.
T Consensus       188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                   248899999999999999999998864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=9e-30  Score=230.03  Aligned_cols=200  Identities=33%  Similarity=0.441  Sum_probs=171.5

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-cHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEE
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLL  171 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  171 (419)
                      |.+.+.||.|++|.||+|...+      .++.+++|.+...... ....+.+|++.++.++|+|++++++++......++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   74 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKG------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYL   74 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcC------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEE
Confidence            5677889999999999996543      3578999999866544 56788899999999999999999999999899999


Q ss_pred             EEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCC
Q 014736          172 VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG  251 (419)
Q Consensus       172 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  251 (419)
                      ++|++.+++|.+++..... .+++..+..++.+++.++.+||  +.+++|+||+|.||+++.++.++|+|||++......
T Consensus        75 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       75 VMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLH--SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             EEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            9999999999999876522 1788899999999999999999  668999999999999999999999999999876544


Q ss_pred             CCceeeecccccccccccccc-cCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 014736          252 SNTHVTTRVMGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGRRSMDK  302 (419)
Q Consensus       252 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~  302 (419)
                      ... ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       152 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      152 LAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            211 12334578889999998 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=2.1e-30  Score=240.38  Aligned_cols=270  Identities=24%  Similarity=0.294  Sum_probs=198.8

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-cccccceeeEEE
Q 014736           86 LRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-HPHLVRLIGYCC  164 (419)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~  164 (419)
                      +..+.+.|..+++||.|.|++||+|++..   .....+.||+|.+......  ..+.+|+++|..+. +.||+++.+++.
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~---~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIE---QDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhh---hccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhc
Confidence            34566789999999999999999997543   1335789999999766443  56889999999984 999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCcEEEeccC
Q 014736          165 EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS-DFTAKLSDFG  243 (419)
Q Consensus       165 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG  243 (419)
                      .++...+||||++.....+++.     .++...+..+++.++.||.++|  .+|||||||||.|+|.+. .+.-.|+|||
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h--~~GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLH--KNGIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhh--ccCccccCCCccccccccccCCceEEech
Confidence            9999999999999998888774     4567889999999999999999  889999999999999986 4678999999


Q ss_pred             ccccCCCCC--------------C----------------------------ceeeecccccccccccccccC-CCCCch
Q 014736          244 LAKMGPEGS--------------N----------------------------THVTTRVMGTYGYAAPEYIST-GHLTTK  280 (419)
Q Consensus       244 la~~~~~~~--------------~----------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~  280 (419)
                      +|.......              .                            ........||++|.|||++.. ..-+.+
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            997210000              0                            000112469999999999865 456889


Q ss_pred             hhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh-----------hHHhhc------c---------cccccc-cccc-
Q 014736          281 SDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA-----------KPYLRS------S---------RRLRYI-VDPR-  332 (419)
Q Consensus       281 ~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~-----------~~~~~~------~---------~~~~~~-~~~~-  332 (419)
                      +||||.|||+..+++++.||-........ +.+.+           ......      .         ..++.. .... 
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~a-l~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~  337 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADA-LAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY  337 (418)
T ss_pred             cceeeccceeehhhccccccccCccccch-HHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence            99999999999999999999765433221 10000           000000      0         000000 0000 


Q ss_pred             -------cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          333 -------LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       333 -------l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                             -........+..+.+|+.+||..||.+|.|+++.|+
T Consensus       338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence                   001111223457899999999999999999999975

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-28  Score=232.82  Aligned_cols=267  Identities=23%  Similarity=0.244  Sum_probs=205.6

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCc----ccccceeeEE-EeC
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRH----PHLVRLIGYC-CED  166 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~~~~~~-~~~  166 (419)
                      +|.+.++||+|+||.||+|......     ...+|+|+...........+..|..++..+..    .++..+++.+ ..+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~-----~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK-----NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC-----CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            7999999999999999999754421     45799998876533333366678888888762    6899999988 577


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-----CcEEEec
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD-----FTAKLSD  241 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~-----~~~kl~D  241 (419)
                      ...|+||+.+ |.+|.++........++..+++.++.|++.+|++||  +.|++||||||+|+++...     ..++|.|
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH--~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH--SKGFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH--hcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            8899999999 999999876665678999999999999999999999  7889999999999999865     3599999


Q ss_pred             cCccccCC--CCCCc----e-e-eecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHH
Q 014736          242 FGLAKMGP--EGSNT----H-V-TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD  313 (419)
Q Consensus       242 fGla~~~~--~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  313 (419)
                      ||+++...  .....    . . ...+.||..|.++..+.+.+.+.+.|+||++.++.+|+.|..||.............
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            99998322  22211    0 0 223569999999999999999999999999999999999999997765433322111


Q ss_pred             hhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCccc
Q 014736          314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDM  379 (419)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~~  379 (419)
                      ......             ....+....+.++.++...+-..+...+|.+..+...|..+....+.
T Consensus       251 ~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~  303 (322)
T KOG1164|consen  251 KDPRKL-------------LTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGS  303 (322)
T ss_pred             HHhhhh-------------ccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCC
Confidence            110000             00002223356788888888889999999999999999888776533

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-28  Score=220.09  Aligned_cols=270  Identities=18%  Similarity=0.233  Sum_probs=213.5

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-cccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-HPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~  169 (419)
                      -+|+++++||+|.||..+.|      .+..+++.||||.-....  ....+..|....+.|. .++|..+|.+...+.+.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G------~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N   99 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLG------KNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN   99 (449)
T ss_pred             ccceeccccccCcceeeecc------cccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence            37999999999999999999      567789999999876443  3356667888888774 79999999988888899


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-----CcEEEeccCc
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD-----FTAKLSDFGL  244 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DfGl  244 (419)
                      .||||++ |.+|.|+. +.....++..++..++.|++.-++|+|  .+.+|+|||||+|+||..-     ..+.|+|||+
T Consensus       100 iLVidLL-GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH--~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm  175 (449)
T KOG1165|consen  100 ILVIDLL-GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVH--EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM  175 (449)
T ss_pred             hhhhhhh-CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHH--hcceeecccCccceeecCCCCCCCceEEEEeccc
Confidence            9999999 99998864 555678999999999999999999999  5559999999999999653     3589999999


Q ss_pred             cccCCCCCCce-----eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHh
Q 014736          245 AKMGPEGSNTH-----VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYL  319 (419)
Q Consensus       245 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  319 (419)
                      |+.+.+.....     ......||..||+-..+.+.+-+.+.|+-|||-++++.|-|.+||.+..........+.+..  
T Consensus       176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe--  253 (449)
T KOG1165|consen  176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE--  253 (449)
T ss_pred             hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc--
Confidence            99876543322     12346799999999999999999999999999999999999999998876553333222110  


Q ss_pred             hcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCcccccc
Q 014736          320 RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMAVS  382 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~~~~~  382 (419)
                        ..+      ...........+.++..-+...-..+-.+-|+++.+...+..++...+....
T Consensus       254 --~Kr------~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~D  308 (449)
T KOG1165|consen  254 --TKR------STPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDD  308 (449)
T ss_pred             --ccc------cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccc
Confidence              000      0001112233567888888888889999999999999999988776555443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=2.6e-29  Score=267.68  Aligned_cols=197  Identities=19%  Similarity=0.205  Sum_probs=139.8

Q ss_pred             cCCCc-ccccceeeEE-------EeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCee
Q 014736          149 GQLRH-PHLVRLIGYC-------CEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVI  220 (419)
Q Consensus       149 ~~l~h-pnIv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~iv  220 (419)
                      +.++| .||++++++|       .....++++|||+ +++|.++|... ...+++..++.++.||+.||.|||  .+||+
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH--~~gIv  102 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAH--SQGIV  102 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            34556 6888888877       2334677889987 77999999653 345899999999999999999999  67899


Q ss_pred             ecCCCCCcEEEcCC-------------------CcEEEeccCccccCCCCCC--------------ceeeeccccccccc
Q 014736          221 YRDFKTSNILLDSD-------------------FTAKLSDFGLAKMGPEGSN--------------THVTTRVMGTYGYA  267 (419)
Q Consensus       221 H~Dlkp~NIll~~~-------------------~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y~  267 (419)
                      ||||||+||||+..                   +.+||+|||+++.......              .......+||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            99999999999654                   4456666666653211000              00011245899999


Q ss_pred             ccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHH
Q 014736          268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAV  347 (419)
Q Consensus       268 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~  347 (419)
                      |||++.+..|+.++|||||||+||||++|.+|+.....    ........          ...+.    .. ....+..+
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~----------~~~~~----~~-~~~~~~~~  243 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHR----------VLPPQ----IL-LNWPKEAS  243 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHh----------hcChh----hh-hcCHHHHH
Confidence            99999999999999999999999999999887653210    00000000          00010    00 11234678


Q ss_pred             HHHHcccCCCCCCCCHHHHHH
Q 014736          348 LALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       348 li~~~l~~dP~~RPs~~eil~  368 (419)
                      ++.+||+.+|.+||++.+|++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhh
Confidence            899999999999999999975

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=3.6e-28  Score=209.84  Aligned_cols=265  Identities=20%  Similarity=0.223  Sum_probs=210.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCc-ccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRH-PHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~  168 (419)
                      ...|.++++||.|+||.+|.|.      ....|+.||||+-...  .....+.-|..+.+.|++ ..|..+..++.+..+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~------~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y   85 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGI------SITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY   85 (341)
T ss_pred             ccceEEEEeecCCchhheeeee------eccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence            4679999999999999999994      5567899999998644  233566778999888875 788889989999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC---CcEEEeccCcc
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD---FTAKLSDFGLA  245 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGla  245 (419)
                      ..+|||++ |.+|.++.. -....++..+++.++-|++.-++|+|  .+++|||||||+|+|..-+   ..+.|+|||+|
T Consensus        86 nvlVMdLL-GPsLEdLfn-fC~R~ftmkTvLMLaDQml~RiEyvH--~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa  161 (341)
T KOG1163|consen   86 NVLVMDLL-GPSLEDLFN-FCSRRFTMKTVLMLADQMLSRIEYVH--LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA  161 (341)
T ss_pred             ceeeeecc-CccHHHHHH-HHhhhhhHHhHHHHHHHHHHHHHHHH--hhccccccCCccceeeccccccceEEEEeccch
Confidence            99999999 999988753 33457889999999999999999999  7789999999999999643   56999999999


Q ss_pred             ccCCCCCCce-----eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhh
Q 014736          246 KMGPEGSNTH-----VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR  320 (419)
Q Consensus       246 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  320 (419)
                      +.+.+.....     ......||..|.+-..+.+.+-+.+.|+-|+|.+|.++.-|..||.+..........+.+...- 
T Consensus       162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK-  240 (341)
T KOG1163|consen  162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK-  240 (341)
T ss_pred             hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh-
Confidence            9765533221     1234679999999988888888999999999999999999999999987766554444332111 


Q ss_pred             cccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       321 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                          +     ....+......+.|+.-.+..|-...-++-|+...+.+.+.-+...
T Consensus       241 ----~-----s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~  287 (341)
T KOG1163|consen  241 ----M-----STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT  287 (341)
T ss_pred             ----c-----CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence                0     0111222334467889999999999999999999988887776553

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=4.8e-27  Score=204.81  Aligned_cols=168  Identities=24%  Similarity=0.225  Sum_probs=126.5

Q ss_pred             CChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCceeee
Q 014736          179 GSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT  258 (419)
Q Consensus       179 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  258 (419)
                      |+|.+++..+ ...+++..++.++.||+.||.|||  +++      ||+|||++.++.+|+  ||++.......      
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH--~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELH--RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH--hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence            6899998754 346999999999999999999999  544      999999999999999  99988644321      


Q ss_pred             cccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCC
Q 014736          259 RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYS  338 (419)
Q Consensus       259 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  338 (419)
                       ..||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ........   .....    .+ ......
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~---~~~~~----~~-~~~~~~  132 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLN---GMPAD----DP-RDRSNL  132 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHH---HhccC----Cc-cccccH
Confidence             258999999999999999999999999999999999999996543211  11111100   00000    00 000112


Q ss_pred             HHHHH--HHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 014736          339 VKGAK--EMAVLALQCISVNPKDRPKMAAVVATLESLL  374 (419)
Q Consensus       339 ~~~~~--~l~~li~~~l~~dP~~RPs~~eil~~L~~l~  374 (419)
                      .....  ++.+++.+||..||.+||++.++++.+..+.
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            22333  6999999999999999999999999887654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.6e-26  Score=221.02  Aligned_cols=171  Identities=20%  Similarity=0.138  Sum_probs=130.4

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-----cccHHHHHHHHHHHcCCCccccccee
Q 014736           86 LRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-----LQGHREWLAEVIFLGQLRHPHLVRLI  160 (419)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~  160 (419)
                      ...+..+|.+.+.||+|+||+||+|+...     .+++.||||++....     ......+.+|+++|++++|+||+..+
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l   87 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAG-----DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQL   87 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcC-----CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence            45567889999999999999999997532     135668999875321     12245688999999999999998643


Q ss_pred             eEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCcEEEcCCCcEEE
Q 014736          161 GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDF-KTSNILLDSDFTAKL  239 (419)
Q Consensus       161 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dl-kp~NIll~~~~~~kl  239 (419)
                      ..   .+..|+||||++|++|... ..     ..   ...++.|++.||.|||  .+||+|||| ||+|||++.++.+||
T Consensus        88 ~~---~~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH--~~gIiHrDL~KP~NILv~~~~~ikL  153 (365)
T PRK09188         88 LA---TGKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLH--RAGITHNDLAKPQNWLMGPDGEAAV  153 (365)
T ss_pred             EE---cCCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHH--HCCCeeCCCCCcceEEEcCCCCEEE
Confidence            22   2568999999999999632 11     11   1467899999999999  678999999 999999999999999


Q ss_pred             eccCccccCCCCCCcee------eecccccccccccccccCC
Q 014736          240 SDFGLAKMGPEGSNTHV------TTRVMGTYGYAAPEYISTG  275 (419)
Q Consensus       240 ~DfGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  275 (419)
                      +|||+++.+........      .....++..|+|||.+...
T Consensus       154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99999987654432111      1345688899999998543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=3e-27  Score=240.20  Aligned_cols=264  Identities=19%  Similarity=0.271  Sum_probs=192.2

Q ss_pred             CCCCeecccCceEEEEEEEcCcccccccccEEEEEEe-ccCCccc-HHHHHHHHHHHcCCCcccccceeeEEEeCCeeEE
Q 014736           94 SSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQG-HREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLL  171 (419)
Q Consensus        94 ~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~-~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  171 (419)
                      ....++|.|.+|.|+.+....... ....+.+.+| . ....... ...+..|+.+-..+.|+|++..+..+.+....+-
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~-~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~  398 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLK-SFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ  398 (601)
T ss_pred             CccceeeecccCceEEEEecCCCc-cchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence            456689999999888775433211 1111222232 1 1111111 1125567888888999999888877777666666


Q ss_pred             EEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCC
Q 014736          172 VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG  251 (419)
Q Consensus       172 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  251 (419)
                      .||||++ +|..++...  ..+...++..++.|++.|++|+|  ..||.|||||++|++++.+|.+||+|||.+..+...
T Consensus       399 ~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h--~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  399 SMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLH--SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHH--hcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            6999999 999988765  46777889999999999999999  777999999999999999999999999999876655


Q ss_pred             CCc--eeeecccccccccccccccCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          252 SNT--HVTTRVMGTYGYAAPEYISTGHLTT-KSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       252 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ...  ......+|+..|+|||++.+..|++ ..||||.|++++.|++|+.||......+.+...       .....-.  
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~-------~~~~~~~--  544 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT-------NNYSDQR--  544 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh-------hcccccc--
Confidence            544  4556788999999999999999986 579999999999999999999877654432100       0000000  


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhh
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA--TLESL  373 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~--~L~~l  373 (419)
                      ....-........+.+.+.++.+||+.||.+|.|+++|++  ++..+
T Consensus       545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence            0000011223445778999999999999999999999986  44444

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=2.7e-24  Score=204.10  Aligned_cols=260  Identities=30%  Similarity=0.401  Sum_probs=196.6

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc---cHHHHHHHHHHHcCCCcc-cccceeeEEEeCCe
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ---GHREWLAEVIFLGQLRHP-HLVRLIGYCCEDEE  168 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~  168 (419)
                      |.+...||.|+||.||++...         ..+++|.+......   ....+.+|+.+++.+.|+ +|+++++.+.....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   72 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS   72 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE
Confidence            667788999999999999643         56899998765433   357788999999999988 79999999977777


Q ss_pred             eEEEEEecCCCChhhhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-cEEEeccCccc
Q 014736          169 RLLVYEFMPRGSLENHLFKRIS-VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-TAKLSDFGLAK  246 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~  246 (419)
                      .+++++++.+++|.+++..... ..+.......++.|++.++.|+|  ..+++|||+||+||+++..+ .++++|||++.
T Consensus        73 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H--~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            8999999999999966654422 26888899999999999999999  67799999999999999998 79999999998


Q ss_pred             cCCCCCCce----eeecccccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCc-cchhHHHhhhHH
Q 014736          247 MGPEGSNTH----VTTRVMGTYGYAAPEYIST---GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPK-SEQNLVDWAKPY  318 (419)
Q Consensus       247 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~  318 (419)
                      .........    ......|+..|++||.+.+   ..++...|+|++|++++++++|..||...... ........... 
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~-  229 (384)
T COG0515         151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE-  229 (384)
T ss_pred             ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh-
Confidence            554443221    2345679999999999987   57889999999999999999999997665431 00111111100 


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                        ....   .................+.+++..++..+|..|.+..+....
T Consensus       230 --~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         230 --LPTP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             --cCCc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence              0000   000000000002223578999999999999999998887764

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.6e-25  Score=195.40  Aligned_cols=249  Identities=23%  Similarity=0.384  Sum_probs=197.0

Q ss_pred             CCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc--HHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEE
Q 014736           95 SNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        95 ~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      +..+|.+...|..|+|+|.+        ..+++|++.......  .++|..|.-.|+-+.||||+.+++.|....++.++
T Consensus       194 l~tkl~e~hsgelwrgrwqg--------ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i  265 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQG--------NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII  265 (448)
T ss_pred             hhhhhccCCCcccccccccC--------cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence            33458888999999998865        347788876544322  35788899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCC
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS  252 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  252 (419)
                      ..|++-|+|+..+.+......+..++.+++..++.|+.|||+.+.-|.---|....|+||++.+.+|. ++-+++..   
T Consensus       266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsf---  341 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF---  341 (448)
T ss_pred             eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeee---
Confidence            99999999999998876666777899999999999999999987766666889999999999887764 22222110   


Q ss_pred             CceeeecccccccccccccccCCCCC---chhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          253 NTHVTTRVMGTYGYAAPEYISTGHLT---TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       253 ~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                         ........+.||+||.++..+-+   .++|+|||++++|||.|...||....+.+..-.+                .
T Consensus       342 ---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki----------------a  402 (448)
T KOG0195|consen  342 ---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI----------------A  402 (448)
T ss_pred             ---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh----------------h
Confidence               11112357889999999776543   4799999999999999999999988765533222                1


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL  374 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~  374 (419)
                      .+.+.-..++..+..+..|+.-|+..||.+||.+..|+-.|+++.
T Consensus       403 leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  403 LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            133444566677889999999999999999999999999988763

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=2e-24  Score=192.50  Aligned_cols=173  Identities=11%  Similarity=0.112  Sum_probs=134.1

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHH---------HHHHHHHHcCCCccccc
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---------WLAEVIFLGQLRHPHLV  157 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~hpnIv  157 (419)
                      ..+..+|+.+++||.|+||.||++..        .+..+|+|++..........         +.+|+..+.++.|++|.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~   98 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT--------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLA   98 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec--------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCC
Confidence            56788999999999999999998632        14569999997543322222         57899999999999999


Q ss_pred             ceeeEEEeC--------CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcE
Q 014736          158 RLIGYCCED--------EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNI  229 (419)
Q Consensus       158 ~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NI  229 (419)
                      .+.+++...        +..+|||||++|.+|.++.      .++.    ....+++.+|..||  ..|++|||+||+||
T Consensus        99 ~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH--~~gi~H~Dikp~Ni  166 (232)
T PRK10359         99 SLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLH--QHGMVSGDPHKGNF  166 (232)
T ss_pred             cceEeeeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHH--HcCCccCCCChHHE
Confidence            999887643        3578999999999998863      1222    34669999999999  78899999999999


Q ss_pred             EEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHH
Q 014736          230 LLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELL  294 (419)
Q Consensus       230 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  294 (419)
                      +++.+| ++|+|||............              .++....|+.++|+|+||+++..+.
T Consensus       167 li~~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        167 IVSKNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEeCCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence            999988 9999999887543221110              0334556778999999999987664

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.90  E-value=3.8e-25  Score=215.32  Aligned_cols=229  Identities=29%  Similarity=0.346  Sum_probs=183.7

Q ss_pred             eecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--cHHHHHHHHHHHcCCC-cccccceeeEEEeCCeeEEEEE
Q 014736           98 LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--GHREWLAEVIFLGQLR-HPHLVRLIGYCCEDEERLLVYE  174 (419)
Q Consensus        98 ~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e  174 (419)
                      .+|+|+||.|+++..-   .....++.+|+|+..+....  .......|..++...+ ||.+|++...|..+...+++++
T Consensus         1 vlg~g~~gkvfLvrk~---~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKA---GGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHh---ccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            3799999999987422   22345678999998754321  1224456788888886 9999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCc
Q 014736          175 FMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT  254 (419)
Q Consensus       175 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  254 (419)
                      +..||.|...+...  ..+.+.....+...++.+++++|  +.+|+|||+|++||+++.+|.+++.|||+++..-.....
T Consensus        78 ~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh--~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLH--KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             hcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcc--hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            99999998877655  45667778888899999999999  788999999999999999999999999999865443321


Q ss_pred             eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccC
Q 014736          255 HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA  334 (419)
Q Consensus       255 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  334 (419)
                            |||..|||||++.  ....++|.||||+++++|++|..||..    +....+                  ....
T Consensus       154 ------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I------------------l~~~  203 (612)
T KOG0603|consen  154 ------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI------------------LKAE  203 (612)
T ss_pred             ------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH------------------hhhc
Confidence                  7999999999997  678899999999999999999999986    111111                  0112


Q ss_pred             CCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014736          335 GQYSVKGAKEMAVLALQCISVNPKDRPKM  363 (419)
Q Consensus       335 ~~~~~~~~~~l~~li~~~l~~dP~~RPs~  363 (419)
                      ..++...+.++.+++.+++..+|.+|.-.
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            24566678889999999999999999655

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=2.7e-23  Score=182.93  Aligned_cols=139  Identities=15%  Similarity=0.101  Sum_probs=106.6

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--c-------H-----------------HHHHHHHHHHc
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--G-------H-----------------REWLAEVIFLG  149 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~  149 (419)
                      ...||+|+||.||+|...       +|+.||+|+++.....  .       .                 .....|+.++.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   74 (190)
T cd05147           2 NGCISTGKEANVYHATTA-------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLK   74 (190)
T ss_pred             CCccccccceEEEEEECC-------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHH
Confidence            457999999999999532       4789999999754211  1       0                 11234999999


Q ss_pred             CCCcccccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCeeecCCCCCc
Q 014736          150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL-HGAENPVIYRDFKTSN  228 (419)
Q Consensus       150 ~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~l-H~~~~~ivH~Dlkp~N  228 (419)
                      .+.++++.....+..  ...+|||||+.|++|...+...  ..++...+..++.|++.+|.|+ |  ..||+||||||+|
T Consensus        75 ~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~N  148 (190)
T cd05147          75 RLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYN  148 (190)
T ss_pred             HHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHH
Confidence            998887755443322  2338999999887776543332  4688889999999999999999 7  5679999999999


Q ss_pred             EEEcCCCcEEEeccCccccC
Q 014736          229 ILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       229 Ill~~~~~~kl~DfGla~~~  248 (419)
                      ||++ ++.++|+|||+|...
T Consensus       149 Ili~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         149 LLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             EEEE-CCcEEEEEccccccC
Confidence            9998 478999999999854

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=1.5e-22  Score=185.84  Aligned_cols=232  Identities=20%  Similarity=0.272  Sum_probs=147.9

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCC----------cccccce
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLR----------HPHLVRL  159 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~----------hpnIv~~  159 (419)
                      +.....||.|+|+.||.+++      ..+++.+|+|++.....   ...+.+.+|.-....+.          |-.++..
T Consensus        14 l~~~~~i~~g~~~~v~~v~d------~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P   87 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTD------VETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP   87 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEE------TTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred             EEEccccccCCceEEEEEEE------ccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence            44566899999999999964      44578999999864432   23456666665444432          2233333


Q ss_pred             eeEEEe---------CC--------eeEEEEEecCCCChhhhhh---hccCC--CCCHHHHHHHHHHHHHHHHHhhcCCC
Q 014736          160 IGYCCE---------DE--------ERLLVYEFMPRGSLENHLF---KRISV--SLPWGTRLKIAIGAAKGLAFLHGAEN  217 (419)
Q Consensus       160 ~~~~~~---------~~--------~~~lv~e~~~~g~L~~~l~---~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~~  217 (419)
                      ++...-         ..        +.+++|+-+ .++|.+++.   .....  .+....++.+..|++..+++||  ..
T Consensus        88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh--~~  164 (288)
T PF14531_consen   88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH--SY  164 (288)
T ss_dssp             SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH--HT
T ss_pred             eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh--hc
Confidence            333321         11        236788887 668877653   22211  2333455677799999999999  67


Q ss_pred             CeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccC--------CCCCchhhHHHHHHH
Q 014736          218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST--------GHLTTKSDVYSFGVV  289 (419)
Q Consensus       218 ~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~i  289 (419)
                      |+||+||||+|+|++.+|.++|+||+........    ... ...+..|.+||....        ..++.+.|.|+||++
T Consensus       165 GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~  239 (288)
T PF14531_consen  165 GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT  239 (288)
T ss_dssp             TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred             ceEecccceeeEEEcCCCCEEEcChHHHeecCce----eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence            7999999999999999999999999887753321    111 335678999997743        257889999999999


Q ss_pred             HHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 014736          290 LLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDR  360 (419)
Q Consensus       290 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~R  360 (419)
                      +|.|.||..||+...+......                     ....+. +.++.+.+||..+|+.||.+|
T Consensus       240 ly~lWC~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  240 LYSLWCGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999999986543221110                     122334 778999999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=3.6e-22  Score=174.38  Aligned_cols=186  Identities=19%  Similarity=0.124  Sum_probs=138.4

Q ss_pred             CCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc----HHHHHHHHHHHcCCC-cccccceeeEEEeCCe
Q 014736           94 SSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG----HREWLAEVIFLGQLR-HPHLVRLIGYCCEDEE  168 (419)
Q Consensus        94 ~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~  168 (419)
                      .+...|++|+||+||.+..        .+.+++.+.+.......    ...+.+|+++|++|+ |++|++++++    +.
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~   72 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DG   72 (218)
T ss_pred             ccceeecCCCcceEEEeec--------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cC
Confidence            3456799999999998742        34678877776443311    225788999999995 5889999886    35


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCcEEEcCCCcEEEeccCcccc
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDF-KTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfGla~~  247 (419)
                      .+++|||+.|.+|...+..         ....++.|++.+|.++|  .+||+|||| ||+|||++.++.++|+|||++..
T Consensus        73 ~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH--~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~  141 (218)
T PRK12274         73 RHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLH--RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVR  141 (218)
T ss_pred             EEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHH--HCcCccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence            6999999999998654321         12357889999999999  778999999 79999999999999999999986


Q ss_pred             CCCCCCc-------ee----eecccccccccccccccCC-CCC-chhhHHHHHHHHHHHHcCCCCCCC
Q 014736          248 GPEGSNT-------HV----TTRVMGTYGYAAPEYISTG-HLT-TKSDVYSFGVVLLELLTGRRSMDK  302 (419)
Q Consensus       248 ~~~~~~~-------~~----~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~il~elltg~~pf~~  302 (419)
                      .......       ..    .....+++.|++|+...-. ..+ .+.++++.|.-+|.++|+..++..
T Consensus       142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            5543321       00    1112367888888754322 233 578999999999999999887654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=4.5e-22  Score=175.61  Aligned_cols=140  Identities=18%  Similarity=0.093  Sum_probs=108.4

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--c------------------------HHHHHHHHHHHc
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--G------------------------HREWLAEVIFLG  149 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~  149 (419)
                      ...||+|+||.||+|...       +|+.||||+++.....  .                        ...+.+|+..+.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   74 (190)
T cd05145           2 NGCISTGKEANVYHARTG-------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLK   74 (190)
T ss_pred             CceeecCCCcEEEEEEcC-------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHH
Confidence            467999999999999532       5789999999754211  0                        112357899999


Q ss_pred             CCCcccccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeecCCCCCc
Q 014736          150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE-NPVIYRDFKTSN  228 (419)
Q Consensus       150 ~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivH~Dlkp~N  228 (419)
                      ++.|++|.....+...  ..||||||++|+++.......  ..++......++.|++.++.++|  . +||+||||||+|
T Consensus        75 ~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH--~~~givHrDlkP~N  148 (190)
T cd05145          75 RLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY--QEAGLVHGDLSEYN  148 (190)
T ss_pred             HHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH--HhCCEecCCCChhh
Confidence            9999988655544433  348999999887554432222  35677888999999999999999  5 789999999999


Q ss_pred             EEEcCCCcEEEeccCccccCC
Q 014736          229 ILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       229 Ill~~~~~~kl~DfGla~~~~  249 (419)
                      ||++ ++.++|+|||++....
T Consensus       149 Ill~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         149 ILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             EEEE-CCCEEEEEcccceecC
Confidence            9999 8899999999998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=4.1e-22  Score=183.79  Aligned_cols=198  Identities=20%  Similarity=0.253  Sum_probs=140.0

Q ss_pred             CcccccceeeEEEeC---------------------------CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHH
Q 014736          152 RHPHLVRLIGYCCED---------------------------EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIG  204 (419)
Q Consensus       152 ~hpnIv~~~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~q  204 (419)
                      +|||||+++++|.++                           ..+|+||.-+ .-+|.+++..+   ..+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHH
Confidence            599999999988542                           3469999888 56899998765   4455567788999


Q ss_pred             HHHHHHHhhcCCCCeeecCCCCCcEEEcC--CC--cEEEeccCccccCCCC----CCceeeecccccccccccccccCCC
Q 014736          205 AAKGLAFLHGAENPVIYRDFKTSNILLDS--DF--TAKLSDFGLAKMGPEG----SNTHVTTRVMGTYGYAAPEYISTGH  276 (419)
Q Consensus       205 i~~al~~lH~~~~~ivH~Dlkp~NIll~~--~~--~~kl~DfGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~  276 (419)
                      +++|+.|||  ++||.|||+|.+||||.-  ++  .++|+|||.+--....    ....-.-...|....||||+....+
T Consensus       350 lLEav~hL~--~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  350 LLEAVTHLH--KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHH--HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            999999999  788999999999999943  33  4789999987532110    0111112245888899999985321


Q ss_pred             -----C-CchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHH
Q 014736          277 -----L-TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLAL  350 (419)
Q Consensus       277 -----~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~  350 (419)
                           . -.++|.|+.|.+.||+++...||-..... ..+..           ..++.-.+    ..+..++..+++|+.
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r-----------~Yqe~qLP----alp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTR-----------TYQESQLP----ALPSRVPPVARQLVF  491 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechh-----------hhhhhhCC----CCcccCChHHHHHHH
Confidence                 1 24899999999999999999999762211 11111           01111112    334556678999999


Q ss_pred             HcccCCCCCCCCHHHHHHHHH
Q 014736          351 QCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       351 ~~l~~dP~~RPs~~eil~~L~  371 (419)
                      .+|+.||.+|++..-....|.
T Consensus       492 ~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHhcCCccccCCccHHHhHHH
Confidence            999999999999775554443

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=6e-21  Score=169.64  Aligned_cols=137  Identities=20%  Similarity=0.193  Sum_probs=105.2

Q ss_pred             CCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-----CcccccceeeEEEeCC-
Q 014736           94 SSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-----RHPHLVRLIGYCCEDE-  167 (419)
Q Consensus        94 ~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~-  167 (419)
                      .-..+||+|+||.||.  ...      .+. .+||++........+.+.+|+.+++.+     +||||++++++++++. 
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~------~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g   75 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPE------DAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG   75 (210)
T ss_pred             CCcceecCCCceEEEE--CCC------CcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence            3456799999999995  222      223 369988765444567789999999999     5799999999998874 


Q ss_pred             --eeE-EEEEe--cCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCeeecCCCCCcEEEcCC----CcE
Q 014736          168 --ERL-LVYEF--MPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL-AFLHGAENPVIYRDFKTSNILLDSD----FTA  237 (419)
Q Consensus       168 --~~~-lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al-~~lH~~~~~ivH~Dlkp~NIll~~~----~~~  237 (419)
                        ..+ +||||  +.+++|.+++.+.   .+++.  ..++.|++.++ +|||  +++|+||||||+|||++.+    +.+
T Consensus        76 ~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh--~~~IvhrDlKp~NILl~~~~~~~~~~  148 (210)
T PRK10345         76 TGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLL--DNRIVTMELKPQNILCQRISESEVIP  148 (210)
T ss_pred             CeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEeccCCCCCcE
Confidence              434 78999  5579999999653   35444  35677888777 9999  6779999999999999743    479


Q ss_pred             EEeccCccc
Q 014736          238 KLSDFGLAK  246 (419)
Q Consensus       238 kl~DfGla~  246 (419)
                      +|+||+.+.
T Consensus       149 ~LiDg~G~~  157 (210)
T PRK10345        149 VVCDNIGES  157 (210)
T ss_pred             EEEECCCCc
Confidence            999954443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=5.2e-21  Score=198.77  Aligned_cols=252  Identities=16%  Similarity=0.162  Sum_probs=179.1

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC---cccccceeeEE
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR---HPHLVRLIGYC  163 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~  163 (419)
                      +.-.+.|.+.+.||+|+||.||+|...+       ++.||+|+-.+......--   =.+++.+|+   -+.|..+...+
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-------~~~~alK~e~P~~~WEfYI---~~q~~~RLk~~~~~~~~~~~~a~  763 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSN-------GKLVALKVEKPPNPWEFYI---CLQVMERLKPQMLPSIMHISSAH  763 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCC-------CcEEEEEeecCCCceeeee---hHHHHHhhchhhhcchHHHHHHH
Confidence            3344578888899999999999996332       7899999998765432111   112222332   34566666666


Q ss_pred             EeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-------CCc
Q 014736          164 CEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS-------DFT  236 (419)
Q Consensus       164 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-------~~~  236 (419)
                      .-.+..+||+||.+.|+|.+++.  ..+.+++..+..++.|++..++.||  ..+|||+||||+|+||..       +.-
T Consensus       764 ~~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH--~~~IIHgDiKPDNfll~~~~~~~~~~~~  839 (974)
T KOG1166|consen  764 VFQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLH--AMGIIHGDIKPDNFLLRREICADSDSKG  839 (974)
T ss_pred             ccCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHH--hcceecccCCcceeEeecccCCCCcccc
Confidence            66778899999999999999997  4478999999999999999999999  566999999999999943       345


Q ss_pred             EEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh
Q 014736          237 AKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK  316 (419)
Q Consensus       237 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  316 (419)
                      ++|+|||.+.....-.........++|-.+--+|...+..++..+|.|.|+.+++.||.|+..=                
T Consensus       840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q----------------  903 (974)
T KOG1166|consen  840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME----------------  903 (974)
T ss_pred             eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH----------------
Confidence            9999999987543333333344567899999999999999999999999999999999986321                


Q ss_pred             HHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          317 PYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                        ..++...  .++..+...+..   +-...++..+|..|-..=|...++...|+.++.
T Consensus       904 --~~~g~~~--~~~~~~~Ry~~~---~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~  955 (974)
T KOG1166|consen  904 --VKNGSSW--MVKTNFPRYWKR---DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA  955 (974)
T ss_pred             --hcCCcce--eccccchhhhhH---HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence              0000000  011111111111   124456666666555555888888888887765

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.85  E-value=4.8e-22  Score=203.11  Aligned_cols=249  Identities=23%  Similarity=0.252  Sum_probs=174.0

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-c---ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-L---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      +|...+.||.+.|=+|.+|+..+       | .|+||++-+.. .   ....+.+.|++ ...++|||.+.+.-+...+.
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-------G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~k   94 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-------G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDK   94 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-------c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhH
Confidence            56667789999999999996443       2 38899985443 2   22334444555 55668999999988877778


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|||=+|+ .-+|+|.+..+  .-+...+.+.|+.|++.||.-+|  +.||+|||||.+||||+.=+=+.|+||..-+.
T Consensus        95 AAylvRqyv-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH--~~gVcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen   95 AAYLVRQYV-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCH--KLGVCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHH-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHH--HcCccccccccceEEEeeechhhhhcccccCC
Confidence            888888888 55888887554  33556677899999999999999  78899999999999999988899999976543


Q ss_pred             C--CCCCCceee---ecccccccccccccccC----------CC-CCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchh
Q 014736          248 G--PEGSNTHVT---TRVMGTYGYAAPEYIST----------GH-LTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQN  310 (419)
Q Consensus       248 ~--~~~~~~~~~---~~~~gt~~y~aPE~~~~----------~~-~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~  310 (419)
                      .  .+.+.....   .+...-.+|+|||.+..          .. .+++-||||+||+++||++ |+++|.-..      
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------  243 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------  243 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------
Confidence            2  222211111   11123346999998743          12 6788999999999999988 688886321      


Q ss_pred             HHHhhhH-HhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHh
Q 014736          311 LVDWAKP-YLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES  372 (419)
Q Consensus       311 ~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~  372 (419)
                      +..+-.. ......-++.+-            ...++.|+..|++.||.+|.++++.++.-..
T Consensus       244 L~aYr~~~~~~~e~~Le~Ie------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  244 LLAYRSGNADDPEQLLEKIE------------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             HHhHhccCccCHHHHHHhCc------------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            1110000 000000011111            1258899999999999999999999977443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.84  E-value=1.1e-21  Score=200.15  Aligned_cols=210  Identities=27%  Similarity=0.321  Sum_probs=146.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ..+|..++.|-.|+||.||.+      +++.+.+.+|+| +++...     +.+-  +|.....|.+|            
T Consensus        82 e~df~~IklisngAygavylv------rh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLV------RHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeee------eccccccchhhc-ccccch-----hhhc--cccccCCccee------------
Confidence            357889999999999999998      455567789994 332211     1111  23333344333            


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                               |+-...+..-  +.++...        +.+++|||  ..||+|||+||+|.+|+.-|++|++|||+++...
T Consensus       136 ---------gDc~tllk~~--g~lPvdm--------vla~Eylh--~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  136 ---------GDCATLLKNI--GPLPVDM--------VLAVEYLH--SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             ---------chhhhhcccC--CCCcchh--------hHHhHhhc--cCCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence                     3333333322  3333222        78899999  7789999999999999999999999999987532


Q ss_pred             CCCCc-------------eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh
Q 014736          250 EGSNT-------------HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK  316 (419)
Q Consensus       250 ~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  316 (419)
                      .....             ......+||+.|+|||++..+.|+..+|+|++|+|+||.+-|+.||.+..+++....+....
T Consensus       195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~  274 (1205)
T KOG0606|consen  195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD  274 (1205)
T ss_pred             hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence            11110             01123589999999999999999999999999999999999999999876655433321110


Q ss_pred             HHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 014736          317 PYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP  361 (419)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP  361 (419)
                      -.+              .+. ....+.|+++++.++|+.+|..|-
T Consensus       275 i~w--------------pE~-dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  275 IEW--------------PEE-DEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             ccc--------------ccc-CcCCCHHHHHHHHHHHHhChHhhc
Confidence            000              011 233457899999999999999994

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.83  E-value=1e-21  Score=187.99  Aligned_cols=172  Identities=26%  Similarity=0.379  Sum_probs=128.6

Q ss_pred             eeEEEEEecCCCChhhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKR-ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      ++||.|++|...+|.+||..+ .....++...+.++.|++.|++|     ++.+|+|+||.||++..+..+||+|||+..
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhhee
Confidence            578999999999999999744 33456778889999999999999     569999999999999999999999999998


Q ss_pred             cCCCCC----CceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhc
Q 014736          247 MGPEGS----NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRS  321 (419)
Q Consensus       247 ~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  321 (419)
                      ......    .....+...||..||+||++.+..|+.++||||||+||+||+. -...|....                 
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~-----------------  467 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA-----------------  467 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH-----------------
Confidence            765544    1112455679999999999999999999999999999999997 222221110                 


Q ss_pred             ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 014736          322 SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMA  364 (419)
Q Consensus       322 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~  364 (419)
                        .+..+.+..+...+-.+ -++-..|+.+++.+.|.+||++.
T Consensus       468 --t~~d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  468 --TLTDIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             --hhhhhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHH
Confidence              00011111111001011 12457899999999999999443

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=3.3e-20  Score=168.81  Aligned_cols=143  Identities=17%  Similarity=0.065  Sum_probs=109.1

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc------------------------cHHHHHHHHHH
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ------------------------GHREWLAEVIF  147 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~  147 (419)
                      -|.+.+.||+|+||.||+|..     +..+++.||+|++......                        ....+.+|+.+
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~-----~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  103 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALD-----FDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN  103 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEe-----cCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence            488899999999999999951     2335789999998754210                        01235679999


Q ss_pred             HcCCCccc--ccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-eeecCC
Q 014736          148 LGQLRHPH--LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP-VIYRDF  224 (419)
Q Consensus       148 l~~l~hpn--Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~-ivH~Dl  224 (419)
                      +.++.+.+  +.++++   . ...++||||+.|.+|...+...  .......+..++.||+.+|.+||  ..| |+||||
T Consensus       104 L~~L~~~~i~~p~~~~---~-~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH--~~g~iiH~Di  175 (237)
T smart00090      104 LQRLYEAGVPVPKPIA---W-RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLY--KEGELVHGDL  175 (237)
T ss_pred             HHHHHhcCCCCCeeeE---e-cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHH--hcCCEEeCCC
Confidence            99997533  334443   2 2358999999988887654332  34555567899999999999999  788 999999


Q ss_pred             CCCcEEEcCCCcEEEeccCccccC
Q 014736          225 KTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       225 kp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      ||+||+++ ++.++|+|||.+...
T Consensus       176 kp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      176 SEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             ChhhEEEE-CCCEEEEEChhhhcc
Confidence            99999999 889999999998853

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=3.2e-20  Score=180.95  Aligned_cols=219  Identities=26%  Similarity=0.409  Sum_probs=163.9

Q ss_pred             HcCCCcccccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 014736          148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTS  227 (419)
Q Consensus       148 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~  227 (419)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+... ...+++.....+++.|+.||.|||...- ..|+.|+..
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeeccc
Confidence            46789999999999999999999999999999999999763 4678888889999999999999996442 399999999


Q ss_pred             cEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCC-------CCCchhhHHHHHHHHHHHHcCCCCC
Q 014736          228 NILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG-------HLTTKSDVYSFGVVLLELLTGRRSM  300 (419)
Q Consensus       228 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~elltg~~pf  300 (419)
                      |++++....+||+|||+.................-..-|.|||.+...       ..+.+.||||||++++|+++.+.||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            999999999999999998875431111111112234569999998653       1467799999999999999999999


Q ss_pred             CCCCCccc-hhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          301 DKLRPKSE-QNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       301 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                      +....... ...+....    ..  -...+-+.+...  .+..+++..++..||..+|.+||++++|-..++.+...
T Consensus       159 ~~~~~~~~~~eii~~~~----~~--~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVK----KG--GSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             ccccccCChHHHHHHHH----hc--CCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            87543332 22222211    10  011111111111  13445799999999999999999999999888876553

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=3.4e-19  Score=160.02  Aligned_cols=134  Identities=19%  Similarity=0.239  Sum_probs=111.5

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--------cHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--------GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      +.||+|++|.||+|.+        .+..+++|+.......        ....+.+|+.++..+.|++|.....++.+.+.
T Consensus         2 ~~l~~G~~~~vy~~~~--------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~   73 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN   73 (211)
T ss_pred             cccccCceEEEEEEee--------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC
Confidence            5799999999999964        2456999986543211        12357789999999999999888878777888


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      .+++|||++|++|.+++...     .. ....++.+++.+|.++|  ..|++|+|++|.|||++ ++.++|+|||++..
T Consensus        74 ~~lv~e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH--~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         74 FIIVMEYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLH--SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CEEEEEEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHH--hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999999999988543     11 77899999999999999  67799999999999999 78899999999874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=3.9e-19  Score=158.12  Aligned_cols=130  Identities=19%  Similarity=0.248  Sum_probs=105.3

Q ss_pred             eecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--------cHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           98 LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--------GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        98 ~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .||+|+||.||+|.+        .+..+++|+.......        ....+.+|++++..++|+++....-++...+..
T Consensus         1 ~ig~G~~~~vy~~~~--------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~   72 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNK   72 (199)
T ss_pred             CCCCCceEEEEEeec--------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCC
Confidence            489999999999963        2467999986532211        124567899999999988776666666677778


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ++||||++|++|.+++....         ..++.+++.+|.+||  ..|++|+|++|+||+++ ++.++++|||++..
T Consensus        73 ~lv~e~~~g~~l~~~~~~~~---------~~~~~~i~~~l~~lH--~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        73 TIVMEYIEGKPLKDVIEEGN---------DELLREIGRLVGKLH--KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEEECCccHHHHHhhcH---------HHHHHHHHHHHHHHH--HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999999999998875431         178999999999999  67899999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=5.8e-19  Score=180.05  Aligned_cols=137  Identities=23%  Similarity=0.265  Sum_probs=110.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC--Cc------ccHHHHHHHHHHHcCCCcccccceee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GL------QGHREWLAEVIFLGQLRHPHLVRLIG  161 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~------~~~~~~~~E~~~l~~l~hpnIv~~~~  161 (419)
                      ...|...++||+|+||.||+|.+.+        ..+++|+....  ..      ...+.+.+|++++..++|++|+....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~  403 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLG--------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI  403 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecC--------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence            4456778899999999999987543        22344432111  11      11346788999999999999998887


Q ss_pred             EEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          162 YCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       162 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                      ++.+....++||||++|++|.+++.          ....++.+++.+|.|||  +.|++||||||+|||+ .++.++|+|
T Consensus       404 ~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH--~~giiHrDlkp~NILl-~~~~~~liD  470 (535)
T PRK09605        404 YDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLH--KAGIVHGDLTTSNFIV-RDDRLYLID  470 (535)
T ss_pred             EEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH--hCCCccCCCChHHEEE-ECCcEEEEe
Confidence            7777778899999999999998874          34678999999999999  7789999999999999 677999999


Q ss_pred             cCcccc
Q 014736          242 FGLAKM  247 (419)
Q Consensus       242 fGla~~  247 (419)
                      ||+++.
T Consensus       471 FGla~~  476 (535)
T PRK09605        471 FGLGKY  476 (535)
T ss_pred             Cccccc
Confidence            999985

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=2.7e-18  Score=152.64  Aligned_cols=138  Identities=16%  Similarity=0.069  Sum_probs=106.8

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc----------------------cHHHHHHHHHHHc
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ----------------------GHREWLAEVIFLG  149 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~  149 (419)
                      .|.+.+.||+|+||.||+|...       +++.||||++......                      ....+..|+.++.
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            4888899999999999999542       4688999987643210                      0112567888888


Q ss_pred             CCCccc--ccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 014736          150 QLRHPH--LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTS  227 (419)
Q Consensus       150 ~l~hpn--Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~  227 (419)
                      .+.|++  ++.+++    ....++||||++|++|......        .....++.+++.++.++|  ..||+|+||||+
T Consensus        89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh--~~gi~H~Dl~p~  154 (198)
T cd05144          89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY--KHGIIHGDLSEF  154 (198)
T ss_pred             HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH--HCCCCcCCCCcc
Confidence            888774  444443    3456899999999998765321        245678899999999999  678999999999


Q ss_pred             cEEEcCCCcEEEeccCccccCCC
Q 014736          228 NILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       228 NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      ||+++.++.++|+|||++.....
T Consensus       155 Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         155 NILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cEEEcCCCcEEEEECCccccCCC
Confidence            99999999999999999975443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=1.7e-19  Score=183.68  Aligned_cols=258  Identities=24%  Similarity=0.276  Sum_probs=192.6

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCC-cccccceeeEEEeCCe
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLR-HPHLVRLIGYCCEDEE  168 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~  168 (419)
                      .|.+.+.||+|+|+.|-++....     .....+|+|.+....  .........|..+-..+. |.|++.+++...+.+.
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~-----~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~   95 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSR-----DPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS   95 (601)
T ss_pred             cccccccccccccchhhhhhhcC-----CCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcc
Confidence            46667779999999998874322     234567777776543  112233344777767776 9999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-cEEEeccCcccc
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-TAKLSDFGLAKM  247 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~  247 (419)
                      .+++++|..|+++.+.+........+...+..++.|+..++.|+|. ..++.|+||||+|.+++..+ .+++.|||+|..
T Consensus        96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~-~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP-ENGVTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc-ccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence            9999999999999988842222245566778899999999999995 56799999999999999999 999999999998


Q ss_pred             CCC-CCCceeeecccc-cccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          248 GPE-GSNTHVTTRVMG-TYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       248 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      +.. ..........+| ++.|+|||...+. ...+..|+||+|+++..+++|..||+........ ...|..    ....
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~----~~~~  249 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKS----NKGR  249 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecc----cccc
Confidence            777 444444555678 9999999999874 5578899999999999999999999876544311 111110    0000


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                              ..-...........+++.+++..+|..|.+.+++..
T Consensus       250 --------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  250 --------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             --------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence                    001112233466889999999999999999888754

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=5.6e-17  Score=142.72  Aligned_cols=138  Identities=20%  Similarity=0.159  Sum_probs=95.2

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--cHHHH----------------------HHHHHHHcCC
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--GHREW----------------------LAEVIFLGQL  151 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l  151 (419)
                      .+.||+|+||+||+|...       +++.||||++......  ....+                      ..|...+..+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l   74 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRL   74 (187)
T ss_pred             CcccccccceeEEEEECC-------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHH
Confidence            567999999999999633       4678999998753221  11111                      2455555555


Q ss_pred             Cccc--ccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcE
Q 014736          152 RHPH--LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNI  229 (419)
Q Consensus       152 ~hpn--Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NI  229 (419)
                      .+..  +.+++++    ...++||||++++.+.........  .. .....++.+++.++.++|. +.||+|+||||+||
T Consensus        75 ~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~-~~~ivH~Dl~p~Ni  146 (187)
T cd05119          75 YEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR-EAGLVHGDLSEYNI  146 (187)
T ss_pred             HHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh-ccCcCcCCCChhhE
Confidence            4332  3444432    346899999998544321111100  11 5678899999999999993 17899999999999


Q ss_pred             EEcCCCcEEEeccCccccCC
Q 014736          230 LLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       230 ll~~~~~~kl~DfGla~~~~  249 (419)
                      +++ ++.++|+|||.+....
T Consensus       147 li~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         147 LVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             EEE-CCcEEEEECccccccc
Confidence            999 8899999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=1.1e-16  Score=135.04  Aligned_cols=134  Identities=22%  Similarity=0.137  Sum_probs=111.4

Q ss_pred             CCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCc--ccccceeeEEEeCCeeEEE
Q 014736           95 SNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRH--PHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        95 ~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~lv  172 (419)
                      +.+.||+|.++.||++...+        ..+++|.......  ...+.+|+.++..++|  .++++++.++...+..+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--------~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v   71 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--------EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLL   71 (155)
T ss_pred             cceecccccccceEEEEecC--------CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEE
Confidence            45679999999999996432        5699999865433  4578889999999976  5899999988887889999


Q ss_pred             EEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE-NPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       173 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      |||+.++.+..+         +......++.+++.++.++|... .+++|+||+|+||+++..+.++++|||.+..
T Consensus        72 ~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          72 MEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            999988877553         44566788999999999999532 5799999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=1.3e-16  Score=145.52  Aligned_cols=135  Identities=23%  Similarity=0.177  Sum_probs=102.4

Q ss_pred             CCeec-ccCceEEEEEEEcCcccccccccEEEEEEeccCCc-------------ccHHHHHHHHHHHcCCCcccc--cce
Q 014736           96 NYLLG-EGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-------------QGHREWLAEVIFLGQLRHPHL--VRL  159 (419)
Q Consensus        96 ~~~lg-~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpnI--v~~  159 (419)
                      ...|| .||.|+||.++..        +..++||.+...+.             .....+.+|++++..|+|++|  +.+
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~p  107 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRP  107 (239)
T ss_pred             CceeecCCCCccEEEEEeC--------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCcee
Confidence            34687 8888999988543        46788888753211             123457889999999998875  667


Q ss_pred             eeEEEeCC----eeEEEEEecCC-CChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 014736          160 IGYCCEDE----ERLLVYEFMPR-GSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD  234 (419)
Q Consensus       160 ~~~~~~~~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~  234 (419)
                      +++.....    ..++|||+++| .+|.+++...   .++..    .+.+|+.+|.+||  .+||+|+||||+|||++.+
T Consensus       108 l~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH--~~GI~HrDlkp~NILv~~~  178 (239)
T PRK01723        108 IAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFH--DAGVYHADLNAHNILLDPD  178 (239)
T ss_pred             EeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHH--HCCCCCCCCCchhEEEcCC
Confidence            76644322    23599999997 6888887542   34433    3678999999999  7889999999999999999


Q ss_pred             CcEEEeccCcccc
Q 014736          235 FTAKLSDFGLAKM  247 (419)
Q Consensus       235 ~~~kl~DfGla~~  247 (419)
                      +.++|+|||.+..
T Consensus       179 ~~v~LIDfg~~~~  191 (239)
T PRK01723        179 GKFWLIDFDRGEL  191 (239)
T ss_pred             CCEEEEECCCccc
Confidence            9999999999885

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=2.3e-15  Score=147.23  Aligned_cols=255  Identities=24%  Similarity=0.285  Sum_probs=187.0

Q ss_pred             HHhcCCCCCCeecc--cCceEEEEEEEcCcccccccccEEEEEEeccC--CcccHHHHHHHHHHHcCCC-cccccceeeE
Q 014736           88 AITQNFSSNYLLGE--GGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQLR-HPHLVRLIGY  162 (419)
Q Consensus        88 ~~~~~y~~~~~lg~--G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~  162 (419)
                      -..+.|-+.+.+|.  |.+|.||.+....    ......+|+|.-+..  .......-++|+.....++ |+|.++.+..
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~----~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~  186 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTN----SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA  186 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCc----ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence            34456778888999  9999999985421    445678999984432  2233334456777777774 9999999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCeeecCCCCCcEEEcCC-CcE
Q 014736          163 CCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK----GLAFLHGAENPVIYRDFKTSNILLDSD-FTA  237 (419)
Q Consensus       163 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~----al~~lH~~~~~ivH~Dlkp~NIll~~~-~~~  237 (419)
                      ++..+.+|+-+|+| +.+|..+.... ..-++....+....+...    ||..+|  .++++|-|+||.||+...+ ...
T Consensus       187 ~e~~~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~h--s~~~~~~~~kp~~i~~~~~~~s~  262 (524)
T KOG0601|consen  187 WEGSGILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLH--SNNIVHDDLKPANIFTTSDWTSC  262 (524)
T ss_pred             cccCCcceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccC--CCcccccccchhheeccccccee
Confidence            99999999999999 67887776544 234677788888888888    999999  6779999999999999999 889


Q ss_pred             EEeccCccccCCCCCCcee---eecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHh
Q 014736          238 KLSDFGLAKMGPEGSNTHV---TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW  314 (419)
Q Consensus       238 kl~DfGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  314 (419)
                      +++|||+......+.....   ..+..|...|++||.+ .+-++...|+|++|.++.+..+|...........      |
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W  335 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS------W  335 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC------c
Confidence            9999999987666543222   2233688899999988 6678999999999999999998876554331111      1


Q ss_pred             hhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          315 AKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ..    ..    .   ..+...|....+.++...+..|++.+|..|++.+.+..
T Consensus       336 ~~----~r----~---~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  336 SQ----LR----Q---GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cc----cc----c---ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            00    00    0   00122233333456667999999999999998877654

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.58  E-value=1.2e-14  Score=143.79  Aligned_cols=140  Identities=21%  Similarity=0.191  Sum_probs=95.5

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHH------------------------------------
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR------------------------------------  139 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~------------------------------------  139 (419)
                      .+.||.|++|+||+|+..+       |+.||||+.++.......                                    
T Consensus       122 ~~plasaSigQVh~A~l~~-------G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l  194 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVD-------GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTL  194 (437)
T ss_pred             CcceeeeehhheEEEEecC-------CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHH
Confidence            3679999999999997643       678999998654211100                                    


Q ss_pred             ----HHHHHHHHHcCC----C-cccccceeeEE-EeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHH-H
Q 014736          140 ----EWLAEVIFLGQL----R-HPHLVRLIGYC-CEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK-G  208 (419)
Q Consensus       140 ----~~~~E~~~l~~l----~-hpnIv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~-a  208 (419)
                          +|.+|...+.++    + +++| .+-.++ ......+|||||++|++|.++...... ..   ....++..++. .
T Consensus       195 ~~Eldf~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~  269 (437)
T TIGR01982       195 RRELDLRREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSF  269 (437)
T ss_pred             HHHHCHHHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHH
Confidence                133455544444    2 2332 222222 224457999999999999887643211 12   23456666655 4


Q ss_pred             HHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       209 l~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      +..+|  ..|++|+|+||.||+++.++.++|+|||++....
T Consensus       270 l~ql~--~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       270 LNQVL--RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHH--hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            67788  6789999999999999999999999999998654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.54  E-value=9.3e-15  Score=132.55  Aligned_cols=201  Identities=20%  Similarity=0.271  Sum_probs=140.0

Q ss_pred             HHHHcCCCcccccceeeEEEeCC-----eeEEEEEecCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 014736          145 VIFLGQLRHPHLVRLIGYCCEDE-----ERLLVYEFMPRGSLENHLFKR--ISVSLPWGTRLKIAIGAAKGLAFLHGAEN  217 (419)
Q Consensus       145 ~~~l~~l~hpnIv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~  217 (419)
                      +..|-++-|.|||+++.++.+..     ...++.||+..|+|..+|++.  ....+......+|+.||+.||.|||++..
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            44455667999999999886543     478999999999999999753  34567777888999999999999999999


Q ss_pred             CeeecCCCCCcEEEcCCCcEEEeccCccccCCC---CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHH
Q 014736          218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE---GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELL  294 (419)
Q Consensus       218 ~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  294 (419)
                      .|+|+++....|++..+|-+|++- +.......   ......+....+.++|.+||.-...+.+.++|||+||....+|.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            999999999999999999888752 21111100   01111122345778999999876667788999999999999998


Q ss_pred             cCCCCCCCCCCcc-chhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 014736          295 TGRRSMDKLRPKS-EQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV  367 (419)
Q Consensus       295 tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil  367 (419)
                      .|..--....... .+..+...         +-. ...           ..-+.++..|++..|..||+|++++
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~---------i~~-len-----------~lqr~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANV---------IIG-LEN-----------GLQRGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             HheeccCCCcceeehhhhhhhh---------eee-ccC-----------ccccCcCcccccCCCCCCcchhhhh
Confidence            7754221111100 00000000         000 000           1124567899999999999999886

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.52  E-value=1.6e-14  Score=144.62  Aligned_cols=148  Identities=18%  Similarity=0.139  Sum_probs=93.9

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc-----------------------------
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-----------------------------  137 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------------------  137 (419)
                      +.+...|+. +.||+|++|+||+|+.++      +|+.||||++++.....                             
T Consensus       116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~  188 (537)
T PRK04750        116 EEWFDDFDI-KPLASASIAQVHFARLKD------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPRE  188 (537)
T ss_pred             HHHHHhcCh-hhhcCCCccEEEEEEECC------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHH
Confidence            344556777 789999999999997654      36889999997542110                             


Q ss_pred             -----HH------HHHHHHHHHcCCC----cccccceeeEEEe-CCeeEEEEEecCCCChhhhh--hhccC--CCCCHHH
Q 014736          138 -----HR------EWLAEVIFLGQLR----HPHLVRLIGYCCE-DEERLLVYEFMPRGSLENHL--FKRIS--VSLPWGT  197 (419)
Q Consensus       138 -----~~------~~~~E~~~l~~l~----hpnIv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~--~~~~~~~  197 (419)
                           .+      ++.+|...+.++.    +.+.+.+-.++.+ ....+|||||+.|+.|.+.-  .....  ..+....
T Consensus       189 ~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~  268 (537)
T PRK04750        189 VVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERG  268 (537)
T ss_pred             HHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHH
Confidence                 01      1233444333332    3333333233322 45568999999999997742  22110  0122223


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC----cEEEeccCccccCCC
Q 014736          198 RLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF----TAKLSDFGLAKMGPE  250 (419)
Q Consensus       198 ~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfGla~~~~~  250 (419)
                      +..++.|++         ..|++|+|+||.||+++.++    .++++|||++..+..
T Consensus       269 v~~~~~Qif---------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        269 VEVFFTQVF---------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHHHH---------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            333444443         46799999999999999988    999999999987644

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.46  E-value=1.1e-12  Score=114.67  Aligned_cols=145  Identities=13%  Similarity=0.071  Sum_probs=98.6

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---------------------cc-HHHH----HHHHHHHc
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---------------------QG-HREW----LAEVIFLG  149 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---------------------~~-~~~~----~~E~~~l~  149 (419)
                      ...||.|--+.||.|...++......+..+|||+.+..-.                     .. ...+    .+|+..|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3469999999999996432100111357899998753110                     00 1122    27999998


Q ss_pred             CCCc--ccccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCeeecCCCC
Q 014736          150 QLRH--PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL-HGAENPVIYRDFKT  226 (419)
Q Consensus       150 ~l~h--pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~l-H~~~~~ivH~Dlkp  226 (419)
                      ++..  -++.+++++    ...+|||||+.+..+.....+.  ..++......+..+++.+|..| |  +.||||+||++
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H--~~glVHGDLs~  153 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK--ECNLVHADLSE  153 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH--hCCeecCCCCH
Confidence            8853  456667654    4678999999665442211111  2344455677889999999998 8  67899999999


Q ss_pred             CcEEEcCCCcEEEeccCccccCC
Q 014736          227 SNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       227 ~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      .|||++ ++.++|+|||.+....
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeCC
Confidence            999997 4689999999887543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.45  E-value=5.1e-13  Score=115.42  Aligned_cols=130  Identities=19%  Similarity=0.054  Sum_probs=94.0

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCccccc-ceeeEEEeCCeeEEEEE
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV-RLIGYCCEDEERLLVYE  174 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~lv~e  174 (419)
                      ++.|+.|.++.||++...        ++.|++|+...... ....+.+|+.+++.+.+.+++ +++.+.  ....++|||
T Consensus         3 ~~~l~~G~~~~vy~~~~~--------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e   71 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITE   71 (170)
T ss_pred             eeecCCcccCceEEEEEC--------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEE
Confidence            356899999999998532        46799999864421 123456789999888665544 454433  334689999


Q ss_pred             ecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCC---CCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          175 FMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE---NPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       175 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      |++|.++.+..       .   ....++.+++.+|..||+..   .+++|+|++|.||+++ ++.++++|||.+..
T Consensus        72 ~i~G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          72 FIEGSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ecCCCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            99998875430       0   12345678999999999542   2359999999999999 67899999998774

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.41  E-value=8.4e-12  Score=123.71  Aligned_cols=165  Identities=18%  Similarity=0.171  Sum_probs=124.5

Q ss_pred             ccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHH
Q 014736          120 LKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRL  199 (419)
Q Consensus       120 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~  199 (419)
                      ..+.+|.|...............+-++.|+.++||||+++++.++.++..|||+|-+  ..|..++.+.     ....+.
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l-----~~~~v~  107 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL-----GKEEVC  107 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh-----HHHHHH
Confidence            346778888877655433455667888999999999999999999999999999988  4676676554     255677


Q ss_pred             HHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCc
Q 014736          200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTT  279 (419)
Q Consensus       200 ~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  279 (419)
                      ..+.||+.||.|||. +.+++|++|....|+|+..|..||++|.++.........  .....--..|..|+.+....  -
T Consensus       108 ~Gl~qIl~AL~FL~~-d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~--~  182 (690)
T KOG1243|consen  108 LGLFQILAALSFLND-DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE--W  182 (690)
T ss_pred             HHHHHHHHHHHHHhc-cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCccc--c
Confidence            888999999999984 567999999999999999999999999887653322210  00111122356666543222  4


Q ss_pred             hhhHHHHHHHHHHHHcC
Q 014736          280 KSDVYSFGVVLLELLTG  296 (419)
Q Consensus       280 ~~DiwslG~il~elltg  296 (419)
                      ..|.|-|||++++++.|
T Consensus       183 s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNG  199 (690)
T ss_pred             chhhhhHHHHHHHHhCc
Confidence            57999999999999999

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.36  E-value=1.2e-11  Score=104.69  Aligned_cols=131  Identities=21%  Similarity=0.224  Sum_probs=99.1

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--cc------HHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QG------HREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~------~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++++|+-+.+|.+.+.+        ..+++|.-.+...  ..      ...-.+|+.++.++.--.|.-..=++.+...
T Consensus         2 ~~i~~GAEa~i~~~~~~g--------~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~   73 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG--------LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN   73 (204)
T ss_pred             chhhCCcceeEEeeeccC--------cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC
Confidence            358899999999985533        3466665432211  11      2345679999988876566555556667778


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+|||++|..|.+.+...         ...++..+-.-+.-||  .+||||+||.++||++..++ +.++|||++.+
T Consensus        74 ~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH--~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          74 GLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLH--KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHH--hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            88999999999999888654         2466777777788999  88899999999999998875 99999999884

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.34  E-value=1.1e-12  Score=128.60  Aligned_cols=248  Identities=22%  Similarity=0.151  Sum_probs=171.6

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHH--HHHHHHHHHcCC-CcccccceeeEEE
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR--EWLAEVIFLGQL-RHPHLVRLIGYCC  164 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~hpnIv~~~~~~~  164 (419)
                      ....+|..+..||.|.|+.|+.....     ...+..|++|.+...-.....  .-+.|+.+...+ .|.+++..+..+.
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r-----~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~  336 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKR-----PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS  336 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeec-----CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc
Confidence            34557888899999999999987532     233567888877543222222  224566666666 4888999888888


Q ss_pred             eCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-CcEEEeccC
Q 014736          165 EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD-FTAKLSDFG  243 (419)
Q Consensus       165 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG  243 (419)
                      ...+.|+-.|||+++++...+  .....+.....+.+..|++.++.++|  ...++|+|+||.||++..+ +..+++|||
T Consensus       337 ~~r~~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~--s~~~~~~d~~psni~i~~~~~~~~~~~~~  412 (524)
T KOG0601|consen  337 QLRQGYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIH--SKLFVHLDVKPSNILISNDGFFSKLGDFG  412 (524)
T ss_pred             ccccccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhcccccc--chhhhcccccccceeeccchhhhhccccc
Confidence            888888999999999887665  22345666788899999999999999  5669999999999999886 778999999


Q ss_pred             ccccCCCCCCceeeecccccccc-cccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          244 LAKMGPEGSNTHVTTRVMGTYGY-AAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       244 la~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      ....+.......    ..++..| .+++......+..+.|++|||+-+.+.++|..--....        .|        
T Consensus       413 ~~t~~~~~~~~~----~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~--------  472 (524)
T KOG0601|consen  413 CWTRLAFSSGVF----HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QS--------  472 (524)
T ss_pred             cccccceecccc----cccccccccchhhccccccccccccccccccccccccCcccCcccc--------cc--------
Confidence            987532222111    1123334 35555566778899999999999999999864222111        00        


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                         ..+....+. .. .....++..+...++..++..||.+.++...
T Consensus       473 ---~~i~~~~~p-~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~  514 (524)
T KOG0601|consen  473 ---LTIRSGDTP-NL-PGLKLQLQVLLKVMINPDRKRRPSAVELSLH  514 (524)
T ss_pred             ---eeeeccccc-CC-CchHHhhhhhhhhhcCCccccchhhhhhccc
Confidence               000011011 01 1122678889999999999999998876543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.34  E-value=2.2e-11  Score=102.63  Aligned_cols=143  Identities=22%  Similarity=0.220  Sum_probs=108.4

Q ss_pred             CCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--------ccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           95 SNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--------QGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        95 ~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      ...+|-+|+-+.|+++.+.        |+..+||.-.....        -...+..+|+.+|.++.--.|.-..-+|.+.
T Consensus        11 ~l~likQGAEArv~~~~~~--------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~   82 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT   82 (229)
T ss_pred             cceeeeccceeeEeeeccC--------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec
Confidence            5667899999999998654        46677776432211        1234567899999888765665555577788


Q ss_pred             CeeEEEEEecCC-CChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC---cEEEecc
Q 014736          167 EERLLVYEFMPR-GSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF---TAKLSDF  242 (419)
Q Consensus       167 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~---~~kl~Df  242 (419)
                      ....|+|||++| .++.+++...............++..|-+.+.-||  .++|||+||..+||++..++   .+.|+||
T Consensus        83 ~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH--~ndiiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   83 YGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH--DNDIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             CCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh--hCCeecccccccceEEecCCCcCceEEEee
Confidence            888999999976 48888887765544444444788999999999999  78899999999999997654   3589999


Q ss_pred             Ccccc
Q 014736          243 GLAKM  247 (419)
Q Consensus       243 Gla~~  247 (419)
                      |++..
T Consensus       161 gls~~  165 (229)
T KOG3087|consen  161 GLSSV  165 (229)
T ss_pred             cchhc
Confidence            99874

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.33  E-value=3.6e-13  Score=138.73  Aligned_cols=249  Identities=19%  Similarity=0.178  Sum_probs=170.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC---CcccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE---GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      .+.+.+++-+-+|.++.++.+.      ....+...+.|+....   ...+.+....+-.++-...+|.++...-.+.-.
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~------pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r  876 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPAS------PAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCR  876 (1205)
T ss_pred             CccceecccccCCCCcccccCC------ccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCC
Confidence            3567777789999999999873      3334444555544322   112223333333333333456666555444456


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      ...+|+++|+.+++|...+...  ...+.......+..+..+++|||+  ..+.|+|++|.|+++..++..++.|||...
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s--~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHS--SLRKHRDLKPDSLLIAYDGHRPLTDFGTLS  952 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhcccc--chhhcccccccchhhcccCCcccCcccccc
Confidence            6789999999999998888665  344555566777788899999994  449999999999999999999999998432


Q ss_pred             cCCCC--------C---------------------CceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCC
Q 014736          247 MGPEG--------S---------------------NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR  297 (419)
Q Consensus       247 ~~~~~--------~---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~  297 (419)
                      .....        .                     .........||+.|.+||.+.+......+|+|++|++++|.++|.
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence            21100        0                     001122357999999999999999999999999999999999999


Q ss_pred             CCCCCCCCccchhHHHhhhHHhhccccccccccc-ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 014736          298 RSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDP-RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMA  364 (419)
Q Consensus       298 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~  364 (419)
                      +||....+......+                ... .-+..-+...+.++.+++.+.+..+|.+|-.+.
T Consensus      1033 pp~na~tpq~~f~ni----------------~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQIFENI----------------LNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCcchhhhhhcc----------------ccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            999876554322111                000 001122334567899999999999999997765

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.28  E-value=4.6e-11  Score=107.74  Aligned_cols=141  Identities=18%  Similarity=0.204  Sum_probs=105.6

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCc--ccccceeeEEEeC---CeeE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRH--PHLVRLIGYCCED---EERL  170 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~---~~~~  170 (419)
                      +.|+.|.++.||++...+       ++.+++|+...... .....+..|++++..+.+  .++.+++.+....   +..+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~   76 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF   76 (223)
T ss_pred             eecCCCccceEEEEEecC-------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence            468999999999986432       46799999865432 134567889999999865  4467777776553   3678


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA-----------------------------------  215 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-----------------------------------  215 (419)
                      +||||++|.++.+.+..   ..++......++.+++.+|..||+.                                   
T Consensus        77 ~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          77 YVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             EEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            99999999888775531   2356666777788888888888742                                   


Q ss_pred             -------------------CCCeeecCCCCCcEEEcC--CCcEEEeccCcccc
Q 014736          216 -------------------ENPVIYRDFKTSNILLDS--DFTAKLSDFGLAKM  247 (419)
Q Consensus       216 -------------------~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~  247 (419)
                                         ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                               245799999999999998  56789999998774

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.26  E-value=1.1e-10  Score=112.55  Aligned_cols=214  Identities=16%  Similarity=0.220  Sum_probs=151.0

Q ss_pred             eEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEE----eCCeeEEEEEecCC-C
Q 014736          105 GTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCC----EDEERLLVYEFMPR-G  179 (419)
Q Consensus       105 g~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----~~~~~~lv~e~~~~-g  179 (419)
                      .+.|+++      ...+|..|++|.++............-+++++++.|.|||++.++|.    .+..++||++|+++ +
T Consensus       290 ~Ttyk~~------s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  290 ITTYKAT------SNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             ceeEeee------eccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            5678885      34557889999996554433333445688899999999999999886    24568999999986 4


Q ss_pred             Chhhhhhhcc-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          180 SLENHLFKRI-------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       180 ~L~~~l~~~~-------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +|.++.+...             +...++...|.++.|+..||.++|  ..|+.-+-|.+.+|+++++.+++|...|+..
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH--ssGLAck~L~~~kIlv~G~~RIriS~C~i~D  441 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH--SSGLACKTLDLKKILVTGKMRIRISGCGIMD  441 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH--hcCceeecccHhHeEeeCcceEEEeccccee
Confidence            8888765432             223567889999999999999999  5679999999999999999999999888877


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      .......                |.+   +--.+-|.=.||.+++.|.||...-.... ........             
T Consensus       442 vl~~d~~----------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d-~~~~s~~~-------------  488 (655)
T KOG3741|consen  442 VLQEDPT----------------EPL---ESQQQNDLRDLGLLLLALATGTENSNRTD-STQSSHLT-------------  488 (655)
T ss_pred             eecCCCC----------------cch---hHHhhhhHHHHHHHHHHHhhccccccccc-chHHHHHH-------------
Confidence            6544321                111   12346799999999999999964311110 00000000             


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                               ......+.++++++......++++ -++.+++.+
T Consensus       489 ---------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  489 ---------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             ---------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                     112334567888888888888886 567777644

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.15  E-value=7.9e-10  Score=102.10  Aligned_cols=124  Identities=14%  Similarity=0.057  Sum_probs=91.0

Q ss_pred             ccEEEEEEeccCCccc-----------HHHHHHHHHHHcCCCcccc--cceeeEEEe-----CCeeEEEEEecCCC-Chh
Q 014736          122 AQAVAVKLLDIEGLQG-----------HREWLAEVIFLGQLRHPHL--VRLIGYCCE-----DEERLLVYEFMPRG-SLE  182 (419)
Q Consensus       122 ~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpnI--v~~~~~~~~-----~~~~~lv~e~~~~g-~L~  182 (419)
                      |+.|.||.........           ...+.+|+..+..+..-+|  +.++.+++.     ....+||||++++. +|.
T Consensus        45 g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~  124 (268)
T PRK15123         45 GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLE  124 (268)
T ss_pred             CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHH
Confidence            4679999775433211           1136789888888754443  444555543     23578999999876 898


Q ss_pred             hhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-------CCcEEEeccCcccc
Q 014736          183 NHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS-------DFTAKLSDFGLAKM  247 (419)
Q Consensus       183 ~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-------~~~~kl~DfGla~~  247 (419)
                      +++........+......++.+++..+.-||  ..||+|+||++.|||++.       +..+.|+||+.+..
T Consensus       125 ~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH--~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        125 DYCADWATNPPDPRLKRMLIKRVATMVRDMH--AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            8875432344556677899999999999999  788999999999999975       46799999998863

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.14  E-value=3.8e-09  Score=99.70  Aligned_cols=264  Identities=18%  Similarity=0.189  Sum_probs=161.3

Q ss_pred             CCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-Ccccccceee------EEEe-
Q 014736           94 SSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHLVRLIG------YCCE-  165 (419)
Q Consensus        94 ~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~------~~~~-  165 (419)
                      ...+.||+|+-+.+|-.--         ....+.|+....-.....+   .+..|... .||-+-.-+.      +.-+ 
T Consensus        14 ~~gr~LgqGgea~ly~l~e---------~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~   81 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE---------VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRR   81 (637)
T ss_pred             CCCccccCCccceeeecch---------hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCc
Confidence            3456799999999996411         1235567776543332232   23333333 4654322111      1112 


Q ss_pred             CCeeEEEEEecCCCC-hhhhhh---h-ccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 014736          166 DEERLLVYEFMPRGS-LENHLF---K-RISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS  240 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~-L~~~l~---~-~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  240 (419)
                      .....++|..+.|.. +..++.   + ..-....|...+.+++.++.+..-||  +.|.+-+|+.++|+|+.+++.|.|.
T Consensus        82 ~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH--~~Gh~vGDVn~~~~lVsd~~~V~LV  159 (637)
T COG4248          82 GKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH--EHGHVVGDVNQNSFLVSDDSKVVLV  159 (637)
T ss_pred             cceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH--hcCCcccccCccceeeecCceEEEE
Confidence            223678899887752 222221   1 11234678899999999999999999  7789999999999999999999999


Q ss_pred             ccCccccCCCCCCceeeeccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCccch-hHHH
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS-----TGHLTTKSDVYSFGVVLLELLTG-RRSMDKLRPKSEQ-NLVD  313 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~-~~~~  313 (419)
                      |-..-....   +.......+|...|.+||.-.     +..-+...|.|.||+++++||.| +.||.+....... +..+
T Consensus       160 dsDsfqi~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E  236 (637)
T COG4248         160 DSDSFQINA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE  236 (637)
T ss_pred             cccceeecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch
Confidence            865433321   112233356899999999753     34557789999999999999886 9999875322111 0000


Q ss_pred             --hhhHHhhcccccccccccccCCCCC-HHHHHHHHHHHHHcccC--CCCCCCCHHHHHHHHHhhhc
Q 014736          314 --WAKPYLRSSRRLRYIVDPRLAGQYS-VKGAKEMAVLALQCISV--NPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       314 --~~~~~~~~~~~~~~~~~~~l~~~~~-~~~~~~l~~li~~~l~~--dP~~RPs~~eil~~L~~l~~  375 (419)
                        .....+....+-..-..+ -....+ .-.+..+..|..+|+..  ++.-|||++-++..|..+..
T Consensus       237 ~~Ia~g~f~ya~~~~~g~~p-~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         237 TDIAHGRFAYASDQRRGLKP-PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             hhhhcceeeechhccCCCCC-CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence              000001000000000001 111222 22456788899999854  36789999999988877644

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.04  E-value=2.6e-09  Score=93.17  Aligned_cols=98  Identities=19%  Similarity=0.204  Sum_probs=63.9

Q ss_pred             HHHHHHHHcCCCcc--cccceeeEEEeCCeeEEEEEecC--CCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHH-hhcC
Q 014736          141 WLAEVIFLGQLRHP--HLVRLIGYCCEDEERLLVYEFMP--RGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF-LHGA  215 (419)
Q Consensus       141 ~~~E~~~l~~l~hp--nIv~~~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~-lH~~  215 (419)
                      ..+|++.|.++..-  ++.+++++.    ..+|||||+.  |..+..+. ..   .+.......++.+++..+.. +|  
T Consensus        55 ~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~-~~---~~~~~~~~~~~~~il~~~~~~~~--  124 (188)
T PF01163_consen   55 AKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLK-DV---DLSPEEPKELLEEILEEIIKMLH--  124 (188)
T ss_dssp             HHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHH-HC---GGGGSTHHHHHHHHHHHHHHHHH--
T ss_pred             HHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHH-hc---cccchhHHHHHHHHHHHHHHHHH--
Confidence            56799999999755  566676542    4579999997  54454332 22   11123456677777775554 57  


Q ss_pred             CCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       216 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ..||+|+||.+.|||++++ .+.|+|||.+....
T Consensus       125 ~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  125 KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             CTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             hcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            6789999999999999988 99999999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.97  E-value=4.4e-09  Score=94.51  Aligned_cols=135  Identities=17%  Similarity=0.081  Sum_probs=94.8

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc----------------------ccHHHHHHHHHHHcC
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL----------------------QGHREWLAEVIFLGQ  150 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~  150 (419)
                      +.++..||-|.-+.||.|...       ++.++|||.-+.-..                      .......+|+++|.+
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~  165 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQR  165 (304)
T ss_pred             HhhccccccCccceEEEEECC-------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHH
Confidence            456788999999999999643       468899997532100                      011235679999999


Q ss_pred             CCcc--cccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCc
Q 014736          151 LRHP--HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSN  228 (419)
Q Consensus       151 l~hp--nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~N  228 (419)
                      |...  .+.+.+++    +...+||||++|-.|...-.       .......++..|+.-+.-+-  ..||||+|+.+-|
T Consensus       166 L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~--~~GiVHGDlSefN  232 (304)
T COG0478         166 LYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAY--RRGIVHGDLSEFN  232 (304)
T ss_pred             hhhcCCCCCCcccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHH--HcCccccCCchhe
Confidence            9654  77777664    56789999999877754321       12233344444444444443  4679999999999


Q ss_pred             EEEcCCCcEEEeccCcccc
Q 014736          229 ILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       229 Ill~~~~~~kl~DfGla~~  247 (419)
                      |+++++|.++++||--+..
T Consensus       233 IlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         233 ILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             EEEecCCCEEEEeCccccc
Confidence            9999999999999966553

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.89  E-value=1.1e-08  Score=102.35  Aligned_cols=143  Identities=17%  Similarity=0.161  Sum_probs=90.9

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHH------------------------------H------
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR------------------------------E------  140 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~------------------------------~------  140 (419)
                      ..|+.++-|+||+|++++       |+.||||+.++.-....+                              +      
T Consensus       131 ~PiAsASIaQVH~A~L~s-------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~  203 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR  203 (517)
T ss_pred             CchhhhhHhhheeEEecC-------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence            579999999999998765       789999998753221110                              0      


Q ss_pred             ----HHHHHHHHcCCC-----cccccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHH
Q 014736          141 ----WLAEVIFLGQLR-----HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF  211 (419)
Q Consensus       141 ----~~~E~~~l~~l~-----hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~  211 (419)
                          +.+|...+.++.     .++|.-..=+.+-.+...|+|||++|-.+.+...-.. ...+.........++.--.-+
T Consensus       204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~~  282 (517)
T COG0661         204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLL  282 (517)
T ss_pred             HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence                234555444442     3333222223333566789999999998888743222 234433322222222211111


Q ss_pred             hhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCC
Q 014736          212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG  251 (419)
Q Consensus       212 lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  251 (419)
                          ..|++|.|.+|.||+++.+|.+.+.|||+.......
T Consensus       283 ----~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         283 ----RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             ----hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence                356999999999999999999999999998875543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.86  E-value=8.3e-10  Score=110.16  Aligned_cols=150  Identities=20%  Similarity=0.246  Sum_probs=106.3

Q ss_pred             HHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCcee-------eecccccccccccccccCC
Q 014736          203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV-------TTRVMGTYGYAAPEYISTG  275 (419)
Q Consensus       203 ~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~  275 (419)
                      .+++.|+.|+|. ..++||++|.|++|.++.++..||+.|+.+...........       ..-..-...|.|||++.+.
T Consensus       106 ~~v~dgl~flh~-sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  106 GNVADGLAFLHR-SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             hcccchhhhhcc-CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            344589999996 56799999999999999999999999998765433211110       0112345679999999888


Q ss_pred             CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHccc
Q 014736          276 HLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCIS  354 (419)
Q Consensus       276 ~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~  354 (419)
                      ..+.++|+||+|+++|-+.. |+.-+............              ...+..-...+....+.++.+=+.+++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~--------------~~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS--------------RNLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhh--------------hcccccccccccccCcHHHHHHHHHHhc
Confidence            88999999999999999984 55444433222111110              0111112234456778999999999999


Q ss_pred             CCCCCCCCHHHHH
Q 014736          355 VNPKDRPKMAAVV  367 (419)
Q Consensus       355 ~dP~~RPs~~eil  367 (419)
                      .++.-||++.++.
T Consensus       251 ~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  251 GDSAVRPTLDLLL  263 (700)
T ss_pred             CCcccCcchhhhh
Confidence            9999999877764

>PRK09902 hypothetical protein; Provisional

Probab=98.86  E-value=4.1e-08  Score=86.27  Aligned_cols=137  Identities=15%  Similarity=0.099  Sum_probs=100.2

Q ss_pred             cccCceEEEEEEEcCcccccccccEEEEEEeccCC------cccHHHHHHHHHHHcCCCccc--ccceeeEEEe-----C
Q 014736          100 GEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG------LQGHREWLAEVIFLGQLRHPH--LVRLIGYCCE-----D  166 (419)
Q Consensus       100 g~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~-----~  166 (419)
                      |+||.+.|+.....+        +.+-+|.-...-      ......|.+|+..|.+|..-+  +.++. ++..     .
T Consensus        27 ~rgG~SgV~r~~~~g--------~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~   97 (216)
T PRK09902         27 RRNGMSGVQCVERNG--------KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGE   97 (216)
T ss_pred             CCCCcceEEEEEeCC--------cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCc
Confidence            569999999875432        358888764210      224567899999998885332  44444 3321     1


Q ss_pred             CeeEEEEEecCC-CChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc--EEEeccC
Q 014736          167 EERLLVYEFMPR-GSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT--AKLSDFG  243 (419)
Q Consensus       167 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfG  243 (419)
                      -..+||+|-+.| -+|.+++.+......+......++.+++.++.-||  +.|+.|+|+-+.|||++.++.  ++++||.
T Consensus        98 ~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH--~~Gv~Hgdly~khIll~~~g~~~v~lIDlE  175 (216)
T PRK09902         98 WRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH--SVNRQHGCCYVRHIYVKTEGKAEAGFLDLE  175 (216)
T ss_pred             eEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence            236899998854 48888886654445677777899999999999999  788999999999999987777  9999997


Q ss_pred             cccc
Q 014736          244 LAKM  247 (419)
Q Consensus       244 la~~  247 (419)
                      -++.
T Consensus       176 k~r~  179 (216)
T PRK09902        176 KSRR  179 (216)
T ss_pred             ccch
Confidence            6553

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.85  E-value=3.3e-08  Score=88.23  Aligned_cols=106  Identities=24%  Similarity=0.235  Sum_probs=83.3

Q ss_pred             HHHHHHHHHHHcCCCcc--cccceeeEEEeCC----eeEEEEEecCCC-ChhhhhhhccCCCCCHHHHHHHHHHHHHHHH
Q 014736          138 HREWLAEVIFLGQLRHP--HLVRLIGYCCEDE----ERLLVYEFMPRG-SLENHLFKRISVSLPWGTRLKIAIGAAKGLA  210 (419)
Q Consensus       138 ~~~~~~E~~~l~~l~hp--nIv~~~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~  210 (419)
                      .....+|...+..|..-  ...+++.+.+...    ..+||+|++++. +|.+++.....  .+......++.+++..+.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence            34577888888777533  3456666665522    458999999885 79998876422  555677899999999999


Q ss_pred             HhhcCCCCeeecCCCCCcEEEcCCC---cEEEeccCcccc
Q 014736          211 FLHGAENPVIYRDFKTSNILLDSDF---TAKLSDFGLAKM  247 (419)
Q Consensus       211 ~lH~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~~  247 (419)
                      -||  .+||+|+|+++.|||++.++   .+.|+||+-++.
T Consensus       133 ~lH--~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLH--DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHH--HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999  78899999999999999887   899999988775

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.71  E-value=3.1e-07  Score=83.12  Aligned_cols=138  Identities=14%  Similarity=0.111  Sum_probs=85.5

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCccc--ccceeeEEEeCCeeEEEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH--LVRLIGYCCEDEERLLVYE  174 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~~lv~e  174 (419)
                      ..||+|..+.||+..          +..+++|+.....  ......+|.++++.+..-+  +.+++++....+...+|||
T Consensus         7 ~~i~~G~t~~~y~~~----------~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e   74 (226)
T TIGR02172         7 TQTGEGGNGESYTHK----------TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYE   74 (226)
T ss_pred             eeecCCCCcceeEec----------CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeee
Confidence            468999999999841          2357889886432  3345678999998886433  4777888878888899999


Q ss_pred             ecCCCC-hhhhh--------------hh---ccC----CCCCHHHHH-HHHH----------HHHH-HHHHhh--cCCCC
Q 014736          175 FMPRGS-LENHL--------------FK---RIS----VSLPWGTRL-KIAI----------GAAK-GLAFLH--GAENP  218 (419)
Q Consensus       175 ~~~~g~-L~~~l--------------~~---~~~----~~~~~~~~~-~i~~----------qi~~-al~~lH--~~~~~  218 (419)
                      +++|.. +...+              .+   ..+    ......... .+..          .+.. ...+|.  .....
T Consensus        75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            998863 21111              00   000    011111100 0000          0111 112222  22345


Q ss_pred             eeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          219 VIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       219 ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ++|+|+.|.||++++++ +.|+||+.+..
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            89999999999999988 99999988764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.64  E-value=5.5e-07  Score=79.51  Aligned_cols=140  Identities=13%  Similarity=0.077  Sum_probs=91.3

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHH---------HHHHHHHcCCC---cc
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---------LAEVIFLGQLR---HP  154 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~---hp  154 (419)
                      ..+..+|...+++-......|.+-..        .++.+++|..........+.|         .+++..+..+.   --
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei--------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~   98 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEI--------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFT   98 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEE--------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcc
Confidence            45667888888888877777777543        357899998875433222222         23344333332   22


Q ss_pred             cccceeeEEEe-----CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcE
Q 014736          155 HLVRLIGYCCE-----DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNI  229 (419)
Q Consensus       155 nIv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NI  229 (419)
                      .+..++-+.+.     ....+|+|||++|..|.+...      ++.    .+...+++++.-||  ..|++|+|.+|.|+
T Consensus        99 ~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH--~~G~~HGD~hpgNF  166 (229)
T PF06176_consen   99 EPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH--KHGFYHGDPHPGNF  166 (229)
T ss_pred             ccccceeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH--HcCCccCCCCcCcE
Confidence            33333322221     234568999999988866531      222    24456777899999  77899999999999


Q ss_pred             EEcCCCcEEEeccCcccc
Q 014736          230 LLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       230 ll~~~~~~kl~DfGla~~  247 (419)
                      ++++++ ++++||+..+.
T Consensus       167 lv~~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  167 LVSNNG-IRIIDTQGKRM  183 (229)
T ss_pred             EEECCc-EEEEECccccc
Confidence            999654 99999977653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.63  E-value=6.8e-07  Score=79.81  Aligned_cols=153  Identities=20%  Similarity=0.133  Sum_probs=100.1

Q ss_pred             CCHHHHHHHhcCCCCCCee---cccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-------------------cH
Q 014736           81 FQLSELRAITQNFSSNYLL---GEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-------------------GH  138 (419)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~l---g~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-------------------~~  138 (419)
                      .+...+..+.++..+..+.   ..|--+.||+|..       ..+..+|+|+....-..                   ..
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~r  107 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAET-------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNR  107 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc-------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCH
Confidence            4445566777777766655   4677778999853       33578999998643110                   01


Q ss_pred             HH-----HHHHHHHHcCCC--cccccceeeEEEeCCeeEEEEEecCCCCh-hhhhhhccCCCCCHHHHHHHHHHHHHHHH
Q 014736          139 RE-----WLAEVIFLGQLR--HPHLVRLIGYCCEDEERLLVYEFMPRGSL-ENHLFKRISVSLPWGTRLKIAIGAAKGLA  210 (419)
Q Consensus       139 ~~-----~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~~i~~qi~~al~  210 (419)
                      +.     ..+|+..|.++.  +-.+.+.+.+.    ...|||||+....+ .-.|.+   -.+...+...+..+++..+.
T Consensus       108 r~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~  180 (268)
T COG1718         108 RKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMR  180 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHH
Confidence            11     245888887774  45566666655    45899999944311 011111   12222256677777888777


Q ss_pred             HhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       211 ~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      -|-. ..++||+||..=|||+. ++.+.|+|||-|....
T Consensus       181 ~l~~-~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         181 RLYK-EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHH-hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            7762 36799999999999999 8899999999887543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.53  E-value=1.6e-06  Score=79.60  Aligned_cols=138  Identities=20%  Similarity=0.114  Sum_probs=82.6

Q ss_pred             ecccCc-eEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-cccccceeeEEEeCCeeEEEEEec
Q 014736           99 LGEGGF-GTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-HPHLVRLIGYCCEDEERLLVYEFM  176 (419)
Q Consensus        99 lg~G~f-g~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~  176 (419)
                      |..|.. ..||+...        .+..+++|+.....   ...+.+|+++++.+. +--+.+++++...++..++|||++
T Consensus         6 ~~~g~~~~~v~~~~~--------~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   74 (244)
T cd05150           6 VTEGQSGATVYRLDG--------KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAV   74 (244)
T ss_pred             cCCCCCcCeEEEEcC--------CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEee
Confidence            444555 78898732        12468888886443   334567888887774 444667788777667789999999


Q ss_pred             CCCChhhhhh----------------hccC-----CCCC--HHHHHHHHH--------------------HHHHHHHHhh
Q 014736          177 PRGSLENHLF----------------KRIS-----VSLP--WGTRLKIAI--------------------GAAKGLAFLH  213 (419)
Q Consensus       177 ~~g~L~~~l~----------------~~~~-----~~~~--~~~~~~i~~--------------------qi~~al~~lH  213 (419)
                      +|.+|.....                .-..     ..+.  .........                    .+...+..|-
T Consensus        75 ~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  154 (244)
T cd05150          75 PGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELE  154 (244)
T ss_pred             CCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHH
Confidence            9987764320                0000     0110  000000000                    0111112221


Q ss_pred             -----cCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          214 -----GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       214 -----~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                           .....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       155 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         155 ATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             hhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence                 0134599999999999999987788999987763

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.46  E-value=9.9e-07  Score=88.13  Aligned_cols=138  Identities=17%  Similarity=0.162  Sum_probs=87.8

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccH---------------------------H----------
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH---------------------------R----------  139 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~---------------------------~----------  139 (419)
                      +.||.-+.|+||+|+.++       |+.||||+-++.-....                           +          
T Consensus       167 ~piaaASlaQVhrA~L~~-------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~EL  239 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQEL  239 (538)
T ss_pred             chhhhcchhheEEEEecC-------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhc
Confidence            579999999999998655       78999999864321110                           0          


Q ss_pred             HHHHHHHHHcC----CCccc------ccceeeEEEeCCeeEEEEEecCCCChhhh--hhhccCCCCCHHHHHHHHHHHHH
Q 014736          140 EWLAEVIFLGQ----LRHPH------LVRLIGYCCEDEERLLVYEFMPRGSLENH--LFKRISVSLPWGTRLKIAIGAAK  207 (419)
Q Consensus       140 ~~~~E~~~l~~----l~hpn------Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~~~~~~~i~~qi~~  207 (419)
                      +|.+|.+...+    +.|-+      |.+++-.  -.....|+||||+|..+.|.  |.+.   .++...+...+.+...
T Consensus       240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~~  314 (538)
T KOG1235|consen  240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAYL  314 (538)
T ss_pred             chHHHHHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHHH
Confidence            13344443322    23444      4444332  23467899999999877654  3333   3444444433333332


Q ss_pred             HHHHhhcCCCCeeecCCCCCcEEEcC----CCcEEEeccCccccCCC
Q 014736          208 GLAFLHGAENPVIYRDFKTSNILLDS----DFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       208 al~~lH~~~~~ivH~Dlkp~NIll~~----~~~~kl~DfGla~~~~~  250 (419)
                      -+-+    ..|++|+|=+|.||++..    ++.+.+.|||+......
T Consensus       315 ~qIf----~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  315 EQIF----KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHH----hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            2222    355999999999999984    67899999999886543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.45  E-value=1.1e-06  Score=79.55  Aligned_cols=141  Identities=21%  Similarity=0.138  Sum_probs=81.5

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcc--cccceeeEEE---eCCeeE
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP--HLVRLIGYCC---EDEERL  170 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~---~~~~~~  170 (419)
                      ++.|+.|..+.||++...+        ..+++|.....  .....+.+|..+++.+...  .+.+++.+..   .....+
T Consensus         2 i~~l~~G~~n~~~~v~~~~--------~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~   71 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--------GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPY   71 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--------SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEE
T ss_pred             CccCCCCCeeeEEEEEECC--------cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccce
Confidence            3568999999999985332        47999998654  3446677888888887533  3556666442   234578


Q ss_pred             EEEEecCCCChhh----------------hhh---hc--cCCCCCHHH---------HHHH------------HHHHHH-
Q 014736          171 LVYEFMPRGSLEN----------------HLF---KR--ISVSLPWGT---------RLKI------------AIGAAK-  207 (419)
Q Consensus       171 lv~e~~~~g~L~~----------------~l~---~~--~~~~~~~~~---------~~~i------------~~qi~~-  207 (419)
                      ++|++++|..+..                .+.   ..  .........         ....            ...+.. 
T Consensus        72 ~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (239)
T PF01636_consen   72 LLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEER  151 (239)
T ss_dssp             EEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             EEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHH
Confidence            9999999988777                111   11  001111100         0000            111122 


Q ss_pred             HHHHhhc-----CCCCeeecCCCCCcEEEc-CCCcEEEeccCccc
Q 014736          208 GLAFLHG-----AENPVIYRDFKTSNILLD-SDFTAKLSDFGLAK  246 (419)
Q Consensus       208 al~~lH~-----~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~  246 (419)
                      .+..++.     ....++|+|+.+.|||++ .++.+.|+||+.+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  152 LLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            2333331     356799999999999999 66667899998765

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.41  E-value=1.5e-08  Score=100.45  Aligned_cols=190  Identities=17%  Similarity=0.114  Sum_probs=131.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCccc-ccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH-LVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~  168 (419)
                      ++.|...+-+++|+++.++|.+      ...+...+ .+.+...     ....-++++|.+++||| .+..++-++.+..
T Consensus       241 ~kws~~fh~fvK~altknpKkR------ptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~  308 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKR------PTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY  308 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccC------CChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence            3444555568999999999873      22222222 4444322     34445899999999999 6777777777788


Q ss_pred             eEEEEEecCCC-ChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          169 RLLVYEFMPRG-SLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       169 ~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      .+++|+++.++ +-...+... ...+..-....+.+.-+.+++++|+..  =+|+|    ||+..+ +..++.||+....
T Consensus       309 ~~i~~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~  380 (829)
T KOG0576|consen  309 LWIPMRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQ  380 (829)
T ss_pred             cchhhhhhcCCccccccCChh-hHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcc
Confidence            89999999776 222111100 011222234456666678899999532  48888    777666 5789999999887


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDK  302 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  302 (419)
                      +....   ......+|+.++|||+.....+....|+|++|+-..+|--|-+|-..
T Consensus       381 L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  381 LTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             cCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence            65554   23446799999999999999999999999999887788777776543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.37  E-value=9e-06  Score=71.56  Aligned_cols=128  Identities=20%  Similarity=0.257  Sum_probs=88.1

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC----------------cccHHHHHHHHHHHcCCC------c
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG----------------LQGHREWLAEVIFLGQLR------H  153 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h  153 (419)
                      ...||+|+.=.||.-  .+       .....||+.....                .....+..+|+.....+.      +
T Consensus         6 ~~~i~~G~~R~cy~H--P~-------dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~   76 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--PD-------DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDW   76 (199)
T ss_pred             CcccccCCCceEEEC--CC-------CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcc
Confidence            456999999999963  11       2457899987665                122345556666554444      8


Q ss_pred             ccccceeeEEEeCCeeEEEEEecCCC------ChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 014736          154 PHLVRLIGYCCEDEERLLVYEFMPRG------SLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTS  227 (419)
Q Consensus       154 pnIv~~~~~~~~~~~~~lv~e~~~~g------~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~  227 (419)
                      .+|.+++|+.+++....+|+|.+.+.      +|.+++.+.   .++. .....+.++   ..||-  +++|+.+||+|.
T Consensus        77 ~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~~f---~~~l~--~~~Iv~~dl~~~  147 (199)
T PF10707_consen   77 SHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALDEF---KRYLL--DHHIVIRDLNPH  147 (199)
T ss_pred             cccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHHHH---HHHHH--HcCCeecCCCcc
Confidence            89999999999999999999988542      677777443   3444 333444444   34555  455999999999


Q ss_pred             cEEEcCCC----cEEEec
Q 014736          228 NILLDSDF----TAKLSD  241 (419)
Q Consensus       228 NIll~~~~----~~kl~D  241 (419)
                      ||++..+.    .+.|+|
T Consensus       148 NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  148 NIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             cEEEEecCCCceEEEEEe
Confidence            99996532    577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.35  E-value=1.9e-06  Score=72.86  Aligned_cols=127  Identities=17%  Similarity=0.120  Sum_probs=85.3

Q ss_pred             CCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCccccc-ceeeEEEeCCeeEEEE
Q 014736           95 SNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV-RLIGYCCEDEERLLVY  173 (419)
Q Consensus        95 ~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~lv~  173 (419)
                      ..+.|++|++|.||+|.|.+        ..+|+|+-..+.  ....+..|.++|..+.-.++- ++|.+..    .++.|
T Consensus        26 v~~~L~KG~~s~Vyl~~~~~--------~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~m   91 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWRG--------GEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRM   91 (201)
T ss_pred             hhhhhhcccccEEEEeeccC--------ceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhh
Confidence            34569999999999997654        479999887553  346788899999988876653 4444432    35569


Q ss_pred             EecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC-C-cEEEcCCCcEEEeccCcccc
Q 014736          174 EFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKT-S-NILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       174 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp-~-NIll~~~~~~kl~DfGla~~  247 (419)
                      ||+.|..|.++-...     +    .+-...+++.---|-  ..||-|+.|.- . ||++.. +.+.|+||.-|+.
T Consensus        92 e~i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD--~~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~  155 (201)
T COG2112          92 EYIDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLD--RLGIEHGELSRPWKNVLVND-RDVYIIDFDSATF  155 (201)
T ss_pred             hhhcCcchhhhhhcc-----c----HHHHHHHHHHHHHHH--HhccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence            999998887654321     1    122333444433333  45688888764 3 555554 4899999998884

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.34  E-value=4.7e-06  Score=75.99  Aligned_cols=73  Identities=14%  Similarity=0.105  Sum_probs=45.8

Q ss_pred             CeecccCceE-EEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcc---cccceeeEEEeC---Cee
Q 014736           97 YLLGEGGFGT-VHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP---HLVRLIGYCCED---EER  169 (419)
Q Consensus        97 ~~lg~G~fg~-Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~~~---~~~  169 (419)
                      +.|+.|+... ||+.           +..+++|+....  .....+.+|.++|..+...   -+.++++.....   ...
T Consensus         3 ~~~~~gG~~n~vy~~-----------~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~   69 (235)
T cd05155           3 EPVDSGGTDNATFRL-----------GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWP   69 (235)
T ss_pred             eeccCCCcccceEEc-----------CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcc
Confidence            4578777764 8875           124778876532  2245678899988777521   344444443322   235


Q ss_pred             EEEEEecCCCChh
Q 014736          170 LLVYEFMPRGSLE  182 (419)
Q Consensus       170 ~lv~e~~~~g~L~  182 (419)
                      +++|++++|.++.
T Consensus        70 ~~l~~~i~G~~l~   82 (235)
T cd05155          70 WSVYRWLEGETAT   82 (235)
T ss_pred             eEEEEeecCCCCC
Confidence            8899999997764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.30  E-value=1.9e-05  Score=69.10  Aligned_cols=99  Identities=27%  Similarity=0.342  Sum_probs=78.5

Q ss_pred             HHHHHHcCCCc-ccccceeeEEEeCCeeEEEEEecCCCChhhh---hhhccCCCCCHHHHHHHHHHHHHHHHHhhcCC-C
Q 014736          143 AEVIFLGQLRH-PHLVRLIGYCCEDEERLLVYEFMPRGSLENH---LFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE-N  217 (419)
Q Consensus       143 ~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~  217 (419)
                      .|.-+|+.+++ +++++++|+|-    .++|.||...+++.+.   +...  ...+|..+.+|+.++++.+.+|+... .
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            47888888876 69999999983    3679999977766432   1111  35689999999999999999998422 3


Q ss_pred             CeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       218 ~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      .+.-.|++++|+-+++++++|++|...+..
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            377789999999999999999999987764

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.26  E-value=1.3e-05  Score=86.18  Aligned_cols=82  Identities=12%  Similarity=0.146  Sum_probs=56.8

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCC-cccc--cceeeEEEeC---Ce
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLR-HPHL--VRLIGYCCED---EE  168 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnI--v~~~~~~~~~---~~  168 (419)
                      .+.|+.|.+..+|+....+.    .....+++|+..... ......+.+|+.+|+.+. |.+|  .+++.++.+.   +.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~----~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNG----GSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEEeCCCCcCceEEEEECCC----CcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            45688999999999754331    112357788765432 223456788999999985 6665  7777777654   46


Q ss_pred             eEEEEEecCCCCh
Q 014736          169 RLLVYEFMPRGSL  181 (419)
Q Consensus       169 ~~lv~e~~~~g~L  181 (419)
                      .|+||||++|..+
T Consensus       119 ~flVME~v~G~~~  131 (822)
T PLN02876        119 AFYIMEYLEGRIF  131 (822)
T ss_pred             ceEEEEecCCccc
Confidence            7999999988654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.17  E-value=2.1e-05  Score=83.48  Aligned_cols=195  Identities=19%  Similarity=0.210  Sum_probs=133.1

Q ss_pred             HHHHHHHcCCCcccccceeeEEEeCCe----eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 014736          142 LAEVIFLGQLRHPHLVRLIGYCCEDEE----RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN  217 (419)
Q Consensus       142 ~~E~~~l~~l~hpnIv~~~~~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~  217 (419)
                      .-|++.+.++.|+|++.++.+......    ..+..++|...++...+...  ...+....+.+..++.+|+.|+|+.. 
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~~-  306 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSLS-  306 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHhc-
Confidence            346677788899999999988765433    23456788888888877665  56788889999999999999999653 


Q ss_pred             CeeecCCCCC---cEEEcCCCcEEEe--ccCccccCCCCCCceeeecccccccccccccccCCCCCch--hhHHHHHHHH
Q 014736          218 PVIYRDFKTS---NILLDSDFTAKLS--DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTK--SDVYSFGVVL  290 (419)
Q Consensus       218 ~ivH~Dlkp~---NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DiwslG~il  290 (419)
                       ..|.-|...   +..++..+.+.++  ||+.+..+.......   ...-+..+.++|......++.+  .|+|.+|.+.
T Consensus       307 -l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  307 -LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             -cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence             333333333   3344556667777  888887665543322   1234566888888876666554  6999999999


Q ss_pred             HHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014736          291 LELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL  370 (419)
Q Consensus       291 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L  370 (419)
                      ..+..|..+-......         ..+              +.    .....+..+.+.+|+..++++|+++.+++...
T Consensus       383 ~~~~~~~~i~~~~~~~---------~~~--------------l~----~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSAVP---------VSL--------------LD----VLSTSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhhcCcccccccch---------hhh--------------hc----cccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence            9999886543221100         000              00    00111578889999999999999999988753

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.06  E-value=2.7e-05  Score=73.52  Aligned_cols=151  Identities=20%  Similarity=0.145  Sum_probs=86.8

Q ss_pred             HHHHhcCCCC-----CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCccc--ccc
Q 014736           86 LRAITQNFSS-----NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH--LVR  158 (419)
Q Consensus        86 ~~~~~~~y~~-----~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~  158 (419)
                      +..+.++|.+     .+.|..|....+|+....        +..+++|+...   .....+..|+.++..+.+.+  +.+
T Consensus         4 l~~~l~~y~~~~~~~i~~i~~G~~n~~y~v~~~--------~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~   72 (296)
T cd05153           4 LASFLADYDLGELLSFEGISAGIENTNYFVTTD--------SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPR   72 (296)
T ss_pred             HHHHHHHcCCCchhheecccCccccceEEEEeC--------CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCc
Confidence            4444445553     345777777899987432        24589998864   22345556777777774322  444


Q ss_pred             eee------EEEeCCeeEEEEEecCCCChhh----hh----------hh---ccCC------CCCHHHHH----------
Q 014736          159 LIG------YCCEDEERLLVYEFMPRGSLEN----HL----------FK---RISV------SLPWGTRL----------  199 (419)
Q Consensus       159 ~~~------~~~~~~~~~lv~e~~~~g~L~~----~l----------~~---~~~~------~~~~~~~~----------  199 (419)
                      ++.      +...++..++|++|++|..+..    .+          ..   ....      ...|....          
T Consensus        73 ~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  152 (296)
T cd05153          73 PIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSA  152 (296)
T ss_pred             cccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCH
Confidence            433      2233456789999999876532    00          00   0000      01111100          


Q ss_pred             HHHHHHHHHHHHhhc-----CCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          200 KIAIGAAKGLAFLHG-----AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       200 ~i~~qi~~al~~lH~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      .....+..++.++..     ...+++|+|+.|.||++++++.+.|+||+.+..
T Consensus       153 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         153 EDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             HHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            011112233444432     245799999999999999987778999988763

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.99  E-value=0.00026  Score=67.57  Aligned_cols=32  Identities=28%  Similarity=0.314  Sum_probs=27.4

Q ss_pred             CCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       216 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..++||+|+.+.||+++.+...-|+||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            46899999999999999765568999998763

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.98  E-value=5.3e-05  Score=69.96  Aligned_cols=136  Identities=13%  Similarity=0.010  Sum_probs=75.6

Q ss_pred             ecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccc-cceeeEEEeCCeeEEEEEecC
Q 014736           99 LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHL-VRLIGYCCEDEERLLVYEFMP  177 (419)
Q Consensus        99 lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~~  177 (419)
                      +..|-...+|+...        .++.+++|+.......-.-...+|..+++.+...++ .+++...  .  .++||||++
T Consensus         4 ~~~G~tn~~y~~~~--------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~   71 (256)
T TIGR02721         4 LSGGLTNRSWRIEH--------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLE   71 (256)
T ss_pred             CCCcCcCCeEEEEe--------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEecc
Confidence            55677788998741        245688987654322110124568888888864333 3444432  2  378999999


Q ss_pred             CCChhhh--------------hhh---cc--CCCCCHHH-HHHHHHHH---------HHHHHHhhc------CCCCeeec
Q 014736          178 RGSLENH--------------LFK---RI--SVSLPWGT-RLKIAIGA---------AKGLAFLHG------AENPVIYR  222 (419)
Q Consensus       178 ~g~L~~~--------------l~~---~~--~~~~~~~~-~~~i~~qi---------~~al~~lH~------~~~~ivH~  222 (419)
                      |..+...              +.+   ..  ...+.... ...+..++         ...+..+-.      ....++|+
T Consensus        72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~  151 (256)
T TIGR02721        72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM  151 (256)
T ss_pred             CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence            8765321              111   00  11112111 11111111         111111211      12358999


Q ss_pred             CCCCCcEEEcCCCcEEEeccCcccc
Q 014736          223 DFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       223 Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      |+.|.||++++++ +.|+||..+..
T Consensus       152 Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       152 DVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CCCcCcEEEeCCC-CEEEeccccCc
Confidence            9999999999877 78999988774

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.98  E-value=9.8e-05  Score=67.15  Aligned_cols=75  Identities=20%  Similarity=0.153  Sum_probs=45.5

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCccc-ccceeeEEEeCCeeEEEEEe
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH-LVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~e~  175 (419)
                      +.|..|-...||+....++     .++.|++|+....... .-...+|+.++..+...+ .+++++.+.    ..+||||
T Consensus         4 ~~l~gG~tN~~~~v~~~~~-----~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~   73 (235)
T cd05157           4 KRFTGGITNKLVKVSNKED-----NQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEF   73 (235)
T ss_pred             EEcCCcccceEEEEEcCCC-----CCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEe
Confidence            4577788889998753210     2357889987643221 112236888888775433 344444332    2489999


Q ss_pred             cCCCCh
Q 014736          176 MPRGSL  181 (419)
Q Consensus       176 ~~~g~L  181 (419)
                      ++|.++
T Consensus        74 i~G~~l   79 (235)
T cd05157          74 IPGRTL   79 (235)
T ss_pred             eCCCcC
Confidence            998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.98  E-value=0.00013  Score=68.83  Aligned_cols=77  Identities=12%  Similarity=0.034  Sum_probs=54.3

Q ss_pred             CCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCc---ccccceeeEEEe---CCe
Q 014736           95 SNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRH---PHLVRLIGYCCE---DEE  168 (419)
Q Consensus        95 ~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~~~~~~~~---~~~  168 (419)
                      ..+.||.|..+.||.....+        ..+++|..+.  ......+..|.+.|+.|.-   -.+.++++++..   .+.
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~--------~~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~   87 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQ--------GNPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP   87 (297)
T ss_pred             eeeecCCccceeEEEEEcCC--------CCEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence            34569999999999974222        2477777542  1123577789999888742   467888887754   366


Q ss_pred             eEEEEEecCCCCh
Q 014736          169 RLLVYEFMPRGSL  181 (419)
Q Consensus       169 ~~lv~e~~~~g~L  181 (419)
                      .+||||+++|.++
T Consensus        88 ~~LVmE~i~G~~~  100 (297)
T PRK10593         88 DVLLLERLRGVSV  100 (297)
T ss_pred             eEEEEeccCCEec
Confidence            8999999998765

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.97  E-value=0.00011  Score=64.41  Aligned_cols=125  Identities=27%  Similarity=0.349  Sum_probs=86.4

Q ss_pred             cCCCCCCeecccCc-eEEEEEEEcCcccccccccEEEEEEecc---CCc-------c-----------cHHHHHHHHHHH
Q 014736           91 QNFSSNYLLGEGGF-GTVHKGYIDDDLRQGLKAQAVAVKLLDI---EGL-------Q-----------GHREWLAEVIFL  148 (419)
Q Consensus        91 ~~y~~~~~lg~G~f-g~Vy~a~~~~~~~~~~~~~~vavK~~~~---~~~-------~-----------~~~~~~~E~~~l  148 (419)
                      .+++.++.||.|.- |.||++.+.        ++.||+|++..   ...       .           ....|..|.+..
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAf  108 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAF  108 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhh
Confidence            68889999999999 999999754        46899999321   110       0           012366777776


Q ss_pred             cCC---Ccccc--cceeeEEEeCC------------------eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHH
Q 014736          149 GQL---RHPHL--VRLIGYCCEDE------------------ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA  205 (419)
Q Consensus       149 ~~l---~hpnI--v~~~~~~~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi  205 (419)
                      .+|   .+.++  |+.+||..-..                  ...||.||+....               .....-+.+|
T Consensus       109 gRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------~~~~~~~~~~  173 (207)
T PF13095_consen  109 GRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------PLQIRDIPQM  173 (207)
T ss_pred             HHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------ccchhHHHHH
Confidence            666   45566  88888873221                  1256777765432               1123346677


Q ss_pred             HHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       206 ~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      .+-|..+|  ..||+-+|+++.|..     .-||+|||.+
T Consensus       174 ~~dl~~~~--k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  174 LRDLKILH--KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHH--HCCeeeccCcccccc-----CCEEEecccC
Confidence            77888999  778999999999986     2389999864

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.93  E-value=0.00016  Score=68.67  Aligned_cols=154  Identities=16%  Similarity=0.120  Sum_probs=86.1

Q ss_pred             HHHHHHhcCCCC-----CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcc--cc
Q 014736           84 SELRAITQNFSS-----NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP--HL  156 (419)
Q Consensus        84 ~~~~~~~~~y~~-----~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nI  156 (419)
                      .++..+.++|.+     ++.++.|....||+....        +..+++|+.....  ....+..|++++..|...  .+
T Consensus        10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~--------~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pv   79 (307)
T TIGR00938        10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD--------VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPV   79 (307)
T ss_pred             HHHHHHHHhcCCCCceeccccCCccccceEEEEeC--------CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCC
Confidence            445555556654     345777777889987422        2358889875421  223445566766666322  23


Q ss_pred             cceeeE------EEeCCeeEEEEEecCCCChhh-----------hh---hhc-cC--CC-------CCHHHHH-------
Q 014736          157 VRLIGY------CCEDEERLLVYEFMPRGSLEN-----------HL---FKR-IS--VS-------LPWGTRL-------  199 (419)
Q Consensus       157 v~~~~~------~~~~~~~~lv~e~~~~g~L~~-----------~l---~~~-~~--~~-------~~~~~~~-------  199 (419)
                      .+++..      ...++..+++|+|++|..+..           .+   ... ..  ..       ..|....       
T Consensus        80 p~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~  159 (307)
T TIGR00938        80 PKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAA  159 (307)
T ss_pred             CccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcc
Confidence            444331      123466789999998865421           00   000 00  00       0111000       


Q ss_pred             -----HHHHHHHHHHHHhhc-----CCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          200 -----KIAIGAAKGLAFLHG-----AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       200 -----~i~~qi~~al~~lH~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                           .....+...++++..     ...+++|+|+++.||+++.++.+.|+||+.+..
T Consensus       160 ~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       160 PQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             cccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence                 001122334555531     357899999999999999988778999988763

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.81  E-value=0.00015  Score=68.70  Aligned_cols=81  Identities=17%  Similarity=0.173  Sum_probs=47.8

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccc-cceeeEEEeCCeeEEEEEe
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHL-VRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~  175 (419)
                      +.|..|--..||+....+.......++.+++|+..... .......+|.+++..+...++ .++++++.    -.+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence            34555666789988643321122345789999976432 222344568888777753333 45555543    2468999


Q ss_pred             cCCCChh
Q 014736          176 MPRGSLE  182 (419)
Q Consensus       176 ~~~g~L~  182 (419)
                      ++|..+.
T Consensus        79 i~G~~l~   85 (302)
T cd05156          79 IPSRTLT   85 (302)
T ss_pred             eCCCcCC
Confidence            9887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.77  E-value=1.9e-05  Score=73.15  Aligned_cols=146  Identities=15%  Similarity=0.119  Sum_probs=95.8

Q ss_pred             CCHHHHHHHhcC---CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-----------------ccH--
Q 014736           81 FQLSELRAITQN---FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-----------------QGH--  138 (419)
Q Consensus        81 ~~~~~~~~~~~~---y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-----------------~~~--  138 (419)
                      +.+-.+..+.++   +.+++.||-|.-+.||.+-..       .|.+.++|+-..-..                 ..+  
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~-------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWly  151 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADE-------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLY  151 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecC-------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhh
Confidence            344445555443   678899999999999998543       357788886431100                 001  


Q ss_pred             ---HHHHHHHHHHcCCC-c-ccccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhh
Q 014736          139 ---REWLAEVIFLGQLR-H-PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH  213 (419)
Q Consensus       139 ---~~~~~E~~~l~~l~-h-pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH  213 (419)
                         -...+|+..|+.|. | --+.+.++    .+..++|||++.|-.|...-.     -.   ....+...+..-+.-|-
T Consensus       152 LSRlaa~kEfafmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-----v~---d~~~ly~~lm~~Iv~la  219 (465)
T KOG2268|consen  152 LSRLAATKEFAFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRH-----VE---DPPTLYDDLMGLIVRLA  219 (465)
T ss_pred             hHHHHHHHHHHHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeee-----cC---ChHHHHHHHHHHHHHHH
Confidence               12356888888774 3 22444544    456789999999888855431     11   12233444444455566


Q ss_pred             cCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       214 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                        ++|+||+|..--||++++++.++++||--...
T Consensus       220 --~~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  220 --NHGLIHGDFNEFNIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             --HcCceecccchheeEEecCCCEEEeechHhhc
Confidence              78899999999999999999999999976543

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.66  E-value=0.0012  Score=64.61  Aligned_cols=76  Identities=16%  Similarity=0.075  Sum_probs=51.5

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccC------C-cccHHHHHHHHHHHcCCC---cccccceeeEEEeC
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE------G-LQGHREWLAEVIFLGQLR---HPHLVRLIGYCCED  166 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~  166 (419)
                      +.||-|.+..||++...++      ++.|+||.-...      . .-...++..|.+.|..+.   ..++++++.+  +.
T Consensus        32 ~elggGn~N~VyrV~~~~g------~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~  103 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEG------GKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DE  103 (401)
T ss_pred             eEcCCCceEEEEEEEeCCC------CeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CC
Confidence            4689999999999864321      247999985421      1 123456677888887763   3457777665  44


Q ss_pred             CeeEEEEEecCCCC
Q 014736          167 EERLLVYEFMPRGS  180 (419)
Q Consensus       167 ~~~~lv~e~~~~g~  180 (419)
                      +..++||||+++..
T Consensus       104 ~~~~lVME~L~~~~  117 (401)
T PRK09550        104 ELAVTVMEDLSDHK  117 (401)
T ss_pred             CCCEEEEecCCCcc
Confidence            66789999997643

>PLN02236 choline kinase

Probab=97.45  E-value=0.0015  Score=63.10  Aligned_cols=143  Identities=17%  Similarity=0.113  Sum_probs=79.6

Q ss_pred             eecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccc-cceeeEEEeCCeeEEEEEec
Q 014736           98 LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHL-VRLIGYCCEDEERLLVYEFM  176 (419)
Q Consensus        98 ~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~  176 (419)
                      .|-.|-.-.+|++.+.+.  ....++.|++|+.......... ..+|+.+++.+..-++ .++++.+.. +   .|++|+
T Consensus        43 ~l~gGlTN~~y~v~~~~~--~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi  115 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTK--EGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFI  115 (344)
T ss_pred             EcCCcccceeEEEEeCCC--CCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEee
Confidence            454577778999865432  1123467999988654322222 2468888888754444 355565532 2   589999


Q ss_pred             CCCChhhh--------------hh---hc---cCC-CCCHHHHHHHHHHH-----------------HHHHHH----hh-
Q 014736          177 PRGSLENH--------------LF---KR---ISV-SLPWGTRLKIAIGA-----------------AKGLAF----LH-  213 (419)
Q Consensus       177 ~~g~L~~~--------------l~---~~---~~~-~~~~~~~~~i~~qi-----------------~~al~~----lH-  213 (419)
                      ++.+|...              +.   ..   ... ...+.....+..++                 ...+..    +. 
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            87766421              00   00   000 11122222222111                 111111    11 


Q ss_pred             -cCCCCeeecCCCCCcEEEcC-CCcEEEeccCcccc
Q 014736          214 -GAENPVIYRDFKTSNILLDS-DFTAKLSDFGLAKM  247 (419)
Q Consensus       214 -~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~  247 (419)
                       .....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             11346899999999999986 46799999988763

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.30  E-value=0.0026  Score=59.32  Aligned_cols=31  Identities=29%  Similarity=0.438  Sum_probs=26.0

Q ss_pred             CCeeecCCCCCcEEEcCCCc-EEEeccCcccc
Q 014736          217 NPVIYRDFKTSNILLDSDFT-AKLSDFGLAKM  247 (419)
Q Consensus       217 ~~ivH~Dlkp~NIll~~~~~-~kl~DfGla~~  247 (419)
                      ..++|+|+++.|||+++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            34899999999999997555 46999998874

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.30  E-value=1.4e-05  Score=86.73  Aligned_cols=159  Identities=14%  Similarity=0.032  Sum_probs=114.9

Q ss_pred             HHHHHHHHcCCCcccccceeeEEEe--CCeeEEEEEecCCCChhhhhhhccCCC--CCHHHHHHHHHHHHHHHHHhhcC-
Q 014736          141 WLAEVIFLGQLRHPHLVRLIGYCCE--DEERLLVYEFMPRGSLENHLFKRISVS--LPWGTRLKIAIGAAKGLAFLHGA-  215 (419)
Q Consensus       141 ~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~i~~qi~~al~~lH~~-  215 (419)
                      .+.|...++...|+++.....-...  +...|..++|+.+|.+.+.+.+.....  +...-+.....+.+.+..-+|+. 
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            3445555666789988776554432  345689999999999999987653322  22222333333436667777754 


Q ss_pred             --CCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHH
Q 014736          216 --ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLEL  293 (419)
Q Consensus       216 --~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  293 (419)
                        .+--+|++||+-|.+|..+-.+|++++|+.+....  .....+...+++.|+.+++.+.-.++.++|+|..|+.+|++
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence              23378999999999999999999999999983221  11223446688999999999888999999999999999999


Q ss_pred             HcCCCCCC
Q 014736          294 LTGRRSMD  301 (419)
Q Consensus       294 ltg~~pf~  301 (419)
                      -.|..+|-
T Consensus      1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred             hcccHHHH
Confidence            88877663

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.21  E-value=0.0053  Score=58.00  Aligned_cols=120  Identities=20%  Similarity=0.259  Sum_probs=72.4

Q ss_pred             ccEEEEEEecc--CCcccHHHHHHHHHHHcCCCc--ccccceeeEEEeCC--eeEEEEEecCCCChhhhhhhccCCCCCH
Q 014736          122 AQAVAVKLLDI--EGLQGHREWLAEVIFLGQLRH--PHLVRLIGYCCEDE--ERLLVYEFMPRGSLENHLFKRISVSLPW  195 (419)
Q Consensus       122 ~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~  195 (419)
                      ++.++++ ...  ..........+|+.+++.+.-  .-+...+++|.++.  ..|.||+|++|..+.+.+.....     
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~-----  121 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESL-----  121 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccc-----
Confidence            5678888 331  122334555678888777642  23344566665554  67999999988544332211100     


Q ss_pred             HHHHHHH-HHHHHHHHHhh--------------------------------------------------c------CCCC
Q 014736          196 GTRLKIA-IGAAKGLAFLH--------------------------------------------------G------AENP  218 (419)
Q Consensus       196 ~~~~~i~-~qi~~al~~lH--------------------------------------------------~------~~~~  218 (419)
                      .  ..++ ..++..|.-||                                                  .      ....
T Consensus       122 ~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~  199 (321)
T COG3173         122 G--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPV  199 (321)
T ss_pred             h--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCce
Confidence            0  0111 13333333333                                                  2      1245


Q ss_pred             eeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       219 ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++|+|+.+.||+++.++.+-++||+++....
T Consensus       200 lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         200 LVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             eeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            9999999999999999889999999998643

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.08  E-value=0.0059  Score=58.05  Aligned_cols=32  Identities=16%  Similarity=0.211  Sum_probs=28.7

Q ss_pred             CCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       216 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..+++|+|+.+.|||+++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45799999999999999999999999987764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.98  E-value=0.002  Score=57.57  Aligned_cols=30  Identities=33%  Similarity=0.382  Sum_probs=21.4

Q ss_pred             CCeeecCCCCCcEEE-cCCCcEEEeccCccc
Q 014736          217 NPVIYRDFKTSNILL-DSDFTAKLSDFGLAK  246 (419)
Q Consensus       217 ~~ivH~Dlkp~NIll-~~~~~~kl~DfGla~  246 (419)
                      ..++|+||.+.|||+ +.++.++|+||..|.
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            458999999999999 888999999998776

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.93  E-value=0.005  Score=54.40  Aligned_cols=102  Identities=14%  Similarity=0.067  Sum_probs=67.8

Q ss_pred             EEEEEeccCCcc-cHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHH
Q 014736          125 VAVKLLDIEGLQ-GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI  203 (419)
Q Consensus       125 vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~  203 (419)
                      ..+|++..-... ...-|.++..++++++  .|+++..-  +.-.+.+|.|+|-....           .   . ..++.
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~---~-~N~i~  148 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------N---F-SNFIT  148 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------c---h-hHHHH
Confidence            556655432222 3455678888888774  46666521  33345689999832111           0   1 12222


Q ss_pred             HHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       204 qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      .=+.+|.-.|+.+.+.+|+|..|+|||-|..|.+||.|-+..
T Consensus       149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence            225678889988889999999999999999999999997654

The function of this family is unknown.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.87  E-value=0.0089  Score=56.84  Aligned_cols=140  Identities=15%  Similarity=0.054  Sum_probs=87.9

Q ss_pred             CCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHH------------------------HHHHHHHHH
Q 014736           95 SNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHR------------------------EWLAEVIFL  148 (419)
Q Consensus        95 ~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~------------------------~~~~E~~~l  148 (419)
                      +...|..|--+.||.|.-.       .|..+|||+.+..-.  .+..                        -...|+..|
T Consensus       148 inGCiSTGKEANVYHat~~-------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNL  220 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEE-------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNL  220 (520)
T ss_pred             cccccccCccceeEeeecC-------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHH
Confidence            3446778889999998533       356799998753211  1110                        023577778


Q ss_pred             cCCCcccccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCc
Q 014736          149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSN  228 (419)
Q Consensus       149 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~N  228 (419)
                      .+|+...|.-.--+..  ....|||+|+ |.+=+-.= ......++...+..+-.|++..|.-|.. .-++||.||.--|
T Consensus       221 kRl~~aGIP~PePIlL--k~hVLVM~Fl-Grdgw~aP-kLKd~~ls~~ka~~~Y~~~v~~MR~lY~-~c~LVHADLSEfN  295 (520)
T KOG2270|consen  221 KRLNNAGIPCPEPILL--KNHVLVMEFL-GRDGWAAP-KLKDASLSTSKARELYQQCVRIMRRLYQ-KCRLVHADLSEFN  295 (520)
T ss_pred             HHHHhcCCCCCCceee--ecceEeeeec-cCCCCcCc-ccccccCChHHHHHHHHHHHHHHHHHHH-Hhceeccchhhhh
Confidence            7776555433322222  2347999999 43322110 1112345555667777777777766652 3459999999999


Q ss_pred             EEEcCCCcEEEeccCcccc
Q 014736          229 ILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       229 Ill~~~~~~kl~DfGla~~  247 (419)
                      +|+.+ |.+.|+|.+-+..
T Consensus       296 ~Lyhd-G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  296 LLYHD-GKLYIIDVSQSVE  313 (520)
T ss_pred             heEEC-CEEEEEEcccccc
Confidence            99875 5899999987764

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.82  E-value=0.0031  Score=60.59  Aligned_cols=61  Identities=18%  Similarity=0.097  Sum_probs=39.7

Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS  233 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~  233 (419)
                      ..|+=+|..|.++..++...   ..++....+++.--+.|+--+-- -.+++|.|+.|.||++--
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~-vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLI-VDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             ceeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHH-hhcceecccCCCcEEEEe
Confidence            35666788888888887654   34444455555544455433321 234999999999999954

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.80  E-value=0.0094  Score=56.58  Aligned_cols=30  Identities=23%  Similarity=0.286  Sum_probs=26.3

Q ss_pred             CCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       216 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      ..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            467999999999999998 678999998765

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.78  E-value=0.016  Score=55.63  Aligned_cols=142  Identities=15%  Similarity=0.152  Sum_probs=76.2

Q ss_pred             eecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccc-cceeeEEEeCCeeEEEEEec
Q 014736           98 LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHL-VRLIGYCCEDEERLLVYEFM  176 (419)
Q Consensus        98 ~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~  176 (419)
                      .|..|---.+|+....+.   ......|++|+........ -...+|..+++.+..-++ .++++++. ++   +|.+|+
T Consensus        21 ~l~gGlTN~~~~v~~~~~---~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi   92 (330)
T PLN02421         21 RISGGITNLLLKVSVKEE---NGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFI   92 (330)
T ss_pred             EeCCcccceEEEEEecCC---CCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhh
Confidence            344466677888754321   1123478999886432211 122458888888865555 45565552 22   589999


Q ss_pred             CCCChhhh-------h-------hhccC------CCC-CHHHHHHHHHHH-------------------------HHHHH
Q 014736          177 PRGSLENH-------L-------FKRIS------VSL-PWGTRLKIAIGA-------------------------AKGLA  210 (419)
Q Consensus       177 ~~g~L~~~-------l-------~~~~~------~~~-~~~~~~~i~~qi-------------------------~~al~  210 (419)
                      +|..|...       +       .+-..      ... .+..+..+..++                         +..+.
T Consensus        93 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~  172 (330)
T PLN02421         93 NARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELK  172 (330)
T ss_pred             cCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHH
Confidence            87665210       1       00000      001 122222222211                         11111


Q ss_pred             -Hhhc--CCCCeeecCCCCCcEEEcC-CCcEEEeccCcccc
Q 014736          211 -FLHG--AENPVIYRDFKTSNILLDS-DFTAKLSDFGLAKM  247 (419)
Q Consensus       211 -~lH~--~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~  247 (419)
                       ++.+  ...-++|.|+.+.|||+++ ++.++++||..|..
T Consensus       173 ~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        173 EITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence             1211  1123799999999999975 57899999988764

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.73  E-value=0.0075  Score=56.48  Aligned_cols=73  Identities=18%  Similarity=0.190  Sum_probs=45.6

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC---CcccccceeeEEEeCCeeEEE
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL---RHPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~lv  172 (419)
                      .+.|+-|....+|+..        ..++.+.||+-...   ....|..|.+-|+.|   ..-.+.+++++....+..|||
T Consensus        22 ~~~v~GG~i~~a~~~~--------~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl   90 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--------TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL   90 (288)
T ss_dssp             EEEE--SSSSEEEEEE--------TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred             eEecCCCChhheEEEE--------CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence            3458889999999874        23578999988722   234566677777776   345688899998888888999


Q ss_pred             EEecCCC
Q 014736          173 YEFMPRG  179 (419)
Q Consensus       173 ~e~~~~g  179 (419)
                      |||++.+
T Consensus        91 le~l~~~   97 (288)
T PF03881_consen   91 LEFLEMG   97 (288)
T ss_dssp             EE-----
T ss_pred             EEeecCC
Confidence            9999766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.70  E-value=0.003  Score=62.29  Aligned_cols=164  Identities=23%  Similarity=0.302  Sum_probs=91.8

Q ss_pred             HHHHHHHHHHcCCCcccccceeeEEEeC-CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 014736          139 REWLAEVIFLGQLRHPHLVRLIGYCCED-EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN  217 (419)
Q Consensus       139 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~  217 (419)
                      ..++..+.+++.+.|+|....+++.... .+..+|||++ +.+|.+.+..+.....+          +      +   .+
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~~s----------~------~---~~   86 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKDES----------L------L---AH   86 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccchhh----------h------c---cc
Confidence            4566778889999999999998876443 4578899999 88999988665311110          0      0   12


Q ss_pred             CeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCC
Q 014736          218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR  297 (419)
Q Consensus       218 ~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~  297 (419)
                      |+.|-.     +       ++++| -++.                 . |  |-.     ..+++|||++|.++.++.-|.
T Consensus        87 ~~~~~~-----~-------~~~td-~~~t-----------------~-~--~~~-----~~pKsdVwsl~~i~~el~L~~  128 (725)
T KOG1093|consen   87 GVLHLN-----I-------IYITD-HFLT-----------------K-Y--PSP-----IGPKSDVWSLGFIILELYLGI  128 (725)
T ss_pred             ccceeh-----h-------hhccc-cccc-----------------c-C--CCC-----CCcchhhhhHHHHHHHHHHhh
Confidence            233332     1       23333 0000                 0 1  111     124999999999999999887


Q ss_pred             CCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 014736          298 RSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV  366 (419)
Q Consensus       298 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~ei  366 (419)
                      .-+......+   .......+.........+.-   ...+-..+...++++...|+-..|..||...+.
T Consensus       129 ~l~~~~~~s~---~l~~i~k~~~~d~~~~~~a~---e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~  191 (725)
T KOG1093|consen  129 SLEAELTESE---YLEILLKYYTDDQELLSTAM---EHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL  191 (725)
T ss_pred             HHHHHHHHHH---HHHHHHHhccCchhHHHHHH---HHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence            6554322111   11111111111110000000   012234556778899999999999888754433

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.65  E-value=0.028  Score=53.96  Aligned_cols=74  Identities=19%  Similarity=0.109  Sum_probs=45.5

Q ss_pred             eecccCceEEEEEEEcCcccccccccEEEEEEeccC------C-cccHHHHHHHHHHHcCCC--cc-cccceeeEEEeCC
Q 014736           98 LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE------G-LQGHREWLAEVIFLGQLR--HP-HLVRLIGYCCEDE  167 (419)
Q Consensus        98 ~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~--hp-nIv~~~~~~~~~~  167 (419)
                      .||-|....||++...+      .++.|+||.-...      . .-...+..-|.+.|+...  .| .++++|.  .+.+
T Consensus         2 EigdGnlN~VfrV~~~~------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e   73 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQE------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTE   73 (370)
T ss_pred             cCCCCceEEEEEEEcCC------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccc
Confidence            47999999999996321      1256999975311      1 122344556777776653  34 4555543  3455


Q ss_pred             eeEEEEEecCCC
Q 014736          168 ERLLVYEFMPRG  179 (419)
Q Consensus       168 ~~~lv~e~~~~g  179 (419)
                      ...+|||+++..
T Consensus        74 ~~~~vMEdL~~~   85 (370)
T TIGR01767        74 MAVTVMEDLSHH   85 (370)
T ss_pred             cceehHhhCccc
Confidence            667999999543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.56  E-value=0.036  Score=54.24  Aligned_cols=73  Identities=11%  Similarity=0.004  Sum_probs=47.3

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-------ccHHHHHHHHHHHcCCC---cccccceeeEEEe
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-------QGHREWLAEVIFLGQLR---HPHLVRLIGYCCE  165 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~  165 (419)
                      .+.||-|....||+....        ++.++||.-.....       ....+-..|.+.|+.+.   ..++.+++.++. 
T Consensus        37 ~~eiggGn~N~VyrV~~~--------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-  107 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-  107 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-
Confidence            456899999999997531        24588998652111       12333344566666553   357788887765 


Q ss_pred             CCeeEEEEEecCC
Q 014736          166 DEERLLVYEFMPR  178 (419)
Q Consensus       166 ~~~~~lv~e~~~~  178 (419)
                       +..+++||++++
T Consensus       108 -d~~vlvME~L~~  119 (418)
T PLN02756        108 -TMALIGMRYLEP  119 (418)
T ss_pred             -CCCEEEEeecCC
Confidence             456889999976

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.56  E-value=0.0078  Score=57.13  Aligned_cols=104  Identities=15%  Similarity=0.126  Sum_probs=70.3

Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      .+.|++|++- |++|.-.      ....++++..++.+.+..+.-+.. +-..-|||+.-.||||+ +|+|.|+||-+++
T Consensus       299 ~y~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         299 LYLYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             eEEEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeeee
Confidence            4567888876 6666332      234577888999988887777763 55699999999999999 9999999999999


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHH
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFG  287 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  287 (419)
                      ....+...       -....-.|-.+.| .-+..=+||-+-
T Consensus       370 l~~~q~~i-------sy~rldhp~lF~G-~dd~QFeIYrlM  402 (488)
T COG5072         370 LSYSQGII-------SYNRLDHPDLFNG-VDDYQFEIYRLM  402 (488)
T ss_pred             cccCCcee-------eccccCchhhhcC-ccceeeeHHHHH
Confidence            53333221       1122334555543 335666776543

>PTZ00384 choline kinase; Provisional

Probab=96.34  E-value=0.041  Score=53.80  Aligned_cols=81  Identities=11%  Similarity=0.063  Sum_probs=45.5

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccc-cceeeEEEeCCeeEEEEEe
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHL-VRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~  175 (419)
                      +.|..|--..+|++...+........+.|.+++.... ....-.-.+|+.+++.+...++ .++++.+.    .++|.||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence            3455577889999865432111111233555543211 1111122458888888865554 55666553    3699999


Q ss_pred             cCCCChh
Q 014736          176 MPRGSLE  182 (419)
Q Consensus       176 ~~~g~L~  182 (419)
                      ++|..|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9987764

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=96.26  E-value=0.024  Score=53.39  Aligned_cols=78  Identities=12%  Similarity=0.068  Sum_probs=45.7

Q ss_pred             cccCceEEEEEEEcC--cccccccccEEEEEEeccCCc-----ccHHHHHHHHHHHcCCC---------c----ccccce
Q 014736          100 GEGGFGTVHKGYIDD--DLRQGLKAQAVAVKLLDIEGL-----QGHREWLAEVIFLGQLR---------H----PHLVRL  159 (419)
Q Consensus       100 g~G~fg~Vy~a~~~~--~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---------h----pnIv~~  159 (419)
                      |.|-.|.+|++....  ..........++||.......     .....|.+|+.+...+-         +    ..+.+.
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            677889999987754  212334456799998762211     11234667777665541         1    223455


Q ss_pred             eeEEEeCCeeEEEEEecC
Q 014736          160 IGYCCEDEERLLVYEFMP  177 (419)
Q Consensus       160 ~~~~~~~~~~~lv~e~~~  177 (419)
                      +....+....+||||-+.
T Consensus        82 ~~~~~~~~~~~lvlEDL~   99 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDLS   99 (294)
T ss_pred             EEeccCCCceeeehhhhh
Confidence            554444446789998764

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.10  E-value=0.1  Score=46.62  Aligned_cols=57  Identities=25%  Similarity=0.290  Sum_probs=42.5

Q ss_pred             cEEEEEEeccCCcccHHHHHHHHHHHcCC---CcccccceeeEEEeCCeeEEEEEecCCCChh
Q 014736          123 QAVAVKLLDIEGLQGHREWLAEVIFLGQL---RHPHLVRLIGYCCEDEERLLVYEFMPRGSLE  182 (419)
Q Consensus       123 ~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~  182 (419)
                      ..+.||+-...   ....|..|+.-|..|   +.-++.+++.+..+.++.|+||||++-+.+.
T Consensus        40 ~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          40 DPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             cceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            56888876532   345677777766666   4466888899889999999999999876554

>PTZ00296 choline kinase; Provisional

Probab=95.93  E-value=0.075  Score=53.01  Aligned_cols=81  Identities=7%  Similarity=0.003  Sum_probs=46.0

Q ss_pred             CCeecccCceEEEEEEEcCccc--ccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCccccc-ceeeEEEeCCeeEEE
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLR--QGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV-RLIGYCCEDEERLLV  172 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~~~~~lv  172 (419)
                      ++.|..|---.+|++...+...  ....++.|.+|+.......-. ....|..+++.+..-+|- ++++.+.    -+.|
T Consensus       110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I  184 (442)
T PTZ00296        110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGRI  184 (442)
T ss_pred             EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence            3456666667888886543211  112256799998854322111 223477777776544443 4555542    3568


Q ss_pred             EEecCCCCh
Q 014736          173 YEFMPRGSL  181 (419)
Q Consensus       173 ~e~~~~g~L  181 (419)
                      .||++|..|
T Consensus       185 ~efi~g~~l  193 (442)
T PTZ00296        185 EEWLYGDPL  193 (442)
T ss_pred             EEeeCCccC
Confidence            999988744

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.83  E-value=0.05  Score=52.97  Aligned_cols=75  Identities=16%  Similarity=0.086  Sum_probs=47.3

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccC-----C-cccHHHHHHHHHHHcCCC--cc-cccceeeEEEeC
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-----G-LQGHREWLAEVIFLGQLR--HP-HLVRLIGYCCED  166 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~--hp-nIv~~~~~~~~~  166 (419)
                      .+.||-|.-..||++....      .++.|+||.-...     + .-..++..-|.+.|+.+.  .| .++++|.  .+.
T Consensus        34 ~~eigdGnlN~VfrV~~~~------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~  105 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQ------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDS  105 (409)
T ss_pred             eeEcCCCceEEEEEEeeCC------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECc
Confidence            4478999999999996421      1356899875321     1 123455566778777653  34 4555643  355


Q ss_pred             CeeEEEEEecCC
Q 014736          167 EERLLVYEFMPR  178 (419)
Q Consensus       167 ~~~~lv~e~~~~  178 (419)
                      ....+|||+++.
T Consensus       106 e~~~~vMEdL~~  117 (409)
T PRK12396        106 VMNCCVMEDLSD  117 (409)
T ss_pred             HHhhHHHHhCcc
Confidence            566788998854

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.74  E-value=0.33  Score=46.49  Aligned_cols=30  Identities=27%  Similarity=0.293  Sum_probs=25.3

Q ss_pred             CCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       216 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..++||+|+.+.|||++ + .+.|+||+.+..
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            56799999999999995 4 578999988763

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	419
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-56
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-56
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-54
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-53
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-43
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-42
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-42
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-39
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-28
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-27
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-22
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-22
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-22
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-21
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-21
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-21
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-21
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-21
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-21
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-21
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-21
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-21
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-21
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-21
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-21
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-21
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-21
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-21
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-21
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-21
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-21
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-21
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-21
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-21
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-21
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-21
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-21
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		9e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-20
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-20
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-20
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-20
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-20
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-20
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-20
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-20
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-20
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-20
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-20
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-20
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-20
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-20
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-20
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-20
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-20
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-20
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-20
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-20
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-19
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-19
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-19
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-19
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-19
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-18
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-18
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-18
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-18
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-18
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-18
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-18
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-18
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-18
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-18
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-18
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-18
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-18
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-18
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-18
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-17
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-17
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-17
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-17
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-17
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-17
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-17
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-17
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		9e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-17
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-16
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-16
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-16
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-16
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-16
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-16
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-16
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-16
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-16
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-16
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-16
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-16
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		8e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-16
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		9e-16
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-15
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-15
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-15
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-15
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-15
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-15
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-15
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-15
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-15
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-15
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		7e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-15
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-15
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-15
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		8e-15
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-15
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-15
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-15
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-15
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-15
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-15
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		9e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-14
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		7e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-14
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		8e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		9e-14
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-13
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-13
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-13
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-13
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-13
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-13
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		9e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		9e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		9e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		9e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		9e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		9e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		9e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-09
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		7e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		7e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-08
3soa_A	444	Full-Length Human Camkii Length = 444		2e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		7e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		8e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		9e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		9e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		8e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		8e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		9e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		7e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		8e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-06
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-05
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-05
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-05
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-05
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		6e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		7e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		8e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-04
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-04

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  216 bits (550), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 126/305 (41%), Positives = 180/305 (59%), Gaps = 12/305 (3%)
Query: 79  YDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH 138
           Y   L +L   T NF   +L+G G FG V+KG     LR G K   VA+K    E  QG 
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGV----LRDGAK---VALKRRTPESSQGI 79
Query: 139 REWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRI--SVSLPWG 196
            E+  E+  L   RHPHLV LIG+C E  E +L+Y++M  G+L+ HL+     ++S+ W 
Sbjct: 80  EEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE 139
Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV 256
            RL+I IGAA+GL +LH     +I+RD K+ NILLD +F  K++DFG++K G E   TH+
Sbjct: 140 QRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK 316
              V GT GY  PEY   G LT KSDVYSFGVVL E+L  R ++ +  P+   NL +WA 
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 317 PYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL 376
               ++ +L  IVDP LA +   +  ++    A++C++++ +DRP M  V+  LE  L L
Sbjct: 258 ES-HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316
Query: 377 KDMAV 381
           ++  +
Sbjct: 317 QESVI 321

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  216 bits (549), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 126/305 (41%), Positives = 180/305 (59%), Gaps = 12/305 (3%)
Query: 79  YDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH 138
           Y   L +L   T NF   +L+G G FG V+KG     LR G K   VA+K    E  QG 
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGV----LRDGAK---VALKRRTPESSQGI 79
Query: 139 REWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRI--SVSLPWG 196
            E+  E+  L   RHPHLV LIG+C E  E +L+Y++M  G+L+ HL+     ++S+ W 
Sbjct: 80  EEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE 139
Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV 256
            RL+I IGAA+GL +LH     +I+RD K+ NILLD +F  K++DFG++K G E   TH+
Sbjct: 140 QRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHL 197
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK 316
              V GT GY  PEY   G LT KSDVYSFGVVL E+L  R ++ +  P+   NL +WA 
Sbjct: 198 XXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 317 PYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL 376
               ++ +L  IVDP LA +   +  ++    A++C++++ +DRP M  V+  LE  L L
Sbjct: 258 ES-HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316
Query: 377 KDMAV 381
           ++  +
Sbjct: 317 QESVI 321

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  209 bits (531), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 124/297 (41%), Positives = 180/297 (60%), Gaps = 15/297 (5%)
Query: 81  FQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-HR 139
           F L EL+  + NFS+  +LG GGFG V+KG + D          VAVK L  E  QG   
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-------GTLVAVKRLKEERXQGGEL 80
Query: 140 EWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLP--WGT 197
           ++  EV  +    H +L+RL G+C    ERLLVY +M  GS+ + L +R     P  W  
Sbjct: 81  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 140
Query: 198 RLKIAIGAAKGLAFLHGAENP-VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV 256
           R +IA+G+A+GLA+LH   +P +I+RD K +NILLD +F A + DFGLAK+  +  + HV
Sbjct: 141 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDXHV 199
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQN--LVDW 314
              V GT G+ APEY+STG  + K+DV+ +GV+LLEL+TG+R+ D  R  ++ +  L+DW
Sbjct: 200 XXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 259
Query: 315 AKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
            K  L+  ++L  +VD  L G Y  +  +++  +AL C   +P +RPKM+ VV  LE
Sbjct: 260 VKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  205 bits (521), Expect = 5e-53,   Method: Compositional matrix adjust.
 Identities = 122/297 (41%), Positives = 178/297 (59%), Gaps = 15/297 (5%)
Query: 81  FQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-HR 139
           F L EL+  + NF +  +LG GGFG V+KG + D          VAVK L  E  QG   
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLAD-------GXLVAVKRLKEERTQGGEL 72
Query: 140 EWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLP--WGT 197
           ++  EV  +    H +L+RL G+C    ERLLVY +M  GS+ + L +R     P  W  
Sbjct: 73  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132
Query: 198 RLKIAIGAAKGLAFLHGAENP-VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV 256
           R +IA+G+A+GLA+LH   +P +I+RD K +NILLD +F A + DFGLAK+  +  + HV
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDXHV 191
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQN--LVDW 314
              V G  G+ APEY+STG  + K+DV+ +GV+LLEL+TG+R+ D  R  ++ +  L+DW
Sbjct: 192 XXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 315 AKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
            K  L+  ++L  +VD  L G Y  +  +++  +AL C   +P +RPKM+ VV  LE
Sbjct: 252 VKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 111/311 (35%), Positives = 171/311 (54%), Gaps = 33/311 (10%)
Query: 78  LYDFQLSELRAITQNFSSNYL------LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--- 128
            + F   EL+ +T NF    +      +GEGGFG V+KGY+++          VAVK   
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--------TTVAVKKLA 63
Query: 129 -LLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK 187
            ++DI   +  +++  E+  + + +H +LV L+G+  + ++  LVY +MP GSL      
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL----LD 119
Query: 188 RISV-----SLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF 242
           R+S       L W  R KIA GAA G+ FLH  EN  I+RD K++NILLD  FTAK+SDF
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDF 177
Query: 243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDK 302
           GLA+   + + T + +R++GT  Y APE +  G +T KSD+YSFGVVLLE++TG  ++D+
Sbjct: 178 GLARASEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 303 LRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK 362
            R    Q L+D  +      + +   +D ++    S    + M  +A QC+      RP 
Sbjct: 237 HR--EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVASQCLHEKKNKRPD 293
Query: 363 MAAVVATLESL 373
           +  V   L+ +
Sbjct: 294 IKKVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  171 bits (432), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 111/311 (35%), Positives = 170/311 (54%), Gaps = 33/311 (10%)
Query: 78  LYDFQLSELRAITQNFSSNYL------LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--- 128
            + F   EL+ +T NF    +      +GEGGFG V+KGY+++          VAVK   
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--------TTVAVKKLA 63
Query: 129 -LLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK 187
            ++DI   +  +++  E+  + + +H +LV L+G+  + ++  LVY +MP GSL      
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL----LD 119
Query: 188 RISV-----SLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF 242
           R+S       L W  R KIA GAA G+ FLH  EN  I+RD K++NILLD  FTAK+SDF
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDF 177
Query: 243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDK 302
           GLA+   + + T +  R++GT  Y APE +  G +T KSD+YSFGVVLLE++TG  ++D+
Sbjct: 178 GLARASEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 303 LRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK 362
            R    Q L+D  +      + +   +D ++    S    + M  +A QC+      RP 
Sbjct: 237 HR--EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVASQCLHEKKNKRPD 293
Query: 363 MAAVVATLESL 373
           +  V   L+ +
Sbjct: 294 IKKVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 110/311 (35%), Positives = 169/311 (54%), Gaps = 33/311 (10%)
Query: 78  LYDFQLSELRAITQNFSSNYL------LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--- 128
            + F   EL+ +T NF    +      +GEGGFG V+KGY+++          VAVK   
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--------TTVAVKKLA 57
Query: 129 -LLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK 187
            ++DI   +  +++  E+  + + +H +LV L+G+  + ++  LVY +MP GSL      
Sbjct: 58  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL----LD 113
Query: 188 RISV-----SLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF 242
           R+S       L W  R KIA GAA G+ FLH  EN  I+RD K++NILLD  FTAK+SDF
Sbjct: 114 RLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDF 171
Query: 243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDK 302
           GLA+   + +   +  R++GT  Y APE +  G +T KSD+YSFGVVLLE++TG  ++D+
Sbjct: 172 GLARASEKFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 230
Query: 303 LRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK 362
            R    Q L+D  +      + +   +D ++    S    + M  +A QC+      RP 
Sbjct: 231 HR--EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVASQCLHEKKNKRPD 287
Query: 363 MAAVVATLESL 373
           +  V   L+ +
Sbjct: 288 IKKVQQLLQEM 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 96/242 (39%), Positives = 140/242 (57%), Gaps = 30/242 (12%)
Query: 78  LYDFQLSELRAITQNFSSNYL------LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--- 128
            + F   EL+ +T NF    +       GEGGFG V+KGY+++          VAVK   
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN--------TTVAVKKLA 54
Query: 129 -LLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK 187
            ++DI   +  +++  E+    + +H +LV L+G+  + ++  LVY + P GSL      
Sbjct: 55  AMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSL----LD 110
Query: 188 RISV-----SLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF 242
           R+S       L W  R KIA GAA G+ FLH  EN  I+RD K++NILLD  FTAK+SDF
Sbjct: 111 RLSCLDGTPPLSWHXRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDF 168
Query: 243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDK 302
           GLA+   + +     +R++GT  Y APE +  G +T KSD+YSFGVVLLE++TG  ++D+
Sbjct: 169 GLARASEKFAQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 227
Query: 303 LR 304
            R
Sbjct: 228 HR 229

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 129/279 (46%), Gaps = 29/279 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR--EWLAEVIFLGQLRHPHL 156
           +G G FGTVH        R       VAVK+L  +     R  E+L EV  + +LRHP++
Sbjct: 45  IGAGSFGTVH--------RAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKR-ISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           V  +G   +     +V E++ RGSL   L K      L    RL +A   AKG+ +LH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
             P+++RD K+ N+L+D  +T K+ DFGL+++  + S    +    GT  + APE +   
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 276 HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAG 335
               KSDVYSFGV+L EL T ++    L P      V +    L   R L          
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN--------- 265
Query: 336 QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                   ++A +   C +  P  RP  A ++  L  L+
Sbjct: 266 -------PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 129/279 (46%), Gaps = 29/279 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR--EWLAEVIFLGQLRHPHL 156
           +G G FGTVH        R       VAVK+L  +     R  E+L EV  + +LRHP++
Sbjct: 45  IGAGSFGTVH--------RAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKR-ISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           V  +G   +     +V E++ RGSL   L K      L    RL +A   AKG+ +LH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
             P+++R+ K+ N+L+D  +T K+ DFGL+++  + S    +    GT  + APE +   
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 276 HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAG 335
               KSDVYSFGV+L EL T ++    L P      V +    L   R L          
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLN--------- 265
Query: 336 QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                   ++A +   C +  P  RP  A ++  L  L+
Sbjct: 266 -------PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 137/289 (47%), Gaps = 42/289 (14%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEG----LQGHREWLAEVIFLGQL 151
           +G+GGFG VHKG +  D         VA+K L   D EG    ++  +E+  EV  +  L
Sbjct: 27  IGKGGFGLVHKGRLVKD------KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
            HP++V+L G         +V EF+P G L + L  + +  + W  +L++ +  A G+ +
Sbjct: 81  NHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEY 137
Query: 212 LHGAENPVIYRDFKTSNILLDS-----DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +     P+++RD ++ NI L S        AK++DFGL++      + H  + ++G + +
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQW 192
Query: 267 AAPEYISTGH--LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
            APE I       T K+D YSF ++L  +LTG    D+      + +    +  LR +  
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT-- 250
Query: 325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           +     PRL             V+ L C S +PK RP  + +V  L  L
Sbjct: 251 IPEDCPPRLRN-----------VIEL-CWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 82/289 (28%), Positives = 136/289 (47%), Gaps = 42/289 (14%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEG----LQGHREWLAEVIFLGQL 151
           +G+GGFG VHKG +  D         VA+K L   D EG    ++  +E+  EV  +  L
Sbjct: 27  IGKGGFGLVHKGRLVKD------KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
            HP++V+L G         +V EF+P G L + L  + +  + W  +L++ +  A G+ +
Sbjct: 81  NHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEY 137
Query: 212 LHGAENPVIYRDFKTSNILLDS-----DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +     P+++RD ++ NI L S        AK++DFG ++      + H  + ++G + +
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGLLGNFQW 192
Query: 267 AAPEYISTGH--LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
            APE I       T K+D YSF ++L  +LTG    D+      + +    +  LR +  
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT-- 250
Query: 325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           +     PRL             V+ L C S +PK RP  + +V  L  L
Sbjct: 251 IPEDCPPRLRN-----------VIEL-CWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 138/289 (47%), Gaps = 42/289 (14%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEG----LQGHREWLAEVIFLGQL 151
           +G+GGFG VHKG +  D         VA+K L   D EG    ++  +E+  EV  +  L
Sbjct: 27  IGKGGFGLVHKGRLVKD------KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
            HP++V+L G    +  R+ V EF+P G L + L  + +  + W  +L++ +  A G+ +
Sbjct: 81  NHPNIVKLYG-LMHNPPRM-VMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEY 137
Query: 212 LHGAENPVIYRDFKTSNILLDS-----DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +     P+++RD ++ NI L S        AK++DF L++      + H  + ++G + +
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLGNFQW 192
Query: 267 AAPEYISTGH--LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
            APE I       T K+D YSF ++L  +LTG    D+      + +    +  LR +  
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT-- 250
Query: 325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           +     PRL             V+ L C S +PK RP  + +V  L  L
Sbjct: 251 IPEDCPPRLRN-----------VIEL-CWSGDPKKRPHFSYIVKELSEL 287

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/213 (38%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 93  FSSNYL-----LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVI 146
           F   YL     LGEG FG V   Y  D    G   + VAVK L  +    HR  W  E+ 
Sbjct: 28  FHKRYLKKIRDLGEGHFGKV-SLYCYDPTNDG-TGEMVAVKALKADAGPQHRSGWKQEID 85
Query: 147 FLGQLRHPHLVRLIGYCCEDE---ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
            L  L H H+++  G CCED       LV E++P GSL ++L  R S+ L     L  A 
Sbjct: 86  ILRTLYHEHIIKYKG-CCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGL--AQLLLFAQ 141
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH-VTTRVMG 262
              +G+A+LH      I+RD    N+LLD+D   K+ DFGLAK  PEG   + V      
Sbjct: 142 QICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDS 199
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
              + APE +        SDV+SFGV L ELLT
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI-----EGLQGHREWLAEVIFLGQLRH 153
           +G G FGTV+KG    D         VAVK+L++     + LQ  +    EV  L + RH
Sbjct: 43  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRH 90
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            +++  +GY  +  +  +V ++    SL +HL   I         + IA   A+G+ +LH
Sbjct: 91  VNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLH 148
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI- 272
                +I+RD K++NI L  D T K+ DFGLA +    S +H   ++ G+  + APE I 
Sbjct: 149 AKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 206
Query: 273 --STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
                  + +SDVY+FG+VL EL+TG+     +  + +Q +    + YL           
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGYL----------S 255
Query: 331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           P L+   S    K M  L  +C+     +RP    ++A++E L
Sbjct: 256 PDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIELL 297

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI-----EGLQGHREWLAEVIFLGQLRH 153
           +G G FGTV+KG    D         VAVK+L++     + LQ  +    EV  L + RH
Sbjct: 18  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRH 65
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            +++  +GY  +  +  +V ++    SL +HL   I         + IA   A+G+ +LH
Sbjct: 66  VNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLH 123
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI- 272
                +I+RD K++NI L  D T K+ DFGLA +    S +H   ++ G+  + APE I 
Sbjct: 124 AKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 181
Query: 273 --STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
                  + +SDVY+FG+VL EL+TG+     +  + +Q +    + YL           
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGYL----------S 230
Query: 331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           P L+   S    K M  L  +C+     +RP    ++A++E L
Sbjct: 231 PDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIELL 272

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI-----EGLQGHREWLAEVIFLGQLRH 153
           +G G FGTV+KG    D         VAVK+L++     + LQ  +    EV  L + RH
Sbjct: 21  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRH 68
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            +++  +GY  +  +  +V ++    SL +HL   I         + IA   A+G+ +LH
Sbjct: 69  VNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLH 126
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI- 272
                +I+RD K++NI L  D T K+ DFGLA +    S +H   ++ G+  + APE I 
Sbjct: 127 AKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 273 --STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
                  + +SDVY+FG+VL EL+TG+     +  + +Q +    + YL           
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGYL----------S 233
Query: 331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           P L+   S    K M  L  +C+     +RP    ++A++E L
Sbjct: 234 PDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIELL 275

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI-----EGLQGHREWLAEVIFLGQLRH 153
           +G G FGTV+KG    D         VAVK+L++     + LQ  +    EV  L + RH
Sbjct: 44  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRH 91
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            +++  +GY  +  +  +V ++    SL +HL   I         + IA   A+G+ +LH
Sbjct: 92  VNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLH 149
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI- 272
                +I+RD K++NI L  D T K+ DFGLA +    S +H   ++ G+  + APE I 
Sbjct: 150 AKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 273 --STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
                  + +SDVY+FG+VL EL+TG+     +  + +Q +    + YL           
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGYL----------S 256
Query: 331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           P L+   S    K M  L  +C+     +RP    ++A++E L
Sbjct: 257 PDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIELL 298

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/213 (38%), Positives = 107/213 (50%), Gaps = 18/213 (8%)
Query: 93  FSSNYL-----LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVI 146
           F   YL     LGEG FG V   Y  D    G   + VAVK L  +    HR  W  E+ 
Sbjct: 11  FHKRYLKKIRDLGEGHFGKV-SLYCYDPTNDG-TGEMVAVKALKADCGPQHRSGWKQEID 68
Query: 147 FLGQLRHPHLVRLIGYCCED--EERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
            L  L H H+++  G CCED  E+ L LV E++P GSL ++L  R S+ L     L  A 
Sbjct: 69  ILRTLYHEHIIKYKG-CCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGL--AQLLLFAQ 124
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH-VTTRVMG 262
              +G+A+LH      I+R+    N+LLD+D   K+ DFGLAK  PEG   + V      
Sbjct: 125 QICEGMAYLHAQH--YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 182
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
              + APE +        SDV+SFGV L ELLT
Sbjct: 183 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI-----EGLQGHREWLAEVIFLGQLRH 153
           +G G FGTV+KG    D         VAVK+L++     + LQ  +    EV  L + RH
Sbjct: 16  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRH 63
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            +++  +GY  +  +  +V ++    SL +HL   I         + IA   A+G+ +LH
Sbjct: 64  VNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI- 272
                +I+RD K++NI L  D T K+ DFGLA +    S +H   ++ G+  + APE I 
Sbjct: 122 AKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 273 --STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
                  + +SDVY+FG+VL EL+TG+     +  + +Q +    + YL           
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGYL----------S 228
Query: 331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           P L+   S    K M  L  +C+     +RP    ++A++E L
Sbjct: 229 PDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI-----EGLQGHREWLAEVIFLGQLRH 153
           +G G FGTV+KG    D         VAVK+L++     + LQ  +    EV  L + RH
Sbjct: 21  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRH 68
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            +++  +GY  +  +  +V ++    SL +HL   I         + IA   A+G+ +LH
Sbjct: 69  VNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLH 126
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI- 272
                +I+RD K++NI L  D T K+ DFGLA +    S +H   ++ G+  + APE I 
Sbjct: 127 AKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 273 --STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
                  + +SDVY+FG+VL EL+TG+     +  + +Q +    + YL           
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGYL----------S 233
Query: 331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           P L+   S    K M  L  +C+     +RP    ++A++E L
Sbjct: 234 PDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIELL 275

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/213 (38%), Positives = 107/213 (50%), Gaps = 18/213 (8%)
Query: 93  FSSNYL-----LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVI 146
           F   YL     LGEG FG V   Y  D    G   + VAVK L  +    HR  W  E+ 
Sbjct: 11  FHKRYLKKIRDLGEGHFGKV-SLYCYDPTNDG-TGEMVAVKALKADCGPQHRSGWKQEID 68
Query: 147 FLGQLRHPHLVRLIGYCCED--EERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
            L  L H H+++  G CCED  E+ L LV E++P GSL ++L  R S+ L     L  A 
Sbjct: 69  ILRTLYHEHIIKYKG-CCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGL--AQLLLFAQ 124
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH-VTTRVMG 262
              +G+A+LH      I+R+    N+LLD+D   K+ DFGLAK  PEG   + V      
Sbjct: 125 QICEGMAYLHSQH--YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 182
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
              + APE +        SDV+SFGV L ELLT
Sbjct: 183 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 88/281 (31%), Positives = 130/281 (46%), Gaps = 36/281 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  GY +   +       VAVK L  +G      +LAE   + QL+H  LVR
Sbjct: 29  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 80
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     + E   ++ E+M  GSL + L     + L     L +A   A+G+AF+   E  
Sbjct: 81  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 137
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +NIL+    + K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 138 YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGT 194
Query: 277 LTTKSDVYSFGVVLLELLT-GRRSMDKL-RPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
            T KSDV+SFG++L E++T GR     +  P+  QNL        R  R +R    P   
Sbjct: 195 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCP--- 244
Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
                   +E+  L   C    P+DRP    + + LE    
Sbjct: 245 --------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 277

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 88/281 (31%), Positives = 130/281 (46%), Gaps = 36/281 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  GY +   +       VAVK L  +G      +LAE   + QL+H  LVR
Sbjct: 27  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 78
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     + E   ++ E+M  GSL + L     + L     L +A   A+G+AF+   E  
Sbjct: 79  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 135
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +NIL+    + K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 136 YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGT 192
Query: 277 LTTKSDVYSFGVVLLELLT-GRRSMDKL-RPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
            T KSDV+SFG++L E++T GR     +  P+  QNL        R  R +R    P   
Sbjct: 193 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCP--- 242
Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
                   +E+  L   C    P+DRP    + + LE    
Sbjct: 243 --------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 275

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 88/281 (31%), Positives = 130/281 (46%), Gaps = 36/281 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  GY +   +       VAVK L  +G      +LAE   + QL+H  LVR
Sbjct: 30  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 81
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     + E   ++ E+M  GSL + L     + L     L +A   A+G+AF+   E  
Sbjct: 82  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 138
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +NIL+    + K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 139 YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGT 195
Query: 277 LTTKSDVYSFGVVLLELLT-GRRSMDKL-RPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
            T KSDV+SFG++L E++T GR     +  P+  QNL        R  R +R    P   
Sbjct: 196 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCP--- 245
Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
                   +E+  L   C    P+DRP    + + LE    
Sbjct: 246 --------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 278

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 135/283 (47%), Gaps = 36/283 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI-----EGLQGHREWLAEVIFLGQLRH 153
           +G G FGTV+KG    D         VAVK+L++     + LQ  +    EV  L + RH
Sbjct: 16  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRH 63
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            +++  +GY     +  +V ++    SL +HL   I         + IA   A+G+ +LH
Sbjct: 64  VNILLFMGYSTA-PQLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI- 272
                +I+RD K++NI L  D T K+ DFGLA +    S +H   ++ G+  + APE I 
Sbjct: 122 AKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 273 --STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
                  + +SDVY+FG+VL EL+TG+     +  + +Q +    + YL           
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGYL----------S 228
Query: 331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           P L+   S    K M  L  +C+     +RP    ++A++E L
Sbjct: 229 PDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 135/283 (47%), Gaps = 36/283 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI-----EGLQGHREWLAEVIFLGQLRH 153
           +G G FGTV+KG    D         VAVK+L++     + LQ  +    EV  L + RH
Sbjct: 36  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRH 83
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            +++  +GY  +  +  +V ++    SL +HL   I         + IA   A+G+ +LH
Sbjct: 84  VNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLH 141
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI- 272
                +I+RD K++NI L  D T K+ DFGLA      S +H   ++ G+  + APE I 
Sbjct: 142 AKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 199
Query: 273 --STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
                  + +SDVY+FG+VL EL+TG+     +  + +Q +    + YL           
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGYL----------S 248
Query: 331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           P L+   S    K M  L  +C+     +RP    ++A++E L
Sbjct: 249 PDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIELL 290

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 88/281 (31%), Positives = 130/281 (46%), Gaps = 36/281 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  GY +   +       VAVK L  +G      +LAE   + QL+H  LVR
Sbjct: 31  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 82
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     + E   ++ E+M  GSL + L     + L     L +A   A+G+AF+   E  
Sbjct: 83  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 139
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +NIL+    + K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 140 YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGT 196
Query: 277 LTTKSDVYSFGVVLLELLT-GRRSMDKL-RPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
            T KSDV+SFG++L E++T GR     +  P+  QNL        R  R +R    P   
Sbjct: 197 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCP--- 246
Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
                   +E+  L   C    P+DRP    + + LE    
Sbjct: 247 --------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 279

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 88/281 (31%), Positives = 130/281 (46%), Gaps = 36/281 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  GY +   +       VAVK L  +G      +LAE   + QL+H  LVR
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     + E   ++ E+M  GSL + L     + L     L +A   A+G+AF+   E  
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 129
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +NIL+    + K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGT 186
Query: 277 LTTKSDVYSFGVVLLELLT-GRRSMDKL-RPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
            T KSDV+SFG++L E++T GR     +  P+  QNL        R  R +R    P   
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCP--- 236
Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
                   +E+  L   C    P+DRP    + + LE    
Sbjct: 237 --------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 88/281 (31%), Positives = 130/281 (46%), Gaps = 36/281 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  GY +   +       VAVK L  +G      +LAE   + QL+H  LVR
Sbjct: 27  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 78
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     + E   ++ E+M  GSL + L     + L     L +A   A+G+AF+   E  
Sbjct: 79  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 135
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +NIL+    + K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 136 YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGT 192
Query: 277 LTTKSDVYSFGVVLLELLT-GRRSMDKL-RPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
            T KSDV+SFG++L E++T GR     +  P+  QNL        R  R +R    P   
Sbjct: 193 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCP--- 242
Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
                   +E+  L   C    P+DRP    + + LE    
Sbjct: 243 --------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 275

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 129/275 (46%), Gaps = 28/275 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG VH GY        L    VA+K +  EG     +++ E   + +L HP LV+
Sbjct: 15  IGSGQFGLVHLGY-------WLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G C E     LV+EFM  G L ++L  +  +     T L + +   +G+A+L   E  
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLE--EAS 123
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
           VI+RD    N L+  +   K+SDFG+ +   +   T  +T       +A+PE  S    +
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYS 182
Query: 279 TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYS 338
           +KSDV+SFGV++ E+ +  +   + R  SE  +V+      R       +  PRLA  + 
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFR-------LYKPRLASTHV 233
Query: 339 VKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
            +       +   C    P+DRP  + ++  L ++
Sbjct: 234 YQ-------IMNHCWKERPEDRPAFSRLLRQLAAI 261

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 88/281 (31%), Positives = 130/281 (46%), Gaps = 36/281 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  GY +   +       VAVK L  +G      +LAE   + QL+H  LVR
Sbjct: 26  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 77
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     + E   ++ E+M  GSL + L     + L     L +A   A+G+AF+   E  
Sbjct: 78  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 134
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +NIL+    + K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 135 YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGT 191
Query: 277 LTTKSDVYSFGVVLLELLT-GRRSMDKL-RPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
            T KSDV+SFG++L E++T GR     +  P+  QNL        R  R +R    P   
Sbjct: 192 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCP--- 241
Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
                   +E+  L   C    P+DRP    + + LE    
Sbjct: 242 --------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 274

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 88/280 (31%), Positives = 130/280 (46%), Gaps = 36/280 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  GY +   +       VAVK L  +G      +LAE   + QL+H  LVR
Sbjct: 22  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 73
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     + E   ++ E+M  GSL + L     + L     L +A   A+G+AF+   E  
Sbjct: 74  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 130
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +NIL+    + K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 131 YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGT 187
Query: 277 LTTKSDVYSFGVVLLELLT-GRRSMDKL-RPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
            T KSDV+SFG++L E++T GR     +  P+  QNL        R  R +R    P   
Sbjct: 188 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCP--- 237
Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                   +E+  L   C    P+DRP    + + LE   
Sbjct: 238 --------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 269

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 88/281 (31%), Positives = 130/281 (46%), Gaps = 36/281 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  GY +   +       VAVK L  +G      +LAE   + QL+H  LVR
Sbjct: 23  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 74
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     + E   ++ E+M  GSL + L     + L     L +A   A+G+AF+   E  
Sbjct: 75  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 131
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +NIL+    + K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 132 YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGT 188
Query: 277 LTTKSDVYSFGVVLLELLT-GRRSMDKL-RPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
            T KSDV+SFG++L E++T GR     +  P+  QNL        R  R +R    P   
Sbjct: 189 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCP--- 238
Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
                   +E+  L   C    P+DRP    + + LE    
Sbjct: 239 --------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 271

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 135/283 (47%), Gaps = 36/283 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI-----EGLQGHREWLAEVIFLGQLRH 153
           +G G FGTV+KG    D         VAVK+L++     + LQ  +    EV  L + RH
Sbjct: 44  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRH 91
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            +++  +GY  +  +  +V ++    SL +HL   I         + IA   A+G+ +LH
Sbjct: 92  VNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLH 149
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI- 272
                +I+RD K++NI L  D T K+ DFGLA      S +H   ++ G+  + APE I 
Sbjct: 150 AKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 273 --STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
                  + +SDVY+FG+VL EL+TG+     +  + +Q +    + YL           
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGYL----------S 256
Query: 331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           P L+   S    K M  L  +C+     +RP    ++A++E L
Sbjct: 257 PDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIELL 298

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 135/283 (47%), Gaps = 36/283 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI-----EGLQGHREWLAEVIFLGQLRH 153
           +G G FGTV+KG    D         VAVK+L++     + LQ  +    EV  L + RH
Sbjct: 16  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRH 63
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            +++  +GY  +  +  +V ++    SL +HL   I         + IA   A+G+ +LH
Sbjct: 64  VNILLFMGYSTK-PQLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI- 272
                +I+RD K++NI L  D T K+ DFGLA      S +H   ++ G+  + APE I 
Sbjct: 122 AKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 273 --STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
                  + +SDVY+FG+VL EL+TG+     +  + +Q +    + YL           
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGYL----------S 228
Query: 331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           P L+   S    K M  L  +C+     +RP    ++A++E L
Sbjct: 229 PDLSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 88/280 (31%), Positives = 130/280 (46%), Gaps = 36/280 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  GY +   +       VAVK L  +G      +LAE   + QL+H  LVR
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     + E   ++ E+M  GSL + L     + L     L +A   A+G+AF+   E  
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 129
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +NIL+    + K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGT 186
Query: 277 LTTKSDVYSFGVVLLELLT-GRRSMDKL-RPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
            T KSDV+SFG++L E++T GR     +  P+  QNL        R  R +R    P   
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCP--- 236
Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                   +E+  L   C    P+DRP    + + LE   
Sbjct: 237 --------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 88/281 (31%), Positives = 130/281 (46%), Gaps = 36/281 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  GY +   +       VAVK L  +G      +LAE   + QL+H  LVR
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     + E   ++ E+M  GSL + L     + L     L +A   A+G+AF+   E  
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 129
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +NIL+    + K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 277 LTTKSDVYSFGVVLLELLT-GRRSMDKL-RPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
            T KSDV+SFG++L E++T GR     +  P+  QNL        R  R +R    P   
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCP--- 236
Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
                   +E+  L   C    P+DRP    + + LE    
Sbjct: 237 --------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 135/283 (47%), Gaps = 36/283 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI-----EGLQGHREWLAEVIFLGQLRH 153
           +G G FGTV+KG    D         VAVK+L++     + LQ  +    EV  L + RH
Sbjct: 20  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRH 67
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            +++  +GY  +  +  +V ++    SL +HL             + IA   A+G+ +LH
Sbjct: 68  VNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH 125
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI- 272
                +I+RD K++NI L  D T K+ DFGLA +    S +H   ++ G+  + APE I 
Sbjct: 126 A--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 183
Query: 273 --STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
              +   + +SDVY+FG+VL EL+TG+     +  + +  +++            R  + 
Sbjct: 184 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVG---------RGSLS 232
Query: 331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           P L+   S    K M  L  +C+     +RP    ++A +E L
Sbjct: 233 PDLSKVRS-NCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 274

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 128/275 (46%), Gaps = 28/275 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG VH GY        L    VA+K +  EG     +++ E   + +L HP LV+
Sbjct: 15  IGSGQFGLVHLGY-------WLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G C E     LV+EFM  G L ++L  +  +     T L + +   +G+A+L   E  
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLE--EAC 123
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
           VI+RD    N L+  +   K+SDFG+ +   +   T  +T       +A+PE  S    +
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYS 182
Query: 279 TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYS 338
           +KSDV+SFGV++ E+ +  +   + R  SE  +V+      R       +  PRLA  + 
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFR-------LYKPRLASTHV 233
Query: 339 VKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
            +       +   C    P+DRP  + ++  L  +
Sbjct: 234 YQ-------IMNHCWKERPEDRPAFSRLLRQLAEI 261

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 88/280 (31%), Positives = 130/280 (46%), Gaps = 36/280 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  GY +   +       VAVK L  +G      +LAE   + QL+H  LVR
Sbjct: 16  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 67
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     + E   ++ E+M  GSL + L     + L     L +A   A+G+AF+   E  
Sbjct: 68  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 124
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +NIL+    + K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 125 YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGT 181
Query: 277 LTTKSDVYSFGVVLLELLT-GRRSMDKL-RPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
            T KSDV+SFG++L E++T GR     +  P+  QNL        R  R +R    P   
Sbjct: 182 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCP--- 231
Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                   +E+  L   C    P+DRP    + + LE   
Sbjct: 232 --------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 263

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 128/275 (46%), Gaps = 28/275 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG VH GY        L    VA+K +  EG     +++ E   + +L HP LV+
Sbjct: 13  IGSGQFGLVHLGY-------WLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G C E     LV+EFM  G L ++L  +  +     T L + +   +G+A+L   E  
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLE--EAC 121
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
           VI+RD    N L+  +   K+SDFG+ +   +   T  +T       +A+PE  S    +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYS 180
Query: 279 TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYS 338
           +KSDV+SFGV++ E+ +  +   + R  SE  +V+      R       +  PRLA  + 
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFR-------LYKPRLASTHV 231
Query: 339 VKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
            +       +   C    P+DRP  + ++  L  +
Sbjct: 232 YQ-------IMNHCWKERPEDRPAFSRLLRQLAEI 259

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 128/287 (44%), Gaps = 32/287 (11%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH 155
           N ++G G FG V+ G + D+   G K       L  I  +    ++L E I +    HP+
Sbjct: 36  NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 156 LVRLIGYCCEDE-ERLLVYEFMPRGSLENHLFKRISVSLPWGTRL-KIAIGAAKGLAFLH 213
           ++ L+G C   E   L+V  +M  G L N  F R     P    L    +  AKG+ FL 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL- 150
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAAPEY 271
            A    ++RD    N +LD  FT K++DFGLA+  +  E  + H  T       + A E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES 209
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL---RYI 328
           + T   TTKSDV+SFGV+L EL+T         P  + N  D    YL   RRL    Y 
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLLQPEYC 263
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            DP             +  + L+C     + RP  + +V+ + ++ +
Sbjct: 264 PDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 297

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 128/275 (46%), Gaps = 28/275 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG VH GY        L    VA+K +  EG     +++ E   + +L HP LV+
Sbjct: 18  IGSGQFGLVHLGY-------WLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 69
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G C E     LV+EFM  G L ++L  +  +     T L + +   +G+A+L   E  
Sbjct: 70  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLE--EAC 126
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
           VI+RD    N L+  +   K+SDFG+ +   +   T  +T       +A+PE  S    +
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYS 185
Query: 279 TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYS 338
           +KSDV+SFGV++ E+ +  +   + R  SE  +V+      R       +  PRLA  + 
Sbjct: 186 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFR-------LYKPRLASTHV 236
Query: 339 VKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
            +       +   C    P+DRP  + ++  L  +
Sbjct: 237 YQ-------IMNHCWRERPEDRPAFSRLLRQLAEI 264

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 133/283 (46%), Gaps = 36/283 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI-----EGLQGHREWLAEVIFLGQLRH 153
           +G G FGTV+KG    D         VAVK+L++     + LQ  +    EV  L + RH
Sbjct: 32  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRH 79
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            +++  +GY  +  +  +V ++    SL +HL             + IA   A+G+ +LH
Sbjct: 80  VNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH 137
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI- 272
                +I+RD K++NI L  D T K+ DFGLA      S +H   ++ G+  + APE I 
Sbjct: 138 A--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 273 --STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
              +   + +SDVY+FG+VL EL+TG+       P S  N  D     +      R  + 
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIEMVG-----RGSLS 244
Query: 331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           P L+   S    K M  L  +C+     +RP    ++A +E L
Sbjct: 245 PDLSKVRS-NCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 128/275 (46%), Gaps = 28/275 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG VH GY        L    VA+K +  EG     +++ E   + +L HP LV+
Sbjct: 35  IGSGQFGLVHLGY-------WLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQ 86
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G C E     LV+EFM  G L ++L  +  +     T L + +   +G+A+L   E  
Sbjct: 87  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLE--EAC 143
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
           VI+RD    N L+  +   K+SDFG+ +   +   T  +T       +A+PE  S    +
Sbjct: 144 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYS 202
Query: 279 TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYS 338
           +KSDV+SFGV++ E+ +  +   + R  SE  +V+      R       +  PRLA  + 
Sbjct: 203 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFR-------LYKPRLASTHV 253
Query: 339 VKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
            +       +   C    P+DRP  + ++  L  +
Sbjct: 254 YQ-------IMNHCWKERPEDRPAFSRLLRQLAEI 281

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 127/287 (44%), Gaps = 32/287 (11%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH 155
           N ++G G FG V+ G + D+   G K       L  I  +    ++L E I +    HP+
Sbjct: 33  NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 156 LVRLIGYCCEDE-ERLLVYEFMPRGSLENHLFKRISVSLPWGTRL-KIAIGAAKGLAFLH 213
           ++ L+G C   E   L+V  +M  G L N  F R     P    L    +  AKG+ FL 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL- 147
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAAPEY 271
            A    ++RD    N +LD  FT K++DFGLA+     E  + H  T       + A E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 206
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL---RYI 328
           + T   TTKSDV+SFGV+L EL+T         P  + N  D    YL   RRL    Y 
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLLQPEYC 260
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            DP             +  + L+C     + RP  + +V+ + ++ +
Sbjct: 261 PDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 294

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 127/287 (44%), Gaps = 32/287 (11%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH 155
           N ++G G FG V+ G + D+   G K       L  I  +    ++L E I +    HP+
Sbjct: 40  NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 156 LVRLIGYCCEDE-ERLLVYEFMPRGSLENHLFKRISVSLPWGTRL-KIAIGAAKGLAFLH 213
           ++ L+G C   E   L+V  +M  G L N  F R     P    L    +  AKG+ FL 
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL- 154
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAAPEY 271
            A    ++RD    N +LD  FT K++DFGLA+     E  + H  T       + A E 
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 213
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL---RYI 328
           + T   TTKSDV+SFGV+L EL+T         P  + N  D    YL   RRL    Y 
Sbjct: 214 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLLQPEYC 267
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            DP             +  + L+C     + RP  + +V+ + ++ +
Sbjct: 268 PDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 301

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 87/280 (31%), Positives = 130/280 (46%), Gaps = 36/280 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  GY +   +       VAVK L  +G      +LAE   + QL+H  LVR
Sbjct: 17  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 68
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     + E   ++ E+M  GSL + L     + L     L +A   A+G+AF+   E  
Sbjct: 69  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 125
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+R+ + +NIL+    + K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 126 YIHRNLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGT 182
Query: 277 LTTKSDVYSFGVVLLELLT-GRRSMDKL-RPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
            T KSDV+SFG++L E++T GR     +  P+  QNL        R  R +R    P   
Sbjct: 183 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCP--- 232
Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                   +E+  L   C    P+DRP    + + LE   
Sbjct: 233 --------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 264

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 127/287 (44%), Gaps = 32/287 (11%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH 155
           N ++G G FG V+ G + D+   G K       L  I  +    ++L E I +    HP+
Sbjct: 36  NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 156 LVRLIGYCCEDE-ERLLVYEFMPRGSLENHLFKRISVSLPWGTRL-KIAIGAAKGLAFLH 213
           ++ L+G C   E   L+V  +M  G L N  F R     P    L    +  AKG+ FL 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL- 150
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAAPEY 271
            A    ++RD    N +LD  FT K++DFGLA+     E  + H  T       + A E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 209
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL---RYI 328
           + T   TTKSDV+SFGV+L EL+T         P  + N  D    YL   RRL    Y 
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLLQPEYC 263
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            DP             +  + L+C     + RP  + +V+ + ++ +
Sbjct: 264 PDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 297

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 127/287 (44%), Gaps = 32/287 (11%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH 155
           N ++G G FG V+ G + D+   G K       L  I  +    ++L E I +    HP+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 156 LVRLIGYCCEDE-ERLLVYEFMPRGSLENHLFKRISVSLPWGTRL-KIAIGAAKGLAFLH 213
           ++ L+G C   E   L+V  +M  G L N  F R     P    L    +  AKG+ FL 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL- 149
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAAPEY 271
            A    ++RD    N +LD  FT K++DFGLA+     E  + H  T       + A E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL---RYI 328
           + T   TTKSDV+SFGV+L EL+T         P  + N  D    YL   RRL    Y 
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLLQPEYC 262
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            DP             +  + L+C     + RP  + +V+ + ++ +
Sbjct: 263 PDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 296

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 133/283 (46%), Gaps = 36/283 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI-----EGLQGHREWLAEVIFLGQLRH 153
           +G G FGTV+KG    D         VAVK+L++     + LQ  +    EV  L + RH
Sbjct: 32  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRH 79
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            +++  +GY     +  +V ++    SL +HL             + IA   A+G+ +LH
Sbjct: 80  VNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH 137
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI- 272
                +I+RD K++NI L  D T K+ DFGLA      S +H   ++ G+  + APE I 
Sbjct: 138 A--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 273 --STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
              +   + +SDVY+FG+VL EL+TG+     +  + +  +++            R  + 
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVG---------RGSLS 244
Query: 331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           P L+   S    K M  L  +C+     +RP    ++A +E L
Sbjct: 245 PDLSKVRS-NCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 127/287 (44%), Gaps = 32/287 (11%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH 155
           N ++G G FG V+ G + D+   G K       L  I  +    ++L E I +    HP+
Sbjct: 94  NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 156 LVRLIGYCCEDE-ERLLVYEFMPRGSLENHLFKRISVSLPWGTRL-KIAIGAAKGLAFLH 213
           ++ L+G C   E   L+V  +M  G L N  F R     P    L    +  AKG+ FL 
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL- 208
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAAPEY 271
            A    ++RD    N +LD  FT K++DFGLA+     E  + H  T       + A E 
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL---RYI 328
           + T   TTKSDV+SFGV+L EL+T         P  + N  D    YL   RRL    Y 
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLLQPEYC 321
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            DP             +  + L+C     + RP  + +V+ + ++ +
Sbjct: 322 PDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 127/287 (44%), Gaps = 32/287 (11%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH 155
           N ++G G FG V+ G + D+   G K       L  I  +    ++L E I +    HP+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 156 LVRLIGYCCEDE-ERLLVYEFMPRGSLENHLFKRISVSLPWGTRL-KIAIGAAKGLAFLH 213
           ++ L+G C   E   L+V  +M  G L N  F R     P    L    +  AKG+ FL 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL- 149
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAAPEY 271
            A    ++RD    N +LD  FT K++DFGLA+     E  + H  T       + A E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL---RYI 328
           + T   TTKSDV+SFGV+L EL+T         P  + N  D    YL   RRL    Y 
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLLQPEYC 262
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            DP             +  + L+C     + RP  + +V+ + ++ +
Sbjct: 263 PDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 296

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 105/194 (54%), Gaps = 10/194 (5%)
Query: 106 TVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE 165
           T+ KG   D +    +   VAVK +  +     + +LAE   + QLRH +LV+L+G   E
Sbjct: 19  TIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 166 DEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDF 224
           ++  L +V E+M +GSL ++L  R    L     LK ++   + + +L G  N  ++RD 
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDL 134
Query: 225 KTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVY 284
              N+L+  D  AK+SDFGL K   E S+T  T ++     + APE +     +TKSDV+
Sbjct: 135 AARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREAAFSTKSDVW 189
Query: 285 SFGVVLLELLTGRR 298
           SFG++L E+ +  R
Sbjct: 190 SFGILLWEIYSFGR 203

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 105/194 (54%), Gaps = 10/194 (5%)
Query: 106 TVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE 165
           T+ KG   D +    +   VAVK +  +     + +LAE   + QLRH +LV+L+G   E
Sbjct: 28  TIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 166 DEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDF 224
           ++  L +V E+M +GSL ++L  R    L     LK ++   + + +L G  N  ++RD 
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDL 143
Query: 225 KTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVY 284
              N+L+  D  AK+SDFGL K   E S+T  T ++     + APE +     +TKSDV+
Sbjct: 144 AARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKFSTKSDVW 198
Query: 285 SFGVVLLELLTGRR 298
           SFG++L E+ +  R
Sbjct: 199 SFGILLWEIYSFGR 212

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 137/285 (48%), Gaps = 24/285 (8%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQ 150
           N S + ++G G FG V  G +        K  +VA+K L +   +  R ++L E   +GQ
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
             HP+++RL G   + +  ++V E+M  GSL++ L K           + +  G A G+ 
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMK 161
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAP 269
           +L  ++   ++RD    NIL++S+   K+SDFGLA++  +      TTR       + +P
Sbjct: 162 YL--SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
           E I+    T+ SDV+S+G+VL E+++        RP  E +  D  K  +    RL   +
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKA-VDEGYRLPPPM 273
Query: 330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           D   A          +  L L C   +  +RPK   +V+ L+ L+
Sbjct: 274 DCPAA----------LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 127/287 (44%), Gaps = 32/287 (11%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH 155
           N ++G G FG V+ G + D+   G K       L  I  +    ++L E I +    HP+
Sbjct: 34  NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 156 LVRLIGYCCEDE-ERLLVYEFMPRGSLENHLFKRISVSLPWGTRL-KIAIGAAKGLAFLH 213
           ++ L+G C   E   L+V  +M  G L N  F R     P    L    +  AKG+ +L 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL- 148
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAAPEY 271
            A    ++RD    N +LD  FT K++DFGLA+     E  + H  T       + A E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL---RYI 328
           + T   TTKSDV+SFGV+L EL+T         P  + N  D    YL   RRL    Y 
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLLQPEYC 261
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            DP             +  + L+C     + RP  + +V+ + ++ +
Sbjct: 262 PDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 295

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 105/194 (54%), Gaps = 10/194 (5%)
Query: 106 TVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE 165
           T+ KG   D +    +   VAVK +  +     + +LAE   + QLRH +LV+L+G   E
Sbjct: 200 TIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 166 DEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDF 224
           ++  L +V E+M +GSL ++L  R    L     LK ++   + + +L G  N  ++RD 
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDL 315
Query: 225 KTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVY 284
              N+L+  D  AK+SDFGL K   E S+T  T ++     + APE +     +TKSDV+
Sbjct: 316 AARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKFSTKSDVW 370
Query: 285 SFGVVLLELLTGRR 298
           SFG++L E+ +  R
Sbjct: 371 SFGILLWEIYSFGR 384

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 105/194 (54%), Gaps = 10/194 (5%)
Query: 106 TVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE 165
           T+ KG   D +    +   VAVK   I+     + +LAE   + QLRH +LV+L+G   E
Sbjct: 13  TIGKGEFGDVMLGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 166 DEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDF 224
           ++  L +V E+M +GSL ++L  R    L     LK ++   + + +L G  N  ++RD 
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--NNFVHRDL 128
Query: 225 KTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVY 284
              N+L+  D  AK+SDFGL K   E S+T  T ++     + APE +     +TKSDV+
Sbjct: 129 AARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKFSTKSDVW 183
Query: 285 SFGVVLLELLTGRR 298
           SFG++L E+ +  R
Sbjct: 184 SFGILLWEIYSFGR 197

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 127/275 (46%), Gaps = 28/275 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG VH GY        L    VA+K +  EG     +++ E   + +L HP LV+
Sbjct: 16  IGSGQFGLVHLGY-------WLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G C E     LV EFM  G L ++L  +  +     T L + +   +G+A+L   E  
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLE--EAC 124
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
           VI+RD    N L+  +   K+SDFG+ +   +   T  +T       +A+PE  S    +
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYS 183
Query: 279 TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYS 338
           +KSDV+SFGV++ E+ +  +   + R  SE  +V+      R       +  PRLA  + 
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGFR-------LYKPRLASTHV 234
Query: 339 VKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
            +       +   C    P+DRP  + ++  L  +
Sbjct: 235 YQ-------IMNHCWRERPEDRPAFSRLLRQLAEI 262

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 129/281 (45%), Gaps = 36/281 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G  G V  GY +   +       VAVK L  +G      +LAE   + QL+H  LVR
Sbjct: 21  LGAGQAGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     + E   ++ E+M  GSL + L     + L     L +A   A+G+AF+   E  
Sbjct: 73  LYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 129
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +NIL+    + K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLI---EDAEXTAREGAKFPIKWTAPEAINYGT 186
Query: 277 LTTKSDVYSFGVVLLELLT-GRRSMDKL-RPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
            T KSDV+SFG++L E++T GR     +  P+  QNL        R  R +R    P   
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RGYRMVRPDNCP--- 236
Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
                   +E+  L   C    P+DRP    + + LE    
Sbjct: 237 --------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 131/283 (46%), Gaps = 36/283 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI-----EGLQGHREWLAEVIFLGQLRH 153
           +G G FGTV+KG    D         VAVK+L +     E  Q  R    EV  L + RH
Sbjct: 44  IGSGSFGTVYKGKWHGD---------VAVKILKVVDPTPEQFQAFRN---EVAVLRKTRH 91
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            +++  +GY  +D    +V ++    SL  HL  +          + IA   A+G+ +LH
Sbjct: 92  VNILLFMGYMTKDN-LAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLH 149
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI- 272
            A+N +I+RD K++NI L    T K+ DFGLA +    S +    +  G+  + APE I 
Sbjct: 150 -AKN-IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIR 207
Query: 273 --STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
                  + +SDVYS+G+VL EL+TG      +  + +Q +    + Y            
Sbjct: 208 MQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-DQIIFMVGRGY----------AS 256
Query: 331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           P L+  Y     K M  L   C+    ++RP    +++++E L
Sbjct: 257 PDLSKLYK-NCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 24/285 (8%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQ 150
           N S + ++G G FG V  G +        K  +VA+K L +   +  R ++L E   +GQ
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
             HP+++RL G   + +  ++V E+M  GSL++ L K           + +  G A G+ 
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMK 161
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAP 269
           +L  ++   ++RD    NIL++S+   K+SDFGL+++  +      TTR       + +P
Sbjct: 162 YL--SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
           E I+    T+ SDV+S+G+VL E+++        RP  E +  D  K  +    RL   +
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKA-VDEGYRLPPPM 273
Query: 330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           D   A          +  L L C   +  +RPK   +V+ L+ L+
Sbjct: 274 DCPAA----------LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 82/213 (38%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 93  FSSNYL-----LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVI 146
           F   YL     LGEG FG V   Y  D    G   + VAVK L +  G Q    W  E+ 
Sbjct: 5   FHKRYLKKIRDLGEGHFGKV-SLYCYDPTNDG-TGEMVAVKALKEGCGPQLRSGWQREIE 62
Query: 147 FLGQLRHPHLVRLIGYCCEDEER---LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
            L  L H H+V+  G CCED+      LV E++P GSL ++L  R  V L     L  A 
Sbjct: 63  ILRTLYHEHIVKYKG-CCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGL--AQLLLFAQ 118
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH-VTTRVMG 262
              +G+A+LH      I+R     N+LLD+D   K+ DFGLAK  PEG   + V      
Sbjct: 119 QICEGMAYLHAQH--YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 176
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
              + APE +        SDV+SFGV L ELLT
Sbjct: 177 PVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 24/285 (8%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQ 150
           N S + ++G G FG V  G +        K  +VA+K L +   +  R ++L E   +GQ
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 100
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
             HP+++RL G   + +  ++V E+M  GSL++ L K           + +  G A G+ 
Sbjct: 101 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMK 159
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAP 269
           +L  ++   ++RD    NIL++S+   K+SDFGL+++  +      TTR       + +P
Sbjct: 160 YL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 217
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
           E I+    T+ SDV+S+G+VL E+++        RP  E +  D  K  +    RL   +
Sbjct: 218 EAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKA-VDEGYRLPPPM 271
Query: 330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           D   A          +  L L C   +  +RPK   +V+ L+ L+
Sbjct: 272 DCPAA----------LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 306

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 24/285 (8%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQ 150
           N S + ++G G FG V  G +        K  +VA+K L +   +  R ++L E   +GQ
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
             HP+++RL G   + +  ++V E+M  GSL++ L K           + +  G A G+ 
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMK 161
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAP 269
           +L  ++   ++RD    NIL++S+   K+SDFGL+++  +      TTR       + +P
Sbjct: 162 YL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
           E I+    T+ SDV+S+G+VL E+++        RP  E +  D  K  +    RL   +
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKA-VDEGYRLPPPM 273
Query: 330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           D   A          +  L L C   +  +RPK   +V+ L+ L+
Sbjct: 274 DCPAA----------LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 24/285 (8%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQ 150
           N S + ++G G FG V  G +        K  +VA+K L +   +  R ++L E   +GQ
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
             HP+++RL G   + +  ++V E+M  GSL++ L K           + +  G A G+ 
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMK 161
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAP 269
           +L  ++   ++RD    NIL++S+   K+SDFGL+++  +      TTR       + +P
Sbjct: 162 YL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
           E I+    T+ SDV+S+G+VL E+++        RP  E +  D  K  +    RL   +
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKA-VDEGYRLPPPM 273
Query: 330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           D   A          +  L L C   +  +RPK   +V+ L+ L+
Sbjct: 274 DCPAA----------LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 24/285 (8%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQ 150
           N S + ++G G FG V  G +        K  +VA+K L +   +  R ++L E   +GQ
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
             HP+++RL G   + +  ++V E+M  GSL++ L K           + +  G A G+ 
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMK 161
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAP 269
           +L  ++   ++RD    NIL++S+   K+SDFGL+++  +      TTR       + +P
Sbjct: 162 YL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
           E I+    T+ SDV+S+G+VL E+++        RP  E +  D  K  +    RL   +
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKA-VDEGYRLPPPM 273
Query: 330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           D   A          +  L L C   +  +RPK   +V+ L+ L+
Sbjct: 274 DCPAA----------LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 127/287 (44%), Gaps = 32/287 (11%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH 155
           N ++G G FG V+ G + D+   G K       L  I  +    ++L E I +    HP+
Sbjct: 27  NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 156 LVRLIGYCCEDE-ERLLVYEFMPRGSLENHLFKRISVSLPWGTRL-KIAIGAAKGLAFLH 213
           ++ L+G C   E   L+V  +M  G L N  F R     P    L    +  AKG+ +L 
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL- 141
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAAPEY 271
            A    ++RD    N +LD  FT K++DFGLA+     E  + H  T       + A E 
Sbjct: 142 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL---RYI 328
           + T   TTKSDV+SFGV+L EL+T         P  + N  D    YL   RRL    Y 
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLLQPEYC 254
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            DP             +  + L+C     + RP  + +V+ + ++ +
Sbjct: 255 PDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 288

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 137/285 (48%), Gaps = 24/285 (8%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQ 150
           N S + ++G G FG V  G +        K  +VA+K L +   +  R ++L E   +GQ
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
             HP+++RL G   + +  ++V E+M  GSL++ L K           + +  G A G+ 
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMK 161
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAP 269
           +L  ++   ++RD    NIL++S+   K+SDFGL+++  +      TTR       + +P
Sbjct: 162 YL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
           E I+    T+ SDV+S+G+VL E+++        RP  E +  D  K  +    RL   +
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKA-VDEGYRLPPPM 273
Query: 330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           D   A          +  L L C   +  +RPK   +V+ L+ L+
Sbjct: 274 DCPAA----------LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 127/287 (44%), Gaps = 32/287 (11%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH 155
           N ++G G FG V+ G + D+   G K       L  I  +    ++L E I +    HP+
Sbjct: 54  NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 156 LVRLIGYCCEDE-ERLLVYEFMPRGSLENHLFKRISVSLPWGTRL-KIAIGAAKGLAFLH 213
           ++ L+G C   E   L+V  +M  G L N  F R     P    L    +  AKG+ +L 
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL- 168
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAAPEY 271
            A    ++RD    N +LD  FT K++DFGLA+     E  + H  T       + A E 
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL---RYI 328
           + T   TTKSDV+SFGV+L EL+T         P  + N  D    YL   RRL    Y 
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLLQPEYC 281
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            DP             +  + L+C     + RP  + +V+ + ++ +
Sbjct: 282 PDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 315

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 139/285 (48%), Gaps = 24/285 (8%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQ 150
           N S + ++G G FG V  G +    ++ +   +VA+K L +   +  R ++L E   +GQ
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEI---SVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
             HP+++RL G   + +  ++V E+M  GSL++ L K           + +  G A G+ 
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMK 132
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAP 269
           +L  ++   ++RD    NIL++S+   K+SDFGL+++  +      TTR       + +P
Sbjct: 133 YL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
           E I+    T+ SDV+S+G+VL E+++        RP  E +  D  K  +    RL   +
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKA-VDEGYRLPPPM 244
Query: 330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           D   A          +  L L C   +  +RPK   +V+ L+ L+
Sbjct: 245 DCPAA----------LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 138/286 (48%), Gaps = 26/286 (9%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQ 150
           N S + ++G G FG V  G +    +   K  +VA+K L +   +  R ++L E   +GQ
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSK---KEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 90
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
             HP+++RL G   + +  ++V E+M  GSL++ L K           + +  G A G+ 
Sbjct: 91  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMK 149
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAP 269
           +L  ++   ++RD    NIL++S+   K+SDFGL+++  +      TTR       + +P
Sbjct: 150 YL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 207
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI 328
           E I+    T+ SDV+S+G+VL E+++ G R   ++  +     VD          RL   
Sbjct: 208 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-------EGYRLPPP 260
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           +D   A          +  L L C   +  +RPK   +V+ L+ L+
Sbjct: 261 MDCPAA----------LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 296

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 82/213 (38%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 93  FSSNYL-----LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVI 146
           F   YL     LGEG FG V   Y  D    G   + VAVK L +  G Q    W  E+ 
Sbjct: 6   FHKRYLKKIRDLGEGHFGKV-SLYCYDPTNDG-TGEMVAVKALKEGCGPQLRSGWQREIE 63
Query: 147 FLGQLRHPHLVRLIGYCCEDEER---LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
            L  L H H+V+  G CCED+      LV E++P GSL ++L  R  V L     L  A 
Sbjct: 64  ILRTLYHEHIVKYKG-CCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGL--AQLLLFAQ 119
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH-VTTRVMG 262
              +G+A+LH      I+R     N+LLD+D   K+ DFGLAK  PEG   + V      
Sbjct: 120 QICEGMAYLHAQH--YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 177
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
              + APE +        SDV+SFGV L ELLT
Sbjct: 178 PVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 127/287 (44%), Gaps = 32/287 (11%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH 155
           N ++G G FG V+ G + D+   G K       L  I  +    ++L E I +    HP+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 156 LVRLIGYCCEDE-ERLLVYEFMPRGSLENHLFKRISVSLPWGTRL-KIAIGAAKGLAFLH 213
           ++ L+G C   E   L+V  +M  G L N  F R     P    L    +  AKG+ +L 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL- 149
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAAPEY 271
            A    ++RD    N +LD  FT K++DFGLA+     E  + H  T       + A E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL---RYI 328
           + T   TTKSDV+SFGV+L EL+T         P  + N  D    YL   RRL    Y 
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLLQPEYC 262
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            DP             +  + L+C     + RP  + +V+ + ++ +
Sbjct: 263 PDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 296

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 86/292 (29%), Positives = 139/292 (47%), Gaps = 41/292 (14%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHL 156
           ++G G FG V+KG +      G K   VA+K L     +  R ++L E   +GQ  H ++
Sbjct: 51  VIGAGEFGEVYKGMLKTS--SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKR---ISVSLPWGTRLKIAIGAAKGLAFLH 213
           +RL G   + +  +++ E+M  G+L+  L ++    SV    G    +  G A G+ +L 
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVG----MLRGIAAGMKYL- 163
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM---GPEGSNTHVTTRVMGTYGYAAPE 270
            A    ++RD    NIL++S+   K+SDFGL+++    PE + T    ++     + APE
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI--PIRWTAPE 220
Query: 271 YISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRY 327
            IS    T+ SDV+SFG+V+ E++T G R                  PY  L +   ++ 
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGER------------------PYWELSNHEVMKA 262
Query: 328 IVDP-RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKD 378
           I D  RL        A  +  L +QC       RPK A +V+ L+ L+   D
Sbjct: 263 INDGFRLPTPMDCPSA--IYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 127/287 (44%), Gaps = 32/287 (11%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH 155
           N ++G G FG V+ G + D+   G K       L  I  +    ++L E I +    HP+
Sbjct: 30  NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 156 LVRLIGYCCEDE-ERLLVYEFMPRGSLENHLFKRISVSLPWGTRL-KIAIGAAKGLAFLH 213
           ++ L+G C   E   L+V  +M  G L N  F R     P    L    +  AKG+ +L 
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL- 144
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAAPEY 271
            A    ++RD    N +LD  FT K++DFGLA+     E  + H  T       + A E 
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL---RYI 328
           + T   TTKSDV+SFGV+L EL+T         P  + N  D    YL   RRL    Y 
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLLQPEYC 257
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            DP             +  + L+C     + RP  + +V+ + ++ +
Sbjct: 258 PDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 127/287 (44%), Gaps = 32/287 (11%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH 155
           N ++G G FG V+ G + D+   G K       L  I  +    ++L E I +    HP+
Sbjct: 33  NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 156 LVRLIGYCCEDE-ERLLVYEFMPRGSLENHLFKRISVSLPWGTRL-KIAIGAAKGLAFLH 213
           ++ L+G C   E   L+V  +M  G L N  F R     P    L    +  AKG+ +L 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL- 147
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAAPEY 271
            A    ++RD    N +LD  FT K++DFGLA+     E  + H  T       + A E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL---RYI 328
           + T   TTKSDV+SFGV+L EL+T         P  + N  D    YL   RRL    Y 
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLLQPEYC 260
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            DP             +  + L+C     + RP  + +V+ + ++ +
Sbjct: 261 PDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 294

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 127/287 (44%), Gaps = 32/287 (11%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH 155
           N ++G G FG V+ G + D+   G K       L  I  +    ++L E I +    HP+
Sbjct: 32  NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 156 LVRLIGYCCEDE-ERLLVYEFMPRGSLENHLFKRISVSLPWGTRL-KIAIGAAKGLAFLH 213
           ++ L+G C   E   L+V  +M  G L N  F R     P    L    +  AKG+ +L 
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL- 146
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAAPEY 271
            A    ++RD    N +LD  FT K++DFGLA+     E  + H  T       + A E 
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL---RYI 328
           + T   TTKSDV+SFGV+L EL+T         P  + N  D    YL   RRL    Y 
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLLQPEYC 259
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            DP             +  + L+C     + RP  + +V+ + ++ +
Sbjct: 260 PDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 127/287 (44%), Gaps = 32/287 (11%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH 155
           N ++G G FG V+ G + D+   G K       L  I  +    ++L E I +    HP+
Sbjct: 34  NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 156 LVRLIGYCCEDE-ERLLVYEFMPRGSLENHLFKRISVSLPWGTRL-KIAIGAAKGLAFLH 213
           ++ L+G C   E   L+V  +M  G L N  F R     P    L    +  AKG+ +L 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL- 148
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAAPEY 271
            A    ++RD    N +LD  FT K++DFGLA+     E  + H  T       + A E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL---RYI 328
           + T   TTKSDV+SFGV+L EL+T         P  + N  D    YL   RRL    Y 
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLLQPEYC 261
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            DP             +  + L+C     + RP  + +V+ + ++ +
Sbjct: 262 PDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 295

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 127/287 (44%), Gaps = 32/287 (11%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH 155
           N ++G G FG V+ G + D+   G K       L  I  +    ++L E I +    HP+
Sbjct: 53  NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 156 LVRLIGYCCEDE-ERLLVYEFMPRGSLENHLFKRISVSLPWGTRL-KIAIGAAKGLAFLH 213
           ++ L+G C   E   L+V  +M  G L N  F R     P    L    +  AKG+ +L 
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL- 167
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAAPEY 271
            A    ++RD    N +LD  FT K++DFGLA+     E  + H  T       + A E 
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL---RYI 328
           + T   TTKSDV+SFGV+L EL+T         P  + N  D    YL   RRL    Y 
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLLQPEYC 280
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            DP             +  + L+C     + RP  + +V+ + ++ +
Sbjct: 281 PDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 314

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 127/287 (44%), Gaps = 32/287 (11%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH 155
           N ++G G FG V+ G + D+   G K       L  I  +    ++L E I +    HP+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 156 LVRLIGYCCEDE-ERLLVYEFMPRGSLENHLFKRISVSLPWGTRL-KIAIGAAKGLAFLH 213
           ++ L+G C   E   L+V  +M  G L N  F R     P    L    +  AKG+ +L 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL- 149
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTYGYAAPEY 271
            A    ++RD    N +LD  FT K++DFGLA+     E  + H  T       + A E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL---RYI 328
           + T   TTKSDV+SFGV+L EL+T         P  + N  D    YL   RRL    Y 
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD-ITVYLLQGRRLLQPEYC 262
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            DP             +  + L+C     + RP  + +V+ + ++ +
Sbjct: 263 PDP-------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 296

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 136/285 (47%), Gaps = 24/285 (8%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQ 150
           N S + ++G G FG V  G +        K  +VA+K L +   +  R ++L E   +GQ
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
             HP+++RL G   + +  ++V E+M  GSL++ L K           + +  G A G+ 
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMK 161
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAP 269
           +L  ++   ++RD    NIL++S+   K+SDFGL ++  +      TTR       + +P
Sbjct: 162 YL--SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
           E I+    T+ SDV+S+G+VL E+++        RP  E +  D  K  +    RL   +
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKA-VDEGYRLPPPM 273
Query: 330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           D   A          +  L L C   +  +RPK   +V+ L+ L+
Sbjct: 274 DCPAA----------LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 136/285 (47%), Gaps = 24/285 (8%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQ 150
           N S + ++G G FG V  G +        K  +VA+K L +   +  R ++L E   +GQ
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
             HP+++RL G   + +  ++V E M  GSL++ L K           + +  G A G+ 
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMK 161
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAP 269
           +L  ++   ++RD    NIL++S+   K+SDFGL+++  +      TTR       + +P
Sbjct: 162 YL--SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
           E I+    T+ SDV+S+G+VL E+++        RP  E +  D  K  +    RL   +
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKA-VDEGYRLPPPM 273
Query: 330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           D   A          +  L L C   +  +RPK   +V+ L+ L+
Sbjct: 274 DCPAA----------LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 107/208 (51%), Gaps = 22/208 (10%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHL 156
           ++G G FG V +G +      G K   VA+K L     +  R E+L+E   +GQ  HP++
Sbjct: 23  VIGAGEFGEVCRGRLK---APGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 79
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHL------FKRISVSLPWGTRLKIAIGAAKGLA 210
           +RL G        +++ EFM  G+L++ L      F  I +       + +  G A G+ 
Sbjct: 80  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL-------VGMLRGIASGMR 132
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG---TYGYA 267
           +L  AE   ++RD    NIL++S+   K+SDFGL++   E S+    T  +G      + 
Sbjct: 133 YL--AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWT 190
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLT 295
           APE I+    T+ SD +S+G+V+ E+++
Sbjct: 191 APEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 107/208 (51%), Gaps = 22/208 (10%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHL 156
           ++G G FG V +G +      G K   VA+K L     +  R E+L+E   +GQ  HP++
Sbjct: 21  VIGAGEFGEVCRGRLK---APGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 77
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHL------FKRISVSLPWGTRLKIAIGAAKGLA 210
           +RL G        +++ EFM  G+L++ L      F  I +       + +  G A G+ 
Sbjct: 78  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL-------VGMLRGIASGMR 130
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG---TYGYA 267
           +L  AE   ++RD    NIL++S+   K+SDFGL++   E S+    T  +G      + 
Sbjct: 131 YL--AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWT 188
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLT 295
           APE I+    T+ SD +S+G+V+ E+++
Sbjct: 189 APEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 136/285 (47%), Gaps = 24/285 (8%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQ 150
           N S + ++G G FG V  G +        K  +VA+K L +   +  R ++L E   +GQ
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLK---LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
             HP+++RL G   + +  ++V E M  GSL++ L K           + +  G A G+ 
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMK 161
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAP 269
           +L  ++   ++RD    NIL++S+   K+SDFGL+++  +      TTR       + +P
Sbjct: 162 YL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
           E I+    T+ SDV+S+G+VL E+++        RP  E +  D  K  +    RL   +
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKA-VDEGYRLPPPM 273
Query: 330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           D   A          +  L L C   +  +RPK   +V+ L+ L+
Sbjct: 274 DCPAA----------LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 138/285 (48%), Gaps = 24/285 (8%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQ 150
           N S + ++G G FG V  G +    ++ +   +VA+K L +   +  R ++L E   +GQ
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEI---SVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
             HP+++RL G   + +  ++V E M  GSL++ L K           + +  G A G+ 
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMK 132
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAP 269
           +L  ++   ++RD    NIL++S+   K+SDFGL+++  +      TTR       + +P
Sbjct: 133 YL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
           E I+    T+ SDV+S+G+VL E+++        RP  E +  D  K  +    RL   +
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGE-----RPYWEMSNQDVIKA-VDEGYRLPPPM 244
Query: 330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           D   A          +  L L C   +  +RPK   +V+ L+ L+
Sbjct: 245 DCPAA----------LYQLMLDCWQKDRNNRPKFEQIVSILDKLI 279

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 134/290 (46%), Gaps = 28/290 (9%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGHREWLAEVIFLGQLRHP 154
           N +LGEG FG V++G   +   +G K   VAVK    +  L    ++++E + +  L HP
Sbjct: 29  NRILGEGFFGEVYEGVYTN--HKGEKIN-VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 85
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
           H+V+LIG   E+E   ++ E  P G L  H  +R   SL   T +  ++   K +A+L  
Sbjct: 86  HIVKLIG-IIEEEPTWIIMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMAYLES 143
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
                ++RD    NIL+ S    KL DFGL++   E  + +  +       + +PE I+ 
Sbjct: 144 IN--CVHRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKASVTRLPIKWMSPESINF 200
Query: 275 GHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL 333
              TT SDV+ F V + E+L+ G++    L  K    +       L    RL     P L
Sbjct: 201 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-------LEKGDRLP---KPDL 250
Query: 334 AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL-KDMAVS 382
                      +  L  +C   +P DRP+   +V +L  +  + KD+A+ 
Sbjct: 251 C-------PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAME 293

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 134/290 (46%), Gaps = 28/290 (9%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGHREWLAEVIFLGQLRHP 154
           N +LGEG FG V++G   +   +G K   VAVK    +  L    ++++E + +  L HP
Sbjct: 13  NRILGEGFFGEVYEGVYTN--HKGEKIN-VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 69
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
           H+V+LIG   E+E   ++ E  P G L  H  +R   SL   T +  ++   K +A+L  
Sbjct: 70  HIVKLIG-IIEEEPTWIIMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMAYLES 127
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
                ++RD    NIL+ S    KL DFGL++   E  + +  +       + +PE I+ 
Sbjct: 128 IN--CVHRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKASVTRLPIKWMSPESINF 184
Query: 275 GHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL 333
              TT SDV+ F V + E+L+ G++    L  K    +       L    RL     P L
Sbjct: 185 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-------LEKGDRLP---KPDL 234
Query: 334 AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL-KDMAVS 382
                      +  L  +C   +P DRP+   +V +L  +  + KD+A+ 
Sbjct: 235 C-------PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAME 277

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 134/290 (46%), Gaps = 28/290 (9%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGHREWLAEVIFLGQLRHP 154
           N +LGEG FG V++G   +   +G K   VAVK    +  L    ++++E + +  L HP
Sbjct: 17  NRILGEGFFGEVYEGVYTN--HKGEKIN-VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 73
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
           H+V+LIG   E+E   ++ E  P G L  H  +R   SL   T +  ++   K +A+L  
Sbjct: 74  HIVKLIG-IIEEEPTWIIMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMAYLES 131
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
                ++RD    NIL+ S    KL DFGL++   E  + +  +       + +PE I+ 
Sbjct: 132 IN--CVHRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKASVTRLPIKWMSPESINF 188
Query: 275 GHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL 333
              TT SDV+ F V + E+L+ G++    L  K    +       L    RL     P L
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-------LEKGDRLP---KPDL 238
Query: 334 AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL-KDMAVS 382
                      +  L  +C   +P DRP+   +V +L  +  + KD+A+ 
Sbjct: 239 C-------PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAME 281

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 78/228 (34%), Positives = 115/228 (50%), Gaps = 43/228 (18%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL------DI-EGLQGHREWLAEVIFLGQ 150
           ++G GGFG V++ +   D         VAVK        DI + ++  R+   E      
Sbjct: 14  IIGIGGFGKVYRAFWIGD--------EVAVKAARHDPDEDISQTIENVRQ---EAKLFAM 62
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLF-KRISVSLPWGTRLKIAIGAAKGL 209
           L+HP+++ L G C ++    LV EF   G L   L  KRI    P    +  A+  A+G+
Sbjct: 63  LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI----PPDILVNWAVQIARGM 118
Query: 210 AFLHG-AENPVIYRDFKTSNILL-----DSDFT---AKLSDFGLAKMGPEGSNTHVTTRV 260
            +LH  A  P+I+RD K+SNIL+     + D +    K++DFGLA+        H TT++
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------EWHRTTKM 172
Query: 261 --MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR---RSMDKL 303
              G Y + APE I     +  SDV+S+GV+L ELLTG    R +D L
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 137/292 (46%), Gaps = 32/292 (10%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHL 156
           ++G G FG V  G++      G +   VA+K L     +  R ++L+E   +GQ  HP++
Sbjct: 40  VIGAGEFGEVCSGHLK---LPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 96
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           + L G   +    +++ EFM  GSL++ L ++          + +  G A G+ +L  A+
Sbjct: 97  IHLEGVVTKSTPVMIITEFMENGSLDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYL--AD 153
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG---TYGYAAPEYIS 273
              ++RD    NIL++S+   K+SDFGL++   + ++    T  +G      + APE I 
Sbjct: 154 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 213
Query: 274 TGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR 332
               T+ SDV+S+G+V+ E+++ G R    +  +   N ++                D R
Sbjct: 214 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE---------------QDYR 258
Query: 333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL----NLKDMA 380
           L        A  +  L L C   +   RPK   +V TL+ ++    +LK MA
Sbjct: 259 LPPPMDCPSA--LHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMA 308

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 133/285 (46%), Gaps = 32/285 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V++G     ++   + +     + +   ++   E+L E   + +    H+VR
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHL------FKRISVSLP--WGTRLKIAIGAAKGLA 210
           L+G   + +  L++ E M RG L+++L       +   V  P      +++A   A G+A
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           +L+   N  ++RD    N ++  DFT K+ DFG+ +   E        + +    + +PE
Sbjct: 138 YLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPE 195
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRYI 328
            +  G  TT SDV+SFGVVL E+ T           +EQ       PY  L + + LR++
Sbjct: 196 SLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQGLSNEQVLRFV 238
Query: 329 VDPRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLES 372
           ++  L  +       +M + L   C   NPK RP    ++++++ 
Sbjct: 239 MEGGLLDKPD--NCPDMLLELMRMCWQYNPKMRPSFLEIISSIKE 281

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 131/283 (46%), Gaps = 30/283 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V++G     ++   + +     + +   ++   E+L E   + +    H+VR
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHL------FKRISVSLP--WGTRLKIAIGAAKGLA 210
           L+G   + +  L++ E M RG L+++L       +   V  P      +++A   A G+A
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           +L+   N  ++RD    N ++  DFT K+ DFG+ +   E        + +    + +PE
Sbjct: 147 YLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPE 204
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRYI 328
            +  G  TT SDV+SFGVVL E+ T           +EQ       PY  L + + LR++
Sbjct: 205 SLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQGLSNEQVLRFV 247
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
           ++  L  +        +  L   C   NPK RP    ++++++
Sbjct: 248 MEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 113/221 (51%), Gaps = 24/221 (10%)
Query: 81  FQLSELRAITQNFSSNYLLGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLLDIEGLQGHR 139
           F+ +ELR +        +LG G FGTVHKG +I +   + +K       + D  G Q  +
Sbjct: 28  FKETELRKLK-------VLGSGVFGTVHKGVWIPEG--ESIKIPVCIKVIEDKSGRQSFQ 78
Query: 140 EWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKR-----ISVSLP 194
                ++ +G L H H+VRL+G C     +L V +++P GSL +H+ +        + L 
Sbjct: 79  AVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLN 137
Query: 195 WGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT 254
           WG ++      AKG+ +L   E+ +++R+    N+LL S    +++DFG+A + P     
Sbjct: 138 WGVQI------AKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 189
Query: 255 HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
            + +       + A E I  G  T +SDV+S+GV + EL+T
Sbjct: 190 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 125/287 (43%), Gaps = 28/287 (9%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           +LGEG FG+V +G +  +    LK  AV    LD    +   E+L+E   +    HP+++
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKV-AVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 158 RLIGYCCEDEER-----LLVYEFMPRGSLENH-LFKRISVS---LPWGTRLKIAIGAAKG 208
           RL+G C E   +     +++  FM  G L  + L+ R+      +P  T LK  +  A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           + +L  +    ++RD    N +L  D T  ++DFGL+K    G              + A
Sbjct: 160 MEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI 328
            E ++    T+KSDV++FGV + E+ T  R M          + D    YL    RL+  
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIAT--RGMTPYPGVQNHEMYD----YLLHGHRLKQP 271
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            D             E+  +   C   +P DRP  + +   LE LL 
Sbjct: 272 ED----------CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 113/221 (51%), Gaps = 24/221 (10%)
Query: 81  FQLSELRAITQNFSSNYLLGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLLDIEGLQGHR 139
           F+ +ELR +        +LG G FGTVHKG +I +   + +K       + D  G Q  +
Sbjct: 10  FKETELRKLK-------VLGSGVFGTVHKGVWIPEG--ESIKIPVCIKVIEDKSGRQSFQ 60
Query: 140 EWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKR-----ISVSLP 194
                ++ +G L H H+VRL+G C     +L V +++P GSL +H+ +        + L 
Sbjct: 61  AVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLN 119
Query: 195 WGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT 254
           WG ++      AKG+ +L   E+ +++R+    N+LL S    +++DFG+A + P     
Sbjct: 120 WGVQI------AKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171
Query: 255 HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
            + +       + A E I  G  T +SDV+S+GV + EL+T
Sbjct: 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 139/311 (44%), Gaps = 37/311 (11%)
Query: 71  AHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL 130
           A  F PD       E     +  + +  LG+G FG V++G     ++   + +     + 
Sbjct: 3   ADVFVPD-------EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN 55
Query: 131 DIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHL----- 185
           +   ++   E+L E   + +    H+VRL+G   + +  L++ E M RG L+++L     
Sbjct: 56  EAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP 115
Query: 186 -FKRISVSLP--WGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF 242
             +   V  P      +++A   A G+A+L+   N  ++RD    N ++  DFT K+ DF
Sbjct: 116 EMENNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDF 173
Query: 243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDK 302
           G+ +   E        + +    + +PE +  G  TT SDV+SFGVVL E+ T       
Sbjct: 174 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------- 226
Query: 303 LRPKSEQNLVDWAKPY--LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDR 360
               +EQ       PY  L + + LR++++  L  +        +  L   C   NPK R
Sbjct: 227 ---LAEQ-------PYQGLSNEQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMR 275
Query: 361 PKMAAVVATLE 371
           P    ++++++
Sbjct: 276 PSFLEIISSIK 286

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 131/283 (46%), Gaps = 30/283 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V++G     ++   + +     + +   ++   E+L E   + +    H+VR
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHL------FKRISVSLP--WGTRLKIAIGAAKGLA 210
           L+G   + +  L++ E M RG L+++L       +   V  P      +++A   A G+A
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           +L+   N  ++RD    N ++  DFT K+ DFG+ +   E        + +    + +PE
Sbjct: 146 YLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 203
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRYI 328
            +  G  TT SDV+SFGVVL E+ T           +EQ       PY  L + + LR++
Sbjct: 204 SLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQGLSNEQVLRFV 246
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
           ++  L  +        +  L   C   NPK RP    ++++++
Sbjct: 247 MEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 288

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 131/283 (46%), Gaps = 30/283 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V++G     ++   + +     + +   ++   E+L E   + +    H+VR
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHL------FKRISVSLP--WGTRLKIAIGAAKGLA 210
           L+G   + +  L++ E M RG L+++L       +   V  P      +++A   A G+A
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           +L+   N  ++RD    N ++  DFT K+ DFG+ +   E        + +    + +PE
Sbjct: 140 YLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 197
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRYI 328
            +  G  TT SDV+SFGVVL E+ T           +EQ       PY  L + + LR++
Sbjct: 198 SLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQGLSNEQVLRFV 240
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
           ++  L  +        +  L   C   NPK RP    ++++++
Sbjct: 241 MEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 282

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 130/282 (46%), Gaps = 30/282 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V++G     ++   + +     + +   ++   E+L E   + +    H+VR
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHL------FKRISVSLP--WGTRLKIAIGAAKGLA 210
           L+G   + +  L++ E M RG L+++L       +   V  P      +++A   A G+A
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           +L+   N  ++RD    N ++  DFT K+ DFG+ +   E        + +    + +PE
Sbjct: 153 YLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 210
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRYI 328
            +  G  TT SDV+SFGVVL E+ T           +EQ       PY  L + + LR++
Sbjct: 211 SLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQGLSNEQVLRFV 253
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL 370
           ++  L  +        +  L   C   NPK RP    +++++
Sbjct: 254 MEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 131/283 (46%), Gaps = 30/283 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V++G     ++   + +     + +   ++   E+L E   + +    H+VR
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHL------FKRISVSLP--WGTRLKIAIGAAKGLA 210
           L+G   + +  L++ E M RG L+++L       +   V  P      +++A   A G+A
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           +L+   N  ++RD    N ++  DFT K+ DFG+ +   E        + +    + +PE
Sbjct: 146 YLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 203
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRYI 328
            +  G  TT SDV+SFGVVL E+ T           +EQ       PY  L + + LR++
Sbjct: 204 SLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQGLSNEQVLRFV 246
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
           ++  L  +        +  L   C   NPK RP    ++++++
Sbjct: 247 MEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 288

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 131/283 (46%), Gaps = 30/283 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V++G     ++   + +     + +   ++   E+L E   + +    H+VR
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHL------FKRISVSLP--WGTRLKIAIGAAKGLA 210
           L+G   + +  L++ E M RG L+++L       +   V  P      +++A   A G+A
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           +L+   N  ++RD    N ++  DFT K+ DFG+ +   E        + +    + +PE
Sbjct: 147 YLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 204
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRYI 328
            +  G  TT SDV+SFGVVL E+ T           +EQ       PY  L + + LR++
Sbjct: 205 SLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQGLSNEQVLRFV 247
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
           ++  L  +        +  L   C   NPK RP    ++++++
Sbjct: 248 MEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 129/282 (45%), Gaps = 39/282 (13%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           ++G G FG V K           +A+ VA+K   IE     + ++ E+  L ++ HP++V
Sbjct: 16  VVGRGAFGVVCKA--------KWRAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIV 65
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR---LKIAIGAAKGLAFLHG 214
           +L G C       LV E+   GSL N L    +  LP+ T    +   +  ++G+A+LH 
Sbjct: 66  KLYGACLNP--VCLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWCLQCSQGVAYLHS 121
Query: 215 AE-NPVIYRDFKTSNILLDSDFTA-KLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
            +   +I+RD K  N+LL +  T  K+ DFG A        TH+T    G+  + APE  
Sbjct: 122 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNN-KGSAAWMAPEVF 176
Query: 273 STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR 332
              + + K DV+S+G++L E++T R+  D++             P  R    +     P 
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVITRRKPFDEI-----------GGPAFRIMWAVHNGTRPP 225
Query: 333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           L         K +  L  +C S +P  RP M  +V  +  L+
Sbjct: 226 LIKNLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 263

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 131/283 (46%), Gaps = 30/283 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V++G     ++   + +     + +   ++   E+L E   + +    H+VR
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHL------FKRISVSLP--WGTRLKIAIGAAKGLA 210
           L+G   + +  L++ E M RG L+++L       +   V  P      +++A   A G+A
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           +L+   N  ++RD    N ++  DFT K+ DFG+ +   E        + +    + +PE
Sbjct: 175 YLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 232
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRYI 328
            +  G  TT SDV+SFGVVL E+ T           +EQ       PY  L + + LR++
Sbjct: 233 SLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQGLSNEQVLRFV 275
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
           ++  L  +        +  L   C   NPK RP    ++++++
Sbjct: 276 MEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 317

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 130/283 (45%), Gaps = 30/283 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V++G     ++   + +     + +   ++   E+L E   + +    H+VR
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHL------FKRISVSLP--WGTRLKIAIGAAKGLA 210
           L+G   + +  L++ E M RG L+++L           V  P      +++A   A G+A
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           +L+   N  ++RD    N ++  DFT K+ DFG+ +   E        + +    + +PE
Sbjct: 153 YLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 210
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRYI 328
            +  G  TT SDV+SFGVVL E+ T           +EQ       PY  L + + LR++
Sbjct: 211 SLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQGLSNEQVLRFV 253
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
           ++  L  +        +  L   C   NPK RP    ++++++
Sbjct: 254 MEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 129/282 (45%), Gaps = 39/282 (13%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           ++G G FG V K           +A+ VA+K   IE     + ++ E+  L ++ HP++V
Sbjct: 15  VVGRGAFGVVCKA--------KWRAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIV 64
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR---LKIAIGAAKGLAFLHG 214
           +L G C       LV E+   GSL N L    +  LP+ T    +   +  ++G+A+LH 
Sbjct: 65  KLYGACLNP--VCLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 215 AE-NPVIYRDFKTSNILLDSDFTA-KLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
            +   +I+RD K  N+LL +  T  K+ DFG A        TH+T    G+  + APE  
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNN-KGSAAWMAPEVF 175
Query: 273 STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR 332
              + + K DV+S+G++L E++T R+  D++             P  R    +     P 
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEI-----------GGPAFRIMWAVHNGTRPP 224
Query: 333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           L         K +  L  +C S +P  RP M  +V  +  L+
Sbjct: 225 LIKNLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 130/283 (45%), Gaps = 30/283 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V++G     ++   + +     + +   ++   E+L E   + +    H+VR
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHL------FKRISVSLP--WGTRLKIAIGAAKGLA 210
           L+G   + +  L++ E M RG L+++L           V  P      +++A   A G+A
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           +L+   N  ++RD    N ++  DFT K+ DFG+ +   E        + +    + +PE
Sbjct: 143 YLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 200
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRYI 328
            +  G  TT SDV+SFGVVL E+ T           +EQ       PY  L + + LR++
Sbjct: 201 SLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQGLSNEQVLRFV 243
Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
           ++  L  +        +  L   C   NPK RP    ++++++
Sbjct: 244 MEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 285

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 134/288 (46%), Gaps = 32/288 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLV 157
           LG+G FG V++G   D ++ G     VAVK ++    L+   E+L E   +      H+V
Sbjct: 22  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHL--FKRISVSLP------WGTRLKIAIGAAKGL 209
           RL+G   + +  L+V E M  G L+++L   +  + + P          +++A   A G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
           A+L+  +   ++RD    N ++  DFT K+ DFG+ +   E        + +    + AP
Sbjct: 141 AYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRY 327
           E +  G  TT SD++SFGVVL E+ +           +EQ       PY  L + + L++
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQ-------PYQGLSNEQVLKF 241
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           ++D     Q      + +  L   C   NPK RP    +V  L+  L+
Sbjct: 242 VMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 288

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 134/288 (46%), Gaps = 32/288 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLV 157
           LG+G FG V++G   D ++ G     VAVK ++    L+   E+L E   +      H+V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHL--FKRISVSLP------WGTRLKIAIGAAKGL 209
           RL+G   + +  L+V E M  G L+++L   +  + + P          +++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
           A+L+  +   ++RD    N ++  DFT K+ DFG+ +   E        + +    + AP
Sbjct: 144 AYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRY 327
           E +  G  TT SD++SFGVVL E+ +           +EQ       PY  L + + L++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQ-------PYQGLSNEQVLKF 244
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           ++D     Q      + +  L   C   NPK RP    +V  L+  L+
Sbjct: 245 VMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 291

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 137/298 (45%), Gaps = 44/298 (14%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHL 156
           ++G G FG V  G++      G +   VA+K L     +  R ++L+E   +GQ  HP++
Sbjct: 14  VIGAGEFGEVCSGHLK---LPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 70
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHL------FKRISVSLPWGTRLKIAIGAAKGLA 210
           + L G   +    +++ EFM  GSL++ L      F  I +       + +  G A G+ 
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL-------VGMLRGIAAGMK 123
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG---TYGYA 267
           +L  A+   ++R     NIL++S+   K+SDFGL++   + ++    T  +G      + 
Sbjct: 124 YL--ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR 326
           APE I     T+ SDV+S+G+V+ E+++ G R    +  +   N ++             
Sbjct: 182 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE------------- 228
Query: 327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL----NLKDMA 380
              D RL        A  +  L L C   +   RPK   +V TL+ ++    +LK MA
Sbjct: 229 --QDYRLPPPMDCPSA--LHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMA 282

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 132/285 (46%), Gaps = 32/285 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V++G     ++   + +     + +   ++   E+L E   + +    H+VR
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHL------FKRISVSLP--WGTRLKIAIGAAKGLA 210
           L+G   + +  L++ E M RG L+++L       +   V  P      +++A   A G+A
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           +L+   N  ++RD    N  +  DFT K+ DFG+ +   E        + +    + +PE
Sbjct: 140 YLNA--NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 197
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRYI 328
            +  G  TT SDV+SFGVVL E+ T           +EQ       PY  L + + LR++
Sbjct: 198 SLKDGVFTTYSDVWSFGVVLWEIAT----------LAEQ-------PYQGLSNEQVLRFV 240
Query: 329 VDPRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLES 372
           ++  L  +       +M + L   C   NPK RP    ++++++ 
Sbjct: 241 MEGGLLDK--PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKE 283

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 135/283 (47%), Gaps = 32/283 (11%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHL 156
           ++G G FG V  G +      G +   VA+K L      +  R++L+E   +GQ  HP++
Sbjct: 36  VIGVGEFGEVCSGRLK---VPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 92
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RISVSLPWGTRLKIAIGAAKGLAFLH 213
           + L G   + +  +++ E+M  GSL+  L K   R +V    G    +  G   G+ +L 
Sbjct: 93  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVG----MLRGIGSGMKYL- 147
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAPEYI 272
            ++   ++RD    NIL++S+   K+SDFG++++  +      TTR       + APE I
Sbjct: 148 -SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 206
Query: 273 STGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDP 331
           +    T+ SDV+S+G+V+ E+++ G R    +   S Q+++      +    RL   +D 
Sbjct: 207 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---SNQDVIK----AIEEGYRLPPPMDC 259
Query: 332 RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
            +A          +  L L C      DRPK   +V  L+ L+
Sbjct: 260 PIA----------LHQLMLDCWQKERSDRPKFGQIVNMLDKLI 292

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 9/200 (4%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQ-AVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPH 155
           +LG G FGTV+KG     + +G   +  VA+K+L +  G + + E++ E + +  + HPH
Sbjct: 45  VLGSGAFGTVYKGIW---VPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPH 101
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LVRL+G C     + LV + MP G L  ++ +    ++     L   +  AKG+ +L   
Sbjct: 102 LVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKD-NIGSQLLLNWCVQIAKGMMYLE-- 157
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           E  +++RD    N+L+ S    K++DFGLA++       +          + A E I   
Sbjct: 158 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 217
Query: 276 HLTTKSDVYSFGVVLLELLT 295
             T +SDV+S+GV + EL+T
Sbjct: 218 KFTHQSDVWSYGVTIWELMT 237

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 133/308 (43%), Gaps = 44/308 (14%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLAEVIFLG 149
           +N      LGEG FG V K      L+       VAVK+L         R+ L+E   L 
Sbjct: 23  KNLVLGKTLGEGEFGKVVKA-TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLK 81
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISV------------------ 191
           Q+ HPH+++L G C +D   LL+ E+   GSL   L +   V                  
Sbjct: 82  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 192 ----SLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM 247
               +L  G  +  A   ++G+ +L  AE  +++RD    NIL+      K+SDFGL++ 
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPK 306
             E  +    ++      + A E +     TT+SDV+SFGV+L E++T G      + P+
Sbjct: 200 VYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 307 SEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
              NL       L++  R+          +     ++EM  L LQC    P  RP  A +
Sbjct: 260 RLFNL-------LKTGHRM----------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302
Query: 367 VATLESLL 374
              LE ++
Sbjct: 303 SKDLEKMM 310

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 133/308 (43%), Gaps = 44/308 (14%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLAEVIFLG 149
           +N      LGEG FG V K      L+       VAVK+L         R+ L+E   L 
Sbjct: 23  KNLVLGKTLGEGEFGKVVKA-TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLK 81
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISV------------------ 191
           Q+ HPH+++L G C +D   LL+ E+   GSL   L +   V                  
Sbjct: 82  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 192 ----SLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM 247
               +L  G  +  A   ++G+ +L  AE  +++RD    NIL+      K+SDFGL++ 
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYL--AEMSLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPK 306
             E  +    ++      + A E +     TT+SDV+SFGV+L E++T G      + P+
Sbjct: 200 VYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 307 SEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
              NL       L++  R+          +     ++EM  L LQC    P  RP  A +
Sbjct: 260 RLFNL-------LKTGHRM----------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302
Query: 367 VATLESLL 374
              LE ++
Sbjct: 303 SKDLEKMM 310

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 9/200 (4%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQ-AVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPH 155
           +LG G FGTV+KG     + +G   +  VA+K+L +  G + + E++ E + +  + HPH
Sbjct: 22  VLGSGAFGTVYKGIW---VPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPH 78
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LVRL+G C     + LV + MP G L  ++ +    ++     L   +  AKG+ +L   
Sbjct: 79  LVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKD-NIGSQLLLNWCVQIAKGMMYLE-- 134
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           E  +++RD    N+L+ S    K++DFGLA++       +          + A E I   
Sbjct: 135 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 194
Query: 276 HLTTKSDVYSFGVVLLELLT 295
             T +SDV+S+GV + EL+T
Sbjct: 195 KFTHQSDVWSYGVTIWELMT 214

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LGEG FG V      + L +  K   VAVK L        +++  E   L  L+H H+VR
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDK-MLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKR-------------ISVSLPWGTRLKIAIGA 205
             G C E    L+V+E+M  G L   L                    L  G  L +A   
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
           A G+ +L G     ++RD  T N L+      K+ DFG+++         V  R M    
Sbjct: 139 AAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 266 YAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
           +  PE I     TT+SDV+SFGVVL E+ T
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LGEG FG V      + L +  K   VAVK L        +++  E   L  L+H H+VR
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDK-MLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKR-------------ISVSLPWGTRLKIAIGA 205
             G C E    L+V+E+M  G L   L                    L  G  L +A   
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
           A G+ +L G     ++RD  T N L+      K+ DFG+++         V  R M    
Sbjct: 145 AAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 266 YAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
           +  PE I     TT+SDV+SFGVVL E+ T
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 133/282 (47%), Gaps = 30/282 (10%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHL 156
           ++G G FG V  G +      G +  AVA+K L +   +  R ++L E   +GQ  HP++
Sbjct: 50  VIGAGEFGEVCSGRLK---LPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNV 106
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           V L G     +  ++V EFM  G+L+  L K           + +  G A G+ +L  A+
Sbjct: 107 VHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDG-QFTVIQLVGMLRGIAAGMRYL--AD 163
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKM---GPEGSNTHVTTRVMGTYGYAAPEYIS 273
              ++RD    NIL++S+   K+SDFGL+++    PE   T    ++     + APE I 
Sbjct: 164 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKI--PVRWTAPEAIQ 221
Query: 274 TGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR 332
               T+ SDV+S+G+V+ E+++ G R    +   S Q+++      +    RL   +D  
Sbjct: 222 YRKFTSASDVWSYGIVMWEVMSYGERPYWDM---SNQDVIK----AIEEGYRLPAPMDCP 274
Query: 333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
            AG +          L L C      +RPK   +V  L+ ++
Sbjct: 275 -AGLHQ---------LMLDCWQKERAERPKFEQIVGILDKMI 306

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  GY ++  +       VAVK L   G    + +L E   +  L+H  LVR
Sbjct: 21  LGAGQFGEVWMGYYNNSTK-------VAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVR 72
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L      +E   ++ E+M +GSL + L       +     +  +   A+G+A++      
Sbjct: 73  LYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--RKN 130
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +N+L+      K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 131 YIHRDLRAANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGC 187
Query: 277 LTTKSDVYSFGVVLLELLT 295
            T KSDV+SFG++L E++T
Sbjct: 188 FTIKSDVWSFGILLYEIVT 206

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  GY ++  +       VAVK L   G    + +L E   +  L+H  LVR
Sbjct: 20  LGAGQFGEVWMGYYNNSTK-------VAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVR 71
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     ++E   ++ EFM +GSL + L       +     +  +   A+G+A++      
Sbjct: 72  LYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--RKN 129
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +N+L+      K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 130 YIHRDLRAANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGC 186
Query: 277 LTTKSDVYSFGVVLLELLT 295
            T KS+V+SFG++L E++T
Sbjct: 187 FTIKSNVWSFGILLYEIVT 205

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 133/308 (43%), Gaps = 44/308 (14%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLAEVIFLG 149
           +N      LGEG FG V K      L+       VAVK+L         R+ L+E   L 
Sbjct: 23  KNLVLGKTLGEGEFGKVVKA-TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLK 81
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISV------------------ 191
           Q+ HPH+++L G C +D   LL+ E+   GSL   L +   V                  
Sbjct: 82  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 192 ----SLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM 247
               +L  G  +  A   ++G+ +L  AE  +++RD    NIL+      K+SDFGL++ 
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPK 306
             E  +    ++      + A E +     TT+SDV+SFGV+L E++T G      + P+
Sbjct: 200 VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 307 SEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
              NL       L++  R+          +     ++EM  L LQC    P  RP  A +
Sbjct: 260 RLFNL-------LKTGHRM----------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302
Query: 367 VATLESLL 374
              LE ++
Sbjct: 303 SKDLEKMM 310

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LGEG FG V      + L +  K   VAVK L        +++  E   L  L+H H+VR
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDK-MLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKR-------------ISVSLPWGTRLKIAIGA 205
             G C E    L+V+E+M  G L   L                    L  G  L +A   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
           A G+ +L G     ++RD  T N L+      K+ DFG+++         V  R M    
Sbjct: 168 AAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 266 YAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
           +  PE I     TT+SDV+SFGVVL E+ T
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 135/288 (46%), Gaps = 32/288 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLV 157
           LG+G FG V++G   D ++ G     VAVK ++    L+   E+L E   +      H+V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHL--FKRISVSLP------WGTRLKIAIGAAKGL 209
           RL+G   + +  L+V E M  G L+++L   +  + + P          +++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
           A+L+  +   ++RD    N ++  DFT K+ DFG+ +   E +      + +    + AP
Sbjct: 144 AYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRY 327
           E +  G  TT SD++SFGVVL E+ +           +EQ       PY  L + + L++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQ-------PYQGLSNEQVLKF 244
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           ++D     Q      + +  L   C   NPK RP    +V  L+  L+
Sbjct: 245 VMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 291

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 135/283 (47%), Gaps = 32/283 (11%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHL 156
           ++G G FG V  G +      G +   VA+K L      +  R++L+E   +GQ  HP++
Sbjct: 21  VIGVGEFGEVCSGRLK---VPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 77
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RISVSLPWGTRLKIAIGAAKGLAFLH 213
           + L G   + +  +++ E+M  GSL+  L K   R +V    G    +  G   G+ +L 
Sbjct: 78  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVG----MLRGIGSGMKYL- 132
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAPEYI 272
            ++   ++RD    NIL++S+   K+SDFG++++  +      TTR       + APE I
Sbjct: 133 -SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 191
Query: 273 STGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDP 331
           +    T+ SDV+S+G+V+ E+++ G R    +   S Q+++      +    RL   +D 
Sbjct: 192 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---SNQDVIK----AIEEGYRLPPPMDC 244
Query: 332 RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
            +A          +  L L C      DRPK   +V  L+ L+
Sbjct: 245 PIA----------LHQLMLDCWQKERSDRPKFGQIVNMLDKLI 277

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 135/283 (47%), Gaps = 32/283 (11%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHL 156
           ++G G FG V  G +      G +   VA+K L      +  R++L+E   +GQ  HP++
Sbjct: 15  VIGVGEFGEVCSGRLK---VPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 71
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RISVSLPWGTRLKIAIGAAKGLAFLH 213
           + L G   + +  +++ E+M  GSL+  L K   R +V    G    +  G   G+ +L 
Sbjct: 72  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVG----MLRGIGSGMKYL- 126
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAPEYI 272
            ++   ++RD    NIL++S+   K+SDFG++++  +      TTR       + APE I
Sbjct: 127 -SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 185
Query: 273 STGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDP 331
           +    T+ SDV+S+G+V+ E+++ G R    +   S Q+++      +    RL   +D 
Sbjct: 186 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---SNQDVIK----AIEEGYRLPPPMDC 238
Query: 332 RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
            +A          +  L L C      DRPK   +V  L+ L+
Sbjct: 239 PIA----------LHQLMLDCWQKERSDRPKFGQIVNMLDKLI 271

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 134/288 (46%), Gaps = 32/288 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLV 157
           LG+G FG V++G   D ++ G     VAVK ++    L+   E+L E   +      H+V
Sbjct: 24  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHL--FKRISVSLP------WGTRLKIAIGAAKGL 209
           RL+G   + +  L+V E M  G L+++L   +  + + P          +++A   A G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
           A+L+  +   ++RD    N ++  DFT K+ DFG+ +   E        + +    + AP
Sbjct: 143 AYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRY 327
           E +  G  TT SD++SFGVVL E+ +           +EQ       PY  L + + L++
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQ-------PYQGLSNEQVLKF 243
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           ++D     Q      + +  L   C   NPK RP    +V  L+  L+
Sbjct: 244 VMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 290

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 134/288 (46%), Gaps = 32/288 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLV 157
           LG+G FG V++G   D ++ G     VAVK ++    L+   E+L E   +      H+V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHL--FKRISVSLP------WGTRLKIAIGAAKGL 209
           RL+G   + +  L+V E M  G L+++L   +  + + P          +++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
           A+L+  +   ++RD    N ++  DFT K+ DFG+ +   E        + +    + AP
Sbjct: 144 AYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRY 327
           E +  G  TT SD++SFGVVL E+ +           +EQ       PY  L + + L++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQ-------PYQGLSNEQVLKF 244
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           ++D     Q      + +  L   C   NPK RP    +V  L+  L+
Sbjct: 245 VMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 291

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 133/288 (46%), Gaps = 32/288 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLV 157
           LG+G FG V++G   D ++ G     VAVK ++    L+   E+L E   +      H+V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHL--FKRISVSLP------WGTRLKIAIGAAKGL 209
           RL+G   + +  L+V E M  G L+++L   +  + + P          +++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
           A+L+  +   ++RD    N ++  DFT K+ DFG+ +   E        + +    + AP
Sbjct: 144 AYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRY 327
           E +  G  TT SD++SFGVVL E+ +           +EQ       PY  L + + L++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQ-------PYQGLSNEQVLKF 244
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           ++D     Q      + +  L   C   NP  RP    +V  L+  L+
Sbjct: 245 VMDGGYLDQPD-NCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLH 291

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 129/279 (46%), Gaps = 24/279 (8%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHL 156
           ++G G FG V  G +      G +   VA+K L +   +  R ++L E   +GQ  HP++
Sbjct: 29  VIGAGEFGEVCSGRLK---LPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 85
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           + L G   + +  ++V E+M  GSL+  L K+          + +  G + G+ +L  ++
Sbjct: 86  IHLEGVVTKSKPVMIVTEYMENGSLDTFL-KKNDGQFTVIQLVGMLRGISAGMKYL--SD 142
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAPEYISTG 275
              ++RD    NIL++S+   K+SDFGL+++  +      TTR       + APE I+  
Sbjct: 143 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFR 202
Query: 276 HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAG 335
             T+ SDV+S+G+V+ E+++        RP  E    D  K  +    RL   +D   A 
Sbjct: 203 KFTSASDVWSYGIVMWEVVSYGE-----RPYWEMTNQDVIKA-VEEGYRLPSPMDCPAA- 255
Query: 336 QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                    +  L L C       RPK   +V  L+ L+
Sbjct: 256 ---------LYQLMLDCWQKERNSRPKFDEIVNMLDKLI 285

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V     +       K   VAVK +   G      +LAE   +  L+H  LV+
Sbjct: 23  LGAGQFGEVWMATYN-------KHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVK 74
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     + E   ++ EFM +GSL + L        P    +  +   A+G+AF+   +  
Sbjct: 75  LHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRN 131
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +NIL+ +    K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 132 YIHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGS 188
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L+E++T  R
Sbjct: 189 FTIKSDVWSFGILLMEIVTYGR 210

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 98/200 (49%), Gaps = 22/200 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V     +       K   VAVK +   G      +LAE   +  L+H  LV+
Sbjct: 190 LGAGQFGEVWMATYN-------KHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVK 241
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     + E   ++ EFM +GSL + L        P    +  +   A+G+AF+   +  
Sbjct: 242 LHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRN 298
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
            I+RD + +NIL+ +    K++DFGLA++G +               + APE I+ G  T
Sbjct: 299 YIHRDLRAANILVSASLVCKIADFGLARVGAKFP-----------IKWTAPEAINFGSFT 347
Query: 279 TKSDVYSFGVVLLELLTGRR 298
            KSDV+SFG++L+E++T  R
Sbjct: 348 IKSDVWSFGILLMEIVTYGR 367

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V     +       K   VAVK +   G      +LAE   +  L+H  LV+
Sbjct: 196 LGAGQFGEVWMATYN-------KHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVK 247
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     + E   ++ EFM +GSL + L        P    +  +   A+G+AF+   +  
Sbjct: 248 LHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRN 304
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD + +NIL+ +    K++DFGLA++     +   T R    +   + APE I+ G 
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L+E++T  R
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGR 383

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 132/306 (43%), Gaps = 35/306 (11%)
Query: 82  QLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL--DIEGLQGHR 139
           +L ++    Q F+   +LG+G FG+V +  +  +    +K   VAVK+L  DI       
Sbjct: 14  KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVK---VAVKMLKADIIASSDIE 70
Query: 140 EWLAEVIFLGQLRHPHLVRLIGYCCEDEER------LLVYEFMPRGSLENHLF-KRIS-- 190
           E+L E   + +  HPH+ +L+G       +      +++  FM  G L   L   RI   
Sbjct: 71  EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130
Query: 191 -VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP 249
             +LP  T ++  +  A G+ +L  +    I+RD    N +L  D T  ++DFGL++   
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188
Query: 250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            G              + A E ++    T  SDV++FGV + E++T G+     +     
Sbjct: 189 SGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248
Query: 309 QNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA 368
            N       YL    RL+             +  +E+  L  QC S +PK RP    +  
Sbjct: 249 YN-------YLIGGNRLK----------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRM 291
Query: 369 TLESLL 374
            LE++L
Sbjct: 292 ELENIL 297

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE---GLQGHREWLAEVIF 147
           Q+F     LG G FG VH       +R     +  A+K+L  E    L+       E + 
Sbjct: 6   QDFQILRTLGTGSFGRVHL------IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLM 59
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           L  + HP ++R+ G   + ++  ++ +++  G L + L  R S   P       A     
Sbjct: 60  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEVCL 117
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L +LH  +  +IYRD K  NILLD +   K++DFG AK  P+     VT  + GT  Y 
Sbjct: 118 ALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDYI 170
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           APE +ST       D +SFG+++ E+L G
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 36/288 (12%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           +LG+G FG   K      +      + + +K L     +  R +L EV  +  L HP+++
Sbjct: 17  VLGKGCFGQAIK------VTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVL 70
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           + IG   +D+    + E++  G+L   + K +    PW  R+  A   A G+A+LH    
Sbjct: 71  KFIGVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN- 128
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKM------GPEG------SNTHVTTRVMGTYG 265
            +I+RD  + N L+  +    ++DFGLA++       PEG       +      V+G   
Sbjct: 129 -IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 266 YAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL 325
           + APE I+      K DV+SFG+VL E++ GR + D   P      +D+    L     L
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNAD---PDYLPRTMDFG---LNVRGFL 240
Query: 326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
                P     +          + ++C  ++P+ RP    +   LE+L
Sbjct: 241 DRYCPPNCPPSF--------FPITVRCCDLDPEKRPSFVKLEHWLETL 280

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FGTV KGY          A  +     +   L+   E LAE   + QL +P++VR
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 92
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           +IG  CE E  +LV E    G L  +L +   V       +++    + G+ +L   E+ 
Sbjct: 93  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLE--ESN 147
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD    N+LL +   AK+SDFGL+K        +   +  G +   + APE I+   
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 277 LTTKSDVYSFGVVLLELLT 295
            ++KSDV+SFGV++ E  +
Sbjct: 207 FSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FGTV KGY          A  +     +   L+   E LAE   + QL +P++VR
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 92
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           +IG  CE E  +LV E    G L  +L +   V       +++    + G+ +L   E+ 
Sbjct: 93  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLE--ESN 147
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD    N+LL +   AK+SDFGL+K        +   +  G +   + APE I+   
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 277 LTTKSDVYSFGVVLLELLT 295
            ++KSDV+SFGV++ E  +
Sbjct: 207 FSSKSDVWSFGVLMWEAFS 225

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 97/198 (48%), Gaps = 8/198 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FGTV KGY          A  +     +   L+   E LAE   + QL +P++VR
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 76
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           +IG  CE E  +LV E    G L  +L +   V       +++    + G+ +L   E+ 
Sbjct: 77  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLE--ESN 131
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH-VTTRVMGTYGYAAPEYISTGHL 277
            ++RD    N+LL +   AK+SDFGL+K      N +   T       + APE I+    
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKF 191
Query: 278 TTKSDVYSFGVVLLELLT 295
           ++KSDV+SFGV++ E  +
Sbjct: 192 SSKSDVWSFGVLMWEAFS 209

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FGTV KGY          A  +     +   L+   E LAE   + QL +P++VR
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 72
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           +IG  CE E  +LV E    G L  +L +   V       +++    + G+ +L   E+ 
Sbjct: 73  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLE--ESN 127
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD    N+LL +   AK+SDFGL+K        +   +  G +   + APE I+   
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 277 LTTKSDVYSFGVVLLELLT 295
            ++KSDV+SFGV++ E  +
Sbjct: 187 FSSKSDVWSFGVLMWEAFS 205

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FGTV KGY          A  +     +   L+   E LAE   + QL +P++VR
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 90
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           +IG  CE E  +LV E    G L  +L +   V       +++    + G+ +L   E+ 
Sbjct: 91  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLE--ESN 145
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD    N+LL +   AK+SDFGL+K        +   +  G +   + APE I+   
Sbjct: 146 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 204
Query: 277 LTTKSDVYSFGVVLLELLT 295
            ++KSDV+SFGV++ E  +
Sbjct: 205 FSSKSDVWSFGVLMWEAFS 223

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FGTV KGY          A  +     +   L+   E LAE   + QL +P++VR
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 76
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           +IG  CE E  +LV E    G L  +L +   V       +++    + G+ +L   E+ 
Sbjct: 77  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLE--ESN 131
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD    N+LL +   AK+SDFGL+K        +   +  G +   + APE I+   
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 190
Query: 277 LTTKSDVYSFGVVLLELLT 295
            ++KSDV+SFGV++ E  +
Sbjct: 191 FSSKSDVWSFGVLMWEAFS 209

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FGTV KGY          A  +     +   L+   E LAE   + QL +P++VR
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 70
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           +IG  CE E  +LV E    G L  +L +   V       +++    + G+ +L   E+ 
Sbjct: 71  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLE--ESN 125
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD    N+LL +   AK+SDFGL+K        +   +  G +   + APE I+   
Sbjct: 126 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 184
Query: 277 LTTKSDVYSFGVVLLELLT 295
            ++KSDV+SFGV++ E  +
Sbjct: 185 FSSKSDVWSFGVLMWEAFS 203

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FGTV KGY          A  +     +   L+   E LAE   + QL +P++VR
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 82
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           +IG  CE E  +LV E    G L  +L +   V       +++    + G+ +L   E+ 
Sbjct: 83  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLE--ESN 137
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD    N+LL +   AK+SDFGL+K        +   +  G +   + APE I+   
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 277 LTTKSDVYSFGVVLLELLT 295
            ++KSDV+SFGV++ E  +
Sbjct: 197 FSSKSDVWSFGVLMWEAFS 215

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 97/198 (48%), Gaps = 8/198 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FGTV KGY          A  +     +   L+   E LAE   + QL +P++VR
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 435
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           +IG  CE E  +LV E    G L  +L +   V       +++    + G+ +L   E+ 
Sbjct: 436 MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLE--ESN 490
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH-VTTRVMGTYGYAAPEYISTGHL 277
            ++RD    N+LL +   AK+SDFGL+K      N +   T       + APE I+    
Sbjct: 491 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 550
Query: 278 TTKSDVYSFGVVLLELLT 295
           ++KSDV+SFGV++ E  +
Sbjct: 551 SSKSDVWSFGVLMWEAFS 568

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 15/224 (6%)
Query: 75  GPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG 134
           G D   F+   L+ + Q       LG+G FG+V     D    Q    + VAVK L    
Sbjct: 1   GSDPTQFEERHLKFLQQ-------LGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHST 51
Query: 135 LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVS 192
            +  R++  E+  L  L+H ++V+  G C     R   L+ E++P GSL ++L K     
Sbjct: 52  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KER 110
Query: 193 LPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS 252
           +     L+      KG+ +L       I+RD  T NIL++++   K+ DFGL K+ P+  
Sbjct: 111 IDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
Query: 253 N-THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
               V         + APE ++    +  SDV+SFGVVL EL T
Sbjct: 169 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 97/198 (48%), Gaps = 8/198 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FGTV KGY          A  +     +   L+   E LAE   + QL +P++VR
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPYIVR 434
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           +IG  CE E  +LV E    G L  +L +   V       +++    + G+ +L   E+ 
Sbjct: 435 MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLE--ESN 489
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH-VTTRVMGTYGYAAPEYISTGHL 277
            ++RD    N+LL +   AK+SDFGL+K      N +   T       + APE I+    
Sbjct: 490 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 549
Query: 278 TTKSDVYSFGVVLLELLT 295
           ++KSDV+SFGV++ E  +
Sbjct: 550 SSKSDVWSFGVLMWEAFS 567

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +GSL + L   +   L     + +A   A G+A++      
Sbjct: 78  LYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 134
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD + +NIL+  +   K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLI---EDNEXTARQGAKFPIKWTAPEAALYGR 191
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL T  R
Sbjct: 192 FTIKSDVWSFGILLTELTTKGR 213

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 8/200 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG+V     D    Q    + VAVK L     +  R++  E+  L  L+H ++V+
Sbjct: 21  LGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 159 LIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
             G C     R   L+ EF+P GSL  +L K     +     L+      KG+ +L    
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKH-KERIDHIKLLQYTSQICKGMEYL--GT 135
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN-THVTTRVMGTYGYAAPEYISTG 275
              I+RD  T NIL++++   K+ DFGL K+ P+      V         + APE ++  
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 276 HLTTKSDVYSFGVVLLELLT 295
             +  SDV+SFGVVL EL T
Sbjct: 196 KFSVASDVWSFGVVLYELFT 215

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 17  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 68
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +GSL + L   +   L     + +A   A G+A++      
Sbjct: 69  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 125
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD + +NIL+  +   K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 126 YVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGR 182
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL T  R
Sbjct: 183 FTIKSDVWSFGILLTELTTKGR 204

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 15  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 66
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +GSL + L   +   L     + +A   A G+A++      
Sbjct: 67  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 123
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD + +NIL+  +   K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 124 YVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGR 180
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL T  R
Sbjct: 181 FTIKSDVWSFGILLTELTTKGR 202

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 128/287 (44%), Gaps = 32/287 (11%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           + +  + LG G FG V++G           +  VAVK L  + ++   E+L E   + ++
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEI 64
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +HP+LV+L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +
Sbjct: 65  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 124
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPE 270
           L   +   I+RD    N L+  +   K++DFGL++ M  +    H   +      + APE
Sbjct: 125 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPE 180
Query: 271 YISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
            ++    + KSDV++FGV+L E+ T G      + P     L++  K Y R  R      
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE--KDY-RMERP----- 232
Query: 330 DPRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLLN 375
                     +G  E    L   C   NP DRP  A +    E++  
Sbjct: 233 ----------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 275 LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 326
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +GSL + L       L     + +A   A G+A++      
Sbjct: 327 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 383
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD + +NIL+  +   K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGR 440
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL T  R
Sbjct: 441 FTIKSDVWSFGILLTELTTKGR 462

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +GSL + L   +   L     + +A   A G+A++      
Sbjct: 78  LYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 134
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD + +NIL+  +   K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGR 191
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL T  R
Sbjct: 192 FTIKSDVWSFGILLTELTTKGR 213

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 105/220 (47%), Gaps = 14/220 (6%)
Query: 84  SELRAITQNFSSNYL-----LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH 138
           SE R  TQ F   +L     LG+G FG+V     D    Q    + VAVK L     +  
Sbjct: 2   SEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHL 58
Query: 139 REWLAEVIFLGQLRHPHLVRLIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWG 196
           R++  E+  L  L+H ++V+  G C     R   L+ E++P GSL ++L K     +   
Sbjct: 59  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHI 117
Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN-TH 255
             L+      KG+ +L       I+RD  T NIL++++   K+ DFGL K+ P+      
Sbjct: 118 KLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 175
Query: 256 VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
           V         + APE ++    +  SDV+SFGVVL EL T
Sbjct: 176 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 8/200 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG+V     D    Q    + VAVK L     +  R++  E+  L  L+H ++V+
Sbjct: 17  LGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 159 LIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
             G C     R   L+ E++P GSL ++L K     +     L+      KG+ +L    
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL--GT 131
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN-THVTTRVMGTYGYAAPEYISTG 275
              I+RD  T NIL++++   K+ DFGL K+ P+      V         + APE ++  
Sbjct: 132 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 191
Query: 276 HLTTKSDVYSFGVVLLELLT 295
             +  SDV+SFGVVL EL T
Sbjct: 192 KFSVASDVWSFGVVLYELFT 211

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 17/211 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LGEG FG V      + L        VAVK L    L   +++  E   L  L+H H+V+
Sbjct: 23  LGEGAFGKVFLAECYN-LSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLF--------------KRISVSLPWGTRLKIAIG 204
             G C + +  ++V+E+M  G L   L               ++    L     L IA  
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY 264
            A G+ +L  A    ++RD  T N L+ ++   K+ DFG+++         V    M   
Sbjct: 142 IASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 265 GYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
            +  PE I     TT+SDV+SFGV+L E+ T
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +GSL + L   +   L     + +A   A G+A++      
Sbjct: 78  LYAVVSE-EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 134
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD + +NIL+  +   K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGR 191
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL T  R
Sbjct: 192 FTIKSDVWSFGILLTELTTKGR 213

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +GSL + L   +   L     + +A   A G+A++      
Sbjct: 78  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 134
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD + +NIL+  +   K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGR 191
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL T  R
Sbjct: 192 FTIKSDVWSFGILLTELTTKGR 213

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 133/288 (46%), Gaps = 32/288 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLV 157
           LG+G FG V++G   D ++ G     VAVK ++    L+   E+L E   +      H+V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHL--FKRISVSLP------WGTRLKIAIGAAKGL 209
           RL+G   + +  L+V E M  G L+++L   +  + + P          +++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
           A+L+  +   ++R+    N ++  DFT K+ DFG+ +   E        + +    + AP
Sbjct: 144 AYLNAKK--FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRY 327
           E +  G  TT SD++SFGVVL E+ +           +EQ       PY  L + + L++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQ-------PYQGLSNEQVLKF 244
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           ++D     Q      + +  L   C   NP  RP    +V  L+  L+
Sbjct: 245 VMDGGYLDQPD-NCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLH 291

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 15/224 (6%)
Query: 75  GPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG 134
           G D   F+   L+ + Q       LG+G FG+V     D    Q    + VAVK L    
Sbjct: 1   GSDPTQFEERHLKFLQQ-------LGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHST 51
Query: 135 LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVS 192
            +  R++  E+  L  L+H ++V+  G C     R   L+ E++P GSL ++L K     
Sbjct: 52  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KER 110
Query: 193 LPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS 252
           +     L+      KG+ +L       I+RD  T NIL++++   K+ DFGL K+ P+  
Sbjct: 111 IDHIKLLQYTSQICKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
Query: 253 N-THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
               V         + APE ++    +  SDV+SFGVVL EL T
Sbjct: 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 133/288 (46%), Gaps = 32/288 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLV 157
           LG+G FG V++G   D ++ G     VAVK ++    L+   E+L E   +      H+V
Sbjct: 26  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHL--FKRISVSLP------WGTRLKIAIGAAKGL 209
           RL+G   + +  L+V E M  G L+++L   +  + + P          +++A   A G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
           A+L+  +   ++R+    N ++  DFT K+ DFG+ +   E        + +    + AP
Sbjct: 145 AYLNAKK--FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRY 327
           E +  G  TT SD++SFGVVL E+ +           +EQ       PY  L + + L++
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITS----------LAEQ-------PYQGLSNEQVLKF 245
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           ++D     Q      + +  L   C   NP  RP    +V  L+  L+
Sbjct: 246 VMDGGYLDQPD-NCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLH 292

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 8/200 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG+V     D    Q    + VAVK L     +  R++  E+  L  L+H ++V+
Sbjct: 23  LGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 159 LIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
             G C     R   L+ E++P GSL ++L K     +     L+      KG+ +L    
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL--GT 137
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN-THVTTRVMGTYGYAAPEYISTG 275
              I+RD  T NIL++++   K+ DFGL K+ P+      V         + APE ++  
Sbjct: 138 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 197
Query: 276 HLTTKSDVYSFGVVLLELLT 295
             +  SDV+SFGVVL EL T
Sbjct: 198 KFSVASDVWSFGVVLYELFT 217

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 8/200 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG+V     D    Q    + VAVK L     +  R++  E+  L  L+H ++V+
Sbjct: 18  LGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 159 LIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
             G C     R   L+ E++P GSL ++L K     +     L+      KG+ +L    
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL--GT 132
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN-THVTTRVMGTYGYAAPEYISTG 275
              I+RD  T NIL++++   K+ DFGL K+ P+      V         + APE ++  
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 276 HLTTKSDVYSFGVVLLELLT 295
             +  SDV+SFGVVL EL T
Sbjct: 193 KFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 8/200 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG+V     D    Q    + VAVK L     +  R++  E+  L  L+H ++V+
Sbjct: 16  LGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 159 LIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
             G C     R   L+ E++P GSL ++L K     +     L+      KG+ +L    
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL--GT 130
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN-THVTTRVMGTYGYAAPEYISTG 275
              I+RD  T NIL++++   K+ DFGL K+ P+      V         + APE ++  
Sbjct: 131 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 190
Query: 276 HLTTKSDVYSFGVVLLELLT 295
             +  SDV+SFGVVL EL T
Sbjct: 191 KFSVASDVWSFGVVLYELFT 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 8/200 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG+V     D    Q    + VAVK L     +  R++  E+  L  L+H ++V+
Sbjct: 22  LGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 159 LIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
             G C     R   L+ E++P GSL ++L K     +     L+      KG+ +L    
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL--GT 136
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN-THVTTRVMGTYGYAAPEYISTG 275
              I+RD  T NIL++++   K+ DFGL K+ P+      V         + APE ++  
Sbjct: 137 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 196
Query: 276 HLTTKSDVYSFGVVLLELLT 295
             +  SDV+SFGVVL EL T
Sbjct: 197 KFSVASDVWSFGVVLYELFT 216

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 27/215 (12%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHL 156
           ++GEG FG V K  I  D   GL+  A   ++ +      HR++  E+  L +L  HP++
Sbjct: 22  VIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKR--------------ISVSLPWGTRLKIA 202
           + L+G C       L  E+ P G+L + L K                + +L     L  A
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
              A+G+ +L  ++   I+RD    NIL+  ++ AK++DFGL++    G   +V  + MG
Sbjct: 139 ADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV-KKTMG 191
Query: 263 TYG--YAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                + A E ++    TT SDV+S+GV+L E+++
Sbjct: 192 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +GSL + L       L     + +A   A G+A++      
Sbjct: 244 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 300
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD + +NIL+  +   K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL T  R
Sbjct: 358 FTIKSDVWSFGILLTELTTKGR 379

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 8/200 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG+V     D    Q    + VAVK L     +  R++  E+  L  L+H ++V+
Sbjct: 25  LGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 159 LIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
             G C     R   L+ E++P GSL ++L K     +     L+      KG+ +L    
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL--GT 139
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN-THVTTRVMGTYGYAAPEYISTG 275
              I+RD  T NIL++++   K+ DFGL K+ P+      V         + APE ++  
Sbjct: 140 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 199
Query: 276 HLTTKSDVYSFGVVLLELLT 295
             +  SDV+SFGVVL EL T
Sbjct: 200 KFSVASDVWSFGVVLYELFT 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 8/200 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG+V     D    Q    + VAVK L     +  R++  E+  L  L+H ++V+
Sbjct: 24  LGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 159 LIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
             G C     R   L+ E++P GSL ++L K     +     L+      KG+ +L    
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL--GT 138
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN-THVTTRVMGTYGYAAPEYISTG 275
              I+RD  T NIL++++   K+ DFGL K+ P+      V         + APE ++  
Sbjct: 139 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 198
Query: 276 HLTTKSDVYSFGVVLLELLT 295
             +  SDV+SFGVVL EL T
Sbjct: 199 KFSVASDVWSFGVVLYELFT 218

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 27/215 (12%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHL 156
           ++GEG FG V K  I  D   GL+  A   ++ +      HR++  E+  L +L  HP++
Sbjct: 32  VIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKR--------------ISVSLPWGTRLKIA 202
           + L+G C       L  E+ P G+L + L K                + +L     L  A
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
              A+G+ +L  ++   I+RD    NIL+  ++ AK++DFGL++    G   +V  + MG
Sbjct: 149 ADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV-KKTMG 201
Query: 263 TYG--YAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                + A E ++    TT SDV+S+GV+L E+++
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +GSL + L       L     + +A   A G+A++      
Sbjct: 244 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 300
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD + +NIL+  +   K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL T  R
Sbjct: 358 FTIKSDVWSFGILLTELTTKGR 379

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 16  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 67
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +GSL + L       L     + +A   A G+A++      
Sbjct: 68  LYAVVSE-EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 124
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD + +NIL+  +   K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 125 YVHRDLRAANILVGENLVCKVADFGLARLI---EDNEXTARQGAKFPIKWTAPEAALYGR 181
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL T  R
Sbjct: 182 FTIKSDVWSFGILLTELTTKGR 203

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 8/200 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG+V     D    Q    + VAVK L     +  R++  E+  L  L+H ++V+
Sbjct: 49  LGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 159 LIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
             G C     R   L+ E++P GSL ++L K     +     L+      KG+ +L    
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL--GT 163
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN-THVTTRVMGTYGYAAPEYISTG 275
              I+RD  T NIL++++   K+ DFGL K+ P+      V         + APE ++  
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 223
Query: 276 HLTTKSDVYSFGVVLLELLT 295
             +  SDV+SFGVVL EL T
Sbjct: 224 KFSVASDVWSFGVVLYELFT 243

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 19  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 70
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +GSL + L       L     + +A   A G+A++      
Sbjct: 71  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 127
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD + +NIL+  +   K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 128 YVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGR 184
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL T  R
Sbjct: 185 FTIKSDVWSFGILLTELTTKGR 206

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 112/212 (52%), Gaps = 17/212 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--GHREWLAEVIFLGQLRHPHL 156
           LG G FG+V +G      R   K   VA+K+L  +G +     E + E   + QL +P++
Sbjct: 18  LGCGNFGSVRQGV----YRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           VRLIG  C+ E  +LV E    G L   L  +    +P     ++    + G+ +L   E
Sbjct: 73  VRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLE--E 128
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTY--GYAAPEYIS 273
              ++RD    N+LL +   AK+SDFGL+K +G +  +++ T R  G +   + APE I+
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD--DSYYTARSAGKWPLKWYAPECIN 186
Query: 274 TGHLTTKSDVYSFGVVLLELLT-GRRSMDKLR 304
               +++SDV+S+GV + E L+ G++   K++
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 8/200 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG+V     D    Q    + VAVK L     +  R++  E+  L  L+H ++V+
Sbjct: 36  LGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 159 LIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
             G C     R   L+ E++P GSL ++L K     +     L+      KG+ +L    
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL--GT 150
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN-THVTTRVMGTYGYAAPEYISTG 275
              I+RD  T NIL++++   K+ DFGL K+ P+      V         + APE ++  
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 276 HLTTKSDVYSFGVVLLELLT 295
             +  SDV+SFGVVL EL T
Sbjct: 211 KFSVASDVWSFGVVLYELFT 230

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  G  + + +       VA+K L   G      +L E   + +L+H  LV+
Sbjct: 17  LGNGQFGEVWMGTWNGNTK-------VAIKTLK-PGTMSPESFLEEAQIMKKLKHDKLVQ 68
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +GSL + L      +L     + +A   A G+A++      
Sbjct: 69  LYAVVSE-EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN-- 125
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            I+RD +++NIL+ +    K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 126 YIHRDLRSANILVGNGLICKIADFGLARLI---EDNEXTARQGAKFPIKWTAPEAALYGR 182
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL+T  R
Sbjct: 183 FTIKSDVWSFGILLTELVTKGR 204

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 128/287 (44%), Gaps = 32/287 (11%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           + +  + LG G +G V++G           +  VAVK L  + ++   E+L E   + ++
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEI 64
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +HP+LV+L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +
Sbjct: 65  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 124
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPE 270
           L   +   I+RD    N L+  +   K++DFGL++ M  +    H   +      + APE
Sbjct: 125 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPE 180
Query: 271 YISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
            ++    + KSDV++FGV+L E+ T G      + P     L++  K Y R  R      
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE--KDY-RMERP----- 232
Query: 330 DPRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLLN 375
                     +G  E    L   C   NP DRP  A +    E++  
Sbjct: 233 ----------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + ++RH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKIRHEKLVQ 77
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +GSL + L   +   L     + +A   A G+A++      
Sbjct: 78  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 134
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD + +NIL+  +   K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGR 191
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL T  R
Sbjct: 192 FTIKSDVWSFGILLTELTTKGR 213

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 8/200 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG+V     D    Q    + VAVK L     +  R++  E+  L  L+H ++V+
Sbjct: 36  LGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 159 LIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
             G C     R   L+ E++P GSL ++L K     +     L+      KG+ +L    
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL--GT 150
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN-THVTTRVMGTYGYAAPEYISTG 275
              I+RD  T NIL++++   K+ DFGL K+ P+      V         + APE ++  
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 276 HLTTKSDVYSFGVVLLELLT 295
             +  SDV+SFGVVL EL T
Sbjct: 211 KFSVASDVWSFGVVLYELFT 230

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +GSL + L   +   L     + +A   A G+A++      
Sbjct: 78  LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 134
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD   +NIL+  +   K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 135 YVHRDLAAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGR 191
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL T  R
Sbjct: 192 FTIKSDVWSFGILLTELTTKGR 213

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +GSL + L       L     + +A   A G+A++      
Sbjct: 244 LYAVVSE-EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN-- 300
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD + +NIL+  +   K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL T  R
Sbjct: 358 FTIKSDVWSFGILLTELTTKGR 379

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +G L + L   +   L     + +A   A G+A++      
Sbjct: 78  LYAVVSE-EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 134
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD + +NIL+  +   K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGR 191
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL T  R
Sbjct: 192 FTIKSDVWSFGILLTELTTKGR 213

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHLV 157
           +GEG FG VH+G     +     A AVA+K          RE +L E + + Q  HPH+V
Sbjct: 18  IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +LIG   E+    ++ E    G L + L  R   SL   + +  A   +  LA+L     
Sbjct: 75  KLIGVITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR- 131
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
             ++RD    N+L+ S+   KL DFGL++   E S  +  ++      + APE I+    
Sbjct: 132 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 278 TTKSDVYSFGVVLLELL 294
           T+ SDV+ FGV + E+L
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           LG G FG V  G      +  L    VAVK+L+   I  L    +   E+  L   RHPH
Sbjct: 24  LGVGTFGKVKVG------KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +++L        +  +V E++  G L +++ K   +      RL   I +  G+ + H  
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS--GVDYCH-- 133
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
            + V++RD K  N+LLD+   AK++DFGL+ M  +G     +    G+  YAAPE IS G
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GSPNYAAPEVIS-G 189
Query: 276 HLTT--KSDVYSFGVVLLELLTGRRSMD 301
            L    + D++S GV+L  LL G    D
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 98/200 (49%), Gaps = 8/200 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG+V     D    Q    + VAVK L     +  R++  E+  L  L+H ++V+
Sbjct: 19  LGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 159 LIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
             G C     R   L+ E++P GSL ++L K     +     L+      KG+ +L    
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL--GT 133
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH-VTTRVMGTYGYAAPEYISTG 275
              I+R+  T NIL++++   K+ DFGL K+ P+    + V         + APE ++  
Sbjct: 134 KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 193
Query: 276 HLTTKSDVYSFGVVLLELLT 295
             +  SDV+SFGVVL EL T
Sbjct: 194 KFSVASDVWSFGVVLYELFT 213

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +G L + L   +   L     + +A   A G+A++      
Sbjct: 78  LYAVVSE-EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 134
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD + +NIL+  +   K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGR 191
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL T  R
Sbjct: 192 FTIKSDVWSFGILLTELTTKGR 213

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 98/200 (49%), Gaps = 8/200 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG+V     D    Q    + VAVK L     +  R++  E+  L  L+H ++V+
Sbjct: 21  LGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 159 LIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
             G C     R   L+ E++P GSL ++L +  +  +     L+      KG+ +L    
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QAHAERIDHIKLLQYTSQICKGMEYL--GT 135
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN-THVTTRVMGTYGYAAPEYISTG 275
              I+RD  T NIL++++   K+ DFGL K+ P+      V         + APE ++  
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 276 HLTTKSDVYSFGVVLLELLT 295
             +  SDV+SFGVVL EL T
Sbjct: 196 KFSVASDVWSFGVVLYELFT 215

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 128/287 (44%), Gaps = 32/287 (11%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           + +  + LG G +G V++G           +  VAVK L  + ++   E+L E   + ++
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEI 64
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +HP+LV+L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +
Sbjct: 65  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 124
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPE 270
           L   +   I+RD    N L+  +   K++DFGL++ M  +    H   +      + APE
Sbjct: 125 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKF--PIKWTAPE 180
Query: 271 YISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
            ++    + KSDV++FGV+L E+ T G      + P     L++  K Y R  R      
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE--KDY-RMERP----- 232
Query: 330 DPRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLLN 375
                     +G  E    L   C   NP DRP  A +    E++  
Sbjct: 233 ----------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHLV 157
           +GEG FG VH+G     +     A AVA+K          RE +L E + + Q  HPH+V
Sbjct: 398 IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +LIG   E+    ++ E    G L + L  R   SL   + +  A   +  LA+L     
Sbjct: 455 KLIGVITENP-VWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR- 511
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
             ++RD    N+L+ S+   KL DFGL++   E S  +  ++      + APE I+    
Sbjct: 512 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 278 TTKSDVYSFGVVLLELL 294
           T+ SDV+ FGV + E+L
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 96/201 (47%), Gaps = 9/201 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-EVIFLGQLRHPHLV 157
           LGEG FG V     D +       + VAVK L  E    H   L  E+  L  L H ++V
Sbjct: 29  LGEGHFGKVELCRYDPEGDN--TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 158 RLIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +  G C ED      L+ EF+P GSL+ +L K  +  +    +LK A+   KG+ +L   
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSR 145
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPEYIST 274
           +   ++RD    N+L++S+   K+ DFGL K +  +     V         + APE +  
Sbjct: 146 Q--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 203
Query: 275 GHLTTKSDVYSFGVVLLELLT 295
                 SDV+SFGV L ELLT
Sbjct: 204 SKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 96/201 (47%), Gaps = 9/201 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-EVIFLGQLRHPHLV 157
           LGEG FG V     D +       + VAVK L  E    H   L  E+  L  L H ++V
Sbjct: 17  LGEGHFGKVELCRYDPEGDN--TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 158 RLIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +  G C ED      L+ EF+P GSL+ +L K  +  +    +LK A+   KG+ +L   
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSR 133
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPEYIST 274
           +   ++RD    N+L++S+   K+ DFGL K +  +     V         + APE +  
Sbjct: 134 Q--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 191
Query: 275 GHLTTKSDVYSFGVVLLELLT 295
                 SDV+SFGV L ELLT
Sbjct: 192 SKFYIASDVWSFGVTLHELLT 212

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 95/197 (48%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHLV 157
           +GEG FG VH+G     +     A AVA+K          RE +L E + + Q  HPH+V
Sbjct: 18  IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +LIG   E+    ++ E    G L + L  R   SL   + +  A   +  LA+L     
Sbjct: 75  KLIGVITENPV-WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR- 131
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
             ++RD    N+L+ S+   KL DFGL++   E S     ++      + APE I+    
Sbjct: 132 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTXXKASKGKLPIKWMAPESINFRRF 189
Query: 278 TTKSDVYSFGVVLLELL 294
           T+ SDV+ FGV + E+L
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 34/280 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 193 LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGNMSPEAFLQEAQVMKKLRHEKLVQ 244
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +GSL + L   +   L     + +A   A G+A++      
Sbjct: 245 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN-- 301
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD + +NIL+  +   K++DFGL ++     +   T R    +   + APE    G 
Sbjct: 302 YVHRDLRAANILVGENLVCKVADFGLGRLI---EDNEYTARQGAKFPIKWTAPEAALYGR 358
Query: 277 LTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAG 335
            T KSDV+SFG++L EL T GR     +  +   + V+         R  R    P    
Sbjct: 359 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---------RGYRMPCPPEC-- 407
Query: 336 QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
                  + +  L  QC   +P++RP    + A LE    
Sbjct: 408 ------PESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFT 441

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 95/318 (29%), Positives = 136/318 (42%), Gaps = 43/318 (13%)
Query: 69  DLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKG-YIDDDLRQGLKAQAVAV 127
           DL      ++ D  +   R +T    S+ ++G+G FG V+ G YID    Q       A+
Sbjct: 2   DLDSALLAEVKDVLIPHERVVTH---SDRVIGKGHFGVVYHGEYID----QAQNRIQCAI 54
Query: 128 KLLD-IEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE---ERLLVYEFMPRGSLEN 183
           K L  I  +Q    +L E + +  L HP+++ LIG     E     LL Y  M  G L  
Sbjct: 55  KSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY--MCHGDLLQ 112
Query: 184 HLFKRISVSLPWGTRL-KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF 242
             F R     P    L    +  A+G+ +L  AE   ++RD    N +LD  FT K++DF
Sbjct: 113 --FIRSPQRNPTVKDLISFGLQVARGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADF 168
Query: 243 GLAK--MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSM 300
           GLA+  +  E  +            + A E + T   TTKSDV+SFGV+L ELLT  R  
Sbjct: 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT--RGA 226
Query: 301 DKLRPKSEQNLVDWAKPYLRSSRRL---RYIVDPRLAGQYSVKGAKEMAVLALQCISVNP 357
              R     +L      +L   RRL    Y  D      Y V           QC   +P
Sbjct: 227 PPYRHIDPFDLTH----FLAQGRRLPQPEYCPD----SLYQVMQ---------QCWEADP 269
Query: 358 KDRPKMAAVVATLESLLN 375
             RP    +V  +E +++
Sbjct: 270 AVRPTFRVLVGEVEQIVS 287

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 27/215 (12%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHL 156
           ++GEG FG V K  I  D   GL+  A   ++ +      HR++  E+  L +L  HP++
Sbjct: 29  VIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 85
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKR--------------ISVSLPWGTRLKIA 202
           + L+G C       L  E+ P G+L + L K                + +L     L  A
Sbjct: 86  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
              A+G+ +L  ++   I+R+    NIL+  ++ AK++DFGL++    G   +V  + MG
Sbjct: 146 ADVARGMDYL--SQKQFIHRNLAARNILVGENYVAKIADFGLSR----GQEVYV-KKTMG 198
Query: 263 T--YGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                + A E ++    TT SDV+S+GV+L E+++
Sbjct: 199 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 23  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 74
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +GSL + L       L     + ++   A G+A++      
Sbjct: 75  LYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN-- 131
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD + +NIL+  +   K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 132 YVHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGR 188
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL T  R
Sbjct: 189 FTIKSDVWSFGILLTELTTKGR 210

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHLV 157
           +GEG FG VH+G     +     A AVA+K          RE +L E + + Q  HPH+V
Sbjct: 18  IGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +LIG   E+    ++ E    G L + L  R   SL   + +  A   +  LA+L     
Sbjct: 75  KLIGVITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR- 131
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
             ++RD    N+L+ S+   KL DFGL++   E S  +  ++      + APE I+    
Sbjct: 132 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 278 TTKSDVYSFGVVLLELL 294
           T+ SDV+ FGV + E+L
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHLV 157
           +GEG FG VH+G     +     A AVA+K          RE +L E + + Q  HPH+V
Sbjct: 15  IGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +LIG   E+    ++ E    G L + L  R   SL   + +  A   +  LA+L     
Sbjct: 72  KLIGVITENP-VWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR- 128
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
             ++RD    N+L+ S+   KL DFGL++   E S  +  ++      + APE I+    
Sbjct: 129 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 278 TTKSDVYSFGVVLLELL 294
           T+ SDV+ FGV + E+L
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHLV 157
           +GEG FG VH+G     +     A AVA+K          RE +L E + + Q  HPH+V
Sbjct: 20  IGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 76
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +LIG   E+    ++ E    G L + L  R   SL   + +  A   +  LA+L     
Sbjct: 77  KLIGVITENP-VWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR- 133
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
             ++RD    N+L+ S+   KL DFGL++   E S  +  ++      + APE I+    
Sbjct: 134 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRF 191
Query: 278 TTKSDVYSFGVVLLELL 294
           T+ SDV+ FGV + E+L
Sbjct: 192 TSASDVWMFGVCMWEIL 208

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 23  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 74
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E E   +V E+M +GSL + L       L     + ++   A G+A++      
Sbjct: 75  LYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN-- 131
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY--GYAAPEYISTGH 276
            ++RD + +NIL+  +   K++DFGLA++     +   T R    +   + APE    G 
Sbjct: 132 YVHRDLRAANILVGENLVCKVADFGLARLI---EDNEWTARQGAKFPIKWTAPEAALYGR 188
Query: 277 LTTKSDVYSFGVVLLELLTGRR 298
            T KSDV+SFG++L EL T  R
Sbjct: 189 FTIKSDVWSFGILLTELTTKGR 210

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 99  LGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHL 156
           +GEG FG VH+G Y+  +      A AVA+K          RE +L E + + Q  HPH+
Sbjct: 46  IGEGQFGDVHQGIYMSPEN----PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 101
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           V+LIG   E+    ++ E    G L + L  R   SL   + +  A   +  LA+L    
Sbjct: 102 VKLIGVITENP-VWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR 159
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH 276
              ++RD    N+L+ S+   KL DFGL++   E S  +  ++      + APE I+   
Sbjct: 160 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRR 216
Query: 277 LTTKSDVYSFGVVLLELL 294
            T+ SDV+ FGV + E+L
Sbjct: 217 FTSASDVWMFGVCMWEIL 234

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 99  LGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHL 156
           +GEG FG VH+G Y+  +      A AVA+K          RE +L E + + Q  HPH+
Sbjct: 21  IGEGQFGDVHQGIYMSPEN----PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 76
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           V+LIG   E+    ++ E    G L + L  R   SL   + +  A   +  LA+L    
Sbjct: 77  VKLIGVITENP-VWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR 134
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH 276
              ++RD    N+L+ S+   KL DFGL++   E S  +  ++      + APE I+   
Sbjct: 135 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRR 191
Query: 277 LTTKSDVYSFGVVLLELL 294
            T+ SDV+ FGV + E+L
Sbjct: 192 FTSASDVWMFGVCMWEIL 209

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 27/279 (9%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           NF     +G G F  V++      L  G+      V++ D+   +   + + E+  L QL
Sbjct: 33  NFRIEKKIGRGQFSEVYRAAC---LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHL--FKRISVSLPWGTRLKIAIGAAKGL 209
            HP++++      ED E  +V E    G L   +  FK+    +P  T  K  +     L
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
             +H     V++RD K +N+ + +    KL D GL +     S T     ++GT  Y +P
Sbjct: 150 EHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 205
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSM--DKLRPKSEQNLVDWAKPYLRSSRRLRY 327
           E I       KSD++S G +L E+   +     DK+      NL    K   +       
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEQCD----- 254
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
              P  +  YS    +E+  L   CI+ +P+ RP +  V
Sbjct: 255 -YPPLPSDHYS----EELRQLVNMCINPDPEKRPDVTYV 288

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 99  LGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHL 156
           +GEG FG VH+G Y+  +      A AVA+K          RE +L E + + Q  HPH+
Sbjct: 23  IGEGQFGDVHQGIYMSPEN----PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           V+LIG   E+    ++ E    G L + L  R   SL   + +  A   +  LA+L    
Sbjct: 79  VKLIGVITENPV-WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR 136
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH 276
              ++RD    N+L+ S+   KL DFGL++   E S  +  ++      + APE I+   
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 277 LTTKSDVYSFGVVLLELL 294
            T+ SDV+ FGV + E+L
Sbjct: 194 FTSASDVWMFGVCMWEIL 211

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 7   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 60
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 61  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 119
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 120 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 175
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQA-VAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LG G FG V  G          K Q  VAVK++  EG     E+  E   + +L HP LV
Sbjct: 16  LGSGQFGVVKLG--------KWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G C ++    +V E++  G L N+L +     L     L++     +G+AFL   + 
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ- 124
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT---YGYAAPEYIST 274
             I+RD    N L+D D   K+SDFG+ +   +  + +V++  +GT     ++APE    
Sbjct: 125 -FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD--DQYVSS--VGTKFPVKWSAPEVFHY 179
Query: 275 GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
              ++KSDV++FG+++ E+ +  +    L   SE          L+ S+  R +  P LA
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE--------VVLKVSQGHR-LYRPHLA 230
Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
                  +  +  +   C    P+ RP    +++++E L
Sbjct: 231 -------SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLV 157
           LGEG +G V            +  +AVAVK++D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSXQEYSDWKEKKTYLNPWKKI 233

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 89/208 (42%), Gaps = 14/208 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LGEG FG V      +   +  K   VAVK L        +++  E   L  L+H H+V+
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKI-LVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 79
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKR-----------ISVSLPWGTRLKIAIGAAK 207
             G C E +  ++V+E+M  G L   L                  L     L IA   A 
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+ +L  A    ++RD  T N L+  +   K+ DFG+++         V    M    + 
Sbjct: 140 GMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLT 295
            PE I     TT+SDV+S GVVL E+ T
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 55
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 115 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 170
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 56
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 116 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 171
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 55
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 115 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 170
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 56
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 116 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 171
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 172 PEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 10  ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 63
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 64  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 122
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 123 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 178
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 179 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 13/207 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LGEG +G+V+K    +        Q VA+K + +E     +E + E+  + Q   PH+V+
Sbjct: 37  LGEGSYGSVYKAIHKE------TGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVK 88
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
             G   ++ +  +V E+   GS+ + +  R + +L       I     KGL +LH     
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRK- 146
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
            I+RD K  NILL+++  AKL+DFG+A  G           V+GT  + APE I      
Sbjct: 147 -IHRDIKAGNILLNTEGHAKLADFGVA--GQLTDXMAKRNXVIGTPFWMAPEVIQEIGYN 203
Query: 279 TKSDVYSFGVVLLELLTGRRSMDKLRP 305
             +D++S G+  +E+  G+     + P
Sbjct: 204 CVADIWSLGITAIEMAEGKPPYADIHP 230

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 111/212 (52%), Gaps = 17/212 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--GHREWLAEVIFLGQLRHPHL 156
           LG G FG+V +G      R   K   VA+K+L  +G +     E + E   + QL +P++
Sbjct: 344 LGCGNFGSVRQGVY----RMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           VRLIG  C+ E  +LV E    G L   L  +    +P     ++    + G+ +L   E
Sbjct: 399 VRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLE--E 454
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTY--GYAAPEYIS 273
              ++R+    N+LL +   AK+SDFGL+K +G    +++ T R  G +   + APE I+
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALG--ADDSYYTARSAGKWPLKWYAPECIN 512
Query: 274 TGHLTTKSDVYSFGVVLLELLT-GRRSMDKLR 304
               +++SDV+S+GV + E L+ G++   K++
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 56
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 116 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 171
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 10  ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 63
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 64  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 122
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 123 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 178
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 179 PEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 4   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 57
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 58  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 117 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 172
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLV 157
           LGEG +G V            +  +AVAVK++D++      E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQEYSDWKEKKTYLNPWKKI 234

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLV 157
           LGEG +G V            +  +AVAVK++D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPS-DSCQEYSDWKEKKTYLNPWKKI 233

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 10/200 (5%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG GG  TV   Y+ +D    +K    A+ +   E  +  + +  EV    QL H ++V 
Sbjct: 19  LGGGGMSTV---YLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           +I    ED+   LV E++   +L  ++     +S+   T +        G+   H  +  
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSV--DTAINFTNQILDGIK--HAHDMR 131
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
           +++RD K  NIL+DS+ T K+ DFG+AK   E S T  T  V+GT  Y +PE  + G  T
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQ-AKGEAT 189
Query: 279 TK-SDVYSFGVVLLELLTGR 297
            + +D+YS G+VL E+L G 
Sbjct: 190 DECTDIYSIGIVLYEMLVGE 209

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G+G  GTV+      D+  G   Q VA++ ++++        + E++ + + ++P++V 
Sbjct: 28  IGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
            +      +E  +V E++  GSL + + +     +  G    +     + L FLH   N 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS--NQ 136
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
           VI+RD K+ NILL  D + KL+DFG  A++ PE S     + ++GT  + APE ++    
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSEMVGTPYWMAPEVVTRKAY 193
Query: 278 TTKSDVYSFGVVLLELLTGR 297
             K D++S G++ +E++ G 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGE 213

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLV 157
           LGEG +G V            +  +AVAVK++D++      E + + I + + L H ++V
Sbjct: 13  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 123
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKEKKTYLNPWKKI 232

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLV 157
           LGEG +G V            +  +AVAVK++D++      E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKEKKTYLNPWKKI 234

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 95/197 (48%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHLV 157
           +GEG FG VH+G     +     A AVA+K          RE +L E + + Q  HPH+V
Sbjct: 18  IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +LIG   E+    ++ E    G L + L  R   SL   + +  A   +  LA+L     
Sbjct: 75  KLIGVITENPV-WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR- 131
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
             ++RD    N+L+ +    KL DFGL++   E S  +  ++      + APE I+    
Sbjct: 132 -FVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 278 TTKSDVYSFGVVLLELL 294
           T+ SDV+ FGV + E+L
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLV 157
           LGEG +G V            +  +AVAVK++D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKEKKTYLNPWKKI 233

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLV 157
           LGEG +G V            +  +AVAVK++D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKEKKTYLNPWKKI 233

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLV 157
           LGEG +G V            +  +AVAVK++D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKEKKTYLNPWKKI 233

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/237 (32%), Positives = 106/237 (44%), Gaps = 40/237 (16%)
Query: 67  NEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVA 126
           + D+A  F  D  +   S+LR I          G G FG V   Y   D+R    ++ VA
Sbjct: 40  DPDVAELFFKDDPEKLFSDLREI----------GHGSFGAV---YFARDVRN---SEVVA 83
Query: 127 VKLLDIEGLQGHREW---LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGS--- 180
           +K +   G Q + +W   + EV FL +LRHP+ ++  G    +    LV E+    +   
Sbjct: 84  IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDL 143
Query: 181 LENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS 240
           LE H      V +   T      GA +GLA+LH   + +I+RD K  NILL      KL 
Sbjct: 144 LEVHKKPLQEVEIAAVTH-----GALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLG 196
Query: 241 DFGLAK-MGPEGSNTHVTTRVMGTYGYAAPEYI---STGHLTTKSDVYSFGVVLLEL 293
           DFG A  M P           +GT  + APE I     G    K DV+S G+  +EL
Sbjct: 197 DFGSASIMAP-------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLV 157
           LGEG +G V            +  +AVAVK++D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKEKKTYLNPWKKI 233

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 122/273 (44%), Gaps = 28/273 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPH 155
           LG+G FG V +G  D       K  +VAVK L  + L   +   +++ EV  +  L H +
Sbjct: 20  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 76
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           L+RL G       ++ V E  P GSL + L K     L  GT  + A+  A+G+ +L   
Sbjct: 77  LIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESK 134
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAPEYIST 274
               I+RD    N+LL +    K+ DFGL +  P+  + +V        + + APE + T
Sbjct: 135 R--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 275 GHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL 333
              +  SD + FGV L E+ T G+     L      + +D      +   RL     PR 
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------KEGERL-----PR- 240
Query: 334 AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
                    +++  + +QC +  P+DRP   A+
Sbjct: 241 ----PEDCPQDIYNVMVQCWAHKPEDRPTFVAL 269

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLV 157
           LGEG +G V            +  +AVAVK++D++      E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKEKKTYLNPWKKI 234

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLV 157
           LGEG +G V            +  +AVAVK++D++      E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKEKKTYLNPWKKI 234

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLV 157
           LGEG +G V            +  +AVAVK++D++      E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKEKKTYLNPWKKI 234

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLV 157
           LGEG +G V            +  +AVAVK++D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKEKKTYLNPWKKI 233

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGHREWLAEVIFLGQLRHPHLV 157
           LGEG +G V            +  +AVAVK++D++  +        E+     L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVV 68
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKEKKTYLNPWKKI 234

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLV 157
           LGEG +G V            +  +AVAVK++D++      E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 68
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKEKKTYLNPWKKI 234

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G+G  GTV+      D+  G   Q VA++ ++++        + E++ + + ++P++V 
Sbjct: 28  IGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
            +      +E  +V E++  GSL + + +     +  G    +     + L FLH   N 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS--NQ 136
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
           VI+RD K+ NILL  D + KL+DFG  A++ PE S     + ++GT  + APE ++    
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAY 193
Query: 278 TTKSDVYSFGVVLLELLTGR 297
             K D++S G++ +E++ G 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGE 213

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 14/212 (6%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           N+     LGEG FG V   Y      Q +  + +  K+L    +QG  E   E+ +L  L
Sbjct: 5   NYQIVKTLGEGSFGKVKLAY-HTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLL 61
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           RHPH+++L       +E ++V E+     L +++ +R  +S     R    I +A  + +
Sbjct: 62  RHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA--VEY 118
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEY 271
            H   + +++RD K  N+LLD     K++DFGL+ +  +G+    +    G+  YAAPE 
Sbjct: 119 CH--RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEV 173
Query: 272 ISTGHLTT--KSDVYSFGVVLLELLTGRRSMD 301
           IS G L    + DV+S GV+L  +L  R   D
Sbjct: 174 IS-GKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLV 157
           LGEG +G V            +  +AVAVK++D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKEKKTYLNPWKKI 233

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 14/212 (6%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           N+     LGEG FG V   Y      Q +  + +  K+L    +QG  E   E+ +L  L
Sbjct: 15  NYQIVKTLGEGSFGKVKLAY-HTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLL 71
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           RHPH+++L       +E ++V E+     L +++ +R  +S     R    I +A  + +
Sbjct: 72  RHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA--VEY 128
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEY 271
            H   + +++RD K  N+LLD     K++DFGL+ +  +G+    +    G+  YAAPE 
Sbjct: 129 CH--RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEV 183
Query: 272 ISTGHLTT--KSDVYSFGVVLLELLTGRRSMD 301
           IS G L    + DV+S GV+L  +L  R   D
Sbjct: 184 IS-GKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G+G  GTV+      D+  G   Q VA++ ++++        + E++ + + ++P++V 
Sbjct: 28  IGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
            +      +E  +V E++  GSL + + +     +  G    +     + L FLH   N 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS--NQ 136
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
           VI+RD K+ NILL  D + KL+DFG  A++ PE S     + ++GT  + APE ++    
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAPEVVTRKAY 193
Query: 278 TTKSDVYSFGVVLLELLTGR 297
             K D++S G++ +E++ G 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGE 213

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 14/212 (6%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           N+     LGEG FG V   Y      Q +  + +  K+L    +QG  E   E+ +L  L
Sbjct: 14  NYQIVKTLGEGSFGKVKLAY-HTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLL 70
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           RHPH+++L       +E ++V E+     L +++ +R  +S     R    I +A  + +
Sbjct: 71  RHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA--VEY 127
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEY 271
            H   + +++RD K  N+LLD     K++DFGL+ +  +G+    +    G+  YAAPE 
Sbjct: 128 CH--RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEV 182
Query: 272 ISTGHLTT--KSDVYSFGVVLLELLTGRRSMD 301
           IS G L    + DV+S GV+L  +L  R   D
Sbjct: 183 IS-GKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G+G  GTV+      D+  G   Q VA++ ++++        + E++ + + ++P++V 
Sbjct: 29  IGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
            +      +E  +V E++  GSL + + +     +  G    +     + L FLH   N 
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS--NQ 137
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
           VI+RD K+ NILL  D + KL+DFG  A++ PE S     + ++GT  + APE ++    
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAPEVVTRKAY 194
Query: 278 TTKSDVYSFGVVLLELLTGR 297
             K D++S G++ +E++ G 
Sbjct: 195 GPKVDIWSLGIMAIEMIEGE 214

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLV 157
           LGEG +G V            +  +AVAVK++D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKEKKTYLNPWKKI 233

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLV 157
           LGEG +G V            +  +AVAVK++D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKEKKTYLNPWKKI 233

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 30/286 (10%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           + +  + LG G +G V++G           +  VAVK L  + ++   E+L E   + ++
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEI 71
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +HP+LV+L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +
Sbjct: 72  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 131
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPE 270
           L   +   I+RD    N L+  +   K++DFGL++ M  +    H   +      + APE
Sbjct: 132 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPE 187
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
            ++    + KSDV++FGV+L E+ T   S                 PY        Y + 
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELL 230
Query: 331 PRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLLN 375
            +       +G  E    L   C   NP DRP  A +    E++  
Sbjct: 231 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 30/286 (10%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           + +  + LG G +G V++G           +  VAVK L  + ++   E+L E   + ++
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEI 67
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +HP+LV+L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +
Sbjct: 68  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 127
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPE 270
           L   +   I+RD    N L+  +   K++DFGL++ M  +    H   +      + APE
Sbjct: 128 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPE 183
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
            ++    + KSDV++FGV+L E+ T   S                 PY        Y + 
Sbjct: 184 SLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELL 226
Query: 331 PRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLLN 375
            +       +G  E    L   C   NP DRP  A +    E++  
Sbjct: 227 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 272

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLV 157
           LGEG +G V            +  +AVAVK++D++      E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKEKKTYLNPWKKI 233

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 30/286 (10%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           + +  + LG G +G V++G           +  VAVK L  + ++   E+L E   + ++
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEI 71
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +HP+LV+L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +
Sbjct: 72  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 131
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPE 270
           L   +   I+RD    N L+  +   K++DFGL++ M  +    H   +      + APE
Sbjct: 132 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 187
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
            ++    + KSDV++FGV+L E+ T   S                 PY        Y + 
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELL 230
Query: 331 PRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLLN 375
            +       +G  E    L   C   NP DRP  A +    E++  
Sbjct: 231 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/235 (32%), Positives = 105/235 (44%), Gaps = 40/235 (17%)
Query: 69  DLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK 128
           D+A  F  D  +   S+LR I          G G FG V   Y   D+R    ++ VA+K
Sbjct: 3   DVAELFFKDDPEKLFSDLREI----------GHGSFGAV---YFARDVRN---SEVVAIK 46
Query: 129 LLDIEGLQGHREW---LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGS---LE 182
            +   G Q + +W   + EV FL +LRHP+ ++  G    +    LV E+    +   LE
Sbjct: 47  KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE 106
Query: 183 NHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF 242
            H      V +   T      GA +GLA+LH   + +I+RD K  NILL      KL DF
Sbjct: 107 VHKKPLQEVEIAAVTH-----GALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDF 159
Query: 243 GLAK-MGPEGSNTHVTTRVMGTYGYAAPEYI---STGHLTTKSDVYSFGVVLLEL 293
           G A  M P           +GT  + APE I     G    K DV+S G+  +EL
Sbjct: 160 GSASIMAP-------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 30/286 (10%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           + +  + LG G +G V++G           +  VAVK L  + ++   E+L E   + ++
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEI 71
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +HP+LV+L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +
Sbjct: 72  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 131
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPE 270
           L   +   I+RD    N L+  +   K++DFGL++ M  +    H   +      + APE
Sbjct: 132 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 187
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
            ++    + KSDV++FGV+L E+ T   S                 PY        Y + 
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELL 230
Query: 331 PRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLLN 375
            +       +G  E    L   C   NP DRP  A +    E++  
Sbjct: 231 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 56
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           L+F H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 116 LSFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 171
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 95/197 (48%), Gaps = 9/197 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHLV 157
           +GEG FG VH+G     +     A AVA+K          RE +L E + + Q  HPH+V
Sbjct: 398 IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +LIG   E+    ++ E    G L + L  R   SL   + +  A   +  LA+L     
Sbjct: 455 KLIGVITENP-VWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR- 511
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
             ++RD    N+L+ +    KL DFGL++   E S  +  ++      + APE I+    
Sbjct: 512 -FVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 278 TTKSDVYSFGVVLLELL 294
           T+ SDV+ FGV + E+L
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 122/273 (44%), Gaps = 28/273 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPH 155
           LG+G FG V +G  D       K  +VAVK L  + L   +   +++ EV  +  L H +
Sbjct: 16  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           L+RL G       ++ V E  P GSL + L K     L  GT  + A+  A+G+ +L   
Sbjct: 73  LIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESK 130
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAPEYIST 274
               I+RD    N+LL +    K+ DFGL +  P+  + +V        + + APE + T
Sbjct: 131 R--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 275 GHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL 333
              +  SD + FGV L E+ T G+     L      + +D      +   RL     PR 
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------KEGERL-----PR- 236
Query: 334 AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
                    +++  + +QC +  P+DRP   A+
Sbjct: 237 ----PEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 30/286 (10%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           + +  + LG G +G V++G           +  VAVK L  + ++   E+L E   + ++
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEI 66
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +HP+LV+L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPE 270
           L   +   I+RD    N L+  +   K++DFGL++ M  +    H   +      + APE
Sbjct: 127 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 182
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
            ++    + KSDV++FGV+L E+ T   S                 PY        Y + 
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELL 225
Query: 331 PRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLLN 375
            +       +G  E    L   C   NP DRP  A +    E++  
Sbjct: 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLV 157
           LGEG +G V            +  +AVAVK++D++      E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKEKKTYLNPWKKI 234

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 56
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L++ +       +P            +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 116 LAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 171
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 30/286 (10%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           + +  + LG G +G V++G           +  VAVK L  + ++   E+L E   + ++
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEI 66
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +HP+LV+L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +
Sbjct: 67  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPE 270
           L   +   I+RD    N L+  +   K++DFGL++ M  +    H   +      + APE
Sbjct: 127 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 182
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
            ++    + KSDV++FGV+L E+ T   S                 PY        Y + 
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELL 225
Query: 331 PRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLLN 375
            +       +G  E    L   C   NP DRP  A +    E++  
Sbjct: 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           LG G FG V  G         L    VAVK+L+   I  L    +   E+  L   RHPH
Sbjct: 19  LGVGTFGKVKIG------EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +++L        +  +V E++  G L +++ K   V      RL   I +A      H  
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH-- 130
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
              V++RD K  N+LLD+   AK++DFGL+ M  +G     +    G+  YAAPE IS G
Sbjct: 131 --MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVIS-G 184
Query: 276 HLTT--KSDVYSFGVVLLELLTGRRSMD 301
            L    + D++S GV+L  LL G    D
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHL 156
           ++G G  G V  G +      G +   VA+K L     +  R ++L+E   +GQ  HP++
Sbjct: 56  IIGSGDSGEVCYGRLR---VPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           +RL G        ++V E+M  GSL+  L +           + +  G   G+ +L  ++
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYL--SD 169
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKM---GPEGSNTHVTTRVMGTYGYAAPEYIS 273
              ++RD    N+L+DS+   K+SDFGL+++    P+ + T    ++     + APE I+
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI--PIRWTAPEAIA 227
Query: 274 TGHLTTKSDVYSFGVVLLELL 294
               ++ SDV+SFGVV+ E+L
Sbjct: 228 FRTFSSASDVWSFGVVMWEVL 248

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 14/212 (6%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           N+     LGEG FG V   Y      Q +  + +  K+L    +QG  E   E+ +L  L
Sbjct: 9   NYQIVKTLGEGSFGKVKLAY-HTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLL 65
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           RHPH+++L       +E ++V E+     L +++ +R  +S     R    I +A  + +
Sbjct: 66  RHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISA--VEY 122
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEY 271
            H   + +++RD K  N+LLD     K++DFGL+ +  +G+    +    G+  YAAPE 
Sbjct: 123 CH--RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEV 177
Query: 272 ISTGHLTT--KSDVYSFGVVLLELLTGRRSMD 301
           IS G L    + DV+S GV+L  +L  R   D
Sbjct: 178 IS-GKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 102/218 (46%), Gaps = 15/218 (6%)
Query: 81  FQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE 140
           F+   L+ I+Q       LG+G FG+V     D  L     A  VAVK L   G    R+
Sbjct: 4   FEERHLKYISQ-------LGKGNFGSVELCRYDP-LGDNTGA-LVAVKQLQHSGPDQQRD 54
Query: 141 WLAEVIFLGQLRHPHLV--RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR 198
           +  E+  L  L    +V  R + Y     E  LV E++P G L + L +R    L     
Sbjct: 55  FQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFL-QRHRARLDASRL 113
Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT 258
           L  +    KG+ +L       ++RD    NIL++S+   K++DFGLAK+ P   +  V  
Sbjct: 114 LLYSSQICKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVR 171
Query: 259 RV-MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                   + APE +S    + +SDV+SFGVVL EL T
Sbjct: 172 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 122/273 (44%), Gaps = 28/273 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPH 155
           LG+G FG V +G  D       K  +VAVK L  + L   +   +++ EV  +  L H +
Sbjct: 26  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           L+RL G       ++ V E  P GSL + L K     L  GT  + A+  A+G+ +L   
Sbjct: 83  LIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESK 140
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAPEYIST 274
               I+RD    N+LL +    K+ DFGL +  P+  + +V        + + APE + T
Sbjct: 141 R--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 275 GHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL 333
              +  SD + FGV L E+ T G+     L      + +D      +   RL     PR 
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------KEGERL-----PR- 246
Query: 334 AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
                    +++  + +QC +  P+DRP   A+
Sbjct: 247 ----PEDCPQDIYNVMVQCWAHKPEDRPTFVAL 275

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 121/279 (43%), Gaps = 30/279 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 26  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 78
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +L   +  
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 136
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            I+RD    N L+  +   K++DFGL++ M  +    H   +      + APE ++    
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKF 194
Query: 278 TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQY 337
           + KSDV++FGV+L E+ T   S                 PY        Y +  +     
Sbjct: 195 SIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDYRME 237
Query: 338 SVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLLN 375
             +G  E    L   C   NP DRP  A +    E++  
Sbjct: 238 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 30/286 (10%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           + +  + LG G +G V++G           +  VAVK L  + ++   E+L E   + ++
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEI 66
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +HP+LV+L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +
Sbjct: 67  KHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPE 270
           L   +   I+RD    N L+  +   K++DFGL++ M  +    H   +      + APE
Sbjct: 127 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 182
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
            ++    + KSDV++FGV+L E+ T   S                 PY        Y + 
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELL 225
Query: 331 PRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLLN 375
            +       +G  E    L   C   NP DRP  A +    E++  
Sbjct: 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 30/286 (10%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           + +  + LG G +G V++G           +  VAVK L  + ++   E+L E   + ++
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEI 71
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +HP+LV+L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +
Sbjct: 72  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 131
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPE 270
           L   +   I+RD    N L+  +   K++DFGL++ M  +    H   +      + APE
Sbjct: 132 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 187
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
            ++    + KSDV++FGV+L E+ T   S                 PY        Y + 
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELL 230
Query: 331 PRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLLN 375
            +       +G  E    L   C   NP DRP  A +    E++  
Sbjct: 231 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 87/302 (28%), Positives = 133/302 (44%), Gaps = 29/302 (9%)
Query: 81  FQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE 140
           F+   L+ I+Q       LG+G FG+V     D  L     A  VAVK L   G    R+
Sbjct: 7   FEERHLKYISQ-------LGKGNFGSVELCRYDP-LGDNTGA-LVAVKQLQHSGPDQQRD 57
Query: 141 WLAEVIFLGQLRHPHLV--RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR 198
           +  E+  L  L    +V  R + Y    +   LV E++P G L + L +R    L     
Sbjct: 58  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRL 116
Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT 258
           L  +    KG+ +L       ++RD    NIL++S+   K++DFGLAK+ P   + +V  
Sbjct: 117 LLYSSQICKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 174
Query: 259 RV-MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-----GRRSMDKLRPK-SEQNL 311
                   + APE +S    + +SDV+SFGVVL EL T        S + LR   SE+++
Sbjct: 175 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDV 234
Query: 312 VDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
              ++         R    P            E+  L   C + +P+DRP  +A+   L+
Sbjct: 235 PALSRLLELLEEGQRLPAPPACPA--------EVHELMKLCWAPSPQDRPSFSALGPQLD 286
Query: 372 SL 373
            L
Sbjct: 287 ML 288

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 30/286 (10%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           + +  + LG G +G V++G           +  VAVK L  + ++   E+L E   + ++
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEI 70
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +HP+LV+L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +
Sbjct: 71  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 130
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPE 270
           L   +   I+RD    N L+  +   K++DFGL++ M  +    H   +      + APE
Sbjct: 131 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 186
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
            ++    + KSDV++FGV+L E+ T   S                 PY        Y + 
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELL 229
Query: 331 PRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLLN 375
            +       +G  E    L   C   NP DRP  A +    E++  
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 30/286 (10%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           + +  + LG G +G V++G           +  VAVK L  + ++   E+L E   + ++
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEI 66
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +HP+LV+L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPE 270
           L   +   I+RD    N L+  +   K++DFGL++ M  +    H   +      + APE
Sbjct: 127 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 182
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
            ++    + KSDV++FGV+L E+ T   S                 PY        Y + 
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELL 225
Query: 331 PRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLLN 375
            +       +G  E    L   C   NP DRP  A +    E++  
Sbjct: 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 122/273 (44%), Gaps = 28/273 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPH 155
           LG+G FG V +G  D       K  +VAVK L  + L   +   +++ EV  +  L H +
Sbjct: 20  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 76
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           L+RL G       ++ V E  P GSL + L K     L  GT  + A+  A+G+ +L   
Sbjct: 77  LIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESK 134
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAPEYIST 274
               I+RD    N+LL +    K+ DFGL +  P+  + +V        + + APE + T
Sbjct: 135 R--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 275 GHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL 333
              +  SD + FGV L E+ T G+     L      + +D      +   RL     PR 
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------KEGERL-----PR- 240
Query: 334 AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
                    +++  + +QC +  P+DRP   A+
Sbjct: 241 ----PEDCPQDIYNVMVQCWAHKPEDRPTFVAL 269

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 122/273 (44%), Gaps = 28/273 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPH 155
           LG+G FG V +G  D       K  +VAVK L  + L   +   +++ EV  +  L H +
Sbjct: 16  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           L+RL G       ++ V E  P GSL + L K     L  GT  + A+  A+G+ +L   
Sbjct: 73  LIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESK 130
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAPEYIST 274
               I+RD    N+LL +    K+ DFGL +  P+  + +V        + + APE + T
Sbjct: 131 R--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 275 GHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL 333
              +  SD + FGV L E+ T G+     L      + +D      +   RL     PR 
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------KEGERL-----PR- 236
Query: 334 AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
                    +++  + +QC +  P+DRP   A+
Sbjct: 237 ----PEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 30/286 (10%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           + +  + LG G +G V++G           +  VAVK L  + ++   E+L E   + ++
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEI 68
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +HP+LV+L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +
Sbjct: 69  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 128
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPE 270
           L   +   I+RD    N L+  +   K++DFGL++ M  +    H   +      + APE
Sbjct: 129 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 184
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
            ++    + KSDV++FGV+L E+ T   S                 PY        Y + 
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELL 227
Query: 331 PRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLLN 375
            +       +G  E    L   C   NP DRP  A +    E++  
Sbjct: 228 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHL 156
           ++G G  G V  G +      G +   VA+K L     +  R ++L+E   +GQ  HP++
Sbjct: 56  IIGSGDSGEVCYGRLR---VPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           +RL G        ++V E+M  GSL+  L +           + +  G   G+ +L  ++
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYL--SD 169
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKM---GPEGSNTHVTTRVMGTYGYAAPEYIS 273
              ++RD    N+L+DS+   K+SDFGL+++    P+ + T    ++     + APE I+
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI--PIRWTAPEAIA 227
Query: 274 TGHLTTKSDVYSFGVVLLELL 294
               ++ SDV+SFGVV+ E+L
Sbjct: 228 FRTFSSASDVWSFGVVMWEVL 248

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 121/279 (43%), Gaps = 30/279 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 21  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 73
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +L   +  
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 131
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            I+RD    N L+  +   K++DFGL++ M  +    H   +      + APE ++    
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKF 189
Query: 278 TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQY 337
           + KSDV++FGV+L E+ T   S                 PY        Y +  +     
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDYRME 232
Query: 338 SVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLLN 375
             +G  E    L   C   NP DRP  A +    E++  
Sbjct: 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 5   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 58
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 59  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 118 LAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 173
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 103/218 (47%), Gaps = 15/218 (6%)
Query: 81  FQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE 140
           F+   L+ I+Q       LG+G FG+V     D  L     A  VAVK L   G    R+
Sbjct: 8   FEERHLKYISQ-------LGKGNFGSVELCRYDP-LGDNTGA-LVAVKQLQHSGPDQQRD 58
Query: 141 WLAEVIFLGQLRHPHLV--RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR 198
           +  E+  L  L    +V  R + Y    +   LV E++P G L + L +R    L     
Sbjct: 59  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRL 117
Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT 258
           L  +    KG+ +L       ++RD    NIL++S+   K++DFGLAK+ P   + +V  
Sbjct: 118 LLYSSQICKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 175
Query: 259 RV-MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                   + APE +S    + +SDV+SFGVVL EL T
Sbjct: 176 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 5   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 58
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 59  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 118 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 173
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 6   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L++ +       +P            +G
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 119 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 174
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 30/286 (10%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           + +  + LG G +G V++G           +  VAVK L  + ++   E+L E   + ++
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEI 68
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +HP+LV+L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +
Sbjct: 69  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 128
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPE 270
           L   +   I+RD    N L+  +   K++DFGL++ M  +    H   +      + APE
Sbjct: 129 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 184
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
            ++    + KSDV++FGV+L E+ T   S                 PY        Y + 
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELL 227
Query: 331 PRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLLN 375
            +       +G  E    L   C   NP DRP  A +    E++  
Sbjct: 228 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 5   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 58
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L++ +       +P            +G
Sbjct: 59  KELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 118 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 173
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 56
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 116 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 171
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 56
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 116 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 171
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 121/279 (43%), Gaps = 30/279 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 34  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 86
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +L   +  
Sbjct: 87  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 144
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            I+RD    N L+  +   K++DFGL++ M  +    H   +      + APE ++    
Sbjct: 145 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKF 202
Query: 278 TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQY 337
           + KSDV++FGV+L E+ T   S                 PY        Y +  +     
Sbjct: 203 SIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDYRME 245
Query: 338 SVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLLN 375
             +G  E    L   C   NP DRP  A +    E++  
Sbjct: 246 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 284

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 55
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 115 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 170
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 128/298 (42%), Gaps = 27/298 (9%)
Query: 83  LSELRAIT-QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW 141
           +S+L+ +  +N +    LG G FG V++G +          Q     L ++   Q   ++
Sbjct: 22  ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 81
Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RIS--VSLPWG 196
           L E + + +L H ++VR IG   +   R ++ E M  G L++ L +   R S   SL   
Sbjct: 82  LMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 141
Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD---FTAKLSDFGLAKMGPEGSN 253
             L +A   A G  +L   EN  I+RD    N LL        AK+ DFG+A+     S 
Sbjct: 142 DLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 199
Query: 254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
                  M    +  PE    G  T+K+D +SFGV+L E+ +          KS Q +++
Sbjct: 200 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLE 257
Query: 314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
               ++ S  R+    DP             +  +  QC    P+DRP  A ++  +E
Sbjct: 258 ----FVTSGGRM----DP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 103/218 (47%), Gaps = 15/218 (6%)
Query: 81  FQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE 140
           F+   L+ I+Q       LG+G FG+V     D  L     A  VAVK L   G    R+
Sbjct: 20  FEERHLKYISQ-------LGKGNFGSVELCRYDP-LGDNTGA-LVAVKQLQHSGPDQQRD 70
Query: 141 WLAEVIFLGQLRHPHLV--RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR 198
           +  E+  L  L    +V  R + Y    +   LV E++P G L + L +R    L     
Sbjct: 71  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRL 129
Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT 258
           L  +    KG+ +L       ++RD    NIL++S+   K++DFGLAK+ P   + +V  
Sbjct: 130 LLYSSQICKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 187
Query: 259 RV-MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                   + APE +S    + +SDV+SFGVVL EL T
Sbjct: 188 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 56
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 116 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 171
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 6   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 119 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 174
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 5   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 58
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 59  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 118 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 173
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+    LD E        + E+  L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALXKIRLDTETEGVPSTAIREISLL 56
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 116 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 171
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 55
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 115 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 170
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+    LD E        + E+  L
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALXKIRLDTETEGVPSTAIREISLL 55
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 115 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 170
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 128/298 (42%), Gaps = 27/298 (9%)
Query: 83  LSELRAIT-QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW 141
           +S+L+ +  +N +    LG G FG V++G +          Q     L ++   Q   ++
Sbjct: 36  ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 95
Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RIS--VSLPWG 196
           L E + + +L H ++VR IG   +   R ++ E M  G L++ L +   R S   SL   
Sbjct: 96  LMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 155
Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF---TAKLSDFGLAKMGPEGSN 253
             L +A   A G  +L   EN  I+RD    N LL        AK+ DFG+A+     S 
Sbjct: 156 DLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 213
Query: 254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
                  M    +  PE    G  T+K+D +SFGV+L E+ +          KS Q +++
Sbjct: 214 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLE 271
Query: 314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
               ++ S  R+    DP             +  +  QC    P+DRP  A ++  +E
Sbjct: 272 ----FVTSGGRM----DP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 4   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 57
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 58  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 117 LAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 172
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 22/209 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQA-VAVKLLDIEGLQG---HREWLAEVIFLGQLRHP 154
           LGEG FG V        L    K Q  VA+K +  + L+    H     E+ +L  LRHP
Sbjct: 17  LGEGSFGKVK-------LATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
           H+++L        + ++V E+   G L +++ ++  ++   G R    I  A  + + H 
Sbjct: 70  HIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICA--IEYCH- 125
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
             + +++RD K  N+LLD +   K++DFGL+ +  +G+    +    G+  YAAPE I+ 
Sbjct: 126 -RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVIN- 180
Query: 275 GHLTT--KSDVYSFGVVLLELLTGRRSMD 301
           G L    + DV+S G+VL  +L GR   D
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 133/275 (48%), Gaps = 30/275 (10%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQ 150
           +F     LG G  G V K      +        +A KL+ +E     R + + E+  L +
Sbjct: 7   DFEKISELGAGNGGVVFK------VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
              P++V   G    D E  +  E M  GSL+  L K  +  +P     K++I   KGL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLT 118
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAP 269
           +L   ++ +++RD K SNIL++S    KL DFG++ ++    +N+ V TR      Y +P
Sbjct: 119 YLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSP 172
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
           E +   H + +SD++S G+ L+E+  GR  +    P ++++    ++P +     L YIV
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP--PDAKED----SRPPMAIFELLDYIV 226
Query: 330 D---PRL-AGQYSVKGAKEMAVLALQCISVNPKDR 360
           +   P+L +G +S+    E      +C+  NP +R
Sbjct: 227 NEPPPKLPSGVFSL----EFQDFVNKCLIKNPAER 257

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 125/292 (42%), Gaps = 42/292 (14%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           + +  + LG G +G V++G           +  VAVK L  + ++   E+L E   + ++
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEI 67
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +HP+LV+L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +
Sbjct: 68  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 127
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM-------GPEGSNTHVTTRVMGTY 264
           L   +   I+RD    N L+  +   K++DFGL+++        P G+   +        
Sbjct: 128 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK------- 178
Query: 265 GYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
            + APE ++    + KSDV++FGV+L E+ T   S                 PY      
Sbjct: 179 -WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLS 220
Query: 325 LRYIVDPRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLLN 375
             Y +  +       +G  E    L   C   NP DRP  A +    E++  
Sbjct: 221 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 272

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 4   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 57
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 58  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 117 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 172
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 121/278 (43%), Gaps = 30/278 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 21  LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 73
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +L   +  
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 131
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            I+RD    N L+  +   K++DFGL++ M  +    H   +      + APE ++    
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKF 189
Query: 278 TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQY 337
           + KSDV++FGV+L E+ T   S                 PY        Y +  +     
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDYRME 232
Query: 338 SVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLL 374
             +G  E    L   C   NP DRP  A +    E++ 
Sbjct: 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 6   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 119 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 174
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 7   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 60
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 61  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 119
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 120 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 175
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 112/220 (50%), Gaps = 11/220 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ 150
            F    +LG G FGTV+KG +I +   + +K     ++L +    + ++E L E   +  
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEG--EKVKIPVAIMELREATSPKANKEILDEAYVMAS 107
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
           + +PH+ RL+G C     +L+  + MP G L +++ +    ++     L   +  AKG+ 
Sbjct: 108 VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMN 165
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAP 269
           +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A 
Sbjct: 166 YLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMAL 222
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
           E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 223 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 261

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 6   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 119 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 174
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 125/292 (42%), Gaps = 42/292 (14%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           + +  + LG G +G V++G           +  VAVK L  + ++   E+L E   + ++
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEI 68
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +HP+LV+L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +
Sbjct: 69  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 128
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM-------GPEGSNTHVTTRVMGTY 264
           L   +   I+RD    N L+  +   K++DFGL+++        P G+   +        
Sbjct: 129 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK------- 179
Query: 265 GYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
            + APE ++    + KSDV++FGV+L E+ T   S                 PY      
Sbjct: 180 -WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLS 221
Query: 325 LRYIVDPRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAVVATLESLLN 375
             Y +  +       +G  E    L   C   NP DRP  A +    E++  
Sbjct: 222 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 114/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQ-AVAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 76
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L++ + MP G L +++ +    ++     L   +  AKG+
Sbjct: 77  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 134
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 135 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 191
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 192 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 231

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           LG G FG V  G         L    VAVK+L+   I  L    +   E+  L   RHPH
Sbjct: 19  LGVGTFGKVKIG------EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +++L        +  +V E++  G L +++ K   V      RL   I +A      H  
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH-- 130
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
              V++RD K  N+LLD+   AK++DFGL+ M  +G     +    G+  YAAPE IS G
Sbjct: 131 --MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYAAPEVIS-G 184
Query: 276 HLTT--KSDVYSFGVVLLELLTGRRSMD 301
            L    + D++S GV+L  LL G    D
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 4   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 57
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 58  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 117 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 172
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 56
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+       T+    V  T  Y A
Sbjct: 116 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 171
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 6   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 119 LAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 174
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 121/273 (44%), Gaps = 28/273 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPH 155
           LG+G FG V +G  D       K  +VAVK L  + L   +   +++ EV  +  L H +
Sbjct: 16  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           L+RL G       ++ V E  P GSL + L K     L  GT  + A+  A+G+ +L   
Sbjct: 73  LIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESK 130
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAPEYIST 274
               I+RD    N+LL +    K+ DFGL +  P+  +  V        + + APE + T
Sbjct: 131 R--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 275 GHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL 333
              +  SD + FGV L E+ T G+     L      + +D      +   RL     PR 
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------KEGERL-----PR- 236
Query: 334 AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
                    +++  + +QC +  P+DRP   A+
Sbjct: 237 ----PEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 114/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 73
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L++ + MP G L +++ +    ++     L   +  AKG+
Sbjct: 74  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 131
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 132 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 188
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 189 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 228

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 4   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 57
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+EF+    L+  +       +P            +G
Sbjct: 58  KELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 117 LAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 172
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 114/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 74
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L++ + MP G L +++ +    ++     L   +  AKG+
Sbjct: 75  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 132
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 133 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 189
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 229

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 107/231 (46%), Gaps = 15/231 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLV 157
           LGEG  G V            +  +AVAVK++D++      E + + I + + L H ++V
Sbjct: 14  LGEGAAGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G+  E   + L  E+   G L + +   I +  P   R    + A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 278 TTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW--AKPYLRSSRRL 325
             +  DV+S G+VL  +L G    D+    S Q   DW   K YL   +++
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKEKKTYLNPWKKI 233

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 114/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 73
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L++ + MP G L +++ +    ++     L   +  AKG+
Sbjct: 74  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYV-REHKDNIGSQYLLNWCVQIAKGM 131
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 132 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 188
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 189 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 228

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/289 (28%), Positives = 128/289 (44%), Gaps = 37/289 (12%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQG-LKAQAVAVKLLDIEGLQGHREWLAEVIF-----LG 149
           N  LG+G F  + KG   +    G L    V +K+LD    + HR + +E  F     + 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD----KAHRNY-SESFFEAASMMS 67
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK-RISVSLPWGTRLKIAIGAAKG 208
           +L H HLV   G C   +E +LV EF+  GSL+ +L K +  +++ W  +L++A   A  
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAA 125
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR--VMGTYGY 266
           + FL   EN +I+ +    NILL  +   K  +    K+   G +  V  +  +     +
Sbjct: 126 MHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPW 183
Query: 267 AAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL 325
             PE I    +L   +D +SFG  L E+ +G       +P S           L S R+L
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGD-----KPLSA----------LDSQRKL 228
Query: 326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           ++  D     Q     A E+A L   C+   P  RP   A++  L SL 
Sbjct: 229 QFYEDRH---QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 113/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 82
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L+  + MP G L +++ +    ++     L   +  AKG+
Sbjct: 83  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 140
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 141 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 197
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 198 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 237

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 13  EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ PRG +   L +++S      T   I    A 
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYIT-ELAN 124
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P        T + GT  Y 
Sbjct: 125 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYL 178
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 229
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 230 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 260

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 114/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L++ + MP G L +++ +    ++     L   +  AKG+
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 130
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 131 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 187
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 227

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 121/273 (44%), Gaps = 28/273 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPH 155
           LG+G FG V +G  D       K  +VAVK L  + L   +   +++ EV  +  L H +
Sbjct: 26  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           L+RL G       ++ V E  P GSL + L K     L  GT  + A+  A+G+ +L   
Sbjct: 83  LIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESK 140
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT-YGYAAPEYIST 274
               I+RD    N+LL +    K+ DFGL +  P+  +  V        + + APE + T
Sbjct: 141 R--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 275 GHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL 333
              +  SD + FGV L E+ T G+     L      + +D      +   RL     PR 
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------KEGERL-----PR- 246
Query: 334 AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
                    +++  + +QC +  P+DRP   A+
Sbjct: 247 ----PEDCPQDIYNVMVQCWAHKPEDRPTFVAL 275

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 114/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 75
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L++ + MP G L +++ +    ++     L   +  AKG+
Sbjct: 76  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 133
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 134 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 190
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 230

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 108/220 (49%), Gaps = 12/220 (5%)
Query: 77  DLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ 136
           +LY   + +      + +  + LG G +G V+ G           +  VAVK L  + ++
Sbjct: 18  NLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKK------YSLTVAVKTLKEDTME 71
Query: 137 GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG 196
              E+L E   + +++HP+LV+L+G C  +    +V E+MP G+L ++L +     +   
Sbjct: 72  V-EEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAV 130
Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTH 255
             L +A   +  + +L   +   I+RD    N L+  +   K++DFGL++ M  +    H
Sbjct: 131 VLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAH 188
Query: 256 VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
              +      + APE ++    + KSDV++FGV+L E+ T
Sbjct: 189 AGAKF--PIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 126/279 (45%), Gaps = 32/279 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 228 LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 280
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +L   +  
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 338
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            I+R+    N L+  +   K++DFGL++ M  +    H   +      + APE ++    
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKF 396
Query: 278 TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRYIVDPRLAG 335
           + KSDV++FGV+L E+ T           S    +D ++ Y  L    R+      R  G
Sbjct: 397 SIKSDVWAFGVLLWEIAT--------YGMSPYPGIDLSQVYELLEKDYRME-----RPEG 443
Query: 336 QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                  +++  L   C   NP DRP  A +    E++ 
Sbjct: 444 -----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 104/200 (52%), Gaps = 15/200 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G+G  GTV+      D+  G   Q VA++ ++++        + E++ + + ++P++V 
Sbjct: 29  IGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
            +      +E  +V E++  GSL + + +     +  G    +     + L FLH   N 
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS--NQ 137
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
           VI+R+ K+ NILL  D + KL+DFG  A++ PE S     + ++GT  + APE ++    
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAY 194
Query: 278 TTKSDVYSFGVVLLELLTGR 297
             K D++S G++ +E++ G 
Sbjct: 195 GPKVDIWSLGIMAIEMIEGE 214

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 113/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 79
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L+  + MP G L +++ +    ++     L   +  AKG+
Sbjct: 80  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 137
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 138 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 194
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 234

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 113/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L+  + MP G L +++ +    ++     L   +  AKG+
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 130
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 131 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 187
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 227

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 113/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 75
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L+  + MP G L +++ +    ++     L   +  AKG+
Sbjct: 76  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 133
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 134 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 190
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 230

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 113/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 74
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L+  + MP G L +++ +    ++     L   +  AKG+
Sbjct: 75  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 132
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 133 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 189
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 229

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 27/298 (9%)
Query: 83  LSELRAIT-QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW 141
           +S+L+ +  +N +    LG G FG V++G +          Q     L ++   Q   ++
Sbjct: 21  ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 80
Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RIS--VSLPWG 196
           L E + + +  H ++VR IG   +   R ++ E M  G L++ L +   R S   SL   
Sbjct: 81  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 140
Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD---FTAKLSDFGLAKMGPEGSN 253
             L +A   A G  +L   EN  I+RD    N LL        AK+ DFG+A+     S 
Sbjct: 141 DLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198
Query: 254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
                  M    +  PE    G  T+K+D +SFGV+L E+ +          KS Q +++
Sbjct: 199 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLE 256
Query: 314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
               ++ S  R+    DP             +  +  QC    P+DRP  A ++  +E
Sbjct: 257 ----FVTSGGRM----DP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 113/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 97
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L+  + MP G L +++ +    ++     L   +  AKG+
Sbjct: 98  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 155
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 156 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 212
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 213 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 252

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 113/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 78
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L+  + MP G L +++ +    ++     L   +  AKG+
Sbjct: 79  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 136
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 137 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 193
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 194 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 233

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 113/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 75
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L+  + MP G L +++ +    ++     L   +  AKG+
Sbjct: 76  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 133
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 134 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 190
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 230

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 27/298 (9%)
Query: 83  LSELRAIT-QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW 141
           +S+L+ +  +N +    LG G FG V++G +          Q     L ++   Q   ++
Sbjct: 13  ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 72
Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RIS--VSLPWG 196
           L E + + +  H ++VR IG   +   R ++ E M  G L++ L +   R S   SL   
Sbjct: 73  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 132
Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF---TAKLSDFGLAKMGPEGSN 253
             L +A   A G  +L   EN  I+RD    N LL        AK+ DFG+A+     S 
Sbjct: 133 DLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 190
Query: 254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
                  M    +  PE    G  T+K+D +SFGV+L E+ +          KS Q +++
Sbjct: 191 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLE 248
Query: 314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
               ++ S  R+    DP             +  +  QC    P+DRP  A ++  +E
Sbjct: 249 ----FVTSGGRM----DP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 292

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 113/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 75
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L+  + MP G L +++ +    ++     L   +  AKG+
Sbjct: 76  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 133
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 134 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 190
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 230

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 113/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L+  + MP G L +++ +    ++     L   +  AKG+
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 130
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 131 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 187
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 227

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 113/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L+  + MP G L +++ +    ++     L   +  AKG+
Sbjct: 67  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 124
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 125 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 181
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 221

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 113/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L+  + MP G L +++ +    ++     L   +  AKG+
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYV-REHKDNIGSQYLLNWCVQIAKGM 130
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 131 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 187
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 227

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 27/298 (9%)
Query: 83  LSELRAIT-QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW 141
           +S+L+ +  +N +    LG G FG V++G +          Q     L ++   Q   ++
Sbjct: 21  ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 80
Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RIS--VSLPWG 196
           L E + + +  H ++VR IG   +   R ++ E M  G L++ L +   R S   SL   
Sbjct: 81  LMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML 140
Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD---FTAKLSDFGLAKMGPEGSN 253
             L +A   A G  +L   EN  I+RD    N LL        AK+ DFG+A+     S 
Sbjct: 141 DLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198
Query: 254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
                  M    +  PE    G  T+K+D +SFGV+L E+ +          KS Q +++
Sbjct: 199 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLE 256
Query: 314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
               ++ S  R+    DP             +  +  QC    P+DRP  A ++  +E
Sbjct: 257 ----FVTSGGRM----DP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 27/298 (9%)
Query: 83  LSELRAIT-QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW 141
           +S+L+ +  +N +    LG G FG V++G +          Q     L ++   Q   ++
Sbjct: 36  ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDF 95
Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RIS--VSLPWG 196
           L E + + +  H ++VR IG   +   R ++ E M  G L++ L +   R S   SL   
Sbjct: 96  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 155
Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF---TAKLSDFGLAKMGPEGSN 253
             L +A   A G  +L   EN  I+RD    N LL        AK+ DFG+A+     S 
Sbjct: 156 DLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 213
Query: 254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
                  M    +  PE    G  T+K+D +SFGV+L E+ +          KS Q +++
Sbjct: 214 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLE 271
Query: 314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
               ++ S  R+    DP             +  +  QC    P+DRP  A ++  +E
Sbjct: 272 ----FVTSGGRM----DP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 126/279 (45%), Gaps = 32/279 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G +G V++G           +  VAVK L  + ++   E+L E   + +++HP+LV+
Sbjct: 267 LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 319
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +L   +  
Sbjct: 320 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 377
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            I+R+    N L+  +   K++DFGL++ M  +    H   +      + APE ++    
Sbjct: 378 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKF 435
Query: 278 TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRYIVDPRLAG 335
           + KSDV++FGV+L E+ T           S    +D ++ Y  L    R+      R  G
Sbjct: 436 SIKSDVWAFGVLLWEIAT--------YGMSPYPGIDLSQVYELLEKDYRME-----RPEG 482
Query: 336 QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                  +++  L   C   NP DRP  A +    E++ 
Sbjct: 483 -----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 516

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 27/298 (9%)
Query: 83  LSELRAIT-QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW 141
           +S+L+ +  +N +    LG G FG V++G +          Q     L ++   Q   ++
Sbjct: 22  ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 81
Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RIS--VSLPWG 196
           L E + + +  H ++VR IG   +   R ++ E M  G L++ L +   R S   SL   
Sbjct: 82  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 141
Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD---FTAKLSDFGLAKMGPEGSN 253
             L +A   A G  +L   EN  I+RD    N LL        AK+ DFG+A+     S 
Sbjct: 142 DLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 199
Query: 254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
                  M    +  PE    G  T+K+D +SFGV+L E+ +          KS Q +++
Sbjct: 200 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLE 257
Query: 314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
               ++ S  R+    DP             +  +  QC    P+DRP  A ++  +E
Sbjct: 258 ----FVTSGGRM----DP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 27/298 (9%)
Query: 83  LSELRAIT-QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW 141
           +S+L+ +  +N +    LG G FG V++G +          Q     L ++   Q   ++
Sbjct: 36  ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 95
Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RIS--VSLPWG 196
           L E + + +  H ++VR IG   +   R ++ E M  G L++ L +   R S   SL   
Sbjct: 96  LMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML 155
Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF---TAKLSDFGLAKMGPEGSN 253
             L +A   A G  +L   EN  I+RD    N LL        AK+ DFG+A+     S 
Sbjct: 156 DLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 213
Query: 254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
                  M    +  PE    G  T+K+D +SFGV+L E+ +          KS Q +++
Sbjct: 214 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLE 271
Query: 314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
               ++ S  R+    DP             +  +  QC    P+DRP  A ++  +E
Sbjct: 272 ----FVTSGGRM----DP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G + TV+KG    +   G+      VKL   EG       + E+  + +L+H ++VR
Sbjct: 13  LGNGTYATVYKGL---NKTTGVYVALKEVKLDSEEGTPSTA--IREISLMKELKHENIVR 67
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA----IGAAKGLAFLHG 214
           L      + +  LV+EFM    L+ ++  R   + P G  L +         +GLAF H 
Sbjct: 68  LYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH- 125
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI-S 273
            EN +++RD K  N+L++     KL DFGLA+      NT  +  V  T  Y AP+ +  
Sbjct: 126 -ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYRAPDVLMG 182
Query: 274 TGHLTTKSDVYSFGVVLLELLTGR 297
           +   +T  D++S G +L E++TG+
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGK 206

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 55
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+E +    L+  +       +P            +G
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y A
Sbjct: 115 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 170
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 27/298 (9%)
Query: 83  LSELRAIT-QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW 141
           +S+L+ +  +N +    LG G FG V++G +          Q     L ++   Q   ++
Sbjct: 22  ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 81
Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RIS--VSLPWG 196
           L E + + +  H ++VR IG   +   R ++ E M  G L++ L +   R S   SL   
Sbjct: 82  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 141
Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD---FTAKLSDFGLAKMGPEGSN 253
             L +A   A G  +L   EN  I+RD    N LL        AK+ DFG+A+     S 
Sbjct: 142 DLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASY 199
Query: 254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
                  M    +  PE    G  T+K+D +SFGV+L E+ +          KS Q +++
Sbjct: 200 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLE 257
Query: 314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
               ++ S  R+    DP             +  +  QC    P+DRP  A ++  +E
Sbjct: 258 ----FVTSGGRM----DP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 301

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 27/298 (9%)
Query: 83  LSELRAIT-QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW 141
           +S+L+ +  +N +    LG G FG V++G +          Q     L ++   Q   ++
Sbjct: 28  ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 87
Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RIS--VSLPWG 196
           L E + + +  H ++VR IG   +   R ++ E M  G L++ L +   R S   SL   
Sbjct: 88  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 147
Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD---FTAKLSDFGLAKMGPEGSN 253
             L +A   A G  +L   EN  I+RD    N LL        AK+ DFG+A+     S 
Sbjct: 148 DLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 205
Query: 254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
                  M    +  PE    G  T+K+D +SFGV+L E+ +          KS Q +++
Sbjct: 206 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLE 263
Query: 314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
               ++ S  R+    DP             +  +  QC    P+DRP  A ++  +E
Sbjct: 264 ----FVTSGGRM----DP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 307

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 27/298 (9%)
Query: 83  LSELRAIT-QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW 141
           +S+L+ +  +N +    LG G FG V++G +          Q     L ++   Q   ++
Sbjct: 48  ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 107
Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RIS--VSLPWG 196
           L E + + +  H ++VR IG   +   R ++ E M  G L++ L +   R S   SL   
Sbjct: 108 LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 167
Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD---FTAKLSDFGLAKMGPEGSN 253
             L +A   A G  +L   EN  I+RD    N LL        AK+ DFG+A+     S 
Sbjct: 168 DLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 225
Query: 254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
                  M    +  PE    G  T+K+D +SFGV+L E+ +          KS Q +++
Sbjct: 226 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLE 283
Query: 314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
               ++ S  R+    DP             +  +  QC    P+DRP  A ++  +E
Sbjct: 284 ----FVTSGGRM----DP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 327

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 121/265 (45%), Gaps = 33/265 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-EVIFLGQLRHPHLV 157
           +G+G FG V KG ID+  ++      VA+K++D+E  +   E +  E+  L Q   P++ 
Sbjct: 30  IGKGSFGEVFKG-IDNRTQK-----VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G   +D +  ++ E++  GS  + L           T L+  +   KGL +LH  + 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEKK 140
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT-TRVMGTYGYAAPEYISTGH 276
             I+RD K +N+LL      KL+DFG+A    + ++T +     +GT  + APE I    
Sbjct: 141 --IHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNXFVGTPFWMAPEVIKQSA 195
Query: 277 LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQ 336
             +K+D++S G+  +EL  G     +L P     L+    P             P L G 
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLEGN 242
Query: 337 YSVKGAKEMAVLALQCISVNPKDRP 361
           YS    K +      C++  P  RP
Sbjct: 243 YS----KPLKEFVEACLNKEPSFRP 263

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 27/298 (9%)
Query: 83  LSELRAIT-QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW 141
           +S+L+ +  +N +    LG G FG V++G +          Q     L ++   Q   ++
Sbjct: 38  ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 97
Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RIS--VSLPWG 196
           L E + + +  H ++VR IG   +   R ++ E M  G L++ L +   R S   SL   
Sbjct: 98  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 157
Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD---FTAKLSDFGLAKMGPEGSN 253
             L +A   A G  +L   EN  I+RD    N LL        AK+ DFG+A+     S 
Sbjct: 158 DLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 215
Query: 254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
                  M    +  PE    G  T+K+D +SFGV+L E+ +          KS Q +++
Sbjct: 216 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLE 273
Query: 314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
               ++ S  R+    DP             +  +  QC    P+DRP  A ++  +E
Sbjct: 274 ----FVTSGGRM----DP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 317

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/289 (28%), Positives = 128/289 (44%), Gaps = 37/289 (12%)
Query: 96  NYLLGEGGFGTVHKGYIDDDLRQG-LKAQAVAVKLLDIEGLQGHREWLAEVIF-----LG 149
           N  LG+G F  + KG   +    G L    V +K+LD    + HR + +E  F     + 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD----KAHRNY-SESFFEAASMMS 67
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK-RISVSLPWGTRLKIAIGAAKG 208
           +L H HLV   G C   +E +LV EF+  GSL+ +L K +  +++ W  +L++A   A  
Sbjct: 68  KLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWA 125
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR--VMGTYGY 266
           + FL   EN +I+ +    NILL  +   K  +    K+   G +  V  +  +     +
Sbjct: 126 MHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPW 183
Query: 267 AAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL 325
             PE I    +L   +D +SFG  L E+ +G       +P S           L S R+L
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGD-----KPLSA----------LDSQRKL 228
Query: 326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           ++  D     Q     A E+A L   C+   P  RP   A++  L SL 
Sbjct: 229 QFYEDRH---QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 121/265 (45%), Gaps = 33/265 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-EVIFLGQLRHPHLV 157
           +G+G FG V KG ID+  ++      VA+K++D+E  +   E +  E+  L Q   P++ 
Sbjct: 15  IGKGSFGEVFKG-IDNRTQK-----VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G   +D +  ++ E++  GS  + L           T L+  +   KGL +LH  + 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEKK 125
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT-TRVMGTYGYAAPEYISTGH 276
             I+RD K +N+LL      KL+DFG+A    + ++T +     +GT  + APE I    
Sbjct: 126 --IHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNXFVGTPFWMAPEVIKQSA 180
Query: 277 LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQ 336
             +K+D++S G+  +EL  G     +L P     L+    P             P L G 
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLEGN 227
Query: 337 YSVKGAKEMAVLALQCISVNPKDRP 361
           YS    K +      C++  P  RP
Sbjct: 228 YS----KPLKEFVEACLNKEPSFRP 248

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 121/265 (45%), Gaps = 33/265 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-EVIFLGQLRHPHLV 157
           +G+G FG V KG ID+  ++      VA+K++D+E  +   E +  E+  L Q   P++ 
Sbjct: 15  IGKGSFGEVFKG-IDNRTQK-----VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G   +D +  ++ E++  GS  + L           T L+  +   KGL +LH  + 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEKK 125
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT-TRVMGTYGYAAPEYISTGH 276
             I+RD K +N+LL      KL+DFG+A    + ++T +     +GT  + APE I    
Sbjct: 126 --IHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSA 180
Query: 277 LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQ 336
             +K+D++S G+  +EL  G     +L P     L+    P             P L G 
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLEGN 227
Query: 337 YSVKGAKEMAVLALQCISVNPKDRP 361
           YS    K +      C++  P  RP
Sbjct: 228 YS----KPLKEFVEACLNKEPSFRP 248

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 34/288 (11%)
Query: 83  LSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EW 141
           L EL+    +F     LG G  G V K      +        +A KL+ +E     R + 
Sbjct: 3   LGELK--DDDFEKISELGAGNGGVVFK------VSHKPSGLVMARKLIHLEIKPAIRNQI 54
Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKI 201
           + E+  L +   P++V   G    D E  +  E M  GSL+  L K  +  +P     K+
Sbjct: 55  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKV 112
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRV 260
           +I   KGL +L   ++ +++RD K SNIL++S    KL DFG++ ++  E +N  V TR 
Sbjct: 113 SIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTR- 170
Query: 261 MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR 320
                Y +PE +   H + +SD++S G+ L+E+  GR                + +P + 
Sbjct: 171 ----SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR----------------YPRPPMA 210
Query: 321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA 368
               L YIV+       S   + E      +C+  NP +R  +  ++ 
Sbjct: 211 IFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMV 258

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 119
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y 
Sbjct: 120 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC----GTLDYL 173
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 224
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 225 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 120/265 (45%), Gaps = 33/265 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-EVIFLGQLRHPHLV 157
           +G+G FG V+KG ID+  ++      VA+K++D+E  +   E +  E+  L Q   P++ 
Sbjct: 27  IGKGSFGEVYKG-IDNHTKE-----VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           R  G   +  +  ++ E++  GS  + L           T L+  +   KGL +LH    
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL---KGLDYLHSERK 137
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT-TRVMGTYGYAAPEYISTGH 276
             I+RD K +N+LL      KL+DFG+A    + ++T +     +GT  + APE I    
Sbjct: 138 --IHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNXFVGTPFWMAPEVIKQSA 192
Query: 277 LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQ 336
              K+D++S G+  +EL  G      L P     L+    P             P L GQ
Sbjct: 193 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLEGQ 239
Query: 337 YSVKGAKEMAVLALQCISVNPKDRP 361
           +S    K        C++ +P+ RP
Sbjct: 240 HS----KPFKEFVEACLNKDPRFRP 260

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 121/265 (45%), Gaps = 33/265 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-EVIFLGQLRHPHLV 157
           +G+G FG V KG ID+  ++      VA+K++D+E  +   E +  E+  L Q   P++ 
Sbjct: 35  IGKGSFGEVFKG-IDNRTQK-----VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G   +D +  ++ E++  GS  + L           T L+  +   KGL +LH  + 
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEKK 145
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT-TRVMGTYGYAAPEYISTGH 276
             I+RD K +N+LL      KL+DFG+A    + ++T +     +GT  + APE I    
Sbjct: 146 --IHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSA 200
Query: 277 LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQ 336
             +K+D++S G+  +EL  G     +L P     L+    P             P L G 
Sbjct: 201 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLEGN 247
Query: 337 YSVKGAKEMAVLALQCISVNPKDRP 361
           YS    K +      C++  P  RP
Sbjct: 248 YS----KPLKEFVEACLNKEPSFRP 268

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 113/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 69
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L+  + MP G L +++ +    ++     L   +  A+G+
Sbjct: 70  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAEGM 127
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 128 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 184
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 185 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 224

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 120/280 (42%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 13  EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ PRG +   L +++S      T   I    A 
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYIT-ELAN 124
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P          + GT  Y 
Sbjct: 125 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLXGTLDYL 178
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 229
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 230 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 260

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 34  EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 87
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 88  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 145
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P        T + GT  Y 
Sbjct: 146 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYL 199
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 200 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 250
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 251 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 281

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 113/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 76
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L++ + MP G L +++ +    ++     L   +  AKG+
Sbjct: 77  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 134
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFG AK +G E    H     +    + A
Sbjct: 135 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-KWMA 191
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 192 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 231

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 113/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +L  G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 79
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L++ + MP G L +++ +    ++     L   +  AKG+
Sbjct: 80  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 137
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 138 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 194
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 234

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 126/298 (42%), Gaps = 27/298 (9%)
Query: 83  LSELRAIT-QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW 141
           +S+L+ +  +N +    LG G FG V++G +          Q     L ++   Q   ++
Sbjct: 39  ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 98
Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RIS--VSLPWG 196
           L E + + +  H ++VR IG   +   R ++ E M  G L++ L +   R S   SL   
Sbjct: 99  LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 158
Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF---TAKLSDFGLAKMGPEGSN 253
             L +A   A G  +L   EN  I+RD    N LL        AK+ DFG+A+       
Sbjct: 159 DLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 216
Query: 254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
                  M    +  PE    G  T+K+D +SFGV+L E+ +          KS Q +++
Sbjct: 217 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLE 274
Query: 314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
               ++ S  R+    DP             +  +  QC    P+DRP  A ++  +E
Sbjct: 275 ----FVTSGGRM----DP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 318

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 9   EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 120
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y 
Sbjct: 121 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYL 174
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 225
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 226 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 256

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 113/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 74
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L++ + MP G L +++ +    ++     L   +  AKG+
Sbjct: 75  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 132
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFG AK +G E    H     +    + A
Sbjct: 133 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-KWMA 189
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 229

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 104/233 (44%), Gaps = 17/233 (7%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH---REWLAEVIF 147
           ++F    LLG+G F  V++    + +  GL+   VA+K++D + +      +    EV  
Sbjct: 11  EDFKVGNLLGKGSFAGVYRA---ESIHTGLE---VAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
             QL+HP ++ L  Y  +     LV E    G +  +L  R+        R         
Sbjct: 65  HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIIT 123
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+ +LH   + +++RD   SN+LL  +   K++DFGLA         H T  + GT  Y 
Sbjct: 124 GMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYI 179
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQN---LVDWAKP 317
           +PE  +      +SDV+S G +   LL GR   D    K+  N   L D+  P
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP 232

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 25  EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 78
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 79  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 136
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P        T + GT  Y 
Sbjct: 137 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYL 190
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 191 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 241
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 242 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 272

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 13  EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 124
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P        T + GT  Y 
Sbjct: 125 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYL 178
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 179 PPEXIEGRXHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 229
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 230 FPD------FVTEGARD---LISRLLKHNPSQRPXLREVL 260

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 119
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y 
Sbjct: 120 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYL 173
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 224
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 225 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 113/221 (51%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 74
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L++ + MP G L +++ +    ++     L   +  AKG+
Sbjct: 75  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 132
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFG AK +G E    H     +    + A
Sbjct: 133 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-KWMA 189
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 229

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 112/221 (50%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 74
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L+  + MP G L +++ +    ++     L   +  AKG+
Sbjct: 75  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 132
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFG AK +G E    H     +    + A
Sbjct: 133 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-KWMA 189
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 229

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 119
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P        T + GT  Y 
Sbjct: 120 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYL 173
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 224
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 225 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 122/280 (43%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 9   EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 120
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P    T ++    GT  Y 
Sbjct: 121 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GTLDYL 174
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 225
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 226 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 256

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 122/280 (43%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+  +   +A+K+L    +E      +   EV  
Sbjct: 5   EDFEIGRPLGKGKFGNVYLA------REKQRKFILALKVLFKAQLEKAGVEHQLRREVEI 58
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 59  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 116
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P        T + GT  Y 
Sbjct: 117 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYL 170
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 171 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 221
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 222 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 252

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 126/298 (42%), Gaps = 27/298 (9%)
Query: 83  LSELRAIT-QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW 141
           +S+L+ +  +N +    LG G FG V++G +          Q     L ++   Q   ++
Sbjct: 62  ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDF 121
Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFK---RIS--VSLPWG 196
           L E + + +  H ++VR IG   +   R ++ E M  G L++ L +   R S   SL   
Sbjct: 122 LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 181
Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD---FTAKLSDFGLAKMGPEGSN 253
             L +A   A G  +L   EN  I+RD    N LL        AK+ DFG+A+       
Sbjct: 182 DLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 239
Query: 254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
                  M    +  PE    G  T+K+D +SFGV+L E+ +          KS Q +++
Sbjct: 240 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLE 297
Query: 314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
               ++ S  R+    DP             +  +  QC    P+DRP  A ++  +E
Sbjct: 298 ----FVTSGGRM----DP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 119
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y 
Sbjct: 120 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYL 173
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 224
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 225 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 112/221 (50%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +L  G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L+  + MP G L +++ +    ++     L   +  AKG+
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 130
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 131 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 187
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 227

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 11  EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 122
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P        T + GT  Y 
Sbjct: 123 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYL 176
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 227
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 228 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 258

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 13  EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 124
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y 
Sbjct: 125 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYL 178
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 229
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 230 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 260

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 87  RAITQNFSSNYLLGEGGFGTVH--KGYIDDDLRQGLKAQAV----AVKLLDIEGLQGHRE 140
           +A    F    +LG+G FG V   K     D RQ L A  V     +K+ D    +  R+
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQ-LYAMKVLKKATLKVRDRVRTKMERD 78
Query: 141 WLAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRL 199
            L EV       HP +V+L  Y  + E +L L+ +F+  G L    F R+S  + +    
Sbjct: 79  ILVEV------NHPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEED 127
Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
                A   LA  H     +IYRD K  NILLD +   KL+DFGL+K   +      +  
Sbjct: 128 VKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-- 185
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
             GT  Y APE ++    T  +D +SFGV++ E+LTG
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 112/221 (50%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +L  G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 79
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L+  + MP G L +++ +    ++     L   +  AKG+
Sbjct: 80  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 137
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFGLAK +G E    H     +    + A
Sbjct: 138 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-KWMA 194
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 234

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 121/281 (43%), Gaps = 49/281 (17%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +GEG FG        +D RQ +  +    ++   E  +  RE    V  L  ++HP++V+
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRRE----VAVLANMKHPNIVQ 87
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS----------LPWGTRLKIAIGAAKG 208
                 E+    +V ++   G L    FKRI+            L W  ++         
Sbjct: 88  YRESFEENGSLYIVMDYCEGGDL----FKRINAQKGVLFQEDQILDWFVQI--------C 135
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LA  H  +  +++RD K+ NI L  D T +L DFG+A++    S   +    +GT  Y +
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLS 193
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI 328
           PE         KSD+++ G VL EL T + + +     S +NLV            L+ I
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFE---AGSMKNLV------------LKII 238
Query: 329 VD--PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
               P ++  YS     ++  L  Q    NP+DRP + +++
Sbjct: 239 SGSFPPVSLHYSY----DLRSLVSQLFKRNPRDRPSVNSIL 275

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 112/221 (50%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L+  + MP G L +++ +    ++     L   +  AKG+
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 130
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFG AK +G E    H     +    + A
Sbjct: 131 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-KWMA 187
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 227

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFL 148
           +NF     +GEG +G V+K       R  L  + VA+K   LD E        + E+  L
Sbjct: 6   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L HP++V+L+     + +  LV+E + +  L+  +       +P            +G
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           LAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y A
Sbjct: 119 LAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 174
Query: 269 PE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE  +   + +T  D++S G +  E++T R
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 34/220 (15%)
Query: 102 GGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAE--VIFLGQLRHPHLVRL 159
           G FG V K  + +D         VAVK+     LQ  + W +E  +     ++H +L++ 
Sbjct: 26  GRFGCVWKAQLMNDF--------VAVKIFP---LQDKQSWQSEREIFSTPGMKHENLLQF 74
Query: 160 IGY----CCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH-- 213
           I         + E  L+  F  +GSL ++L   I   + W     +A   ++GL++LH  
Sbjct: 75  IAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI---ITWNELCHVAETMSRGLSYLHED 131
Query: 214 -------GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
                  G +  + +RDFK+ N+LL SD TA L+DFGLA     G     T   +GT  Y
Sbjct: 132 VPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRY 191
Query: 267 AAPEYISTG-----HLTTKSDVYSFGVVLLELLTGRRSMD 301
            APE +            + D+Y+ G+VL EL++  ++ D
Sbjct: 192 MAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 13  EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 66
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 67  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 124
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P        T + GT  Y 
Sbjct: 125 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYL 178
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 229
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 230 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 260

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHLV 157
           LGE  FG V+KG++      G + QAVA+K L  +     RE +  E +   +L+HP++V
Sbjct: 34  LGEDRFGKVYKGHLFGP-APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 92
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKR--------------ISVSLPWGTRLKIAI 203
            L+G   +D+   +++ +   G L   L  R              +  +L     + +  
Sbjct: 93  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT 263
             A G+ +L  + + V+++D  T N+L+      K+SD GL +         +    +  
Sbjct: 153 QIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 264 YGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
             + APE I  G  +  SD++S+GVVL E+ +
Sbjct: 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 98  LLGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPH 155
           +LG G FGTV+KG +I D   + +K   VA+K+L +    + ++E L E   +  +  P+
Sbjct: 24  VLGSGAFGTVYKGIWIPDG--ENVKI-PVAIKVLRENTSPKANKEILDEAYVMAGVGSPY 80
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           + RL+G C     +L V + MP G L +H+ +     L     L   +  AKG+++L   
Sbjct: 81  VSRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRG-RLGSQDLLNWCMQIAKGMSYLEDV 138
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
              +++RD    N+L+ S    K++DFGLA++       +          + A E I   
Sbjct: 139 R--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRR 196
Query: 276 HLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVD 313
             T +SDV+S+GV + EL+T G +  D +  +   +L++
Sbjct: 197 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE 235

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 7   EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 60
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 61  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 118
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P        T + GT  Y 
Sbjct: 119 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYL 172
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 173 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 223
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 224 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 254

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 87  RAITQNFSSNYLLGEGGFGTVH--KGYIDDDLRQGLKAQAV----AVKLLDIEGLQGHRE 140
           +A    F    +LG+G FG V   K     D RQ L A  V     +K+ D    +  R+
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQ-LYAMKVLKKATLKVRDRVRTKMERD 78
Query: 141 WLAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRL 199
            L EV       HP +V+L  Y  + E +L L+ +F+  G L    F R+S  + +    
Sbjct: 79  ILVEV------NHPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEED 127
Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
                A   LA  H     +IYRD K  NILLD +   KL+DFGL+K   +      +  
Sbjct: 128 VKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-- 185
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
             GT  Y APE ++    T  +D +SFGV++ E+LTG
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 112/221 (50%), Gaps = 13/221 (5%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA-VAVK-LLDIEGLQGHREWLAEVIFLG 149
            F    +LG G FGTV+KG     + +G K +  VA+K L +    + ++E L E   + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLW---IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 79
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            + +PH+ RL+G C     +L+  + MP G L +++ +    ++     L   +  AKG+
Sbjct: 80  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGM 137
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L   +  +++RD    N+L+ +    K++DFG AK +G E    H     +    + A
Sbjct: 138 NYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI-KWMA 194
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSE 308
            E I     T +SDV+S+GV + EL+T G +  D + P SE
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASE 234

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 87  RAITQNFSSNYLLGEGGFGTVH--KGYIDDDLRQGLKAQAV----AVKLLDIEGLQGHRE 140
           +A    F    +LG+G FG V   K     D RQ L A  V     +K+ D    +  R+
Sbjct: 21  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQ-LYAMKVLKKATLKVRDRVRTKMERD 79
Query: 141 WLAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRL 199
            L EV       HP +V+L  Y  + E +L L+ +F+  G L    F R+S  + +    
Sbjct: 80  ILVEV------NHPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEED 128
Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
                A   LA  H     +IYRD K  NILLD +   KL+DFGL+K   +      +  
Sbjct: 129 VKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-- 186
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
             GT  Y APE ++    T  +D +SFGV++ E+LTG
Sbjct: 187 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 119
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y 
Sbjct: 120 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC----GTLDYL 173
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 224
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 225 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHLV 157
           LGE  FG V+KG++      G + QAVA+K L  +     RE +  E +   +L+HP++V
Sbjct: 17  LGEDRFGKVYKGHLFGP-APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKR--------------ISVSLPWGTRLKIAI 203
            L+G   +D+   +++ +   G L   L  R              +  +L     + +  
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT 263
             A G+ +L  + + V+++D  T N+L+      K+SD GL +         +    +  
Sbjct: 136 QIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 264 YGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
             + APE I  G  +  SD++S+GVVL E+ +
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 11  EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 122
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P        T + GT  Y 
Sbjct: 123 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYL 176
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 227
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 228 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 258

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 12  EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 65
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 123
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P        T + GT  Y 
Sbjct: 124 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYL 177
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 228
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 229 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 259

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL-AEVIFLGQL-RHPHL 156
           LG G FG V +      L +      VAVK+L        +E L +E+  +  L +H ++
Sbjct: 54  LGAGAFGKVVEA-TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSL------PWGTR--LKIAIGAAKG 208
           V L+G C      L++ E+   G L N L ++    L      P   R  L  +   A+G
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQG 172
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           +AFL  A    I+RD    N+LL +   AK+ DFGLA+     SN  V         + A
Sbjct: 173 MAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 230
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT 295
           PE I     T +SDV+S+G++L E+ +
Sbjct: 231 PESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 107/228 (46%), Gaps = 14/228 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +GEG  G V         R+    + VAVK++D+   Q       EV+ +   +H ++V 
Sbjct: 53  IGEGSTGIVCLA------REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           +       EE  ++ EF+  G+L + + +   V L       +     + LA+LH     
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHA--QG 161
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
           VI+RD K+ +ILL  D   KLSDFG         +      ++GT  + APE IS     
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKXLVGTPYWMAPEVISRSLYA 219
Query: 279 TKSDVYSFGVVLLELLTGRRSMDKLRP-KSEQNLVDWAKPYLRSSRRL 325
           T+ D++S G++++E++ G        P ++ + L D   P L++S ++
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKV 267

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 95/215 (44%), Gaps = 16/215 (7%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLA 143
           R     F    LLG+G FG V        +++    +  A+K+L  E +    E    L 
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHTLT 197
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           E   L   RHP L  L  Y  +  +RL  V E+   G L  HL +    S          
Sbjct: 198 ENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 256
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I +A  L +LH  +N V+YRD K  N++LD D   K++DFGL K G +   T  T    G
Sbjct: 257 IVSA--LDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCG 311
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 99/228 (43%), Gaps = 26/228 (11%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL-AEVIFLG 149
           +N     +LG G FG V         + G+  Q VAVK+L  +     RE L +E+  + 
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQ-VAVKMLKEKADSSEREALMSELKMMT 103
Query: 150 QL-RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHL------FKRISVSLPWGTRLK-- 200
           QL  H ++V L+G C       L++E+   G L N+L      F    +      RL+  
Sbjct: 104 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 201 -------------IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM 247
                         A   AKG+ FL       ++RD    N+L+      K+ DFGLA+ 
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
               SN  V         + APE +  G  T KSDV+S+G++L E+ +
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 95/215 (44%), Gaps = 16/215 (7%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLA 143
           R     F    LLG+G FG V        +++    +  A+K+L  E +    E    L 
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHTLT 200
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           E   L   RHP L  L  Y  +  +RL  V E+   G L  HL +    S          
Sbjct: 201 ENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 259
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I +A  L +LH  +N V+YRD K  N++LD D   K++DFGL K G +   T  T    G
Sbjct: 260 IVSA--LDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCG 314
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 315 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL-AEVIFLGQL-RHPHL 156
           LG G FG V +      L +      VAVK+L        +E L +E+  +  L +H ++
Sbjct: 46  LGAGAFGKVVEA-TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 104
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSL------PWGTR--LKIAIGAAKG 208
           V L+G C      L++ E+   G L N L ++    L      P   R  L  +   A+G
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQG 164
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           +AFL  A    I+RD    N+LL +   AK+ DFGLA+     SN  V         + A
Sbjct: 165 MAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 222
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT 295
           PE I     T +SDV+S+G++L E+ +
Sbjct: 223 PESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 119/284 (41%), Gaps = 42/284 (14%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL------DIEGLQGHREWLAEVIFLGQLR 152
           +G G FG V  G +  D         VAVK        D++      ++L E   L Q  
Sbjct: 122 IGRGNFGEVFSGRLRAD------NTLVAVKSCRETLPPDLKA-----KFLQEARILKQYS 170
Query: 153 HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
           HP++VRLIG C + +   +V E +  G     L +     L   T L++   AA G+ +L
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
                  I+RD    N L+      K+SDFG+++   +G              + APE +
Sbjct: 230 ES--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEAL 287
Query: 273 STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR-SSRRLRYIVDP 331
           + G  +++SDV+SFG++L E  +                   A PY   S+++ R  V+ 
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLG-----------------ASPYPNLSNQQTREFVEK 330
Query: 332 RLAGQYSVKGAKEMAVLAL--QCISVNPKDRPKMAAVVATLESL 373
              G+         AV  L  QC +  P  RP  + +   L+S+
Sbjct: 331 --GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 120/280 (42%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 34  EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 87
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 88  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 145
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P      +     GT  Y 
Sbjct: 146 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDYL 199
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 200 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 250
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 251 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 281

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 104/231 (45%), Gaps = 11/231 (4%)
Query: 85  ELRAITQNFSSNY-LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA 143
           E + +T+N    Y +LG+GGFG V    +      G       ++   I+  +G    L 
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGEAMALN 233
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           E   L ++    +V L  Y  E ++ L LV   M  G L+ H++       P    +  A
Sbjct: 234 EKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
                GL  LH     ++YRD K  NILLD     ++SD GLA   PEG    +  RV G
Sbjct: 293 AEICCGLEDLH--RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-G 347
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
           T GY APE +     T   D ++ G +L E++ G+    + + K ++  V+
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 119/284 (41%), Gaps = 42/284 (14%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL------DIEGLQGHREWLAEVIFLGQLR 152
           +G G FG V  G +  D         VAVK        D++      ++L E   L Q  
Sbjct: 122 IGRGNFGEVFSGRLRAD------NTLVAVKSCRETLPPDLKA-----KFLQEARILKQYS 170
Query: 153 HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
           HP++VRLIG C + +   +V E +  G     L +     L   T L++   AA G+ +L
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
                  I+RD    N L+      K+SDFG+++   +G              + APE +
Sbjct: 230 ES--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 273 STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR-SSRRLRYIVDP 331
           + G  +++SDV+SFG++L E  +                   A PY   S+++ R  V+ 
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLG-----------------ASPYPNLSNQQTREFVEK 330
Query: 332 RLAGQYSVKGAKEMAVLAL--QCISVNPKDRPKMAAVVATLESL 373
              G+         AV  L  QC +  P  RP  + +   L+S+
Sbjct: 331 --GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 104/231 (45%), Gaps = 11/231 (4%)
Query: 85  ELRAITQNFSSNY-LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA 143
           E + +T+N    Y +LG+GGFG V    +      G       ++   I+  +G    L 
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVR---ATGKMYACKKLEKKRIKKRKGEAMALN 233
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           E   L ++    +V L  Y  E ++ L LV   M  G L+ H++       P    +  A
Sbjct: 234 EKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
                GL  LH     ++YRD K  NILLD     ++SD GLA   PEG    +  RV G
Sbjct: 293 AEICCGLEDLH--RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-G 347
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
           T GY APE +     T   D ++ G +L E++ G+    + + K ++  V+
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 16/201 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHLV 157
           LG G  G V K      ++       +A KL+ +E     R + + E+  L +   P++V
Sbjct: 24  LGAGNGGVVTK------VQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 77
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
              G    D E  +  E M  GSL+  L  + +  +P     K++I   +GLA+L   ++
Sbjct: 78  GFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLR-EKH 134
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAPEYISTGH 276
            +++RD K SNIL++S    KL DFG++ ++    +N+ V     GT  Y APE +   H
Sbjct: 135 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMAPERLQGTH 189
Query: 277 LTTKSDVYSFGVVLLELLTGR 297
            + +SD++S G+ L+EL  GR
Sbjct: 190 YSVQSDIWSMGLSLVELAVGR 210

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQ 150
           +F     LG G  G V K      +        +A KL+ +E     R + + E+  L +
Sbjct: 69  DFEKISELGAGNGGVVFK------VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 122
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
              P++V   G    D E  +  E M  GSL+  L K  +  +P     K++I   KGL 
Sbjct: 123 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLT 180
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAP 269
           +L   ++ +++RD K SNIL++S    KL DFG++ ++    +N+ V TR      Y +P
Sbjct: 181 YLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSP 234
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGR 297
           E +   H + +SD++S G+ L+E+  GR
Sbjct: 235 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 10  EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 63
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 64  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 121
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K+++FG +   P        T + GT  Y 
Sbjct: 122 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLDYL 175
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 176 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 226
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 227 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 257

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 120/280 (42%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 10  EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 63
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 64  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 121
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P      +     GT  Y 
Sbjct: 122 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYL 175
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 176 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 226
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 227 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 257

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 120/280 (42%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 9   EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 63  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 120
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P          + GT  Y 
Sbjct: 121 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DTLCGTLDYL 174
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 225
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 226 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 256

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 120/280 (42%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 11  EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 122
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P      +     GT  Y 
Sbjct: 123 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYL 176
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 227
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 228 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 258

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQ 150
           +F     LG G  G V K      +        +A KL+ +E     R + + E+  L +
Sbjct: 34  DFEKISELGAGNGGVVFK------VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 87
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
              P++V   G    D E  +  E M  GSL+  L K  +  +P     K++I   KGL 
Sbjct: 88  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLT 145
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAP 269
           +L   ++ +++RD K SNIL++S    KL DFG++ ++    +N+ V TR      Y +P
Sbjct: 146 YLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSP 199
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGR 297
           E +   H + +SD++S G+ L+E+  GR
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH--REWLAEVIFLGQLRHPH 155
           +LG+G FG V K       +  +  Q  AVK+++    +       L EV  L +L HP+
Sbjct: 29  MLGKGSFGEVLK------CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +++L     +     +V E    G L + + KR   S     R  I      G+ ++H  
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITYMH-- 138
Query: 216 ENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
           ++ +++RD K  NILL+S   D   K+ DFGL+    +  NT +  R+ GT  Y APE +
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRI-GTAYYIAPEVL 195
Query: 273 STGHLTTKSDVYSFGVVLLELLTG 296
             G    K DV+S GV+L  LL+G
Sbjct: 196 R-GTYDEKCDVWSAGVILYILLSG 218

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 11  EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 122
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K+++FG +   P        T + GT  Y 
Sbjct: 123 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLDYL 176
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 227
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 228 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 258

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 127/289 (43%), Gaps = 31/289 (10%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQ 150
           ++    ++G G    V   Y         K + VA+K +++E  Q    E L E+  + Q
Sbjct: 16  DYELQEVIGSGATAVVQAAYC------APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQ 69
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRI-------SVSLPWGTRLKIAI 203
             HP++V         +E  LV + +  GS+ + + K I       S  L   T   I  
Sbjct: 70  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLDESTIATILR 128
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM---GPEGSNTHVTTRV 260
              +GL +LH  +N  I+RD K  NILL  D + +++DFG++     G + +   V    
Sbjct: 129 EVLEGLEYLH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 261 MGTYGYAAPEYISTGH-LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNL-VDWAKPY 318
           +GT  + APE +        K+D++SFG+  +EL TG     K  P     L +    P 
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 246
Query: 319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
           L +      + D  +  +Y  K  ++M  L   C+  +P+ RP  A ++
Sbjct: 247 LETG-----VQDKEMLKKYG-KSFRKMISL---CLQKDPEKRPTAAELL 286

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 120/280 (42%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 119
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P      +     GT  Y 
Sbjct: 120 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYL 173
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 224
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 225 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 120/280 (42%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 11  EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 122
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P      +     GT  Y 
Sbjct: 123 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDYL 176
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 227
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 228 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 258

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 120/280 (42%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 11  EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 122
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P      +     GT  Y 
Sbjct: 123 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYL 176
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 227
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 228 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 258

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 99  LGEGGFG-TVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLAEVIFLGQL-RHPH 155
           LGEG FG  V    I  D  +  +   VAVK+L  +  +    + ++E+  +  + +H +
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR--------------LKI 201
           ++ L+G C +D    ++ E+  +G+L  +L  R    L +                 +  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
           A   A+G+ +L  A    I+RD    N+L+  D   K++DFGLA+          TT   
Sbjct: 149 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 206
Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
               + APE +     T +SDV+SFGV+L E+ T
Sbjct: 207 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 120/280 (42%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 119
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P      +     GT  Y 
Sbjct: 120 ALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYL 173
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   + + Y R SR    
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQETYKRISRVEFT 224
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 225 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQ 150
           +F     LG G  G V K      +        +A KL+ +E     R + + E+  L +
Sbjct: 7   DFEKISELGAGNGGVVFK------VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
              P++V   G    D E  +  E M  GSL+  L K  +  +P     K++I   KGL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLT 118
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAP 269
           +L   ++ +++RD K SNIL++S    KL DFG++ ++    +N+ V TR      Y +P
Sbjct: 119 YLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSP 172
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGR 297
           E +   H + +SD++S G+ L+E+  GR
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 99  LGEGGFG-TVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLAEVIFLGQL-RHPH 155
           LGEG FG  V    I  D  +  +   VAVK+L  +  +    + ++E+  +  + +H +
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR--------------LKI 201
           ++ L+G C +D    ++ E+  +G+L  +L  R    L +                 +  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
           A   A+G+ +L  A    I+RD    N+L+  D   K++DFGLA+          TT   
Sbjct: 148 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 205
Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
               + APE +     T +SDV+SFGV+L E+ T
Sbjct: 206 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 127/289 (43%), Gaps = 31/289 (10%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQ 150
           ++    ++G G    V   Y         K + VA+K +++E  Q    E L E+  + Q
Sbjct: 11  DYELQEVIGSGATAVVQAAYC------APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQ 64
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRI-------SVSLPWGTRLKIAI 203
             HP++V         +E  LV + +  GS+ + + K I       S  L   T   I  
Sbjct: 65  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLDESTIATILR 123
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM---GPEGSNTHVTTRV 260
              +GL +LH  +N  I+RD K  NILL  D + +++DFG++     G + +   V    
Sbjct: 124 EVLEGLEYLH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 181
Query: 261 MGTYGYAAPEYISTGH-LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNL-VDWAKPY 318
           +GT  + APE +        K+D++SFG+  +EL TG     K  P     L +    P 
Sbjct: 182 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS 241
Query: 319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
           L +      + D  +  +Y  K  ++M  L   C+  +P+ RP  A ++
Sbjct: 242 LETG-----VQDKEMLKKYG-KSFRKMISL---CLQKDPEKRPTAAELL 281

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 99/226 (43%), Gaps = 38/226 (16%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHLV 157
           +GEG FG V +      L        VAVK+L  E     + ++  E   + +  +P++V
Sbjct: 55  IGEGAFGRVFQARAPGLLPYE-PFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 158 RLIGYCCEDEERLLVYEFMPRGSL----------------ENHLFKRISVSLP------W 195
           +L+G C   +   L++E+M  G L                 + L  R  VS P       
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 196 GTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL------AKMGP 249
             +L IA   A G+A+L  +E   ++RD  T N L+  +   K++DFGL      A    
Sbjct: 174 AEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
              N  +  R M       PE I     TT+SDV+++GVVL E+ +
Sbjct: 232 ADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 99  LGEGGFG-TVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLAEVIFLGQL-RHPH 155
           LGEG FG  V    I  D  +  +   VAVK+L  +  +    + ++E+  +  + +H +
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR--------------LKI 201
           ++ L+G C +D    ++ E+  +G+L  +L  R    L +                 +  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
           A   A+G+ +L  A    I+RD    N+L+  D   K++DFGLA+          TT   
Sbjct: 145 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 202
Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
               + APE +     T +SDV+SFGV+L E+ T
Sbjct: 203 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 99  LGEGGFG-TVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLAEVIFLGQL-RHPH 155
           LGEG FG  V    I  D  +  +   VAVK+L  +  +    + ++E+  +  + +H +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR--------------LKI 201
           ++ L+G C +D    ++ E+  +G+L  +L  R    L +                 +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
           A   A+G+ +L  A    I+RD    N+L+  D   K++DFGLA+          TT   
Sbjct: 156 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGR 213
Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
               + APE +     T +SDV+SFGV+L E+ T
Sbjct: 214 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 120/280 (42%), Gaps = 35/280 (12%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLA------REKNSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 62  QSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELAN 119
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H  +  VI+RD K  N+LL S    K++DFG +   P      +     GT  Y 
Sbjct: 120 ALSYCHSKK--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYL 173
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            PE I       K D++S GV+  E L G       +P  E N   +   Y R SR    
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG-------KPPFEAN--TYQDTYKRISRVEFT 224
Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
             D      +  +GA++   L  + +  NP  RP +  V+
Sbjct: 225 FPD------FVTEGARD---LISRLLKHNPSQRPMLREVL 255

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 99  LGEGGFG-TVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLAEVIFLGQL-RHPH 155
           LGEG FG  V    I  D  +  +   VAVK+L  +  +    + ++E+  +  + +H +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR--------------LKI 201
           ++ L+G C +D    ++ E+  +G+L  +L  R    L +                 +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
           A   A+G+ +L  A    I+RD    N+L+  D   K++DFGLA+          TT   
Sbjct: 156 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 213
Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
               + APE +     T +SDV+SFGV+L E+ T
Sbjct: 214 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQ 150
           +F     LG G  G V K      +        +A KL+ +E     R + + E+  L +
Sbjct: 7   DFEKISELGAGNGGVVFK------VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
              P++V   G    D E  +  E M  GSL+  L K  +  +P     K++I   KGL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLT 118
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAP 269
           +L   ++ +++RD K SNIL++S    KL DFG++ ++    +N+ V TR      Y +P
Sbjct: 119 YLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSP 172
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGR 297
           E +   H + +SD++S G+ L+E+  GR
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQ 150
           +F     LG G  G V K      +        +A KL+ +E     R + + E+  L +
Sbjct: 7   DFEKISELGAGNGGVVFK------VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
              P++V   G    D E  +  E M  GSL+  L K  +  +P     K++I   KGL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLT 118
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAP 269
           +L   ++ +++RD K SNIL++S    KL DFG++ ++    +N+ V TR      Y +P
Sbjct: 119 YLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSP 172
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGR 297
           E +   H + +SD++S G+ L+E+  GR
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQ 150
           +F     LG G  G V K      +        +A KL+ +E     R + + E+  L +
Sbjct: 7   DFEKISELGAGNGGVVFK------VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
              P++V   G    D E  +  E M  GSL+  L K  +  +P     K++I   KGL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLT 118
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAP 269
           +L   ++ +++RD K SNIL++S    KL DFG++ ++    +N+ V TR      Y +P
Sbjct: 119 YLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSP 172
Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGR 297
           E +   H + +SD++S G+ L+E+  GR
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 99  LGEGGFG-TVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLAEVIFLGQL-RHPH 155
           LGEG FG  V    I  D  +  +   VAVK+L  +  +    + ++E+  +  + +H +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR--------------LKI 201
           ++ L+G C +D    ++ E+  +G+L  +L  R    L +                 +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
           A   A+G+ +L  A    I+RD    N+L+  D   K++DFGLA+          TT   
Sbjct: 156 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 213
Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
               + APE +     T +SDV+SFGV+L E+ T
Sbjct: 214 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE--WLAEVIFLGQLRHPH 155
            LG+GGF   ++   D D ++    + V   +L    L+ H++     E+     L +PH
Sbjct: 49  FLGKGGFAKCYE-ITDMDTKEVFAGKVVPKSML----LKPHQKEKMSTEIAIHKSLDNPH 103
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLP---WGTRLKIAIGAAKGLAFL 212
           +V   G+  +D+   +V E   R SL     +R +V+ P   +  R  I     +G+ +L
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYL 158
Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAPEY 271
           H   N VI+RD K  N+ L+ D   K+ DFGLA K+  +G        + GT  Y APE 
Sbjct: 159 HN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT---LCGTPNYIAPEV 213
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGR 297
           +     + + D++S G +L  LL G+
Sbjct: 214 LCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 94/215 (43%), Gaps = 16/215 (7%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLA 143
           R     F    LLG+G FG V        +++    +  A+K+L  E +    E    L 
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHTLT 59
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           E   L   RHP L  L  Y  +  +RL  V E+   G L  HL +    S          
Sbjct: 60  ENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 118
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I +A  L +LH  +N V+YRD K  N++LD D   K++DFGL K G +   T       G
Sbjct: 119 IVSA--LDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCG 173
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 174 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 15/210 (7%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F TV         R+   ++  A+K+L+   +    +      E   
Sbjct: 37  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 90
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLV-YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAA 206
           + +L HP  V+L  +C +D+E+L     +   G L  ++ ++I       TR   A    
Sbjct: 91  MSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 147
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
             L +LHG    +I+RD K  NILL+ D   +++DFG AK+    S        +GT  Y
Sbjct: 148 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 205
Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            +PE ++       SD+++ G ++ +L+ G
Sbjct: 206 VSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 94/215 (43%), Gaps = 16/215 (7%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLA 143
           R     F    LLG+G FG V        +++    +  A+K+L  E +    E    L 
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHTLT 57
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           E   L   RHP L  L  Y  +  +RL  V E+   G L  HL +    S          
Sbjct: 58  ENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 116
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I +A  L +LH  +N V+YRD K  N++LD D   K++DFGL K G +   T       G
Sbjct: 117 IVSA--LDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCG 171
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 172 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/176 (31%), Positives = 93/176 (52%), Gaps = 10/176 (5%)
Query: 124 AVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLE 182
            +A KL+ +E     R + + E+  L +   P++V   G    D E  +  E M  GSL+
Sbjct: 52  VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 111
Query: 183 NHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF 242
             L K  +  +P     K++I   KGL +L   ++ +++RD K SNIL++S    KL DF
Sbjct: 112 QVLKK--AGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDF 168
Query: 243 GLA-KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           G++ ++    +N+ V TR      Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 169 GVSGQLIDSMANSFVGTR-----SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 94/215 (43%), Gaps = 16/215 (7%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLA 143
           R     F    LLG+G FG V        +++    +  A+K+L  E +    E    L 
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHTLT 58
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           E   L   RHP L  L  Y  +  +RL  V E+   G L  HL +    S          
Sbjct: 59  ENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 117
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I +A  L +LH  +N V+YRD K  N++LD D   K++DFGL K G +   T       G
Sbjct: 118 IVSA--LDYLHSEKN-VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCG 172
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 99  LGEGGFG-TVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLAEVIFLGQL-RHPH 155
           LGEG FG  V    I  D  +  +   VAVK+L  +  +    + ++E+  +  + +H +
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR--------------LKI 201
           ++ L+G C +D    ++ E+  +G+L  +L  R    L +                 +  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
           A   A+G+ +L  A    I+RD    N+L+  D   K++DFGLA+          TT   
Sbjct: 141 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 198
Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
               + APE +     T +SDV+SFGV+L E+ T
Sbjct: 199 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE--WLAEVIFLGQLRHPH 155
            LG+GGF   ++   D D ++    + V   +L    L+ H++     E+     L +PH
Sbjct: 49  FLGKGGFAKCYE-ITDMDTKEVFAGKVVPKSML----LKPHQKEKMSTEIAIHKSLDNPH 103
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLP---WGTRLKIAIGAAKGLAFL 212
           +V   G+  +D+   +V E   R SL     +R +V+ P   +  R  I     +G+ +L
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYL 158
Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAPEY 271
           H   N VI+RD K  N+ L+ D   K+ DFGLA K+  +G        + GT  Y APE 
Sbjct: 159 HN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKXLCGTPNYIAPEV 213
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGR 297
           +     + + D++S G +L  LL G+
Sbjct: 214 LCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH--REWLAEVIFLGQLRHPH 155
           +LG+G FG V K       +  +  Q  AVK+++    +       L EV  L +L HP+
Sbjct: 29  MLGKGSFGEVLK------CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +++L     +     +V E    G L + + KR   S     R  I      G+ ++H  
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITYMH-- 138
Query: 216 ENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
           ++ +++RD K  NILL+S   D   K+ DFGL+    +  NT +  R+ GT  Y APE +
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRI-GTAYYIAPEVL 195
Query: 273 STGHLTTKSDVYSFGVVLLELLTG 296
             G    K DV+S GV+L  LL+G
Sbjct: 196 R-GTYDEKCDVWSAGVILYILLSG 218

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGH-----REWLAE 144
           Q +     +GEG +G V K     DL+ G   + VA+K + ++ G +G      RE +A 
Sbjct: 11  QQYECVAEIGEGAYGKVFKAR---DLKNG--GRFVALKRVRVQTGEEGMPLSTIRE-VAV 64
Query: 145 VIFLGQLRHPHLVRLIGYCC----EDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRL 199
           +  L    HP++VRL   C     + E +L LV+E + +  L  +L K     +P  T  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK 123
Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
            +     +GL FLH   + V++RD K  NIL+ S    KL+DFGLA++    S     T 
Sbjct: 124 DMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTS 178
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELL 294
           V+ T  Y APE +      T  D++S G +  E+ 
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 97/211 (45%), Gaps = 17/211 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL-AEVIFLGQL-RHPHL 156
           LG G FG V +      L +      VAVK+L        +E L +E+  +  L +H ++
Sbjct: 54  LGAGAFGKVVEA-TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISV------------SLPWGTRLKIAIG 204
           V L+G C      L++ E+   G L N L ++  V            +L     L  +  
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQ 172
Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY 264
            A+G+AFL  A    I+RD    N+LL +   AK+ DFGLA+     SN  V        
Sbjct: 173 VAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 265 GYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
            + APE I     T +SDV+S+G++L E+ +
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE--WLAEVIFLGQLRHPH 155
            LG+GGF   ++   D D ++    + V   +L    L+ H++     E+     L +PH
Sbjct: 49  FLGKGGFAKCYE-ITDMDTKEVFAGKVVPKSML----LKPHQKEKMSTEIAIHKSLDNPH 103
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLP---WGTRLKIAIGAAKGLAFL 212
           +V   G+  +D+   +V E   R SL     +R +V+ P   +  R  I     +G+ +L
Sbjct: 104 VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYL 158
Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAPEY 271
           H   N VI+RD K  N+ L+ D   K+ DFGLA K+  +G        + GT  Y APE 
Sbjct: 159 HN--NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIAPEV 213
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGR 297
           +     + + D++S G +L  LL G+
Sbjct: 214 LCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH--REWLAEVIFLGQLRHPH 155
           +LG+G FG V K       +  +  Q  AVK+++    +       L EV  L +L HP+
Sbjct: 29  MLGKGSFGEVLK------CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +++L     +     +V E    G L + + KR   S     R+   + +  G+ ++H  
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS--GITYMH-- 138
Query: 216 ENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
           ++ +++RD K  NILL+S   D   K+ DFGL+    +  NT +  R+ GT  Y APE +
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRI-GTAYYIAPEVL 195
Query: 273 STGHLTTKSDVYSFGVVLLELLTG 296
             G    K DV+S GV+L  LL+G
Sbjct: 196 R-GTYDEKCDVWSAGVILYILLSG 218

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 120/257 (46%), Gaps = 41/257 (15%)
Query: 91  QNFSSNYL-LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLG 149
           + + +N++ +GEG  G V    I  +   G   + VAVK +D+   Q       EV+ + 
Sbjct: 44  REYLANFIKIGEGSTGIV---CIATEKHTG---KQVAVKKMDLRKQQRRELLFNEVVIMR 97
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------IAI 203
              H ++V +       +E  +V EF+  G+L +         +   TR+       + +
Sbjct: 98  DYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIATVCL 148
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGSNTHVTTRVMG 262
              + L++LH     VI+RD K+ +ILL SD   KLSDFG  A++  E         ++G
Sbjct: 149 SVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RKXLVG 203
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS 322
           T  + APE IS     T+ D++S G++++E++ G                 + +P L++ 
Sbjct: 204 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY-------------FNEPPLQAM 250
Query: 323 RRLRYIVDPRLAGQYSV 339
           RR+R  + PR+   + V
Sbjct: 251 RRIRDSLPPRVKDLHKV 267

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGH-----REWLAE 144
           Q +     +GEG +G V K     DL+ G   + VA+K + ++ G +G      RE +A 
Sbjct: 11  QQYECVAEIGEGAYGKVFKAR---DLKNG--GRFVALKRVRVQTGEEGMPLSTIRE-VAV 64
Query: 145 VIFLGQLRHPHLVRLIGYCC----EDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRL 199
           +  L    HP++VRL   C     + E +L LV+E + +  L  +L K     +P  T  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK 123
Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
            +     +GL FLH   + V++RD K  NIL+ S    KL+DFGLA++    S     T 
Sbjct: 124 DMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTS 178
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELL 294
           V+ T  Y APE +      T  D++S G +  E+ 
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 99  LGEGGFG-TVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLAEVIFLGQL-RHPH 155
           LGEG FG  V    I  D  +  +   VAVK+L  +  +    + ++E+  +  + +H +
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR--------------LKI 201
           ++ L+G C +D    ++ E+  +G+L  +L  R    L +                 +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
           A   A+G+ +L  A    I+RD    N+L+  D   K++DFGLA+          TT   
Sbjct: 156 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 213
Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
               + APE +     T +SDV+SFGV+L E+ T
Sbjct: 214 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 12  EDFDIGRPLGKGKFGNVYLA------RERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSRFDEQRTATYIT-ELAN 123
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S+   K++DFG +   P        T + GT  Y 
Sbjct: 124 ALSYCHSKR--VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTLCGTLDYL 177
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
            PE I       K D++S GV+  E L G
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 29/209 (13%)
Query: 102 GGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIG 161
           G FG V K          L  + VAVK+  I+  Q  +    EV  L  ++H ++++ IG
Sbjct: 35  GRFGCVWKAQ--------LLNEYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIG 85
Query: 162 Y----CCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH---- 213
                   D +  L+  F  +GSL + L   +   + W     IA   A+GLA+LH    
Sbjct: 86  AEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIP 142
Query: 214 ----GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
               G +  + +RD K+ N+LL ++ TA ++DFGLA     G +   T   +GT  Y AP
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202
Query: 270 EYISTG-----HLTTKSDVYSFGVVLLEL 293
           E +            + D+Y+ G+VL EL
Sbjct: 203 EVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 99  LGEGGFG-TVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLAEVIFLGQL-RHPH 155
           LGEG FG  V    I  D  +  +   VAVK+L  +  +    + ++E+  +  + +H +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR--------------LKI 201
           ++ L+G C +D    ++ E+  +G+L  +L  R    L +                 +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
           A   A+G+ +L  A    I+RD    N+L+  D   K++DFGLA+          TT   
Sbjct: 197 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 254
Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
               + APE +     T +SDV+SFGV+L E+ T
Sbjct: 255 LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 92/216 (42%), Gaps = 14/216 (6%)
Query: 85  ELRAITQNFSSNYLLGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLLD--IEGLQGHREW 141
           +++   ++F  + +LG+G FG V    +   +    +KA    V L+D  +E     +  
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKI 201
           L+         HP L  +       E    V E++  G L  H+       L   T    
Sbjct: 72  LSLA-----WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA 126
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
            I    GL FLH     ++YRD K  NILLD D   K++DFG+ K    G     T    
Sbjct: 127 EI--ILGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNEFC 180
Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           GT  Y APE +         D +SFGV+L E+L G+
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 132/285 (46%), Gaps = 34/285 (11%)
Query: 92  NFSSNYLLGEG-GFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA---EVIF 147
           + S  Y LGE  GFG + + ++  DLR     + VAVK+L  +  +    +L    E   
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDH---RDVAVKVLRADLARDPSFYLRFRREAQN 65
Query: 148 LGQLRHPHLVRLIGYCCEDEER------LLVYEFMPRGSLENHLFKRISVSLPWGTRLKI 201
              L HP +V +  Y   + E        +V E++   +L + +     ++      +++
Sbjct: 66  AAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA--IEV 121
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRV 260
              A + L F H  +N +I+RD K +NIL+ +    K+ DFG+A+ +   G++   T  V
Sbjct: 122 IADACQALNFSH--QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAV 179
Query: 261 MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR 320
           +GT  Y +PE      +  +SDVYS G VL E+LTG        P +  + V  A  ++R
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVR 233
Query: 321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAA 365
                    DP          + ++  + L+ ++ NP++R + AA
Sbjct: 234 E--------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA 270

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGH-----REWLAE 144
           Q +     +GEG +G V K     DL+ G   + VA+K + ++ G +G      RE +A 
Sbjct: 11  QQYECVAEIGEGAYGKVFKAR---DLKNG--GRFVALKRVRVQTGEEGMPLSTIRE-VAV 64
Query: 145 VIFLGQLRHPHLVRLIGYCC----EDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRL 199
           +  L    HP++VRL   C     + E +L LV+E + +  L  +L K     +P  T  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK 123
Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
            +     +GL FLH   + V++RD K  NIL+ S    KL+DFGLA++    S     T 
Sbjct: 124 DMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTS 178
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELL 294
           V+ T  Y APE +      T  D++S G +  E+ 
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE--WLAEVIFLGQLRHPH 155
            LG+GGF   ++   D D ++    + V   +L    L+ H++     E+     L +PH
Sbjct: 33  FLGKGGFAKCYE-ITDMDTKEVFAGKVVPKSML----LKPHQKEKMSTEIAIHKSLDNPH 87
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +V   G+  +D+   +V E   R SL     +R +V+ P            +G+ +LH  
Sbjct: 88  VVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF--MRQTIQGVQYLHN- 144
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            N VI+RD K  N+ L+ D   K+ DFGLA K+  +G        + GT  Y APE +  
Sbjct: 145 -NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIAPEVLCK 200
Query: 275 GHLTTKSDVYSFGVVLLELLTGR 297
              + + D++S G +L  LL G+
Sbjct: 201 KGHSFEVDIWSLGCILYTLLVGK 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 102/235 (43%), Gaps = 32/235 (13%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHLV 157
           LG GGFG V + +I  D       + VA+K    E    +RE W  E+  + +L HP++V
Sbjct: 23  LGTGGFGYVLR-WIHQD-----TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 158 RL------IGYCCEDEERLLVYEFMPRGSLENHLFK-RISVSLPWGTRLKIAIGAAKGLA 210
                   +     ++  LL  E+   G L  +L +      L  G    +    +  L 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 211 FLHGAENPVIYRDFKTSNILLD---SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           +LH  EN +I+RD K  NI+L         K+ D G AK   +G    + T  +GT  Y 
Sbjct: 137 YLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELCTEFVGTLQYL 191
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSM----------DKLRPKSEQNLV 312
           APE +     T   D +SFG +  E +TG R             K+R KS +++V
Sbjct: 192 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 246

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 102/235 (43%), Gaps = 32/235 (13%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHLV 157
           LG GGFG V + +I  D       + VA+K    E    +RE W  E+  + +L HP++V
Sbjct: 22  LGTGGFGYVLR-WIHQD-----TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 158 RL------IGYCCEDEERLLVYEFMPRGSLENHLFK-RISVSLPWGTRLKIAIGAAKGLA 210
                   +     ++  LL  E+   G L  +L +      L  G    +    +  L 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 211 FLHGAENPVIYRDFKTSNILLD---SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           +LH  EN +I+RD K  NI+L         K+ D G AK   +G    + T  +GT  Y 
Sbjct: 136 YLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELCTEFVGTLQYL 190
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGRRSM----------DKLRPKSEQNLV 312
           APE +     T   D +SFG +  E +TG R             K+R KS +++V
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 118/265 (44%), Gaps = 33/265 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-EVIFLGQLRHPHLV 157
           +G+G FG V KG ID+  +Q      VA+K++D+E  +   E +  E+  L Q    ++ 
Sbjct: 31  IGKGSFGEVFKG-IDNRTQQ-----VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +  G   +  +  ++ E++  GS  + L           T LK  +   KGL +LH  + 
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSEKK 141
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT-TRVMGTYGYAAPEYISTGH 276
             I+RD K +N+LL      KL+DFG+A    + ++T +     +GT  + APE I    
Sbjct: 142 --IHRDIKAANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIQQSA 196
Query: 277 LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQ 336
             +K+D++S G+  +EL  G      + P     L+    P             P L G 
Sbjct: 197 YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-------------PTLVGD 243
Query: 337 YSVKGAKEMAVLALQCISVNPKDRP 361
           ++    K        C++ +P  RP
Sbjct: 244 FT----KSFKEFIDACLNKDPSFRP 264

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 90/186 (48%), Gaps = 15/186 (8%)
Query: 119 GLKAQAVAVKLLDIEGLQGHREWLA-EVIFLGQLR-HPHLVRLIGYCCEDEERLLVYEFM 176
            +K   V  + L  E L+  RE    E   L Q+  HPH++ LI          LV++ M
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLM 182
Query: 177 PRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT 236
            +G L ++L +++++S    TR  I     + ++FLH   N +++RD K  NILLD +  
Sbjct: 183 RKGELFDYLTEKVALS-EKETR-SIMRSLLEAVSFLHA--NNIVHRDLKPENILLDDNMQ 238
Query: 237 AKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTT------KSDVYSFGVVL 290
            +LSDFG +     G        + GT GY APE +      T      + D+++ GV+L
Sbjct: 239 IRLSDFGFSCHLEPGEKLR---ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
Query: 291 LELLTG 296
             LL G
Sbjct: 296 FTLLAG 301

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 132/285 (46%), Gaps = 34/285 (11%)
Query: 92  NFSSNYLLGEG-GFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA---EVIF 147
           + S  Y LGE  GFG + + ++  DLR     + VAVK+L  +  +    +L    E   
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRLH---RDVAVKVLRADLARDPSFYLRFRREAQN 65
Query: 148 LGQLRHPHLVRLIGYCCEDEER------LLVYEFMPRGSLENHLFKRISVSLPWGTRLKI 201
              L HP +V +  Y   + E        +V E++   +L + +     ++      +++
Sbjct: 66  AAALNHPAIVAV--YATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA--IEV 121
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRV 260
              A + L F H  +N +I+RD K +NI++ +    K+ DFG+A+ +   G++   T  V
Sbjct: 122 IADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 261 MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR 320
           +GT  Y +PE      +  +SDVYS G VL E+LTG        P +  + V  A  ++R
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVR 233
Query: 321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAA 365
                    DP          + ++  + L+ ++ NP++R + AA
Sbjct: 234 E--------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA 270

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL-AEVIFLGQL-RHPHL 156
           LG G FG V +      L +      VAVK+L        +E L +E+  +  L +H ++
Sbjct: 54  LGAGAFGKVVEA-TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR--------------LKIA 202
           V L+G C      L++ E+   G L N L ++    L +                 L  +
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFS 172
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
              A+G+AFL  A    I+RD    N+LL +   AK+ DFGLA+     SN  V      
Sbjct: 173 SQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 230
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
              + APE I     T +SDV+S+G++L E+ +
Sbjct: 231 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 17/211 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL-AEVIFLGQL-RHPHL 156
           LG G FG V +      L +      VAVK+L        +E L +E+  +  L +H ++
Sbjct: 54  LGAGAFGKVVEA-TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISV----------SLPWGTR--LKIAIG 204
           V L+G C      L++ E+   G L N L ++  V          +    TR  L  +  
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY 264
            A+G+AFL  A    I+RD    N+LL +   AK+ DFGLA+     SN  V        
Sbjct: 173 VAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 265 GYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
            + APE I     T +SDV+S+G++L E+ +
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 132/285 (46%), Gaps = 34/285 (11%)
Query: 92  NFSSNYLLGEG-GFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA---EVIF 147
           + S  Y LGE  GFG + + ++  DLR     + VAVK+L  +  +    +L    E   
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDH---RDVAVKVLRADLARDPSFYLRFRREAQN 65
Query: 148 LGQLRHPHLVRLIGYCCEDEER------LLVYEFMPRGSLENHLFKRISVSLPWGTRLKI 201
              L HP +V +  Y   + E        +V E++   +L + +     ++      +++
Sbjct: 66  AAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA--IEV 121
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRV 260
              A + L F H  +N +I+RD K +NI++ +    K+ DFG+A+ +   G++   T  V
Sbjct: 122 IADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 261 MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR 320
           +GT  Y +PE      +  +SDVYS G VL E+LTG        P +  + V  A  ++R
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVR 233
Query: 321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAA 365
                    DP          + ++  + L+ ++ NP++R + AA
Sbjct: 234 E--------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA 270

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 131 DIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLL-VYEFMPRGSLENHLFKRI 189
           DI+ +Q  +      +F     HP LV L   C + E RL  V E++  G L  H+ ++ 
Sbjct: 63  DIDWVQTEKH-----VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQR 116
Query: 190 SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP 249
            +           I  A  L +LH  E  +IYRD K  N+LLDS+   KL+D+G+ K G 
Sbjct: 117 KLPEEHARFYSAEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 172
Query: 250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMD 301
              +T  T+   GT  Y APE +         D ++ GV++ E++ GR   D
Sbjct: 173 RPGDT--TSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-----EVIFLGQLR- 152
           +G G +GTV+K       R       VA+K + +    G    L      EV  L +L  
Sbjct: 17  IGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 153 --HPHLVRLIGYCCE---DEE--RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
             HP++VRL+  C     D E    LV+E + +  L  +L K     LP  T   +    
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
            +GL FLH   N +++RD K  NIL+ S  T KL+DFGLA++    S     T V+ T  
Sbjct: 130 LRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALTPVVVTLW 184
Query: 266 YAAPEYISTGHLTTKSDVYSFGVVLLELL 294
           Y APE +      T  D++S G +  E+ 
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 102/220 (46%), Gaps = 18/220 (8%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL--DIEGLQGHREW-LA 143
           R    +F+   +LG+G FG V         R+G + +  A+K+L  D+       E  + 
Sbjct: 15  RVKLTDFNFLMVLGKGSFGKVMLAD-----RKGTE-ELYAIKILKKDVVIQDDDVECTMV 68
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           E   L  L  P  +  +  C +  +RL  V E++  G L  H+ +      P        
Sbjct: 69  EKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE 128
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR-VM 261
           I    GL FLH  +  +IYRD K  N++LDS+   K++DFG+ K   E     VTTR   
Sbjct: 129 ISI--GLFFLH--KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMMDGVTTREFC 181
Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMD 301
           GT  Y APE I+        D +++GV+L E+L G+   D
Sbjct: 182 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 92/216 (42%), Gaps = 14/216 (6%)
Query: 85  ELRAITQNFSSNYLLGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLLD--IEGLQGHREW 141
           +++   ++F  + +LG+G FG V    +   +    +KA    V L+D  +E     +  
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKI 201
           L+         HP L  +       E    V E++  G L  H+       L   T    
Sbjct: 71  LSLA-----WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA 125
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
            I    GL FLH     ++YRD K  NILLD D   K++DFG+ K    G     T    
Sbjct: 126 EI--ILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXFC 179
Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           GT  Y APE +         D +SFGV+L E+L G+
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 99  LGEGGFGTVHK----GYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL-AEVIFLGQL-R 152
           LG G FG V +    G I  D      A  VAVK+L        RE L +E+  L  L  
Sbjct: 54  LGAGAFGKVVEATAYGLIKSD-----AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 153 HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKI----------- 201
           H ++V L+G C      L++ E+   G L N L ++    +   T   I           
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 202 -----AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV 256
                +   AKG+AFL  A    I+RD    NILL      K+ DFGLA+     SN  V
Sbjct: 169 DLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVV 226
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                    + APE I     T +SDV+S+G+ L EL +
Sbjct: 227 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 99  LGEGGFGTVHK----GYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL-AEVIFLGQL-R 152
           LG G FG V +    G I  D      A  VAVK+L        RE L +E+  L  L  
Sbjct: 47  LGAGAFGKVVEATAYGLIKSD-----AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 101
Query: 153 HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKI----------- 201
           H ++V L+G C      L++ E+   G L N L ++    +   T   I           
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 161
Query: 202 -----AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV 256
                +   AKG+AFL  A    I+RD    NILL      K+ DFGLA+     SN  V
Sbjct: 162 DLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 219
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                    + APE I     T +SDV+S+G+ L EL +
Sbjct: 220 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 88/187 (47%), Gaps = 15/187 (8%)
Query: 131 DIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLL-VYEFMPRGSLENHLFKRI 189
           DI+ +Q  +      +F     HP LV L   C + E RL  V E++  G L  H+ ++ 
Sbjct: 95  DIDWVQTEKH-----VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQR 148
Query: 190 SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP 249
            +           I  A  L +LH  E  +IYRD K  N+LLDS+   KL+D+G+ K G 
Sbjct: 149 KLPEEHARFYSAEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204
Query: 250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKL--RPKS 307
              +T  T+   GT  Y APE +         D ++ GV++ E++ GR   D +      
Sbjct: 205 RPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 262
Query: 308 EQNLVDW 314
           +QN  D+
Sbjct: 263 DQNTEDY 269

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 131 DIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLL-VYEFMPRGSLENHLFKRI 189
           DI+ +Q  +      +F     HP LV L   C + E RL  V E++  G L  H+ ++ 
Sbjct: 48  DIDWVQTEKH-----VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQR 101
Query: 190 SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP 249
            +           I  A  L +LH  E  +IYRD K  N+LLDS+   KL+D+G+ K G 
Sbjct: 102 KLPEEHARFYSAEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 157
Query: 250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMD 301
              +T  T+   GT  Y APE +         D ++ GV++ E++ GR   D
Sbjct: 158 RPGDT--TSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 126/297 (42%), Gaps = 42/297 (14%)
Query: 99  LGEGGFGTVHKGYIDDD---LRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQL-R 152
           LG G FG V    I+ D   + +    + VAVK+L  EG     HR  ++E+  L  +  
Sbjct: 36  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGH 90
Query: 153 HPHLVRLIGYCCEDEERLLV-YEFMPRGSLENHLFKRISVSLPWGT-------------R 198
           H ++V L+G C +    L+V  EF   G+L  +L  + +  +P+ T              
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT 258
           +  +   AKG+ FL  A    I+RD    NILL      K+ DFGLA+   +  +     
Sbjct: 151 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 259 RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY 318
                  + APE I     T +SDV+SFGV+L E+ +   S     P     + +     
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRR 263
Query: 319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           L+   R+R       A  Y+     EM    L C    P  RP  + +V  L +LL 
Sbjct: 264 LKEGTRMR-------APDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 99  LGEGGFGTVHK----GYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL-AEVIFLGQL-R 152
           LG G FG V +    G I  D      A  VAVK+L        RE L +E+  L  L  
Sbjct: 31  LGAGAFGKVVEATAYGLIKSD-----AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 153 HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKI----------- 201
           H ++V L+G C      L++ E+   G L N L ++    +   T   I           
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 202 -----AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV 256
                +   AKG+AFL  A    I+RD    NILL      K+ DFGLA+     SN  V
Sbjct: 146 DLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                    + APE I     T +SDV+S+G+ L EL +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 130/285 (45%), Gaps = 34/285 (11%)
Query: 92  NFSSNYLLGEG-GFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA---EVIF 147
           + S  Y LGE  GFG + + ++  DLR     + VAVK+L  +  +    +L    E   
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRDH---RDVAVKVLRADLARDPSFYLRFRREAQN 65
Query: 148 LGQLRHPHLVRLIGYCCEDEER------LLVYEFMPRGSLENHLFKRISVSLPWGTRLKI 201
              L HP +V +  Y   + E        +V E++   +L + +     ++      +++
Sbjct: 66  AAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA--IEV 121
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRV 260
              A + L F H  +N +I+RD K +NI++ +    K+ DFG+A+ +   G++   T  V
Sbjct: 122 IADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 261 MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR 320
           +GT  Y +PE      +  +SDVYS G VL E+LTG        P S       A  ++R
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDS------VAYQHVR 233
Query: 321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAA 365
                    DP          + ++  + L+ ++ NP++R + AA
Sbjct: 234 E--------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA 270

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 82/172 (47%), Gaps = 13/172 (7%)
Query: 131 DIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLL-VYEFMPRGSLENHLFKRI 189
           DI+ +Q  +      +F     HP LV L   C + E RL  V E++  G L  H+ ++ 
Sbjct: 52  DIDWVQTEKH-----VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQR 105
Query: 190 SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP 249
            +           I  A  L +LH  E  +IYRD K  N+LLDS+   KL+D+G+ K G 
Sbjct: 106 KLPEEHARFYSAEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161
Query: 250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMD 301
              +T  T+   GT  Y APE +         D ++ GV++ E++ GR   D
Sbjct: 162 RPGDT--TSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKL--LDIEGLQGHREWLAEVIFLGQLRHPHL 156
           +GEG +G V+K        +  + + VA+K   LD E        + E+  L +L HP++
Sbjct: 29  VGEGTYGVVYKA-------KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG---TRLKIAI-GAAKGLAFL 212
           V LI     +    LV+EFM +        K++      G   +++KI +    +G+A  
Sbjct: 82  VSLIDVIHSERCLTLVFEFMEKD------LKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG--PEGSNTHVTTRVMGTYGYAAPE 270
           H  ++ +++RD K  N+L++SD   KL+DFGLA+    P  S TH       T  Y AP+
Sbjct: 136 H--QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPD 189
Query: 271 YI-STGHLTTKSDVYSFGVVLLELLTGR 297
            +  +   +T  D++S G +  E++TG+
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 15/210 (7%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F TV         R+   ++  A+K+L+   +    +      E   
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +L HP  V+L     +DE+      +   G L  ++ ++I       TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI-RKIGSFDETCTRFYTA-EIVS 143
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGY 266
            L +LHG    +I+RD K  NILL+ D   +++DFG AK + PE       + V GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQY 200
Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            +PE ++    +  SD+++ G ++ +L+ G
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 99  LGEGGFGTVHK----GYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL-AEVIFLGQL-R 152
           LG G FG V +    G I  D      A  VAVK+L        RE L +E+  L  L  
Sbjct: 49  LGAGAFGKVVEATAYGLIKSD-----AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 103
Query: 153 HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKI----------- 201
           H ++V L+G C      L++ E+   G L N L ++    +   T   I           
Sbjct: 104 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 163
Query: 202 -----AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV 256
                +   AKG+AFL  A    I+RD    NILL      K+ DFGLA+     SN  V
Sbjct: 164 DLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 221
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                    + APE I     T +SDV+S+G+ L EL +
Sbjct: 222 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKL--LDIEGLQGHREWLAEVIFLGQLRHPHL 156
           +GEG +G V+K        +  + + VA+K   LD E        + E+  L +L HP++
Sbjct: 29  VGEGTYGVVYKA-------KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG---TRLKIAI-GAAKGLAFL 212
           V LI     +    LV+EFM +        K++      G   +++KI +    +G+A  
Sbjct: 82  VSLIDVIHSERCLTLVFEFMEKD------LKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG--PEGSNTHVTTRVMGTYGYAAPE 270
           H  ++ +++RD K  N+L++SD   KL+DFGLA+    P  S TH       T  Y AP+
Sbjct: 136 H--QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPD 189
Query: 271 YI-STGHLTTKSDVYSFGVVLLELLTGR 297
            +  +   +T  D++S G +  E++TG+
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F TV         R+   ++  A+K+L+   +    +      E   
Sbjct: 9   EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 62
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +L HP  V+L     +DE+      +   G L  ++ ++I       TR   A     
Sbjct: 63  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 120
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L +LHG    +I+RD K  NILL+ D   +++DFG AK+    S        +GT  Y 
Sbjct: 121 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           +PE ++       SD+++ G ++ +L+ G
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 99  LGEGGFGTVHK----GYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL-AEVIFLGQL-R 152
           LG G FG V +    G I  D      A  VAVK+L        RE L +E+  L  L  
Sbjct: 54  LGAGAFGKVVEATAYGLIKSD-----AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 153 HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKI----------- 201
           H ++V L+G C      L++ E+   G L N L ++    +   T   I           
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 202 -----AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV 256
                +   AKG+AFL  A    I+RD    NILL      K+ DFGLA+     SN  V
Sbjct: 169 DLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 226
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                    + APE I     T +SDV+S+G+ L EL +
Sbjct: 227 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 132/285 (46%), Gaps = 34/285 (11%)
Query: 92  NFSSNYLLGEG-GFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA---EVIF 147
           + S  Y LGE  GFG + + ++  DLR     + VAVK+L  +  +    +L    E   
Sbjct: 9   HLSDRYELGEILGFGGMSEVHLARDLRLH---RDVAVKVLRADLARDPSFYLRFRREAQN 65
Query: 148 LGQLRHPHLVRLIGYCCEDEER------LLVYEFMPRGSLENHLFKRISVSLPWGTRLKI 201
              L HP +V +  Y   + E        +V E++   +L + +     ++      +++
Sbjct: 66  AAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA--IEV 121
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRV 260
              A + L F H  +N +I+RD K +NI++ +    K+ DFG+A+ +   G++   T  V
Sbjct: 122 IADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 261 MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR 320
           +GT  Y +PE      +  +SDVYS G VL E+LTG        P +  + V  A  ++R
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVR 233
Query: 321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAA 365
                    DP          + ++  + L+ ++ NP++R + AA
Sbjct: 234 E--------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA 270

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F TV         R+   ++  A+K+L+   +    +      E   
Sbjct: 10  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 63
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +L HP  V+L     +DE+      +   G L  ++ ++I       TR   A     
Sbjct: 64  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 121
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L +LHG    +I+RD K  NILL+ D   +++DFG AK+    S        +GT  Y 
Sbjct: 122 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           +PE ++       SD+++ G ++ +L+ G
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F TV         R+   ++  A+K+L+   +    +      E   
Sbjct: 8   EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 61
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +L HP  V+L     +DE+      +   G L  ++ ++I       TR   A     
Sbjct: 62  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 119
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L +LHG    +I+RD K  NILL+ D   +++DFG AK+    S        +GT  Y 
Sbjct: 120 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           +PE ++       SD+++ G ++ +L+ G
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F TV         R+   ++  A+K+L+   +    +      E   
Sbjct: 7   EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 60
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +L HP  V+L     +DE+      +   G L  ++ ++I       TR   A     
Sbjct: 61  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 118
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L +LHG    +I+RD K  NILL+ D   +++DFG AK+    S        +GT  Y 
Sbjct: 119 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           +PE ++       SD+++ G ++ +L+ G
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F TV         R+   ++  A+K+L+   +    +      E   
Sbjct: 33  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 86
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +L HP  V+L     +DE+      +   G L  ++ ++I       TR   A     
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 144
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGY 266
            L +LHG    +I+RD K  NILL+ D   +++DFG AK + PE       + V GT  Y
Sbjct: 145 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQY 201
Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            +PE ++       SD+++ G ++ +L+ G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIF 147
           ++F     LG+G FG V+        R+      +A+K+L    +E      +   EV  
Sbjct: 12  EDFDIGRPLGKGKFGNVYLA------RERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              LRHP+++RL GY  +     L+ E+ P G++   L +++S      T   I    A 
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSRFDEQRTATYIT-ELAN 123
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S+   K++DFG +   P          + GT  Y 
Sbjct: 124 ALSYCHSKR--VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----DTLCGTLDYL 177
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
            PE I       K D++S GV+  E L G
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 125/294 (42%), Gaps = 39/294 (13%)
Query: 99  LGEGGFGTVHKGYIDDD---LRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQL-R 152
           LG G FG V    I+ D   + +    + VAVK+L  EG     HR  ++E+  L  +  
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLK-EGATHSEHRALMSELKILIHIGH 89
Query: 153 HPHLVRLIGYCCEDEERLLV-YEFMPRGSLENHLFKRISVSLPWGTRLK----------I 201
           H ++V L+G C +    L+V  EF   G+L  +L  + +  +P+    K           
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
           +   AKG+ FL  A    I+RD    NILL      K+ DFGLA+   +  +        
Sbjct: 150 SFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDAR 207
Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS 321
               + APE I     T +SDV+SFGV+L E+ +   S     P     + +     L+ 
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFXRRLKE 262
Query: 322 SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
             R+R       A  Y+     EM    L C    P  RP  + +V  L +LL 
Sbjct: 263 GTRMR-------APDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLA 143
           +    +F    LLG+G FG V        +R+    +  A+K+L  E +    E    + 
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVT 57
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           E   L   RHP L  L  Y  +  +RL  V E+   G L  HL  R  V      R   A
Sbjct: 58  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGA 115
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
                 L +LH  +  V+YRD K  N++LD D   K++DFGL K G     T  T    G
Sbjct: 116 -EIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCG 170
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 171 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI----EGLQGHREWLAEVIFLGQLR-- 152
           +G G +GTV+K       R       VA+K + +    EGL      + EV  L +L   
Sbjct: 12  IGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGEEGLP--ISTVREVALLRRLEAF 63
Query: 153 -HPHLVRLIGYCCE---DEE--RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAA 206
            HP++VRL+  C     D E    LV+E + +  L  +L K     LP  T   +     
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +GL FLH   N +++RD K  NIL+ S  T KL+DFGLA++    S       V+ T  Y
Sbjct: 123 RGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALAPVVVTLWY 177
Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLELL 294
            APE +      T  D++S G +  E+ 
Sbjct: 178 RAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLA 143
           +    +F    LLG+G FG V        +R+    +  A+K+L  E +    E    + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVT 54
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           E   L   RHP L  L  Y  +  +RL  V E+   G L  HL  R  V      R   A
Sbjct: 55  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGA 112
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
                 L +LH  +  V+YRD K  N++LD D   K++DFGL K G     T  T    G
Sbjct: 113 -EIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCG 167
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 132/285 (46%), Gaps = 34/285 (11%)
Query: 92  NFSSNYLLGEG-GFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA---EVIF 147
           + S  Y LGE  GFG + + ++  DLR     + VAVK+L  +  +    +L    E   
Sbjct: 26  HLSDRYELGEILGFGGMSEVHLARDLRLH---RDVAVKVLRADLARDPSFYLRFRREAQN 82
Query: 148 LGQLRHPHLVRLIGYCCEDEER------LLVYEFMPRGSLENHLFKRISVSLPWGTRLKI 201
              L HP +V +  Y   + E        +V E++   +L + +     ++      +++
Sbjct: 83  AAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA--IEV 138
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRV 260
              A + L F H  +N +I+RD K +NI++ +    K+ DFG+A+ +   G++   T  V
Sbjct: 139 IADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 196
Query: 261 MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR 320
           +GT  Y +PE      +  +SDVYS G VL E+LTG        P +  + V  A  ++R
Sbjct: 197 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVR 250
Query: 321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAA 365
                    DP          + ++  + L+ ++ NP++R + AA
Sbjct: 251 E--------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA 287

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 99  LGEGGFGTVHKGY---IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL--RH 153
           LGEG FG V       ID D  +  +A  VAVK+L  +  +     L   + + ++  +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKD--KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------------- 200
            +++ L+G C +D    ++ E+  +G+L  +L  R    + +   +              
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 201 -IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
                 A+G+ +L  A    I+RD    N+L+  +   K++DFGLA+          TT 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V+K       +    +   A K++D +  +   +++ E+  L    HP++V+
Sbjct: 45  LGDGAFGKVYKA------QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L+     +    ++ EF   G+++  + + +   L       +       L +LH  +N 
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLH--DNK 155
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR---VMGTYGYAAPEYISTG 275
           +I+RD K  NIL   D   KL+DFG++       NT    R    +GT  + APE +   
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCE 210
Query: 276 H-----LTTKSDVYSFGVVLLELLTGRRSMDKLRP 305
                    K+DV+S G+ L+E+        +L P
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 245

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLA-EVIFLGQLRHPH 155
            LG+GGF    +   D D ++    + V   LL    L+ H RE ++ E+     L H H
Sbjct: 46  FLGKGGFAKCFE-ISDADTKEVFAGKIVPKSLL----LKPHQREKMSMEISIHRSLAHQH 100
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +V   G+  +++   +V E   R SL     +R +++ P        I    G  +LH  
Sbjct: 101 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI--VLGCQYLH-- 156
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            N VI+RD K  N+ L+ D   K+ DFGLA K+  +G    V   + GT  Y APE +S 
Sbjct: 157 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSK 213
Query: 275 GHLTTKSDVYSFGVVLLELLTGR 297
              + + DV+S G ++  LL G+
Sbjct: 214 KGHSFEVDVWSIGCIMYTLLVGK 236

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLA-EVIFLGQLRHPH 155
            LG+GGF    +   D D ++    + V   LL    L+ H RE ++ E+     L H H
Sbjct: 48  FLGKGGFAKCFE-ISDADTKEVFAGKIVPKSLL----LKPHQREKMSMEISIHRSLAHQH 102
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +V   G+  +++   +V E   R SL     +R +++ P        I    G  +LH  
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI--VLGCQYLH-- 158
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            N VI+RD K  N+ L+ D   K+ DFGLA K+  +G    V   + GT  Y APE +S 
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSK 215
Query: 275 GHLTTKSDVYSFGVVLLELLTGR 297
              + + DV+S G ++  LL G+
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGK 238

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 10/202 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +GEG +G V   Y  D +R   K +    K+   E     +  L E+  L + RH +++ 
Sbjct: 51  IGEGAYGMVSSAY--DHVR---KTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIG 105
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRI-SVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +           +   ++ +  +E  L+K + S  L             +GL ++H A  
Sbjct: 106 IRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN- 164
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGSNTHVTTRVMGTYGYAAPEYISTGH 276
            V++RD K SN+L+++    K+ DFGLA++  PE  +T   T  + T  Y APE +    
Sbjct: 165 -VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSK 223
Query: 277 LTTKS-DVYSFGVVLLELLTGR 297
             TKS D++S G +L E+L+ R
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNR 245

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 120/295 (40%), Gaps = 53/295 (17%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +F    L+G GGFG V K       +  +  +   +K +     +  RE  A    L +L
Sbjct: 12  DFKEIELIGSGGFGQVFKA------KHRIDGKTYVIKRVKYNNEKAEREVKA----LAKL 61
Query: 152 RHPHLVRLIG------YCCEDEER----------LLVYEFMPRGSLENHLFKRISVSLPW 195
            H ++V   G      Y  E   +           +  EF  +G+LE  + KR    L  
Sbjct: 62  DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 196 GTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH 255
              L++     KG+ ++H  +  +I RD K SNI L      K+ DFGL        N  
Sbjct: 122 VLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLV---TSLKNDG 176
Query: 256 VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA 315
              R  GT  Y +PE IS+     + D+Y+ G++L ELL               ++ D A
Sbjct: 177 KRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---------------HVCDTA 221
Query: 316 KPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL 370
                +S   ++  D R      +   KE  +L  + +S  P+DRP  + ++ TL
Sbjct: 222 ---FETS---KFFTDLRDGIISDIFDKKEKTLLQ-KLLSKKPEDRPNTSEILRTL 269

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 94/215 (43%), Gaps = 17/215 (7%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLA 143
           +    +F    LLG+G FG V        +R+    +  A+K+L  E +    E    + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVT 54
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           E   L   RHP L  L  Y  +  +RL  V E+   G L  HL +    +          
Sbjct: 55  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I +A  L +LH  +  V+YRD K  N++LD D   K++DFGL K G     T  T    G
Sbjct: 114 IVSA--LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCG 167
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI----EGLQG-HREWLAEVIFLGQLR 152
            LGEG F TV+K       R     Q VA+K + +    E   G +R  L E+  L +L 
Sbjct: 17  FLGEGQFATVYKA------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 153 HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
           HP+++ L+          LV++FM    LE  + K  S+ L         +   +GL +L
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFM-ETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
           H  ++ +++RD K +N+LLD +   KL+DFGLAK    GS        + T  Y APE +
Sbjct: 129 H--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYXHQVVTRWYRAPELL 184
Query: 273 STGHLT-TKSDVYSFGVVLLELL 294
               +     D+++ G +L ELL
Sbjct: 185 FGARMYGVGVDMWAVGCILAELL 207

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI----EGLQGHREWLAEVIFLGQLR-- 152
           +G G +GTV+K       R       VA+K + +    EGL      + EV  L +L   
Sbjct: 12  IGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGEEGLP--ISTVREVALLRRLEAF 63
Query: 153 -HPHLVRLIGYCCE---DEE--RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAA 206
            HP++VRL+  C     D E    LV+E + +  L  +L K     LP  T   +     
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +GL FLH   N +++RD K  NIL+ S  T KL+DFGLA++    S       V+ T  Y
Sbjct: 123 RGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALDPVVVTLWY 177
Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLELL 294
            APE +      T  D++S G +  E+ 
Sbjct: 178 RAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 15/210 (7%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F TV         R+   ++  A+K+L+   +    +      E   
Sbjct: 30  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 83
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +L HP  V+L     +DE+      +   G L  ++ ++I       TR   A     
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 141
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGY 266
            L +LHG    +I+RD K  NILL+ D   +++DFG AK + PE         V GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV-GTAQY 198
Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            +PE ++       SD+++ G ++ +L+ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F TV         R+   ++  A+K+L+   +    +      E   
Sbjct: 29  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 82
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +L HP  V+L     +DE+      +   G L  ++ ++I       TR   A     
Sbjct: 83  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 140
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGY 266
            L +LHG    +I+RD K  NILL+ D   +++DFG AK + PE       + V GT  Y
Sbjct: 141 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQY 197
Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            +PE ++       SD+++ G ++ +L+ G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F TV         R+   ++  A+K+L+   +    +      E   
Sbjct: 30  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 83
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +L HP  V+L     +DE+      +   G L  ++ ++I       TR   A     
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 141
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L +LHG    +I+RD K  NILL+ D   +++DFG AK+    S        +GT  Y 
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           +PE ++       SD+++ G ++ +L+ G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F TV         R+   ++  A+K+L+   +    +      E   
Sbjct: 30  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 83
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +L HP  V+L     +DE+      +   G L  ++ ++I       TR   A     
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 141
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L +LHG    +I+RD K  NILL+ D   +++DFG AK+    S        +GT  Y 
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           +PE ++       SD+++ G ++ +L+ G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F TV         R+   ++  A+K+L+   +    +      E   
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +L HP  V+L     +DE+      +   G L  ++ ++I       TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 143
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L +LHG    +I+RD K  NILL+ D   +++DFG AK+    S        +GT  Y 
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           +PE ++       SD+++ G ++ +L+ G
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 125/296 (42%), Gaps = 41/296 (13%)
Query: 99  LGEGGFGTVHKGYIDDD---LRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQL-R 152
           LG G FG V    I+ D   + +    + VAVK+L  EG     HR  ++E+  L  +  
Sbjct: 37  LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLK-EGATHSEHRALMSELKILIHIGH 91
Query: 153 HPHLVRLIGYCCEDEERLLV-YEFMPRGSLENHLFKRISVSLPWGTR------------L 199
           H ++V L+G C +    L+V  EF   G+L  +L  + +  +P+               +
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
             +   AKG+ FL  A    I+RD    NILL      K+ DFGLA+   +  +      
Sbjct: 152 XYSFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYL 319
                 + APE I     T +SDV+SFGV+L E+ +   S     P     + +     L
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRRL 264
Query: 320 RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           +   R+R       A  Y+     EM    L C    P  RP  + +V  L +LL 
Sbjct: 265 KEGTRMR-------APDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 125/294 (42%), Gaps = 39/294 (13%)
Query: 99  LGEGGFGTVHKGYIDDD---LRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQL-R 152
           LG G FG V    I+ D   + +    + VAVK+L  EG     HR  ++E+  L  +  
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLK-EGATHSEHRALMSELKILIHIGH 89
Query: 153 HPHLVRLIGYCCEDEERLLV-YEFMPRGSLENHLFKRISVSLPWGTRLK----------I 201
           H ++V L+G C +    L+V  EF   G+L  +L  + +  +P+    K           
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
           +   AKG+ FL  A    I+RD    NILL      K+ DFGLA+   +  +        
Sbjct: 150 SFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 207
Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS 321
               + APE I     T +SDV+SFGV+L E+ +   S     P     + +     L+ 
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRRLKE 262
Query: 322 SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
             R+R       A  Y+     EM    L C    P  RP  + +V  L +LL 
Sbjct: 263 GTRMR-------APDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F TV         R+   ++  A+K+L+   +    +      E   
Sbjct: 14  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 67
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +L HP  V+L     +DE+      +   G L  ++ ++I       TR   A     
Sbjct: 68  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 125
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L +LHG    +I+RD K  NILL+ D   +++DFG AK+    S        +GT  Y 
Sbjct: 126 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           +PE ++       SD+++ G ++ +L+ G
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F TV         R+   ++  A+K+L+   +    +      E   
Sbjct: 33  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 86
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +L HP  V+L     +DE+      +   G L  ++ ++I       TR   A     
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 144
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L +LHG    +I+RD K  NILL+ D   +++DFG AK+    S        +GT  Y 
Sbjct: 145 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 202
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           +PE ++       SD+++ G ++ +L+ G
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F TV         R+   ++  A+K+L+   +    +      E   
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +L HP  V+L     +DE+      +   G L  ++ ++I       TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 143
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L +LHG    +I+RD K  NILL+ D   +++DFG AK+    S        +GT  Y 
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           +PE ++       SD+++ G ++ +L+ G
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F TV         R+   ++  A+K+L+   +    +      E   
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +L HP  V+L     +DE+      +   G L  ++ ++I       TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 143
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L +LHG    +I+RD K  NILL+ D   +++DFG AK+    S        +GT  Y 
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           +PE ++       SD+++ G ++ +L+ G
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V+K       +    +   A K++D +  +   +++ E+  L    HP++V+
Sbjct: 45  LGDGAFGKVYKA------QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L+     +    ++ EF   G+++  + + +   L       +       L +LH  +N 
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLH--DNK 155
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR---VMGTYGYAAPEYISTG 275
           +I+RD K  NIL   D   KL+DFG++       NT    R    +GT  + APE +   
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRXIQRRDSFIGTPYWMAPEVVMCE 210
Query: 276 H-----LTTKSDVYSFGVVLLELLTGRRSMDKLRP 305
                    K+DV+S G+ L+E+        +L P
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 245

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V+K       +    +   A K++D +  +   +++ E+  L    HP++V+
Sbjct: 45  LGDGAFGKVYKA------QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L+     +    ++ EF   G+++  + + +   L       +       L +LH  +N 
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNYLH--DNK 155
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR---VMGTYGYAAPEYISTG 275
           +I+RD K  NIL   D   KL+DFG++       NT    R    +GT  + APE +   
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRXIQRRDXFIGTPYWMAPEVVMCE 210
Query: 276 H-----LTTKSDVYSFGVVLLELLTGRRSMDKLRP 305
                    K+DV+S G+ L+E+        +L P
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 245

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL-AEVIFLGQL-RHPHL 156
           LG G FG V +      L +      VAVK+L        +E L +E+  +  L +H ++
Sbjct: 39  LGAGAFGKVVEA-TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 97
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSL-------------------PWGT 197
           V L+G C      L++ E+   G L N L ++    L                   P   
Sbjct: 98  VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLEL 157
Query: 198 R--LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH 255
           R  L  +   A+G+AFL  A    I+RD    N+LL +   AK+ DFGLA+     SN  
Sbjct: 158 RDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 215
Query: 256 VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
           V         + APE I     T +SDV+S+G++L E+ +
Sbjct: 216 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F TV         R+   ++  A+K+L+   +    +      E   
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +L HP  V+L     +DE+      +   G L  ++ ++I       TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 143
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L +LHG    +I+RD K  NILL+ D   +++DFG AK+    S        +GT  Y 
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           +PE ++       SD+++ G ++ +L+ G
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 99  LGEGGFGTVHKGY---IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL--RH 153
           LGEG FG V       ID D  +  +A  VAVK+L  +  +     L   + + ++  +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKD--KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKR--------------ISVSLPWGTRL 199
            +++ L+G C +D    ++ E+  +G+L  +L  R                  + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
                 A+G+ +L  A    I+RD    N+L+  +   K++DFGLA+          TT 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI----EGLQGHREWLAEVIFLGQLR-- 152
           +G G +GTV+K       R       VA+K + +    EGL      + EV  L +L   
Sbjct: 12  IGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGEEGLP--ISTVREVALLRRLEAF 63
Query: 153 -HPHLVRLIGYCCE---DEE--RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAA 206
            HP++VRL+  C     D E    LV+E + +  L  +L K     LP  T   +     
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +GL FLH   N +++RD K  NIL+ S  T KL+DFGLA++    S       V+ T  Y
Sbjct: 123 RGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALFPVVVTLWY 177
Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLELL 294
            APE +      T  D++S G +  E+ 
Sbjct: 178 RAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F TV         R+   ++  A+K+L+   +    +      E   
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +L HP  V+L     +DE+      +   G L  ++ ++I       TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 143
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L +LHG    +I+RD K  NILL+ D   +++DFG AK+    S        +GT  Y 
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           +PE ++       SD+++ G ++ +L+ G
Sbjct: 202 SPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLA-EVIFLGQLRHPH 155
            LG+GGF    +   D D ++    + V   LL    L+ H RE ++ E+     L H H
Sbjct: 22  FLGKGGFAKCFE-ISDADTKEVFAGKIVPKSLL----LKPHQREKMSMEISIHRSLAHQH 76
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +V   G+  +++   +V E   R SL     +R +++ P        I    G  +LH  
Sbjct: 77  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI--VLGCQYLH-- 132
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            N VI+RD K  N+ L+ D   K+ DFGLA K+  +G    V   + GT  Y APE +S 
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSK 189
Query: 275 GHLTTKSDVYSFGVVLLELLTGR 297
              + + DV+S G ++  LL G+
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGK 212

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F TV         R+   ++  A+K+L+   +    +      E   
Sbjct: 35  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 88
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +L HP  V+L     +DE+      +   G L  ++ ++I       TR   A     
Sbjct: 89  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 146
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L +LHG    +I+RD K  NILL+ D   +++DFG AK+    S        +GT  Y 
Sbjct: 147 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 204
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           +PE ++       SD+++ G ++ +L+ G
Sbjct: 205 SPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F TV         R+   ++  A+K+L+   +    +      E   
Sbjct: 29  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 82
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +L HP  V+L     +DE+      +   G L  ++ ++I       TR   A     
Sbjct: 83  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 140
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L +LHG    +I+RD K  NILL+ D   +++DFG AK+    S        +GT  Y 
Sbjct: 141 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           +PE ++       SD+++ G ++ +L+ G
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 125/298 (41%), Gaps = 43/298 (14%)
Query: 99  LGEGGFGTVHKGYIDDD---LRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQL-R 152
           LG G FG V    I+ D   + +    + VAVK+L  EG     HR  ++E+  L  +  
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGH 80
Query: 153 HPHLVRLIGYCCEDEERLLVY-EFMPRGSLENHLFKRISVSLPWGTR------------- 198
           H ++V L+G C +    L+V  EF   G+L  +L  + +  +P+                
Sbjct: 81  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 199 -LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT 257
            +  +   AKG+ FL  A    I+RD    NILL      K+ DFGLA+   +  +    
Sbjct: 141 LICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 258 TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP 317
                   + APE I     T +SDV+SFGV+L E+ +   S     P     + +    
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCR 253
Query: 318 YLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            L+   R+R       A  Y+     EM    L C    P  RP  + +V  L +LL 
Sbjct: 254 RLKEGTRMR-------APDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 17/215 (7%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLA 143
           +    +F    LLG+G FG V        +R+    +  A+K+L  E +    E    + 
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVT 59
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           E   L   RHP L  L  Y  +  +RL  V E+   G L  HL +    +          
Sbjct: 60  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 118
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I +A  L +LH  +  V+YRD K  N++LD D   K++DFGL K G   S+        G
Sbjct: 119 IVSA--LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKXFCG 172
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 114/258 (44%), Gaps = 43/258 (16%)
Query: 91  QNFSSNYL-LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLG 149
           +++  N++ +GEG  G V    +          + VAVK +D+   Q       EV+ + 
Sbjct: 150 RSYLDNFIKIGEGSTGIVCIATVRSS------GKLVAVKKMDLRKQQRRELLFNEVVIMR 203
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------IAI 203
             +H ++V +       +E  +V EF+  G+L + +           TR+       + +
Sbjct: 204 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCL 254
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR--VM 261
              + L+ LH     VI+RD K+ +ILL  D   KLSDFG         +  V  R  ++
Sbjct: 255 AVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQ----VSKEVPRRKXLV 308
Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS 321
           GT  + APE IS      + D++S G++++E++ G                 + +P L++
Sbjct: 309 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKA 355
Query: 322 SRRLRYIVDPRLAGQYSV 339
            + +R  + PRL   + V
Sbjct: 356 MKMIRDNLPPRLKNLHKV 373

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLA 143
           +    +F    LLG+G FG V        +R+    +  A+K+L  E +    E    + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVT 54
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           E   L   RHP L  L  Y  +  +RL  V E+   G L  HL  R  V      R   A
Sbjct: 55  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGA 112
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
                 L +LH  +  V+YRD K  N++LD D   K++DFGL K G   S+        G
Sbjct: 113 -EIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKXFCG 167
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 125/298 (41%), Gaps = 43/298 (14%)
Query: 99  LGEGGFGTVHKGYIDDD---LRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQL-R 152
           LG G FG V    I+ D   + +    + VAVK+L  EG     HR  ++E+  L  +  
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGH 80
Query: 153 HPHLVRLIGYCCEDEERLLVY-EFMPRGSLENHLFKRISVSLPWGTR------------- 198
           H ++V L+G C +    L+V  EF   G+L  +L  + +  +P+                
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 199 -LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT 257
            +  +   AKG+ FL  A    I+RD    NILL      K+ DFGLA+   +  +    
Sbjct: 141 LICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 258 TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP 317
                   + APE I     T +SDV+SFGV+L E+ +   S     P     + +    
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCR 253
Query: 318 YLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            L+   R+R       A  Y+     EM    L C    P  RP  + +V  L +LL 
Sbjct: 254 RLKEGTRMR-------APDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 125/298 (41%), Gaps = 43/298 (14%)
Query: 99  LGEGGFGTVHKGYIDDD---LRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQL-R 152
           LG G FG V    I+ D   + +    + VAVK+L  EG     HR  ++E+  L  +  
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGH 89
Query: 153 HPHLVRLIGYCCEDEERLLV-YEFMPRGSLENHLFKRISVSLPWGTR------------- 198
           H ++V L+G C +    L+V  EF   G+L  +L  + +  +P+                
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 199 -LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT 257
            +  +   AKG+ FL  A    I+RD    NILL      K+ DFGLA+   +  +    
Sbjct: 150 LICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 258 TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP 317
                   + APE I     T +SDV+SFGV+L E+ +   S     P     + +    
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCR 262
Query: 318 YLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            L+   R+R       A  Y+     EM    L C    P  RP  + +V  L +LL 
Sbjct: 263 RLKEGTRMR-------APDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 99  LGEGGFGTVHKGY---IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL--RH 153
           LGEG FG V       ID D  +  +A  VAVK+L  +  +     L   + + ++  +H
Sbjct: 89  LGEGCFGQVVMAEAVGIDKD--KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------------- 200
            +++ L+G C +D    ++ E+  +G+L  +L  R    + +   +              
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 201 -IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
                 A+G+ +L  A    I+RD    N+L+  +   K++DFGLA+          TT 
Sbjct: 207 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 13/226 (5%)
Query: 75  GPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG 134
           GP++   Q+ ++     N S    +GEG +G V   Y  D+L    K +    K+   E 
Sbjct: 14  GPEMVRGQVFDVGPRYTNLS---YIGEGAYGMVCSAY--DNLN---KVRVAIKKISPFEH 65
Query: 135 LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-L 193
               +  L E+  L + RH +++ +           +   ++ +  +E  L+K +    L
Sbjct: 66  QTYXQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL 125
Query: 194 PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGS 252
                        +GL ++H A   V++RD K SN+LL++    K+ DFGLA++  P+  
Sbjct: 126 SNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHD 183
Query: 253 NTHVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
           +T   T  + T  Y APE +      TKS D++S G +L E+L+ R
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 17/215 (7%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLA 143
           +    +F    LLG+G FG V        +R+    +  A+K+L  E +    E    + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVT 54
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           E   L   RHP L  L  Y  +  +RL  V E+   G L  HL +    +          
Sbjct: 55  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I +A  L +LH  +  V+YRD K  N++LD D   K++DFGL K G   S+        G
Sbjct: 114 IVSA--LEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKXFCG 167
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 99  LGEGGFGTVHKGY---IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL--RH 153
           LGEG FG V       ID D  +  +A  VAVK+L  +  +     L   + + ++  +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKD--KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------------- 200
            +++ L+G C +D    ++ E+  +G+L  +L  R    + +   +              
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 201 -IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
                 A+G+ +L  A    I+RD    N+L+  +   K++DFGLA+          TT 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTN 218
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 99  LGEGGFGTVHKGY---IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL--RH 153
           LGEG FG V       ID D  +  +A  VAVK+L  +  +     L   + + ++  +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKD--KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------------- 200
            +++ L+G C +D    ++ E+  +G+L  +L  R    + +   +              
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 201 -IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
                 A+G+ +L  A    I+RD    N+L+  +   K++DFGLA+          TT 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLA 143
           +    +F    LLG+G FG V        +R+    +  A+K+L  E +    E    + 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVT 54
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           E   L   RHP L  L  Y  +  +RL  V E+   G L  HL  R  V      R   A
Sbjct: 55  ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGA 112
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
                 L +LH  +  V+YRD K  N++LD D   K++DFGL K G   S+        G
Sbjct: 113 -EIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKXFCG 167
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           T  Y APE +         D +  GVV+ E++ GR
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 105/220 (47%), Gaps = 27/220 (12%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--------GH 138
           +A   +F    +LG+G FG V   ++   + +       A+K+L    L+          
Sbjct: 24  KADPSHFELLKVLGQGSFGKV---FLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKME 80
Query: 139 REWLAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGT 197
           R+ LA+V       HP +V+L  Y  + E +L L+ +F+  G L   L K +  +     
Sbjct: 81  RDILADV------NHPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT---EE 130
Query: 198 RLKIAIGA-AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV 256
            +K  +   A GL  LH     +IYRD K  NILLD +   KL+DFGL+K   +      
Sbjct: 131 DVKFYLAELALGLDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAY 188
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           +    GT  Y APE ++    +  +D +S+GV++ E+LTG
Sbjct: 189 S--FCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  G       +      VA+K++  EG     E++ E   +  L H  LV+
Sbjct: 32  LGTGQFGVVKYG-------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G C +     ++ E+M  G L N+L + +         L++     + + +L   +  
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQ-- 140
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
            ++RD    N L++     K+SDFGL++   +   T           ++ PE +     +
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPV-RWSPPEVLMYSKFS 199
Query: 279 TKSDVYSFGVVLLELLT 295
           +KSD+++FGV++ E+ +
Sbjct: 200 SKSDIWAFGVLMWEIYS 216

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 99  LGEGGFGTVHKGY---IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL--RH 153
           LGEG FG V       ID D  +  +A  VAVK+L  +  +     L   + + ++  +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKD--KPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------------- 200
            +++ L+G C +D    ++ E+  +G+L  +L  R    + +   +              
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 201 -IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
                 A+G+ +L  A    I+RD    N+L+  +   K++DFGLA+          TT 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 120/292 (41%), Gaps = 41/292 (14%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLK-AQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LGEGGF  V       DL +GL      A+K +     Q   E   E        HP+++
Sbjct: 37  LGEGGFSYV-------DLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 158 RLIGYCCED----EERLLVYEFMPRGSLENHL--FKRISVSLPWGTRLKIAIGAAKGLAF 211
           RL+ YC  +     E  L+  F  RG+L N +   K     L     L + +G  +GL  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFG---LAKMGPEGSNTHVTTRVMG----TY 264
           +H       +RD K +NILL  +    L D G    A +  EGS   +T +       T 
Sbjct: 150 IHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 265 GYAAPEYISTGH---LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS 321
            Y APE  S      +  ++DV+S G VL  ++ G    D +  K +             
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS------------ 255
Query: 322 SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
              +   V  +L+   S + +  +  L    ++V+P  RP +  +++ LE+L
Sbjct: 256 ---VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 13/226 (5%)
Query: 75  GPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG 134
           GP++   Q+ ++     N S    +GEG +G V   Y  D+L    K +    K+   E 
Sbjct: 14  GPEMVRGQVFDVGPRYTNLS---YIGEGAYGMVCSAY--DNLN---KVRVAIKKISPFEH 65
Query: 135 LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-L 193
               +  L E+  L + RH +++ +           +   ++ +  +E  L+K +    L
Sbjct: 66  QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHL 125
Query: 194 PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGS 252
                        +GL ++H A   V++RD K SN+LL++    K+ DFGLA++  P+  
Sbjct: 126 SNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 253 NTHVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
           +T   T  + T  Y APE +      TKS D++S G +L E+L+ R
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 99  LGEGGFGTVHKGY---IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL--RH 153
           LGEG FG V       ID D  +  +A  VAVK+L  +  +     L   + + ++  +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKD--KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------------- 200
            +++ L+G C +D    ++ E+  +G+L  +L  R    + +   +              
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 201 -IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
                 A+G+ +L  A    I+RD    N+L+  +   K++DFGLA+          TT 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 13/226 (5%)
Query: 75  GPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG 134
           GP++   Q+ ++     N S    +GEG +G V   Y  D+L    K +    K+   E 
Sbjct: 14  GPEMVRGQVFDVGPRYTNLS---YIGEGAYGMVCSAY--DNLN---KVRVAIKKISPFEH 65
Query: 135 LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-L 193
               +  L E+  L + RH +++ +           +   ++ +  +E  L+K +    L
Sbjct: 66  QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL 125
Query: 194 PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGS 252
                        +GL ++H A   V++RD K SN+LL++    K+ DFGLA++  P+  
Sbjct: 126 SNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHD 183
Query: 253 NTHVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
           +T   T  + T  Y APE +      TKS D++S G +L E+L+ R
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/308 (24%), Positives = 123/308 (39%), Gaps = 66/308 (21%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +F    L+G GGFG V K       +  +  +   ++ +     +  RE  A    L +L
Sbjct: 13  DFKEIELIGSGGFGQVFKA------KHRIDGKTYVIRRVKYNNEKAEREVKA----LAKL 62
Query: 152 RHPHLVRLIG--------------------YCCEDEER---------LLVYEFMPRGSLE 182
            H ++V   G                    Y  E+ +           +  EF  +G+LE
Sbjct: 63  DHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLE 122
Query: 183 NHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF 242
             + KR    L     L++     KG+ ++H  +  +I+RD K SNI L      K+ DF
Sbjct: 123 QWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LIHRDLKPSNIFLVDTKQVKIGDF 180
Query: 243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDK 302
           GL        N    TR  GT  Y +PE IS+     + D+Y+ G++L ELL        
Sbjct: 181 GLV---TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL-------- 229
Query: 303 LRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK 362
                  ++ D A     +S   ++  D R      +   KE  +L  + +S  P+DRP 
Sbjct: 230 -------HVCDTA---FETS---KFFTDLRDGIISDIFDKKEKTLLQ-KLLSKKPEDRPN 275
Query: 363 MAAVVATL 370
            + ++ TL
Sbjct: 276 TSEILRTL 283

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 125/298 (41%), Gaps = 43/298 (14%)
Query: 99  LGEGGFGTVHKGYIDDD---LRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQL-R 152
           LG G FG V    I+ D   + +    + VAVK+L  EG     HR  ++E+  L  +  
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGH 89
Query: 153 HPHLVRLIGYCCEDEERLLV-YEFMPRGSLENHLFKRISVSLPWGTR------------- 198
           H ++V L+G C +    L+V  EF   G+L  +L  + +  +P+                
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 199 -LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT 257
            +  +   AKG+ FL  A    I+RD    NILL      K+ DFGLA+   +  +    
Sbjct: 150 LICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRK 207
Query: 258 TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP 317
                   + APE I     T +SDV+SFGV+L E+ +   S     P     + +    
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCR 262
Query: 318 YLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            L+   R+R       A  Y+     EM    L C    P  RP  + +V  L +LL 
Sbjct: 263 RLKEGTRMR-------APDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 13/226 (5%)
Query: 75  GPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG 134
           GP++   Q+ ++     N S    +GEG +G V   Y  D+L    K +    K+   E 
Sbjct: 15  GPEMVRGQVFDVGPRYTNLS---YIGEGAYGMVCSAY--DNLN---KVRVAIKKISPFEH 66
Query: 135 LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-L 193
               +  L E+  L + RH +++ +           +   ++ +  +E  L+K +    L
Sbjct: 67  QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL 126
Query: 194 PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGS 252
                        +GL ++H A   V++RD K SN+LL++    K+ DFGLA++  P+  
Sbjct: 127 SNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 184
Query: 253 NTHVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
           +T   T  + T  Y APE +      TKS D++S G +L E+L+ R
Sbjct: 185 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 13/226 (5%)
Query: 75  GPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG 134
           GP++   Q+ ++     N S    +GEG +G V   Y  D+L    K +    K+   E 
Sbjct: 16  GPEMVRGQVFDVGPRYTNLS---YIGEGAYGMVCSAY--DNLN---KVRVAIKKISPFEH 67
Query: 135 LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-L 193
               +  L E+  L + RH +++ +           +   ++ +  +E  L+K +    L
Sbjct: 68  QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL 127
Query: 194 PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGS 252
                        +GL ++H A   V++RD K SN+LL++    K+ DFGLA++  P+  
Sbjct: 128 SNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 185
Query: 253 NTHVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
           +T   T  + T  Y APE +      TKS D++S G +L E+L+ R
Sbjct: 186 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 13/226 (5%)
Query: 75  GPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG 134
           GP++   Q+ ++     N S    +GEG +G V   Y  D+L    K +    K+   E 
Sbjct: 7   GPEMVRGQVFDVGPRYTNLS---YIGEGAYGMVCSAY--DNLN---KVRVAIKKISPFEH 58
Query: 135 LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-L 193
               +  L E+  L + RH +++ +           +   ++ +  +E  L+K +    L
Sbjct: 59  QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL 118
Query: 194 PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGS 252
                        +GL ++H A   V++RD K SN+LL++    K+ DFGLA++  P+  
Sbjct: 119 SNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 176
Query: 253 NTHVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
           +T   T  + T  Y APE +      TKS D++S G +L E+L+ R
Sbjct: 177 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 13/226 (5%)
Query: 75  GPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG 134
           GP++   Q+ ++     N S    +GEG +G V   Y  D+L    K +    K+   E 
Sbjct: 14  GPEMVRGQVFDVGPRYTNLS---YIGEGAYGMVCSAY--DNLN---KVRVAIKKISPFEH 65
Query: 135 LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-L 193
               +  L E+  L + RH +++ +           +   ++ +  +E  L+K +    L
Sbjct: 66  QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL 125
Query: 194 PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGS 252
                        +GL ++H A   V++RD K SN+LL++    K+ DFGLA++  P+  
Sbjct: 126 SNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 253 NTHVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
           +T   T  + T  Y APE +      TKS D++S G +L E+L+ R
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  G       +      VA+K++  EG     E++ E   +  L H  LV+
Sbjct: 12  LGTGQFGVVKYG-------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G C +     ++ E+M  G L N+L + +         L++     + + +L   +  
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQ-- 120
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
            ++RD    N L++     K+SDFGL++   +   T           ++ PE +     +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFS 179
Query: 279 TKSDVYSFGVVLLELLT 295
           +KSD+++FGV++ E+ +
Sbjct: 180 SKSDIWAFGVLMWEIYS 196

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 13/226 (5%)
Query: 75  GPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG 134
           GP++   Q+ ++     N S    +GEG +G V   Y  D+L    K +    K+   E 
Sbjct: 8   GPEMVRGQVFDVGPRYTNLS---YIGEGAYGMVCSAY--DNLN---KVRVAIKKISPFEH 59
Query: 135 LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-L 193
               +  L E+  L + RH +++ +           +   ++ +  +E  L+K +    L
Sbjct: 60  QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL 119
Query: 194 PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGS 252
                        +GL ++H A   V++RD K SN+LL++    K+ DFGLA++  P+  
Sbjct: 120 SNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 177
Query: 253 NTHVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
           +T   T  + T  Y APE +      TKS D++S G +L E+L+ R
Sbjct: 178 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 13/226 (5%)
Query: 75  GPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG 134
           GP++   Q+ ++     N S    +GEG +G V   Y  D+L    K +    K+   E 
Sbjct: 14  GPEMVRGQVFDVGPRYTNLS---YIGEGAYGMVCSAY--DNLN---KVRVAIRKISPFEH 65
Query: 135 LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-L 193
               +  L E+  L + RH +++ +           +   ++ +  +E  L+K +    L
Sbjct: 66  QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL 125
Query: 194 PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGS 252
                        +GL ++H A   V++RD K SN+LL++    K+ DFGLA++  P+  
Sbjct: 126 SNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 253 NTHVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
           +T   T  + T  Y APE +      TKS D++S G +L E+L+ R
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 13/226 (5%)
Query: 75  GPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG 134
           GP++   Q+ ++     N S    +GEG +G V   Y  D+L    K +    K+   E 
Sbjct: 8   GPEMVRGQVFDVGPRYTNLS---YIGEGAYGMVCSAY--DNLN---KVRVAIKKISPFEH 59
Query: 135 LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-L 193
               +  L E+  L + RH +++ +           +   ++ +  +E  L+K +    L
Sbjct: 60  QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL 119
Query: 194 PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGS 252
                        +GL ++H A   V++RD K SN+LL++    K+ DFGLA++  P+  
Sbjct: 120 SNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 177
Query: 253 NTHVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
           +T   T  + T  Y APE +      TKS D++S G +L E+L+ R
Sbjct: 178 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 99  LGEGGFGTVHKGY---IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL--RH 153
           LGEG FG V       ID D  +  +A  VAVK+L  +  +     L   + + ++  +H
Sbjct: 30  LGEGCFGQVVMAEAVGIDKD--KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------------- 200
            +++ L+G C +D    ++ E+  +G+L  +L  R    + +   +              
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 201 -IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
                 A+G+ +L  A    I+RD    N+L+  +   K++DFGLA+          TT 
Sbjct: 148 SCTYQLARGMEYL--ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 205
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 206 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 125/298 (41%), Gaps = 43/298 (14%)
Query: 99  LGEGGFGTVHKGYIDDD---LRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQL-R 152
           LG G FG V    I+ D   + +    + VAVK+L  EG     HR  ++E+  L  +  
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGH 80
Query: 153 HPHLVRLIGYCCEDEERLLVY-EFMPRGSLENHLFKRISVSLPWGTR------------- 198
           H ++V L+G C +    L+V  EF   G+L  +L  + +  +P+                
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 199 -LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT 257
            +  +   AKG+ FL  A    I+RD    NILL      K+ DFGLA+   +  +    
Sbjct: 141 LICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 258 TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP 317
                   + APE I     T +SDV+SFGV+L E+ +   S     P     + +    
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCR 253
Query: 318 YLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            L+   R+R       A  Y+     EM    L C    P  RP  + +V  L +LL 
Sbjct: 254 RLKEGTRMR-------APDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLA-EVIFLGQLRHPH 155
            LG+GGF    +   D D ++    + V   LL    L+ H RE ++ E+     L H H
Sbjct: 28  FLGKGGFAKCFE-ISDADTKEVFAGKIVPKSLL----LKPHQREKMSMEISIHRSLAHQH 82
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +V   G+  +++   +V E   R SL     +R +++ P        I    G  +LH  
Sbjct: 83  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI--VLGCQYLH-- 138
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            N VI+RD K  N+ L+ D   K+ DFGLA K+  +G        + GT  Y APE +S 
Sbjct: 139 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNYIAPEVLSK 195
Query: 275 GHLTTKSDVYSFGVVLLELLTGR 297
              + + DV+S G ++  LL G+
Sbjct: 196 KGHSFEVDVWSIGCIMYTLLVGK 218

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 125/298 (41%), Gaps = 43/298 (14%)
Query: 99  LGEGGFGTVHKGYIDDD---LRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQL-R 152
           LG G FG V    I+ D   + +    + VAVK+L  EG     HR  ++E+  L  +  
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGH 80
Query: 153 HPHLVRLIGYCCEDEERLLVY-EFMPRGSLENHLFKRISVSLPWGTR------------- 198
           H ++V L+G C +    L+V  EF   G+L  +L  + +  +P+                
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 199 -LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT 257
            +  +   AKG+ FL  A    I+RD    NILL      K+ DFGLA+   +  +    
Sbjct: 141 LICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 258 TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP 317
                   + APE I     T +SDV+SFGV+L E+ +   S     P     + +    
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCR 253
Query: 318 YLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            L+   R+R       A  Y+     EM    L C    P  RP  + +V  L +LL 
Sbjct: 254 RLKEGTRMR-------APDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  G       +      VA+K++  EG     E++ E   +  L H  LV+
Sbjct: 16  LGTGQFGVVKYG-------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 67
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G C +     ++ E+M  G L N+L + +         L++     + + +L   +  
Sbjct: 68  LYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQ-- 124
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
            ++RD    N L++     K+SDFGL++   +   T           ++ PE +     +
Sbjct: 125 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFS 183
Query: 279 TKSDVYSFGVVLLELLT 295
           +KSD+++FGV++ E+ +
Sbjct: 184 SKSDIWAFGVLMWEIYS 200

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 99  LGEGGFGTVHKGY---IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL--RH 153
           LGEG FG V       ID D  +  +A  VAVK+L  +  +     L   + + ++  +H
Sbjct: 35  LGEGCFGQVVMAEAVGIDKD--KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------------- 200
            +++ L+G C +D    ++ E+  +G+L  +L  R    + +   +              
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 201 -IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
                 A+G+ +L  A    I+RD    N+L+  +   K++DFGLA+          TT 
Sbjct: 153 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 210
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 211 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLA-EVIFLGQLRHPH 155
            LG+GGF    +   D D ++    + V   LL    L+ H RE ++ E+     L H H
Sbjct: 24  FLGKGGFAKCFE-ISDADTKEVFAGKIVPKSLL----LKPHQREKMSMEISIHRSLAHQH 78
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +V   G+  +++   +V E   R SL     +R +++ P        I    G  +LH  
Sbjct: 79  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI--VLGCQYLH-- 134
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            N VI+RD K  N+ L+ D   K+ DFGLA K+  +G        + GT  Y APE +S 
Sbjct: 135 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNYIAPEVLSK 191
Query: 275 GHLTTKSDVYSFGVVLLELLTGR 297
              + + DV+S G ++  LL G+
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 99  LGEGGFGTVHKGY---IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL--RH 153
           LGEG FG V       ID D  +  +A  VAVK+L  +  +     L   + + ++  +H
Sbjct: 32  LGEGCFGQVVMAEAVGIDKD--KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------------- 200
            +++ L+G C +D    ++ E+  +G+L  +L  R    + +   +              
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 201 -IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
                 A+G+ +L  A    I+RD    N+L+  +   K++DFGLA+          TT 
Sbjct: 150 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 207
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 208 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  G       +      VA+K++  EG     E++ E   +  L H  LV+
Sbjct: 32  LGTGQFGVVKYG-------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G C +     ++ E+M  G L N+L + +         L++     + + +L   +  
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQ-- 140
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
            ++RD    N L++     K+SDFGL++   +   T           ++ PE +     +
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFS 199
Query: 279 TKSDVYSFGVVLLELLT 295
           +KSD+++FGV++ E+ +
Sbjct: 200 SKSDIWAFGVLMWEIYS 216

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 115/257 (44%), Gaps = 41/257 (15%)
Query: 91  QNFSSNYL-LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLG 149
           +++  N++ +GEG  G V    +          + VAVK +D+   Q       EV+ + 
Sbjct: 28  RSYLDNFIKIGEGSTGIVCIATVRS------SGKLVAVKKMDLRKQQRRELLFNEVVIMR 81
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------IAI 203
             +H ++V +       +E  +V EF+  G+L + +           TR+       + +
Sbjct: 82  DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCL 132
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGSNTHVTTRVMG 262
              + L+ LH     VI+RD K+ +ILL  D   KLSDFG  A++  E         ++G
Sbjct: 133 AVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVG 187
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS 322
           T  + APE IS      + D++S G++++E++ G                 + +P L++ 
Sbjct: 188 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAM 234
Query: 323 RRLRYIVDPRLAGQYSV 339
           + +R  + PRL   + V
Sbjct: 235 KMIRDNLPPRLKNLHKV 251

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 90/209 (43%), Gaps = 19/209 (9%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIFL 148
           +F     LG+G FG V+        R+      VA+K+L    IE      +   E+   
Sbjct: 24  DFEIGRPLGKGKFGNVYLA------REKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQ 77
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
             L HP+++RL  Y  +     L+ E+ PRG L   L K  S +        I    A  
Sbjct: 78  AHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQK--SCTFDEQRTATIMEELADA 135
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM-GTYGYA 267
           L + HG +  VI+RD K  N+LL      K++DFG +   P      +  + M GT  Y 
Sbjct: 136 LMYCHGKK--VIHRDIKPENLLLGLKGELKIADFGWSVHAPS-----LRRKTMCGTLDYL 188
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
            PE I       K D++  GV+  ELL G
Sbjct: 189 PPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 125/298 (41%), Gaps = 43/298 (14%)
Query: 99  LGEGGFGTVHKGYIDDD---LRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQL-R 152
           LG G FG V    I+ D   + +    + VAVK+L  EG     HR  ++E+  L  +  
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGH 89
Query: 153 HPHLVRLIGYCCEDEERLLVY-EFMPRGSLENHLFKRISVSLPWGTR------------- 198
           H ++V L+G C +    L+V  EF   G+L  +L  + +  +P+                
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 199 -LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT 257
            +  +   AKG+ FL  A    I+RD    NILL      K+ DFGLA+   +  +    
Sbjct: 150 LICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 258 TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP 317
                   + APE I     T +SDV+SFGV+L E+ +   S     P     + +    
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCR 262
Query: 318 YLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            L+   R+R       A  Y+     EM    L C    P  RP  + +V  L +LL 
Sbjct: 263 RLKEGTRMR-------APDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  G       +      VA+K++  EG     E++ E   +  L H  LV+
Sbjct: 17  LGTGQFGVVKYG-------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G C +     ++ E+M  G L N+L + +         L++     + + +L   +  
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQ-- 125
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
            ++RD    N L++     K+SDFGL++   +   T           ++ PE +     +
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFS 184
Query: 279 TKSDVYSFGVVLLELLT 295
           +KSD+++FGV++ E+ +
Sbjct: 185 SKSDIWAFGVLMWEIYS 201

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 115/257 (44%), Gaps = 41/257 (15%)
Query: 91  QNFSSNYL-LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLG 149
           +++  N++ +GEG  G V    +          + VAVK +D+   Q       EV+ + 
Sbjct: 30  RSYLDNFIKIGEGSTGIVCIATVRS------SGKLVAVKKMDLRKQQRRELLFNEVVIMR 83
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------IAI 203
             +H ++V +       +E  +V EF+  G+L + +           TR+       + +
Sbjct: 84  DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCL 134
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGSNTHVTTRVMG 262
              + L+ LH     VI+RD K+ +ILL  D   KLSDFG  A++  E         ++G
Sbjct: 135 AVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVG 189
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS 322
           T  + APE IS      + D++S G++++E++ G                 + +P L++ 
Sbjct: 190 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAM 236
Query: 323 RRLRYIVDPRLAGQYSV 339
           + +R  + PRL   + V
Sbjct: 237 KMIRDNLPPRLKNLHKV 253

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 13/209 (6%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIF 147
           ++F    +LGEG F T          R+   ++  A+K+L+   +    +      E   
Sbjct: 30  EDFKFGKILGEGSFSTTVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 83
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + +L HP  V+L     +DE+      +   G L  ++ ++I       TR   A     
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 141
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L +LHG    +I+RD K  NILL+ D   +++DFG AK+    S        +GT  Y 
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           +PE ++       SD+++ G ++ +L+ G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 99  LGEGGFGTVHKGY---IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL--RH 153
           LGEG FG V       ID D  +  +A  VAVK+L  +  +     L   + + ++  +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKD--KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------------- 200
            +++ L+G C +D    ++ E+  +G+L  +L  R    + +   +              
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 201 -IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
                 A+G+ +L  A    I+RD    N+L+  +   +++DFGLA+          TT 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTN 218
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 99/216 (45%), Gaps = 24/216 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V+K       +        A K+++ +  +   +++ E+  L    HP++V+
Sbjct: 27  LGDGAFGKVYKA------KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG-TRLKIAI---GAAKGLAFLHG 214
           L+G    D +  ++ EF P G+++      I + L  G T  +I +      + L FLH 
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDA-----IMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
               +I+RD K  N+L+  +   +L+DFG++               +GT  + APE +  
Sbjct: 136 KR--IIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMC 191
Query: 275 GHLTT-----KSDVYSFGVVLLELLTGRRSMDKLRP 305
             +       K+D++S G+ L+E+        +L P
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---------DIEGLQG 137
           R    NF    +LG+G FG V    + +           AVK+L         D+E    
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKE------TGDLYAVKVLKKDVILQDDDVECTMT 72
Query: 138 HREWLAEVIFLGQLRHPHLVRLIGYCC-EDEERLL-VYEFMPRGSLENHLFKRISVSLPW 195
            +  L+    L +  HP L +L  +CC +  +RL  V EF+  G L  H+ K  S     
Sbjct: 73  EKRILS----LAR-NHPFLTQL--FCCFQTPDRLFFVMEFVNGGDLMFHIQK--SRRFDE 123
Query: 196 GTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH 255
                 A      L FLH  +  +IYRD K  N+LLD +   KL+DFG+ K   EG    
Sbjct: 124 ARARFYAAEIISALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNG 178
Query: 256 VTTRVM-GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           VTT    GT  Y APE +         D ++ GV+L E+L G 
Sbjct: 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 115/238 (48%), Gaps = 27/238 (11%)
Query: 70  LAHTFGPDLYDFQLSE-LRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK 128
           ++H   P  Y  +L++ +  + + + +   +G G +G+V   Y   D++ GLK   +AVK
Sbjct: 29  MSHKERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSY---DVKSGLK---IAVK 82
Query: 129 LLD--IEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGS 180
            L    + +   +    E+  L  ++H +++ L+          E  +  LV   M  G+
Sbjct: 83  KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM--GA 140
Query: 181 LENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS 240
             N++ K   ++      L   I   +GL ++H A+  +I+RD K SN+ ++ D   K+ 
Sbjct: 141 DLNNIVKCQKLTDDHVQFLIYQI--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKIL 196
Query: 241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
           DFGLA+   +    +V TR      Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 197 DFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 99/216 (45%), Gaps = 24/216 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V+K       +        A K+++ +  +   +++ E+  L    HP++V+
Sbjct: 19  LGDGAFGKVYKA------KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 72
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG-TRLKIAI---GAAKGLAFLHG 214
           L+G    D +  ++ EF P G+++      I + L  G T  +I +      + L FLH 
Sbjct: 73  LLGAYYHDGKLWIMIEFCPGGAVD-----AIMLELDRGLTEPQIQVVCRQMLEALNFLHS 127
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
               +I+RD K  N+L+  +   +L+DFG++               +GT  + APE +  
Sbjct: 128 KR--IIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMC 183
Query: 275 GHLTT-----KSDVYSFGVVLLELLTGRRSMDKLRP 305
             +       K+D++S G+ L+E+        +L P
Sbjct: 184 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 219

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLA-EVIFLGQLRHPH 155
            LG+GGF    +   D D ++    + V   LL    L+ H RE ++ E+     L H H
Sbjct: 24  FLGKGGFAKCFE-ISDADTKEVFAGKIVPKSLL----LKPHQREKMSMEISIHRSLAHQH 78
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +V   G+  +++   +V E   R SL     +R +++ P        I    G  +LH  
Sbjct: 79  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI--VLGCQYLH-- 134
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            N VI+RD K  N+ L+ D   K+ DFGLA K+  +G        + GT  Y APE +S 
Sbjct: 135 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNYIAPEVLSK 191
Query: 275 GHLTTKSDVYSFGVVLLELLTGR 297
              + + DV+S G ++  LL G+
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 114/258 (44%), Gaps = 43/258 (16%)
Query: 91  QNFSSNYL-LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLG 149
           +++  N++ +GEG  G V    +          + VAVK +D+   Q       EV+ + 
Sbjct: 73  RSYLDNFIKIGEGSTGIVCIATVRSS------GKLVAVKKMDLRKQQRRELLFNEVVIMR 126
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------IAI 203
             +H ++V +       +E  +V EF+  G+L + +           TR+       + +
Sbjct: 127 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCL 177
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR--VM 261
              + L+ LH     VI+RD K+ +ILL  D   KLSDFG         +  V  R  ++
Sbjct: 178 AVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ----VSKEVPRRKXLV 231
Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS 321
           GT  + APE IS      + D++S G++++E++ G                 + +P L++
Sbjct: 232 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKA 278
Query: 322 SRRLRYIVDPRLAGQYSV 339
            + +R  + PRL   + V
Sbjct: 279 MKMIRDNLPPRLKNLHKV 296

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 125/298 (41%), Gaps = 43/298 (14%)
Query: 99  LGEGGFGTVHKGYIDDD---LRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQL-R 152
           LG G FG V    I+ D   + +    + VAVK+L  EG     HR  ++E+  L  +  
Sbjct: 72  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGH 126
Query: 153 HPHLVRLIGYCCEDEERLLV-YEFMPRGSLENHLFKRISVSLPWGTR------------- 198
           H ++V L+G C +    L+V  EF   G+L  +L  + +  +P+                
Sbjct: 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 186
Query: 199 -LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT 257
            +  +   AKG+ FL  A    I+RD    NILL      K+ DFGLA+   +  +    
Sbjct: 187 LICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 244
Query: 258 TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP 317
                   + APE I     T +SDV+SFGV+L E+ +   S     P     + +    
Sbjct: 245 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCR 299
Query: 318 YLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            L+   R+R       A  Y+     EM    L C    P  RP  + +V  L +LL 
Sbjct: 300 RLKEGTRMR-------APDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  G       +      VA+K++  EG     E++ E   +  L H  LV+
Sbjct: 17  LGTGQFGVVKYG-------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G C +     ++ E+M  G L N+L + +         L++     + + +L   +  
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQ-- 125
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
            ++RD    N L++     K+SDFGL++   +   T           ++ PE +     +
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPV-RWSPPEVLMYSKFS 184
Query: 279 TKSDVYSFGVVLLELLT 295
           +KSD+++FGV++ E+ +
Sbjct: 185 SKSDIWAFGVLMWEIYS 201

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 125/298 (41%), Gaps = 43/298 (14%)
Query: 99  LGEGGFGTVHKGYIDDD---LRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQL-R 152
           LG G FG V    I+ D   + +    + VAVK+L  EG     HR  ++E+  L  +  
Sbjct: 37  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGH 91
Query: 153 HPHLVRLIGYCCEDEERLLVY-EFMPRGSLENHLFKRISVSLPWGTR------------- 198
           H ++V L+G C +    L+V  EF   G+L  +L  + +  +P+                
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEH 151
Query: 199 -LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT 257
            +  +   AKG+ FL  A    I+RD    NILL      K+ DFGLA+   +  +    
Sbjct: 152 LICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 209
Query: 258 TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP 317
                   + APE I     T +SDV+SFGV+L E+ +   S     P     + +    
Sbjct: 210 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCR 264
Query: 318 YLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            L+   R+R       A  Y+     EM    L C    P  RP  + +V  L +LL 
Sbjct: 265 RLKEGTRMR-------APDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 312

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 115/257 (44%), Gaps = 41/257 (15%)
Query: 91  QNFSSNYL-LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLG 149
           +++  N++ +GEG  G V    +          + VAVK +D+   Q       EV+ + 
Sbjct: 19  RSYLDNFIKIGEGSTGIVCIATVRS------SGKLVAVKKMDLRKQQRRELLFNEVVIMR 72
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------IAI 203
             +H ++V +       +E  +V EF+  G+L + +           TR+       + +
Sbjct: 73  DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCL 123
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGSNTHVTTRVMG 262
              + L+ LH     VI+RD K+ +ILL  D   KLSDFG  A++  E         ++G
Sbjct: 124 AVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVG 178
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS 322
           T  + APE IS      + D++S G++++E++ G                 + +P L++ 
Sbjct: 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAM 225
Query: 323 RRLRYIVDPRLAGQYSV 339
           + +R  + PRL   + V
Sbjct: 226 KMIRDNLPPRLKNLHKV 242

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  G       +      VA+K++  EG     E++ E   +  L H  LV+
Sbjct: 23  LGTGQFGVVKYG-------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 74
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G C +     ++ E+M  G L N+L + +         L++     + + +L   +  
Sbjct: 75  LYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQ-- 131
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
            ++RD    N L++     K+SDFGL++   +   T           ++ PE +     +
Sbjct: 132 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFS 190
Query: 279 TKSDVYSFGVVLLELLT 295
           +KSD+++FGV++ E+ +
Sbjct: 191 SKSDIWAFGVLMWEIYS 207

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAV--AVKLLDIEGLQGHRE---WLAE-VIFLGQL 151
           ++G+G FG V        L    KA+ V  AVK+L  + +   +E    ++E  + L  +
Sbjct: 45  VIGKGSFGKV--------LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV 96
Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +HP LV L       ++   V +++  G L  HL +      P        I +A  L +
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA--LGY 154
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEY 271
           LH     ++YRD K  NILLDS     L+DFGL K   E ++T  T+   GT  Y APE 
Sbjct: 155 LHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEV 210
Query: 272 ISTGHLTTKSDVYSFGVVLLELLTG 296
           +         D +  G VL E+L G
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG VH+      + +       A K +             E+  +  LRHP LV 
Sbjct: 59  LGTGAFGVVHR------VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 112
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS---LPWGTRLKIAIGAAKGLAFLHGA 215
           L     +D E +++YEFM  G     LF++++     +     ++      KGL  +H  
Sbjct: 113 LHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-- 166
Query: 216 ENPVIYRDFKTSNILLDSDFTA--KLSDFGL-AKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
           EN  ++ D K  NI+  +  +   KL DFGL A + P+ S   VTT   GT  +AAPE  
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-VKVTT---GTAEFAAPEVA 222
Query: 273 STGHLTTKSDVYSFGVVLLELLTG 296
               +   +D++S GV+   LL+G
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 115/257 (44%), Gaps = 41/257 (15%)
Query: 91  QNFSSNYL-LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLG 149
           +++  N++ +GEG  G V    +          + VAVK +D+   Q       EV+ + 
Sbjct: 23  RSYLDNFIKIGEGSTGIVCIATVRS------SGKLVAVKKMDLRKQQRRELLFNEVVIMR 76
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------IAI 203
             +H ++V +       +E  +V EF+  G+L +         +   TR+       + +
Sbjct: 77  DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCL 127
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGSNTHVTTRVMG 262
              + L+ LH     VI+RD K+ +ILL  D   KLSDFG  A++  E         ++G
Sbjct: 128 AVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVG 182
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS 322
           T  + APE IS      + D++S G++++E++ G                 + +P L++ 
Sbjct: 183 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAM 229
Query: 323 RRLRYIVDPRLAGQYSV 339
           + +R  + PRL   + V
Sbjct: 230 KMIRDNLPPRLKNLHKV 246

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-EVIFLGQLRHPHL 156
           +LG G F  V    + +D R     + VA+K +  E L+G    +  E+  L +++HP++
Sbjct: 25  VLGTGAFSEV---ILAEDKRT---QKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           V L           L+ + +  G L + + ++   +    +RL   +  A  + +LH  +
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYLH--D 134
Query: 217 NPVIYRDFKTSNIL---LDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
             +++RD K  N+L   LD D    +SDFGL+KM   GS   V +   GT GY APE ++
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLA 191
Query: 274 TGHLTTKSDVYSFGVVLLELLTG 296
               +   D +S GV+   LL G
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG VH+      + +       A K +             E+  +  LRHP LV 
Sbjct: 165 LGTGAFGVVHR------VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS---LPWGTRLKIAIGAAKGLAFLHGA 215
           L     +D E +++YEFM  G     LF++++     +     ++      KGL  +H  
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-- 272
Query: 216 ENPVIYRDFKTSNILLDSDFTA--KLSDFGL-AKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
           EN  ++ D K  NI+  +  +   KL DFGL A + P+ S   VTT   GT  +AAPE  
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-VKVTT---GTAEFAAPEVA 328
Query: 273 STGHLTTKSDVYSFGVVLLELLTG 296
               +   +D++S GV+   LL+G
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 96/226 (42%), Gaps = 23/226 (10%)
Query: 82  QLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-----DIEGLQ 136
           ++ + +    +F     LG+G FG V+        R+      +A+K+L     + EG++
Sbjct: 6   EMPKRKFTIDDFDIGRPLGKGKFGNVYLA------REKQNKFIMALKVLFKSQLEKEGVE 59
Query: 137 GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG 196
              +   E+     LRHP+++R+  Y  + +   L+ EF PRG L   L K         
Sbjct: 60  --HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS 117
Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV 256
                 +  A  L + H  E  VI+RD K  N+L+      K++DFG +   P      +
Sbjct: 118 ATFMEEL--ADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----L 168
Query: 257 TTRVM-GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMD 301
             R M GT  Y  PE I       K D++  GV+  E L G    D
Sbjct: 169 RRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 92  NFSSNYLLGEGGFGTV---HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA---EV 145
           +F+   +LG+G FG V    +   D+     +  + V ++  D+E     +  LA   + 
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 146 IFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIG 204
            FL QL           C +  +RL  V E++  G L  H+ +      P        I 
Sbjct: 402 PFLTQLHS---------CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI- 451
Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM-GT 263
            A GL FL      +IYRD K  N++LDS+   K++DFG+ K   E     VTT+   GT
Sbjct: 452 -AIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGT 505
Query: 264 YGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
             Y APE I+        D ++FGV+L E+L G+
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-EVIFLGQLRHPHL 156
           +LG G F  V    + +D R     + VA+K +  E L+G    +  E+  L +++HP++
Sbjct: 25  VLGTGAFSEV---ILAEDKRT---QKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           V L           L+ + +  G L + + ++   +    +RL   +  A  + +LH  +
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYLH--D 134
Query: 217 NPVIYRDFKTSNIL---LDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
             +++RD K  N+L   LD D    +SDFGL+KM   GS   V +   GT GY APE ++
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLA 191
Query: 274 TGHLTTKSDVYSFGVVLLELLTG 296
               +   D +S GV+   LL G
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFL 148
           +FS + ++G GGFG V+        R+    +  A+K LD   I+  QG    L E I L
Sbjct: 190 DFSVHRIIGRGGFGEVY------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 149 GQLRH---PHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIG 204
             +     P +V  + Y     ++L  + + M  G L  HL +    S        +   
Sbjct: 244 SLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-----EADMRFY 297
Query: 205 AAK---GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA----KMGPEGSNTHVT 257
           AA+   GL  +H     V+YRD K +NILLD     ++SD GLA    K  P  S     
Sbjct: 298 AAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----- 350
Query: 258 TRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNL 311
              +GT+GY APE +  G    + +D +S G +L +LL G     + + K +  +
Sbjct: 351 ---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +GEG +G V   Y  D++    K +    K+   E     +  L E+  L + RH +++ 
Sbjct: 31  IGEGAYGMVCSAY--DNVN---KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 85
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-LPWGTRLKIAIGAAKGLAFLHGAEN 217
           +           +   ++ +  +E  L+K +    L             +GL ++H A  
Sbjct: 86  INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 144
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGSNTHVTTRVMGTYGYAAPEYISTGH 276
            V++RD K SN+LL++    K+ DFGLA++  P+  +T   T  + T  Y APE +    
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 277 LTTKS-DVYSFGVVLLELLTGR 297
             TKS D++S G +L E+L+ R
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFL 148
           +FS + ++G GGFG V+        R+    +  A+K LD   I+  QG    L E I L
Sbjct: 189 DFSVHRIIGRGGFGEVY------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 149 GQLRH---PHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIG 204
             +     P +V  + Y     ++L  + + M  G L  HL +    S        +   
Sbjct: 243 SLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-----EADMRFY 296
Query: 205 AAK---GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA----KMGPEGSNTHVT 257
           AA+   GL  +H     V+YRD K +NILLD     ++SD GLA    K  P  S     
Sbjct: 297 AAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----- 349
Query: 258 TRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNL 311
              +GT+GY APE +  G    + +D +S G +L +LL G     + + K +  +
Sbjct: 350 ---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 401

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 47/227 (20%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAE--VIFLGQLRHPH 155
           L+G G +G V+KG +D+        + VAVK+      Q    ++ E  +  +  + H +
Sbjct: 20  LIGRGRYGAVYKGSLDE--------RPVAVKVFSFANRQN---FINEKNIYRVPLMEHDN 68
Query: 156 LVRLIGYCCEDE--------ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
           + R I     DE        E LLV E+ P GSL  +L    S    W +  ++A    +
Sbjct: 69  IARFI---VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS---DWVSSCRLAHSVTR 122
Query: 208 GLAFLHGA------ENPVI-YRDFKTSNILLDSDFTAKLSDFGLA------KMGPEGSNT 254
           GLA+LH          P I +RD  + N+L+ +D T  +SDFGL+      ++   G   
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 255 HVTTRVMGTYGYAAPEYISTG-------HLTTKSDVYSFGVVLLELL 294
           +     +GT  Y APE +              + D+Y+ G++  E+ 
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +GEG +G V   Y  D++    K +    K+   E     +  L E+  L + RH +++ 
Sbjct: 31  IGEGAYGMVCSAY--DNVN---KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 85
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-LPWGTRLKIAIGAAKGLAFLHGAEN 217
           +           +   ++ +  +E  L+K +    L             +GL ++H A  
Sbjct: 86  INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 144
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGSNTHVTTRVMGTYGYAAPEYISTGH 276
            V++RD K SN+LL++    K+ DFGLA++  P+  +T   T  + T  Y APE +    
Sbjct: 145 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 277 LTTKS-DVYSFGVVLLELLTGR 297
             TKS D++S G +L E+L+ R
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 23/209 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-----DIEGLQGHREWLAEVIFLGQLRH 153
           LG+G FG V+        R+      +A+K+L     + EG++   +   E+     LRH
Sbjct: 22  LGKGKFGNVYLA------REKQNKFIMALKVLFKSQLEKEGVE--HQLRREIEIQSHLRH 73
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
           P+++R+  Y  + +   L+ EF PRG L   L K               +  A  L + H
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL--ADALHYCH 131
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM-GTYGYAAPEYI 272
             E  VI+RD K  N+L+      K++DFG +   P      +  R M GT  Y  PE I
Sbjct: 132 --ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----LRRRXMCGTLDYLPPEMI 184
Query: 273 STGHLTTKSDVYSFGVVLLELLTGRRSMD 301
                  K D++  GV+  E L G    D
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFL 148
           +FS + ++G GGFG V+        R+    +  A+K LD   I+  QG    L E I L
Sbjct: 190 DFSVHRIIGRGGFGEVY------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 149 GQLRH---PHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIG 204
             +     P +V  + Y     ++L  + + M  G L  HL +    S        +   
Sbjct: 244 SLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-----EADMRFY 297
Query: 205 AAK---GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA----KMGPEGSNTHVT 257
           AA+   GL  +H     V+YRD K +NILLD     ++SD GLA    K  P  S     
Sbjct: 298 AAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----- 350
Query: 258 TRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNL 311
              +GT+GY APE +  G    + +D +S G +L +LL G     + + K +  +
Sbjct: 351 ---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFL 148
           +FS + ++G GGFG V+        R+    +  A+K LD   I+  QG    L E I L
Sbjct: 190 DFSVHRIIGRGGFGEVY------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 149 GQLRH---PHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIG 204
             +     P +V  + Y     ++L  + + M  G L  HL +    S        +   
Sbjct: 244 SLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-----EADMRFY 297
Query: 205 AAK---GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA----KMGPEGSNTHVT 257
           AA+   GL  +H     V+YRD K +NILLD     ++SD GLA    K  P  S     
Sbjct: 298 AAEIILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----- 350
Query: 258 TRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNL 311
              +GT+GY APE +  G    + +D +S G +L +LL G     + + K +  +
Sbjct: 351 ---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 94/233 (40%), Gaps = 41/233 (17%)
Query: 139 REWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHL-----FKRISVSL 193
           R    E+  +  L HP LV L     ++E+  +V + +  G L  HL     FK  +V L
Sbjct: 60  RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL 119
Query: 194 PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN 253
                          L +L      +I+RD K  NILLD      ++DF +A M P    
Sbjct: 120 -------FICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--E 168
Query: 254 THVTTRVMGTYGYAAPEYIST---GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQN 310
           T +TT + GT  Y APE  S+      +   D +S GV   ELL GRR            
Sbjct: 169 TQITT-MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR------------ 215
Query: 311 LVDWAKPY-LRSSRRLRYIVD--PRLAGQYSVKGAKEMAVLALQCISVNPKDR 360
                 PY +RSS   + IV         Y    ++EM  L  + +  NP  R
Sbjct: 216 ------PYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQR 262

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +GEG +G V   Y  D++    K +    K+   E     +  L E+  L + RH +++ 
Sbjct: 31  IGEGAYGMVCSAY--DNVN---KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 85
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-LPWGTRLKIAIGAAKGLAFLHGAEN 217
           +           +   ++ +  +E  L+K +    L             +GL ++H A  
Sbjct: 86  INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 144
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGSNTHVTTRVMGTYGYAAPEYISTGH 276
            V++RD K SN+LL++    K+ DFGLA++  P+  +T   T  + T  Y APE +    
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 277 LTTKS-DVYSFGVVLLELLTGR 297
             TKS D++S G +L E+L+ R
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 99  LGEGGFGTVHKGY---IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL--RH 153
           LGEG FG V       ID D  +  +A  VAVK+L  +  +     L   + + ++  +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKD--KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------------- 200
            +++ L+G C +D    ++  +  +G+L  +L  R    + +   +              
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 201 -IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
                 A+G+ +L  A    I+RD    N+L+  +   K++DFGLA+          TT 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 13/226 (5%)
Query: 75  GPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG 134
           GP++   Q+ ++     N S    +GEG +G V   Y  D+L    K +    K+   E 
Sbjct: 14  GPEMVRGQVFDVGPRYTNLS---YIGEGAYGMVCSAY--DNLN---KVRVAIKKISPFEH 65
Query: 135 LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-L 193
               +  L E+  L + RH +++ +           +   ++ +  +E  L+K +    L
Sbjct: 66  QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL 125
Query: 194 PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGS 252
                        +GL ++H A   V++RD K SN+LL++    K+ DFGLA++  P+  
Sbjct: 126 SNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 253 NTHVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
           +T      + T  Y APE +      TKS D++S G +L E+L+ R
Sbjct: 184 HTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 13/226 (5%)
Query: 75  GPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG 134
           GP++   Q+ ++     N S    +GEG +G V   Y  D+L    K +    K+   E 
Sbjct: 15  GPEMVRGQVFDVGPRYTNLS---YIGEGAYGMVCSAY--DNLN---KVRVAIKKISPFEH 66
Query: 135 LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-L 193
               +  L E+  L + RH +++ +           +   ++ +  +E  L+K +    L
Sbjct: 67  QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL 126
Query: 194 PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGS 252
                        +GL ++H A   V++RD K SN+LL++    K+ DFGLA++  P+  
Sbjct: 127 SNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 184
Query: 253 NTHVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
           +T      + T  Y APE +      TKS D++S G +L E+L+ R
Sbjct: 185 HTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-EVIFLGQLRHPHL 156
           +LG G F  V    + +D R     + VA+K +  E L+G    +  E+  L +++HP++
Sbjct: 25  VLGTGAFSEV---ILAEDKR---TQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           V L           L+ + +  G L + + ++   +    +RL   +  A  + +LH  +
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYLH--D 134
Query: 217 NPVIYRDFKTSNIL---LDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
             +++RD K  N+L   LD D    +SDFGL+KM   GS   V +   GT GY APE ++
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLA 191
Query: 274 TGHLTTKSDVYSFGVVLLELLTG 296
               +   D +S GV+   LL G
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +GEG +G V   Y  D++    K +    K+   E     +  L E+  L + RH +++ 
Sbjct: 39  IGEGAYGMVCSAY--DNVN---KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 93
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-LPWGTRLKIAIGAAKGLAFLHGAEN 217
           +           +   ++ +  +E  L+K +    L             +GL ++H A  
Sbjct: 94  INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 152
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGSNTHVTTRVMGTYGYAAPEYISTGH 276
            V++RD K SN+LL++    K+ DFGLA++  P+  +T   T  + T  Y APE +    
Sbjct: 153 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 211
Query: 277 LTTKS-DVYSFGVVLLELLTGR 297
             TKS D++S G +L E+L+ R
Sbjct: 212 GYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +GEG +G V   Y  D++    K +    K+   E     +  L E+  L + RH +++ 
Sbjct: 31  IGEGAYGMVCSAY--DNVN---KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 85
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-LPWGTRLKIAIGAAKGLAFLHGAEN 217
           +           +   ++ +  +E  L+K +    L             +GL ++H A  
Sbjct: 86  INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 144
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGSNTHVTTRVMGTYGYAAPEYISTGH 276
            V++RD K SN+LL++    K+ DFGLA++  P+  +T   T  + T  Y APE +    
Sbjct: 145 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 277 LTTKS-DVYSFGVVLLELLTGR 297
             TKS D++S G +L E+L+ R
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWL 142
           T  FS  Y    +LG+G FG V         +  +  Q  AVK++    ++        L
Sbjct: 21  TAIFSDRYKGQRVLGKGSFGEVIL------CKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 143 AEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
            EV  L QL HP++++L  +  +     LV E    G L + +  R   S     R  I 
Sbjct: 75  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--II 132
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTR 259
                G+ ++H  +N +++RD K  N+LL+S   D   ++ DFGL+        +     
Sbjct: 133 RQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKD 187
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            +GT  Y APE +  G    K DV+S GV+L  LL+G
Sbjct: 188 KIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +GEG +G V   Y  D++    K +    K+   E     +  L E+  L + RH +++ 
Sbjct: 33  IGEGAYGMVCSAY--DNVN---KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 87
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-LPWGTRLKIAIGAAKGLAFLHGAEN 217
           +           +   ++ +  +E  L+K +    L             +GL ++H A  
Sbjct: 88  INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 146
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGSNTHVTTRVMGTYGYAAPEYISTGH 276
            V++RD K SN+LL++    K+ DFGLA++  P+  +T   T  + T  Y APE +    
Sbjct: 147 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 277 LTTKS-DVYSFGVVLLELLTGR 297
             TKS D++S G +L E+L+ R
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNR 227

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 100/220 (45%), Gaps = 26/220 (11%)
Query: 87  RAITQNFSSNYLLGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL 142
           R    +F+   +LG+G FG V     KG  D+     +  + V ++  D+E     +  L
Sbjct: 16  RMKLTDFNFLMVLGKGSFGKVMLSERKG-TDELYAVKILKKDVVIQDDDVECTMVEKRVL 74
Query: 143 A---EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTR 198
           A   +  FL QL           C +  +RL  V E++  G L  H+ +      P    
Sbjct: 75  ALPGKPPFLTQLHS---------CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF 125
Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT 258
               I  A GL FL      +IYRD K  N++LDS+   K++DFG+ K   E     VTT
Sbjct: 126 YAAEI--AIGLFFLQS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTT 178
Query: 259 RVM-GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           +   GT  Y APE I+        D ++FGV+L E+L G+
Sbjct: 179 KXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +GEG +G V   Y  D++    K +    K+   E     +  L E+  L + RH +++ 
Sbjct: 51  IGEGAYGMVCSAY--DNVN---KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 105
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-LPWGTRLKIAIGAAKGLAFLHGAEN 217
           +           +   ++ +  +E  L+K +    L             +GL ++H A  
Sbjct: 106 INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 164
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGSNTHVTTRVMGTYGYAAPEYISTGH 276
            V++RD K SN+LL++    K+ DFGLA++  P+  +T   T  + T  Y APE +    
Sbjct: 165 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 277 LTTKS-DVYSFGVVLLELLTGR 297
             TKS D++S G +L E+L+ R
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNR 245

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +GEG +G V   Y  D++    K +    K+   E     +  L E+  L + RH +++ 
Sbjct: 31  IGEGAYGMVCSAY--DNVN---KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 85
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-LPWGTRLKIAIGAAKGLAFLHGAEN 217
           +           +   ++ +  +E  L+K +    L             +GL ++H A  
Sbjct: 86  INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 144
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGSNTHVTTRVMGTYGYAAPEYISTGH 276
            V++RD K SN+LL++    K+ DFGLA++  P+  +T   T  + T  Y APE +    
Sbjct: 145 -VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 277 LTTKS-DVYSFGVVLLELLTGR 297
             TKS D++S G +L E+L+ R
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNR 225

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 34/222 (15%)
Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWL 142
           T  FS  Y    +LG+G FG V         +  +  Q  AVK++    ++        L
Sbjct: 45  TAIFSDRYKGQRVLGKGSFGEVIL------CKDKITGQECAVKVISKRQVKQKTDKESLL 98
Query: 143 AEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
            EV  L QL HP++++L  +  +     LV E    G L + +  R   S     R  I 
Sbjct: 99  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--II 156
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTR 259
                G+ ++H  +N +++RD K  N+LL+S   D   ++ DFGL+        TH    
Sbjct: 157 RQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--------THFEAS 206
Query: 260 -----VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
                 +GT  Y APE +  G    K DV+S GV+L  LL+G
Sbjct: 207 KKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 247

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 106/245 (43%), Gaps = 34/245 (13%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--GHREWLAEVIFLG 149
           N+     +G+G F  V         R  L  + VAVK++D   L     ++   EV  + 
Sbjct: 16  NYRLQKTIGKGNFAKVKLA------RHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMK 69
Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK-- 207
            L HP++V+L      ++   LV E+   G + ++L            R+K     AK  
Sbjct: 70  ILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFR 121
Query: 208 ----GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT 263
                + + H  +  +++RD K  N+LLD D   K++DFG +     G+         G+
Sbjct: 122 QIVSAVQYCH--QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGS 176
Query: 264 YGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS 322
             YAAPE +    +   + DV+S GV+L  L++G    D       QNL +  +  LR  
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG------QNLKELRERVLRGK 230
Query: 323 RRLRY 327
            R+ +
Sbjct: 231 YRIPF 235

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 99/222 (44%), Gaps = 34/222 (15%)
Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWL 142
           T  FS  Y    +LG+G FG V         +  +  Q  AVK++    ++        L
Sbjct: 44  TAIFSDRYKGQRVLGKGSFGEVIL------CKDKITGQECAVKVISKRQVKQKTDKESLL 97
Query: 143 AEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
            EV  L QL HP++++L  +  +     LV E    G L + +  R   S     R  I 
Sbjct: 98  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--II 155
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTR 259
                G+ ++H  +N +++RD K  N+LL+S   D   ++ DFGL+        TH    
Sbjct: 156 RQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--------THFEAS 205
Query: 260 -----VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
                 +GT  Y APE +  G    K DV+S GV+L  LL+G
Sbjct: 206 KKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 246

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWL 142
           T  FS  Y    +LG+G FG V         +  +  Q  AVK++    ++        L
Sbjct: 27  TAIFSDRYKGQRVLGKGSFGEVIL------CKDKITGQECAVKVISKRQVKQKTDKESLL 80
Query: 143 AEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
            EV  L QL HP++++L  +  +     LV E    G L + +  R   S     R  I 
Sbjct: 81  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--II 138
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTR 259
                G+ ++H  +N +++RD K  N+LL+S   D   ++ DFGL+        +     
Sbjct: 139 RQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKD 193
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            +GT  Y APE +  G    K DV+S GV+L  LL+G
Sbjct: 194 KIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 229

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKA-QAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHL 156
           +LG G F  V     +D   Q L A + +A K L  EG +G  E   E+  L +++HP++
Sbjct: 25  VLGTGAFSEVILA--EDKRTQKLVAIKCIAKKAL--EGKEGSME--NEIAVLHKIKHPNI 78
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           V L           L+ + +  G L + + ++   +    +RL   +  A  + +LH  +
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYLH--D 134
Query: 217 NPVIYRDFKTSNIL---LDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
             +++RD K  N+L   LD D    +SDFGL+KM   GS   V +   GT GY APE ++
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLA 191
Query: 274 TGHLTTKSDVYSFGVVLLELLTG 296
               +   D +S GV+   LL G
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 105/238 (44%), Gaps = 34/238 (14%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH--REWLAEVIFLGQLRHPHL 156
           +G+G F  V         R  L  + VAVK++D   L     ++   EV  +  L HP++
Sbjct: 22  IGKGNFAKVKLA------RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK------GLA 210
           V+L      ++   LV E+   G + ++L            R+K     AK       + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFRQIVSAVQ 127
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           + H  +  +++RD K  N+LLD+D   K++DFG +     G+         G+  YAAPE
Sbjct: 128 YCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPE 182
Query: 271 -YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            +    +   + DV+S GV+L  L++G    D       QNL +  +  LR   R+ +
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG------QNLKELRERVLRGKYRIPF 234

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +GEG +G V   Y  D++    K +    K+   E     +  L E+  L   RH +++ 
Sbjct: 33  IGEGAYGMVCSAY--DNVN---KVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIG 87
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-LPWGTRLKIAIGAAKGLAFLHGAEN 217
           +           +   ++ +  +E  L+K +    L             +GL ++H A  
Sbjct: 88  INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 146
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGSNTHVTTRVMGTYGYAAPEYISTGH 276
            V++RD K SN+LL++    K+ DFGLA++  P+  +T   T  + T  Y APE +    
Sbjct: 147 -VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 277 LTTKS-DVYSFGVVLLELLTGR 297
             TKS D++S G +L E+L+ R
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNR 227

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 105/238 (44%), Gaps = 34/238 (14%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH--REWLAEVIFLGQLRHPHL 156
           +G+G F  V         R  L  + VAVK++D   L     ++   EV  +  L HP++
Sbjct: 22  IGKGNFAKVKLA------RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK------GLA 210
           V+L      ++   LV E+   G + ++L            R+K     AK       + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFRQIVSAVQ 127
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           + H  +  +++RD K  N+LLD+D   K++DFG +     G+         G+  YAAPE
Sbjct: 128 YCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPE 182
Query: 271 -YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            +    +   + DV+S GV+L  L++G    D       QNL +  +  LR   R+ +
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG------QNLKELRERVLRGKYRIPF 234

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 26/234 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH--REWLAEVIFLGQLRHPHL 156
           +G+G F  V         R  L  + VAVK++D   L     ++   EV  +  L HP++
Sbjct: 15  IGKGNFAKVKLA------RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL--AFLHG 214
           V+L      ++   LV E+   G + ++L     V+  W  + K A    + +  A  + 
Sbjct: 69  VKLFEVIETEKTLYLVMEYASGGEVFDYL-----VAHGW-MKEKEARAKFRQIVSAVQYC 122
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE-YIS 273
            +  +++RD K  N+LLD+D   K++DFG +     G+         G+  YAAPE +  
Sbjct: 123 HQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GSPPYAAPELFQG 179
Query: 274 TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
             +   + DV+S GV+L  L++G    D       QNL +  +  LR   R+ +
Sbjct: 180 KKYDGPEVDVWSLGVILYTLVSGSLPFDG------QNLKELRERVLRGKYRIPF 227

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 99  LGEGGFGTVHKGY---IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL--RH 153
           LGEG FG V       ID D  +  +A  VAVK+L  +  +     L   + + ++  +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKD--KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------------- 200
            +++ L+G C +D    ++  +  +G+L  +L  R    + +   +              
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 201 -IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
                 A+G+ +L  A    I+RD    N+L+  +   K++DFGLA+          TT 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHL 156
           LGE G GT  + +    +R       +AVK +   G   +  R  +   + L     P++
Sbjct: 30  LGEMGSGTCGQVW---KMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           V+  G    + +  +  E M  G+    L KR+   +P     K+ +   K L +L   +
Sbjct: 87  VQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK-EK 143
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH 276
           + VI+RD K SNILLD     KL DFG++       +     R  G   Y APE I    
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 277 LT-----TKSDVYSFGVVLLELLTGR 297
            T      ++DV+S G+ L+EL TG+
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +GEG +G V   Y  D++    K +    K+   E     +  L E+  L   RH +++ 
Sbjct: 33  IGEGAYGMVCSAY--DNVN---KVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIG 87
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-LPWGTRLKIAIGAAKGLAFLHGAEN 217
           +           +   ++ +  +E  L+K +    L             +GL ++H A  
Sbjct: 88  INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 146
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGSNTHVTTRVMGTYGYAAPEYISTGH 276
            V++RD K SN+LL++    K+ DFGLA++  P+  +T   T  + T  Y APE +    
Sbjct: 147 -VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 277 LTTKS-DVYSFGVVLLELLTGR 297
             TKS D++S G +L E+L+ R
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNR 227

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 111/247 (44%), Gaps = 62/247 (25%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVI 146
           R + +  +    +G+G +G V +G     L  G   ++VAVK+      Q    W  E  
Sbjct: 4   RTVARQVALVECVGKGRYGEVWRG-----LWHG---ESVAVKIFSSRDEQS---WFRETE 52
Query: 147 FLGQ--LRHPHLVRLIGYCCED----------------EERLLVYEFMPRGSLENHLFKR 188
                 LRH ++   +G+   D                 E   +Y+F+ R +LE HL   
Sbjct: 53  IYNTVLLRHDNI---LGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHL--- 106
Query: 189 ISVSLPWGTRLKIAIGAAKGLAFLH----GAE-NPVI-YRDFKTSNILLDSDFTAKLSDF 242
                     L++A+ AA GLA LH    G +  P I +RDFK+ N+L+ S+    ++D 
Sbjct: 107 ---------ALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADL 157
Query: 243 GLAKMGPEGS---NTHVTTRVMGTYGYAAPEYISTGHLT------TKSDVYSFGVVLLEL 293
           GLA M  +GS   +     RV GT  Y APE +     T        +D+++FG+VL E+
Sbjct: 158 GLAVMHSQGSDYLDIGNNPRV-GTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216
Query: 294 LTGRRSM 300
              RR++
Sbjct: 217 --ARRTI 221

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFLGQLRHPHL 156
           +G G +G+V   Y D  LRQ      VAVK L    + L   R    E+  L  L+H ++
Sbjct: 36  VGSGAYGSVCSAY-DARLRQ-----KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENV 89
Query: 157 VRLI-----GYCCED-EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
           + L+         ED  E  LV   M  G+  N++ K  ++S      L   +   +GL 
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALSDEHVQFLVYQL--LRGLK 145
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           ++H A   +I+RD K SN+ ++ D   ++ DFGLA+   E    +V TR      Y APE
Sbjct: 146 YIHSA--GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPE 198
Query: 271 -YISTGHLTTKSDVYSFGVVLLELLTGR 297
             ++  H     D++S G ++ ELL G+
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 34/227 (14%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL--AE 144
           R I +       +G+G FG V +G          + + VAVK+      +  R W   AE
Sbjct: 38  RTIARTIVLQESIGKGRFGEVWRG--------KWRGEEVAVKIF---SSREERSWFREAE 86
Query: 145 VIFLGQLRHPHLVRLIGYCCEDE----ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK 200
           +     LRH +++  I    +D     +  LV ++   GSL ++L  R +V++     +K
Sbjct: 87  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVE--GMIK 143
Query: 201 IAIGAAKGLAFLH----GAE-NPVI-YRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT 254
           +A+  A GLA LH    G +  P I +RD K+ NIL+  + T  ++D GLA      ++T
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 203
Query: 255 --HVTTRVMGTYGYAAPEY----ISTGHLTT--KSDVYSFGVVLLEL 293
                   +GT  Y APE     I+  H  +  ++D+Y+ G+V  E+
Sbjct: 204 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 104/238 (43%), Gaps = 34/238 (14%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH--REWLAEVIFLGQLRHPHL 156
           +G+G F  V         R  L  + VAVK++D   L     ++   EV  +  L HP++
Sbjct: 22  IGKGNFAKVKLA------RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK------GLA 210
           V+L      ++   LV E+   G + ++L            R+K     AK       + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFRQIVSAVQ 127
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           + H  +  +++RD K  N+LLD+D   K++DFG +     G+         G   YAAPE
Sbjct: 128 YCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPE 182
Query: 271 -YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            +    +   + DV+S GV+L  L++G    D       QNL +  +  LR   R+ +
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG------QNLKELRERVLRGKYRIPF 234

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +GEG +G V   Y  D++    K +    K+   E     +  L E+  L + RH +++ 
Sbjct: 51  IGEGAYGMVCSAY--DNVN---KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 105
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK------IAIGAAKGLAFL 212
           +      D  R    E M    L  HL       L     L             +GL ++
Sbjct: 106 I-----NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 160
Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGSNTHVTTRVMGTYGYAAPEY 271
           H A   V++RD K SN+LL++    K+ DFGLA++  P+  +T   T  + T  Y APE 
Sbjct: 161 HSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 272 ISTGHLTTKS-DVYSFGVVLLELLTGR 297
           +      TKS D++S G +L E+L+ R
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 118/275 (42%), Gaps = 42/275 (15%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL--DIEGLQGHREWLAEVIFLGQLRHPHL 156
           LG G +G V K      +R     Q +AVK +   +   +  R  +   I +  +  P  
Sbjct: 59  LGRGAYGVVEK------MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 112
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRI---SVSLPWGTRLKIAIGAAKGLAFLH 213
           V   G    + +  +  E M   SL+   +K++     ++P     KIA+   K L  LH
Sbjct: 113 VTFYGALFREGDVWICMELM-DTSLDK-FYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 170
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI- 272
              + VI+RD K SN+L+++    K+ DFG++       ++   T   G   Y APE I 
Sbjct: 171 SKLS-VIHRDVKPSNVLINALGQVKMCDFGISGY---LVDSVAKTIDAGCKPYMAPERIN 226
Query: 273 ---STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
              +    + KSD++S G+ ++EL   R   D            W  P+    ++L+ +V
Sbjct: 227 PELNQKGYSVKSDIWSLGITMIELAILRFPYDS-----------WGTPF----QQLKQVV 271
Query: 330 D---PRLAGQYSVKGAKEMAVLALQCISVNPKDRP 361
           +   P+L      K + E      QC+  N K+RP
Sbjct: 272 EEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERP 303

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 34/227 (14%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL--AE 144
           R I +       +G+G FG V +G          + + VAVK+      +  R W   AE
Sbjct: 25  RTIARTIVLQESIGKGRFGEVWRG--------KWRGEEVAVKIF---SSREERSWFREAE 73
Query: 145 VIFLGQLRHPHLVRLIGYCCEDE----ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK 200
           +     LRH +++  I    +D     +  LV ++   GSL ++L  R +V++     +K
Sbjct: 74  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVE--GMIK 130
Query: 201 IAIGAAKGLAFLH----GAE-NPVI-YRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT 254
           +A+  A GLA LH    G +  P I +RD K+ NIL+  + T  ++D GLA      ++T
Sbjct: 131 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 190
Query: 255 --HVTTRVMGTYGYAAPEY----ISTGHLTT--KSDVYSFGVVLLEL 293
                   +GT  Y APE     I+  H  +  ++D+Y+ G+V  E+
Sbjct: 191 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFLGQLRHPHL 156
           +G G +G+V   Y D  LRQ      VAVK L    + L   R    E+  L  L+H ++
Sbjct: 28  VGSGAYGSVCSAY-DARLRQ-----KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENV 81
Query: 157 VRLI-----GYCCED-EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
           + L+         ED  E  LV   M  G+  N++ K  ++S      L   +   +GL 
Sbjct: 82  IGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQL--LRGLK 137
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           ++H A   +I+RD K SN+ ++ D   ++ DFGLA+   E    +V TR      Y APE
Sbjct: 138 YIHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WYRAPE 190
Query: 271 -YISTGHLTTKSDVYSFGVVLLELLTGR 297
             ++  H     D++S G ++ ELL G+
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 29/205 (14%)
Query: 122 AQAVAVKLLDIEG--------LQGHRE-WLAEVIFLGQLR-HPHLVRLIGYCCEDEERLL 171
            +  AVK++D+ G        +Q  RE  L EV  L ++  HP++++L      +    L
Sbjct: 29  CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 88
Query: 172 VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL 231
           V++ M +G L ++L +++++S    TR KI     + +  LH     +++RD K  NILL
Sbjct: 89  VFDLMKKGELFDYLTEKVTLS-EKETR-KIMRALLEVICALHKLN--IVHRDLKPENILL 144
Query: 232 DSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH------LTTKSDVYS 285
           D D   KL+DFG +     G        V GT  Y APE I             + D++S
Sbjct: 145 DDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 201
Query: 286 FGVVLLELLTG------RRSMDKLR 304
            GV++  LL G      R+ M  LR
Sbjct: 202 TGVIMYTLLAGSPPFWHRKQMLMLR 226

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 122/283 (43%), Gaps = 27/283 (9%)
Query: 78  LYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG 137
           L +  LS LR     F    L+G G +G V+KG      R     Q  A+K++D+ G + 
Sbjct: 11  LDEIDLSALRDPAGIFELVELVGNGTYGQVYKG------RHVKTGQLAAIKVMDVTGDE- 63
Query: 138 HREWLAEVIFLGQL-RHPHLVRLIGYCCE------DEERLLVYEFMPRGSLENHLFKRIS 190
             E   E+  L +   H ++    G   +      D++  LV EF   GS+ + +     
Sbjct: 64  EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG 123
Query: 191 VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE 250
            +L       I     +GL+ LH  ++ VI+RD K  N+LL  +   KL DFG++     
Sbjct: 124 NTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181
Query: 251 GSNTHVTTRVMGTYGYAAPEYISTGH-----LTTKSDVYSFGVVLLELLTGRRSMDKLRP 305
                 T   +GT  + APE I+           KSD++S G+  +E+  G   +  + P
Sbjct: 182 TVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239
Query: 306 KSEQNLVDW-AKPYLRS---SRRLRYIVDPRLAGQYSVKGAKE 344
                L+     P L+S   S++ +  ++  L   +S + A E
Sbjct: 240 MRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATE 282

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 100/235 (42%), Gaps = 39/235 (16%)
Query: 80  DFQLSELRAITQNFSSNYL-----LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG 134
           D +  E +A+  +    +L     +G G F TV+KG     L      +    +L D + 
Sbjct: 10  DIEELETKAVGXSNDGRFLKFDIEIGRGSFKTVYKG-----LDTETTVEVAWCELQDRKL 64
Query: 135 LQGHRE-WLAEVIFLGQLRHPHLVRLI--------GYCCEDEERLLVYEFMPRGSLENHL 185
            +  R+ +  E   L  L+HP++VR          G  C     +LV E    G+L+ +L
Sbjct: 65  TKSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKC----IVLVTELXTSGTLKTYL 120
Query: 186 --FK--RISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-TAKLS 240
             FK  +I V   W  ++       KGL FLH    P+I+RD K  NI +     + K+ 
Sbjct: 121 KRFKVXKIKVLRSWCRQI------LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 174
Query: 241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
           D GLA +            V+GT  + APE     +     DVY+FG   LE  T
Sbjct: 175 DLGLATL----KRASFAKAVIGTPEFXAPEXYEEKY-DESVDVYAFGXCXLEXAT 224

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 106/238 (44%), Gaps = 34/238 (14%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH--REWLAEVIFLGQLRHPHL 156
           +G+G F  V         R  L  + VAV+++D   L     ++   EV  +  L HP++
Sbjct: 22  IGKGNFAKVKLA------RHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK------GLA 210
           V+L      ++   LV E+   G + ++L            R+K     AK       + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFRQIVSAVQ 127
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           + H  +  +++RD K  N+LLD+D   K++DFG +    E +  +      G+  YAAPE
Sbjct: 128 YCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSN---EFTFGNKLDEFCGSPPYAAPE 182
Query: 271 -YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            +    +   + DV+S GV+L  L++G    D       QNL +  +  LR   R+ +
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG------QNLKELRERVLRGKYRIPF 234

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 34/215 (15%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL--AEVIFLGQLRHPHL 156
           +G+G FG V +G          + + VAVK+      +  R W   AE+     LRH ++
Sbjct: 12  IGKGRFGEVWRG--------KWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENI 60
Query: 157 VRLIGYCCEDE----ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
           +  I    +D     +  LV ++   GSL ++L  R +V++     +K+A+  A GLA L
Sbjct: 61  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVE--GMIKLALSTASGLAHL 117
Query: 213 H----GAE-NPVI-YRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT--HVTTRVMGTY 264
           H    G +  P I +RD K+ NIL+  + T  ++D GLA      ++T        +GT 
Sbjct: 118 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 177
Query: 265 GYAAPEY----ISTGHLTT--KSDVYSFGVVLLEL 293
            Y APE     I+  H  +  ++D+Y+ G+V  E+
Sbjct: 178 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 34/238 (14%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH--REWLAEVIFLGQLRHPHL 156
           +G+G F  V         R  L  + VAV+++D   L     ++   EV  +  L HP++
Sbjct: 22  IGKGNFAKVKLA------RHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK------GLA 210
           V+L      ++   LV E+   G + ++L            R+K     AK       + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFRQIVSAVQ 127
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           + H  +  +++RD K  N+LLD+D   K++DFG +     G+         G+  YAAPE
Sbjct: 128 YCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPE 182
Query: 271 -YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            +    +   + DV+S GV+L  L++G    D       QNL +  +  LR   R+ +
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG------QNLKELRERVLRGKYRIPF 234

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 97/228 (42%), Gaps = 31/228 (13%)
Query: 82  QLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD----IEGLQG 137
           ++ +LR   +++    ++G G FG V        +R     +  A+KLL     I+    
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQL------VRHKSTRKVYAMKLLSKFEMIKRSDS 113
Query: 138 HREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG- 196
              W  E   +     P +V+L     +D    +V E+MP G L N L     V   W  
Sbjct: 114 AFFW-EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWAR 171
Query: 197 ---TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGS 252
                + +A+ A   + F+H        RD K  N+LLD     KL+DFG   KM  EG 
Sbjct: 172 FYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223
Query: 253 NTHVTTRVMGTYGYAAPEYIST----GHLTTKSDVYSFGVVLLELLTG 296
               T   +GT  Y +PE + +    G+   + D +S GV L E+L G
Sbjct: 224 VRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 34/215 (15%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL--AEVIFLGQLRHPHL 156
           +G+G FG V +G          + + VAVK+      +  R W   AE+     LRH ++
Sbjct: 11  IGKGRFGEVWRG--------KWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENI 59
Query: 157 VRLIGYCCEDE----ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
           +  I    +D     +  LV ++   GSL ++L  R +V++     +K+A+  A GLA L
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVE--GMIKLALSTASGLAHL 116
Query: 213 H----GAE-NPVI-YRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT--HVTTRVMGTY 264
           H    G +  P I +RD K+ NIL+  + T  ++D GLA      ++T        +GT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 265 GYAAPEY----ISTGHLTT--KSDVYSFGVVLLEL 293
            Y APE     I+  H  +  ++D+Y+ G+V  E+
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 34/215 (15%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL--AEVIFLGQLRHPHL 156
           +G+G FG V +G          + + VAVK+      +  R W   AE+     LRH ++
Sbjct: 17  IGKGRFGEVWRG--------KWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENI 65
Query: 157 VRLIGYCCEDE----ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
           +  I    +D     +  LV ++   GSL ++L  R +V++     +K+A+  A GLA L
Sbjct: 66  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVE--GMIKLALSTASGLAHL 122
Query: 213 H----GAE-NPVI-YRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT--HVTTRVMGTY 264
           H    G +  P I +RD K+ NIL+  + T  ++D GLA      ++T        +GT 
Sbjct: 123 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 182
Query: 265 GYAAPEY----ISTGHLTT--KSDVYSFGVVLLEL 293
            Y APE     I+  H  +  ++D+Y+ G+V  E+
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 26/208 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFLGQLRHPHL 156
           +G G +G+V   Y D  LRQ      VAVK L    + L   R    E+  L  L+H ++
Sbjct: 36  VGSGAYGSVCSAY-DARLRQ-----KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENV 89
Query: 157 VRLI-----GYCCED-EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
           + L+         ED  E  LV   M  G+  N++ K  ++S      L   +   +GL 
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQL--LRGLK 145
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           ++H A   +I+RD K SN+ ++ D   ++ DFGLA+   E    +V TR      Y APE
Sbjct: 146 YIHSA--GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPE 198
Query: 271 -YISTGHLTTKSDVYSFGVVLLELLTGR 297
             ++  H     D++S G ++ ELL G+
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 107/241 (44%), Gaps = 39/241 (16%)
Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--------LQG 137
           T  F  NY    +LG G    V +             +  AVK++D+ G        +Q 
Sbjct: 12  THGFYENYEPKEILGRGVSSVVRRCI------HKPTCKEYAVKIIDVTGGGSFSAEEVQE 65
Query: 138 HRE-WLAEVIFLGQLR-HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPW 195
            RE  L EV  L ++  HP++++L      +    LV++ M +G L ++L +++++S   
Sbjct: 66  LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS-EK 124
Query: 196 GTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH 255
            TR KI     + +  LH     +++RD K  NILLD D   KL+DFG +     G    
Sbjct: 125 ETR-KIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 181
Query: 256 VTTRVMGTYGYAAPEYISTGH------LTTKSDVYSFGVVLLELLTG------RRSMDKL 303
               V GT  Y APE I             + D++S GV++  LL G      R+ M  L
Sbjct: 182 ---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 304 R 304
           R
Sbjct: 239 R 239

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 34/215 (15%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL--AEVIFLGQLRHPHL 156
           +G+G FG V +G          + + VAVK+      +  R W   AE+     LRH ++
Sbjct: 14  IGKGRFGEVWRG--------KWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENI 62
Query: 157 VRLIGYCCEDE----ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
           +  I    +D     +  LV ++   GSL ++L  R +V++     +K+A+  A GLA L
Sbjct: 63  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVE--GMIKLALSTASGLAHL 119
Query: 213 H----GAE-NPVI-YRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT--HVTTRVMGTY 264
           H    G +  P I +RD K+ NIL+  + T  ++D GLA      ++T        +GT 
Sbjct: 120 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 179
Query: 265 GYAAPEY----ISTGHLTT--KSDVYSFGVVLLEL 293
            Y APE     I+  H  +  ++D+Y+ G+V  E+
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 97/228 (42%), Gaps = 31/228 (13%)
Query: 82  QLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD----IEGLQG 137
           ++ +LR   +++    ++G G FG V        +R     +  A+KLL     I+    
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEVQL------VRHKSTRKVYAMKLLSKFEMIKRSDS 118
Query: 138 HREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG- 196
              W  E   +     P +V+L     +D    +V E+MP G L N L     V   W  
Sbjct: 119 AFFW-EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWAR 176
Query: 197 ---TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGS 252
                + +A+ A   + F+H        RD K  N+LLD     KL+DFG   KM  EG 
Sbjct: 177 FYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 228
Query: 253 NTHVTTRVMGTYGYAAPEYIST----GHLTTKSDVYSFGVVLLELLTG 296
                T V GT  Y +PE + +    G+   + D +S GV L E+L G
Sbjct: 229 -VRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWL 142
           T  FS  Y    +LG+G FG V         +  +  Q  AVK++    ++        L
Sbjct: 21  TAIFSDRYKGQRVLGKGSFGEVIL------CKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 143 AEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
            EV  L QL HP++ +L  +  +     LV E    G L + +  R   S     R  I 
Sbjct: 75  REVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--II 132
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTR 259
                G+ + H  +N +++RD K  N+LL+S   D   ++ DFGL+        +     
Sbjct: 133 RQVLSGITYXH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKXKD 187
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            +GT  Y APE +  G    K DV+S GV+L  LL+G
Sbjct: 188 KIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 118/275 (42%), Gaps = 42/275 (15%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL--DIEGLQGHREWLAEVIFLGQLRHPHL 156
           LG G +G V K      +R     Q +AVK +   +   +  R  +   I +  +  P  
Sbjct: 15  LGRGAYGVVEK------MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRI---SVSLPWGTRLKIAIGAAKGLAFLH 213
           V   G    + +  +  E M   SL+   +K++     ++P     KIA+   K L  LH
Sbjct: 69  VTFYGALFREGDVWICMELM-DTSLDK-FYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI- 272
            ++  VI+RD K SN+L+++    K+ DFG++    +     +     G   Y APE I 
Sbjct: 127 -SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYMAPERIN 182
Query: 273 ---STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
              +    + KSD++S G+ ++EL   R   D            W  P+    ++L+ +V
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRFPYDS-----------WGTPF----QQLKQVV 227
Query: 330 D---PRLAGQYSVKGAKEMAVLALQCISVNPKDRP 361
           +   P+L      K + E      QC+  N K+RP
Sbjct: 228 EEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERP 259

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 107/241 (44%), Gaps = 39/241 (16%)
Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--------LQG 137
           T  F  NY    +LG G    V +             +  AVK++D+ G        +Q 
Sbjct: 12  THGFYENYEPKEILGRGVSSVVRRCI------HKPTCKEYAVKIIDVTGGGSFSAEEVQE 65
Query: 138 HRE-WLAEVIFLGQLR-HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPW 195
            RE  L EV  L ++  HP++++L      +    LV++ M +G L ++L +++++S   
Sbjct: 66  LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS-EK 124
Query: 196 GTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH 255
            TR KI     + +  LH     +++RD K  NILLD D   KL+DFG +     G    
Sbjct: 125 ETR-KIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR 181
Query: 256 VTTRVMGTYGYAAPEYISTGH------LTTKSDVYSFGVVLLELLTG------RRSMDKL 303
               V GT  Y APE I             + D++S GV++  LL G      R+ M  L
Sbjct: 182 ---SVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 304 R 304
           R
Sbjct: 239 R 239

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 97/228 (42%), Gaps = 31/228 (13%)
Query: 82  QLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD----IEGLQG 137
           ++ +LR   +++    ++G G FG V        +R     +  A+KLL     I+    
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEVQL------VRHKSTRKVYAMKLLSKFEMIKRSDS 118
Query: 138 HREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG- 196
              W  E   +     P +V+L     +D    +V E+MP G L N L     V   W  
Sbjct: 119 AFFW-EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWAR 176
Query: 197 ---TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGS 252
                + +A+ A   + F+H        RD K  N+LLD     KL+DFG   KM  EG 
Sbjct: 177 FYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 228
Query: 253 NTHVTTRVMGTYGYAAPEYIST----GHLTTKSDVYSFGVVLLELLTG 296
               T   +GT  Y +PE + +    G+   + D +S GV L E+L G
Sbjct: 229 VRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 25  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQ 133
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 134 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR--- 186
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 25  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 134 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 186
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 187 --WYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 25  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQ 133
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 134 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 186
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFLGQLRHPH 155
           L+GEG +G V K       R     + VA+K  L   +     +  + E+  L QLRH +
Sbjct: 32  LVGEGSYGMVMK------CRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLEN-HLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
           LV L+  C + +   LV+EF+    L++  LF      L +    K       G+ F H 
Sbjct: 86  LVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHS 142
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM--GP-EGSNTHVTTRVMGTYGYAAPEY 271
             + +I+RD K  NIL+      KL DFG A+    P E  +  V TR      Y APE 
Sbjct: 143 --HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRAPEL 195
Query: 272 ISTGHLTTKS-DVYSFGVVLLELLTGR 297
           +       K+ DV++ G ++ E+  G 
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 107/239 (44%), Gaps = 25/239 (10%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQG-LKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHL 156
           +LG+GG+G V +         G + A  V  K + +   +      AE   L +++HP +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 157 VRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           V LI Y  +   +L L+ E++  G L    F ++     +         A   +A  H  
Sbjct: 84  VDLI-YAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGSNTHVTTRVMGTYGYAAPEYIST 274
           +  +IYRD K  NI+L+     KL+DFGL K    +G+ TH      GT  Y APE +  
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT---FCGTIEYMAPEILMR 195
Query: 275 GHLTTKSDVYSFGVVLLELLTG---------RRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
                  D +S G ++ ++LTG         ++++DK+  K + NL     PYL    R
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL-KCKLNL----PPYLTQEAR 249

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 86  LRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD----IEGLQGHREW 141
           L+   +++    ++G G FG V        +R     +  A+KLL     I+       W
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQL------VRHKASQKVYAMKLLSKFEMIKRSDSAFFW 123
Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG----T 197
             E   +     P +V+L     +D+   +V E+MP G L N L     V   W      
Sbjct: 124 -EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTA 181
Query: 198 RLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT 257
            + +A+ A   +  +H        RD K  N+LLD     KL+DFG      E    H  
Sbjct: 182 EVVLALDAIHSMGLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCD 233
Query: 258 TRVMGTYGYAAPEYIST----GHLTTKSDVYSFGVVLLELLTG 296
           T V GT  Y +PE + +    G+   + D +S GV L E+L G
Sbjct: 234 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 121/289 (41%), Gaps = 44/289 (15%)
Query: 96  NYL--LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQL 151
           N+L  L E   G + KG          +   + VK+L +     +  R++  E   L   
Sbjct: 13  NFLTKLNENHSGELWKGR--------WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 152 RHPHLVRLIGYCCEDE--ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            HP+++ ++G C         L+  +MP GSL N L +  +  +     +K A+  A+G+
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLS--DFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           AFLH  E  +      + ++++D D TA++S  D   +   P           M    + 
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR---------MYAPAWV 175
Query: 268 APEYISTGHLTTK---SDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
           APE +      T    +D++SF V+L EL+T       L      N+    K  L     
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL-----SNMEIGMKVALEG--- 227
Query: 325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           LR  + P ++   S    K M +    C++ +P  RPK   +V  LE +
Sbjct: 228 LRPTIPPGISPHVS----KLMKI----CMNEDPAKRPKFDMIVPILEKM 268

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 27/228 (11%)
Query: 79  YDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQG 137
           +DF   +L+ + +       +G G +G+V+K      +      Q +AVK +      + 
Sbjct: 17  WDFTAEDLKDLGE-------IGRGAYGSVNK------MVHKPSGQIMAVKRIRSTVDEKE 63
Query: 138 HREWLAEV-IFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRG--SLENHLFKRISVSLP 194
            ++ L ++ + +     P++V+  G    + +  +  E M         +++  +   +P
Sbjct: 64  QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIP 123
Query: 195 WGTRLKIAIGAAKGLAFLHGAEN-PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN 253
                KI +   K L   H  EN  +I+RD K SNILLD     KL DFG++    +  +
Sbjct: 124 EEILGKITLATVKALN--HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVD 178
Query: 254 THVTTRVMGTYGYAAPEYI----STGHLTTKSDVYSFGVVLLELLTGR 297
           +   TR  G   Y APE I    S      +SDV+S G+ L EL TGR
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 107/239 (44%), Gaps = 25/239 (10%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQG-LKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHL 156
           +LG+GG+G V +         G + A  V  K + +   +      AE   L +++HP +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 157 VRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           V LI Y  +   +L L+ E++  G L    F ++     +         A   +A  H  
Sbjct: 84  VDLI-YAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG-PEGSNTHVTTRVMGTYGYAAPEYIST 274
           +  +IYRD K  NI+L+     KL+DFGL K    +G+ TH      GT  Y APE +  
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHX---FCGTIEYMAPEILMR 195
Query: 275 GHLTTKSDVYSFGVVLLELLTG---------RRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
                  D +S G ++ ++LTG         ++++DK+  K + NL     PYL    R
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL-KCKLNL----PPYLTQEAR 249

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 32  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 141 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR--- 193
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 194 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 30  QNLSP---IGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 138
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 139 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR--- 191
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 192 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 52/237 (21%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-----WLAEVI 146
           +F    +LG+G FG V K       R  L ++  A+K +       H E      L+EV+
Sbjct: 7   DFEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKI------RHTEEKLSTILSEVM 54
Query: 147 FLGQLRHPHLVRLIGYCCEDEERLLV---------------YEFMPRGSLENHLFKRISV 191
            L  L H ++VR   Y    E R  V                E+   G+L + L    ++
Sbjct: 55  LLASLNHQYVVRY--YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD-LIHSENL 111
Query: 192 SLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK----- 246
           +       ++     + L+++H     +I+RD K  NI +D     K+ DFGLAK     
Sbjct: 112 NQQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 247 --------MGPEGSNTHVTTRVMGTYGYAAPEYIS-TGHLTTKSDVYSFGVVLLELL 294
                       GS+ ++T+ + GT  Y A E +  TGH   K D+YS G++  E++
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 36  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 87  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 144
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 145 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR--- 197
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 198 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 24/233 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--GHREWLAEVIFLGQLRHPHL 156
           +G+G F  V         R  L  + VA+K++D   L     ++   EV  +  L HP++
Sbjct: 20  IGKGNFAKVKLA------RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG-TRLKIAIGAAKGLAFLHGA 215
           V+L      ++   L+ E+   G + ++L     +      ++ +  + A +   + H  
Sbjct: 74  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCH-- 128
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE-YIST 274
           +  +++RD K  N+LLD+D   K++DFG +     G          G+  YAAPE +   
Sbjct: 129 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT---FCGSPPYAAPELFQGK 185
Query: 275 GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            +   + DV+S GV+L  L++G    D       QNL +  +  LR   R+ +
Sbjct: 186 KYDGPEVDVWSLGVILYTLVSGSLPFDG------QNLKELRERVLRGKYRIPF 232

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 104/233 (44%), Gaps = 24/233 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--GHREWLAEVIFLGQLRHPHL 156
           +G+G F  V         R  L  + VA+K++D   L     ++   EV  +  L HP++
Sbjct: 23  IGKGNFAKVKLA------RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG-TRLKIAIGAAKGLAFLHGA 215
           V+L      ++   L+ E+   G + ++L     +      ++ +  + A +   + H  
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCH-- 131
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE-YIST 274
           +  +++RD K  N+LLD+D   K++DFG +     G          G   YAAPE +   
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA---FCGAPPYAAPELFQGK 188
Query: 275 GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            +   + DV+S GV+L  L++G    D       QNL +  +  LR   R+ +
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDG------QNLKELRERVLRGKYRIPF 235

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 32  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 141 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR--- 193
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 194 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 94  SSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRH 153
           S   +LG G FG VHK    ++   GLK   +A K++   G++   E   E+  + QL H
Sbjct: 92  SKTEILGGGRFGQVHKC---EETATGLK---LAAKIIKTRGMKDKEEVKNEISVMNQLDH 145
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRI---SVSLPWGTRLKIAIGAAKGLA 210
            +L++L        + +LV E++  G L    F RI   S +L     +       +G+ 
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIR 201
Query: 211 FLHGAENPVIYRDFKTSNIL-LDSDFTA-KLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
            +H  +  +++ D K  NIL ++ D    K+ DFGLA+         V     GT  + A
Sbjct: 202 HMH--QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN---FGTPEFLA 256
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLTG 296
           PE ++   ++  +D++S GV+   LL+G
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 32  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 141 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR--- 193
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 194 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 32  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 141 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 193
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 194 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 36  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 86
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 87  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 144
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 145 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 197
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 198 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 27  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 135
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 136 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 188
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 189 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 30  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 138
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 139 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR--- 191
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 192 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 25  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 134 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 186
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 25  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 134 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 186
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 25  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 134 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 186
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 37  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSKPFQSIIHAKRTYRELRLL 87
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 145
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 146 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 198
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 199 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 25  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 134 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 186
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 30  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 138
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 139 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 191
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 192 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 37  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 145
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 146 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 198
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 199 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 25  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 134 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 186
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 24  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 74
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 75  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 132
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 133 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 185
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 186 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 37  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 87
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 145
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 146 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 198
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 199 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 27  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 135
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 136 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 188
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 189 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 21  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 129
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 130 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 182
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 183 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 25  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 134 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 186
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 25  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 134 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 186
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 22  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 73  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 130
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 131 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 183
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 184 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 22  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 72
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 73  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 130
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 131 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 183
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 184 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 31  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 139
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 140 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 192
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 193 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 45  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 95
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 96  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 153
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 154 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 206
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 207 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 27  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 135
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 136 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 188
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 189 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 27  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 77
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 135
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 136 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR--- 188
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 189 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 44  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 94
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 95  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 152
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 153 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 205
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 206 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 30  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 80
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 138
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 139 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 191
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 192 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 23  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 73
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 74  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 131
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 132 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 184
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 185 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 48  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 99  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 156
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 157 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 209
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 210 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 88/208 (42%), Gaps = 18/208 (8%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-----REWLAEVIFLGQLR 152
           ++G+G F  V +    +        Q  AVK++D+            +   E      L+
Sbjct: 31  VIGKGAFSVVRRCINRE------TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 153 HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
           HPH+V L+     D    +V+EFM    L   + KR      +   +          A  
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 213 HGAENPVIYRDFKTSNILLDSDFTA---KLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAA 268
           +  +N +I+RD K  N+LL S   +   KL DFG+A ++G  G    V    +GT  + A
Sbjct: 145 YCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGL---VAGGRVGTPHFMA 201
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLTG 296
           PE +         DV+  GV+L  LL+G
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 31  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 139
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 140 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR--- 192
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 193 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 48  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 98
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 99  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 156
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 157 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR--- 209
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 210 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL----DIEGLQGHREWLAEVIFLGQLRHP 154
           +GEG +GTV K       +     + VA+K +    D EG+      L E+  L +L+H 
Sbjct: 10  IGEGTYGTVFKA------KNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHK 61
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
           ++VRL      D++  LV+EF  +  L+ + F   +  L             KGL F H 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQ-DLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
               V++RD K  N+L++ +   KL+DFGLA+    G      +  + T  Y  P+ +  
Sbjct: 120 RN--VLHRDLKPQNLLINRNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 275 GHL-TTKSDVYSFGVVLLELLTGRRSM 300
             L +T  D++S G +  EL    R +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 31  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 81
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 139
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 140 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 192
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 193 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 103/244 (42%), Gaps = 49/244 (20%)
Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVI 146
           +  N+   +L+G G +G V+  Y  +        + VA+K ++   E L   +  L E+ 
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKN------TEKNVAIKKVNRMFEDLIDCKRILREIT 77
Query: 147 FLGQLRHPHLVRLIGYCCEDE-----ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKI 201
            L +L+  +++RL      D+     E  +V E     S    LFK   + L       I
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKT-PIFLTEEHIKTI 134
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM-------------- 247
                 G  F+H  E+ +I+RD K +N LL+ D + K+ DFGLA+               
Sbjct: 135 LYNLLLGENFIH--ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 248 -----GPEGSN------THVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLT 295
                GP   N      +HV TR      Y APE I      TKS D++S G +  ELL 
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYTKSIDIWSTGCIFAELLN 247
Query: 296 GRRS 299
             +S
Sbjct: 248 MLQS 251

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 13/159 (8%)
Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-LPWGTRLK 200
           L EV  L  L HP++++L  +  +     LV E    G L + +  R+  + +     +K
Sbjct: 84  LEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK 143
Query: 201 IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVT 257
             +    G+ +LH  ++ +++RD K  N+LL+S   D   K+ DFGL+ +     N    
Sbjct: 144 QVLS---GVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKM 195
Query: 258 TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
              +GT  Y APE +   +   K DV+S GV+L  LL G
Sbjct: 196 KERLGTAYYIAPEVLRKKY-DEKCDVWSIGVILFILLAG 233

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 92  NFSSNYLLGEGGFGTVH--KGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFL 148
           +F     LG GGFG V   K  +DD           A+K + +   +  RE  + EV  L
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDD--------CNYAIKRIRLPNRELAREKVMREVKAL 57
Query: 149 GQLRHPHLVRLIGYCCEDE--ERLL-----VYEFMP-----RGSLENHLFKRISVS-LPW 195
            +L HP +VR      E    E+L      VY ++      + +L++ +  R ++     
Sbjct: 58  AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 196 GTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL--AKMGPEGSN 253
              L I +  A+ + FLH     +++RD K SNI    D   K+ DFGL  A    E   
Sbjct: 118 SVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 254 THVT--------TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELL 294
           T +T        T  +GT  Y +PE I     + K D++S G++L ELL
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 102/238 (42%), Gaps = 34/238 (14%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH--REWLAEVIFLGQLRHPHL 156
           +G+G F  V         R  L  + VAVK++D   L     ++   EV     L HP++
Sbjct: 22  IGKGNFAKVKLA------RHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK------GLA 210
           V+L      ++   LV E+   G + ++L            R K     AK       + 
Sbjct: 76  VKLFEVIETEKTLYLVXEYASGGEVFDYLVAH--------GRXKEKEARAKFRQIVSAVQ 127
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           + H  +  +++RD K  N+LLD+D   K++DFG +     G+         G   YAAPE
Sbjct: 128 YCH--QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPE 182
Query: 271 -YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
            +    +   + DV+S GV+L  L++G    D       QNL +  +  LR   R+ +
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG------QNLKELRERVLRGKYRIPF 234

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHLV 157
           LGEG + TV+KG      +  L    VA+K + +E  +G     + EV  L  L+H ++V
Sbjct: 10  LGEGTYATVYKG------KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
            L      ++   LV+E++ +  L+ +L    ++      +L       +GLA+ H    
Sbjct: 64  TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKL-FLFQLLRGLAYCH--RQ 119
Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE-YISTGH 276
            V++RD K  N+L++     KL+DFGLA+     + T+    V  T  Y  P+  + +  
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTD 177
Query: 277 LTTKSDVYSFGVVLLELLTGR 297
            +T+ D++  G +  E+ TGR
Sbjct: 178 YSTQIDMWGVGCIFYEMATGR 198

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 80/176 (45%), Gaps = 17/176 (9%)
Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT 258
           +  +   A+G+ FL  +    I+RD    NILL  +   K+ DFGLA+   +  +     
Sbjct: 202 ISYSFQVARGMEFL--SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKG 259
Query: 259 RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY 318
                  + APE I     +TKSDV+S+GV+L E+ +   S     P     + +     
Sbjct: 260 DTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGS-----PYPGVQMDEDFCSR 314
Query: 319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           LR   R+R       A +YS     E+  + L C   +PK+RP+ A +V  L  LL
Sbjct: 315 LREGMRMR-------APEYST---PEIYQIMLDCWHRDPKERPRFAELVEKLGDLL 360

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 25  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQ 133
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGL +   +    +V TR   
Sbjct: 134 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR--- 186
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 19/220 (8%)
Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD-IEGLQGHREWLAEVIF 147
           I+ +F    LLGEG +G V               + VA+K ++  +        L E+  
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSA------THKPTGEIVAIKKIEPFDKPLFALRTLREIKI 62
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI-GAA 206
           L   +H +++ +      D        ++ +  ++  L + IS  +     ++  I    
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS--NTHVT------T 258
           + +  LHG+   VI+RD K SN+L++S+   K+ DFGLA++  E +  N+  T      T
Sbjct: 123 RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 259 RVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
             + T  Y APE + T    +++ DV+S G +L EL   R
Sbjct: 181 EXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 25  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +     V TR   
Sbjct: 134 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATR--- 186
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 19/220 (8%)
Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD-IEGLQGHREWLAEVIF 147
           I+ +F    LLGEG +G V               + VA+K ++  +        L E+  
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSA------THKPTGEIVAIKKIEPFDKPLFALRTLREIKI 62
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI-GAA 206
           L   +H +++ +      D        ++ +  ++  L + IS  +     ++  I    
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS--NTHVT------T 258
           + +  LHG+   VI+RD K SN+L++S+   K+ DFGLA++  E +  N+  T      T
Sbjct: 123 RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 259 RVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
             + T  Y APE + T    +++ DV+S G +L EL   R
Sbjct: 181 EYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 25  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ D+GLA+   +    +V TR   
Sbjct: 134 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR--- 186
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 14/220 (6%)
Query: 80  DFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR 139
           +F ++     + N+     LG+G F  V +  +         A+ +  K L     Q   
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRC-VHKTTGLEFAAKIINTKKLSARDFQKLE 76
Query: 140 EWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRL 199
               E     +L+HP++VRL     E+    LV++ +  G L   +  R   S    +  
Sbjct: 77  R---EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC 133
Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF---TAKLSDFGLAKMGPEGSNTHV 256
              I   + +A+ H   N +++R+ K  N+LL S       KL+DFGLA    E +++  
Sbjct: 134 IQQI--LESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEA 186
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
                GT GY +PE +     +   D+++ GV+L  LL G
Sbjct: 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 17/203 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HREWLAEVIFLGQLRHPHL 156
           LG+G F  V +        + L  Q  A K+++ + L    H++   E      L+HP++
Sbjct: 30  LGKGAFSVVRRCV------KVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           VRL     E+    L+++ +  G L   +  R   S    +     I  A     LH  +
Sbjct: 84  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA----VLHCHQ 139
Query: 217 NPVIYRDFKTSNILLDSDF---TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
             V++RD K  N+LL S       KL+DFGLA +  EG          GT GY +PE + 
Sbjct: 140 MGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQ-QAWFGFAGTPGYLSPEVLR 197
Query: 274 TGHLTTKSDVYSFGVVLLELLTG 296
                   D+++ GV+L  LL G
Sbjct: 198 KDPYGKPVDLWACGVILYILLVG 220

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 91  QNFSSNYLLGEGGFGTVH-----KGYIDDDL--RQGLKAQAVAVKLLDIEGLQGHREWLA 143
           +NF    +LG G +G V       G+    L   + LK   +  K    E  +  R+ L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
            +      + P LV L  Y  + E +L L+ +++  G L  HL +R   +      ++I 
Sbjct: 114 HI-----RQSPFLVTL-HYAFQTETKLHLILDYINGGELFTHLSQRERFT---EHEVQIY 164
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           +G    LA  H  +  +IYRD K  NILLDS+    L+DFGL+K       T       G
Sbjct: 165 VGEIV-LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCG 222
Query: 263 TYGYAAPEYI---STGHLTTKSDVYSFGVVLLELLTG 296
           T  Y AP+ +    +GH     D +S GV++ ELLTG
Sbjct: 223 TIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTG 258

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK-LLDIEGLQGHREW-LAEVIFLGQLRHPHL 156
           +GEG +G V K       R     Q VA+K  L+ E     ++  L E+  L QL+HP+L
Sbjct: 11  IGEGSYGVVFK------CRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           V L+          LV+E+     L  H   R    +P      I     + + F H  +
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVKSITWQTLQAVNFCH--K 120
Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKM--GP-EGSNTHVTTRVMGTYGYAAPE-YI 272
           +  I+RD K  NIL+      KL DFG A++  GP +  +  V TR      Y +PE  +
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPELLV 175
Query: 273 STGHLTTKSDVYSFGVVLLELLTG 296
                    DV++ G V  ELL+G
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 17/212 (8%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWL-AEVIFL 148
           +++   Y +G G +G   K      +R+    + +  K LD   + +  ++ L +EV  L
Sbjct: 6   EDYEVLYTIGTGSYGRCQK------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 59
Query: 149 GQLRHPHLVRLIGYCCE--DEERLLVYEFMPRGSLENHLFK--RISVSLPWGTRLKIAIG 204
            +L+HP++VR      +  +    +V E+   G L + + K  +    L     L++   
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 205 AAKGLAFLH---GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
               L   H      + V++RD K +N+ LD     KL DFGLA++     +T      +
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFV 177
Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLEL 293
           GT  Y +PE ++      KSD++S G +L EL
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 99/236 (41%), Gaps = 50/236 (21%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-----WLAEVI 146
           +F    +LG+G FG V K       R  L ++  A+K +       H E      L+EV+
Sbjct: 7   DFEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKI------RHTEEKLSTILSEVM 54
Query: 147 FLGQLRHPHLVRLIGYCCEDEERLLVYE----------FMPRGSLENH----LFKRISVS 192
            L  L H ++VR   Y    E R  V            F+     EN     L    +++
Sbjct: 55  LLASLNHQYVVRY--YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLN 112
Query: 193 LPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK------ 246
                  ++     + L+++H     +I+RD K  NI +D     K+ DFGLAK      
Sbjct: 113 QQRDEYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 247 -------MGPEGSNTHVTTRVMGTYGYAAPEYIS-TGHLTTKSDVYSFGVVLLELL 294
                      GS+ ++T+ + GT  Y A E +  TGH   K D+YS G++  E++
Sbjct: 171 DILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 104/244 (42%), Gaps = 52/244 (21%)
Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVI 146
           I   +   +L+G G +G V + Y        L+ + VA+K  L   E L   +  L E+ 
Sbjct: 51  IPDRYEIRHLIGTGSYGHVCEAY------DKLEKRVVAIKKILRVFEDLIDCKRILREIA 104
Query: 147 FLGQLRHPHLVRLIGYCC-EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI-- 203
            L +L H H+V+++     +D E+    E      + +  FK++  +  + T L I    
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKF--DELYVVLEIADSDFKKLFRTPVYLTELHIKTLL 162
Query: 204 -GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM--GPEGSNT------ 254
                G+ ++H A   +++RD K +N L++ D + K+ DFGLA+    PE  N+      
Sbjct: 163 YNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 255 ----------------------HVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLL 291
                                 HV TR      Y APE I      T++ DV+S G +  
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTR-----WYRAPELILLQENYTEAIDVWSIGCIFA 275
Query: 292 ELLT 295
           ELL 
Sbjct: 276 ELLN 279

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL------DIEGLQGHREWLAEVIFLGQLR 152
           +G G +G+V       D R G K   VA+K L      +I   + +RE    ++ L  ++
Sbjct: 32  VGSGAYGSVCSAI---DKRSGEK---VAIKKLSRPFQSEIFAKRAYRE----LLLLKHMQ 81
Query: 153 HPHLVRLIGYCCEDEERLLVYEF---MPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
           H +++ L+            Y+F   MP   ++  L K + +         +     KGL
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMP--FMQTDLQKIMGLKFSEEKIQYLVYQMLKGL 139
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
            ++H A   V++RD K  N+ ++ D   K+ DFGLA+        +V TR      Y AP
Sbjct: 140 KYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAP 192
Query: 270 EYI-STGHLTTKSDVYSFGVVLLELLTGR 297
           E I S  H     D++S G ++ E+LTG+
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL------DIEGLQGHREWL 142
           + + + S   +G G +G+V       D R G K   VA+K L      +I   + +RE  
Sbjct: 40  LPKTYVSPTHVGSGAYGSVCSAI---DKRSGEK---VAIKKLSRPFQSEIFAKRAYRE-- 91
Query: 143 AEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEF---MPRGSLENHLFKRISVSLPWGTRL 199
             ++ L  ++H +++ L+            Y+F   MP   ++  L K + +        
Sbjct: 92  --LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP--FMQTDLQKIMGMEFSEEKIQ 147
Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
            +     KGL ++H A   V++RD K  N+ ++ D   K+ DFGLA+        +V TR
Sbjct: 148 YLVYQMLKGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR 205
Query: 260 VMGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
                 Y APE I S  H     D++S G ++ E+LTG+
Sbjct: 206 -----WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG VH+        +    +    K ++            E+  + QL HP L+ 
Sbjct: 59  LGSGAFGVVHR------CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS---LPWGTRLKIAIGAAKGLAFLHGA 215
           L     +  E +L+ EF+  G     LF RI+     +     +     A +GL  +H  
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMH-- 166
Query: 216 ENPVIYRDFKTSNILLDSD--FTAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAPEYI 272
           E+ +++ D K  NI+ ++    + K+ DFGLA K+ P+     +      T  +AAPE +
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD----EIVKVTTATAEFAAPEIV 222
Query: 273 STGHLTTKSDVYSFGVVLLELLTG 296
               +   +D+++ GV+   LL+G
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 17/212 (8%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWL-AEVIFL 148
           +++   Y +G G +G   K      +R+    + +  K LD   + +  ++ L +EV  L
Sbjct: 6   EDYEVLYTIGTGSYGRCQK------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 59
Query: 149 GQLRHPHLVRLIGYCCE--DEERLLVYEFMPRGSLENHLFK--RISVSLPWGTRLKIAIG 204
            +L+HP++VR      +  +    +V E+   G L + + K  +    L     L++   
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 205 AAKGLAFLH---GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
               L   H      + V++RD K +N+ LD     KL DFGLA++     +T      +
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFV 177
Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLEL 293
           GT  Y +PE ++      KSD++S G +L EL
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 267 AAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
            APE  ++  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 146 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 198
Query: 267 AAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
            APE  ++  H     D++S G ++ ELLTGR
Sbjct: 199 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 34/214 (15%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           +LG+G +G V+ G    DL   ++   +A+K +     +  +    E+     L+H ++V
Sbjct: 29  VLGKGTYGIVYAG---RDLSNQVR---IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV 82
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG--TRLKIAIG-----AAKGLA 210
           + +G   E+    +  E +P GSL   L  +      WG     +  IG       +GL 
Sbjct: 83  QYLGSFSENGFIKIFMEQVPGGSLSALLRSK------WGPLKDNEQTIGFYTKQILEGLK 136
Query: 211 FLHGAENPVIYRDFKTSNILLDS-DFTAKLSDFG----LAKMGPEGSNTHVTTRVMGTYG 265
           +LH  +N +++RD K  N+L+++     K+SDFG    LA + P       T    GT  
Sbjct: 137 YLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP------CTETFTGTLQ 188
Query: 266 YAAPEYISTG--HLTTKSDVYSFGVVLLELLTGR 297
           Y APE I  G       +D++S G  ++E+ TG+
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 267 AAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
            APE  ++  H     D++S G ++ ELLTGR
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + G +   VAVK L    + +   +    E+  L
Sbjct: 21  QNLSP---VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDDHVQFLIYQ 129
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR   
Sbjct: 130 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 182
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 183 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 155 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 207
Query: 267 AAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
            APE  ++  H     D++S G ++ ELLTGR
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 156 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 208
Query: 267 AAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
            APE  ++  H     D++S G ++ ELLTGR
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 267 AAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
            APE  ++  H     D++S G ++ ELLTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 11/162 (6%)
Query: 138 HREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGT 197
           H E   E+  L  L HP++++L     + +   LV EF   G L   +  R         
Sbjct: 90  HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA 149
Query: 198 RLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD---FTAKLSDFGLAKMGPEGSNT 254
            +   I +  G+ +LH  ++ +++RD K  NILL++       K+ DFGL+      S  
Sbjct: 150 NIMKQILS--GICYLH--KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF---FSKD 202
Query: 255 HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           +     +GT  Y APE +   +   K DV+S GV++  LL G
Sbjct: 203 YKLRDRLGTAYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCG 243

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 19/220 (8%)
Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD-IEGLQGHREWLAEVIF 147
           I+ +F    LLGEG +G V               + VA+K ++  +        L E+  
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSA------THKPTGEIVAIKKIEPFDKPLFALRTLREIKI 62
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI-GAA 206
           L   +H +++ +      D        ++ +  ++  L + IS  +     ++  I    
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS--NTHVT------T 258
           + +  LHG+   VI+RD K SN+L++S+   K+ DFGLA++  E +  N+  T       
Sbjct: 123 RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 259 RVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
             + T  Y APE + T    +++ DV+S G +L EL   R
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 18/214 (8%)
Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEV 145
           +  FS NY     LG+G F  V +  +         A+ +  K L     Q       E 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRC-VHKTTGLEFAAKIINTKKLSARDFQKLER---EA 56
Query: 146 IFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
               +L+HP++VRL     E+    LV++ +  G L   +  R   S    +     I  
Sbjct: 57  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI-- 114
Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDF---TAKLSDFGLAKMGPEGSNTHVTTRVMG 262
            + +A+ H   N +++R+ K  N+LL S       KL+DFGLA    E +++       G
Sbjct: 115 LESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAG 169
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           T GY +PE +     +   D+++ GV+L  LL G
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 18/211 (8%)
Query: 93  FSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFL 148
           FS NY     LG+G F  V +  +         A+ +  K L     Q       E    
Sbjct: 3   FSDNYDVKEELGKGAFSVVRRC-VHKTTGLEFAAKIINTKKLSARDFQKLER---EARIC 58
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
            +L+HP++VRL     E+    LV++ +  G L   +  R   S    +     I   + 
Sbjct: 59  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI--LES 116
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDF---TAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
           +A+ H   N +++R+ K  N+LL S       KL+DFGLA    E +++       GT G
Sbjct: 117 IAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPG 171
Query: 266 YAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           Y +PE +     +   D+++ GV+L  LL G
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL----DIEGLQGHREWLAEVIFLGQLRHP 154
           +GEG +GTV K       +     + VA+K +    D EG+      L E+  L +L+H 
Sbjct: 10  IGEGTYGTVFKA------KNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHK 61
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
           ++VRL      D++  LV+EF  +  L+ + F   +  L             KGL F H 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQ-DLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
               V++RD K  N+L++ +   KL++FGLA+    G      +  + T  Y  P+ +  
Sbjct: 120 RN--VLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 275 GHL-TTKSDVYSFGVVLLELLTGRRSM 300
             L +T  D++S G +  EL    R +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 18/214 (8%)
Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEV 145
           +  FS NY     LG+G F  V +  +         A+ +  K L     Q       E 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRC-VHKTTGLEFAAKIINTKKLSARDFQKLER---EA 56
Query: 146 IFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
               +L+HP++VRL     E+    LV++ +  G L   +  R   S    +     I  
Sbjct: 57  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI-- 114
Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDF---TAKLSDFGLAKMGPEGSNTHVTTRVMG 262
            + +A+ H   N +++R+ K  N+LL S       KL+DFGLA    E +++       G
Sbjct: 115 LESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAG 169
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           T GY +PE +     +   D+++ GV+L  LL G
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 101
Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            LV+L  Y  +D   L +V E++P G + +HL +    S P        I       +LH
Sbjct: 102 FLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLH 158
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
             +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I 
Sbjct: 159 SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIIL 211
Query: 274 TGHLTTKSDVYSFGVVLLELLTG 296
           +       D ++ GV++ E+  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 101
Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            LV+L  Y  +D   L +V E++P G + +HL +    S P        I       +LH
Sbjct: 102 FLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLH 158
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
             +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I 
Sbjct: 159 SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIIL 211
Query: 274 TGHLTTKSDVYSFGVVLLELLTG 296
           +       D ++ GV++ E+  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 101
Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            LV+L  Y  +D   L +V E++P G + +HL +    S P        I       +LH
Sbjct: 102 FLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLH 158
Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
             +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I 
Sbjct: 159 SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIIL 211
Query: 274 TGHLTTKSDVYSFGVVLLELLTG 296
           +       D ++ GV++ E+  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 17/212 (8%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWL-AEVIFL 148
           +++   Y +G G +G   K      +R+    + +  K LD   + +  ++ L +EV  L
Sbjct: 6   EDYEVLYTIGTGSYGRCQK------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 59
Query: 149 GQLRHPHLVRLIGYCCE--DEERLLVYEFMPRGSLENHLFK--RISVSLPWGTRLKIAIG 204
            +L+HP++VR      +  +    +V E+   G L + + K  +    L     L++   
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 205 AAKGLAFLH---GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
               L   H      + V++RD K +N+ LD     KL DFGLA++     +       +
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDEDFAKEFV 177
Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLEL 293
           GT  Y +PE ++      KSD++S G +L EL
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 25  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+  FGLA+   +    +V TR   
Sbjct: 134 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR--- 186
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 25  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ D GLA+   +    +V TR   
Sbjct: 134 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR--- 186
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 34/214 (15%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           +LG+G +G V+ G    DL   ++   +A+K +     +  +    E+     L+H ++V
Sbjct: 15  VLGKGTYGIVYAG---RDLSNQVR---IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV 68
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG--TRLKIAIG-----AAKGLA 210
           + +G   E+    +  E +P GSL   L  +      WG     +  IG       +GL 
Sbjct: 69  QYLGSFSENGFIKIFMEQVPGGSLSALLRSK------WGPLKDNEQTIGFYTKQILEGLK 122
Query: 211 FLHGAENPVIYRDFKTSNILLDS-DFTAKLSDFG----LAKMGPEGSNTHVTTRVMGTYG 265
           +LH  +N +++RD K  N+L+++     K+SDFG    LA + P       T    GT  
Sbjct: 123 YLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP------CTETFTGTLQ 174
Query: 266 YAAPEYISTG--HLTTKSDVYSFGVVLLELLTGR 297
           Y APE I  G       +D++S G  ++E+ TG+
Sbjct: 175 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 94
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++P G + +HL +RI        R   A        +LH 
Sbjct: 95  FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARF-YAAQIVLTFEYLHS 152
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 153 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 205
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 206 KGYNKAVDWWALGVLIYEMAAG 227

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 30/219 (13%)
Query: 93  FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR 152
           F    + G+G FGTV  G      ++     +VA+K + I+  +     L  +  L  L 
Sbjct: 25  FQVERMAGQGTFGTVQLG------KEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLH 77
Query: 153 HPHLVRLIGYCCEDEER-------LLVYEFMP---RGSLENHLFKRISVSLPWGTRLKIA 202
           HP++V+L  Y     ER        +V E++P        N+  ++++   P    +K+ 
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVA---PPPILIKVF 134
Query: 203 I-GAAKGLAFLHGAENPVIYRDFKTSNILL-DSDFTAKLSDFGLAK-MGPEGSNT-HVTT 258
           +    + +  LH     V +RD K  N+L+ ++D T KL DFG AK + P   N  ++ +
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICS 194
Query: 259 RVMGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTG 296
           R      Y APE I    H TT  D++S G +  E++ G
Sbjct: 195 RY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 118/275 (42%), Gaps = 33/275 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL-AEVIFLGQLRHPHLV 157
           LG G FG VH   + ++   GL+     +K ++ +  Q   E + AE+  L  L HP+++
Sbjct: 30  LGSGAFGDVH---LVEERSSGLER---VIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRIS--VSLPWGTRLKIAIGAAKGLAFLHGA 215
           ++     +     +V E    G L   +    +   +L  G   ++       LA+ H  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 216 ENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
              V+++D K  NIL          K+ DFGLA++    S+ H +T   GT  Y APE  
Sbjct: 144 H--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KSDEH-STNAAGTALYMAPEVF 198
Query: 273 STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR 332
               +T K D++S GVV+  LLTG         +  Q    + +P         Y V+ R
Sbjct: 199 KRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP--------NYAVECR 249
Query: 333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
                +V   K+M       ++ +P+ RP  A V+
Sbjct: 250 PLTPQAVDLLKQM-------LTKDPERRPSAAQVL 277

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 76/159 (47%), Gaps = 13/159 (8%)
Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-LPWGTRLK 200
           L EV  L QL HP++++L  +  +     LV E    G L + +  R   S +     +K
Sbjct: 52  LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK 111
Query: 201 IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVT 257
             +    G  +LH  ++ +++RD K  N+LL+S   D   K+ DFGL+     G      
Sbjct: 112 QVLS---GTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK---M 163
Query: 258 TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
              +GT  Y APE +   +   K DV+S GV+L  LL G
Sbjct: 164 KERLGTAYYIAPEVLRKKY-DEKCDVWSCGVILYILLCG 201

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           +G G FG V        ++        A+K+LD   +  L+     L E   L  +  P 
Sbjct: 49  IGTGSFGRVML------VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LV+L     ++    +V E+MP G + +HL +    S P        I       +LH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHSL 160
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +IYRD K  N+L+D     K++DFG AK   +G     T  + GT  Y APE I + 
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIKVADFGFAKR-VKGR----TWXLCGTPEYLAPEIILSK 213
Query: 276 HLTTKSDVYSFGVVLLELLTG 296
                 D ++ GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 25  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ D GLA+   +    +V TR   
Sbjct: 134 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR--- 186
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           +G G FG V        ++        A+K+LD   +  L+     L E   L  +  P 
Sbjct: 49  IGTGSFGRVML------VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LV+L     ++    +V E+MP G + +HL +    S P        I       +LH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHSL 160
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +IYRD K  N+L+D     K++DFG AK   +G     T  + GT  Y APE I + 
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIKVADFGFAKR-VKGR----TWXLCGTPEYLAPEIILSK 213
Query: 276 HLTTKSDVYSFGVVLLELLTG 296
                 D ++ GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +     V TR      Y
Sbjct: 156 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATR-----WY 208
Query: 267 AAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
            APE  ++  H     D++S G ++ ELLTGR
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 102
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++P G + +HL +    S P        I       +LH 
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 160
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 161 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 213
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAG 235

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +     V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 188
Query: 267 AAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
            APE  ++  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 94
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++P G + +HL +    S P        I       +LH 
Sbjct: 95  FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 152
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 153 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 205
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 206 KGYNKAVDWWALGVLIYEMAAG 227

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 122
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++P G + +HL +    S P        I       +LH 
Sbjct: 123 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 180
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 181 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 233
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 234 KGYNKAVDWWALGVLIYEMAAG 255

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +     V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 188
Query: 267 AAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
            APE  ++  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFL 148
           QN S    +G G +G+V   +   D + GL+   VAVK L    + +   +    E+  L
Sbjct: 25  QNLSP---VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLL 75
Query: 149 GQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
             ++H +++ L+          E  +  LV   M  G+  N++ K   ++      L   
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I   +GL ++H A+  +I+RD K SN+ ++ D   K+ D GLA+   +    +V TR   
Sbjct: 134 I--LRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR--- 186
Query: 263 TYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
              Y APE  ++  H     D++S G ++ ELLTGR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 102
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++P G + +HL +    S P        I       +LH 
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 160
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 161 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 213
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 102
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++P G + +HL +    S P        I       +LH 
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 160
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 161 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 213
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 104/247 (42%), Gaps = 52/247 (21%)
Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVI 146
           +  N+   +L+G G +G V+  Y D +  +      VA+K ++   E L   +  L E+ 
Sbjct: 26  VPDNYEIKHLIGRGSYGYVYLAY-DKNANKN-----VAIKKVNRMFEDLIDCKRILREIT 79
Query: 147 FLGQLRHPHLVRLIGYCC-ED----EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKI 201
            L +L+  +++RL      ED    +E  +V E     S    LFK   + L       I
Sbjct: 80  ILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIA--DSDLKKLFKT-PIFLTEQHVKTI 136
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM-------------- 247
                 G  F+H  E+ +I+RD K +N LL+ D + K+ DFGLA+               
Sbjct: 137 LYNLLLGEKFIH--ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLE 194
Query: 248 --------GPEGSN------THVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLE 292
                   GP   N      +HV TR      Y APE I      T S D++S G +  E
Sbjct: 195 EKEENEEPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYTNSIDIWSTGCIFAE 249
Query: 293 LLTGRRS 299
           LL   +S
Sbjct: 250 LLNMMKS 256

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 102
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E+ P G + +HL +    S P        I       +LH 
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 160
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+++D     K++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 161 LD--LIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 213
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAG 235

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 16/202 (7%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G +G V    +  D   G +     +K   +         L EV  L QL HP++++
Sbjct: 29  LGSGAYGEV---LLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMK 85
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS-LPWGTRLKIAIGAAKGLAFLHGAEN 217
           L  +  +     LV E    G L + +  R   S +     +K  +    G  +LH  ++
Sbjct: 86  LYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS---GTTYLH--KH 140
Query: 218 PVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +++RD K  N+LL+S   D   K+ DFGL+     G         +GT  Y APE +  
Sbjct: 141 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK---MKERLGTAYYIAPEVLRK 197
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
            +   K DV+S GV+L  LL G
Sbjct: 198 KY-DEKCDVWSCGVILYILLCG 218

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG VH+     D + G +    AVK + +E  +     + E++    L  P +V 
Sbjct: 80  LGRGSFGEVHR---MKDKQTGFQC---AVKKVRLEVFR-----VEELVACAGLSSPRIVP 128
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G   E     +  E +  GSL   L K++   LP    L     A +GL +LH     
Sbjct: 129 LYGAVREGPWVNIFMELLEGGSL-GQLIKQMGC-LPEDRALYYLGQALEGLEYLH--TRR 184
Query: 219 VIYRDFKTSNILLDSDFT-AKLSDFGLA-KMGPEGSNTHVTT--RVMGTYGYAAPEYIST 274
           +++ D K  N+LL SD + A L DFG A  + P+G    + T   + GT  + APE +  
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 244
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                K D++S   ++L +L G
Sbjct: 245 KPCDAKVDIWSSCCMMLHMLNG 266

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +     V TR      Y
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 184
Query: 267 AAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
            APE  ++  H     D++S G ++ ELLTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 104
Query: 152 RHPHLVRLIGYCC-----EDEERL-LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +       +DE  L LV +++P     +  H + R   +LP         
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 163
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAKMGPEGSNTHVTTRVMG 262
              + LA++H     + +RD K  N+LLD D    KL DFG AK    G      + +  
Sbjct: 164 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICS 219
Query: 263 TYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
            Y Y APE I      T+  DV+S G VL ELL G+
Sbjct: 220 RY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 104
Query: 152 RHPHLVRLIGYCC-----EDEERL-LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +       +DE  L LV +++P     +  H + R   +LP         
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 163
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAK--MGPEGSNTHVTTRV 260
              + LA++H     + +RD K  N+LLD D    KL DFG AK  +  E + +++ +R 
Sbjct: 164 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221
Query: 261 MGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
                Y APE I      T+  DV+S G VL ELL G+
Sbjct: 222 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    H    +    + L  Q V VKL +IE     +  L  V F      P
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKV-VKLKEIEHTLNEKRILQAVNF------P 101
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E+ P G + +HL +    S P        I       +LH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 159
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+++D     K++DFGLAK   +G     T  + GT  Y APE I +
Sbjct: 160 LD--LIYRDLKPENLMIDQQGYIKVTDFGLAKR-VKGR----TWXLCGTPEYLAPEIILS 212
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 98
Query: 152 RHPHLVRLIGYCC-----EDEERL-LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +       +DE  L LV +++P     +  H + R   +LP         
Sbjct: 99  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 157
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAK--MGPEGSNTHVTTRV 260
              + LA++H     + +RD K  N+LLD D    KL DFG AK  +  E + +++ +R 
Sbjct: 158 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 215
Query: 261 MGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
                Y APE I      T+  DV+S G VL ELL G+
Sbjct: 216 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 19/207 (9%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG---HREWLAEVIFLGQLRHP 154
           +LG GGFG V    +    +     +    +L   +G QG    ++ LA+V       H 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK---GLA 210
             +  + Y  E +  L LV   M  G +  H++  +    P     +     A+   GL 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYN-VDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
            LH  +  +IYRD K  N+LLD D   ++SD GLA     G     T    GT G+ APE
Sbjct: 304 HLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE 359
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGR 297
            +         D ++ GV L E++  R
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 82
Query: 152 RHPHLVRLIGYCC-----EDEERL-LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +       +DE  L LV +++P     +  H + R   +LP         
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 141
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAKMGPEGSNTHVTTRVMG 262
              + LA++H     + +RD K  N+LLD D    KL DFG AK    G      + +  
Sbjct: 142 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICS 197
Query: 263 TYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
            Y Y APE I      T+  DV+S G VL ELL G+
Sbjct: 198 RY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K    + LQ  R    E+  + +L
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIK----KVLQDKRFKNRELQIMRKL 89
Query: 152 RHPHLVRLIGYCC-----EDEERL-LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +       +DE  L LV +++P     +  H + R   +LP         
Sbjct: 90  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 148
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAKMGPEGSNTHVTTRVMG 262
              + LA++H     + +RD K  N+LLD D    KL DFG AK    G      + +  
Sbjct: 149 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICS 204
Query: 263 TYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
            Y Y APE I      T+  DV+S G VL ELL G+
Sbjct: 205 RY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 78
Query: 152 RHPHLVRLIGYCC-----EDEERL-LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +       +DE  L LV +++P     +  H + R   +LP         
Sbjct: 79  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 137
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAKMGPEGSNTHVTTRVMG 262
              + LA++H     + +RD K  N+LLD D    KL DFG AK    G      + +  
Sbjct: 138 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICS 193
Query: 263 TYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
            Y Y APE I      T+  DV+S G VL ELL G+
Sbjct: 194 RY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 19/207 (9%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG---HREWLAEVIFLGQLRHP 154
           +LG GGFG V    +    +     +    +L   +G QG    ++ LA+V       H 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK---GLA 210
             +  + Y  E +  L LV   M  G +  H++  +    P     +     A+   GL 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYN-VDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
            LH  +  +IYRD K  N+LLD D   ++SD GLA     G     T    GT G+ APE
Sbjct: 304 HLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE 359
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGR 297
            +         D ++ GV L E++  R
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 106
Query: 152 RHPHLVRLIGYCC-----EDEERL-LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +       +DE  L LV +++P     +  H + R   +LP         
Sbjct: 107 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 165
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAK--MGPEGSNTHVTTRV 260
              + LA++H     + +RD K  N+LLD D    KL DFG AK  +  E + +++ +R 
Sbjct: 166 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 223
Query: 261 MGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
                Y APE I      T+  DV+S G VL ELL G+
Sbjct: 224 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 19/207 (9%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG---HREWLAEVIFLGQLRHP 154
           +LG GGFG V    +    +     +    +L   +G QG    ++ LA+V       H 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK---GLA 210
             +  + Y  E +  L LV   M  G +  H++  +    P     +     A+   GL 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYN-VDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
            LH  +  +IYRD K  N+LLD D   ++SD GLA     G     T    GT G+ APE
Sbjct: 304 HLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE 359
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGR 297
            +         D ++ GV L E++  R
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 19/207 (9%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG---HREWLAEVIFLGQLRHP 154
           +LG GGFG V    +    +     +    +L   +G QG    ++ LA+V       H 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK---GLA 210
             +  + Y  E +  L LV   M  G +  H++  +    P     +     A+   GL 
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYN-VDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
            LH  +  +IYRD K  N+LLD D   ++SD GLA     G     T    GT G+ APE
Sbjct: 304 HLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPE 359
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGR 297
            +         D ++ GV L E++  R
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 108
Query: 152 RHPHLVRLIGYCCEDEERL------LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +     E+       LV +++P     +  H + R   +LP         
Sbjct: 109 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 167
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAK--MGPEGSNTHVTTRV 260
              + LA++H     + +RD K  N+LLD D    KL DFG AK  +  E + +++ +R 
Sbjct: 168 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 225
Query: 261 MGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
                Y APE I      T+  DV+S G VL ELL G+
Sbjct: 226 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 82
Query: 152 RHPHLVRLIGYCC-----EDEERL-LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +       +DE  L LV +++P     +  H + R   +LP         
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 141
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAKMGPEGSNTHVTTRVMG 262
              + LA++H     + +RD K  N+LLD D    KL DFG AK    G      + +  
Sbjct: 142 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICS 197
Query: 263 TYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
            Y Y APE I      T+  DV+S G VL ELL G+
Sbjct: 198 RY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/239 (23%), Positives = 102/239 (42%), Gaps = 24/239 (10%)
Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFL 148
           I + F    +LG G F  V        ++Q L  +  A+K +             E+  L
Sbjct: 7   IRKTFIFMEVLGSGAFSEVFL------VKQRLTGKLFALKCIKKSPAFRDSSLENEIAVL 60
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKR-ISVSLPWGTRLKIAIGAAK 207
            +++H ++V L           LV + +  G L + + +R +         ++  + A K
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVK 120
Query: 208 GLAFLHGAENPVIYRDFKTSNILL---DSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY 264
              +LH  EN +++RD K  N+L    + +    ++DFGL+KM   G    + +   GT 
Sbjct: 121 ---YLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTP 171
Query: 265 GYAAPEYISTGHLTTKSDVYSFGVVLLELLTG-----RRSMDKLRPKSEQNLVDWAKPY 318
           GY APE ++    +   D +S GV+   LL G       +  KL  K ++   ++  P+
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPF 230

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 94/217 (43%), Gaps = 19/217 (8%)
Query: 91  QNFSSNY----LLGEGGFGTVHKGY-IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEV 145
           + F + Y    LLG+GGFGTV  G+ + D L+  +K      ++L    L        EV
Sbjct: 27  EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRN-RVLGWSPLSDSVTCPLEV 85
Query: 146 IFLGQL----RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKI 201
             L ++     HP ++RL+ +    E  +LV E   R      LF  I+   P G     
Sbjct: 86  ALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLE---RPLPAQDLFDYITEKGPLGEGPSR 142
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLD-SDFTAKLSDFGLAKMGPEGSNTHVTTRV 260
                   A  H     V++RD K  NIL+D     AKL DFG   +     +    T  
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL----LHDEPYTDF 198
Query: 261 MGTYGYAAPEYISTGHL-TTKSDVYSFGVVLLELLTG 296
            GT  Y+ PE+IS        + V+S G++L +++ G
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K    + LQ  R    E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIK----KVLQDKRFKNRELQIMRKL 70
Query: 152 RHPHLVRLIGYCC-----EDEERL-LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +       +DE  L LV +++P     +  H + R   +LP         
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAKMGPEGSNTHVTTRVMG 262
              + LA++H     + +RD K  N+LLD D    KL DFG AK    G      + +  
Sbjct: 130 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICS 185
Query: 263 TYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
            Y Y APE I      T+  DV+S G VL ELL G+
Sbjct: 186 RY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 75
Query: 152 RHPHLVRLIGYCC-----EDEERL-LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +       +DE  L LV +++P     +  H + R   +LP         
Sbjct: 76  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 134
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAK--MGPEGSNTHVTTRV 260
              + LA++H     + +RD K  N+LLD D    KL DFG AK  +  E + +++ +R 
Sbjct: 135 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 192
Query: 261 MGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
                Y APE I      T+  DV+S G VL ELL G+
Sbjct: 193 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K    + LQ  R    E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIK----KVLQDKRFKNRELQIMRKL 70
Query: 152 RHPHLVRLIGYCC-----EDEERL-LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +       +DE  L LV +++P     +  H + R   +LP         
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAKMGPEGSNTHVTTRVMG 262
              + LA++H     + +RD K  N+LLD D    KL DFG AK    G      + +  
Sbjct: 130 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICS 185
Query: 263 TYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
            Y Y APE I      T+  DV+S G VL ELL G+
Sbjct: 186 RY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K    + LQ  R    E+  + +L
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIK----KVLQDKRFKNRELQIMRKL 83
Query: 152 RHPHLVRLIGYCC-----EDEERL-LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +       +DE  L LV +++P     +  H + R   +LP         
Sbjct: 84  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 142
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAK--MGPEGSNTHVTTRV 260
              + LA++H     + +RD K  N+LLD D    KL DFG AK  +  E + +++ +R 
Sbjct: 143 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 200
Query: 261 MGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
                Y APE I      T+  DV+S G VL ELL G+
Sbjct: 201 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K    + LQ  R    E+  + +L
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIK----KVLQDKRFKNRELQIMRKL 71
Query: 152 RHPHLVRLIGYCC-----EDEERL-LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +       +DE  L LV +++P     +  H + R   +LP         
Sbjct: 72  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 130
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAKMGPEGSNTHVTTRVMG 262
              + LA++H     + +RD K  N+LLD D    KL DFG AK    G      + +  
Sbjct: 131 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICS 186
Query: 263 TYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
            Y Y APE I      T+  DV+S G VL ELL G+
Sbjct: 187 RY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K +    LQ  R    E+  + +L
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQDKRFKNRELQIMRKL 149
Query: 152 RHPHLVRLIGYCC-----EDEERL-LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +       +DE  L LV +++P     +  H + R   +LP         
Sbjct: 150 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 208
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAK--MGPEGSNTHVTTRV 260
              + LA++H     + +RD K  N+LLD D    KL DFG AK  +  E + +++ +R 
Sbjct: 209 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 266
Query: 261 MGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
                Y APE I      T+  DV+S G VL ELL G+
Sbjct: 267 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K    + LQ  R    E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIK----KVLQDKRFKNRELQIMRKL 70
Query: 152 RHPHLVRLIGYCC-----EDEERL-LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +       +DE  L LV +++P     +  H + R   +LP         
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAK--MGPEGSNTHVTTRV 260
              + LA++H     + +RD K  N+LLD D    KL DFG AK  +  E + +++ +R 
Sbjct: 130 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 261 MGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
                Y APE I      T+  DV+S G VL ELL G+
Sbjct: 188 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG VH+     D + G +    AVK + +E  +     + E++    L  P +V 
Sbjct: 66  VGRGSFGEVHR---MKDKQTGFQC---AVKKVRLEVFR-----VEELVACAGLSSPRIVP 114
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G   E     +  E +  GSL   L K++   LP    L     A +GL +LH     
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSL-GQLIKQMGC-LPEDRALYYLGQALEGLEYLH--TRR 170
Query: 219 VIYRDFKTSNILLDSDFT-AKLSDFGLA-KMGPEGSNTHVTT--RVMGTYGYAAPEYIST 274
           +++ D K  N+LL SD + A L DFG A  + P+G    + T   + GT  + APE +  
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                K D++S   ++L +L G
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 78/177 (44%), Gaps = 29/177 (16%)
Query: 192 SLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG 251
           ++P     KIA+   K L  LH   + VI+RD K SN+L+++    K  DFG++    + 
Sbjct: 132 TIPEDILGKIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKXCDFGISGYLVDD 190
Query: 252 SNTHVTTRVMGTYGYAAPEYI----STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKS 307
               +     G   Y APE I    +    + KSD++S G+  +EL   R   D      
Sbjct: 191 VAKDIDA---GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDS----- 242
Query: 308 EQNLVDWAKPYLRSSRRLRYIVD---PRLAGQYSVKGAKEMAVLALQCISVNPKDRP 361
                 W  P+    ++L+ +V+   P+L      K + E      QC+  N K+RP
Sbjct: 243 ------WGTPF----QQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERP 286

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K    + LQ  R    E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIK----KVLQDKRFKNRELQIMRKL 70
Query: 152 RHPHLVRLIGYCCEDEERL------LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +     E+       LV +++P     +  H + R   +LP         
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAKMGPEGSNTHVTTRVMG 262
              + LA++H     + +RD K  N+LLD D    KL DFG AK    G      + +  
Sbjct: 130 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICS 185
Query: 263 TYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
            Y Y APE I      T+  DV+S G VL ELL G+
Sbjct: 186 RY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K    + LQ  R    E+  + +L
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIK----KVLQDKRFKNRELQIMRKL 74
Query: 152 RHPHLVRLIGYCC-----EDEERL-LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +       +DE  L LV +++P     +  H + R   +LP         
Sbjct: 75  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 133
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAKMGPEGSNTHVTTRVMG 262
              + LA++H     + +RD K  N+LLD D    KL DFG AK    G      + +  
Sbjct: 134 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICS 189
Query: 263 TYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
            Y Y APE I      T+  DV+S G VL ELL G+
Sbjct: 190 RY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/120 (32%), Positives = 59/120 (49%), Gaps = 13/120 (10%)
Query: 196 GTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNT 254
           G  L I I  A+ + FLH     +++RD K SNI    D   K+ DFGL   M  +    
Sbjct: 164 GVCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 255 HVTTRV---------MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELL-TGRRSMDKLR 304
            V T +         +GT  Y +PE I   + + K D++S G++L ELL +    M+++R
Sbjct: 222 TVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR 281

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 39/227 (17%)
Query: 85  ELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL------DIEGLQGH 138
           E+RA+ ++      +G G +G V       D R G K   VA+K L      ++   + +
Sbjct: 22  EVRAVYRDLQP---VGSGAYGAVCSAV---DGRTGAK---VAIKKLYRPFQSELFAKRAY 72
Query: 139 REWLAEVIFLGQLRHPHLVRLIGYCCEDE------ERLLVYEFMPRGSLENHLFKRISVS 192
           RE    +  L  +RH +++ L+     DE      +  LV  FM  G+    L K   + 
Sbjct: 73  RE----LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLG 126
Query: 193 LPWGTRLKIAI-GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG 251
                R++  +    KGL ++H A   +I+RD K  N+ ++ D   K+ DFGLA+     
Sbjct: 127 ---EDRIQFLVYQMLKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
Query: 252 SNTHVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
               V TR      Y APE I      T++ D++S G ++ E++TG+
Sbjct: 182 MXGXVVTR-----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG VH+    +D + G +    AVK + +E  +       E++    L  P +V 
Sbjct: 101 LGRGSFGEVHR---MEDKQTGFQC---AVKKVRLEVFRAE-----ELMACAGLTSPRIVP 149
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G   E     +  E +  GSL   L K     LP    L     A +GL +LH     
Sbjct: 150 LYGAVREGPWVNIFMELLEGGSL-GQLVKEQGC-LPEDRALYYLGQALEGLEYLHSRR-- 205
Query: 219 VIYRDFKTSNILLDSDFT-AKLSDFGLAK-MGPEGSNTHVTT--RVMGTYGYAAPEYIST 274
           +++ D K  N+LL SD + A L DFG A  + P+G    + T   + GT  + APE +  
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG 265
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                K DV+S   ++L +L G
Sbjct: 266 RSCDAKVDVWSSCCMMLHMLNG 287

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG VH+    +D + G +    AVK + +E  +       E++    L  P +V 
Sbjct: 82  LGRGSFGEVHR---MEDKQTGFQC---AVKKVRLEVFRAE-----ELMACAGLTSPRIVP 130
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G   E     +  E +  GSL   L K     LP    L     A +GL +LH     
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSL-GQLVKEQGC-LPEDRALYYLGQALEGLEYLHSRR-- 186
Query: 219 VIYRDFKTSNILLDSDFT-AKLSDFGLAK-MGPEGSNTHVTT--RVMGTYGYAAPEYIST 274
           +++ D K  N+LL SD + A L DFG A  + P+G    + T   + GT  + APE +  
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG 246
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                K DV+S   ++L +L G
Sbjct: 247 RSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 97/360 (26%), Positives = 150/360 (41%), Gaps = 71/360 (19%)
Query: 75  GPDLYDF-----QLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKL 129
           G D  DF     +L ELR          +L EGGF  V++     D+  G   +  A+K 
Sbjct: 12  GRDQSDFVGQTVELGELR-----LRVRRVLAEGGFAFVYEA---QDVGSG---REYALKR 60
Query: 130 LDIEGLQGHREWLAEVIFLGQLR-HPHLVRL-----IGYCCED--EERLLVYEFMPRGSL 181
           L     + +R  + EV F+ +L  HP++V+      IG    D  +   L+   + +G L
Sbjct: 61  LLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQL 120
Query: 182 ENHLFKRISVS-LPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS 240
              L K  S   L   T LKI     + +  +H  + P+I+RD K  N+LL +  T KL 
Sbjct: 121 VEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180
Query: 241 DFGLA---------------KMGPEGSNTHVTTRVMGTYGYAAPEYI---STGHLTTKSD 282
           DFG A               +   E   T  TT +     Y  PE I   S   +  K D
Sbjct: 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPM-----YRTPEIIDLYSNFPIGEKQD 235
Query: 283 VYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGA 342
           +++ G +L  LL  R          +    D AK  + +    +Y + P    QY+V  +
Sbjct: 236 IWALGCILY-LLCFR----------QHPFEDGAKLRIVNG---KYSIPPH-DTQYTVFHS 280
Query: 343 KEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMAVSCGQWPATQKSTRNGVSPKAT 402
              A+L      VNP++R  +A VV  L+ +   +++     + P T+   +NG    AT
Sbjct: 281 LIRAML-----QVNPEERLSIAEVVHQLQEIAAARNVN---PKSPITELLEQNGGYGSAT 332

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DF LA+   +    +V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR-----WY 188
Query: 267 AAPE-YISTGHLTTKSDVYSFGVVLLELLTGR 297
            APE  ++  H     D++S G ++ ELLTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 52/89 (58%), Gaps = 5/89 (5%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           APE I         D++S GV++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K    + LQG      E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIK----KVLQGKAFKNRELQIMRKL 70
Query: 152 RHPHLVRLIGYCC-----EDEERL-LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +       +DE  L LV +++P     +  H + R   +LP         
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAK--MGPEGSNTHVTTRV 260
              + LA++H     + +RD K  N+LLD D    KL DFG AK  +  E + +++ +R 
Sbjct: 130 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 261 MGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
                Y APE I      T+  DV+S G VL ELL G+
Sbjct: 188 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K    + LQG      E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIK----KVLQGKAFKNRELQIMRKL 70
Query: 152 RHPHLVRLIGYCC-----EDEERL-LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +       +DE  L LV +++P     +  H + R   +LP         
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAK--MGPEGSNTHVTTRV 260
              + LA++H     + +RD K  N+LLD D    KL DFG AK  +  E + +++ +R 
Sbjct: 130 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 261 MGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
                Y APE I      T+  DV+S G VL ELL G+
Sbjct: 188 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 17/213 (7%)
Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HREWLAEVI 146
            T+ +     LG+G F  V +        + L  Q  A  +++ + L    H++   E  
Sbjct: 9   FTEEYQLFEELGKGAFSVVRRCV------KVLAGQEYAAMIINTKKLSARDHQKLEREAR 62
Query: 147 FLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAA 206
               L+HP++VRL     E+    L+++ +  G L   +  R   S    +     I  A
Sbjct: 63  ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA 122
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDF---TAKLSDFGLAKMGPEGSNTHVTTRVMGT 263
                LH  +  V++R+ K  N+LL S       KL+DFGLA +  EG          GT
Sbjct: 123 ----VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQ-QAWFGFAGT 176
Query: 264 YGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            GY +PE +         D+++ GV+L  LL G
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG VH+     D + G +    AVK + +E  +     + E++    L  P +V 
Sbjct: 82  VGRGSFGEVHR---MKDKQTGFQC---AVKKVRLEVFR-----VEELVACAGLSSPRIVP 130
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G   E     +  E +  GSL   L K++   LP    L     A +GL +LH     
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSL-GQLIKQMGC-LPEDRALYYLGQALEGLEYLH--TRR 186
Query: 219 VIYRDFKTSNILLDSDFT-AKLSDFGLA-KMGPEGSNTHVTT--RVMGTYGYAAPEYIST 274
           +++ D K  N+LL SD + A L DFG A  + P+G    + T   + GT  + APE +  
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 246
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                K D++S   ++L +L G
Sbjct: 247 KPCDAKVDIWSSCCMMLHMLNG 268

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 52/89 (58%), Gaps = 5/89 (5%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           APE I         D++S GV++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           +G G FG V        ++        A+K+LD   +  L+     L E   L  +  P 
Sbjct: 49  IGTGSFGRVML------VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LV+L     ++    +V E++P G + +HL +    S P        I       +LH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHSL 160
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +IYRD K  N+L+D     K++DFG AK   +G     T  + GT  Y APE I + 
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIKVADFGFAKR-VKGR----TWXLCGTPEYLAPEIILSK 213
Query: 276 HLTTKSDVYSFGVVLLELLTG 296
                 D ++ GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    H    +    + L  Q V VKL +IE     +  L  V F      P
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKV-VKLKEIEHTLNEKRILQAVNF------P 101
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E+ P G + +HL +    S P        I       +LH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 159
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+++D     +++DFGLAK   +G     T  + GT  Y APE I +
Sbjct: 160 LD--LIYRDLKPENLMIDQQGYIQVTDFGLAKR-VKGR----TWXLCGTPEYLAPEIILS 212
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 96/236 (40%), Gaps = 50/236 (21%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-----WLAEVI 146
           +F    +LG+G FG V K       R  L ++  A+K +       H E      L+EV 
Sbjct: 7   DFEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKI------RHTEEKLSTILSEVX 54
Query: 147 FLGQLRHPHLVRLIGYCCEDEERLLVYE----------FMPRGSLENH----LFKRISVS 192
            L  L H ++VR   Y    E R  V            F+     EN     L    +++
Sbjct: 55  LLASLNHQYVVRY--YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLN 112
Query: 193 LPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK------ 246
                  ++     + L+++H     +I+R+ K  NI +D     K+ DFGLAK      
Sbjct: 113 QQRDEYWRLFRQILEALSYIHS--QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 247 -------MGPEGSNTHVTTRVMGTYGYAAPEYIS-TGHLTTKSDVYSFGVVLLELL 294
                      GS+ ++T+  +GT  Y A E +  TGH   K D YS G++  E +
Sbjct: 171 DILKLDSQNLPGSSDNLTS-AIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +     V F      P
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRIQQAVNF------P 102
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E+ P G + +HL +    S P        I       +LH 
Sbjct: 103 FLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 160
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     K++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 161 LD--LIYRDLKPENLLIDQQGYIKVADFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 213
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           LG G FG V        ++        A+K+LD   +  L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVML------VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LV+L     ++    +V E++P G + +HL +RI        R   A        +LH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARF-YAAQIVLTFEYLHSL 160
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I + 
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILSK 213
Query: 276 HLTTKSDVYSFGVVLLELLTG 296
                 D ++ GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           LG G FG V        ++        A+K+LD   +  L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVML------VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LV+L     ++    +V E++P G + +HL +RI        R   A        +LH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARF-YAAQIVLTFEYLHSL 160
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I + 
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILSK 213
Query: 276 HLTTKSDVYSFGVVLLELLTG 296
                 D ++ GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           +++   ++G G FG V++  + D        + VA+K    + LQG      E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDS------GELVAIK----KVLQGKAFKNRELQIMRKL 70
Query: 152 RHPHLVRLIGYCC-----EDEERL-LVYEFMPRG--SLENHLFKRISVSLPWGTRLKIAI 203
            H ++VRL  +       +DE  L LV +++P     +  H + R   +LP         
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARH-YSRAKQTLPVIYVKLYMY 129
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-KLSDFGLAKMGPEGSNTHVTTRVMG 262
              + LA++H     + +RD K  N+LLD D    KL DFG AK    G      + +  
Sbjct: 130 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSXICS 185
Query: 263 TYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
            Y Y APE I      T+  DV+S G VL ELL G+
Sbjct: 186 RY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           LG G FG V        ++        A+K+LD   +  L+     L E   L  +  P 
Sbjct: 50  LGTGSFGRVML------VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LV+L     ++    +V E++P G + +HL +RI        R   A        +LH  
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-RRIGRFXEPHARF-YAAQIVLTFEYLHSL 161
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I + 
Sbjct: 162 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILSK 214
Query: 276 HLTTKSDVYSFGVVLLELLTG 296
                 D ++ GV++ E+  G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           LG G FG V        ++        A+K+LD   +  L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVML------VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LV+L     ++    +V E+ P G + +HL +RI        R   A        +LH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFXEPHARF-YAAQIVLTFEYLHSL 160
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +IYRD K  N+++D     K++DFG AK   +G     T  + GT  Y APE I + 
Sbjct: 161 D--LIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILSK 213
Query: 276 HLTTKSDVYSFGVVLLELLTG 296
                 D ++ GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 144 EVIFLGQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGT 197
           E++ +  + H +++ L+          E ++  LV E M     + +L + I + L    
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHER 127
Query: 198 RLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT 257
              +      G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T
Sbjct: 128 MSYLLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMT 183
Query: 258 TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLE------LLTGRRSMDKLRPKSEQ 309
             V+  Y Y APE I         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 184 PYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           LG G FG V        ++        A+K+LD   +  L+     L E   L  +  P 
Sbjct: 50  LGTGSFGRVML------VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LV+L     ++    +V E++P G + +HL +    S P        I       +LH  
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHSL 161
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I + 
Sbjct: 162 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILSK 214
Query: 276 HLTTKSDVYSFGVVLLELLTG 296
                 D ++ GV++ E+  G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 69/148 (46%), Gaps = 5/148 (3%)
Query: 149 GQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
           G+L+ PH+V +  +   D +  +    +    L   L ++  ++ P    +   IG+A  
Sbjct: 89  GRLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALD 148
Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
            A          +RD K  NIL+ +D  A L DFG+A    +   T +   V GT  Y A
Sbjct: 149 AA----HAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXA 203
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLTG 296
           PE  S  H T ++D+Y+   VL E LTG
Sbjct: 204 PERFSESHATYRADIYALTCVLYECLTG 231

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           LG G FG V        ++        A+K+LD   +  L+     L E   L  +  P 
Sbjct: 50  LGTGSFGRVML------VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LV+L     ++    +V E++P G + +HL +    S P        I       +LH  
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHSL 161
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I + 
Sbjct: 162 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWTLCGTPEYLAPEIILSK 214
Query: 276 HLTTKSDVYSFGVVLLELLTG 296
                 D ++ GV++ E+  G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           LG G FG V        ++        A+K+LD   +  L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVML------VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LV+L     ++    +V E++P G + +HL +    S P        I       +LH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHSL 160
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I + 
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILSK 213
Query: 276 HLTTKSDVYSFGVVLLELLTG 296
                 D ++ GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           LG G FG V        ++        A+K+LD   +  L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVML------VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LV+L     ++    +V E++P G + +HL +    S P        I       +LH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHSL 160
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I + 
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILSK 213
Query: 276 HLTTKSDVYSFGVVLLELLTG 296
                 D ++ GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           LG G FG V        ++        A+K+LD   +  L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVML------VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LV+L     ++    +V E++P G + +HL +    S P        I       +LH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHSL 160
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I + 
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILSK 213
Query: 276 HLTTKSDVYSFGVVLLELLTG 296
                 D ++ GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPEVVTRY-YR 192
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           APE I         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA------EVIFLGQLR 152
           LG G F  V K       RQ    +  A K +    L   R  ++      EV  L ++R
Sbjct: 13  LGSGQFAIVRK------CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 153 HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
           HP+++ L        + +L+ E +  G L + L ++ S++    T+    I    G+ +L
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--LDGVHYL 124
Query: 213 HGAENPVIYRDFKTSNI-LLDSDF---TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           H     + + D K  NI LLD +      KL DFG+A     G+       + GT  + A
Sbjct: 125 HSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVA 179
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLTG 296
           PE ++   L  ++D++S GV+   LL+G
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 87/201 (43%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           LG G FG V        ++        A+K+LD   +  L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVML------VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LV+L     ++    +V E+ P G + +HL +    S P        I       +LH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHSL 160
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +IYRD K  N+++D     K++DFG AK   +G     T  + GT  Y APE I + 
Sbjct: 161 D--LIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILSK 213
Query: 276 HLTTKSDVYSFGVVLLELLTG 296
                 D ++ GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           LG G FG V        ++        A+K+LD   +  L+     L E   L  +  P 
Sbjct: 35  LGTGSFGRVML------VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 88
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LV+L     ++    +V E++P G + +HL +    S P        I       +LH  
Sbjct: 89  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHSL 146
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I + 
Sbjct: 147 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWTLCGTPEYLAPEIILSK 199
Query: 276 HLTTKSDVYSFGVVLLELLTG 296
                 D ++ GV++ E+  G
Sbjct: 200 GYNKAVDWWALGVLIYEMAAG 220

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 122
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++  G + +HL +    S P        I       +LH 
Sbjct: 123 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 180
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK     + T     + GT  Y APE I +
Sbjct: 181 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT-----LCGTPEYLAPEIILS 233
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 234 KGYNKAVDWWALGVLIYEMAAG 255

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA------EVIFLGQLR 152
           LG G F  V K       RQ    +  A K +    L   R  ++      EV  L ++R
Sbjct: 20  LGSGQFAIVRK------CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 153 HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
           HP+++ L        + +L+ E +  G L + L ++ S++    T+    I    G+ +L
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--LDGVHYL 131
Query: 213 HGAENPVIYRDFKTSNI-LLDSDF---TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           H     + + D K  NI LLD +      KL DFG+A     G+       + GT  + A
Sbjct: 132 HSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVA 186
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLTG 296
           PE ++   L  ++D++S GV+   LL+G
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+     +N  +T  V+  Y Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--CTNFMMTPYVVTRY-YR 192
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           APE I         D++S G ++ EL+ G
Sbjct: 193 APEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 17/225 (7%)
Query: 77  DLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ 136
           +LY   ++     T ++     LG+G F  V +        +    Q  A K+++ + L 
Sbjct: 17  NLYFQXMATCTRFTDDYQLFEELGKGAFSVVRRCV------KKTPTQEYAAKIINTKKLS 70
Query: 137 G--HREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLP 194
              H++   E      L+HP++VRL     E+    LV++ +  G L   +  R   S  
Sbjct: 71  ARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEA 130
Query: 195 WGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF---TAKLSDFGLAKMGPEG 251
             +     I  +      H  ++ +++RD K  N+LL S       KL+DFGLA +  +G
Sbjct: 131 DASHCIHQILESVN----HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQG 185
Query: 252 SNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
                     GT GY +PE +         D+++ GV+L  LL G
Sbjct: 186 EQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 23/206 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLK---AQAVAVKLLDIEGLQG--HREWLAEVIFLGQLRH 153
           LG+G F  V         R+ +K    Q  A K+++ + L    H++   E      L+H
Sbjct: 12  LGKGAFSVV---------RRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
           P++VRL     E+    LV++ +  G L   +  R   S    +     I  +     L+
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 214 GAENPVIYRDFKTSNILLDSD---FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
           G    +++RD K  N+LL S       KL+DFGLA +  +G +        GT GY +PE
Sbjct: 123 G----IVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQG-DQQAWFGFAGTPGYLSPE 176
Query: 271 YISTGHLTTKSDVYSFGVVLLELLTG 296
            +         D+++ GV+L  LL G
Sbjct: 177 VLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           APE I         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 24/164 (14%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSL-----ENHLFKRISVSLPWGTR 198
           E+  L +L HP ++++  +  + E+  +V E M  G L      N   K  +  L +  +
Sbjct: 65  EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQ 122
Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTH 255
           + +A+       +LH  EN +I+RD K  N+LL S   D   K++DFG +K+  E   T 
Sbjct: 123 MLLAV------QYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TS 171
Query: 256 VTTRVMGTYGYAAPEY---ISTGHLTTKSDVYSFGVVLLELLTG 296
           +   + GT  Y APE    + T       D +S GV+L   L+G
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 193
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           APE I         D++S G ++ E++ G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 144 EVIFLGQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGT 197
           E++ +  + H +++ L+          E ++  LV E M     + +L + I + L    
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHER 127
Query: 198 RLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT 257
              +      G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T
Sbjct: 128 MSYLLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMT 183
Query: 258 TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLE------LLTGRRSMDKLRPKSEQ 309
             V+  Y Y APE I         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 184 PYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 24/164 (14%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSL-----ENHLFKRISVSLPWGTR 198
           E+  L +L HP ++++  +  + E+  +V E M  G L      N   K  +  L +   
Sbjct: 65  EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTH 255
           L         + +LH  EN +I+RD K  N+LL S   D   K++DFG +K+  E   T 
Sbjct: 124 LL-------AVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TS 171
Query: 256 VTTRVMGTYGYAAPEY---ISTGHLTTKSDVYSFGVVLLELLTG 296
           +   + GT  Y APE    + T       D +S GV+L   L+G
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA------EVIFLGQLR 152
           LG G F  V K       RQ    +  A K +    L   R  ++      EV  L ++R
Sbjct: 34  LGSGQFAIVRK------CRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 153 HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
           HP+++ L        + +L+ E +  G L + L ++ S++    T+    I    G+ +L
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--LDGVHYL 145
Query: 213 HGAENPVIYRDFKTSNI-LLDSDF---TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
           H     + + D K  NI LLD +      KL DFG+A     G+       + GT  + A
Sbjct: 146 HSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVA 200
Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLTG 296
           PE ++   L  ++D++S GV+   LL+G
Sbjct: 201 PEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 24/164 (14%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSL-----ENHLFKRISVSLPWGTR 198
           E+  L +L HP ++++  +  + E+  +V E M  G L      N   K  +  L +  +
Sbjct: 71  EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQ 128
Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTH 255
           + +A+       +LH  EN +I+RD K  N+LL S   D   K++DFG +K+  E   T 
Sbjct: 129 MLLAV------QYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TS 177
Query: 256 VTTRVMGTYGYAAPEY---ISTGHLTTKSDVYSFGVVLLELLTG 296
           +   + GT  Y APE    + T       D +S GV+L   L+G
Sbjct: 178 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 55/95 (57%), Gaps = 5/95 (5%)
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTY 264
           +GL ++H A+  VI+RD K SN+L++ +   K+ DFG+A+        + +  T  + T 
Sbjct: 170 RGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 265 GYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGRR 298
            Y APE + + H  T++ D++S G +  E+L  R+
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 24/164 (14%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSL-----ENHLFKRISVSLPWGTR 198
           E+  L +L HP ++++  +  + E+  +V E M  G L      N   K  +  L +  +
Sbjct: 64  EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQ 121
Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTH 255
           + +A+       +LH  EN +I+RD K  N+LL S   D   K++DFG +K+  E   T 
Sbjct: 122 MLLAV------QYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TS 170
Query: 256 VTTRVMGTYGYAAPEY---ISTGHLTTKSDVYSFGVVLLELLTG 296
           +   + GT  Y APE    + T       D +S GV+L   L+G
Sbjct: 171 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 101
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++  G + +HL +RI        R   A        +LH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARF-YAAQIVLTFEYLHS 159
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 212
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           APE I         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 24/164 (14%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSL-----ENHLFKRISVSLPWGTR 198
           E+  L +L HP ++++  +  + E+  +V E M  G L      N   K  +  L +   
Sbjct: 65  EIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTH 255
           L         + +LH  EN +I+RD K  N+LL S   D   K++DFG +K+  E   T 
Sbjct: 124 LL-------AVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TS 171
Query: 256 VTTRVMGTYGYAAPEY---ISTGHLTTKSDVYSFGVVLLELLTG 296
           +   + GT  Y APE    + T       D +S GV+L   L+G
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 101
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++  G + +HL +RI        R   A        +LH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARF-YAAQIVLTFEYLHS 159
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 212
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 101
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++  G + +HL +    S P        I       +LH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 159
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 212
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 144 EVIFLGQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGT 197
           E++ +  + H +++ L+          E ++  LV E M     + +L + I + L    
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHER 120
Query: 198 RLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT 257
              +      G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T
Sbjct: 121 MSYLLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMT 176
Query: 258 TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLE------LLTGRRSMDKLRPKSEQ 309
             V+  Y Y APE I         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 177 PYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 144 EVIFLGQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGT 197
           E++ +  + H +++ L+          E ++  LV E M     + +L + I + L    
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHER 127
Query: 198 RLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT 257
              +      G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T
Sbjct: 128 MSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMT 183
Query: 258 TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLE------LLTGRRSMDKLRPKSEQ 309
             V+  Y Y APE I         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 184 PYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-HPHL 156
           LLGEG +  V        L+ G   +  AVK+++ +          EV  L Q + + ++
Sbjct: 20  LLGEGAYAKVQGAV---SLQNG---KEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNI 73
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           + LI +  +D    LV+E +  GS+  H+ K+   +    +R+   + AA  L FLH   
Sbjct: 74  LELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAA--LDFLH--T 129
Query: 217 NPVIYRDFKTSNILLDSDFT---AKLSDFGLAK-MGPEGSNTHVTTRVM----GTYGYAA 268
             + +RD K  NIL +S       K+ DF L   M    S T +TT  +    G+  Y A
Sbjct: 130 KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMA 189
Query: 269 PEYIS--TGHLT---TKSDVYSFGVVLLELLTG 296
           PE +   T   T    + D++S GVVL  +L+G
Sbjct: 190 PEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 39/225 (17%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLAEVIFLGQLR-HP 154
           LG+G +G V K     D R G   + VAVK +  +  Q   +      E++ L +L  H 
Sbjct: 17  LGKGAYGIVWKSI---DRRTG---EVVAVKKI-FDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 155 HLVRLIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
           ++V L+     D +R   LV+++M     + H   R ++  P   +  +     K + +L
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYM---ETDLHAVIRANILEPVHKQY-VVYQLIKVIKYL 125
Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE------------GSNTH----- 255
           H     +++RD K SNILL+++   K++DFGL++                  NT      
Sbjct: 126 HSG--GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 256 --VTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
             + T  + T  Y APE +      TK  D++S G +L E+L G+
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 101
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++  G + +HL +    S P        I       +LH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 159
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLXGTPEYLAPEIILS 212
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           APE I         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 101
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++  G + +HL +    S P        I       +LH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 159
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLAGTPEYLAPEIILS 212
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 101
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++  G + +HL +RI        R   A        +LH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARF-YAAQIVLTFEYLHS 159
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 212
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+     +N  +T  V+  Y Y 
Sbjct: 136 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--STNFMMTPYVVTRY-YR 190
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           APE I         D++S G ++ EL+ G
Sbjct: 191 APEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 101
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++  G + +HL +    S P        I       +LH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 159
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 212
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 101
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++  G + +HL +RI        R   A        +LH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFAEPHARF-YAAQIVLTFEYLHS 159
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 212
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 96
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++  G + +HL +RI        R   A        +LH 
Sbjct: 97  FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARF-YAAQIVLTFEYLHS 154
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 155 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 207
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 208 KGYNKAVDWWALGVLIYEMAAG 229

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 122
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++  G + +HL +RI        R   A        +LH 
Sbjct: 123 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFXEPHARF-YAAQIVLTFEYLHS 180
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 181 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 233
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 234 KGYNKAVDWWALGVLIYEMAAG 255

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 102
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++  G + +HL +    S P        I       +LH 
Sbjct: 103 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 160
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 161 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 213
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAG 235

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           APE I         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 101
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++  G + +HL +    S P        I       +LH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 159
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 212
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 101
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++  G + +HL +    S P        I       +LH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 159
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 212
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 101
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++  G + +HL +    S P        I       +LH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 159
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 212
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           APE I         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           APE I         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 30/225 (13%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFLGQLRHPHL 156
           +G G  G V   Y        +  + VA+K L    +     +    E++ +  + H ++
Sbjct: 70  IGSGAQGIVCAAY------DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 157 VRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
           + L+          E ++  LV E M     + +L + I + L       +      G+ 
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQMLCGIK 178
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
            LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y APE
Sbjct: 179 HLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAPE 233
Query: 271 YISTGHLTTKSDVYSFGVVLLE------LLTGRRSMDKLRPKSEQ 309
            I         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 24/165 (14%)
Query: 143 AEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSL-----ENHLFKRISVSLPWGT 197
            E+  L +L HP ++++  +  + E+  +V E M  G L      N   K  +  L +  
Sbjct: 203 TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 261
Query: 198 RLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNT 254
            L         LA  +  EN +I+RD K  N+LL S   D   K++DFG +K+  E   T
Sbjct: 262 ML---------LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---T 309
Query: 255 HVTTRVMGTYGYAAPEY---ISTGHLTTKSDVYSFGVVLLELLTG 296
            +   + GT  Y APE    + T       D +S GV+L   L+G
Sbjct: 310 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 77/160 (48%), Gaps = 18/160 (11%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           E+  L +L HP++++L        E  LV E +  G     LF RI     +  R   A 
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG----ELFDRIVEKGYYSER--DAA 151
Query: 204 GAAK----GLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHV 256
            A K     +A+LH  EN +++RD K  N+L  +   D   K++DFGL+K+     +  +
Sbjct: 152 DAVKQILEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVL 206
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
              V GT GY APE +       + D++S G++   LL G
Sbjct: 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 81/324 (25%), Positives = 137/324 (42%), Gaps = 48/324 (14%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEV 145
           R I +       +G+G +G V  G          + + VAVK+    E     RE   E+
Sbjct: 33  RTIAKQIQMVKQIGKGRYGEVWMG--------KWRGEKVAVKVFFTTEEASWFRE--TEI 82
Query: 146 IFLGQLRHPHLVRLIGYCCED-------EERLLVYEFMPRGSLENHLFKRISVSLPWGTR 198
                +RH ++   +G+   D        +  L+ ++   GSL ++L    S +L   + 
Sbjct: 83  YQTVLMRHENI---LGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSM 136
Query: 199 LKIAIGAAKGLAFLHG------AENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEG 251
           LK+A  +  GL  LH        +  + +RD K+ NIL+  + T  ++D GLA K   + 
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196
Query: 252 SNTHV--TTRVMGTYGYAAPEY----ISTGHLTT--KSDVYSFGVVLLELLTGRRSMDKL 303
           +   +   TRV GT  Y  PE     ++  H  +   +D+YSFG++L E+   RR +   
Sbjct: 197 NEVDIPPNTRV-GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGG 253
Query: 304 RPKSEQNLVDWAKPYLRSSRRLRYIV-----DPRLAGQYSV-KGAKEMAVLALQCISVNP 357
             +  Q       P   S   +R IV      P    ++S  +  ++M  L  +C + NP
Sbjct: 254 IVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNP 313
Query: 358 KDRPKMAAVVATLESLLNLKDMAV 381
             R     V  TL  +   +D+ +
Sbjct: 314 ASRLTALRVKKTLAKMSESQDIKL 337

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 55/95 (57%), Gaps = 5/95 (5%)
Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK--MGPEGSNTHVTTRVMGTY 264
           +GL ++H A+  VI+RD K SN+L++ +   K+ DFG+A+        + +  T  + T 
Sbjct: 169 RGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 265 GYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGRR 298
            Y APE + + H  T++ D++S G +  E+L  R+
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 24/165 (14%)
Query: 143 AEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSL-----ENHLFKRISVSLPWGT 197
            E+  L +L HP ++++  +  + E+  +V E M  G L      N   K  +  L +  
Sbjct: 189 TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 247
Query: 198 RLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNT 254
            L         LA  +  EN +I+RD K  N+LL S   D   K++DFG +K+  E   T
Sbjct: 248 ML---------LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---T 295
Query: 255 HVTTRVMGTYGYAAPEY---ISTGHLTTKSDVYSFGVVLLELLTG 296
            +   + GT  Y APE    + T       D +S GV+L   L+G
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 88  AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLK---AQAVAVKLLDIEGLQG--HREWL 142
           ++T  +     LG+G F  V         R+ +K    Q  A K+++ + L    H++  
Sbjct: 1   SMTDEYQLFEELGKGAFSVV---------RRCMKIPTGQEYAAKIINTKKLSARDHQKLE 51
Query: 143 AEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
            E      L+HP++VRL     E+    LV++ +  G L   +  R   S    +     
Sbjct: 52  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQ 111
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSD---FTAKLSDFGLAKMGPEGSNTHVTTR 259
           I  +     L+G    +++RD K  N+LL S       KL+DFGLA +  +G +      
Sbjct: 112 ILESVNHCHLNG----IVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQG-DQQAWFG 165
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
             GT GY +PE +         D+++ GV+L  LL G
Sbjct: 166 FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           LG G FG V        ++        A+K+LD   +  L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVML------VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LV+L     ++    +V E+ P G + +HL +    S P        I       +LH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHSL 160
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +IYRD K  N+++D     +++DFG AK   +G     T  + GT  Y APE I + 
Sbjct: 161 D--LIYRDLKPENLMIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILSK 213
Query: 276 HLTTKSDVYSFGVVLLELLTG 296
                 D ++ GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE----GLQGHREWLAEVIFLGQLRHP 154
           +GEG +G V+K        Q    +  A+K + +E    G+      + E+  L +L+H 
Sbjct: 10  IGEGTYGVVYKA-------QNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHS 60
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISV---SLPWGTRLKIAIGAAKGLAF 211
           ++V+L       +  +LV+E      L+  L K + V    L   T     +    G+A+
Sbjct: 61  NIVKLYDVIHTKKRLVLVFE-----HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEY 271
            H  +  V++RD K  N+L++ +   K++DFGLA+    G      T  + T  Y AP+ 
Sbjct: 116 CH--DRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDV 171
Query: 272 I-STGHLTTKSDVYSFGVVLLELLTG 296
           +  +   +T  D++S G +  E++ G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 144 EVIFLGQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGT 197
           E++ +  + H +++ L+          E ++  LV E M     + +L + I + L    
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 127
Query: 198 RLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT 257
              +      G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T
Sbjct: 128 MSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMT 183
Query: 258 TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLE------LLTGRRSMDKLRPKSEQ 309
             V+  Y Y APE I         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 184 PYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 88
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++  G + +HL +    S P        I       +LH 
Sbjct: 89  FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 146
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 147 LD--LIYRDLKPENLLIDEQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 199
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 200 KGYNKAVDWWALGVLIYEMAAG 221

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 87/201 (43%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           LG G FG V        ++        A+K+LD   +  L+     L E   L  +  P 
Sbjct: 50  LGTGSFGRVML------VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           L +L     ++    +V E+ P G + +HL +RI        R   A        +LH  
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHL-RRIGRFXEPHARF-YAAQIVLTFEYLHSL 161
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +IYRD K  N+++D     K++DFG AK   +G     T  + GT  Y APE I + 
Sbjct: 162 D--LIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILSK 214
Query: 276 HLTTKSDVYSFGVVLLELLTG 296
                 D ++ GV++ E+  G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE----GLQGHREWLAEVIFLGQLRHP 154
           +GEG +G V+K        Q    +  A+K + +E    G+      + E+  L +L+H 
Sbjct: 10  IGEGTYGVVYKA-------QNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHS 60
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISV---SLPWGTRLKIAIGAAKGLAF 211
           ++V+L       +  +LV+E      L+  L K + V    L   T     +    G+A+
Sbjct: 61  NIVKLYDVIHTKKRLVLVFE-----HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEY 271
            H  +  V++RD K  N+L++ +   K++DFGLA+    G      T  + T  Y AP+ 
Sbjct: 116 CH--DRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDV 171
Query: 272 I-STGHLTTKSDVYSFGVVLLELLTG 296
           +  +   +T  D++S G +  E++ G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 101
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++  G + +HL +    S P        I       +LH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 159
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+++D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 160 LD--LIYRDLKPENLIIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIIIS 212
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE----GLQGHREWLAEVIFLGQLRHP 154
           +GEG +G V+K        Q    +  A+K + +E    G+      + E+  L +L+H 
Sbjct: 10  IGEGTYGVVYKA-------QNNYGETFALKKIRLEKEDEGIPSTT--IREISILKELKHS 60
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISV---SLPWGTRLKIAIGAAKGLAF 211
           ++V+L       +  +LV+E      L+  L K + V    L   T     +    G+A+
Sbjct: 61  NIVKLYDVIHTKKRLVLVFE-----HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEY 271
            H  +  V++RD K  N+L++ +   K++DFGLA+    G      T  + T  Y AP+ 
Sbjct: 116 CH--DRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDV 171
Query: 272 I-STGHLTTKSDVYSFGVVLLELLTG 296
           +  +   +T  D++S G +  E++ G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 56/108 (51%), Gaps = 11/108 (10%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 132 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 186
Query: 268 APEYISTGHLTTKSDVYSFGVVLLE------LLTGRRSMDKLRPKSEQ 309
           APE I         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 122 AQAVAVKLLDIEGLQGH-----REWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFM 176
            Q  AVK++D+            +   E      L+HPH+V L+     D    +V+EFM
Sbjct: 51  GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 110
Query: 177 PRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT 236
               L   + KR      +   +          A  +  +N +I+RD K   +LL S   
Sbjct: 111 DGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKEN 170
Query: 237 A---KLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLE 292
           +   KL  FG+A ++G  G    V    +GT  + APE +         DV+  GV+L  
Sbjct: 171 SAPVKLGGFGVAIQLGESGL---VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFI 227
Query: 293 LLTG 296
           LL+G
Sbjct: 228 LLSG 231

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 56/108 (51%), Gaps = 11/108 (10%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 131 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 185
Query: 268 APEYISTGHLTTKSDVYSFGVVLLE------LLTGRRSMDKLRPKSEQ 309
           APE I         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 30/225 (13%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFLGQLRHPHL 156
           +G G  G V   Y        +  + VA+K L    +     +    E++ +  + H ++
Sbjct: 33  IGSGAQGIVCAAY------DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 157 VRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
           + L+          E ++  LV E M     + +L + I + L       +      G+ 
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQMLCGIK 141
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
            LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y APE
Sbjct: 142 HLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAPE 196
Query: 271 YISTGHLTTKSDVYSFGVVLLE------LLTGRRSMDKLRPKSEQ 309
            I         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 56/108 (51%), Gaps = 11/108 (10%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 193
Query: 268 APEYISTGHLTTKSDVYSFGVVLLE------LLTGRRSMDKLRPKSEQ 309
           APE I         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 56/108 (51%), Gaps = 11/108 (10%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 137 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 191
Query: 268 APEYISTGHLTTKSDVYSFGVVLLE------LLTGRRSMDKLRPKSEQ 309
           APE I         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 192 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 239

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 56/108 (51%), Gaps = 11/108 (10%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 268 APEYISTGHLTTKSDVYSFGVVLLE------LLTGRRSMDKLRPKSEQ 309
           APE I         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 56/108 (51%), Gaps = 11/108 (10%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 192
Query: 268 APEYISTGHLTTKSDVYSFGVVLLE------LLTGRRSMDKLRPKSEQ 309
           APE I         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 56/108 (51%), Gaps = 11/108 (10%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 132 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 186
Query: 268 APEYISTGHLTTKSDVYSFGVVLLE------LLTGRRSMDKLRPKSEQ 309
           APE I         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           LG G FG V        ++        A+K+LD   +  L+     L E   L  +  P 
Sbjct: 50  LGTGSFGRVML------VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           L +L     ++    +V E+ P G + +HL +    S P        I       +LH  
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHSL 161
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +IYRD K  N+++D     K++DFG AK   +G     T  + GT  Y APE I + 
Sbjct: 162 D--LIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILSK 214
Query: 276 HLTTKSDVYSFGVVLLELLTG 296
                 D ++ GV++ E+  G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           LG G FG V        ++        A+K+LD   +  L+     L E   L  +  P 
Sbjct: 50  LGTGSFGRVML------VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           L +L     ++    +V E+ P G + +HL +    S P        I       +LH  
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHSL 161
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +IYRD K  N+++D     K++DFG AK   +G     T  + GT  Y APE I + 
Sbjct: 162 D--LIYRDLKPENLMIDQQGYIKVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILSK 214
Query: 276 HLTTKSDVYSFGVVLLELLTG 296
                 D ++ GV++ E+  G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 30/225 (13%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFLGQLRHPHL 156
           +G G  G V   Y        +  + VA+K L    +     +    E++ +  + H ++
Sbjct: 70  IGSGAQGIVCAAY------DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 157 VRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
           + L+          E ++  LV E M     + +L + I + L       +      G+ 
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQMLCGIK 178
Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
            LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y APE
Sbjct: 179 HLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAPE 233
Query: 271 YISTGHLTTKSDVYSFGVVLLE------LLTGRRSMDKLRPKSEQ 309
            I         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 77/184 (41%), Gaps = 12/184 (6%)
Query: 122 AQAVAVKLLDIEGLQGH-----REWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFM 176
            Q  AVK++D+            +   E      L+HPH+V L+     D    +V+EFM
Sbjct: 49  GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 108
Query: 177 PRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT 236
               L   + KR      +   +          A  +  +N +I+RD K   +LL S   
Sbjct: 109 DGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKEN 168
Query: 237 A---KLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLE 292
           +   KL  FG+A ++G  G    V    +GT  + APE +         DV+  GV+L  
Sbjct: 169 SAPVKLGGFGVAIQLGESGL---VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFI 225
Query: 293 LLTG 296
           LL+G
Sbjct: 226 LLSG 229

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-EVIF 147
           I + F     LG G F  V          +    +  AVK +  + L+G    +  E+  
Sbjct: 20  IKKIFEFKETLGTGAFSEVVLA------EEKATGKLFAVKCIPKKALKGKESSIENEIAV 73
Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKR-ISVSLPWGTRLKIAIGAA 206
           L +++H ++V L           LV + +  G L + + ++         T ++  + A 
Sbjct: 74  LRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDA- 132
Query: 207 KGLAFLHGAENPVIYRDFKTSNILL---DSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT 263
             + +LH     +++RD K  N+L    D +    +SDFGL+KM  +G    V +   GT
Sbjct: 133 --VYYLH--RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTACGT 185
Query: 264 YGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            GY APE ++    +   D +S GV+   LL G
Sbjct: 186 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 21/204 (10%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVIFLGQLRHPHL 156
           LGEG F    K             QA AVK++   +E     +E  A  +  G   HP++
Sbjct: 19  LGEGSFSICRKCV------HKKSNQAFAVKIISKRMEA-NTQKEITALKLCEG---HPNI 68
Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           V+L     +     LV E +  G L    F+RI     +       I      A  H  +
Sbjct: 69  VKLHEVFHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 217 NPVIYRDFKTSNILL---DSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
             V++RD K  N+L    + +   K+ DFG A++ P   N  + T    T  YAAPE ++
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCF-TLHYAAPELLN 182
Query: 274 TGHLTTKSDVYSFGVVLLELLTGR 297
                   D++S GV+L  +L+G+
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 101
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++  G + +HL +    S P        I       +LH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 159
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I +
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILS 212
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ ++  G
Sbjct: 213 KGYNKAVDWWALGVLIYQMAAG 234

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 71/171 (41%), Gaps = 17/171 (9%)
Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY 264
            AKG+ FL  A    I+RD    NILL      K+ DFGLA+   +  +           
Sbjct: 209 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 266
Query: 265 GYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
            + APE I     T +SDV+SFGV+L E+ +   S     P     + +     L+   R
Sbjct: 267 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRRLKEGTR 321
Query: 325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           +R       A  Y+     EM    L C    P  RP  + +V  L +LL 
Sbjct: 322 MR-------APDYTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 362

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           EV  L +++HP+++ L        + +L+ E +  G L + L ++ S++    T     I
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNI-LLDSDF---TAKLSDFGLA---KMGPEGSNTHV 256
               G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G E  N   
Sbjct: 124 --LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--- 176
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
              + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 177 ---IFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 71/171 (41%), Gaps = 17/171 (9%)
Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY 264
            AKG+ FL  A    I+RD    NILL      K+ DFGLA+   +  +           
Sbjct: 202 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259
Query: 265 GYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
            + APE I     T +SDV+SFGV+L E+ +   S     P     + +     L+   R
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRRLKEGTR 314
Query: 325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           +R       A  Y+     EM    L C    P  RP  + +V  L +LL 
Sbjct: 315 MR-------APDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +   V+  Y Y 
Sbjct: 140 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMVPFVVTRY-YR 194
Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTG 296
           APE I         D++S G ++ E++ G
Sbjct: 195 APEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 71/171 (41%), Gaps = 17/171 (9%)
Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY 264
            AKG+ FL  A    I+RD    NILL      K+ DFGLA+   +  +           
Sbjct: 207 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 264
Query: 265 GYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
            + APE I     T +SDV+SFGV+L E+ +   S     P     + +     L+   R
Sbjct: 265 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRRLKEGTR 319
Query: 325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           +R       A  Y+     EM    L C    P  RP  + +V  L +LL 
Sbjct: 320 MR-------APDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 360

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 42/231 (18%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVI 146
           R + ++ +    +G+G +G V +G          + + VAVK+      +  + W  E  
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRG--------SWQGENVAVKIF---SSRDEKSWFRETE 52
Query: 147 FLG--QLRHPHLVRLIGYCCED-------EERLLVYEFMPRGSLENHLFKRISVSLPWGT 197
                 LRH ++   +G+   D        +  L+  +   GSL ++L      +L   +
Sbjct: 53  LYNTVMLRHENI---LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVS 106
Query: 198 RLKIAIGAAKGLAFLH----GAE-NPVI-YRDFKTSNILLDSDFTAKLSDFGLAKMGPEG 251
            L+I +  A GLA LH    G +  P I +RD K+ NIL+  +    ++D GLA M  + 
Sbjct: 107 CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS 166
Query: 252 SN---THVTTRVMGTYGYAAPEY------ISTGHLTTKSDVYSFGVVLLEL 293
           +N        RV GT  Y APE       +       + D+++FG+VL E+
Sbjct: 167 TNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 56/108 (51%), Gaps = 11/108 (10%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 143 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 197
Query: 268 APEYISTGHLTTKSDVYSFGVVLLE------LLTGRRSMDKLRPKSEQ 309
           APE I         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 198 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 245

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 71/171 (41%), Gaps = 17/171 (9%)
Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY 264
            AKG+ FL  A    I+RD    NILL      K+ DFGLA+   +  +           
Sbjct: 200 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 257
Query: 265 GYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
            + APE I     T +SDV+SFGV+L E+ +   S     P     + +     L+   R
Sbjct: 258 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRRLKEGTR 312
Query: 325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           +R       A  Y+     EM    L C    P  RP  + +V  L +LL 
Sbjct: 313 MR-------APDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 353

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 27/227 (11%)
Query: 80  DFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR 139
           D +  E R I   +++  ++G G FG V +  +       +++  VA+K    + LQ  R
Sbjct: 31  DGKTGEQREIA--YTNCKVIGNGSFGVVFQAKL-------VESDEVAIK----KVLQDKR 77
Query: 140 EWLAEVIFLGQLRHPHLVRLIGYCC-----EDEERL-LVYEFMPRGSLE-NHLFKRISVS 192
               E+  +  ++HP++V L  +       +DE  L LV E++P      +  + ++  +
Sbjct: 78  FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQT 137
Query: 193 LPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-TAKLSDFGLAKMGPEG 251
           +P            + LA++H     + +RD K  N+LLD      KL DFG AK+   G
Sbjct: 138 MPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195
Query: 252 SNTHVTTRVMGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
                 + +   Y Y APE I    + TT  D++S G V+ EL+ G+
Sbjct: 196 EPN--VSXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 56/108 (51%), Gaps = 11/108 (10%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +T  V+  Y Y 
Sbjct: 132 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 186
Query: 268 APEYISTGHLTTKSDVYSFGVVLLE------LLTGRRSMDKLRPKSEQ 309
           APE I         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 187 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 234

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 91  QNFSSNYLL-----GEGGFGTVHKGYIDDDLRQGLK---AQAVAVKLLDIE--GLQGHRE 140
           +NF++ Y+L     G G F  V         RQ +     Q  A K L     G     E
Sbjct: 24  ENFNNFYILTSKELGRGKFAVV---------RQCISKSTGQEYAAKFLKKRRRGQDCRAE 74
Query: 141 WLAEVIFLGQLRH-PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRL 199
            L E+  L   +  P ++ L        E +L+ E+   G + +     ++  +     +
Sbjct: 75  ILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI 134
Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF---TAKLSDFGLAKMGPEGSNTHV 256
           ++     +G+ +LH  +N +++ D K  NILL S +     K+ DFG+++          
Sbjct: 135 RLIKQILEGVYYLH--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR- 191
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
              +MGT  Y APE ++   +TT +D+++ G++   LLT
Sbjct: 192 --EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 138 HREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSL---ENHLF---KRISV 191
           + ++  E+  +  +++ + +   G     +E  ++YE+M   S+   + + F   K  + 
Sbjct: 87  YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 192 SLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEG 251
            +P      I        +++H  +N + +RD K SNIL+D +   KLSDFG        
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKNGRVKLSDFG-------E 198
Query: 252 SNTHVTTRVM---GTYGYAAPEYIS--TGHLTTKSDVYSFGVVL 290
           S   V  ++    GTY +  PE+ S  + +   K D++S G+ L
Sbjct: 199 SEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 11/157 (7%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           EV  L Q+ HP+++ L        + +L+ E +  G L + L ++ S+S    T     I
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNI-LLDSDF---TAKLSDFGLAKMGPEGSNTHVTTR 259
               G+ +LH  +  + + D K  NI LLD +      KL DFGLA    +G        
Sbjct: 125 --LDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KN 177
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +   V+  Y Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVVTRY-YR 192
Query: 268 APEYISTGHLTTKSDVYSFGVVLLE------LLTGRRSMDKLRPKSEQ 309
           APE I         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 240

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           EV  L +++HP+++ L        + +L+ E +  G L + L ++ S++    T     I
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNI-LLDSDF---TAKLSDFGLA---KMGPEGSNTHV 256
               G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G E  N   
Sbjct: 124 --LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--- 176
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
              + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 177 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 42/231 (18%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVI 146
           R +    +    +G+G +G V +G          + + VAVK+      +  + W  E  
Sbjct: 4   RTVAHQITLLECVGKGRYGEVWRG--------SWQGENVAVKIF---SSRDEKSWFRETE 52
Query: 147 FLG--QLRHPHLVRLIGYCCED-------EERLLVYEFMPRGSLENHLFKRISVSLPWGT 197
                 LRH ++   +G+   D        +  L+  +   GSL ++L      +L   +
Sbjct: 53  LYNTVMLRHENI---LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVS 106
Query: 198 RLKIAIGAAKGLAFLH----GAE-NPVI-YRDFKTSNILLDSDFTAKLSDFGLAKMGPEG 251
            L+I +  A GLA LH    G +  P I +RD K+ NIL+  +    ++D GLA M  + 
Sbjct: 107 CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS 166
Query: 252 SN---THVTTRVMGTYGYAAPEY------ISTGHLTTKSDVYSFGVVLLEL 293
           +N        RV GT  Y APE       +       + D+++FG+VL E+
Sbjct: 167 TNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 18/201 (8%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHPH 155
           LG G FG V        ++        A+K+LD   +  L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVML------VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LV+L     ++    +V E++  G + +HL +    S P        I       +LH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHSL 160
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y APE I + 
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPEIILSK 213
Query: 276 HLTTKSDVYSFGVVLLELLTG 296
                 D ++ GV++ E+  G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           EV  L +++HP+++ L        + +L+ E +  G L + L ++ S++    T     I
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNI-LLDSDFTA---KLSDFGLA---KMGPEGSNTHV 256
               G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G E  N   
Sbjct: 124 --LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--- 176
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
              + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 177 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 101
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++  G + +HL +    S P        I       +LH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 159
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT  Y AP  I +
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEYLAPAIILS 212
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 101/231 (43%), Gaps = 42/231 (18%)
Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVI 146
           R + +  +    +G+G +G V +G          + + VAVK+      +  + W  E  
Sbjct: 33  RTVARQITLLECVGKGRYGEVWRG--------SWQGENVAVKIF---SSRDEKSWFRETE 81
Query: 147 FLG--QLRHPHLVRLIGYCCED-------EERLLVYEFMPRGSLENHLFKRISVSLPWGT 197
                 LRH ++   +G+   D        +  L+  +   GSL ++L      +L   +
Sbjct: 82  LYNTVMLRHENI---LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVS 135
Query: 198 RLKIAIGAAKGLAFLH----GAE-NPVI-YRDFKTSNILLDSDFTAKLSDFGLAKMGPEG 251
            L+I +  A GLA LH    G +  P I +RD K+ NIL+  +    ++D GLA M  + 
Sbjct: 136 CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS 195
Query: 252 SN---THVTTRVMGTYGYAAPEY------ISTGHLTTKSDVYSFGVVLLEL 293
           +N        RV GT  Y APE       +       + D+++FG+VL E+
Sbjct: 196 TNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           EV  L +++HP+++ L        + +L+ E +  G L + L ++ S++    T     I
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNI-LLDSDFTA---KLSDFGLA---KMGPEGSNTHV 256
               G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G E  N   
Sbjct: 123 --LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--- 175
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
              + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 176 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           EV  L +++HP+++ L        + +L+ E +  G L + L ++ S++    T     I
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNI-LLDSDFTA---KLSDFGLA---KMGPEGSNTHV 256
               G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G E  N   
Sbjct: 124 --LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--- 176
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
              + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 177 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           EV  L +++HP+++ L        + +L+ E +  G L + L ++ S++    T     I
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNI-LLDSDFTA---KLSDFGLA---KMGPEGSNTHV 256
               G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G E  N   
Sbjct: 124 --LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--- 176
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
              + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 177 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           EV  L +++HP+++ L        + +L+ E +  G L + L ++ S++    T     I
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNI-LLDSDFTA---KLSDFGLA---KMGPEGSNTHV 256
               G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G E  N   
Sbjct: 123 --LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--- 175
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
              + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 176 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           EV  L +++HP+++ L        + +L+ E +  G L + L ++ S++    T     I
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNI-LLDSDFTA---KLSDFGLA---KMGPEGSNTHV 256
               G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G E  N   
Sbjct: 124 --LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--- 176
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
              + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 177 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           EV  L +++HP+++ L        + +L+ E +  G L + L ++ S++    T     I
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNI-LLDSDFTA---KLSDFGLA---KMGPEGSNTHV 256
               G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G E  N   
Sbjct: 124 --LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--- 176
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
              + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 177 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           EV  L +++HP+++ L        + +L+ E +  G L + L ++ S++    T     I
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNI-LLDSDFTA---KLSDFGLA---KMGPEGSNTHV 256
               G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G E  N   
Sbjct: 124 --LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--- 176
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
              + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 177 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+  LH A   +I+RD K SNI++ SD T K+ DFGLA+    G++  +   V+  Y Y 
Sbjct: 138 GIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVVTRY-YR 192
Query: 268 APEYISTGHLTTKSDVYSFGVVLLE------LLTGRRSMDKLRPKSEQ 309
           APE I         D++S G ++ E      L  GR  +D+     EQ
Sbjct: 193 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 240

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           EV  L +++HP+++ L        + +L+ E +  G L + L ++ S++    T     I
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNI-LLDSDFTA---KLSDFGLA---KMGPEGSNTHV 256
               G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G E  N   
Sbjct: 124 --LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--- 176
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
              + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 177 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           EV  L +++HP+++ L        + +L+ E +  G L + L ++ S++    T     I
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNI-LLDSDFTA---KLSDFGLA---KMGPEGSNTHV 256
               G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G E  N   
Sbjct: 124 --LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--- 176
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
              + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 177 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           EV  L +++HP+++ L        + +L+ E +  G L + L ++ S++    T     I
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNI-LLDSDFTA---KLSDFGLA---KMGPEGSNTHV 256
               G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G E  N   
Sbjct: 124 --LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--- 176
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
              + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 177 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 112/287 (39%), Gaps = 44/287 (15%)
Query: 96  NYL--LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQL 151
           N+L  L E   G + KG          +   + VK+L +     +  R++  E   L   
Sbjct: 13  NFLTKLNENHSGELWKGR--------WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 152 RHPHLVRLIGYCCEDE--ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            HP+++ ++G C         L+  + P GSL N L +  +  +     +K A+  A+G 
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGX 124
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLS--DFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           AFLH  E  +      + ++ +D D TA++S  D   +   P         R      + 
Sbjct: 125 AFLHTLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSP--------GRXYAP-AWV 175
Query: 268 APEYISTGHLTTK---SDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
           APE +      T    +D +SF V+L EL+T       L      N     K  L     
Sbjct: 176 APEALQKKPEDTNRRSADXWSFAVLLWELVTREVPFADL-----SNXEIGXKVALEG--- 227
Query: 325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
           LR  + P ++   S         L   C + +P  RPK   +V  LE
Sbjct: 228 LRPTIPPGISPHVS--------KLXKICXNEDPAKRPKFDXIVPILE 266

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP 154
           LG G FG V    HK   +    + L  Q V VKL  IE     +  L  V F      P
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF------P 101
Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            LV+L     ++    +V E++  G + +HL +    S P        I       +LH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLHS 159
Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
            +  +IYRD K  N+L+D     +++DFG AK   +G     T  + GT    APE I +
Sbjct: 160 LD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGR----TWXLCGTPEALAPEIILS 212
Query: 275 GHLTTKSDVYSFGVVLLELLTG 296
                  D ++ GV++ E+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           EV  L +++HP+++ L        + +L+ E +  G L + L ++ S++    T     I
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNI-LLDSDFTA---KLSDFGLA---KMGPEGSNTHV 256
               G+ +LH  +  + + D K  NI LLD +      K+ DFGLA     G E  N   
Sbjct: 124 --LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--- 176
Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
              + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 177 ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 17/214 (7%)
Query: 88  AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HREWLAEV 145
           ++T  +     +G+G F  V +        +       A K+++ + L    H++   E 
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCV------KLCTGHEYAAKIINTKKLSARDHQKLEREA 54
Query: 146 IFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
                L+H ++VRL     E+    LV++ +  G L   +  R   S    +     I  
Sbjct: 55  RICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE 114
Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDF---TAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           A     LH  +  V++RD K  N+LL S       KL+DFGLA +  +G +        G
Sbjct: 115 A----VLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQG-DQQAWFGFAG 168
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           T GY +PE +         D+++ GV+L  LL G
Sbjct: 169 TPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/264 (21%), Positives = 109/264 (41%), Gaps = 38/264 (14%)
Query: 121 KAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRH--PHLVRLIGYCCEDEERLLVYEFM 176
           K Q  A+K +++E    Q    +  E+ +L +L+     ++RL  Y   D+    +Y  M
Sbjct: 79  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVM 135
Query: 177 PRGSLE-NHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF 235
             G+++ N   K+     PW  R        + +  +H  ++ +++ D K +N L+  D 
Sbjct: 136 ECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDG 191
Query: 236 TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKS-----------DVY 284
             KL DFG+A      + + V    +GT  Y  PE I     + ++           DV+
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 285 SFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKE 344
           S G +L  +  G+    ++               +    +L  I+DP    ++     K+
Sbjct: 252 SLGCILYYMTYGKTPFQQI---------------INQISKLHAIIDPNHEIEFPDIPEKD 296
Query: 345 MAVLALQCISVNPKDRPKMAAVVA 368
           +  +   C+  +PK R  +  ++A
Sbjct: 297 LQDVLKCCLKRDPKQRISIPELLA 320

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 33/215 (15%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFLGQLRHPHL 156
           +G+G FG V K       R     Q VA+K  L++ E        L E+  L  L+H ++
Sbjct: 26  IGQGTFGEVFKA------RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 157 VRLIGYC---------CEDEERLLVYEFMPR---GSLENHLFKRISVSLPWGTRLKIAIG 204
           V LI  C         C+     LV++F      G L N L K     +      ++   
Sbjct: 80  VNLIEICRTKASPYNRCKGS-IYLVFDFCEHDLAGLLSNVLVKFTLSEIK-----RVMQM 133
Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH---VTTRVM 261
              GL ++H   N +++RD K +N+L+  D   KL+DFGLA+      N+       RV+
Sbjct: 134 LLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 262 GTYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLT 295
            T  Y  PE  +         D++  G ++ E+ T
Sbjct: 192 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 107/243 (44%), Gaps = 29/243 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG GG G V    +D+D  +      VA+K + +   Q  +  L E+  + +L H ++V+
Sbjct: 19  LGCGGNGLVFSA-VDNDCDK-----RVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 159 L--------------IGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIG 204
           +              +G   E     +V E+M    L N L +     L    RL     
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQ--GPLLEEHARL-FMYQ 128
Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDS-DFTAKLSDFGLAK-MGPEGSNTHVTTRVMG 262
             +GL ++H A   V++RD K +N+ +++ D   K+ DFGLA+ M P  S+    +  + 
Sbjct: 129 LLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 263 TYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS 321
           T  Y +P  + S  + T   D+++ G +  E+LTG+          +  L+  + P +  
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246
Query: 322 SRR 324
             R
Sbjct: 247 EDR 249

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 33/215 (15%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFLGQLRHPHL 156
           +G+G FG V K       R     Q VA+K  L++ E        L E+  L  L+H ++
Sbjct: 26  IGQGTFGEVFKA------RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 157 VRLIGYC---------CEDEERLLVYEFMPR---GSLENHLFKRISVSLPWGTRLKIAIG 204
           V LI  C         C+     LV++F      G L N L K     +      ++   
Sbjct: 80  VNLIEICRTKASPYNRCK-ASIYLVFDFCEHDLAGLLSNVLVKFTLSEIK-----RVMQM 133
Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH---VTTRVM 261
              GL ++H   N +++RD K +N+L+  D   KL+DFGLA+      N+       RV+
Sbjct: 134 LLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 262 GTYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLT 295
            T  Y  PE  +         D++  G ++ E+ T
Sbjct: 192 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/264 (21%), Positives = 109/264 (41%), Gaps = 38/264 (14%)
Query: 121 KAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRH--PHLVRLIGYCCEDEERLLVYEFM 176
           K Q  A+K +++E    Q    +  E+ +L +L+     ++RL  Y   D+    +Y  M
Sbjct: 79  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVM 135
Query: 177 PRGSLE-NHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF 235
             G+++ N   K+     PW  R        + +  +H  ++ +++ D K +N L+  D 
Sbjct: 136 ECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDG 191
Query: 236 TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKS-----------DVY 284
             KL DFG+A      + + V    +GT  Y  PE I     + ++           DV+
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 285 SFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKE 344
           S G +L  +  G+    ++               +    +L  I+DP    ++     K+
Sbjct: 252 SLGCILYYMTYGKTPFQQI---------------INQISKLHAIIDPNHEIEFPDIPEKD 296
Query: 345 MAVLALQCISVNPKDRPKMAAVVA 368
           +  +   C+  +PK R  +  ++A
Sbjct: 297 LQDVLKCCLKRDPKQRISIPELLA 320

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 86/160 (53%), Gaps = 14/160 (8%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCE-DEERL-LVYEFMPRGS-LENHLFKRISVSLPWGTRLK 200
           E+  L +L HP++V+L+    + +E+ L +V+E + +G  +E    K +S       R  
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED---QARFY 142
Query: 201 IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRV 260
                 KG+ +LH  +  +I+RD K SN+L+  D   K++DFG++    +GS+  ++  V
Sbjct: 143 FQ-DLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KGSDALLSNTV 198
Query: 261 MGTYGYAAPEYISTGH--LTTKS-DVYSFGVVLLELLTGR 297
            GT  + APE +S      + K+ DV++ GV L   + G+
Sbjct: 199 -GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 120/290 (41%), Gaps = 43/290 (14%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQLRHPH 155
           L+G+G FG V+ G    +         VA++L+DIE       + +  EV+   Q RH +
Sbjct: 40  LIGKGRFGQVYHGRWHGE---------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +V  +G  C     L +   + +G     + +   + L      +IA    KG+ +LH  
Sbjct: 91  VVLFMG-ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA- 148
Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP--EGSNTHVTTRVM-GTYGYAAPEYI 272
              ++++D K+ N+  D+     ++DFGL  +    +        R+  G   + APE I
Sbjct: 149 -KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 273 STGHLTTK---------SDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSR 323
                 T+         SDV++ G +  EL   R    K +P      + W         
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYEL-HAREWPFKTQPAEA---IIW--------- 253
Query: 324 RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
           ++   + P L+    +   KE++ + L C +   ++RP    ++  LE L
Sbjct: 254 QMGTGMKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/264 (21%), Positives = 109/264 (41%), Gaps = 38/264 (14%)
Query: 121 KAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRH--PHLVRLIGYCCEDEERLLVYEFM 176
           K Q  A+K +++E    Q    +  E+ +L +L+     ++RL  Y   D+    +Y  M
Sbjct: 35  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVM 91
Query: 177 PRGSLE-NHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF 235
             G+++ N   K+     PW  R        + +  +H  ++ +++ D K +N L+  D 
Sbjct: 92  ECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDG 147
Query: 236 TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKS-----------DVY 284
             KL DFG+A      + + V    +GT  Y  PE I     + ++           DV+
Sbjct: 148 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 207
Query: 285 SFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKE 344
           S G +L  +  G+    ++               +    +L  I+DP    ++     K+
Sbjct: 208 SLGCILYYMTYGKTPFQQI---------------INQISKLHAIIDPNHEIEFPDIPEKD 252
Query: 345 MAVLALQCISVNPKDRPKMAAVVA 368
           +  +   C+  +PK R  +  ++A
Sbjct: 253 LQDVLKCCLKRDPKQRISIPELLA 276

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/264 (21%), Positives = 109/264 (41%), Gaps = 38/264 (14%)
Query: 121 KAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRH--PHLVRLIGYCCEDEERLLVYEFM 176
           K Q  A+K +++E    Q    +  E+ +L +L+     ++RL  Y   D+    +Y  M
Sbjct: 32  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVM 88
Query: 177 PRGSLE-NHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF 235
             G+++ N   K+     PW  R        + +  +H  ++ +++ D K +N L+  D 
Sbjct: 89  ECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDG 144
Query: 236 TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKS-----------DVY 284
             KL DFG+A      + + V    +GT  Y  PE I     + ++           DV+
Sbjct: 145 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204
Query: 285 SFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKE 344
           S G +L  +  G+    ++               +    +L  I+DP    ++     K+
Sbjct: 205 SLGCILYYMTYGKTPFQQI---------------INQISKLHAIIDPNHEIEFPDIPEKD 249
Query: 345 MAVLALQCISVNPKDRPKMAAVVA 368
           +  +   C+  +PK R  +  ++A
Sbjct: 250 LQDVLKCCLKRDPKQRISIPELLA 273

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 33/215 (15%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFLGQLRHPHL 156
           +G+G FG V K       R     Q VA+K  L++ E        L E+  L  L+H ++
Sbjct: 26  IGQGTFGEVFKA------RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 157 VRLIGYC---------CEDEERLLVYEFMPR---GSLENHLFKRISVSLPWGTRLKIAIG 204
           V LI  C         C+     LV++F      G L N L K     +      ++   
Sbjct: 80  VNLIEICRTKASPYNRCKGS-IYLVFDFCEHDLAGLLSNVLVKFTLSEIK-----RVMQM 133
Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH---VTTRVM 261
              GL ++H   N +++RD K +N+L+  D   KL+DFGLA+      N+       RV+
Sbjct: 134 LLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 262 GTYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLT 295
            T  Y  PE  +         D++  G ++ E+ T
Sbjct: 192 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/264 (21%), Positives = 109/264 (41%), Gaps = 38/264 (14%)
Query: 121 KAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRH--PHLVRLIGYCCEDEERLLVYEFM 176
           K Q  A+K +++E    Q    +  E+ +L +L+     ++RL  Y   D+    +Y  M
Sbjct: 51  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVM 107
Query: 177 PRGSLE-NHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF 235
             G+++ N   K+     PW  R        + +  +H  ++ +++ D K +N L+  D 
Sbjct: 108 ECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDG 163
Query: 236 TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKS-----------DVY 284
             KL DFG+A      + + V    +GT  Y  PE I     + ++           DV+
Sbjct: 164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 223
Query: 285 SFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKE 344
           S G +L  +  G+    ++               +    +L  I+DP    ++     K+
Sbjct: 224 SLGCILYYMTYGKTPFQQI---------------INQISKLHAIIDPNHEIEFPDIPEKD 268
Query: 345 MAVLALQCISVNPKDRPKMAAVVA 368
           +  +   C+  +PK R  +  ++A
Sbjct: 269 LQDVLKCCLKRDPKQRISIPELLA 292

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 33/215 (15%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFLGQLRHPHL 156
           +G+G FG V K       R     Q VA+K  L++ E        L E+  L  L+H ++
Sbjct: 25  IGQGTFGEVFKA------RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 157 VRLIGYC---------CEDEERLLVYEFMPR---GSLENHLFKRISVSLPWGTRLKIAIG 204
           V LI  C         C+     LV++F      G L N L K     +      ++   
Sbjct: 79  VNLIEICRTKASPYNRCKGS-IYLVFDFCEHDLAGLLSNVLVKFTLSEIK-----RVMQM 132
Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH---VTTRVM 261
              GL ++H   N +++RD K +N+L+  D   KL+DFGLA+      N+       RV+
Sbjct: 133 LLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 190
Query: 262 GTYGYAAPE-YISTGHLTTKSDVYSFGVVLLELLT 295
            T  Y  PE  +         D++  G ++ E+ T
Sbjct: 191 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 18/168 (10%)
Query: 144 EVIFLGQLRHPHLVRL--IGYCCEDEERLLVYEFMPRGSLENHLFKRIS------VSLPW 195
           E+  L +L+HP+++ L  +     D +  L++++          F R S      V LP 
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 196 GTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT----AKLSDFGLAKM--GP 249
           G    +      G+ +LH   N V++RD K +NIL+  +       K++D G A++   P
Sbjct: 128 GMVKSLLYQILDGIHYLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185
Query: 250 EGSNTHVTTRVMGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTG 296
                 +   V+ T+ Y APE +    H T   D+++ G +  ELLT 
Sbjct: 186 LKPLADLDP-VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 81/206 (39%), Gaps = 27/206 (13%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG          +R  L  + VAVK ++  G         E+I    LRHP++VR
Sbjct: 28  IGSGNFGVARL------MRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVR 80
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHL-----FKRISVSLPWGTRLKIAIGAAKGLAFLH 213
                       ++ E+   G L   +     F        +   L        G+++ H
Sbjct: 81  FKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL-------SGVSYCH 133
Query: 214 GAENPVIYRDFKTSNILLDSDFTA--KLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEY 271
             +  + +RD K  N LLD       K+ DFG +K     S    T   +GT  Y APE 
Sbjct: 134 SMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEV 188
Query: 272 ISTGHLTTK-SDVYSFGVVLLELLTG 296
           +       K +DV+S GV L  +L G
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 100/247 (40%), Gaps = 35/247 (14%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG          +R     + VAVK ++  G +       E+I    LRHP++VR
Sbjct: 26  IGSGNFGVARL------MRDKQSNELVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVR 78
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG---TRLKIAIGAAKGLAFLHGA 215
                       +V E+   G     LF+RI  +  +     R         G+++ H  
Sbjct: 79  FKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFFFQ-QLISGVSYCHAM 133
Query: 216 ENPVIYRDFKTSNILLDSDFTA--KLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
           +  V +RD K  N LLD       K+ DFG +K     S    T   +GT  Y APE + 
Sbjct: 134 Q--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLL 188
Query: 274 TGHLTTK-SDVYSFGVVLLELLTGRRSMDKLRPKSEQNL---------VDWAKP-YLRSS 322
                 K +DV+S GV L  +L G    +   P+  +N          V +A P Y+  S
Sbjct: 189 KKEYDGKVADVWSCGVTLYVMLVGAYPFED--PEEPKNFRKTIHRILNVQYAIPDYVHIS 246
Query: 323 RRLRYIV 329
              R+++
Sbjct: 247 PECRHLI 253

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/264 (21%), Positives = 109/264 (41%), Gaps = 38/264 (14%)
Query: 121 KAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRH--PHLVRLIGYCCEDEERLLVYEFM 176
           K Q  A+K +++E    Q    +  E+ +L +L+     ++RL  Y   D+    +Y  M
Sbjct: 31  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVM 87
Query: 177 PRGSLE-NHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF 235
             G+++ N   K+     PW  R        + +  +H  ++ +++ D K +N L+  D 
Sbjct: 88  ECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDG 143
Query: 236 TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKS-----------DVY 284
             KL DFG+A      + + V    +GT  Y  PE I     + ++           DV+
Sbjct: 144 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 203
Query: 285 SFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKE 344
           S G +L  +  G+    ++               +    +L  I+DP    ++     K+
Sbjct: 204 SLGCILYYMTYGKTPFQQI---------------INQISKLHAIIDPNHEIEFPDIPEKD 248
Query: 345 MAVLALQCISVNPKDRPKMAAVVA 368
           +  +   C+  +PK R  +  ++A
Sbjct: 249 LQDVLKCCLKRDPKQRISIPELLA 272

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 100/247 (40%), Gaps = 35/247 (14%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG          +R     + VAVK ++  G +       E+I    LRHP++VR
Sbjct: 27  IGSGNFGVARL------MRDKQSNELVAVKYIE-RGEKIAANVKREIINHRSLRHPNIVR 79
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG---TRLKIAIGAAKGLAFLHGA 215
                       +V E+   G     LF+RI  +  +     R         G+++ H  
Sbjct: 80  FKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFFFQ-QLISGVSYCHAM 134
Query: 216 ENPVIYRDFKTSNILLDSDFTA--KLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
           +  V +RD K  N LLD       K+ DFG +K     S    T   +GT  Y APE + 
Sbjct: 135 Q--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLL 189
Query: 274 TGHLTTK-SDVYSFGVVLLELLTGRRSMDKLRPKSEQNL---------VDWAKP-YLRSS 322
                 K +DV+S GV L  +L G    +   P+  +N          V +A P Y+  S
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFED--PEEPKNFRKTIHRILNVQYAIPDYVHIS 247
Query: 323 RRLRYIV 329
              R+++
Sbjct: 248 PECRHLI 254

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           EV  L Q+ H +++ L        + +L+ E +  G L + L ++ S+S    T     I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNI-LLDSDF---TAKLSDFGLAKMGPEGSNTHVTTR 259
               G+ +LH  +  + + D K  NI LLD +      KL DFGLA    +G        
Sbjct: 125 --LDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KN 177
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 102/248 (41%), Gaps = 37/248 (14%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG          +R     + VAVK ++  G +       E+I    LRHP++VR
Sbjct: 27  IGAGNFGVARL------MRDKQANELVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVR 79
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG---TRLKIAIGAAKGLAFLHGA 215
                       +V E+   G     LF+RI  +  +     R         G+++ H  
Sbjct: 80  FKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFFFQ-QLISGVSYAHAM 134
Query: 216 ENPVIYRDFKTSNILLDSDFTA--KLSDFGLAKMGPEGSNTHVTTR-VMGTYGYAAPEYI 272
           +  V +RD K  N LLD       K++DFG +K     S  H   +  +GT  Y APE +
Sbjct: 135 Q--VAHRDLKLENTLLDGSPAPRLKIADFGYSK----ASVLHSQPKSAVGTPAYIAPEVL 188
Query: 273 STGHLTTK-SDVYSFGVVLLELLTGRRSMDKLRPKSEQNL---------VDWAKP-YLRS 321
                  K +DV+S GV L  +L G    +   P+  +N          V +A P Y+  
Sbjct: 189 LKKEYDGKVADVWSCGVTLYVMLVGAYPFED--PEEPKNFRKTIHRILNVQYAIPDYVHI 246
Query: 322 SRRLRYIV 329
           S   R+++
Sbjct: 247 SPECRHLI 254

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           EV  L Q+ H +++ L        + +L+ E +  G L + L ++ S+S    T     I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNI-LLDSDF---TAKLSDFGLAKMGPEGSNTHVTTR 259
               G+ +LH  +  + + D K  NI LLD +      KL DFGLA    +G        
Sbjct: 125 --LDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KN 177
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           EV  L Q+ H +++ L        + +L+ E +  G L + L ++ S+S    T     I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNI-LLDSDF---TAKLSDFGLAKMGPEGSNTHVTTR 259
               G+ +LH  +  + + D K  NI LLD +      KL DFGLA    +G        
Sbjct: 125 --LDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KN 177
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/265 (21%), Positives = 111/265 (41%), Gaps = 40/265 (15%)
Query: 121 KAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRH--PHLVRLIGYCCEDEERLLVYEFM 176
           K Q  A+K +++E    Q    +  E+ +L +L+     ++RL  Y   D+    +Y  M
Sbjct: 51  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVM 107
Query: 177 PRGSLE-NHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF 235
             G+++ N   K+     PW  R        + +  +H  ++ +++ D K +N L+  D 
Sbjct: 108 ECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDG 163
Query: 236 TAKLSDFGLA-KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKS-----------DV 283
             KL DFG+A +M P+     V    +GT  Y  PE I     + ++           DV
Sbjct: 164 MLKLIDFGIANQMQPDXXXV-VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 222
Query: 284 YSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAK 343
           +S G +L  +  G+    ++               +    +L  I+DP    ++     K
Sbjct: 223 WSLGCILYYMTYGKTPFQQI---------------INQISKLHAIIDPNHEIEFPDIPEK 267
Query: 344 EMAVLALQCISVNPKDRPKMAAVVA 368
           ++  +   C+  +PK R  +  ++A
Sbjct: 268 DLQDVLKCCLKRDPKQRISIPELLA 292

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           EV  L Q+ H +++ L        + +L+ E +  G L + L ++ S+S    T     I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNI-LLDSDF---TAKLSDFGLAKMGPEGSNTHVTTR 259
               G+ +LH  +  + + D K  NI LLD +      KL DFGLA    +G        
Sbjct: 125 --LDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KN 177
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/264 (20%), Positives = 108/264 (40%), Gaps = 38/264 (14%)
Query: 121 KAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRH--PHLVRLIGYCCEDEERLLVYEFM 176
           K Q  A+K +++E    Q    +  E+ +L +L+     ++RL  Y   D+    +Y  M
Sbjct: 79  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVM 135
Query: 177 PRGSLE-NHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF 235
             G+++ N   K+     PW  R        + +  +H  ++ +++ D K +N L+  D 
Sbjct: 136 ECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLI-VDG 191
Query: 236 TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKS-----------DVY 284
             KL DFG+A      + + V    +G   Y  PE I     + ++           DV+
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 285 SFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKE 344
           S G +L  +  G+    ++               +    +L  I+DP    ++     K+
Sbjct: 252 SLGCILYYMTYGKTPFQQI---------------INQISKLHAIIDPNHEIEFPDIPEKD 296
Query: 345 MAVLALQCISVNPKDRPKMAAVVA 368
           +  +   C+  +PK R  +  ++A
Sbjct: 297 LQDVLKCCLKRDPKQRISIPELLA 320

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           EV  L Q+ H +++ L        + +L+ E +  G L + L ++ S+S    T     I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNI-LLDSDF---TAKLSDFGLAKMGPEGSNTHVTTR 259
               G+ +LH  +  + + D K  NI LLD +      KL DFGLA    +G        
Sbjct: 125 --LDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KN 177
Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 58/130 (44%), Gaps = 9/130 (6%)
Query: 170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNI 229
           L++ E M  G L + + +R   +       +I       + FLH   + + +RD K  N+
Sbjct: 83  LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENL 140
Query: 230 LLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSF 286
           L  S   D   KL+DFG AK   E +   + T     Y Y APE +         D++S 
Sbjct: 141 LYTSKEKDAVLKLTDFGFAK---ETTQNALQTPCYTPY-YVAPEVLGPEKYDKSCDMWSL 196
Query: 287 GVVLLELLTG 296
           GV++  LL G
Sbjct: 197 GVIMYILLCG 206

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 58/130 (44%), Gaps = 9/130 (6%)
Query: 170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNI 229
           L++ E M  G L + + +R   +       +I       + FLH   + + +RD K  N+
Sbjct: 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENL 159
Query: 230 LLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSF 286
           L  S   D   KL+DFG AK   E +   + T     Y Y APE +         D++S 
Sbjct: 160 LYTSKEKDAVLKLTDFGFAK---ETTQNALQTPCYTPY-YVAPEVLGPEKYDKSCDMWSL 215
Query: 287 GVVLLELLTG 296
           GV++  LL G
Sbjct: 216 GVIMYILLCG 225

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 15/176 (8%)
Query: 126 AVKLLDIEGLQGHREWLAEV-IFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENH 184
           AVK++D    +  R+   E+ I L   +HP+++ L     + +   +V E M  G L + 
Sbjct: 51  AVKIID----KSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDK 106
Query: 185 LFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF----TAKLS 240
           + ++   S    + +   I   K + +LH     V++RD K SNIL   +     + ++ 
Sbjct: 107 ILRQKFFSEREASAVLFTI--TKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRIC 162
Query: 241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           DFG AK      N  + T    T  + APE +         D++S GV+L  +LTG
Sbjct: 163 DFGFAKQ-LRAENGLLMTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 139 REWLAEVIFLGQLRHPHLVRLIGYCCE-----DEERLLVYEFMPRGSLENHLFKRISVSL 193
           R++LAEV+      HP +V++  +        D    +V E++   SL+    +++ V+ 
Sbjct: 130 RQFLAEVV------HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAE 183
Query: 194 PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN 253
                L+I       L++LH     ++Y D K  NI+L ++   KL D G        S 
Sbjct: 184 AIAYLLEI----LPALSYLHSIG--LVYNDLKPENIML-TEEQLKLIDLGAV------SR 230
Query: 254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVL----LELLT-GRRSMDKLRPKSE 308
            +    + GT G+ APE + TG  T  +D+Y+ G  L    L+L T   R +D L P+ +
Sbjct: 231 INSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-PEDD 288
Query: 309 QNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMA 346
             L    K Y    R LR  +DP    +++   A+EM+
Sbjct: 289 PVL----KTYDSYGRLLRRAIDPDPRQRFTT--AEEMS 320

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 20/154 (12%)
Query: 154 PHLVRLI--------GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
           PH+VR++        G  C     L+V E +  G L + +  R   +       +I    
Sbjct: 121 PHIVRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 176
Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
            + + +LH     + +RD K  N+L  S   +   KL+DFG AK     S+  +TT    
Sbjct: 177 GEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYT 232
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            Y Y APE +         D++S GV++  LL G
Sbjct: 233 PY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 265

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 20/154 (12%)
Query: 154 PHLVRLI--------GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
           PH+VR++        G  C     L+V E +  G L + +  R   +       +I    
Sbjct: 115 PHIVRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 170
Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
            + + +LH     + +RD K  N+L  S   +   KL+DFG AK     S+  +TT    
Sbjct: 171 GEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYT 226
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            Y Y APE +         D++S GV++  LL G
Sbjct: 227 PY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 20/154 (12%)
Query: 154 PHLVRLI--------GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
           PH+VR++        G  C     L+V E +  G L + +  R   +       +I    
Sbjct: 71  PHIVRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 126
Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
            + + +LH     + +RD K  N+L  S   +   KL+DFG AK     S+  +TT    
Sbjct: 127 GEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYT 182
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            Y Y APE +         D++S GV++  LL G
Sbjct: 183 PY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 215

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 20/154 (12%)
Query: 154 PHLVRLI--------GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
           PH+VR++        G  C     L+V E +  G L + +  R   +       +I    
Sbjct: 76  PHIVRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 131
Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
            + + +LH     + +RD K  N+L  S   +   KL+DFG AK     S+  +TT    
Sbjct: 132 GEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYT 187
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            Y Y APE +         D++S GV++  LL G
Sbjct: 188 PY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 220

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 77  DLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEG 134
           +LY FQ S    I Q ++    +G G +G V        +++G + +  A K+    +E 
Sbjct: 13  NLY-FQGSTKGDINQYYTLENTIGRGSWGEVKIA-----VQKGTRIRRAAKKIPKYFVED 66
Query: 135 LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSL-ENHLFKRISVSL 193
           +   ++   E+  +  L HP+++RL     ++ +  LV E    G L E  + KR+    
Sbjct: 67  VDRFKQ---EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES 123
Query: 194 PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL--DS-DFTAKLSDFGLAKMGPE 250
                +K  + A   +A+ H     V +RD K  N L   DS D   KL DFGLA     
Sbjct: 124 DAARIMKDVLSA---VAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 178
Query: 251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           G    + T+V GT  Y +P+ +  G    + D +S GV++  LL G
Sbjct: 179 GK--MMRTKV-GTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 220

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 20/154 (12%)
Query: 154 PHLVRLI--------GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
           PH+VR++        G  C     L+V E +  G L + +  R   +       +I    
Sbjct: 75  PHIVRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 130
Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
            + + +LH     + +RD K  N+L  S   +   KL+DFG AK     S+  +TT    
Sbjct: 131 GEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYT 186
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            Y Y APE +         D++S GV++  LL G
Sbjct: 187 PY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 219

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 20/154 (12%)
Query: 154 PHLVRLI--------GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
           PH+VR++        G  C     L+V E +  G L + +  R   +       +I    
Sbjct: 77  PHIVRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 132
Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
            + + +LH     + +RD K  N+L  S   +   KL+DFG AK     S+  +TT    
Sbjct: 133 GEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYT 188
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            Y Y APE +         D++S GV++  LL G
Sbjct: 189 PY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 221

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 20/154 (12%)
Query: 154 PHLVRLI--------GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
           PH+VR++        G  C     L+V E +  G L + +  R   +       +I    
Sbjct: 71  PHIVRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 126
Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
            + + +LH     + +RD K  N+L  S   +   KL+DFG AK     S+  +TT    
Sbjct: 127 GEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYT 182
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            Y Y APE +         D++S GV++  LL G
Sbjct: 183 PY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 215

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 20/154 (12%)
Query: 154 PHLVRLI--------GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
           PH+VR++        G  C     L+V E +  G L + +  R   +       +I    
Sbjct: 69  PHIVRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 124
Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
            + + +LH     + +RD K  N+L  S   +   KL+DFG AK     S+  +TT    
Sbjct: 125 GEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYT 180
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            Y Y APE +         D++S GV++  LL G
Sbjct: 181 PY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LLGEG +G V +    + L +  +A  +  K        G      E+  L +LRH +++
Sbjct: 12  LLGEGSYGKVKEVLDSETLCR--RAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 158 RLIG--YCCEDEERLLVYEFMPRGS---LENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
           +L+   Y  E ++  +V E+   G    L++   KR  V    G   ++      GL +L
Sbjct: 70  QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLI----DGLEYL 125
Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPEY 271
           H     ++++D K  N+LL +  T K+S  G+A+ + P  ++    T   G+  +  PE 
Sbjct: 126 H--SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPPE- 181
Query: 272 ISTGHLT---TKSDVYSFGVVLLELLTG 296
           I+ G  T    K D++S GV L  + TG
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 20/154 (12%)
Query: 154 PHLVRLI--------GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
           PH+VR++        G  C     L+V E +  G L + +  R   +       +I    
Sbjct: 85  PHIVRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 140
Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
            + + +LH     + +RD K  N+L  S   +   KL+DFG AK     S+  +TT    
Sbjct: 141 GEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYT 196
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            Y Y APE +         D++S GV++  LL G
Sbjct: 197 PY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 229

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 99/247 (40%), Gaps = 35/247 (14%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG          +R     + VAVK ++  G +       E+I    LRHP++VR
Sbjct: 27  IGSGNFGVARL------MRDKQSNELVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVR 79
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG---TRLKIAIGAAKGLAFLHGA 215
                       +V E+   G     LF+RI  +  +     R         G+++ H  
Sbjct: 80  FKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFFFQ-QLISGVSYCHAM 134
Query: 216 ENPVIYRDFKTSNILLDSDFTA--KLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
           +  V +RD K  N LLD       K+  FG +K     S    T   +GT  Y APE + 
Sbjct: 135 Q--VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST---VGTPAYIAPEVLL 189
Query: 274 TGHLTTK-SDVYSFGVVLLELLTGRRSMDKLRPKSEQNL---------VDWAKP-YLRSS 322
                 K +DV+S GV L  +L G    +   P+  +N          V +A P Y+  S
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFED--PEEPKNFRKTIHRILNVQYAIPDYVHIS 247
Query: 323 RRLRYIV 329
              R+++
Sbjct: 248 PECRHLI 254

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 20/154 (12%)
Query: 154 PHLVRLI--------GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
           PH+VR++        G  C     L+V E +  G L + +  R   +       +I    
Sbjct: 70  PHIVRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 125
Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
            + + +LH     + +RD K  N+L  S   +   KL+DFG AK     S+  +TT    
Sbjct: 126 GEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYT 181
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            Y Y APE +         D++S GV++  LL G
Sbjct: 182 PY-YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 214

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 67/154 (43%), Gaps = 20/154 (12%)
Query: 154 PHLVRLI--------GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
           PH+VR++        G  C     L+V E +  G L + +  R   +       +I    
Sbjct: 69  PHIVRIVDVYENLYAGRKC----LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 124
Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
            + + +LH     + +RD K  N+L  S   +   KL+DFG AK   E ++ +  T    
Sbjct: 125 GEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTEPCY 179
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           T  Y APE +         D++S GV++  LL G
Sbjct: 180 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 99/247 (40%), Gaps = 35/247 (14%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG          +R     + VAVK ++  G +       E+I    LRHP++VR
Sbjct: 27  IGSGNFGVARL------MRDKQSNELVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVR 79
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG---TRLKIAIGAAKGLAFLHGA 215
                       +V E+   G     LF+RI  +  +     R         G+++ H  
Sbjct: 80  FKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFFFQ-QLISGVSYCHAM 134
Query: 216 ENPVIYRDFKTSNILLDSDFTA--KLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
           +  V +RD K  N LLD       K+  FG +K     S    T   +GT  Y APE + 
Sbjct: 135 Q--VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT---VGTPAYIAPEVLL 189
Query: 274 TGHLTTK-SDVYSFGVVLLELLTGRRSMDKLRPKSEQNL---------VDWAKP-YLRSS 322
                 K +DV+S GV L  +L G    +   P+  +N          V +A P Y+  S
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPFED--PEEPKNFRKTIHRILNVQYAIPDYVHIS 247
Query: 323 RRLRYIV 329
              R+++
Sbjct: 248 PECRHLI 254

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 41/216 (18%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           ++G+G FG V K Y D  + Q      VA+K++  E  + HR+   E+  L  LR     
Sbjct: 104 VIGKGSFGQVVKAY-DHKVHQ-----HVALKMVRNEK-RFHRQAAEEIRILEHLRKQ--- 153
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHL---FKRISVSLP--------WGTRL----KIA 202
                  + +  + V   +   +  NH+   F+ +S++L          G  L    K A
Sbjct: 154 -------DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFA 206
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA--KLSDFGLAKMGPEGSNTHVTTRV 260
               + L  LH  +N +I+ D K  NILL     +  K+ DFG +    +   T + +R 
Sbjct: 207 HSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF 264
Query: 261 MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
                Y APE I         D++S G +L ELLTG
Sbjct: 265 -----YRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 41/216 (18%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           ++G+G FG V K Y D  + Q      VA+K++  E  + HR+   E+  L  LR     
Sbjct: 104 VIGKGSFGQVVKAY-DHKVHQ-----HVALKMVRNEK-RFHRQAAEEIRILEHLRKQ--- 153
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHL---FKRISVSLP--------WGTRL----KIA 202
                  + +  + V   +   +  NH+   F+ +S++L          G  L    K A
Sbjct: 154 -------DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFA 206
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA--KLSDFGLAKMGPEGSNTHVTTRV 260
               + L  LH  +N +I+ D K  NILL     +  K+ DFG +    +   T + +R 
Sbjct: 207 HSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF 264
Query: 261 MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
                Y APE I         D++S G +L ELLTG
Sbjct: 265 -----YRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 23/214 (10%)
Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEGLQGHREWLAEVI 146
           I Q ++    +G G +G V        +++G + +  A K+    +E +   ++   E+ 
Sbjct: 7   INQYYTLENTIGRGSWGEVKIA-----VQKGTRIRRAAKKIPKYFVEDVDRFKQ---EIE 58
Query: 147 FLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSL-ENHLFKRISVSLPWGTRLKIAIGA 205
            +  L HP+++RL     ++ +  LV E    G L E  + KR+         +K  + A
Sbjct: 59  IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118
Query: 206 AKGLAFLHGAENPVIYRDFKTSNILL--DS-DFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
              +A+ H     V +RD K  N L   DS D   KL DFGLA     G    + T+V G
Sbjct: 119 ---VAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKV-G 170
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           T  Y +P+ +  G    + D +S GV++  LL G
Sbjct: 171 TPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCG 203

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG VH+  ++   ++   A+ V VK  D   ++       E+  L   RH +++ 
Sbjct: 13  LGRGEFGIVHRC-VETSSKKTYMAKFVKVKGTDQVLVK------KEISILNIARHRNILH 65
Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS---LPWGTRLKIAIGAAKGLAFLHGA 215
           L       EE ++++EF+    L+  +F+RI+ S   L     +       + L FLH  
Sbjct: 66  LHESFESMEELVMIFEFI--SGLD--IFERINTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 216 ENPVIYRDFKTSNILLDS--DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTY-GYAAPEYI 272
            + + + D +  NI+  +    T K+ +FG A+    G N     R++ T   Y APE  
Sbjct: 121 -HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF----RLLFTAPEYYAPEVH 175
Query: 273 STGHLTTKSDVYSFGVVLLELLTG 296
               ++T +D++S G ++  LL+G
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSG 199

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 65/154 (42%), Gaps = 20/154 (12%)
Query: 154 PHLVRLI--------GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
           PH+VR++        G  C     L+V E +  G L + +  R   +       +I    
Sbjct: 115 PHIVRIVDVYENLYAGRKC----LLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSI 170
Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
            + + +LH     + +RD K  N+L  S   +   KL+DFG AK     S+  +TT    
Sbjct: 171 GEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPCYT 226
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            Y Y APE +         D +S GV+   LL G
Sbjct: 227 PY-YVAPEVLGPEKYDKSCDXWSLGVIXYILLCG 259

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 72/182 (39%), Gaps = 38/182 (20%)
Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNIL-LDSDFTA------------------KLS 240
           K+A    K + FLH   N + + D K  NIL + SD+T                   K+ 
Sbjct: 122 KMAYQICKSVNFLHS--NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179
Query: 241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSM 300
           DFG A    E  +T V+TR      Y APE I     +   DV+S G +L+E   G    
Sbjct: 180 DFGSATYDDEHHSTLVSTR-----HYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234
Query: 301 DKLRPKSEQNLVD-----WAKPYLRSSRRLRYIVDPRL-------AGQYSVKGAKEMAVL 348
                K    +++       K  ++ +R+ +Y    RL       AG+Y  +  K +   
Sbjct: 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEF 294
Query: 349 AL 350
            L
Sbjct: 295 ML 296

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 15/176 (8%)
Query: 126 AVKLLDIEGLQGHREWLAEV-IFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENH 184
           AVK++D    +  R+   E+ I L   +HP+++ L     + +   LV E M  G L + 
Sbjct: 56  AVKVID----KSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDK 111
Query: 185 LFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF----TAKLS 240
           + ++   S    + +   IG  K + +LH     V++RD K SNIL   +       ++ 
Sbjct: 112 ILRQKFFSEREASFVLHTIG--KTVEYLHS--QGVVHRDLKPSNILYVDESGNPECLRIC 167
Query: 241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           DFG AK      N  + T    T  + APE +         D++S G++L  +L G
Sbjct: 168 DFGFAKQ-LRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 24/154 (15%)
Query: 157 VRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLP------WGTRLKIAIGAAKGL 209
           +  + Y  +DE  L LV ++   G L   L  +    LP      +   + +AI +   L
Sbjct: 152 ITALHYAFQDENHLYLVMDYYVGGDLLT-LLSKFEDKLPEDMARFYIGEMVLAIDSIHQL 210
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFG-LAKMGPEGSNTHVTTRVMGTYGYAA 268
            ++H        RD K  N+LLD +   +L+DFG   KM  +G  T  ++  +GT  Y +
Sbjct: 211 HYVH--------RDIKPDNVLLDVNGHIRLADFGSCLKMNDDG--TVQSSVAVGTPDYIS 260
Query: 269 PEYIST-----GHLTTKSDVYSFGVVLLELLTGR 297
           PE +       G    + D +S GV + E+L G 
Sbjct: 261 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 24/154 (15%)
Query: 157 VRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLP------WGTRLKIAIGAAKGL 209
           +  + Y  +DE  L LV ++   G L   L  +    LP      +   + +AI +   L
Sbjct: 136 ITALHYAFQDENHLYLVMDYYVGGDLLT-LLSKFEDKLPEDMARFYIGEMVLAIDSIHQL 194
Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFG-LAKMGPEGSNTHVTTRVMGTYGYAA 268
            ++H        RD K  N+LLD +   +L+DFG   KM  +G  T  ++  +GT  Y +
Sbjct: 195 HYVH--------RDIKPDNVLLDVNGHIRLADFGSCLKMNDDG--TVQSSVAVGTPDYIS 244
Query: 269 PEYIST-----GHLTTKSDVYSFGVVLLELLTGR 297
           PE +       G    + D +S GV + E+L G 
Sbjct: 245 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 15/176 (8%)
Query: 126 AVKLLDIEGLQGHREWLAEV-IFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENH 184
           AVK++D    +  R+   E+ I L   +HP+++ L     + +   LV E M  G L + 
Sbjct: 56  AVKVID----KSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDK 111
Query: 185 LFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF----TAKLS 240
           + ++   S    + +   IG  K + +LH     V++RD K SNIL   +       ++ 
Sbjct: 112 ILRQKFFSEREASFVLHTIG--KTVEYLHS--QGVVHRDLKPSNILYVDESGNPECLRIC 167
Query: 241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           DFG AK      N  + T    T  + APE +         D++S G++L  +L G
Sbjct: 168 DFGFAKQ-LRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 79/176 (44%), Gaps = 15/176 (8%)
Query: 126 AVKLLDIEGLQGHREWLAEV-IFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENH 184
           AVK++D    +  R+   E+ I L   +HP+++ L     + +   +V E    G L + 
Sbjct: 51  AVKIID----KSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDK 106
Query: 185 LFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF----TAKLS 240
           + ++   S    + +   I   K + +LH     V++RD K SNIL   +     + ++ 
Sbjct: 107 ILRQKFFSEREASAVLFTI--TKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRIC 162
Query: 241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           DFG AK      N  + T    T  + APE +         D++S GV+L   LTG
Sbjct: 163 DFGFAKQ-LRAENGLLXTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 13/219 (5%)
Query: 83  LSELRAITQNFSSNYLLGEGGFGTVHKGY-IDDDLRQGLKAQAVAVKLLDIEGLQGHREW 141
           + E   +   +    LLG GGFG+V+ G  + D+L   +K      ++ D   L      
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK-HVEKDRISDWGELPNGTRV 59
Query: 142 LAEVIFLGQLR--HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRL 199
             EV+ L ++      ++RL+ +    +  +L+ E   R      LF  I+        L
Sbjct: 60  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEEL 116
Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-TAKLSDFGLAKMGPEGSNTHVTT 258
             +       A  H     V++RD K  NIL+D +    KL DFG   +        V T
Sbjct: 117 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYT 172
Query: 259 RVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTG 296
              GT  Y+ PE+I       +S  V+S G++L +++ G
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 13/219 (5%)
Query: 83  LSELRAITQNFSSNYLLGEGGFGTVHKGY-IDDDLRQGLKAQAVAVKLLDIEGLQGHREW 141
           + E   +   +    LLG GGFG+V+ G  + D+L   +K      ++ D   L      
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK-HVEKDRISDWGELPNGTRV 59
Query: 142 LAEVIFLGQLR--HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRL 199
             EV+ L ++      ++RL+ +    +  +L+ E   R      LF  I+        L
Sbjct: 60  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEEL 116
Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-TAKLSDFGLAKMGPEGSNTHVTT 258
             +       A  H     V++RD K  NIL+D +    KL DFG   +        V T
Sbjct: 117 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYT 172
Query: 259 RVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTG 296
              GT  Y+ PE+I       +S  V+S G++L +++ G
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 49/111 (44%), Gaps = 7/111 (6%)
Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI-STGHL 277
           +I+RD K  NI++  DFT KL DFG A     G   +      GT  Y APE +    + 
Sbjct: 151 IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---FCGTIEYCAPEVLMGNPYR 207
Query: 278 TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI 328
             + +++S GV L  L+       +L    E  +     PYL S   +  +
Sbjct: 208 GPELEMWSLGVTLYTLVFEENPFCELEETVEAAI---HPPYLVSKELMSLV 255

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 13/219 (5%)
Query: 83  LSELRAITQNFSSNYLLGEGGFGTVHKGY-IDDDLRQGLKAQAVAVKLLDIEGLQGHREW 141
           + E   +   +    LLG GGFG+V+ G  + D+L   +K      ++ D   L      
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK-HVEKDRISDWGELPNGTRV 59
Query: 142 LAEVIFLGQLR--HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRL 199
             EV+ L ++      ++RL+ +    +  +L+ E   R      LF  I+        L
Sbjct: 60  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEEL 116
Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-TAKLSDFGLAKMGPEGSNTHVTT 258
             +       A  H     V++RD K  NIL+D +    KL DFG   +        V T
Sbjct: 117 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYT 172
Query: 259 RVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTG 296
              GT  Y+ PE+I       +S  V+S G++L +++ G
Sbjct: 173 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFL 148
             Q+F     LG G +G V K    +D R      AV   +    G +     LAEV   
Sbjct: 55  FQQSFQRLSRLGHGSYGEVFKVRSKEDGR----LYAVKRSMSPFRGPKDRARKLAEVGSH 110
Query: 149 GQL-RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLP----WGTRLKIAI 203
            ++ +HP  VRL     E+   L +   +   SL+ H  +    SLP    WG  L+  +
Sbjct: 111 EKVGQHPCCVRLE-QAWEEGGILYLQTELCGPSLQQHC-EAWGASLPEAQVWGY-LRDTL 167
Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFG-LAKMGPEGSNTHVTTRVMG 262
                LA  H     +++ D K +NI L      KL DFG L ++G  G+         G
Sbjct: 168 -----LALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE----G 218
Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLEL 293
              Y APE +  G   T +DV+S G+ +LE+
Sbjct: 219 DPRYMAPELLQ-GSYGTAADVFSLGLTILEV 248

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 13/217 (5%)
Query: 85  ELRAITQNFSSNYLLGEGGFGTVHKGY-IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA 143
           E   +   +    LLG GGFG+V+ G  + D+L   +K      ++ D   L        
Sbjct: 17  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK-HVEKDRISDWGELPNGTRVPM 75
Query: 144 EVIFLGQLR--HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKI 201
           EV+ L ++      ++RL+ +    +  +L+ E   R      LF  I+        L  
Sbjct: 76  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELAR 132
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-TAKLSDFGLAKMGPEGSNTHVTTRV 260
           +       A  H     V++RD K  NIL+D +    KL DFG   +        V T  
Sbjct: 133 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDF 188
Query: 261 MGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTG 296
            GT  Y+ PE+I       +S  V+S G++L +++ G
Sbjct: 189 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 13/220 (5%)
Query: 82  QLSELRAITQNFSSNYLLGEGGFGTVHKGY-IDDDLRQGLKAQAVAVKLLDIEGLQGHRE 140
            + E   +   +    LLG GGFG+V+ G  + D+L   +K      ++ D   L     
Sbjct: 22  HMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK-HVEKDRISDWGELPNGTR 80
Query: 141 WLAEVIFLGQLR--HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR 198
              EV+ L ++      ++RL+ +    +  +L+ E   R      LF  I+        
Sbjct: 81  VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEE 137
Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-TAKLSDFGLAKMGPEGSNTHVT 257
           L  +       A  H     V++RD K  NIL+D +    KL DFG   +        V 
Sbjct: 138 LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVY 193
Query: 258 TRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTG 296
           T   GT  Y+ PE+I       +S  V+S G++L +++ G
Sbjct: 194 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 13/217 (5%)
Query: 85  ELRAITQNFSSNYLLGEGGFGTVHKGY-IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA 143
           E   +   +    LLG GGFG+V+ G  + D+L   +K      ++ D   L        
Sbjct: 18  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK-HVEKDRISDWGELPNGTRVPM 76
Query: 144 EVIFLGQLR--HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKI 201
           EV+ L ++      ++RL+ +    +  +L+ E   R      LF  I+        L  
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELAR 133
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-TAKLSDFGLAKMGPEGSNTHVTTRV 260
           +       A  H     V++RD K  NIL+D +    KL DFG   +        V T  
Sbjct: 134 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDF 189
Query: 261 MGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTG 296
            GT  Y+ PE+I       +S  V+S G++L +++ G
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 13/217 (5%)
Query: 85  ELRAITQNFSSNYLLGEGGFGTVHKGY-IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA 143
           E   +   +    LLG GGFG+V+ G  + D+L   +K      ++ D   L        
Sbjct: 17  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK-HVEKDRISDWGELPNGTRVPM 75
Query: 144 EVIFLGQLR--HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKI 201
           EV+ L ++      ++RL+ +    +  +L+ E   R      LF  I+        L  
Sbjct: 76  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELAR 132
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-TAKLSDFGLAKMGPEGSNTHVTTRV 260
           +       A  H     V++RD K  NIL+D +    KL DFG   +        V T  
Sbjct: 133 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDF 188
Query: 261 MGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTG 296
            GT  Y+ PE+I       +S  V+S G++L +++ G
Sbjct: 189 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 13/217 (5%)
Query: 85  ELRAITQNFSSNYLLGEGGFGTVHKGY-IDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA 143
           E   +   +    LLG GGFG+V+ G  + D+L   +K      ++ D   L        
Sbjct: 37  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK-HVEKDRISDWGELPNGTRVPM 95
Query: 144 EVIFLGQLR--HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKI 201
           EV+ L ++      ++RL+ +    +  +L+ E   R      LF  I+        L  
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELAR 152
Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-TAKLSDFGLAKMGPEGSNTHVTTRV 260
           +       A  H     V++RD K  NIL+D +    KL DFG   +        V T  
Sbjct: 153 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDF 208
Query: 261 MGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTG 296
            GT  Y+ PE+I       +S  V+S G++L +++ G
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 92/216 (42%), Gaps = 41/216 (18%)
Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           ++G+G FG V K Y D  + Q      VA+K++  E  + HR+   E+  L  LR     
Sbjct: 104 VIGKGXFGQVVKAY-DHKVHQ-----HVALKMVRNEK-RFHRQAAEEIRILEHLRKQ--- 153
Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHL---FKRISVSLP--------WGTRL----KIA 202
                  + +  + V   +   +  NH+   F+ +S++L          G  L    K A
Sbjct: 154 -------DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFA 206
Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA--KLSDFGLAKMGPEGSNTHVTTRV 260
               + L  LH  +N +I+ D K  NILL     +  K+ DFG +    +     + +R 
Sbjct: 207 HSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQSRF 264
Query: 261 MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
                Y APE I         D++S G +L ELLTG
Sbjct: 265 -----YRAPEVILGARYGMPIDMWSLGCILAELLTG 295
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	419
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	0.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	0.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-151
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-89
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-68
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-67
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-64
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-64
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-64
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-63
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-63
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-63
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-62
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-60
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-58
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-58
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-57
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-56
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-46
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-44
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-44
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-44
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-44
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	9e-44
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-43
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-42
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-41
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-41
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-41
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-41
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-40
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-40
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-40
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-40
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-40
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-40
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-40
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-40
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-40
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-40
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-40
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-40
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-39
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-39
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-39
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-39
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-39
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-39
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-39
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-38
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-38
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-38
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-38
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-37
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-37
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-37
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-37
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-37
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-37
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-37
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-36
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-36
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-36
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-36
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-35
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-35
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-35
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-35
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-34
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-34
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-34
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-34
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-33
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-32
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-31
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-31
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-30
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-30
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-30
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-29
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	9e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-27
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-27
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-27
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-26
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-26
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-26
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-25
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-25
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-25
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	9e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-24
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-24
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-24
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-24
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-24
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-24
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-24
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-23
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-23
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-23
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-23
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-22
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-22
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-22
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-22
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-22
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-22
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-21
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-21
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-21
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-21
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-21
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-21
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-21
3bhy_A	283	Death-associated protein kinase 3; death associate	8e-21
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	9e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-20
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-20
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-20
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-20
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-20
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-20
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-20
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-20
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-19
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-18
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-18
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-09
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-18
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-16
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-16
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	9e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	9e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-12
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-10
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-06

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  518 bits (1336), Expect = 0.0
 Identities = 113/319 (35%), Positives = 172/319 (53%), Gaps = 26/319 (8%)

Query: 67  NEDLAHTFGPDLYDFQLSELRAITQNFSSNY------LLGEGGFGTVHKGYIDDDLRQGL 120
           N+ L  +     + F   EL+ +T NF           +GEGGFG V+KGY+++      
Sbjct: 2   NKSLEVS-DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN------ 54

Query: 121 KAQAVAVKLL----DIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFM 176
               VAVK L    DI   +  +++  E+  + + +H +LV L+G+  + ++  LVY +M
Sbjct: 55  --TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112

Query: 177 PRGSLENHLFKRISVS-LPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF 235
           P GSL + L        L W  R KIA GAA G+ FLH  EN  I+RD K++NILLD  F
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAF 170

Query: 236 TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT 295
           TAK+SDFGLA+   + + T +T+R++GT  Y APE +  G +T KSD+YSFGVVLLE++T
Sbjct: 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIIT 229

Query: 296 GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISV 355
           G  ++D+ R    Q L+D  +      + +   +D ++         + M  +A QC+  
Sbjct: 230 GLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHE 286

Query: 356 NPKDRPKMAAVVATLESLL 374
               RP +  V   L+ + 
Sbjct: 287 KKNKRPDIKKVQQLLQEMT 305

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  507 bits (1308), Expect = 0.0
 Identities = 127/330 (38%), Positives = 188/330 (56%), Gaps = 14/330 (4%)

Query: 54  SFSDLSRSSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYID 113
            +S  + S +  ++      F  + Y   L +L   T NF   +L+G G FG V+KG + 
Sbjct: 4   KYSKATNSINDALSSSYLVPF--ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61

Query: 114 DDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVY 173
           D          VA+K    E  QG  E+  E+  L   RHPHLV LIG+C E  E +L+Y
Sbjct: 62  DG-------AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114

Query: 174 EFMPRGSLENHLFKR--ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL 231
           ++M  G+L+ HL+     ++S+ W  RL+I IGAA+GL +LH     +I+RD K+ NILL
Sbjct: 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILL 172

Query: 232 DSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLL 291
           D +F  K++DFG++K G E   TH++T V GT GY  PEY   G LT KSDVYSFGVVL 
Sbjct: 173 DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLF 232

Query: 292 ELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQ 351
           E+L  R ++ +  P+   NL +WA      + +L  IVDP LA +   +  ++    A++
Sbjct: 233 EVLCARSAIVQSLPREMVNLAEWAVESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVK 291

Query: 352 CISVNPKDRPKMAAVVATLESLLNLKDMAV 381
           C++++ +DRP M  V+  LE  L L++  +
Sbjct: 292 CLALSSEDRPSMGDVLWKLEYALRLQESVI 321

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  431 bits (1110), Expect = e-151
 Identities = 126/298 (42%), Positives = 180/298 (60%), Gaps = 15/298 (5%)

Query: 81  FQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-R 139
           F L EL+  + NFS+  +LG GGFG V+KG + D          VAVK L  E  QG   
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-------TLVAVKRLKEERTQGGEL 72

Query: 140 EWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRIS--VSLPWGT 197
           ++  EV  +    H +L+RL G+C    ERLLVY +M  GS+ + L +R      L W  
Sbjct: 73  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132

Query: 198 RLKIAIGAAKGLAFLH-GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV 256
           R +IA+G+A+GLA+LH   +  +I+RD K +NILLD +F A + DFGLAK+     +THV
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK-DTHV 191

Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQ--NLVDW 314
           TT V GT G+ APEY+STG  + K+DV+ +GV+LLEL+TG+R+ D  R  ++    L+DW
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251

Query: 315 AKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES 372
            K  L+  ++L  +VD  L G Y  +  +++  +AL C   +P +RPKM+ VV  LE 
Sbjct: 252 VKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  273 bits (700), Expect = 1e-89
 Identities = 74/325 (22%), Positives = 125/325 (38%), Gaps = 40/325 (12%)

Query: 80  DFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR 139
           D     L   +       +   G FG V K  + +        + VAVK+  I   Q  +
Sbjct: 13  DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN--------EYVAVKIFPI---QDKQ 61

Query: 140 EWLAE--VIFLGQLRHPHLVRLIGYCCEDE----ERLLVYEFMPRGSLENHLFKRISVSL 193
            W  E  V  L  ++H ++++ IG          +  L+  F  +GSL + L       +
Sbjct: 62  SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VV 118

Query: 194 PWGTRLKIAIGAAKGLAFLH-------GAENP-VIYRDFKTSNILLDSDFTAKLSDFGLA 245
            W     IA   A+GLA+LH           P + +RD K+ N+LL ++ TA ++DFGLA
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178

Query: 246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTT-----KSDVYSFGVVLLELLTGRRSM 300
                G +   T   +GT  Y APE +            + D+Y+ G+VL EL +   + 
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238

Query: 301 DKLRPKSEQNLVDWAKPYLRSSRRLRYIV-----DPRLAGQY-SVKGAKEMAVLALQCIS 354
           D    +      +       S   ++ +V      P L   +    G   +     +C  
Sbjct: 239 DGPVDEYMLPFEEEI-GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297

Query: 355 VNPKDRPKMAAVVATLESLLNLKDM 379
            + + R     V   +  +  L ++
Sbjct: 298 HDAEARLSAGCVGERITQMQRLTNI 322

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  220 bits (561), Expect = 1e-68
 Identities = 64/334 (19%), Positives = 120/334 (35%), Gaps = 49/334 (14%)

Query: 80  DFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR 139
           +   SE      N     L+G G +G V+KG         L  + VAVK+         +
Sbjct: 2   EAAASEPSLDLDNLKLLELIGRGRYGAVYKGS--------LDERPVAVKVFSF---ANRQ 50

Query: 140 EWLAE--VIFLGQLRHPHLVRLIGYCCEDE-----ERLLVYEFMPRGSLENHLFKRISVS 192
            ++ E  +  +  + H ++ R I            E LLV E+ P GSL  +L      +
Sbjct: 51  NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---T 107

Query: 193 LPWGTRLKIAIGAAKGLAFLH-------GAENPVIYRDFKTSNILLDSDFTAKLSDFGLA 245
             W +  ++A    +GLA+LH         +  + +RD  + N+L+ +D T  +SDFGL+
Sbjct: 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

Query: 246 KM------GPEGSNTHVTTRVMGTYGYAAPEYI-------STGHLTTKSDVYSFGVVLLE 292
                      G   +     +GT  Y APE +              + D+Y+ G++  E
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227

Query: 293 LLTGRRSMDKLRPKSEQNLV-DWAKPYLRSSRRLRYIVD-----PRLAGQYSV--KGAKE 344
           +      +       E  +          +   ++ +V      P+    +       + 
Sbjct: 228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287

Query: 345 MAVLALQCISVNPKDRPKMAAVVATLESLLNLKD 378
           +      C   + + R         +  L+ + +
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  216 bits (551), Expect = 2e-67
 Identities = 82/281 (29%), Positives = 128/281 (45%), Gaps = 31/281 (11%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH--REWLAEVIFLGQLRHPHL 156
           +G G FGTVH+               VAVK+L  +        E+L EV  + +LRHP++
Sbjct: 45  IGAGSFGTVHRAE--------WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRIS-VSLPWGTRLKIAIGAAKGLAFLHGA 215
           V  +G   +     +V E++ RGSL   L K  +   L    RL +A   AKG+ +LH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
             P+++R+ K+ N+L+D  +T K+ DFGL+++  + S    +    GT  + APE +   
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE 214

Query: 276 HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD-PRLA 334
               KSDVYSFGV+L EL T +      +P    N            +RL    +     
Sbjct: 215 PSNEKSDVYSFGVILWELATLQ------QPWGNLNPAQVVAAVGFKCKRLEIPRNLN--- 265

Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
                    ++A +   C +  P  RP  A ++  L  L+ 
Sbjct: 266 --------PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  207 bits (530), Expect = 1e-64
 Identities = 78/290 (26%), Positives = 130/290 (44%), Gaps = 44/290 (15%)

Query: 99  LGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLLDIEGLQGH-------REWLAEVIFLGQ 150
           +G+GGFG VHKG  + D          VA+K L +   +G        +E+  EV  +  
Sbjct: 27  IGKGGFGLVHKGRLVKDK-------SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79

Query: 151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
           L HP++V+L G         +V EF+P G L + L  + +  + W  +L++ +  A G+ 
Sbjct: 80  LNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIE 136

Query: 211 FLHGAENPVIYRDFKTSNILLDS-----DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
           ++     P+++RD ++ NI L S        AK++DFGL++      + H  + ++G + 
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQ 191

Query: 266 YAAPEYISTGHL--TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSR 323
           + APE I       T K+D YSF ++L  +LTG        P  E +        +    
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGE------GPFDEYSYGKIKFINMIREE 245

Query: 324 RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
            LR    P +           +  +   C S +PK RP  + +V  L  L
Sbjct: 246 GLR----PTIPEDCP----PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  206 bits (527), Expect = 3e-64
 Identities = 76/281 (27%), Positives = 124/281 (44%), Gaps = 30/281 (10%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH--REWLAEVIFLGQLRHPHL 156
           +G G FGTV+KG    D         VAVK+L++        + +  EV  L + RH ++
Sbjct: 32  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           +  +G      +  +V ++    SL +HL             + IA   A+G+ +LH   
Sbjct: 83  LLFMG-YSTAPQLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLH--A 138

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI---S 273
             +I+RD K++NI L  D T K+ DFGLA      S +H   ++ G+  + APE I    
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 274 TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL 333
           +   + +SDVY+FG+VL EL+TG+     +  + +   +       R S           
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEM--VGRGSLSPDLSKVRS- 252

Query: 334 AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                    K M  L  +C+     +RP    ++A +E L 
Sbjct: 253 ------NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  205 bits (524), Expect = 5e-64
 Identities = 61/284 (21%), Positives = 114/284 (40%), Gaps = 38/284 (13%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH--REWLAEVIFLGQLRHPHL 156
           L E   G + KG          +   + VK+L +        R++  E   L    HP++
Sbjct: 18  LNENHSGELWKGR--------WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69

Query: 157 VRLIGYCCEDEERLL--VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
           + ++G C          +  +MP GSL N L +  +  +     +K A+  A+G+AFLH 
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129

Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI-- 272
            E  +      + ++++D D TA++S   +         +  +   M    + APE +  
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQK 182

Query: 273 -STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDP 331
                    +D++SF V+L EL+T         P ++ + ++          R      P
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTRE------VPFADLSNMEIGMKVALEGLR------P 230

Query: 332 RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            +    S      ++ L   C++ +P  RPK   +V  LE + +
Sbjct: 231 TIPPGIS----PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  204 bits (522), Expect = 3e-63
 Identities = 71/312 (22%), Positives = 127/312 (40%), Gaps = 44/312 (14%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG   K       R+    + + +K L     +  R +L EV  +  L HP++++
Sbjct: 18  LGKGCFGQAIKVT----HRE--TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
            IG   +D+    + E++  G+L   +        PW  R+  A   A G+A+LH     
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLH--SMN 128

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR------------VMGTYGY 266
           +I+RD  + N L+  +    ++DFGLA++  +        R            V+G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR 326
            APE I+      K DV+SFG+VL E++    +     P++    ++     +R      
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-----VRGFLDR- 242

Query: 327 YI---VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMAVSC 383
           Y      P                + ++C  ++P+ RP    +   LE+L     +A   
Sbjct: 243 YCPPNCPPSFFP------------ITVRCCDLDPEKRPSFVKLEHWLETL--RMHLAGHL 288

Query: 384 GQWPATQKSTRN 395
              P  ++  R 
Sbjct: 289 PLGPQLEQLDRG 300

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  204 bits (520), Expect = 6e-63
 Identities = 76/280 (27%), Positives = 131/280 (46%), Gaps = 37/280 (13%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG V K           +A+ VA+K ++ E  +  + ++ E+  L ++ HP++V+
Sbjct: 16  VGRGAFGVVCKAK--------WRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVK 65

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFK-RISVSLPWGTRLKIAIGAAKGLAFLHGAE- 216
           L G C       LV E+   GSL N L              +   +  ++G+A+LH  + 
Sbjct: 66  LYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123

Query: 217 NPVIYRDFKTSNILLDSDFT-AKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
             +I+RD K  N+LL +  T  K+ DFG A        TH+T    G+  + APE     
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNK-GSAAWMAPEVFEGS 178

Query: 276 HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD-PRLA 334
           + + K DV+S+G++L E++T R+  D++   + +  + WA   + +  R   I + P   
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWA---VHNGTRPPLIKNLP--- 230

Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                   K +  L  +C S +P  RP M  +V  +  L+
Sbjct: 231 --------KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  200 bits (512), Expect = 3e-62
 Identities = 77/288 (26%), Positives = 120/288 (41%), Gaps = 44/288 (15%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH----REWLAEVIFLGQLRHP 154
           +G GGFG V++ +             VAVK    +  +           E      L+HP
Sbjct: 15  IGIGGFGKVYRAF--------WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66

Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
           +++ L G C ++    LV EF   G L   L  +    +P    +  A+  A+G+ +LH 
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHD 123

Query: 215 -AENPVIYRDFKTSNILLDSDF--------TAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
            A  P+I+RD K+SNIL+              K++DFGLA+   E   T   +   G Y 
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAA-GAYA 179

Query: 266 YAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL 325
           + APE I     +  SDV+S+GV+L ELLTG        P    + +  A     +   L
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGLAVAYGVAMNKLAL 233

Query: 326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
                P  +        +  A L   C + +P  RP    ++  L ++
Sbjct: 234 -----PIPST-----CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  196 bits (500), Expect = 9e-60
 Identities = 59/290 (20%), Positives = 107/290 (36%), Gaps = 43/290 (14%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH--REWLAEVIFLGQLRHPHL 156
           +G+G FG V+ G    +         VA++L+DIE       + +  EV+   Q RH ++
Sbjct: 41  IGKGRFGQVYHGRWHGE---------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           V  +G C       ++       +L + +     + L      +IA    KG+ +LH   
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHA-- 148

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKM---GPEGSNTHVTTRVMGTYGYAAPEYIS 273
             ++++D K+ N+  D +    ++DFGL  +      G          G   + APE I 
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207

Query: 274 TG---------HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
                        +  SDV++ G +  EL           P   Q             + 
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHARE------WPFKTQPAEAIIWQMGTGMKP 261

Query: 325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                  ++         KE++ + L C +   ++RP    ++  LE L 
Sbjct: 262 N----LSQI------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  193 bits (491), Expect = 3e-58
 Identities = 70/310 (22%), Positives = 123/310 (39%), Gaps = 46/310 (14%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL--AEVIFLGQLRHPH 155
            +G+G +G V  G          + + VAVK+           W    E+     +RH +
Sbjct: 44  QIGKGRYGEVWMGK--------WRGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHEN 92

Query: 156 LVRLIGYCCEDEER----LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           ++  I    +         L+ ++   GSL ++L      +L   + LK+A  +  GL  
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCH 149

Query: 212 LH------GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH--VTTRVMGT 263
           LH        +  + +RD K+ NIL+  + T  ++D GLA      +N         +GT
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209

Query: 264 YGYAAPE----YISTGHL--TTKSDVYSFGVVLLELLTGRRSMDKLR----PKSEQNLVD 313
             Y  PE     ++  H      +D+YSFG++L E+     S   +     P  +    D
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269

Query: 314 WAKPYLRS---SRRLRYIVDPRLAGQYSVKGA-KEMAVLALQCISVNPKDRPKMAAVVAT 369
            +   +R     ++LR    P    ++S     ++M  L  +C + NP  R     V  T
Sbjct: 270 PSYEDMREIVCIKKLR----PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325

Query: 370 LESLLNLKDM 379
           L  +   +D+
Sbjct: 326 LAKMSESQDI 335

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  190 bits (484), Expect = 1e-57
 Identities = 69/315 (21%), Positives = 125/315 (39%), Gaps = 46/315 (14%)

Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEV- 145
           R + ++ +    +G+G +G V +G          + + VAVK+      +  + W  E  
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGS--------WQGENVAVKIFSS---RDEKSWFRETE 52

Query: 146 IF-LGQLRHPHLVRLIGYC----CEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK 200
           ++    LRH +++  I           +  L+  +   GSL ++L      +L   + L+
Sbjct: 53  LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLR 109

Query: 201 IAIGAAKGLAFLH------GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT 254
           I +  A GLA LH        +  + +RD K+ NIL+  +    ++D GLA M  + +N 
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169

Query: 255 HVT--TRVMGTYGYAAPE------YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLR-- 304
                   +GT  Y APE       +       + D+++FG+VL E+     S   +   
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229

Query: 305 --PKSEQNLVDWAKPYLRS---SRRLRYIVDPRL-AGQYSVKGAKEMAVLALQCISVNPK 358
             P  +    D +   +R      + R    P +    +S      +A L  +C   NP 
Sbjct: 230 KPPFYDVVPNDPSFEDMRKVVCVDQQR----PNIPNRWFSDPTLTSLAKLMKECWYQNPS 285

Query: 359 DRPKMAAVVATLESL 373
            R     +  TL  +
Sbjct: 286 ARLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  187 bits (477), Expect = 4e-56
 Identities = 70/309 (22%), Positives = 126/309 (40%), Gaps = 40/309 (12%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAE--VIFLGQLRHPH 155
            +G+G FG V +G          + + VAVK+      +  R W  E  +     LRH +
Sbjct: 49  SIGKGRFGEVWRGK--------WRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHEN 97

Query: 156 LVRLIGYCCEDE----ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           ++  I    +D     +  LV ++   GSL ++L +    ++     +K+A+  A GLA 
Sbjct: 98  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAH 154

Query: 212 LH------GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH--VTTRVMGT 263
           LH        +  + +RD K+ NIL+  + T  ++D GLA      ++T        +GT
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214

Query: 264 YGYAAPE----YISTGHL--TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP 317
             Y APE     I+  H     ++D+Y+ G+V  E+   R S+  +    +    D    
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPS 273

Query: 318 YLRSSRRLRYIVDPRL-----AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES 372
                   + + + +L         S +  + MA +  +C   N   R     +  TL  
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333

Query: 373 LLNLKDMAV 381
           L   + + +
Sbjct: 334 LSQQEGIKM 342

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  163 bits (414), Expect = 1e-46
 Identities = 71/286 (24%), Positives = 113/286 (39%), Gaps = 44/286 (15%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           +G G FG V  G +  D         VAVK   +        ++L E   L Q  HP++V
Sbjct: 122 IGRGNFGEVFSGRLRADNTL------VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 175

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           RLIG C + +   +V E +  G     L    +  L   T L++   AA G+ +L     
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLE--SK 232

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
             I+RD    N L+      K+SDFG+++   +G              + APE ++ G  
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRY 292

Query: 278 TTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR--LRYIVD---- 330
           +++SDV+SFG++L E  + G                    PY   S +    ++      
Sbjct: 293 SSESDVWSFGILLWETFSLGAS------------------PYPNLSNQQTREFVEKGGRL 334

Query: 331 --PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
             P L           +  L  QC +  P  RP  + +   L+S+ 
Sbjct: 335 PCPELC-------PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  155 bits (395), Expect = 1e-44
 Identities = 77/302 (25%), Positives = 112/302 (37%), Gaps = 55/302 (18%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LGEG FG V     D +       + VAVK L    G     +   E+  L  L H ++V
Sbjct: 29  LGEGHFGKVELCRYDPEGDNT--GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 158 RLIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +  G C ED      L+ EF+P GSL+ +L K     +    +LK A+   KG+ +L   
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYL--G 143

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT-------RVMGTYGYAA 268
               ++RD    N+L++S+   K+ DFGL K        +                   A
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY------A 197

Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPY--------- 318
           PE +        SDV+SFGV L ELLT                L      +         
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSD----SSPMALFLKMIGPTHGQMTVTRLV 253

Query: 319 --LRSSRRLRYIVDPRLAG----QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES 372
             L+  +RL     P         Y +     M     +C    P +R     ++   E+
Sbjct: 254 NTLKEGKRL-----PCPPNCPDEVYQL-----M----RKCWEFQPSNRTSFQNLIEGFEA 299

Query: 373 LL 374
           LL
Sbjct: 300 LL 301

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  154 bits (392), Expect = 4e-44
 Identities = 76/301 (25%), Positives = 123/301 (40%), Gaps = 51/301 (16%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG+V     D    Q    + VAVK L     +  R++  E+  L  L+H ++V+
Sbjct: 18  LGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 159 LIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
             G C     R   L+ E++P GSL ++L ++    +     L+      KG+ +L    
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLG--T 132

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT-------RVMGTYGYAAP 269
              I+RD  T NIL++++   K+ DFGL K+ P+                        AP
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY------AP 186

Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY----------- 318
           E ++    +  SDV+SFGVVL EL T         P +E   +                 
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244

Query: 319 LRSSRRLRYIVDPRLAG----QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           L+++ RL     PR  G     Y +     M     +C + N   RP    +   ++ + 
Sbjct: 245 LKNNGRL-----PRPDGCPDEIYMI-----M----TECWNNNVNQRPSFRDLALRVDQIR 290

Query: 375 N 375
           +
Sbjct: 291 D 291

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  154 bits (392), Expect = 6e-44
 Identities = 77/301 (25%), Positives = 123/301 (40%), Gaps = 51/301 (16%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG+V     D    Q    + VAVK L     +  R++  E+  L  L+H ++V+
Sbjct: 49  LGKGNFGSVEMCRYD--PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 159 LIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
             G C     R   L+ E++P GSL ++L K     +     L+      KG+ +L    
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL--GT 163

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT-------RVMGTYGYAAP 269
              I+RD  T NIL++++   K+ DFGL K+ P+    +                   AP
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY------AP 217

Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY----------- 318
           E ++    +  SDV+SFGVVL EL T         P +E   +                 
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275

Query: 319 LRSSRRLRYIVDPRLAG----QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           L+++ RL     PR  G     Y +     M     +C + N   RP    +   ++ + 
Sbjct: 276 LKNNGRL-----PRPDGCPDEIYMI-----M----TECWNNNVNQRPSFRDLALRVDQIR 321

Query: 375 N 375
           +
Sbjct: 322 D 322

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  154 bits (392), Expect = 7e-44
 Identities = 84/297 (28%), Positives = 119/297 (40%), Gaps = 47/297 (15%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LGEG FG V     D         + VAVK L    G Q    W  E+  L  L H H++
Sbjct: 39  LGEGHFGKVSLYCYDPT--NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 158 RLIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +  G C +       LV E++P GSL ++L +    S+     L  A    +G+A+LH  
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH-- 151

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT-------RVMGTYGYAA 268
               I+RD    N+LLD+D   K+ DFGLAK  PEG   +                   A
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY------A 205

Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLR-SSRRLR 326
           PE +        SDV+SFGV L ELLT    S    +    + L        + +  RL 
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSS----QSPPTKFLELIGIAQGQMTVLRLT 261

Query: 327 YIVDP--RL-------AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
            +++   RL       A  Y +     M      C       RP    ++  L+++ 
Sbjct: 262 ELLERGERLPRPDKCPAEVYHL-----M----KNCWETEASFRPTFENLIPILKTVH 309

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  154 bits (391), Expect = 9e-44
 Identities = 69/289 (23%), Positives = 123/289 (42%), Gaps = 47/289 (16%)

Query: 99  LGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHL 156
           LG G FGTV+KG +I +  +  +    VA+K L +    + ++E L E   +  + +PH+
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
            RL+G  C      L+ + MP G L +++ +    ++     L   +  AKG+ +L   +
Sbjct: 80  CRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYL--ED 135

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH 276
             +++RD    N+L+ +    K++DFGLAK+       +          + A E I    
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195

Query: 277 LTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRYIVDP-R 332
            T +SDV+S+GV + EL+T G +                  PY  + +S     +    R
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK------------------PYDGIPASEISSILEKGER 237

Query: 333 L-------AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           L          Y +     M     +C  ++   RPK   ++     + 
Sbjct: 238 LPQPPICTIDVYMI-----M----RKCWMIDADSRPKFRELIIEFSKMA 277

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  154 bits (390), Expect = 1e-43
 Identities = 77/298 (25%), Positives = 118/298 (39%), Gaps = 46/298 (15%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG+V     D           VAVK L   G    R++  E+  L  L    +V+
Sbjct: 31  LGKGNFGSVELCRYDPL--GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 159 LIGYCCEDEER--LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
             G       +   LV E++P G L + L +     L     L  +    KG+ +L    
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLG--S 145

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT-------RVMGTYGYAAP 269
              ++RD    NIL++S+   K++DFGLAK+ P   + +V                  AP
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY------AP 199

Query: 270 EYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKP-------YLRS 321
           E +S    + +SDV+SFGVVL EL T   +S             +   P        L  
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259

Query: 322 SRRLRYIVDPRLAG----QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            +RL     P         + +     M      C + +P+DRP  +A+   L+ L +
Sbjct: 260 GQRL-----PAPPACPAEVHEL-----M----KLCWAPSPQDRPSFSALGPQLDMLWS 303

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  149 bits (378), Expect = 3e-42
 Identities = 75/294 (25%), Positives = 113/294 (38%), Gaps = 51/294 (17%)

Query: 99  LGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LG+G F  + KG   +      L    V +K+LD         +      + +L H HLV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
              G C   +E +LV EF+  GSL+ +L K+    +    +L++A   A  + FL   EN
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFL--EEN 132

Query: 218 PVIYRDFKTSNILLDSDFT--------AKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
            +I+ +    NILL  +           KLSD G++               +       P
Sbjct: 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV------PP 186

Query: 270 EYISTG-HLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPY--LRSSRRL 325
           E I    +L   +D +SFG  L E+ + G                   KP   L S R+L
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICSGGD------------------KPLSALDSQRKL 228

Query: 326 RYIVD----PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           ++  D    P            E+A L   C+   P  RP   A++  L SL  
Sbjct: 229 QFYEDRHQLPAPKA-------AELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  148 bits (375), Expect = 2e-41
 Identities = 74/282 (26%), Positives = 122/282 (43%), Gaps = 33/282 (11%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LG G FGTVHKG    +         V +K++ D  G Q  +     ++ +G L H H+V
Sbjct: 21  LGSGVFGTVHKGVWIPEGESI--KIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           RL+G  C      LV +++P GSL +H+ +    +L     L   +  AKG+ +L   E+
Sbjct: 79  RLLG-LCPGSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYL--EEH 134

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
            +++R+    N+LL S    +++DFG+A + P      + +       + A E I  G  
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194

Query: 278 TTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR---- 332
           T +SDV+S+GV + EL+T G        P +   L +     L    RL      +    
Sbjct: 195 THQSDVWSYGVTVWELMTFGA------EPYAGLRLAEVPD-LLEKGERL-----AQPQIC 242

Query: 333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
               Y V     M    ++C  ++   RP    +      + 
Sbjct: 243 TIDVYMV-----M----VKCWMIDENIRPTFKELANEFTRMA 275

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  147 bits (374), Expect = 3e-41
 Identities = 69/283 (24%), Positives = 124/283 (43%), Gaps = 35/283 (12%)

Query: 99  LGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHL 156
           LG G FGTV+KG +I +  +  +    VA+K L +    + ++E L E   +  + +PH+
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
            RL+G  C      L+ + MP G L +++ +    ++     L   +  AKG+ +L   +
Sbjct: 80  CRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYL--ED 135

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH 276
             +++RD    N+L+ +    K++DFGLAK+       +          + A E I    
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195

Query: 277 LTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR--- 332
            T +SDV+S+GV + EL+T G       +P       + +   L    RL     P+   
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGS------KPYDGIPASEISS-ILEKGERL-----PQPPI 243

Query: 333 -LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                Y +     M    ++C  ++   RPK   ++     + 
Sbjct: 244 CTIDVYMI-----M----VKCWMIDADSRPKFRELIIEFSKMA 277

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  151 bits (384), Expect = 3e-41
 Identities = 68/277 (24%), Positives = 118/277 (42%), Gaps = 26/277 (9%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G +G V++G           +  VAVK L  E      E+L E   + +++HP+LV+
Sbjct: 228 LGGGQYGEVYEGVWKK------YSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQ 280

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +L   +  
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKN 338

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
            I+R+    N L+  +   K++DFGL+++   G              + APE ++    +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397

Query: 279 TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYS 338
            KSDV++FGV+L E+ T         P    +L       L    R+     P       
Sbjct: 398 IKSDVWAFGVLLWEIATYGM-----SPYPGIDLSQ-VYELLEKDYRM---ERPEGC---- 444

Query: 339 VKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
               +++  L   C   NP DRP  A +    E++  
Sbjct: 445 ---PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  149 bits (378), Expect = 9e-41
 Identities = 75/277 (27%), Positives = 115/277 (41%), Gaps = 28/277 (10%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-------VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 243

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L      +E   +V E+M +GSL + L       L     + +A   A G+A++      
Sbjct: 244 LYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMN 300

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
            ++RD + +NIL+  +   K++DFGLA++  +   T           + APE    G  T
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFT 359

Query: 279 TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYS 338
            KSDV+SFG++L EL T  R      P       +     +    R+     P       
Sbjct: 360 IKSDVWSFGILLTELTTKGR-----VPYPGMVNRE-VLDQVERGYRM---PCPPEC---- 406

Query: 339 VKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
               + +  L  QC    P++RP    + A LE    
Sbjct: 407 ---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  145 bits (367), Expect = 1e-40
 Identities = 75/294 (25%), Positives = 120/294 (40%), Gaps = 58/294 (19%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LG G FG+V +G      R   K   VA+K+L          E + E   + QL +P++V
Sbjct: 18  LGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           RLIG  C+ E  +LV E    G L   L  +    +P     ++    + G+ +L   E 
Sbjct: 74  RLIG-VCQAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYL--EEK 129

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG------TYGYAAPEY 271
             ++RD    N+LL +   AK+SDFGL+K      + + T R  G           APE 
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWY----APEC 184

Query: 272 ISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR--LRYI 328
           I+    +++SDV+S+GV + E L+ G++                  PY +      + +I
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQK------------------PYKKMKGPEVMAFI 226

Query: 329 VDP-RL-------AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
               R+          Y++     M      C     +DRP    V   + +  
Sbjct: 227 EQGKRMECPPECPPELYAL-----M----SDCWIYKWEDRPDFLTVEQRMRACY 271

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  148 bits (376), Expect = 2e-40
 Identities = 73/289 (25%), Positives = 119/289 (41%), Gaps = 58/289 (20%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G+G FG V  G          +   VAVK +        + +LAE   + QLRH +LV+
Sbjct: 201 IGKGEFGDVMLGD--------YRGNKVAVKCIK-NDAT-AQAFLAEASVMTQLRHSNLVQ 250

Query: 159 LIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           L+G   E++  L +V E+M +GSL ++L  R    L     LK ++   + + +L    N
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN 308

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT---YGYAAPEYIST 274
             ++RD    N+L+  D  AK+SDFGL K          ++          + APE +  
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVKWTAPEALRE 360

Query: 275 GHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR--LRYIVD- 330
              +TKSDV+SFG++L E+ + GR                   PY R   +  +  +   
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRV------------------PYPRIPLKDVVPRVEKG 402

Query: 331 -----PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                P             +  +   C  ++   RP    +   LE + 
Sbjct: 403 YKMDAPDGC-------PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  144 bits (365), Expect = 3e-40
 Identities = 80/295 (27%), Positives = 124/295 (42%), Gaps = 60/295 (20%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL--DIEGLQGHREWLAEVIFLGQLRHPHL 156
           LG G FGTV KGY     +     + VAVK+L  +        E LAE   + QL +P++
Sbjct: 25  LGSGNFGTVKKGY----YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           VR+IG  CE E  +LV E    G L  +L +   V       +++    + G+ +L   E
Sbjct: 81  VRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYL--EE 135

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG------TYGYAAPE 270
           +  ++RD    N+LL +   AK+SDFGL+K      N +   +  G           APE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YYKAQTHGKWPVKWY----APE 190

Query: 271 YISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR--LRY 327
            I+    ++KSDV+SFGV++ E  + G++                  PY           
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQK------------------PYRGMKGSEVTAM 232

Query: 328 IVDP-RL-------AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           +    R+          Y +     M      C + + ++RP  AAV   L +  
Sbjct: 233 LEKGERMGCPAGCPREMYDL-----M----NLCWTYDVENRPGFAAVELRLRNYY 278

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  143 bits (363), Expect = 3e-40
 Identities = 70/289 (24%), Positives = 118/289 (40%), Gaps = 52/289 (17%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  G              VAVK++  EG     E+  E   + +L HP LV+
Sbjct: 16  LGSGQFGVVKLGKWKGQYD-------VAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVK 67

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
             G C ++    +V E++  G L N+L       L     L++     +G+AFL    + 
Sbjct: 68  FYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFL--ESHQ 124

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT---YGYAAPEYISTG 275
            I+RD    N L+D D   K+SDFG+ +   +          +GT     ++APE     
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD----QYVSSVGTKFPVKWSAPEVFHYF 180

Query: 276 HLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR--LRYIVD-- 330
             ++KSDV++FG+++ E+ + G+                   PY   +    +  +    
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKM------------------PYDLYTNSEVVLKVSQGH 222

Query: 331 ----PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
               P LA       +  +  +   C    P+ RP    +++++E L  
Sbjct: 223 RLYRPHLA-------SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  145 bits (367), Expect = 4e-40
 Identities = 80/303 (26%), Positives = 113/303 (37%), Gaps = 52/303 (17%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LGEG FG V      + L        VAVK L        +++  E   L  L+H H+VR
Sbjct: 49  LGEGAFGKVFLAECHN-LLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR-------------LKIAIGA 205
             G C E    L+V+E+M  G L   L      +                   L +A   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167

Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRV----- 260
           A G+ +L  A    ++RD  T N L+      K+ DFG+++         V  R      
Sbjct: 168 AAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225

Query: 261 -MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP---KSEQNLVDWA 315
            M       PE I     TT+SDV+SFGVVL E+ T G+      +P    S    +D  
Sbjct: 226 WM------PPESILYRKFTTESDVWSFGVVLWEIFTYGK------QPWYQLSNTEAID-- 271

Query: 316 KPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
              +   R L     PR           E+  +   C    P+ R  +  V A L++L  
Sbjct: 272 --CITQGRELER---PRAC-------PPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319

Query: 376 LKD 378
              
Sbjct: 320 APP 322

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  143 bits (364), Expect = 4e-40
 Identities = 80/293 (27%), Positives = 126/293 (43%), Gaps = 50/293 (17%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           +G G FG V+ G + D+     K    AVK L  I  +    ++L E I +    HP+++
Sbjct: 33  IGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 158 RLIGYCCEDEE-RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
            L+G C   E   L+V  +M  G L N +    + +      +   +  AKG+ +L  A 
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYL--AS 146

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAK----MGPEGSNTHVTTRV----MGTYGYAA 268
              ++RD    N +LD  FT K++DFGLA+          +     ++    M      A
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM------A 200

Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP---KSEQNLVDWAKPYLRSSRR 324
            E + T   TTKSDV+SFGV+L EL+T G        P    +  ++      YL   RR
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGA------PPYPDVNTFDITV----YLLQGRR 250

Query: 325 LRYIVD--PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           L         L   Y V     M    L+C     + RP  + +V+ + ++ +
Sbjct: 251 LLQPEYCPDPL---YEV-----M----LKCWHPKAEMRPSFSELVSRISAIFS 291

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  144 bits (366), Expect = 4e-40
 Identities = 80/293 (27%), Positives = 129/293 (44%), Gaps = 53/293 (18%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHL 156
           +G G FG V+KG +      G K   VA+K L   G   +   ++L E   +GQ  H ++
Sbjct: 52  IGAGEFGEVYKGMLKTS--SGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           +RL G   + +  +++ E+M  G+L+  L +           + +  G A G+ +L  A 
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYL--AN 165

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG------YAAPE 270
              ++RD    NIL++S+   K+SDFGL+++  +      TT      G      + APE
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIRWTAPE 220

Query: 271 YISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR--LRY 327
            IS    T+ SDV+SFG+V+ E++T G R                  PY   S    ++ 
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGER------------------PYWELSNHEVMKA 262

Query: 328 IVD------PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           I D      P             +  L +QC       RPK A +V+ L+ L+
Sbjct: 263 INDGFRLPTPMDC-------PSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  144 bits (366), Expect = 4e-40
 Identities = 70/295 (23%), Positives = 124/295 (42%), Gaps = 48/295 (16%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LG+G FG V++G     + +      VA+K + +   ++   E+L E   + +    H+V
Sbjct: 33  LGQGSFGMVYEGVAKG-VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKR--------ISVSLPWGTRLKIAIGAAKGL 209
           RL+G   + +  L++ E M RG L+++L           +         +++A   A G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRV------MGT 263
           A+L    N  ++RD    N ++  DFT K+ DFG+ +   E        +       M  
Sbjct: 152 AYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207

Query: 264 YGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP---KSEQNLVDWAKPYL 319
               +PE +  G  TT SDV+SFGVVL E+ T         +P    S + ++     ++
Sbjct: 208 ----SPESLKDGVFTTYSDVWSFGVVLWEIATLAE------QPYQGLSNEQVLR----FV 253

Query: 320 RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                L     P             +  L   C   NPK RP    ++++++  +
Sbjct: 254 MEGGLLDK---PDNCPD-------MLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  146 bits (369), Expect = 4e-40
 Identities = 93/357 (26%), Positives = 148/357 (41%), Gaps = 54/357 (15%)

Query: 41  SKNIAPMPSFRRLSFSDLSRSSSTRINEDLAHTFGPDLYDF---QLSELRAITQNFSSNY 97
           S  +  + S   LS S   ++ S  +    A+T   DL       +  ++ +    SS  
Sbjct: 31  SPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLI 90

Query: 98  L-----LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQL 151
           +     +G G FG V+ G + D+     K    AVK L  I  +    ++L E I +   
Sbjct: 91  VHFNEVIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 147

Query: 152 RHPHLVRLIGYCCEDEE-RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
            HP+++ L+G C   E   L+V  +M  G L N +    + +      +   +  AKG+ 
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMK 206

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG------TY 264
           FL  A    ++RD    N +LD  FT K++DFGLA+   +     V  +           
Sbjct: 207 FL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM- 263

Query: 265 GYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP---KSEQNLVDWAKPYLR 320
              A E + T   TTKSDV+SFGV+L EL+T G        P    +  ++      YL 
Sbjct: 264 ---ALESLQTQKFTTKSDVWSFGVLLWELMTRGA------PPYPDVNTFDITV----YLL 310

Query: 321 SSRRLRYIVD--PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
             RRL         L   Y V     M    L+C     + RP  + +V+ + ++ +
Sbjct: 311 QGRRLLQPEYCPDPL---YEV-----M----LKCWHPKAEMRPSFSELVSRISAIFS 355

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  143 bits (363), Expect = 5e-40
 Identities = 69/290 (23%), Positives = 118/290 (40%), Gaps = 54/290 (18%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G +G V++G           +  VAVK L  E      E+L E   + +++HP+LV+
Sbjct: 21  LGGGQYGEVYEGVWKK------YSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQ 73

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +L   +  
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKN 131

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT-HVTTRV----MGTYGYAAPEYIS 273
            I+RD    N L+  +   K++DFGL+++    + T H   +            APE ++
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------APESLA 185

Query: 274 TGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR--LRYIVD 330
               + KSDV++FGV+L E+ T G                    PY           +  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS------------------PYPGIDLSQVYELLEK 227

Query: 331 ------PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                 P           +++  L   C   NP DRP  A +    E++ 
Sbjct: 228 DYRMERPEGC-------PEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  143 bits (363), Expect = 6e-40
 Identities = 78/293 (26%), Positives = 120/293 (40%), Gaps = 54/293 (18%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREWLAEVIFLGQLRHPH 155
           LG+G FG V +G  D       K  +VAVK L    +   +   +++ EV  +  L H +
Sbjct: 26  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           L+RL G         +V E  P GSL + L K        GT  + A+  A+G+ +L   
Sbjct: 83  LIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYL--E 138

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT---YGYAAPEYI 272
               I+RD    N+LL +    K+ DFGL +  P+  + +V          + + APE +
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESL 196

Query: 273 STGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR--LRYIV 329
            T   +  SD + FGV L E+ T G+                  +P++  +    L  I 
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQ------------------EPWIGLNGSQILHKID 238

Query: 330 DP--RL-------AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
               RL          Y+V     M    +QC +  P+DRP   A+   L   
Sbjct: 239 KEGERLPRPEDCPQDIYNV-----M----VQCWAHKPEDRPTFVALRDFLLEA 282

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  142 bits (361), Expect = 8e-40
 Identities = 83/288 (28%), Positives = 124/288 (43%), Gaps = 52/288 (18%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  GY +   +       VAVK L  +G      +LAE   + QL+H  LVR
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-------VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L       E   ++ E+M  GSL + L     + L     L +A   A+G+AF+   E  
Sbjct: 73  LYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 129

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT---YGYAAPEYISTG 275
            I+RD + +NIL+    + K++DFGLA++  +       T   G      + APE I+ G
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDN----EYTAREGAKFPIKWTAPEAINYG 185

Query: 276 HLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR--LRYIVD-- 330
             T KSDV+SFG++L E++T GR                   PY   +    ++ +    
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI------------------PYPGMTNPEVIQNLERGY 227

Query: 331 ----PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
               P           +E+  L   C    P+DRP    + + LE   
Sbjct: 228 RMVRPDNC-------PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  142 bits (361), Expect = 1e-39
 Identities = 81/293 (27%), Positives = 121/293 (41%), Gaps = 50/293 (17%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           +G+G FG V+ G   D   Q       A+K L  I  +Q    +L E + +  L HP+++
Sbjct: 29  IGKGHFGVVYHGEYID---QAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 158 RLIGYCCEDEERLL-VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
            LIG     E     +  +M  G L   + +    +      +   +  A+G+ +L  AE
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYL--AE 142

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG------TYGYAAPE 270
              ++RD    N +LD  FT K++DFGLA+   +     V            T    A E
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----ALE 198

Query: 271 YISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP---KSEQNLVDWAKPYLRSSRRLR 326
            + T   TTKSDV+SFGV+L ELLT G        P       +L      +L   RRL 
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGA------PPYRHIDPFDLTH----FLAQGRRL- 247

Query: 327 YIVDPRLAG----QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
               P+        Y V     M     QC   +P  RP    +V  +E +++
Sbjct: 248 ----PQPEYCPDSLYQV-----M----QQCWEADPAVRPTFRVLVGEVEQIVS 287

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  141 bits (359), Expect = 2e-39
 Identities = 61/289 (21%), Positives = 118/289 (40%), Gaps = 52/289 (17%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  G              VA+K++  EG     E++ E   +  L H  LV+
Sbjct: 32  LGTGQFGVVKYGKWRGQYD-------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 83

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G C +     ++ E+M  G L N+L + +         L++     + + +L      
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYL--ESKQ 140

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT---YGYAAPEYISTG 275
            ++RD    N L++     K+SDFGL++   +       T  +G+     ++ PE +   
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----EYTSSVGSKFPVRWSPPEVLMYS 196

Query: 276 HLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR--LRYIVD-- 330
             ++KSD+++FGV++ E+ + G+                   PY R +      +I    
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKM------------------PYERFTNSETAEHIAQGL 238

Query: 331 ----PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
               P LA       ++++  +   C      +RP    +++ +  +++
Sbjct: 239 RLYRPHLA-------SEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  143 bits (362), Expect = 2e-39
 Identities = 72/287 (25%), Positives = 125/287 (43%), Gaps = 42/287 (14%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           +G G  G V  G +      G +   VA+K L      +  R++L+E   +GQ  HP+++
Sbjct: 57  IGSGDSGEVCYGRL---RVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           RL G        ++V E+M  GSL+  L             + +  G   G+ +L  ++ 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYL--SDL 170

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPEYISTGH 276
             ++RD    N+L+DS+   K+SDFGL++ +  +    + TT       + APE I+   
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230

Query: 277 LTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR--LRYIVD--- 330
            ++ SDV+SFGVV+ E+L  G R                  PY   + R  +  + +   
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGER------------------PYWNMTNRDVISSVEEGYR 272

Query: 331 ---PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
              P             +  L L C   +   RP+ + +V+ L++L+
Sbjct: 273 LPAPMGC-------PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  141 bits (359), Expect = 2e-39
 Identities = 77/291 (26%), Positives = 123/291 (42%), Gaps = 60/291 (20%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G+G FG V  G          +   VAVK +        + +LAE   + QLRH +LV+
Sbjct: 29  IGKGEFGDVMLGD--------YRGNKVAVKCIK-NDAT-AQAFLAEASVMTQLRHSNLVQ 78

Query: 159 LIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           L+G   E++  L +V E+M +GSL ++L  R    L     LK ++   + + +L    N
Sbjct: 79  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN 136

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRV----MGTYGYAAPEYIS 273
             ++RD    N+L+  D  AK+SDFGL K   E S+T  T ++           APE + 
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALR 187

Query: 274 TGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR--LRYIVD 330
               +TKSDV+SFG++L E+ + GR                   PY R   +  +  +  
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRV------------------PYPRIPLKDVVPRVEK 229

Query: 331 ------PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
                 P             +  +   C  ++   RP    +   LE +  
Sbjct: 230 GYKMDAPDGC-------PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  147 bits (372), Expect = 2e-39
 Identities = 75/276 (27%), Positives = 115/276 (41%), Gaps = 28/276 (10%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 275 LGQGCFGEVWMGTWNGTTR-------VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 326

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L      +E   +V E+M +GSL + L       L     + +A   A G+A++      
Sbjct: 327 LYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMN 383

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
            ++RD + +NIL+  +   K++DFGLA++  +   T           + APE    G  T
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFT 442

Query: 279 TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYS 338
            KSDV+SFG++L EL T  R      P       +     +    R+     P       
Sbjct: 443 IKSDVWSFGILLTELTTKGR-----VPYPGMVNRE-VLDQVERGYRM---PCPPEC---- 489

Query: 339 VKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
               + +  L  QC    P++RP    + A LE   
Sbjct: 490 ---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  140 bits (356), Expect = 3e-39
 Identities = 79/288 (27%), Positives = 124/288 (43%), Gaps = 52/288 (18%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG VH GY  +  +       VA+K +  EG     +++ E   + +L HP LV+
Sbjct: 16  IGSGQFGLVHLGYWLNKDK-------VAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 67

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G C E     LV EFM  G L ++L  +        T L + +   +G+A+L   E  
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYL--EEAC 124

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT---YGYAAPEYISTG 275
           VI+RD    N L+  +   K+SDFG+ +   +       T   GT     +A+PE  S  
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD----QYTSSTGTKFPVKWASPEVFSFS 180

Query: 276 HLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR--LRYIVD-- 330
             ++KSDV+SFGV++ E+ + G+                   PY   S    +  I    
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKI------------------PYENRSNSEVVEDISTGF 222

Query: 331 ----PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
               PRLA       +  +  +   C    P+DRP  + ++  L  + 
Sbjct: 223 RLYKPRLA-------STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  140 bits (356), Expect = 4e-39
 Identities = 69/299 (23%), Positives = 114/299 (38%), Gaps = 57/299 (19%)

Query: 88  AITQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA 143
            + + F  ++    L+G GGFG V K       +  +  +   +K +     +  RE   
Sbjct: 4   TVDKRFGMDFKEIELIGSGGFGQVFKA------KHRIDGKTYVIKRVKYNNEKAERE--- 54

Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL----------------LVYEFMPRGSLENHLFK 187
            V  L +L H ++V   G     +                   +  EF  +G+LE  + K
Sbjct: 55  -VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113

Query: 188 RISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM 247
           R    L     L++     KG+ ++H     +I RD K SNI L      K+ DFGL   
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIH--SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171

Query: 248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKS 307
                N    TR  GT  Y +PE IS+     + D+Y+ G++L ELL             
Sbjct: 172 ---LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV----------- 217

Query: 308 EQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
                        +S+    + D  ++  +     K+   L  + +S  P+DRP  + +
Sbjct: 218 -------CDTAFETSKFFTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEI 265

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  140 bits (354), Expect = 8e-39
 Identities = 75/301 (24%), Positives = 124/301 (41%), Gaps = 71/301 (23%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LGEG FG V++G   +   + +    VAVK       L    ++++E + +  L HPH+V
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKIN---VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +LIG   E+E   ++ E  P G L ++L +R   SL   T +  ++   K +A+L     
Sbjct: 77  KLIG-IIEEEPTWIIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYL--ESI 132

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY----------- 266
             ++RD    NIL+ S    KL DFGL+             R +    Y           
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLS-------------RYIEDEDYYKASVTRLPIK 179

Query: 267 -AAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
             +PE I+    TT SDV+ F V + E+L+ G++                  P+     +
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ------------------PFFWLENK 221

Query: 325 --LRYIVDP-RL-------AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
             +  +    RL          Y++     M     +C   +P DRP+   +V +L  + 
Sbjct: 222 DVIGVLEKGDRLPKPDLCPPVLYTL-----M----TRCWDYDPSDRPRFTELVCSLSDVY 272

Query: 375 N 375
            
Sbjct: 273 Q 273

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  140 bits (356), Expect = 8e-39
 Identities = 79/299 (26%), Positives = 123/299 (41%), Gaps = 56/299 (18%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL--DIEGLQGHREWLAEVIFLGQLRHPHL 156
           LGEG FG+V +G +  +      +  VAVK +  D    +   E+L+E   +    HP++
Sbjct: 42  LGEGEFGSVMEGNLKQE---DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 157 VRLIGYCCEDE-----ERLLVYEFMPRGSLENHLFKR----ISVSLPWGTRLKIAIGAAK 207
           +RL+G C E       + +++  FM  G L  +L           +P  T LK  +  A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRV------M 261
           G+ +L  +    ++RD    N +L  D T  ++DFGL+K    G               +
Sbjct: 159 GMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216

Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP---KSEQNLVDWAKP 317
                 A E ++    T+KSDV++FGV + E+ T G        P        + D    
Sbjct: 217 ------AIESLADRVYTSKSDVWAFGVTMWEIATRGM------TPYPGVQNHEMYD---- 260

Query: 318 YLRSSRRLRYIVD--PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           YL    RL+   D    L   Y +     M      C   +P DRP  + +   LE LL
Sbjct: 261 YLLHGHRLKQPEDCLDEL---YEI-----M----YSCWRTDPLDRPTFSVLRLQLEKLL 307

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  140 bits (354), Expect = 1e-38
 Identities = 77/301 (25%), Positives = 118/301 (39%), Gaps = 53/301 (17%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LGEG FG V      + L        VAVK L    L   +++  E   L  L+H H+V+
Sbjct: 23  LGEGAFGKVFLAECYN-LSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKR--------------ISVSLPWGTRLKIAIG 204
             G C + +  ++V+E+M  G L   L                     L     L IA  
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141

Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRV---- 260
            A G+ +L  A    ++RD  T N L+ ++   K+ DFG+++         V        
Sbjct: 142 IASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199

Query: 261 --MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP---KSEQNLVDW 314
             M       PE I     TT+SDV+SFGV+L E+ T G+      +P    S   +++ 
Sbjct: 200 RWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGK------QPWFQLSNTEVIE- 246

Query: 315 AKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
               +   R L     PR+         KE+  + L C    P+ R  +  +   L +L 
Sbjct: 247 ---CITQGRVLER---PRVC-------PKEVYDVMLGCWQREPQQRLNIKEIYKILHALG 293

Query: 375 N 375
            
Sbjct: 294 K 294

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  142 bits (359), Expect = 1e-38
 Identities = 78/291 (26%), Positives = 134/291 (46%), Gaps = 50/291 (17%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLGQLRHPHLV 157
           +G G FG V  G +        K  +VA+K L +   +  R ++L E   +GQ  HP+++
Sbjct: 53  VGAGEFGEVCSGRL---KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           RL G   + +  ++V E+M  GSL++ L K           + +  G A G+ +L  ++ 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYL--SDM 166

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT---YGYAAPEYIST 274
             ++RD    NIL++S+   K+SDFGL ++  +      TTR  G      + +PE I+ 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAIAY 224

Query: 275 GHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR--LRYIVD- 330
              T+ SDV+S+G+VL E+++ G R                  PY   S +  ++ + + 
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGER------------------PYWEMSNQDVIKAVDEG 266

Query: 331 -----PRL--AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                P    A  Y +     M    L C   +  +RPK   +V+ L+ L+
Sbjct: 267 YRLPPPMDCPAALYQL-----M----LDCWQKDRNNRPKFEQIVSILDKLI 308

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  143 bits (363), Expect = 1e-38
 Identities = 75/288 (26%), Positives = 123/288 (42%), Gaps = 52/288 (18%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V     +   +       VAVK +   G      +LAE   +  L+H  LV+
Sbjct: 196 LGAGQFGEVWMATYNKHTK-------VAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 247

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L       E   ++ EFM +GSL + L        P    +  +   A+G+AF+   +  
Sbjct: 248 LHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQRN 304

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT---YGYAAPEYISTG 275
            I+RD + +NIL+ +    K++DFGLA++  +    +  T   G      + APE I+ G
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIED----NEYTAREGAKFPIKWTAPEAINFG 360

Query: 276 HLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR--LRYIVD-- 330
             T KSDV+SFG++L+E++T GR                   PY   S    +R +    
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRI------------------PYPGMSNPEVIRALERGY 402

Query: 331 ----PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
               P           +E+  + ++C    P++RP    + + L+   
Sbjct: 403 RMPRPENC-------PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  139 bits (353), Expect = 1e-38
 Identities = 72/275 (26%), Positives = 115/275 (41%), Gaps = 43/275 (15%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWL-AEVIFLGQLRHPH 155
            +G G F TV+KG    D         VA   L    L +  R+    E   L  L+HP+
Sbjct: 33  EIGRGSFKTVYKGL---DTETT---VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86

Query: 156 LVRLIGYC---CEDEERLLVY-EFMPRGSLENHL--FKRISVSL--PWGTRLKIAIGAAK 207
           +VR         + ++ +++  E M  G+L+ +L  FK + + +   W  ++       K
Sbjct: 87  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI------LK 140

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDS-DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           GL FLH    P+I+RD K  NI +     + K+ D GLA +            V+GT  +
Sbjct: 141 GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEF 196

Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR 326
            APE     +     DVY+FG+ +LE+ T         P SE      A+ Y R +  ++
Sbjct: 197 MAPEMYEEKY-DESVDVYAFGMCMLEMATSE------YPYSECQNA--AQIYRRVTSGVK 247

Query: 327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP 361
                ++A         E+  +   CI  N  +R 
Sbjct: 248 PASFDKVAI-------PEVKEIIEGCIRQNKDERY 275

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  140 bits (355), Expect = 1e-38
 Identities = 78/292 (26%), Positives = 123/292 (42%), Gaps = 40/292 (13%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LG G FG V++G +   +        VAVK L ++   Q   ++L E + + +  H ++V
Sbjct: 38  LGHGAFGEVYEGQVSG-MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKR-----ISVSLPWGTRLKIAIGAAKGLAFL 212
           R IG   +   R ++ E M  G L++ L +         SL     L +A   A G  +L
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156

Query: 213 HGAENPVIYRDFKTSNILLD---SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
              EN  I+RD    N LL        AK+ DFG+A+     S        M    +  P
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214

Query: 270 EYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP---KSEQNLVDWAKPYLRSSRRL 325
           E    G  T+K+D +SFGV+L E+ + G        P   KS Q +++    ++ S  R+
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGY------MPYPSKSNQEVLE----FVTSGGRM 264

Query: 326 RYIVD--PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
               +    +   Y +     M     QC    P+DRP  A ++  +E    
Sbjct: 265 DPPKNCPGPV---YRI-----M----TQCWQHQPEDRPNFAIILERIEYCTQ 304

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  139 bits (353), Expect = 3e-38
 Identities = 74/299 (24%), Positives = 124/299 (41%), Gaps = 53/299 (17%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL--DIEGLQGHREWLAEVIFLGQLRHPHL 156
           LG+G FG+V +  +  +         VAVK+L  DI       E+L E   + +  HPH+
Sbjct: 31  LGKGEFGSVREAQLKQE---DGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 157 VRLIGYCCEDEER------LLVYEFMPRGSLENHLFKRI----SVSLPWGTRLKIAIGAA 206
            +L+G       +      +++  FM  G L   L          +LP  T ++  +  A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE------GSNTHVTTRV 260
            G+ +L  +    I+RD    N +L  D T  ++DFGL++          G  + +  + 
Sbjct: 148 CGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205

Query: 261 MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP---KSEQNLVDWAK 316
           +      A E ++    T  SDV++FGV + E++T G+       P        + +   
Sbjct: 206 L------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQ------TPYAGIENAEIYN--- 250

Query: 317 PYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            YL    RL+    P           +E+  L  QC S +PK RP    +   LE++L 
Sbjct: 251 -YLIGGNRLKQ---PPEC-------MEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  143 bits (363), Expect = 7e-38
 Identities = 74/290 (25%), Positives = 121/290 (41%), Gaps = 50/290 (17%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LG G FG+V +G      R   K   VA+K+L          E + E   + QL +P++V
Sbjct: 344 LGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           RLIG  C+ E  +LV E    G L   L  +    +P     ++    + G+ +L   E 
Sbjct: 400 RLIG-VCQAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYL--EEK 455

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA--APEYISTG 275
             ++R+    N+LL +   AK+SDFGL+K      + + T R  G +     APE I+  
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINFR 514

Query: 276 HLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR--LRYIVDP- 331
             +++SDV+S+GV + E L+ G++                  PY +      + +I    
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQK------------------PYKKMKGPEVMAFIEQGK 556

Query: 332 RL-------AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           R+          Y++     M      C     +DRP    V   + +  
Sbjct: 557 RMECPPECPPELYAL-----M----SDCWIYKWEDRPDFLTVEQRMRACY 597

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  137 bits (347), Expect = 1e-37
 Identities = 74/291 (25%), Positives = 120/291 (41%), Gaps = 53/291 (18%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           +GEG FG VH+G         L    VA+K   +        ++L E + + Q  HPH+V
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALA---VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +LIG    +    ++ E    G L + L  R   SL   + +  A   +  LA+L     
Sbjct: 80  KLIG-VITENPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYL--ESK 135

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
             ++RD    N+L+ S+   KL DFGL++   E S  +  ++      + APE I+    
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRRF 194

Query: 278 TTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR--LRYIVD---- 330
           T+ SDV+ FGV + E+L  G +                  P+        +  I +    
Sbjct: 195 TSASDVWMFGVCMWEILMHGVK------------------PFQGVKNNDVIGRIENGERL 236

Query: 331 -------PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                  P L   YS+     M     +C + +P  RP+   + A L ++L
Sbjct: 237 PMPPNCPPTL---YSL-----M----TKCWAYDPSRRPRFTELKAQLSTIL 275

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  137 bits (347), Expect = 1e-37
 Identities = 74/306 (24%), Positives = 130/306 (42%), Gaps = 62/306 (20%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LGE  FG V+KG++      G + QAVA+K L D        E+  E +   +L+HP++V
Sbjct: 17  LGEDRFGKVYKGHLFG-PAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKR--------------ISVSLPWGTRLKIAI 203
            L+G   +D+   +++ +   G L   L  R              +  +L     + +  
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135

Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT----- 258
             A G+ +L  + + V+++D  T N+L+      K+SD GL +         +       
Sbjct: 136 QIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193

Query: 259 -RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP---KSEQNLVD 313
            R M      APE I  G  +  SD++S+GVVL E+ + G       +P    S Q++V+
Sbjct: 194 IRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGL------QPYCGYSNQDVVE 241

Query: 314 WAKPYLRSSRRLRYIVDPRLAG----QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT 369
                +R+ + L     P         Y++     M    ++C +  P  RP+   + + 
Sbjct: 242 ----MIRNRQVL-----PCPDDCPAWVYAL-----M----IECWNEFPSRRPRFKDIHSR 283

Query: 370 LESLLN 375
           L +  N
Sbjct: 284 LRAWGN 289

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  139 bits (351), Expect = 1e-37
 Identities = 72/334 (21%), Positives = 126/334 (37%), Gaps = 45/334 (13%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH--REWLAEVIFLGQLRHPH 155
            +GEG FG        +D       +   +K ++I  +      E   EV  L  ++HP+
Sbjct: 31  KIGEGSFGKAILVKSTED------GRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           +V+      E+    +V ++   G L   +  +  V       L   +     L  +H  
Sbjct: 85  IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH-- 142

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  +++RD K+ NI L  D T +L DFG+A++    S   +    +GT  Y +PE     
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPEICENK 200

Query: 276 HLTTKSDVYSFGVVLLELLTGRR-----SMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
               KSD+++ G VL EL T +      SM  L  K                        
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF------------------ 242

Query: 331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRP------KMAAVVATLESLLNLKDMAVSCG 384
           P ++  YS     ++  L  Q    NP+DRP      +   +   +E  L+ + +A    
Sbjct: 243 PPVSLHYS----YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFC 298

Query: 385 QWPATQKSTRNGVSPKATRGGNVRKSAPVTQNRK 418
               ++  ++   + +   G N     P  +  K
Sbjct: 299 LKTFSKFGSQPIPAKRPASGQNSISVMPAQKITK 332

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  138 bits (349), Expect = 1e-37
 Identities = 69/294 (23%), Positives = 107/294 (36%), Gaps = 39/294 (13%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
            LGEGGF  V        L  G      A+K +     Q   E   E        HP+++
Sbjct: 36  KLGEGGFSYVDLVE---GLHDG---HFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 158 RLIGYCCEDEER----LLVYEFMPRGSLENHLFKRISVSLPWGTR--LKIAIGAAKGLAF 211
           RL+ YC  +        L+  F  RG+L N + +             L + +G  +GL  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM-------GTY 264
           +H       +RD K +NILL  +    L D G                 +        T 
Sbjct: 150 IH--AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207

Query: 265 GYAAPEYIST---GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS 321
            Y APE  S      +  ++DV+S G VL  ++ G    D +  K +          L  
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA-------LAV 260

Query: 322 SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
             +L     PR    +S      +  L    ++V+P  RP +  +++ LE+L  
Sbjct: 261 QNQLSIPQSPR----HS----SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  139 bits (352), Expect = 1e-37
 Identities = 77/292 (26%), Positives = 122/292 (41%), Gaps = 40/292 (13%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LG G FG V++G +   +        VAVK L ++   Q   ++L E + + +  H ++V
Sbjct: 79  LGHGAFGEVYEGQVSG-MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKR-----ISVSLPWGTRLKIAIGAAKGLAFL 212
           R IG   +   R ++ E M  G L++ L +         SL     L +A   A G  +L
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

Query: 213 HGAENPVIYRDFKTSNILLD---SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
              EN  I+RD    N LL        AK+ DFG+A+              M    +  P
Sbjct: 198 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255

Query: 270 EYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP---KSEQNLVDWAKPYLRSSRRL 325
           E    G  T+K+D +SFGV+L E+ + G        P   KS Q +++    ++ S  R+
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFSLGY------MPYPSKSNQEVLE----FVTSGGRM 305

Query: 326 RYIVD--PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
               +    +   Y +     M     QC    P+DRP  A ++  +E    
Sbjct: 306 DPPKNCPGPV---YRI-----M----TQCWQHQPEDRPNFAIILERIEYCTQ 345

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  138 bits (349), Expect = 1e-37
 Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 55/300 (18%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQL-RHPH 155
           ++GEG FG V K  I  D          A+K + +      HR++  E+  L +L  HP+
Sbjct: 32  VIGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 87

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKR--------------ISVSLPWGTRLKI 201
           ++ L+G C       L  E+ P G+L + L K                + +L     L  
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE---GSNTHVTT 258
           A   A+G+ +L  ++   I+RD    NIL+  ++ AK++DFGL++        +   +  
Sbjct: 148 AADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 205

Query: 259 RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP---KSEQNLVDW 314
           R M      A E ++    TT SDV+S+GV+L E+++ G        P    +   L + 
Sbjct: 206 RWM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGG------TPYCGMTCAELYE- 252

Query: 315 AKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
               L    RL     P            E+  L  QC    P +RP  A ++ +L  +L
Sbjct: 253 ---KLPQGYRLE---KPLNCDD-------EVYDLMRQCWREKPYERPSFAQILVSLNRML 299

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  136 bits (345), Expect = 3e-37
 Identities = 68/288 (23%), Positives = 111/288 (38%), Gaps = 51/288 (17%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHL 156
            LG GGFG V +       +  +     A+K + +   +  RE  + EV  L +L HP +
Sbjct: 12  CLGRGGFGVVFEA------KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65

Query: 157 VRLIGYCCEDEE---------RLLVY---EFMPRGSLENHLFKRISVSLP-WGTRLKIAI 203
           VR      E            ++ +Y   +   + +L++ +  R ++        L I +
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125

Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM----------GPEGSN 253
             A+ + FLH     +++RD K SNI    D   K+ DFGL                   
Sbjct: 126 QIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD 313
               T  +GT  Y +PE I     + K D++S G++L ELL           + E+    
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------PFSTQMERVRT- 236

Query: 314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP 361
                L   R L++   P L  Q          V+    +S +P +RP
Sbjct: 237 -----LTDVRNLKF---PPLFTQKY----PCEYVMVQDMLSPSPMERP 272

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  136 bits (344), Expect = 4e-37
 Identities = 67/300 (22%), Positives = 119/300 (39%), Gaps = 58/300 (19%)

Query: 93  FSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFL 148
           ++S++    +LG+G FG V K       R  L ++  A+K +     +     L+EV+ L
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKIRHTEEK-LSTILSEVMLL 56

Query: 149 GQLRHPHLVRLIGYCCEDEERL-------------LVYEFMPRGSLENHLFKRISVSLPW 195
             L H ++VR      E    +             +  E+   G+L + +    +++   
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQR 115

Query: 196 GTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM-------- 247
               ++     + L+++H     +I+RD K  NI +D     K+ DFGLAK         
Sbjct: 116 DEYWRLFRQILEALSYIH--SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173

Query: 248 -----GPEGSNTHVTTRVMGTYGYAAPEYIS-TGHLTTKSDVYSFGVVLLELLTGRRSMD 301
                   GS+ ++T+ + GT  Y A E +  TGH   K D+YS G++  E++       
Sbjct: 174 KLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP----- 227

Query: 302 KLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP 361
                 E+  +      L+  R +     P        K  K+   +    I  +P  RP
Sbjct: 228 -FSTGMERVNI------LKKLRSVSIEFPPDFDDNKM-KVEKK---IIRLLIDHDPNKRP 276

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  136 bits (344), Expect = 4e-37
 Identities = 68/299 (22%), Positives = 113/299 (37%), Gaps = 52/299 (17%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE---WLAEVIFLGQLRHP 154
            +G G F  V++     D         VA+K + I  L   +     + E+  L QL HP
Sbjct: 39  KIGRGQFSEVYRAACLLD------GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92

Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHL--FKRISVSLPWGTRLKIAIGAAKGLAFL 212
           ++++      ED E  +V E    G L   +  FK+    +P  T  K  +     L  +
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152

Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
           H     V++RD K +N+ + +    KL D GL +       T   + V GT  Y +PE I
Sbjct: 153 H--SRRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLV-GTPYYMSPERI 208

Query: 273 STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV--- 329
                  KSD++S G +L E+   +                   P+      L  +    
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQS------------------PFYGDKMNLYSLCKKI 250

Query: 330 -----DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMAVSC 383
                 P  +  YS    +E+  L   CI+ +P+ RP        +  + ++     +C
Sbjct: 251 EQCDYPPLPSDHYS----EELRQLVNMCINPDPEKRP-------DVTYVYDVAKRMHAC 298

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  135 bits (343), Expect = 9e-37
 Identities = 71/304 (23%), Positives = 123/304 (40%), Gaps = 55/304 (18%)

Query: 99  LGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQL-RHPH 155
           LGEG FG V     +  D  +  +A  VAVK+L D    +   + ++E+  +  + +H +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKR--------------ISVSLPWGTRLKI 201
           ++ L+G C +D    ++ E+  +G+L  +L  R                  + +   +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162

Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT--- 258
               A+G+ +L  A    I+RD    N+L+  +   K++DFGLA+          TT   
Sbjct: 163 TYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220

Query: 259 ---RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP---KSEQNL 311
              + M      APE +     T +SDV+SFGV++ E+ T G        P      + L
Sbjct: 221 LPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGG------SPYPGIPVEEL 268

Query: 312 VDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
                  L+   R+     P            E+ ++   C    P  RP    +V  L+
Sbjct: 269 FK----LLKEGHRMDK---PANCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 314

Query: 372 SLLN 375
            +L 
Sbjct: 315 RILT 318

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  141 bits (356), Expect = 1e-36
 Identities = 72/284 (25%), Positives = 122/284 (42%), Gaps = 39/284 (13%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           +GEG FG VH+G           A AVA+K   +        ++L E + + Q  HPH+V
Sbjct: 398 IGEGQFGDVHQGIYMSP---ENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           +LIG    +    ++ E    G L + L  R   SL   + +  A   +  LA+L     
Sbjct: 455 KLIG-VITENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYL--ESK 510

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
             ++RD    N+L+ S+   KL DFGL++   E S  +  ++      + APE I+    
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRRF 569

Query: 278 TTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPY--LRSSRRLRYIVD---- 330
           T+ SDV+ FGV + E+L  G +                  P+  ++++  +  I +    
Sbjct: 570 TSASDVWMFGVCMWEILMHGVK------------------PFQGVKNNDVIGRIENGERL 611

Query: 331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           P             +  L  +C + +P  RP+   + A L ++L
Sbjct: 612 PMPPN-----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  135 bits (341), Expect = 1e-36
 Identities = 85/309 (27%), Positives = 129/309 (41%), Gaps = 62/309 (20%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           LGEG FG V K      L+       VAVK+L +       R+ L+E   L Q+ HPH++
Sbjct: 31  LGEGEFGKVVKATAFH-LKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKR----------------------ISVSLPW 195
           +L G C +D   LL+ E+   GSL   L +                          +L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 196 GTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH 255
           G  +  A   ++G+ +L  AE  +++RD    NIL+      K+SDFGL++   E  +  
Sbjct: 150 GDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207

Query: 256 VTT------RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP--- 305
             +      + M      A E +     TT+SDV+SFGV+L E++T G        P   
Sbjct: 208 KRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGG------NPYPG 255

Query: 306 KSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAA 365
              + L +     L++  R+     P    +       EM  L LQC    P  RP  A 
Sbjct: 256 IPPERLFN----LLKTGHRMER---PDNCSE-------EMYRLMLQCWKQEPDKRPVFAD 301

Query: 366 VVATLESLL 374
           +   LE ++
Sbjct: 302 ISKDLEKMM 310

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  135 bits (342), Expect = 3e-36
 Identities = 71/303 (23%), Positives = 123/303 (40%), Gaps = 55/303 (18%)

Query: 99  LGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQL-RHPH 155
           LGEG FG V     +  D  +  +A  VAVK+L D    +   + ++E+  +  + +H +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKR--------------ISVSLPWGTRLKI 201
           ++ L+G C +D    ++ E+  +G+L  +L  R                  + +   +  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT--- 258
               A+G+ +L  A    I+RD    N+L+  +   K++DFGLA+          TT   
Sbjct: 209 TYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 266

Query: 259 ---RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP---KSEQNL 311
              + M      APE +     T +SDV+SFGV++ E+ T G        P      + L
Sbjct: 267 LPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGG------SPYPGIPVEEL 314

Query: 312 VDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
                  L+   R+     P            E+ ++   C    P  RP    +V  L+
Sbjct: 315 FK----LLKEGHRMDK---PANC-------TNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360

Query: 372 SLL 374
            +L
Sbjct: 361 RIL 363

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  133 bits (338), Expect = 6e-36
 Identities = 74/316 (23%), Positives = 124/316 (39%), Gaps = 62/316 (19%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHPHLV 157
           +GEG FG V +      L        VAVK+L +        ++  E   + +  +P++V
Sbjct: 55  IGEGAFGRVFQARAPG-LLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR------------------- 198
           +L+G C   +   L++E+M  G L   L      ++   +                    
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173

Query: 199 ---LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE----- 250
              L IA   A G+A+L  +E   ++RD  T N L+  +   K++DFGL++         
Sbjct: 174 AEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231

Query: 251 -GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP--- 305
              N  +  R M       PE I     TT+SDV+++GVVL E+ + G       +P   
Sbjct: 232 ADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFSYGL------QPYYG 279

Query: 306 KSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAA 365
            + + ++     Y+R    L     P            E+  L   C S  P DRP   +
Sbjct: 280 MAHEEVIY----YVRDGNILAC---PENC-------PLELYNLMRLCWSKLPADRPSFCS 325

Query: 366 VVATLESLLNLKDMAV 381
           +   L+ +    +  V
Sbjct: 326 IHRILQRMCERAEGTV 341

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  132 bits (333), Expect = 1e-35
 Identities = 65/276 (23%), Positives = 94/276 (34%), Gaps = 54/276 (19%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAEVIFLGQL-RHP 154
            LG G +G V K    +D       +  AVK  +    G +     LAEV    ++ +HP
Sbjct: 64  RLGHGSYGEVFKVRSKED------GRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
             VRL     E+   L L  E     SL+ H  +    SLP              LA LH
Sbjct: 118 CCVRLEQ-AWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLH 174

Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM--GPEGSNTHVTTRVMGTYGYAAPEY 271
                +++ D K +NI L      KL DFGL                   G   Y APE 
Sbjct: 175 --SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-----GDPRYMAPEL 227

Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGR------RSMDKLRPKSEQNLVDWAKPYLRSSRRL 325
           +   +  T +DV+S G+ +LE+              +LR                     
Sbjct: 228 LQGSY-GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQG------------------- 267

Query: 326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP 361
              + P      S     E+  + +  +  +PK R 
Sbjct: 268 --YLPPEFTAGLS----SELRSVLVMMLEPDPKLRA 297

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  132 bits (335), Expect = 2e-35
 Identities = 72/301 (23%), Positives = 115/301 (38%), Gaps = 54/301 (17%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQL-RHPHL 156
           LG G FG V +      L +      VAVK+L            ++E+  +  L +H ++
Sbjct: 54  LGAGAFGKVVEATAFG-LGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHL------------FKRISVSLPWGTRLKIAIG 204
           V L+G C      L++ E+   G L N L            F   + +      L  +  
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172

Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT------ 258
            A+G+AFL  A    I+RD    N+LL +   AK+ DFGLA+     SN  V        
Sbjct: 173 VAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230

Query: 259 RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP----KSEQNLVD 313
           + M      APE I     T +SDV+S+G++L E+ + G        P            
Sbjct: 231 KWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGL------NPYPGILVNSKFYK 278

Query: 314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
                ++   ++     P  A        K +  +   C ++ P  RP    + + L+  
Sbjct: 279 ----LVKDGYQMAQ---PAFA-------PKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324

Query: 374 L 374
            
Sbjct: 325 A 325

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  131 bits (331), Expect = 2e-35
 Identities = 63/281 (22%), Positives = 107/281 (38%), Gaps = 50/281 (17%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPH 155
            +G G +G   K     D       + +  K LD   +     +  ++EV  L +L+HP+
Sbjct: 13  TIGTGSYGRCQKIRRKSD------GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66

Query: 156 LVRLIGYCCEDEERLL--VYEFMPRGSLENHL--FKRISVSLPWGTRLKIAIGAAKGLAF 211
           +VR      +     L  V E+   G L + +    +    L     L++       L  
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126

Query: 212 LH---GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
            H      + V++RD K +N+ LD     KL DFGLA++     +T      +GT  Y +
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVGTPYYMS 184

Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLTGRR-----SMDKLRPKSEQNLVDWAKPYLRSSR 323
           PE ++      KSD++S G +L EL          S  +L  K                 
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK----------------- 227

Query: 324 RLRYIVD---PRLAGQYSVKGAKEMAVLALQCISVNPKDRP 361
               I +    R+  +YS     E+  +  + +++    RP
Sbjct: 228 ----IREGKFRRIPYRYS----DELNEIITRMLNLKDYHRP 260

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  131 bits (332), Expect = 3e-35
 Identities = 80/304 (26%), Positives = 116/304 (38%), Gaps = 56/304 (18%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQL-RHPHL 156
           LG G FG V +      L +   A  VAVK+L     L      ++E+  L  L  H ++
Sbjct: 31  LGAGAFGKVVEATAYG-LIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKR----------------ISVSLPWGTRLK 200
           V L+G C      L++ E+   G L N L ++                  ++L     L 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 201 IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT-- 258
            +   AKG+AFL  A    I+RD    NILL      K+ DFGLA+     SN  V    
Sbjct: 150 FSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 259 ----RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRR---SMDKLRPKSEQN 310
               + M      APE I     T +SDV+S+G+ L EL + G      M       +  
Sbjct: 208 RLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP-----VDSK 256

Query: 311 LVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL 370
                   ++   R+     P  A         EM  +   C   +P  RP    +V  +
Sbjct: 257 FYK----MIKEGFRMLS---PEHA-------PAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

Query: 371 ESLL 374
           E  +
Sbjct: 303 EKQI 306

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  131 bits (331), Expect = 1e-34
 Identities = 73/303 (24%), Positives = 122/303 (40%), Gaps = 55/303 (18%)

Query: 99  LGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQL-RHPH 155
           LGEG FG V     I  D  +  +   VAVK+L      +   + ++E+  +  + +H +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR--------------LKI 201
           ++ L+G C +D    ++ E+  +G+L  +L  R    L +                 +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT--- 258
           A   A+G+ +L  A    I+RD    N+L+  D   K++DFGLA+          TT   
Sbjct: 197 AYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 254

Query: 259 ---RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP---KSEQNL 311
              + M      APE +     T +SDV+SFGV+L E+ T G        P      + L
Sbjct: 255 LPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGG------SPYPGVPVEEL 302

Query: 312 VDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
                  L+   R+     P            E+ ++   C    P  RP    +V  L+
Sbjct: 303 FK----LLKEGHRMDK---PSNCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 348

Query: 372 SLL 374
            ++
Sbjct: 349 RIV 351

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  128 bits (325), Expect = 2e-34
 Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 22/208 (10%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA----EVIFLGQLRH 153
           L+G GG G V++     D  +    + VA+KL+    L     +      E    G+L+ 
Sbjct: 41  LVGRGGMGDVYEAE---DTVRE---RIVALKLMSET-LSSDPVFRTRMQREARTAGRLQE 93

Query: 154 PHLVRL--IGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
           PH+V +   G   E + +L +    +    L   L ++    L     + I       L 
Sbjct: 94  PHVVPIHDFG---EIDGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALD 148

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
             H       +RD K  NIL+ +D  A L DFG+A    +   T      +GT  Y APE
Sbjct: 149 AAH--AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPE 205

Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRR 298
             S  H T ++D+Y+   VL E LTG  
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSP 233

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  128 bits (325), Expect = 2e-34
 Identities = 78/305 (25%), Positives = 118/305 (38%), Gaps = 59/305 (19%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQL-RHPHL 156
           LG G FG V +      + +    + VAVK+L +      HR  ++E+  L  +  H ++
Sbjct: 35  LGRGAFGQVIEADAFG-IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93

Query: 157 VRLIGYCCEDEER--LLVYEFMPRGSLENHLFKR--------------ISVSLPWGTRLK 200
           V L+G  C       +++ EF   G+L  +L  +                  L     + 
Sbjct: 94  VNLLG-ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 201 IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT-- 258
            +   AKG+ FL  A    I+RD    NILL      K+ DFGLA+   +  +       
Sbjct: 153 YSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210

Query: 259 ----RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP----KSEQ 309
               + M      APE I     T +SDV+SFGV+L E+ + G        P    K ++
Sbjct: 211 RLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGA------SPYPGVKIDE 258

Query: 310 NLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT 369
                    L+   R+R    P            EM    L C    P  RP  + +V  
Sbjct: 259 EFCR----RLKEGTRMRA---PDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEH 304

Query: 370 LESLL 374
           L +LL
Sbjct: 305 LGNLL 309

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  128 bits (323), Expect = 4e-34
 Identities = 64/205 (31%), Positives = 93/205 (45%), Gaps = 16/205 (7%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA----EVIFLGQLRH 153
            LG GG  TV+      D         VA+K + I   +   E L     EV    QL H
Sbjct: 18  KLGGGGMSTVYLAE---DTILN---IKVAIKAIFIP-PREKEETLKRFEREVHNSSQLSH 70

Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
            ++V +I    ED+   LV E++   +L  ++       L   T +        G+   H
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAH 128

Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
             +  +++RD K  NIL+DS+ T K+ DFG+AK   E S T  T  V+GT  Y +PE   
Sbjct: 129 --DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAK 185

Query: 274 TGHLTTKSDVYSFGVVLLELLTGRR 298
                  +D+YS G+VL E+L G  
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEP 210

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  128 bits (324), Expect = 7e-34
 Identities = 69/309 (22%), Positives = 117/309 (37%), Gaps = 61/309 (19%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQL-RHPHL 156
           LG G FG V        + +   +  VAVK+L +          ++E+  + QL  H ++
Sbjct: 53  LGSGAFGKVMNATAYG-ISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR------------------ 198
           V L+G C       L++E+   G L N+L  +                            
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171

Query: 199 ---LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH 255
              L  A   AKG+ FL       ++RD    N+L+      K+ DFGLA+     SN  
Sbjct: 172 EDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229

Query: 256 VTT------RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRR---SMDKLRP 305
           V        + M      APE +  G  T KSDV+S+G++L E+ + G      +     
Sbjct: 230 VRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP---- 279

Query: 306 KSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAA 365
             + N        +++  ++     P  A +       E+ ++   C + + + RP    
Sbjct: 280 -VDANFYK----LIQNGFKMDQ---PFYATE-------EIYIIMQSCWAFDSRKRPSFPN 324

Query: 366 VVATLESLL 374
           + + L   L
Sbjct: 325 LTSFLGCQL 333

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  125 bits (316), Expect = 6e-33
 Identities = 61/261 (23%), Positives = 99/261 (37%), Gaps = 36/261 (13%)

Query: 49  SFRRLSFSDLSRSSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVH 108
           ++   S         T  NE +  T      D    E R      +    +G G FG VH
Sbjct: 19  TWSSGSAKLQRLGPETEDNEGVLLTEKLKPVD---YEYREEVHWMTHQPRVGRGSFGEVH 75

Query: 109 KGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE 168
           +     D + G      AVK + +E  +     + E++    L  P +V L G    +  
Sbjct: 76  RMK---DKQTG---FQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYG-AVREGP 123

Query: 169 RLLVY-EFMPRGSLENHL--FKRISVSLPWGTRLKIAIGAA---KGLAFLHGAENPVIYR 222
            + ++ E +  GSL   +     +                    +GL +LH     +++ 
Sbjct: 124 WVNIFMELLEGGSLGQLIKQMGCLPEDR-------ALYYLGQALEGLEYLH--TRRILHG 174

Query: 223 DFKTSNILLDSD-FTAKLSDFGLAK-MGPEGSNTHVTTR--VMGTYGYAAPEYIS-TGHL 277
           D K  N+LL SD   A L DFG A  + P+G    + T   + GT  + APE +      
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC- 233

Query: 278 TTKSDVYSFGVVLLELLTGRR 298
             K D++S   ++L +L G  
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCH 254

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  125 bits (316), Expect = 9e-33
 Identities = 41/229 (17%), Positives = 86/229 (37%), Gaps = 48/229 (20%)

Query: 99  LGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA----------- 143
           L +G F  +                   +  A+K  +   L+  R++             
Sbjct: 39  LNQGKFNKIILCEKDN------------KFYALKKYEKSLLEKKRDFTKSNNDKISIKSK 86

Query: 144 ------EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWG 196
                 E+  +  +++ + +   G    + + + ++YE+M   S+         +   + 
Sbjct: 87  YDDFKNELQIITDIKNEYCLTCEGII-TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145

Query: 197 TRLKIAIGA------AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE 250
             + I +            +++H  +N + +RD K SNIL+D +   KLSDFG ++   +
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204

Query: 251 GSNTHVTTRVMGTYGYAAPEYIST--GHLTTKSDVYSFGVVLLELLTGR 297
                +     GTY +  PE+ S    +   K D++S G+ L  +    
Sbjct: 205 K---KIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  128 bits (323), Expect = 3e-32
 Identities = 50/209 (23%), Positives = 85/209 (40%), Gaps = 29/209 (13%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHL 156
            +  GG G ++      D    +  + V +K L   G    +   +AE  FL ++ HP +
Sbjct: 87  CIAHGGLGWIYLAL---DRN--VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141

Query: 157 VRLIGYCCEDEERL------LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
           V++  +  E  +R       +V E++   SL+    ++    LP    +   +     L+
Sbjct: 142 VQIFNFV-EHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALS 196

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAP 269
           +LH     ++Y D K  NI+L  +   KL D G    +   G        + GT G+ AP
Sbjct: 197 YLH--SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-------LYGTPGFQAP 246

Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRR 298
           E I     T  +D+Y+ G  L  L     
Sbjct: 247 E-IVRTGPTVATDIYTVGRTLAALTLDLP 274

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  120 bits (303), Expect = 2e-31
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 22/209 (10%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           +LG+G +G V+ G    DL        +A+K +     +  +    E+     L+H ++V
Sbjct: 29  VLGKGTYGIVYAGR---DLSNQ---VRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV 82

Query: 158 RLIGYCCEDEERLLVY-EFMPRGSLENHLFKRISVSLPWGTRLKIAIGAA---KGLAFLH 213
           + +G    +   + ++ E +P GSL   L +     L    +  I        +GL +LH
Sbjct: 83  QYLG-SFSENGFIKIFMEQVPGGSLSA-LLRSKWGPLKDNEQT-IGFYTKQILEGLKYLH 139

Query: 214 GAENPVIYRDFKTSNILLDS-DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
             +N +++RD K  N+L+++     K+SDFG +K    G N    T   GT  Y APE I
Sbjct: 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR-LAGINPCTET-FTGTLQYMAPEII 195

Query: 273 ---STGHLTTKSDVYSFGVVLLELLTGRR 298
                G+    +D++S G  ++E+ TG+ 
Sbjct: 196 DKGPRGY-GKAADIWSLGCTIIEMATGKP 223

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  120 bits (302), Expect = 2e-31
 Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 31/210 (14%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR---EWLAEVIFLGQLRHP 154
            LG+G FG V+        R+      +A+K+L    L+      +   EV     LRHP
Sbjct: 16  PLGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69

Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA------AK 207
           +++RL GY   D  R+ L+ E+ P G++   L K         ++      A      A 
Sbjct: 70  NILRLYGYF-HDATRVYLILEYAPLGTVYRELQKL--------SKFDEQRTATYITELAN 120

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L++ H     VI+RD K  N+LL S    K++DFG +   P  S+        GT  Y 
Sbjct: 121 ALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDL--CGTLDYL 174

Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGR 297
            PE I       K D++S GV+  E L G+
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (305), Expect = 3e-31
 Identities = 77/328 (23%), Positives = 127/328 (38%), Gaps = 53/328 (16%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-HPHL 156
           +L EGGF  V++     D+  G   +  A+K L     + +R  + EV F+ +L  HP++
Sbjct: 35  VLAEGGFAFVYEAQ---DVGSG---REYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 157 VRLIGYCCEDEER-------LLVYEFMPRGSLENHLFKRISV-SLPWGTRLKIAIGAAKG 208
           V+        +E         L+   + +G L   L K  S   L   T LKI     + 
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA---KMGPEGSNTHVTTRVM---- 261
           +  +H  + P+I+RD K  N+LL +  T KL DFG A      P+ S +     ++    
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208

Query: 262 ---GTYGYAAPEYIST---GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA 315
               T  Y  PE I       +  K D+++ G +L  L   +       P  +       
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ------HPFEDGAK---- 258

Query: 316 KPYLR-SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
              LR  + +                       L    + VNP++R  +A VV  L+ + 
Sbjct: 259 ---LRIVNGKYSIPPHDT----QY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307

Query: 375 NLKDMAVSCGQWPATQKSTRNGVSPKAT 402
             +++       P T+   +NG    AT
Sbjct: 308 AARNVNPKS---PITELLEQNGGYGSAT 332

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  121 bits (306), Expect = 4e-31
 Identities = 64/318 (20%), Positives = 114/318 (35%), Gaps = 44/318 (13%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHL 156
           +LG+G    V +G      R        A+K+ +        +  + E   L +L H ++
Sbjct: 16  ILGQGATANVFRG------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 157 VRLIGYCCEDEER----LLVYEFMPRGSLENHLFKRISVS-LPWGTRLKIAIGAAKGLAF 211
           V+L  +  E+E      +L+ EF P GSL   L +  +   LP    L +      G+  
Sbjct: 70  VKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 212 LHGAENPVIYRDFKTSNILL----DSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           L   EN +++R+ K  NI+     D     KL+DFG A+      +    +   GT  Y 
Sbjct: 128 LR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEYL 182

Query: 268 APEYISTGHLTT--------KSDVYSFGVVLLELLTGR---------RSMDKLRPK--SE 308
            P+      L            D++S GV      TG          R   ++  K  + 
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242

Query: 309 QNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCI-SVNPKDRPKMAAVV 367
           +     +      +  + +  D  ++   S +G + +    L  I   + +         
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLS-RGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 368 ATLESLLNLKDMAVSCGQ 385
           A    +L+   + V   Q
Sbjct: 302 AETSDILHRMVIHVFSLQ 319

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  119 bits (301), Expect = 6e-31
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 20/210 (9%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA----EVIFLGQLRH 153
           +LG GG   VH      DLR     + VAVK+L  + L     +      E      L H
Sbjct: 19  ILGFGGMSEVHLAR---DLRDH---RDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNH 71

Query: 154 PHLVRLIGYCCEDEERL----LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
           P +V +      +        +V E++   +L + +       +     +++   A + L
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQAL 129

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT-RVMGTYGYAA 268
            F H  +N +I+RD K +NI++ +    K+ DFG+A+   +  N+   T  V+GT  Y +
Sbjct: 130 NFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLTGRR 298
           PE      +  +SDVYS G VL E+LTG  
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  118 bits (298), Expect = 1e-30
 Identities = 60/293 (20%), Positives = 107/293 (36%), Gaps = 44/293 (15%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHL 156
           +LG+G    V +G      R        A+K+ +        +  + E   L +L H ++
Sbjct: 16  ILGQGATANVFRG------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 157 VRLIGYCCEDEER----LLVYEFMPRGSLENHLFKRISVS-LPWGTRLKIAIGAAKGLAF 211
           V+L  +  E+E      +L+ EF P GSL   L +  +   LP    L +      G+  
Sbjct: 70  VKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 212 LHGAENPVIYRDFKTSNILL----DSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           L   EN +++R+ K  NI+     D     KL+DFG A+      +    +   GT  Y 
Sbjct: 128 LR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEYL 182

Query: 268 APEYISTGHLTT--------KSDVYSFGVVLLELLTGR---------RSMDKLRPK--SE 308
            P+      L            D++S GV      TG          R   ++  K  + 
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242

Query: 309 QNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCI-SVNPKDR 360
           +     +      +  + +  D  ++   S +G + +    L  I   + +  
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLS-RGLQVLLTPVLANILEADQEKC 294

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  121 bits (304), Expect = 1e-30
 Identities = 68/304 (22%), Positives = 119/304 (39%), Gaps = 44/304 (14%)

Query: 76  PDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL 135
            D  D + S +     +F    +LG G  GT+    + D+       + VAVK +  E  
Sbjct: 9   QDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDN-------RDVAVKRILPECF 61

Query: 136 QGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSL 193
                   EV  L +   HP+++R      +D +   +  E     +L+ ++ ++   + 
Sbjct: 62  SFADR---EVQLLRESDEHPNVIRYFC-TEKDRQFQYIAIELCA-ATLQEYVEQK-DFAH 115

Query: 194 PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL-----DSDFTAKLSDFGLAKM- 247
                + +      GLA LH     +++RD K  NIL+          A +SDFGL K  
Sbjct: 116 LGLEPITLLQQTTSGLAHLH--SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173

Query: 248 GPEGSNTHVTTRVMGTYGYAAPEYIS---TGHLTTKSDVYSFGVVLLELLTGRRSMDKLR 304
                +    + V GT G+ APE +S     + T   D++S G V   +++         
Sbjct: 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS-----H 228

Query: 305 PKSEQNLVDWAKPYLRSSRRL--RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK 362
           P        + K   R +  L     +D     ++    A+E   L  + I+++P+ RP 
Sbjct: 229 P--------FGKSLQRQANILLGACSLDCLHPEKHEDVIARE---LIEKMIAMDPQKRPS 277

Query: 363 MAAV 366
              V
Sbjct: 278 AKHV 281

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  116 bits (294), Expect = 4e-30
 Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 30/211 (14%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR---EWLAEVIFLGQLRHP 154
           LLG+G F  V   Y  + +  G     VA+K++D + +           EV    QL+HP
Sbjct: 18  LLGKGSFAGV---YRAESIHTG---LEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71

Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA------AK 207
            ++ L  Y  ED   + LV E    G +  +L  R                         
Sbjct: 72  SILELYNYF-EDSNYVYLVLEMCHNGEMNRYLKNR-------VKPFSENEARHFMHQIIT 123

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+ +LH   + +++RD   SN+LL  +   K++DFGLA         H T    GT  Y 
Sbjct: 124 GMLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYI 179

Query: 268 APEYIS-TGHLTTKSDVYSFGVVLLELLTGR 297
           +PE  + + H   +SDV+S G +   LL GR
Sbjct: 180 SPEIATRSAH-GLESDVWSLGCMFYTLLIGR 209

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  122 bits (306), Expect = 4e-30
 Identities = 63/213 (29%), Positives = 88/213 (41%), Gaps = 26/213 (12%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHLV 157
           LG GGFG V +             + VA+K    E    +RE W  E+  + +L HP++V
Sbjct: 22  LGTGGFGYVLRW------IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75

Query: 158 RLIGYCCEDEER--------LLVYEFMPRGSLENHLFKR-ISVSLPWGTRLKIAIGAAKG 208
                   D  +        LL  E+   G L  +L +      L  G    +    +  
Sbjct: 76  SA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 209 LAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
           L +LH  EN +I+RD K  NI+L         K+ D G AK   +G     T  V GT  
Sbjct: 134 LRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC--TEFV-GTLQ 188

Query: 266 YAAPEYISTGHLTTKSDVYSFGVVLLELLTGRR 298
           Y APE +     T   D +SFG +  E +TG R
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  118 bits (297), Expect = 4e-30
 Identities = 73/342 (21%), Positives = 130/342 (38%), Gaps = 52/342 (15%)

Query: 48  PSFRRLSFSDLSRSSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTV 107
                L   +  R            T    + + +  +   I++       LG G  G V
Sbjct: 2   KKLEELELDEQQRKRLEAFL-----TQKQKVGELKDDDFEKISE-------LGAGNGGVV 49

Query: 108 HKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCED 166
            K         G     +A KL+ +E       + + E+  L +   P++V   G    D
Sbjct: 50  FKVS---HKPSG---LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103

Query: 167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKT 226
            E  +  E M  GSL+  + K+    +P     K++I   KGL +L   ++ +++RD K 
Sbjct: 104 GEISICMEHMDGGSLDQ-VLKKAGR-IPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKP 160

Query: 227 SNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSF 286
           SNIL++S    KL DFG++    +  ++   + V GT  Y +PE +   H + +SD++S 
Sbjct: 161 SNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSM 216

Query: 287 GVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMA 346
           G+ L+E+  GR  +     K  + +         +    R     R   ++ +     MA
Sbjct: 217 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMA 276

Query: 347 VLAL--------------------------QCISVNPKDRPK 362
           +  L                          +C+  NP +R  
Sbjct: 277 IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 318

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  116 bits (293), Expect = 5e-30
 Identities = 63/210 (30%), Positives = 88/210 (41%), Gaps = 31/210 (14%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR--EWLA-EVIFLGQLRHP 154
            LG+G FG V+        R+      +A+K+L    L+       L  E+     LRHP
Sbjct: 21  PLGKGKFGNVYLA------REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74

Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA------AK 207
           +++R+  Y   D +R+ L+ EF PRG L   L K          R      A      A 
Sbjct: 75  NILRMYNYF-HDRKRIYLMLEFAPRGELYKELQKH--------GRFDEQRSATFMEELAD 125

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
            L + H  E  VI+RD K  N+L+      K++DFG +   P  S    T    GT  Y 
Sbjct: 126 ALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP--SLRRRTM--CGTLDYL 179

Query: 268 APEYISTGHLTTKSDVYSFGVVLLELLTGR 297
            PE I       K D++  GV+  E L G 
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  117 bits (296), Expect = 9e-30
 Identities = 65/364 (17%), Positives = 126/364 (34%), Gaps = 70/364 (19%)

Query: 31  SRCKTSRSDFSKNIAPMPSFRRLSFSDLSRSSSTRINEDLAHTFGPDLYDFQLSELRAIT 90
           S      S   +  A     + +   DL      + +             + + +     
Sbjct: 8   SGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQ---- 63

Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFL 148
                   +G GG   V +           K Q  A+K +++E    Q    +  E+ +L
Sbjct: 64  --------IGSGGSSKVFQVL-------NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108

Query: 149 GQLRHP--HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
            +L+     ++RL  Y    ++ + +V E      L + L K+   S+    R       
Sbjct: 109 NKLQQHSDKIIRLYDYE-ITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNM 164

Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
            + +  +H  ++ +++ D K +N L+      KL DFG+A      + + V    +G   
Sbjct: 165 LEAVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVN 221

Query: 266 YAAPEYIS-----------TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW 314
           Y  PE I               ++ KSDV+S G +L  +  G+                 
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK----------------- 264

Query: 315 AKPY---LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
             P+   +    +L  I+DP    ++     K++  +   C+  +PK R        ++ 
Sbjct: 265 -TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI-------SIP 316

Query: 372 SLLN 375
            LL 
Sbjct: 317 ELLA 320

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  115 bits (291), Expect = 1e-29
 Identities = 59/300 (19%), Positives = 102/300 (34%), Gaps = 65/300 (21%)

Query: 92  NFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEV 145
            +++ +     +G G FG+V K         G      A+K       G    +  L EV
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCV---KRLDG---CIYAIKRSKKPLAGSVDEQNALREV 61

Query: 146 IFLGQL-RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHL--FKRISVSLPWGTRLKIA 202
                L +H H+VR      ED+  L+  E+   GSL + +    RI           + 
Sbjct: 62  YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121

Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSD-------------------FTAKLSDFG 243
           +   +GL ++H     +++ D K SNI +                         K+ D G
Sbjct: 122 LQVGRGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179

Query: 244 LAKMGPEGSNTHVTTRVMGTYGYAAPEYI--STGHLTTKSDVYSFGVVLLELLTGRRSMD 301
                   S+  V     G   + A E +  +  HL  K+D+++  + ++          
Sbjct: 180 HVTRI---SSPQVEE---GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAE---- 228

Query: 302 KLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP 361
                   +   W +  +R  R       PR+    S    +E   L    I  +P+ RP
Sbjct: 229 --PLPRNGDQ--WHE--IRQGRL------PRIPQVLS----QEFTELLKVMIHPDPERRP 272

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  117 bits (294), Expect = 1e-29
 Identities = 43/229 (18%), Positives = 76/229 (33%), Gaps = 19/229 (8%)

Query: 84  SELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA 143
           +E +  ++    ++LLGEG F  V++     DL      Q   +K+              
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEA-TQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ 116

Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS---LPWGTRLK 200
            +  L        ++           +LV E    G+L N +    +     +P G  + 
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 201 IAIGAAKGLAFLHGAENPVIYRDFKTSNILL-----------DSDFTAKLSDFGLAK-MG 248
            A+     +  +H  E  +I+ D K  N +L           D      L D G +  M 
Sbjct: 177 FAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
                T  T +   T G+   E +S      + D +     +  +L G 
Sbjct: 235 LFPKGTIFTAKC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  115 bits (290), Expect = 2e-29
 Identities = 73/275 (26%), Positives = 120/275 (43%), Gaps = 29/275 (10%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-EVIFLGQLRHPHLV 157
           +G G    V   Y      +    + VA+K +++E  Q   + L  E+  + Q  HP++V
Sbjct: 23  IGSGATAVVQAAY---CAPKK---EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK---IAI---GAAKGLAF 211
                    +E  LV + +  GS+ + +   ++        L    IA       +GL +
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136

Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGSNTHVTTR--VMGTYGYAA 268
           LH  +N  I+RD K  NILL  D + +++DFG+ A +   G  T    R   +GT  + A
Sbjct: 137 LH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194

Query: 269 PEYISTGHL-TTKSDVYSFGVVLLELLTGRRSMDKLRP-KSEQNLVDWAKPYLRSSRRLR 326
           PE +        K+D++SFG+  +EL TG     K  P K     +    P L +  +  
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ-- 252

Query: 327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP 361
              D  +  +Y  K  ++M  L LQ    +P+ RP
Sbjct: 253 ---DKEMLKKYG-KSFRKMISLCLQ---KDPEKRP 280

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  117 bits (294), Expect = 2e-29
 Identities = 49/346 (14%), Positives = 106/346 (30%), Gaps = 80/346 (23%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-------HREWLAEVIFLGQ 150
           +LG+       +     D   G   ++  V +                 E L   +  G 
Sbjct: 85  VLGQEDPYAYLEAT---DQETG---ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138

Query: 151 ------------------LRHPHLVRLIGYCCEDEERLLVYEF--MPR-----GSLENHL 185
                             ++ P   ++I    ++ +  ++  F   PR      +    L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198

Query: 186 FKRISV--SLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFG 243
               S   SL    RL++ +   + LA LH     +++   +  +I+LD      L+ F 
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 244 LAKMGPEGSNTHVTTRVMGTYGYAAPEYIS----------TGHLTTKSDVYSFGVVLLEL 293
                 +G+    +       G+A PE  +             +T   D ++ G+ +  +
Sbjct: 257 HLV--RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310

Query: 294 LTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCI 353
                      P ++   +  ++   RS + +     P+               L    +
Sbjct: 311 WCAD------LPNTDDAALGGSEWIFRSCKNI-----PQPVRA-----------LLEGFL 348

Query: 354 SVNPKDRPKMAAVVATLESLLNLKDMAVSCGQWPATQKSTRNGVSP 399
               +DR      + T E      +++ +   +    + TR G +P
Sbjct: 349 RYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAP 394

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  115 bits (291), Expect = 2e-29
 Identities = 60/297 (20%), Positives = 113/297 (38%), Gaps = 58/297 (19%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH--REWLAEVIFLGQLRHP- 154
            +G GG   V +           K Q  A+K +++E         +  E+ +L +L+   
Sbjct: 16  QIGSGGSSKVFQVL-------NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 155 -HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
             ++RL  Y    ++ + +V E      L + L K+   S+    R        + +  +
Sbjct: 69  DKIIRLYDYE-ITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTI 124

Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
           H  ++ +++ D K +N L+      KL DFG+A      + + V    +GT  Y  PE I
Sbjct: 125 H--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

Query: 273 S-----------TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--- 318
                          ++ KSDV+S G +L  +  G+                   P+   
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------------------PFQQI 223

Query: 319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           +    +L  I+DP    ++     K++  +   C+  +PK R        ++  LL 
Sbjct: 224 INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI-------SIPELLA 273

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  114 bits (288), Expect = 3e-29
 Identities = 61/297 (20%), Positives = 114/297 (38%), Gaps = 58/297 (19%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH--REWLAEVIFLGQLRHP- 154
            +G GG   V +           K Q  A+K +++E         +  E+ +L +L+   
Sbjct: 35  QIGSGGSSKVFQVL-------NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 155 -HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
             ++RL  Y    ++ + +V E      L + L K+   S+    R        + +  +
Sbjct: 88  DKIIRLYDYE-ITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTI 143

Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
           H  ++ +++ D K +N L+      KL DFG+A      + + V    +GT  Y  PE I
Sbjct: 144 H--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200

Query: 273 -----------STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--- 318
                      S   ++ KSDV+S G +L  +  G+                   P+   
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------------------PFQQI 242

Query: 319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           +    +L  I+DP    ++     K++  +   C+  +PK R        ++  LL 
Sbjct: 243 INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI-------SIPELLA 292

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  115 bits (289), Expect = 4e-29
 Identities = 72/318 (22%), Positives = 119/318 (37%), Gaps = 52/318 (16%)

Query: 58  LSRSSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLR 117
           +S  SS ++       +     D +                +G G +G+V+K        
Sbjct: 1   MSIESSGKLKISPEQHWDFTAEDLKDLGE------------IGRGAYGSVNKMV---HKP 45

Query: 118 QGLKAQAVAVKLLDIEG-LQGHREWLAEV-IFLGQLRHPHLVRLIGYCCEDEERLLVYEF 175
            G   Q +AVK +      +  ++ L ++ + +     P++V+  G    + +  +  E 
Sbjct: 46  SG---QIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102

Query: 176 MPRGSLENHLFKRISVSLPWGTR----LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL 231
           M   S +   +K +   L          KI +   K L  L      +I+RD K SNILL
Sbjct: 103 MS-TSFD-KFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK-IIHRDIKPSNILL 159

Query: 232 DSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL----TTKSDVYSFG 287
           D     KL DFG++    +  ++   TR  G   Y APE I           +SDV+S G
Sbjct: 160 DRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLG 216

Query: 288 VVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD---PRLAGQYSVKGAKE 344
           + L EL TGR    K     +Q               L  +V    P+L+     + +  
Sbjct: 217 ITLYELATGRFPYPKWNSVFDQ---------------LTQVVKGDPPQLSNSEEREFSPS 261

Query: 345 MAVLALQCISVNPKDRPK 362
                  C++ +   RPK
Sbjct: 262 FINFVNLCLTKDESKRPK 279

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  114 bits (287), Expect = 4e-29
 Identities = 76/273 (27%), Positives = 114/273 (41%), Gaps = 49/273 (17%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL-AEVIFLGQLRHPHLV 157
           +G+G FG V KG    D R     + VA+K++D+E  +   E +  E+  L Q   P++ 
Sbjct: 30  IGKGSFGEVFKGI---DNRTQ---KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI---GAAKGLAFLHG 214
           +  G   +D +  ++ E++  GS    L +   +         IA       KGL +LH 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDETQ-----IATILREILKGLDYLH- 136

Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR---VMGTYGYAAPEY 271
                I+RD K +N+LL      KL+DFG+A     G  T    +    +GT  + APE 
Sbjct: 137 -SEKKIHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNTFVGTPFWMAPEV 190

Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD- 330
           I      +K+D++S G+  +EL  G     +L P                 + L  I   
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHP----------------MKVLFLIPKN 234

Query: 331 --PRLAGQYSVKGAKEMAVLALQCISVNPKDRP 361
             P L G YS K  KE     L      P  RP
Sbjct: 235 NPPTLEGNYS-KPLKEFVEACLN---KEPSFRP 263

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  114 bits (288), Expect = 6e-29
 Identities = 59/205 (28%), Positives = 87/205 (42%), Gaps = 19/205 (9%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR---EWLAEVIFLGQLRHP 154
            LG+GGF    +     D       +  A K++    L       +   E+     L H 
Sbjct: 48  FLGKGGFAKCFEIS---DADTK---EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101

Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
           H+V   G+  ED + + +V E   R SL     +R +++ P   R         G  +LH
Sbjct: 102 HVVGFHGFF-EDNDFVFVVLELCRRRSLLELHKRRKALTEP-EAR-YYLRQIVLGCQYLH 158

Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
              N VI+RD K  N+ L+ D   K+ DFGLA                GT  Y APE +S
Sbjct: 159 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLS 214

Query: 274 -TGHLTTKSDVYSFGVVLLELLTGR 297
             GH + + DV+S G ++  LL G+
Sbjct: 215 KKGH-SFEVDVWSIGCIMYTLLVGK 238

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  113 bits (286), Expect = 6e-29
 Identities = 59/205 (28%), Positives = 87/205 (42%), Gaps = 19/205 (9%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR---EWLAEVIFLGQLRHP 154
            LG+GGF    +     D       +  A K++    L       +   E+     L H 
Sbjct: 22  FLGKGGFAKCFEIS---DADTK---EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
           H+V   G+  ED + + +V E   R SL     +R +++ P   R         G  +LH
Sbjct: 76  HVVGFHGFF-EDNDFVFVVLELCRRRSLLELHKRRKALTEP-EAR-YYLRQIVLGCQYLH 132

Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
              N VI+RD K  N+ L+ D   K+ DFGLA                GT  Y APE +S
Sbjct: 133 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLS 188

Query: 274 -TGHLTTKSDVYSFGVVLLELLTGR 297
             GH + + DV+S G ++  LL G+
Sbjct: 189 KKGH-SFEVDVWSIGCIMYTLLVGK 212

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  113 bits (285), Expect = 7e-29
 Identities = 73/296 (24%), Positives = 121/296 (40%), Gaps = 49/296 (16%)

Query: 79  YDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQG 137
            + +  +L  I +       LG G +G V K      +  G   Q +AVK +      Q 
Sbjct: 2   MEVKADDLEPIME-------LGRGAYGVVEKMR---HVPSG---QIMAVKRIRATVNSQE 48

Query: 138 HREWLAEV-IFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG 196
            +  L ++ I +  +  P  V   G    + +  +  E M   SL+    + I       
Sbjct: 49  QKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIP 107

Query: 197 TRL--KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT 254
             +  KIA+   K L  LH   + VI+RD K SN+L+++    K+ DFG++       + 
Sbjct: 108 EDILGKIAVSIVKALEHLHSKLS-VIHRDVKPSNVLINALGQVKMCDFGISG---YLVDD 163

Query: 255 HVTTRVMGTYGYAAPEYISTGHL----TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQN 310
                  G   Y APE I+        + KSD++S G+ ++EL   R       P     
Sbjct: 164 VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR------FP----- 212

Query: 311 LVDWAKPYLRSSRRLRYIVD---PRL-AGQYSVKGAKEMAVLALQCISVNPKDRPK 362
              W  P+    ++L+ +V+   P+L A ++S     E      QC+  N K+RP 
Sbjct: 213 YDSWGTPF----QQLKQVVEEPSPQLPADKFS----AEFVDFTSQCLKKNSKERPT 260

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  114 bits (286), Expect = 1e-28
 Identities = 39/350 (11%), Positives = 80/350 (22%), Gaps = 59/350 (16%)

Query: 56  SDLSRSSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDD 115
            +  +  +  +    A  +  +      S L    +       L  G    V       D
Sbjct: 27  EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVR---D 83

Query: 116 LRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIFLGQLRHPHLVRLIGYC--------- 163
           + +    +  A+K+  +       E            +L                     
Sbjct: 84  VERL---EDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140

Query: 164 --------------CEDEERLLVYEFMPR--GSLEN--HLFKRISVS---LPWGTRLKIA 202
                          +D         MP     LE        + V            + 
Sbjct: 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILT 200

Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
               +  A L      +++  F   N+ +  D    L D                     
Sbjct: 201 AQLIRLAANLQ--SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPV--- 255

Query: 263 TYGYAAPEYI--STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR 320
              YA  E++  ST   T   + +  G+ +  +         + P  +         + R
Sbjct: 256 --TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG-------SWKR 306

Query: 321 SSRRLRYIVDPRLAGQYSV-KGAKEMAVLALQCISVNPKDRPKMAAVVAT 369
            S R+             +    K    L  + ++ + + R      + T
Sbjct: 307 PSLRVPGTDSLAFGSCTPLPDFVKT---LIGRFLNFDRRRRLLPLEAMET 353

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  113 bits (283), Expect = 2e-28
 Identities = 54/291 (18%), Positives = 107/291 (36%), Gaps = 36/291 (12%)

Query: 83  LSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL 142
           + E++A+ +      +     +         +++ +           L            
Sbjct: 52  MREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSP--SPMDAPS 109

Query: 143 AEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLP-WGTRLKI 201
            ++  +      + V  +          +  +   + +L++ + +R S+     G  L I
Sbjct: 110 VKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHI 169

Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-----------MGPE 250
            I  A+ + FLH     +++RD K SNI    D   K+ DFGL             + P 
Sbjct: 170 FIQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 227

Query: 251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQN 310
            +    T +V GT  Y +PE I   + + K D++S G++L ELL           + E+ 
Sbjct: 228 PAYATHTGQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS------FSTQMERV 280

Query: 311 LVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP 361
            +      +   R L++   P L  Q       +  ++    +S +P +RP
Sbjct: 281 RI------ITDVRNLKF---PLLFTQKY----PQEHMMVQDMLSPSPTERP 318

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  112 bits (281), Expect = 9e-28
 Identities = 42/312 (13%), Positives = 97/312 (31%), Gaps = 71/312 (22%)

Query: 98  LLGEGGFGTVHKG------------------YIDDDLRQGLKAQAVAVKLL----DIEGL 135
           +LG+       +                       +  + +K + + ++LL    + +  
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 136 QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPR-----GSLENHLFKRIS 190
           + H  ++     +   +   ++R+      D   L  +   PR      +    L    S
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDE-RDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 191 V--SLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG 248
              SL    RL++ +   + LA LH     +++   +  +I+LD      L+ F      
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254

Query: 249 PEGSNTHVTTRVMGTYGYAAPEYIST-----------GHLTTKSDVYSFGVVLLELLTGR 297
            +G+          + G+  PE  +              +T   D ++ G+V+  +    
Sbjct: 255 RDGA----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 298 RSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNP 357
                  P ++   +  ++   RS + +     P+               L    +    
Sbjct: 311 ------LPITKDAALGGSEWIFRSCKNI-----PQPVRA-----------LLEGFLRYPK 348

Query: 358 KDRPKMAAVVAT 369
           +DR      + T
Sbjct: 349 EDRLLPLQAMET 360

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  110 bits (277), Expect = 1e-27
 Identities = 74/298 (24%), Positives = 131/298 (43%), Gaps = 60/298 (20%)

Query: 83  LSELRAI------TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ 136
           L +LR+I       + ++    +G+G  GTV+      D+  G   Q VA++ ++++   
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQP 59

Query: 137 GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG 196
                + E++ + + ++P++V  +      +E  +V E++  GSL + +     +     
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQ- 117

Query: 197 TRLKIAI---GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGS 252
               IA       + L FLH   N VI+RD K+ NILL  D + KL+DFG  A++ PE S
Sbjct: 118 ----IAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171

Query: 253 --NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQN 310
             +T V     GT  + APE ++      K D++S G++ +E++ G        P     
Sbjct: 172 KRSTMV-----GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-------EP----- 214

Query: 311 LVDWAKPYLRSS--RRLRYIVD---PRLAG--QYSVKGAKEMAVLALQCISVNPKDRP 361
                 PYL  +  R L  I     P L    + S            +C+ ++ + R 
Sbjct: 215 ------PYLNENPLRALYLIATNGTPELQNPEKLS----AIFRDFLNRCLEMDVEKRG 262

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  110 bits (276), Expect = 2e-27
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 19/206 (9%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIFLGQLRHP 154
           +LGEG F TV         R+       A+K+L+   +    +      E   + +L HP
Sbjct: 37  ILGEGSFSTVVLARELATSRE------YAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90

Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA-IGAAKGLAFL 212
             V+L  +  +D+E+L     +   G L  ++ K  S      TR   A I +A  L +L
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-CTRFYTAEIVSA--LEYL 146

Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
           H     +I+RD K  NILL+ D   +++DFG AK+    S        +GT  Y +PE +
Sbjct: 147 H--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 204

Query: 273 -STGHLTTKSDVYSFGVVLLELLTGR 297
                    SD+++ G ++ +L+ G 
Sbjct: 205 TEKSA-CKSSDLWALGCIIYQLVAGL 229

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  109 bits (274), Expect = 3e-27
 Identities = 71/303 (23%), Positives = 121/303 (39%), Gaps = 50/303 (16%)

Query: 72  HTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD 131
            T G   Y  ++++L  + +       +G G  G V K       + G     +AVK + 
Sbjct: 13  LTIGGQRYQAEINDLENLGE-------MGSGTCGQVWKMR---FRKTG---HVIAVKQMR 59

Query: 132 IEG-LQGHREWLAEV-IFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRI 189
             G  + ++  L ++ + L     P++V+  G    + +  +  E M   + +  L KR+
Sbjct: 60  RSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK--LKKRM 117

Query: 190 SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP 249
              +P     K+ +   K L +L   ++ VI+RD K SNILLD     KL DFG++    
Sbjct: 118 QGPIPERILGKMTVAIVKALYYLK-EKHGVIHRDVKPSNILLDERGQIKLCDFGISG--- 173

Query: 250 EGSNTHVTTRVMGTYGYAAPEYISTGHL-----TTKSDVYSFGVVLLELLTGRRSMDKLR 304
              +     R  G   Y APE I            ++DV+S G+ L+EL TG+      +
Sbjct: 174 RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233

Query: 305 PKSEQNLVDWAKPYLRSSRRLRYIVD---PRLAG--QYSVKGAKEMAVLALQCISVNPKD 359
              E                L  ++    P L G   +S     +       C++ + + 
Sbjct: 234 TDFEV---------------LTKVLQEEPPLLPGHMGFS----GDFQSFVKDCLTKDHRK 274

Query: 360 RPK 362
           RPK
Sbjct: 275 RPK 277

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  111 bits (278), Expect = 4e-27
 Identities = 66/327 (20%), Positives = 109/327 (33%), Gaps = 77/327 (23%)

Query: 82  QLSELRAITQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG 137
           +++ +    Q+  +      +LG G  GTV               + VAVK + I+    
Sbjct: 2   RIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQG-------RPVAVKRMLIDFCDI 54

Query: 138 HREWLAEVIFLGQL-RHPHLVRLIGYCCEDEERLLVYEFMPRGSL-----ENHLFKRISV 191
                 E+  L +   HP+++R       D    +  E     +L       ++      
Sbjct: 55  ALM---EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLK 110

Query: 192 SLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS-------------DFTAK 238
                  + +    A G+A LH     +I+RD K  NIL+ +             +    
Sbjct: 111 LQKEYNPISLLRQIASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168

Query: 239 LSDFGLAKM--GPEGSNTHVTTRVMGTYGYAAPEYIS-------TGHLTTKSDVYSFGVV 289
           +SDFGL K     + S         GT G+ APE +           LT   D++S G V
Sbjct: 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228

Query: 290 LLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVL 348
              +L+ G+                   P+     R   I    + G +S+   K +   
Sbjct: 229 FYYILSKGKH------------------PFGDKYSRESNI----IRGIFSLDEMKCLHDR 266

Query: 349 AL---------QCISVNPKDRPKMAAV 366
           +L         Q I  +P  RP    V
Sbjct: 267 SLIAEATDLISQMIDHDPLKRPTAMKV 293

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  108 bits (273), Expect = 5e-27
 Identities = 71/298 (23%), Positives = 126/298 (42%), Gaps = 60/298 (20%)

Query: 83  LSELRAI------TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ 136
            + LR +           S   +GEG  G V       +   G   + VAVK++D+   Q
Sbjct: 31  KAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR---EKHSG---RQVAVKMMDLRKQQ 84

Query: 137 GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG 196
                  EV+ +   +H ++V +       EE  ++ EF+  G+L + +  ++ ++    
Sbjct: 85  RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQ- 142

Query: 197 TRLKIAI---GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGS 252
               IA       + LA+LH     VI+RD K+ +ILL  D   KLSDFG  A++  +  
Sbjct: 143 ----IATVCEAVLQALAYLH--AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 196

Query: 253 --NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQN 310
              + V     GT  + APE IS     T+ D++S G++++E++ G        P     
Sbjct: 197 KRKSLV-----GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG-------EP----- 239

Query: 311 LVDWAKPYLRSS--RRLRYIVD---PRLAG--QYSVKGAKEMAVLALQCISVNPKDRP 361
                 PY   S  + ++ + D   P+L    + S      +     + +  +P++R 
Sbjct: 240 ------PYFSDSPVQAMKRLRDSPPPKLKNSHKVS----PVLRDFLERMLVRDPQERA 287

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  109 bits (275), Expect = 6e-27
 Identities = 59/338 (17%), Positives = 100/338 (29%), Gaps = 58/338 (17%)

Query: 70  LAHTFGPDLYDFQLSELRAITQNFSSNYLL------GEGGFGTVHKGYIDDDLRQGLKAQ 123
           +AH     + +     + +        Y L      G     TV+          G   +
Sbjct: 1   MAHHHHHHMENLYFQGMSSFLPE-GGCYELLTVIGKGFEDLMTVNLAR---YKPTG---E 53

Query: 124 AVAVKLLDIEGLQ--GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSL 181
            V V+ +++E            E+       HP++V        D E  +V  FM  GS 
Sbjct: 54  YVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA 113

Query: 182 ENHLFKRISVSLPWGTRLKIAI---GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAK 238
           ++ +       +     L IA    G  K L ++H      ++R  K S+IL+  D    
Sbjct: 114 KDLICTHFMDGMN---ELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVY 168

Query: 239 LSDFG-LAKMGPEGS--NTHVTTRVM--GTYGYAAPEYISTGHL--TTKSDVYSFGVVLL 291
           LS       M   G                  + +PE +         KSD+YS G+   
Sbjct: 169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITAC 228

Query: 292 ELLTGR----------------------------RSMDKLRPKSEQNLVDWAKPYLRSSR 323
           EL  G                                ++L     +++ +       ++ 
Sbjct: 229 ELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTS 288

Query: 324 RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP 361
             R       +  Y    +        QC+  NP  RP
Sbjct: 289 TPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  106 bits (267), Expect = 3e-26
 Identities = 66/227 (29%), Positives = 108/227 (47%), Gaps = 31/227 (13%)

Query: 82  QLSELRAI------TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL 135
           QL +L          + F     LGEG +G+V+K         G   Q VA+K + +E  
Sbjct: 14  QLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAI---HKETG---QIVAIKQVPVE-- 65

Query: 136 QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPW 195
              +E + E+  + Q   PH+V+  G   ++ +  +V E+   GS+ + + +  + +L  
Sbjct: 66  SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTL-- 122

Query: 196 GTRLKIAI---GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS 252
            T  +IA       KGL +LH      I+RD K  NILL+++  AKL+DFG+A     G 
Sbjct: 123 -TEDEIATILQSTLKGLEYLH--FMRKIHRDIKAGNILLNTEGHAKLADFGVA-----GQ 174

Query: 253 NTHVTTR---VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            T    +   V+GT  + APE I        +D++S G+  +E+  G
Sbjct: 175 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  107 bits (270), Expect = 3e-26
 Identities = 68/233 (29%), Positives = 102/233 (43%), Gaps = 41/233 (17%)

Query: 77  DLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAV-AVKLLDIEGL 135
           +   F++  LRAI          G+G FG V        + Q    + + A+K ++ +  
Sbjct: 13  NFDHFEI--LRAI----------GKGSFGKVC-------IVQKNDTKKMYAMKYMNKQKC 53

Query: 136 QGHREW---LAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISV 191
               E      E+  +  L HP LV L  Y  +DEE + +V + +  G L  HL + +  
Sbjct: 54  VERNEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHF 112

Query: 192 SLPWGTRLKIA-IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE 250
                 +L I  +  A  L +L      +I+RD K  NILLD      ++DF +A M P 
Sbjct: 113 KEET-VKLFICELVMA--LDYLQ--NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167

Query: 251 GSNTHVTTRVMGTYGYAAPEYIS----TGHLTTKS-DVYSFGVVLLELLTGRR 298
            +     T + GT  Y APE  S     G+  + + D +S GV   ELL GRR
Sbjct: 168 ET---QITTMAGTKPYMAPEMFSSRKGAGY--SFAVDWWSLGVTAYELLRGRR 215

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  106 bits (266), Expect = 4e-26
 Identities = 52/218 (23%), Positives = 101/218 (46%), Gaps = 28/218 (12%)

Query: 90  TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLG 149
            + +     LG+G FG V+K     +   G      A K+++ +  +   +++ E+  L 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAK---NKETG---ALAAAKVIETKSEEELEDYIVEIEILA 71

Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI---GAA 206
              HP++V+L+G    D +  ++ EF P G+++  +   +   L   T  +I +      
Sbjct: 72  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGL---TEPQIQVVCRQML 127

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGS--NTHVTTRVMGT 263
           + L FLH     +I+RD K  N+L+  +   +L+DFG+ AK        ++ +     GT
Sbjct: 128 EALNFLH--SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GT 180

Query: 264 YGYAAPEYISTGHLT-----TKSDVYSFGVVLLELLTG 296
             + APE +    +       K+D++S G+ L+E+   
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  104 bits (262), Expect = 2e-25
 Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 29/214 (13%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA----EVIFLGQLRH 153
           LLGEG +G V +     D          AVK+L  + L+      A    E+  L +LRH
Sbjct: 12  LLGEGSYGKVKEVL---DSETL---CRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 154 PHLVRLIG-YCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK---- 207
            ++++L+     E+++++ +V E+   G  E  +   +        R  +          
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVP-----EKRFPVCQAHGYFCQL 118

Query: 208 --GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
             GL +LH     ++++D K  N+LL +  T K+S  G+A+     +         G+  
Sbjct: 119 IDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176

Query: 266 YAAPEYISTGHL--TTKSDVYSFGVVLLELLTGR 297
           +  PE  +        K D++S GV L  + TG 
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  106 bits (267), Expect = 3e-25
 Identities = 70/297 (23%), Positives = 114/297 (38%), Gaps = 37/297 (12%)

Query: 16  SKCCSAEGQIIFGNLSRCKTSRSDFSKNIAPMPSFRRLSFSDLSRSSSTRINEDLAHTFG 75
           +     + Q+    L     +R+   +  A    F+ L  + L+        E L   + 
Sbjct: 112 AAYLEPQAQLFCSFLDAETVARA---RAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYF 168

Query: 76  PDLYDFQLSELRAIT-QNFSSNYLLGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLL 130
                ++  E + +    F    +LG GGFG V     K             +  A K L
Sbjct: 169 LRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKA----------TGKLYACKKL 218

Query: 131 D---IEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLF 186
           +   ++  +G++  + E   L ++    +V L  Y  E +  L LV   M  G +  H++
Sbjct: 219 NKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIY 277

Query: 187 KRISVSLPWG---TRLKIA-IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF 242
                +  +         A I    GL  LH  +  +IYRD K  N+LLD D   ++SD 
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQI--VSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDL 333

Query: 243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYI-STGHLTTKS-DVYSFGVVLLELLTGR 297
           GLA     G          GT G+ APE +    +    S D ++ GV L E++  R
Sbjct: 334 GLAVELKAGQTK-TKGYA-GTPGFMAPELLLGEEY--DFSVDYFALGVTLYEMIAAR 386

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  106 bits (267), Expect = 4e-25
 Identities = 63/220 (28%), Positives = 90/220 (40%), Gaps = 33/220 (15%)

Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAV-AVKLL---------DIEGLQGHRE 140
            +FS + ++G GGFG V+         +      + A+K L                 R 
Sbjct: 189 NDFSVHRIIGRGGFGEVY-------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241

Query: 141 WLAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRL 199
            L+ V        P +V +  Y     ++L  + + M  G L  HL +    S     R 
Sbjct: 242 MLSLV---STGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD-MRF 296

Query: 200 KIA-IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT 258
             A I    GL  +H     V+YRD K +NILLD     ++SD GLA    +    H   
Sbjct: 297 YAAEI--ILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PH--A 349

Query: 259 RVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
            V GT+GY APE +  G     S D +S G +L +LL G 
Sbjct: 350 SV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  105 bits (264), Expect = 9e-25
 Identities = 68/229 (29%), Positives = 100/229 (43%), Gaps = 29/229 (12%)

Query: 80  DFQLSELRAIT-QNFSSNYLLGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLD--- 131
            ++  E + +T   F    +LG+GGFG V     +             +  A K L+   
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRA----------TGKMYACKKLEKKR 221

Query: 132 IEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRIS 190
           I+  +G    L E   L ++    +V L  Y  E ++ L LV   M  G L+ H++    
Sbjct: 222 IKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQ 280

Query: 191 VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE 250
              P    +  A     GL  LH     ++YRD K  NILLD     ++SD GLA   PE
Sbjct: 281 AGFPEARAVFYAAEICCGLEDLH--RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338

Query: 251 GSNTHVTTRVMGTYGYAAPEYIS-TGHLTTKS-DVYSFGVVLLELLTGR 297
           G       RV GT GY APE +    +  T S D ++ G +L E++ G+
Sbjct: 339 GQTIK--GRV-GTVGYMAPEVVKNERY--TFSPDWWALGCLLYEMIAGQ 382

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  102 bits (255), Expect = 2e-24
 Identities = 78/272 (28%), Positives = 115/272 (42%), Gaps = 49/272 (18%)

Query: 35  TSRSDFSKNIAPMPSFRRLSFSDLSRSSSTRINEDLAHTFGPDLYDFQLSELRAITQNFS 94
           T    F   + PMP+  R         +     +D      P              + FS
Sbjct: 17  TENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDD------P-------------EKLFS 57

Query: 95  SNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIFLGQL 151
               +G G FG V+      D+R     + VA+K +   G Q + +W   + EV FL +L
Sbjct: 58  DLREIGHGSFGAVYFAR---DVRNS---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 111

Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI---GAAKG 208
           RHP+ ++  G    +    LV E+   GS  + L +     L     ++IA    GA +G
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPL---QEVEIAAVTHGALQG 166

Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL-AKMGPEGSNTHVTTRVMGTYGYA 267
           LA+LH   + +I+RD K  NILL      KL DFG  + M P  +N+      +GT  + 
Sbjct: 167 LAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANS-----FVGTPYWM 217

Query: 268 APEYIST---GHLTTKSDVYSFGVVLLELLTG 296
           APE I     G    K DV+S G+  +EL   
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAER 249

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  102 bits (255), Expect = 3e-24
 Identities = 69/329 (20%), Positives = 115/329 (34%), Gaps = 61/329 (18%)

Query: 1   MRESSEPSKPWRPFTSKCCSAEGQIIFGNLSRCKTSRSDFSKNIAPMPSFRRLSFSDLSR 60
           M      S       +K      + I    +  +  R  F +++   PS      ++  +
Sbjct: 1   MHHHHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKK 60

Query: 61  SSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNY----LLGEGGFGTVHKGYIDDDL 116
            +  +        F     + +L +  A  + F   Y    ++G G    V +       
Sbjct: 61  LNDAQPKGTENLYFQSMGPEDELPDWAA-AKEFYQKYDPKDVIGRGVSSVVRRC------ 113

Query: 117 RQGLKAQAVAVKLLDIEGLQGHREWLA--------EVIFLGQLR-HPHLVRLIGYCCEDE 167
                    AVK++++   +   E L         E   L Q+  HPH++ LI    E  
Sbjct: 114 VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-ESS 172

Query: 168 ERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIG------AAK-------GLAFLH 213
             + LV++ M +G  E  LF  +                                ++FLH
Sbjct: 173 SFMFLVFDLMRKG--E--LFDYL-----------TEKVALSEKETRSIMRSLLEAVSFLH 217

Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE--- 270
              N +++RD K  NILLD +   +LSDFG +     G          GT GY APE   
Sbjct: 218 --ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELC-GTPGYLAPEILK 272

Query: 271 ---YISTGHLTTKSDVYSFGVVLLELLTG 296
                +      + D+++ GV+L  LL G
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAG 301

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  100 bits (252), Expect = 5e-24
 Identities = 68/210 (32%), Positives = 99/210 (47%), Gaps = 27/210 (12%)

Query: 98  LLGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW--LAEVIFLGQL 151
           +LG+G FG V         D         Q  A+K+L    L+         E   L ++
Sbjct: 31  VLGQGSFGKVFLVKKISGSDAR-------QLYAMKVLKKATLKVRDRVRTKMERDILVEV 83

Query: 152 RHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA-IGAAKGL 209
            HP +V+L  Y  + E +L L+ +F+  G L   L K +  +     +  +A +  A  L
Sbjct: 84  NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-VKFYLAELALA--L 139

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
             LH     +IYRD K  NILLD +   KL+DFGL+K   +           GT  Y AP
Sbjct: 140 DHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAP 195

Query: 270 EYIS-TGHLTTKS-DVYSFGVVLLELLTGR 297
           E ++  GH  T+S D +SFGV++ E+LTG 
Sbjct: 196 EVVNRRGH--TQSADWWSFGVLMFEMLTGT 223

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  102 bits (257), Expect = 5e-24
 Identities = 62/236 (26%), Positives = 94/236 (39%), Gaps = 51/236 (21%)

Query: 86  LRAITQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HR 139
           + +   + S  Y     LG G +G V       D          A+K++    +    + 
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCR---DKVTH---VERAIKIIRKTSVSTSSNS 81

Query: 140 EWLAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTR 198
           + L EV  L  L HP++++L  +  ED+    LV E    G     LF  I         
Sbjct: 82  KLLEEVAVLKLLDHPNIMKLYDF-FEDKRNYYLVMECYKGGE----LFDEI--------- 127

Query: 199 LKIAIG------AAK-------GLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDF 242
             I         AA        G+ +LH  ++ +++RD K  N+LL+S   D   K+ DF
Sbjct: 128 --IHRMKFNEVDAAVIIKQVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDF 183

Query: 243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRR 298
           GL+ +             +GT  Y APE +       K DV+S GV+L  LL G  
Sbjct: 184 GLSAVFENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYP 235

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  100 bits (252), Expect = 6e-24
 Identities = 65/247 (26%), Positives = 102/247 (41%), Gaps = 27/247 (10%)

Query: 59  SRSSSTRINEDLAHTFGPDLYDFQLSELRAIT-QNFSSNYLLGEGGFGTVHKGYIDDDLR 117
             S    + E LA      L  ++           F     LG G FG V        ++
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVML------VK 61

Query: 118 QGLKAQAVAVKLLDIEGLQGHREW---LAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVY 173
                   A+K+LD + +   ++    L E   L  +  P LV+L  +  +D   L +V 
Sbjct: 62  HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNSNLYMVM 120

Query: 174 EFMPRGSLENHLFKRISVSLPWGTRLKIA-IGAAKGLAFLHGAENPVIYRDFKTSNILLD 232
           E++  G + +HL +    S P   R   A I       +LH     +IYRD K  N+L+D
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT--FEYLH--SLDLIYRDLKPENLLID 175

Query: 233 SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI-STGHLTTKS-DVYSFGVVL 290
                +++DFG AK     + T     + GT    APE I S G+   K+ D ++ GV++
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGY--NKAVDWWALGVLI 228

Query: 291 LELLTGR 297
            E+  G 
Sbjct: 229 YEMAAGY 235

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =   99 bits (250), Expect = 6e-24
 Identities = 57/228 (25%), Positives = 91/228 (39%), Gaps = 49/228 (21%)

Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEV 145
           T N    +    +LG G F  V         +Q L  +  A+K +             E+
Sbjct: 4   TTNIRKTFIFMEVLGSGAFSEVFLV------KQRLTGKLFALKCIKKSPAFRDSSLENEI 57

Query: 146 IFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIG 204
             L +++H ++V L     E      LV + +  G  E  LF RI           +  G
Sbjct: 58  AVLKKIKHENIVTLEDIY-ESTTHYYLVMQLVSGG--E--LFDRI-----------LERG 101

Query: 205 ------AAK-------GLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMG 248
                 A+         + +LH  EN +++RD K  N+L  +   +    ++DFGL+KM 
Sbjct: 102 VYTEKDASLVIQQVLSAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159

Query: 249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
             G    + +   GT GY APE ++    +   D +S GV+   LL G
Sbjct: 160 QNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  102 bits (256), Expect = 7e-24
 Identities = 67/236 (28%), Positives = 103/236 (43%), Gaps = 52/236 (22%)

Query: 86  LRAITQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW 141
           ++  T  FS  Y    +LG+G FG V         +  +  Q  AVK++    ++   + 
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILC------KDKITGQECAVKVISKRQVKQKTDK 70

Query: 142 ---LAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGT 197
              L EV  L QL HP++++L  +  ED+    LV E    G     LF  I        
Sbjct: 71  ESLLREVQLLKQLDHPNIMKLYEF-FEDKGYFYLVGEVYTGGE----LFDEI-------- 117

Query: 198 RLKIAIG------AAK-------GLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSD 241
              I+        AA+       G+ ++H  +N +++RD K  N+LL+S   D   ++ D
Sbjct: 118 ---ISRKRFSEVDAARIIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIID 172

Query: 242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           FGL+               +GT  Y APE +  G    K DV+S GV+L  LL+G 
Sbjct: 173 FGLSTHFEAS---KKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGC 224

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 98.8 bits (247), Expect = 1e-23
 Identities = 60/222 (27%), Positives = 89/222 (40%), Gaps = 32/222 (14%)

Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-E 144
                  +     LG G FG VH         +        +K ++ +  Q   E +  E
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLV------EERSSGLERVIKTINKDRSQVPMEQIEAE 70

Query: 145 VIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRL--KI 201
           +  L  L HP+++++     ED   + +V E    G  E  L +RI  +   G  L    
Sbjct: 71  IEVLKSLDHPNIIKIFEV-FEDYHNMYIVMETCEGG--E--LLERIVSAQARGKALSEGY 125

Query: 202 AIGAAK----GLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNT 254
                K     LA+ H     V+++D K  NIL          K+ DFGLA++       
Sbjct: 126 VAELMKQMMNALAYFH--SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--- 180

Query: 255 HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
             +T   GT  Y APE      +T K D++S GVV+  LLTG
Sbjct: 181 EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 99.5 bits (249), Expect = 1e-23
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 31/213 (14%)

Query: 98  LLGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLL---DIEGLQGHREW-LAEVIFLG 149
           +LG+GG+G V         +         +  A+K+L    I           AE   L 
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTG-------KIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 150 QLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA-IGAAK 207
           +++HP +V LI Y  +   +L L+ E++  G L   L +             +A I  A 
Sbjct: 77  EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT-ACFYLAEISMA- 133

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM-GTYGY 266
            L  LH  +  +IYRD K  NI+L+     KL+DFGL K   E  +    T    GT  Y
Sbjct: 134 -LGHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDGTVTHTFCGTIEY 187

Query: 267 AAPEYIS-TGHLTTKS-DVYSFGVVLLELLTGR 297
            APE +  +GH   ++ D +S G ++ ++LTG 
Sbjct: 188 MAPEILMRSGH--NRAVDWWSLGALMYDMLTGA 218

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  101 bits (253), Expect = 2e-23
 Identities = 60/247 (24%), Positives = 96/247 (38%), Gaps = 62/247 (25%)

Query: 86  LRAITQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK------------L 129
           +R        +Y     LG G +G V       +          A+K             
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCK---EKNGH---SEKAIKVIKKSQFDKGRYS 80

Query: 130 LDIEGLQGHREWLA-EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFK 187
            D + ++   E +  E+  L  L HP++++L     ED++   LV EF   G     LF+
Sbjct: 81  DDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-FEDKKYFYLVTEFYEGGE----LFE 135

Query: 188 RISVSLPWGTRLKIAIG------AAK-------GLAFLHGAENPVIYRDFKTSNILLDS- 233
           +I           I         AA        G+ +LH  ++ +++RD K  NILL++ 
Sbjct: 136 QI-----------INRHKFDECDAANIMKQILSGICYLH--KHNIVHRDIKPENILLENK 182

Query: 234 --DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLL 291
                 K+ DFGL+    +    +     +GT  Y APE +       K DV+S GV++ 
Sbjct: 183 NSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMY 238

Query: 292 ELLTGRR 298
            LL G  
Sbjct: 239 ILLCGYP 245

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 65/238 (27%), Positives = 103/238 (43%), Gaps = 35/238 (14%)

Query: 77  DLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ 136
            L +  LS LR     F    L+G G +G V+KG     ++ G   Q  A+K++D+ G  
Sbjct: 10  SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGR---HVKTG---QLAAIKVMDVTG-D 62

Query: 137 GHREWLAEVIFLGQL-RHPHLVRLIG-----YCCEDEERL-LVYEFMPRGSLENHLFKRI 189
              E   E+  L +   H ++    G          +++L LV EF   GS+ + +    
Sbjct: 63  EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122

Query: 190 SVSLPWGTRLKIAI---GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK 246
             +L       IA       +GL+ LH  ++ VI+RD K  N+LL  +   KL DFG++ 
Sbjct: 123 GNTL---KEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVS- 176

Query: 247 MGPEGSNTHVTTR---VMGTYGYAAPEYISTGHLT-----TKSDVYSFGVVLLELLTG 296
                       R    +GT  + APE I+           KSD++S G+  +E+  G
Sbjct: 177 ----AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 97.3 bits (243), Expect = 4e-23
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 26/209 (12%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-EVIFLGQLRHPHL 156
            LGEG +G V       +       +AVAVK++D++      E +  E+     L H ++
Sbjct: 14  TLGEGAYGEVQLAV---NRVTE---EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK-------GL 209
           V+  G+  E   + L  E+   G L + +   I         +     A +       G+
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--------GMPEPD-AQRFFHQLMAGV 118

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
            +LHG    + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y AP
Sbjct: 119 VYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 270 EYIS-TGHLTTKSDVYSFGVVLLELLTGR 297
           E +          DV+S G+VL  +L G 
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 98.9 bits (247), Expect = 4e-23
 Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 29/214 (13%)

Query: 98  LLGEGGFGTVH---KGYIDDDLR----QGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ 150
           +LG G +G V    K    D  +    + LK   +  K    E  +  R+ L  +     
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI----- 115

Query: 151 LRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA-IGAAKG 208
            + P LV L  Y  + E +L L+ +++  G L  HL +R   +     ++ +  I  A  
Sbjct: 116 RQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-VQIYVGEIVLA-- 171

Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM-GTYGYA 267
           L  LH  +  +IYRD K  NILLDS+    L+DFGL+K                GT  Y 
Sbjct: 172 LEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE--RAYDFCGTIEYM 227

Query: 268 APEYI---STGHLTTKS-DVYSFGVVLLELLTGR 297
           AP+ +    +GH   K+ D +S GV++ ELLTG 
Sbjct: 228 APDIVRGGDSGH--DKAVDWWSLGVLMYELLTGA 259

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 99.4 bits (248), Expect = 8e-23
 Identities = 66/232 (28%), Positives = 97/232 (41%), Gaps = 51/232 (21%)

Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HREWLA 143
              F+  Y    +LG+G FG V K     D       Q  AVK+++    +       L 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCK---DRITQ---QEYAVKVINKASAKNKDTSTILR 70

Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           EV  L +L HP++++L     ED     +V E    G     LF  I           I 
Sbjct: 71  EVELLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGE----LFDEI-----------IK 114

Query: 203 IG------AAK-------GLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAK 246
                   AA+       G+ ++H  ++ +++RD K  NILL+S   D   K+ DFGL+ 
Sbjct: 115 RKRFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172

Query: 247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRR 298
              +          +GT  Y APE +  G    K DV+S GV+L  LL+G  
Sbjct: 173 CFQQN---TKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTP 220

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 59/238 (24%), Positives = 98/238 (41%), Gaps = 36/238 (15%)

Query: 79  YDFQLSELRAITQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG 134
           +D  + +     +     Y     LG G  G V   +   + +     + VA++++    
Sbjct: 119 FDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAF---ERKTC---KKVAIRIISKRK 172

Query: 135 LQGHREWLA--------EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLF 186
                   A        E+  L +L HP ++++  +  + E+  +V E M  G  E  LF
Sbjct: 173 FAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG--E--LF 227

Query: 187 KRI--SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSD 241
            ++  +  L   T           + +LH  EN +I+RD K  N+LL S   D   K++D
Sbjct: 228 DKVVGNKRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITD 285

Query: 242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL---TTKSDVYSFGVVLLELLTG 296
           FG +K+  E S     T   GT  Y APE + +          D +S GV+L   L+G
Sbjct: 286 FGHSKILGETSLM--RTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 96.4 bits (241), Expect = 1e-22
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 26/207 (12%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIFLGQLRHP 154
            LG G FG VH       +R     +  A+K+L  E +   ++      E + L  + HP
Sbjct: 13  TLGTGSFGRVHL------IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66

Query: 155 HLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA-IGAAKGLAFL 212
            ++R+     +D +++ ++ +++  G L + L K      P   +   A +  A  L +L
Sbjct: 67  FIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-VAKFYAAEVCLA--LEYL 122

Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
           H     +IYRD K  NILLD +   K++DFG AK  P+ + T     + GT  Y APE +
Sbjct: 123 H--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIAPEVV 175

Query: 273 -STGHLTTKS-DVYSFGVVLLELLTGR 297
            +  +   KS D +SFG+++ E+L G 
Sbjct: 176 STKPY--NKSIDWWSFGILIYEMLAGY 200

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 26/209 (12%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-EVIFLGQLRHPHL 156
            LGEG +G V       +       +AVAVK++D++      E +  E+     L H ++
Sbjct: 14  TLGEGAYGEVQLAV---NRVTE---EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK-------GL 209
           V+  G+  E   + L  E+   G L + +   I         +     A +       G+
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--------GMPEPD-AQRFFHQLMAGV 118

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
            +LHG    + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y AP
Sbjct: 119 VYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 270 EYIS-TGHLTTKSDVYSFGVVLLELLTGR 297
           E +          DV+S G+VL  +L G 
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 95.4 bits (238), Expect = 3e-22
 Identities = 61/241 (25%), Positives = 91/241 (37%), Gaps = 61/241 (25%)

Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI--------EGLQG 137
           T  F  NY    +LG G    V +             +  AVK++D+        E +Q 
Sbjct: 12  THGFYENYEPKEILGRGVSSVVRRCI---HKPTC---KEYAVKIIDVTGGGSFSAEEVQE 65

Query: 138 HREWLA-EVIFLGQL-RHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLP 194
            RE    EV  L ++  HP++++L     E      LV++ M +G  E  LF  +     
Sbjct: 66  LREATLKEVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKG--E--LFDYL----- 115

Query: 195 WGTRLKIAIG------AAK-------GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD 241
                             K        +  LH  +  +++RD K  NILLD D   KL+D
Sbjct: 116 ------TEKVTLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTD 167

Query: 242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPE------YISTGHLTTKSDVYSFGVVLLELLT 295
           FG +     G          GT  Y APE        +      + D++S GV++  LL 
Sbjct: 168 FGFSCQLDPGEKL--REVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

Query: 296 G 296
           G
Sbjct: 225 G 225

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 94.9 bits (237), Expect = 3e-22
 Identities = 59/230 (25%), Positives = 96/230 (41%), Gaps = 50/230 (21%)

Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HREWLA 143
           +  FS NY     LG+G F  V +         G      A K+++ + L     ++   
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCV---HKTTG---LEFAAKIINTKKLSARDFQKLER 54

Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           E     +L+HP++VRL     ++E    LV++ +  G  E  LF+ I           +A
Sbjct: 55  EARICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGG--E--LFEDI-----------VA 98

Query: 203 IG------AAK-------GLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAK 246
                   A+         +A+ H   N +++R+ K  N+LL S       KL+DFGLA 
Sbjct: 99  REFYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156

Query: 247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
              +           GT GY +PE +     +   D+++ GV+L  LL G
Sbjct: 157 EVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 98.0 bits (244), Expect = 3e-22
 Identities = 63/288 (21%), Positives = 105/288 (36%), Gaps = 20/288 (6%)

Query: 14  FTSKCCSAEGQIIFGNLSRCKTSRSDFSKNIAPMPSFRRLSFSDLSRSSSTRINEDLAHT 73
           F     +  GQ      +       D  K         +        + S+  +  +   
Sbjct: 80  FRIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDI 139

Query: 74  FGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE 133
           +          +   +  ++  +  LG G FG VH+        +       A K +   
Sbjct: 140 WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV------TERATGNNFAAKFVMTP 193

Query: 134 GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSL 193
                     E+  +  LRHP LV L     +D E +++YEFM  G  E  LF++++   
Sbjct: 194 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG--E--LFEKVADEH 249

Query: 194 PWGTRLKIAIGA---AKGLAFLHGAENPVIYRDFKTSNILLDSDFTA--KLSDFGLAKMG 248
              +  +         KGL  +H  EN  ++ D K  NI+  +  +   KL DFGL    
Sbjct: 250 NKMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307

Query: 249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
               +  V     GT  +AAPE      +   +D++S GV+   LL+G
Sbjct: 308 DPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 96.2 bits (240), Expect = 3e-22
 Identities = 70/254 (27%), Positives = 107/254 (42%), Gaps = 54/254 (21%)

Query: 61  SSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTV----HKGYIDDDL 116
           + S +IN   +        DF    L+          ++G+G FG V    HK       
Sbjct: 20  APSQQINLGPSSNPHAKPSDFHF--LK----------VIGKGSFGKVLLARHKA------ 61

Query: 117 RQGLKAQAVAVKLL---------DIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE 167
               +    AVK+L         + + +   R      + L  ++HP LV L  +  +  
Sbjct: 62  ----EEVFYAVKVLQKKAILKKKEEKHIMSERN-----VLLKNVKHPFLVGLH-FSFQTA 111

Query: 168 ERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA-IGAAKGLAFLHGAENPVIYRDFK 225
           ++L  V +++  G L  HL +      P   R   A I +A  L +LH     ++YRD K
Sbjct: 112 DKLYFVLDYINGGELFYHLQRERCFLEPR-ARFYAAEIASA--LGYLH--SLNIVYRDLK 166

Query: 226 TSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI-STGHLTTKS-DV 283
             NILLDS     L+DFGL K   E ++T  T+   GT  Y APE +    +   ++ D 
Sbjct: 167 PENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEVLHKQPY--DRTVDW 222

Query: 284 YSFGVVLLELLTGR 297
           +  G VL E+L G 
Sbjct: 223 WCLGAVLYEMLYGL 236

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 95.8 bits (239), Expect = 4e-22
 Identities = 63/217 (29%), Positives = 89/217 (41%), Gaps = 43/217 (19%)

Query: 98  LLGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLL---------DIEGLQGHREWLAE 144
           LLG+G FG V     K             +  A+K+L         ++         L  
Sbjct: 12  LLGKGTFGKVILVREKA----------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 145 VIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA- 202
                  RHP L  L  Y  +  +RL  V E+   G L  HL +    +     R   A 
Sbjct: 62  T------RHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER-ARFYGAE 113

Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I +A  L +LH     V+YRD K  N++LD D   K++DFGL K G     T       G
Sbjct: 114 IVSA--LEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCG 167

Query: 263 TYGYAAPEYIS-TGHLTTKS-DVYSFGVVLLELLTGR 297
           T  Y APE +    +   ++ D +  GVV+ E++ GR
Sbjct: 168 TPEYLAPEVLEDNDY--GRAVDWWGLGVVMYEMMCGR 202

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 96.7 bits (241), Expect = 4e-22
 Identities = 67/210 (31%), Positives = 91/210 (43%), Gaps = 28/210 (13%)

Query: 98  LLGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIFLGQ 150
           LLG+G FG V     K             +  A+K+L  E +    E    L E   L  
Sbjct: 155 LLGKGTFGKVILVKEKA----------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204

Query: 151 LRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
            RHP L  L  Y  +  +RL  V E+   G L  HL +    S     R   A      L
Sbjct: 205 SRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARFYGA-EIVSAL 261

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
            +LH  E  V+YRD K  N++LD D   K++DFGL K G +   T       GT  Y AP
Sbjct: 262 DYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAP 318

Query: 270 EYIS-TGHLTTKS-DVYSFGVVLLELLTGR 297
           E +    +   ++ D +  GVV+ E++ GR
Sbjct: 319 EVLEDNDY--GRAVDWWGLGVVMYEMMCGR 346

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 95.9 bits (239), Expect = 5e-22
 Identities = 52/219 (23%), Positives = 88/219 (40%), Gaps = 30/219 (13%)

Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEV 145
             +    Y     LG G FG VH+        +    +    K ++            E+
Sbjct: 46  QGSVYDYYDILEELGSGAFGVVHRC------VEKATGRVFVAKFINTPYPLDKYTVKNEI 99

Query: 146 IFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRL--KIAI 203
             + QL HP L+ L     +  E +L+ EF+  G  E  LF RI        ++     I
Sbjct: 100 SIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG--E--LFDRI---AAEDYKMSEAEVI 152

Query: 204 GAAK----GLAFLHGAENPVIYRDFKTSNILLDSDFTA--KLSDFGLAKMGPEGSNTHVT 257
              +    GL  +H  E+ +++ D K  NI+ ++   +  K+ DFGLA          + 
Sbjct: 153 NYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IV 207

Query: 258 TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
                T  +AAPE +    +   +D+++ GV+   LL+G
Sbjct: 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 94.3 bits (235), Expect = 5e-22
 Identities = 53/238 (22%), Positives = 96/238 (40%), Gaps = 58/238 (24%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-------------- 143
            +G+G +G V   Y   +          A+K+L  + L     +                
Sbjct: 20  EIGKGSYGVVKLAY---NENDN---TYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 144 ------------EVIFLGQLRHPHLVRLIG-YCCEDEERL-LVYEFMPRGSLENHLFKRI 189
                       E+  L +L HP++V+L+      +E+ L +V+E + +G +     +  
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVP 129

Query: 190 SVSLPWGTRLKIAIGAAK-------GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF 242
           +        L     A         G+ +LH     +I+RD K SN+L+  D   K++DF
Sbjct: 130 T-----LKPLSEDQ-ARFYFQDLIKGIEYLH--YQKIIHRDIKPSNLLVGEDGHIKIADF 181

Query: 243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT---TKSDVYSFGVVLLELLTGR 297
           G++    +GS+  ++  V GT  + APE +S           DV++ GV L   + G+
Sbjct: 182 GVSNE-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 95.5 bits (238), Expect = 6e-22
 Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 34/231 (14%)

Query: 81  FQLSELRAITQNFSSNY------LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG 134
           F    + A     +S Y      +LG G FG VHK    ++   GLK   +A K++   G
Sbjct: 73  FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC---EETATGLK---LAAKIIKTRG 126

Query: 135 LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSL 193
           ++   E   E+  + QL H +L++L     E +  + LV E++  G  E  LF RI   +
Sbjct: 127 MKDKEEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGG--E--LFDRI---I 178

Query: 194 PWGTRL--KIAIGAAK----GLAFLHGAENPVIYRDFKTSNILLDSDFTA--KLSDFGLA 245
                L     I   K    G+  +H  +  +++ D K  NIL  +      K+ DFGLA
Sbjct: 179 DESYNLTELDTILFMKQICEGIRHMH--QMYILHLDLKPENILCVNRDAKQIKIIDFGLA 236

Query: 246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           +         V     GT  + APE ++   ++  +D++S GV+   LL+G
Sbjct: 237 RRYKPREKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 95.4 bits (238), Expect = 6e-22
 Identities = 71/239 (29%), Positives = 98/239 (41%), Gaps = 41/239 (17%)

Query: 76  PDLYDFQLSELRAIT-QNFSSNYLLGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLL 130
           P+L   + S    +  ++F  + +LG+G FG V     K             Q  A+K L
Sbjct: 1   PELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKK----------TNQFFAIKAL 50

Query: 131 ---------DIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGS 180
                    D+E     +  L+         HP L  +     + +E L  V E++  G 
Sbjct: 51  KKDVVLMDDDVECTMVEKRVLSLAW-----EHPFLTHMF-CTFQTKENLFFVMEYLNGGD 104

Query: 181 LENHLFKRISVSLPWGTRLKIA-IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKL 239
           L  H+       L        A I    GL FLH     ++YRD K  NILLD D   K+
Sbjct: 105 LMYHIQSCHKFDLSR-ATFYAAEI--ILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKI 159

Query: 240 SDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
           +DFG+ K    G     T    GT  Y APE I  G     S D +SFGV+L E+L G+
Sbjct: 160 ADFGMCKENMLGDAK--TNTFCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 93.8 bits (234), Expect = 6e-22
 Identities = 54/228 (23%), Positives = 87/228 (38%), Gaps = 49/228 (21%)

Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEV 145
             + +  Y     +G G +G V          Q       A K +    ++    +  E+
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIA------VQKGTRIRRAAKKIPKYFVEDVDRFKQEI 57

Query: 146 IFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIG 204
             +  L HP+++RL     ED   + LV E    G  E  LF+R+           +   
Sbjct: 58  EIMKSLDHPNIIRLYET-FEDNTDIYLVMELCTGG--E--LFERV-----------VHKR 101

Query: 205 ------AAK-------GLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMG 248
                 AA+        +A+ H  +  V +RD K  N L  +   D   KL DFGLA   
Sbjct: 102 VFRESDAARIMKDVLSAVAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159

Query: 249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
             G    +    +GT  Y +P+ +   +   + D +S GV++  LL G
Sbjct: 160 KPG---KMMRTKVGTPYYVSPQVLEGLY-GPECDEWSAGVMMYVLLCG 203

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 94.5 bits (235), Expect = 9e-22
 Identities = 58/263 (22%), Positives = 93/263 (35%), Gaps = 65/263 (24%)

Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-- 143
                  Y     +G+G +G V       + +        A+K+++   ++         
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAI---ENQTR---AIRAIKIMNKNKIRQINPKDVER 74

Query: 144 ---EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRL 199
              EV  + +L HP++ RL     EDE+ + LV E    G L + L   I  S       
Sbjct: 75  IKTEVRLMKKLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMD 133

Query: 200 KIAIG-------------------------------AAK-------GLAFLHGAENPVIY 221
            +                                   +         L +LH     + +
Sbjct: 134 VVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH--NQGICH 191

Query: 222 RDFKTSNILLDSDFTA--KLSDFGLAKM---GPEGSNTHVTTRVMGTYGYAAPEYISTGH 276
           RD K  N L  ++ +   KL DFGL+K       G    +TT+  GT  + APE ++T +
Sbjct: 192 RDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTN 250

Query: 277 L--TTKSDVYSFGVVLLELLTGR 297
                K D +S GV+L  LL G 
Sbjct: 251 ESYGPKCDAWSAGVLLHLLLMGA 273

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 51/230 (22%)

Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE--WLA 143
              F+  Y    +LG+G FG V K       +  +  Q  AVK+++    +       L 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKC------KDRITQQEYAVKVINKASAKNKDTSTILR 70

Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           EV  L +L HP++++L     ED     +V E    G  E  LF  I           I 
Sbjct: 71  EVELLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGG--E--LFDEI-----------IK 114

Query: 203 IG------AAK-------GLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAK 246
                   AA+       G+ ++H  ++ +++RD K  NILL+S   D   K+ DFGL+ 
Sbjct: 115 RKRFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172

Query: 247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
              + +        +GT  Y APE +  G    K DV+S GV+L  LL+G
Sbjct: 173 CFQQNT---KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 57/237 (24%), Positives = 92/237 (38%), Gaps = 58/237 (24%)

Query: 91  QNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA--- 143
           +     Y     LG G  G V   +   + +     + VA+K++            A   
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAF---ERKTC---KKVAIKIISKRKFAIGSAREADPA 59

Query: 144 -----EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR 198
                E+  L +L HP ++++  +  + E+  +V E M  G  E  LF ++         
Sbjct: 60  LNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG--E--LFDKV--------- 105

Query: 199 LKIAIG------AAK-------GLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDF 242
             +                    + +LH  EN +I+RD K  N+LL S   D   K++DF
Sbjct: 106 --VGNKRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDF 161

Query: 243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL---TTKSDVYSFGVVLLELLTG 296
           G +K+  E S     T   GT  Y APE + +          D +S GV+L   L+G
Sbjct: 162 GHSKILGETSLM--RTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 68/217 (31%), Positives = 95/217 (43%), Gaps = 42/217 (19%)

Query: 98  LLGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLL---------DIEGLQGHREWLAE 144
           +LG+G FG V     KG            +  AVK+L         D+E     +  LA 
Sbjct: 27  VLGKGSFGKVMLSERKG----------TDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76

Query: 145 VIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA- 202
                  + P L +L   C +  +RL  V E++  G L  H+ +      P       A 
Sbjct: 77  PG-----KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH-AVFYAAE 129

Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM- 261
           I     L FL      +IYRD K  N++LDS+   K++DFG+ K   E     VTT+   
Sbjct: 130 IAIG--LFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKTFC 182

Query: 262 GTYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
           GT  Y APE I       KS D ++FGV+L E+L G+
Sbjct: 183 GTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 69/218 (31%), Positives = 94/218 (43%), Gaps = 44/218 (20%)

Query: 98  LLGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLL---------DIEGLQGHREWLAE 144
           +LG+G FG V     K                AVK+L         D+E     +  L+ 
Sbjct: 30  VLGKGSFGKVMLARVKE----------TGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79

Query: 145 VIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA- 202
                   HP L +L   C +  +RL  V EF+  G L  H+ K          R   A 
Sbjct: 80  AR-----NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR-ARFYAAE 132

Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM- 261
           I +A  L FLH  +  +IYRD K  N+LLD +   KL+DFG+ K   EG    VTT    
Sbjct: 133 IISA--LMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFC 185

Query: 262 GTYGYAAPEYIS-TGHLTTKS-DVYSFGVVLLELLTGR 297
           GT  Y APE +    +    + D ++ GV+L E+L G 
Sbjct: 186 GTPDYIAPEILQEMLY--GPAVDWWAMGVLLYEMLCGH 221

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 93.4 bits (233), Expect = 2e-21
 Identities = 61/216 (28%), Positives = 87/216 (40%), Gaps = 43/216 (19%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREW-----LAEVIFLGQL 151
           +GEG +G V K       R     Q VA+K  L   +             L E+  L QL
Sbjct: 11  IGEGSYGVVFKC------RNRDTGQIVAIKKFLESED-----DPVIKKIALREIRMLKQL 59

Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +HP+LV L+          LV+E+    ++ + L  R    +P      I     + + F
Sbjct: 60  KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITWQTLQAVNF 117

Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM--GPEGSNTH-VTTRVMGTYGYAA 268
            H  ++  I+RD K  NIL+      KL DFG A++  GP       V TR      Y +
Sbjct: 118 CH--KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRS 170

Query: 269 PE-------YISTGHLTTKSDVYSFGVVLLELLTGR 297
           PE       Y          DV++ G V  ELL+G 
Sbjct: 171 PELLVGDTQY------GPPVDVWAIGCVFAELLSGV 200

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 40/216 (18%)

Query: 98  LLGEGGFGTV----HKGYIDDDLRQGLKAQAVAVKLL---------DIEGLQGHREWLAE 144
           ++G G +  V     K             +  A+K++         DI+ +Q  +    +
Sbjct: 16  VIGRGSYAKVLLVRLKK----------TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65

Query: 145 VIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA- 202
                   HP LV L   C + E RL  V E++  G L  H+ ++  +      R   A 
Sbjct: 66  A-----SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAE 118

Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
           I  A  L +LH  E  +IYRD K  N+LLDS+   KL+D+G+ K G    +T  T+   G
Sbjct: 119 ISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCG 172

Query: 263 TYGYAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR 297
           T  Y APE I  G     S D ++ GV++ E++ GR
Sbjct: 173 TPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 207

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 49/219 (22%), Positives = 91/219 (41%), Gaps = 33/219 (15%)

Query: 91  QNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVI 146
           +     Y     LG G FG VH+        +    +    K + ++G         E+ 
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRC------VETSSKKTYMAKFVKVKGTD-QVLVKKEIS 53

Query: 147 FLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRL--KIAI 203
            L   RH +++ L     E  E L +++EF+     +  +F+RI+ S      L  +  +
Sbjct: 54  ILNIARHRNILHLHESF-ESMEELVMIFEFISGL--D--IFERINTS---AFELNEREIV 105

Query: 204 GAAK----GLAFLHGAENPVIYRDFKTSNILLDSDFTA--KLSDFGLAKMGPEGSNTHVT 257
                    L FLH   + + + D +  NI+  +  ++  K+ +FG A+    G N  + 
Sbjct: 106 SYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL- 162

Query: 258 TRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
             +     Y APE      ++T +D++S G ++  LL+G
Sbjct: 163 --LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 93.2 bits (232), Expect = 2e-21
 Identities = 58/236 (24%), Positives = 91/236 (38%), Gaps = 39/236 (16%)

Query: 82  QLSELRAITQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG 137
           +L  L A    +S  Y     LG G FG V             K + V VK +  E +  
Sbjct: 11  ELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTA------VDKEKNKEVVVKFIKKEKVLE 64

Query: 138 HREWLA--------EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKR 188
                         E+  L ++ H ++++++    E++    LV E    G L+  LF  
Sbjct: 65  DCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF-ENQGFFQLVMEKHGSG-LD--LFAF 120

Query: 189 ISVSLPWGTRLKIAIGAAK------GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF 242
           I        RL   + +         + +L      +I+RD K  NI++  DFT KL DF
Sbjct: 121 IDRH----PRLDEPLASYIFRQLVSAVGYLR--LKDIIHRDIKDENIVIAEDFTIKLIDF 174

Query: 243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS-TGHLTTKSDVYSFGVVLLELLTGR 297
           G A     G   +      GT  Y APE +    +   + +++S GV L  L+   
Sbjct: 175 GSAAYLERGKLFYTFC---GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 71/286 (24%), Positives = 115/286 (40%), Gaps = 68/286 (23%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA----EVIFLGQLRHP 154
           +G+G F  V         R  L  + VA+K++D   L      L     EV  +  L HP
Sbjct: 23  IGKGNFAKVKLA------RHILTGREVAIKIIDKTQLN--PTSLQKLFREVRIMKILNHP 74

Query: 155 HLVRLIGY-CCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK----- 207
           ++V+L  +   E E+ L L+ E+   G + ++L            R+K     +K     
Sbjct: 75  NIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAH--------GRMKEKEARSKFRQIV 124

Query: 208 -GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGS--NTHVTTRVMGTY 264
             + + H  +  +++RD K  N+LLD+D   K++DFG +     G   +        G  
Sbjct: 125 SAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-----GAP 177

Query: 265 GYAAPEYIS-TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSR 323
            YAAPE      +   + DV+S GV+L  L++G    D       QNL           +
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNL-----------K 220

Query: 324 RLRYIVDPRLAGQYSV-----KGAKEMAVLALQCISVNPKDRPKMA 364
            LR  V   L G+Y +        + +    L    +NP  R  + 
Sbjct: 221 ELRERV---LRGKYRIPFYMSTDCENLLKRFLV---LNPIKRGTLE 260

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 71/258 (27%), Positives = 111/258 (43%), Gaps = 54/258 (20%)

Query: 56  SDLSRSSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTV----HKGY 111
            +   + +TR +   + + G    DF L  LR          ++G G +  V     K  
Sbjct: 31  EEEKEAMNTRESGKASSSLGLQ--DFDL--LR----------VIGRGSYAKVLLVRLKK- 75

Query: 112 IDDDLRQGLKAQAVAVKLL---------DIEGLQGHREWLAEVIFLGQLRHPHLVRLIGY 162
                      +  A++++         DI+ +Q  +    +        HP LV L   
Sbjct: 76  ---------TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA-----SNHPFLVGLH-S 120

Query: 163 CCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA-IGAAKGLAFLHGAENPVI 220
           C + E RL  V E++  G L  H+ ++  +      R   A I  A  L +LH  E  +I
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAEISLA--LNYLH--ERGII 175

Query: 221 YRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTK 280
           YRD K  N+LLDS+   KL+D+G+ K G    +T  T+   GT  Y APE I  G     
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPE-ILRGEDYGF 232

Query: 281 S-DVYSFGVVLLELLTGR 297
           S D ++ GV++ E++ GR
Sbjct: 233 SVDWWALGVLMFEMMAGR 250

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 91.9 bits (229), Expect = 3e-21
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 33/212 (15%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA---EVIFLGQLRHP 154
            LG G FG V  G         L    VAVK+L+ + ++          E+  L   RHP
Sbjct: 18  TLGVGTFGKVKIG------EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71

Query: 155 HLVRLIGY-CCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK----- 207
           H+++L  Y          +V E++  G L +++ K          R++            
Sbjct: 72  HIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKH--------GRVEEMEARRLFQQIL 121

Query: 208 -GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
             + + H   + V++RD K  N+LLD+   AK++DFGL+ M  +G     +    G+  Y
Sbjct: 122 SAVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNY 176

Query: 267 AAPEYIS-TGHLTTKSDVYSFGVVLLELLTGR 297
           AAPE IS   +   + D++S GV+L  LL G 
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 94.7 bits (235), Expect = 4e-21
 Identities = 75/306 (24%), Positives = 107/306 (34%), Gaps = 52/306 (16%)

Query: 7   PSKPWRPFTSKCCSAEGQIIFGNLSRCKTSRSDFSKNIAPMPSFRRLSFSDLSRSSSTRI 66
               W    S+       +                   A +    +      + + S   
Sbjct: 271 GVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFD 330

Query: 67  NEDLAHTFGPDLYDFQLSELRAITQNFSSNYLLGEGGFGTV----HKGYIDDDLRQGLKA 122
           N            DF    L           +LG+G FG V     KG            
Sbjct: 331 NNGNRDRMKLT--DFNF--LM----------VLGKGSFGKVMLSERKG----------TD 366

Query: 123 QAVAVKLL---------DIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL-LV 172
           +  AVK+L         D+E     +  LA        + P L +L   C +  +RL  V
Sbjct: 367 ELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-----KPPFLTQLH-SCFQTMDRLYFV 420

Query: 173 YEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD 232
            E++  G L  H+ +      P       A   A GL FL      +IYRD K  N++LD
Sbjct: 421 MEYVNGGDLMYHIQQVGRFKEPH-AVFYAA-EIAIGLFFLQ--SKGIIYRDLKLDNVMLD 476

Query: 233 SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLL 291
           S+   K++DFG+ K       T  T    GT  Y APE I       KS D ++FGV+L 
Sbjct: 477 SEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLY 533

Query: 292 ELLTGR 297
           E+L G+
Sbjct: 534 EMLAGQ 539

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 92.4 bits (230), Expect = 6e-21
 Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 50/230 (21%)

Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HREWLA 143
           +  FS NY     LG+G F  V +                A K+++ + L     ++   
Sbjct: 24  STKFSDNYDVKEELGKGAFSVVRRC------VHKTTGLEFAAKIINTKKLSARDFQKLER 77

Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           E     +L+HP++VRL     ++E    LV++ +  G  E  LF+ I           +A
Sbjct: 78  EARICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGG--E--LFEDI-----------VA 121

Query: 203 IG------AAK-------GLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAK 246
                   A+         +A+ H   N +++R+ K  N+LL S       KL+DFGLA 
Sbjct: 122 REFYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179

Query: 247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
              +           GT GY +PE +     +   D+++ GV+L  LL G
Sbjct: 180 EVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 90.7 bits (226), Expect = 8e-21
 Identities = 55/232 (23%), Positives = 89/232 (38%), Gaps = 53/232 (22%)

Query: 92  NFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA---- 143
               +Y     LG G F  V K       RQ    +  A K +    L   R  ++    
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKC------RQKGTGKEYAAKFIKKRRLSSSRRGVSREEI 55

Query: 144 --EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKI 201
             EV  L ++RHP+++ L        + +L+ E +  G  E  LF  +            
Sbjct: 56  EREVNILREIRHPNIITLHDIFENKTDVVLILELVSGG--E--LFDFL-----------A 100

Query: 202 AIG------AAK-------GLAFLHGAENPVIYRDFKTSNILLDS----DFTAKLSDFGL 244
                    A +       G+ +LH     + + D K  NI+L      +   KL DFG+
Sbjct: 101 EKESLTEDEATQFLKQILDGVHYLH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158

Query: 245 AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           A     G+       + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 159 AHKIEAGNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 92.0 bits (229), Expect = 9e-21
 Identities = 58/228 (25%), Positives = 85/228 (37%), Gaps = 34/228 (14%)

Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---- 141
              F   Y    ++G+G F  V +             Q  AVK++D+             
Sbjct: 19  DVLFEDVYELCEVIGKGPFSVVRRC------INRETGQQFAVKIVDVAKFTSSPGLSTED 72

Query: 142 -LAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRL 199
              E      L+HPH+V L+      +  L +V+EFM     +  L   I      G   
Sbjct: 73  LKREASICHMLKHPHIVELLET-YSSDGMLYMVFEFMDGA--D--LCFEIVKRADAGFVY 127

Query: 200 --KIAIGAAK----GLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPE 250
              +A    +     L + H  +N +I+RD K   +LL S       KL  FG+A    E
Sbjct: 128 SEAVASHYMRQILEALRYCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE 185

Query: 251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRR 298
                   RV GT  + APE +         DV+  GV+L  LL+G  
Sbjct: 186 SGLV-AGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 31/210 (14%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREW-----LAEVIFLGQL 151
           +GEG +G V K     +   G   + VA+K  L   +      +      + E+  L QL
Sbjct: 33  VGEGSYGMVMKCR---NKDTG---RIVAIKKFLESDD-----DKMVKKIAMREIKLLKQL 81

Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           RH +LV L+  C + +   LV+EF+   ++ + L +     L +    K       G+ F
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLFQIINGIGF 139

Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM--GPEGSNTH-VTTRVMGTYGYAA 268
            H   + +I+RD K  NIL+      KL DFG A+    P       V TR      Y A
Sbjct: 140 CH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRA 192

Query: 269 PEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
           PE +          DV++ G ++ E+  G 
Sbjct: 193 PELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 52/227 (22%), Positives = 91/227 (40%), Gaps = 24/227 (10%)

Query: 82  QLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE- 140
           ++ ++R   ++F    ++G G FG V        ++     +  A+K+L+   +    E 
Sbjct: 65  KVKQMRLHREDFEILKVIGRGAFGEVAV------VKLKNADKVFAMKILNKWEMLKRAET 118

Query: 141 --WLAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFK-RISVSLPWG 196
             +  E   L       +  L  Y  +D+  L LV ++   G L   L K    +     
Sbjct: 119 ACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM- 176

Query: 197 TRLKIA-IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH 255
            R  +A +  A  +  +H  +   ++RD K  NIL+D +   +L+DFG      E     
Sbjct: 177 ARFYLAEMVIA--IDSVH--QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232

Query: 256 VTTRVMGTYGYAAPEYISTGHLTTKS-----DVYSFGVVLLELLTGR 297
            +  V GT  Y +PE +              D +S GV + E+L G 
Sbjct: 233 SSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 55/231 (23%), Positives = 87/231 (37%), Gaps = 30/231 (12%)

Query: 82  QLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE- 140
           +L E+R    +F    ++G G F  V        ++     Q  A+K+++   +    E 
Sbjct: 52  RLKEVRLQRDDFEILKVIGRGAFSEVAV------VKMKQTGQVYAMKIMNKWDMLKRGEV 105

Query: 141 --WLAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFK---RISVSLP 194
             +  E   L       + +L  +  +DE  L LV E+   G L   L K   RI   + 
Sbjct: 106 SCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM- 163

Query: 195 WGTRLKIA-IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN 253
              R  +A I  A  +  +H      ++RD K  NILLD     +L+DFG          
Sbjct: 164 --ARFYLAEIVMA--IDSVH--RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217

Query: 254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVY-------SFGVVLLELLTGR 297
                 V GT  Y +PE +        +  Y       + GV   E+  G+
Sbjct: 218 VRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 91.8 bits (228), Expect = 2e-20
 Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 26/218 (11%)

Query: 96  NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH 155
              +G G +G V+K     D +     +  A+K ++  G+        E+  L +L+HP+
Sbjct: 26  GCKVGRGTYGHVYKA-KRKDGKDD---KDYALKQIEGTGI--SMSACREIALLRELKHPN 79

Query: 156 LVRLIGYCCEDEERL--LVYEFMP---RGSLENH---LFKRISVSLPWGTRLKIAIGAAK 207
           ++ L        +R   L++++        ++ H      +  V LP G    +      
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTA----KLSDFGLAKM--GPEGSNTHVTTRVM 261
           G+ +LH   N V++RD K +NIL+  +       K++D G A++   P      +   V+
Sbjct: 140 GIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197

Query: 262 GTYGYAAPEYI--STGHLTTKSDVYSFGVVLLELLTGR 297
            T+ Y APE +  +  H T   D+++ G +  ELLT  
Sbjct: 198 -TFWYRAPELLLGAR-HYTKAIDIWAIGCIFAELLTSE 233

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 69/322 (21%), Positives = 109/322 (33%), Gaps = 76/322 (23%)

Query: 88  AITQNFSSNY-----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL 142
           + +  F   Y     +LGEG    V       +L      Q  AVK+++ +         
Sbjct: 5   SFSGRFEDVYQLQEDVLGEGAHARVQTCI---NLITS---QEYAVKIIEKQPGHIRSRVF 58

Query: 143 AEVIFLGQLR-HPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLK 200
            EV  L Q + H +++ LI +  E+E+R  LV+E M  GS    +   I           
Sbjct: 59  REVEMLYQCQGHRNVLELIEF-FEEEDRFYLVFEKMRGGS----ILSHI----------- 102

Query: 201 IAIG------AAK-------GLAFLHGAENPVIYRDFKTSNILL---DSDFTAKLSDFGL 244
                     A+         L FLH     + +RD K  NIL    +     K+ DF L
Sbjct: 103 HKRRHFNELEASVVVQDVASALDFLH--NKGIAHRDLKPENILCEHPNQVSPVKICDFDL 160

Query: 245 AK-MGPEGSNTHVTTRVM----GTYGYAAPEYISTGHLTTKS-----DVYSFGVVLLELL 294
              +   G  + ++T  +    G+  Y APE +              D++S GV+L  LL
Sbjct: 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220

Query: 295 TGRRSMDKLRP-KSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKG---------AKE 344
           +G        P                       + +    G+Y             AK+
Sbjct: 221 SGY------PPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKD 274

Query: 345 MAVLALQCISVNPKDRPKMAAV 366
              L  + +  + K R   A V
Sbjct: 275 ---LISKLLVRDAKQRLSAAQV 293

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 55/234 (23%), Positives = 84/234 (35%), Gaps = 53/234 (22%)

Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-- 143
            Q     Y     LG G F  V K       R+       A K +     +  R  +   
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKC------REKSTGLEYAAKFIKKRQSRASRRGVCRE 60

Query: 144 ----EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRL 199
               EV  L Q+ HP+++ L        + +L+ E +  G  E  LF  +          
Sbjct: 61  EIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGG--E--LFDFL---------- 106

Query: 200 KIAIG------AAK-------GLAFLHGAENPVIYRDFKTSNILLDS----DFTAKLSDF 242
                      A         G+ +LH     + + D K  NI+L          KL DF
Sbjct: 107 -AQKESLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163

Query: 243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           GLA    +G        + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 38/227 (16%)

Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVI 146
           R    +++   ++G G FG V++  + D        + VA+K +    LQ  R    E+ 
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDS------GELVAIKKV----LQDKRFKNRELQ 99

Query: 147 FLGQLRHPHLVRLIGYCCEDEERL------LVYEFMPRGSLENHLFKRISVSLPWGTRLK 200
            + +L H ++VRL  +     E+       LV +++P    E  +++           L 
Sbjct: 100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ET-VYRVARHYSRAKQTLP 154

Query: 201 IAIG------AAKGLAFLHGAENPVIYRDFKTSNILLDSD-FTAKLSDFGLAKM-GPEGS 252
           +           + LA++H     + +RD K  N+LLD D    KL DFG AK       
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212

Query: 253 NTH-VTTRVMGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
           N   + +R    Y Y APE I      T+  DV+S G VL ELL G+
Sbjct: 213 NVSYICSR----Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 90.0 bits (224), Expect = 3e-20
 Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 29/211 (13%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-----REWLAEVIFLGQLRH 153
           LG G + TV+KG    +   G     VA+K + ++  +G      RE    +  + +L+H
Sbjct: 13  LGNGTYATVYKGL---NKTTG---VYVALKEVKLDSEEGTPSTAIRE----ISLMKELKH 62

Query: 154 PHLVRLIGYCCEDEERLLVYEFMP---RGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
            ++VRL      + +  LV+EFM    +  +++         L             +GLA
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM--GPEGSNTHVTTRVMGTYGYAA 268
           F H  EN +++RD K  N+L++     KL DFGLA+    P  + +     V+ T  Y A
Sbjct: 123 FCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWYRA 176

Query: 269 PEYI--STGHLTTKSDVYSFGVVLLELLTGR 297
           P+ +  S    +T  D++S G +L E++TG+
Sbjct: 177 PDVLMGSR-TYSTSIDIWSCGCILAEMITGK 206

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 91.2 bits (227), Expect = 4e-20
 Identities = 56/230 (24%), Positives = 89/230 (38%), Gaps = 49/230 (21%)

Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLA- 143
              F+  Y     LG+G F  V +        + L  Q  A  +++ + L     + L  
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRC------VKVLAGQEYAAMIINTKKLSARDHQKLER 59

Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA 202
           E      L+HP++VRL      +E    L+++ +  G  E  LF+ I           +A
Sbjct: 60  EARICRLLKHPNIVRLHDSI-SEEGHHYLIFDLVTGG--E--LFEDI-----------VA 103

Query: 203 IG------AAK-------GLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAK 246
                   A+         +   H  +  V++R+ K  N+LL S       KL+DFGLA 
Sbjct: 104 REYYSEADASHCIQQILEAVLHCH--QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161

Query: 247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
                          GT GY +PE +         D+++ GV+L  LL G
Sbjct: 162 EVEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 89.6 bits (223), Expect = 4e-20
 Identities = 55/224 (24%), Positives = 89/224 (39%), Gaps = 34/224 (15%)

Query: 90  TQNFSSNY-----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HREWL 142
            +NF++ Y      LG G F  V +         G   Q  A K L           E L
Sbjct: 23  MENFNNFYILTSKELGRGKFAVVRQCI---SKSTG---QEYAAKFLKKRRRGQDCRAEIL 76

Query: 143 AEVIFLGQLRH-PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRL-- 199
            E+  L   +  P ++ L        E +L+ E+   G  E  +F    +       +  
Sbjct: 77  HEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG--E--IFSLC-LPELAE-MVSE 130

Query: 200 KIAIGAAK----GLAFLHGAENPVIYRDFKTSNILL---DSDFTAKLSDFGLAKMGPEGS 252
              I   K    G+ +LH  +N +++ D K  NILL         K+ DFG+++      
Sbjct: 131 NDVIRLIKQILEGVYYLH--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188

Query: 253 NTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
                  +MGT  Y APE ++   +TT +D+++ G++   LLT 
Sbjct: 189 ELRE---IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 90.0 bits (224), Expect = 4e-20
 Identities = 63/232 (27%), Positives = 95/232 (40%), Gaps = 42/232 (18%)

Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHREWLAE 144
           R     F    + G+G FGTV  G    +   G    +VA+K  + D      +RE L  
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGK---EKSTG---MSVAIKKVIQDPR--FRNRE-LQI 69

Query: 145 VIFLGQLRHPHLVRLI------GYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGT 197
           +  L  L HP++V+L       G     +  L +V E++P    +  L +          
Sbjct: 70  MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DT-LHRCCRNYYRRQV 124

Query: 198 RLKIA--------IGAAKGLAFLHGAENPVIYRDFKTSNILLD-SDFTAKLSDFGLAKM- 247
                        +   + +  LH     V +RD K  N+L++ +D T KL DFG AK  
Sbjct: 125 APPPILIKVFLFQL--IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 248 GPEGSNTH-VTTRVMGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
            P   N   + +R    Y Y APE I    H TT  D++S G +  E++ G 
Sbjct: 183 SPSEPNVAYICSR----Y-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 90.5 bits (225), Expect = 4e-20
 Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 23/225 (10%)

Query: 82  QLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE- 140
           ++ +LR   +++    ++G G FG V        +R     +  A+KLL    +    + 
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQL------VRHKSTRKVYAMKLLSKFEMIKRSDS 113

Query: 141 --WLAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGT 197
             +  E   +     P +V+L  Y  +D+  L +V E+MP G L N +     V   W  
Sbjct: 114 AFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKW-A 170

Query: 198 RLKIA-IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV 256
           R   A +  A  L  +H      I+RD K  N+LLD     KL+DFG      +      
Sbjct: 171 RFYTAEVVLA--LDAIH--SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226

Query: 257 TTRVMGTYGYAAPEYISTGHLT---TKS-DVYSFGVVLLELLTGR 297
            T V GT  Y +PE + +        +  D +S GV L E+L G 
Sbjct: 227 DTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 89.2 bits (222), Expect = 5e-20
 Identities = 55/234 (23%), Positives = 86/234 (36%), Gaps = 53/234 (22%)

Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-- 143
            Q     Y     LG G F  V K     +   GL+    A K +     +  R  ++  
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKC---REKSTGLE---YAAKFIKKRQSRASRRGVSRE 60

Query: 144 ----EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRL 199
               EV  L Q+ H +++ L        + +L+ E +  G  E  LF  +          
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGG--E--LFDFL---------- 106

Query: 200 KIAIG------AAK-------GLAFLHGAENPVIYRDFKTSNILLDS----DFTAKLSDF 242
                      A         G+ +LH     + + D K  NI+L          KL DF
Sbjct: 107 -AQKESLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163

Query: 243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           GLA    +G        + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 89.7 bits (223), Expect = 5e-20
 Identities = 56/228 (24%), Positives = 93/228 (40%), Gaps = 50/228 (21%)

Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEV 145
               S  +     LG G    V++       ++    + +  K +D + ++       E+
Sbjct: 48  RDALSDFFEVESELGRGATSIVYRC-KQKGTQKPYALKVLK-KTVDKKIVR------TEI 99

Query: 146 IFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIG 204
             L +L HP++++L     E    + LV E +  G L    F RI           +  G
Sbjct: 100 GVLLRLSHPNIIKLKEIF-ETPTEISLVLELVTGGEL----FDRI-----------VEKG 143

Query: 205 ------AAK-------GLAFLHGAENPVIYRDFKTSNILL---DSDFTAKLSDFGLAKMG 248
                 AA         +A+LH  EN +++RD K  N+L      D   K++DFGL+K+ 
Sbjct: 144 YYSERDAADAVKQILEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201

Query: 249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
                  +   V GT GY APE +       + D++S G++   LL G
Sbjct: 202 EHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 89.2 bits (222), Expect = 5e-20
 Identities = 54/235 (22%), Positives = 90/235 (38%), Gaps = 55/235 (23%)

Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-- 143
            +N    Y     LG G F  V K       R+       A K +     +  R  ++  
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKC------REKSTGLQYAAKFIKKRRTKSSRRGVSRE 59

Query: 144 ----EVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTR 198
               EV  L +++HP+++ L     E++  + L+ E +  G  E  LF  +         
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVY-ENKTDVILILELVAGG--E--LFDFL--------- 105

Query: 199 LKIAIG------AAK-------GLAFLHGAENPVIYRDFKTSNILLDS----DFTAKLSD 241
                       A +       G+ +LH     + + D K  NI+L          K+ D
Sbjct: 106 --AEKESLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIID 161

Query: 242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           FGLA     G+       + GT  + APE ++   L  ++D++S GV+   LL+G
Sbjct: 162 FGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 89.3 bits (222), Expect = 5e-20
 Identities = 52/235 (22%), Positives = 86/235 (36%), Gaps = 51/235 (21%)

Query: 84  SELRAITQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR 139
            +L   +  F+  Y     +G G +    +                AVK++D        
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCI---HKATN---MEFAVKIIDKSKRDPTE 64

Query: 140 EWLAEVIFLGQLRHPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTR 198
           E     I L   +HP+++ L     +D + + +V E M  G     L  +I         
Sbjct: 65  E---IEILLRYGQHPNIITLKDV-YDDGKYVYVVTELMKGGE----LLDKI--------- 107

Query: 199 LKIAIG------AAK-------GLAFLHGAENPVIYRDFKTSNILLDSD----FTAKLSD 241
             +         A+         + +LH     V++RD K SNIL   +     + ++ D
Sbjct: 108 --LRQKFFSEREASAVLFTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICD 163

Query: 242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           FG AK      N  + T    T  + APE +         D++S GV+L  +LTG
Sbjct: 164 FGFAKQL-RAENGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 33/212 (15%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA---EVIFLGQLRHP 154
            LG G FG V  G      +  L    VAVK+L+ + ++          E+  L   RHP
Sbjct: 23  TLGVGTFGKVKVG------KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76

Query: 155 HLVRLIGY-CCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK----- 207
           H+++L  Y        + +V E++  G L +++ K          RL             
Sbjct: 77  HIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKN--------GRLDEKESRRLFQQIL 126

Query: 208 -GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
            G+ + H   + V++RD K  N+LLD+   AK++DFGL+ M  +G     T+   G+  Y
Sbjct: 127 SGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR-TS--CGSPNY 181

Query: 267 AAPEYIS-TGHLTTKSDVYSFGVVLLELLTGR 297
           AAPE IS   +   + D++S GV+L  LL G 
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 41/216 (18%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG V +  + +          VA+K +    LQ  R    E+  +  ++HP++V 
Sbjct: 48  IGNGSFGVVFQAKLVES-------DEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVD 96

Query: 159 LIGY-----CCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIG------AA 206
           L  +       +DE  L LV E++P    E  +++           + + +         
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVP----ET-VYRASRHYAKLKQTMPMLLIKLYMYQLL 151

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSD-FTAKLSDFGLAKM-GPEGSNTH-VTTRVMGT 263
           + LA++H     + +RD K  N+LLD      KL DFG AK+      N   + +R    
Sbjct: 152 RSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR---- 205

Query: 264 YGYAAPEYI--STGHLTTKSDVYSFGVVLLELLTGR 297
           Y Y APE I  +T + TT  D++S G V+ EL+ G+
Sbjct: 206 Y-YRAPELIFGAT-NYTTNIDIWSTGCVMAELMQGQ 239

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 57/232 (24%), Positives = 91/232 (39%), Gaps = 54/232 (23%)

Query: 90  TQNFSSNY-------LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL 142
              F  +Y        LGEG F    K       +     QA AVK++        ++  
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCV---HKKSN---QAFAVKIISKRMEANTQK-- 54

Query: 143 AEVIFLGQLR-HPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLK 200
            E+  L     HP++V+L      D+    LV E +  G     LF+RI           
Sbjct: 55  -EITALKLCEGHPNIVKLHEV-FHDQLHTFLVMELLNGGE----LFERI----------- 97

Query: 201 IAIG------AAK-------GLAFLHGAENPVIYRDFKTSNILL---DSDFTAKLSDFGL 244
                     A+         ++ +H  +  V++RD K  N+L    + +   K+ DFG 
Sbjct: 98  KKKKHFSETEASYIMRKLVSAVSHMH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGF 155

Query: 245 AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           A++ P   N  + T    T  YAAPE ++        D++S GV+L  +L+G
Sbjct: 156 ARLKPPD-NQPLKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 58/266 (21%), Positives = 101/266 (37%), Gaps = 41/266 (15%)

Query: 53  LSFSDLSRSSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNY----LLGEGGFGTVH 108
           +  S      S+ +    +H    +             +   S Y    LLG GGFG+V+
Sbjct: 1   MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVY 60

Query: 109 KGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA------EVIFLGQLRH--PHLVRLI 160
            G     +   L    VA+K ++ + +    E         EV+ L ++      ++RL+
Sbjct: 61  SGI---RVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114

Query: 161 GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRL------KIAIGAAKGLAFLHG 214
            +    +  +L+ E  P    +  LF  I+        L             + +   H 
Sbjct: 115 DWFERPDSFVLILER-PEPVQD--LFDFITER----GALQEELARSFFWQVLEAVRHCH- 166

Query: 215 AENPVIYRDFKTSNILLDSD-FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS 273
               V++RD K  NIL+D +    KL DFG   +  +      T    GT  Y+ PE+I 
Sbjct: 167 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFD-GTRVYSPPEWIR 221

Query: 274 TGHL--TTKSDVYSFGVVLLELLTGR 297
             H      + V+S G++L +++ G 
Sbjct: 222 -YHRYHGRSAAVWSLGILLYDMVCGD 246

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 87.2 bits (217), Expect = 3e-19
 Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 36/214 (16%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-----WLAEVIFLGQLRH 153
           LGEG F TV+K     D       Q VA+K + +      ++      L E+  L +L H
Sbjct: 18  LGEGQFATVYKAR---DKNTN---QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71

Query: 154 PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
           P+++ L+          LV++FM    LE  + K  S+ L         +   +GL +LH
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFMET-DLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129

Query: 214 GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM--GPEGSNTH-VTTRVMGTYGYAAPE 270
             ++ +++RD K +N+LLD +   KL+DFGLAK    P  + TH V TR      Y APE
Sbjct: 130 --QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-----WYRAPE 182

Query: 271 -------YISTGHLTTKSDVYSFGVVLLELLTGR 297
                  Y          D+++ G +L ELL   
Sbjct: 183 LLFGARMY------GVGVDMWAVGCILAELLLRV 210

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 86.0 bits (214), Expect = 4e-19
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 31/211 (14%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHRE-----WLAEVIFLGQL 151
           +GEG +GTV K     +       + VA+K   LD +      E      L E+  L +L
Sbjct: 10  IGEGTYGTVFKAK---NRETH---EIVALKRVRLDDD-----DEGVPSSALREICLLKEL 58

Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +H ++VRL      D++  LV+EF  +  L+   F   +  L             KGL F
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLK-KYFDSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM--GPEGSNTHVTTRVMGTYGYAAP 269
            H     V++RD K  N+L++ +   KL++FGLA+    P    +     V+ T  Y  P
Sbjct: 117 CH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRPP 170

Query: 270 EYI--STGHLTTKSDVYSFGVVLLELLTGRR 298
           + +  +    +T  D++S G +  EL    R
Sbjct: 171 DVLFGAK-LYSTSIDMWSAGCIFAELANAGR 200

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 86.6 bits (215), Expect = 6e-19
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 34/212 (16%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA---EVIFLGQLRHP 154
            LGEG FG V               Q VA+K +  + L+     +    E+ +L  LRHP
Sbjct: 16  TLGEGSFGKVKLA------THYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 155 HLVRLIGY-CCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK----- 207
           H+++L  Y        + +V E+   G L +++ ++         R+    G        
Sbjct: 70  HIIKL--YDVITTPTDIVMVIEYAG-GELFDYIVEK--------KRMTEDEGRRFFQQII 118

Query: 208 -GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
             + + H   + +++RD K  N+LLD +   K++DFGL+ +  +G+    T+   G+  Y
Sbjct: 119 CAIEYCH--RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK-TS--CGSPNY 173

Query: 267 AAPEYIS-TGHLTTKSDVYSFGVVLLELLTGR 297
           AAPE I+   +   + DV+S G+VL  +L GR
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 86.3 bits (214), Expect = 7e-19
 Identities = 53/214 (24%), Positives = 77/214 (35%), Gaps = 39/214 (18%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHP 154
            +G G FG         D       + VAVK ++          RE    +I    LRHP
Sbjct: 27  DIGSGNFGVARLMR---DKLTK---ELVAVKYIERGAAIDENVQRE----IINHRSLRHP 76

Query: 155 HLVRLIGY-CCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK----- 207
           ++VR            L ++ E+   G L   +            R              
Sbjct: 77  NIVRF--KEVILTPTHLAIIMEYASGGELYERICNA--------GRFSEDEARFFFQQLL 126

Query: 208 -GLAFLHGAENPVIYRDFKTSNILLDSDFTA--KLSDFGLAKMGPEGSNTHVTTRVMGTY 264
            G+++ H     + +RD K  N LLD       K+ DFG +K     S     + V GT 
Sbjct: 127 SGVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTP 181

Query: 265 GYAAPEYIS-TGHLTTKSDVYSFGVVLLELLTGR 297
            Y APE +    +    +DV+S GV L  +L G 
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 59/236 (25%), Positives = 87/236 (36%), Gaps = 62/236 (26%)

Query: 90  TQNFSSNY-----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAE 144
               + +Y     +LG G  G V + +     R G   Q  A+KLL             E
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECF---HRRTG---QKCALKLLYDSPKARQ-----E 71

Query: 145 V-IFLGQLRHPHLVRLIGYCCEDEER-----LLVYEFMPRGSLENHLFKRISVSLPWGTR 198
           V         PH+V ++    E+        L++ E M  G L    F RI         
Sbjct: 72  VDHHWQASGGPHIVCILDVY-ENMHHGKRCLLIIMECMEGGEL----FSRI--------- 117

Query: 199 LKIAIG--------AAK-------GLAFLHGAENPVIYRDFKTSNILL---DSDFTAKLS 240
                G        AA+        + FLH   + + +RD K  N+L    + D   KL+
Sbjct: 118 --QERGDQAFTEREAAEIMRDIGTAIQFLH--SHNIAHRDVKPENLLYTSKEKDAVLKLT 173

Query: 241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           DFG AK   + +   + T    T  Y APE +         D++S GV++  LL G
Sbjct: 174 DFGFAKETTQNA---LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 48/218 (22%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-----REWLAEVIFLGQLRH 153
           LGEG + TV+KG      +  L    VA+K + +E  +G      RE    V  L  L+H
Sbjct: 10  LGEGTYATVYKG------KSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKH 59

Query: 154 PHLVRLIGYCCEDEERLLVYEFM----------PRGSLENHLFKRISVSLPWGTRLKIAI 203
            ++V L      ++   LV+E++              +  H  K     L          
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLL--------- 110

Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM--GPEGSNTHVTTRVM 261
              +GLA+ H     V++RD K  N+L++     KL+DFGLA+    P  +  +    V+
Sbjct: 111 ---RGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV 162

Query: 262 GTYGYAAPEYI--STGHLTTKSDVYSFGVVLLELLTGR 297
            T  Y  P+ +  ST   +T+ D++  G +  E+ TGR
Sbjct: 163 -TLWYRPPDILLGST-DYSTQIDMWGVGCIFYEMATGR 198

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 84.1 bits (209), Expect = 2e-18
 Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 34/211 (16%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHRE-----WLAEVIFLGQL 151
           +GEG +G V+K   D    QG   + VA+K   LD E      E      + E+  L +L
Sbjct: 29  VGEGTYGVVYKA-KD---SQG---RIVALKRIRLDAE-----DEGIPSTAIREISLLKEL 76

Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
            HP++V LI     +    LV+EFM +  L+  L       L             +G+A 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL-DENKTGLQDSQIKIYLYQLLRGVAH 134

Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM--GPEGSNTH-VTTRVMGTYGYAA 268
            H  ++ +++RD K  N+L++SD   KL+DFGLA+    P  S TH V T       Y A
Sbjct: 135 CH--QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL-----WYRA 187

Query: 269 PEYI--STGHLTTKSDVYSFGVVLLELLTGR 297
           P+ +  S    +T  D++S G +  E++TG+
Sbjct: 188 PDVLMGSK-KYSTSVDIWSIGCIFAEMITGK 217

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 83.6 bits (207), Expect = 3e-18
 Identities = 33/204 (16%), Positives = 58/204 (28%), Gaps = 44/204 (21%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHP 154
             G        +   D  L +      VA+  +D +G+      +E L+  + L ++  P
Sbjct: 38  FHGGVPPLQFWQAL-DTALDR-----QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKP 91

Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            + R++         L+V E++  GSL+       S   P G  ++     A      H 
Sbjct: 92  GVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPS---PVGA-IRAMQSLAAAADAAH- 146

Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
               V       S + +  D    L+                                  
Sbjct: 147 -RAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA---- 179

Query: 275 GHLTTKSDVYSFGVVLLELLTGRR 298
                + D+   G  L  LL  R 
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRW 200

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 83.3 bits (207), Expect = 4e-18
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 34/211 (16%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHRE-----WLAEVIFLGQL 151
           +GEG +G V+K   +     G   +  A+K   L+ E      E      + E+  L +L
Sbjct: 10  IGEGTYGVVYKA-QN---NYG---ETFALKKIRLEKE-----DEGIPSTTIREISILKEL 57

Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +H ++V+L       +  +LV+E + +  L+  L       L   T     +    G+A+
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLK-KLLDVCEGGLESVTAKSFLLQLLNGIAY 115

Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM--GPEGSNTH-VTTRVMGTYGYAA 268
            H  +  V++RD K  N+L++ +   K++DFGLA+    P    TH + T       Y A
Sbjct: 116 CH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL-----WYRA 168

Query: 269 PEYI--STGHLTTKSDVYSFGVVLLELLTGR 297
           P+ +  S    +T  D++S G +  E++ G 
Sbjct: 169 PDVLMGSK-KYSTTIDIWSVGCIFAEMVNGT 198

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 84.2 bits (208), Expect = 4e-18
 Identities = 51/181 (28%), Positives = 72/181 (39%), Gaps = 27/181 (14%)

Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT 258
           +  +   AKG+ FL  A    I+RD    NILL      K+ DFGLA+   +  +     
Sbjct: 196 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253

Query: 259 RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP----KSEQNLVD 313
                  + APE I     T +SDV+SFGV+L E+ + G        P    K ++    
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA------SPYPGVKIDEEFCR 307

Query: 314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
                L+   R+R    P            EM    L C    P  RP  + +V  L +L
Sbjct: 308 ----RLKEGTRMR---APDYT-------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

Query: 374 L 374
           L
Sbjct: 354 L 354

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 25/93 (26%), Positives = 44/93 (47%), Gaps = 4/93 (4%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQL-RHPHL 156
           LG G FG V +      + +    + VAVK+L +      HR  ++E+  L  +  H ++
Sbjct: 30  LGRGAFGQVIEADAFG-IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88

Query: 157 VRLIGYCC-EDEERLLVYEFMPRGSLENHLFKR 188
           V L+G C       +++ EF   G+L  +L  +
Sbjct: 89  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 82.6 bits (205), Expect = 8e-18
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 27/213 (12%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW-----LAEVIFLGQLR- 152
           +G G +GTV+K     D   G     VA+K + +    G         + EV  L +L  
Sbjct: 17  IGVGAYGTVYKAR---DPHSG---HFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70

Query: 153 --HPHLVRLI----GYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
             HP++VRL+        + E ++ LV+E + +  L  +L K     LP  T   +    
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQF 129

Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM-GPEGSNTHVTTRVMGTY 264
            +GL FLH   N +++RD K  NIL+ S  T KL+DFGLA++   + + T     V+ T 
Sbjct: 130 LRGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP---VVV-TL 183

Query: 265 GYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
            Y APE +      T  D++S G +  E+   +
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 62/230 (26%), Positives = 94/230 (40%), Gaps = 43/230 (18%)

Query: 91  QNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA--- 143
           + F + Y    LLG+GGFGTV  G+    L   L+   VA+K++    + G         
Sbjct: 27  EAFEAEYRLGPLLGKGGFGTVFAGH---RLTDRLQ---VAIKVIPRNRVLGWSPLSDSVT 80

Query: 144 ---EVIFLGQLR----HPHLVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPW 195
              EV  L ++     HP ++RL+ +  E +E   LV E          LF  I+     
Sbjct: 81  CPLEVALLWKVGAGGGHPGVIRLLDWF-ETQEGFMLVLERPLPA---QDLFDYITEK--- 133

Query: 196 GTRL------KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD-FTAKLSDFGLAKMG 248
              L               +   H     V++RD K  NIL+D     AKL DFG   + 
Sbjct: 134 -GPLGEGPSRCFFGQVVAAIQHCH--SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190

Query: 249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLT-TKSDVYSFGVVLLELLTGR 297
            +      T    GT  Y+ PE+IS        + V+S G++L +++ G 
Sbjct: 191 HDE---PYTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 82.2 bits (203), Expect = 3e-17
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 36/223 (16%)

Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL------DIEGLQGHREWL 142
           + + + +   +G G  G V   Y   D       + VA+K L           + +RE  
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAY---DAVLD---RNVAIKKLSRPFQNQTHAKRAYRE-- 111

Query: 143 AEVIFLGQLRHPHLVRLI------GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG 196
             ++ +  + H +++ L+          E ++  LV E M     + +L + I + L   
Sbjct: 112 --LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHE 164

Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNT- 254
               +      G+  LH A   +I+RD K SNI++ SD T K+ DFGLA   G     T 
Sbjct: 165 RMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 222

Query: 255 HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           +V TR      Y APE I         D++S G ++ E++  +
Sbjct: 223 YVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 53/224 (23%), Positives = 85/224 (37%), Gaps = 55/224 (24%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHRE-----WLAEVIFLGQL 151
           LGEG +G V+K     D       + VA+K   L+ E      E      + EV  L +L
Sbjct: 42  LGEGTYGEVYKAI---DTVTN---ETVAIKRIRLEHE-----EEGVPGTAIREVSLLKEL 90

Query: 152 RHPHLVRLIGYCCEDEERLLVYEFM---------PRGSLENHLFKRISVSLPWGTRLKIA 202
           +H +++ L      +    L++E+              +   + K     L         
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQL--------- 141

Query: 203 IGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-----KLSDFGLAKM--GPEGSNTH 255
                G+ F H      ++RD K  N+LL     +     K+ DFGLA+    P    TH
Sbjct: 142 ---INGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196

Query: 256 VTTRVMGTYGYAAPEYI--STGHLTTKSDVYSFGVVLLELLTGR 297
               ++ T  Y  PE +  S  H +T  D++S   +  E+L   
Sbjct: 197 ---EII-TLWYRPPEILLGSR-HYSTSVDIWSIACIWAEMLMKT 235

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 58/234 (24%), Positives = 89/234 (38%), Gaps = 67/234 (28%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHRE-----WLAEVIFLGQL 151
           +G+G FG V K       + G   Q VA+K  L++ E     +E      L E+  L  L
Sbjct: 25  IGQGTFGEVFKA---RHRKTG---QKVALKKVLMENE-----KEGFPITALREIKILQLL 73

Query: 152 RHPHLVRLIGYCCEDEERL--------LVYEFM----------PRGSLENHLFKRISVSL 193
           +H ++V LI  C               LV++F                     KR+   L
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 133

Query: 194 PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK---MGPE 250
                         GL ++H   N +++RD K +N+L+  D   KL+DFGLA+   +   
Sbjct: 134 ------------LNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179

Query: 251 GSNTHVTTRVMGTYGYAAPE-------YISTGHLTTKSDVYSFGVVLLELLTGR 297
                 T RV+ T  Y  PE       Y          D++  G ++ E+ T  
Sbjct: 180 SQPNRYTNRVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 62/226 (27%), Positives = 94/226 (41%), Gaps = 55/226 (24%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVK--LLDIEGLQGHRE-----WLAEVIFLGQL 151
           +GEG +G V K     DL+ G   + VA+K   +         E      + EV  L  L
Sbjct: 19  IGEGAYGKVFKAR---DLKNG--GRFVALKRVRVQTG-----EEGMPLSTIREVAVLRHL 68

Query: 152 R---HPHLVRLI----GYCCEDEERL-LVYEFM-----------PRGSLENHLFKRISVS 192
               HP++VRL         + E +L LV+E +           P   +     K +   
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128

Query: 193 LPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM-GPEG 251
           L             +GL FLH   + V++RD K  NIL+ S    KL+DFGLA++   + 
Sbjct: 129 L------------LRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174

Query: 252 SNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           + T     V+ T  Y APE +      T  D++S G +  E+   +
Sbjct: 175 ALTS---VVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 27/218 (12%)

Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK-LLDIEGLQGH-REWLAEVI 146
           + + + S   +G G +G+V       D R G   + VA+K L      +   +    E++
Sbjct: 22  LPKTYVSPTHVGSGAYGSVCSAI---DKRSG---EKVAIKKLSRPFQSEIFAKRAYRELL 75

Query: 147 FLGQLRHPHLVRLI------GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK 200
            L  ++H +++ L+             +  LV  FM     +  L K + +         
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQY 130

Query: 201 IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRV 260
           +     KGL ++H A   V++RD K  N+ ++ D   K+ DFGLA+        +V TR 
Sbjct: 131 LVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR- 187

Query: 261 MGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
              + Y APE I S  H     D++S G ++ E+LTG+
Sbjct: 188 ---W-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 77.8 bits (192), Expect = 7e-16
 Identities = 57/236 (24%), Positives = 91/236 (38%), Gaps = 61/236 (25%)

Query: 90  TQNFSSNY-----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLA 143
                 +Y     +LG G  G V + +   + R     +  A+K+L D    +  RE   
Sbjct: 56  KNAIIDDYKVTSQVLGLGINGKVLQIF---NKRTQ---EKFALKMLQDCPKAR--RE--- 104

Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEER-----LLVYEFMPRGSLENHLFKRISVSLPWGTR 198
             +     + PH+VR++    E+        L+V E +  G L    F RI         
Sbjct: 105 VELHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGEL----FSRI--------- 150

Query: 199 LKIAIG--------AA-------KGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLS 240
                G        A+       + + +LH     + +RD K  N+L  S   +   KL+
Sbjct: 151 --QDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLT 206

Query: 241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           DFG AK     ++  +TT    T  Y APE +         D++S GV++  LL G
Sbjct: 207 DFGFAKETTSHNS--LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 77.5 bits (191), Expect = 9e-16
 Identities = 54/259 (20%), Positives = 100/259 (38%), Gaps = 74/259 (28%)

Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFL 148
            ++ +S    LG G FG V + +   D+  G   +  A+K +  +    +RE    +  +
Sbjct: 5   SSKKYSLGKTLGTGSFGIVCEVF---DIESG---KRFALKKVLQDPRYKNRE----LDIM 54

Query: 149 GQLRHPHLVRLIGY-------------------------------------CCEDEERL- 170
             L H ++++L+ Y                                          + L 
Sbjct: 55  KVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114

Query: 171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIA--------IGAAKGLAFLHGAENPVIYR 222
           ++ E++P    +  L K +   +  G  + +         +   + + F+H     + +R
Sbjct: 115 VIMEYVP----DT-LHKVLKSFIRSGRSIPMNLISIYIYQL--FRAVGFIHSLG--ICHR 165

Query: 223 DFKTSNILLDS-DFTAKLSDFGLAKM-GPEGSNTH-VTTRVMGTYGYAAPEYI-STGHLT 278
           D K  N+L++S D T KL DFG AK   P   +   + +R    + Y APE +      T
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEYT 220

Query: 279 TKSDVYSFGVVLLELLTGR 297
              D++S G V  EL+ G+
Sbjct: 221 PSIDLWSIGCVFGELILGK 239

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 28/219 (12%)

Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK-LLDIEGLQGH-REWLAEVI 146
           + + + +   +G G  G V   Y   D       + VA+K L      Q H +    E++
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAY---DAILE---RNVAIKKLSRPFQNQTHAKRAYRELV 76

Query: 147 FLGQLRHPHLVRLI-----GYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLK 200
            +  + H +++ L+         E+ + + +V E M     + +L + I + L       
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSY 131

Query: 201 IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA-KMGPEGSNT-HVTT 258
           +      G+  LH A   +I+RD K SNI++ SD T K+ DFGLA   G     T +V T
Sbjct: 132 LLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 189

Query: 259 RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
           R      Y APE I         D++S G ++ E++ G 
Sbjct: 190 RY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 54/251 (21%), Positives = 84/251 (33%), Gaps = 59/251 (23%)

Query: 80  DFQLSELRAITQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL 135
           +  + +L A      S Y     +  G +G V  G +D       +   VA+K +     
Sbjct: 7   EAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAG-VDS------EGIPVAIKRVFNTVS 59

Query: 136 QGHREW-----------LAEVIFLGQLRHPHLVRLI-----GYCCEDEERLLVYEFM--- 176
            G               L E+  L    HP+++ L             +  LV E M   
Sbjct: 60  DGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD 119

Query: 177 -------PRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNI 229
                   R  +     +     +              GL  LH A   V++RD    NI
Sbjct: 120 LAQVIHDQRIVISPQHIQYFMYHI------------LLGLHVLHEAG--VVHRDLHPGNI 165

Query: 230 LLDSDFTAKLSDFGLAKMGPEGSNT--HVTTRVMGTYGYAAPEYI-STGHLTTKSDVYSF 286
           LL  +    + DF LA+     +N   +VT R      Y APE +      T   D++S 
Sbjct: 166 LLADNNDITICDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSA 220

Query: 287 GVVLLELLTGR 297
           G V+ E+   +
Sbjct: 221 GCVMAEMFNRK 231

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 53/236 (22%), Positives = 95/236 (40%), Gaps = 58/236 (24%)

Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD-----IEGLQGHREWLA 143
           +   +++   +GEG +G V   Y   D         VA+K +          +  RE   
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAY---DNLNK---VRVAIKKISPFEHQTYCQRTLRE--- 75

Query: 144 EVIFLGQLRHPHLVRLI-----GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR 198
            +  L + RH +++ +          + ++  +V + M                    T 
Sbjct: 76  -IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-------------------ETD 115

Query: 199 LKIAIGAA---------------KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFG 243
           L   +                  +GL ++H A   V++RD K SN+LL++    K+ DFG
Sbjct: 116 LYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFG 173

Query: 244 LAK-MGPEGSNTHVTTRVMGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
           LA+   P+  +T   T  + T  Y APE + ++   T   D++S G +L E+L+ R
Sbjct: 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 54/234 (23%), Positives = 96/234 (41%), Gaps = 45/234 (19%)

Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFL 148
           +   +     LG GG G V       D       + VA+K + +   Q  +  L E+  +
Sbjct: 9   LGSRYMDLKPLGCGGNGLVFSAV---DNDCD---KRVAIKKIVLTDPQSVKHALREIKII 62

Query: 149 GQLRHPHLVRLI--------------GYCCEDEERLLVYEFMP--------RGSLENHLF 186
            +L H ++V++               G   E     +V E+M         +G L     
Sbjct: 63  RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA 122

Query: 187 KRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS-DFTAKLSDFGLA 245
           +     L             +GL ++H A   V++RD K +N+ +++ D   K+ DFGLA
Sbjct: 123 RLFMYQL------------LRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLA 168

Query: 246 K-MGPEGSNTHVTTRVMGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
           + M P  S+    +  + T  Y +P  + S  + T   D+++ G +  E+LTG+
Sbjct: 169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 58/235 (24%), Positives = 94/235 (40%), Gaps = 49/235 (20%)

Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDI-EGLQGHREWLAEVIF 147
           I+ +F    LLGEG +G V           G   + VA+K ++  +        L E+  
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSAT---HKPTG---EIVAIKKIEPFDKPLFALRTLREIKI 62

Query: 148 LGQLRHPHLVRLI-----GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK-- 200
           L   +H +++ +             E  ++ E M     +  L + IS        L   
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVIS-----TQMLSDD 112

Query: 201 ----IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT-- 254
                     + +  LHG+   VI+RD K SN+L++S+   K+ DFGLA++  E +    
Sbjct: 113 HIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170

Query: 255 -----------HVTTRVMGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
                       V TR      Y APE + ++   +   DV+S G +L EL   R
Sbjct: 171 EPTGQQSGMVEFVATR-----WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 8/92 (8%)

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           KGL ++H A   +I+RD K  N+ ++ D   K+ DFGLA+        +V TR      Y
Sbjct: 139 KGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----Y 191

Query: 267 AAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
            APE I +    T   D++S G ++ E++TG+
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 50/246 (20%), Positives = 95/246 (38%), Gaps = 31/246 (12%)

Query: 62  SSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNYLL----GEGGFGTVHKGYIDDDLR 117
           S  R+  D+      + +D+   E   +      +Y L    G G +  V +     ++ 
Sbjct: 6   SRARVYTDVNTHRPREYWDY---ESHVVEWGNQDDYQLVRKLGRGKYSEVFEAI---NIT 59

Query: 118 QGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-HPHLVRLIGYCCEDEERLLVYEFM 176
                + V VK+L        ++   E+  L  LR  P+++ L     +   R     F 
Sbjct: 60  NN---EKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113

Query: 177 PRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT 236
               + N  FK++  +L             K L + H     +++RD K  N+++D +  
Sbjct: 114 H---VNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHR 168

Query: 237 A-KLSDFGLAKMGPEGS--NTHVTTRVMGTYGYAAPEYISTGHLTTKS-DVYSFGVVLLE 292
             +L D+GLA+    G   N  V +R      +  PE +    +   S D++S G +L  
Sbjct: 169 KLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPELLVDYQMYDYSLDMWSLGCMLAS 223

Query: 293 LLTGRR 298
           ++  + 
Sbjct: 224 MIFRKE 229

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 71.2 bits (175), Expect = 9e-14
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 8/92 (8%)

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +GL ++H A+  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----Y 195

Query: 267 AAPEYI-STGHLTTKSDVYSFGVVLLELLTGR 297
            APE + +  H     D++S G ++ ELLTGR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 43/236 (18%), Positives = 81/236 (34%), Gaps = 65/236 (27%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR----- 152
            LG G F TV       D+        VA+K++             E+  L ++      
Sbjct: 26  KLGWGHFSTVWLAK---DMVNN---THVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNT 78

Query: 153 ------HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHL-------------------FK 187
                   H+++L+ +            F  +G    H+                    +
Sbjct: 79  KEDSMGANHILKLLDH------------FNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 126

Query: 188 RISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD------SDFTAKLSD 241
            I +      + +I+     GL ++H     +I+ D K  N+L++      +    K++D
Sbjct: 127 GIPLIY---VK-QISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIAD 181

Query: 242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
            G A    E     + TR      Y +PE +        +D++S   ++ EL+TG 
Sbjct: 182 LGNACWYDEHYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 66.3 bits (162), Expect = 4e-12
 Identities = 58/264 (21%), Positives = 92/264 (34%), Gaps = 89/264 (33%)

Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK-LLDIEGLQGHREWLA---- 143
           +  N+   +L+G G +G V+  Y   D       + VA+K +  +               
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAY---DKNTE---KNVAIKKVNRMF----EDLIDCKRIL 73

Query: 144 -EVIFLGQLRHPHLVRLI-----GYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGT 197
            E+  L +L+  +++RL          + +E  +V E                      +
Sbjct: 74  REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-------------------DS 114

Query: 198 RLKIAIGAA----------------KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD 241
            LK                       G  F+H +   +I+RD K +N LL+ D + K+ D
Sbjct: 115 DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCD 172

Query: 242 FGLAKMGPEGSNT-------------------------HVTTRVMGTYGYAAPEYISTGH 276
           FGLA+      +T                         HV TR      Y APE I    
Sbjct: 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQE 227

Query: 277 LTTKS-DVYSFGVVLLELLTGRRS 299
             TKS D++S G +  ELL   +S
Sbjct: 228 NYTKSIDIWSTGCIFAELLNMLQS 251

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 65.1 bits (159), Expect = 6e-12
 Identities = 49/215 (22%), Positives = 80/215 (37%), Gaps = 33/215 (15%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKL--LDIEGLQGHREWLAEVIFLGQLRHPHL 156
           +GEG FG + +G    +L      Q VA+K      +  Q   E+    +  G      +
Sbjct: 18  IGEGSFGVIFEGT---NLLNN---QQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---TGI 68

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
             +  +  E    +LV + +   SLE  L           T    A      +  +H  E
Sbjct: 69  PNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVKTVAMAAKQMLARVQSIH--E 124

Query: 217 NPVIYRDFKTSNILLDSDFTAK-----LSDFGLAKM-GPEGSNTHVTTR----VMGTYGY 266
             ++YRD K  N L+    +       + DFG+ K      +  H+  R    + GT  Y
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184

Query: 267 AAPEYISTGHLTT----KSDVYSFGVVLLELLTGR 297
            +   I+T HL      + D+ + G V +  L G 
Sbjct: 185 MS---INT-HLGREQSRRDDLEALGHVFMYFLRGS 215

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 64.7 bits (158), Expect = 7e-12
 Identities = 54/212 (25%), Positives = 87/212 (41%), Gaps = 29/212 (13%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRH-PHLV 157
           +G G FG ++ G    D+  G   + VA+KL  ++    H +   E      ++    + 
Sbjct: 17  IGSGSFGDIYLGT---DIAAG---EEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIP 68

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
            +     E +  ++V E +   SLE  LF   S      T L +A      + ++H    
Sbjct: 69  TIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLKTVLLLADQMISRIEYIH--SK 124

Query: 218 PVIYRDFKTSNILLDSDFTAK---LSDFGLAKM-GPEGSNTHVTTR----VMGTYGYAAP 269
             I+RD K  N L+          + DFGLAK      ++ H+  R    + GT  YA+ 
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS- 183

Query: 270 EYISTGHLTT----KSDVYSFGVVLLELLTGR 297
             I+T HL      + D+ S G VL+    G 
Sbjct: 184 --INT-HLGIEQSRRDDLESLGYVLMYFNLGS 212

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 56/304 (18%), Positives = 96/304 (31%), Gaps = 72/304 (23%)

Query: 45  APMPSFRRLSFSDLSRSSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNY----LLG 100
           +   +  +   S    + S    E                            Y    L+G
Sbjct: 3   SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62

Query: 101 EGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA-----EVIFLGQLRHPH 155
            G +G V + Y   D  +    + VA+K   I  +             E+  L +L H H
Sbjct: 63  TGSYGHVCEAY---DKLEK---RVVAIK--KILRVFED-LIDCKRILREIAILNRLNHDH 113

Query: 156 LVRLI-----GYCCEDEERLLVYEFMP---------RGSLENHLFKRISVSLPWGTRLKI 201
           +V+++         + +E  +V E               L     K +  +L        
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNL-------- 165

Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
                 G+ ++H A   +++RD K +N L++ D + K+ DFGLA+      N +    + 
Sbjct: 166 ----LVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219

Query: 262 GTYG-------------------------YAAPEYI-STGHLTTKSDVYSFGVVLLELLT 295
                                        Y APE I    + T   DV+S G +  ELL 
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

Query: 296 GRRS 299
             + 
Sbjct: 280 MIKE 283

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 47/221 (21%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHP-- 154
           L+G+G FG V K Y   D  +    + VA+K++ + +      +   EV  L  +     
Sbjct: 61  LIGKGSFGQVVKAY---DRVEQ---EWVAIKIIKNKKAF--LNQAQIEVRLLELMNKHDT 112

Query: 155 ----HLVRLIGY-------C--CEDEERLL---VYEFMPRGSLENHLFKRISVSLPWGTR 198
               ++V L  +       C   E    +L   +Y+      L N  F+ +S++L   TR
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFE----MLSYNLYDL-----LRNTNFRGVSLNL---TR 160

Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA--KLSDFGLAKMGPEGSNTHV 256
            K A      L FL   E  +I+ D K  NILL +   +  K+ DFG +    +    ++
Sbjct: 161 -KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 219

Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
            +R      Y +PE +         D++S G +L+E+ TG 
Sbjct: 220 QSRF-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 35/216 (16%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKL--LDIEGLQGHREWLAEVIFLGQLRHPHL 156
           +G G FG +  G    +L      + VA+KL  +     Q H E+              +
Sbjct: 17  IGCGNFGELRLGK---NLYTN---EYVAIKLEPMKSRAPQLHLEYRFYKQLGSG---DGI 67

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
            ++  +    +   +V E +   SLE  LF     +    T L IAI     + ++H   
Sbjct: 68  PQVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLKTVLMIAIQLISRMEYVH--S 123

Query: 217 NPVIYRDFKTSNILLDSDFTAK-----LSDFGLAK--MGPEGSNTHVTTR----VMGTYG 265
             +IYRD K  N L+            + DF LAK  + PE +  H+  R    + GT  
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE-TKKHIPYREHKSLTGTAR 182

Query: 266 YAAPEYISTGHL----TTKSDVYSFGVVLLELLTGR 297
           Y +   I+T HL    + + D+ + G + +  L G 
Sbjct: 183 YMS---INT-HLGKEQSRRDDLEALGHMFMYFLRGS 214

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 49/221 (22%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRH--- 153
           ++G+G FG V K Y   D +     Q VA+K++ + +    HR+   E+  L  LR    
Sbjct: 104 VIGKGSFGQVVKAY---DHKVH---QHVALKMVRNEKRF--HRQAAEEIRILEHLRKQDK 155

Query: 154 ---PHLVRLIGY-------C--CEDEERLL---VYEFMPRGSLENHLFKRISVSLPWGTR 198
               +++ ++         C   E    LL   +YE      ++ + F+  S+ L    R
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFE----LLSMNLYEL-----IKKNKFQGFSLPL---VR 203

Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA--KLSDFGLAKMGPEGSNTHV 256
            K A    + L  LH  +N +I+ D K  NILL     +  K+ DFG +    +   T++
Sbjct: 204 -KFAHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYI 260

Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR 297
            +R      Y APE I         D++S G +L ELLTG 
Sbjct: 261 QSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 56/253 (22%), Positives = 95/253 (37%), Gaps = 75/253 (29%)

Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL------DIEGLQGHREWL 142
           + + +     LG+G +G V K     D R G   + VAVK +        +  +  RE  
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSI---DRRTG---EVVAVKKIFDAFQNSTDAQRTFRE-- 58

Query: 143 AEVIFLGQLR-HPHLVRL--IGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRL 199
             ++ L +L  H ++V L  +     D +  LV+++M                    T L
Sbjct: 59  --IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-------------------ETDL 97

Query: 200 KIAIGAA---------------KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL 244
              I A                K + +LH     +++RD K SNILL+++   K++DFGL
Sbjct: 98  HAVIRANILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGL 155

Query: 245 AKMGPEGSNTHVTTRVMGTYG-------------------YAAPEYI-STGHLTTKSDVY 284
           ++             +                        Y APE +  +   T   D++
Sbjct: 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMW 215

Query: 285 SFGVVLLELLTGR 297
           S G +L E+L G+
Sbjct: 216 SLGCILGEILCGK 228

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 29/212 (13%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-HPHLV 157
           +G G FG ++ G    +++     + VA+KL +++    H + L E      L+    + 
Sbjct: 15  IGSGSFGEIYLGT---NIQTN---EEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIP 66

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
            +  +  E +  +LV + +   SLE  LF   S  L   T L +A      + F+H    
Sbjct: 67  NVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVH--SK 122

Query: 218 PVIYRDFKTSNILLDSDFTAK---LSDFGLAKM-GPEGSNTHVTTR----VMGTYGYAAP 269
             ++RD K  N L+     A    + DFGLAK      ++ H+  R    + GT  YA+ 
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS- 181

Query: 270 EYISTGHL----TTKSDVYSFGVVLLELLTGR 297
             ++T HL    + + D+ S G VL+  L G 
Sbjct: 182 --VNT-HLGIEQSRRDDLESLGYVLMYFLRGS 210

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 48/227 (21%), Positives = 81/227 (35%), Gaps = 39/227 (17%)

Query: 99  LGEGGFGTVHKGY--IDDDLRQGLKAQAVAVKL------LDIEGLQGHREWLAEVIF--- 147
                 G +++           G + Q  ++KL      L  E     R      +    
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 148 -LGQLRHPHLVRLIGY-CCEDEERLLVYEFMPR--GSLENHLFKRISVSLPWGTRLKIAI 203
            L       +   +G+   +D+ R LV   +P    SL++ L       L   + L++A 
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLGRSLQSALDVSPKHVLSERSVLQVAC 166

Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAK--LSDFGLAKMGPEGSNTHVTTR-- 259
                L FLH  EN  ++ +    NI +D +  ++  L+ +G A      S  HV     
Sbjct: 167 RLLDALEFLH--ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP-SGKHVAYVEG 223

Query: 260 ----VMGTYGYAAPEYIST-GHL----TTKSDVYSFGVVLLELLTGR 297
                 G       E+IS   H     + +SD+ S G  +L+ L G 
Sbjct: 224 SRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 47/226 (20%), Positives = 89/226 (39%), Gaps = 35/226 (15%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW-----LAEVIFLGQLR 152
            +G+GGFG ++   ++     G  A    VK+   +      E       A+   + +  
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAP-CVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 153 HPHLVRLIG-----YCCEDEERLLVYEF--MPR-G-SLENHLFKRISVSLPWGTRLKIAI 203
               ++ +G          ++    Y F  M R G  L+  +++  +      T L++++
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQ-KIYEANAKRFSRKTVLQLSL 159

Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAK--LSDFGLAKM-GPEGSNTHVTTR- 259
                L ++H  E+  ++ D K SN+LL+     +  L D+GLA    PEG +       
Sbjct: 160 RILDILEYIH--EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP 217

Query: 260 ---VMGTYGYAAPEYIST-GHL----TTKSDVYSFGVVLLELLTGR 297
                GT      E+ S   H     + + D+   G  +++ LTG 
Sbjct: 218 KRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 53/236 (22%), Positives = 84/236 (35%), Gaps = 82/236 (34%)

Query: 90  TQNFSSNY-----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLA 143
                 +Y     +LG G  G V + +   + R     +  A+K+L D    +  RE   
Sbjct: 12  KNAIIDDYKVTSQVLGLGINGKVLQIF---NKRTQ---EKFALKMLQDCPKAR--RE--- 60

Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEER-----LLVYEFMPRGSLENHLFKRISVSLPWGTR 198
             +     + PH+VR++    E+        L+V E +  G  E  LF RI         
Sbjct: 61  VELHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGG--E--LFSRI--------- 106

Query: 199 LKIAIG--------AA-------KGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLS 240
                G        A+       + + +LH     + +RD K  N+L  S   +   KL+
Sbjct: 107 --QDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLT 162

Query: 241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
           DFG A    E      T      Y  +              D++S GV++  LL G
Sbjct: 163 DFGFA---KE-----TTGE---KYDKSC-------------DMWSLGVIMYILLCG 194

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 55/282 (19%), Positives = 87/282 (30%), Gaps = 93/282 (32%)

Query: 89  ITQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAE 144
           I   F+  Y     LG G F TV   +   D++     + VA+K++           L E
Sbjct: 31  IGDLFNGRYHVIRKLGWGHFSTVWLSW---DIQGK---KFVAMKVV-KSAEHYTETALDE 83

Query: 145 VIFLGQLR-----HP---HLVRLIGY-----------CCEDEERLLVYEFMPRGSLENHL 185
           +  L  +R      P    +V+L+             C       +V+E +    L   +
Sbjct: 84  IRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC-------MVFEVL-GHHLLKWI 135

Query: 186 FKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL-------------- 231
            K     LP     KI     +GL +LH  +  +I+ D K  NILL              
Sbjct: 136 IKSNYQGLPLPCVKKIIQQVLQGLDYLH-TKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194

Query: 232 -----------------------------------DSDFTAKLSDFGLAKMGPEGSNTHV 256
                                                    K++D G A    +     +
Sbjct: 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDI 254

Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRR 298
            TR      Y + E +      T +D++S   +  EL TG  
Sbjct: 255 QTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGDY 291

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 63/241 (26%), Positives = 94/241 (39%), Gaps = 73/241 (30%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW-LAEVIFLGQLRHP-- 154
            LGEG FG V +     D +     + VAVK+  ++ +  + E   +E+  L  L     
Sbjct: 21  TLGEGAFGKVVECI---DHKA--GGRHVAVKI--VKNVDRYCEAARSEIQVLEHLNTTDP 73

Query: 155 ----HLVRLIGY-------C--CEDEERLL---VYEFMPRGSLENHLFKRISVSLPWGTR 198
                 V+++ +       C   E    LL    Y+F     ++ + F    +      R
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFE----LLGLSTYDF-----IKENGFLPFRLDH---IR 121

Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL-DSDFTA------------------KL 239
            K+A    K + FLH   N + + D K  NIL   SD+T                   K+
Sbjct: 122 -KMAYQICKSVNFLH--SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178

Query: 240 SDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL----TTKSDVYSFGVVLLELLT 295
            DFG A    E  +T V+TR      Y APE I    L    +   DV+S G +L+E   
Sbjct: 179 VDFGSATYDDEHHSTLVSTRH-----YRAPEVI----LALGWSQPCDVWSIGCILIEYYL 229

Query: 296 G 296
           G
Sbjct: 230 G 230

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 57/241 (23%), Positives = 84/241 (34%), Gaps = 73/241 (30%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL-DIEGLQGHREWLAEVIFLGQLRHP-- 154
            LGEG FG V +     D  +G     VA+K++ ++           E+  L +++    
Sbjct: 26  NLGEGTFGKVVECL---DHARG--KSQVALKIIRNVGKY--REAARLEINVLKKIKEKDK 78

Query: 155 ----HLVRLIGY-------C--CEDEERLL---VYEFMPRGSLENHLFKRISVSLPWGTR 198
                 V +  +       C   E    LL    +EF     L+ + F+   +      R
Sbjct: 79  ENKFLCVLMSDWFNFHGHMCIAFE----LLGKNTFEF-----LKENNFQPYPLPH---VR 126

Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA-------------------KL 239
             +A      L FLH  EN + + D K  NIL  +                       ++
Sbjct: 127 -HMAYQLCHALRFLH--ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183

Query: 240 SDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL----TTKSDVYSFGVVLLELLT 295
           +DFG A    E   T V TR      Y  PE I    L        DV+S G +L E   
Sbjct: 184 ADFGSATFDHEHHTTIVATRH-----YRPPEVI----LELGWAQPCDVWSIGCILFEYYR 234

Query: 296 G 296
           G
Sbjct: 235 G 235

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 53/246 (21%), Positives = 85/246 (34%), Gaps = 79/246 (32%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW-LAEVIFLGQLRH--- 153
            +G+G FG V        +      +  AVK+  +  ++ +      E   L ++++   
Sbjct: 42  KMGDGTFGRVLLCQ---HIDNK---KYYAVKV--VRNIKKYTRSAKIEADILKKIQNDDI 93

Query: 154 --PHLVRLIGY-------C--CEDEERLL---VYEFMPRGSLENHLFKRISVSLPWGTRL 199
              ++V+  G        C   E     L   +YE      +  + +    +      + 
Sbjct: 94  NNNNIVKYHGKFMYYDHMCLIFE----PLGPSLYEI-----ITRNNYNGFHIED---IK- 140

Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA---------------------- 237
              I   K L +L   +  + + D K  NILLD  +                        
Sbjct: 141 LYCIEILKALNYLR--KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198

Query: 238 ---KLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL----TTKSDVYSFGVVL 290
              KL DFG A    +   + + TR      Y APE I    L       SD++SFG VL
Sbjct: 199 TGIKLIDFGCATFKSDYHGSIINTRQ-----YRAPEVI----LNLGWDVSSDMWSFGCVL 249

Query: 291 LELLTG 296
            EL TG
Sbjct: 250 AELYTG 255

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 50/233 (21%), Positives = 85/233 (36%), Gaps = 52/233 (22%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKL-------LDIEG-----LQGHREWLAEV 145
            +G GGFG ++  +      +  K     VK+       L  E      +   ++ + + 
Sbjct: 44  KIGSGGFGLIYLAF---PTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAK-KDCIKKW 99

Query: 146 IFLGQLRHPHLVRLIGY----CCEDEERLLVYEFMPR--GSLENHLFK---RISVSLPWG 196
           I   QL +  +    G           R +V   M R    L+  +         S    
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMV---MERLGIDLQ-KISGQNGTFKKS---- 151

Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAK--LSDFGLAKM-GPEGSN 253
           T L++ I     L ++H  EN  ++ D K +N+LL      +  L+D+GL+    P G++
Sbjct: 152 TVLQLGIRMLDVLEYIH--ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209

Query: 254 THVTTRV----MGTYGYAAPEYIS-TGHL----TTKSDVYSFGVVLLELLTGR 297
                       GT      E+ S   H     + +SDV   G  +L  L G+
Sbjct: 210 KQYQENPRKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 52.6 bits (125), Expect = 1e-07
 Identities = 48/256 (18%), Positives = 72/256 (28%), Gaps = 71/256 (27%)

Query: 90  TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH--------REW 141
           T+       +GEG FG V +   D           VA+K++ IEG             E 
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIADH--------TPVAIKIIAIEGPDLVNGSHQKTFEEI 70

Query: 142 LAEVIFLGQL---------RHPHLVRLIGYCC---------------------------- 164
           L E+I   +L         R    + L    C                            
Sbjct: 71  LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130

Query: 165 --EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYR 222
             +D++  +V EF   G     L +  +      T   I       LA    A     +R
Sbjct: 131 FFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAE-ASLRFEHR 186

Query: 223 DFKTSNILLDSDFTAKLSDFGLAKMGPEGS-------NTHVTTRVMGT-----YGYAAPE 270
           D    N+LL      KL      K     S         +  +R+           +  E
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDE 246

Query: 271 YISTGHLTTKSDVYSF 286
            + TG    + D+Y  
Sbjct: 247 DLFTGDGDYQFDIYRL 262

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.2 bits (111), Expect = 8e-06
 Identities = 52/339 (15%), Positives = 110/339 (32%), Gaps = 88/339 (25%)

Query: 67  NEDLAHTFGPDL---YDFQ--LSELRAITQNFSSNYLLGEGGFGTVHKGY--IDDDLRQG 119
            +D+   F       +D +      ++I      ++++       V          L + 
Sbjct: 18  YKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKD--AVSGTLRLFWTLLSKQ 75

Query: 120 LKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRG 179
            +     V+    E L+ + ++L   I   + R P ++  + Y    E+R  +Y      
Sbjct: 76  EEMVQKFVE----EVLRINYKFLMSPI-KTEQRQPSMMTRM-Y---IEQRDRLYN----- 121

Query: 180 SLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDF---KTS---NILLDS 233
             +N +F + +V     +RL+  +   + L  L  A+N +I       KT    ++ L  
Sbjct: 122 --DNQVFAKYNV-----SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSY 174

Query: 234 DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLEL 293
               K+ DF +                          +++  +  +   V     +L +L
Sbjct: 175 KVQCKM-DFKIF-------------------------WLNLKNCNSPETVLE---MLQKL 205

Query: 294 LTGRRSMDKLRPKSEQNL---VDWAKPYLRSSRRL----RY-----IVDPRLAGQYSVKG 341
           L         R     N+   +   +  L   RRL     Y     ++        +V+ 
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAEL---RRLLKSKPYENCLLVLL-------NVQN 255

Query: 342 AKEMAVLALQC-ISVNPKDRPKMAAVVATLESLLNLKDM 379
           AK      L C I +  + +     + A   + ++L   
Sbjct: 256 AKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHH 294

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	419
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.45
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.23
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.15
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.84
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.71
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.67
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.61
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.55
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.49
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.35
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.31
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.01
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.88
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.88
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.81
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.67
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.63
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.49
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.47
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.44
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.35
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.3
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.22
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.04
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.93
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.06
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.59
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	92.86
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	91.58

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.1e-60  Score=450.14  Aligned_cols=266  Identities=29%  Similarity=0.419  Sum_probs=212.5

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|.+.++||+|+||+||+|++.+. .+..+++.||||+++.......++|.+|+++|++++|||||+++++|.+.+.+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~-~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNL-LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSS-CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCc-ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4677888999999999999987642 234567899999998766666788999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhcc-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcE
Q 014736          171 LVYEFMPRGSLENHLFKRI-------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA  237 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~  237 (419)
                      ||||||++|+|.+++....             ...+++..++.|+.||+.||.|||  +++||||||||+||||+.++.+
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA--GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHhhEEECCCCcE
Confidence            9999999999999997542             245899999999999999999999  5679999999999999999999


Q ss_pred             EEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhh
Q 014736          238 KLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAK  316 (419)
Q Consensus       238 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  316 (419)
                      ||+|||+++...........+..+||+.|||||++.+..|+.++|||||||++|||+| |+.||.......   .+... 
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~i-  273 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AIDCI-  273 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HHHHH-
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HHHHH-
Confidence            9999999997655544444556789999999999999999999999999999999999 899998654322   11111 


Q ss_pred             HHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          317 PYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                         .....          ...+..+++++.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       274 ---~~g~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          274 ---TQGRE----------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             ---HHTCC----------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ---HcCCC----------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence               11111          122345668899999999999999999999999999998764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.4e-60  Score=448.57  Aligned_cols=265  Identities=28%  Similarity=0.408  Sum_probs=218.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|.+.+.||+|+||+||+|.+.+. ....++..||||+++.......++|.+|+++|++++|||||+++++|.+.+..|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~-~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNL-CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSC-C----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCc-ccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            5788899999999999999987542 233457889999998766666788999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhcc-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEE
Q 014736          171 LVYEFMPRGSLENHLFKRI-----------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKL  239 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  239 (419)
                      ||||||++|+|.++|....           ...+++..++.++.||+.||.|||  +++||||||||+||||+.++.+||
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCccCHhhEEECCCCcEEE
Confidence            9999999999999997542           356899999999999999999999  567999999999999999999999


Q ss_pred             eccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHH
Q 014736          240 SDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       240 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      +|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||......+   .....   
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~i---  243 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECI---  243 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHH---
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---
Confidence            99999986554443333344569999999999999999999999999999999998 899998754322   11111   


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                       .....          ...+..+++++.+|+.+||+.||++|||+.+|.+.|+.+..
T Consensus       244 -~~~~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          244 -TQGRV----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             -HHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HcCCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence             11111          12334567889999999999999999999999999998754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=9.8e-61  Score=456.32  Aligned_cols=251  Identities=24%  Similarity=0.355  Sum_probs=205.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|++++.||+|+||+||+|+.      ..+++.||||++.....  ...+.+.+|+.+|++++|||||+++++|.+++.
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~------~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   97 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKS------TEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGS   97 (350)
T ss_dssp             CCEEEEEEC------CEEEEEE------TTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cceEEeEEEecCCCeEEEEEEE------CCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence            5899999999999999999954      45678999999976533  345678999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      +|||||||+||+|.++|.......+++..++.++.||+.||.|||  ++|||||||||+||||+.+|.+||+|||+|+..
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  175 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL  175 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHHHEEECCCCCEEEcccccceee
Confidence            999999999999999998766667899999999999999999999  677999999999999999999999999999875


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ....  ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+......   ..   .....  ..   
T Consensus       176 ~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~~---~i~~~--~~---  242 (350)
T 4b9d_A          176 NSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL---VL---KIISG--SF---  242 (350)
T ss_dssp             CHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH---HHHHT--CC---
T ss_pred             cCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HH---HHHcC--CC---
Confidence            4321  123456799999999999999999999999999999999999999986543221   11   11110  00   


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                            ...+..++.++.+||.+||+.||++|||+.|+++
T Consensus       243 ------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          243 ------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  1123345678999999999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.4e-60  Score=446.50  Aligned_cols=250  Identities=22%  Similarity=0.288  Sum_probs=212.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|+++++||+|+||+||+|+      +..+++.||||++....   ....+.+.+|+++|+.++|||||+++++|.+++
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~------~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  105 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE  105 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEE------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cccEEEEEEecccCeEEEEEE------ECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            469999999999999999995      44567899999997532   234577899999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      .+|||||||+||+|.+++.+.  +.+++..+..++.||+.||+|||  ++|||||||||+||||+.++.+||+|||+|+.
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH--~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~  181 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKV  181 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence            999999999999999999876  57999999999999999999999  67799999999999999999999999999998


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      +............+||+.|||||++.+..|+.++|||||||++|+|++|+.||...........+      ....     
T Consensus       182 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i------~~~~-----  250 (311)
T 4aw0_A          182 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI------IKLE-----  250 (311)
T ss_dssp             CCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHTC-----
T ss_pred             cCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HcCC-----
Confidence            76554444456678999999999999999999999999999999999999999764322211111      1100     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                             -.++...++++.+||.+||+.||++|||++|++.
T Consensus       251 -------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          251 -------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             -------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence                   0123345678999999999999999999998753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.4e-59  Score=447.60  Aligned_cols=250  Identities=23%  Similarity=0.351  Sum_probs=210.8

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      +.|++.++||+|+||+||+|+.      ..+++.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~------~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  147 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATV------RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  147 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEE------TTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEE------CCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5699999999999999999964      4457899999998766666677889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      ||||||+||+|.+++.+.   .+++..+..++.||+.||+|||  ++|||||||||+||||+.+|.+||+|||+|+....
T Consensus       148 ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          148 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             EEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence            999999999999998653   6999999999999999999999  67799999999999999999999999999987644


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD  330 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (419)
                      ...  .....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.........+   .   ..       ..
T Consensus       223 ~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~---~~-------~~  287 (346)
T 4fih_A          223 EVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---R---DN-------LP  287 (346)
T ss_dssp             SSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---H---HS-------SC
T ss_pred             CCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---H---cC-------CC
Confidence            322  244578999999999999999999999999999999999999999865432211111   0   00       00


Q ss_pred             cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       331 ~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      +.  ......+++++.+||.+||+.||++|||+.|+++
T Consensus       288 ~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          288 PR--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CC--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CC--CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11  1122345688999999999999999999999875

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=9.9e-59  Score=436.29  Aligned_cols=260  Identities=28%  Similarity=0.474  Sum_probs=205.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|.+.++||+|+||+||+|.+.+         .||||+++....  ...+.|.+|+.+|++++|||||++++++. ++.
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~---------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~  105 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG---------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDN  105 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS---------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC---------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCe
Confidence            578889999999999999996532         499999975432  34577999999999999999999999875 467


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      +|||||||+||+|.++|... ...+++..++.|+.||+.||.|||  +++||||||||+||||+.++.+||+|||+|+..
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH--~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLH--AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             EEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            89999999999999999654 346999999999999999999999  567999999999999999999999999999876


Q ss_pred             CCCCCceeeecccccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYIST---GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      ............+||+.|||||++.+   +.|+.++|||||||++|||+||+.||............      .....  
T Consensus       183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~------~~~~~--  254 (307)
T 3omv_A          183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM------VGRGY--  254 (307)
T ss_dssp             -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH------HHTTC--
T ss_pred             ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH------HhcCC--
Confidence            54444334456789999999999864   46899999999999999999999999865432211111      11110  


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                         ..+.+ ...+..+++++.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       255 ---~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          255 ---ASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             ---CCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             ---CCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence               11111 12334567889999999999999999999999999988754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.1e-59  Score=442.39  Aligned_cols=265  Identities=25%  Similarity=0.373  Sum_probs=215.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .++++.++||+|+||+||+|.+.+. ....+++.||||+++... ....++|.+|+.+|++++|||||+++|++.+++..
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~-~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~  104 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGP-APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL  104 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC--------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCC-ccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence            3466778899999999999987542 234457889999997543 23457899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 014736          170 LLVYEFMPRGSLENHLFKRI--------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF  235 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~  235 (419)
                      +||||||++|+|.++|..+.              ...+++..++.++.||+.||.|||  +++||||||||+||||++++
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS--SHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCCCCCCccccceEECCCC
Confidence            99999999999999996532              245899999999999999999999  56799999999999999999


Q ss_pred             cEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHh
Q 014736          236 TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDW  314 (419)
Q Consensus       236 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~  314 (419)
                      .+||+|||+++...........+..+||+.|||||++.++.|+.++|||||||++|||+| |..||.+.....   ....
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~~  259 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVEM  259 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence            999999999987654443334455679999999999999999999999999999999998 899998754322   2211


Q ss_pred             hhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          315 AKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      .    .....          ...+..++.++.+|+.+||+.||++|||+.+|++.|+...+
T Consensus       260 i----~~~~~----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n  306 (308)
T 4gt4_A          260 I----RNRQV----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN  306 (308)
T ss_dssp             H----HTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred             H----HcCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence            1    11111          12344567889999999999999999999999999987654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1e-58  Score=440.43  Aligned_cols=256  Identities=23%  Similarity=0.239  Sum_probs=210.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      +.|.+.++||+|+||.||+|+      +..+++.||||+++.....     .+|+.+|+.++|||||+++++|.+++.+|
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~------~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~  126 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMK------DKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVN  126 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEE------ETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred             hheEeCcEeccCCCeEEEEEE------ECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            467888899999999999995      4456789999999765332     36999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-cEEEeccCccccCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-TAKLSDFGLAKMGP  249 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~~~~  249 (419)
                      ||||||+||+|.+++.+.  ..+++..++.++.||+.||+|||  ++|||||||||+||||+.+| .+||+|||+|+...
T Consensus       127 ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             EEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             EEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            999999999999999776  57999999999999999999999  67899999999999999987 59999999998765


Q ss_pred             CCCCce---eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          250 EGSNTH---VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       250 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ......   .....+||+.|||||++.+..|+.++|||||||++|||++|++||...........+..      ..    
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------~~----  272 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS------EP----  272 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH------SC----
T ss_pred             CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc------CC----
Confidence            432211   12346799999999999999999999999999999999999999987654433222211      00    


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                           .....++..+++++.+||.+||+.||.+|||+.||++.|...+..
T Consensus       273 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          273 -----PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             -----CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence                 001123345678899999999999999999999999998877653

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.3e-58  Score=449.87  Aligned_cols=250  Identities=24%  Similarity=0.362  Sum_probs=211.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      +.|+++++||+|+||.||+|+.      ..+++.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~------~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  224 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATV------RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  224 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEE------TTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEE------CCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEE
Confidence            5699999999999999999954      4567899999998776666677899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      ||||||+||+|.+++...   .+++..+..++.||+.||+|||  .+|||||||||+||||+.+|.+||+|||+|+.+..
T Consensus       225 iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH--~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             EEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHH--HCCeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            999999999999998653   6899999999999999999999  67799999999999999999999999999987644


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD  330 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (419)
                      ...  .....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.........+   .   ..       ..
T Consensus       300 ~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~---~~-------~~  364 (423)
T 4fie_A          300 EVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---R---DN-------LP  364 (423)
T ss_dssp             SCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---H---HS-------CC
T ss_pred             CCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---H---cC-------CC
Confidence            322  244578999999999999999999999999999999999999999765432211111   0   00       00


Q ss_pred             cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       331 ~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      +.+  .....++.++.+||.+||+.||++|||+.|+++
T Consensus       365 ~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          365 PRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111  112345678999999999999999999999876

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.9e-58  Score=423.91  Aligned_cols=246  Identities=26%  Similarity=0.399  Sum_probs=193.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++.+.||+|+||+||+|.      +..+++.||+|+++....   .....+.+|+.+|+.++|||||++++++.+++
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~------~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   86 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAY------HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD   86 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEE------CTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             eCeEEEEEEecCcCeEEEEEE------ECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            589999999999999999995      455688999999975432   33567899999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      .+||||||+ +|+|.+++.++  ..+++..+..++.||+.||+|||  ++||+||||||+|||++.++.+||+|||+|+.
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~  161 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCH--RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI  161 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred             EEEEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCChHHeEECCCCCEEEeecCCCee
Confidence            999999999 78999999776  67999999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCceeeecccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHL-TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      .....   .....+||+.|||||++.+..| +.++|||||||++|+|++|+.||.......   ...   ......    
T Consensus       162 ~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~~---~i~~~~----  228 (275)
T 3hyh_A          162 MTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LFK---NISNGV----  228 (275)
T ss_dssp             ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHTC----
T ss_pred             cCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHH---HHHcCC----
Confidence            54332   2345689999999999988776 589999999999999999999997643221   111   111000    


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                              ..++...++++.+||.+||+.||++|||++|+++
T Consensus       229 --------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          229 --------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                    0123345678999999999999999999999987

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.8e-57  Score=424.61  Aligned_cols=247  Identities=25%  Similarity=0.356  Sum_probs=197.7

Q ss_pred             CCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEe----CC
Q 014736           94 SSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCE----DE  167 (419)
Q Consensus        94 ~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~  167 (419)
                      ++.++||+|+||+||+|.+.      .+++.||+|++....  ....+.|.+|+.+|++++|||||+++++|.+    ++
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~  102 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDT------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEET------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred             EeeeEEecCcCcEEEEEEEC------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence            56678999999999999643      457889999996543  2335678999999999999999999999875    34


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCcEEEeccCccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS-DFTAKLSDFGLAK  246 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~  246 (419)
                      .+|||||||+||+|.+++.+.  ..+++..++.++.||+.||+|||+.+.+||||||||+||||+. ++.+||+|||+|+
T Consensus       103 ~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          103 CIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            689999999999999999776  5789999999999999999999954334999999999999985 7899999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      .....    .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.......  ......    ...    
T Consensus       181 ~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~~~i----~~~----  245 (290)
T 3fpq_A          181 LKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRV----TSG----  245 (290)
T ss_dssp             GCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHH----TTT----
T ss_pred             eCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHHHHH----HcC----
Confidence            64332    2345689999999999864 69999999999999999999999997543221  111110    000    


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                           .....++...++++.+||.+||+.||++|||+.++++
T Consensus       246 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          246 -----VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0001122233567999999999999999999999875

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.6e-58  Score=430.79  Aligned_cols=246  Identities=28%  Similarity=0.334  Sum_probs=198.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|++++.||+|+||+||+|+...   ...+++.||||+++....  .....+.+|+.+|++++|||||+++++|.+++.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~---~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKIS---GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECS---STTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             cccEEEEEEecCCCeEEEEEEEcc---CCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            579999999999999999997532   234578999999975432  233467889999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      +|||||||+||+|.+++.+.  ..+++..+..++.||+.||+|||  ++|||||||||+|||++.+|.+||+|||+|+..
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            99999999999999999876  57999999999999999999999  677999999999999999999999999999865


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      .....  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........+      ....      
T Consensus       177 ~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i------~~~~------  242 (304)
T 3ubd_A          177 IDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI------LKAK------  242 (304)
T ss_dssp             ----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC------
T ss_pred             cCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH------HcCC------
Confidence            43322  234578999999999999999999999999999999999999999865432211111      1100      


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKM  363 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~  363 (419)
                            ..++..+++++.+||.+||+.||++|||+
T Consensus       243 ------~~~p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          243 ------LGMPQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             ------CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence                  12233456889999999999999999984

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.2e-57  Score=437.84  Aligned_cols=275  Identities=27%  Similarity=0.360  Sum_probs=223.6

Q ss_pred             CHHHHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCc-ccccce
Q 014736           82 QLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRH-PHLVRL  159 (419)
Q Consensus        82 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-pnIv~~  159 (419)
                      ...+++.-.++|+++++||+|+||+||+|.+... .....++.||||++..... ...+.|.+|+.+|.+++| ||||++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~-~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCC-CcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            3344455567899999999999999999987653 3445667899999975533 335679999999999965 999999


Q ss_pred             eeEEEeC-CeeEEEEEecCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 014736          160 IGYCCED-EERLLVYEFMPRGSLENHLFKRI--------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDF  224 (419)
Q Consensus       160 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dl  224 (419)
                      +++|.+. +.+|||||||++|+|.++|....              ...+++..++.++.||+.||+|||  +++||||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH--~~~iiHRDL  211 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDL  211 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh--hCCeecCcc
Confidence            9998664 57899999999999999997532              234789999999999999999999  567999999


Q ss_pred             CCCcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 014736          225 KTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKL  303 (419)
Q Consensus       225 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~  303 (419)
                      ||+|||++.++.+||+|||+|+...........+..+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999997765554444556779999999999999999999999999999999998 99999875


Q ss_pred             CCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          304 RPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      .....  ...    .+....          ....+..+++++.+|+.+||+.||++|||+.+|++.|+.++.
T Consensus       292 ~~~~~--~~~----~i~~g~----------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          292 KIDEE--FCR----RLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             CCSHH--HHH----HHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHH--HHH----HHHcCC----------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence            43221  111    111111          112233456789999999999999999999999999998865

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3e-55  Score=414.44  Aligned_cols=269  Identities=25%  Similarity=0.366  Sum_probs=201.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHH--HHHHHHcCCCcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWL--AEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .++|.+.++||+|+||+||+|++.        ++.||||+++...   ...+.  .|+..+.+++|||||++++++.+++
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~~--------g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~   70 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKWR--------GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN   70 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET--------TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC--------CEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC
Confidence            356888899999999999999753        5789999997542   23333  4566667889999999999998754


Q ss_pred             ----eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeeecCCCCCcEEEcCCCcE
Q 014736          168 ----ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA------ENPVIYRDFKTSNILLDSDFTA  237 (419)
Q Consensus       168 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~------~~~ivH~Dlkp~NIll~~~~~~  237 (419)
                          .+|||||||++|+|.+++...   .+++..+..++.|++.||.|||+.      ..+||||||||+||||+.++.+
T Consensus        71 ~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~  147 (303)
T 3hmm_A           71 GTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence                579999999999999999764   689999999999999999999953      3489999999999999999999


Q ss_pred             EEeccCccccCCCCCCce--eeecccccccccccccccCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccch
Q 014736          238 KLSDFGLAKMGPEGSNTH--VTTRVMGTYGYAAPEYISTG------HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQ  309 (419)
Q Consensus       238 kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  309 (419)
                      ||+|||+|+.........  .....+||+.|||||++.+.      .|+.++|||||||++|||+||.+||.........
T Consensus       148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p  227 (303)
T 3hmm_A          148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence            999999998754433221  12345799999999999654      4678999999999999999998877543221100


Q ss_pred             --------hHHHhhhHHhhcccccccccccccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          310 --------NLVDWAKPYLRSSRRLRYIVDPRLAGQ-YSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       310 --------~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                              ........... ..    ...+.+... ...+.++.+.+|+.+||+.||++|||+.+|++.|+++....
T Consensus       228 ~~~~~~~~~~~~~~~~~~~-~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~  299 (303)
T 3hmm_A          228 YYDLVPSDPSVEEMRKVVC-EQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             TTTTSCSSCCHHHHHHHHT-TS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             chhcccccchHHHHHHHHh-cc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence                    00010011000 01    111222111 12356678999999999999999999999999999987654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.6e-55  Score=411.54  Aligned_cols=252  Identities=25%  Similarity=0.374  Sum_probs=188.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCC-
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE-  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-  167 (419)
                      .++|++++.||+|+||+||+|+.      ..+++.||||++..... ...+.+.+|+.+|++++|||||+++++|.+.+ 
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~------~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   77 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKN------KVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNT   77 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEE------TTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred             chhCEEeeEEecCCCeEEEEEEE------CCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence            35699999999999999999954      44578999999975543 33467899999999999999999999987654 


Q ss_pred             -----------eeEEEEEecCCCChhhhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 014736          168 -----------ERLLVYEFMPRGSLENHLFKRIS-VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF  235 (419)
Q Consensus       168 -----------~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~  235 (419)
                                 .+|||||||+||+|.+++..+.. ...++..++.++.||+.||+|||  ++|||||||||+||||+.++
T Consensus        78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH--~~~IiHRDlKp~NILl~~~~  155 (299)
T 4g31_A           78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDD  155 (299)
T ss_dssp             ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTC
T ss_pred             cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH--HCcCccccCcHHHeEECCCC
Confidence                       37999999999999999976533 23456678899999999999999  67799999999999999999


Q ss_pred             cEEEeccCccccCCCCCCce----------eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 014736          236 TAKLSDFGLAKMGPEGSNTH----------VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRP  305 (419)
Q Consensus       236 ~~kl~DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  305 (419)
                      .+||+|||+|+.........          ..+..+||+.|||||++.+..|+.++|||||||++|||++   ||.... 
T Consensus       156 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-  231 (299)
T 4g31_A          156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-  231 (299)
T ss_dssp             CEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-
T ss_pred             cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-
Confidence            99999999998765432211          1234679999999999999999999999999999999996   665311 


Q ss_pred             ccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          306 KSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                          ........ ... ...     +    ......++++.+|+.+||+.||++|||+.|+++
T Consensus       232 ----~~~~~~~~-~~~-~~~-----p----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          232 ----ERVRTLTD-VRN-LKF-----P----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             ----HHHHHHHH-HHT-TCC-----C----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----HHHHHHHH-Hhc-CCC-----C----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                11110000 000 000     0    011223456788999999999999999999876

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-53  Score=416.06  Aligned_cols=268  Identities=21%  Similarity=0.282  Sum_probs=203.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEe--
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCE--  165 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--  165 (419)
                      .++|++++.||+|+||+||+|+      +..+++.||||++.....  ...+.+++|+++|+.++|||||++++++..  
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~------~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  126 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSAR------RRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV  126 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEE------ETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred             CCCeEEEEEEecccCeEEEEEE------ECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence            3679999999999999999995      445688999999975432  334678899999999999999999998764  


Q ss_pred             ----CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          166 ----DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       166 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                          .+.+|||||||. |+|.+++.+.  ..+++..+..++.||+.||.|||  ++|||||||||+|||++.++.+||+|
T Consensus       127 ~~~~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH--~~~iiHRDlKP~NIl~~~~~~~Ki~D  201 (398)
T 4b99_A          127 PYGEFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMH--SAQVIHRDLKPSNLLVNENCELKIGD  201 (398)
T ss_dssp             CTTTCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTCCEEECC
T ss_pred             ccccCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCcCcCCCcCccccccCCCCCEEEee
Confidence                367899999995 6899998765  67999999999999999999999  67799999999999999999999999


Q ss_pred             cCccccCCCCCC--ceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          242 FGLAKMGPEGSN--THVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       242 fGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      ||+|+.+.....  .......+||+.|||||++.+. .|+.++||||+|||+|||++|++||.+.........+......
T Consensus       202 FGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~  281 (398)
T 4b99_A          202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT  281 (398)
T ss_dssp             CTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             cceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999987543321  2233457899999999998775 5799999999999999999999999876543322222111000


Q ss_pred             hhcc-------cccccc---cccccC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 LRSS-------RRLRYI---VDPRLA---GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 ~~~~-------~~~~~~---~~~~l~---~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ....       ......   +.....   .......++++.+||.+||..||.+|||+.|+++
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000       000000   000000   0011234678999999999999999999999876

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.8e-52  Score=404.16  Aligned_cols=269  Identities=22%  Similarity=0.221  Sum_probs=201.6

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-CcccccceeeEEEeC
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHLVRLIGYCCED  166 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  166 (419)
                      .+.++|++.++||+|+||+||+|+.+.   +..+++.||+|++....  ....+.+|+++|+.+ +|||||+++++|.+.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~---~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQL---QVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEB---TTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcc---cCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            456889999999999999999997532   23456889999986543  345678899999988 699999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-CcEEEeccCcc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD-FTAKLSDFGLA  245 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGla  245 (419)
                      +++||||||++||+|.+++.     .+++..++.++.||+.||+|||  ++|||||||||+|||++.+ +.+||+|||+|
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH--~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIH--QFGIVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             CEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            99999999999999999883     5899999999999999999999  6779999999999999877 79999999999


Q ss_pred             ccCCCCCCc--------------------------eeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCC
Q 014736          246 KMGPEGSNT--------------------------HVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRR  298 (419)
Q Consensus       246 ~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~  298 (419)
                      +........                          ...+..+||+.|+|||++.+. .|+.++||||+||++|||++|+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            764432110                          112345799999999999775 58999999999999999999999


Q ss_pred             CCCCCCCccch-hHHHh----------hhHHh------------------hccccccccc--------ccccCCCCCHHH
Q 014736          299 SMDKLRPKSEQ-NLVDW----------AKPYL------------------RSSRRLRYIV--------DPRLAGQYSVKG  341 (419)
Q Consensus       299 pf~~~~~~~~~-~~~~~----------~~~~~------------------~~~~~~~~~~--------~~~l~~~~~~~~  341 (419)
                      ||........+ ..+..          ...+.                  ..........        ............
T Consensus       246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i  325 (361)
T 4f9c_A          246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV  325 (361)
T ss_dssp             SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred             CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence            99654432111 00000          00000                  0000000000        000000111234


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          342 AKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       342 ~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ++++.+||.+||+.||++|+|++|+++
T Consensus       326 s~~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          326 PDEAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            678999999999999999999999875

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.4e-52  Score=424.15  Aligned_cols=249  Identities=24%  Similarity=0.320  Sum_probs=203.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHH---HHHHHHHcCCCcccccceeeEEE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREW---LAEVIFLGQLRHPHLVRLIGYCC  164 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~hpnIv~~~~~~~  164 (419)
                      ++|+++++||+|+||.||+|.      +..+++.||||++.+..   ......+   ..++.+++.++|||||+++++|.
T Consensus       189 ddf~i~k~LG~G~fG~V~la~------~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~  262 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCR------KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH  262 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEE------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             HHeEEEEEEecccCeEEEEEE------ECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence            579999999999999999995      44568899999996432   1222233   34467788899999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCc
Q 014736          165 EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL  244 (419)
Q Consensus       165 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  244 (419)
                      +.+.+|||||||+||+|.++|.+.  ..+++..++.++.||+.||+|||  .+|||||||||+||||+.+|.+||+|||+
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH--~~gIiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHeEEeCCCCEEecccce
Confidence            999999999999999999999876  67999999999999999999999  77899999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccc
Q 014736          245 AKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSR  323 (419)
Q Consensus       245 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  323 (419)
                      |+......    ....+||+.|||||++.. ..|+.++||||||||+|||++|.+||...............   ...  
T Consensus       339 A~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i---~~~--  409 (689)
T 3v5w_A          339 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTM--  409 (689)
T ss_dssp             CEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH---HHC--
T ss_pred             eeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh---cCC--
Confidence            98764432    344689999999999964 57999999999999999999999999765433322211111   100  


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 014736          324 RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK-----MAAVVA  368 (419)
Q Consensus       324 ~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs-----~~eil~  368 (419)
                                ...++...+.++.+||.+||+.||.+|++     +++|++
T Consensus       410 ----------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          410 ----------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ----------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                      11233445688999999999999999998     677764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.3e-52  Score=425.47  Aligned_cols=254  Identities=22%  Similarity=0.310  Sum_probs=211.8

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      +.++|++++.||+|+||.||+|.      +..+++.||+|++........+.+.+|+.+|+.++|||||+++++|.+.+.
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~------~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  228 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVT------ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE  228 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEE------ETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE
T ss_pred             CccccEEEEEEeeccCeEEEEEE------ECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            34689999999999999999995      445678999999987666667788999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC--CcEEEeccCccc
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD--FTAKLSDFGLAK  246 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGla~  246 (419)
                      +|||||||+||+|.++|.+. ...+++..+..++.||+.||+|||  ++||+||||||+|||++.+  +.+||+|||+|+
T Consensus       229 ~~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH--~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~  305 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA  305 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCCSSCE
T ss_pred             EEEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCChhhccccCCCCCCEEEeecccee
Confidence            99999999999999998643 246899999999999999999999  6779999999999999864  899999999999


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      .+.....   ....+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.........+.      ....   
T Consensus       306 ~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~------~~~~---  373 (573)
T 3uto_A          306 HLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK------SCDW---  373 (573)
T ss_dssp             ECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH------TTCC---
T ss_pred             EccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH------hCCC---
Confidence            8654432   344679999999999999999999999999999999999999998654322211111      0000   


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                           .+.......+++++.+||.+||+.||.+|||+.|+++
T Consensus       374 -----~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          374 -----NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             -----CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0111112234678999999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.5e-50  Score=385.90  Aligned_cols=283  Identities=43%  Similarity=0.734  Sum_probs=240.8

Q ss_pred             HHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEE
Q 014736           85 ELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCC  164 (419)
Q Consensus        85 ~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  164 (419)
                      ++....++|++.+.||+|+||.||+|.+.       +++.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  105 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD  105 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECT-------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEEC-------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            34556789999999999999999999642       36789999998766666788999999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEecc
Q 014736          165 EDEERLLVYEFMPRGSLENHLFKRIS--VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       165 ~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                      +.+..++||||+++++|.+++.....  ..+++..++.++.||+.||.|||  .+||+||||||+|||++.++.+||+||
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCSTTEEECTTCCEEECCC
T ss_pred             CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc--CCCeecCCCCHHHEEECCCCCEEEeec
Confidence            99999999999999999999865432  35899999999999999999999  677999999999999999999999999


Q ss_pred             CccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       243 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      |++................||+.|+|||++.+..++.++||||||+++|+|++|+.||....+........|..... ..
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~  262 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-NN  262 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH-TT
T ss_pred             ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc-cc
Confidence            99986544333333344568999999999988999999999999999999999999998877666666665544332 33


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                      ..+...+++.+........+.++.+++.+||+.||++|||+.+|++.|+.++...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            4455556666677778889999999999999999999999999999999987654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.4e-48  Score=368.51  Aligned_cols=251  Identities=22%  Similarity=0.360  Sum_probs=210.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .++|++.+.||+|+||.||+|.      +..+++.||+|++........+.+.+|+.+++.++||||+++++++...+..
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAM------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEE------BTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhceeeeeeeccCCCeEEEEEE------ECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence            4689999999999999999995      3456789999999876666677889999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+||||+.+++|.+++...   .+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++....
T Consensus        93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            9999999999999998764   5889999999999999999999  6679999999999999999999999999998654


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      ....  ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+      ....       
T Consensus       168 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------~~~~-------  232 (297)
T 3fxz_A          168 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNG-------  232 (297)
T ss_dssp             STTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHHC-------
T ss_pred             Cccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC-------
Confidence            4332  233467999999999999999999999999999999999999999765432211111      0000       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        ......+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       233 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          233 --TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             --SCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence              0011123345678999999999999999999999976

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.5e-48  Score=379.57  Aligned_cols=268  Identities=24%  Similarity=0.378  Sum_probs=218.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcc-cccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCC-CcccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDL-RQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQL-RHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~-~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  166 (419)
                      .++|.+.+.||+|+||.||+|.+.... .....+..||||++..... .....+.+|+.+|+.+ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467999999999999999999865321 1234567899999975532 3456789999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRI--------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD  232 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~  232 (419)
                      +..|+||||+.+|+|.+++....              ...+++..++.++.||+.||.|||  ++||+||||||+||||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAARNVLVT  237 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEC
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCeeccccchhhEEEC
Confidence            99999999999999999997653              135789999999999999999999  67799999999999999


Q ss_pred             CCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhH
Q 014736          233 SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNL  311 (419)
Q Consensus       233 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~  311 (419)
                      .++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~  317 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL  317 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            999999999999986654433333344567899999999999999999999999999999999 9999987543321111


Q ss_pred             HHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          312 VDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                      +       ...          .....+..++.++.+|+.+||+.||.+||++.+|++.|+.++..
T Consensus       318 ~-------~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          318 L-------KEG----------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             H-------HTT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H-------hcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            1       011          01122334567899999999999999999999999999998764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2e-48  Score=371.99  Aligned_cols=287  Identities=44%  Similarity=0.721  Sum_probs=235.0

Q ss_pred             CcCCCHHHHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-cHHHHHHHHHHHcCCCcccc
Q 014736           78 LYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQLRHPHL  156 (419)
Q Consensus        78 ~~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnI  156 (419)
                      ...+...++....++|.+.++||+|+||.||+|...       +++.||||++...... ....+.+|+.+++.++||||
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i   89 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-------DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL   89 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-------SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTB
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEec-------CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCc
Confidence            445788899999999999999999999999999522       3678999999754322 23368899999999999999


Q ss_pred             cceeeEEEeCCeeEEEEEecCCCChhhhhhhccC--CCCCHHHHHHHHHHHHHHHHHhhcC-CCCeeecCCCCCcEEEcC
Q 014736          157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRIS--VSLPWGTRLKIAIGAAKGLAFLHGA-ENPVIYRDFKTSNILLDS  233 (419)
Q Consensus       157 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~  233 (419)
                      +++++++.+.+..++||||+.+++|.+++.....  ..+++..+..++.|++.||.|||+. ..||+||||||+|||++.
T Consensus        90 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~  169 (326)
T 3uim_A           90 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE  169 (326)
T ss_dssp             CCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT
T ss_pred             cceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC
Confidence            9999999999999999999999999999976532  3489999999999999999999943 118999999999999999


Q ss_pred             CCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--CccchhH
Q 014736          234 DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLR--PKSEQNL  311 (419)
Q Consensus       234 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~  311 (419)
                      ++.+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....  .......
T Consensus       170 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  248 (326)
T 3uim_A          170 EFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML  248 (326)
T ss_dssp             TCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBH
T ss_pred             CCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhH
Confidence            99999999999987644332 23344569999999999988899999999999999999999999996321  1122233


Q ss_pred             HHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          312 VDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                      ..|..... ....+....+..+...+....+.++.+++.+||+.||.+|||+.+|++.|+..
T Consensus       249 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          249 LDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HHHHTTTT-SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHHHh-hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            34433322 23345555666677778888999999999999999999999999999999874

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.5e-48  Score=370.23  Aligned_cols=262  Identities=24%  Similarity=0.413  Sum_probs=214.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|.+.++||+|+||.||+|...      .+++.||+|++........+.+.+|+++++.++||||+++++++.+++..+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHR------ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEET------TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             hHeeccceecCCCCEEEEEEEEC------CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence            57889999999999999999643      347889999987666666788999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+++++|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++.....
T Consensus        84 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLH--SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             EEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             EEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            999999999999999764 356899999999999999999999  67799999999999999999999999999986543


Q ss_pred             CCCce------------eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          251 GSNTH------------VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       251 ~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      .....            ......||+.|+|||++.+..++.++||||||+++|+|++|..||.............. ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~~~  239 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-RGF  239 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-HHH
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-hcc
Confidence            32211            11145799999999999999999999999999999999999999876543322110000 000


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                                .+    ...+..++.++.+|+.+||+.||++|||+.++++.|+.+...
T Consensus       240 ----------~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          240 ----------LD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             ----------HH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------cc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                      00    011233456799999999999999999999999999988653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.5e-48  Score=373.23  Aligned_cols=248  Identities=23%  Similarity=0.365  Sum_probs=207.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ..+|++.+.||+|+||.||+|..      ..+++.||||++....  ....+.+.+|+.+|+.++||||+++++++.+.+
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   87 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARH------ILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK   87 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEE------TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEE------CCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            35799999999999999999954      4557899999997543  234567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+++++|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  163 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNE  163 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred             EEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence            999999999999999999776  56899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLT-TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ......   ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...........+      ....    
T Consensus       164 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i------~~~~----  230 (328)
T 3fe3_A          164 FTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV------LRGK----  230 (328)
T ss_dssp             GSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC----
T ss_pred             cCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC----
Confidence            544332   3456799999999999888775 8999999999999999999999865432211111      1110    


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                              ..++...+.++.+|+.+||..||.+|||++++++
T Consensus       231 --------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          231 --------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             --------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                    0122234678999999999999999999999976

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.8e-48  Score=371.94  Aligned_cols=273  Identities=25%  Similarity=0.337  Sum_probs=208.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCC--
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE--  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--  167 (419)
                      .++|++.++||+|+||.||+|.+.        ++.||||++.... .....+.+|+.++++++||||+++++++....  
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--------NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV   93 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--------TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             hhhchhhheecccCceEEEEEEEC--------CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence            368999999999999999999643        4789999997543 23345566899999999999999999998754  


Q ss_pred             --eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCC----------CeeecCCCCCcEEEcCCC
Q 014736          168 --ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN----------PVIYRDFKTSNILLDSDF  235 (419)
Q Consensus       168 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~----------~ivH~Dlkp~NIll~~~~  235 (419)
                        .+++||||+++|+|.+++...   .+++..++.++.||+.||.|||  +.          ||+||||||+|||++.++
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH--~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~  168 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLH--EDIPGLKDGHKPAISHRDIKSKNVLLKNNL  168 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHT--CCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred             CceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--hhccccccccCCCEEeCCCChHhEEECCCC
Confidence              469999999999999999764   5899999999999999999999  55          899999999999999999


Q ss_pred             cEEEeccCccccCCCCCCceeeecccccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchh
Q 014736          236 TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-----GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQN  310 (419)
Q Consensus       236 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  310 (419)
                      .+||+|||+++...............||+.|+|||++.+     ..++.++|||||||++|||++|+.||..........
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  248 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP  248 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence            999999999987654443333344679999999999976     356678999999999999999999998754432221


Q ss_pred             HHHhhhHH--hhc--ccccccccccccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          311 LVDWAKPY--LRS--SRRLRYIVDPRLAGQ-YSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       311 ~~~~~~~~--~~~--~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                      ........  ...  .........+.+... -....+.++.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            11100000  000  000000001111111 1224567799999999999999999999999999998754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.3e-48  Score=370.61  Aligned_cols=248  Identities=26%  Similarity=0.332  Sum_probs=206.8

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC---CcccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE---GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++++.||+|+||.||+|..      ..+++.||+|++...   .......+.+|+.+|+.++||||+++++++.+.+
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~   78 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVRE------KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD   78 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred             HHeEEEEEEecCCCeEEEEEEE------CCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC
Confidence            5789999999999999999954      445789999999753   2234567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||++||+|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++.
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  154 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence            999999999999999998765  57899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..   ......     
T Consensus       155 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~---~i~~~~-----  221 (337)
T 1o6l_A          155 GISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FE---LILMEE-----  221 (337)
T ss_dssp             SCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HHHHCC-----
T ss_pred             cccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH---HH---HHHcCC-----
Confidence            433221  23446799999999999999999999999999999999999999976432211   11   111110     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~  368 (419)
                             ..++...+.++.+||.+||+.||.+||     ++.+|++
T Consensus       222 -------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          222 -------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                   112334567899999999999999999     8999876

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.9e-48  Score=368.40  Aligned_cols=260  Identities=30%  Similarity=0.470  Sum_probs=204.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .++|++.+.||+|+||.||+|...        ++.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEWH--------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             hhHceeeeEeecCCCeEEEEEEEC--------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            467999999999999999999643        46799999975543  33467889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCcEEEcCCCcEEEeccCc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRIS-VSLPWGTRLKIAIGAAKGLAFLHGAENP--VIYRDFKTSNILLDSDFTAKLSDFGL  244 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfGl  244 (419)
                      ..++||||+.+++|.+++..... ..+++..++.++.||+.||.|||  ++|  |+||||||+|||++.++.+||+|||+
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH--NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH--TSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence            99999999999999999975421 23889999999999999999999  667  99999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          245 AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       245 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      ++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.      ...  
T Consensus       186 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~------~~~--  255 (309)
T 3p86_A          186 SRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG------FKC--  255 (309)
T ss_dssp             ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH------HSC--
T ss_pred             Ccccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hcC--
Confidence            985433221  1234569999999999999999999999999999999999999998654322111110      000  


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                              ....++..++.++.+|+.+||+.||.+|||+.+|++.|+.+....
T Consensus       256 --------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          256 --------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             --------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             --------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence                    111233445678999999999999999999999999999998754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.3e-48  Score=368.22  Aligned_cols=265  Identities=26%  Similarity=0.442  Sum_probs=213.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|.+.++||+|+||.||+|.+..+   ...+..||||++.... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVP---GQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCT---TSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecC---CCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            35789999999999999999976532   2335679999997542 3345678999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||+++++|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++...
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLS--DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             cEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            99999999999999998654 346899999999999999999999  677999999999999999999999999999876


Q ss_pred             CCCCCce-eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          249 PEGSNTH-VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       249 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+.       ..    
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-------~~----  270 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-------EG----  270 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-------TT----
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-------cC----
Confidence            5433221 2223456889999999998999999999999999999999 999997654322111110       11    


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                            .....+..++.++.+|+.+||+.||.+|||+.+|++.|+.+....
T Consensus       271 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          271 ------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             ------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence                  111223345678999999999999999999999999999997653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.5e-48  Score=372.93  Aligned_cols=253  Identities=22%  Similarity=0.287  Sum_probs=207.5

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc------cHHHHHHHHHHHcCCCcccccceeeE
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ------GHREWLAEVIFLGQLRHPHLVRLIGY  162 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~  162 (419)
                      +.++|.+.+.||+|+||.||+|..      ..+++.||+|++......      ..+.+.+|+.+|+.++||||++++++
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~------~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~   83 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCRE------KSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDV   83 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEE------TTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEE------CCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEE
Confidence            457899999999999999999964      445789999999754322      35778999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC----cEE
Q 014736          163 CCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF----TAK  238 (419)
Q Consensus       163 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~----~~k  238 (419)
                      +.+.+..|+||||+.||+|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++    .+|
T Consensus        84 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           84 YENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EEeCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEeCCCCCccCEE
Confidence            99999999999999999999999765  57899999999999999999999  67799999999999998877    799


Q ss_pred             EeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          239 LSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       239 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      |+|||++........   ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+      
T Consensus       160 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i------  230 (361)
T 2yab_A          160 LIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI------  230 (361)
T ss_dssp             ECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------
T ss_pred             EEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------
Confidence            999999987654322   23457999999999999999999999999999999999999999764322211111      


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ......    ++..    +....+.++.+||.+||..||.+|||+.++++
T Consensus       231 ~~~~~~----~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          231 TAVSYD----FDEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HTTCCC----CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhcCCC----CCch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000000    0000    11224578999999999999999999999985

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.6e-48  Score=377.42  Aligned_cols=277  Identities=26%  Similarity=0.358  Sum_probs=222.3

Q ss_pred             CCHHHHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCC-Ccccccc
Q 014736           81 FQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQL-RHPHLVR  158 (419)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~  158 (419)
                      +....++...++|.+.+.||+|+||.||+|.+.+. .+..+++.||||++..... ...+.+.+|++++.++ +||||++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccc-cccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            34455566678999999999999999999976542 3456678999999975433 3346789999999999 7999999


Q ss_pred             eeeEEEeCC-eeEEEEEecCCCChhhhhhhccC-----------------------------------------------
Q 014736          159 LIGYCCEDE-ERLLVYEFMPRGSLENHLFKRIS-----------------------------------------------  190 (419)
Q Consensus       159 ~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------  190 (419)
                      +++++.+.+ ..++||||+.+|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            999998755 48999999999999999976532                                               


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCC
Q 014736          191 -----------------VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN  253 (419)
Q Consensus       191 -----------------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  253 (419)
                                       ..+++..++.++.||+.||.|||  .+||+||||||+|||++.++.+||+|||++........
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                             12888999999999999999999  66799999999999999999999999999987655444


Q ss_pred             ceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       254 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                      ........||+.|+|||++.+..++.++||||||+++|+|++ |..||.........  ...    ....          
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~----~~~~----------  312 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRR----LKEG----------  312 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHH----HHHT----------
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHH----HHcC----------
Confidence            444455678999999999999999999999999999999998 99999865433211  110    0011          


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                      .....+...+.++.+|+.+||+.||.+|||+.+|++.|+.++..
T Consensus       313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            01112233457899999999999999999999999999998753

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.1e-46  Score=354.77  Aligned_cols=285  Identities=37%  Similarity=0.596  Sum_probs=229.5

Q ss_pred             CCcCCCHHHHHHHhcCCCCC------CeecccCceEEEEEEEcCcccccccccEEEEEEeccCC----cccHHHHHHHHH
Q 014736           77 DLYDFQLSELRAITQNFSSN------YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG----LQGHREWLAEVI  146 (419)
Q Consensus        77 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~  146 (419)
                      ....|...++..++++|...      +.||+|+||.||+|..        .++.||+|++....    ....+.+.+|+.
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~   82 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--------NNTTVAVKKLAAMVDITTEELKQQFDQEIK   82 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--------SSCEEEEEEECCCTTSCTTTHHHHHHHHHH
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--------CCceEEEEEEecccCcchHHHHHHHHHHHH
Confidence            34567888999999998877      8999999999999963        35789999986432    233567889999


Q ss_pred             HHcCCCcccccceeeEEEeCCeeEEEEEecCCCChhhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 014736          147 FLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRI-SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFK  225 (419)
Q Consensus       147 ~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlk  225 (419)
                      +++.++||||+++++++.+.+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||  ++||+|||||
T Consensus        83 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dlk  160 (307)
T 2nru_A           83 VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIK  160 (307)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCC
T ss_pred             HHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecCCCC
Confidence            9999999999999999999999999999999999999986532 356899999999999999999999  6779999999


Q ss_pred             CCcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 014736          226 TSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRP  305 (419)
Q Consensus       226 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  305 (419)
                      |+|||++.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||.....
T Consensus       161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            9999999999999999999987655443333445679999999998854 689999999999999999999999987654


Q ss_pred             ccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          306 KSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      ......+.  .........+...+++.+ .......+..+.+++.+||+.||.+|||+.+|++.|+.+.+
T Consensus       240 ~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          240 PQLLLDIK--EEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             SSBTTHHH--HHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             hHHHHHHH--HHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            33222211  111111222222233322 34566788899999999999999999999999999998753

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.3e-47  Score=364.03  Aligned_cols=267  Identities=30%  Similarity=0.418  Sum_probs=218.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|.+.+.||+|+||.||+|..... .....++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHL-KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETG-GGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEecc-CcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            46799999999999999999976442 223456889999997543 2345678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccC----------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 014736          169 RLLVYEFMPRGSLENHLFKRIS----------------------VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKT  226 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp  226 (419)
                      .++||||+.+++|.+++.....                      ..+++..++.++.||+.||.|||  ++||+||||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dikp  178 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA--EMKLVHRDLAA  178 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH--HTTEECCCCSG
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH--HCCCcccccch
Confidence            9999999999999999976532                      23788999999999999999999  67799999999


Q ss_pred             CcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 014736          227 SNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP  305 (419)
Q Consensus       227 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~  305 (419)
                      +|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654433333334567899999999999999999999999999999999 9999986554


Q ss_pred             ccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          306 KSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                      ......+.       ..          .....+..++.++.+|+.+||+.||.+|||+.+|++.|+++...
T Consensus       259 ~~~~~~~~-------~~----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          259 ERLFNLLK-------TG----------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             GGHHHHHH-------TT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHHHhh-------cC----------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            32221111       11          01122334567899999999999999999999999999998764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8e-48  Score=362.74  Aligned_cols=265  Identities=26%  Similarity=0.336  Sum_probs=210.4

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      +.++|++.+.||+|+||.||+|..      ..+++.||+|++.....   ...+.+.+|+.++++++||||+++++++.+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~   82 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAED------TILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE   82 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEE------TTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred             hhccEEEEEEEccCCCEEEEEEEE------CCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence            356899999999999999999954      44578899999865432   234678899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      .+..|+||||++|++|.+++...  ..+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  158 (294)
T 4eqm_A           83 DDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAH--DMRIVHRDIKPQNILIDSNKTLKIFDFGIA  158 (294)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEEeCCCc
Confidence            99999999999999999999776  57899999999999999999999  677999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      ......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........      ......  ..
T Consensus       159 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~--~~  229 (294)
T 4eqm_A          159 KALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQD--SV  229 (294)
T ss_dssp             TTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHSS--CC
T ss_pred             ccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhhc--cC
Confidence            875433221 233456999999999999999999999999999999999999999865422110      000000  00


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhhcCc
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP-KMAAVVATLESLLNLK  377 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-s~~eil~~L~~l~~~~  377 (419)
                           +..........++.+.+++.+||+.||.+|| +++++.+.|..++...
T Consensus       230 -----~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          230 -----PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             -----CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             -----CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence                 0111112234567899999999999999998 9999999999887653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.7e-48  Score=369.20  Aligned_cols=255  Identities=24%  Similarity=0.361  Sum_probs=205.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-cHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|++.+.||+|+||.||+|...      .+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   79 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNR------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI   79 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhceeeeEEecCCCEEEEEEEEC------CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence            468999999999999999999643      45788999999754332 23567899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||+++++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (323)
T ss_dssp             EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccccchHHEEEeCCCCEEEEEeecccee
Confidence            99999999999999998655  56899999999999999999999  677999999999999999999999999999865


Q ss_pred             CCCCCceeeecccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHL-TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      .............||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ...+..    ..     
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~----~~-----  225 (323)
T 3tki_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKE----KK-----  225 (323)
T ss_dssp             EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHT----TC-----
T ss_pred             ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhc----cc-----
Confidence            44333333445679999999999987776 77999999999999999999999865433211 111110    00     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                           .........+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       226 -----~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          226 -----TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             -----TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -----ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                 0001112346789999999999999999999999763

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.6e-47  Score=366.56  Aligned_cols=275  Identities=20%  Similarity=0.219  Sum_probs=217.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-CcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~  168 (419)
                      .++|++.+.||+|+||.||+|..      ..+++.||||++.....  ...+.+|+.+++.+ +||||+++++++...+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   79 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKN------LYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY   79 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEE------TTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred             cCCeEEEEEeeccCCceEEEEEE------CCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence            46799999999999999999963      34578999999875432  24577899999999 89999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc-----EEEeccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT-----AKLSDFG  243 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfG  243 (419)
                      .++||||+ +++|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.     +||+|||
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH--~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg  155 (330)
T 2izr_A           80 NAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVH--SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA  155 (330)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred             cEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence            99999999 99999998764 357999999999999999999999  667999999999999999887     9999999


Q ss_pred             ccccCCCCCCce-----eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          244 LAKMGPEGSNTH-----VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       244 la~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      +++.........     ......||+.|+|||++.+..++.++|||||||++|||++|..||..................
T Consensus       156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~  235 (330)
T 2izr_A          156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT  235 (330)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred             cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence            998654432211     123467999999999999999999999999999999999999999876544433322221110


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCcccccc-CCCCC
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMAVS-CGQWP  387 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~~~~~-~~~~~  387 (419)
                      .... .     ..    ......+ ++.+|+.+||+.||.+||++.+|.+.|+.+....+.... ..+|.
T Consensus       236 ~~~~-~-----~~----~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  294 (330)
T 2izr_A          236 KRAT-P-----IE----VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI  294 (330)
T ss_dssp             HHHS-C-----HH----HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred             hccC-C-----HH----HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence            0000 0     00    0011134 899999999999999999999999999988775544433 33444

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-48  Score=377.43  Aligned_cols=270  Identities=27%  Similarity=0.368  Sum_probs=214.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|.+.+.||+|+||.||+|.+... .+..+++.||||++.... ......+.+|+.++++++||||+++++++.+.+.
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGM-PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccC-CCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            36789999999999999999986542 234567889999996542 3345578899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC---cEEEe
Q 014736          169 RLLVYEFMPRGSLENHLFKRIS-----VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF---TAKLS  240 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~---~~kl~  240 (419)
                      .|+||||+.+|+|.+++.....     ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++   .+||+
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            9999999999999999976532     35889999999999999999999  67799999999999999555   49999


Q ss_pred             ccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHh
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYL  319 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  319 (419)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.......   .....    
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~~~i----  299 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFV----  299 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHH----
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----
Confidence            9999975322222222334568999999999999999999999999999999998 999997654322   11111    


Q ss_pred             hcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCccc
Q 014736          320 RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDM  379 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~~  379 (419)
                      ....          ....+..++.++.+|+.+||+.||.+|||+.+|++.|+.+......
T Consensus       300 ~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~  349 (367)
T 3l9p_A          300 TSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV  349 (367)
T ss_dssp             HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             HcCC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence            1111          1112334567899999999999999999999999999998775443

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-47  Score=372.46  Aligned_cols=269  Identities=25%  Similarity=0.375  Sum_probs=219.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCccc-ccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCC-CcccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLR-QGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQL-RHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  166 (419)
                      .++|.+.++||+|+||.||+|....... ....+..||+|++..... .....+.+|+++++.+ +||||+++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            4689999999999999999998654211 224456899999975532 3346788999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRIS--------------VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD  232 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~  232 (419)
                      +..++||||+.+|+|.+++.....              ..+++..++.++.||+.||.|||  ++||+||||||+||||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVT  225 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEC
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCcceEEEc
Confidence            999999999999999999976532              35899999999999999999999  66799999999999999


Q ss_pred             CCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhH
Q 014736          233 SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNL  311 (419)
Q Consensus       233 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~  311 (419)
                      .++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||........   
T Consensus       226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~---  302 (382)
T 3tt0_A          226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL---  302 (382)
T ss_dssp             TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---
T ss_pred             CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---
Confidence            999999999999987655443333444568899999999999999999999999999999999 9999976542221   


Q ss_pred             HHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          312 VDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                      ...    ....          .....+..++.++.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus       303 ~~~----~~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          303 FKL----LKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             HHH----HHTT----------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             HHH----HHcC----------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            111    1111          011122345678999999999999999999999999999997654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.1e-46  Score=359.53  Aligned_cols=261  Identities=25%  Similarity=0.353  Sum_probs=212.4

Q ss_pred             CCHHHHHHHhcC----------CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcC
Q 014736           81 FQLSELRAITQN----------FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ  150 (419)
Q Consensus        81 ~~~~~~~~~~~~----------y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~  150 (419)
                      +...+++.+.+.          |...+.||+|+||.||+|...      .+++.||||++........+.+.+|+.+++.
T Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~   98 (321)
T 2c30_A           25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK------HSGRQVAVKMMDLRKQQRRELLFNEVVIMRD   98 (321)
T ss_dssp             CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEETTTCCSHHHHHHHHHHHTT
T ss_pred             CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEEC------CCCcEEEEEEEeccchhHHHHHHHHHHHHHh
Confidence            455555555543          667779999999999999643      3478999999987766667889999999999


Q ss_pred             CCcccccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 014736          151 LRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNIL  230 (419)
Q Consensus       151 l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIl  230 (419)
                      ++||||+++++++...+..++||||+++++|.+++..   ..+++..+..++.||+.||.|||  ++||+||||||+|||
T Consensus        99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIl  173 (321)
T 2c30_A           99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLH--AQGVIHRDIKSDSIL  173 (321)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEE
T ss_pred             CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEE
Confidence            9999999999999999999999999999999998864   36899999999999999999999  677999999999999


Q ss_pred             EcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchh
Q 014736          231 LDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQN  310 (419)
Q Consensus       231 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  310 (419)
                      ++.++.+||+|||++........  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......   
T Consensus       174 l~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---  248 (321)
T 2c30_A          174 LTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---  248 (321)
T ss_dssp             ECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---
T ss_pred             ECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence            99999999999999986544322  1234579999999999999999999999999999999999999997643221   


Q ss_pred             HHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          311 LVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      .....   . ..      ..+.+  ......+.++.+|+.+||+.||++|||+.++++.
T Consensus       249 ~~~~~---~-~~------~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          249 AMKRL---R-DS------PPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HHHHH---H-HS------SCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHH---h-cC------CCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11111   0 00      00111  1122346789999999999999999999999863

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6e-48  Score=372.58  Aligned_cols=249  Identities=27%  Similarity=0.355  Sum_probs=202.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC---CcccHHHHHHHHHHHcCC-CcccccceeeEEEe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE---GLQGHREWLAEVIFLGQL-RHPHLVRLIGYCCE  165 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  165 (419)
                      .++|++.++||+|+||.||+|...      .+++.||||++...   .......+.+|..+|..+ +||||+++++++.+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~------~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~   95 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVK------ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT   95 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEc------CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe
Confidence            468999999999999999999643      45788999999753   223456678899999887 79999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      .+..|+||||+.||+|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+||||+.++.+||+|||++
T Consensus        96 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NILl~~~g~ikL~DFG~a  171 (353)
T 3txo_A           96 PDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMC  171 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCCHHHEEECCCCCEEEccccce
Confidence            99999999999999999999776  56899999999999999999999  677999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      +......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+      ....   
T Consensus       172 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~~~---  240 (353)
T 3txo_A          172 KEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI------LNDE---  240 (353)
T ss_dssp             BCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC---
T ss_pred             eecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH------HcCC---
Confidence            8543222  1234567999999999999989999999999999999999999999865432211111      1110   


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKM------AAVVA  368 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~------~eil~  368 (419)
                               ..++...+.++.+||.+||+.||.+||++      .+|++
T Consensus       241 ---------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 ---------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                     11233356789999999999999999998      77765

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.8e-47  Score=362.56  Aligned_cols=267  Identities=26%  Similarity=0.431  Sum_probs=199.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC--CcccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .++|.+.+.||+|+||.||+|....+   ......||+|++...  .....+.+.+|+.+++.++||||+++++++....
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQE---DGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC----------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             hhHeEEeceecccCCeEEEEEEEccc---CCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            46899999999999999999975432   112237999999754  2344678999999999999999999999998776


Q ss_pred             ee------EEEEEecCCCChhhhhhhccC----CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcE
Q 014736          168 ER------LLVYEFMPRGSLENHLFKRIS----VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA  237 (419)
Q Consensus       168 ~~------~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~  237 (419)
                      ..      ++||||+.+++|.+++.....    ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--~~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS--SRNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTSCE
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH--cCCcccCCCCcceEEEcCCCCE
Confidence            55      999999999999999865432    25899999999999999999999  6679999999999999999999


Q ss_pred             EEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhh
Q 014736          238 KLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAK  316 (419)
Q Consensus       238 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  316 (419)
                      ||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+.   
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~---  253 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI---  253 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh---
Confidence            9999999987654443333334557889999999999999999999999999999999 999998755433211111   


Q ss_pred             HHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCcc
Q 014736          317 PYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKD  378 (419)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~  378 (419)
                          ...          ....+...+.++.+|+.+||+.||.+|||+.++++.|++++....
T Consensus       254 ----~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          254 ----GGN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             ----TTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             ----cCC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence                000          112233456789999999999999999999999999999987543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-47  Score=367.13  Aligned_cols=269  Identities=25%  Similarity=0.377  Sum_probs=216.3

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      ...++|.+.+.||+|+||.||+|...+. ....+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGL-LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETS-STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCc-CCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            3457899999999999999999986542 1224568899999976533 3356789999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhcc----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 014736          167 EERLLVYEFMPRGSLENHLFKRI----------------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDF  224 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dl  224 (419)
                      +..|+||||+++++|.+++....                      ...+++..++.++.||+.||.|||  ++||+||||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dl  200 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDL  200 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCC
Confidence            99999999999999999997642                      156889999999999999999999  667999999


Q ss_pred             CCCcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 014736          225 KTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKL  303 (419)
Q Consensus       225 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~  303 (419)
                      ||+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999976543322222334568999999999998999999999999999999999 99999765


Q ss_pred             CCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          304 RPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                      ....   ....    .....          ....+..++.++.+|+.+||+.||.+|||+.+|++.|+++...
T Consensus       281 ~~~~---~~~~----~~~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          281 AHEE---VIYY----VRDGN----------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             CHHH---HHHH----HHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             ChHH---HHHH----HhCCC----------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            4221   1111    11110          0112334567899999999999999999999999999998764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.4e-47  Score=363.09  Aligned_cols=264  Identities=24%  Similarity=0.379  Sum_probs=208.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|++.++||+|+||.||+|.+..+  ......+||+|.+.... ....+.+.+|+.++++++||||+++++++.+.. .
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~   91 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCC--CceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence            5789999999999999999976542  12223457888886432 344578999999999999999999999998754 7


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+.+|+|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++...
T Consensus        92 ~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            8999999999999998764 356899999999999999999999  5679999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ............||..|+|||++.+..++.++|||||||++|+|++ |+.||...........+.       ..      
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-------~~------  235 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KG------  235 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TT------
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-------cC------
Confidence            4443333344567889999999999999999999999999999999 999998765433222211       11      


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                          .....+..++.++.+|+.+||+.||.+||++.++++.|+.+....
T Consensus       236 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          236 ----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             ----CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             ----CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence                111223345678999999999999999999999999999887643

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.7e-47  Score=358.01  Aligned_cols=272  Identities=26%  Similarity=0.359  Sum_probs=212.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeC--C
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCED--E  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~  167 (419)
                      .++|++.+.||+|+||.||+|.+..  .+..+++.||||++........+.+.+|+.+++.++||||+++++++...  .
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECT--TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred             HHHhhhhheeeccCCEEEEEEEEec--ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            4689999999999999999997543  24456789999999876666667899999999999999999999998553  5


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             ceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            6899999999999999997652 35899999999999999999999  67799999999999999999999999999987


Q ss_pred             CCCCCCc-eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcc---------chhHHHhhhH
Q 014736          248 GPEGSNT-HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKS---------EQNLVDWAKP  317 (419)
Q Consensus       248 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---------~~~~~~~~~~  317 (419)
                      ....... .......++..|+|||++.+..++.++||||||+++|+|++|..||.......         ..........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            5443221 12233457888999999999999999999999999999999999986532110         0000000011


Q ss_pred             HhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          318 YLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                      ...          .......+..++.++.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       244 ~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          244 LLK----------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHH----------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHh----------ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            111          1111223345568899999999999999999999999999998653

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.2e-47  Score=364.77  Aligned_cols=264  Identities=26%  Similarity=0.419  Sum_probs=209.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|++.++||+|+||.||+|.+..+  ......+||+|++.... ......+.+|+.+++.++||||+++++++. ++..
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   89 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPE--GESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL   89 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCT--TCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCC--CceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence            5788999999999999999976542  12223458888885432 233356678999999999999999999886 5678


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+.+|+|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHH--HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHH--hCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            9999999999999998654 246788899999999999999999  6679999999999999999999999999999876


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ............||..|+|||++.+..++.++||||||+++|+|++ |..||...........+.       ....    
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~----  235 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-------KGER----  235 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-------TTCB----
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-------cCCC----
Confidence            5544444455668889999999998999999999999999999999 999998765433222221       1100    


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                            ...+..++.++.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus       236 ------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          236 ------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             ------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             ------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                  1112223456889999999999999999999999999987654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.8e-47  Score=376.13  Aligned_cols=256  Identities=22%  Similarity=0.296  Sum_probs=207.5

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEE
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCC  164 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  164 (419)
                      ..+.++|++.+.||+|+||.||+|..      ..+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++.
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~------~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~   80 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVK------VLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS   80 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEE------TTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEE------CCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence            34567899999999999999999953      44578999999976543  23466889999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc---CCCcEEEec
Q 014736          165 EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD---SDFTAKLSD  241 (419)
Q Consensus       165 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~---~~~~~kl~D  241 (419)
                      +.+..|+||||+.||+|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++   .++.+||+|
T Consensus        81 ~~~~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH--~~givHrDlKp~NIll~~~~~~~~vkL~D  156 (444)
T 3soa_A           81 EEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCH--QMGVVHRNLKPENLLLASKLKGAAVKLAD  156 (444)
T ss_dssp             CSSEEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSSTTEEESBSSTTCCEEECC
T ss_pred             ECCEEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEeccCCCCcEEEcc
Confidence            999999999999999999999776  56899999999999999999999  67799999999999998   467899999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhc
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS  321 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  321 (419)
                      ||++........  ......||+.|+|||++.+..|+.++|||||||++|+|++|.+||...........+      ...
T Consensus       157 FG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~  228 (444)
T 3soa_A          157 FGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI------KAG  228 (444)
T ss_dssp             CSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HHT
T ss_pred             CceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHH------HhC
Confidence            999987554322  233467999999999999999999999999999999999999999764322111111      000


Q ss_pred             ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          322 SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       322 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .  .      ..........++++.+|+.+||+.||.+|||+.++++
T Consensus       229 ~--~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          229 A--Y------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             C--C------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             C--C------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0  0      0011111234678999999999999999999999986

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4e-47  Score=361.79  Aligned_cols=245  Identities=27%  Similarity=0.384  Sum_probs=205.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++.+.||+|+||.||+|..      ..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~   79 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRS------RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   79 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             HHcEEEEEEeeCCCEEEEEEEE------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC
Confidence            5789999999999999999964      3457899999997532   234567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||++||+|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~  155 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKY  155 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChheEEEcCCCCEEEeecCccee
Confidence            999999999999999999765  56899999999999999999999  67899999999999999999999999999986


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ....     ....+||+.|+|||++.+..++.++|||||||++|+|++|..||........   .   .......     
T Consensus       156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~---~~i~~~~-----  219 (318)
T 1fot_A          156 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---Y---EKILNAE-----  219 (318)
T ss_dssp             CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H---HHHHHCC-----
T ss_pred             cCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---H---HHHHhCC-----
Confidence            5432     2345799999999999999999999999999999999999999976432211   1   1111110     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~  368 (419)
                             ..++...+.++.+|+.+||..||.+||     ++++|++
T Consensus       220 -------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          220 -------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -------CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                   012334567899999999999999999     8888874

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.5e-47  Score=369.84  Aligned_cols=250  Identities=27%  Similarity=0.375  Sum_probs=207.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|.+.+.||+|+||.||+|..      ..+++.||+|++....   ......+.+|+.+|+.++||||++++++|.+.+
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~------~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   88 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQK------NDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE   88 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEE------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             HHeEEEEEEeeCCCeEEEEEEE------CCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            5799999999999999999964      3457889999996432   234567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+.||+|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+||||+.++.+||+|||++..
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~vkL~DFG~a~~  164 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQ--NQRIIHRDMKPDNILLDEHGHVHITDFNIAAM  164 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCcHHHeEECCCCCEEEeccceeee
Confidence            999999999999999999765  57899999999999999999999  67799999999999999999999999999987


Q ss_pred             CCCCCCceeeecccccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYIST---GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      .....   .....+||+.|+|||++.+   ..|+.++|||||||++|+|++|+.||.................   .   
T Consensus       165 ~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~---~---  235 (384)
T 4fr4_A          165 LPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET---T---  235 (384)
T ss_dssp             CCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH---C---
T ss_pred             ccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh---c---
Confidence            54432   2345679999999999863   4689999999999999999999999986554433322221110   0   


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK-MAAVVA  368 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs-~~eil~  368 (419)
                               ...++..++.++.+||.+||+.||.+||+ +++|++
T Consensus       236 ---------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 ---------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ---------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                     11233445688999999999999999998 666654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.5e-47  Score=361.86  Aligned_cols=267  Identities=28%  Similarity=0.375  Sum_probs=218.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCC-CcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  167 (419)
                      .++|.+.+.||+|+||.||+|.+... .+...++.||+|++..... ...+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGL-IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeec-cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            46799999999999999999976432 2345678899999976543 3456788999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccC----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 014736          168 ERLLVYEFMPRGSLENHLFKRIS----------------VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL  231 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~----------------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll  231 (419)
                      ..++||||+++|+|.+++.....                ..+++..++.++.||+.||.|||  ++||+||||||+|||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILL  178 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCccceEEE
Confidence            99999999999999999976532                24899999999999999999999  6779999999999999


Q ss_pred             cCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchh
Q 014736          232 DSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQN  310 (419)
Q Consensus       232 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~  310 (419)
                      +.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||......... 
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-  257 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-  257 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH-
Confidence            9999999999999987665544434445568889999999999999999999999999999999 99999865432211 


Q ss_pred             HHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          311 LVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                       ....    ...          .....+...+.++.+|+.+||+.||.+|||+.+|++.|++++.
T Consensus       258 -~~~~----~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          258 -YKMI----KEG----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             -HHHH----HHT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHh----ccC----------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence             1100    000          0111223346789999999999999999999999999998865

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-47  Score=367.75  Aligned_cols=268  Identities=25%  Similarity=0.374  Sum_probs=215.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCC-CcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  167 (419)
                      .++|.+.+.||+|+||.||+|..... .....++.||+|++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGI-SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESC-SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeecc-ccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            46899999999999999999986432 223456789999997542 23456788999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccC---------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 014736          168 ERLLVYEFMPRGSLENHLFKRIS---------------------VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKT  226 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp  226 (419)
                      ..|+||||+++|+|.+++.....                     ..+++..++.++.||+.||.|||  .+||+||||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp  200 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAA  200 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH--HTTEEETTCSG
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCh
Confidence            99999999999999999976532                     23788999999999999999999  67799999999


Q ss_pred             CcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 014736          227 SNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP  305 (419)
Q Consensus       227 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~  305 (419)
                      +|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            999999999999999999987654444334445568899999999999999999999999999999998 9999987543


Q ss_pred             ccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          306 KSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                      ....  ...    ....          .....+...+.++.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       281 ~~~~--~~~----~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          281 DANF--YKL----IQNG----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             SHHH--HHH----HHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             HHHH--HHH----HhcC----------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            2211  110    1111          11122334467899999999999999999999999999998764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-46  Score=356.11  Aligned_cols=275  Identities=21%  Similarity=0.271  Sum_probs=215.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCC-
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE-  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-  167 (419)
                      .++|.+.++||+|+||.||+|...      .+++.||||++.... ....+.+.+|+++++.++||||+++++++.... 
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHK------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CCCEEEEEEecCCCCeEEEEEEEC------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence            367999999999999999999644      347889999997543 234577889999999999999999999998765 


Q ss_pred             -eeEEEEEecCCCChhhhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE----cCCCcEEEec
Q 014736          168 -ERLLVYEFMPRGSLENHLFKRIS-VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL----DSDFTAKLSD  241 (419)
Q Consensus       168 -~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll----~~~~~~kl~D  241 (419)
                       ..++||||+++++|.+++..... ..+++..++.++.||+.||.|||  ++||+||||||+|||+    +.++.+||+|
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence             78999999999999999976533 34899999999999999999999  6779999999999999    7788899999


Q ss_pred             cCccccCCCCCCceeeeccccccccccccccc--------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHH
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS--------TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD  313 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  313 (419)
                      ||+++.......   .....||+.|+|||++.        +..++.++|||||||++|+|++|+.||.............
T Consensus       160 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  236 (319)
T 4euu_A          160 FGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM  236 (319)
T ss_dssp             CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred             CCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence            999987654432   23456999999999986        5789999999999999999999999997654433222111


Q ss_pred             hhhHHhhcccc-----------cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          314 WAKPYLRSSRR-----------LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       314 ~~~~~~~~~~~-----------~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      ...........           +...........+....+..+.+|+.+||+.||++|||+.|+++.......
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            11000000000           000001112234567888999999999999999999999999998876543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-47  Score=363.20  Aligned_cols=253  Identities=21%  Similarity=0.296  Sum_probs=206.5

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc------ccHHHHHHHHHHHcCCCcccccceeeE
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL------QGHREWLAEVIFLGQLRHPHLVRLIGY  162 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~  162 (419)
                      +.++|.+.+.||+|+||.||+|..      ..+++.||+|++.....      ...+.+.+|+.+|+.++||||++++++
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~------~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   82 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCRE------KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV   82 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEE------TTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccceEeceEEeeCCCeEEEEEEE------CCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            346799999999999999999964      34578899999975432      135778999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC----cEE
Q 014736          163 CCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF----TAK  238 (419)
Q Consensus       163 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~----~~k  238 (419)
                      +.+.+..|+||||+++++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++    .+|
T Consensus        83 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~NIll~~~~~~~~~~k  158 (326)
T 2y0a_A           83 YENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIK  158 (326)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCSSSSSCCEE
T ss_pred             EEeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH--HCCeEcCCCCHHHEEEecCCCCCCCEE
Confidence            99999999999999999999999764  57899999999999999999999  67799999999999999887    799


Q ss_pred             EeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          239 LSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       239 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      |+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.     
T Consensus       159 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-----  230 (326)
T 2y0a_A          159 IIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS-----  230 (326)
T ss_dssp             ECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-----
T ss_pred             EEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH-----
Confidence            999999987644322   234569999999999998999999999999999999999999997643221111110     


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       .....        ....+....+.++.+|+.+||+.||.+|||+.++++
T Consensus       231 -~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          231 -AVNYE--------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             -HTCCC--------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -hcCCC--------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             00000        000011123578999999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.1e-47  Score=374.50  Aligned_cols=260  Identities=25%  Similarity=0.402  Sum_probs=210.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|.+.+.||+|+||.||+|.+..      +++.||||++..... .....+.+|+.+|+.++||||+++++++.+.+.
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  186 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRA------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP  186 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEec------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence            4678899999999999999997543      467899999875432 233568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||+++|+|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++..
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~  263 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE  263 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             cEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence            99999999999999999754 235889999999999999999999  677999999999999999999999999999864


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      .............++..|+|||++.++.++.++|||||||++|||++ |..||...........       .....    
T Consensus       264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~-------~~~~~----  332 (377)
T 3cbl_A          264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF-------VEKGG----  332 (377)
T ss_dssp             TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH-------HHTTC----
T ss_pred             CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCC----
Confidence            43221111112235778999999998999999999999999999998 9999986543221111       11111    


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                            ....+..++.++.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       333 ------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          333 ------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence                  112233456789999999999999999999999999998854

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8.5e-47  Score=369.14  Aligned_cols=250  Identities=25%  Similarity=0.363  Sum_probs=200.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCC-CcccccceeeEEEeC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQL-RHPHLVRLIGYCCED  166 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  166 (419)
                      ++|+++++||+|+||.||+|...      .+++.||+|++.....   .....+.+|..+|.++ +||||++++++|.+.
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~------~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~  125 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLK------KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE  125 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             hHcEEEEEEeeCCCeEEEEEEEC------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC
Confidence            57999999999999999999644      4578899999975422   2334577899999876 899999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..|+||||+.||+|..++...  ..+++..++.++.||+.||.|||  ++||+||||||+||||+.++.+||+|||+++
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH--~~givHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             CEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEEeccCCHHHEEECCCCCEEEeecceee
Confidence            9999999999999999999775  57899999999999999999999  6779999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccc--hhHHHhhhHHhhcccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSE--QNLVDWAKPYLRSSRR  324 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~  324 (419)
                      ......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||........  .............   
T Consensus       202 ~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~---  276 (396)
T 4dc2_A          202 EGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---  276 (396)
T ss_dssp             CCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH---
T ss_pred             ecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc---
Confidence            533222  124456899999999999999999999999999999999999999975432211  0011111100000   


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKM  363 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~  363 (419)
                            .  .-.++...+.++.+||.+||+.||.+||++
T Consensus       277 ------~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          277 ------K--QIRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             ------C--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ------c--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                  0  012334456789999999999999999985

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-47  Score=362.68  Aligned_cols=253  Identities=19%  Similarity=0.255  Sum_probs=207.0

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      +.++|.+.+.||+|+||.||+|..      ..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   75 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVE------TSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEE   75 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEE------TTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEE------CCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCE
Confidence            357899999999999999999964      3457889999997543 345668899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC--CCcEEEeccCccc
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS--DFTAKLSDFGLAK  246 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~  246 (419)
                      .|+||||++|++|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.  ++.+||+|||++.
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH--~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~  152 (321)
T 1tki_A           76 LVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence            99999999999999998654 246899999999999999999999  677999999999999987  7899999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      .......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+      ....... 
T Consensus       153 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------~~~~~~~-  222 (321)
T 1tki_A          153 QLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI------MNAEYTF-  222 (321)
T ss_dssp             ECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHTCCCC-
T ss_pred             ECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH------HcCCCCC-
Confidence            7654432   33456999999999999888999999999999999999999999765432211111      1100000 


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                         ...    .....+.++.+|+.+||..||.+|||+.++++
T Consensus       223 ---~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          223 ---DEE----AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---CHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---Chh----hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               000    00124578999999999999999999999997

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.4e-47  Score=364.75  Aligned_cols=247  Identities=24%  Similarity=0.340  Sum_probs=204.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .+|.+.+.||+|+||.||+|..      ..+++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   82 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATH------YKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT   82 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEE------TTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCEEEEEEEecCCCeEEEEEEE------CCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            5799999999999999999954      4457899999986432   122457889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..++||||+ +|+|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~  157 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCH--RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI  157 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HHTCCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred             EEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCchhhEEEcCCCCEEEEEecccee
Confidence            999999999 78999998766  57899999999999999999999  66799999999999999999999999999987


Q ss_pred             CCCCCCceeeecccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHL-TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ......   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+              
T Consensus       158 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--------------  220 (336)
T 3h4j_B          158 MTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--------------  220 (336)
T ss_dssp             TTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--------------
T ss_pred             ccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--------------
Confidence            554332   234579999999999988776 78999999999999999999999764332211100              


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                        .  .....++...+.++.+|+.+||+.||.+|||+.++++.
T Consensus       221 --~--~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          221 --N--SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             --C--SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             --H--cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence              0  00112233456789999999999999999999999873

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6e-47  Score=367.13  Aligned_cols=255  Identities=23%  Similarity=0.323  Sum_probs=207.4

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEE
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCC  164 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  164 (419)
                      ..+.++|.+.+.||+|+||.||+|..      ..+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++.
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~~~~------~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~   98 (362)
T 2bdw_A           25 TKFSDNYDVKEELGKGAFSVVRRCVH------KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ   98 (362)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEE------TTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCcccCeEEeeEEecCCCeEEEEEEE------CCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            34567899999999999999999964      34578999999975533  33467889999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC---cEEEec
Q 014736          165 EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF---TAKLSD  241 (419)
Q Consensus       165 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~---~~kl~D  241 (419)
                      +.+..|+||||+.||+|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++   .+||+|
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~Dlkp~NIll~~~~~~~~~kl~D  174 (362)
T 2bdw_A           99 EESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLAD  174 (362)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred             eCCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCchHHEEEecCCCCCCEEEee
Confidence            999999999999999999998765  56899999999999999999999  66799999999999998654   599999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhc
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS  321 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  321 (419)
                      ||++........   .....||+.|+|||++.+..|+.++|||||||++|+|++|..||.......   .....   ...
T Consensus       175 fG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~i---~~~  245 (362)
T 2bdw_A          175 FGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQI---KAG  245 (362)
T ss_dssp             CTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HHT
T ss_pred             cCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH---HhC
Confidence            999987654322   234579999999999999899999999999999999999999997643221   11111   000


Q ss_pred             ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          322 SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       322 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .  ..      ........++.++.+||.+||+.||.+||++.++++
T Consensus       246 ~--~~------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          246 A--YD------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             C--CC------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             C--CC------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0  00      000111234678999999999999999999999975

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=7.2e-47  Score=364.92  Aligned_cols=249  Identities=25%  Similarity=0.334  Sum_probs=205.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCC-CcccccceeeEEEe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCE  165 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  165 (419)
                      .++|.+.++||+|+||.||+|...      .+++.||+|++....   ....+.+..|..+|..+ +||||+++++++.+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~   92 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERK------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT   92 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEET------TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEEC------CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc
Confidence            468999999999999999999644      346889999997542   23456788999999988 79999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      .+..|+||||++||+|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~vkL~DFG~a  168 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMC  168 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence            99999999999999999999765  46899999999999999999999  677999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      +.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ...   ......   
T Consensus       169 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~---~i~~~~---  237 (353)
T 2i0e_A          169 KENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQ---SIMEHN---  237 (353)
T ss_dssp             BCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHCC---
T ss_pred             cccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HHH---HHHhCC---
Confidence            86432221  2345679999999999999999999999999999999999999997643221   111   111110   


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK-----MAAVVA  368 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs-----~~eil~  368 (419)
                               ..++...+.++.+||.+||..||.+||+     +.+|++
T Consensus       238 ---------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          238 ---------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             ---------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                     1223345688999999999999999995     566654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.5e-47  Score=367.19  Aligned_cols=265  Identities=27%  Similarity=0.461  Sum_probs=203.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|.+.+.||+|+||.||+|.....   ...+..||||++.... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLP---SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCT---TSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecC---CCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            5899999999999999999965421   2346789999997543 23456799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+++++|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++...
T Consensus       122 ~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            9999999999999999754 346899999999999999999999  6779999999999999999999999999998754


Q ss_pred             CCCCce-eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          250 EGSNTH-VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       250 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ...... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.......   .....    ...     
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~~~i----~~~-----  266 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VIKAV----DEG-----  266 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HHHHH----HTT-----
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcC-----
Confidence            432211 1122346778999999999999999999999999999998 999997654221   11111    111     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCcc
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKD  378 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~  378 (419)
                           .....+..++.++.+|+.+||+.||.+||++.+|++.|+.+.....
T Consensus       267 -----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~  312 (373)
T 2qol_A          267 -----YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG  312 (373)
T ss_dssp             -----EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred             -----CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence                 0111223456789999999999999999999999999999977543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-46  Score=366.84  Aligned_cols=253  Identities=20%  Similarity=0.277  Sum_probs=208.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .++|.+.+.||+|+||.||+|..      ..+++.||+|++..........+.+|+.+|+.++||||+++++++.+.+..
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~------~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  123 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVE------KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  123 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEE------TTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEE------CCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence            46899999999999999999964      345788999999866555566788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC--CCcEEEeccCcccc
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS--DFTAKLSDFGLAKM  247 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~  247 (419)
                      ++||||+.+++|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.  ++.+||+|||++..
T Consensus       124 ~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccchHHeEEecCCCCceEEEeccccee
Confidence            9999999999999988654 346899999999999999999999  677999999999999974  47799999999987


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......   .....   ....     
T Consensus       201 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~i---~~~~-----  266 (387)
T 1kob_A          201 LNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNV---KRCD-----  266 (387)
T ss_dssp             CCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHH---HHCC-----
T ss_pred             cCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---HHHHH---HhCC-----
Confidence            654332   233469999999999999999999999999999999999999998643221   11111   0000     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                         ...........+.++.+||.+||+.||.+|||+.++++
T Consensus       267 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          267 ---WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             ---CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ---CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence               00111122345678999999999999999999999986

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=7.4e-47  Score=364.67  Aligned_cols=245  Identities=23%  Similarity=0.284  Sum_probs=205.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++++.||+|+||.||+|...      .+++.||+|++....   ....+.+.+|+.+|+.++||||+++++++.+.+
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  114 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHK------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             HHCEEEEEeecCcCcEEEEEEEC------CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            57999999999999999999643      457899999996432   234567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||++||+|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++.
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~  190 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCccceEEECCCCCEEEccccccee
Confidence            999999999999999999876  56899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ....     ....+||+.|+|||++.+..++.++|||||||++|+|++|..||........   ..   ......     
T Consensus       191 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~---~i~~~~-----  254 (350)
T 1rdq_E          191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---YE---KIVSGK-----  254 (350)
T ss_dssp             CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HHHHCC-----
T ss_pred             ccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH---HH---HHHcCC-----
Confidence            5432     2345699999999999999999999999999999999999999976432211   11   111110     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK-----MAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs-----~~eil~  368 (419)
                             ..++...+.++.+||.+||+.||.+||+     +++|++
T Consensus       255 -------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          255 -------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                   0123345678999999999999999998     888865

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.1e-47  Score=351.74  Aligned_cols=257  Identities=26%  Similarity=0.432  Sum_probs=210.5

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|++.+.||+|+||.||+|...+       ++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLN-------KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   81 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-------TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hhceeeheecCCCccEEEEEEecC-------CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence            578899999999999999997543       4679999997543 34567899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+++++|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++.....
T Consensus        82 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             EEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             EEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHH--hCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            999999999999998654 346899999999999999999999  67799999999999999999999999999986543


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      .... ......||..|+|||++.+..++.++||||||+++|+|++ |..||...........+      . ..       
T Consensus       159 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~------~-~~-------  223 (269)
T 4hcu_A          159 DQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI------S-TG-------  223 (269)
T ss_dssp             HHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------H-TT-------
T ss_pred             cccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH------h-cC-------
Confidence            2211 1223457788999999998999999999999999999999 99999865432211111      0 00       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                         .....+...+.++.+|+.+||+.||.+|||+.++++.|+.+.+.
T Consensus       224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          224 ---FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ---ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence               01112223457899999999999999999999999999988653

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2e-47  Score=367.64  Aligned_cols=249  Identities=27%  Similarity=0.353  Sum_probs=204.9

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCC-CcccccceeeEEE
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQL-RHPHLVRLIGYCC  164 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  164 (419)
                      ..++|.+.+.||+|+||.||+|...      .+++.||+|++....   ......+..|..++..+ +||||+++++++.
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~   88 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFK------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ   88 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEET------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEEC------CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence            3468999999999999999999643      457889999997532   23456678899999876 8999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCc
Q 014736          165 EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL  244 (419)
Q Consensus       165 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  244 (419)
                      +.+..|+||||++||+|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+
T Consensus        89 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~vkL~DFG~  164 (345)
T 1xjd_A           89 TKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGM  164 (345)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCChhhEEECCCCCEEEeEChh
Confidence            999999999999999999999765  56899999999999999999999  67799999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          245 AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       245 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      ++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+      ....  
T Consensus       165 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~~~--  234 (345)
T 1xjd_A          165 CKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI------RMDN--  234 (345)
T ss_dssp             CBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC--
T ss_pred             hhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------HhCC--
Confidence            986433221  234567999999999999999999999999999999999999999764422111111      0000  


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMA-AVV  367 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~-eil  367 (419)
                                ..++...+.++.+||.+||+.||.+||++. +|+
T Consensus       235 ----------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 ----------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ----------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ----------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                      112333567899999999999999999997 664

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=9.7e-47  Score=350.10  Aligned_cols=259  Identities=24%  Similarity=0.401  Sum_probs=211.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .++|++.+.||+|+||.||+|.+.+       +..||+|++..... ....+.+|+.++..++||||+++++++.+.+..
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKG-------QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             hhheeeeeeeccCCCceEEEEEecC-------ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            4679999999999999999996543       45699999975433 456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+++++|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++....
T Consensus        79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  155 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLE--SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL  155 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHH--HTTEEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred             EEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCcCcceEEECCCCCEEEccCccceecc
Confidence            9999999999999999765 235899999999999999999999  6779999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+.       ...     
T Consensus       156 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------~~~-----  222 (268)
T 3sxs_A          156 DDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-------QGH-----  222 (268)
T ss_dssp             TTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-------TTC-----
T ss_pred             hhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-------cCC-----
Confidence            44322 2233457788999999998899999999999999999999 999997654322111110       000     


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                           ....+...++++.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus       223 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          223 -----RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             -----CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence                 01112223578999999999999999999999999999986643

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.8e-47  Score=367.15  Aligned_cols=255  Identities=24%  Similarity=0.336  Sum_probs=204.7

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-----cccHHHHHHHHHHHcCCCcccccceeeEE
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-----LQGHREWLAEVIFLGQLRHPHLVRLIGYC  163 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  163 (419)
                      +.++|++.+.||+|+||.||+|..      ..+++.||||++....     ....+.+.+|+.+++.++||||+++++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   95 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCIN------RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY   95 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEE------TTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEE------CCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            456799999999999999999964      3457899999986431     12457789999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc---EE
Q 014736          164 CEDEERLLVYEFMPRGSLENHLFKRI--SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT---AK  238 (419)
Q Consensus       164 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~---~k  238 (419)
                      .+++..|+||||++|++|.+++....  ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.   +|
T Consensus        96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivHrDlkp~NIl~~~~~~~~~vk  173 (351)
T 3c0i_A           96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH--DNNIIHRDVKPHCVLLASKENSAPVK  173 (351)
T ss_dssp             EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECSSSTTCCEE
T ss_pred             EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCChHHeEEecCCCCCcEE
Confidence            99999999999999999998886542  345899999999999999999999  677999999999999987655   99


Q ss_pred             EeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          239 LSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       239 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      |+|||++........  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.....    ....   ..
T Consensus       174 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~---~i  244 (351)
T 3c0i_A          174 LGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFE---GI  244 (351)
T ss_dssp             ECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHH---HH
T ss_pred             EecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHH---HH
Confidence            999999987654322  23345799999999999999999999999999999999999999976321    1111   00


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ......    ..+...    ...+.++.+|+.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~----~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          245 IKGKYK----MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHTCCC----CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HcCCCC----CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000000    000000    123578999999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.5e-46  Score=364.72  Aligned_cols=286  Identities=16%  Similarity=0.167  Sum_probs=214.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc-----------HHHHHHHHHHHcCCCcccccc
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-----------HREWLAEVIFLGQLRHPHLVR  158 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpnIv~  158 (419)
                      .++|.+.++||+|+||.||+|.+..+ .....++.||||++.......           ...+..|+..+..++||||++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSS-ESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCS-SCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCc-cccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            45899999999999999999977553 223456889999987553211           122455777788899999999


Q ss_pred             eeeEEEeC----CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc--
Q 014736          159 LIGYCCED----EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD--  232 (419)
Q Consensus       159 ~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--  232 (419)
                      +++++...    ...||||||+ |++|.+++... ...+++..++.++.||+.||.|||  .+||+||||||+|||++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH--~~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIH--EHEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeEEecCCHHHEEEecC
Confidence            99998765    4589999999 99999998764 356999999999999999999999  56799999999999999  


Q ss_pred             CCCcEEEeccCccccCCCCCCce-----eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcc
Q 014736          233 SDFTAKLSDFGLAKMGPEGSNTH-----VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKS  307 (419)
Q Consensus       233 ~~~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  307 (419)
                      .++.+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            88999999999997654322111     1133459999999999999999999999999999999999999998643322


Q ss_pred             chhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCcccccc-CCCC
Q 014736          308 EQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMAVS-CGQW  386 (419)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~~~~~-~~~~  386 (419)
                      ..  ........  ...+..+.++.+.   ....+.++.+|+.+||+.||.+||++.+|++.|..++........ ..+|
T Consensus       269 ~~--~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  341 (364)
T 3op5_A          269 KY--VRDSKIRY--RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL  341 (364)
T ss_dssp             HH--HHHHHHHH--HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred             HH--HHHHHHHh--hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence            11  11111110  1111222222221   123357899999999999999999999999999998875554443 3344


Q ss_pred             C
Q 014736          387 P  387 (419)
Q Consensus       387 ~  387 (419)
                      .
T Consensus       342 ~  342 (364)
T 3op5_A          342 S  342 (364)
T ss_dssp             -
T ss_pred             E
Confidence            3

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.2e-46  Score=352.82  Aligned_cols=268  Identities=18%  Similarity=0.213  Sum_probs=214.8

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-CcccccceeeEEEeCC
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDE  167 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  167 (419)
                      +.++|.+.+.||+|+||.||+|..      ..+++.||+|++....  ....+.+|+.+++.+ +|+||+++++++.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   79 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTN------LLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   79 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEE------TTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             cccceEEEEEEeecCCEEEEEEEE------CCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence            346899999999999999999964      3457899999986443  234577899999999 7999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc-----EEEecc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT-----AKLSDF  242 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Df  242 (419)
                      ..++||||+ +++|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.     +||+||
T Consensus        80 ~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df  155 (298)
T 1csn_A           80 HNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF  155 (298)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             eeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence            999999999 99999999764 346899999999999999999999  678999999999999987776     999999


Q ss_pred             CccccCCCCCCc-----eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH
Q 014736          243 GLAKMGPEGSNT-----HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP  317 (419)
Q Consensus       243 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~  317 (419)
                      |++.........     .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.................
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (298)
T 1csn_A          156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  235 (298)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence            999875543221     112345799999999999999999999999999999999999999987654443332222111


Q ss_pred             HhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCcc
Q 014736          318 YLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKD  378 (419)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~  378 (419)
                      ..... ..     +    .....+++++.+|+.+||+.||.+||++.+|++.|+++.....
T Consensus       236 ~~~~~-~~-----~----~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          236 KKQST-PL-----R----ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             HHHHS-CH-----H----HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             hccCc-cH-----H----HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            00000 00     0    0111345789999999999999999999999999999877443

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-46  Score=357.02  Aligned_cols=264  Identities=24%  Similarity=0.376  Sum_probs=206.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC-CcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|++.++||+|+||.||+|.+..+  ......+||+|.+... .......+.+|+.+++.++||||+++++++.... .
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~   91 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCT--TCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCC--CceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence            5799999999999999999976542  1122345788887543 3345678999999999999999999999998754 7


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+.+|+|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++....
T Consensus        92 ~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             eEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh--hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            8999999999999998764 346899999999999999999999  6679999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ............||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.       ..      
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-------~~------  235 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KG------  235 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TT------
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cC------
Confidence            4443333344557889999999999999999999999999999999 999998765433222111       11      


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                          .....+..++.++.+|+.+||+.||.+|||+.++++.|..+....
T Consensus       236 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          236 ----ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             ----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             ----CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence                111223345678999999999999999999999999999997654

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.8e-46  Score=371.82  Aligned_cols=253  Identities=28%  Similarity=0.412  Sum_probs=210.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCC-e
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE-E  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~  168 (419)
                      .++|++.+.||+|+||.||+|.+.        ++.||||+++...  ..+.|.+|+.+|++++||||+++++++.+.. .
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            457888999999999999999653        4679999997543  4578999999999999999999999987765 7


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||+++|+|.+++.......+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++..
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  339 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  339 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence            899999999999999998775556799999999999999999999  677999999999999999999999999999854


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ....     ....++..|+|||++.+..++.++||||||+++|||++ |+.||...........+.       ..     
T Consensus       340 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-------~~-----  402 (450)
T 1k9a_A          340 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KG-----  402 (450)
T ss_dssp             C-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-------TT-----
T ss_pred             cccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cC-----
Confidence            3221     22357889999999999999999999999999999998 999998765433221111       11     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                           .....+..++.++.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       403 -----~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          403 -----YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -----CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                 11122344568899999999999999999999999999988654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.1e-47  Score=362.12  Aligned_cols=271  Identities=24%  Similarity=0.378  Sum_probs=217.0

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      +...++|.+.+.||+|+||.||+|.+... .....++.||+|++..... .....+.+|+.+++.++||||+++++++.+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGV-VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEE-ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCc-cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            34457899999999999999999976532 1224567899999975432 334578899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhcc--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcE
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRI--------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA  237 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~  237 (419)
                      .+..++||||+.+++|.+++....        ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCSGGGEEECTTCCE
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCCccCCCccceEEEcCCCeE
Confidence            999999999999999999986532        145688999999999999999999  6679999999999999999999


Q ss_pred             EEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhh
Q 014736          238 KLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAK  316 (419)
Q Consensus       238 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  316 (419)
                      ||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||........   ...  
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~--  252 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---LRF--  252 (322)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH---HHH--
T ss_pred             EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH---HHH--
Confidence            9999999986543332222233457889999999998999999999999999999999 8999976532211   111  


Q ss_pred             HHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          317 PYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                        .....          ....+..++.++.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus       253 --~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~  301 (322)
T 1p4o_A          253 --VMEGG----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  301 (322)
T ss_dssp             --HHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             --HHcCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence              00110          01122345678999999999999999999999999999886643

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.7e-46  Score=351.08  Aligned_cols=262  Identities=26%  Similarity=0.407  Sum_probs=201.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|++.+.||+|+||.||+|....+   ...+..||+|++..... ...+.+.+|+.+++.++||||+++++++ .++.
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~   89 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSP---ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENP   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSS
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecC---CCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCc
Confidence            46899999999999999999976542   23456799999875432 3356788999999999999999999998 4567


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||+.+++|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++...
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             cEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHHHEEECCCCCEEECcccccccc
Confidence            89999999999999998754 346899999999999999999999  677999999999999999999999999999875


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+.       ...    
T Consensus       167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-------~~~----  234 (281)
T 1mp8_A          167 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------NGE----  234 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC----
T ss_pred             Cccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-------cCC----
Confidence            443221 1223457889999999998999999999999999999996 999998654332211110       110    


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                            ....+..++.++.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       235 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          235 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                  0112334567899999999999999999999999999998754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.2e-47  Score=361.40  Aligned_cols=262  Identities=26%  Similarity=0.354  Sum_probs=198.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      .++|++.+.||+|+||.||+|..      ..+++.||||++.....   .....+.+|+.+++.++||||+++++++...
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   84 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARD------LRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE   84 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE------TTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEE------CCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence            46899999999999999999954      34578999999976533   2245788999999999999999999998765


Q ss_pred             Ce----eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEecc
Q 014736          167 EE----RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       167 ~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                      ..    .|+||||++|++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+||
T Consensus        85 ~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Df  160 (311)
T 3ork_A           85 TPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDF  160 (311)
T ss_dssp             ETTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEETTSCEEECCC
T ss_pred             CCCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCCcCCCCHHHEEEcCCCCEEEeec
Confidence            53    49999999999999999765  56899999999999999999999  677999999999999999999999999


Q ss_pred             CccccCCCCCCc-eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhc
Q 014736          243 GLAKMGPEGSNT-HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS  321 (419)
Q Consensus       243 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  321 (419)
                      |++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........      ......
T Consensus       161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~  234 (311)
T 3ork_A          161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVRE  234 (311)
T ss_dssp             SCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHC
T ss_pred             cCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcC
Confidence            999865443222 1223456999999999999999999999999999999999999999765432111      111111


Q ss_pred             ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH-HHHHhhhc
Q 014736          322 SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV-ATLESLLN  375 (419)
Q Consensus       322 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil-~~L~~l~~  375 (419)
                      ....        ........+.++.+|+.+||+.||.+||++.+++ ..|..+..
T Consensus       235 ~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          235 DPIP--------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             CCCC--------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             CCCC--------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            0000        0001122457899999999999999999666555 45665544

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.8e-46  Score=360.04  Aligned_cols=250  Identities=25%  Similarity=0.362  Sum_probs=200.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCC-CcccccceeeEEEeC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQL-RHPHLVRLIGYCCED  166 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  166 (419)
                      ++|++.+.||+|+||.||+|...      .+++.||+|++.....   .....+.+|..++.++ +||||+++++++.+.
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~   82 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLK------KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE   82 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             hheEEEEEEEecCCeEEEEEEEC------CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence            57899999999999999999643      4578899999975432   3345678899999887 899999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..|+||||+.||+|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~  158 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK  158 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCGGGCB
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEECCCCCEEEEeccccc
Confidence            9999999999999999999765  56899999999999999999999  6679999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccch--hHHHhhhHHhhcccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQ--NLVDWAKPYLRSSRR  324 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~  324 (419)
                      .......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ............   
T Consensus       159 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~---  233 (345)
T 3a8x_A          159 EGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---  233 (345)
T ss_dssp             CSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH---
T ss_pred             cccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc---
Confidence            6432221  234567999999999999999999999999999999999999999753221110  000111000000   


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKM  363 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~  363 (419)
                            .  ...++...+.++.+||.+||+.||.+||++
T Consensus       234 ------~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          234 ------K--QIRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             ------C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             ------C--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                  0  012333456789999999999999999995

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.6e-46  Score=350.81  Aligned_cols=264  Identities=22%  Similarity=0.255  Sum_probs=201.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|++.+.||+|+||+||+|...      .+++.||+|++.....  .....+.+|+.++++++||||+++++++.+++.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   75 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNR------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEET------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCceeeeEecCCCCeEEEEEEEC------CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE
Confidence            57899999999999999999643      4578899999975433  234678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .++||||+.+ +|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++...
T Consensus        76 ~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH--~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           76 LTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            9999999965 666665443 357899999999999999999999  667999999999999999999999999999865


Q ss_pred             CCCCCceeeecccccccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc--ccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGH-LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS--RRL  325 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~  325 (419)
                      .....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.......  .............  ...
T Consensus       152 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~  227 (292)
T 3o0g_A          152 GIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQW  227 (292)
T ss_dssp             CSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTC
T ss_pred             CCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhh
Confidence            43222  233456899999999997765 8999999999999999999888864432211  1111111110000  000


Q ss_pred             ---cccc---------ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          326 ---RYIV---------DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       326 ---~~~~---------~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                         ....         ............+.++.+|+.+||+.||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence               0000         000011122345678999999999999999999999976

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-46  Score=353.38  Aligned_cols=261  Identities=25%  Similarity=0.394  Sum_probs=218.1

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ..++|++.+.||+|+||.||+|.+.      .+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   83 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWK------KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   83 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEG------GGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             cccceeEEeecCCCCceeEEEeEec------CCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3568999999999999999999654      346789999997543 346778999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||+.+++|.+++.......+++..++.++.||+.||.|||  ++||+|+||||+||+++.++.+||+|||++...
T Consensus        84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH--HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH--HCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            999999999999999998766677999999999999999999999  677999999999999999999999999999876


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+.              
T Consensus       162 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~--------------  226 (288)
T 3kfa_A          162 TGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--------------  226 (288)
T ss_dssp             CSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH--------------
T ss_pred             cCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh--------------
Confidence            54332 22333457889999999998999999999999999999999 999998754332211111              


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                         .......+..+++++.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       227 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          227 ---KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             ---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence               0111122334567899999999999999999999999999988764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=354.52  Aligned_cols=249  Identities=22%  Similarity=0.321  Sum_probs=196.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--------------------------cHHHHHHH
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--------------------------GHREWLAE  144 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E  144 (419)
                      ++|.+.+.||+|+||.||+|..      ..+++.||||++......                          ..+.+.+|
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E   86 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYN------ENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE   86 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEE------TTTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred             cceEEEeEEeecCCEEEEEEEE------CCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence            5799999999999999999964      345788999999754321                          13468899


Q ss_pred             HHHHcCCCcccccceeeEEEe--CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 014736          145 VIFLGQLRHPHLVRLIGYCCE--DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYR  222 (419)
Q Consensus       145 ~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~  222 (419)
                      +.+|+.++||||+++++++.+  .+..|+||||+++++|.+++..   ..+++..++.++.||+.||.|||  ++||+||
T Consensus        87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~  161 (298)
T 2zv2_A           87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLH--YQKIIHR  161 (298)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECC
T ss_pred             HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeecc
Confidence            999999999999999999987  5689999999999999886543   47899999999999999999999  6679999


Q ss_pred             CCCCCcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCC---CCchhhHHHHHHHHHHHHcCCCC
Q 014736          223 DFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH---LTTKSDVYSFGVVLLELLTGRRS  299 (419)
Q Consensus       223 Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~p  299 (419)
                      ||||+|||++.++.+||+|||++........  ......||+.|+|||++.+..   ++.++|||||||++|+|++|+.|
T Consensus       162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  239 (298)
T 2zv2_A          162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP  239 (298)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            9999999999999999999999987544322  234457999999999997655   47899999999999999999999


Q ss_pred             CCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          300 MDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       300 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      |.......   ..   .......  .        ........+.++.+|+.+||+.||++|||+.++++
T Consensus       240 f~~~~~~~---~~---~~~~~~~--~--------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          240 FMDERIMC---LH---SKIKSQA--L--------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SCCSSHHH---HH---HHHHHCC--C--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCccHHH---HH---HHHhccc--C--------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            97543211   11   1100000  0        00111234578999999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.3e-46  Score=355.20  Aligned_cols=270  Identities=29%  Similarity=0.366  Sum_probs=212.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeC--C
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCED--E  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~  167 (419)
                      ++|++.+.||+|+||.||+|.+..  .+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.  .
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDP--EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECT--TSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhccCCCCceEEEEEEEcc--ccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            468899999999999999997643  245578899999997543 33457889999999999999999999999876  6


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..++||||+++++|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             eEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhh--cCCcccCCCchheEEEcCCCCEEECccccccc
Confidence            689999999999999998654 246899999999999999999999  67799999999999999999999999999987


Q ss_pred             CCCCCCc-eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------ccchhHHHhhhHH
Q 014736          248 GPEGSNT-HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRP--------KSEQNLVDWAKPY  318 (419)
Q Consensus       248 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~~~~~~~~  318 (419)
                      ....... .......||..|+|||++.+..++.++||||||+++|+|++|..|+.....        .............
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            6544322 223345688999999999999999999999999999999999988653210        0000001000111


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      .          ........+..+++++.+|+.+||+.||.+|||+.++++.|+.+++
T Consensus       256 ~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          256 L----------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             H----------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             H----------hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            1          1111122344556889999999999999999999999999998753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.8e-46  Score=355.09  Aligned_cols=267  Identities=24%  Similarity=0.306  Sum_probs=191.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|++.+.||+|+||.||+|.      +..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+++..
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   78 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGL------NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKL   78 (317)
T ss_dssp             --------------CEEEEEE------CSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEE
T ss_pred             cceeEeeEECCCCCEEEEEEE------ECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeE
Confidence            579999999999999999995      344578999999975532 3346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          170 LLVYEFMPRGSLENHLFKRI----SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      |+||||+. ++|.+++....    ...+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++
T Consensus        79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~  155 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLA  155 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred             EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCChHHeEEcCCCCEEECcCccc
Confidence            99999996 69999886542    235889999999999999999999  677999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH-----h
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY-----L  319 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----~  319 (419)
                      ........  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+......     +
T Consensus       156 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  233 (317)
T 2pmi_A          156 RAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW  233 (317)
T ss_dssp             EETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred             eecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence            86543221  1234568999999999876 46899999999999999999999999865433222111100000     0


Q ss_pred             hccccccc---cccc--------ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          320 RSSRRLRY---IVDP--------RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       320 ~~~~~~~~---~~~~--------~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .....+..   .+..        .+........+.++.+|+.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            00000000   0000        0000111234578999999999999999999999876

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.9e-46  Score=356.23  Aligned_cols=267  Identities=22%  Similarity=0.288  Sum_probs=202.7

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      +.++|++.++||+|+||+||+|...       .++.||+|++.....  .....+.+|+.+++.++||||+++++++.+.
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   91 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS-------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE   91 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET-------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC-------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence            4478999999999999999999642       267899999975432  2246788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..++||||+. ++|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++.
T Consensus        92 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           92 RCLTLVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCH--QHRILHRDLKPQNLLINSDGALKLADFGLAR  167 (311)
T ss_dssp             SCEEEEEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCchHhEEECCCCCEEEccCcCce
Confidence            99999999996 5888887654 345899999999999999999999  6779999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHh-----h
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYL-----R  320 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-----~  320 (419)
                      .......  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.......     .
T Consensus       168 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  245 (311)
T 3niz_A          168 AFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP  245 (311)
T ss_dssp             ETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred             ecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence            7543322  2334568999999999876 568999999999999999999999998765544322221100000     0


Q ss_pred             cccccc-------cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          321 SSRRLR-------YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       321 ~~~~~~-------~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ....+.       ...............++++.+|+.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            000000       000000000111234578999999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1e-46  Score=380.10  Aligned_cols=260  Identities=24%  Similarity=0.397  Sum_probs=216.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .++|.+.++||+|+||.||+|.+..      .+..||||++.... ...+.|.+|+.+|++++||||+++++++.+.+..
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGG------GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcC------CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            4678889999999999999997543      36789999997543 3467899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+||||+.+|+|.+++.......+++..++.++.||+.||.|||  ++||+||||||+||||+.++.+||+|||+++...
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            99999999999999998766667899999999999999999999  6779999999999999999999999999998754


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      .... .......++..|+|||++.+..++.++|||||||++|||++ |..||...........+       ..       
T Consensus       370 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~-------~~-------  434 (495)
T 1opk_A          370 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EK-------  434 (495)
T ss_dssp             TCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-------HT-------
T ss_pred             CCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------Hc-------
Confidence            3321 12223456789999999998999999999999999999999 99999876533221111       11       


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                         ......+..++.++.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       435 ---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          435 ---DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence               111122344568899999999999999999999999999988653

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-46  Score=356.57  Aligned_cols=268  Identities=27%  Similarity=0.440  Sum_probs=208.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|.+.++||+|+||.||+|....+  ....+..||+|++..... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  121 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTS--SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM  121 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecC--CCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence            4678889999999999999976542  223356799999975432 3345788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+++++|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++....
T Consensus       122 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            9999999999999998754 356899999999999999999999  6679999999999999999999999999998754


Q ss_pred             CCCCce-eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          250 EGSNTH-VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       250 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ...... ......+|..|+|||++.+..++.++||||||+++|+|++ |..||.......   ....    .....    
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~~----~~~~~----  267 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMKA----INDGF----  267 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHH----HHTTC----
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HHHH----HHCCC----
Confidence            432211 1223346889999999999999999999999999999999 999997643221   1111    11110    


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCcccc
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMA  380 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~~~  380 (419)
                            ....+..++.++.+|+.+||+.||.+||++.+|++.|+++.......
T Consensus       268 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~  314 (333)
T 1mqb_A          268 ------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL  314 (333)
T ss_dssp             ------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred             ------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence                  11122345678999999999999999999999999999988754443

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.7e-47  Score=359.41  Aligned_cols=276  Identities=26%  Similarity=0.360  Sum_probs=220.3

Q ss_pred             CHHHHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCC-Ccccccce
Q 014736           82 QLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQL-RHPHLVRL  159 (419)
Q Consensus        82 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~  159 (419)
                      ....+....++|++.+.||+|+||.||+|.+... .+..+++.||+|++..... ...+.+.+|+.++..+ +||||+++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecC-CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            3344455567899999999999999999976442 2345678999999975433 3346788999999999 69999999


Q ss_pred             eeEEEeCC-eeEEEEEecCCCChhhhhhhccC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 014736          160 IGYCCEDE-ERLLVYEFMPRGSLENHLFKRIS--------------VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDF  224 (419)
Q Consensus       160 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dl  224 (419)
                      ++++...+ ..++||||+++++|.+++.....              ..+++..++.++.||+.||.|||  ++||+||||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~di  174 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDL  174 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH--HTTCCCSCC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH--hCCcccccC
Confidence            99987654 58999999999999999976532              12788999999999999999999  667999999


Q ss_pred             CCCcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 014736          225 KTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKL  303 (419)
Q Consensus       225 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~  303 (419)
                      ||+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987655444333445568999999999999999999999999999999998 99999765


Q ss_pred             CCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          304 RPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                      .....  ....    .....          ....+...+.++.+++.+||+.||.+|||+.+|++.|+.++..
T Consensus       255 ~~~~~--~~~~----~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          255 KIDEE--FCRR----LKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             CCSHH--HHHH----HHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chhHH--HHHH----hccCc----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            43221  1110    00110          0112223457899999999999999999999999999998753

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2e-46  Score=350.75  Aligned_cols=258  Identities=20%  Similarity=0.386  Sum_probs=208.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .++|++.+.||+|+||.||+|.+.+       +..||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   94 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRG-------QYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI   94 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETT-------TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcC-------CCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence            3578999999999999999996543       46799999975433 356789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+.+++|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++....
T Consensus        95 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  171 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  171 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred             EEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence            9999999999999998763 246899999999999999999999  6779999999999999999999999999998654


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+.       ..      
T Consensus       172 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-------~~------  237 (283)
T 3gen_A          172 DDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QG------  237 (283)
T ss_dssp             CHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-------TT------
T ss_pred             ccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-------cc------
Confidence            32211 1222447788999999998999999999999999999998 999998654322111110       00      


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                          .....+...++++.+|+.+||+.||.+|||+.++++.|..+...
T Consensus       238 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          238 ----LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence                11112223357899999999999999999999999999988653

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.5e-47  Score=362.53  Aligned_cols=268  Identities=25%  Similarity=0.360  Sum_probs=216.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCC-CcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  167 (419)
                      .++|.+.+.||+|+||.||+|..... ......+.||+|++..... ...+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGL-GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTC-SSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCC-CcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            46899999999999999999976543 2233456899999975533 3456788999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhcc------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 014736          168 ERLLVYEFMPRGSLENHLFKRI------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF  235 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~  235 (419)
                      ..|+||||+++|+|.+++....            ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA--SKNCIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGCEEEGGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh--cCCcccCCcccceEEECCCC
Confidence            9999999999999999987542            345789999999999999999999  66799999999999999999


Q ss_pred             cEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHh
Q 014736          236 TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDW  314 (419)
Q Consensus       236 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~  314 (419)
                      .+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||..........  ..
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~--~~  279 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY--KL  279 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH--HH
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH--HH
Confidence            999999999986544443333344567889999999999999999999999999999998 999998654322111  11


Q ss_pred             hhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          315 AKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                      .    ...          .....+...+.++.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       280 ~----~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          280 V----KDG----------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             H----HHT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H----hcC----------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence            0    010          01111223457899999999999999999999999999987653

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.9e-46  Score=346.89  Aligned_cols=252  Identities=24%  Similarity=0.351  Sum_probs=207.1

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeC--
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCED--  166 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--  166 (419)
                      ++|.+.+.||+|+||.||+|.+.        ++.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.  
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~--------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ--------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA   81 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET--------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC--------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence            57899999999999999999753        46799999976532  3346789999999999999999999999877  


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCcEEEcCCCcEEEeccCc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP--VIYRDFKTSNILLDSDFTAKLSDFGL  244 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfGl  244 (419)
                      +..++||||+++++|.+++.......+++..++.++.||+.||.|||  ++|  |+||||||+|||++.++.++|+|||+
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~  159 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHALNSRSVMIDEDMTARISMADV  159 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT--TSSSCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred             CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh--cCCCceecCCCccceEEEcCCcceeEEeccc
Confidence            78899999999999999998765557899999999999999999999  566  99999999999999999999999988


Q ss_pred             cccCCCCCCceeeecccccccccccccccCCCCCc---hhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhc
Q 014736          245 AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTT---KSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS  321 (419)
Q Consensus       245 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  321 (419)
                      +......       ...||+.|+|||++.+..++.   ++||||||+++|+|++|+.||..........      .... 
T Consensus       160 ~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~-  225 (271)
T 3kmu_A          160 KFSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM------KVAL-  225 (271)
T ss_dssp             CCTTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH------HHHH-
T ss_pred             eeeeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH------HHHh-
Confidence            7643222       235899999999998765554   8999999999999999999998654322111      1110 


Q ss_pred             ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          322 SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       322 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                               .......+...+.++.+++.+||+.||++|||+.++++.|+.+..
T Consensus       226 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          226 ---------EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ---------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ---------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                     111112334456789999999999999999999999999998754

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.3e-46  Score=362.92  Aligned_cols=254  Identities=22%  Similarity=0.283  Sum_probs=195.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .++|.+.+.||+|+||.||+|..      ..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~------~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   91 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRD------KLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   91 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEE------TTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEE------CCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence            35799999999999999999954      44578999999975432 346688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc--EEEeccCcccc
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT--AKLSDFGLAKM  247 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfGla~~  247 (419)
                      |+||||+.+|+|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.  +||+|||+++.
T Consensus        92 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH--~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            9999999999999998765  56899999999999999999999  677999999999999987765  99999999974


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTK-SDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      .....   ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............  ........    
T Consensus       168 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--~~~~~~~~----  238 (361)
T 3uc3_A          168 SVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT--IQRILSVK----  238 (361)
T ss_dssp             ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH--HHHHHTTC----
T ss_pred             ccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH--HHHHhcCC----
Confidence            32222   1234569999999999988888765 89999999999999999999875443322111  11111110    


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                            .........+.++.+||.+||+.||.+|||+.++++.
T Consensus       239 ------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          239 ------YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ------CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ------CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                  0001111245789999999999999999999999874

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.4e-46  Score=346.91  Aligned_cols=253  Identities=28%  Similarity=0.527  Sum_probs=203.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc-------HHHHHHHHHHHcCCCcccccceeeEE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-------HREWLAEVIFLGQLRHPHLVRLIGYC  163 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~~~~~~  163 (419)
                      ++|++.+.||+|+||.||+|...      .+++.||+|++.......       .+.+.+|+.+++.++||||+++++++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   92 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLV------KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM   92 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEET------TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccceehhccccCCceeEEEEEEc------CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence            57899999999999999999653      346889999996543221       16788999999999999999999998


Q ss_pred             EeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCcEEEcCCCc-----
Q 014736          164 CEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP--VIYRDFKTSNILLDSDFT-----  236 (419)
Q Consensus       164 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~-----  236 (419)
                      .+..  ++||||+++++|.+++... ...+++..++.++.|++.||.|||  .+|  |+||||||+|||++.++.     
T Consensus        93 ~~~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH--~~~~~ivH~dikp~Nil~~~~~~~~~~~  167 (287)
T 4f0f_A           93 HNPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQ--NQNPPIVHRDLRSPNIFLQSLDENAPVC  167 (287)
T ss_dssp             TTTT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH--TSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred             cCCC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHH--hCCCCeecCCCCcceEEEeccCCCCcee
Confidence            5544  7999999999999988654 346899999999999999999999  667  999999999999988776     


Q ss_pred             EEEeccCccccCCCCCCceeeecccccccccccccc--cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHh
Q 014736          237 AKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI--STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW  314 (419)
Q Consensus       237 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  314 (419)
                      +||+|||++.....     ......||+.|+|||++  ....++.++||||||+++|+|++|+.||............. 
T Consensus       168 ~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-  241 (287)
T 4f0f_A          168 AKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM-  241 (287)
T ss_dssp             EEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH-
T ss_pred             EEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH-
Confidence            99999999985332     13446799999999998  45668899999999999999999999998654432211111 


Q ss_pred             hhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          315 AKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                         ..          .......++..++.++.+|+.+||+.||.+|||+.+|++.|+++
T Consensus       242 ---~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          242 ---IR----------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ---HH----------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ---Hh----------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence               00          01111223344567899999999999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-46  Score=358.77  Aligned_cols=278  Identities=30%  Similarity=0.397  Sum_probs=214.1

Q ss_pred             cCC-CCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeC--
Q 014736           91 QNF-SSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCED--  166 (419)
Q Consensus        91 ~~y-~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--  166 (419)
                      ++| ++++.||+|+||.||+|.+..  .+..+++.||||++..... .....+.+|+++|+.++||||+++++++.+.  
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDP--TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECS--CC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             HHHHhhhheecCCCCeEEEEEEEcc--CCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            345 889999999999999987644  3455788999999976532 3356788999999999999999999999884  


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      ...++||||+++++|.+++...   .+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++.
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH--~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH--AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             ceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCchheEEEcCCCCEEECCccccc
Confidence            6789999999999999999765   4899999999999999999999  6779999999999999999999999999998


Q ss_pred             cCCCCCCce-eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          247 MGPEGSNTH-VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       247 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      ......... ......||..|+|||++.+..++.++||||||+++|+|++|..||........ ....+..... ....+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~-~~~~~  260 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQM-TVLRL  260 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHH-HHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccch-hHHHH
Confidence            765543321 23345688999999999999999999999999999999999999875321100 0000000000 00000


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                      ............+..++.++.+|+.+||+.||.+|||+.++++.|+.+.+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            1111111222334456688999999999999999999999999999987643

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.1e-46  Score=360.22  Aligned_cols=280  Identities=26%  Similarity=0.343  Sum_probs=216.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEE--eCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCC--EDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~~  168 (419)
                      ++|++.+.||+|+||.||+|.+..  .+...++.||+|++........+.+.+|++++++++||||+++++++.  +...
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDP--LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECT--TSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             hhhhhhhhccCCCCeEEEEEEecc--CCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            579999999999999999997543  244567899999998776666678999999999999999999999887  4567


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||+++++|.+++.... ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++...
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLG--SRRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            899999999999999997642 35899999999999999999999  677999999999999999999999999999876


Q ss_pred             CCCCCce-eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          249 PEGSNTH-VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       249 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ....... ......||..|+|||++.+..++.++||||||+++|+|++|+.||............ . .........+..
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~-~~~~~~~~~~~~  255 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-C-ERDVPALSRLLE  255 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-c-ccccccHHHHHH
Confidence            5443322 223356888999999999999999999999999999999999998653211000000 0 000000000000


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                      ..........+..+++++.+|+.+||+.||.+|||+.++++.|+.++...
T Consensus       256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            11111222334456788999999999999999999999999999987643

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.5e-46  Score=358.78  Aligned_cols=268  Identities=24%  Similarity=0.382  Sum_probs=215.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCccc-ccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCC-CcccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLR-QGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQL-RHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  166 (419)
                      .++|.+.+.||+|+||.||+|.+..... ....+..||+|++..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            4689999999999999999998653211 224567899999975532 3456788999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRIS--------------VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD  232 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~  232 (419)
                      +..|+||||+.+++|.+++.....              ..+++..++.++.||+.||.|||  ++||+||||||+|||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAARNVLVT  191 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEC
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCccceEEEc
Confidence            999999999999999999976532              24889999999999999999999  67799999999999999


Q ss_pred             CCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhH
Q 014736          233 SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNL  311 (419)
Q Consensus       233 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~  311 (419)
                      .++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||........   
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---  268 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL---  268 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---
T ss_pred             CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH---
Confidence            999999999999987655443333344567899999999988899999999999999999999 9999976532211   


Q ss_pred             HHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          312 VDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                      ....    ....          ....+..++.++.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       269 ~~~~----~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          269 FKLL----KEGH----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             HHHH----HHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHH----hcCC----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            1111    0110          1112234567899999999999999999999999999999764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.3e-46  Score=375.71  Aligned_cols=261  Identities=26%  Similarity=0.418  Sum_probs=213.0

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      +...++|.+.+.||+|+||.||+|.+..       +..||||++.... ...+.|.+|+.+|+.++||||+++++++. .
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~  254 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNK-------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-K  254 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETT-------TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECC-------ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence            3445688999999999999999997643       4679999998643 45678999999999999999999999986 6


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..|+||||+.+|+|.+++.......+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  332 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLAR  332 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred             CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence            67899999999999999997654456889999999999999999999  5679999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      ........ ......++..|+|||++....++.++|||||||++|||++ |+.||........   ....    ....  
T Consensus       333 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~---~~~i----~~~~--  402 (454)
T 1qcf_A          333 VIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRAL----ERGY--  402 (454)
T ss_dssp             GBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHHH----HHTC--
T ss_pred             EcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HcCC--
Confidence            75432111 1122346789999999998999999999999999999999 9999986543221   1111    1110  


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                              ....+..+++++.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       403 --------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          403 --------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             --------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence                    1112334567899999999999999999999999999988654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.1e-46  Score=350.32  Aligned_cols=265  Identities=24%  Similarity=0.361  Sum_probs=202.2

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcC--CCcccccceeeEEEeC
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ--LRHPHLVRLIGYCCED  166 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~  166 (419)
                      +.++|++.+.||+|+||.||+|.+        +++.||||++...   ....+.+|.+++..  ++||||+++++++...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~   74 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--------QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS   74 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--------TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--------CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence            457899999999999999999964        2578999999653   33455566666555  7999999999987553


Q ss_pred             ----CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeeecCCCCCcEEEcCCCc
Q 014736          167 ----EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA------ENPVIYRDFKTSNILLDSDFT  236 (419)
Q Consensus       167 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~------~~~ivH~Dlkp~NIll~~~~~  236 (419)
                          ...++||||+++|+|.+++..   ..+++..++.++.||+.||.|||+.      ++||+||||||+|||++.++.
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~  151 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ  151 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred             cCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC
Confidence                458999999999999999954   3689999999999999999999932      466999999999999999999


Q ss_pred             EEEeccCccccCCCCCCcee--eecccccccccccccccCC------CCCchhhHHHHHHHHHHHHcC----------CC
Q 014736          237 AKLSDFGLAKMGPEGSNTHV--TTRVMGTYGYAAPEYISTG------HLTTKSDVYSFGVVLLELLTG----------RR  298 (419)
Q Consensus       237 ~kl~DfGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg----------~~  298 (419)
                      +||+|||++...........  .....||+.|+|||++.+.      .++.++|||||||++|||++|          ..
T Consensus       152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~  231 (301)
T 3q4u_A          152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP  231 (301)
T ss_dssp             EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence            99999999976544332211  2234799999999999776      456799999999999999999          88


Q ss_pred             CCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          299 SMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       299 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                      ||.............  ..........    .......+....+.++.+|+.+||+.||++|||+.+|++.|+++
T Consensus       232 pf~~~~~~~~~~~~~--~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          232 PFYDVVPNDPSFEDM--RKVVCVDQQR----PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTTTSCSSCCHHHH--HHHHTTSCCC----CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccCCCCcchhhh--hHHHhccCCC----CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            886654333211111  1111000000    00111112345678999999999999999999999999999876

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.3e-46  Score=375.02  Aligned_cols=250  Identities=26%  Similarity=0.342  Sum_probs=197.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC---CcccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE---GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      .++|++.++||+|+||.||+|..      ..+++.||||++...   .......+.+|+.+++.++||||+++++++.+.
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~  220 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKE------KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH  220 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEE------TTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEE------cCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC
Confidence            46799999999999999999954      445789999999753   223345678899999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..|+||||+++++|.+++...  ..+++..+..++.||+.||.|||+ .+||+||||||+||||+.++.+||+|||+++
T Consensus       221 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~-~~giiHrDlkp~NIll~~~~~~kl~DFG~a~  297 (446)
T 4ejn_A          221 DRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCK  297 (446)
T ss_dssp             TEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred             CEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh-cCCEEECCCCHHHEEECCCCCEEEccCCCce
Confidence            9999999999999999998765  578999999999999999999994 1679999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      .......  .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+      ....    
T Consensus       298 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~~~----  365 (446)
T 4ejn_A          298 EGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEE----  365 (446)
T ss_dssp             TTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC----
T ss_pred             eccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------HhCC----
Confidence            6433221  234567999999999999999999999999999999999999999765432211111      1110    


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVA  368 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~  368 (419)
                              ..++...+.++.+||.+||+.||.+||     ++.++++
T Consensus       366 --------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 --------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                    112334567899999999999999999     9999976

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3e-46  Score=365.76  Aligned_cols=270  Identities=20%  Similarity=0.232  Sum_probs=205.4

Q ss_pred             cCCCCCCeeccc--CceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           91 QNFSSNYLLGEG--GFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        91 ~~y~~~~~lg~G--~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      ++|++.++||+|  +||.||+|...      .+++.||||++....  ....+.+.+|+.+++.++|||||++++++.+.
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   98 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYK------PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD   98 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEET------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             CcEEEEecccCCcCCceEEEEEEEc------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence            579999999999  99999999643      457899999997553  23346788899999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..|+||||+++++|.+++.......+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++.
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~  176 (389)
T 3gni_B           99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSNL  176 (389)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence            99999999999999999998766677999999999999999999999  6779999999999999999999999999986


Q ss_pred             cCCCCCCc-----eeeecccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHH-hhhHH
Q 014736          247 MGPEGSNT-----HVTTRVMGTYGYAAPEYIST--GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD-WAKPY  318 (419)
Q Consensus       247 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~-~~~~~  318 (419)
                      ........     .......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||............. ...+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  256 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC  256 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred             eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence            53222111     11122468999999999977  679999999999999999999999998654433211000 00000


Q ss_pred             -hhcc----c-------------cccccc---------ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 -LRSS----R-------------RLRYIV---------DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 -~~~~----~-------------~~~~~~---------~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       ....    .             .+....         .......+....+.++.+||.+||+.||.+|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence             0000    0             000000         000011233445678999999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.8e-46  Score=350.21  Aligned_cols=261  Identities=30%  Similarity=0.503  Sum_probs=197.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .++|++.++||+|+||.||+|...         ..||+|++.....  ...+.+.+|+.+++.++||||+++++++ ...
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~   92 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH---------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP   92 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS---------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc---------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence            468999999999999999999643         2499999975533  3356789999999999999999999964 566


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..++||||+.+++|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  169 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH--AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE  169 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred             ccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH--hCCcccccCccceEEECCCCCEEEccceeccc
Confidence            789999999999999998654 356899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCceeeeccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYIS---TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      ..............||+.|+|||++.   +..++.++||||||+++|+|++|+.||........  ......    .. .
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~----~~-~  242 (289)
T 3og7_A          170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVG----RG-S  242 (289)
T ss_dssp             --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHH----HT-S
T ss_pred             cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhc----cc-c
Confidence            54433333334467999999999986   66789999999999999999999999986543221  111110    10 0


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      .    .+. .......++.++.+|+.+||+.||.+|||+.+|++.|+++..
T Consensus       243 ~----~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          243 L----SPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             C----CCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             c----Ccc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            0    011 112233456789999999999999999999999999998754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.5e-46  Score=356.89  Aligned_cols=252  Identities=26%  Similarity=0.326  Sum_probs=197.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC----cccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG----LQGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      .++|++.++||+|+||.||+|....   ...+++.||+|++....    ......+.+|+.+|+.++||||+++++++.+
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVT---GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECS---STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEec---cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            3679999999999999999997532   23467899999997542    2234567889999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      .+..|+||||+.|++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            99999999999999999999765  56889999999999999999999  677999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      +......  ......+||+.|+|||++.+..++.++||||||+++|+|++|+.||........   ..   ......   
T Consensus       169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~---~i~~~~---  237 (327)
T 3a62_A          169 KESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT---ID---KILKCK---  237 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH---HHHHTC---
T ss_pred             cccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH---HH---HHHhCC---
Confidence            7543222  123446799999999999999999999999999999999999999986432211   11   111110   


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVA  368 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~  368 (419)
                               ..++...+.++.+|+.+||+.||.+||     ++.++++
T Consensus       238 ---------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 ---------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ---------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                     112234567899999999999999999     7777765

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.1e-46  Score=366.26  Aligned_cols=249  Identities=25%  Similarity=0.305  Sum_probs=195.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHH-HcCCCcccccceeeEEEeC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIF-LGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~  166 (419)
                      ++|+++++||+|+||.||+|...      .+++.||+|++.....   .....+.+|..+ ++.++||||+++++++.+.
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~------~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~  111 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHK------AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA  111 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEET------TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS
T ss_pred             hheEEEEEEeeCCCeEEEEEEEc------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence            57999999999999999999643      4578899999975432   234456677776 5778999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..|+||||+.||+|.+++.+.  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~ikL~DFG~a~  187 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCK  187 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred             CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEECCCCCEEEeeCcccc
Confidence            9999999999999999999765  56889999999999999999999  6779999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      .......  .....+||+.|+|||++.+..|+.++|||||||++|||++|..||........   .   .......    
T Consensus       188 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~---~~i~~~~----  255 (373)
T 2r5t_A          188 ENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---Y---DNILNKP----  255 (373)
T ss_dssp             GGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH---H---HHHHHSC----
T ss_pred             ccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---H---HHHHhcc----
Confidence            6332221  23456799999999999999999999999999999999999999976432211   1   1111110    


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                              ..++...+.++.+||.+||+.||.+||++.+.++.
T Consensus       256 --------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~  290 (373)
T 2r5t_A          256 --------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  290 (373)
T ss_dssp             --------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred             --------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence                    01223456789999999999999999998644333

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.3e-46  Score=348.00  Aligned_cols=250  Identities=29%  Similarity=0.469  Sum_probs=195.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc----ccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL----QGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      ++|++.++||+|+||.||+|.+.        ++.||+|++.....    ...+.+.+|+++++.++||||+++++++.+.
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI--------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE   78 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET--------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC
T ss_pred             hheeeeeeeccCCCeEEEEEEEc--------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            57889999999999999999643        46799999875432    2346788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCC---eeecCCCCCcEEEcC--------CC
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP---VIYRDFKTSNILLDS--------DF  235 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~--------~~  235 (419)
                      +..++||||+++++|.+++..   ..+++..++.++.|++.||.|||  ++|   |+||||||+|||++.        ++
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH--~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~  153 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLH--DEAIVPIIHRDLKSSNILILQKVENGDLSNK  153 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHH--HSSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred             CceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH--hCCCCceeecCCchHHEEEecccccccccCc
Confidence            999999999999999998853   47899999999999999999999  566   999999999999986        67


Q ss_pred             cEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh
Q 014736          236 TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA  315 (419)
Q Consensus       236 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~  315 (419)
                      .+||+|||++.......    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||............   
T Consensus       154 ~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---  226 (271)
T 3dtc_A          154 ILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV---  226 (271)
T ss_dssp             CEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH---
T ss_pred             ceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh---
Confidence            89999999998654332    22346999999999999999999999999999999999999999865422111100   


Q ss_pred             hHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          316 KPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                         .          ........+..+++++.+|+.+||+.||.+|||+.++++.|+.+
T Consensus       227 ---~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          227 ---A----------MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ---H----------TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ---h----------cCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence               0          01111223344567899999999999999999999999999864

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.4e-46  Score=360.00  Aligned_cols=254  Identities=22%  Similarity=0.320  Sum_probs=203.8

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-CcccccceeeEEEeC
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHLVRLIGYCCED  166 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  166 (419)
                      .+.++|.+.+.||+|+||.||+|..      ..+++.||+|++......    ..+|++++.++ +||||+++++++.+.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~------~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~   88 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIH------KATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDG   88 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEE------TTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEE------CCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence            3567899999999999999999964      345789999999765332    33588888777 799999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC----CcEEEecc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD----FTAKLSDF  242 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~----~~~kl~Df  242 (419)
                      +..|+||||+.||+|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||+..+    +.+||+||
T Consensus        89 ~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH--~~givHrDlkp~NIl~~~~~~~~~~~kl~Df  164 (342)
T 2qr7_A           89 KYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICDF  164 (342)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence            9999999999999999998765  56899999999999999999999  6779999999999998543    35999999


Q ss_pred             CccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       243 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      |++........  .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||................    ..
T Consensus       165 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~~  238 (342)
T 2qr7_A          165 GFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG----SG  238 (342)
T ss_dssp             TTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH----HC
T ss_pred             CCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc----cC
Confidence            99986543322  2334679999999999988889999999999999999999999998654333222222111    00


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       .      ..+...+....+.++.+|+.+||..||++|||+.++++
T Consensus       239 -~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          239 -K------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             -C------CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -C------cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             0      01112223345688999999999999999999999987

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=9.2e-47  Score=370.75  Aligned_cols=256  Identities=21%  Similarity=0.226  Sum_probs=205.6

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEE
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCC  164 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  164 (419)
                      ...++|.+.++||+|+||.||+|...      .+++.||+|++....   ......+.+|+.+++.++||||++++++|.
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~------~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~  139 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHK------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  139 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEEC------CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            34568999999999999999999643      457889999996421   122345778999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCc
Q 014736          165 EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL  244 (419)
Q Consensus       165 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  244 (419)
                      +.+.+|+||||++||+|.+++...   .+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH--~~givHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeeECCCCCEEEeccce
Confidence            999999999999999999998654   6899999999999999999999  67799999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccccccccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhh
Q 014736          245 AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH----LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR  320 (419)
Q Consensus       245 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  320 (419)
                      ++....... ......+||+.|+|||++.+..    |+.++|||||||++|||++|+.||...........+.      .
T Consensus       215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~------~  287 (410)
T 3v8s_A          215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM------N  287 (410)
T ss_dssp             CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------T
T ss_pred             eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH------h
Confidence            987544322 1233567999999999997655    8899999999999999999999998654322111111      0


Q ss_pred             cccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 014736          321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKD--RPKMAAVVAT  369 (419)
Q Consensus       321 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~--RPs~~eil~~  369 (419)
                      ....+.        .......+.++.+||.+||..+|.+  ||++++|++.
T Consensus       288 ~~~~~~--------~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          288 HKNSLT--------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HHHHCC--------CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             cccccc--------CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            000000        0011134578999999999999998  9999999863

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=362.35  Aligned_cols=253  Identities=23%  Similarity=0.304  Sum_probs=191.5

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .+.++|.+.+.||+|+||.||+|...      .+++.||||++....  ..+.+.+|+.+|+.++||||+++++++.+.+
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  121 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQK------GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT  121 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEEC------CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence            35678999999999999999999654      346789999997543  3456788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCcEEEeccCc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGL  244 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGl  244 (419)
                      ..++||||+++++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.   ++.+||+|||+
T Consensus       122 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~  197 (349)
T 2w4o_A          122 EISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGL  197 (349)
T ss_dssp             EEEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred             eEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCcccEEEecCCCCCCEEEccCcc
Confidence            999999999999999998765  56899999999999999999999  677999999999999975   88999999999


Q ss_pred             cccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          245 AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       245 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      +.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||........  ...   ......  
T Consensus       198 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~---~i~~~~--  267 (349)
T 2w4o_A          198 SKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFR---RILNCE--  267 (349)
T ss_dssp             ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHH---HHHTTC--
T ss_pred             ccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHH---HHHhCC--
Confidence            98654322   22345699999999999999999999999999999999999999976443211  111   111000  


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                            ...........+.++.+|+.+||+.||++|||+.++++
T Consensus       268 ------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          268 ------YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             ------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ------CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  00111122345678999999999999999999999976

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.4e-46  Score=353.64  Aligned_cols=265  Identities=26%  Similarity=0.418  Sum_probs=203.0

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      ..++|.+.+.||+|+||.||+|....+   ..+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++.+.
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQE---DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECT---TSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             CHHHeeeccceeecCCeEEEEEEEecc---CCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            356899999999999999999976542   33467899999975532  3346788999999999999999999999775


Q ss_pred             C-----eeEEEEEecCCCChhhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcE
Q 014736          167 E-----ERLLVYEFMPRGSLENHLFKR----ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA  237 (419)
Q Consensus       167 ~-----~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~  237 (419)
                      +     ..++||||+.+++|.+++...    ....+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS--NRNFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCSGGGEEECTTSCE
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCcE
Confidence            5     359999999999999998532    2356899999999999999999999  6789999999999999999999


Q ss_pred             EEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhh
Q 014736          238 KLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAK  316 (419)
Q Consensus       238 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~  316 (419)
                      ||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||...........+.   
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~---  263 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL---  263 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH---
Confidence            9999999987654433222334557889999999999999999999999999999999 899997654332211110   


Q ss_pred             HHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          317 PYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                          ...          ....+..++.++.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       264 ----~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          264 ----HGH----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             ----TTC----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----cCC----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                100          111223455789999999999999999999999999998865

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.9e-46  Score=360.35  Aligned_cols=274  Identities=22%  Similarity=0.246  Sum_probs=209.8

Q ss_pred             CCCHHHHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-----cc
Q 014736           80 DFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-----HP  154 (419)
Q Consensus        80 ~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hp  154 (419)
                      .+.+.+...+.++|.+.++||+|+||.||+|...      .+++.||||++... ......+..|+.+++.++     ||
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~------~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~   96 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHI------DNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNN   96 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEEC------CCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCC
Confidence            4455555667789999999999999999999643      34688999999743 233456777999998886     99


Q ss_pred             cccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-
Q 014736          155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS-  233 (419)
Q Consensus       155 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-  233 (419)
                      ||+++++++...+..++||||+ +++|.+++.......+++..++.++.||+.||.|||  ++||+||||||+|||++. 
T Consensus        97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~  173 (360)
T 3llt_A           97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR--KMSLTHTDLKPENILLDDP  173 (360)
T ss_dssp             GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCT
T ss_pred             CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCcccEEEccc
Confidence            9999999999999999999999 999999998776667999999999999999999999  677999999999999975 


Q ss_pred             ------------------------CCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHH
Q 014736          234 ------------------------DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVV  289 (419)
Q Consensus       234 ------------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  289 (419)
                                              ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  248 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCV  248 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence                                    788999999999864432     234569999999999999999999999999999


Q ss_pred             HHHHHcCCCCCCCCCCccchhHHHhhhHH-----hhc--ccccccccc-ccc----CCC----------------CCHHH
Q 014736          290 LLELLTGRRSMDKLRPKSEQNLVDWAKPY-----LRS--SRRLRYIVD-PRL----AGQ----------------YSVKG  341 (419)
Q Consensus       290 l~elltg~~pf~~~~~~~~~~~~~~~~~~-----~~~--~~~~~~~~~-~~l----~~~----------------~~~~~  341 (419)
                      +|+|++|+.||...........+......     ...  ......... ..+    ...                +....
T Consensus       249 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (360)
T 3llt_A          249 LAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK  328 (360)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCC
T ss_pred             HHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccch
Confidence            99999999999865433222111111000     000  000000000 000    000                00111


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          342 AKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       342 ~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .+.+.+|+.+||+.||.+|||+.++++
T Consensus       329 ~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          329 HELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            267889999999999999999999875

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.4e-46  Score=377.84  Aligned_cols=254  Identities=27%  Similarity=0.399  Sum_probs=210.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      .++|.+.++||+|+||.||+|..      ..+++.||+|++....   ......+.+|+.+|+.++||||+++++++.+.
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~------~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  256 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQV------RATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK  256 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEE------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccceEEEEEEeeCCCEEEEEEEE------CCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC
Confidence            45799999999999999999964      3457899999996532   23456788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..|+||||++||+|.+++.......+++..++.++.||+.||.|||  ++||+||||||+||||+.++.+||+|||++.
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH--~~gIvHrDLKPeNILld~~g~vKL~DFGla~  334 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH--RERIVYRDLKPENILLDDHGHIRISDLGLAV  334 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeccCCchheEEEeCCCCeEEEecccce
Confidence            99999999999999999998765566999999999999999999999  6679999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      .......   ....+||+.|+|||++.+..|+.++|||||||++|||++|..||...........+...  ...      
T Consensus       335 ~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~--i~~------  403 (576)
T 2acx_A          335 HVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--VKE------  403 (576)
T ss_dssp             ECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH--HHH------
T ss_pred             ecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH--hhc------
Confidence            7654332   33457999999999999999999999999999999999999999875433222111110  000      


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVA  368 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~  368 (419)
                            ....++...+.++.+||.+||+.||.+||     ++.+|++
T Consensus       404 ------~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          404 ------VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ------ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                  01123344568899999999999999999     7888875

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-46  Score=353.62  Aligned_cols=268  Identities=26%  Similarity=0.308  Sum_probs=202.2

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-----ccHHHHHHHHHHHcCCC---cccccce
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-----QGHREWLAEVIFLGQLR---HPHLVRL  159 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---hpnIv~~  159 (419)
                      .+.++|++.++||+|+||+||+|.      +..+++.||+|++.....     .....+.+|+.+++.++   ||||+++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~   79 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKAR------DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRL   79 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEE------CTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCE
T ss_pred             ccccceEEEEEEecCCCeEEEEEE------ECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEe
Confidence            456799999999999999999995      445578999999964321     12345667888777764   9999999


Q ss_pred             eeEEEeCC-----eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 014736          160 IGYCCEDE-----ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD  234 (419)
Q Consensus       160 ~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~  234 (419)
                      ++++....     ..++||||+. ++|.+++.......+++..++.++.||+.||.|||  ++||+||||||+|||++.+
T Consensus        80 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~Nil~~~~  156 (308)
T 3g33_A           80 MDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSG  156 (308)
T ss_dssp             EEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCTTTEEECTT
T ss_pred             eeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCC
Confidence            99998765     5799999995 69999998776566999999999999999999999  6679999999999999999


Q ss_pred             CcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHh
Q 014736          235 FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW  314 (419)
Q Consensus       235 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  314 (419)
                      +.+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..
T Consensus       157 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~  233 (308)
T 3g33_A          157 GTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD  233 (308)
T ss_dssp             SCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred             CCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999999986543322   3446799999999999999999999999999999999999999986543322211111


Q ss_pred             hhHHhhccccccc-------ccccc---cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          315 AKPYLRSSRRLRY-------IVDPR---LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       315 ~~~~~~~~~~~~~-------~~~~~---l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ....... .....       .+.+.   .........+.++.+||.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          234 LIGLPPE-DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHCCCCT-TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhCCCCh-hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            0000000 00000       00000   000011234678999999999999999999999875

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.3e-46  Score=352.99  Aligned_cols=259  Identities=27%  Similarity=0.402  Sum_probs=206.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCccc-ccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLR-QGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|.+.+.||+|+||.||+|....+.. ....+..||+|++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3678999999999999999997654311 112346799999977666667889999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc--------EEEe
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT--------AKLS  240 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~--------~kl~  240 (419)
                      .++||||+.+++|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHh--hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            99999999999999999765 234889999999999999999999  677999999999999998887        9999


Q ss_pred             ccCccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCccchhHHHhhhHH
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGR-RSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      |||++......      ....||..|+|||++.+ ..++.++||||||+++|+|++|. +||.......   ...    .
T Consensus       164 Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~----~  230 (289)
T 4fvq_A          164 DPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR---KLQ----F  230 (289)
T ss_dssp             CCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHH----H
T ss_pred             cCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH---HHH----H
Confidence            99998754322      22458899999999987 77999999999999999999965 4444322111   111    0


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                      .....            ..+...+.++.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       231 ~~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          231 YEDRH------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             HHTTC------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             hhccC------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            11111            11112245689999999999999999999999999999774

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-46  Score=372.71  Aligned_cols=260  Identities=20%  Similarity=0.231  Sum_probs=207.4

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeE
Q 014736           86 LRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGY  162 (419)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~  162 (419)
                      ++...++|++.++||+|+||+||+|...      .+++.||+|++.....   .....+.+|+.++..++||||++++++
T Consensus        69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~------~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~  142 (437)
T 4aw2_A           69 MRLHREDFEILKVIGRGAFGEVAVVKLK------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA  142 (437)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred             ccCChhheEEEEEEEeCCCEEEEEEEEc------CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3445678999999999999999999654      3468899999964321   222347889999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEecc
Q 014736          163 CCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       163 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                      |.+.+.+||||||+.||+|.+++.+. ...+++..++.++.||+.||.|||  ++||+||||||+||||+.++.+||+||
T Consensus       143 ~~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH--~~giiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          143 FQDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVH--QLHYVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             EECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EeeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHH--hCCeEecccCHHHeeEcCCCCEEEcch
Confidence            99999999999999999999999763 356899999999999999999999  677999999999999999999999999


Q ss_pred             CccccCCCCCCceeeeccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH
Q 014736          243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS-----TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP  317 (419)
Q Consensus       243 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~  317 (419)
                      |+++....... ......+||+.|+|||++.     ...|+.++|||||||++|||++|+.||...........+.    
T Consensus       220 Gla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~----  294 (437)
T 4aw2_A          220 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM----  294 (437)
T ss_dssp             TTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----
T ss_pred             hhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh----
Confidence            99986544332 2234467999999999986     5679999999999999999999999998654322211111    


Q ss_pred             HhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 014736          318 YLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKD--RPKMAAVVA  368 (419)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~--RPs~~eil~  368 (419)
                        .....+.  + +    ......+.++.+||.+||..+|++  ||++++|++
T Consensus       295 --~~~~~~~--~-p----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          295 --NHKERFQ--F-P----TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             --THHHHCC--C-C----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             --hcccccc--C-C----cccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence              0000000  0 0    111224678999999999998888  999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8.1e-46  Score=370.43  Aligned_cols=247  Identities=27%  Similarity=0.376  Sum_probs=205.8

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .+|.+.+.||+|+||.||+|..      ..+++.||||++....   ......+.+|+.+|+.++||||+++++++.+.+
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~------~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~   89 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKH------ELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS   89 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEE------TTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCEEEEEEEeeCCCeEEEEEEE------CCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            5799999999999999999954      4457899999996542   123467889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||++||+|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDLkp~NIll~~~~~vkL~DFG~a~~  165 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM  165 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence            999999999999999999764  56899999999999999999999  67899999999999999999999999999987


Q ss_pred             CCCCCCceeeecccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHL-TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ......   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+      . .. .  
T Consensus       166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i------~-~~-~--  232 (476)
T 2y94_A          166 MSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI------C-DG-I--  232 (476)
T ss_dssp             CCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH------H-TT-C--
T ss_pred             cccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH------h-cC-C--
Confidence            654332   334579999999999988766 68999999999999999999999865432211111      0 00 0  


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                              ...+...+.++.+|+.+||+.||.+|||+.+|++
T Consensus       233 --------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          233 --------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                    0112234578999999999999999999999997

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4e-46  Score=356.15  Aligned_cols=253  Identities=24%  Similarity=0.377  Sum_probs=197.0

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      +.++|++.+.||+|+||.||+|...      .+++.||||++..... ...+.+.+|+.+|++++||||+++++++.+..
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   77 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNK------VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETP   77 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEET------TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEc------CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence            4568999999999999999999643      4578899999975443 34577899999999999999999999986643


Q ss_pred             ---------------------------------------------------------eeEEEEEecCCCChhhhhhhccC
Q 014736          168 ---------------------------------------------------------ERLLVYEFMPRGSLENHLFKRIS  190 (419)
Q Consensus       168 ---------------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~  190 (419)
                                                                               ..++||||+++++|.+++.....
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~  157 (332)
T 3qd2_B           78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS  157 (332)
T ss_dssp             SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred             cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence                                                                     37999999999999999976532


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCc----------eeeec
Q 014736          191 -VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT----------HVTTR  259 (419)
Q Consensus       191 -~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~----------~~~~~  259 (419)
                       ...++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++.........          .....
T Consensus       158 ~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T 3qd2_B          158 LEDREHGVCLHIFIQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG  235 (332)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCS
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHH--hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccc
Confidence             23556678999999999999999  677999999999999999999999999999876544221          11234


Q ss_pred             ccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCH
Q 014736          260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSV  339 (419)
Q Consensus       260 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  339 (419)
                      ..||+.|+|||++.+..++.++||||||+++|+|++|..|+...     ....   ... ... .         ......
T Consensus       236 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~---~~~-~~~-~---------~~~~~~  296 (332)
T 3qd2_B          236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRII---TDV-RNL-K---------FPLLFT  296 (332)
T ss_dssp             CC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHH---HHH-HTT-C---------CCHHHH
T ss_pred             cCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHH---HHh-hcc-C---------CCcccc
Confidence            56999999999999999999999999999999999986654210     0000   000 000 0         001112


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          340 KGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       340 ~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ..+.++.+|+.+||+.||.+|||+.++++
T Consensus       297 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          297 QKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             cCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            34567899999999999999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1e-45  Score=363.15  Aligned_cols=253  Identities=21%  Similarity=0.265  Sum_probs=193.8

Q ss_pred             hcCCCCC-CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHc-CCCcccccceeeEEEe--
Q 014736           90 TQNFSSN-YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLG-QLRHPHLVRLIGYCCE--  165 (419)
Q Consensus        90 ~~~y~~~-~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~--  165 (419)
                      .++|.+. ++||+|+||.||+|..      ..+++.||||++..     ...+.+|+.++. ..+||||++++++|..  
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~------~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFN------KRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEE------TTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEE------CCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            3567766 6899999999999964      34578999999963     245667888874 4589999999999876  


Q ss_pred             --CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCcEEEe
Q 014736          166 --DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLS  240 (419)
Q Consensus       166 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~---~~~~kl~  240 (419)
                        ...+||||||+.||+|.+++.......+++..++.++.||+.||.|||  ++||+||||||+|||++.   ++.+||+
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCcCcceEEEecCCCCccEEEE
Confidence              567899999999999999998765567999999999999999999999  677999999999999998   7889999


Q ss_pred             ccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchh-HHHhhhHHh
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQN-LVDWAKPYL  319 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~~  319 (419)
                      |||+++......   .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.......... ......   
T Consensus       207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---  280 (400)
T 1nxk_A          207 DFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---  280 (400)
T ss_dssp             CCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---
T ss_pred             ecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---
Confidence            999998654322   2344679999999999999999999999999999999999999998654432111 111100   


Q ss_pred             hcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          320 RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                       . +..      .+.......++.++.+||.+||+.||.+|||+.+|++.
T Consensus       281 -~-~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          281 -M-GQY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             -H-TCC------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -c-Ccc------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             0 000      00011112356789999999999999999999999974

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.5e-46  Score=348.47  Aligned_cols=262  Identities=21%  Similarity=0.280  Sum_probs=199.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|.+.+.||+|+||.||+|..       .+++.||+|++.....  .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-------NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-------TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             ccchhhhhcccCCCEEEEEEEc-------CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence            5789999999999999999964       2367899999975432  234678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .++||||+.+ +|.+++... ...+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++...
T Consensus        75 ~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           75 LVLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAF  150 (288)
T ss_dssp             EEEEEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             EEEEEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence            9999999964 898888653 356889999999999999999999  677999999999999999999999999999764


Q ss_pred             CCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc--ccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS--RRL  325 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~  325 (419)
                      .....  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+   .......  ...
T Consensus       151 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~  225 (288)
T 1ob3_A          151 GIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI---FRILGTPNSKNW  225 (288)
T ss_dssp             CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCTTTS
T ss_pred             Ccccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHHCCCChhhc
Confidence            33211  1233468999999999865 46899999999999999999999999865432211111   1100000  000


Q ss_pred             cc-----ccc-------cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          326 RY-----IVD-------PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       326 ~~-----~~~-------~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ..     ..+       +.....+....+.++.+|+.+||+.||++|||+.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00     000       00011122345678999999999999999999999875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.5e-45  Score=343.69  Aligned_cols=259  Identities=21%  Similarity=0.268  Sum_probs=209.7

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .+.++|++.+.||+|+||.||+|...      .++..||+|++........+.+.+|+++++.++||||+++++++.+.+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQK------GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT   79 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeC------CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            35678999999999999999999644      346789999998765666788999999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCcEEEeccCc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL---DSDFTAKLSDFGL  244 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGl  244 (419)
                      ..++||||+++++|.+++...  ..+++..++.++.|++.||.|||  ++||+||||||+|||+   +.++.+||+|||+
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~  155 (277)
T 3f3z_A           80 DIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGL  155 (277)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             eEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCCHHHEEEecCCCCCcEEEEeccc
Confidence            999999999999999998765  56899999999999999999999  6779999999999999   7889999999999


Q ss_pred             cccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          245 AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       245 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      +........   .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+      ......
T Consensus       156 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------~~~~~~  225 (277)
T 3f3z_A          156 AARFKPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI------REGTFT  225 (277)
T ss_dssp             CEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCCC
T ss_pred             ceeccCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH------HhCCCC
Confidence            986554332   234569999999999865 4999999999999999999999999765432111111      000000


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhh
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA--TLESLL  374 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~--~L~~l~  374 (419)
                      .        ........+.++.+|+.+||+.||.+|||+.++++  ++++..
T Consensus       226 ~--------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          226 F--------PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             C--------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             C--------CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence            0        00000123578999999999999999999999986  454443

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.1e-46  Score=358.74  Aligned_cols=252  Identities=24%  Similarity=0.366  Sum_probs=197.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCc--ccccceeeEEEe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRH--PHLVRLIGYCCE  165 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~  165 (419)
                      .++|++.+.||+|+||.||+|...       .++.||+|++.....  .....+.+|+.+|..++|  +||+++++++.+
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   80 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   80 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence            357999999999999999999632       367899999975533  334678899999999976  999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      .+..|+|||+ .+++|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++ ++.+||+|||++
T Consensus        81 ~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH--~~~iiHrDikp~NIll~-~~~~kl~DFG~a  154 (343)
T 3dbq_A           81 DQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKLIDFGIA  154 (343)
T ss_dssp             SSEEEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred             CCEEEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEE-CCcEEEeecccc
Confidence            9999999995 588999999775  57899999999999999999999  67799999999999997 678999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHh
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYIST-----------GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW  314 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  314 (419)
                      ................||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.......     ..
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~  229 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SK  229 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HH
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----HH
Confidence            87655443333445679999999999864           678999999999999999999999997543211     11


Q ss_pred             hhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          315 AKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      ...          ..++.....++...+.++.+|+.+||+.||.+|||+.++++.
T Consensus       230 ~~~----------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          230 LHA----------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHH----------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHH----------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            111          111112222333345789999999999999999999999874

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.6e-46  Score=356.47  Aligned_cols=251  Identities=23%  Similarity=0.323  Sum_probs=179.2

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-cccccceeeEEEeCCeeEEEEE
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-HPHLVRLIGYCCEDEERLLVYE  174 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e  174 (419)
                      .++||+|+||.||+|...      .+++.||||++...   ....+.+|+.+++.+. ||||+++++++.+....|+|||
T Consensus        16 ~~~lG~G~~g~V~~~~~~------~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e   86 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHK------KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME   86 (325)
T ss_dssp             SCCSEEETTEEEEEEEET------TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCccccCCCeEEEEEEEC------CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence            478999999999999643      45788999999643   3466778999999997 9999999999999999999999


Q ss_pred             ecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC---cEEEeccCccccCCCC
Q 014736          175 FMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF---TAKLSDFGLAKMGPEG  251 (419)
Q Consensus       175 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGla~~~~~~  251 (419)
                      |+++++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++   .+||+|||++......
T Consensus        87 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           87 LLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             CCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            99999999999775  57899999999999999999999  67799999999999998765   7999999999865433


Q ss_pred             CCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccccc
Q 014736          252 SNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDP  331 (419)
Q Consensus       252 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (419)
                      ..  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...................... ..      
T Consensus       163 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~-~~------  233 (325)
T 3kn6_A          163 NQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-DF------  233 (325)
T ss_dssp             -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT-CC------
T ss_pred             CC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC-CC------
Confidence            22  2234568999999999999999999999999999999999999998654322111111111111000 00      


Q ss_pred             ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          332 RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       332 ~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .+........++++.+|+.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          234 SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            0000111234678999999999999999999998864

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8.7e-46  Score=345.83  Aligned_cols=248  Identities=26%  Similarity=0.380  Sum_probs=203.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      .++|++.+.||+|+||.||+|...      .+++.||+|++....   ......+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   81 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREK------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA   81 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccEEEeeEEecCCCeEEEEEEEc------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC
Confidence            367999999999999999999644      346789999986432   12346788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..++||||+++++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++.
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~  157 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSV  157 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--TTTCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred             CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHhEEEcCCCCEEEEeccccc
Confidence            9999999999999999999766  56899999999999999999999  6789999999999999999999999999986


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.      .      
T Consensus       158 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~------  221 (279)
T 3fdn_A          158 HAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------R------  221 (279)
T ss_dssp             CC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------H------
T ss_pred             cCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH------h------
Confidence            543322    234569999999999999999999999999999999999999998643221111110      0      


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                            ....++...+.++.+|+.+||+.||.+|||+.+|++.
T Consensus       222 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          222 ------VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             ------TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             ------CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                  0112233345789999999999999999999999974

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=6.7e-46  Score=361.10  Aligned_cols=252  Identities=22%  Similarity=0.293  Sum_probs=200.0

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEe
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  175 (419)
                      .++||+|+||.||+|..      ..+++.||+|++........+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus        94 ~~~lG~G~~g~Vy~a~~------~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~  167 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEE------TATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY  167 (373)
T ss_dssp             EEECC-----CEEEEEE------TTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceEEecCcCEEEEEEEE------cCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            56799999999999964      345788999999876666677899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE--cCCCcEEEeccCccccCCCCCC
Q 014736          176 MPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL--DSDFTAKLSDFGLAKMGPEGSN  253 (419)
Q Consensus       176 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll--~~~~~~kl~DfGla~~~~~~~~  253 (419)
                      +++++|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||+  +.++.+||+|||++........
T Consensus       168 ~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~  244 (373)
T 2x4f_A          168 VDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMH--QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK  244 (373)
T ss_dssp             CTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred             CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence            9999999988654 246889999999999999999999  6779999999999999  5678899999999987654332


Q ss_pred             ceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccccccc
Q 014736          254 THVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL  333 (419)
Q Consensus       254 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  333 (419)
                         .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+      ......+    ..  
T Consensus       245 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i------~~~~~~~----~~--  309 (373)
T 2x4f_A          245 ---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI------LACRWDL----ED--  309 (373)
T ss_dssp             ---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHTCCCS----CS--
T ss_pred             ---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhccCCC----Ch--
Confidence               23346999999999999999999999999999999999999999865432211111      1111000    00  


Q ss_pred             CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhh
Q 014736          334 AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA--TLESL  373 (419)
Q Consensus       334 ~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~--~L~~l  373 (419)
                        ......+.++.+||.+||+.||.+|||+.++++  ++...
T Consensus       310 --~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          310 --EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             --GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             --hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence              011234578999999999999999999999997  45543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-44  Score=346.11  Aligned_cols=275  Identities=25%  Similarity=0.376  Sum_probs=207.8

Q ss_pred             HHHHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC--Cccccccee
Q 014736           83 LSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL--RHPHLVRLI  160 (419)
Q Consensus        83 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~~~  160 (419)
                      ......+.++|++.++||+|+||.||+|...        ++.||||++...   ....+..|.+++..+  +||||++++
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~   97 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--------GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFI   97 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEET--------TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEEC--------CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEE
Confidence            3444566789999999999999999999643        578999998643   234455566666554  899999999


Q ss_pred             eEEEeC----CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeeecCCCCCcEE
Q 014736          161 GYCCED----EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA------ENPVIYRDFKTSNIL  230 (419)
Q Consensus       161 ~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~------~~~ivH~Dlkp~NIl  230 (419)
                      +++...    ...|+||||+++|+|.+++...   .+++..++.++.|++.||.|||+.      ..||+||||||+|||
T Consensus        98 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nil  174 (337)
T 3mdy_A           98 AADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL  174 (337)
T ss_dssp             EEEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEE
T ss_pred             EEEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEE
Confidence            999887    7899999999999999999654   689999999999999999999943      228999999999999


Q ss_pred             EcCCCcEEEeccCccccCCCCCCcee--eecccccccccccccccCCCCCch------hhHHHHHHHHHHHHcC------
Q 014736          231 LDSDFTAKLSDFGLAKMGPEGSNTHV--TTRVMGTYGYAAPEYISTGHLTTK------SDVYSFGVVLLELLTG------  296 (419)
Q Consensus       231 l~~~~~~kl~DfGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~elltg------  296 (419)
                      ++.++.+||+|||++...........  .....||+.|+|||++.+..++..      +|||||||++|||++|      
T Consensus       175 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~  254 (337)
T 3mdy_A          175 VKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI  254 (337)
T ss_dssp             ECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccc
Confidence            99999999999999976543322211  124579999999999987766654      9999999999999999      


Q ss_pred             ----CCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          297 ----RRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQ-YSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       297 ----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                          +.||............ . .... .....    .+.+... ....+++++.+|+.+||+.||.+|||+.+|++.|+
T Consensus       255 ~~~~~~p~~~~~~~~~~~~~-~-~~~~-~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  327 (337)
T 3mdy_A          255 VEEYQLPYHDLVPSDPSYED-M-REIV-CIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA  327 (337)
T ss_dssp             CCCCCCTTTTTSCSSCCHHH-H-HHHH-TTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             cccccccHhhhcCCCCchhh-h-HHHH-hhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence                6666554332211111 0 0000 00000    1111111 12367888999999999999999999999999999


Q ss_pred             hhhcCcc
Q 014736          372 SLLNLKD  378 (419)
Q Consensus       372 ~l~~~~~  378 (419)
                      ++.....
T Consensus       328 ~l~~~~~  334 (337)
T 3mdy_A          328 KMSESQD  334 (337)
T ss_dssp             HHHHTTT
T ss_pred             HHHhhcc
Confidence            9987543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.5e-46  Score=370.87  Aligned_cols=259  Identities=28%  Similarity=0.419  Sum_probs=207.5

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ..++|++.+.||+|+||.||+|.+.+       +..||||++.... ...+.|.+|+.+|++++||||+++++++.+ +.
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~  252 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  252 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-------CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence            35678899999999999999997654       3569999997543 345789999999999999999999999865 77


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||+.+|+|.+++.......+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++..
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence            899999999999999997654456899999999999999999999  677999999999999999999999999999875


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ...... ......++..|+|||++.+..++.++||||||+++|||++ |+.||........   ...    ....     
T Consensus       331 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~~----i~~~-----  397 (452)
T 1fmk_A          331 EDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQ----VERG-----  397 (452)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHH----HHTT-----
T ss_pred             CCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHcC-----
Confidence            433221 1223457889999999998999999999999999999999 9999986543221   111    1111     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                           .....+..++.++.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       398 -----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          398 -----YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                 11122334567899999999999999999999999999988654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=347.82  Aligned_cols=254  Identities=28%  Similarity=0.468  Sum_probs=199.8

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|++.+.||+|+||.||+|.+.        ++.||+|++...  ...+.+.+|+.++++++||||+++++++.  +..+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~   75 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--------AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVC   75 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--------TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--------CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcE
Confidence            57888999999999999999653        467999999643  34577899999999999999999999875  4589


Q ss_pred             EEEEecCCCChhhhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhcCC-CCeeecCCCCCcEEEcCCCc-EEEeccCcccc
Q 014736          171 LVYEFMPRGSLENHLFKRIS-VSLPWGTRLKIAIGAAKGLAFLHGAE-NPVIYRDFKTSNILLDSDFT-AKLSDFGLAKM  247 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~-~kl~DfGla~~  247 (419)
                      +||||+++++|.+++..... ..+++..++.++.|++.||.|||+.. +||+||||||+|||++.++. +||+|||++..
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            99999999999999976532 24788899999999999999999532 78999999999999998887 79999999975


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ....     .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.........  ..+..  . ...    
T Consensus       156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~--~-~~~----  221 (307)
T 2eva_A          156 IQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAV--H-NGT----  221 (307)
T ss_dssp             --------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHHH--H-TTC----
T ss_pred             cccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHHH--h-cCC----
Confidence            4322     22345999999999999999999999999999999999999999765432211  11110  0 000    


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                            ........+..+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       222 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          222 ------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             ------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             ------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence                  0112223457899999999999999999999999999998664

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.8e-45  Score=345.87  Aligned_cols=261  Identities=30%  Similarity=0.418  Sum_probs=209.3

Q ss_pred             hcCCCCCC-eecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           90 TQNFSSNY-LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~-~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      .++|.+.+ .||+|+||.||+|.+..    ...++.||+|++.....  ...+.+.+|+.+++.++||||+++++++ ..
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~   89 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQM----KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA   89 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEEC----SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred             chhhhhccCccccccCeeeEeeeecC----CCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence            35688877 99999999999996532    33468899999975432  2356789999999999999999999999 66


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..++||||+.+++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++.
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHH--hCCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence            7889999999999999999765  56899999999999999999999  6679999999999999999999999999998


Q ss_pred             cCCCCCCce-eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          247 MGPEGSNTH-VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       247 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      ......... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||...........+       .... 
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-------~~~~-  237 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGE-  237 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------HTTC-
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-------HcCC-
Confidence            765443321 1223457789999999988899999999999999999999 99999865432211111       1110 


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                               ....+..++.++.+++.+||+.||.+||++.+|++.|+.+...
T Consensus       238 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          238 ---------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                     1122334567899999999999999999999999999998764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.2e-45  Score=343.95  Aligned_cols=255  Identities=24%  Similarity=0.367  Sum_probs=206.8

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      +.++|++.+.||+|+||.||+|...      .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNR------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN   78 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEET------TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             eecceEEEEEeecCCCcEEEEEEEC------CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC
Confidence            4567999999999999999999643      3568899999975432 34567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+++++|.+++...  ..+++..++.++.||+.||.|||  ++||+|+||||+||+++.++.+||+|||++..
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  154 (276)
T 2yex_A           79 IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATV  154 (276)
T ss_dssp             EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCChHHEEEccCCCEEEeeCCCccc
Confidence            999999999999999998654  56899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCceeeecccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHL-TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ..............||+.|+|||++.+..+ +.++||||||+++|+|++|..||......... ...+..    ...   
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~----~~~---  226 (276)
T 2yex_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKE----KKT---  226 (276)
T ss_dssp             CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHT----TCT---
T ss_pred             cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhh----ccc---
Confidence            543332222344679999999999987665 78999999999999999999999875433211 111110    000   


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                             ........+.++.+|+.+||+.||.+|||+.++++
T Consensus       227 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          227 -------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                   00111234578999999999999999999999875

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=368.23  Aligned_cols=259  Identities=19%  Similarity=0.188  Sum_probs=205.3

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeE
Q 014736           86 LRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGY  162 (419)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~  162 (419)
                      .+...++|++.++||+|+||.||+|..      ..+++.||+|++....   ......+.+|..++..++||||++++++
T Consensus        56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~------~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~  129 (412)
T 2vd5_A           56 VRLQRDDFEILKVIGRGAFSEVAVVKM------KQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA  129 (412)
T ss_dssp             HSCCGGGEEEEEEEEECSSCEEEEEEE------TTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred             ccCChhhEEEEEEEeeCCCeEEEEEEE------CCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            344467899999999999999999964      3457899999996432   1223457889999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEecc
Q 014736          163 CCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       163 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                      |.+.+.+|+||||++||+|.+++.+. ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+||
T Consensus       130 ~~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH--~~giiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          130 FQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVH--RLGYVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EeeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccCHHHeeecCCCCEEEeec
Confidence            99999999999999999999999764 236899999999999999999999  677999999999999999999999999


Q ss_pred             CccccCCCCCCceeeeccccccccccccccc-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh
Q 014736          243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS-------TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA  315 (419)
Q Consensus       243 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~  315 (419)
                      |+++....... ......+||+.|+|||++.       ...|+.++|||||||++|||++|+.||...........+.. 
T Consensus       207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~-  284 (412)
T 2vd5_A          207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH-  284 (412)
T ss_dssp             TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-
T ss_pred             hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh-
Confidence            99987544322 1223467999999999986       46789999999999999999999999976543222111110 


Q ss_pred             hHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 014736          316 KPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDR---PKMAAVVA  368 (419)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~R---Ps~~eil~  368 (419)
                           ....+.   .+    .+....+.++.+||.+||. +|.+|   |++++|++
T Consensus       285 -----~~~~~~---~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          285 -----YKEHLS---LP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             -----HHHHCC---CC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             -----cccCcC---CC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence                 000000   01    1123356789999999999 99998   58999875

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.5e-45  Score=350.35  Aligned_cols=261  Identities=23%  Similarity=0.254  Sum_probs=199.6

Q ss_pred             hcCCCCC-CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-CcccccceeeEEEeCC
Q 014736           90 TQNFSSN-YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~-~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  167 (419)
                      .++|.+. ++||+|+||.||+|.      +..+++.||||++..........+.+|+.++.++ +||||+++++++.+.+
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~   84 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCI------NLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED   84 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEE------CSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             ceeEEecCceecCCceEEEEEEE------EcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            4678874 789999999999995      3445789999999876555677899999999885 7999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc---EEEeccCc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT---AKLSDFGL  244 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGl  244 (419)
                      ..|+||||+++++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.   +||+|||+
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~  160 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLH--NKGIAHRDLKPENILCEHPNQVSPVKICDFDL  160 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred             EEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence            999999999999999999776  56899999999999999999999  667999999999999998776   99999999


Q ss_pred             cccCCCCCCc-----eeeecccccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHH--
Q 014736          245 AKMGPEGSNT-----HVTTRVMGTYGYAAPEYIST-----GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV--  312 (419)
Q Consensus       245 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--  312 (419)
                      +.........     .......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||............  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  240 (316)
T 2ac3_A          161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE  240 (316)
T ss_dssp             CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred             ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence            8765322111     11223469999999999865     56899999999999999999999999875433211000  


Q ss_pred             -------HhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          313 -------DWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       313 -------~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                             ..........  .      .+........+.++.+|+.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~i~~~~--~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          241 ACPACQNMLFESIQEGK--Y------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CCHHHHHHHHHHHHHCC--C------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cchhHHHHHHHHHhccC--c------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                   0000000000  0      0000000124578999999999999999999999976

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=362.90  Aligned_cols=275  Identities=20%  Similarity=0.268  Sum_probs=216.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCC-
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE-  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-  167 (419)
                      .++|.+.++||+|+||.||+|...      .+++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+ 
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   81 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHK------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CCceEEEEEEEcCCCeEEEEEEEC------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence            367999999999999999999643      457899999997543 234577889999999999999999999998765 


Q ss_pred             -eeEEEEEecCCCChhhhhhhccC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE----cCCCcEEEec
Q 014736          168 -ERLLVYEFMPRGSLENHLFKRIS-VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL----DSDFTAKLSD  241 (419)
Q Consensus       168 -~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll----~~~~~~kl~D  241 (419)
                       ..++||||+++++|.+++..... ..+++..++.++.||+.||.|||  ++||+||||||+|||+    +.++.+||+|
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (396)
T 4eut_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (396)
T ss_dssp             CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred             CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH--HCCEEECCcCHHHEEEeecCCCceeEEEec
Confidence             78999999999999999976532 34899999999999999999999  6779999999999999    7788899999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccC--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHH
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST--------GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD  313 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  313 (419)
                      ||+++.......   .....||+.|+|||++.+        ..++.++|||||||++|+|++|+.||.............
T Consensus       160 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  236 (396)
T 4eut_A          160 FGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM  236 (396)
T ss_dssp             GGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred             CCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence            999987544321   234569999999999864        567889999999999999999999997654322211111


Q ss_pred             hhhHHhhcc--c-----------ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          314 WAKPYLRSS--R-----------RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       314 ~~~~~~~~~--~-----------~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                        .......  .           .+...........+....+..+.+++.+||+.||++||++.++++.+..++...
T Consensus       237 --~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~  311 (396)
T 4eut_A          237 --YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM  311 (396)
T ss_dssp             --HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred             --HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence              1111000  0           000000111223455778899999999999999999999999999999987753

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9.5e-46  Score=352.83  Aligned_cols=253  Identities=21%  Similarity=0.277  Sum_probs=206.3

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc------cHHHHHHHHHHHcCCCcccccceeeE
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ------GHREWLAEVIFLGQLRHPHLVRLIGY  162 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~~~~~  162 (419)
                      +.++|.+.+.||+|+||.||+|..      ..+++.||+|++......      ..+.+.+|+.+++.++||||++++++
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   83 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCRE------KSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDV   83 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEE------TTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEE------CCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            456799999999999999999964      345788999999754321      35778999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC----cEE
Q 014736          163 CCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF----TAK  238 (419)
Q Consensus       163 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~----~~k  238 (419)
                      +.+.+..++||||+++++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++    .+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH--~~~ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           84 YENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EecCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCChHHEEEecCCCCcCCEE
Confidence            99999999999999999999999764  56889999999999999999999  66799999999999999888    799


Q ss_pred             EeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          239 LSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       239 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      |+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+      
T Consensus       160 l~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i------  230 (321)
T 2a2a_A          160 LIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI------  230 (321)
T ss_dssp             ECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------
T ss_pred             EccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------
Confidence            999999987554322   23456999999999999999999999999999999999999999764322111111      


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ......    .++.    +....+.++.+|+.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~----~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          231 TSVSYD----FDEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HTTCCC----CCHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             Hhcccc----cChh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            000000    0000    11123567999999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.8e-46  Score=356.49  Aligned_cols=271  Identities=27%  Similarity=0.371  Sum_probs=209.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|.+.+.||+|+||.||+|.+.+. .+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGM-PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC---------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCC-CCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            36899999999999999999975432 234567889999997442 3345678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCcEEEe
Q 014736          169 RLLVYEFMPRGSLENHLFKRIS-----VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLS  240 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~---~~~~kl~  240 (419)
                      .|+||||+++++|.+++.....     ..+++..++.++.||+.||.|||  ++||+||||||+|||++.   +..+||+
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh--hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            9999999999999999976532     34889999999999999999999  677999999999999994   4469999


Q ss_pred             ccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHh
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYL  319 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  319 (419)
                      |||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.......   .....    
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~----  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFV----  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHH----
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HHHHH----
Confidence            9999875433332222334568999999999988999999999999999999998 999997643221   11111    


Q ss_pred             hcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCcccc
Q 014736          320 RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMA  380 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~~~  380 (419)
                      ....          ....+..++.++.+|+.+||+.||.+||++.+|++.|+.+.......
T Consensus       259 ~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~  309 (327)
T 2yfx_A          259 TSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI  309 (327)
T ss_dssp             HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred             hcCC----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHh
Confidence            1110          01122345678999999999999999999999999999987755443

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.7e-46  Score=362.51  Aligned_cols=251  Identities=24%  Similarity=0.359  Sum_probs=196.8

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCC--cccccceeeEEEeC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLR--HPHLVRLIGYCCED  166 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~  166 (419)
                      ++|.+.+.||+|+||.||+|...       .++.||||++.....  .....+.+|+.+|..++  ||||+++++++...
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~  128 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  128 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             CceEEEEEEccCCCeEEEEEEcC-------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC
Confidence            46999999999999999999532       267899999975432  34567899999999996  59999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..|+||| +.+++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++ ++.+||+|||+++
T Consensus       129 ~~~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~  202 (390)
T 2zmd_A          129 QYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKLIDFGIAN  202 (390)
T ss_dssp             SEEEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred             CEEEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence            99999999 5588999999776  47888899999999999999999  67799999999999995 5789999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYIST-----------GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA  315 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~  315 (419)
                      ..............+||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.......     ...
T Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~  277 (390)
T 2zmd_A          203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKL  277 (390)
T ss_dssp             CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHH
T ss_pred             cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HHH
Confidence            7654433333345679999999999865           468999999999999999999999997543211     111


Q ss_pred             hHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          316 KPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      ...          ++......++...+.++.+|+.+||+.||.+|||+.++++.
T Consensus       278 ~~~----------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          278 HAI----------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHH----------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHH----------hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            111          11111112222335789999999999999999999999864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.2e-45  Score=345.31  Aligned_cols=262  Identities=27%  Similarity=0.418  Sum_probs=209.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|.+.+.||+|+||.||+|.+...   ...+..||+|++.... ....+.+.+|+.+++.++||||+++++++.+ +.
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   86 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNH---KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP   86 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECT---TCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCC---CCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence            46799999999999999999976542   2345679999997653 3345778999999999999999999999864 56


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||+.+++|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++...
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLE--SINCVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             CEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence            79999999999999999764 345899999999999999999999  677999999999999999999999999999875


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+.       ....   
T Consensus       164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-------~~~~---  232 (281)
T 3cc6_A          164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-------KGDR---  232 (281)
T ss_dssp             ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-------HTCC---
T ss_pred             cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-------cCCC---
Confidence            443221 1233457889999999988999999999999999999998 999997654433221111       1100   


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                             ...+...++.+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       233 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          233 -------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence                   111223457899999999999999999999999999998764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-45  Score=345.41  Aligned_cols=266  Identities=26%  Similarity=0.395  Sum_probs=213.0

Q ss_pred             cCCCCCC-eecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNY-LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~-~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|.+.. .||+|+||.||+|.+..    ...++.||+|++.... ....+.+.+|+.+++.++||||+++++++ ..+.
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~   83 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRM----RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA   83 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred             HHhhhhhccccccCceeEEEeEecc----CCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence            4566666 89999999999997532    2346789999997643 23456788999999999999999999999 5667


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .++||||+.+++|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++...
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             cEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            89999999999999998643 346899999999999999999999  677999999999999999999999999999876


Q ss_pred             CCCCCce-eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          249 PEGSNTH-VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       249 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ....... ......||+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+       ....   
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i-------~~~~---  230 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------EQGK---  230 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH-------HTTC---
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-------hcCC---
Confidence            4433221 1223457899999999988899999999999999999998 99999865432211111       1110   


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCccccc
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMAV  381 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~~~~  381 (419)
                             ...++..++.++.+|+.+||+.||.+||++.++++.|+.++.....+.
T Consensus       231 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~  278 (287)
T 1u59_A          231 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  278 (287)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred             -------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence                   112334456889999999999999999999999999999987554433

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.1e-46  Score=356.68  Aligned_cols=268  Identities=19%  Similarity=0.226  Sum_probs=195.0

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--cHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--GHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      ...++|++.++||+|+||.||+|..      ..+++.||||++......  ....+.+|+.+++.++||||+++++++.+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAID------TVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH  104 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEE------TTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEE------CCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence            3456899999999999999999954      445789999999755332  24567789999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc-----CCCcEEEe
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD-----SDFTAKLS  240 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~-----~~~~~kl~  240 (419)
                      ++..|+||||+. ++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++     .++.+||+
T Consensus       105 ~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~  179 (329)
T 3gbz_A          105 NHRLHLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVLKIG  179 (329)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred             CCEEEEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCEECCCCCHHHEEEecCCCCccceEEEC
Confidence            999999999996 5999998765  56899999999999999999999  66799999999999994     45569999


Q ss_pred             ccCccccCCCCCCceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHh
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYL  319 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  319 (419)
                      |||++........  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+.......
T Consensus       180 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  257 (329)
T 3gbz_A          180 DFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP  257 (329)
T ss_dssp             CTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             cCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            9999986543221  22345689999999999764 58999999999999999999999998654322111111000000


Q ss_pred             hcc------------cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          320 RSS------------RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       320 ~~~------------~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ...            ..+.......+...+....+.++.+||.+||+.||.+|||+.++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            000            0000000000000011224578999999999999999999999976

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=9.2e-46  Score=370.67  Aligned_cols=269  Identities=22%  Similarity=0.268  Sum_probs=212.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCc-ccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRH-PHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~  168 (419)
                      .++|++.++||+|+||.||+|...      .+++.||||++.....  ...+.+|+++++.++| ++|..+..++...+.
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~------~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~   77 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNI------QTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDY   77 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEET------TTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEEC------CCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence            478999999999999999999643      4478899999875433  2357789999999986 566667777788889


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCcEEEeccCcc
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL---DSDFTAKLSDFGLA  245 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla  245 (419)
                      .+|||||+ +++|.+++... ...+++..++.++.||+.||.|||  .+|||||||||+||||   +.++.+||+|||++
T Consensus        78 ~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH--~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla  153 (483)
T 3sv0_A           78 NVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (483)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence            99999999 99999998643 357999999999999999999999  6779999999999999   68899999999999


Q ss_pred             ccCCCCCCce-----eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhh
Q 014736          246 KMGPEGSNTH-----VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR  320 (419)
Q Consensus       246 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  320 (419)
                      +.........     ......||..|+|||++.+..++.++|||||||++|||++|+.||....................
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (483)
T 3sv0_A          154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (483)
T ss_dssp             EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred             eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence            8765433211     12246799999999999999999999999999999999999999988665443333322211100


Q ss_pred             cccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCcccc
Q 014736          321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMA  380 (419)
Q Consensus       321 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~~~  380 (419)
                      . ..+.     .+.    ..++.++.+|+.+||+.||++||++.+|++.|+.++......
T Consensus       234 ~-~~~~-----~l~----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~  283 (483)
T 3sv0_A          234 A-TSIE-----ALC----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQ  283 (483)
T ss_dssp             H-SCHH-----HHH----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             c-ccHH-----HHh----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCC
Confidence            0 0000     011    123578999999999999999999999999999997755443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.5e-46  Score=365.24  Aligned_cols=268  Identities=22%  Similarity=0.297  Sum_probs=194.5

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC--CcccHHHHHHHHHHHcCCC-cccccceeeEE
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQLR-HPHLVRLIGYC  163 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~  163 (419)
                      ..+.++|.+.+.||+|+||.||+|..      ..+++.||||++...  .......+.+|+.+|+.+. ||||+++++++
T Consensus         5 ~~~~~~y~~~~~lG~G~~g~V~~~~~------~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~   78 (388)
T 3oz6_A            5 RHVLRKYELVKKLGKGAYGIVWKSID------RRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVL   78 (388)
T ss_dssp             HHHHTTEEEEEC-------CEEEEEE------TTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             CcccCceEEEEEeeeCCCeEEEEEEE------CCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEE
Confidence            45678999999999999999999954      445789999998643  2334567889999999997 99999999999


Q ss_pred             EeCC--eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          164 CEDE--ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       164 ~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                      ...+  ..|+||||+. ++|.+++...   .+++..+..++.||+.||+|||  ++||+||||||+|||++.++.+||+|
T Consensus        79 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~D  152 (388)
T 3oz6_A           79 RADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLH--SGGLLHRDMKPSNILLNAECHVKVAD  152 (388)
T ss_dssp             ECTTSSCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             ecCCCCEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHeEEcCCCCEEecC
Confidence            7654  6899999996 6899888653   6889999999999999999999  66799999999999999999999999


Q ss_pred             cCccccCCCCC-------------------CceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 014736          242 FGLAKMGPEGS-------------------NTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMD  301 (419)
Q Consensus       242 fGla~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~  301 (419)
                      ||+++......                   .....+..+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.
T Consensus       153 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  232 (388)
T 3oz6_A          153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP  232 (388)
T ss_dssp             CTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence            99998653211                   1112344679999999999876 679999999999999999999999998


Q ss_pred             CCCCccchhHHHhhhHHhhccc--cccccc------------------ccccCCC------------CCHHHHHHHHHHH
Q 014736          302 KLRPKSEQNLVDWAKPYLRSSR--RLRYIV------------------DPRLAGQ------------YSVKGAKEMAVLA  349 (419)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~------------------~~~l~~~------------~~~~~~~~l~~li  349 (419)
                      +.........+.   .......  .+..+.                  .......            .....+.++.+|+
T Consensus       233 ~~~~~~~~~~i~---~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll  309 (388)
T 3oz6_A          233 GSSTMNQLERII---GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL  309 (388)
T ss_dssp             CSSHHHHHHHHH---HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHH
T ss_pred             CCCHHHHHHHHH---HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHH
Confidence            754332221111   0000000  000000                  0000000            0013457899999


Q ss_pred             HHcccCCCCCCCCHHHHHHH
Q 014736          350 LQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       350 ~~~l~~dP~~RPs~~eil~~  369 (419)
                      .+||+.||.+|||+.++++.
T Consensus       310 ~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          310 DKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHHCCSSGGGSCCHHHHTTS
T ss_pred             HHhhccCcccCCCHHHHhCC
Confidence            99999999999999998763

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.3e-46  Score=345.86  Aligned_cols=259  Identities=30%  Similarity=0.455  Sum_probs=210.7

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ..++|++.+.||+|+||.||+|...+       +..||+|++.... ...+.+.+|+++++.++||||+++++++. ++.
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~   81 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNG-------HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEP   81 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcC-------CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCC
Confidence            34689999999999999999997543       4679999997543 34578899999999999999999999886 456


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .++||||+.+++|.+++.......+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++...
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence            899999999999999997654446899999999999999999999  677999999999999999999999999999875


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ...... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.......   .....    ...     
T Consensus       160 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~----~~~-----  226 (279)
T 1qpc_A          160 EDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNL----ERG-----  226 (279)
T ss_dssp             SSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHH----HTT-----
T ss_pred             cCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HHHHH----hcc-----
Confidence            443211 1223457889999999988899999999999999999999 999997653221   11110    010     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                           .....+...+.++.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       227 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          227 -----YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence                 01112234567899999999999999999999999999998753

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.6e-45  Score=343.27  Aligned_cols=253  Identities=23%  Similarity=0.326  Sum_probs=206.2

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      +.++|++.+.||+|+||.||+|...      .+++.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHK------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE   77 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEc------CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC
Confidence            4578999999999999999999643      4478899999975432  3346788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc---EEEeccC
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT---AKLSDFG  243 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG  243 (419)
                      +..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.   +||+|||
T Consensus        78 ~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           78 SFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            9999999999999999988766  56899999999999999999999  677999999999999987655   9999999


Q ss_pred             ccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccc
Q 014736          244 LAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSR  323 (419)
Q Consensus       244 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  323 (419)
                      ++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.      ....
T Consensus       154 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~------~~~~  224 (284)
T 3kk8_A          154 LAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK------AGAY  224 (284)
T ss_dssp             TCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HTCC
T ss_pred             eeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH------hccc
Confidence            9976544322   234569999999999999999999999999999999999999997643221111110      0000


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          324 RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       324 ~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .        .........+.++.+|+.+||+.||.+|||+.++++
T Consensus       225 ~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          225 D--------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             C--------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             c--------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0        011111234578999999999999999999999987

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-45  Score=345.32  Aligned_cols=252  Identities=25%  Similarity=0.324  Sum_probs=199.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|.+.+.||+|+||.||+|..      ..+++.||+|++.... ....+.+.+|+++|+.++||||+++++++.+.+.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   94 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEE------RSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN   94 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEE------TTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhheeecceeccCCCeEEEEEEE------ccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence            46799999999999999999964      3457889999997553 2346788999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCcEEEeccC
Q 014736          169 RLLVYEFMPRGSLENHLFKR--ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL---DSDFTAKLSDFG  243 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG  243 (419)
                      .++||||+++++|.+++...  ....+++..++.++.||+.||.|||  ++||+||||||+|||+   +.++.+||+|||
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg  172 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH--SQHVVHKDLKPENILFQDTSPHSPIKIIDFG  172 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence            99999999999999988643  2367899999999999999999999  6779999999999999   456789999999


Q ss_pred             ccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccc
Q 014736          244 LAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSR  323 (419)
Q Consensus       244 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  323 (419)
                      ++........   .....||+.|+|||++. +.++.++||||||+++|+|++|+.||..............      ...
T Consensus       173 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~------~~~  242 (285)
T 3is5_A          173 LAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY------KEP  242 (285)
T ss_dssp             CCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCC
T ss_pred             cceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc------CCc
Confidence            9986543321   33456999999999985 6789999999999999999999999986543221111110      000


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          324 RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       324 ~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ..        . ......++++.+|+.+||+.||++|||+.+|++
T Consensus       243 ~~--------~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          243 NY--------A-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CC--------C-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cc--------c-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00        0 001113578999999999999999999999975

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=355.38  Aligned_cols=259  Identities=16%  Similarity=0.169  Sum_probs=207.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC---cccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR---HPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~  166 (419)
                      .++|.+.++||+|+||.||+|.+.+. .+...++.||+|++...   ...++..|+.++..++   |+||+++++++...
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDL-NDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC--------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCC-cccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            46799999999999999999965432 34566889999999754   3456667777777765   99999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC----------
Q 014736          167 EERLLVYEFMPRGSLENHLFKR---ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS----------  233 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~----------  233 (419)
                      +..|+||||+++|+|.+++...   ....+++..++.++.||+.||.|||  ++|||||||||+||||+.          
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH--~~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH--DCEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECGGGTCC-----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEecccccCcccccc
Confidence            9999999999999999999753   2356999999999999999999999  677999999999999998          


Q ss_pred             -CCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHH
Q 014736          234 -DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV  312 (419)
Q Consensus       234 -~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~  312 (419)
                       ++.+||+|||+++..............+||+.|+|||++.+..|+.++|||||||++|||++|+.||........    
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----  293 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----  293 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE----
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce----
Confidence             899999999999764433333445567899999999999999999999999999999999999999864322110    


Q ss_pred             HhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHHhhhcC
Q 014736          313 DWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDR-PKMAAVVATLESLLNL  376 (419)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~R-Ps~~eil~~L~~l~~~  376 (419)
                                 ..    ...+. .+  ...+.+.+++..||+.+|.+| |++.++.+.|+.++..
T Consensus       294 -----------~~----~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          294 -----------KP----EGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             -----------EE----CSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -----------ee----chhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence                       00    01111 11  125678899999999999999 7888888888887653

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.9e-45  Score=348.91  Aligned_cols=263  Identities=23%  Similarity=0.271  Sum_probs=202.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc---cHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ---GHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      .++|.+.+.||+|+||.||+|...      .+++.||+|++......   ..+.+.+|+.+++.++||||+++++++..+
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDT------VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID  106 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEET------TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEc------CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence            478999999999999999999643      34688999999754322   246788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..|+||||+++++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++.
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~  182 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAH--AAGATHRDVKPENILVSADDFAYLVDFGIAS  182 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECSCCC--
T ss_pred             CeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCcCCcCCCChHHEEEcCCCCEEEecCccCc
Confidence            9999999999999999999765  56899999999999999999999  6679999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......    ..   .........  
T Consensus       183 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~---~~~~~~~~~--  252 (309)
T 2h34_A          183 ATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VM---GAHINQAIP--  252 (309)
T ss_dssp             ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HH---HHHHHSCCC--
T ss_pred             cccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HH---HHHhccCCC--
Confidence            65443221 223456999999999999999999999999999999999999999764321    11   011111000  


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhhcCcc
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP-KMAAVVATLESLLNLKD  378 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-s~~eil~~L~~l~~~~~  378 (419)
                            .........+.++.+|+.+||+.||++|| +++++++.|+.++....
T Consensus       253 ------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          253 ------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             ------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             ------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence                  01122234457899999999999999999 99999999998876543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.7e-46  Score=356.69  Aligned_cols=268  Identities=22%  Similarity=0.239  Sum_probs=205.6

Q ss_pred             HHHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC-----CcccHHHHHHHHHHHcCCCcccccc
Q 014736           84 SELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-----GLQGHREWLAEVIFLGQLRHPHLVR  158 (419)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~  158 (419)
                      ..+..+.++|.+.+.||+|+||.||+|..      ..+++.||+|++...     .....+.+.+|+.+++.++||||++
T Consensus        19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~   92 (345)
T 3hko_A           19 GSLLELQKKYHLKGAIGQGSYGVVRVAIE------NQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR   92 (345)
T ss_dssp             BCHHHHHHHEEEEEEEEECSSCEEEEEEE------TTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             chhhhhhhheeecceeeecCCeEEEEEEE------CCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            34567788999999999999999999964      345788999998643     2344577899999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEecCCCChhhhhhhcc--------------------------------------CCCCCHHHHHH
Q 014736          159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRI--------------------------------------SVSLPWGTRLK  200 (419)
Q Consensus       159 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------------------------------~~~~~~~~~~~  200 (419)
                      +++++.+.+..++||||+++|+|.+++....                                      ...+++..++.
T Consensus        93 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (345)
T 3hko_A           93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN  172 (345)
T ss_dssp             EEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHH
T ss_pred             eehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHH
Confidence            9999999999999999999999999885211                                      11235667889


Q ss_pred             HHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC--cEEEeccCccccCCCCCC--ceeeecccccccccccccccC--
Q 014736          201 IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF--TAKLSDFGLAKMGPEGSN--THVTTRVMGTYGYAAPEYIST--  274 (419)
Q Consensus       201 i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--  274 (419)
                      ++.||+.||.|||  ++||+||||||+|||++.++  .+||+|||++........  ........||+.|+|||++.+  
T Consensus       173 i~~qi~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  250 (345)
T 3hko_A          173 IMRQIFSALHYLH--NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN  250 (345)
T ss_dssp             HHHHHHHHHHHHH--HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred             HHHHHHHHHHHHH--HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence            9999999999999  56799999999999998776  899999999986433211  112334569999999999865  


Q ss_pred             CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHccc
Q 014736          275 GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCIS  354 (419)
Q Consensus       275 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~  354 (419)
                      ..++.++||||||+++|+|++|+.||..........      .........        ........+.++.+|+.+||+
T Consensus       251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~------~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~  316 (345)
T 3hko_A          251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTIS------QVLNKKLCF--------ENPNYNVLSPLARDLLSNLLN  316 (345)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCCCCT--------TSGGGGGSCHHHHHHHHHHSC
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHH------HHHhccccc--------CCcccccCCHHHHHHHHHHcC
Confidence            678999999999999999999999997654322111      111111000        001112345789999999999


Q ss_pred             CCCCCCCCHHHHHH--HHHhh
Q 014736          355 VNPKDRPKMAAVVA--TLESL  373 (419)
Q Consensus       355 ~dP~~RPs~~eil~--~L~~l  373 (419)
                      .||.+||++.++++  ++..+
T Consensus       317 ~~p~~Rps~~~~l~hp~~~~~  337 (345)
T 3hko_A          317 RNVDERFDAMRALQHPWISQF  337 (345)
T ss_dssp             SCTTTSCCHHHHHHSHHHHTT
T ss_pred             CChhHCCCHHHHhcChhhccC
Confidence            99999999999987  45444

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.5e-45  Score=345.95  Aligned_cols=263  Identities=27%  Similarity=0.398  Sum_probs=206.5

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEE-EeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYC-CEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~  168 (419)
                      .+|.+.++||+|+||.||+|.+.++   ......||+|.+.... ....+.+.+|+.++++++||||+++++++ ..++.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC--------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             eehhhcceeeecCCceEEEEEEecC---CCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            4688889999999999999976432   2234569999987543 23456788999999999999999999985 45568


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .++||||+.+++|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++...
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             eEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCchheEEECCCCCEEECcccccccc
Confidence            89999999999999999653 356889999999999999999999  677999999999999999999999999999865


Q ss_pred             CCCCCc--eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          249 PEGSNT--HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       249 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      ......  .......||+.|+|||++.+..++.++||||||+++|+|++ |.+||.............       ...  
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-------~~~--  249 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-------QGR--  249 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-------TTC--
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-------cCC--
Confidence            443221  12233568889999999999999999999999999999999 566776544332211110       000  


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                              ....+..++.++.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       250 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          250 --------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                    0111223457899999999999999999999999999998764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.8e-45  Score=346.74  Aligned_cols=267  Identities=22%  Similarity=0.275  Sum_probs=200.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--cHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--GHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .++|++.+.||+|+||.||+|...      .+++.||+|++......  ..+.+.+|+.++++++||||+++++++.+.+
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   75 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNR------DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR   75 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cccceEeeEEeecCCeEEEEEEeC------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC
Confidence            468999999999999999999643      44788999998654332  2456789999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++..
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  151 (311)
T 4agu_A           76 RLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCH--KHNCIHRDVKPENILITKHSVIKLCDFGFARL  151 (311)
T ss_dssp             EEEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             eEEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence            999999999999998887654  56899999999999999999999  67799999999999999999999999999987


Q ss_pred             CCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh--------hHH
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA--------KPY  318 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~--------~~~  318 (419)
                      ......  ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+...        ...
T Consensus       152 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (311)
T 4agu_A          152 LTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV  229 (311)
T ss_dssp             CC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             ccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence            543322  2234569999999999876 67899999999999999999999999876543322211110        000


Q ss_pred             hhcccccccccccccCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 LRSSRRLRYIVDPRLAGQ-----YSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~-----~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      +...........+.....     .....+.++.+|+.+||+.||.+|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            001100000000000000     01235677999999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9.8e-46  Score=351.27  Aligned_cols=247  Identities=26%  Similarity=0.258  Sum_probs=193.7

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCC-CcccccceeeEEEe
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQL-RHPHLVRLIGYCCE  165 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  165 (419)
                      +.++|++.++||+|+||+||+|...      .+++.||||++.....  .....+..|+..+..+ +||||+++++++.+
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~  128 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSK------EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE  128 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEET------TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEEC------CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence            4568999999999999999999654      3478899999865432  2334455666665554 89999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      .+..|+||||+ +++|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++
T Consensus       129 ~~~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~kl~DFG~a  204 (311)
T 3p1a_A          129 GGILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLH--SQGLVHLDVKPANIFLGPRGRCKLGDFGLL  204 (311)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred             CCEEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEECCCCCEEEccceee
Confidence            99999999999 78999988765 346999999999999999999999  567999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      .......   ......||+.|+|||++.+ .++.++|||||||++|||++|..++.....     ...     +..    
T Consensus       205 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~-----~~~----  266 (311)
T 3p1a_A          205 VELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----WQQ-----LRQ----  266 (311)
T ss_dssp             EECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----HHH-----HTT----
T ss_pred             eecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHH-----Hhc----
Confidence            8654332   2334569999999999865 799999999999999999999766543210     000     000    


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                           ......+....+.++.+|+.+||+.||++|||+.++++
T Consensus       267 -----~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          267 -----GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             -----TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -----cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                 00011111234578999999999999999999999976

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=8.7e-46  Score=370.25  Aligned_cols=267  Identities=23%  Similarity=0.304  Sum_probs=186.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC--CcccHHHHHHHHHHHcCCCcccccceeeEEEeC-
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCED-  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-  166 (419)
                      .++|+++++||+|+||.||+|..      ..+++.||||++...  .....+.+.+|+.+|+.++||||+++++++... 
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~------~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  125 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYD------KLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD  125 (458)
T ss_dssp             CTTEEECCC-------CEEEEEE------CC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEE------CCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            36899999999999999999964      445789999999653  233456788999999999999999999998443 


Q ss_pred             ----CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEecc
Q 014736          167 ----EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       167 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                          ..+|+||||+ +++|.+++...  ..+++..++.++.||+.||.|||  .+|||||||||+||||+.++.+||+||
T Consensus       126 ~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH--~~~iiHrDlKp~NILl~~~~~~kl~DF  200 (458)
T 3rp9_A          126 VEKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVH--SAGILHRDLKPANCLVNQDCSVKVCDF  200 (458)
T ss_dssp             TTTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTCCEEECCC
T ss_pred             cccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHH--hCCcCCCCCChhhEEECCCCCEeeccc
Confidence                5789999998 67999988654  56899999999999999999999  567999999999999999999999999


Q ss_pred             CccccCCCCCCc-------------------------eeeecccccccccccccc-cCCCCCchhhHHHHHHHHHHHHc-
Q 014736          243 GLAKMGPEGSNT-------------------------HVTTRVMGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLT-  295 (419)
Q Consensus       243 Gla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ellt-  295 (419)
                      |+++........                         ...+..+||+.|+|||++ .+..|+.++||||||||+|||++ 
T Consensus       201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            999875432211                         123446789999999976 56779999999999999999999 


Q ss_pred             ----------CCCCCCCCCCccc-----------------hhHHHhhhHHhhcc-----------------ccccccccc
Q 014736          296 ----------GRRSMDKLRPKSE-----------------QNLVDWAKPYLRSS-----------------RRLRYIVDP  331 (419)
Q Consensus       296 ----------g~~pf~~~~~~~~-----------------~~~~~~~~~~~~~~-----------------~~~~~~~~~  331 (419)
                                |+++|.+......                 ...+......+...                 ..+......
T Consensus       281 ~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~  360 (458)
T 3rp9_A          281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT  360 (458)
T ss_dssp             STTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCC
T ss_pred             ccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCC
Confidence                      6666654331100                 00000000000000                 000000000


Q ss_pred             ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          332 RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       332 ~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .+.. .....+.++.+||.+||..||.+|||+.|+++
T Consensus       361 ~~~~-~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          361 DLAE-RFPASSADAIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             CGGG-GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CHHH-HCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            0011 11234678999999999999999999999987

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-45  Score=342.38  Aligned_cols=256  Identities=27%  Similarity=0.437  Sum_probs=209.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|++.+.||+|+||.||+|.+.+       ++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLN-------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   79 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeEecCCCceeEEEEEecC-------CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence            578899999999999999997542       46799999976543 3467899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+++++|.+++... ...+++..++.++.|++.||.|||  ++||+|+||||+||+++.++.+||+|||++.....
T Consensus        80 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             EEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             EEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence            999999999999998754 346889999999999999999999  67799999999999999999999999999986543


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      ... .......|+..|+|||++.+..++.++||||||+++|+|++ |..||.......   .....    ...       
T Consensus       157 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~i----~~~-------  221 (267)
T 3t9t_A          157 DQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDI----STG-------  221 (267)
T ss_dssp             HHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH----HTT-------
T ss_pred             ccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HHHHH----hcC-------
Confidence            211 11223457889999999988999999999999999999999 899997643221   11110    010       


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                         .....+...+.++.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       222 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          222 ---FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence               0011122345789999999999999999999999999998865

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.3e-45  Score=345.42  Aligned_cols=272  Identities=20%  Similarity=0.248  Sum_probs=208.8

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEE-EeC
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYC-CED  166 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~  166 (419)
                      .+.++|++.+.||+|+||.||+|..      ..+++.||+|++.....  ...+.+|+.+++.++|++++..+..+ ...
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTD------IAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG   77 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEE------TTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEE------cCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence            3457899999999999999999964      34578899998765432  23577899999999988777666655 667


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCcEEEeccC
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL---DSDFTAKLSDFG  243 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG  243 (419)
                      +..++||||+ +++|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||+   +.++.+||+|||
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg  153 (296)
T 4hgt_A           78 DYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred             CceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence            7889999999 99999998643 346899999999999999999999  6679999999999999   788999999999


Q ss_pred             ccccCCCCCCce-----eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          244 LAKMGPEGSNTH-----VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       244 la~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      ++..........     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..................
T Consensus       154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  233 (296)
T 4hgt_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  233 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred             cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence            998754433211     123457999999999999999999999999999999999999999876554433333221111


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCccccc
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMAV  381 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~~~~  381 (419)
                      .... .     .+    ......+.++.+|+.+||+.||++|||+.+|++.|+++........
T Consensus       234 ~~~~-~-----~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~  286 (296)
T 4hgt_A          234 KMST-P-----IE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY  286 (296)
T ss_dssp             HHHS-C-----HH----HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred             cccc-h-----hh----hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence            0000 0     00    0011235789999999999999999999999999999987655433

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.2e-45  Score=347.42  Aligned_cols=252  Identities=21%  Similarity=0.311  Sum_probs=204.5

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      +.++|.+.+.||+|+||.||+|..      ..+++.||+|++..........+.+|+.+++.++||||+++++++.+.+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQ------RLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTH   80 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEE------TTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccceeeeeccCCCCceEEEEEE------CCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence            457899999999999999999964      34578899999986554455678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCcEEEeccCcc
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL---DSDFTAKLSDFGLA  245 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla  245 (419)
                      .|+||||+++++|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||+   +.++.+||+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~  156 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLS  156 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred             EEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence            99999999999999998765  56899999999999999999999  6779999999999999   77889999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      .......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||.......   .....   .....  
T Consensus       157 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i---~~~~~--  224 (304)
T 2jam_A          157 KMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---LFEKI---KEGYY--  224 (304)
T ss_dssp             CCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHH---HHCCC--
T ss_pred             eecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH---HcCCC--
Confidence            7643321    223469999999999999999999999999999999999999997643221   11111   00000  


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                            .....+....+.++.+|+.+||+.||.+|||+.++++
T Consensus       225 ------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          225 ------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             ------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                  0111222345678999999999999999999999987

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=8.8e-45  Score=343.19  Aligned_cols=254  Identities=21%  Similarity=0.266  Sum_probs=202.0

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC----cccHHHHHHHHHHHcCCCcccccceeeEEE
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG----LQGHREWLAEVIFLGQLRHPHLVRLIGYCC  164 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  164 (419)
                      +.++|.+.+.||+|+||.||+|..      ..+++.||+|++....    ......+.+|+.+++.++||||+++++++.
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~------~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   76 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLD------SETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLY   76 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEB------TTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccceeEeeEEecCCCeEEEEEEE------CCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence            457899999999999999999953      4457889999997542    234567899999999999999999999984


Q ss_pred             --eCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEecc
Q 014736          165 --EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       165 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                        +....|+||||+.++ |.+++.......+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+||
T Consensus        77 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~NIl~~~~~~~kl~df  153 (305)
T 2wtk_C           77 NEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH--SQGIVHKDIKPGNLLLTTGGTLKISAL  153 (305)
T ss_dssp             CC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCcccEEEcCCCcEEeecc
Confidence              455789999999766 888877665678999999999999999999999  667999999999999999999999999


Q ss_pred             CccccCCCCCCceeeecccccccccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhh
Q 014736          243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH--LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR  320 (419)
Q Consensus       243 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  320 (419)
                      |++................||+.|+|||++.+..  ++.++||||||+++|+|++|+.||.......   ...   ... 
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~i~-  226 (305)
T 2wtk_C          154 GVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK---LFE---NIG-  226 (305)
T ss_dssp             TTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH---HHH-
T ss_pred             ccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH---HHH---HHh-
Confidence            9998765433333344567999999999987644  4789999999999999999999998643211   111   000 


Q ss_pred             cccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       321 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      .. .          ..++..++.++.+|+.+||+.||.+|||+.++++.
T Consensus       227 ~~-~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          227 KG-S----------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HC-C----------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             cC-C----------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00 0          01222345789999999999999999999999873

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.5e-45  Score=348.03  Aligned_cols=266  Identities=23%  Similarity=0.333  Sum_probs=201.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++.+.||+|+||.||+|...      .+++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  105 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACL------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN  105 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEET------TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cceEEEEeecCCCCceEEEEEEc------CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            57999999999999999999643      346889999997532   234567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          168 ERLLVYEFMPRGSLENHLFKR--ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      ..++||||+.+++|.+++...  ....+++..++.++.||+.||.|||  ++||+|+||||+|||++.++.+||+|||++
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~  183 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLG  183 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence            999999999999999998652  2456899999999999999999999  677999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      ........  ......|++.|+|||++.+..++.++||||||+++|+|++|+.||....... .....   . .... . 
T Consensus       184 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~---~-~~~~-~-  254 (310)
T 2wqm_A          184 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCK---K-IEQC-D-  254 (310)
T ss_dssp             -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHH---H-HHTT-C-
T ss_pred             eeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHH---H-hhcc-c-
Confidence            86543321  1233568999999999999999999999999999999999999997543211 11111   1 0000 0 


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCcccc
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMA  380 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~~~  380 (419)
                             .........+.++.+|+.+||+.||.+|||+.+|++.|+.+.+....+
T Consensus       255 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~  302 (310)
T 2wqm_A          255 -------YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS  302 (310)
T ss_dssp             -------SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             -------CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence                   001111234578999999999999999999999999999997764443

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7.7e-46  Score=355.66  Aligned_cols=245  Identities=24%  Similarity=0.305  Sum_probs=203.5

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--------cHHHHHHHHHHHcCCCcccccce
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--------GHREWLAEVIFLGQLRHPHLVRL  159 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~  159 (419)
                      .+.++|++.+.||+|+||.||+|..      ..+++.||||++......        ....+.+|+.+|+.++||||+++
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~   94 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVD------KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV   94 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEE------TTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCE
T ss_pred             ccccceEEEeEEEecCCEEEEEEEE------CCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            4567899999999999999999954      445788999999764321        22356779999999999999999


Q ss_pred             eeEEEeCCeeEEEEEecCCC-ChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEE
Q 014736          160 IGYCCEDEERLLVYEFMPRG-SLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAK  238 (419)
Q Consensus       160 ~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~k  238 (419)
                      ++++.+.+..++||||+.+| +|.+++...  ..+++..++.++.||+.||.|||  .+||+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~k  170 (335)
T 3dls_A           95 LDIFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLR--LKDIIHRDIKDENIVIAEDFTIK  170 (335)
T ss_dssp             EEEEECSSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEE
T ss_pred             EEEEeeCCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEEeccCHHHEEEcCCCcEE
Confidence            99999999999999999766 999998765  56899999999999999999999  67799999999999999999999


Q ss_pred             EeccCccccCCCCCCceeeecccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH
Q 014736          239 LSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL-TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP  317 (419)
Q Consensus       239 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~  317 (419)
                      |+|||++........   .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......          
T Consensus       171 L~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------  237 (335)
T 3dls_A          171 LIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV----------  237 (335)
T ss_dssp             ECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT----------
T ss_pred             EeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH----------
Confidence            999999987654432   233569999999999988777 889999999999999999999997522100          


Q ss_pred             HhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          318 YLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                                  ....  ..+...+.++.+|+.+||+.||++|||+.++++.
T Consensus       238 ------------~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 ------------EAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ------------TTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ------------hhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                        0000  1112245789999999999999999999999873

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-45  Score=343.36  Aligned_cols=262  Identities=26%  Similarity=0.371  Sum_probs=207.4

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee-
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER-  169 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~-  169 (419)
                      .|.+.++||+|+||.||+|.+.++   ...+..||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.. 
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQ---AQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECS---SSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             EEccCceeccCCCceEEEEEEecC---CCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            466678999999999999976542   23345799999975433 3456788999999999999999999999776655 


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+.+++|.+++... ...+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++....
T Consensus        99 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLA--EQKFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            9999999999999998653 356889999999999999999999  6779999999999999999999999999998654


Q ss_pred             CCCCc--eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCCCccchhHHHhhhHHhhcccccc
Q 014736          250 EGSNT--HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRS-MDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       250 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      .....  .......+|+.|+|||++.+..++.++||||||+++|+|++|..| |...........+.       ...   
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-------~~~---  245 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-------QGR---  245 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-------TTC---
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-------cCC---
Confidence            33211  112335688999999999999999999999999999999995554 44433222111111       110   


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                             ....+...+.++.+|+.+||+.||.+|||+.++++.|+++...
T Consensus       246 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  288 (298)
T 3pls_A          246 -------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA  288 (298)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                   1112233457899999999999999999999999999998764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.6e-45  Score=343.47  Aligned_cols=269  Identities=20%  Similarity=0.249  Sum_probs=211.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEE-EeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYC-CEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~  168 (419)
                      .++|++.+.||+|+||.||+|..      ..+++.||+|++.....  ...+.+|+.+++.++|++++..+.++ ...+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~   79 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTD------IAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   79 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEE------TTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEE------cCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence            46899999999999999999964      34578999999875433  24678899999999988866666555 66778


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCcEEEeccCcc
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL---DSDFTAKLSDFGLA  245 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGla  245 (419)
                      .++||||+ +++|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||+   +.++.+||+|||++
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  155 (296)
T 3uzp_A           80 NVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             eEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence            89999999 99999998643 356899999999999999999999  6779999999999999   48889999999999


Q ss_pred             ccCCCCCCce-----eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhh
Q 014736          246 KMGPEGSNTH-----VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR  320 (419)
Q Consensus       246 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  320 (419)
                      ..........     ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 3uzp_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence            8755433211     12345799999999999999999999999999999999999999987654443333222111000


Q ss_pred             cccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCcccc
Q 014736          321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMA  380 (419)
Q Consensus       321 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~~~  380 (419)
                      ...      .+.    ....+++++.+|+.+||+.||.+|||+.+|++.|+.+.......
T Consensus       236 ~~~------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  285 (296)
T 3uzp_A          236 STP------IEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             HSC------HHH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             CCc------hHH----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence            000      000    11223578999999999999999999999999999998765544

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.2e-45  Score=351.33  Aligned_cols=249  Identities=23%  Similarity=0.313  Sum_probs=206.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      .++|.+.+.||+|+||.||+|...      .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  113 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDA------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN  113 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEC------CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            367999999999999999999644      346889999987542   23456788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..|+||||+.+++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++.
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  189 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT  189 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence            9999999999999999998765  57899999999999999999999  6679999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      .......  ......||..|+|||++.+..++.++||||||+++|+|++|+.||..........      ......    
T Consensus       190 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~~----  257 (335)
T 2owb_A          190 KVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------RIKKNE----  257 (335)
T ss_dssp             ECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHTC----
T ss_pred             ecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH------HHhcCC----
Confidence            6543322  1234569999999999999999999999999999999999999997643221111      000000    


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                              ..++...+.++.+|+.+||+.||++|||+.++++
T Consensus       258 --------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          258 --------YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             --------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    0122234578999999999999999999999987

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=349.27  Aligned_cols=263  Identities=25%  Similarity=0.335  Sum_probs=205.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEe----
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE----  165 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----  165 (419)
                      .++|++.+.||+|+||.||+|..      ..+++.||+|++........+.+.+|+.+++.++||||+++++++..    
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEG------LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA  101 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEE------TTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred             CeEEEEEEEecCCCCeEEEEEEe------cCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence            36799999999999999999964      34578999999976655667788999999999999999999999873    


Q ss_pred             CCeeEEEEEecCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccC
Q 014736          166 DEERLLVYEFMPRGSLENHLFKR--ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFG  243 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  243 (419)
                      ....|+||||+.+++|.+++...  ....+++..++.++.||+.||.|||  .+||+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--AKGYAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence            34789999999999999998753  2356899999999999999999999  5679999999999999999999999999


Q ss_pred             ccccCCCCCCce-------eeecccccccccccccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHH
Q 014736          244 LAKMGPEGSNTH-------VTTRVMGTYGYAAPEYISTGH---LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD  313 (419)
Q Consensus       244 la~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  313 (419)
                      ++..........       ......||+.|+|||++.+..   ++.++||||||+++|+|++|+.||......... ...
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~  258 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VAL  258 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHH
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhH
Confidence            987543211100       011235799999999987554   789999999999999999999999642111100 000


Q ss_pred             hhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      .    ...          ..........+.++.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       259 ~----~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          259 A----VQN----------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             H----HHC----------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             H----hhc----------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence            0    000          00111123345789999999999999999999999999998854

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2e-45  Score=367.51  Aligned_cols=263  Identities=21%  Similarity=0.276  Sum_probs=195.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC--CcccHHHHHHHHHHHcCCCcccccceeeEEEeC-
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCED-  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-  166 (419)
                      .++|+++++||+|+||.||+|+.      ..+++.||||++...  .....+.+.+|+.+|+.++||||+++++++... 
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~------~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  134 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYD------AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK  134 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEE------TTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEE------CCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence            46899999999999999999954      445788999999754  233456788999999999999999999999654 


Q ss_pred             -----CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          167 -----EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       167 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                           ...|+||||+.+ +|.+.+.    ..+++..+..++.||+.||+|||  .+||+||||||+|||++.++.+||+|
T Consensus       135 ~~~~~~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH--~~~iiHrDlkp~NIll~~~~~~kl~D  207 (464)
T 3ttj_A          135 TLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILD  207 (464)
T ss_dssp             STTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChHhEEEeCCCCEEEEE
Confidence                 357999999965 5666664    34889999999999999999999  56799999999999999999999999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh------
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA------  315 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~------  315 (419)
                      ||+++......   .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+...      
T Consensus       208 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~  284 (464)
T 3ttj_A          208 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  284 (464)
T ss_dssp             CCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             EEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            99998654332   234467999999999999999999999999999999999999999875432221111100      


Q ss_pred             ----------hHHhhccccc-----ccccccccCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          316 ----------KPYLRSSRRL-----RYIVDPRLAG---QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       316 ----------~~~~~~~~~~-----~~~~~~~l~~---~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                                ..+.......     ...+...+..   ......+.++.+||.+||+.||++|||+.|+++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                      0000000000     0000000000   001123678999999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.1e-45  Score=370.57  Aligned_cols=249  Identities=24%  Similarity=0.342  Sum_probs=204.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|.+.++||+|+||.||+|..      ..+++.||+|++....   ......+.+|+.+|+.++||||+++++++.+.+
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~------~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  258 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQM------KATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT  258 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hheEEEEEEeeCCCeEEEEEEE------CCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC
Confidence            5788999999999999999964      3457899999996532   234567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRI--SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      .+|+||||++||+|.+++....  ...+++..++.++.||+.||.|||  ++||+||||||+||||+.+|.+||+|||++
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH--~~gIvHrDLKP~NILl~~~g~vkL~DFGla  336 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLA  336 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH--HcCCcccCCChHHEEEeCCCCEEEeeccee
Confidence            9999999999999999987643  356899999999999999999999  677999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      +.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+  ........   
T Consensus       337 ~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~--~~~i~~~~---  409 (543)
T 3c4z_A          337 VELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQRVLEQA---  409 (543)
T ss_dssp             EECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH--HHHHHHCC---
T ss_pred             eeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH--HHHHhhcc---
Confidence            87554332  123457999999999999999999999999999999999999999875432211111  11111110   


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKM  363 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~  363 (419)
                               ..++...+.++.+||.+||+.||.+||++
T Consensus       410 ---------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          410 ---------VTYPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             ---------cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence                     12334456889999999999999999975

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.2e-45  Score=342.10  Aligned_cols=246  Identities=24%  Similarity=0.341  Sum_probs=205.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|.+.+.||+|+||.||+|...      .+++.||+|++....   ......+.+|+++++.++||||+++++++.+.+
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   87 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREK------QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK   87 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhceeeheecCCCCeEEEEEEEc------CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence            57999999999999999999643      346789999996432   223467889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+++++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+||+++.++.+||+|||++..
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~  163 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVH  163 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEEcCCCCEEEeccccccc
Confidence            999999999999999999776  46899999999999999999999  67899999999999999999999999999876


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      .....    .....|++.|+|||++.+..++.++||||||+++|+|++|..||..........      .....      
T Consensus       164 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~------  227 (284)
T 2vgo_A          164 APSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR------RIVNV------  227 (284)
T ss_dssp             CSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHTT------
T ss_pred             Ccccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH------HHhcc------
Confidence            44322    233569999999999999999999999999999999999999997643221111      11100      


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                            ...++...+.++.+|+.+||+.||.+|||+.++++
T Consensus       228 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          228 ------DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                  01123344678999999999999999999999987

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.3e-45  Score=350.97  Aligned_cols=261  Identities=27%  Similarity=0.427  Sum_probs=207.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCccccccccc--EEEEEEeccCC-cccHHHHHHHHHHHcCC-CcccccceeeEEEeC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQ--AVAVKLLDIEG-LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCED  166 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  166 (419)
                      ++|.+.+.||+|+||.||+|....      ++.  .+|+|.+.... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~   98 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKK------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   98 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEE------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             HHccceeeeecCCCceEEEEEEcc------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence            579999999999999999997543      234  35999886432 23446788999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRI--------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD  232 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~  232 (419)
                      +..|+||||+++++|.+++....              ...+++..++.++.||+.||.|||  ++||+||||||+|||++
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVG  176 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEC
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCccceEEEc
Confidence            99999999999999999997642              246899999999999999999999  67799999999999999


Q ss_pred             CCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhH
Q 014736          233 SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNL  311 (419)
Q Consensus       233 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~  311 (419)
                      .++.+||+|||++.......   ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.......   .
T Consensus       177 ~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~  250 (327)
T 1fvr_A          177 ENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L  250 (327)
T ss_dssp             GGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H
T ss_pred             CCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH---H
Confidence            99999999999997432211   1223457889999999988899999999999999999998 999997653221   1


Q ss_pred             HHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCccc
Q 014736          312 VDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDM  379 (419)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~~  379 (419)
                      ...    ....          .....+..++.++.+|+.+||+.||.+|||+.++++.|..+......
T Consensus       251 ~~~----~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  304 (327)
T 1fvr_A          251 YEK----LPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  304 (327)
T ss_dssp             HHH----GGGT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             HHH----hhcC----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence            111    0000          11122334567899999999999999999999999999999876543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-45  Score=357.30  Aligned_cols=262  Identities=27%  Similarity=0.404  Sum_probs=199.7

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEE-eCCee
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCC-EDEER  169 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~  169 (419)
                      .|.+.++||+|+||.||+|.+.+.   ......||+|.+.... ....+.+.+|+.++++++||||+++++++. .++..
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEET---TTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECC---CCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            466778999999999999976432   2234579999986543 344578999999999999999999999865 45678


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+++|+|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++...
T Consensus       167 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH--HCCEecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999998654 346788999999999999999999  6779999999999999999999999999998654


Q ss_pred             CCCCce--eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          250 EGSNTH--VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       250 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ......  ......+|+.|+|||++.+..++.++||||||+++|||++ |.+||...........+.       ....  
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-------~~~~--  314 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-------QGRR--  314 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-------TTCC--
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-------cCCC--
Confidence            332211  1233457889999999999999999999999999999999 788887654433221111       1110  


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                              ...+..++.++.+|+.+||+.||++|||+.++++.|+.+...
T Consensus       315 --------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          315 --------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                    011223457899999999999999999999999999998764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.3e-45  Score=344.42  Aligned_cols=252  Identities=28%  Similarity=0.408  Sum_probs=201.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeC-Ce
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCED-EE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~  168 (419)
                      .++|++.+.||+|+||.||+|...        ++.||+|++....  ..+.+.+|+.+++.++||||+++++++.+. +.
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--------CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence            367999999999999999999643        5689999997543  457789999999999999999999987554 57


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||+++++|.+++.......+++..++.++.|++.||.|||  ++||+||||||+||+++.++.+||+|||++...
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence            899999999999999997664344788999999999999999999  677999999999999999999999999998854


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ....     ....++..|+|||++.+..++.++||||||+++|+|++ |..||...........+       ...     
T Consensus       168 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~-------~~~-----  230 (278)
T 1byg_A          168 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKG-----  230 (278)
T ss_dssp             -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-------TTT-----
T ss_pred             cccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------hcC-----
Confidence            3321     22357889999999998999999999999999999998 99999865432211111       000     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                           .....+...+.++.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       231 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          231 -----YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence                 1112233456789999999999999999999999999998865

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.4e-45  Score=351.09  Aligned_cols=260  Identities=20%  Similarity=0.293  Sum_probs=207.7

Q ss_pred             HHHHHHhcCCCCC-CeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCC-cccccce
Q 014736           84 SELRAITQNFSSN-YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLR-HPHLVRL  159 (419)
Q Consensus        84 ~~~~~~~~~y~~~-~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~~  159 (419)
                      ...+.+.++|.+. ++||+|+||.||+|...      .+++.||+|++....  ......+.+|+.++..+. ||||+++
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~   94 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISK------STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL   94 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEEC------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEE
Confidence            3456777888888 89999999999999643      457899999997542  234678899999999984 6999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCc
Q 014736          160 IGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFT  236 (419)
Q Consensus       160 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~---~~~  236 (419)
                      ++++.+.+..|+||||+.+++|.+++.......+++..++.++.||+.||.|||  .+||+||||||+|||++.   ++.
T Consensus        95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH--~~givH~Dikp~NIl~~~~~~~~~  172 (327)
T 3lm5_A           95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH--QNNIVHLDLKPQNILLSSIYPLGD  172 (327)
T ss_dssp             EEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESCBTTBCC
T ss_pred             EEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCeecCcCChHHEEEecCCCCCc
Confidence            999999999999999999999999987665678999999999999999999999  677999999999999998   789


Q ss_pred             EEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh
Q 014736          237 AKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK  316 (419)
Q Consensus       237 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  316 (419)
                      +||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.   
T Consensus       173 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---  246 (327)
T 3lm5_A          173 IKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS---  246 (327)
T ss_dssp             EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---
T ss_pred             EEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH---
Confidence            99999999987543322   234569999999999999999999999999999999999999997654322111110   


Q ss_pred             HHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          317 PYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       317 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                         ...        ...........+.++.+|+.+||+.||.+|||+.++++
T Consensus       247 ---~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          247 ---QVN--------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             ---HTC--------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---hcc--------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence               000        01111222345678999999999999999999999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.6e-45  Score=367.06  Aligned_cols=254  Identities=24%  Similarity=0.356  Sum_probs=204.8

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC--CcccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      .+.++|.+.++||+|+||.||+|..      ..+++.||||++...  .......+.+|+.+|++++||||+++++++.+
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   92 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKD------RITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED   92 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEE------TTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEE------CCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc
Confidence            3457899999999999999999954      445789999998643  22346788999999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc---CCCcEEEecc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD---SDFTAKLSDF  242 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~---~~~~~kl~Df  242 (419)
                      .+..|+||||+.+++|.+++...  ..+++..++.++.||+.||.|||  .+||+||||||+|||++   .++.+||+||
T Consensus        93 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  168 (486)
T 3mwu_A           93 SSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDF  168 (486)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCchHHEEEecCCCCCCEEEEEC
Confidence            99999999999999999998766  56899999999999999999999  67799999999999995   4567999999


Q ss_pred             CccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       243 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      |++........   ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...........+.      .. 
T Consensus       169 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------~~-  237 (486)
T 3mwu_A          169 GLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE------TG-  237 (486)
T ss_dssp             SCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HT-
T ss_pred             CcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hC-
Confidence            99986544322   334579999999999965 69999999999999999999999997654322111110      00 


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                       ...  .+    .......+.++.+||.+||+.||.+|||+.++++.
T Consensus       238 -~~~--~~----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          238 -KYA--FD----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             -CCC--SC----SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             -CCC--CC----CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             000  00    01112346789999999999999999999999873

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=354.06  Aligned_cols=270  Identities=20%  Similarity=0.192  Sum_probs=201.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-----------cHHHHHHHHHHHcCCCcccccc
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-----------GHREWLAEVIFLGQLRHPHLVR  158 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpnIv~  158 (419)
                      .++|.+.+.||+|+||.||+|....+   ...+..||+|++......           ....+.+|+.+++.++||||++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNK---PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSS---CGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCC---CCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            35799999999999999999976542   224678999999755321           1234667889999999999999


Q ss_pred             eeeEEEe----CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 014736          159 LIGYCCE----DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD  234 (419)
Q Consensus       159 ~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~  234 (419)
                      +++++..    ....|+||||+ +++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIH--ENEYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEESS
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCcCHHHEEEccC
Confidence            9999988    67899999999 99999999766  37899999999999999999999  5679999999999999988


Q ss_pred             C--cEEEeccCccccCCCCCCc-----eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcc
Q 014736          235 F--TAKLSDFGLAKMGPEGSNT-----HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKS  307 (419)
Q Consensus       235 ~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  307 (419)
                      +  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  9999999999765432111     11134579999999999999999999999999999999999999996532221


Q ss_pred             chhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 014736          308 EQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL  374 (419)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~  374 (419)
                      ... ..........   +.........   ....+.++.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       268 ~~~-~~~~~~~~~~---~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          268 VAV-QTAKTNLLDE---LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHH-HHHHHHHHHT---TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHH-HHHHHhhccc---ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            111 1111110000   0000000000   0134578999999999999999999999999998763

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=353.64  Aligned_cols=259  Identities=25%  Similarity=0.304  Sum_probs=190.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-cccccceeeEEEe---
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-HPHLVRLIGYCCE---  165 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~---  165 (419)
                      ..+|++.++||+|+||.||+|...      .+++.||+|++..........+.+|+.++.++. ||||+++++++..   
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~  100 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDV------GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE  100 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEET------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred             CceEEEEEEEccCCceEEEEEEEC------CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence            357999999999999999999643      357889999997665556678899999999996 9999999999843   


Q ss_pred             -----CCeeEEEEEecCCCChhhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCcEEEcCCCcE
Q 014736          166 -----DEERLLVYEFMPRGSLENHLFKR-ISVSLPWGTRLKIAIGAAKGLAFLHGAENP--VIYRDFKTSNILLDSDFTA  237 (419)
Q Consensus       166 -----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~  237 (419)
                           ....++||||+ +|+|.+++... ....+++..++.++.||+.||.|||  .+|  |+||||||+|||++.++.+
T Consensus       101 ~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A          101 ESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH--RQKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH--TSSSCCBCCCCCGGGCEECTTSCE
T ss_pred             ccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCEEEccCCcccEEECCCCCE
Confidence                 34579999999 57999988652 2356999999999999999999999  566  9999999999999999999


Q ss_pred             EEeccCccccCCCCCCce----------eeecccccccccccccc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 014736          238 KLSDFGLAKMGPEGSNTH----------VTTRVMGTYGYAAPEYI---STGHLTTKSDVYSFGVVLLELLTGRRSMDKLR  304 (419)
Q Consensus       238 kl~DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~elltg~~pf~~~~  304 (419)
                      ||+|||++..........          ......||+.|+|||++   .+..++.++||||||+++|+|++|+.||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            999999998754432211          11134699999999998   56778999999999999999999999997543


Q ss_pred             CccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          305 PKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                      ....   ..                 ...........+..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus       258 ~~~~---~~-----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          258 KLRI---VN-----------------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             ----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHHh---hc-----------------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            2110   00                 00000111122346889999999999999999999999999987643

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=354.51  Aligned_cols=275  Identities=19%  Similarity=0.251  Sum_probs=210.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCccc--ccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccc----------
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLR--QGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR----------  158 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~----------  158 (419)
                      ++|.+.+.||+|+||.||+|....+..  ....++.||+|++...     ..+.+|+.++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            689999999999999999997654210  0113688999999754     35778999999999999988          


Q ss_pred             -----eeeEEEe-CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 014736          159 -----LIGYCCE-DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD  232 (419)
Q Consensus       159 -----~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~  232 (419)
                           +++++.. ++..|+||||+ +++|.+++.......+++..++.++.||+.||.|||  ++||+||||||+|||++
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH--ENEYVHGNVTAENIFVD  193 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCCGGGEEEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCHHHEEEc
Confidence                 6777766 67899999999 999999998764567999999999999999999999  56799999999999999


Q ss_pred             CCC--cEEEeccCccccCCCCCCce-----eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 014736          233 SDF--TAKLSDFGLAKMGPEGSNTH-----VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRP  305 (419)
Q Consensus       233 ~~~--~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  305 (419)
                      .++  .+||+|||+++.........     ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  273 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP  273 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence            998  89999999998654322111     11334799999999999999999999999999999999999999986542


Q ss_pred             ccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCcccc
Q 014736          306 KSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMA  380 (419)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~~~  380 (419)
                      ... ........+......   ......   .....+.++.+|+.+||+.||.+|||+.+|++.|+.+.......
T Consensus       274 ~~~-~~~~~~~~~~~~~~~---~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  341 (352)
T 2jii_A          274 NTE-DIMKQKQKFVDKPGP---FVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS  341 (352)
T ss_dssp             CHH-HHHHHHHHHHHSCCC---EECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             CHH-HHHHHHHhccCChhh---hhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence            221 111111111111111   111000   01123578999999999999999999999999999998765544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.2e-45  Score=341.64  Aligned_cols=259  Identities=22%  Similarity=0.326  Sum_probs=206.3

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc------ccHHHHHHHHHHHcCCCcccccceeeE
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL------QGHREWLAEVIFLGQLRHPHLVRLIGY  162 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~  162 (419)
                      +.++|++.+.||+|+||.||+|...      .+++.||+|++.....      ...+.+.+|+.+++.++||||++++++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   76 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQK------GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDI   76 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEc------CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhe
Confidence            3467999999999999999999643      3468899999875432      235788999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC----cEE
Q 014736          163 CCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF----TAK  238 (419)
Q Consensus       163 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~----~~k  238 (419)
                      +.+.+..++||||+++++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+||+++.++    .+|
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~~~~k  152 (283)
T 3bhy_A           77 FENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLH--SKRIAHFDLKPENIMLLDKNVPNPRIK  152 (283)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSSSSCCEE
T ss_pred             ecCCCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCChHHEEEecCCCCCCceE
Confidence            99999999999999999999999765  56899999999999999999999  67799999999999998877    799


Q ss_pred             EeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          239 LSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       239 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      |+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+      
T Consensus       153 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------  223 (283)
T 3bhy_A          153 LIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI------  223 (283)
T ss_dssp             ECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------
T ss_pred             EEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh------
Confidence            999999986543322   23356999999999999999999999999999999999999999765322111111      


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhh
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA--TLESLL  374 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~--~L~~l~  374 (419)
                      ......    ...    ......+.++.+|+.+||+.||.+|||+.++++  +++.+.
T Consensus       224 ~~~~~~----~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          224 SAVNYD----FDE----EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HTTCCC----CCH----HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             HhcccC----Ccc----hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            000000    000    011123567999999999999999999999997  455553

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.8e-45  Score=341.17  Aligned_cols=249  Identities=27%  Similarity=0.358  Sum_probs=183.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|.+.+.||+|+||.||+|..      ..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAES------IHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN   84 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred             ccceeeeeecCCCceEEEEEEE------ccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence            5799999999999999999964      3457889999996432   123467889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+++++|.+++... ...+++..++.++.|++.||.|||  ++||+|+||||+|||++.++.+||+|||++..
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~  161 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFGLATQ  161 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence            999999999999999998754 346899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||............               
T Consensus       162 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---------------  224 (278)
T 3cok_A          162 LKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV---------------  224 (278)
T ss_dssp             CC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C---------------
T ss_pred             ccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH---------------
Confidence            543221  122356899999999999889999999999999999999999999765432211000               


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       ....  ...+...+.++.+|+.+||+.||++|||+.++++
T Consensus       225 -~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          225 -VLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             -CSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -hhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence             0000  0122334678999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.8e-45  Score=342.70  Aligned_cols=253  Identities=28%  Similarity=0.380  Sum_probs=207.9

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEe-
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE-  165 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-  165 (419)
                      ..+.++|++.+.||+|+||.||+|...      .+++.||+|++....    ..+.+|+++++.++||||+++++++.. 
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~   76 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHR------IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGF   76 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEET------TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEE
T ss_pred             chhccccceeeeeccCCceEEEEEEEc------CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEecc
Confidence            345678999999999999999999643      346889999997543    346679999999999999999998865 


Q ss_pred             ---------------CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 014736          166 ---------------DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNIL  230 (419)
Q Consensus       166 ---------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIl  230 (419)
                                     ....|+||||+++++|.+++.......+++..++.++.||+.||.|||  ++||+|+||||+|||
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~Nil  154 (284)
T 2a19_B           77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH--SKKLINRDLKPSNIF  154 (284)
T ss_dssp             EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEE
T ss_pred             ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCHHHEE
Confidence                           345899999999999999998766678999999999999999999999  667999999999999


Q ss_pred             EcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchh
Q 014736          231 LDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQN  310 (419)
Q Consensus       231 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  310 (419)
                      ++.++.+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||...       
T Consensus       155 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------  224 (284)
T 2a19_B          155 LVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------  224 (284)
T ss_dssp             EEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------
T ss_pred             EcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------
Confidence            99999999999999987654322   23346999999999999999999999999999999999998876421       


Q ss_pred             HHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          311 LVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                       ...... .         ...    .++...+.++.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       225 -~~~~~~-~---------~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          225 -SKFFTD-L---------RDG----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             -HHHHHH-H---------HTT----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             -HHHHHH-h---------hcc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence             000000 0         001    11223456799999999999999999999999999988664

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6e-45  Score=367.52  Aligned_cols=257  Identities=23%  Similarity=0.338  Sum_probs=202.8

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      +.++|.++++||+|+||.||+|..      ..++..||+|++....  ......+.+|+.+|+.++||||+++++++.+.
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  108 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRD------KVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK  108 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEE------TTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEE------CCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            456799999999999999999964      4457889999997543  23356788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC---CcEEEeccC
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD---FTAKLSDFG  243 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG  243 (419)
                      +..|+||||+.+|+|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.+   +.+||+|||
T Consensus       109 ~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          109 RNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence            9999999999999999988766  56899999999999999999999  6779999999999999764   459999999


Q ss_pred             ccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccc
Q 014736          244 LAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSR  323 (419)
Q Consensus       244 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  323 (419)
                      ++.......   .....+||+.|+|||++. +.|+.++|||||||++|+|++|..||...........+.      ....
T Consensus       185 ~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------~~~~  254 (494)
T 3lij_A          185 LSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE------KGKY  254 (494)
T ss_dssp             TCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HTCC
T ss_pred             CCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCCC
Confidence            998754432   233457999999999985 579999999999999999999999998654322111111      0000


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhh
Q 014736          324 RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA--TLESL  373 (419)
Q Consensus       324 ~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~--~L~~l  373 (419)
                      .    .....    ....+.++.+||.+||+.||.+|||+.++++  +|...
T Consensus       255 ~----~~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          255 T----FDSPE----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             C----CCSGG----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             C----CCchh----cccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            0    00111    1234578999999999999999999999986  35443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.2e-45  Score=375.63  Aligned_cols=259  Identities=28%  Similarity=0.418  Sum_probs=211.3

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ..++|++.++||+|+||.||+|.+.+       +..||||++.... ...+.|.+|+.+|++++||||+++++++.+ +.
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~  335 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  335 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-------CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence            34678888999999999999997654       3569999997543 345789999999999999999999999865 77


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .||||||+.+|+|.+++.......+++..++.++.||+.||.|||  .+||+||||||+||||+.++.+||+|||+++..
T Consensus       336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            899999999999999997654456899999999999999999999  677999999999999999999999999999865


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ..... .......++..|+|||++....++.++|||||||++|||++ |+.||.......   ....    +....    
T Consensus       414 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~~~~----i~~~~----  481 (535)
T 2h8h_A          414 EDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQ----VERGY----  481 (535)
T ss_dssp             CCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---HHHH----HHTTC----
T ss_pred             CCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCC----
Confidence            43211 11122347789999999998999999999999999999999 999998654322   1111    11110    


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                            ....+..++.++.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       482 ------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          482 ------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence                  1112334567899999999999999999999999999988654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4e-45  Score=361.18  Aligned_cols=255  Identities=24%  Similarity=0.363  Sum_probs=194.5

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--------ccHHHHHHHHHHHcCCCcccccc
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--------QGHREWLAEVIFLGQLRHPHLVR  158 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~  158 (419)
                      ..+.++|.+.+.||+|+||.||+|...      .+++.||+|++.....        .....+.+|+.+|++++||||++
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  204 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFER------KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK  204 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEET------TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCC
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEEC------CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEee
Confidence            566789999999999999999999643      4578899999975321        11234788999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC---
Q 014736          159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF---  235 (419)
Q Consensus       159 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~---  235 (419)
                      +++++. .+..|+||||+.+++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++   
T Consensus       205 l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~NIll~~~~~~~  279 (419)
T 3i6u_A          205 IKNFFD-AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDC  279 (419)
T ss_dssp             CCEEEE-SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSSSC
T ss_pred             EEEEEe-cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEecCCCcc
Confidence            999975 45689999999999999988765  57899999999999999999999  66799999999999997654   


Q ss_pred             cEEEeccCccccCCCCCCceeeecccccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHH
Q 014736          236 TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST---GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV  312 (419)
Q Consensus       236 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~  312 (419)
                      .+||+|||+++......   .....+||+.|+|||++.+   ..|+.++|||||||++|+|++|..||.........  .
T Consensus       280 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~  354 (419)
T 3i6u_A          280 LIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--K  354 (419)
T ss_dssp             CEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--H
T ss_pred             eEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--H
Confidence            59999999998754332   2344679999999999853   67889999999999999999999999865432211  1


Q ss_pred             HhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          313 DWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ....    . ....  ..+..    ....+.++.+|+.+||+.||++|||+.++++
T Consensus       355 ~~i~----~-~~~~--~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          355 DQIT----S-GKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHHH----T-TCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHh----c-CCCC--CCchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            1000    0 0000  00000    0123578999999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3e-45  Score=368.87  Aligned_cols=252  Identities=24%  Similarity=0.348  Sum_probs=206.4

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      +.++|++.++||+|+||.||+|..      ..+++.||||++....   ......+.+|+.++++++||||+++++++.+
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   97 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKD------KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED   97 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEE------TTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccCceEEeeEEecCCCEEEEEEEE------CCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            456899999999999999999954      4457899999996543   3356788999999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---cCCCcEEEecc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL---DSDFTAKLSDF  242 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll---~~~~~~kl~Df  242 (419)
                      .+..|+||||+.+++|.+++...  ..+++..++.++.||+.||.|||  .+||+||||||+|||+   +.++.+||+||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  173 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDF  173 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred             CCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEEecCCCCCcEEEEee
Confidence            99999999999999999998765  56899999999999999999999  6679999999999999   56789999999


Q ss_pred             CccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       243 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      |++........   .....||+.|+|||++.+ .|+.++|||||||++|+|++|.+||...........+.      ...
T Consensus       174 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------~~~  243 (484)
T 3nyv_A          174 GLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE------KGK  243 (484)
T ss_dssp             THHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC
T ss_pred             eeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------cCC
Confidence            99987654332   234569999999999865 79999999999999999999999998654322111111      000


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        ..      .........++++.+||.+||+.||.+|||+.++++
T Consensus       244 --~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          244 --YT------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             --CC------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CC------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence              00      000111234678999999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4e-45  Score=380.71  Aligned_cols=250  Identities=25%  Similarity=0.322  Sum_probs=206.5

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC---CcccHHHHHHHHHHHcCC-CcccccceeeEEE
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE---GLQGHREWLAEVIFLGQL-RHPHLVRLIGYCC  164 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  164 (419)
                      ..++|.++++||+|+||.||+|...      .+++.||||++...   .....+.+..|..+|..+ +||||+++++++.
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~------~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~  412 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERK------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ  412 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEES------SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred             cccceEEEEEEccCCCEEEEEEEEC------CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence            3467999999999999999999643      45788999999743   223456788899999988 7999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCc
Q 014736          165 EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL  244 (419)
Q Consensus       165 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  244 (419)
                      +.+.+||||||++||+|.+++...  ..+++..++.++.||+.||.|||  ++|||||||||+||||+.++.+||+|||+
T Consensus       413 ~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~gIiHrDLKp~NILl~~~g~ikL~DFGl  488 (674)
T 3pfq_A          413 TMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGM  488 (674)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTSEECCCCCSTTEEECSSSCEEECCCTT
T ss_pred             eCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeccCChhhEEEcCCCcEEEeecce
Confidence            999999999999999999999876  56899999999999999999999  67799999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          245 AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       245 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      ++.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+      ...   
T Consensus       489 a~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~~---  557 (674)
T 3pfq_A          489 CKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------MEH---  557 (674)
T ss_dssp             CEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HSS---
T ss_pred             eeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH------HhC---
Confidence            986433222  234568999999999999999999999999999999999999999865332211111      110   


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKM-----AAVVA  368 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~-----~eil~  368 (419)
                               ...++...+.++.+||.+||+.||.+||++     ++|++
T Consensus       558 ---------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          558 ---------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ---------CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                     012334567889999999999999999997     66654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.5e-45  Score=346.99  Aligned_cols=271  Identities=26%  Similarity=0.368  Sum_probs=213.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCC--
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE--  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--  167 (419)
                      .++|++.+.||+|+||.||+|.+..  .+..+++.||+|++........+.+.+|+.+++.++||||+++++++...+  
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECT--TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             HHHceeeeeeccCCCeEEEEEEecc--ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence            3568899999999999999997543  234567899999998766566678999999999999999999999986544  


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..++||||+++++|.+++... ...+++..++.++.||+.||.|||  .+||+||||||+|||++.++.+||+|||++..
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             ceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--hCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            789999999999999999765 245899999999999999999999  67799999999999999999999999999987


Q ss_pred             CCCCCCce-eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCc---------cchhHHHhhhH
Q 014736          248 GPEGSNTH-VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPK---------SEQNLVDWAKP  317 (419)
Q Consensus       248 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---------~~~~~~~~~~~  317 (419)
                      ........ ......++..|+|||++.+..++.++||||||+++|+|++|..||......         ...........
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            65443221 122345788899999998889999999999999999999999988642100         00000000001


Q ss_pred             HhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          318 YLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      ....          ......+..++.++.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       275 ~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          275 LLKN----------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHT----------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Hhhc----------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1111          11112234456889999999999999999999999999998854

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=373.48  Aligned_cols=260  Identities=26%  Similarity=0.396  Sum_probs=205.8

Q ss_pred             CCCCCC-eecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           92 NFSSNY-LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        92 ~y~~~~-~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++.+.. .||+|+||.||+|.+..    ...+..||||+++... ....+.+.+|+++|++++|||||++++++.. +..
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~----~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRM----RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEEC----SSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEec----CCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence            334444 79999999999997643    2235679999997643 3356789999999999999999999999976 568


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+||||+.+|+|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+||||+.++.+||+|||+++...
T Consensus       411 ~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH--~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE--EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             EEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            9999999999999998654 356899999999999999999999  6679999999999999999999999999998754


Q ss_pred             CCCCce-eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          250 EGSNTH-VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       250 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ...... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||...........+       ....    
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i-------~~~~----  556 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------EQGK----  556 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH-------HTTC----
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HcCC----
Confidence            332211 1122346789999999999999999999999999999998 99999876543221111       1111    


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                            ...++..++.++.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus       557 ------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          557 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                  1123344668899999999999999999999999999988653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.3e-45  Score=357.48  Aligned_cols=266  Identities=27%  Similarity=0.359  Sum_probs=204.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|++.+.||+|+||.||+|...      .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++.
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  105 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHK------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE  105 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET------TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred             cccceeeeeecCCCCeEEEEEEEC------CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence            457999999999999999999643      4578899999976532 335678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||+++++|.+++...  ..+++..+..++.|++.||.|||+. +||+||||||+|||++.++.+||+|||++...
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  182 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  182 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHh-CCEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence            99999999999999999775  4688999999999999999999941 37999999999999999999999999998653


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh-----HH-----
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK-----PY-----  318 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-----~~-----  318 (419)
                      ...    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||................     ..     
T Consensus       183 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3eqc_A          183 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  258 (360)
T ss_dssp             HHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred             ccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence            221    1233569999999999999999999999999999999999999998654322111100000     00     


Q ss_pred             -----h----h---cc----cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 -----L----R---SS----RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 -----~----~---~~----~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                           .    .   ..    .....+.............+.++.+|+.+||+.||.+|||+.++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                 0    0   00    0000000011111112234678999999999999999999999987

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.6e-45  Score=352.69  Aligned_cols=247  Identities=28%  Similarity=0.400  Sum_probs=200.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      +.|.+.+.||+|+||.||+|..      ..+++.||||++.....   ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  127 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARD------VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH  127 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEE------TTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hheeeeeEEccCCCEEEEEEEE------ccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            4588999999999999999954      34578899999975432   22457889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+. |+|.+++... ...+++..++.++.|++.||.|||  .+||+||||||+|||++.++.+||+|||++..
T Consensus       128 ~~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  203 (348)
T 1u5q_A          128 TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             eEEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence            9999999996 6888877543 357899999999999999999999  66799999999999999999999999999986


Q ss_pred             CCCCCCceeeeccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYIS---TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      ....      ....||+.|+|||++.   ...++.++|||||||++|||++|+.||........   .   .......  
T Consensus       204 ~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---~---~~~~~~~--  269 (348)
T 1u5q_A          204 MAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---L---YHIAQNE--  269 (348)
T ss_dssp             SSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H---HHHHHSC--
T ss_pred             cCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---H---HHHHhcC--
Confidence            5432      2356999999999984   57799999999999999999999999976532211   1   1111110  


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                           .+.   ......+.++.+|+.+||+.||++|||+.++++.
T Consensus       270 -----~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          270 -----SPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             -----CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -----CCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                 011   1122345789999999999999999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.3e-45  Score=342.58  Aligned_cols=250  Identities=23%  Similarity=0.312  Sum_probs=206.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      .++|.+.+.||+|+||.||+|...      .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   87 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDA------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN   87 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             ccceEEEEEEeecCCEEEEEEEEC------CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence            367999999999999999999643      346889999986542   23456788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..++||||+++++|.+++...  ..+++..++.++.|++.||.|||  ++||+||||||+|||++.++.+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  163 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT  163 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEcCCCCEEEEeccCce
Confidence            9999999999999999988765  57899999999999999999999  6779999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      .......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..........      ......    
T Consensus       164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~~~----  231 (294)
T 2rku_A          164 KVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------RIKKNE----  231 (294)
T ss_dssp             ECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHTTC----
T ss_pred             ecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHhhcc----
Confidence            6543322  1233569999999999998899999999999999999999999997643221110      000000    


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                              ..++...+.++.+|+.+||+.||++|||+.++++.
T Consensus       232 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          232 --------YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             --------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                    01223345789999999999999999999999873

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.7e-44  Score=338.90  Aligned_cols=248  Identities=25%  Similarity=0.344  Sum_probs=198.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEe---
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCE---  165 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---  165 (419)
                      +.|.+.+.||+|+||.||+|...      .++..||+|++....  ....+.+.+|+.+++.++||||+++++++..   
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDT------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   99 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred             eeEEeeeeccCCCCeEEEEeEec------CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence            34778889999999999999643      446889999987543  2345678899999999999999999999876   


Q ss_pred             -CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--eeecCCCCCcEEEc-CCCcEEEec
Q 014736          166 -DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP--VIYRDFKTSNILLD-SDFTAKLSD  241 (419)
Q Consensus       166 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~-~~~~~kl~D  241 (419)
                       ....++||||+++++|.+++...  ..+++..++.++.||+.||.|||  .+|  |+||||||+|||++ .++.+||+|
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~~~i~H~dikp~Nil~~~~~~~~kl~D  175 (290)
T 1t4h_A          100 GKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH--TRTPPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--TSSSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             CCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHH--cCCCCEEECCCCHHHEEEECCCCCEEEee
Confidence             35689999999999999999765  56889999999999999999999  556  99999999999998 789999999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhc
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS  321 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  321 (419)
                      ||++.......    .....||+.|+|||++. +.++.++||||||+++|+|++|+.||........  .....   . .
T Consensus       176 fg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~---~-~  244 (290)
T 1t4h_A          176 LGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRV---T-S  244 (290)
T ss_dssp             TTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHH---T-T
T ss_pred             CCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH--HHHHH---h-c
Confidence            99997644332    23456999999999886 5699999999999999999999999976433211  11100   0 0


Q ss_pred             ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          322 SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       322 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .         .....++...+.++.+|+.+||+.||.+|||+.++++
T Consensus       245 ~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          245 G---------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             T---------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c---------CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            0         0001112223467999999999999999999999976

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=9e-45  Score=375.61  Aligned_cols=253  Identities=30%  Similarity=0.427  Sum_probs=202.5

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYE  174 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  174 (419)
                      ++||+|+||.||+|.+..    ...++.||||+++....  ...+++.+|+.+|++++|||||++++++. .+..++|||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~----~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E  449 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQM----KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVME  449 (635)
T ss_dssp             EEEEECSSEEEEEEEEEC----SSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEE
T ss_pred             CEeccCCCEEEEEEEEcC----CCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEE
Confidence            479999999999997543    33467899999975432  33578999999999999999999999986 456899999


Q ss_pred             ecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCc
Q 014736          175 FMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT  254 (419)
Q Consensus       175 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  254 (419)
                      |+.+|+|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+||||+.++.+||+|||+++........
T Consensus       450 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH--~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          450 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             ccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHH--HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            99999999999765  57899999999999999999999  677999999999999999999999999999876543321


Q ss_pred             -eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          255 -HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       255 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                       .......||..|+|||++.+..++.++|||||||++|||++ |+.||...........+       ...          
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i-------~~~----------  588 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKG----------  588 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------HTT----------
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcC----------
Confidence             12233457889999999999999999999999999999998 99999875432211111       111          


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      .....+..++.++.+|+.+||+.||++||++.+|++.|+.+..
T Consensus       589 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          589 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            1112334456889999999999999999999999999998753

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9.8e-45  Score=366.87  Aligned_cols=252  Identities=23%  Similarity=0.322  Sum_probs=202.5

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-------------ccHHHHHHHHHHHcCCCccc
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-------------QGHREWLAEVIFLGQLRHPH  155 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpn  155 (419)
                      +.++|.++++||+|+||.||+|..      ..+++.||+|++.....             ...+.+.+|+.+|+.++|||
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  107 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKE------KNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPN  107 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEE------TTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTT
T ss_pred             cccceEEEeEecccCCeEEEEEEE------CCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCC
Confidence            567899999999999999999964      34578899999975432             23467889999999999999


Q ss_pred             ccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 014736          156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF  235 (419)
Q Consensus       156 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~  235 (419)
                      |+++++++.+....|+||||+.||+|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++
T Consensus       108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLH--KHNIVHRDIKPENILLENKN  183 (504)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESSTT
T ss_pred             CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCcHHHEEEecCC
Confidence            999999999999999999999999999998766  56899999999999999999999  66799999999999999876


Q ss_pred             ---cEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHH
Q 014736          236 ---TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV  312 (419)
Q Consensus       236 ---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~  312 (419)
                         .+||+|||++........   .....||+.|+|||++. +.|+.++|||||||++|+|++|..||...........+
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i  259 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV  259 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence               699999999987654322   33456999999999986 57999999999999999999999999875432211111


Q ss_pred             HhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          313 DWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .       .. ...  .....    ....+.++.+|+.+||+.||.+|||+.++++
T Consensus       260 ~-------~~-~~~--~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          260 E-------KG-KYY--FDFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             H-------HC-CCC--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             H-------cC-CCC--CCccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1       00 000  00000    0124578999999999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.8e-44  Score=342.57  Aligned_cols=276  Identities=26%  Similarity=0.400  Sum_probs=213.8

Q ss_pred             CCHHHHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcC--CCcccccc
Q 014736           81 FQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ--LRHPHLVR  158 (419)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~  158 (419)
                      ........+.++|.+.+.||+|+||.||+|...        ++.||||++...   ....+.+|++++..  ++||||++
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~  100 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--------GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILG  100 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--------TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCC
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEEc--------CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEE
Confidence            344555777889999999999999999999642        578999999643   34567788888876  78999999


Q ss_pred             eeeEEEeCC----eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeeecCCCCCc
Q 014736          159 LIGYCCEDE----ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA------ENPVIYRDFKTSN  228 (419)
Q Consensus       159 ~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~------~~~ivH~Dlkp~N  228 (419)
                      +++++....    ..|+||||+++|+|.+++.+.   .+++..++.++.||+.||.|||+.      ++||+||||||+|
T Consensus       101 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~N  177 (342)
T 1b6c_B          101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN  177 (342)
T ss_dssp             EEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGG
T ss_pred             EEeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHH
Confidence            999998876    789999999999999999754   689999999999999999999942      4679999999999


Q ss_pred             EEEcCCCcEEEeccCccccCCCCCCce--eeecccccccccccccccCC------CCCchhhHHHHHHHHHHHHcC----
Q 014736          229 ILLDSDFTAKLSDFGLAKMGPEGSNTH--VTTRVMGTYGYAAPEYISTG------HLTTKSDVYSFGVVLLELLTG----  296 (419)
Q Consensus       229 Ill~~~~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg----  296 (419)
                      ||++.++.+||+|||++..........  ......||+.|+|||++.+.      .++.++||||||+++|+|++|    
T Consensus       178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~  257 (342)
T 1b6c_B          178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  257 (342)
T ss_dssp             EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence            999999999999999997654433221  12345699999999999765      334789999999999999999    


Q ss_pred             ------CCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          297 ------RRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQ-YSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       297 ------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                            ..||.......... ..+..... . ..    ..+.+... .....+..+.+|+.+||+.||.+|||+.+|++.
T Consensus       258 ~~~~~~~~p~~~~~~~~~~~-~~~~~~~~-~-~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          258 GIHEDYQLPYYDLVPSDPSV-EEMRKVVC-E-QK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TBCCCCCCTTTTTSCSSCCH-HHHHHHHT-T-SC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             CcccccccCccccCcCcccH-HHHHHHHH-H-HH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                  77886554322111 11111110 0 00    11111111 123567889999999999999999999999999


Q ss_pred             HHhhhcCc
Q 014736          370 LESLLNLK  377 (419)
Q Consensus       370 L~~l~~~~  377 (419)
                      |+.+....
T Consensus       331 L~~i~~~~  338 (342)
T 1b6c_B          331 LSQLSQQE  338 (342)
T ss_dssp             HHHHHHTT
T ss_pred             HHHHHHHh
Confidence            99987654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.2e-45  Score=362.52  Aligned_cols=201  Identities=29%  Similarity=0.382  Sum_probs=166.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC--CcccHHHHHHHHHHHcCCCcccccceeeEEEeC-
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE--GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCED-  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-  166 (419)
                      .++|.+.++||+|+||.||+|..      ..+++.||||++...  .....+.+.+|+.+|+.++||||+++++++... 
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~------~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~   98 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYD------KNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD   98 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEE------TTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEE------CCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            46899999999999999999964      345788999999753  223456788999999999999999999999776 


Q ss_pred             ----CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEecc
Q 014736          167 ----EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       167 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                          ...|+||||+. ++|.+++...  ..+++..++.++.||+.||.|||  .+||+||||||+||||+.++.+||+||
T Consensus        99 ~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH--~~givHrDlkp~NILl~~~~~~kL~DF  173 (432)
T 3n9x_A           99 LLKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIH--ESGIIHRDLKPANCLLNQDCSVKVCDF  173 (432)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             CCcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCCCCCCCHHHeEECCCCCEEEccC
Confidence                57899999994 6999998654  56899999999999999999999  567999999999999999999999999


Q ss_pred             CccccCCCCCCc--------------------eeeecccccccccccccc-cCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 014736          243 GLAKMGPEGSNT--------------------HVTTRVMGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGRRSMD  301 (419)
Q Consensus       243 Gla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~  301 (419)
                      |+++........                    ...+..+||+.|+|||++ ....|+.++|||||||++|||++|..||.
T Consensus       174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            999875443221                    123456799999999986 56679999999999999999998655543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=346.71  Aligned_cols=267  Identities=22%  Similarity=0.360  Sum_probs=197.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHH--HcCCCcccccceeeEEEe---
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIF--LGQLRHPHLVRLIGYCCE---  165 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~hpnIv~~~~~~~~---  165 (419)
                      ++|++.+.||+|+||.||+|..        +++.||||++....   ...+..|.++  +..++||||+++++.+..   
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~--------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~   81 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL--------DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTA   81 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE--------TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred             HHhheeeecccCCCeEEEEEEE--------CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence            5799999999999999999954        25789999997542   3444445554  455899999999986643   


Q ss_pred             --CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcC-------CCCeeecCCCCCcEEEcCCCc
Q 014736          166 --DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA-------ENPVIYRDFKTSNILLDSDFT  236 (419)
Q Consensus       166 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-------~~~ivH~Dlkp~NIll~~~~~  236 (419)
                        ....++||||+++|+|.+++...   ..++..++.++.||+.||.|||+.       ..||+||||||+|||++.++.
T Consensus        82 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           82 DGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             TSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred             CCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence              23578999999999999999665   458889999999999999999943       118999999999999999999


Q ss_pred             EEEeccCccccCCCCCC------ceeeecccccccccccccccC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 014736          237 AKLSDFGLAKMGPEGSN------THVTTRVMGTYGYAAPEYIST-------GHLTTKSDVYSFGVVLLELLTGRRSMDKL  303 (419)
Q Consensus       237 ~kl~DfGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltg~~pf~~~  303 (419)
                      +||+|||++........      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||...
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  238 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG  238 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence            99999999986543221      112234579999999999976       45678999999999999999997776443


Q ss_pred             CCccch-hHHH----------hhhHHhhcccccccccccccCCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014736          304 RPKSEQ-NLVD----------WAKPYLRSSRRLRYIVDPRLAGQ--YSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL  370 (419)
Q Consensus       304 ~~~~~~-~~~~----------~~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L  370 (419)
                      ...... ....          ......... ..    .+.+...  .....++++.+|+.+||+.||++|||+.++++.|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L  313 (336)
T 3g2f_A          239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSRE-KQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM  313 (336)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHHHHTTS-CC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             cchhHHHHhhhcccCCCchHHHHHhhhccc-cc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence            322111 1000          000000000 00    1111111  1234677899999999999999999999999999


Q ss_pred             HhhhcC
Q 014736          371 ESLLNL  376 (419)
Q Consensus       371 ~~l~~~  376 (419)
                      +.++..
T Consensus       314 ~~ll~~  319 (336)
T 3g2f_A          314 AELMMI  319 (336)
T ss_dssp             HHHHHC
T ss_pred             HHHHHH
Confidence            999864

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=337.42  Aligned_cols=252  Identities=23%  Similarity=0.349  Sum_probs=199.8

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEE
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLL  171 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  171 (419)
                      +|....+||+|+||.||+|...      .+++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   96 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDL------SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI   96 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEET------TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEEC------CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence            4556668999999999999643      4468899999987665566789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-CCcEEEeccCccccCC
Q 014736          172 VYEFMPRGSLENHLFKRI-SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS-DFTAKLSDFGLAKMGP  249 (419)
Q Consensus       172 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGla~~~~  249 (419)
                      ||||+++++|.+++.... ...+++..+..++.||+.||.|||  ++||+|+||||+|||++. ++.+||+|||++....
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A           97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH--hCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            999999999999997653 235678889999999999999999  677999999999999988 8999999999998654


Q ss_pred             CCCCceeeecccccccccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGH--LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ....  ......||+.|+|||++.+..  ++.++||||||+++|+|++|+.||.........  . ......        
T Consensus       175 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~-~~~~~~--------  241 (295)
T 2clq_A          175 GINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA--M-FKVGMF--------  241 (295)
T ss_dssp             C-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH--H-HHHHHH--------
T ss_pred             CCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH--H-Hhhccc--------
Confidence            3221  123456999999999986643  889999999999999999999999754322110  0 000000        


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                          .....++...+.++.+|+.+||+.||++||++.++++
T Consensus       242 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          242 ----KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ----CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ----cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                0111223345678999999999999999999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-44  Score=354.99  Aligned_cols=265  Identities=22%  Similarity=0.245  Sum_probs=205.8

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC--------ccccccee
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR--------HPHLVRLI  160 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hpnIv~~~  160 (419)
                      +.++|++.++||+|+||.||+|+.      ..+++.||||++... ....+.+.+|+.+|+.++        |+||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~  107 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWD------IQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL  107 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEE------TTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEe------cCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence            357899999999999999999954      345788999999743 233567888999998885        88899999


Q ss_pred             eEEE----eCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeecCCCCCcEEEcCCC
Q 014736          161 GYCC----EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN-PVIYRDFKTSNILLDSDF  235 (419)
Q Consensus       161 ~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~-~ivH~Dlkp~NIll~~~~  235 (419)
                      +++.    +....|+||||+ +++|.+++.......+++..++.++.||+.||.|||  .+ ||+||||||+||||+.++
T Consensus       108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--~~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECCCCSGGGEEECCCH
T ss_pred             cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--HhCCEecCCCCHHHeeEeccc
Confidence            9987    456889999999 778888877665567999999999999999999999  55 799999999999999775


Q ss_pred             -------------------------------------------------cEEEeccCccccCCCCCCceeeecccccccc
Q 014736          236 -------------------------------------------------TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY  266 (419)
Q Consensus       236 -------------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  266 (419)
                                                                       .+||+|||++......     .....||+.|
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y  259 (397)
T 1wak_A          185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQY  259 (397)
T ss_dssp             HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGG
T ss_pred             hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcc
Confidence                                                             7999999999865432     2334699999


Q ss_pred             cccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhh---------------------ccccc
Q 014736          267 AAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR---------------------SSRRL  325 (419)
Q Consensus       267 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~---------------------~~~~~  325 (419)
                      +|||++.+..++.++|||||||++|+|++|+.||....................                     ....+
T Consensus       260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  339 (397)
T 1wak_A          260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL  339 (397)
T ss_dssp             CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred             cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence            999999999999999999999999999999999987654432211111110000                     00000


Q ss_pred             cccccccc---------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          326 RYIVDPRL---------AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       326 ~~~~~~~l---------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ..+.....         ...++...+.++.+||.+||+.||.+|||+.+|++
T Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            00000000         01245677889999999999999999999999975

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=351.37  Aligned_cols=268  Identities=23%  Similarity=0.312  Sum_probs=197.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc-HHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-HREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|.+.+.||+|+||.||+|...      .+++.||+|++....... ...+.+|+.+++.++||||+++++++.+.+..
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   75 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSK------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   75 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCE
T ss_pred             CceEEEEEEcCCCCEEEEEEEEC------CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEE
Confidence            57899999999999999999643      456889999997543221 12355799999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+. ++|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++....
T Consensus        76 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           76 TLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKS  151 (324)
T ss_dssp             EEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred             EEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence            99999996 6899988764 346889999999999999999999  6779999999999999999999999999998644


Q ss_pred             CCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc--cccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS--RRLR  326 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~  326 (419)
                      ....  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.   ......  ..+.
T Consensus       152 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~~  226 (324)
T 3mtl_A          152 IPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIF---RILGTPTEETWP  226 (324)
T ss_dssp             -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCCCCTTTST
T ss_pred             CCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHhCCCChHhch
Confidence            3221  2234568999999999876 678999999999999999999999998754332221111   110000  0000


Q ss_pred             cccc---------cccC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhh
Q 014736          327 YIVD---------PRLA----GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA--TLESL  373 (419)
Q Consensus       327 ~~~~---------~~l~----~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~--~L~~l  373 (419)
                      ....         +...    .......+.++.+|+.+||+.||.+|||+.|+++  ++..+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence            0000         0000    0011234578999999999999999999999987  34444

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.7e-44  Score=341.16  Aligned_cols=251  Identities=25%  Similarity=0.372  Sum_probs=206.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .+.|.+.+.||+|+||.||+|..      ..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   94 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGID------NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK   94 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEE------TTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEE------CCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            35789999999999999999964      3457889999997553 2345788999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||+++++|.+++..   ..+++..++.++.||+.||.|||  .+||+|+||||+|||++.++.+||+|||++...
T Consensus        95 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL  169 (303)
T ss_dssp             EEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCChheEEECCCCCEEEeecccceec
Confidence            9999999999999999864   46899999999999999999999  677999999999999999999999999999765


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      .....  ......||+.|+|||++.+..++.++||||||+++|+|++|..||........   ....    ...      
T Consensus       170 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~----~~~------  234 (303)
T 3a7i_A          170 TDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV---LFLI----PKN------  234 (303)
T ss_dssp             BTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHH----HHS------
T ss_pred             Ccccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH---HHHh----hcC------
Confidence            43321  12345699999999999999999999999999999999999999976532211   1110    000      


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATL  370 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L  370 (419)
                      ..+    .+....+.++.+|+.+||+.||.+|||+.++++..
T Consensus       235 ~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          235 NPP----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             CCC----CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             CCC----CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            011    12223457799999999999999999999998743

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.4e-44  Score=351.55  Aligned_cols=212  Identities=23%  Similarity=0.272  Sum_probs=178.2

Q ss_pred             CCHHHHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-cc-----
Q 014736           81 FQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-HP-----  154 (419)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----  154 (419)
                      +.....+.+.++|.+.++||+|+||.||+|..      ..+++.||||++... ......+..|+.+++.++ |+     
T Consensus        44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~------~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~  116 (382)
T 2vx3_A           44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYD------RVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKY  116 (382)
T ss_dssp             BCCCTTCEETTTEEEEEEEEEETTEEEEEEEE------TTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGG
T ss_pred             EEeecCCEeeeeEEEEEEEeecCCEEEEEEEE------cCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccce
Confidence            33344455678999999999999999999964      345688999999743 223456677888887774 44     


Q ss_pred             cccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc--
Q 014736          155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD--  232 (419)
Q Consensus       155 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--  232 (419)
                      +|+++++++...+..|+||||+. ++|.+++.......+++..++.++.||+.||.|||+++.||+||||||+||||+  
T Consensus       117 ~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~  195 (382)
T 2vx3_A          117 YIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP  195 (382)
T ss_dssp             GBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESST
T ss_pred             eEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecC
Confidence            59999999999999999999995 699999987655679999999999999999999997778899999999999995  


Q ss_pred             CCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 014736          233 SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRP  305 (419)
Q Consensus       233 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  305 (419)
                      .++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus       196 ~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          196 KRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             TSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            4778999999999875432     2345699999999999999999999999999999999999999987543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.4e-45  Score=350.53  Aligned_cols=266  Identities=24%  Similarity=0.343  Sum_probs=200.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--cHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|++.++||+|+||.||+|...      .+++.||+|++......  ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   98 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNK------DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR   98 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEET------TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             hhheeeeEEeecCCEEEEEEEEC------CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence            57999999999999999999643      44788999998654332  24567899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||+.+++|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++...
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  174 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL  174 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             EEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH--HCCEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence            99999999998888876544  56899999999999999999999  677999999999999999999999999999865


Q ss_pred             CCCCCceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh--------hHHh
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA--------KPYL  319 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~--------~~~~  319 (419)
                      .....  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+...        ...+
T Consensus       175 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (331)
T 4aaa_A          175 AAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF  252 (331)
T ss_dssp             -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             cCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence            43222  22345699999999999765 7899999999999999999999999875433221111000        0000


Q ss_pred             hcccccccccccccCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          320 RSSRRLRYIVDPRLAGQ-----YSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~~-----~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ...........+.....     .....++++.+|+.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            01111111111111111     11234678999999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-45  Score=352.32  Aligned_cols=261  Identities=21%  Similarity=0.283  Sum_probs=196.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .++|.+.+.||+|+||.||+|..      ..+++.||||++....  ....+.+.+|+.+|+.++||||+++++++...+
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   97 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVD------GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   97 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEE------TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             cceEEEeEEeeecCCeEEEEEEE------CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence            46899999999999999999954      4457899999996432  233467889999999999999999999997653


Q ss_pred             ------eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          168 ------ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       168 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                            ..|+||||+ +++|.+++..   ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~D  171 (367)
T 1cm8_A           98 TLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILD  171 (367)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             ccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCcCHHHEEEcCCCCEEEEe
Confidence                  469999999 8899999865   36899999999999999999999  67799999999999999999999999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH---
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP---  317 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~---  317 (419)
                      ||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....   
T Consensus       172 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~  246 (367)
T 1cm8_A          172 FGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP  246 (367)
T ss_dssp             CTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9999875432     234569999999999877 7899999999999999999999999987543222111110000   


Q ss_pred             --Hhhcc---------cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          318 --YLRSS---------RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       318 --~~~~~---------~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        .....         ..+.......+ .......+.++.+|+.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence              00000         00000000011 1122345678999999999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.3e-45  Score=359.86  Aligned_cols=248  Identities=15%  Similarity=0.165  Sum_probs=192.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC---CcccHHHHHHHH---HHHcCCCccccccee---
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE---GLQGHREWLAEV---IFLGQLRHPHLVRLI---  160 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~hpnIv~~~---  160 (419)
                      .++|.+.+.||+|+||.||+|..      ..+++.||||++...   .....+.+.+|+   .+|+.++|||||+++   
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~  145 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATD------QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF  145 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred             CceEEEcceeecCCCEEEEEEEE------CCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence            36788999999999999999964      345789999999743   333457788999   555666899999998   


Q ss_pred             ----eEEEeCCe-----------------eEEEEEecCCCChhhhhhhccCC-----CCCHHHHHHHHHHHHHHHHHhhc
Q 014736          161 ----GYCCEDEE-----------------RLLVYEFMPRGSLENHLFKRISV-----SLPWGTRLKIAIGAAKGLAFLHG  214 (419)
Q Consensus       161 ----~~~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~  214 (419)
                          +++.+.+.                 .||||||+ +|+|.+++......     .+++..++.++.||+.||.||| 
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-  223 (377)
T 3byv_A          146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH-  223 (377)
T ss_dssp             CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH-
Confidence                66665532                 78999999 78999999764211     1234778889999999999999 


Q ss_pred             CCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCC-----------CCCchhhH
Q 014736          215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG-----------HLTTKSDV  283 (419)
Q Consensus       215 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Di  283 (419)
                       ++||+||||||+||||+.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++||
T Consensus       224 -~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv  296 (377)
T 3byv_A          224 -HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA  296 (377)
T ss_dssp             -HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred             -hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence             56799999999999999999999999999985322     2344568 999999999877           89999999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 014736          284 YSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKM  363 (419)
Q Consensus       284 wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~  363 (419)
                      |||||++|||++|+.||...........                +..      ....++.++.+|+.+||+.||.+|||+
T Consensus       297 wSlG~il~elltg~~Pf~~~~~~~~~~~----------------~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~  354 (377)
T 3byv_A          297 WALGLVIYWIWCADLPITKDAALGGSEW----------------IFR------SCKNIPQPVRALLEGFLRYPKEDRLLP  354 (377)
T ss_dssp             HHHHHHHHHHHHSSCCC------CCSGG----------------GGS------SCCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred             HHHHHHHHHHHHCCCCCcccccccchhh----------------hhh------hccCCCHHHHHHHHHHcCCCchhCCCH
Confidence            9999999999999999976443221110                000      012335789999999999999999999


Q ss_pred             HHHHH--HHHhhh
Q 014736          364 AAVVA--TLESLL  374 (419)
Q Consensus       364 ~eil~--~L~~l~  374 (419)
                      .++++  ++..+.
T Consensus       355 ~e~l~hp~f~~~~  367 (377)
T 3byv_A          355 LQAMETPEYEQLR  367 (377)
T ss_dssp             HHHHTSHHHHHHH
T ss_pred             HHHhhChHHHHHH
Confidence            99986  455543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=348.89  Aligned_cols=269  Identities=24%  Similarity=0.264  Sum_probs=197.2

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc-----HHHHHHHHHHHcCCCcccccceeeE
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-----HREWLAEVIFLGQLRHPHLVRLIGY  162 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~~~  162 (419)
                      ...++|.+.+.||+|+||.||+|..      ..+++.||+|++.......     ...+.+|+.+++.++||||++++++
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARD------KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA   80 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEEC------SSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEE------CCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEE
Confidence            3457899999999999999999953      3457899999997542211     2467899999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEecc
Q 014736          163 CCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       163 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                      +.+.+..++||||+.+ +|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~kl~Df  156 (346)
T 1ua2_A           81 FGHKSNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADF  156 (346)
T ss_dssp             ECCTTCCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             EeeCCceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHH--HCCEECCCCCHHHEEEcCCCCEEEEec
Confidence            9999999999999965 888887654 245788899999999999999999  677999999999999999999999999


Q ss_pred             CccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhc
Q 014736          243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS  321 (419)
Q Consensus       243 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  321 (419)
                      |++........  ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+...... ..
T Consensus       157 g~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~-~~  233 (346)
T 1ua2_A          157 GLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT-PT  233 (346)
T ss_dssp             GGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC-CC
T ss_pred             ccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCC-CC
Confidence            99987543322  2334569999999999865 45899999999999999999999999865432211111100000 00


Q ss_pred             cccccc---ccccccCC---C-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          322 SRRLRY---IVDPRLAG---Q-----YSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       322 ~~~~~~---~~~~~l~~---~-----~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      ......   ..+.....   .     .....+.++.+||.+||+.||.+|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            000000   00000000   0     012345789999999999999999999999773

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.4e-44  Score=338.38  Aligned_cols=247  Identities=21%  Similarity=0.271  Sum_probs=198.9

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCC-CcccccceeeEEE
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQL-RHPHLVRLIGYCC  164 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~  164 (419)
                      .+.++|++.+.||+|+||.||+|...      .+++.||+|++....  ......+.+|+..+..+ +||||+++++++.
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~   81 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKR------LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA   81 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEc------CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence            34578999999999999999999643      347899999997542  23456788899999998 8999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC--------
Q 014736          165 EDEERLLVYEFMPRGSLENHLFKRI--SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD--------  234 (419)
Q Consensus       165 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~--------  234 (419)
                      +.+..++||||+++++|.+++....  ...+++..++.++.||+.||.|||  ++||+||||||+|||++.+        
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dikp~NIl~~~~~~~~~~~~  159 (289)
T 1x8b_A           82 EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAASE  159 (289)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEC----------
T ss_pred             cCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH--hCCEeecCCCHHHEEEcCCCCCccccc
Confidence            9999999999999999999997643  256899999999999999999999  6779999999999999844        


Q ss_pred             -----------CcEEEeccCccccCCCCCCceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCC
Q 014736          235 -----------FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDK  302 (419)
Q Consensus       235 -----------~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~  302 (419)
                                 ..+||+|||++.......      ...||+.|+|||++.+. .++.++||||||+++|+|++|.+++..
T Consensus       160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~  233 (289)
T 1x8b_A          160 EGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN  233 (289)
T ss_dssp             ----------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred             ccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence                       479999999998754332      23499999999999765 567899999999999999999877643


Q ss_pred             CCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          303 LRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ..     ....     ... ..         ...++...+.++.+|+.+||+.||.+|||+.++++
T Consensus       234 ~~-----~~~~-----~~~-~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          234 GD-----QWHE-----IRQ-GR---------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             SH-----HHHH-----HHT-TC---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hh-----HHHH-----HHc-CC---------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            21     0000     000 00         01222334578999999999999999999999875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.6e-44  Score=349.04  Aligned_cols=258  Identities=24%  Similarity=0.375  Sum_probs=206.5

Q ss_pred             HHHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--------cHHHHHHHHHHHcCC-Ccc
Q 014736           84 SELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--------GHREWLAEVIFLGQL-RHP  154 (419)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~hp  154 (419)
                      .....+.++|.+.+.||+|+||.||+|...      .+++.||||++......        ..+.+.+|+.+++++ +||
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp  160 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHR------ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP  160 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCT
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEEC------CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            345667788999999999999999999653      34788999999754321        134577899999998 799


Q ss_pred             cccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 014736          155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD  234 (419)
Q Consensus       155 nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~  234 (419)
                      ||+++++++...+..|+||||++|++|.+++...  ..+++..+..++.||+.||.|||  ..||+|+||||+|||++.+
T Consensus       161 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH--~~gi~H~Dlkp~NIl~~~~  236 (365)
T 2y7j_A          161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLH--ANNIVHRDLKPENILLDDN  236 (365)
T ss_dssp             TBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTT
T ss_pred             CEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCC
Confidence            9999999999999999999999999999999765  56899999999999999999999  6779999999999999999


Q ss_pred             CcEEEeccCccccCCCCCCceeeecccccccccccccccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccc
Q 014736          235 FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST------GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSE  308 (419)
Q Consensus       235 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  308 (419)
                      +.+||+|||++........   .....||+.|+|||++.+      ..++.++|||||||++|+|++|..||....... 
T Consensus       237 ~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-  312 (365)
T 2y7j_A          237 MQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL-  312 (365)
T ss_dssp             CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred             CCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-
Confidence            9999999999987654332   234679999999999853      368899999999999999999999997643211 


Q ss_pred             hhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          309 QNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        .....   .......    .....    ...+.++.+|+.+||+.||.+|||+.++++
T Consensus       313 --~~~~i---~~~~~~~----~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          313 --MLRMI---MEGQYQF----SSPEW----DDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             --HHHHH---HHTCCCC----CHHHH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --HHHHH---HhCCCCC----CCccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              11110   0000000    00000    123467999999999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2e-44  Score=335.78  Aligned_cols=249  Identities=27%  Similarity=0.384  Sum_probs=196.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      .++|.+.+.||+|+||.||+|...      .+++.||+|++....   ......+.+|+.+++.++||||+++++++.+.
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   83 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQ------LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP   83 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             eccEEEEeeecCCCCeEEEEEEEC------CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            368999999999999999999643      357889999996432   23356788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..|+||||+.+++|.+++...  ..+++..++.++.||+.||.|||  ++||+|+||||+|||++.++.+||+|||++.
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~  159 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSN  159 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HHCSSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred             CeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCChhhEEECCCCCEEEeeccccc
Confidence            9999999999999999999766  56899999999999999999999  6779999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHL-TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      .......   .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......   .....   . .. . 
T Consensus       160 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~---~-~~-~-  227 (276)
T 2h6d_A          160 MMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LFKKI---R-GG-V-  227 (276)
T ss_dssp             CCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---H-HC-C-
T ss_pred             ccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHh---h-cC-c-
Confidence            7544321   233468999999999987765 689999999999999999999997643211   11110   0 00 0 


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                               ...+...+.++.+++.+||+.||.+|||+.++++.
T Consensus       228 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 ---------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ---------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                     01122345789999999999999999999999873

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.1e-45  Score=344.87  Aligned_cols=264  Identities=26%  Similarity=0.377  Sum_probs=187.8

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ..++|.+.+.||+|+||.||+|..      ..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   86 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYC------APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD   86 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS
T ss_pred             chhhhhhhheeccccceEEEEEEE------CCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence            357899999999999999999953      3346889999987543 233567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhc------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          168 ERLLVYEFMPRGSLENHLFKR------ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                      ..++||||+++++|.+++...      ....+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~d  164 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--KNGQIHRDVKAGNILLGEDGSVQIAD  164 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCCCCChhhEEEcCCCCEEEEe
Confidence            999999999999999998642      2356899999999999999999999  67799999999999999999999999


Q ss_pred             cCccccCCCCCCc---eeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH
Q 014736          242 FGLAKMGPEGSNT---HVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP  317 (419)
Q Consensus       242 fGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~  317 (419)
                      ||++.........   .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.............    
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----  240 (303)
T 2vwi_A          165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL----  240 (303)
T ss_dssp             CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH----
T ss_pred             ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh----
Confidence            9998765433211   11234569999999999865 568999999999999999999999998754332111110    


Q ss_pred             HhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          318 YLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       318 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       .......   .............+.++.+|+.+||+.||.+|||+.++++
T Consensus       241 -~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          241 -QNDPPSL---ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             -TSSCCCT---TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -ccCCCcc---ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence             0000000   0000011122234578999999999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.1e-44  Score=345.65  Aligned_cols=255  Identities=25%  Similarity=0.368  Sum_probs=198.4

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--------ccHHHHHHHHHHHcCCCcccccc
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--------QGHREWLAEVIFLGQLRHPHLVR  158 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~  158 (419)
                      ..+.++|.+.+.||+|+||.||+|...      .+++.||||++.....        .....+.+|+.+|+.++||||++
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~   79 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFER------KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK   79 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCC
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEc------CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCce
Confidence            345678999999999999999999643      4568899999965421        12235788999999999999999


Q ss_pred             eeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc--
Q 014736          159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT--  236 (419)
Q Consensus       159 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~--  236 (419)
                      +++++..+. .|+||||+++++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.  
T Consensus        80 ~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~~~~  154 (322)
T 2ycf_A           80 IKNFFDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDC  154 (322)
T ss_dssp             EEEEEESSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSSSC
T ss_pred             EeeEEcCCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEecCCCCC
Confidence            999987654 89999999999999988654  57899999999999999999999  677999999999999987665  


Q ss_pred             -EEEeccCccccCCCCCCceeeeccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHH
Q 014736          237 -AKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS---TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV  312 (419)
Q Consensus       237 -~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~  312 (419)
                       +||+|||++.......   ......||+.|+|||++.   ...++.++|||||||++|+|++|..||.........  .
T Consensus       155 ~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~  229 (322)
T 2ycf_A          155 LIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--K  229 (322)
T ss_dssp             CEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--H
T ss_pred             eEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--H
Confidence             9999999998754321   123356999999999973   567899999999999999999999999865433211  1


Q ss_pred             HhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          313 DWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ....    .. ...  ..+..    ....+.++.+|+.+||+.||.+||++.++++
T Consensus       230 ~~~~----~~-~~~--~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          230 DQIT----SG-KYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHH----HT-CCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHH----hC-ccc--cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            1100    00 000  00000    1123578999999999999999999999984

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.8e-45  Score=341.97  Aligned_cols=262  Identities=27%  Similarity=0.399  Sum_probs=200.5

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++.+.||+|+||.||+|.+...   ...+..||+|++....   ....+.+.+|+.+++.++||||+++++++....
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   94 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAP---SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP   94 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECT---TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeeeeeeecCCCceeEEEEEeccC---CCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence            5799999999999999999975432   1223469999987542   234567889999999999999999999987654


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                       .++||||+.+++|.+++... ...+++..+..++.||+.||.|||  ++||+|+||||+|||++.++.+||+|||++..
T Consensus        95 -~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           95 -MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             -CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             -ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHH--hCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence             89999999999999998764 245889999999999999999999  66799999999999999999999999999987


Q ss_pred             CCCCCCce-eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          248 GPEGSNTH-VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       248 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      ........ ......+|..|+|||++.+..++.++||||||+++|+|++ |+.||.......   ...   ......   
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~---~~~~~~---  241 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILH---KIDKEG---  241 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---HHHTSC---
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---HHH---HHHccC---
Confidence            65443322 1223457889999999988899999999999999999999 999997654221   111   111110   


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                             .....+..++.++.+++.+||+.||.+|||+.++++.|.++..
T Consensus       242 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          242 -------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             -------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                   0111223456789999999999999999999999999998865

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.6e-44  Score=356.33  Aligned_cols=202  Identities=25%  Similarity=0.309  Sum_probs=173.6

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC------CcccccceeeE
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL------RHPHLVRLIGY  162 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~~~~~  162 (419)
                      +..+|++.++||+|+||.||+|...      .+++.||||++... ......+.+|+.+++.+      +|+||++++++
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~------~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~  167 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDH------KVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN  167 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEET------TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEEC------CCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence            4568999999999999999999643      45788999999753 22345666787777665      57899999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc--EEEe
Q 014736          163 CCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT--AKLS  240 (419)
Q Consensus       163 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~--~kl~  240 (419)
                      +...+..++||||+ +++|.+++.......+++..++.++.||+.||.|||  ++||+||||||+||||+.++.  +||+
T Consensus       168 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlKp~NILl~~~~~~~vkL~  244 (429)
T 3kvw_A          168 FTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVI  244 (429)
T ss_dssp             EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HHTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred             cccCCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEEccCCCcceEEe
Confidence            99999999999999 579999998776667999999999999999999999  567999999999999999987  9999


Q ss_pred             ccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRP  305 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  305 (419)
                      |||++......     ....+||+.|+|||++.+..++.++|||||||++|||++|.+||.....
T Consensus       245 DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          245 DFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             CCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            99999764332     2335699999999999999999999999999999999999999987543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-45  Score=351.09  Aligned_cols=257  Identities=25%  Similarity=0.299  Sum_probs=204.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC----cccHHHHHHHHHHHcCC-CcccccceeeEEEe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG----LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCE  165 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~  165 (419)
                      ++|.+.++||+|+||.||+|....   ...+++.||||++....    ......+.+|+.+|+.+ +||||+++++++..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKIS---GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECS---STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcc---cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            579999999999999999997532   13457899999986432    12345567799999999 69999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      .+..|+||||+++++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             CceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            99999999999999999999766  56899999999999999999999  667999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYIST--GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSR  323 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  323 (419)
                      +....... ......+||+.|+|||++.+  ..++.++|||||||++|+|++|+.||...........+  .......  
T Consensus       207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~~--  281 (355)
T 1vzo_A          207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKS--  281 (355)
T ss_dssp             EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHHC--
T ss_pred             eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HHHHhcc--
Confidence            86543222 12334579999999999975  45789999999999999999999999765433222111  1111111  


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 014736          324 RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVAT  369 (419)
Q Consensus       324 ~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~~  369 (419)
                                ...++...+..+.+||.+||..||.+||     ++.++++.
T Consensus       282 ----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          282 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence                      1123344567899999999999999999     89988764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-44  Score=352.87  Aligned_cols=272  Identities=21%  Similarity=0.241  Sum_probs=200.7

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEe-
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE-  165 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-  165 (419)
                      +...++|.+.+.||+|+||.||+|..      ..+++.||||++......    ..+|+.+|+.++||||++++++|.. 
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~------~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~   72 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFD------IESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTT   72 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEE------TTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEE------CCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeec
Confidence            34567899999999999999999964      345789999998654222    2369999999999999999999844 


Q ss_pred             -------------------------------------CCeeEEEEEecCCCChhhhhhh--ccCCCCCHHHHHHHHHHHH
Q 014736          166 -------------------------------------DEERLLVYEFMPRGSLENHLFK--RISVSLPWGTRLKIAIGAA  206 (419)
Q Consensus       166 -------------------------------------~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~  206 (419)
                                                           ....++||||+. ++|.+.+..  .....+++..++.++.||+
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~  151 (383)
T 3eb0_A           73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF  151 (383)
T ss_dssp             -------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence                                                 334889999996 588877754  2346789999999999999


Q ss_pred             HHHHHhhcCCCCeeecCCCCCcEEEc-CCCcEEEeccCccccCCCCCCceeeecccccccccccccccCC-CCCchhhHH
Q 014736          207 KGLAFLHGAENPVIYRDFKTSNILLD-SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVY  284 (419)
Q Consensus       207 ~al~~lH~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diw  284 (419)
                      .||.|||  ++||+||||||+|||++ .++.+||+|||+++.......   .....||+.|+|||++.+. .++.++|||
T Consensus       152 ~aL~~LH--~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  226 (383)
T 3eb0_A          152 RAVGFIH--SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLW  226 (383)
T ss_dssp             HHHHHHH--TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred             HHHHHHH--HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence            9999999  67899999999999998 688999999999986544332   2345689999999998764 589999999


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH------Hhhccc-----ccccccccccCCCCCHHHHHHHHHHHHHcc
Q 014736          285 SFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP------YLRSSR-----RLRYIVDPRLAGQYSVKGAKEMAVLALQCI  353 (419)
Q Consensus       285 slG~il~elltg~~pf~~~~~~~~~~~~~~~~~------~~~~~~-----~~~~~~~~~l~~~~~~~~~~~l~~li~~~l  353 (419)
                      ||||++|+|++|+.||.+.........+.....      ......     .+.......+...++...+.++.+|+.+||
T Consensus       227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  306 (383)
T 3eb0_A          227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL  306 (383)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence            999999999999999987543322111110000      000000     000000111111233445678999999999


Q ss_pred             cCCCCCCCCHHHHHH--HHHhhh
Q 014736          354 SVNPKDRPKMAAVVA--TLESLL  374 (419)
Q Consensus       354 ~~dP~~RPs~~eil~--~L~~l~  374 (419)
                      +.||.+|||+.++++  +++.+.
T Consensus       307 ~~dP~~R~t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          307 RYEPDLRINPYEAMAHPFFDHLR  329 (383)
T ss_dssp             CSSGGGSCCHHHHHTSGGGHHHH
T ss_pred             cCChhhCCCHHHHhcCHHHHHHH
Confidence            999999999999985  355443

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.8e-44  Score=338.63  Aligned_cols=253  Identities=25%  Similarity=0.366  Sum_probs=201.0

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ...++|.+.+.||+|+||.||+|...      .+++.||+|++....  ....+.+|+.+++.++||||+++++++...+
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   97 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHK------ETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT   97 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEET------TTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cchhhhhhheeeccCCCeEEEEEEEC------CCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence            44578999999999999999999643      347889999997543  3467889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+.+++|.+++... ...+++..++.++.||+.||.|||  ++||+|+||||+||+++.++.+||+|||++..
T Consensus        98 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  174 (314)
T 3com_A           98 DLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLH--FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ  174 (314)
T ss_dssp             EEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence            999999999999999998643 357899999999999999999999  67799999999999999999999999999976


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........      .. ...    
T Consensus       175 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~-~~~----  241 (314)
T 3com_A          175 LTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM------IP-TNP----  241 (314)
T ss_dssp             CBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HH-HSC----
T ss_pred             hhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH------Hh-cCC----
Confidence            543221  12345699999999999999999999999999999999999999976432211100      00 000    


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                          ......+...+.++.+|+.+||+.||.+|||+.++++
T Consensus       242 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          242 ----PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ----CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ----CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                0000112334678999999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6e-45  Score=347.71  Aligned_cols=254  Identities=27%  Similarity=0.378  Sum_probs=198.5

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-CcccccceeeEEEe-
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHLVRLIGYCCE-  165 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~-  165 (419)
                      ...++|++.+.||+|+||.||+|...      .+++.||+|++.... .....+.+|+.+++.+ +||||+++++++.. 
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHV------KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEEC------CCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            34578999999999999999999643      346889999997543 3456788999999998 79999999999987 


Q ss_pred             -----CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 014736          166 -----DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS  240 (419)
Q Consensus       166 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  240 (419)
                           .+..|+||||+.+++|.+++.......+++..++.++.||+.||.|||  .+||+|+||||+|||++.++.+||+
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCcHHHEEEcCCCCEEEe
Confidence                 468899999999999999998765567899999999999999999999  6779999999999999999999999


Q ss_pred             ccCccccCCCCCCceeeeccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS-----TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA  315 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~  315 (419)
                      |||++........  ......||+.|+|||++.     +..++.++|||||||++|+|++|..||...........    
T Consensus       172 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----  245 (326)
T 2x7f_A          172 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----  245 (326)
T ss_dssp             CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----
T ss_pred             eCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH----
Confidence            9999986543221  123356999999999986     56789999999999999999999999976442211110    


Q ss_pred             hHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          316 KPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        .....  .     +   ......++.++.+|+.+||..||.+||++.++++
T Consensus       246 --~~~~~--~-----~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          246 --IPRNP--A-----P---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             --HHHSC--C-----C---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             --hhcCc--c-----c---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence              00000  0     0   0112234578999999999999999999999987

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.3e-45  Score=339.32  Aligned_cols=255  Identities=22%  Similarity=0.353  Sum_probs=203.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEe--
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCE--  165 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--  165 (419)
                      .++|++.+.||+|+||.||+|...      .+++.||+|++.....  ...+.+.+|+.++++++||||+++++++.+  
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRK------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT   78 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET------TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred             hhheeeehhccCCCCcEEEEEEEC------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence            357999999999999999999643      4578899999975432  345678899999999999999999998854  


Q ss_pred             CCeeEEEEEecCCCChhhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHhhcCCCC-----eeecCCCCCcEEEcCCCcEE
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRI--SVSLPWGTRLKIAIGAAKGLAFLHGAENP-----VIYRDFKTSNILLDSDFTAK  238 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~-----ivH~Dlkp~NIll~~~~~~k  238 (419)
                      ....|+||||+++++|.+++....  ...+++..++.++.||+.||.|||  ++|     |+||||||+|||++.++.+|
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~~~ivH~dl~p~NIl~~~~~~~k  156 (279)
T 2w5a_A           79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH--RRSDGGHTVLHRDLKPANVFLDGKQNVK  156 (279)
T ss_dssp             GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HHC------CCCCCSGGGEEECSSSCEE
T ss_pred             CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh--cccCCCCeeEEeccchhhEEEcCCCCEE
Confidence            568999999999999999997542  245899999999999999999999  556     99999999999999999999


Q ss_pred             EeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          239 LSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       239 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      |+|||++........  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......   .....   
T Consensus       157 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~i---  228 (279)
T 2w5a_A          157 LGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKI---  228 (279)
T ss_dssp             ECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---
T ss_pred             EecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHHHH---
Confidence            999999986543321  1223468999999999999999999999999999999999999998654221   11111   


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                      . .. .         ....+...+.++.+|+.+||+.||.+|||+.+|++.+.
T Consensus       229 ~-~~-~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          229 R-EG-K---------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             H-HT-C---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             h-hc-c---------cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            0 10 0         01122345678999999999999999999999987544

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.6e-44  Score=346.10  Aligned_cols=268  Identities=22%  Similarity=0.274  Sum_probs=199.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEe---
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCE---  165 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---  165 (419)
                      ++|++.+.||+|+||.||+|..      ..+++.||+|++.....  .....+.+|+.+++.++||||+++++++..   
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   90 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARH------RKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS   90 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEE------TTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             cceeEEEEEecCCCcEEEEEEE------CCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence            5799999999999999999964      34578999999865433  234578899999999999999999999987   


Q ss_pred             -----CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 014736          166 -----DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS  240 (419)
Q Consensus       166 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  240 (419)
                           .+..|+||||+. ++|.+.+... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+
T Consensus        91 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIl~~~~~~~kl~  166 (351)
T 3mi9_A           91 PYNRCKGSIYLVFDFCE-HDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLA  166 (351)
T ss_dssp             ------CEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             ccccCCceEEEEEeccC-CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCHHHEEEcCCCCEEEc
Confidence                 456899999996 4777777543 246899999999999999999999  6779999999999999999999999


Q ss_pred             ccCccccCCCCCCc--eeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH
Q 014736          241 DFGLAKMGPEGSNT--HVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP  317 (419)
Q Consensus       241 DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~  317 (419)
                      |||++.........  .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus       167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  246 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  246 (351)
T ss_dssp             CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            99999865432221  12234568999999999876 5689999999999999999999999987543322222111100


Q ss_pred             Hh-----hccccccccccc-ccCC---CCCH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          318 YL-----RSSRRLRYIVDP-RLAG---QYSV-----KGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       318 ~~-----~~~~~~~~~~~~-~l~~---~~~~-----~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ..     ............ ....   ....     ..+.++.+|+.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            00     000000000000 0000   0000     11456899999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.6e-44  Score=336.56  Aligned_cols=254  Identities=25%  Similarity=0.365  Sum_probs=204.6

Q ss_pred             HHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---------ccHHHHHHHHHHHcCCC-ccccc
Q 014736           88 AITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---------QGHREWLAEVIFLGQLR-HPHLV  157 (419)
Q Consensus        88 ~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-hpnIv  157 (419)
                      .+.++|.+.+.||+|+||.||+|...      .+++.||||++.....         ...+.+.+|+.+++++. ||||+
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~   87 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHK------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII   87 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred             chhhccceeeeecCCCceEEEEEEEc------CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEe
Confidence            34578999999999999999999643      4578899999975431         12356788999999995 99999


Q ss_pred             ceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcE
Q 014736          158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTA  237 (419)
Q Consensus       158 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~  237 (419)
                      ++++++...+..++||||+++++|.+++...  ..+++..++.++.||+.||.|||  ++||+|+||||+||+++.++.+
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~  163 (298)
T 1phk_A           88 QLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNI  163 (298)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCE
T ss_pred             eeeeeeccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEEcCCCcE
Confidence            9999999999999999999999999999765  57899999999999999999999  6779999999999999999999


Q ss_pred             EEeccCccccCCCCCCceeeeccccccccccccccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhH
Q 014736          238 KLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS------TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNL  311 (419)
Q Consensus       238 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  311 (419)
                      ||+|||++........   .....||+.|+|||++.      ...++.++||||||+++|+|++|..||...........
T Consensus       164 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  240 (298)
T 1phk_A          164 KLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM  240 (298)
T ss_dssp             EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH
Confidence            9999999987544322   23456999999999984      45789999999999999999999999976432211111


Q ss_pred             HHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          312 VDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      +      ....  .      ..........+.++.+|+.+||+.||.+|||+.++++
T Consensus       241 ~------~~~~--~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          241 I------MSGN--Y------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             H------HHTC--C------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             H------hcCC--c------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            1      1000  0      0001111345678999999999999999999999875

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.3e-44  Score=341.50  Aligned_cols=254  Identities=22%  Similarity=0.352  Sum_probs=200.1

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ..++|++.+.||+|+||.||+|...      .+++.||+|++........+.+.+|+.+++.++||||+++++++...+.
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNK------ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK   90 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEET------TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred             CccceeecceeccCCCeEEEEEEEc------CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence            3468999999999999999999643      3468899999987666677889999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .++||||+++++|.+++... ...+++..++.++.||+.||.|||  .+||+||||||+|||++.++.+||+|||++...
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLH--SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence            99999999999999988653 346899999999999999999999  677999999999999999999999999987532


Q ss_pred             CCCCCceeeecccccccccccccc-----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYI-----STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSR  323 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  323 (419)
                      ...  ........||+.|+|||++     .+..++.++||||||+++|+|++|..||........   .   ....... 
T Consensus       168 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~---~~~~~~~-  238 (302)
T 2j7t_A          168 LKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---L---LKIAKSD-  238 (302)
T ss_dssp             HHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H---HHHHHSC-
T ss_pred             ccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---H---HHHhccC-
Confidence            111  0112234699999999998     467789999999999999999999999986543211   1   0110000 


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          324 RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       324 ~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .        .....+..++.++.+|+.+||+.||.+|||+.++++
T Consensus       239 ~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          239 P--------PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             C--------CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             C--------cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0        001122344678999999999999999999999875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2e-44  Score=338.06  Aligned_cols=256  Identities=25%  Similarity=0.310  Sum_probs=188.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-c-HHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-G-HREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .++|++.+.||+|+||.||+|..      ..+++.||+|++...... . .+.+.++...++.++||||+++++++.+.+
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~   79 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRH------VPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG   79 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE------TTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEe------cCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC
Confidence            46899999999999999999964      345788999999754322 2 233445555688899999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeecCCCCCcEEEcCCCcEEEeccCc
Q 014736          168 ERLLVYEFMPRGSLENHLFKR--ISVSLPWGTRLKIAIGAAKGLAFLHGAEN-PVIYRDFKTSNILLDSDFTAKLSDFGL  244 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~-~ivH~Dlkp~NIll~~~~~~kl~DfGl  244 (419)
                      ..++||||++ ++|.+++...  ....+++..++.++.||+.||.|||  .+ ||+||||||+|||++.++.+||+|||+
T Consensus        80 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T 3fme_A           80 DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGI  156 (290)
T ss_dssp             SEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HHSCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred             CEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh--hcCCeecCCCCHHHEEECCCCCEEEeecCC
Confidence            9999999996 5888877542  3457899999999999999999999  55 799999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccccccccccccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhh
Q 014736          245 AKMGPEGSNTHVTTRVMGTYGYAAPEYI----STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR  320 (419)
Q Consensus       245 a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  320 (419)
                      +........   .....||+.|+|||++    .+..++.++||||||+++|+|++|+.||........ ...    ....
T Consensus       157 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~----~~~~  228 (290)
T 3fme_A          157 SGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLK----QVVE  228 (290)
T ss_dssp             ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHH----HHHH
T ss_pred             ccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHH----HHhc
Confidence            986544322   2234699999999996    566789999999999999999999999975432111 111    1111


Q ss_pred             cccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHh
Q 014736          321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA--TLES  372 (419)
Q Consensus       321 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~--~L~~  372 (419)
                      .          ..........+.++.+|+.+||+.||++|||+.++++  ++..
T Consensus       229 ~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          229 E----------PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             S----------CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             c----------CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            1          0011112234678999999999999999999999987  4443

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.4e-44  Score=341.18  Aligned_cols=258  Identities=19%  Similarity=0.253  Sum_probs=200.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-cccccceeeEEEe--CC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-HPHLVRLIGYCCE--DE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~--~~  167 (419)
                      ++|++.+.||+|+||.||+|..      ..+++.||+|++...   ..+.+.+|+.+++.++ ||||+++++++.+  ..
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~  106 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAIN------ITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSR  106 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE------TTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CceEEEEEecccCCeEEEEEEE------CCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence            6799999999999999999964      345789999999743   3467889999999997 9999999999988  66


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-cEEEeccCccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-TAKLSDFGLAK  246 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~  246 (419)
                      ..++||||+.+++|.+++.     .+++..++.++.||+.||.|||  ++||+||||||+|||++.++ .+||+|||++.
T Consensus       107 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             ceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            7899999999999999874     3788899999999999999999  67799999999999999776 89999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh--------H
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK--------P  317 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--------~  317 (419)
                      .......   .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||......... ......        .
T Consensus       180 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~  255 (330)
T 3nsz_A          180 FYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYD  255 (330)
T ss_dssp             ECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHH
T ss_pred             EcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhh
Confidence            6554332   233569999999999877 67999999999999999999999999654322111 000000        0


Q ss_pred             Hhhcc-----ccc--------ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          318 YLRSS-----RRL--------RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       318 ~~~~~-----~~~--------~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .....     ..+        ................+.++.+||.+||+.||.+|||+.++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000     000        0000011111122335688999999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=6.4e-44  Score=347.13  Aligned_cols=263  Identities=21%  Similarity=0.276  Sum_probs=192.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .++|.+.+.||+|+||.||+|+.      ..+++.||||++....  ......+.+|+.+++.++||||+++++++...+
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   97 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYD------AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   97 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEE------TTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEE------CCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence            46899999999999999999964      3457889999997542  233467889999999999999999999997665


Q ss_pred             ------eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          168 ------ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       168 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                            ..|+||||+. ++|.+++.    ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~D  170 (371)
T 2xrw_A           98 SLEEFQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILD  170 (371)
T ss_dssp             STTTCCEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccccceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHH--HCCeecccCCHHHEEEcCCCCEEEEE
Confidence                  7899999995 57888774    35889999999999999999999  67799999999999999999999999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHh-------
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW-------  314 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~-------  314 (419)
                      ||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+..       
T Consensus       171 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  247 (371)
T 2xrw_A          171 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  247 (371)
T ss_dssp             CCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred             eeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99998654321   23345799999999999999999999999999999999999999986543221111100       


Q ss_pred             ---------hhHHhhcccc-----cccccccccCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          315 ---------AKPYLRSSRR-----LRYIVDPRLAG---QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       315 ---------~~~~~~~~~~-----~~~~~~~~l~~---~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                               ...+......     +...+......   ......+.++.+||.+||+.||.+|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                     0000000000     00000000000   011234678999999999999999999999987

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=7.6e-45  Score=345.83  Aligned_cols=269  Identities=22%  Similarity=0.345  Sum_probs=199.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .++|++.+.||+|+||.||+|...+         .||+|++.....  ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            4689999999999999999996532         399999875432  23355778999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..++||||+.+++|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++ ++.+||+|||++..
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKVVITDFGLFSI  178 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHH--HTTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred             ceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence            999999999999999998654 346888999999999999999999  66799999999999998 67999999999875


Q ss_pred             CCCCCC---ceeeecccccccccccccccC---------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh
Q 014736          248 GPEGSN---THVTTRVMGTYGYAAPEYIST---------GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA  315 (419)
Q Consensus       248 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~  315 (419)
                      ......   ........||+.|+|||++.+         ..++.++||||||+++|+|++|+.||...........+   
T Consensus       179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---  255 (319)
T 2y4i_B          179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM---  255 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH---
T ss_pred             cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh---
Confidence            432111   111233469999999999864         45789999999999999999999999764322111100   


Q ss_pred             hHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCccccccCCCCC
Q 014736          316 KPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMAVSCGQWP  387 (419)
Q Consensus       316 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~~~~  387 (419)
                          ...      ..+.+   .....+.++.+|+.+||..||.+|||+.+|++.|+.+.........+..++
T Consensus       256 ----~~~------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~  314 (319)
T 2y4i_B          256 ----GTG------MKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFW  314 (319)
T ss_dssp             ----HTT------CCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------------
T ss_pred             ----ccC------CCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccc
Confidence                000      00111   111234679999999999999999999999999999987655544444433

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1e-43  Score=344.80  Aligned_cols=267  Identities=22%  Similarity=0.287  Sum_probs=202.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeC--
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCED--  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--  166 (419)
                      .++|++.++||+|+||.||+|..      ..+++.||+|++..... .....+.+|+.+|++++||||+++++++...  
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYD------NLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE------TTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             cccEEEEEEeecCCCeEEEEEEE------CCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence            46899999999999999999964      34578899999975432 3346788999999999999999999999664  


Q ss_pred             ---CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccC
Q 014736          167 ---EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFG  243 (419)
Q Consensus       167 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  243 (419)
                         ...|+||||+. ++|.+++...   .+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||
T Consensus       100 ~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  173 (364)
T 3qyz_A          100 EQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFG  173 (364)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             cccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCChHhEEECCCCCEEEEeCc
Confidence               36899999995 6999988654   6899999999999999999999  6779999999999999999999999999


Q ss_pred             ccccCCCCCCce-eeeccccccccccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH---
Q 014736          244 LAKMGPEGSNTH-VTTRVMGTYGYAAPEYIS-TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY---  318 (419)
Q Consensus       244 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---  318 (419)
                      ++.......... ......||+.|+|||++. +..++.++|||||||++|+|++|+.||...........+......   
T Consensus       174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  253 (364)
T 3qyz_A          174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  253 (364)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred             ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            998654332111 123457999999999865 456899999999999999999999999876544432222110000   


Q ss_pred             --hhcc------ccccccccc--ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 --LRSS------RRLRYIVDP--RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 --~~~~------~~~~~~~~~--~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        ....      .........  .....+....+.++.+|+.+||+.||.+|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              0000      000000000  0000011234578999999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.7e-43  Score=338.71  Aligned_cols=266  Identities=21%  Similarity=0.279  Sum_probs=205.8

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCccc------ccceeeE
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH------LVRLIGY  162 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~~~~~  162 (419)
                      +.++|++.+.||+|+||.||+|...     ...++.||+|++... ....+.+.+|+.+++.++|++      |++++++
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~   85 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDH-----KAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW   85 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEET-----TTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEec-----CCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence            3568999999999999999999642     334688999999743 233467788999998887665      9999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---------
Q 014736          163 CCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---------  233 (419)
Q Consensus       163 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~---------  233 (419)
                      +.+.+..++||||+ +++|.+++.......+++..++.++.||+.||.|||  ++||+||||||+|||++.         
T Consensus        86 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           86 FEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH--SNKLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             cccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHEEEeccccccccCC
Confidence            99999999999999 999999998776567899999999999999999999  677999999999999987         


Q ss_pred             ----------CCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 014736          234 ----------DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKL  303 (419)
Q Consensus       234 ----------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  303 (419)
                                ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                      668999999999864332     23356999999999999999999999999999999999999999865


Q ss_pred             CCccchhHHHhhhH-----Hhhccccccc--------------------cccc-ccCCCCCHHHHHHHHHHHHHcccCCC
Q 014736          304 RPKSEQNLVDWAKP-----YLRSSRRLRY--------------------IVDP-RLAGQYSVKGAKEMAVLALQCISVNP  357 (419)
Q Consensus       304 ~~~~~~~~~~~~~~-----~~~~~~~~~~--------------------~~~~-~l~~~~~~~~~~~l~~li~~~l~~dP  357 (419)
                      ........+.....     ..........                    ...+ .-........++++.+|+.+||+.||
T Consensus       238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence            43322211111000     0000000000                    0000 00011233557889999999999999


Q ss_pred             CCCCCHHHHHH
Q 014736          358 KDRPKMAAVVA  368 (419)
Q Consensus       358 ~~RPs~~eil~  368 (419)
                      .+|||+.++++
T Consensus       318 ~~Rpt~~ell~  328 (339)
T 1z57_A          318 AKRITLREALK  328 (339)
T ss_dssp             TTSCCHHHHTT
T ss_pred             ccccCHHHHhc
Confidence            99999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5e-44  Score=344.43  Aligned_cols=261  Identities=19%  Similarity=0.249  Sum_probs=204.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc-----------------HHHHHHHHHHHcCCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-----------------HREWLAEVIFLGQLR  152 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~  152 (419)
                      .++|.+.+.||+|+||.||+|..        +++.||+|++.......                 ...+.+|+.+++.++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  101 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK  101 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence            46899999999999999999964        46889999996432211                 178899999999999


Q ss_pred             cccccceeeEEEeCCeeEEEEEecCCCChhhh------hhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 014736          153 HPHLVRLIGYCCEDEERLLVYEFMPRGSLENH------LFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKT  226 (419)
Q Consensus       153 hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp  226 (419)
                      ||||+++++++.+.+..|+||||+++++|.++      +.......+++..++.++.||+.||.|||+ ++||+|+||||
T Consensus       102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dl~p  180 (348)
T 2pml_X          102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKP  180 (348)
T ss_dssp             CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TSCEECCCCCG
T ss_pred             CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc-cCCEeecCCCh
Confidence            99999999999999999999999999999998      655445779999999999999999999994 27799999999


Q ss_pred             CcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCC-CCCc-hhhHHHHHHHHHHHHcCCCCCCCCC
Q 014736          227 SNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG-HLTT-KSDVYSFGVVLLELLTGRRSMDKLR  304 (419)
Q Consensus       227 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~elltg~~pf~~~~  304 (419)
                      +|||++.++.+||+|||++......    ......||..|+|||++.+. .++. ++||||||+++|+|++|..||....
T Consensus       181 ~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          181 SNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             GGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999865433    23446799999999999877 6766 9999999999999999999998654


Q ss_pred             CccchhHHHhhhHHhhcccccccc-------cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          305 PKSEQNLVDWAKPYLRSSRRLRYI-------VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ...  .......   .....+...       .............+.++.+|+.+||+.||.+|||+.++++
T Consensus       257 ~~~--~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          257 SLV--ELFNNIR---TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             CSH--HHHHHHT---SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cHH--HHHHHHh---ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            321  1111110   000000000       0000000111345678999999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-43  Score=351.05  Aligned_cols=267  Identities=23%  Similarity=0.265  Sum_probs=196.8

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeC----
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCED----  166 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----  166 (419)
                      .+|.+.++||+|+||.||+|.+.      .+++.||||++.....    .+.+|+++|+.++||||++++++|...    
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~------~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  123 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLC------DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK  123 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEET------TTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred             ceEEeeeEEeeCCCEEEEEEEEC------CCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence            46899999999999999999654      3468899999864322    233699999999999999999998542    


Q ss_pred             --CeeEEEEEecCCCChhhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-CcEEEec
Q 014736          167 --EERLLVYEFMPRGSLENHLFK--RISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD-FTAKLSD  241 (419)
Q Consensus       167 --~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~-~~~kl~D  241 (419)
                        ..+++||||+.+ +|.+.+..  .....+++..++.++.||+.||.|||  ++||+||||||+||||+.+ +.+||+|
T Consensus       124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NILl~~~~~~~kl~D  200 (420)
T 1j1b_A          124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCD  200 (420)
T ss_dssp             TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred             cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChhhEEEeCCCCeEEecc
Confidence              236799999964 67666543  23467899999999999999999999  6789999999999999965 5689999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh----
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK----  316 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~----  316 (419)
                      ||+++.......   .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.........+....    
T Consensus       201 FG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~  277 (420)
T 1j1b_A          201 FGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT  277 (420)
T ss_dssp             CTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             chhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999987544322   2345699999999998764 79999999999999999999999998754322111111000    


Q ss_pred             -HHh-hcccccccccccc-----cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhh
Q 014736          317 -PYL-RSSRRLRYIVDPR-----LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA--TLESL  373 (419)
Q Consensus       317 -~~~-~~~~~~~~~~~~~-----l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~--~L~~l  373 (419)
                       ..+ ...........+.     +...+....+.++.+||.+||+.||.+|||+.++++  ++..+
T Consensus       278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence             000 0000000000010     011123345688999999999999999999999986  34444

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=9e-44  Score=345.78  Aligned_cols=263  Identities=21%  Similarity=0.255  Sum_probs=200.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-----------cccccce
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-----------HPHLVRL  159 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~~  159 (419)
                      ++|.+.+.||+|+||.||+|..      ..+++.||||++... ......+.+|+.++++++           |+||+++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKD------MVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE------TTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CeEEEEEeeeecCCeEEEEEEe------cCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            5899999999999999999964      345788999999743 223466788999988876           8999999


Q ss_pred             eeEEEeCC----eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeecCCCCCcEEEc--
Q 014736          160 IGYCCEDE----ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN-PVIYRDFKTSNILLD--  232 (419)
Q Consensus       160 ~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~-~ivH~Dlkp~NIll~--  232 (419)
                      ++++...+    ..++||||+ +++|.+++.......+++..++.++.||+.||.|||  ++ ||+||||||+|||++  
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--~~~~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECSCCSGGGEEEEEE
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH--hcCCEEecCCChHHeEEecc
Confidence            99997654    789999999 999999998766667999999999999999999999  55 799999999999995  


Q ss_pred             ----CCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccc
Q 014736          233 ----SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSE  308 (419)
Q Consensus       233 ----~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  308 (419)
                          ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  243 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY  243 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence                3447999999999865432     2334699999999999999999999999999999999999999986543221


Q ss_pred             hhHHHhhhHHhh---------------------ccccccccccc---------ccCCCCCHHHHHHHHHHHHHcccCCCC
Q 014736          309 QNLVDWAKPYLR---------------------SSRRLRYIVDP---------RLAGQYSVKGAKEMAVLALQCISVNPK  358 (419)
Q Consensus       309 ~~~~~~~~~~~~---------------------~~~~~~~~~~~---------~l~~~~~~~~~~~l~~li~~~l~~dP~  358 (419)
                      ............                     ....+..+...         .....++...+.++.+||.+||+.||.
T Consensus       244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  323 (373)
T 1q8y_A          244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  323 (373)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence            111110000000                     00000000000         001135567889999999999999999


Q ss_pred             CCCCHHHHHH
Q 014736          359 DRPKMAAVVA  368 (419)
Q Consensus       359 ~RPs~~eil~  368 (419)
                      +|||+.++++
T Consensus       324 ~Rpt~~ell~  333 (373)
T 1q8y_A          324 KRADAGGLVN  333 (373)
T ss_dssp             TCBCHHHHHT
T ss_pred             ccCCHHHHhh
Confidence            9999999987

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.4e-44  Score=349.06  Aligned_cols=258  Identities=12%  Similarity=0.035  Sum_probs=184.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHH---HHHHcCCCccccccee----
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAE---VIFLGQLRHPHLVRLI----  160 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E---~~~l~~l~hpnIv~~~----  160 (419)
                      .+|.+.+.||+|+||.||+|.+.      .+++.||||++.....   ...+.+.+|   +.+|+. +||||++++    
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~  134 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDV------ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLL  134 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBC
T ss_pred             eeeeeeeeccCCCCEEEEEEEEC------CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEE
Confidence            45889999999999999999643      3478999999987543   234556777   455566 799988754    


Q ss_pred             ---eEEEeC-----------------CeeEEEEEecCCCChhhhhhhccCCCCCHHHH------HHHHHHHHHHHHHhhc
Q 014736          161 ---GYCCED-----------------EERLLVYEFMPRGSLENHLFKRISVSLPWGTR------LKIAIGAAKGLAFLHG  214 (419)
Q Consensus       161 ---~~~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~------~~i~~qi~~al~~lH~  214 (419)
                         +++...                 ...|+||||+. ++|.+++..... .+.+..+      ..++.||+.||.||| 
T Consensus       135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH-  211 (371)
T 3q60_A          135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQ-  211 (371)
T ss_dssp             CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             eeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHH-
Confidence               555443                 23799999997 899999976422 2344445      677899999999999 


Q ss_pred             CCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccC--CCCCchhhHHHHHHHHHH
Q 014736          215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST--GHLTTKSDVYSFGVVLLE  292 (419)
Q Consensus       215 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~e  292 (419)
                       ++||+||||||+||||+.++.+||+|||+++.....     .....||+.|+|||++.+  ..++.++|||||||++|+
T Consensus       212 -~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e  285 (371)
T 3q60_A          212 -SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR  285 (371)
T ss_dssp             -HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred             -HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence             677999999999999999999999999999865321     224457799999999987  789999999999999999


Q ss_pred             HHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HH
Q 014736          293 LLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA--TL  370 (419)
Q Consensus       293 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~--~L  370 (419)
                      |++|+.||............        .. .........+........+.++.+|+.+||+.||++|||+.++++  ++
T Consensus       286 lltg~~Pf~~~~~~~~~~~~--------~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  356 (371)
T 3q60_A          286 VWCLFLPFGLVTPGIKGSWK--------RP-SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF  356 (371)
T ss_dssp             HHHSSCSTTBCCTTCTTCCC--------BC-CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred             HHhCCCCCCCcCcccccchh--------hh-hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence            99999999876432211000        00 000000111111112345688999999999999999999999985  44


Q ss_pred             Hhh
Q 014736          371 ESL  373 (419)
Q Consensus       371 ~~l  373 (419)
                      ..+
T Consensus       357 ~~~  359 (371)
T 3q60_A          357 LQL  359 (371)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            444

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.7e-44  Score=347.32  Aligned_cols=262  Identities=22%  Similarity=0.300  Sum_probs=184.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEeC-
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCED-  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-  166 (419)
                      .++|.+.+.||+|+||.||+|..      ..+++.||||++....  ......+.+|+.+|+.++||||+++++++... 
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  101 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFD------TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR  101 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEE------TTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CCceEEeeEEeecCCeEEEEEEE------CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            36899999999999999999954      4457899999996532  23456788999999999999999999998654 


Q ss_pred             -----CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          167 -----EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       167 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                           ...|+|||++ +++|.+++..   ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|
T Consensus       102 ~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kL~D  175 (367)
T 2fst_X          102 SLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILD  175 (367)
T ss_dssp             SGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             ccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHhhEEECCCCCEEEee
Confidence                 5679999999 7899988865   46899999999999999999999  67799999999999999999999999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH---
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP---  317 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~---  317 (419)
                      ||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....   
T Consensus       176 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~  250 (367)
T 2fst_X          176 FGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  250 (367)
T ss_dssp             --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             cccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999864332     234569999999999876 6899999999999999999999999987543222211110000   


Q ss_pred             --Hhhcc--ccccccc---ccccC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          318 --YLRSS--RRLRYIV---DPRLA---GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       318 --~~~~~--~~~~~~~---~~~l~---~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        .+...  ......+   .....   .......+.++.+||.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence              00000  0000000   00000   0001123578999999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=348.45  Aligned_cols=272  Identities=22%  Similarity=0.319  Sum_probs=185.8

Q ss_pred             HHhcCCCC-CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEe-
Q 014736           88 AITQNFSS-NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE-  165 (419)
Q Consensus        88 ~~~~~y~~-~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-  165 (419)
                      .+.+.|.+ .++||+|+||.||+|...+    ...++.||||++.....  ...+.+|+.+|+.++||||+++++++.. 
T Consensus        17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~----~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~   90 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGRGTYGHVYKAKRKD----GKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSH   90 (405)
T ss_dssp             CHHHHEECSSCCCC-----EEEEEEESS----SSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred             hhhhhhhhcCcEeeecCCeEEEEEEEcc----CCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence            34455776 5589999999999997543    23567899999975432  3568899999999999999999999965 


Q ss_pred             -CCeeEEEEEecCCCChhhhhhhcc-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE----cC
Q 014736          166 -DEERLLVYEFMPRGSLENHLFKRI-------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL----DS  233 (419)
Q Consensus       166 -~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll----~~  233 (419)
                       ....|+||||+. ++|.+++....       ...+++..++.++.||+.||.|||  .+||+||||||+||||    +.
T Consensus        91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~Dlkp~NIll~~~~~~  167 (405)
T 3rgf_A           91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPE  167 (405)
T ss_dssp             TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECCSSTT
T ss_pred             CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCEeCCCcCHHHeEEecCCCC
Confidence             678999999995 68888775321       224899999999999999999999  6779999999999999    67


Q ss_pred             CCcEEEeccCccccCCCCCCc-eeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccc---
Q 014736          234 DFTAKLSDFGLAKMGPEGSNT-HVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSE---  308 (419)
Q Consensus       234 ~~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---  308 (419)
                      ++.+||+|||+++........ ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||........   
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  247 (405)
T 3rgf_A          168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN  247 (405)
T ss_dssp             TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred             CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence            789999999999875433211 12234679999999999977 4599999999999999999999999976543210   


Q ss_pred             ---hhHHHhhhHHhhcc--cccccc------------cccccCC---------CCCHHHHHHHHHHHHHcccCCCCCCCC
Q 014736          309 ---QNLVDWAKPYLRSS--RRLRYI------------VDPRLAG---------QYSVKGAKEMAVLALQCISVNPKDRPK  362 (419)
Q Consensus       309 ---~~~~~~~~~~~~~~--~~~~~~------------~~~~l~~---------~~~~~~~~~l~~li~~~l~~dP~~RPs  362 (419)
                         ...+......+...  ..+..+            +......         ......+.++.+||.+||+.||.+|||
T Consensus       248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t  327 (405)
T 3rgf_A          248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT  327 (405)
T ss_dssp             CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred             cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence               01111110000000  000000            0000000         000111467899999999999999999


Q ss_pred             HHHHHH
Q 014736          363 MAAVVA  368 (419)
Q Consensus       363 ~~eil~  368 (419)
                      +.|+++
T Consensus       328 a~e~L~  333 (405)
T 3rgf_A          328 SEQAMQ  333 (405)
T ss_dssp             HHHHHT
T ss_pred             HHHHhc
Confidence            999987

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=8.9e-44  Score=344.73  Aligned_cols=272  Identities=21%  Similarity=0.257  Sum_probs=198.0

Q ss_pred             HHHHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-----------cHHHHHHHHHHHcCC
Q 014736           83 LSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-----------GHREWLAEVIFLGQL  151 (419)
Q Consensus        83 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l  151 (419)
                      ..++..+.++|.+.+.||+|+||.||+|...       .++.||||++......           ..+.+.+|+.+++.+
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   86 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS-------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF   86 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECT-------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECC-------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC
Confidence            4567888999999999999999999999632       2688999998643221           136789999999999


Q ss_pred             CcccccceeeEEEeC-----CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 014736          152 RHPHLVRLIGYCCED-----EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKT  226 (419)
Q Consensus       152 ~hpnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp  226 (419)
                      +||||+++++++...     ...|+||||+. |+|.+++... ...+++..++.++.||+.||.|||  .+||+||||||
T Consensus        87 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp  162 (362)
T 3pg1_A           87 HHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLH--EAGVVHRDLHP  162 (362)
T ss_dssp             CCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCG
T ss_pred             CCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH--HCcCEecCCCh
Confidence            999999999998543     36899999996 6888887643 346899999999999999999999  66799999999


Q ss_pred             CcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 014736          227 SNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRP  305 (419)
Q Consensus       227 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~  305 (419)
                      +|||++.++.+||+|||++.......   ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus       163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  239 (362)
T 3pg1_A          163 GNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF  239 (362)
T ss_dssp             GGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             HHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            99999999999999999997543322   2334569999999999876 7799999999999999999999999987543


Q ss_pred             ccchhHHHhhhHH--hh-----ccccccccc-------ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          306 KSEQNLVDWAKPY--LR-----SSRRLRYIV-------DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       306 ~~~~~~~~~~~~~--~~-----~~~~~~~~~-------~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ......+......  ..     .........       ............+..+.+|+.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            2221111000000  00     000000000       000000112234577999999999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.5e-44  Score=340.90  Aligned_cols=267  Identities=21%  Similarity=0.286  Sum_probs=195.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEE-----
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCC-----  164 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----  164 (419)
                      .++|.+.+.||+|+||.||+|...      .+++.||+|++........+.+.+|+.+++.++||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   83 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDN------DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ   83 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEET------TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred             CCceeEEEEeccCCCeEEEEEEEC------CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence            468999999999999999999643      346889999998766666778999999999999999999999873     


Q ss_pred             ---------eCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc-CC
Q 014736          165 ---------EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD-SD  234 (419)
Q Consensus       165 ---------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~-~~  234 (419)
                               +....|+||||+. ++|.+++..   ..+++..++.++.||+.||.|||  ++||+||||||+|||++ .+
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~  157 (320)
T 2i6l_A           84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIH--SANVLHRDLKPANLFINTED  157 (320)
T ss_dssp             CCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETTT
T ss_pred             cccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCC
Confidence                     3467899999996 699998864   46889999999999999999999  67799999999999997 56


Q ss_pred             CcEEEeccCccccCCCCCCc-eeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHH
Q 014736          235 FTAKLSDFGLAKMGPEGSNT-HVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV  312 (419)
Q Consensus       235 ~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~  312 (419)
                      +.+||+|||++......... .......||..|+|||++.+ ..++.++||||||+++|+|++|+.||...........+
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  237 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI  237 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            79999999999865432111 11233457999999998865 77999999999999999999999999875432211111


Q ss_pred             HhhhHHhhc------ccccccccccccC------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          313 DWAKPYLRS------SRRLRYIVDPRLA------GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       313 ~~~~~~~~~------~~~~~~~~~~~l~------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ....+....      ...+.........      .......+.++.+|+.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            100000000      0000000000000      0011234678999999999999999999999987

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.5e-43  Score=336.27  Aligned_cols=252  Identities=23%  Similarity=0.352  Sum_probs=195.3

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCC--cccccceeeEEEe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLR--HPHLVRLIGYCCE  165 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~  165 (419)
                      .++|++.+.||+|+||.||+|...       .++.||+|++.....  .....+.+|+.++..++  |+||+++++++.+
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   99 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   99 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence            467999999999999999999632       267899999975432  34567889999999997  5999999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      .+..|+||| +.+++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||+++ +.+||+|||++
T Consensus       100 ~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~  173 (313)
T 3cek_A          100 DQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVD-GMLKLIDFGIA  173 (313)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred             CCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcccEEEEC-CeEEEeecccc
Confidence            999999999 5588999999765  57889999999999999999999  667999999999999965 89999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHh
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYIST-----------GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW  314 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~  314 (419)
                      ................||+.|+|||++.+           ..++.++||||||+++|+|++|+.||.......     ..
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~  248 (313)
T 3cek_A          174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SK  248 (313)
T ss_dssp             CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HH
T ss_pred             ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----HH
Confidence            87654433222334569999999999865           478899999999999999999999997543211     11


Q ss_pred             hhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          315 AKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                      .....          +......++...+.++.+|+.+||+.||.+||++.++++.
T Consensus       249 ~~~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          249 LHAII----------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HHHHH----------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHH----------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            11111          1111112222335789999999999999999999999873

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.7e-43  Score=338.60  Aligned_cols=273  Identities=25%  Similarity=0.275  Sum_probs=192.0

Q ss_pred             HHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEE
Q 014736           85 ELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCC  164 (419)
Q Consensus        85 ~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  164 (419)
                      ......++|.+.+.||+|+||.||+|...      .+++.||||++..... ....+.+|+..+..++||||+++++++.
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~   89 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEK------STGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFY   89 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEET------TTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEEC------CCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence            45566789999999999999999999643      4578899999865422 2345667888888899999999999997


Q ss_pred             eCCe-------eEEEEEecCCCChhhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-C
Q 014736          165 EDEE-------RLLVYEFMPRGSLENHLFK--RISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS-D  234 (419)
Q Consensus       165 ~~~~-------~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-~  234 (419)
                      ..+.       .++||||+.+ +|.+.+..  .....+++..+..++.|++.||.|||.+.+||+||||||+|||++. +
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~  168 (360)
T 3e3p_A           90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEAD  168 (360)
T ss_dssp             EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTT
T ss_pred             ccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCC
Confidence            6443       7899999965 55554432  2235688899999999999999999966778999999999999997 8


Q ss_pred             CcEEEeccCccccCCCCCCceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHH
Q 014736          235 FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD  313 (419)
Q Consensus       235 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  313 (419)
                      +.+||+|||++........   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  245 (360)
T 3e3p_A          169 GTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV  245 (360)
T ss_dssp             TEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHH
Confidence            9999999999987654332   2345689999999998654 48999999999999999999999998754332211111


Q ss_pred             hhh-----HH---h-hcccccccccc-----cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          314 WAK-----PY---L-RSSRRLRYIVD-----PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       314 ~~~-----~~---~-~~~~~~~~~~~-----~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ...     ..   . ...........     ...........+.++.+|+.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            000     00   0 00000000000     00011122235788999999999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.6e-43  Score=330.52  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=204.4

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEE
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCC  164 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~  164 (419)
                      ..+.++|++.+.||+|+||.||+|...      .+++.||+|++....  ......+.+|+.++++++||||+++++++.
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDR------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE   91 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEc------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence            456678999999999999999999643      356889999986542  245678899999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC---CcEEEec
Q 014736          165 EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD---FTAKLSD  241 (419)
Q Consensus       165 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~---~~~kl~D  241 (419)
                      +.+..|+||||+.+++|.+++...  ..+++..++.++.||+.||.|||  .+||+|+||||+||+++.+   +.+||+|
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dl~p~NIlv~~~~~~~~~kL~D  167 (287)
T 2wei_A           92 DSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIID  167 (287)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTTCCEEECS
T ss_pred             CCCeEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChhhEEEecCCCcccEEEec
Confidence            999999999999999999988765  46899999999999999999999  6679999999999999764   4699999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhc
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS  321 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  321 (419)
                      ||++........   .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.......   ...   .....
T Consensus       168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~---~~~~~  237 (287)
T 2wei_A          168 FGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILK---RVETG  237 (287)
T ss_dssp             TTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHC
T ss_pred             cCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHcC
Confidence            999986544322   223458999999999865 58999999999999999999999998653221   111   11000


Q ss_pred             ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          322 SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       322 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .  ..  .+...    ....+.++.+|+.+||+.||.+|||+.++++
T Consensus       238 ~--~~--~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          238 K--YA--FDLPQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             C--CC--CCSGG----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C--CC--CCchh----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            0  00  00000    1224578999999999999999999999987

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.7e-43  Score=337.52  Aligned_cols=266  Identities=25%  Similarity=0.326  Sum_probs=202.8

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCC---CcccccceeeEE
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQL---RHPHLVRLIGYC  163 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~~~~~~  163 (419)
                      +.++|++.+.||+|+||.||+|...     ...++.||+|++.....  .....+.+|+.+++.+   +||||+++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~   83 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDL-----KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVC   83 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEET-----TTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEec-----CCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeee
Confidence            4578999999999999999999652     13467899999864322  1223456677777665   899999999998


Q ss_pred             E-----eCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEE
Q 014736          164 C-----EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAK  238 (419)
Q Consensus       164 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~k  238 (419)
                      .     .....++||||+. ++|.+++.......+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~gi~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           84 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             EEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEE
T ss_pred             eecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHHHeEEcCCCCEE
Confidence            7     4567899999996 69999998766566999999999999999999999  67799999999999999999999


Q ss_pred             EeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          239 LSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       239 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      |+|||++.......   ......||..|+|||++.+..++.++||||||+++|+|++|+.||...........+.   ..
T Consensus       161 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~---~~  234 (326)
T 1blx_A          161 LADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL---DV  234 (326)
T ss_dssp             ECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HH
T ss_pred             EecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---HH
Confidence            99999998654322   2234568999999999999999999999999999999999999998654322111111   00


Q ss_pred             hhcc--cccc-------ccc---ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 LRSS--RRLR-------YIV---DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 ~~~~--~~~~-------~~~---~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ....  ....       ..+   .......+....+.++.+|+.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0000  0000       000   000011223345678999999999999999999999985

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.1e-43  Score=366.75  Aligned_cols=265  Identities=25%  Similarity=0.404  Sum_probs=210.3

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      +...++|.+.+.||+|+||.||+|.+...   ...+..||+|++..... ...+.+.+|+.++++++||||+++++++. 
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-  461 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSP---ENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-  461 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCS---SSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecC---CCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence            33457899999999999999999976542   22356899999875432 33467899999999999999999999984 


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      ++..|+||||+.+|+|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++
T Consensus       462 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          462 ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             cCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccchHhEEEeCCCCEEEEecCCC
Confidence            56789999999999999998754 346899999999999999999999  667999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      +........ ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.......   .....    .... 
T Consensus       539 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~~i----~~~~-  609 (656)
T 2j0j_A          539 RYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI----ENGE-  609 (656)
T ss_dssp             CSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH----HHTC-
T ss_pred             eecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHH----HcCC-
Confidence            876443221 2233457889999999998999999999999999999997 999998654322   11111    0111 


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                               ....+..++.++.+|+.+||+.||.+|||+.+|++.|..+...
T Consensus       610 ---------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          610 ---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                     0112334567899999999999999999999999999998753

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.3e-43  Score=347.72  Aligned_cols=262  Identities=21%  Similarity=0.286  Sum_probs=192.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCe-
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE-  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-  168 (419)
                      ..+|++.++||+|+||.||+|....+       ..||+|++......    ..+|+.+++.++||||+++++++...+. 
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~-------~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~  107 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVES-------DEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDK  107 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTT-------EEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCC-------CeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence            35799999999999999999975432       34888887543221    2359999999999999999999965443 


Q ss_pred             -----eEEEEEecCCCChhhhhh--hccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc-CCCcEEEe
Q 014736          169 -----RLLVYEFMPRGSLENHLF--KRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD-SDFTAKLS  240 (419)
Q Consensus       169 -----~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~-~~~~~kl~  240 (419)
                           .++||||+.++ |...+.  ......+++..++.++.||+.||.|||  .+||+||||||+||||+ .++.+||+
T Consensus       108 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~~kL~  184 (394)
T 4e7w_A          108 KDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH--SIGICHRDIKPQNLLLDPPSGVLKLI  184 (394)
T ss_dssp             SSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             CCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCCHHHEEEcCCCCcEEEe
Confidence                 78999999664 444332  222467899999999999999999999  66799999999999999 79999999


Q ss_pred             ccCccccCCCCCCceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh---
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK---  316 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~---  316 (419)
                      |||+++.......   .....||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.........+....   
T Consensus       185 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p  261 (394)
T 4e7w_A          185 DFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP  261 (394)
T ss_dssp             CCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             eCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999987544332   2345689999999998664 59999999999999999999999998754332211111000   


Q ss_pred             --HHh--hccc----ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          317 --PYL--RSSR----RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       317 --~~~--~~~~----~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        ..+  ....    .+.......+...+....+.++.+|+.+||+.||.+|||+.++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence              000  0000    000001111111223345678999999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.1e-43  Score=338.88  Aligned_cols=258  Identities=22%  Similarity=0.268  Sum_probs=176.7

Q ss_pred             HhcCCCCCC-eecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHH-HHHcCCCcccccceeeEEEe-
Q 014736           89 ITQNFSSNY-LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEV-IFLGQLRHPHLVRLIGYCCE-  165 (419)
Q Consensus        89 ~~~~y~~~~-~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~-  165 (419)
                      +.++|.+.+ +||+|+||.||+|...      .+++.||||++...     ....+|+ ..++.++||||+++++++.. 
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~------~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   94 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHR------RTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENM   94 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEEC------CCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhc
Confidence            356898855 6999999999999643      45789999999643     1222233 33566789999999999976 


Q ss_pred             ---CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCcEEE
Q 014736          166 ---DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKL  239 (419)
Q Consensus       166 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~---~~~~kl  239 (419)
                         ....++||||+++|+|.+++.......+++..++.++.||+.||.|||  .+||+||||||+|||++.   ++.+||
T Consensus        95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH--~~~ivH~dlkp~NIll~~~~~~~~~kl  172 (336)
T 3fhr_A           95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH--SHNIAHRDVKPENLLYTSKEKDAVLKL  172 (336)
T ss_dssp             ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSTTCCEEE
T ss_pred             cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEEecCCCceEEE
Confidence               445899999999999999998776667999999999999999999999  667999999999999986   455999


Q ss_pred             eccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHh
Q 014736          240 SDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYL  319 (419)
Q Consensus       240 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  319 (419)
                      +|||++.......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||.............   ...
T Consensus       173 ~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~  245 (336)
T 3fhr_A          173 TDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRI  245 (336)
T ss_dssp             CCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred             eccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhh
Confidence            9999998644322    234568999999999988899999999999999999999999997654322111000   000


Q ss_pred             hcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhh
Q 014736          320 RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA--TLESL  373 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~--~L~~l  373 (419)
                      .. .      ............+.++.+|+.+||+.||.+|||+.++++  ++...
T Consensus       246 ~~-~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          246 RL-G------QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             ------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             hc-c------ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            00 0      000111112245678999999999999999999999998  45443

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.4e-43  Score=331.35  Aligned_cols=254  Identities=24%  Similarity=0.366  Sum_probs=193.7

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEe---
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE---  165 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---  165 (419)
                      +.++|++.+.||+|+||.||+|..      ..+++.||+|++... ....+.+.+|+.+++.++||||+++++++.+   
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   76 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARN------ALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN   76 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEE------TTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred             ccccchhhheeccCCcEEEEEEEE------cCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence            457899999999999999999964      345788999999643 2345678899999999999999999998865   


Q ss_pred             ----------CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 014736          166 ----------DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF  235 (419)
Q Consensus       166 ----------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~  235 (419)
                                .+..|+||||+++++|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++
T Consensus        77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dlkp~Nil~~~~~  153 (303)
T 1zy4_A           77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIH--SQGIIHRDLKPMNIFIDESR  153 (303)
T ss_dssp             CCC------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTS
T ss_pred             hhhhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHH--hCCeecccCCHHhEEEcCCC
Confidence                      35689999999999999999754 245778899999999999999999  66799999999999999999


Q ss_pred             cEEEeccCccccCCCCCC------------ceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCC
Q 014736          236 TAKLSDFGLAKMGPEGSN------------THVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDK  302 (419)
Q Consensus       236 ~~kl~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~  302 (419)
                      .+||+|||++........            ........||+.|+|||++.+. .++.++||||||+++|+|++   ||..
T Consensus       154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~  230 (303)
T 1zy4_A          154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST  230 (303)
T ss_dssp             CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence            999999999986543211            1112345699999999999764 78999999999999999998   4432


Q ss_pred             CCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          303 LRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ..     ...........        ....+...+....+..+.+|+.+||+.||.+|||+.++++
T Consensus       231 ~~-----~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          231 GM-----ERVNILKKLRS--------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HH-----HHHHHHHHHHS--------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ch-----hHHHHHHhccc--------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            11     11111111100        0111223344555678999999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1e-42  Score=335.69  Aligned_cols=266  Identities=20%  Similarity=0.269  Sum_probs=203.7

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCccc------ccceeeE
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH------LVRLIGY  162 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~~~~~  162 (419)
                      +.++|++.+.||+|+||.||+|....+     .++.||+|++... ....+.+.+|+.+++.++|++      ++.++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~   90 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHAR-----GKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW   90 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCC-----CceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence            457899999999999999999965332     2368999999743 233567788999999988766      8999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE-----------
Q 014736          163 CCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL-----------  231 (419)
Q Consensus       163 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll-----------  231 (419)
                      +...+..++||||+ +++|.+++.......+++..++.++.||+.||.|||  ++||+||||||+|||+           
T Consensus        91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH--~~~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH--ENQLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred             eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEecccccccccc
Confidence            99999999999999 778888887765567999999999999999999999  6789999999999999           


Q ss_pred             --------cCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 014736          232 --------DSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKL  303 (419)
Q Consensus       232 --------~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  303 (419)
                              +.++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence                    66789999999999864332     23356999999999999999999999999999999999999999865


Q ss_pred             CCccchhHHHhhhH-----Hhhcccccccccc--------------------c-ccCCCCCHHHHHHHHHHHHHcccCCC
Q 014736          304 RPKSEQNLVDWAKP-----YLRSSRRLRYIVD--------------------P-RLAGQYSVKGAKEMAVLALQCISVNP  357 (419)
Q Consensus       304 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~--------------------~-~l~~~~~~~~~~~l~~li~~~l~~dP  357 (419)
                      ........+.....     .............                    + ..........+.++.+|+.+||+.||
T Consensus       243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  322 (355)
T 2eu9_A          243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP  322 (355)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence            43222111111000     0000000000000                    0 00001123446789999999999999


Q ss_pred             CCCCCHHHHHH
Q 014736          358 KDRPKMAAVVA  368 (419)
Q Consensus       358 ~~RPs~~eil~  368 (419)
                      .+|||+.++++
T Consensus       323 ~~Rpt~~e~l~  333 (355)
T 2eu9_A          323 AQRITLAEALL  333 (355)
T ss_dssp             TTSCCHHHHTT
T ss_pred             hhCcCHHHHhc
Confidence            99999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.5e-44  Score=344.30  Aligned_cols=265  Identities=23%  Similarity=0.296  Sum_probs=199.4

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeC-
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCED-  166 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-  166 (419)
                      +.++|.+.+.||+|+||.||+|...      .+++.||||++..... .....+.+|+.+++.++||||+++++++... 
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   82 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHK------PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDS   82 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEET------TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEEC------CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence            3468999999999999999999643      3578899999975432 3345788999999999999999999988654 


Q ss_pred             ----CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEecc
Q 014736          167 ----EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       167 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                          ...|+||||+. ++|.+++..   ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+||
T Consensus        83 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~Dlkp~Nil~~~~~~~kl~Df  156 (353)
T 2b9h_A           83 FENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLH--GSNVIHRDLKPSNLLINSNCDLKVCDF  156 (353)
T ss_dssp             STTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECCC
T ss_pred             cCccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEEcCCCcEEEEec
Confidence                67899999995 689998865   36899999999999999999999  677999999999999999999999999


Q ss_pred             CccccCCCCCCce--------eeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHH
Q 014736          243 GLAKMGPEGSNTH--------VTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD  313 (419)
Q Consensus       243 Gla~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  313 (419)
                      |++..........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+ 
T Consensus       157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-  235 (353)
T 2b9h_A          157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI-  235 (353)
T ss_dssp             TTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-
T ss_pred             ccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH-
Confidence            9998754322111        1223578999999998754 77999999999999999999999999865432211111 


Q ss_pred             hhhHHhhccc---ccc--------cccc------cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          314 WAKPYLRSSR---RLR--------YIVD------PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       314 ~~~~~~~~~~---~~~--------~~~~------~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        ........   ...        ....      ...........+.++.+|+.+||+.||++|||+.++++
T Consensus       236 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          236 --FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             --HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence              00000000   000        0000      00000011234678999999999999999999999976

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.5e-43  Score=341.13  Aligned_cols=261  Identities=21%  Similarity=0.285  Sum_probs=196.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .++|.+.+.||+|+||.||+|..      ..+++.||||++.....  .....+.+|+.+++.++||||+++++++...+
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  114 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAID------KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS  114 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEE------TTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             cccEEEEeEEecCCCeEEEEEEE------CCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence            46899999999999999999964      44578999999975432  23467889999999999999999999998776


Q ss_pred             ee------EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          168 ER------LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       168 ~~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                      ..      |+||||+. ++|.+++.    ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|
T Consensus       115 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~kL~D  187 (371)
T 4exu_A          115 SLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIH--SAGVVHRDLKPGNLAVNEDCELKILD  187 (371)
T ss_dssp             SSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECS
T ss_pred             CcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCcCHHHeEECCCCCEEEEe
Confidence            55      99999995 68887763    34899999999999999999999  66799999999999999999999999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH---
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP---  317 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~---  317 (419)
                      ||++......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.....   
T Consensus       188 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  262 (371)
T 4exu_A          188 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  262 (371)
T ss_dssp             TTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence            9999864332     234568999999999877 7899999999999999999999999986543221111100000   


Q ss_pred             --Hhhcc--c---ccccccccccCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          318 --YLRSS--R---RLRYIVDPRLAG---QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       318 --~~~~~--~---~~~~~~~~~l~~---~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        .....  .   ............   ......+.++.+||.+||+.||++|||+.++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence              00000  0   000000000000   011234678999999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5.3e-43  Score=334.54  Aligned_cols=254  Identities=26%  Similarity=0.346  Sum_probs=179.5

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHH-HHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVI-FLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|++.+.||+|+||.||+|...      .+++.||||++..... .....+..|+. +++.++||||+++++++.+.+.
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~   95 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHK------PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD   95 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEET------TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred             HHhhehheeccCCCEEEEEEEEc------CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence            67899999999999999999643      3578899999976532 23345566666 7788899999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeecCCCCCcEEEcCCCcEEEeccCc
Q 014736          169 RLLVYEFMPRGSLENHLFK---RISVSLPWGTRLKIAIGAAKGLAFLHGAEN-PVIYRDFKTSNILLDSDFTAKLSDFGL  244 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~i~~qi~~al~~lH~~~~-~ivH~Dlkp~NIll~~~~~~kl~DfGl  244 (419)
                      .++||||+.+ +|.+++..   .....+++..+..++.|++.||.|||  .+ ||+||||||+|||++.++.+||+|||+
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~  172 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGI  172 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH--HHHSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred             eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh--ccCCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence            9999999964 88777653   22467899999999999999999999  56 799999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccccccccccccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhh
Q 014736          245 AKMGPEGSNTHVTTRVMGTYGYAAPEYI----STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR  320 (419)
Q Consensus       245 a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  320 (419)
                      +........   .....||+.|+|||++    .+..++.++||||||+++|+|++|+.||........     ...    
T Consensus       173 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~----  240 (327)
T 3aln_A          173 SGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLT----  240 (327)
T ss_dssp             SCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------C----
T ss_pred             ceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHH----
Confidence            986543321   2234699999999998    466789999999999999999999999976432110     000    


Q ss_pred             cccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       321 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                         .......+.+........+.++.+|+.+||+.||.+|||+.+|++
T Consensus       241 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          241 ---QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             ---CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence               000000111112222345678999999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=334.94  Aligned_cols=245  Identities=25%  Similarity=0.402  Sum_probs=191.4

Q ss_pred             HHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc------cHHHHHHHHHHHcCC----Cccc
Q 014736           86 LRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ------GHREWLAEVIFLGQL----RHPH  155 (419)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~hpn  155 (419)
                      .+.+.++|++.+.||+|+||.||+|..      ..+++.||+|++......      ....+.+|+.++.++    +|||
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~   99 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHR------LTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG   99 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEEC------TTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSS
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEE------ccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCC
Confidence            456678999999999999999999953      345789999999754332      122355688888887    8999


Q ss_pred             ccceeeEEEeCCeeEEEEEe-cCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc-C
Q 014736          156 LVRLIGYCCEDEERLLVYEF-MPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD-S  233 (419)
Q Consensus       156 Iv~~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~-~  233 (419)
                      |+++++++...+..++|||+ +.+++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++ .
T Consensus       100 i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~  175 (312)
T 2iwi_A          100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCH--SRGVVHRDIKDENILIDLR  175 (312)
T ss_dssp             BCCEEEEC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HHTEECCCCSGGGEEEETT
T ss_pred             eeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChhhEEEeCC
Confidence            99999999999999999999 7899999999775  56899999999999999999999  66799999999999999 8


Q ss_pred             CCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCccchhHH
Q 014736          234 DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT-TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV  312 (419)
Q Consensus       234 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~  312 (419)
                      ++.+||+|||++.......    .....||..|+|||++.+..+. .++||||||+++|+|++|+.||....     ...
T Consensus       176 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~  246 (312)
T 2iwi_A          176 RGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EIL  246 (312)
T ss_dssp             TTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH
T ss_pred             CCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HHh
Confidence            8999999999998765432    2345699999999998776664 58999999999999999999996421     000


Q ss_pred             HhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          313 DWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                             ...            ..++...+.++.+|+.+||+.||++|||+.++++
T Consensus       247 -------~~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          247 -------EAE------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             -------HTC------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------hhc------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   000            0122334578999999999999999999999976

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=335.25  Aligned_cols=260  Identities=21%  Similarity=0.293  Sum_probs=196.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .++|.+.+.||+|+||.||+|..      ..+++.||||++.....  .....+.+|+.+++.++||||+++++++...+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   96 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAID------KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS   96 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEE------TTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CceEEEeeeEecCCCeEEEEEEE------CCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence            46799999999999999999964      34578999999975432  23467889999999999999999999998765


Q ss_pred             e------eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          168 E------RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       168 ~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                      .      .|+||||+. ++|.+++.    ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|
T Consensus        97 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp~NIl~~~~~~~kl~D  169 (353)
T 3coi_A           97 SLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIH--SAGVVHRDLKPGNLAVNEDCELKILD  169 (353)
T ss_dssp             SGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECTTCCEEECS
T ss_pred             ccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEeECCCCcEEEee
Confidence            4      499999996 68887764    34899999999999999999999  67799999999999999999999999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH---
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP---  317 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~---  317 (419)
                      ||++......     .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+.....   
T Consensus       170 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  244 (353)
T 3coi_A          170 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  244 (353)
T ss_dssp             TTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred             cccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999864322     233568999999999876 6789999999999999999999999986543221111100000   


Q ss_pred             --Hhhcc---------cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          318 --YLRSS---------RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       318 --~~~~~---------~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        +....         ..+.......+ .......+.++.+|+.+||+.||.+|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              00000         00000000001 1122345788999999999999999999999976

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.4e-43  Score=337.73  Aligned_cols=246  Identities=23%  Similarity=0.370  Sum_probs=199.7

Q ss_pred             HHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc------cHHHHHHHHHHHcCCC--cccc
Q 014736           85 ELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ------GHREWLAEVIFLGQLR--HPHL  156 (419)
Q Consensus        85 ~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpnI  156 (419)
                      +.+.+.++|.+.+.||+|+||.||+|...      .+++.||||++......      ....+.+|+.+++.++  |+||
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i  110 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRV------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV  110 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEET------TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEEC------CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence            34556678999999999999999999643      44688999999754321      1244667999999986  5999


Q ss_pred             cceeeEEEeCCeeEEEEEecCC-CChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc-CC
Q 014736          157 VRLIGYCCEDEERLLVYEFMPR-GSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD-SD  234 (419)
Q Consensus       157 v~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~-~~  234 (419)
                      +++++++...+..++|||++.+ ++|.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++ .+
T Consensus       111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~  186 (320)
T 3a99_A          111 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNR  186 (320)
T ss_dssp             CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTT
T ss_pred             eEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcEeCCCCHHHEEEeCCC
Confidence            9999999999999999999976 8999999775  57899999999999999999999  67799999999999999 78


Q ss_pred             CcEEEeccCccccCCCCCCceeeecccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHH
Q 014736          235 FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL-TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD  313 (419)
Q Consensus       235 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  313 (419)
                      +.+||+|||++.......    .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....     ... 
T Consensus       187 ~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~-  256 (320)
T 3a99_A          187 GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII-  256 (320)
T ss_dssp             TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH-
T ss_pred             CCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hhh-
Confidence            899999999998754432    234569999999999977665 688999999999999999999996421     000 


Q ss_pred             hhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                            ...        .    .+....+.++.+|+.+||+.||++|||+.+|++
T Consensus       257 ------~~~--------~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          257 ------RGQ--------V----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ------HCC--------C----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------ccc--------c----cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  000        0    112234578999999999999999999999976

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.1e-41  Score=319.56  Aligned_cols=234  Identities=14%  Similarity=0.116  Sum_probs=185.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc---cHHHHHHHHHHHcCCCcccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ---GHREWLAEVIFLGQLRHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  166 (419)
                      .++|++.+.||+|+||.||+|..      ..+++.||||++......   ..+.+.+|+.++.+++||||+++++++.+.
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~  103 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALD------TALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR  103 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEE------TTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             cCcEEEEEEEcccCCeEEEEEEe------cCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC
Confidence            46799999999999999999964      344688999999765332   246788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..|+||||++|++|.+++...    .....+..++.||+.||.|||  ++||+||||||+|||++.++.+||+++|   
T Consensus       104 ~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH--~~givH~Dikp~NIll~~~g~~kl~~~~---  174 (286)
T 3uqc_A          104 AGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH--RAGVALSIDHPSRVRVSIDGDVVLAYPA---  174 (286)
T ss_dssp             TEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEEETTSCEEECSCC---
T ss_pred             CcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHH--HCCCccCCCCcccEEEcCCCCEEEEecc---
Confidence            9999999999999999998542    355578899999999999999  6779999999999999999999998543   


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                                         |++       .++.++|||||||++|+|++|+.||............         .....
T Consensus       175 -------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---------~~~~~  219 (286)
T 3uqc_A          175 -------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---------ERDTA  219 (286)
T ss_dssp             -------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---------CBCTT
T ss_pred             -------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---------HHHhc
Confidence                               333       3789999999999999999999999875433211000         00000


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                      .  ...........+++++.+|+.+||+.||.+| |+.++++.|..+...
T Consensus       220 ~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          220 G--QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             S--CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             c--CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            0  0000001123356789999999999999999 999999999998764

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=7.2e-42  Score=324.96  Aligned_cols=251  Identities=25%  Similarity=0.377  Sum_probs=179.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-cH-HHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GH-REWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|++.+.||+|+||.||+|...      .+++.||||++...... .. +.+.++..+++.++||||+++++++.+.+.
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~   98 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFR------KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD   98 (318)
T ss_dssp             GGEEEEEEC------CEEEEEET------TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ccccccceeeecCCeeEEEEEEe------cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence            57889999999999999999653      34688999999765332 22 334445557888899999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN-PVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~-~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      .|+||||+ ++.+..+. ......+++..++.++.||+.||.|||  .+ ||+|+||||+|||++.++.+||+|||++..
T Consensus        99 ~~lv~e~~-~~~~~~l~-~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  174 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLK-KRMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISGR  174 (318)
T ss_dssp             EEEEECCC-SEEHHHHH-HHHTSCCCHHHHHHHHHHHHHHHHHHH--HHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             EEEEEecc-CCcHHHHH-HHhccCCCHHHHHHHHHHHHHHHHHHH--hhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence            99999999 55554444 333467899999999999999999999  53 799999999999999999999999999976


Q ss_pred             CCCCCCceeeeccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYIS-----TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      ......   .....||+.|+|||++.     ...++.++||||||+++|+|++|+.||.......  ...   .......
T Consensus       175 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~---~~~~~~~  246 (318)
T 2dyl_A          175 LVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EVL---TKVLQEE  246 (318)
T ss_dssp             ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHH---HHHHHSC
T ss_pred             ccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HHH---HHHhccC
Confidence            543321   23356999999999984     5678999999999999999999999997643211  111   1111110


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .       +.+.  .....+.++.+|+.+||+.||.+||++.+|++
T Consensus       247 ~-------~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          247 P-------PLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             C-------CCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             C-------CCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            0       0010  01124578999999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.1e-42  Score=342.02  Aligned_cols=252  Identities=26%  Similarity=0.324  Sum_probs=186.8

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-CcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  169 (419)
                      +.|.+.++||+|+||+||.+.       ..+++.||||++...   ..+.+.+|+.+|.++ +||||+++++++.+.+..
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~-------~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   84 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQG-------SFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFL   84 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEE-------ESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             heeeccCeEeeCCCeEEEEEE-------EECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence            456667889999999998652       234789999998643   235677899999876 899999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCC-----CHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC----------
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSL-----PWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD----------  234 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~-----~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~----------  234 (419)
                      |+||||+. |+|.+++........     ++..++.++.||+.||.|||  ++||+||||||+|||++.+          
T Consensus        85 ~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~~~~~~~~~  161 (434)
T 2rio_A           85 YIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTG  161 (434)
T ss_dssp             EEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred             EEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEecCcccccccccC
Confidence            99999995 699999976532211     22345789999999999999  5679999999999999754          


Q ss_pred             ---CcEEEeccCccccCCCCCCce--eeecccccccccccccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 014736          235 ---FTAKLSDFGLAKMGPEGSNTH--VTTRVMGTYGYAAPEYIST-------GHLTTKSDVYSFGVVLLELLT-GRRSMD  301 (419)
Q Consensus       235 ---~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ellt-g~~pf~  301 (419)
                         +.+||+|||++..........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |..||.
T Consensus       162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  241 (434)
T 2rio_A          162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG  241 (434)
T ss_dssp             CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence               479999999998765433211  1234579999999999965       678999999999999999999 999997


Q ss_pred             CCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          302 KLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ...... ....       ......     +.+........+.++.+|+.+||+.||.+|||+.+|++
T Consensus       242 ~~~~~~-~~i~-------~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          242 DKYSRE-SNII-------RGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             STTTHH-HHHH-------HTCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CchhhH-HHHh-------cCCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            543221 1111       010000     11112234567889999999999999999999999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.6e-42  Score=351.98  Aligned_cols=273  Identities=25%  Similarity=0.330  Sum_probs=207.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC-CcccHHHHHHHHHHHcCCCcccccceeeEEEe---
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE---  165 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---  165 (419)
                      ..+|++.++||+|+||.||+|.      +..+++.||||++... .......+.+|+.+++.++||||+++++++..   
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~------~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~   86 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWI------HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK   86 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCC------CTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEE------ECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence            3689999999999999999984      4456788999998754 23345678899999999999999999998755   


Q ss_pred             ---CCeeEEEEEecCCCChhhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc---EE
Q 014736          166 ---DEERLLVYEFMPRGSLENHLFKRI-SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT---AK  238 (419)
Q Consensus       166 ---~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~---~k  238 (419)
                         .+..|+||||++|++|.+++.... ...+++..++.++.||+.||.|||  .+||+||||||+|||++.++.   +|
T Consensus        87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH--s~gIVHrDLKP~NILl~~~g~~~~vK  164 (676)
T 3qa8_A           87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHK  164 (676)
T ss_dssp             CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH--HTTBCCCCCCSTTEEEECCSSSCEEE
T ss_pred             ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHeEeecCCCceeEE
Confidence               667899999999999999997643 235888899999999999999999  677999999999999997765   99


Q ss_pred             EeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          239 LSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       239 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      |+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||......     ..|....
T Consensus       165 L~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i  236 (676)
T 3qa8_A          165 IIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKV  236 (676)
T ss_dssp             ECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTC
T ss_pred             Ecccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhh
Confidence            999999987654332   23457999999999999999999999999999999999999999753211     1111000


Q ss_pred             hh-----------cccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH-----HHHHHHhhhcCcc
Q 014736          319 LR-----------SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAA-----VVATLESLLNLKD  378 (419)
Q Consensus       319 ~~-----------~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~e-----il~~L~~l~~~~~  378 (419)
                      ..           ..+.............+....+.++.+|+.+||..||.+|||+.+     +.+.+..++....
T Consensus       237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ki  312 (676)
T 3qa8_A          237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKL  312 (676)
T ss_dssp             C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCCE
T ss_pred             hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhccc
Confidence            00           000000000111123455668899999999999999999999988     5677777777553

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=336.24  Aligned_cols=249  Identities=24%  Similarity=0.314  Sum_probs=184.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-CcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~  169 (419)
                      .+|.+.++||+|+||+||...       ..+++.||||++......   .+.+|+.+|+.+ +|||||++++++.+....
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~-------~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~   93 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRG-------MFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQ   93 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEE-------ESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred             EEEecCCeeecCcCEEEEEEE-------EeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence            468888999999999966431       234688999999754433   245699999998 799999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-----CCcEEEeccCc
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS-----DFTAKLSDFGL  244 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGl  244 (419)
                      |+||||+. |+|.+++.... .......++.++.||+.||.|||  .+||+||||||+|||++.     ...+||+|||+
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLH--SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHH--HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             EEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHH--HCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            99999995 69999987653 23444567899999999999999  567999999999999953     33588999999


Q ss_pred             cccCCCCCCc-eeeeccccccccccccccc---CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHh
Q 014736          245 AKMGPEGSNT-HVTTRVMGTYGYAAPEYIS---TGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYL  319 (419)
Q Consensus       245 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  319 (419)
                      ++........ .......||+.|+|||++.   ...++.++|||||||++|||++ |..||.......    ...    .
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~~~----~  241 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANI----L  241 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----HHH----H
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----HHH----H
Confidence            9876543221 1234467999999999997   4567889999999999999999 999996432211    100    0


Q ss_pred             hcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          320 RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .......       ........+..+.+|+.+||+.||.+|||+.+|++
T Consensus       242 ~~~~~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          242 LGACSLD-------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TTCCCCT-------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccCCcc-------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            0000000       00112345667899999999999999999999984

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-42  Score=340.57  Aligned_cols=241  Identities=15%  Similarity=0.150  Sum_probs=180.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCc-ccccc--------
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRH-PHLVR--------  158 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-pnIv~--------  158 (419)
                      .+|...++||+|+||.||+|.+.      .+++.||||++.....   ...+.+.+|+.+++.++| .|+..        
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~  151 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQ------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  151 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEET------TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred             eeEEEecccccCCCEEEEEEEec------CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence            35777889999999999999643      4578999999974432   235778899999999976 22111        


Q ss_pred             -ee------------eEEEe-----CCeeEEEEEecCCCChhhhhhh-----ccCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 014736          159 -LI------------GYCCE-----DEERLLVYEFMPRGSLENHLFK-----RISVSLPWGTRLKIAIGAAKGLAFLHGA  215 (419)
Q Consensus       159 -~~------------~~~~~-----~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~i~~qi~~al~~lH~~  215 (419)
                       .+            .++..     ....+++|+++ +++|.+++..     .....+++..++.++.||+.||.|||  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--  228 (413)
T 3dzo_A          152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH--  228 (413)
T ss_dssp             CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH--
T ss_pred             cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence             11            11111     12456777776 7899988842     22344677888999999999999999  


Q ss_pred             CCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccc----------cCCCCCchhhHHH
Q 014736          216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI----------STGHLTTKSDVYS  285 (419)
Q Consensus       216 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Diws  285 (419)
                      ++||+||||||+||||+.++.+||+|||+++.....     ....+| +.|+|||++          .+..++.++||||
T Consensus       229 ~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS  302 (413)
T 3dzo_A          229 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT  302 (413)
T ss_dssp             HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred             hCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence            677999999999999999999999999998864322     344568 999999999          5667889999999


Q ss_pred             HHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 014736          286 FGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAA  365 (419)
Q Consensus       286 lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~e  365 (419)
                      |||++|+|++|+.||..........                .++..      ....++++.+|+.+||+.||++||++.+
T Consensus       303 lGvil~elltg~~Pf~~~~~~~~~~----------------~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~  360 (413)
T 3dzo_A          303 LGLAIYWIWCADLPNTDDAALGGSE----------------WIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQ  360 (413)
T ss_dssp             HHHHHHHHHHSSCCCCTTGGGSCSG----------------GGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHCCCCCCCcchhhhHH----------------HHHhh------cccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            9999999999999997643221111                01110      0123578999999999999999999888


Q ss_pred             HHH
Q 014736          366 VVA  368 (419)
Q Consensus       366 il~  368 (419)
                      +++
T Consensus       361 ~l~  363 (413)
T 3dzo_A          361 AME  363 (413)
T ss_dssp             HTT
T ss_pred             HHh
Confidence            764

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.8e-40  Score=311.83  Aligned_cols=228  Identities=21%  Similarity=0.287  Sum_probs=180.3

Q ss_pred             hcCCCCC-CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHH-cCCCcccccceeeEEEe--
Q 014736           90 TQNFSSN-YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFL-GQLRHPHLVRLIGYCCE--  165 (419)
Q Consensus        90 ~~~y~~~-~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~--  165 (419)
                      .++|.+. ++||+|+||.||+|..      ..+++.||+|++..     ...+.+|+.++ +.++||||+++++++..  
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~------~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~   84 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFN------KRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLY   84 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEE------TTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEE------cCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence            3567776 7899999999999964      34578999999963     24567788887 55689999999999987  


Q ss_pred             --CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCcEEEe
Q 014736          166 --DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLS  240 (419)
Q Consensus       166 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~---~~~~kl~  240 (419)
                        ....++||||+++++|.+++.......+++..++.++.||+.||.|||  .+||+||||||+|||++.   ++.+||+
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence              678899999999999999998876667999999999999999999999  677999999999999998   7889999


Q ss_pred             ccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhh
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR  320 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  320 (419)
                      |||++....                        +..++.++|||||||++|+|++|..||............        
T Consensus       163 Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~--------  210 (299)
T 3m2w_A          163 DFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------  210 (299)
T ss_dssp             CCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS--------
T ss_pred             ccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH--------
Confidence            999986422                        245788999999999999999999999764322110000        


Q ss_pred             cccccccccccccCCCCC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          321 SSRRLRYIVDPRLAGQYS----VKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       321 ~~~~~~~~~~~~l~~~~~----~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       ...   ....  ...++    ...+.++.+|+.+||+.||.+|||+.++++
T Consensus       211 -~~~---~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          211 -KTR---IRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             -CCS---SCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHH---Hhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             000   0000  00111    234678999999999999999999999987

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.5e-41  Score=350.53  Aligned_cols=243  Identities=23%  Similarity=0.346  Sum_probs=194.4

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      +.++|++.++||+|+||.||+|.+..     .+++.||||++..... .....+.+|+.++.+++||||+++++++...+
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  152 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRN-----VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD  152 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGG-----GTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcC-----CCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence            34789999999999999999996532     2467899999865432 33457889999999999999999999998766


Q ss_pred             e-----eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEecc
Q 014736          168 E-----RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       168 ~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                      .     .||||||++|++|.+++..    .+++..++.++.||+.||.|||  ++||+||||||+|||++.+ .+||+||
T Consensus       153 ~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH--~~giiHrDlkp~NIll~~~-~~kl~DF  225 (681)
T 2pzi_A          153 RHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH--SIGLVYNDLKPENIMLTEE-QLKLIDL  225 (681)
T ss_dssp             TTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECSS-CEEECCC
T ss_pred             CCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH--HCCCeecccChHHeEEeCC-cEEEEec
Confidence            5     7999999999999887643    6899999999999999999999  6779999999999999986 8999999


Q ss_pred             CccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       243 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      |+++.....      ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.........             
T Consensus       226 G~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~-------------  285 (681)
T 2pzi_A          226 GAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP-------------  285 (681)
T ss_dssp             TTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-------------
T ss_pred             ccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc-------------
Confidence            999875433      335699999999998665 489999999999999999999888642211000             


Q ss_pred             cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhh
Q 014736          323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP-KMAAVVATLESLL  374 (419)
Q Consensus       323 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-s~~eil~~L~~l~  374 (419)
                                 ........+..+.+||.+||+.||.+|| +++++...|..++
T Consensus       286 -----------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          286 -----------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -----------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -----------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                       0001112346799999999999999999 5666767777654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.9e-40  Score=315.32  Aligned_cols=242  Identities=16%  Similarity=0.186  Sum_probs=180.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--------ccHHHHHHHHHHHcCCC---------
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--------QGHREWLAEVIFLGQLR---------  152 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------  152 (419)
                      .++|.+.+.||+|+||.||+|+.        +++.||||++.....        ...+.+.+|+.+|+.++         
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~   90 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNR   90 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSB
T ss_pred             cccchheeeecccCceEEEEEEe--------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhcccccc
Confidence            35788999999999999999964        357899999975532        23477888999888875         


Q ss_pred             cccccceeeE-----------------EEe-------------CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHH
Q 014736          153 HPHLVRLIGY-----------------CCE-------------DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIA  202 (419)
Q Consensus       153 hpnIv~~~~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~  202 (419)
                      ||||++++++                 |.+             .+..||||||+.+|++.+.+.+   ..+++..++.++
T Consensus        91 h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~  167 (336)
T 2vuw_A           91 TEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSIL  167 (336)
T ss_dssp             CCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHH
T ss_pred             CCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHH
Confidence            6666555554                 332             6789999999999987777643   468999999999


Q ss_pred             HHHHHHHHHhh-cCCCCeeecCCCCCcEEEcCCC--------------------cEEEeccCccccCCCCCCceeeeccc
Q 014736          203 IGAAKGLAFLH-GAENPVIYRDFKTSNILLDSDF--------------------TAKLSDFGLAKMGPEGSNTHVTTRVM  261 (419)
Q Consensus       203 ~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~  261 (419)
                      .||+.||.||| +.  ||+||||||+||||+.++                    .+||+|||+++.....       ..+
T Consensus       168 ~qi~~aL~~lH~~~--~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~  238 (336)
T 2vuw_A          168 HQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVV  238 (336)
T ss_dssp             HHHHHHHHHHHHHH--CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEE
T ss_pred             HHHHHHHHHHHHhC--CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEE
Confidence            99999999999 54  599999999999999887                    8999999999865432       236


Q ss_pred             ccccccccccccCCCCCchhhHHHHHHH-HHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccccccCCCCCHH
Q 014736          262 GTYGYAAPEYISTGHLTTKSDVYSFGVV-LLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVK  340 (419)
Q Consensus       262 gt~~y~aPE~~~~~~~~~~~DiwslG~i-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  340 (419)
                      ||+.|+|||++.+.. +.++||||||++ .+++++|..||....      ..............    ............
T Consensus       239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~------~~~~~~~~~~~~~~----~~~~~~~~~~~~  307 (336)
T 2vuw_A          239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL------WLHYLTDKMLKQMT----FKTKCNTPAMKQ  307 (336)
T ss_dssp             CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH------HHHHHHHHHHHTCC----CSSCCCSHHHHH
T ss_pred             EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh------hhhHHHHhhhhhhc----cCcccchhhhhh
Confidence            999999999997666 999999998777 778888988884210      00000000000000    001111122346


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHH
Q 014736          341 GAKEMAVLALQCISVNPKDRPKMAAVV  367 (419)
Q Consensus       341 ~~~~l~~li~~~l~~dP~~RPs~~eil  367 (419)
                      .++++.+||.+||+.|     |+.+++
T Consensus       308 ~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          308 IKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             cCHHHHHHHHHHhccC-----CHHHHH
Confidence            7889999999999977     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2.1e-34  Score=294.03  Aligned_cols=185  Identities=18%  Similarity=0.126  Sum_probs=129.9

Q ss_pred             ecccCceEEEEEEEcCcccccccccEEEEEEeccCCc----------ccHHHHHHHHHHHcCC-CcccccceeeEEEeCC
Q 014736           99 LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL----------QGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDE  167 (419)
Q Consensus        99 lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  167 (419)
                      ++.|++|.+..+      +....|+.|++|++.....          ...++|.+|+++|+++ .|+||+++++++++++
T Consensus       242 ~~~~~~~~h~~~------rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~  315 (569)
T 4azs_A          242 PYAGAGLAHKRS------RRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ  315 (569)
T ss_dssp             -C--------CC------EEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS
T ss_pred             cccCCccccccc------ccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC
Confidence            455666655543      3445678899999975421          2235689999999999 6999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..||||||++|++|.++|.+.  ..++..   .|+.||+.||+|||  ++|||||||||+||||+.+|.+||+|||+|+.
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH--~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~  388 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALE--KQGFWHDDVRPWNVMVDARQHARLIDFGSIVT  388 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHH--HTTCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred             EEEEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHH--HCCceeccCchHhEEECCCCCEEEeecccCee
Confidence            999999999999999999766  455543   58999999999999  67899999999999999999999999999987


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRS  299 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p  299 (419)
                      ......  .....+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus       389 ~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          389 TPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            544322  2345679999999999964 577889999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=6.4e-30  Score=259.47  Aligned_cols=185  Identities=17%  Similarity=0.202  Sum_probs=143.7

Q ss_pred             CCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc--------cHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           94 SSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ--------GHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        94 ~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      ...++||+|+||.||+|...        ++.+++|+.......        ..+.+.+|+++|++++||||+++..++..
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~--------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  410 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL--------DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD  410 (540)
T ss_dssp             ---------CCEEEEEEECS--------SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEEC--------CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe
Confidence            44668999999999999432        467899886543211        13457899999999999999976666667


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      .+..||||||++|++|.+++..          +..++.|++.||.|||  ++||+||||||+|||++.  .+||+|||++
T Consensus       411 ~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH--~~gIiHrDiKp~NILl~~--~~kL~DFGla  476 (540)
T 3en9_A          411 LDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLH--KNDVIHNDLTTSNFIFDK--DLYIIDFGLG  476 (540)
T ss_dssp             TTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH--HTTEECTTCCTTSEEESS--SEEECCCTTC
T ss_pred             CCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH--HCcCccCCCCHHHEEECC--eEEEEECccC
Confidence            8888999999999999999865          5689999999999999  677999999999999999  9999999999


Q ss_pred             ccCCCCCCce-----eeecccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCC
Q 014736          246 KMGPEGSNTH-----VTTRVMGTYGYAAPEYIST--GHLTTKSDVYSFGVVLLELLTGRRSM  300 (419)
Q Consensus       246 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf  300 (419)
                      +.........     .....+||+.|||||++..  ..|+..+|+|+..+-..+.+.++.+|
T Consensus       477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            9765432111     1234679999999999976  67888999999999988888776655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=4.1e-26  Score=212.82  Aligned_cols=146  Identities=16%  Similarity=0.081  Sum_probs=116.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc------------------ccHHHHHHHHHHHcCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL------------------QGHREWLAEVIFLGQL  151 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l  151 (419)
                      ...|.+.+.||+|+||.||+|.+       .+++.||+|++.....                  .....+.+|+.+|+.+
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~-------~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYS-------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEE-------TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             CeEEEecCEeccCCCceEEEEEe-------CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            34566779999999999999964       2467899999964321                  1245688999999999


Q ss_pred             CcccccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 014736          152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL  231 (419)
Q Consensus       152 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll  231 (419)
                      +  | +++.+++.. +..|+||||++|++|.+ +..        .....++.||+.||.|||  .+||+||||||+|||+
T Consensus       162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH--~~giiHrDlkp~NILl  226 (282)
T 1zar_A          162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFY--HRGIVHGDLSQYNVLV  226 (282)
T ss_dssp             T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEEE
T ss_pred             c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHH--HCCCEeCCCCHHHEEE
Confidence            8  5 777776544 56799999999999988 421        234579999999999999  6779999999999999


Q ss_pred             cCCCcEEEeccCccccCCCCCCceeeeccccccccccccccc
Q 014736          232 DSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIS  273 (419)
Q Consensus       232 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~  273 (419)
                      + ++.+||+|||+++.               +..|+|||++.
T Consensus       227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             E-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             E-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence            9 99999999999873               34478899874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=4e-21  Score=176.78  Aligned_cols=137  Identities=18%  Similarity=0.084  Sum_probs=103.5

Q ss_pred             CCCCCeecccCceEEEEEEEcCcccccccccE--EEEEEeccCCcc------------------------cHHHHHHHHH
Q 014736           93 FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQA--VAVKLLDIEGLQ------------------------GHREWLAEVI  146 (419)
Q Consensus        93 y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~  146 (419)
                      |.+.+.||+|+||.||+|...      .+++.  ||||++......                        ....+.+|+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~------~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  122 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGV------FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR  122 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEE------ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEc------CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHH
Confidence            567889999999999999652      23577  999997543111                        0135788999


Q ss_pred             HHcCCCcccc--cceeeEEEeCCeeEEEEEecCC-C----ChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhh-cCCCC
Q 014736          147 FLGQLRHPHL--VRLIGYCCEDEERLLVYEFMPR-G----SLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH-GAENP  218 (419)
Q Consensus       147 ~l~~l~hpnI--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~~~  218 (419)
                      +|..+.|++|  +.++++    +..+|||||+.+ |    +|.++...     .++..+..++.|++.||.||| +.  |
T Consensus       123 ~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~--g  191 (258)
T 1zth_A          123 NLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA--E  191 (258)
T ss_dssp             HHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS--C
T ss_pred             HHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC--C
Confidence            9999988865  334432    357899999942 3    66665432     223467889999999999999 64  5


Q ss_pred             eeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       219 ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      |+||||||+|||++.  .++|+|||+|...
T Consensus       192 ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          192 LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999999998  9999999999753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=2.3e-19  Score=172.14  Aligned_cols=143  Identities=13%  Similarity=0.114  Sum_probs=100.0

Q ss_pred             HHHHhcC---CCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--------------ccHHH--------
Q 014736           86 LRAITQN---FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--------------QGHRE--------  140 (419)
Q Consensus        86 ~~~~~~~---y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------  140 (419)
                      +..+.++   |.+...||+|+||.||+|...       .|+.||||+++....              .....        
T Consensus        87 L~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~-------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~  159 (397)
T 4gyi_A           87 LHTHAARKDVYSVGSRIGVGKESDIMIVADE-------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLA  159 (397)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEECT-------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHH
T ss_pred             HHHHHHCCCEEEecCEeeeCCceEEEEEECC-------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHH
Confidence            3444454   889999999999999999632       378899999753210              00111        


Q ss_pred             HHHHHHHHcCCCcccccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCee
Q 014736          141 WLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVI  220 (419)
Q Consensus       141 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~iv  220 (419)
                      ..+|...|.++.+.++.-.. .+.. ...+|||||++|++|..+..      .  .....++.||+.+|.|||  ..|||
T Consensus       160 A~kE~~nL~rL~~~gv~vp~-p~~~-~~~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH--~~gIV  227 (397)
T 4gyi_A          160 AIKEFAFMKALYEEGFPVPE-PIAQ-SRHTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLA--KHGLI  227 (397)
T ss_dssp             HHHHHHHHHHHHHTTCSCCC-EEEE-ETTEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHHHHhcCCCCCe-eeec-cCceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHH--HCCCc
Confidence            12456666666544432221 1211 23479999999988866532      1  134678899999999999  67799


Q ss_pred             ecCCCCCcEEEcCCC----------cEEEeccCcccc
Q 014736          221 YRDFKTSNILLDSDF----------TAKLSDFGLAKM  247 (419)
Q Consensus       221 H~Dlkp~NIll~~~~----------~~kl~DfGla~~  247 (419)
                      ||||||.|||+++++          .+.|+||+-+..
T Consensus       228 HrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          228 HGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            999999999998876          389999998764

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.45  E-value=2.2e-13  Score=125.00  Aligned_cols=145  Identities=12%  Similarity=0.007  Sum_probs=112.0

Q ss_pred             HHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-cccccceeeEEEe
Q 014736           87 RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-HPHLVRLIGYCCE  165 (419)
Q Consensus        87 ~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~  165 (419)
                      ......|++...++.|+.+.||++..        .++.+++|+...........+.+|+.+++.+. +..+.++++++.+
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~--------~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~   81 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVG--------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH   81 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEEC--------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEEC--------CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec
Confidence            34456788888899999999999842        14679999987532222345778999998884 6778899999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCC-----------------------------
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE-----------------------------  216 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-----------------------------  216 (419)
                      .+..|+||||++|.+|.+.+..       ......++.+++.+|..||+..                             
T Consensus        82 ~~~~~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (263)
T 3tm0_A           82 DGWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD  154 (263)
T ss_dssp             TTEEEEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCS
T ss_pred             CCceEEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccc
Confidence            9999999999999999775321       1233577889999999999611                             


Q ss_pred             ----------------------------CCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          217 ----------------------------NPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       217 ----------------------------~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                                                  ..++|+|+++.|||++++..+.|+||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                        459999999999999876556799998765

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.30  E-value=4.7e-12  Score=115.59  Aligned_cols=135  Identities=16%  Similarity=0.023  Sum_probs=96.3

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCccc--ccceeeEEEeCCee
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH--LVRLIGYCCEDEER  169 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~~~~~~~~~~~~  169 (419)
                      .|.+..+.+.|..+.||++...       .+..+++|+....   ....+.+|+.+++.+.+.+  +.++++++...+..
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~-------~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~   90 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQ-------GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD   90 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECT-------TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred             CCceEecccCCCCceEEEEecC-------CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence            3444333345666999998422       2467999997643   2234667888888885434  56688888888889


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCC---------------------------------
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE---------------------------------  216 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---------------------------------  216 (419)
                      ++||||++|.+|.  ..     ...   ...++.+++..|..||+..                                 
T Consensus        91 ~~v~e~i~G~~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (264)
T 1nd4_A           91 WLLLGEVPGQDLL--SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE  160 (264)
T ss_dssp             EEEEECCSSEETT--TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred             EEEEEecCCcccC--cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence            9999999998884  21     111   2366778888888888532                                 


Q ss_pred             -----------------------CCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          217 -----------------------NPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       217 -----------------------~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                                             .+++|+|++|.|||+++++.+.|+|||.+.
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                   129999999999999877666799999876

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.23  E-value=2.3e-11  Score=116.86  Aligned_cols=141  Identities=13%  Similarity=0.184  Sum_probs=104.5

Q ss_pred             CCCeecccCceEEEEEEEcCcccccccccEEEEEEec--cCC-cccHHHHHHHHHHHcCCC--cccccceeeEEEeC---
Q 014736           95 SNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD--IEG-LQGHREWLAEVIFLGQLR--HPHLVRLIGYCCED---  166 (419)
Q Consensus        95 ~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~---  166 (419)
                      ..+.|+.|.++.||++...        +..+++|+..  ... ......+.+|+.+++.+.  +..+++++.++.+.   
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~  113 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI  113 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT
T ss_pred             eEEEcCCcccceEEEEEEC--------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc
Confidence            4567899999999998532        2568888876  322 122346778999988886  45688888888766   


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcC-------------------------------
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA-------------------------------  215 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-------------------------------  215 (419)
                      +..|+||||++|..+.+...    ..++......++.+++.+|..||+.                               
T Consensus       114 g~~~~vme~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (359)
T 3dxp_A          114 GRAFYIMEFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS  189 (359)
T ss_dssp             SSCEEEEECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence            45899999999988754221    3467778889999999999999962                               


Q ss_pred             -------------------------CCCeeecCCCCCcEEEcCCCc--EEEeccCcccc
Q 014736          216 -------------------------ENPVIYRDFKTSNILLDSDFT--AKLSDFGLAKM  247 (419)
Q Consensus       216 -------------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DfGla~~  247 (419)
                                               ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                     257999999999999998753  68999998874

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.15  E-value=1.7e-11  Score=114.94  Aligned_cols=186  Identities=18%  Similarity=0.211  Sum_probs=119.3

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCC-Cccc--ccceeeEEEeCC---ee
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL-RHPH--LVRLIGYCCEDE---ER  169 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpn--Iv~~~~~~~~~~---~~  169 (419)
                      ++.++.|....||++.           ..+++|+....  .....+.+|+.+|+.+ .+..  +.+++......+   ..
T Consensus        25 i~~~~~G~~n~v~~v~-----------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~   91 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMS   91 (304)
T ss_dssp             CCEEEECSSEEEEEST-----------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCS
T ss_pred             eEecCCCCcceEEEEC-----------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcc
Confidence            4568999999999861           45899986532  3346788899998877 3333  345554443333   34


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA----------------------------------  215 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~----------------------------------  215 (419)
                      |+||++++|.+|.+...    ..++......++.+++..+..||+.                                  
T Consensus        92 ~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           92 FAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             CEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             eEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            89999999988865432    2356667778888888888888841                                  


Q ss_pred             ----------------------CCCeeecCCCCCcEEEcC--CCcEEEeccCccccCCCCCCceeee------------c
Q 014736          216 ----------------------ENPVIYRDFKTSNILLDS--DFTAKLSDFGLAKMGPEGSNTHVTT------------R  259 (419)
Q Consensus       216 ----------------------~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~------------~  259 (419)
                                            ...++|+|+++.||+++.  +..+.|+||+.+.............            .
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHH
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHH
Confidence                                  134899999999999998  4567899999987532210000000            0


Q ss_pred             ccccccccc-cccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 014736          260 VMGTYGYAA-PEYISTGHLTTKSDVYSFGVVLLELLTGRRSM  300 (419)
Q Consensus       260 ~~gt~~y~a-PE~~~~~~~~~~~DiwslG~il~elltg~~pf  300 (419)
                      +.....+.. |+...  ......+.|++|.++|.+.+|..+|
T Consensus       248 ~l~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            000001111 22111  0122368999999999999998655

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.71  E-value=6.5e-08  Score=90.60  Aligned_cols=135  Identities=19%  Similarity=0.135  Sum_probs=91.3

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcc---cccceeeEEE-eCCeeEE
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP---HLVRLIGYCC-EDEERLL  171 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~~~~~~~-~~~~~~l  171 (419)
                      .+.++.|....||+.           +..+++|+...  ......+.+|..+|+.+.+.   .+.+++.+.. ..+..|+
T Consensus        24 v~~l~~G~~n~v~~v-----------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~   90 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFV   90 (306)
T ss_dssp             EEEEEECSSEEEEEE-----------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEE
T ss_pred             eeecCCCcceeEEEE-----------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEE
Confidence            346888888999986           24588998532  22346788899999888642   3566676664 3456789


Q ss_pred             EEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhc-------------------------------------
Q 014736          172 VYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG-------------------------------------  214 (419)
Q Consensus       172 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-------------------------------------  214 (419)
                      |||+++|..|.+....    .++......++.+++..|..||+                                     
T Consensus        91 v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~  166 (306)
T 3tdw_A           91 GYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDE  166 (306)
T ss_dssp             EEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCH
T ss_pred             EEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccch
Confidence            9999999888653211    22333444444444444444443                                     


Q ss_pred             ---------------------CCCCeeecCCCCCcEEEcC---CCc-EEEeccCcccc
Q 014736          215 ---------------------AENPVIYRDFKTSNILLDS---DFT-AKLSDFGLAKM  247 (419)
Q Consensus       215 ---------------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~DfGla~~  247 (419)
                                           ....++|+|+++.|||++.   ++. +.|+||+.+..
T Consensus       167 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          167 SLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                 2335799999999999997   455 48999998774

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.61  E-value=2.8e-07  Score=84.37  Aligned_cols=133  Identities=19%  Similarity=0.100  Sum_probs=92.8

Q ss_pred             ecccCce-EEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-cccccceeeEEEeCCeeEEEEEec
Q 014736           99 LGEGGFG-TVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-HPHLVRLIGYCCEDEERLLVYEFM  176 (419)
Q Consensus        99 lg~G~fg-~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~  176 (419)
                      +..|..| .||+....      ..+..+++|+-...   ....+.+|...|+.+. +--+.+++.++.+.+..|+|||++
T Consensus        32 ~~~G~S~~~v~rl~~~------~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l  102 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGK------PNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI  102 (272)
T ss_dssp             EECSSSSCEEEEEECC------TTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             ccCCCcCCeEEEEEec------CCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence            4445544 68986432      23456899987532   3456778998887774 334778899999999999999999


Q ss_pred             CCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCC----------------------------------------
Q 014736          177 PRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE----------------------------------------  216 (419)
Q Consensus       177 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~----------------------------------------  216 (419)
                      +|.++.+.....      ......+..+++..|.-||+..                                        
T Consensus       103 ~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A          103 PGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             CSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             CCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            998877654321      1123345556666666666321                                        


Q ss_pred             ----------------CCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          217 ----------------NPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       217 ----------------~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                                      ..++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                            127999999999999987777899998876

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.49  E-value=3.1e-07  Score=87.71  Aligned_cols=87  Identities=3%  Similarity=-0.128  Sum_probs=54.4

Q ss_pred             Cee-cccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCC-c--ccccceeeEEEeC---
Q 014736           97 YLL-GEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLR-H--PHLVRLIGYCCED---  166 (419)
Q Consensus        97 ~~l-g~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pnIv~~~~~~~~~---  166 (419)
                      +.| +.|....+|+............++.+++|+.....   ......+.+|+.+|+.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            457 78888999987542000000014578999875432   111234667888888774 3  3467788776554   


Q ss_pred             CeeEEEEEecCCCChhh
Q 014736          167 EERLLVYEFMPRGSLEN  183 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~  183 (419)
                      +..|+||||++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999877653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.35  E-value=2.9e-06  Score=82.22  Aligned_cols=76  Identities=17%  Similarity=0.083  Sum_probs=48.5

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-------ccHHHHHHHHHHHcCCCc--c-cccceeeEEEe
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-------QGHREWLAEVIFLGQLRH--P-HLVRLIGYCCE  165 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--p-nIv~~~~~~~~  165 (419)
                      .+.||.|.++.||++....      .++.+++|.......       .....+..|.++|+.+..  + .+.+++.+  +
T Consensus        35 ~~~lg~G~~n~vyrv~~~~------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d  106 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQE------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D  106 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred             EEECCCCceEEEEEEEECC------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c
Confidence            4579999999999985322      246799998653211       123456678888877632  3 34455543  4


Q ss_pred             CCeeEEEEEecCCC
Q 014736          166 DEERLLVYEFMPRG  179 (419)
Q Consensus       166 ~~~~~lv~e~~~~g  179 (419)
                      .+..++|||++.|.
T Consensus       107 ~~~~~lvmE~l~g~  120 (397)
T 2olc_A          107 TEMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTTEEEECCCTTS
T ss_pred             CCccEEEEEeCCCc
Confidence            55678999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.31  E-value=3.3e-06  Score=79.80  Aligned_cols=31  Identities=19%  Similarity=0.230  Sum_probs=28.1

Q ss_pred             CCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       216 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      ...++|+|+++.|||++.++.+.|+||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            5679999999999999888899999998765

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.01  E-value=2.5e-05  Score=72.96  Aligned_cols=136  Identities=14%  Similarity=0.103  Sum_probs=89.5

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC---cccccceeeEEEeCCeeEEE
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR---HPHLVRLIGYCCEDEERLLV  172 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~lv  172 (419)
                      .+.|+.|....+|+...        .+..+++|+....   ....+..|...|+.|.   ...+++++.+....+..|+|
T Consensus        41 ~~~l~gG~~n~~y~v~~--------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv  109 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL  109 (312)
T ss_dssp             EEEECCSSSSEEEEEES--------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred             eEEeCCccceeeeEEEE--------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence            45689999999999742        2467889987643   3456778988888874   35688899888888899999


Q ss_pred             EEecCCCChhh--------hh---hhccC-C-------------------CCCHHHHH---HHH----------------
Q 014736          173 YEFMPRGSLEN--------HL---FKRIS-V-------------------SLPWGTRL---KIA----------------  202 (419)
Q Consensus       173 ~e~~~~g~L~~--------~l---~~~~~-~-------------------~~~~~~~~---~i~----------------  202 (419)
                      |||++|..+..        .|   ..... .                   .-+|....   ++.                
T Consensus       110 me~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~  189 (312)
T 3jr1_A          110 LEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNI  189 (312)
T ss_dssp             EECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCH
T ss_pred             EEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHH
Confidence            99999876521        11   11100 0                   01343221   011                


Q ss_pred             HHHHHHH-HHh--hcCCCCeeecCCCCCcEEEcCCCcEEEeccC
Q 014736          203 IGAAKGL-AFL--HGAENPVIYRDFKTSNILLDSDFTAKLSDFG  243 (419)
Q Consensus       203 ~qi~~al-~~l--H~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG  243 (419)
                      ..++..+ ..|  |.....+||+|+.+.||+++.++ +.|+||.
T Consensus       190 ~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          190 DLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1122222 234  22356799999999999999887 8899974

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.88  E-value=5.6e-05  Score=69.69  Aligned_cols=79  Identities=16%  Similarity=0.121  Sum_probs=54.3

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-c--ccccceeeEEEeCCe
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-H--PHLVRLIGYCCEDEE  168 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--pnIv~~~~~~~~~~~  168 (419)
                      .......+|.|..+.||+....+       |+.|++|+...........|..|...|+.|. .  --+.+++.+.    .
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~D-------G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~   84 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELAD-------GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----D   84 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETT-------SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----T
T ss_pred             CeEEEEecCCCCCeEEEEEEECC-------CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----C
Confidence            34456679999999999986543       5789999876544443455778988887774 2  2345555432    3


Q ss_pred             eEEEEEecCCCCh
Q 014736          169 RLLVYEFMPRGSL  181 (419)
Q Consensus       169 ~~lv~e~~~~g~L  181 (419)
                      .++||||+.++..
T Consensus        85 ~~lv~e~l~~~~~   97 (288)
T 3f7w_A           85 RTLAMEWVDERPP   97 (288)
T ss_dssp             TEEEEECCCCCCC
T ss_pred             ceEEEEeecccCC
Confidence            4789999987654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.88  E-value=3.5e-05  Score=72.11  Aligned_cols=156  Identities=13%  Similarity=0.098  Sum_probs=84.4

Q ss_pred             CCHHHHHHHhcCCCCC-----CeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCccc
Q 014736           81 FQLSELRAITQNFSSN-----YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH  155 (419)
Q Consensus        81 ~~~~~~~~~~~~y~~~-----~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn  155 (419)
                      ++..++..+..+|.+.     +.|+.|....||+....+        ..+++|+.....  ....+..|+.++..+...+
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~--------g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g   76 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK--------DPLILTLYEKRV--EKNDLPFFLGLMQHLAAKG   76 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS--------CCEEEEEECC-----CCHHHHHHHHHHHHHHTT
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC--------ccEEEEEeCCCC--CHHHHHHHHHHHHHHHHCC
Confidence            4455666666677653     346678888999985322        258899987521  1233445666666553211


Q ss_pred             --ccceee------EEEeCCeeEEEEEecCCCChhh-----------h---hhhc-cC--CC----CC---HHHHHH---
Q 014736          156 --LVRLIG------YCCEDEERLLVYEFMPRGSLEN-----------H---LFKR-IS--VS----LP---WGTRLK---  200 (419)
Q Consensus       156 --Iv~~~~------~~~~~~~~~lv~e~~~~g~L~~-----------~---l~~~-~~--~~----~~---~~~~~~---  200 (419)
                        +.+++.      +....+..+++|+|++|..+..           .   +... ..  ..    ..   |.....   
T Consensus        77 ~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~  156 (322)
T 2ppq_A           77 LSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSE  156 (322)
T ss_dssp             CCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHG
T ss_pred             CCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHH
Confidence              233332      1233567799999998865421           0   1110 00  00    11   111000   


Q ss_pred             ---------HHHHHHHHHHHhhc-----CCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          201 ---------IAIGAAKGLAFLHG-----AENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       201 ---------i~~qi~~al~~lH~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                               +...+...+..++.     ...+++|+|+++.|||++.++.+.|+||+.+.
T Consensus       157 ~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          157 ERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                     00113334444442     23579999999999999987656899998765

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.81  E-value=8.6e-05  Score=72.41  Aligned_cols=77  Identities=16%  Similarity=0.170  Sum_probs=47.1

Q ss_pred             CCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCceeeeccc--ccccccccccccCCC---CCchhhHHHHHHHH
Q 014736          216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM--GTYGYAAPEYISTGH---LTTKSDVYSFGVVL  290 (419)
Q Consensus       216 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~---~~~~~DiwslG~il  290 (419)
                      ...++|+|+++.|||++.++ ++|+||+.+........  . ....  -...|++|+......   -....++..+...+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--l-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--I-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--H-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--H-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            57799999999999999876 99999998875321110  0 0000  113466665543111   11234555777777


Q ss_pred             HHHHcC
Q 014736          291 LELLTG  296 (419)
Q Consensus       291 ~elltg  296 (419)
                      |+.+.+
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            777664

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.67  E-value=0.00016  Score=67.07  Aligned_cols=71  Identities=6%  Similarity=0.045  Sum_probs=43.9

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccc-cceeeEEEeCCeeEEEEE
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHL-VRLIGYCCEDEERLLVYE  174 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e  174 (419)
                      .+.|+.|....+|++            +.+++|+....... .....+|+.+++.+...++ .+++.+  +.+.-++|+|
T Consensus        23 i~~l~gG~tN~~~~~------------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e   87 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTR   87 (301)
T ss_dssp             CEEEESCSSEEEEEE------------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEE
T ss_pred             eeEcCCcccccccee------------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEe
Confidence            667989999999997            24889988643111 1112357777766643333 455543  3445689999


Q ss_pred             ec-CCCCh
Q 014736          175 FM-PRGSL  181 (419)
Q Consensus       175 ~~-~~g~L  181 (419)
                      |+ +|.+|
T Consensus        88 ~i~~g~~l   95 (301)
T 3dxq_A           88 YIAGAQTM   95 (301)
T ss_dssp             CCTTCEEC
T ss_pred             ecCCCccC
Confidence            99 66554

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.63  E-value=0.00018  Score=70.28  Aligned_cols=80  Identities=15%  Similarity=0.151  Sum_probs=50.4

Q ss_pred             CCeecccCceEEEEEEEcCccc-ccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccc-cceeeEEEeCCeeEEEE
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLR-QGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHL-VRLIGYCCEDEERLLVY  173 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~  173 (419)
                      .+.|+.|....||++...+... ....++.+++|+....  .....+.+|..+++.+...++ .++++.+.  +  .+||
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            4467888889999986543100 0112467999988432  122556689998888754344 56666543  2  3899


Q ss_pred             EecCCCCh
Q 014736          174 EFMPRGSL  181 (419)
Q Consensus       174 e~~~~g~L  181 (419)
                      ||++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987444

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.49  E-value=0.0023  Score=59.73  Aligned_cols=155  Identities=14%  Similarity=0.049  Sum_probs=84.5

Q ss_pred             CHHHHHHHhcCCCC-----CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCccc-
Q 014736           82 QLSELRAITQNFSS-----NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH-  155 (419)
Q Consensus        82 ~~~~~~~~~~~y~~-----~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-  155 (419)
                      +...+..+.+.|.+     ...|+ |....||+....       .++.+++|+...... ....+..|..++..+.... 
T Consensus        12 ~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-------~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~   82 (328)
T 1zyl_A           12 HPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-------DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEV   82 (328)
T ss_dssp             CHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-------TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTC
T ss_pred             CHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-------CCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCC
Confidence            33444444444433     23466 888899987322       245699999864322 3455666777777664212 


Q ss_pred             -ccceeeE-----EEeCCeeEEEEEecCCCChhh-----------hh---hh---cc----CCCCCHHHH----------
Q 014736          156 -LVRLIGY-----CCEDEERLLVYEFMPRGSLEN-----------HL---FK---RI----SVSLPWGTR----------  198 (419)
Q Consensus       156 -Iv~~~~~-----~~~~~~~~lv~e~~~~g~L~~-----------~l---~~---~~----~~~~~~~~~----------  198 (419)
                       +++++..     ...++..+++|++++|..+..           .+   ..   ..    .....+...          
T Consensus        83 ~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  162 (328)
T 1zyl_A           83 PVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFED  162 (328)
T ss_dssp             SBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHT
T ss_pred             eecceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhh
Confidence             3444432     233566789999998754321           00   00   00    001111110          


Q ss_pred             ------------HHHHHHHHHHHHHhh--cCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          199 ------------LKIAIGAAKGLAFLH--GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       199 ------------~~i~~qi~~al~~lH--~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                                  ...+..++..+.-+-  .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          163 ATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             cCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                        111112222222221  1245689999999999999 4 899999988764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.47  E-value=0.00049  Score=64.62  Aligned_cols=32  Identities=28%  Similarity=0.398  Sum_probs=28.1

Q ss_pred             CCCeeecCCCCCcEEEcCC----CcEEEeccCcccc
Q 014736          216 ENPVIYRDFKTSNILLDSD----FTAKLSDFGLAKM  247 (419)
Q Consensus       216 ~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~~  247 (419)
                      ...++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            4679999999999999875    6799999998875

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.44  E-value=0.00051  Score=65.80  Aligned_cols=145  Identities=20%  Similarity=0.238  Sum_probs=81.3

Q ss_pred             CeecccCceEEEEEEEcCccc-ccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCccc-ccceeeEEEeCCeeEEEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLR-QGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH-LVRLIGYCCEDEERLLVYE  174 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~e  174 (419)
                      +.|.-|-...+|++...+... ....++.|++|+... .......+.+|..+++.|.--+ ..++++++.  +  .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEE
Confidence            456667778899986532110 112346799998643 2234456678999988875322 356666553  2  39999


Q ss_pred             ecCCCChhhh--------------hhh---c---cCCCCC--HHHHHHHHHHHHH-------------------HHHHh-
Q 014736          175 FMPRGSLENH--------------LFK---R---ISVSLP--WGTRLKIAIGAAK-------------------GLAFL-  212 (419)
Q Consensus       175 ~~~~g~L~~~--------------l~~---~---~~~~~~--~~~~~~i~~qi~~-------------------al~~l-  212 (419)
                      |++|..|...              |.+   .   ......  +..+..+..++..                   .+..| 
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998655311              000   0   011112  3344444433321                   12222 


Q ss_pred             ---hc--CCCCeeecCCCCCcEEEcCC----CcEEEeccCccc
Q 014736          213 ---HG--AENPVIYRDFKTSNILLDSD----FTAKLSDFGLAK  246 (419)
Q Consensus       213 ---H~--~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGla~  246 (419)
                         ..  ....++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               21  23469999999999999886    789999998776

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.35  E-value=0.0018  Score=56.21  Aligned_cols=99  Identities=14%  Similarity=0.031  Sum_probs=64.6

Q ss_pred             CChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCceeee
Q 014736          179 GSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT  258 (419)
Q Consensus       179 g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  258 (419)
                      -+|.+.|... ..++++.+++.++.|.+.+|.-+-. .+.-..+=+-|..|+|..+|.|-+.+ +.+.            
T Consensus        33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~-~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAAR-RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhh-cccCCceecCCcceEEecCCceeccc-cccc------------
Confidence            3788888665 4689999999999999999877621 01111233456899999999988764 1111            


Q ss_pred             cccccccccccccccCCCCCchhhHHHHHHHHHHHHc
Q 014736          259 RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT  295 (419)
Q Consensus       259 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt  295 (419)
                        .....+.+||... ...+.+.=|||||+++|.-+-
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence              0123467888763 455788999999999999885

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.30  E-value=0.0012  Score=64.83  Aligned_cols=75  Identities=13%  Similarity=0.004  Sum_probs=44.7

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccc-cceeeEEEeCCeeEEEEE
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHL-VRLIGYCCEDEERLLVYE  174 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e  174 (419)
                      .+.|+.|-...+|++...+      .+..+++|+......... ...+|..+++.|...++ .++++++  .+  .+|||
T Consensus       113 i~~lsgG~tN~~y~v~~~~------~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e  181 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMS------KQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFF--TN--GRIEE  181 (458)
T ss_dssp             EEEECC--CEEEEEEEETT------TTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEE
T ss_pred             EEEcCCCeEeEEEEEEECC------CCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEE
Confidence            3467778889999985432      235788998753211111 11368888877754444 5677666  22  35999


Q ss_pred             ecCCCCh
Q 014736          175 FMPRGSL  181 (419)
Q Consensus       175 ~~~~g~L  181 (419)
                      |++|..|
T Consensus       182 ~I~G~~l  188 (458)
T 2qg7_A          182 FMDGYAL  188 (458)
T ss_dssp             CCCSEEC
T ss_pred             eeCCccC
Confidence            9987554

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.22  E-value=0.00061  Score=65.04  Aligned_cols=80  Identities=8%  Similarity=-0.015  Sum_probs=43.2

Q ss_pred             CeecccCceEEEEEEEcCccc--ccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCccc-ccceeeEEEeCCeeEEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLR--QGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH-LVRLIGYCCEDEERLLVY  173 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~  173 (419)
                      ..|+.|..-.+|++...+...  ....++.+++|+...... .......|..+++.+...+ ..++++.+  .  -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            457778888999986432100  001235788998754211 1112346777777775333 34666544  2  37899


Q ss_pred             EecCCCCh
Q 014736          174 EFMPRGSL  181 (419)
Q Consensus       174 e~~~~g~L  181 (419)
                      ||++|..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.04  E-value=0.0043  Score=58.45  Aligned_cols=32  Identities=13%  Similarity=0.241  Sum_probs=28.0

Q ss_pred             CCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       216 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            35699999999999999888899999987764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.06  E-value=0.01  Score=57.65  Aligned_cols=81  Identities=12%  Similarity=0.018  Sum_probs=46.4

Q ss_pred             CCeecccCceEEEEEEEcCccc-ccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCccc-ccceeeEEEeCCeeEEEE
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLR-QGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH-LVRLIGYCCEDEERLLVY  173 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~  173 (419)
                      ++.|..|-...+|+....+... ....++.|++|+..... ...-...+|..+++.+...+ ..++++.+  .  -++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence            3457667788899986542110 01124679999875321 11112245788777774323 35555533  2  37899


Q ss_pred             EecCCCCh
Q 014736          174 EFMPRGSL  181 (419)
Q Consensus       174 e~~~~g~L  181 (419)
                      ||++|..|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.59  E-value=0.16  Score=48.69  Aligned_cols=30  Identities=27%  Similarity=0.302  Sum_probs=24.9

Q ss_pred             CeeecCCCCCcEEE------cCCCcEEEeccCcccc
Q 014736          218 PVIYRDFKTSNILL------DSDFTAKLSDFGLAKM  247 (419)
Q Consensus       218 ~ivH~Dlkp~NIll------~~~~~~kl~DfGla~~  247 (419)
                      .++|+|+.+.|||+      +++..++++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4466799999988763

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=92.86  E-value=0.51  Score=40.74  Aligned_cols=116  Identities=9%  Similarity=0.106  Sum_probs=79.1

Q ss_pred             CcccccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 014736          152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL  231 (419)
Q Consensus       152 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll  231 (419)
                      .||+++.. .+-.+++.+.+.++.-..+.=+..+     ...+....+.++.+|+....+++  .  -+|--|.|+||++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~--~--r~tf~L~P~NL~f  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNR--T--RYTFVLAPDELFF  112 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGG--S--SEECCCSGGGEEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhc--C--ceEEEEecceEEE
Confidence            58888866 4556666666666554322112222     35677889999999998876666  4  6788999999999


Q ss_pred             cCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 014736          232 DSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMD  301 (419)
Q Consensus       232 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  301 (419)
                      +.++.+++.-.|+...                   ++|.     .++...=+-.+=+++..+++++..|+
T Consensus       113 ~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          113 TRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             cCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999987766432                   2221     12222233468899999999988875

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=91.58  E-value=0.5  Score=40.95  Aligned_cols=114  Identities=11%  Similarity=0.116  Sum_probs=79.0

Q ss_pred             CcccccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHH-HhhcCCCCeeecCCCCCcEE
Q 014736          152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA-FLHGAENPVIYRDFKTSNIL  230 (419)
Q Consensus       152 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~-~lH~~~~~ivH~Dlkp~NIl  230 (419)
                      .||++  -..+-.+++.+.+.++.-+++.=+..+     ..++...+++++.+|+.... +++  .  -+|--|.|+||+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~~--~--r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHSA--R--RLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCCS--S--SEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhhh--C--ceeEEEeCceEE
Confidence            57877  445556777777777765444333333     25678889999999887666 555  4  788899999999


Q ss_pred             EcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHH-HHHHHHHHHHcCCCCCC
Q 014736          231 LDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVY-SFGVVLLELLTGRRSMD  301 (419)
Q Consensus       231 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw-slG~il~elltg~~pf~  301 (419)
                      ++.++.++|.-.|+-.                   -++|.-     ++ ..|.| .+=+++..++.++..|+
T Consensus       117 f~~~~~p~i~hRGi~~-------------------~lpP~e-----~~-ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          117 FNRALEPFFLHVGVKE-------------------SLPPDE-----WD-DERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             ECTTCCEEESCCEETT-------------------TBSSCS-----CC-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EeCCCcEEEEEcCCcc-------------------cCCCCC-----CC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999998776643                   233321     12 23444 67888999998887765

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	419
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	7e-77
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-68
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-67
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-67
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-67
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-66
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-66
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-66
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-66
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-65
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-65
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-65
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-65
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-64
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-63
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-62
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-62
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-61
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-61
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-61
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-60
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-59
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-58
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-58
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-58
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-57
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-56
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-55
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-52
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-51
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-50
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-50
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-48
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-48
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-48
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-48
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-46
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-46
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-45
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-45
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-44
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-43
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-43
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-43
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-43
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-43
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-41
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-40
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-38
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-38
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-36
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-16

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  237 bits (607), Expect = 7e-77
 Identities = 83/282 (29%), Positives = 132/282 (46%), Gaps = 30/282 (10%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPH 155
            +G G FGTV+KG    D         VAVK+L++     Q  + +  EV  L + RH +
Sbjct: 15  RIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           ++  +GY     +  +V ++    SL +HL             + IA   A+G+ +LH  
Sbjct: 66  ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLH-- 121

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST- 274
              +I+RD K++NI L  D T K+ DFGLA +    S +H   ++ G+  + APE I   
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 275 --GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR 332
                + +SDVY+FG+VL EL+TG+       P S  N  D     +      R  + P 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVG-----RGYLSPD 230

Query: 333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
           L+ +      K M  L  +C+     +RP    ++A++E L 
Sbjct: 231 LS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 7e-68
 Identities = 81/277 (29%), Positives = 122/277 (44%), Gaps = 28/277 (10%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
            LG G FG V  GY +           VAVK L  +G      +LAE   + QL+H  LV
Sbjct: 20  RLGAGQFGEVWMGYYNGH-------TKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           RL       E   ++ E+M  GSL + L     + L     L +A   A+G+AF+   E 
Sbjct: 72  RLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ER 128

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL 277
             I+RD + +NIL+    + K++DFGLA++  + +             + APE I+ G  
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGTF 187

Query: 278 TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQY 337
           T KSDV+SFG++L E++T  R         E          +++  R   +V P      
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPDNC--- 235

Query: 338 SVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                +E+  L   C    P+DRP    + + LE   
Sbjct: 236 ----PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 1e-67
 Identities = 77/291 (26%), Positives = 129/291 (44%), Gaps = 28/291 (9%)

Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLAEVIF 147
           +  +F+   ++G G FG V+ G + D+  +       AVK L+     G   ++L E I 
Sbjct: 27  LIVHFNE--VIGRGHFGCVYHGTLLDNDGKK---IHCAVKSLNRITDIGEVSQFLTEGII 81

Query: 148 LGQLRHPHLVRLIGYCCEDEER-LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAA 206
           +    HP+++ L+G C   E   L+V  +M  G L N +    + +      +   +  A
Sbjct: 82  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVA 140

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM--GPEGSNTHVTTRVMGTY 264
           KG+ FL       ++RD    N +LD  FT K++DFGLA+     E  + H  T      
Sbjct: 141 KGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198

Query: 265 GYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
            + A E + T   TTKSDV+SFGV+L EL+T         P  + N  D     L+  R 
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQGRR- 252

Query: 325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
              ++ P             +  + L+C     + RP  + +V+ + ++ +
Sbjct: 253 ---LLQPEYC-------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 3e-67
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 28/276 (10%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           +G G FG VH GY  +          VA+K +  EG     +++ E   + +L HP LV+
Sbjct: 13  IGSGQFGLVHLGYWLNK-------DKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G C E     LV+EFM  G L ++L  +  +     T L + +   +G+A+L   E  
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAYLE--EAC 121

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
           VI+RD    N L+  +   K+SDFG+ +   +   T  +T       +A+PE  S    +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYS 180

Query: 279 TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYS 338
           +KSDV+SFGV++ E+ +  +   + R  SE          +        +  PRLA    
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---------VEDISTGFRLYKPRLA---- 227

Query: 339 VKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
              +  +  +   C    P+DRP  + ++  L  + 
Sbjct: 228 ---STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  213 bits (542), Expect = 6e-67
 Identities = 70/307 (22%), Positives = 129/307 (42%), Gaps = 35/307 (11%)

Query: 81  FQLSELRAITQNFSSNY---------LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD 131
           F   +     + F+            ++G G FG V  G++      G +   VA+K L 
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLP---GKREIFVAIKTLK 63

Query: 132 IEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRIS 190
                +  R++L+E   +GQ  HP+++ L G   +    +++ EFM  GSL++ L +   
Sbjct: 64  SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG 123

Query: 191 VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE 250
                   + +  G A G+ +L   +   ++RD    NIL++S+   K+SDFGL++   +
Sbjct: 124 QF-TVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 251 GSNTHVTTRV---MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKS 307
            ++    T          + APE I     T+ SDV+S+G+V+ E+++        RP  
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPYW 235

Query: 308 EQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
           +    D               ++        +     +  L L C   +   RPK   +V
Sbjct: 236 DMTNQDVIN-----------AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 368 ATLESLL 374
            TL+ ++
Sbjct: 285 NTLDKMI 291

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 1e-66
 Identities = 70/305 (22%), Positives = 125/305 (40%), Gaps = 38/305 (12%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-HREWLAEVIFLGQLRHPHLV 157
           +G+G FG V +G          + + VAVK+      +   RE  AE+     LRH +++
Sbjct: 11  IGKGRFGEVWRGK--------WRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENIL 60

Query: 158 RLIGYCCEDE----ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
             I    +D     +  LV ++   GSL ++L +    ++     +K+A+  A GLA LH
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLH 117

Query: 214 ------GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT--HVTTRVMGTYG 265
                   +  + +RD K+ NIL+  + T  ++D GLA      ++T        +GT  
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 266 YAAPEYIST------GHLTTKSDVYSFGVVLLELLTGRR----SMDKLRPKSEQNLVDWA 315
           Y APE +             ++D+Y+ G+V  E+           D   P  +    D +
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 316 KPYLRSSRRLRYIVDPRLAGQY-SVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
              +R        + P +  ++ S +  + MA +  +C   N   R     +  TL  L 
Sbjct: 238 VEEMR-KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296

Query: 375 NLKDM 379
             + +
Sbjct: 297 QQEGI 301

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 1e-66
 Identities = 73/279 (26%), Positives = 117/279 (41%), Gaps = 34/279 (12%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
            +G+G FG V  G          +   VAVK +  +     + +LAE   + QLRH +LV
Sbjct: 14  TIGKGEFGDVMLGD--------YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 158 RLIGYCCEDEERL-LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           +L+G   E++  L +V E+M +GSL ++L  R    L     LK ++   + + +L    
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--G 121

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH 276
           N  ++RD    N+L+  D  AK+SDFGL K      +T           + APE +    
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKK 176

Query: 277 LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQ 336
            +TKSDV+SFG++L E+ +  R      P     L D          R+           
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVV-------PRVEKGYKMDAPDG 224

Query: 337 YSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
                   +  +   C  ++   RP    +   LE +  
Sbjct: 225 CP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 3e-66
 Identities = 72/290 (24%), Positives = 128/290 (44%), Gaps = 23/290 (7%)

Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR-EWLAEVIFLG 149
              +   ++G G FG V+KG +      G K   VA+K L     +  R ++L E   +G
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTS--SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64

Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
           Q  H +++RL G   + +  +++ E+M  G+L+  L ++          + +  G A G+
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGM 123

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAA 268
            +L       ++RD    NIL++S+   K+SDFGL++ +  +   T+ T+       + A
Sbjct: 124 KYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 269 PEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI 328
           PE IS    T+ SDV+SFG+V+ E++T            E                +   
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------VMKA 225

Query: 329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKD 378
           ++        +     +  L +QC       RPK A +V+ L+ L+   D
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 8e-66
 Identities = 68/300 (22%), Positives = 114/300 (38%), Gaps = 41/300 (13%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQL-RHPH 155
           +LG G FG V        + +   +  VAVK+L  +     RE  ++E+  + QL  H +
Sbjct: 44  VLGSGAFGKVMNA-TAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKR---------------------ISVSLP 194
           +V L+G C       L++E+   G L N+L  +                         L 
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162

Query: 195 WGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT 254
           +   L  A   AKG+ FL       ++RD    N+L+      K+ DFGLA+     SN 
Sbjct: 163 FEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 255 HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW 314
            V         + APE +  G  T KSDV+S+G++L E+ +         P     +   
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-----NPYPGIPVDAN 275

Query: 315 AKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                        ++             +E+ ++   C + + + RP    + + L   L
Sbjct: 276 ----------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 325

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  209 bits (532), Expect = 1e-65
 Identities = 65/289 (22%), Positives = 126/289 (43%), Gaps = 26/289 (8%)

Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQL 151
           + +  + LG G +G V++G           +  VAVK L  + ++   E+L E   + ++
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEI 70

Query: 152 RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAF 211
           +HP+LV+L+G C  +    ++ EFM  G+L ++L +     +     L +A   +  + +
Sbjct: 71  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 130

Query: 212 LHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEY 271
           L   +   I+RD    N L+  +   K++DFGL+++   G              + APE 
Sbjct: 131 LE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 187

Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDP 331
           ++    + KSDV++FGV+L E+ T   S       S+                +  +++ 
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLEK 231

Query: 332 RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLKDMA 380
               +      +++  L   C   NP DRP  A +    E++     ++
Sbjct: 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 280

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 2e-65
 Identities = 75/296 (25%), Positives = 112/296 (37%), Gaps = 36/296 (12%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQL-RHPH 155
            LG G FG V +      ++    A  VAVK+L        RE  ++E+  L  L  H +
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSD-AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKR----------------ISVSLPWGTRL 199
           +V L+G C      L++ E+   G L N L ++                  ++L     L
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTR 259
             +   AKG+AFL       I+RD    NILL      K+ DFGLA+     SN  V   
Sbjct: 149 SFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 260 VMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYL 319
                 + APE I     T +SDV+S+G+ L EL +   S     P   +          
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---------- 256

Query: 320 RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
                   ++              EM  +   C   +P  RP    +V  +E  ++
Sbjct: 257 -----FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  208 bits (529), Expect = 6e-65
 Identities = 72/318 (22%), Positives = 117/318 (36%), Gaps = 42/318 (13%)

Query: 80  DFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHR 139
           + +L  L     N      +GEG FG V +      L        VAVK+L  E     +
Sbjct: 2   NPKLLSLEYPRNNIEYVRDIGEGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 140 -EWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKR---------- 188
            ++  E   + +  +P++V+L+G C   +   L++E+M  G L   L             
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120

Query: 189 ------------ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT 236
                           L    +L IA   A G+A+L   E   ++RD  T N L+  +  
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMV 178

Query: 237 AKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG 296
            K++DFGL++                   +  PE I     TT+SDV+++GVVL E+ + 
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238

Query: 297 RRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVN 356
                      E                + Y+ D  +          E+  L   C S  
Sbjct: 239 GLQPYYGMAHEEV---------------IYYVRDGNIL-ACPENCPLELYNLMRLCWSKL 282

Query: 357 PKDRPKMAAVVATLESLL 374
           P DRP   ++   L+ + 
Sbjct: 283 PADRPSFCSIHRILQRMC 300

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 6e-65
 Identities = 57/273 (20%), Positives = 111/273 (40%), Gaps = 28/273 (10%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG G FG V  G              VA+K++  EG     E++ E   +  L H  LV+
Sbjct: 12  LGTGQFGVVKYGKWRGQ-------YDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L G C +     ++ E+M  G L N+L +           L++     + + +L      
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLE--SKQ 120

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
            ++RD    N L++     K+SDFGL++   +      +        ++ PE +     +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFS 179

Query: 279 TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYS 338
           +KSD+++FGV++ E+ +  +      P       + A+   +  R    +  P LA    
Sbjct: 180 SKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETAEHIAQGLR----LYRPHLA---- 226

Query: 339 VKGAKEMAVLALQCISVNPKDRPKMAAVVATLE 371
              ++++  +   C      +RP    +++ + 
Sbjct: 227 ---SEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 8e-65
 Identities = 74/309 (23%), Positives = 124/309 (40%), Gaps = 42/309 (13%)

Query: 85  ELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLA 143
           EL+    +F     LG G  G V K         G     +A KL+ +E     R   + 
Sbjct: 2   ELK--DDDFEKISELGAGNGGVVFKVS---HKPSG---LVMARKLIHLEIKPAIRNQIIR 53

Query: 144 EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAI 203
           E+  L +   P++V   G    D E  +  E M  GSL+  L K     +P     K++I
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSI 111

Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGT 263
              KGL +L   ++ +++RD K SNIL++S    KL DFG++    +     +    +GT
Sbjct: 112 AVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGT 166

Query: 264 YGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRR------------------------- 298
             Y +PE +   H + +SD++S G+ L+E+  GR                          
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226

Query: 299 -SMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNP 357
               +   +   +    ++P +     L YIV+       S   + E      +C+  NP
Sbjct: 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 286

Query: 358 KDRPKMAAV 366
            +R  +  +
Sbjct: 287 AERADLKQL 295

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 3e-64
 Identities = 71/278 (25%), Positives = 118/278 (42%), Gaps = 26/278 (9%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHLV 157
           LG G FG+V +G      R   K   VA+K+L     +   E  + E   + QL +P++V
Sbjct: 17  LGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
           RLIG  C+ E  +LV E    G L   L  +    +P     ++    + G+ +L   E 
Sbjct: 73  RLIG-VCQAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE--EK 128

Query: 218 PVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPEYISTGH 276
             ++RD    N+LL +   AK+SDFGL+K +G + S     +       + APE I+   
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188

Query: 277 LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQ 336
            +++SDV+S+GV + E L+  +     +P  +    +      +  R            +
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMAFIEQGKR-------MECPPE 236

Query: 337 YSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                  E+  L   C     +DRP    V   + +  
Sbjct: 237 CP----PELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (516), Expect = 3e-63
 Identities = 78/277 (28%), Positives = 124/277 (44%), Gaps = 28/277 (10%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HREWLAEVIFLGQLRHPHL 156
           LG G FGTV KGY     +     + VAVK+L  E        E LAE   + QL +P++
Sbjct: 15  LGSGNFGTVKKGY----YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           VR+IG  CE E  +LV E    G L  +L +     +     +++    + G+ +L   E
Sbjct: 71  VRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE--E 125

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
           +  ++RD    N+LL +   AK+SDFGL+K +  + +     T       + APE I+  
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 276 HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAG 335
             ++KSDV+SFGV++ E  +  +     +P       +      +  R            
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSEVTAMLEKGER-------MGCPA 233

Query: 336 QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLES 372
                  +EM  L   C + + ++RP  AAV   L +
Sbjct: 234 GCP----REMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 1e-62
 Identities = 75/277 (27%), Positives = 117/277 (42%), Gaps = 28/277 (10%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V  G  +   R       VA+K L   G      +L E   + +LRH  LV+
Sbjct: 25  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L     E+    +V E+M +GSL + L       L     + +A   A G+A++      
Sbjct: 77  LYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMN 133

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLT 278
            ++RD + +NIL+  +   K++DFGLA++  + +             + APE    G  T
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFT 192

Query: 279 TKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYS 338
            KSDV+SFG++L EL T  R          + ++D  +      R  R    P       
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYP--GMVNREVLDQVE------RGYRMPCPPEC----- 239

Query: 339 VKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
               + +  L  QC    P++RP    + A LE    
Sbjct: 240 ---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 7e-62
 Identities = 71/307 (23%), Positives = 127/307 (41%), Gaps = 41/307 (13%)

Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQ 150
           +     ++GEG FG V K      +++       A+K +        HR++  E+  L +
Sbjct: 11  DIKFQDVIGEGNFGQVLKAR----IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66

Query: 151 L-RHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISV--------------SLPW 195
           L  HP+++ L+G C       L  E+ P G+L + L K   +              +L  
Sbjct: 67  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126

Query: 196 GTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTH 255
              L  A   A+G+ +L   +   I+RD    NIL+  ++ AK++DFGL++         
Sbjct: 127 QQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184

Query: 256 VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA 315
           +         + A E ++    TT SDV+S+GV+L E+++   +     P       +  
Sbjct: 185 MGR---LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELY 236

Query: 316 KPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           +  L    RL   ++             E+  L  QC    P +RP  A ++ +L  +L 
Sbjct: 237 E-KLPQGYRLEKPLNC----------DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285

Query: 376 LKDMAVS 382
            +   V+
Sbjct: 286 ERKTYVN 292

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 1e-61
 Identities = 74/279 (26%), Positives = 118/279 (42%), Gaps = 26/279 (9%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPH 155
           LG+G FG V +G  D    +     +VAVK L  + L   +   +++ EV  +  L H +
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKT---VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           L+RL G       + +V E  P GSL + L K        GT  + A+  A+G+ +L   
Sbjct: 73  LIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLE-- 128

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV-TTRVMGTYGYAAPEYIST 274
               I+RD    N+LL +    K+ DFGL +  P+  + +V        + + APE + T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188

Query: 275 GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
              +  SD + FGV L E+ T  +      P    N         +   RL    D    
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERLPRPEDC--- 240

Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
                   +++  + +QC +  P+DRP   A+   L   
Sbjct: 241 -------PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 2e-61
 Identities = 66/294 (22%), Positives = 125/294 (42%), Gaps = 24/294 (8%)

Query: 84  SELRAITQN-FSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVK-LLDIEGLQGHREW 141
           + LR + +  F    +LG G FGTV+KG    +  +      VA+K L +    + ++E 
Sbjct: 1   ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEI 58

Query: 142 LAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKI 201
           L E   +  + +PH+ RL+   C      L+ + MP G L +++ +    ++     L  
Sbjct: 59  LDEAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNW 116

Query: 202 AIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
            +  AKG+ +L   +  +++RD    N+L+ +    K++DFGLAK+       +      
Sbjct: 117 CVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174

Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS 321
               + A E I     T +SDV+S+GV + EL+T         P SE             
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------------- 221

Query: 322 SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
              +  I++             ++ ++ ++C  ++   RPK   ++     +  
Sbjct: 222 ---ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 8e-61
 Identities = 66/280 (23%), Positives = 109/280 (38%), Gaps = 31/280 (11%)

Query: 93  FSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIF 147
           F  ++     LGEG +G V       +       +AVAVK++D++      E    E+  
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAV---NRVTE---EAVAVKIVDMKRAVDCPENIKKEICI 56

Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
              L H ++V+  G+  E   + L  E+   G L + +   I   +P     +       
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 114

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYA 267
           G+ +LH     + +RD K  N+LLD     K+SDFGLA +    +   +  ++ GT  Y 
Sbjct: 115 GVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172

Query: 268 APEYISTGHL-TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR 326
           APE +          DV+S G+VL  +L G    D+    S Q   DW +     +   +
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD-SCQEYSDWKEKKTYLNPWKK 231

Query: 327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
                                L  + +  NP  R  +  +
Sbjct: 232 I--------------DSAPLALLHKILVENPSARITIPDI 257

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 1e-60
 Identities = 72/278 (25%), Positives = 115/278 (41%), Gaps = 25/278 (8%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIFLGQLRHPHL 156
            +GEG FG VH+G             AVA+K          RE +L E + + Q  HPH+
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPA---LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           V+LIG   E+    ++ E    G L + L  R   SL   + +  A   +  LA+L    
Sbjct: 71  VKLIGVITENP-VWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLE--S 126

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH 276
              ++RD    N+L+ S+   KL DFGL++   + S  +  ++      + APE I+   
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRR 185

Query: 277 LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQ 336
            T+ SDV+ FGV + E+L         +P       D         R         +   
Sbjct: 186 FTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENGER-------LPMPPN 233

Query: 337 YSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
                   +  L  +C + +P  RP+   + A L ++L
Sbjct: 234 CP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 2e-59
 Identities = 66/276 (23%), Positives = 101/276 (36%), Gaps = 35/276 (12%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHL 156
           +G G F TV+KG   +          VA   L    L     + +  E   L  L+HP++
Sbjct: 17  IGRGSFKTVYKGLDTET------TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 157 VRLIGYCCEDEER----LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
           VR         +     +LV E M  G+L+ +L +     +             KGL FL
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFL 128

Query: 213 HGAENPVIYRDFKTSNILLDS-DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEY 271
           H    P+I+RD K  NI +     + K+ D GLA +            V+GT  + APE 
Sbjct: 129 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEM 184

Query: 272 ISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDP 331
                     DVY+FG+ +LE+ T         P SE                 R +   
Sbjct: 185 YE-EKYDESVDVYAFGMCMLEMATSE------YPYSECQNAAQI---------YRRVTSG 228

Query: 332 RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
                +      E+  +   CI  N  +R  +  ++
Sbjct: 229 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 2e-59
 Identities = 63/285 (22%), Positives = 113/285 (39%), Gaps = 34/285 (11%)

Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLG 149
           ++   Y +G G +G   K     D +       +  K LD   +     +  ++EV  L 
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKI------LVWKELDYGSMTEAEKQMLVSEVNLLR 58

Query: 150 QLRHPHLVRLIGYCCEDEERLL--VYEFMPRGSLENHLFK--RISVSLPWGTRLKIAIGA 205
           +L+HP++VR      +     L  V E+   G L + + K  +    L     L++    
Sbjct: 59  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118

Query: 206 AKGLAFLH---GAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
              L   H      + V++RD K +N+ LD     KL DFGLA++     +T      +G
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVG 176

Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS 322
           T  Y +PE ++      KSD++S G +L EL           P +  +  + A       
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKIREGK 230

Query: 323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
                    R+  +YS     E+  +  + +++    RP +  ++
Sbjct: 231 F-------RRIPYRYS----DELNEIITRMLNLKDYHRPSVEEIL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 1e-58
 Identities = 57/273 (20%), Positives = 104/273 (38%), Gaps = 31/273 (11%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVR 158
           LG+G FG V+K    +       +   A K++D +  +   +++ E+  L    HP++V+
Sbjct: 20  LGDGAFGKVYKAQNKET------SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 159 LIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENP 218
           L+     +    ++ EF   G+++  + +     L       +       L +LH  +N 
Sbjct: 74  LLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLH--DNK 130

Query: 219 VIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST---- 274
           +I+RD K  NIL   D   KL+DFG++               +GT  + APE +      
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSK 188

Query: 275 -GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRL 333
                 K+DV+S G+ L+E+           P  E N +       + S         R 
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVLLKIAK-SEPPTLAQPSRW 241

Query: 334 AGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
                   +        +C+  N   R   + +
Sbjct: 242 --------SSNFKDFLKKCLEKNVDARWTTSQL 266

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 1e-58
 Identities = 71/308 (23%), Positives = 133/308 (43%), Gaps = 35/308 (11%)

Query: 76  PDLYDFQLSELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL 135
           PD ++    ++    +       LG+G FG V++G +   + +      VA+K ++    
Sbjct: 12  PDEWEVAREKITMSRE-------LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAAS 63

Query: 136 QGHR-EWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKR------ 188
              R E+L E   + +    H+VRL+G   + +  L++ E M RG L+++L         
Sbjct: 64  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 123

Query: 189 --ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK 246
             +         +++A   A G+A+L+   N  ++RD    N ++  DFT K+ DFG+ +
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 181

Query: 247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPK 306
              E        + +    + +PE +  G  TT SDV+SFGVVL E+ T      +    
Sbjct: 182 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241

Query: 307 SEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
            +                LR++++  L  +        +  L   C   NPK RP    +
Sbjct: 242 EQV---------------LRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEI 285

Query: 367 VATLESLL 374
           +++++  +
Sbjct: 286 ISSIKEEM 293

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  191 bits (487), Expect = 1e-58
 Identities = 74/285 (25%), Positives = 117/285 (41%), Gaps = 40/285 (14%)

Query: 90  TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVI 146
            + FS    +G G FG V+      D+R     + VA+K +   G Q + +W   + EV 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFAR---DVRNS---EVVAIKKMSYSGKQSNEKWQDIIKEVR 67

Query: 147 FLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAA 206
           FL +LRHP+ ++  G    +    LV E+    + +     +    L       +  GA 
Sbjct: 68  FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGAL 125

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
           +GLA+LH   + +I+RD K  NILL      KL DFG A +             +GT  +
Sbjct: 126 QGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYW 177

Query: 267 AAPEYIST---GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSE-QNLVDWAKPYLRSS 322
            APE I     G    K DV+S G+  +EL   +  +  +   S   ++     P L+S 
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS- 236

Query: 323 RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
                       G +S    +        C+   P+DRP    ++
Sbjct: 237 ------------GHWS----EYFRNFVDSCLQKIPQDRPTSEVLL 265

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 1e-57
 Identities = 75/294 (25%), Positives = 113/294 (38%), Gaps = 35/294 (11%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-HREWLAEVIFLGQ-LRHPH 155
            LG G FG V +      + +    + VAVK+L        HR  ++E+  L     H +
Sbjct: 20  PLGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 156 LVRLIGYCCEDEERL-LVYEFMPRGSLENHLFKR--------------ISVSLPWGTRLK 200
           +V L+G C +    L ++ EF   G+L  +L  +                  L     + 
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 201 IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRV 260
            +   AKG+ FL       I+RD    NILL      K+ DFGLA+   +  +       
Sbjct: 139 YSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196

Query: 261 MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR 320
                + APE I     T +SDV+SFGV+L E+ +   S     P     + +     L+
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRRLK 251

Query: 321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
              R+R                 EM    L C    P  RP  + +V  L +LL
Sbjct: 252 EGTRMRAPDYT----------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 1e-57
 Identities = 68/273 (24%), Positives = 100/273 (36%), Gaps = 35/273 (12%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHP 154
            LG+G FG V+                +A+K+L    +E      +   EV     LRHP
Sbjct: 13  PLGKGKFGNVYLAREKQSKFI------LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
           +++RL GY  +     L+ E+ P G++   L K                  A  L++ H 
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH- 123

Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
               VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE I  
Sbjct: 124 -SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEG 178

Query: 275 GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
                K D++S GV+  E L G+       P       +  K   R        V     
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYKRISRVEFTFPDFVTE--- 229

Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVV 367
                        L  + +  NP  RP +  V+
Sbjct: 230 ---------GARDLISRLLKHNPSQRPMLREVL 253

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 4e-56
 Identities = 62/291 (21%), Positives = 124/291 (42%), Gaps = 36/291 (12%)

Query: 83  LSELRAIT--QNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ 136
           L +LR+I    +    Y     +G+G  GTV+      D+  G   Q VA++ ++++   
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQP 59

Query: 137 GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWG 196
                + E++ + + ++P++V  +      +E  +V E++  GSL + + +     +  G
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEG 116

Query: 197 TRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHV 256
               +     + L FLH   N VI+RD K+ NILL  D + KL+DFG         +   
Sbjct: 117 QIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172

Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSE-QNLVDWA 315
            + ++GT  + APE ++      K D++S G++ +E++ G        P      +    
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232

Query: 316 KPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
            P L++  +L                +        +C+ ++ + R     +
Sbjct: 233 TPELQNPEKL----------------SAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 1e-55
 Identities = 70/296 (23%), Positives = 118/296 (39%), Gaps = 35/296 (11%)

Query: 98  LLGEGGFGTVHKG-YIDDDLRQGLKAQAVAVKLLDIEGLQGH-REWLAEVIFLGQL-RHP 154
            LGEG FG V     I  D  +  +   VAVK+L  +  +    + ++E+  +  + +H 
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVS--------------LPWGTRLK 200
           +++ L+G C +D    ++ E+  +G+L  +L  R                  L     + 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 201 IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRV 260
            A   A+G+ +L       I+RD    N+L+  D   K++DFGLA+          TT  
Sbjct: 140 CAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197

Query: 261 MGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR 320
                + APE +     T +SDV+SFGV+L E+ T   S     P  E            
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------------ 245

Query: 321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL 376
               L  ++              E+ ++   C    P  RP    +V  L+ ++ L
Sbjct: 246 ----LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  175 bits (445), Expect = 7e-52
 Identities = 62/271 (22%), Positives = 101/271 (37%), Gaps = 28/271 (10%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
            LG G FG VH+     +   G      A K +             E+  +  LRHP LV
Sbjct: 33  ELGTGAFGVVHRVT---ERATG---NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
            L     +D E +++YEFM  G L   +    +  +     ++      KGL  +H  EN
Sbjct: 87  NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH--EN 143

Query: 218 PVIYRDFKTSNILLDSDF--TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
             ++ D K  NI+  +      KL DFGL        +  VTT   GT  +AAPE     
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGK 200

Query: 276 HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAG 335
            +   +D++S GV+   LL+G        P   +N  +  +        +       +  
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVKSCDWNMDDSAFSGI-- 252

Query: 336 QYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
                 +++      + +  +P  R  +   
Sbjct: 253 ------SEDGKDFIRKLLLADPNTRMTIHQA 277

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 2e-51
 Identities = 57/279 (20%), Positives = 100/279 (35%), Gaps = 31/279 (11%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHP 154
           +LGEG F TV       +L      +  A+K+L+   +           E   + +L HP
Sbjct: 15  ILGEGSFSTVVLAR---ELATS---REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
             V+L     +DE+      +   G L  ++ K    S                L +LH 
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLH- 125

Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
               +I+RD K  NILL+ D   +++DFG AK+    S        +GT  Y +PE ++ 
Sbjct: 126 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

Query: 275 GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
                 SD+++ G ++ +L+ G        P    N         +   +L Y    +  
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYL----IFQKIIKLEYDFPEKF- 233

Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL 373
                    +   L  + + ++   R     +       
Sbjct: 234 -------FPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 265

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  172 bits (436), Expect = 2e-50
 Identities = 59/271 (21%), Positives = 107/271 (39%), Gaps = 28/271 (10%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
            LG G FG VH+     +   G   +    K ++            E+  + QL HP L+
Sbjct: 36  ELGSGAFGVVHRCV---EKATG---RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
            L     +  E +L+ EF+  G L + +       +     +     A +GL  +H  E+
Sbjct: 90  NLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH--EH 146

Query: 218 PVIYRDFKTSNILLDS--DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
            +++ D K  NI+ ++    + K+ DFGLA          VTT    T  +AAPE +   
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDRE 203

Query: 276 HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAG 335
            +   +D+++ GV+   LL+G        P + ++ ++     L++ +R  +  D     
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLET----LQNVKRCDWEFDEDAFS 253

Query: 336 QYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
             S     E        +   P+ R  +   
Sbjct: 254 SVS----PEAKDFIKNLLQKEPRKRLTVHDA 280

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  169 bits (428), Expect = 2e-50
 Identities = 71/287 (24%), Positives = 126/287 (43%), Gaps = 33/287 (11%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG---HREWLAEVIFLGQLRHP 154
           +LG GG   VH      DLR     + VAVK+L  +  +    +  +  E      L HP
Sbjct: 14  ILGFGGMSEVHLAR---DLRLH---RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67

Query: 155 HLVRLIGYCCEDEERL----LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLA 210
            +V +      +        +V E++   +L + +       +     +++   A + L 
Sbjct: 68  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALN 125

Query: 211 FLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK-MGPEGSNTHVTTRVMGTYGYAAP 269
           F H  +N +I+RD K +NI++ +    K+ DFG+A+ +   G++   T  V+GT  Y +P
Sbjct: 126 FSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
           E      +  +SDVYS G VL E+LTG        P +  + V  A  ++R         
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVREDPIPPSAR 237

Query: 330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK-MAAVVATLESLLN 375
              L        + ++  + L+ ++ NP++R +  A + A L  + N
Sbjct: 238 HEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  167 bits (423), Expect = 1e-48
 Identities = 67/285 (23%), Positives = 108/285 (37%), Gaps = 36/285 (12%)

Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVI-- 146
           +FS + ++G GGFG V+          G   +  A+K LD + +   QG    L E I  
Sbjct: 5   DFSVHRIIGRGGFGEVYGCR---KADTG---KMYAMKCLDKKRIKMKQGETLALNERIML 58

Query: 147 -FLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGA 205
             +     P +V +       ++   + + M  G L  HL +              A   
Sbjct: 59  SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEI 116

Query: 206 AKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYG 265
             GL  +H     V+YRD K +NILLD     ++SD GLA    +          +GT+G
Sbjct: 117 ILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHG 170

Query: 266 YAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR 324
           Y APE +  G    + +D +S G +L +LL G     + + K +  +            R
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----------R 219

Query: 325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT 369
           +   +   L   +S     E+  L    +  +   R       A 
Sbjct: 220 MTLTMAVELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQ 260

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  162 bits (412), Expect = 7e-48
 Identities = 66/294 (22%), Positives = 112/294 (38%), Gaps = 47/294 (15%)

Query: 93  FSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---------QGHR 139
           F  NY    +LG G    V +             +  AVK++D+ G          +   
Sbjct: 1   FYENYEPKEILGRGVSSVVRRCI---HKPTC---KEYAVKIIDVTGGGSFSAEEVQELRE 54

Query: 140 EWLAEVIFLGQLR-HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTR 198
             L EV  L ++  HP++++L      +    LV++ M +G L ++L ++  V+L     
Sbjct: 55  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKET 112

Query: 199 LKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTT 258
            KI     + +  LH  +  +++RD K  NILLD D   KL+DFG +     G       
Sbjct: 113 RKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLR 167

Query: 259 RVMGTYGYAAPEYISTGHL------TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV 312
            V GT  Y APE I             + D++S GV++  LL G        P   +  +
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQM 221

Query: 313 DWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
              +  +  + +                 +  +  L  + + V P+ R      
Sbjct: 222 LMLRMIMSGNYQFGSPEWDDY--------SDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  163 bits (414), Expect = 7e-48
 Identities = 60/285 (21%), Positives = 108/285 (37%), Gaps = 35/285 (12%)

Query: 90  TQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAE 144
            ++    Y    +LG G F  V       D R     + VA+K +  + L+G       E
Sbjct: 4   AEDIRDIYDFRDVLGTGAFSEVILAE---DKRTQ---KLVAIKCIAKKALEGKEGSMENE 57

Query: 145 VIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIG 204
           +  L +++HP++V L           L+ + +  G L + + ++           ++   
Sbjct: 58  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQ 115

Query: 205 AAKGLAFLHGAENPVIYRDFKTSNILL---DSDFTAKLSDFGLAKMGPEGSNTHVTTRVM 261
               + +LH  +  +++RD K  N+L    D D    +SDFGL+KM   GS   V +   
Sbjct: 116 VLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTAC 170

Query: 262 GTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS 321
           GT GY APE ++    +   D +S GV+   LL G        P  ++N     +  L++
Sbjct: 171 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKA 224

Query: 322 SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
                      +        +          +  +P+ R      
Sbjct: 225 EYEFDSPYWDDI--------SDSAKDFIRHLMEKDPEKRFTCEQA 261

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  163 bits (413), Expect = 8e-48
 Identities = 60/285 (21%), Positives = 101/285 (35%), Gaps = 29/285 (10%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
            +G G FG ++ G    D+  G   + VA+KL  ++    H +   E      ++    +
Sbjct: 14  KIGSGSFGDIYLGT---DIAAG---EEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGI 65

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
             I +C  + +  ++   +   SLE  LF   S      T L +A      + ++H    
Sbjct: 66  PTIRWCGAEGDYNVMVMELLGPSLE-DLFNFCSRKFSLKTVLLLADQMISRIEYIH--SK 122

Query: 218 PVIYRDFKTSNIL---LDSDFTAKLSDFGLAKMGPEGSNT-----HVTTRVMGTYGYAAP 269
             I+RD K  N L           + DFGLAK   +              + GT  YA+ 
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182

Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV 329
                   + + D+ S G VL+    G      L+  +++        Y R S +     
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK------YERISEKKMSTP 236

Query: 330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL 374
              L   Y      E A     C S+   D+P  + +     +L 
Sbjct: 237 IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 1e-46
 Identities = 63/279 (22%), Positives = 99/279 (35%), Gaps = 34/279 (12%)

Query: 91  QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE----WLAEVI 146
           ++F  + +LG+G FG V         +     Q  A+K L  + +    +     + + +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAE---FKKTN---QFFAIKALKKDVVLMDDDVECTMVEKRV 55

Query: 147 FLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAA 206
                 HP L  +       E    V E++  G L  H+                A    
Sbjct: 56  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEII 113

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGY 266
            GL FLH     ++YRD K  NILLD D   K++DFG+ K    G          GT  Y
Sbjct: 114 LGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDY 169

Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR 326
            APE +         D +SFGV+L E+L G+       P   Q+  +        +    
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRMDNPFYP 223

Query: 327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAA 365
             ++             E   L ++     P+ R  +  
Sbjct: 224 RWLEK------------EAKDLLVKLFVREPEKRLGVRG 250

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (407), Expect = 1e-46
 Identities = 51/271 (18%), Positives = 96/271 (35%), Gaps = 29/271 (10%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
            LG G FG VH+     +       +    K + ++G         E+  L   RH +++
Sbjct: 12  DLGRGEFGIVHRCV---ETSSK---KTYMAKFVKVKGTD-QVLVKKEISILNIARHRNIL 64

Query: 158 RLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAEN 217
            L       EE ++++EF+    +   +    +  L     +       + L FLH   +
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH--SH 121

Query: 218 PVIYRDFKTSNILLDSD--FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
            + + D +  NI+  +    T K+ +FG A+    G N  +         Y APE     
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL---FTAPEYYAPEVHQHD 178

Query: 276 HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAG 335
            ++T +D++S G ++  LL+G        P   +         + +     Y  D     
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGI------NPFLAETNQQI----IENIMNAEYTFDEEAFK 228

Query: 336 QYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
           + S     E      + +    K R   +  
Sbjct: 229 EIS----IEAMDFVDRLLVKERKSRMTASEA 255

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  159 bits (403), Expect = 2e-46
 Identities = 46/289 (15%), Positives = 86/289 (29%), Gaps = 33/289 (11%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRH-PHL 156
            +GEG FG + +G    +L      Q VA+K           +   E      L     +
Sbjct: 12  RIGEGSFGVIFEGT---NLLNN---QQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGI 63

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
             +  +  E    +LV + +  G     L           T    A      +  +H  E
Sbjct: 64  PNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH--E 119

Query: 217 NPVIYRDFKTSNILLDSDFT-----AKLSDFGLAKMGPEGSNT-----HVTTRVMGTYGY 266
             ++YRD K  N L+    +       + DFG+ K   +              + GT  Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 267 AAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR 326
            +         + + D+ + G V +  L G      L+  + +   +      +S+    
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL-- 237

Query: 327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
                 L   +     +E         ++     P    +      +L 
Sbjct: 238 ----RELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 2e-45
 Identities = 60/295 (20%), Positives = 115/295 (38%), Gaps = 25/295 (8%)

Query: 89  ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE-WLAEVIF 147
           +   +++   +GEG +G V   Y   D         VA+K +     Q + +  L E+  
Sbjct: 6   VGPRYTNLSYIGEGAYGMVCSAY---DNVNK---VRVAIKKISPFEHQTYCQRTLREIKI 59

Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRI-SVSLPWGTRLKIAIGAA 206
           L + RH +++ +           +   ++    +   L+K + +  L             
Sbjct: 60  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQIL 119

Query: 207 KGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT-TRVMGTYG 265
           +GL ++H     V++RD K SN+LL++    K+ DFGLA++     +     T  + T  
Sbjct: 120 RGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 266 YAAPEYISTGHLTTKS-DVYSFGVVLLELLTGR-------------RSMDKLRPKSEQNL 311
           Y APE +      TKS D++S G +L E+L+ R               +  L   S+++L
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237

Query: 312 VDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
                   R+        +     +       +   L  + ++ NP  R ++   
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  156 bits (394), Expect = 8e-45
 Identities = 69/281 (24%), Positives = 112/281 (39%), Gaps = 38/281 (13%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLD---IEGLQGHREWLAEVIFLGQLRHP 154
            LG G FG VH          G   +  A+K+L    +  L+       E + L  + HP
Sbjct: 11  TLGTGSFGRVHLIR---SRHNG---RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64

Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            ++R+ G   + ++  ++ +++  G L + L K      P       A      L +LH 
Sbjct: 65  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCLALEYLH- 121

Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
               +IYRD K  NILLD +   K++DFG AK  P+ + T       GT  Y APE +ST
Sbjct: 122 -SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEVVST 175

Query: 275 GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
                  D +SFG+++ E+L G        P  + N +   +  L +  R     +    
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGY------TPFYDSNTMKTYEKILNAELRFPPFFNE--- 226

Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
                    ++  L  + I+ +   R          E + N
Sbjct: 227 ---------DVKDLLSRLITRDLSQRLGNLQ--NGTEDVKN 256

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 5e-44
 Identities = 69/289 (23%), Positives = 110/289 (38%), Gaps = 36/289 (12%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-----HREWLAEVIFLGQLR 152
            LGEG F TV+K     D       Q VA+K + +          +R  L E+  L +L 
Sbjct: 5   FLGEGQFATVYKAR---DKNTN---QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 58

Query: 153 HPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
           HP+++ L+          LV++FM            +   L         +   +GL +L
Sbjct: 59  HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYL 116

Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
           H  ++ +++RD K +N+LLD +   KL+DFGLAK    GS     T  + T  Y APE +
Sbjct: 117 H--QHWILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELL 172

Query: 273 STGHL-TTKSDVYSFGVVLLELLTGR-------------RSMDKLRPKSEQNLVDWAK-P 317
               +     D+++ G +L ELL                R  + L   +E+   D    P
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232

Query: 318 YLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
              + +    I    +          ++  L       NP  R      
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAG----DDLLDLIQGLFLFNPCARITATQA 277

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-43
 Identities = 64/288 (22%), Positives = 114/288 (39%), Gaps = 23/288 (7%)

Query: 92  NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLG 149
           NF     +GEG +G V+K     +   G   + VA+K + ++          + E+  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKAR---NKLTG---EVVALKKIRLDTETEGVPSTAIREISLLK 56

Query: 150 QLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
           +L HP++V+L+     + +  LV+EF+ +  L+  +       +P            +GL
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGL 115

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
           AF H   + V++RD K  N+L++++   KL+DFGLA+          T  V+  +  A  
Sbjct: 116 AFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPE 172

Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMD----------KLRPKSEQNLVDWAKPYL 319
             +   + +T  D++S G +  E++T R                R     + V W     
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232

Query: 320 RSSRRLRYIVDPRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAV 366
               +  +    R      V    E    L  Q +  +P  R    A 
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-43
 Identities = 59/290 (20%), Positives = 104/290 (35%), Gaps = 41/290 (14%)

Query: 91  QNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA--- 143
           +N    Y     LG G F  V K     +   G      A K +     +  R  ++   
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCR---EKSTG---LQYAAKFIKKRRTKSSRRGVSRED 59

Query: 144 ---EVIFLGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLK 200
              EV  L +++HP+++ L        + +L+ E +  G L + L ++ S  L      +
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATE 117

Query: 201 IAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD----FTAKLSDFGLAKMGPEGSNTHV 256
                  G+ +LH     + + D K  NI+L          K+ DFGLA     G+    
Sbjct: 118 FLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---E 172

Query: 257 TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK 316
              + GT  + APE ++   L  ++D++S GV+   LL+G         +          
Sbjct: 173 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--------- 223

Query: 317 PYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
             L +   + Y  +       S            + +  +PK R  +   
Sbjct: 224 -TLANVSAVNYEFEDEYFSNTS----ALAKDFIRRLLVKDPKKRMTIQDS 268

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 2e-43
 Identities = 57/276 (20%), Positives = 103/276 (37%), Gaps = 32/276 (11%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLV 157
           +LG G  G V + +   + R     +  A+K+L  +  +  RE     +     + PH+V
Sbjct: 19  VLGLGINGKVLQIF---NKRTQ---EKFALKMLQ-DCPKARRE---VELHWRASQCPHIV 68

Query: 158 RLIGYC----CEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLH 213
           R++          +  L+V E +  G L + +  R   +       +I     + + +LH
Sbjct: 69  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128

Query: 214 GAENPVIYRDFKTSNILLDS---DFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE 270
                + +RD K  N+L  S   +   KL+DFG AK     ++         T  Y APE
Sbjct: 129 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPE 183

Query: 271 YISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
            +         D++S GV++  LL G        P    + +  +       R  +Y   
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGY------PPFYSNHGLAISPGMKTRIRMGQYEFP 237

Query: 331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
                + S    +E+ +L    +   P  R  +   
Sbjct: 238 NPEWSEVS----EEVKMLIRNLLKTEPTQRMTITEF 269

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-43
 Identities = 67/287 (23%), Positives = 112/287 (39%), Gaps = 30/287 (10%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW-----LAEVIFLGQLRH 153
           +GEG +G V K     DL+ G   + VA+K + ++  +          +A +  L    H
Sbjct: 15  IGEGAYGKVFKAR---DLKNG--GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69

Query: 154 PHLVRLIGYCCEDEERLLVYEFMP----RGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
           P++VRL   C            +        L  +L K     +P  T   +     +GL
Sbjct: 70  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129

Query: 210 AFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP 269
            FLH   + V++RD K  NIL+ S    KL+DFGLA++    S     T V+ T  Y AP
Sbjct: 130 DFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAP 184

Query: 270 EYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV----------DWAKPYL 319
           E +      T  D++S G +  E+   +          +   +          DW +   
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV- 243

Query: 320 RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
              R+  +    +   ++     +    L L+C++ NP  R    + 
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  150 bits (379), Expect = 5e-43
 Identities = 54/281 (19%), Positives = 109/281 (38%), Gaps = 25/281 (8%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHL 156
           +GEG +G V+K   +         +  A+K + +E          + E+  L +L+H ++
Sbjct: 10  IGEGTYGVVYKAQNNYG-------ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           V+L       +  +LV+E + +   +          L   T     +    G+A+ H  +
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH--D 118

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH 276
             V++RD K  N+L++ +   K++DFGLA+        + T  ++  +  A    + +  
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIVTLWYRAPDVLMGSKK 177

Query: 277 LTTKSDVYSFGVVLLELLTGRRSMDK----------LRPKSEQNLVDWAKPYLRSSRRLR 326
            +T  D++S G +  E++ G                 R     N  +W            
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 327 YIVDPRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAV 366
           + V   L  +  +KG  E  + L  + + ++P  R      
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 1e-41
 Identities = 59/279 (21%), Positives = 102/279 (36%), Gaps = 47/279 (16%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHRE------WLAEVIFLGQL 151
           LLG GGFG+V+ G     +        VA+K ++ + +    E         EV+ L ++
Sbjct: 11  LLGSGGFGSVYSGI---RVSDN---LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 152 RHPH--LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGL 209
                 ++RL+ +    +  +L+ E                 +L             + +
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAV 123

Query: 210 AFLHGAENPVIYRDFKTSNILLDSD-FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAA 268
              H     V++RD K  NIL+D +    KL DFG   +        V T   GT  Y+ 
Sbjct: 124 RHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVYSP 177

Query: 269 PEYISTGHLTTKS-DVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY 327
           PE+I       +S  V+S G++L +++ G        P      +   + + R       
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGD------IPFEHDEEIIRGQVFFRQ------ 225

Query: 328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAV 366
                   + S     E   L   C+++ P DRP    +
Sbjct: 226 --------RVS----SECQHLIRWCLALRPSDRPTFEEI 252

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 2e-40
 Identities = 69/281 (24%), Positives = 99/281 (35%), Gaps = 35/281 (12%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIFLGQLRHP 154
           LLG+G FG V       +   G   +  A+K+L  E +    E    + E   L   RHP
Sbjct: 12  LLGKGTFGKVILVR---EKATG---RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 155 HLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHG 214
            L  L       +    V E+   G L  HL +                     L +LH 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLH- 122

Query: 215 AENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST 274
               V+YRD K  N++LD D   K++DFGL K G     T       GT  Y APE +  
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLED 179

Query: 275 GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLA 334
                  D +  GVV+ E++ GR       P   Q+     +  L    R    + P   
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILMEEIRFPRTLSP--- 230

Query: 335 GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
                    E   L    +  +PK R       +  + ++ 
Sbjct: 231 ---------EAKSLLAGLLKKDPKQRLGGGP--SDAKEVME 260

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 2e-40
 Identities = 65/301 (21%), Positives = 108/301 (35%), Gaps = 37/301 (12%)

Query: 87  RAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVI 146
           R    +++   ++G G FG V++         G   + VA+K +    LQ  R    E+ 
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAK---LCDSG---ELVAIKKV----LQDKRFKNRELQ 65

Query: 147 FLGQLRHPHLVRLIGYCCEDEER------LLVYEFMPRGSLENHL-FKRISVSLPWGTRL 199
            + +L H ++VRL  +     E+       LV +++P         + R   +LP     
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125

Query: 200 KIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD-FTAKLSDFGLAKMGPEGSNTHVTT 258
                  + LA++H     + +RD K  N+LLD D    KL DFG AK    G      +
Sbjct: 126 LYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--S 181

Query: 259 RVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR-------------RSMDKLRP 305
            +   Y  A          T+  DV+S G VL ELL G+               +  L  
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241

Query: 306 KSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAA 365
            + + + +    Y     +   I        +  +   E   L  + +   P  R     
Sbjct: 242 PTREQIREMNPNYTE--FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299

Query: 366 V 366
            
Sbjct: 300 A 300

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 4e-38
 Identities = 60/295 (20%), Positives = 105/295 (35%), Gaps = 37/295 (12%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG--HREWLAEVIFLGQLRHPHL 156
           +G+G FG V K       + G   Q VA+K + +E  +       L E+  L  L+H ++
Sbjct: 18  IGQGTFGEVFKAR---HRKTG---QKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 157 VRLIGYCCEDEER--------LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKG 208
           V LI  C               LV++F               V        ++      G
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLLNG 129

Query: 209 LAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVT--TRVMGTYGY 266
           L ++H   N +++RD K +N+L+  D   KL+DFGLA+      N+     T  + T  Y
Sbjct: 130 LYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187

Query: 267 AAPEYISTGHL-TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLV------------- 312
             PE +          D++  G ++ E+ T    M     + +  L+             
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247

Query: 313 DWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAV 366
           +     L     L      ++  +         A+ L  + + ++P  R      
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 5e-38
 Identities = 58/312 (18%), Positives = 111/312 (35%), Gaps = 41/312 (13%)

Query: 80  DFQLSELRAITQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL 135
            F   E+        + Y     +G G +G V       D R G     VA+K L     
Sbjct: 3   GFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAV---DGRTG---AKVAIKKLYRPFQ 56

Query: 136 --QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE------ERLLVYEFMPRGSLENHLFK 187
                +    E+  L  +RH +++ L+     DE      +  LV  FM  G+    L K
Sbjct: 57  SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMK 114

Query: 188 RISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM 247
                L       +     KGL ++H     +I+RD K  N+ ++ D   K+ DFGLA+ 
Sbjct: 115 HE--KLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170

Query: 248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR---------- 297
               +++ +T  V+  +  A    ++    T   D++S G ++ E++TG+          
Sbjct: 171 ----ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226

Query: 298 ---RSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCIS 354
                M        + +        ++  +    ++ +         +     L  + + 
Sbjct: 227 QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLV 286

Query: 355 VNPKDRPKMAAV 366
           ++ + R      
Sbjct: 287 LDAEQRVTAGEA 298

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 8e-38
 Identities = 55/282 (19%), Positives = 97/282 (34%), Gaps = 25/282 (8%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHL 156
           +GEG +GTV K     +       + VA+K + ++          L E+  L +L+H ++
Sbjct: 10  IGEGTYGTVFKAK---NRETH---EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 157 VRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAE 216
           VRL      D++  LV+EF  +   +        +               KGL F H   
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL--DPEIVKSFLFQLLKGLGFCH--S 119

Query: 217 NPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGH 276
             V++RD K  N+L++ +   KL++FGLA+        + +  V+  +            
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKL 178

Query: 277 LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQ-----------NLVDWAKPYLRSSRRL 325
            +T  D++S G +  EL    R +       +Q               W         + 
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 326 RYIVDPRLAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAV 366
             +     +    V         L    +  NP  R      
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  133 bits (334), Expect = 6e-36
 Identities = 59/280 (21%), Positives = 99/280 (35%), Gaps = 38/280 (13%)

Query: 99  LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREW---LAEVIFLGQLRHPH 155
           LG G FG V           G      A+K+LD + +   ++    L E   L  +  P 
Sbjct: 49  LGTGSFGRVMLVK---HKESG---NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA 215
           LV+L     ++    +V E++  G + +HL +              A        +LH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH-- 158

Query: 216 ENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG 275
              +IYRD K  N+L+D     +++DFG AK     + T     + GT    APE I + 
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSK 213

Query: 276 HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAG 335
                 D ++ GV++ E+  G       +P      +   K    S              
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS-------------- 259

Query: 336 QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
            +S     ++  L    + V+   R         +  + N
Sbjct: 260 HFS----SDLKDLLRNLLQVDLTKRFGNLK--NGVNDIKN 293

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 1e-34
 Identities = 66/285 (23%), Positives = 100/285 (35%), Gaps = 31/285 (10%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL----QGHREWLAEVIFLGQLRH 153
           +LG G +G V           G   +  A+K+L    +    +       E   L  +R 
Sbjct: 31  VLGTGAYGKVFLVRKISGHDTG---KLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87

Query: 154 -PHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFL 212
            P LV L      + +  L+ +++  G L  HL +R                    L  L
Sbjct: 88  SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHL 145

Query: 213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYI 272
           H  +  +IYRD K  NILLDS+    L+DFGL+K               GT  Y AP+ +
Sbjct: 146 H--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIV 202

Query: 273 STGH--LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD 330
             G        D +S GV++ ELLTG         K+ Q  +           R     +
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI----------SRRILKSE 252

Query: 331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN 375
           P    + S         L  + +  +PK R          + +  
Sbjct: 253 PPYPQEMS----ALAKDLIQRLLMKDPKKRLGCGP--RDADEIKE 291

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 3e-32
 Identities = 58/321 (18%), Positives = 113/321 (35%), Gaps = 49/321 (15%)

Query: 79  YDFQLSELRA-ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-- 135
           Y  ++ +    + + + +   +G G  G V   Y   D       + VA+K L       
Sbjct: 4   YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAY---DAVLD---RNVAIKKLSRPFQNQ 57

Query: 136 QGHREWLAEVIFLGQLRHPHLVRLIGYCC------EDEERLLVYEFMPRGSLENHLFKRI 189
              +    E++ +  + H +++ L+          E ++  LV E M     +    +  
Sbjct: 58  THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL- 116

Query: 190 SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP 249
                      +      G+  LH     +I+RD K SNI++ SD T K+ DFGLA+   
Sbjct: 117 ----DHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 169

Query: 250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR------------ 297
               + + T  + T  Y APE I         D++S G ++ E++  +            
Sbjct: 170 --GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227

Query: 298 ----RSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAV------ 347
                 +    P+  + L    + Y+ +  +   +  P+L          E         
Sbjct: 228 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 287

Query: 348 --LALQCISVNPKDRPKMAAV 366
             L  + + ++P  R  +   
Sbjct: 288 RDLLSKMLVIDPAKRISVDDA 308

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  121 bits (305), Expect = 4e-32
 Identities = 50/335 (14%), Positives = 108/335 (32%), Gaps = 51/335 (15%)

Query: 61  SSSTRINEDLAHTFGPDLYDFQLSELRAITQNFSSNY----LLGEGGFGTVHKGYIDDDL 116
            S  R+  D+      + +D++   +    Q+   +Y     LG G +  V +     ++
Sbjct: 4   PSRARVYTDVNTHRPREYWDYESHVVEWGNQD---DYQLVRKLGRGKYSEVFEAI---NI 57

Query: 117 RQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-HPHLVRLIGYCCEDEERL--LVY 173
                 + V VK+L     +   +   E+  L  LR  P+++ L     +   R   LV+
Sbjct: 58  TNN---EKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111

Query: 174 EFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS 233
           E +     +          L             K L + H     +++RD K  N+++D 
Sbjct: 112 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDH 164

Query: 234 DF-TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPE-YISTGHLTTKSDVYSFGVVLL 291
           +    +L D+GLA+    G         + +  +  PE  +         D++S G +L 
Sbjct: 165 EHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 221

Query: 292 ELLTGRR-------------------SMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR 332
            ++  +                      + L    ++  ++    +     R       R
Sbjct: 222 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 281

Query: 333 LAGQYSVKGAKEMAV-LALQCISVNPKDRPKMAAV 366
                +       A+    + +  + + R      
Sbjct: 282 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 2e-31
 Identities = 62/313 (19%), Positives = 119/313 (38%), Gaps = 42/313 (13%)

Query: 76  PDLYDFQLSELRAITQNFSSNY----LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLL- 130
           P  Y  +L++           Y     +G G +G+V   +   D + G     VAVK L 
Sbjct: 2   PTFYRQELNK---TIWEVPERYQNLSPVGSGAYGSVCAAF---DTKTG---LRVAVKKLS 52

Query: 131 -DIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYC-----CEDEERLLVYEFMPRGSLENH 184
              + +   +    E+  L  ++H +++ L+         E+   + +   +    L N 
Sbjct: 53  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 112

Query: 185 LFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL 244
           +  +    L       +     +GL ++H     +I+RD K SN+ ++ D   K+ DFGL
Sbjct: 113 VKCQ---KLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGL 167

Query: 245 AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR------- 297
           A+     ++  +T  V   +  A    ++  H     D++S G ++ ELLTGR       
Sbjct: 168 ARH----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

Query: 298 -----RSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAV-LALQ 351
                + + +L       L+         +        P++       GA  +AV L  +
Sbjct: 224 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 283

Query: 352 CISVNPKDRPKMA 364
            + ++   R   A
Sbjct: 284 MLVLDSDKRITAA 296

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (266), Expect = 2e-26
 Identities = 55/314 (17%), Positives = 106/314 (33%), Gaps = 53/314 (16%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHP--- 154
            LG G F TV       D+        VA+K++  + +        E+  L ++      
Sbjct: 20  KLGWGHFSTVWLAK---DMVNN---THVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNT 72

Query: 155 --------HLVRLIGYCCEDEERLLVYEFMPRGSLENHLF---KRISVSLPWGTRLKIAI 203
                   H+++L+ +        +    +     EN L    K     +P     +I+ 
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132

Query: 204 GAAKGLAFLHGAENPVIYRDFKTSNILLDS-DFTAKLSDFGLAKMGPEGSNTHVTTRVMG 262
               GL ++H     +I+ D K  N+L++  D    L    +A +G         T  + 
Sbjct: 133 QLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 263 TYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD--------- 313
           T  Y +PE +        +D++S   ++ EL+TG    +     S     D         
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251

Query: 314 ------------WAKPYLRSSRRLRYIVDPRL---------AGQYSVKGAKEMAVLALQC 352
                       + + +  S   LR I   +            ++S   AKE++      
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311

Query: 353 ISVNPKDRPKMAAV 366
           + ++P+ R     +
Sbjct: 312 LQLDPRKRADAGGL 325

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 74.0 bits (181), Expect = 4e-16
 Identities = 21/159 (13%), Positives = 44/159 (27%), Gaps = 25/159 (15%)

Query: 98  LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL----------QGHREWLAEVIF 147
           L+GEG    V   Y +             VK   +              G   +    I 
Sbjct: 7   LMGEGKESAVFNCYSEKF-------GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59

Query: 148 LGQLRHPHLVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAK 207
             +     L +L G           Y +     L   +  +    +      ++     +
Sbjct: 60  SARNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILE 114

Query: 208 GLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK 246
            +A  +     +++ D    N+L+  +    + DF  + 
Sbjct: 115 EVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	419
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.78
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.25
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.02
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.29
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.18
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.14

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-58  Score=425.62  Aligned_cols=254  Identities=24%  Similarity=0.353  Sum_probs=206.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|++++.||+|+||+||+|..      ..+++.||||++..... ...+.+.+|+++|++++|||||++++++.+++.
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~------~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~   77 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVN------RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI   77 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEE------TTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             CcceEEEEEEecCcCeEEEEEEE------CCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCce
Confidence            35799999999999999999964      44578999999976533 234568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|||||||+||+|.+++...  ..+++..++.++.||+.||+|||  ++||+||||||+|||++.++.+||+|||+|+..
T Consensus        78 ~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH--~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~  153 (271)
T d1nvra_          78 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVF  153 (271)
T ss_dssp             EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--HcCCccCcccHHHEEECCCCCEEEccchhheee
Confidence            99999999999999999654  57999999999999999999999  677999999999999999999999999999876


Q ss_pred             CCCCCceeeecccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHL-TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ............+||+.|||||++.+..+ +.++|||||||++|||++|+.||............ ..     ..     
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-~~-----~~-----  222 (271)
T d1nvra_         154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-WK-----EK-----  222 (271)
T ss_dssp             EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-HH-----TT-----
T ss_pred             ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-Hh-----cC-----
Confidence            54444334456789999999999988776 57899999999999999999999865433221111 00     00     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                          ..........++++.+|+.+||+.||++|||++|+++
T Consensus       223 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         223 ----KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ----CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                0011112344678999999999999999999999865

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-57  Score=422.88  Aligned_cols=250  Identities=22%  Similarity=0.362  Sum_probs=210.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|++.+.||+|+||+||+|.      +..+++.||||++........+.+.+|+.+|+.++|||||+++++|.+++..|
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~------~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   93 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAM------DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEE------BTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cccEEEEEEecCcCcEEEEEE------ECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence            479999999999999999995      44567899999998766666788999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      ||||||+||+|.+++.++   .+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++....
T Consensus        94 ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH--~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            999999999999987654   6899999999999999999999  67799999999999999999999999999987644


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD  330 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (419)
                      ...  .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+      ....        
T Consensus       169 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~------~~~~--------  232 (293)
T d1yhwa1         169 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNG--------  232 (293)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHHC--------
T ss_pred             ccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH------HhCC--------
Confidence            332  234567999999999999999999999999999999999999999764432211111      0000        


Q ss_pred             cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       331 ~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       ...-..+..++.++.+||.+||+.||.+|||+.|+++
T Consensus       233 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         233 -TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -CCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0011223445688999999999999999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-57  Score=417.93  Aligned_cols=246  Identities=26%  Similarity=0.369  Sum_probs=207.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++++.||+|+||+||+|..      ..+++.||+|++....   ....+.+.+|+.+|+.++|||||++++++.+++
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~------~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~   79 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLARE------KQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   79 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hHeEEEEEEecCCCcEEEEEEE------CCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence            5799999999999999999964      3457899999986432   234567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+|||||++|+|.+++...  ..+++..++.++.||+.||+|||  ++||+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH--~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~  155 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVH  155 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred             EEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeeeeccccceecCCCCEeecccceeee
Confidence            999999999999999999766  57899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      .....    .....||+.|||||++.+..|+.++|||||||++|+|++|+.||...........+      . ..     
T Consensus       156 ~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~-~~-----  219 (263)
T d2j4za1         156 APSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI------S-RV-----  219 (263)
T ss_dssp             CCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------H-TT-----
T ss_pred             cCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH------H-cC-----
Confidence            54432    33467999999999999999999999999999999999999999764432211111      0 00     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                            ...++...++++.+|+.+||+.||++|||++|+++
T Consensus       220 ------~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         220 ------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                  01223345688999999999999999999999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=416.30  Aligned_cols=261  Identities=29%  Similarity=0.481  Sum_probs=205.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .++|.+.++||+|+||+||+|+++         ..||||+++...  ....+.|.+|+.+|++++|||||++++++. ++
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~   76 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-AP   76 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-cc
Confidence            368999999999999999999643         249999997543  344678999999999999999999999864 56


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      .+++|||||++|+|.+++... ...+++..++.++.||+.||+|||  ++|||||||||+||||+.++.+||+|||+|+.
T Consensus        77 ~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH--~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~  153 (276)
T d1uwha_          77 QLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV  153 (276)
T ss_dssp             SCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred             EEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHh--cCCEeccccCHHHEEEcCCCCEEEccccceee
Confidence            789999999999999998654 246899999999999999999999  56799999999999999999999999999987


Q ss_pred             CCCCCCceeeecccccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYIST---GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      ..............||+.|||||++.+   ..|+.++|||||||++|||+||+.||............  .    ... .
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~--~----~~~-~  226 (276)
T d1uwha_         154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM--V----GRG-Y  226 (276)
T ss_dssp             ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--H----HHT-S
T ss_pred             ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH--H----hcC-C
Confidence            655444444456789999999999864   45899999999999999999999999875433211111  0    010 0


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                          ..+. ....+..+++++.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       227 ----~~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         227 ----LSPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             ----CCCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                0011 112334456889999999999999999999999999998865

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.6e-57  Score=421.31  Aligned_cols=261  Identities=25%  Similarity=0.377  Sum_probs=216.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .++|++.+.||+|+||+||+|.+..      +++.||||+++... ...++|.+|+.+|++++|||||+++++|.+++..
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGG------GTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECC------CCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            4678899999999999999996543      46789999997543 3567899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+||||+++|+|.+++.......+++..++.++.||+.||+|||  ++||+||||||+||||+.++.+||+|||+++...
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH--~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH--HCCcccCccccCeEEECCCCcEEEccccceeecC
Confidence            99999999999999998776778999999999999999999999  6779999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      .... .......||+.|+|||++.+..|+.++|||||||++|||++|..||.......  .....    ...        
T Consensus       167 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--~~~~~----i~~--------  231 (287)
T d1opja_         167 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYEL----LEK--------  231 (287)
T ss_dssp             SSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHH----HHT--------
T ss_pred             CCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--HHHHH----Hhc--------
Confidence            4332 22334458999999999999999999999999999999999776654332211  11111    111        


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                        .....++..+++++.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       232 --~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         232 --DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             --CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence              111223345568899999999999999999999999999988654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-57  Score=420.56  Aligned_cols=251  Identities=22%  Similarity=0.279  Sum_probs=206.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++++.||+|+||+||+|..      ..+++.||||++....   ....+.+.+|+++|++++|||||+++++|.+++
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~------~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   81 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARE------LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE   81 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred             CCCEEEEEEeeCCCeEEEEEEE------CCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC
Confidence            5799999999999999999964      4457889999996432   234567899999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+|||||+||+|.+++...  ..+++..++.++.|++.||+|||  ++|||||||||+|||++.++.+||+|||+|+.
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH--~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~  157 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKV  157 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhc--cccEEcCcCCccccccCCCceEEeccccccee
Confidence            999999999999999998766  57999999999999999999999  67799999999999999999999999999997


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      .............+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...........+      ...  .   
T Consensus       158 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i------~~~--~---  226 (288)
T d1uu3a_         158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------IKL--E---  226 (288)
T ss_dssp             CC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HTT--C---
T ss_pred             cccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH------HcC--C---
Confidence            76544444445567999999999999999999999999999999999999999865322211111      100  0   


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT  369 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~  369 (419)
                             -.++...++++.+||.+||+.||.+|||++|+++.
T Consensus       227 -------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         227 -------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             -------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             -------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence                   11233456789999999999999999999998653

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-56  Score=416.09  Aligned_cols=252  Identities=22%  Similarity=0.328  Sum_probs=208.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      +.|++++.||+|+||.||+|..      ..+++.||||++........+.+.+|+++|++++|||||++++++.+++..|
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~------~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   85 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQN------KETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW   85 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEE------TTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEE------CCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEE
Confidence            4689999999999999999964      4457889999998776666788999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      ||||||++|+|.+++.+. ...+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+|+....
T Consensus        86 lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH--~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             EEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             EEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            999999999999987654 346899999999999999999999  67799999999999999999999999999975422


Q ss_pred             CCCceeeeccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYIS-----TGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      ..  ......+||+.|+|||++.     +..|+.++|||||||++|+|++|+.||...........+.       ...  
T Consensus       163 ~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~-------~~~--  231 (288)
T d2jfla1         163 TI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-------KSE--  231 (288)
T ss_dssp             HH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-------HSC--
T ss_pred             Cc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH-------cCC--
Confidence            11  1123467999999999983     4668999999999999999999999998765433211111       000  


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                            ...-..+...++++.+||.+||+.||.+|||+.|+++
T Consensus       232 ------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         232 ------PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ------CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  0011223445688999999999999999999999875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-56  Score=412.70  Aligned_cols=253  Identities=23%  Similarity=0.360  Sum_probs=195.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEe--C
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCE--D  166 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~  166 (419)
                      ++|++.+.||+|+||+||+|..      ..+++.||+|++.....  ...+.+.+|+++|++++|||||++++++.+  +
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~------~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   77 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRR------KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN   77 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE------TTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred             hhCEEeEEEecCCCeEEEEEEE------CCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence            6799999999999999999954      44578999999976543  334678899999999999999999999865  4


Q ss_pred             CeeEEEEEecCCCChhhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHhhcCC---CCeeecCCCCCcEEEcCCCcEEEec
Q 014736          167 EERLLVYEFMPRGSLENHLFKR--ISVSLPWGTRLKIAIGAAKGLAFLHGAE---NPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                      +.+|+|||||++|+|.+++.+.  ....+++..++.++.||+.||.|||+.+   ++|+||||||+||||+.++.+||+|
T Consensus        78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D  157 (269)
T d2java1          78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  157 (269)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence            5689999999999999998653  2467999999999999999999999532   3599999999999999999999999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhc
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRS  321 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  321 (419)
                      ||+++.......  ......||+.|||||++.+..|+.++|||||||++|||++|+.||.......   .....   . .
T Consensus       158 FG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~~i---~-~  228 (269)
T d2java1         158 FGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKI---R-E  228 (269)
T ss_dssp             HHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH---H-H
T ss_pred             ccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHHHH---H-c
Confidence            999987644322  2345679999999999999999999999999999999999999997654322   11111   0 1


Q ss_pred             ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          322 SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       322 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      . ..         ...+..+++++.+|+.+||+.||.+|||+.||++
T Consensus       229 ~-~~---------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         229 G-KF---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             T-CC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C-CC---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            0 00         1223345678999999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-55  Score=413.76  Aligned_cols=263  Identities=25%  Similarity=0.438  Sum_probs=203.4

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|++.++||+|+||+||+|.+..+   ......||||.+..... ...+.|.+|+.+|++++|||||++++++.+++..
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  102 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLP---GKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV  102 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCC---CCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            4677888999999999999976542   12234689999865433 3456799999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+|||||++|+|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+||||+.++.+||+|||+++...
T Consensus       103 ~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHh--hCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence            9999999999999988654 346899999999999999999999  6779999999999999999999999999998765


Q ss_pred             CCCCcee---eecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          250 EGSNTHV---TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       250 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      .......   .....||+.|||||++.++.|+.++|||||||++|||+| |+.||.......   .....    ...   
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~~i----~~~---  249 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VINAI----EQD---  249 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH----HTT---
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcC---
Confidence            4332221   122458999999999999999999999999999999998 899998654322   11111    111   


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                             .....+..+++++.+|+.+||+.||.+|||+.+|++.|++++..
T Consensus       250 -------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         250 -------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence                   11123345678899999999999999999999999999998764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-56  Score=407.62  Aligned_cols=256  Identities=27%  Similarity=0.431  Sum_probs=200.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|++.+.||+|+||+||+|.+.+       ++.||||+++... ...++|.+|++++++++|||||++++++.+++..|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~-------~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLN-------KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   76 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETT-------TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECC-------CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence            478889999999999999997543       4579999997543 34578999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+++|+|.+++... ...+++..++.++.||+.||.|||  +++|+||||||+|||++.++.+||+|||+++....
T Consensus        77 lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH--~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  153 (263)
T ss_dssp             EEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred             EEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhh--ccceeecccchhheeecCCCCeEecccchheeccC
Confidence            999999999999988654 356889999999999999999999  67799999999999999999999999999987644


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG-RRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      .... ......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||......   .......    ...      
T Consensus       154 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~---~~~~~i~----~~~------  219 (263)
T d1sm2a_         154 DQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDIS----TGF------  219 (263)
T ss_dssp             ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH---HHHHHHH----HTC------
T ss_pred             CCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH---HHHHHHH----hcC------
Confidence            3322 22335699999999999999999999999999999999995 5555443221   1111111    110      


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                          ....+..+++++.+|+.+||+.||++|||+++|++.|+++.+
T Consensus       220 ----~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         220 ----RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                111223446789999999999999999999999999998854

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-56  Score=421.04  Aligned_cols=263  Identities=25%  Similarity=0.384  Sum_probs=213.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCC-CcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  167 (419)
                      .++|+++++||+|+||+||+|++... ........||+|++.... ......+.+|+.+|.++ +|||||++++++.+.+
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGI-SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESC-SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCC-CcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            36789999999999999999987653 222344579999986542 33456788999999998 8999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccC---------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 014736          168 ERLLVYEFMPRGSLENHLFKRIS---------------------VSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKT  226 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp  226 (419)
                      ..|+|||||++|+|.+++..+..                     ..+++..++.++.||+.||.|||  ++|||||||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH--~~~IiHRDlKp  192 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAA  192 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH--HTTEEETTCSG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCch
Confidence            99999999999999999975431                     34788999999999999999999  56799999999


Q ss_pred             CcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 014736          227 SNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRP  305 (419)
Q Consensus       227 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~  305 (419)
                      +|||++.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||++ |+.||.+...
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987655544444455678999999999999999999999999999999998 8999986543


Q ss_pred             ccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 014736          306 KSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLE  371 (419)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~  371 (419)
                      .....  .    .....          .....+..+++++.+|+.+||+.||++|||++||++.|.
T Consensus       273 ~~~~~--~----~~~~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DANFY--K----LIQNG----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHHHH--H----HHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHH--H----HHhcC----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            32111  1    11111          111233445688999999999999999999999999985

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-56  Score=424.14  Aligned_cols=270  Identities=27%  Similarity=0.362  Sum_probs=208.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|+++++||+|+||+||+|+.      ..+++.||+|+++.... .....+.+|+.+|+.++|||||+++++|.+.++
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~------~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   78 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSH------KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE   78 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEE------TTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEE------CCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            56899999999999999999954      44578999999976533 335678999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .||||||++||+|.+++.+.  ..+++..+..++.||+.||.|||+ .+||+||||||+||||+.++.+||+|||+|+..
T Consensus        79 ~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~-~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          79 ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH-hCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            99999999999999999776  568999999999999999999994 147999999999999999999999999999864


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHh-hhH----------
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW-AKP----------  317 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~-~~~----------  317 (419)
                      ...    .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.............. ...          
T Consensus       156 ~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (322)
T d1s9ja_         156 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  231 (322)
T ss_dssp             HHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred             CCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence            322    12346799999999999999999999999999999999999999976543221100000 000          


Q ss_pred             --------Hhhcc-------cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHh
Q 014736          318 --------YLRSS-------RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA--TLES  372 (419)
Q Consensus       318 --------~~~~~-------~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~--~L~~  372 (419)
                              .....       ...................+.++.+|+.+||+.||.+|||++|+++  +|+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                    00000       0000000000000111224578999999999999999999999987  4554

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.1e-56  Score=416.41  Aligned_cols=253  Identities=22%  Similarity=0.321  Sum_probs=193.6

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-cHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      +.+.|++.++||+|+||+||+|..      ..+++.||||++...... ....+.+|+.+|+.++|||||++++++.+++
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~------~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   80 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAED------KRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG   80 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEE------TTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CccceEEEEEEeeccCeEEEEEEE------CCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            567899999999999999999954      445789999999755332 2356778999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc---CCCcEEEeccCc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD---SDFTAKLSDFGL  244 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGl  244 (419)
                      .+|||||||+||+|.+++...  ..+++..+..++.||+.||+|||  ++||+||||||+|||+.   .++.+||+|||+
T Consensus        81 ~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH--~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~  156 (307)
T d1a06a_          81 HLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGL  156 (307)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred             EEEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhh--hceeeeEEecccceeecccCCCceEEEeccce
Confidence            999999999999999999765  57999999999999999999999  67799999999999995   478999999999


Q ss_pred             cccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          245 AKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       245 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      ++......   .....+||+.|||||++.+..|+.++|||||||++|+|++|+.||...........+      ....  
T Consensus       157 a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i------~~~~--  225 (307)
T d1a06a_         157 SKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI------LKAE--  225 (307)
T ss_dssp             -------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HTTC--
T ss_pred             eEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------hccC--
Confidence            98654332   233467999999999999999999999999999999999999999764322211111      1110  


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                            ...........++++.+|+.+||+.||++|||+.|+++
T Consensus       226 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         226 ------YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             ------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ------CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                  11112223445688999999999999999999999986

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-55  Score=404.11  Aligned_cols=247  Identities=25%  Similarity=0.352  Sum_probs=196.8

Q ss_pred             CCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEe----CC
Q 014736           94 SSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCE----DE  167 (419)
Q Consensus        94 ~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~  167 (419)
                      ++.++||+|+||+||+|...      .+++.||+|++....  ....+.+.+|+++|++++|||||++++++.+    ..
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~------~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   85 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDT------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK   85 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEET------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             EeeeEEecCcCcEEEEEEEC------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence            55668999999999999643      456889999987543  2345678899999999999999999999875    34


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc-CCCcEEEeccCccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD-SDFTAKLSDFGLAK  246 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGla~  246 (419)
                      .+|+||||+++|+|.+++.+.  ..+++..++.++.||+.||+|||+.+.+|+||||||+||||+ .++.+||+|||+++
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            689999999999999999776  578999999999999999999994333499999999999997 47899999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ......    ....+||+.|||||++.+ .|+.++|||||||++|||++|+.||........  .....   . ...   
T Consensus       164 ~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~~i---~-~~~---  229 (270)
T d1t4ha_         164 LKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRV---T-SGV---  229 (270)
T ss_dssp             GCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHH---T-TTC---
T ss_pred             eccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHHHH---H-cCC---
Confidence            643322    334679999999999865 699999999999999999999999975432211  11110   0 000   


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                            ....++...++++.+|+.+||+.||++|||+.|+++
T Consensus       230 ------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         230 ------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                  001122234567999999999999999999999975

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.7e-55  Score=417.90  Aligned_cols=253  Identities=21%  Similarity=0.289  Sum_probs=211.1

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .++|++++.||+|+||.||+|.      +..+++.||||++..........+.+|+.+|++++|||||+++++|.+++.+
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~------~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~  101 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCV------EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  101 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEE------ETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEecCCCeEEEEEE------ECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            4679999999999999999995      4455789999999876655667788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc--CCCcEEEeccCcccc
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD--SDFTAKLSDFGLAKM  247 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfGla~~  247 (419)
                      |||||||+||+|.+++... ...+++..++.++.||+.||.|||  ++|||||||||+||||+  .++.+||+|||+|..
T Consensus       102 ~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH--~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_         102 VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             EEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccccccccccccCCCeEEEeeccccee
Confidence            9999999999999887554 346899999999999999999999  67799999999999998  578999999999987


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ......   .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+      ...      
T Consensus       179 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~~------  243 (352)
T d1koba_         179 LNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV------KRC------  243 (352)
T ss_dssp             CCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HHC------
T ss_pred             cCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhC------
Confidence            655432   34456999999999999999999999999999999999999999865432211111      000      


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        +..+........+.++.+||.+||+.||.+|||+.|+++
T Consensus       244 --~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         244 --DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             --CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             --CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              011122223345688999999999999999999999976

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.3e-55  Score=418.46  Aligned_cols=253  Identities=23%  Similarity=0.298  Sum_probs=210.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .++|++++.||+|+||.||+|..      ..+++.||||++........+.+.+|+.+|++++|||||++++++.+++.+
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~------~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   98 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTE------RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM   98 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEE------TTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEE------CCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46899999999999999999954      445789999999877666677889999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC--CCcEEEeccCcccc
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS--DFTAKLSDFGLAKM  247 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGla~~  247 (419)
                      |||||||+||+|.+++.+. ...+++..++.++.||+.||.|||  ++|||||||||+|||++.  ++.+||+|||+++.
T Consensus        99 ~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH--~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  175 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH--hcCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence            9999999999999998644 246999999999999999999999  677999999999999964  67899999999987


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ......   .....||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.........+      .....    
T Consensus       176 ~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~~~----  242 (350)
T d1koaa2         176 LDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------KSCDW----  242 (350)
T ss_dssp             CCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHTCC----
T ss_pred             cccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCC----
Confidence            654432   33467999999999999999999999999999999999999999765332211111      11110    


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                          .........+++++.+||.+||+.||.+|||+.|+++
T Consensus       243 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         243 ----NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             ----CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ----CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0111122345678999999999999999999999987

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=407.46  Aligned_cols=257  Identities=30%  Similarity=0.449  Sum_probs=208.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      .++|++.+.||+|+||.||+|.+++       ++.||||+++... ...+.|.+|+++|++++|||||++++++. ++..
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~   82 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNG-------HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPI   82 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECC-------CCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCe
Confidence            4678899999999999999997543       4679999997543 34578999999999999999999999875 4667


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+||||+++|+|.+++.......+++..++.++.||+.||.|||  ++||+||||||+||||+.++.+||+|||+|+...
T Consensus        83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH--~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~  160 (272)
T d1qpca_          83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (272)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCccchhheeeecccceeeccccceEEcc
Confidence            99999999999999887665557999999999999999999999  6779999999999999999999999999998765


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRS-MDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      .... .......||+.|+|||++.++.|+.++|||||||++|||+||..| |......   ......    ...      
T Consensus       161 ~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~---~~~~~i----~~~------  226 (272)
T d1qpca_         161 DNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNL----ERG------  226 (272)
T ss_dssp             SSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH----HTT------
T ss_pred             CCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH---HHHHHH----Hhc------
Confidence            4322 223345699999999999999999999999999999999996555 4432211   111111    111      


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                          .....+..+++++.+|+.+||+.||++|||+++|++.|+.+..
T Consensus       227 ----~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         227 ----YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence                1112233456789999999999999999999999999987653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=402.61  Aligned_cols=252  Identities=31%  Similarity=0.432  Sum_probs=203.4

Q ss_pred             CeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeEEEEE
Q 014736           97 YLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERLLVYE  174 (419)
Q Consensus        97 ~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  174 (419)
                      ++||+|+||+||+|.+.+    ...++.||||+++...  ....+.|.+|+.+|++++|||||++++++.+ +..|||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~----~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE   87 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQM----KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME   87 (277)
T ss_dssp             EEEEECSSEEEEEEEEEC----SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             CCcccCCCeEEEEEEEcc----CCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEE
Confidence            469999999999997643    2346789999996542  2335679999999999999999999999865 56789999


Q ss_pred             ecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCCc
Q 014736          175 FMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSNT  254 (419)
Q Consensus       175 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  254 (419)
                      |+++|+|.+++...  ..+++..++.++.||+.||+|||  ++||+||||||+||||+.++.+||+|||+++........
T Consensus        88 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH--~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          88 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             cCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHH--hCCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            99999999998765  56899999999999999999999  677999999999999999999999999999876544332


Q ss_pred             e-eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccccccc
Q 014736          255 H-VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDPR  332 (419)
Q Consensus       255 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (419)
                      . ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+       ....         
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i-------~~~~---------  227 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGE---------  227 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------HTTC---------
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH-------HcCC---------
Confidence            2 2234579999999999999999999999999999999998 89999865432211111       1111         


Q ss_pred             cCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhh
Q 014736          333 LAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLL  374 (419)
Q Consensus       333 l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~  374 (419)
                       ....+..+++++.+|+.+||+.||.+|||+++|++.|+...
T Consensus       228 -~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         228 -RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             -CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence             11233445688999999999999999999999998887653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=404.79  Aligned_cols=266  Identities=26%  Similarity=0.411  Sum_probs=205.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      +.|++.++||+|+||.||+|.+..+  .......||||++..... .....|.+|+.+|++++|||||++++++.+.+..
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~--~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTS--SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCC--CCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            4577888999999999999987653  223345799999975433 3345789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      ++||||+.+++|.+++... ...+++..++.++.||+.||.|||  +++|+||||||+||||+.++.+||+|||+++...
T Consensus        85 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH--~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          85 MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcc--ccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999999887654 357899999999999999999999  6779999999999999999999999999998764


Q ss_pred             CCCCc-eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNT-HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ..... .......||+.|+|||++.++.++.++|||||||++|||++|..|+......  ......    ....      
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~----i~~~------  229 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKA----INDG------  229 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHH----HHTT------
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHH----Hhcc------
Confidence            43222 2233456899999999999999999999999999999999965555432211  111111    1111      


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                          .....+..++.++.+|+.+||+.||++|||+.+|++.|+++....
T Consensus       230 ----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         230 ----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             ----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             ----CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence                112233446688999999999999999999999999999987653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-54  Score=396.47  Aligned_cols=254  Identities=20%  Similarity=0.380  Sum_probs=211.9

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|++.++||+|+||+||+|++++       ++.||||+++.... ..++|.+|+.++++++||||+++++++.+++..+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~-------~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~   75 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRG-------QYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   75 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETT-------TEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECC-------CCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Confidence            579999999999999999997542       56899999986543 4578999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+.+|+|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|||+++....
T Consensus        76 iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH--~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          76 IITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  152 (258)
T ss_dssp             EEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH--HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred             EEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHh--hcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence            999999999999987554 246889999999999999999999  67799999999999999999999999999986554


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIV  329 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (419)
                      .... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+....+       ....      
T Consensus       153 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i-------~~~~------  218 (258)
T d1k2pa_         153 DEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------AQGL------  218 (258)
T ss_dssp             SSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-------HTTC------
T ss_pred             CCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH-------HhCC------
Confidence            4322 2334669999999999999999999999999999999998 89999876533221111       1111      


Q ss_pred             ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          330 DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       330 ~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                          ....+...+.++.+|+.+||+.||++|||+++|++.|.+|
T Consensus       219 ----~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         219 ----RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             ----CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                1122334567899999999999999999999999988653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=404.36  Aligned_cols=260  Identities=27%  Similarity=0.410  Sum_probs=209.8

Q ss_pred             cCCCCCCe-ecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYL-LGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~-lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|.+... ||+|+||.||+|.+..    ..++..||||+++... ....+.|.+|+++|++++|||||++++++.+ +.
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~----~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRM----RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             cCeEECCcEEecccCeEEEEEEEec----CCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            45666664 9999999999997643    2234679999997543 3345789999999999999999999999865 56


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .||||||+++|+|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+||||+.++.+||+|||+++..
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH--~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence            89999999999999987543 356899999999999999999999  577999999999999999999999999999876


Q ss_pred             CCCCCce-eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          249 PEGSNTH-VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       249 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      ....... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+....+       ..+.   
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i-------~~~~---  229 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------EQGK---  229 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH-------HTTC---
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcCC---
Confidence            5443222 2234568999999999999999999999999999999998 99999876533211111       1111   


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                             ....+..+++++.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       230 -------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         230 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                   112334566889999999999999999999999999987754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-54  Score=411.87  Aligned_cols=248  Identities=26%  Similarity=0.343  Sum_probs=208.8

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC---CcccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE---GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++++.||+|+||.||+|+      +..+++.||||++...   .....+.+.+|+.+|+.++||||++++++|.+.+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~------~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   78 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVR------EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD   78 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEE------ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred             HhcEEEEEEecCcCeEEEEEE------ECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc
Confidence            579999999999999999995      4456789999999753   2234677889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      .+|+|||||+||+|.+++...  ..+++..++.++.||+.||+|||  ++|||||||||+|||++.+|.+||+|||+|+.
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH--~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~  154 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             ccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhh--hcCccccccCHHHeEecCCCCEEEeecccccc
Confidence            999999999999999998876  57899999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ......  .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.........+      ...  .   
T Consensus       155 ~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i------~~~--~---  221 (337)
T d1o6la_         155 GISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LME--E---  221 (337)
T ss_dssp             SCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHC--C---
T ss_pred             cccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH------hcC--C---
Confidence            543322  234567999999999999999999999999999999999999999875432211111      000  0   


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK-----MAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs-----~~eil~  368 (419)
                             -.++...+.++.+||.+||++||.+|++     +++|++
T Consensus       222 -------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 -------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                   1233445678999999999999999995     788876

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.2e-55  Score=410.55  Aligned_cols=246  Identities=27%  Similarity=0.378  Sum_probs=202.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc---cHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ---GHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      +.|+.++.||+|+||.||+|+.      ..+++.||||++......   ..+.+.+|+.+|++++|||||++++++.+++
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~------~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   88 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARD------VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH   88 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEE------TTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             HhcEeeEEEecCCCeEEEEEEE------CCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC
Confidence            3589999999999999999954      445788999999765432   3456889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+|||||.+|+|..++..+  ..+++..++.++.||+.||.|||  ++|||||||||+||||+.++.+||+|||++..
T Consensus        89 ~~~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH--~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~  164 (309)
T d1u5ra_          89 TAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (309)
T ss_dssp             EEEEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             EEEEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--hCCEeccCCCcceEEECCCCCEEEeecccccc
Confidence            999999999999997766554  57999999999999999999999  67799999999999999999999999999986


Q ss_pred             CCCCCCceeeecccccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYIST---GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRR  324 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  324 (419)
                      ....      ....||+.|||||++.+   +.|+.++|||||||++|||++|+.||........   ..   ......  
T Consensus       165 ~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~---~~---~i~~~~--  230 (309)
T d1u5ra_         165 MAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LY---HIAQNE--  230 (309)
T ss_dssp             SSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HH---HHHHSC--
T ss_pred             cCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH---HH---HHHhCC--
Confidence            4332      23569999999999854   4689999999999999999999999976532211   11   111110  


Q ss_pred             cccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          325 LRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       325 ~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                              .....+..+++++.+|+.+||+.||.+|||+.++++
T Consensus       231 --------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         231 --------SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             --------CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                    011112334678999999999999999999999976

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=406.30  Aligned_cols=253  Identities=21%  Similarity=0.293  Sum_probs=207.8

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc------ccHHHHHHHHHHHcCCCcccccceeeE
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL------QGHREWLAEVIFLGQLRHPHLVRLIGY  162 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~~~~~  162 (419)
                      +.++|++++.||+|+||+||+|..      ..+++.||||++.....      ...+.+.+|+.+|++++|||||+++++
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~------~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~   81 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCRE------KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV   81 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEE------TTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEE------CCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            457899999999999999999964      44578999999964322      235778999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC----cEE
Q 014736          163 CCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF----TAK  238 (419)
Q Consensus       163 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~----~~k  238 (419)
                      |.+.+.+|||||||+||+|.+++...  ..+++..++.++.||+.||+|||  ++||+||||||+|||++.++    .+|
T Consensus        82 ~~~~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH--~~~ivHrDiKp~Nill~~~~~~~~~vk  157 (293)
T d1jksa_          82 YENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIK  157 (293)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCSSSSSCCEE
T ss_pred             EEECCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhh--hcceeecccccceEEEecCCCcccceE
Confidence            99999999999999999999999776  57999999999999999999999  67799999999999998876    499


Q ss_pred             EeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          239 LSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       239 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      |+|||++........   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+      
T Consensus       158 l~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i------  228 (293)
T d1jksa_         158 IIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------  228 (293)
T ss_dssp             ECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------
T ss_pred             ecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH------
Confidence            999999987654432   33457999999999999999999999999999999999999999864322211111      


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ......        .........+.++.+||.+||+.||.+|||++++++
T Consensus       229 ~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         229 SAVNYE--------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HTTCCC--------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HhcCCC--------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000        000111234578999999999999999999999975

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6e-54  Score=405.24  Aligned_cols=245  Identities=27%  Similarity=0.386  Sum_probs=206.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC---CcccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE---GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++++.||+|+||+||+|..      ..+++.||||+++..   .....+.+.+|+.+|+.++|||||++++++.+.+
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~------~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   77 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRS------RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   77 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             hHeEEEEEEecCcCcEEEEEEE------CCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence            5799999999999999999954      445789999999643   2234577899999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      .+|+|||||.||+|..++...  ..+++..++.++.||+.||.|||  ++||+||||||+||||+.+|.+||+|||+|+.
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH--~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~  153 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKY  153 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             eeeeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhc--cCcEEccccCchheeEcCCCCEEEecCccceE
Confidence            999999999999999988766  56788899999999999999999  67899999999999999999999999999987


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ....     ....+||+.|||||++.+..|+.++|||||||++|+|++|+.||...........      .....     
T Consensus       154 ~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------i~~~~-----  217 (316)
T d1fota_         154 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK------ILNAE-----  217 (316)
T ss_dssp             CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHHCC-----
T ss_pred             eccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHH------HHcCC-----
Confidence            5433     2346799999999999999999999999999999999999999986543221111      11110     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~  368 (419)
                             ..++...++++.+++.+||..||.+|+     |+++|++
T Consensus       218 -------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         218 -------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -------CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                   122334567899999999999999996     8999876

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.5e-54  Score=398.14  Aligned_cols=263  Identities=25%  Similarity=0.355  Sum_probs=205.9

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHHHHHHHHcCCCcccccceeeEEEe
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWLAEVIFLGQLRHPHLVRLIGYCCE  165 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  165 (419)
                      +.++|++.+.||+|+||.||+|..      ..+++.||||++.....   .....+.+|+.+|+.++|||||++++++..
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~------~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~   78 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARD------LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA   78 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEE------TTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEE------CCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeee
Confidence            357899999999999999999954      44578999999975533   234578899999999999999999999977


Q ss_pred             CC----eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          166 DE----ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       166 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                      .+    ..||||||++|++|.+++...  ..+++..++.++.||+.||+|||  ++||+||||||+|||++.++.++|+|
T Consensus        79 ~~~~~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH--~~~iiHrDiKP~NIll~~~~~~~l~d  154 (277)
T d1o6ya_          79 ETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMD  154 (277)
T ss_dssp             ECSSSEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTSCEEECC
T ss_pred             ccCCCceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHH--hCCccCccccCcccccCccccceeeh
Confidence            54    379999999999999988776  57899999999999999999999  67799999999999999999999999


Q ss_pred             cCccccCCCCCCc-eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhh
Q 014736          242 FGLAKMGPEGSNT-HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR  320 (419)
Q Consensus       242 fGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  320 (419)
                      ||.+......... ......+||+.|+|||++.+..|+.++|||||||++|+|+||++||.........      .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~~~~  228 (277)
T d1o6ya_         155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVR  228 (277)
T ss_dssp             CTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHH
T ss_pred             hhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH------HHHHh
Confidence            9998765433222 2234467999999999999999999999999999999999999999865432211      11111


Q ss_pred             cccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHhhhc
Q 014736          321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP-KMAAVVATLESLLN  375 (419)
Q Consensus       321 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-s~~eil~~L~~l~~  375 (419)
                      ..        +.........+++++.+||.+||+.||.+|| |++++++.|.++.+
T Consensus       229 ~~--------~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         229 ED--------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             CC--------CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             cC--------CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            11        1111122234567899999999999999999 89999999988753

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.6e-54  Score=402.70  Aligned_cols=266  Identities=26%  Similarity=0.365  Sum_probs=215.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc-cHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ-GHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|++++.||+|+||+||+|++.+. ....+++.||||+++..... ..+.|.+|+++|++++||||+++++++.+.+.
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~-~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGL-LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETS-STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCC-ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            46899999999999999999987642 23455678999999765433 35679999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhcc----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 014736          169 RLLVYEFMPRGSLENHLFKRI----------------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKT  226 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp  226 (419)
                      .++||||+.+|+|.+++....                      ...+++..++.++.||+.||+|||  +++||||||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH--~~~ivHrDlKp  168 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLAT  168 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSG
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc--cCCeEeeEEcc
Confidence            999999999999999986532                      234788899999999999999999  66799999999


Q ss_pred             CcEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCC
Q 014736          227 SNILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR-RSMDKLRP  305 (419)
Q Consensus       227 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~  305 (419)
                      +||||+.++.+||+|||+++...........+...||+.|+|||++.+..|+.++|||||||++|||++|. +||.....
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            99999999999999999998654444333445567999999999999999999999999999999999985 57766543


Q ss_pred             ccchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          306 KSEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      .+....+       ....          ....+..++.++.+|+.+||+.||++|||+.+|+++|+++.+
T Consensus       249 ~e~~~~v-------~~~~----------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         249 EEVIYYV-------RDGN----------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             HHHHHHH-------HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HHHHHHH-------HcCC----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            2211111       1111          112233456789999999999999999999999999998853

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-54  Score=398.91  Aligned_cols=258  Identities=28%  Similarity=0.401  Sum_probs=205.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      ++|++++.||+|+||+||+|++.+       ++.||||++.... ...+.|.+|+.++++++|||||++++++. ++..|
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~-------~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~   87 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNG-------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY   87 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECC-------CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeE
Confidence            579999999999999999997644       2469999997543 34578999999999999999999999985 56689


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+++|+|.+++.......+++..++.++.||+.||+|||  ++||+||||||+||||+.++.+||+|||+++....
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH--~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIED  165 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh--hhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence            9999999999999987765567999999999999999999999  67799999999999999999999999999987644


Q ss_pred             CCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccccccc
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVD  330 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (419)
                      .... ......||+.|+|||++..+.++.++|||||||++|||++|..||......  ........    ..        
T Consensus       166 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~----~~--------  230 (285)
T d1fmka3         166 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVE----RG--------  230 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH----TT--------
T ss_pred             CCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHH----hc--------
Confidence            3322 233456999999999999999999999999999999999976555433221  11111111    11        


Q ss_pred             cccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          331 PRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       331 ~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                        .....+..+++++.+|+.+||+.||++|||+++|+++|+.....
T Consensus       231 --~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         231 --YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             --CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             --CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence              11123345568899999999999999999999999999987654

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-54  Score=403.90  Aligned_cols=272  Identities=26%  Similarity=0.350  Sum_probs=208.1

Q ss_pred             HHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCC-CcccccceeeE
Q 014736           85 ELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQL-RHPHLVRLIGY  162 (419)
Q Consensus        85 ~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~  162 (419)
                      +++.-.++|+++++||+|+||.||+|.+... .+..+++.||||+++.... ...+.+.+|..++.++ +|+||+.++++
T Consensus         7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~-~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHBCCGGGEEEEEEEEECSSCEEEEEEEEST-TSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccccHHHEEEeeEEeecCCeEEEEEEEcCC-CcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            3333357899999999999999999987653 3455678999999975432 3456678888888776 68999999998


Q ss_pred             EEeC-CeeEEEEEecCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 014736          163 CCED-EERLLVYEFMPRGSLENHLFKRI--------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTS  227 (419)
Q Consensus       163 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~  227 (419)
                      +... ..+++|||||++|+|.+++....              ...+++..++.++.||+.||.|||  ++|||||||||+
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH--~~~ivHrDlKp~  163 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAAR  163 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH--hCCCcCCcCCcc
Confidence            7654 46899999999999999996542              234789999999999999999999  677999999999


Q ss_pred             cEEEcCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCc
Q 014736          228 NILLDSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG-RRSMDKLRPK  306 (419)
Q Consensus       228 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~  306 (419)
                      ||||+.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++| .+||......
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999876554444344456799999999999999999999999999999999987 5677655432


Q ss_pred             cchhHHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          307 SEQNLVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      ..  ...    .+....          ....+..+++++.+|+.+||+.||++|||+.+|++.|+.+++
T Consensus       244 ~~--~~~----~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         244 EE--FCR----RLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             HH--HHH----HHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH--HHH----HHhcCC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            21  111    111111          112233456789999999999999999999999999998864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=394.91  Aligned_cols=262  Identities=26%  Similarity=0.410  Sum_probs=202.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      .++|++.+.||+|+||.||+|.+..+   ...+..||||.+..... ...+.+.+|+.+|++++|||||++++++. ++.
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~---~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSP---ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecC---CceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence            36799999999999999999976542   22346799999865433 33567999999999999999999999985 567


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||+++|+|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+||+++.++.+||+|||+++..
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH--~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhc--ccCeeccccchhheeecCCCcEEEccchhheec
Confidence            89999999999999987654 357899999999999999999999  677999999999999999999999999999875


Q ss_pred             CCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ..... .......||+.|+|||++.+..|+.++|||||||++|||++ |.+||...........+       .....   
T Consensus       159 ~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i-------~~~~~---  227 (273)
T d1mp8a_         159 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-------ENGER---  227 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------HTTCC---
T ss_pred             cCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH-------HcCCC---
Confidence            44322 22344568999999999999999999999999999999998 89999876543322111       11111   


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                             ...+..+++++.+|+.+||+.||++|||+.+|++.|+.+++.
T Consensus       228 -------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         228 -------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                   123345668899999999999999999999999999988653

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-53  Score=400.89  Aligned_cols=263  Identities=24%  Similarity=0.387  Sum_probs=209.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC-CcccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|+++++||+|+||+||+|.+..+  ......+||+|.+... .....+.|.+|+.+|++++|||||++++++.++ ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCC--CCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            3699999999999999999976542  1222346999988643 334567899999999999999999999999764 56


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      +++|||+.+++|.+++... ...+++..++.++.||+.||.|||  ++|||||||||+||||+.++.+||+|||+++...
T Consensus        86 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH--~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             eEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHH--HcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence            7889999999999987654 457899999999999999999999  5679999999999999999999999999999876


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ............||+.|+|||++.++.|+.++|||||||++|||+| |.+||.+.........+.       .+.     
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-------~~~-----  230 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE-----  230 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-------HTC-----
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCC-----
Confidence            5544444445569999999999999999999999999999999998 899998765433222211       111     


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                           ....+..++.++.+|+.+||+.||.+|||+.+|++.|..+...
T Consensus       231 -----~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         231 -----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             -----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -----CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence                 1122344567899999999999999999999999999887653

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-53  Score=405.99  Aligned_cols=245  Identities=23%  Similarity=0.282  Sum_probs=206.5

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC---CcccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE---GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++++.||+|+||.||+|..      ..+++.||||++...   .....+.+.+|+.+|+.++|||||++++++.+..
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~------~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  114 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKH------KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE------TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCeEEEEEeecCcCcEEEEEEE------CCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc
Confidence            5799999999999999999954      455789999998643   2234567899999999999999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..|+||||+.+|+|.+++.+.  ..+++..++.++.||+.||.|||  ++|||||||||+||||+.++.+||+|||+|+.
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH--~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~  190 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCcCCHHHcccCCCCCEEeeeceeeee
Confidence            999999999999999999776  57899999999999999999999  67799999999999999999999999999987


Q ss_pred             CCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccc
Q 014736          248 GPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRY  327 (419)
Q Consensus       248 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (419)
                      ....     .....||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.........+      ....     
T Consensus       191 ~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~~-----  254 (350)
T d1rdqe_         191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------VSGK-----  254 (350)
T ss_dssp             CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC-----
T ss_pred             cccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH------hcCC-----
Confidence            6433     23456999999999999999999999999999999999999999764322111111      1000     


Q ss_pred             ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 014736          328 IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRP-----KMAAVVA  368 (419)
Q Consensus       328 ~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP-----s~~eil~  368 (419)
                             ..++...++++.+||.+||+.||.+|+     |+++|++
T Consensus       255 -------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 -------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -------CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                   012334567899999999999999994     8999876

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6.6e-53  Score=405.56  Aligned_cols=249  Identities=24%  Similarity=0.327  Sum_probs=202.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc---ccHHHHH---HHHHHHcCCCcccccceeeEEE
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL---QGHREWL---AEVIFLGQLRHPHLVRLIGYCC  164 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~hpnIv~~~~~~~  164 (419)
                      ++|+++++||+|+||.||+|+.      ..+++.||||++.....   .....+.   +|+.+++.++|||||+++++|.
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~------~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~   77 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRK------ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH   77 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEE------TTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEE------CCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE
Confidence            5799999999999999999964      44578999999864321   1222333   4577888899999999999999


Q ss_pred             eCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCc
Q 014736          165 EDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL  244 (419)
Q Consensus       165 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  244 (419)
                      +.+..|+|||||+||+|.+++.+.  ..+++..++.++.||+.||.|||  ++|||||||||+|||++.+|.+||+|||+
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH--~~~iiHrDlKP~NILl~~~g~iKl~DFGl  153 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGL  153 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred             ECCEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHH--HCCccceeeccceeEEcCCCcEEEeeece
Confidence            999999999999999999999776  57889999999999999999999  67799999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccc
Q 014736          245 AKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSR  323 (419)
Q Consensus       245 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  323 (419)
                      |+......    ....+||+.|+|||++.. ..|+.++|||||||++|||++|+.||................       
T Consensus       154 a~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-------  222 (364)
T d1omwa3         154 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-------  222 (364)
T ss_dssp             CEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS-------
T ss_pred             eeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-------
Confidence            98755432    334579999999999864 568999999999999999999999998765443222211100       


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 014736          324 RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK-----MAAVVA  368 (419)
Q Consensus       324 ~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs-----~~eil~  368 (419)
                              .....++..+++++.+||.+||+.||.+|||     ++++++
T Consensus       223 --------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         223 --------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             --------SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             --------cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                    0011223345678999999999999999999     688875

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=391.67  Aligned_cols=251  Identities=28%  Similarity=0.413  Sum_probs=201.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEe-CCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE-DEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~  169 (419)
                      ++|++++.||+|+||.||+|.++        +..||||+++..  ...+.|.+|++++++++||||+++++++.+ .+.+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--------~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--------TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--------CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            56888999999999999999753        357999999754  345789999999999999999999998854 4668


Q ss_pred             EEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCC
Q 014736          170 LLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGP  249 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~  249 (419)
                      |+||||+++|+|.+++..+....+++..++.++.||+.||.|||  +++|+||||||+|||++.++.+||+|||+++...
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH--~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc--cCceeccccchHhheecCCCCEeecccccceecC
Confidence            99999999999999997765556899999999999999999999  5679999999999999999999999999998644


Q ss_pred             CCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhcccccccc
Q 014736          250 EGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYI  328 (419)
Q Consensus       250 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (419)
                      ..     .....+|..|+|||++.++.++.++|||||||++|||+| |++||.......   ......    .       
T Consensus       155 ~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~----~-------  215 (262)
T d1byga_         155 ST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVE----K-------  215 (262)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHT----T-------
T ss_pred             CC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----c-------
Confidence            32     223458999999999999999999999999999999998 788887654332   222111    1       


Q ss_pred             cccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          329 VDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       329 ~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                         .....++...++++.+|+.+||+.||.+|||+.+|+++|+.+..
T Consensus       216 ---~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         216 ---GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence               11122344456789999999999999999999999999998854

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6e-53  Score=391.01  Aligned_cols=252  Identities=25%  Similarity=0.358  Sum_probs=206.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc---------cHHHHHHHHHHHcCCC-cccccce
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ---------GHREWLAEVIFLGQLR-HPHLVRL  159 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-hpnIv~~  159 (419)
                      .++|++.+.||+|+||+||+|+.      ..+++.||||++......         ..+.+.+|+.+|++++ |||||++
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~------~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~   75 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIH------KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL   75 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE------TTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             cccCEEceEEecCcCeEEEEEEE------CCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEE
Confidence            47899999999999999999954      445789999999754321         1245789999999997 9999999


Q ss_pred             eeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEE
Q 014736          160 IGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKL  239 (419)
Q Consensus       160 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  239 (419)
                      ++++.++++.||||||++||+|.+++..+  ..+++..++.++.||+.||+|||  ++||+||||||+|||++.++.+||
T Consensus        76 ~~~~~~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nill~~~~~~kl  151 (277)
T d1phka_          76 KDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKL  151 (277)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEE
T ss_pred             EeecccCcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HcCCcccccccceEEEcCCCCeEE
Confidence            99999999999999999999999999766  57999999999999999999999  677999999999999999999999


Q ss_pred             eccCccccCCCCCCceeeecccccccccccccccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHH
Q 014736          240 SDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST------GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD  313 (419)
Q Consensus       240 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~  313 (419)
                      +|||+++.......   .....||+.|+|||++.+      ..++.++||||+||++|+|++|+.||...........+ 
T Consensus       152 ~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i-  227 (277)
T d1phka_         152 TDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-  227 (277)
T ss_dssp             CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-
T ss_pred             ccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH-
Confidence            99999987655432   334679999999999853      45788999999999999999999999865432211111 


Q ss_pred             hhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                           .....        ..........++++.+|+.+||+.||++|||++||++
T Consensus       228 -----~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         228 -----MSGNY--------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             -----HHTCC--------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -----HhCCC--------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                 11110        1111222356688999999999999999999999865

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-53  Score=397.75  Aligned_cols=267  Identities=28%  Similarity=0.377  Sum_probs=218.6

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCC-CcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~  167 (419)
                      .++|++.++||+|+||.||+|++... .+...++.||||+++.... .....|.+|+.+++.+ +|||||++++++.+.+
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~-~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGL-IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEecc-ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            36888999999999999999987643 2345678999999976543 3456789999999998 6999999999999999


Q ss_pred             eeEEEEEecCCCChhhhhhhcc----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 014736          168 ERLLVYEFMPRGSLENHLFKRI----------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILL  231 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll  231 (419)
                      ..|+|||||++|+|.+++....                ...+++..++.++.||+.||+|||  .+|||||||||+|||+
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH--~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILL  178 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccccccccc
Confidence            9999999999999999987542                235889999999999999999999  6679999999999999


Q ss_pred             cCCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchh
Q 014736          232 DSDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQN  310 (419)
Q Consensus       232 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~  310 (419)
                      +.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |.+||..........
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~  258 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999998766655555566789999999999999999999999999999999999 555565543322111


Q ss_pred             HHHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          311 LVDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      .+      ...          ......+...+.++.+||.+||+.||.+|||+.+|+++|++++.
T Consensus       259 ~~------i~~----------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         259 KM------IKE----------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             HH------HHH----------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH------Hhc----------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            11      111          11112233456789999999999999999999999999987654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-53  Score=398.86  Aligned_cols=253  Identities=19%  Similarity=0.254  Sum_probs=207.0

Q ss_pred             HhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           89 ITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        89 ~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      +.++|++++.||+|+||+||+|..      ..+++.||||+++.... ....+.+|+++|+.++|||||+++++|.+++.
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~------~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   75 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVE------TSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEE   75 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEE------TTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred             CccceEEEEEEecCCCeEEEEEEE------CCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            457899999999999999999964      44578899999986543 34567899999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC--CcEEEeccCccc
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD--FTAKLSDFGLAK  246 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGla~  246 (419)
                      +|||||||+||+|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+|||++.+  +.+||+|||++.
T Consensus        76 ~~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH--~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~  152 (321)
T d1tkia_          76 LVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             EEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--HcCCCcccccccceeecCCCceEEEEcccchhh
Confidence            99999999999999998654 246899999999999999999999  6779999999999999854  579999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      .......   .....||+.|+|||.+.+..|+.++|||||||++|+|++|..||...........+      ......+ 
T Consensus       153 ~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i------~~~~~~~-  222 (321)
T d1tkia_         153 QLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI------MNAEYTF-  222 (321)
T ss_dssp             ECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHTCCCC-
T ss_pred             ccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCCCC-
Confidence            7644332   33456999999999999999999999999999999999999999865432211111      1110000 


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                         +.    ......++++.+||.+||..||.+|||+.|+++
T Consensus       223 ---~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         223 ---DE----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---CH----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---Ch----hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               00    001124578999999999999999999999987

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=399.64  Aligned_cols=253  Identities=21%  Similarity=0.256  Sum_probs=200.9

Q ss_pred             hcCCCCCC-eecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcC-CCcccccceeeEEEe--
Q 014736           90 TQNFSSNY-LLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQ-LRHPHLVRLIGYCCE--  165 (419)
Q Consensus        90 ~~~y~~~~-~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~--  165 (419)
                      .++|.+.. +||+|+||+||+|..      ..+++.||||+++.     ...+.+|+.++.+ ++|||||+++++|.+  
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~------~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFN------KRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEE------TTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEE------CCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            46788875 699999999999964      44578999999863     2456789998655 589999999999976  


Q ss_pred             --CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCcEEEe
Q 014736          166 --DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLS  240 (419)
Q Consensus       166 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~---~~~~kl~  240 (419)
                        +..+|||||||+||+|.+++.++....+++..++.++.||+.||+|||  ++||+||||||+|||++.   ++.+||+
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH--~~~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH--HcCCcccccccccccccccccccccccc
Confidence              467899999999999999998765667999999999999999999999  677999999999999986   4579999


Q ss_pred             ccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhh
Q 014736          241 DFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLR  320 (419)
Q Consensus       241 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~  320 (419)
                      |||+++.......   ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+..      
T Consensus       157 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~------  227 (335)
T d2ozaa1         157 DFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT------  227 (335)
T ss_dssp             CCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------
T ss_pred             ccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH------
Confidence            9999987654332   3446799999999999999999999999999999999999999976543322111100      


Q ss_pred             cccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       321 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ....    ....+.......+++++.+||.+||+.||++|||+.|+++
T Consensus       228 ~i~~----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         228 RIRM----GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CCCS----CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhc----CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            0000    0000111112345788999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-53  Score=395.29  Aligned_cols=268  Identities=25%  Similarity=0.389  Sum_probs=213.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCccc-ccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCC-CcccccceeeEEEeC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLR-QGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQL-RHPHLVRLIGYCCED  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~  166 (419)
                      .++|.+++.||+|+||.||+|....... ...++..||||+++.... ....++.+|...+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            3578999999999999999998655322 123456899999976543 3356788899988888 799999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhcc--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRI--------------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLD  232 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~  232 (419)
                      +..++||||+++|+|.+++..+.              ...+++..++.++.||+.||+|||  +++||||||||+|||++
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH--~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEC
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh--hCCEEeeeecccceeec
Confidence            99999999999999999997553              245899999999999999999999  67799999999999999


Q ss_pred             CCCcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhH
Q 014736          233 SDFTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNL  311 (419)
Q Consensus       233 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~  311 (419)
                      .++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |.+||.......   .
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~---~  246 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---L  246 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---H
Confidence            999999999999997665544444555679999999999999999999999999999999998 788887654322   1


Q ss_pred             HHhhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          312 VDWAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                      ..    .+....          ....+..+++++.+|+.+||+.||.+|||+.||++.|+++++.
T Consensus       247 ~~----~i~~~~----------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         247 FK----LLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             HH----HHHTTC----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HH----HHHcCC----------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            11    111111          1122334567899999999999999999999999999998753

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-53  Score=399.66  Aligned_cols=248  Identities=27%  Similarity=0.375  Sum_probs=204.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHc-CCCcccccceeeEEEeC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLG-QLRHPHLVRLIGYCCED  166 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~  166 (419)
                      ++|.+++.||+|+||+||+|+.      ..+++.||||++....   ....+.+..|..++. .++|||||++++++.++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~------~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~   75 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEF------KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   75 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEE------TTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CCeEEeeEEecCCCcEEEEEEE------CCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence            5799999999999999999964      4457899999996432   234456777777765 68999999999999999


Q ss_pred             CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          167 EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       167 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                      +..||||||+++|+|.+++...  ..+++..++.++.||+.||+|||  ++||+||||||+|||++.++.+||+|||+++
T Consensus        76 ~~~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH--~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~  151 (320)
T d1xjda_          76 ENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCK  151 (320)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             CceeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCcccceeecCCCceeccccchhh
Confidence            9999999999999999999776  56899999999999999999999  5679999999999999999999999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcccccc
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLR  326 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (419)
                      .......  ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+.       ..    
T Consensus       152 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~-------~~----  218 (320)
T d1xjda_         152 ENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR-------MD----  218 (320)
T ss_dssp             CCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HC----
T ss_pred             hcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH-------cC----
Confidence            6543322  2344679999999999999999999999999999999999999998654322111110       00    


Q ss_pred             cccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 014736          327 YIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMA-AVVA  368 (419)
Q Consensus       327 ~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~-eil~  368 (419)
                         .+    .++..++.++.+||.+||+.||.+||++. ++++
T Consensus       219 ---~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         219 ---NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ---CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---CC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence               01    22334567899999999999999999985 6754

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-53  Score=391.46  Aligned_cols=260  Identities=27%  Similarity=0.397  Sum_probs=201.3

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC---cccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG---LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      ++|++.+.||+|+||.||+|.....   ......||||++....   ....+.|.+|+.+|++++|||||++++++.+ .
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~---~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAP---SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECT---TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECC---CCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            5689999999999999999976542   2234579999987542   2335679999999999999999999999965 5


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      ..++||||+++|+|.+++... ...+++..++.++.||+.||.|||  ++||+||||||+||||+.++.+||+|||+++.
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH--~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             chheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhh--hCCEeeeeecHHHhccccccceeeccchhhhh
Confidence            779999999999999987654 246899999999999999999999  56799999999999999999999999999998


Q ss_pred             CCCCCCcee-eecccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccchhHHHhhhHHhhccccc
Q 014736          248 GPEGSNTHV-TTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLT-GRRSMDKLRPKSEQNLVDWAKPYLRSSRRL  325 (419)
Q Consensus       248 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  325 (419)
                      ......... .....|+..|+|||++.+..++.++|||||||++|||+| |..||........   ....   ....   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~---~~~i---~~~~---  231 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---LHKI---DKEG---  231 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHH---HTSC---
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH---HHHH---HhCC---
Confidence            655543332 234568889999999999999999999999999999998 8999976543221   1111   1111   


Q ss_pred             ccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhh
Q 014736          326 RYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESL  373 (419)
Q Consensus       326 ~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l  373 (419)
                             .....+..++.++.+|+.+||+.||++|||+.+|++.|++.
T Consensus       232 -------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         232 -------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                   11122334567899999999999999999999999999875

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-52  Score=389.56  Aligned_cols=267  Identities=24%  Similarity=0.304  Sum_probs=201.8

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|++++.||+|+||+||+|+.      ..+++.||||++.....  .....+.+|+++|++++|||||++++++.+.+.
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~------~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~   75 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARN------KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK   75 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEE------TTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCCEeccEEecCcCeEEEEEEE------CCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc
Confidence            5799999999999999999954      44578999999965432  235678999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .|+||||+. +++.+++.......+++..+..++.||+.||.|||  ++|||||||||+|||++.++.+||+|||+|+..
T Consensus        76 ~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH--~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~  152 (298)
T d1gz8a_          76 LYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF  152 (298)
T ss_dssp             EEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred             eeEEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh--cCCEEccccCchheeecccCcceeccCCcceec
Confidence            999999995 56666666555677999999999999999999999  677999999999999999999999999999865


Q ss_pred             CCCCCceeeecccccccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH--------h
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGH-LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY--------L  319 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------~  319 (419)
                      .....  ......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.........+......        .
T Consensus       153 ~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         153 GVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             CCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             cCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence            43322  233456999999999876655 578999999999999999999999865432211111000000        0


Q ss_pred             hcccccccccccccCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          320 RSSRRLRYIVDPRLAGQ---YSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~~---~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .................   .....+.++.+|+.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            00000000000000000   01234578999999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-52  Score=390.76  Aligned_cols=261  Identities=27%  Similarity=0.408  Sum_probs=207.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccC-CcccHHHHHHHHHHHcCC-CcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGHREWLAEVIFLGQL-RHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~  168 (419)
                      ++|++.++||+|+||.||+|++.++    .....||||.+... .....+.|.+|+++|.++ +|||||++++++.+++.
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   85 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKD----GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   85 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEET----TEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCC----CeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence            5788999999999999999976542    11235788887543 233456799999999998 79999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhc--------------cCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC
Q 014736          169 RLLVYEFMPRGSLENHLFKR--------------ISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD  234 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~  234 (419)
                      +|+||||+++|+|.+++...              ....+++..++.++.||+.||.|||  ++||+||||||+|||++.+
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH--~~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECGG
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh--cCCccccccccceEEEcCC
Confidence            99999999999999998654              2357899999999999999999999  6679999999999999999


Q ss_pred             CcEEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCccchhHHH
Q 014736          235 FTAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGR-RSMDKLRPKSEQNLVD  313 (419)
Q Consensus       235 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~~~  313 (419)
                      +.+||+|||+++.......   .....||..|+|||.+.++.|+.++|||||||++|||++|. +||.......   ...
T Consensus       164 ~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~  237 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE  237 (309)
T ss_dssp             GCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH
T ss_pred             CceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HHH
Confidence            9999999999986443322   22346899999999999999999999999999999999975 5676543221   111


Q ss_pred             hhhHHhhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          314 WAKPYLRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                      ..    ...          .....+..+++++.+|+.+||+.||++|||+++|++.|+++....
T Consensus       238 ~i----~~~----------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         238 KL----PQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             HG----GGT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HH----Hhc----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            11    111          111233446689999999999999999999999999999997654

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-52  Score=389.03  Aligned_cols=258  Identities=24%  Similarity=0.273  Sum_probs=194.9

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCccc-----HHHHHHHHHHHcCCCcccccceeeEEEeCCeeE
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQG-----HREWLAEVIFLGQLRHPHLVRLIGYCCEDEERL  170 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  170 (419)
                      +++||+|+||+||+|+      +..+++.||||+++......     .+.+.+|+.+|++++|||||++++++.++++.|
T Consensus         3 l~~lG~G~fg~Vy~~~------~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~   76 (299)
T d1ua2a_           3 LDFLGEGQFATVYKAR------DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   76 (299)
T ss_dssp             EEEEEEETTEEEEEEE------CSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             ceEeccCcCeEEEEEE------ECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCcee
Confidence            5689999999999995      44567899999997543221     246889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCC
Q 014736          171 LVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPE  250 (419)
Q Consensus       171 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~  250 (419)
                      +||||+.++++..++...  ..+++..+..++.||+.||+|||  ++||+||||||+|||++.++.+||+|||+++....
T Consensus        77 ivmE~~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH--~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~  152 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  152 (299)
T ss_dssp             EEEECCSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             ehhhhhcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhh--ccceecccCCcceEEecCCCccccccCccccccCC
Confidence            999999888776665433  56888899999999999999999  67799999999999999999999999999987554


Q ss_pred             CCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc--cccc-
Q 014736          251 GSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS--RRLR-  326 (419)
Q Consensus       251 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~-  326 (419)
                      ...  .....+||+.|+|||++.. ..|+.++|||||||++|||++|.+||.+....+....+.   ......  .... 
T Consensus       153 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~---~~~~~~~~~~~~~  227 (299)
T d1ua2a_         153 PNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF---ETLGTPTEEQWPD  227 (299)
T ss_dssp             CCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HHHCCCCTTTSSS
T ss_pred             Ccc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHH---HhcCCCChhhccc
Confidence            332  2234579999999999865 468999999999999999999999998654332211111   110000  0000 


Q ss_pred             --cccc----cccC----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          327 --YIVD----PRLA----GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       327 --~~~~----~~l~----~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        ....    ....    .......++++.+|+.+||+.||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence              0000    0000    0011234678999999999999999999999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-52  Score=389.94  Aligned_cols=265  Identities=25%  Similarity=0.390  Sum_probs=214.8

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC-cccHHHHHHHHHHHcCCCcccccceeeEEEeCCee
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG-LQGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEER  169 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  169 (419)
                      ++|.+.+.||+|+||+||+|.+... .....+..||||+++... ......|.+|++++++++|||||++++++..++..
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~-~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGV-VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEE-ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCc-ccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            6788999999999999999987542 223345789999997543 23345689999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhhhcc--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          170 LLVYEFMPRGSLENHLFKRI--------SVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       170 ~lv~e~~~~g~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                      ++||||+.+|+|.+++....        ...+++..+..++.|++.||.|||  .++|+||||||+||||+.++.+||+|
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH--~~~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh--hCCeeeceEcCCceeecCCceEEEee
Confidence            99999999999999886432        234688899999999999999999  56799999999999999999999999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCccchhHHHhhhHHhh
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTG-RRSMDKLRPKSEQNLVDWAKPYLR  320 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~  320 (419)
                      ||+++...............||+.|+|||.+.+..++.++||||||+++|||+|| .+||........   ...    ..
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~---~~~----i~  249 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---LRF----VM  249 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH---HHH----HH
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HH
Confidence            9999876554444344455799999999999999999999999999999999998 577765432221   111    11


Q ss_pred             cccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhc
Q 014736          321 SSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLN  375 (419)
Q Consensus       321 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~  375 (419)
                      ....          ...+..++.++.+|+.+||+.||++|||+++|++.|++..+
T Consensus       250 ~~~~----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         250 EGGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             TTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             hCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            1111          11223456789999999999999999999999999988755

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-51  Score=383.06  Aligned_cols=259  Identities=27%  Similarity=0.403  Sum_probs=204.5

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccC-CcccHHHHHHHHHHHcCCCcccccceeeEEEe-CCeeEEEE
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE-GLQGHREWLAEVIFLGQLRHPHLVRLIGYCCE-DEERLLVY  173 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~  173 (419)
                      .++||+|+||+||+|.+.++   ..+...||||.++.. .....++|.+|+++|++++|||||++++++.+ ++..++||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~---~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC-------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECC---CCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            46799999999999987543   122346999999743 34455789999999999999999999999876 46889999


Q ss_pred             EecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccCCCCCC
Q 014736          174 EFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSN  253 (419)
Q Consensus       174 e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  253 (419)
                      |||++|+|.+++... ....++..++.++.|++.||.|||  +++|+||||||+||||++++.+||+|||+++.......
T Consensus       109 E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH--~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             ECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             EEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhc--ccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            999999999987654 346778889999999999999999  66799999999999999999999999999987654432


Q ss_pred             ce--eeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccccccccccc
Q 014736          254 TH--VTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSRRLRYIVDP  331 (419)
Q Consensus       254 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (419)
                      ..  ......||..|+|||++....++.++||||||+++|||++|..||.......  ......    ..+..       
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i----~~g~~-------  252 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL----LQGRR-------  252 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTCC-------
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHH----HcCCC-------
Confidence            21  2233568999999999999999999999999999999999887776432211  111111    11111       


Q ss_pred             ccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          332 RLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       332 ~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                         ...+..+++++.+|+.+||+.||++||++.||++.|++++..
T Consensus       253 ---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         253 ---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ---CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence               112234567899999999999999999999999999999763

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-51  Score=384.73  Aligned_cols=268  Identities=25%  Similarity=0.372  Sum_probs=201.8

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHH--HHHHHcCCCcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLA--EVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .++|.+.+.||+|+||.||+|++.        ++.||||++....   .+.+..  |+..+.+++|||||++++++.+.+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~--------g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~   70 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWR--------GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN   70 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--------TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC--------CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC
Confidence            456788899999999999999642        5789999996442   334444  455556789999999999997654


Q ss_pred             ----eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCeeecCCCCCcEEEcCCCcE
Q 014736          168 ----ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA------ENPVIYRDFKTSNILLDSDFTA  237 (419)
Q Consensus       168 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~------~~~ivH~Dlkp~NIll~~~~~~  237 (419)
                          .+|+||||+++|+|.+++.+.   .+++..++.++.|++.||.|||+.      .+|||||||||+||||+.++.+
T Consensus        71 ~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~  147 (303)
T d1vjya_          71 GTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred             CcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCe
Confidence                579999999999999999764   689999999999999999999963      4689999999999999999999


Q ss_pred             EEeccCccccCCCCCCce--eeecccccccccccccccCCC------CCchhhHHHHHHHHHHHHcCCCCCCCCCCccch
Q 014736          238 KLSDFGLAKMGPEGSNTH--VTTRVMGTYGYAAPEYISTGH------LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQ  309 (419)
Q Consensus       238 kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~elltg~~pf~~~~~~~~~  309 (419)
                      ||+|||+++.........  ......||+.|+|||++.+..      ++.++|||||||++|||+||..||.........
T Consensus       148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~  227 (303)
T d1vjya_         148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence            999999998764433221  223467999999999986543      677999999999999999999887543322110


Q ss_pred             --------hHHHhhhHHhhcccccccccccccCCCC-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcC
Q 014736          310 --------NLVDWAKPYLRSSRRLRYIVDPRLAGQY-SVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNL  376 (419)
Q Consensus       310 --------~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~  376 (419)
                              ........... ...    ..+.+...+ ......++.+|+.+||+.||.+|||+.||++.|+++...
T Consensus       228 ~~~~~~~~~~~~~~~~~~~-~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         228 YYDLVPSDPSVEEMRKVVC-EQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTTTSCSSCCHHHHHHHHT-TSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhcccccchHHHHHHHHh-ccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence                    00111111110 001    111111111 234567799999999999999999999999999988653

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-52  Score=386.00  Aligned_cols=241  Identities=23%  Similarity=0.370  Sum_probs=197.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc------cHHHHHHHHHHHcCCC--cccccceee
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ------GHREWLAEVIFLGQLR--HPHLVRLIG  161 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpnIv~~~~  161 (419)
                      .++|++.++||+|+||+||+|..      ..+++.||||++......      ....+.+|+.+|++++  |||||++++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~------~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~   76 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIR------VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD   76 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEE------TTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEE------CCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEE
Confidence            46899999999999999999964      445789999998753221      1233567999999886  899999999


Q ss_pred             EEEeCCeeEEEEEecCC-CChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCC-CcEEE
Q 014736          162 YCCEDEERLLVYEFMPR-GSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSD-FTAKL  239 (419)
Q Consensus       162 ~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~-~~~kl  239 (419)
                      ++.+.+..|+||||+.+ +++.+++...  ..+++..++.++.||+.||.|||  ++||+||||||+|||++.+ +.+||
T Consensus        77 ~~~~~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH--~~~iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          77 WFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTEEEE
T ss_pred             EEeeCCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCccccCcccceEEecCCCeEEE
Confidence            99999999999999976 5788887665  57899999999999999999999  6779999999999999854 79999


Q ss_pred             eccCccccCCCCCCceeeecccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          240 SDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHL-TTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       240 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      +|||+++......    .+...||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....     ...      
T Consensus       153 ~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~------  217 (273)
T d1xwsa_         153 IDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII------  217 (273)
T ss_dssp             CCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH------
T ss_pred             Cccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHh------
Confidence            9999998654332    344679999999999977665 678999999999999999999997421     110      


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                       ...        .    .++...+.++.+||.+||+.||++|||++|+++
T Consensus       218 -~~~--------~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         218 -RGQ--------V----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -HCC--------C----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -hcc--------c----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence             000        0    122234578999999999999999999999976

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.2e-50  Score=376.43  Aligned_cols=265  Identities=19%  Similarity=0.253  Sum_probs=200.6

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|+++++||+|+||+||+|..+       +++.||||++.....  ...+.+.+|+.+|++++|||||++++++.+++.
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   74 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             CCceeccEEecCCCcEEEEEEeC-------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence            58999999999999999999643       357899999976532  235788999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .+++|||+.++.+..+....  ..+++..+..++.||+.||+|||  ++|||||||||+|||++.++.+||+|||++...
T Consensus        75 ~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH--~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~  150 (286)
T d1ob3a_          75 LVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAF  150 (286)
T ss_dssp             EEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             eeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhc--cCcEEecCCCCceeeEcCCCCEEecccccceec
Confidence            99999999777666655443  67999999999999999999999  567999999999999999999999999999875


Q ss_pred             CCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH-----hhcc
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY-----LRSS  322 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----~~~~  322 (419)
                      .....  ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+......     ....
T Consensus       151 ~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         151 GIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV  228 (286)
T ss_dssp             CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             ccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccch
Confidence            43322  1233468999999999865 45789999999999999999999999865432221111110000     0000


Q ss_pred             ccccc------ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          323 RRLRY------IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       323 ~~~~~------~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      .....      ...+.....+....++++.+|+.+||+.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000      00011111223345678999999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-50  Score=379.00  Aligned_cols=268  Identities=25%  Similarity=0.304  Sum_probs=199.0

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCC---CcccccceeeEEE
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQL---RHPHLVRLIGYCC  164 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~  164 (419)
                      .++|+++++||+|+||+||+|....     ..++.||||++.....  .....+.+|+.+|+.|   +||||++++++|.
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~   80 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLK-----NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT   80 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT-----TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEEC-----CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence            4789999999999999999996432     2356799999864322  2233456777776665   7999999999985


Q ss_pred             e-----CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEE
Q 014736          165 E-----DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKL  239 (419)
Q Consensus       165 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl  239 (419)
                      .     ....+++|||+.++.+... .......+++..++.++.||+.||+|||  ++|||||||||+|||++.++.+||
T Consensus        81 ~~~~~~~~~~~~~~e~~~~~~~~~~-~~~~~~~~~~~~~~~~~~qi~~aL~yLH--~~~ivHrDiKp~NILi~~~~~~kl  157 (305)
T d1blxa_          81 VSRTDRETKLTLVFEHVDQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKL  157 (305)
T ss_dssp             EEECSSEEEEEEEEECCSCBHHHHH-HHSCTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             ccccccCceEEEEEEeccCCchhhh-hhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEEecCCCccEEEEcCCCCeee
Confidence            3     3468999999977665443 3344467899999999999999999999  677999999999999999999999


Q ss_pred             eccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHh
Q 014736          240 SDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYL  319 (419)
Q Consensus       240 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~  319 (419)
                      +|||+++......   ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+.......
T Consensus       158 ~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  234 (305)
T d1blxa_         158 ADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP  234 (305)
T ss_dssp             CSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence            9999988643322   2345679999999999999999999999999999999999999998654333222211110000


Q ss_pred             -----hccccc-cc---ccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          320 -----RSSRRL-RY---IVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       320 -----~~~~~~-~~---~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                           ...... ..   .........+....++++.+||.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                 000000 00   00001111233445678999999999999999999999976

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8.3e-49  Score=366.69  Aligned_cols=266  Identities=18%  Similarity=0.207  Sum_probs=210.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCc-ccccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRH-PHLVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~  168 (419)
                      .++|+++++||+|+||+||+|+.      ..+++.||||++....  ....+.+|+++++.++| +||+.+++++.++..
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~------~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   75 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTN------LLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   75 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEE------TTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             CCceEEEEEEecCCCeEEEEEEE------CCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCc
Confidence            46899999999999999999964      3457899999986543  22346678888888865 899999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC-----CCcEEEeccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS-----DFTAKLSDFG  243 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfG  243 (419)
                      .++||||+ +++|.+++... ...++...+..++.|++.||+|||  ++||+||||||+|||++.     ++.+||+|||
T Consensus        76 ~~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH--~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG  151 (293)
T d1csna_          76 NVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  151 (293)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             cEEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHH--HCCceeccCCccceeecCcccccCCceEEcccc
Confidence            99999999 88999987654 346899999999999999999999  778999999999999974     5789999999


Q ss_pred             ccccCCCCCCc-----eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH
Q 014736          244 LAKMGPEGSNT-----HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY  318 (419)
Q Consensus       244 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  318 (419)
                      +|+........     ......+||+.|||||++.+..++.++|||||||++|||++|+.||.+................
T Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~  231 (293)
T d1csna_         152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK  231 (293)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred             eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence            99876443221     1233467999999999999999999999999999999999999999876555433322211111


Q ss_pred             hhcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          319 LRSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       319 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                      ... ...     +.+    ...+++++.+++..|+..+|++||+++.+.+.|+++....
T Consensus       232 ~~~-~~~-----~~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         232 KQS-TPL-----REL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HHH-SCH-----HHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cCC-CCh-----HHh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            000 000     011    1223578999999999999999999999999999886543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-49  Score=377.77  Aligned_cols=266  Identities=22%  Similarity=0.289  Sum_probs=197.7

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCC
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  167 (419)
                      .++|+++++||+|+||+||+|..      ..+++.||||++.....  ...+.+.+|+.+|+.++|||||+++++|...+
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~------~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~   90 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVD------GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE   90 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEE------TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred             CCcEEEEEEEecCCCeEEEEEEE------CCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence            47899999999999999999964      44578999999975432  33467889999999999999999999997654


Q ss_pred             ------eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          168 ------ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       168 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                            ++|+||||+ +.+|..++..   ..+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+|
T Consensus        91 ~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH--~~~IiHrDiKp~NIL~~~~~~~kl~D  164 (346)
T d1cm8a_          91 TLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILD  164 (346)
T ss_dssp             STTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             cccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHH--hCCCcccccCcchhhccccccccccc
Confidence                  579999999 6677776644   46999999999999999999999  67799999999999999999999999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH---
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP---  317 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~---  317 (419)
                      ||+++.....     .+...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.................   
T Consensus       165 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (346)
T d1cm8a_         165 FGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP  239 (346)
T ss_dssp             CTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence            9999875433     234569999999999876 4578999999999999999999999987543222111110000   


Q ss_pred             --Hhhc---------ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHhh
Q 014736          318 --YLRS---------SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVAT--LESL  373 (419)
Q Consensus       318 --~~~~---------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~--L~~l  373 (419)
                        ....         ...+....... ........++++.+||.+||..||++|||+.|+++.  |+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         240 AEFVQRLQSDEAKNYMKGLPELEKKD-FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCC-GGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHHhhhcchhhhhhhccCCcccccc-hHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence              0000         00000000000 111223446789999999999999999999999873  5443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-49  Score=376.29  Aligned_cols=268  Identities=23%  Similarity=0.261  Sum_probs=197.8

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccccceeeEEEeC-----
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHLVRLIGYCCED-----  166 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----  166 (419)
                      +|+..++||+|+||+||+|+.      ..+++.||||++......    +.+|+++|++++||||++++++|...     
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~------~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~   90 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKL------CDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD   90 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEE------TTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred             CcEeeeEEeeCcCeEEEEEEE------CCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence            588889999999999999964      345789999999754322    23699999999999999999998543     


Q ss_pred             -CeeEEEEEecCCCChhhhhh-hccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-cEEEeccC
Q 014736          167 -EERLLVYEFMPRGSLENHLF-KRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-TAKLSDFG  243 (419)
Q Consensus       167 -~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG  243 (419)
                       .++||||||+.++.+..... ......+++..++.++.||+.||+|||  ++||+||||||+|||++.++ .+||+|||
T Consensus        91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH--~~~IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH--hcCCcccCCCcceEEEecCCCceeEeccc
Confidence             35789999996654333322 223457999999999999999999999  67899999999999999875 89999999


Q ss_pred             ccccCCCCCCceeeecccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhh-------
Q 014736          244 LAKMGPEGSNTHVTTRVMGTYGYAAPEYIST-GHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWA-------  315 (419)
Q Consensus       244 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~-------  315 (419)
                      ++........   .....||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||...........+...       
T Consensus       169 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~  245 (350)
T d1q5ka_         169 SAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE  245 (350)
T ss_dssp             TCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             chhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence            9987644332   234579999999998765 57899999999999999999999999865433221111100       


Q ss_pred             --hHHhhc--ccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHhhh
Q 014736          316 --KPYLRS--SRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA--TLESLL  374 (419)
Q Consensus       316 --~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~--~L~~l~  374 (419)
                        ......  ...+.......+........++++.+||.+||..||++|||+.|+++  +|+.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence              000000  00011111111112223345678999999999999999999999986  355543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=369.33  Aligned_cols=267  Identities=21%  Similarity=0.259  Sum_probs=194.7

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEe---
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCE---  165 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---  165 (419)
                      ++|+++++||+|+||+||+|+.      ..+++.||||++.....  .....+.+|+++|+.++||||+++++++..   
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~------~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~   83 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARH------RKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS   83 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE------TTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred             CCEEEEEEEecCcCeEEEEEEE------CCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence            6899999999999999999964      34578999999865432  335678899999999999999999998855   


Q ss_pred             -----CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEe
Q 014736          166 -----DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLS  240 (419)
Q Consensus       166 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~  240 (419)
                           .+..|+||||+.++.+......  ...+++..++.++.||+.||.|||  ++||+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH--~~~ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          84 PYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             -------CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             cccccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhc--cCCEEecCcCchheeecCCCcEEee
Confidence                 3468999999977666544333  357889999999999999999999  6779999999999999999999999


Q ss_pred             ccCccccCCCCCCce--eeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhH
Q 014736          241 DFGLAKMGPEGSNTH--VTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKP  317 (419)
Q Consensus       241 DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~  317 (419)
                      |||++..........  .....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.........+.....
T Consensus       160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~  239 (318)
T d3blha1         160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  239 (318)
T ss_dssp             CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999997654332211  12335799999999998754 689999999999999999999999986543322222111100


Q ss_pred             Hhhcccccccccccc-------cCC-CCC-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          318 YLRSSRRLRYIVDPR-------LAG-QYS-------VKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       318 ~~~~~~~~~~~~~~~-------l~~-~~~-------~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ... ...........       ... ...       ...+.++.+||.+||+.||++|||++|+++
T Consensus       240 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         240 SIT-PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             CCC-TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCC-hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            000 00000000000       000 000       112457889999999999999999999975

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=377.58  Aligned_cols=268  Identities=21%  Similarity=0.288  Sum_probs=197.2

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc-ccHHHHHHHHHHHcCCCcccccceeeEEEeCC-
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL-QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDE-  167 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-  167 (419)
                      ..+|+++++||+|+||+||+|+.      ..+++.||||++..... ...+.+++|+++|+.++||||+++++++.... 
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~------~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~   80 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYD------NVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   80 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEE------TTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             CCCeEEEEEEeeccCeEEEEEEE------CCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence            46799999999999999999953      44578999999975433 33567889999999999999999999986653 


Q ss_pred             ---eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCc
Q 014736          168 ---ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGL  244 (419)
Q Consensus       168 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl  244 (419)
                         ..+++|+|+.+|+|.+++..+   .+++..++.++.||+.||+|||  ++|||||||||+||||+.++.+||+|||+
T Consensus        81 ~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH--~~~iiHRDIKp~NILl~~~~~~kl~DfG~  155 (345)
T d1pmea_          81 EQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFGL  155 (345)
T ss_dssp             TTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             cccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCcceEEECCCCCEEEcccCc
Confidence               234555666799999999654   6899999999999999999999  67799999999999999999999999999


Q ss_pred             cccCCCCCCce-eeecccccccccccccc-cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc
Q 014736          245 AKMGPEGSNTH-VTTRVMGTYGYAAPEYI-STGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS  322 (419)
Q Consensus       245 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  322 (419)
                      +.......... .....+||+.|+|||++ .+..++.++||||+||++|+|++|+.||......................
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (345)
T d1pmea_         156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  235 (345)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence            98654432211 22346799999999998 44577899999999999999999999998654322221111100000000


Q ss_pred             --------cccccccccccCC-----CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          323 --------RRLRYIVDPRLAG-----QYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       323 --------~~~~~~~~~~l~~-----~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                              .............     ......+.++.+|+.+||+.||.+|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    0000000000000     011233567999999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-48  Score=366.03  Aligned_cols=265  Identities=20%  Similarity=0.227  Sum_probs=202.4

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCccc-ccceeeEEEeCCe
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPH-LVRLIGYCCEDEE  168 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~  168 (419)
                      .++|++.+.||+|+||.||+|++.      .+++.||||++.....  ..++..|+++++.++|+| |+.+..++.+.+.
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~------~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~   77 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDI------AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   77 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEET------TTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEEC------CCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCE
Confidence            357999999999999999999643      4578899999875432  245778999999998766 4555666678889


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcC---CCcEEEeccCcc
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDS---DFTAKLSDFGLA  245 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGla  245 (419)
                      .++||||+ +++|.+.+... ...+++..++.++.|++.||+|||  ++||+||||||+|||++.   +..+||+|||+|
T Consensus        78 ~~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a  153 (299)
T d1ckia_          78 NVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  153 (299)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred             EEEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHhhccccccCCCceeeeeccCcc
Confidence            99999999 66777665443 357899999999999999999999  677999999999999864   457999999999


Q ss_pred             ccCCCCCCc-----eeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhh-HHh
Q 014736          246 KMGPEGSNT-----HVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAK-PYL  319 (419)
Q Consensus       246 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-~~~  319 (419)
                      +........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||................ ...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ckia_         154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  233 (299)
T ss_dssp             EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred             eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence            876543322     12334679999999999999999999999999999999999999998765544332221111 100


Q ss_pred             hcccccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHhhhcCc
Q 014736          320 RSSRRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVATLESLLNLK  377 (419)
Q Consensus       320 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~~L~~l~~~~  377 (419)
                      ...       .+    .....+++++.+|+.+||+.||++||++++|.+.|+.+....
T Consensus       234 ~~~-------~~----~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         234 STP-------IE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HSC-------HH----HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             CCC-------hh----HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            000       00    111234578999999999999999999999999999876543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-48  Score=362.12  Aligned_cols=264  Identities=22%  Similarity=0.239  Sum_probs=205.2

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeCCe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCEDEE  168 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  168 (419)
                      ++|+++++||+|+||+||+|+.      ..+++.||||+++....  .....+.+|+.+|+.++||||+++++++.+...
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~------~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   75 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKN------RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEE------TTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCCEeeeEEecCcCeEEEEEEE------CCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc
Confidence            5799999999999999999964      44578899999965432  345788999999999999999999999999999


Q ss_pred             eEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCccccC
Q 014736          169 RLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKMG  248 (419)
Q Consensus       169 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~~  248 (419)
                      .++||+++.+++|..++...  ..+++..+..++.|++.||+|||  ++||+||||||+|||++.++.+||+|||.++..
T Consensus        76 ~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH--~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~  151 (292)
T d1unla_          76 LTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eeEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhh--cCCEeeecccCcccccccCCceeeeecchhhcc
Confidence            99999999998888877654  67889999999999999999999  677999999999999999999999999999876


Q ss_pred             CCCCCceeeecccccccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhcc-----
Q 014736          249 PEGSNTHVTTRVMGTYGYAAPEYISTGH-LTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSS-----  322 (419)
Q Consensus       249 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-----  322 (419)
                      ......  .....++..|+|||++.... ++.++|||||||++|||++|+.||.........  ...........     
T Consensus       152 ~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~  227 (292)
T d1unla_         152 GIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQW  227 (292)
T ss_dssp             CSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTC
T ss_pred             cCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--HHHHHhhcCCCChhhh
Confidence            543322  23345788999999987654 689999999999999999999997544332211  11111100000     


Q ss_pred             ---------cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          323 ---------RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       323 ---------~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                               ...................++++.+|+.+||+.||++|||++||++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     0000000001111223345678999999999999999999999876

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6e-48  Score=366.97  Aligned_cols=259  Identities=17%  Similarity=0.230  Sum_probs=199.0

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-cccccceeeEEEeC--C
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-HPHLVRLIGYCCED--E  167 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~--~  167 (419)
                      ++|+++++||+|+||+||+|+      +..+++.||||+++..   ..+.+.+|+++|+.++ ||||++++++|...  .
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~------~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~  105 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAI------NITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSR  105 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEE------ETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             cCeEEEEEEecCcCeEEEEEE------ECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence            579999999999999999995      4456789999999754   3467889999999995 99999999999754  5


Q ss_pred             eeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC-cEEEeccCccc
Q 014736          168 ERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF-TAKLSDFGLAK  246 (419)
Q Consensus       168 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGla~  246 (419)
                      ..++||||+.+++|..+.     ..+++..++.++.||+.||+|||  ++||+||||||+||||+.++ .+||+|||++.
T Consensus       106 ~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH--~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         106 TPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             SEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             ceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHh--hcccccccccccceEEcCCCCeeeecccccce
Confidence            689999999999997764     46899999999999999999999  67799999999999998755 69999999998


Q ss_pred             cCCCCCCceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHH-hh------hHH
Q 014736          247 MGPEGSNTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVD-WA------KPY  318 (419)
Q Consensus       247 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~-~~------~~~  318 (419)
                      .......   ....+||+.|+|||.+.+. .++.++||||+||++|+|++|+.||............. ..      ...
T Consensus       179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  255 (328)
T d3bqca1         179 FYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY  255 (328)
T ss_dssp             ECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred             eccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence            7654432   3445799999999998764 57999999999999999999999997654432211100 00      000


Q ss_pred             hh-----ccccccccc--------ccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 LR-----SSRRLRYIV--------DPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 ~~-----~~~~~~~~~--------~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                      ..     .........        ............++++.+||.+||..||++|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00     000000000        011111122345678999999999999999999999976

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=369.98  Aligned_cols=256  Identities=26%  Similarity=0.306  Sum_probs=205.8

Q ss_pred             cCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC----cccHHHHHHHHHHHcCCCc-ccccceeeEEEe
Q 014736           91 QNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG----LQGHREWLAEVIFLGQLRH-PHLVRLIGYCCE  165 (419)
Q Consensus        91 ~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~  165 (419)
                      ++|++++.||+|+||+||+|+...   ...+++.||||+++...    ....+.+.+|+++|++++| |||+++++++.+
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~---~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKIS---GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECS---STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEECc---cCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            579999999999999999997532   24467899999986532    2234567889999999976 899999999999


Q ss_pred             CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEeccCcc
Q 014736          166 DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDFGLA  245 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla  245 (419)
                      ....+++|||+.+|+|.+++...  ..+++..+..++.||+.||.|||  ++||+||||||+|||++.++.+||+|||++
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH--~~~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             CCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhh--cCCEEeccCCccceeecCCCCEEEeeccch
Confidence            99999999999999999999776  56788899999999999999999  667999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccccccccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHHhhccc
Q 014736          246 KMGPEGSNTHVTTRVMGTYGYAAPEYISTG--HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPYLRSSR  323 (419)
Q Consensus       246 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  323 (419)
                      +........ ......|++.|+|||.+.+.  .++.++|||||||++|+|++|+.||...........+...  ....  
T Consensus       177 ~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~--~~~~--  251 (322)
T d1vzoa_         177 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--ILKS--  251 (322)
T ss_dssp             EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH--HHHC--
T ss_pred             hhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh--cccC--
Confidence            865443322 23345799999999998654  4788999999999999999999999876554433222111  0000  


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 014736          324 RLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPK-----MAAVVA  368 (419)
Q Consensus       324 ~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs-----~~eil~  368 (419)
                                ...++...+.++.+|+.+||+.||.+|||     ++|+++
T Consensus       252 ----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                      11233445789999999999999999994     788875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=367.70  Aligned_cols=263  Identities=21%  Similarity=0.270  Sum_probs=190.9

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCC--cccHHHHHHHHHHHcCCCcccccceeeEEEe--
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEG--LQGHREWLAEVIFLGQLRHPHLVRLIGYCCE--  165 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--  165 (419)
                      .++|+++++||+|+||+||+|.      +..+++.||||++....  ......+.+|+.+|++++|||||+++++|..  
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~------d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~   89 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAY------DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK   89 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEE------ETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEE------ECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence            3689999999999999999995      44567899999997543  2334568899999999999999999999964  


Q ss_pred             ----CCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEec
Q 014736          166 ----DEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSD  241 (419)
Q Consensus       166 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~D  241 (419)
                          ..++|+||||+.++ +.+.+.    ..+++..++.++.||+.||.|||  .+||+||||||+|||++.++.+|++|
T Consensus        90 ~~~~~~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH--~~giiHrDlKP~Nil~~~~~~~kl~d  162 (355)
T d2b1pa1          90 TLEEFQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_dssp             STTTCCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred             ccccCceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhh--hcccccccCCccccccccccceeeec
Confidence                36889999999654 444443    45899999999999999999999  67799999999999999999999999


Q ss_pred             cCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHh-------
Q 014736          242 FGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDW-------  314 (419)
Q Consensus       242 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~-------  314 (419)
                      ||+++......   .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.........+..       
T Consensus       163 f~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~  239 (355)
T d2b1pa1         163 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  239 (355)
T ss_dssp             CCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             hhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence            99988654432   23445799999999999999999999999999999999999999976543221111100       


Q ss_pred             --h-------hHHhhccccc-----ccccccccC---CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          315 --A-------KPYLRSSRRL-----RYIVDPRLA---GQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       315 --~-------~~~~~~~~~~-----~~~~~~~l~---~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        .       ..+.......     .........   .......+.++.+||.+||..||++|||++||++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence              0       0000000000     000000000   1112345788999999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-47  Score=363.25  Aligned_cols=262  Identities=21%  Similarity=0.284  Sum_probs=195.5

Q ss_pred             hcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCc--ccHHHHHHHHHHHcCCCcccccceeeEEEeC-
Q 014736           90 TQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGL--QGHREWLAEVIFLGQLRHPHLVRLIGYCCED-  166 (419)
Q Consensus        90 ~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-  166 (419)
                      .++|+++++||+|+||+||+|..      ..+++.||||++.....  ...+.+.+|+.+|+.++|||||++++++... 
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~------~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~   90 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFD------TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   90 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEE------TTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CCCeEEEEEEecCCCeEEEEEEE------CCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence            46899999999999999999953      45678999999975533  3345788999999999999999999998643 


Q ss_pred             ----CeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCcEEEecc
Q 014736          167 ----EERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFTAKLSDF  242 (419)
Q Consensus       167 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~kl~Df  242 (419)
                          ...+++|+|+.||+|.+++..+   .+++..++.++.||+.||+|||  ++||+||||||+|||++.++.+|++||
T Consensus        91 ~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH--~~giiHrDiKp~NILi~~~~~~kl~df  165 (348)
T d2gfsa1          91 SLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDF  165 (348)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             ccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHH--hCCCcccccCCcccccccccccccccc
Confidence                3446677788899999998643   6999999999999999999999  677999999999999999999999999


Q ss_pred             CccccCCCCCCceeeecccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhHHHhhhHH---
Q 014736          243 GLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTG-HLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNLVDWAKPY---  318 (419)
Q Consensus       243 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---  318 (419)
                      |++......     .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+......   
T Consensus       166 g~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~  240 (348)
T d2gfsa1         166 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA  240 (348)
T ss_dssp             ----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             chhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            999764322     2345699999999987665 5689999999999999999999999865433222211100000   


Q ss_pred             --hhcc---------cccccccccccCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 014736          319 --LRSS---------RRLRYIVDPRLAGQYSVKGAKEMAVLALQCISVNPKDRPKMAAVVA  368 (419)
Q Consensus       319 --~~~~---------~~~~~~~~~~l~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~eil~  368 (419)
                        ....         ..........+. ......+.++.+||.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence              0000         000000000000 001234578999999999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.7e-42  Score=331.20  Aligned_cols=264  Identities=22%  Similarity=0.244  Sum_probs=191.4

Q ss_pred             CCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-----------ccccccee
Q 014736           92 NFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-----------HPHLVRLI  160 (419)
Q Consensus        92 ~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~~~  160 (419)
                      +|+++++||+|+||+||+|+      +..+++.||||+++.... ..+.+.+|+.+++.++           |+||++++
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~------~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAK------DMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEE------ETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             cEEEEEEEeeCCCeEEEEEE------ECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence            59999999999999999995      445578999999975432 2456778888887775           57899999


Q ss_pred             eEEEe--CCeeEEEEEecCCCCh-hhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCCc-
Q 014736          161 GYCCE--DEERLLVYEFMPRGSL-ENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDFT-  236 (419)
Q Consensus       161 ~~~~~--~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~-  236 (419)
                      +++..  ....+++|+++..+.. ...........+++..+..++.||+.||.|||+ ..||+||||||+||||+.++. 
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~-~~~IvHrDlKp~NIll~~~~~~  165 (362)
T d1q8ya_          87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSP  165 (362)
T ss_dssp             EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEETT
T ss_pred             EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh-hcCcccccCChhHeeeeccCcc
Confidence            88854  3566777777755543 333444445678999999999999999999994 367999999999999987653 


Q ss_pred             -----EEEeccCccccCCCCCCceeeecccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccchhH
Q 014736          237 -----AKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAPEYISTGHLTTKSDVYSFGVVLLELLTGRRSMDKLRPKSEQNL  311 (419)
Q Consensus       237 -----~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  311 (419)
                           ++|+|||.+......     ....+||+.|+|||++.+..|+.++||||+||++++|++|+.||...........
T Consensus       166 ~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~  240 (362)
T d1q8ya_         166 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  240 (362)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence                 999999999864432     2345699999999999999999999999999999999999999976543221111


Q ss_pred             HHhhh---HHh--------hccc----------ccccccc---------cccCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 014736          312 VDWAK---PYL--------RSSR----------RLRYIVD---------PRLAGQYSVKGAKEMAVLALQCISVNPKDRP  361 (419)
Q Consensus       312 ~~~~~---~~~--------~~~~----------~~~~~~~---------~~l~~~~~~~~~~~l~~li~~~l~~dP~~RP  361 (419)
                      .....   ..+        ....          ....+..         ......+....+.++.+||.+||..||.+||
T Consensus       241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp  320 (362)
T d1q8ya_         241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  320 (362)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence            10000   000        0000          0000000         0012234567788999999999999999999


Q ss_pred             CHHHHHH
Q 014736          362 KMAAVVA  368 (419)
Q Consensus       362 s~~eil~  368 (419)
                      |++|+++
T Consensus       321 ta~e~L~  327 (362)
T d1q8ya_         321 DAGGLVN  327 (362)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhc
Confidence            9999976

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1e-25  Score=195.88  Aligned_cols=163  Identities=16%  Similarity=0.136  Sum_probs=117.2

Q ss_pred             CCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcc------------------cHHHHHHHHHHHcCCCccc
Q 014736           94 SSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQ------------------GHREWLAEVIFLGQLRHPH  155 (419)
Q Consensus        94 ~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~hpn  155 (419)
                      .++++||+|+||+||+|...       +++.||||+++.....                  ......+|+..+.++.|.+
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   75 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA   75 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred             hhCCEeeeCcceEEEEEECC-------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC
Confidence            45788999999999999643       3678999987532110                  0123456888999999999


Q ss_pred             ccceeeEEEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEcCCC
Q 014736          156 LVRLIGYCCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGAENPVIYRDFKTSNILLDSDF  235 (419)
Q Consensus       156 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~  235 (419)
                      ++..+++.    ..+++|||+++..+.+         ++...+..++.|++.+|.|||  .+||+||||||+|||++++ 
T Consensus        76 v~~~~~~~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH--~~giiHrDiKP~NILv~~~-  139 (191)
T d1zara2          76 VPKVYAWE----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFY--HRGIVHGDLSQYNVLVSEE-  139 (191)
T ss_dssp             SCCEEEEE----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEEEETT-
T ss_pred             cceEEEec----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHh--hCCEEEccCChhheeeeCC-
Confidence            99887653    2479999998765533         233456789999999999999  6779999999999999965 


Q ss_pred             cEEEeccCccccCCCCCCceeeeccccccccccc------ccccCCCCCchhhHHHHHHHH
Q 014736          236 TAKLSDFGLAKMGPEGSNTHVTTRVMGTYGYAAP------EYISTGHLTTKSDVYSFGVVL  290 (419)
Q Consensus       236 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DiwslG~il  290 (419)
                      .++|+|||+|........          ..|...      +.+ ...|+.++|+||+.--+
T Consensus       140 ~~~liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         140 GIWIIDFPQSVEVGEEGW----------REILERDVRNIITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EEEECCCTTCEETTSTTH----------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             CEEEEECCCcccCCCCCc----------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence            589999999976433221          112111      111 35688899999986443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.78  E-value=1.1e-08  Score=91.18  Aligned_cols=148  Identities=14%  Similarity=0.036  Sum_probs=99.5

Q ss_pred             HHHHHHhcCCCCCCeecccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC-cccccceeeE
Q 014736           84 SELRAITQNFSSNYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR-HPHLVRLIGY  162 (419)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~  162 (419)
                      .++....+.|+..+..+-++.+.||+...        .++.+++|+...........+.+|...+..+. +--+.+++.+
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~   78 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHF   78 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC--------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe--------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEE
Confidence            45666677887766655455578998742        23568889886543333445667888776663 4346778888


Q ss_pred             EEeCCeeEEEEEecCCCChhhhhhhccCCCCCHHHHHHHHHHHHHHHHHhhcC---------------------------
Q 014736          163 CCEDEERLLVYEFMPRGSLENHLFKRISVSLPWGTRLKIAIGAAKGLAFLHGA---------------------------  215 (419)
Q Consensus       163 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---------------------------  215 (419)
                      ..+++..++||++++|.++.+.....    .   ....++.+++..+..||+.                           
T Consensus        79 ~~~~~~~~lv~~~l~G~~~~~~~~~~----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (263)
T d1j7la_          79 ERHDGWSNLLMSEADGVLCSEEYEDE----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA  151 (263)
T ss_dssp             EEETTEEEEEEECCSSEEHHHHTTTC----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred             EecCCceEEEEEeccccccccccccc----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhh
Confidence            88889999999999988876543211    1   1223344455555555521                           


Q ss_pred             ------------------------------CCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          216 ------------------------------ENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       216 ------------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                                                    ...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                          1237999999999999987666799998776

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.25  E-value=3.6e-06  Score=73.90  Aligned_cols=74  Identities=18%  Similarity=0.045  Sum_probs=49.8

Q ss_pred             ecccCc-eEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCC--cccccceeeEEEeCCeeEEEEEe
Q 014736           99 LGEGGF-GTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLR--HPHLVRLIGYCCEDEERLLVYEF  175 (419)
Q Consensus        99 lg~G~f-g~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~~~~~~~~~~~~~lv~e~  175 (419)
                      +..|.. +.||+....       .+..+++|........   .+..|...|+.+.  .-.+.+++.+..+.+..++||++
T Consensus        18 ~~~G~s~~~v~r~~~~-------~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~   87 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ-------GRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   87 (255)
T ss_dssp             CSCTTSSCEEEEEECT-------TSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             cCCcccCCeEEEEEeC-------CCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence            445543 689987532       2456888987654332   3455777766653  23367788888888899999999


Q ss_pred             cCCCChh
Q 014736          176 MPRGSLE  182 (419)
Q Consensus       176 ~~~g~L~  182 (419)
                      ++|.++.
T Consensus        88 i~G~~~~   94 (255)
T d1nd4a_          88 VPGQDLL   94 (255)
T ss_dssp             CSSEETT
T ss_pred             eeccccc
Confidence            9887663

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.02  E-value=1.7e-05  Score=74.34  Aligned_cols=78  Identities=17%  Similarity=0.070  Sum_probs=47.8

Q ss_pred             CCeecccCceEEEEEEEcCcccccccccEEEEEEeccC------Cc-ccHHHHHHHHHHHcCCC-c--ccccceeeEEEe
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIE------GL-QGHREWLAEVIFLGQLR-H--PHLVRLIGYCCE  165 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~------~~-~~~~~~~~E~~~l~~l~-h--pnIv~~~~~~~~  165 (419)
                      .+.||.|....||++...      ..++.|+||.-...      .. ....+...|.+.|+.+. +  ..+++++.  .+
T Consensus        31 ~~eig~G~~N~vfrV~~~------~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d  102 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQ------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SD  102 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EE
T ss_pred             EEEeCCCceEeEEEEEeC------CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--Ec
Confidence            346899999999998532      23567999975421      11 12334556887776652 2  34555654  35


Q ss_pred             CCeeEEEEEecCCCCh
Q 014736          166 DEERLLVYEFMPRGSL  181 (419)
Q Consensus       166 ~~~~~lv~e~~~~g~L  181 (419)
                      .+..++|||++.+..+
T Consensus       103 ~~~~~lvmE~L~~~~~  118 (392)
T d2pula1         103 TEMAVTVMEDLSHLKI  118 (392)
T ss_dssp             TTTTEEEECCCTTSEE
T ss_pred             CCCCEEEEeccCCccc
Confidence            5667899999976543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.29  E-value=0.00076  Score=60.99  Aligned_cols=133  Identities=16%  Similarity=0.073  Sum_probs=74.7

Q ss_pred             eEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccc-----cce--eeEEEeCCeeEEEEEecC
Q 014736          105 GTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHL-----VRL--IGYCCEDEERLLVYEFMP  177 (419)
Q Consensus       105 g~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~--~~~~~~~~~~~lv~e~~~  177 (419)
                      -.||++...       .|+.|++|+.+... ...+++..|...+..|...+|     +..  -..+..++..+.+++++.
T Consensus        36 N~vy~v~~~-------dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~  107 (325)
T d1zyla1          36 NRVYQFQDE-------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  107 (325)
T ss_dssp             SEEEEECCT-------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             ceeEEEEcC-------CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence            479998533       35779999987543 245667778887777642222     111  123355677889999997


Q ss_pred             CCChhh-----h------h---hh----c---cCCCCCH----------------------HHHHHHHHHHHHHHHHh--
Q 014736          178 RGSLEN-----H------L---FK----R---ISVSLPW----------------------GTRLKIAIGAAKGLAFL--  212 (419)
Q Consensus       178 ~g~L~~-----~------l---~~----~---~~~~~~~----------------------~~~~~i~~qi~~al~~l--  212 (419)
                      |..+..     +      +   ..    .   .......                      ......+..+...+.-+  
T Consensus       108 G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~  187 (325)
T d1zyla1         108 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR  187 (325)
T ss_dssp             CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred             CcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcc
Confidence            643311     0      0   00    0   0001111                      11122233333333222  


Q ss_pred             hcCCCCeeecCCCCCcEEEcCCCcEEEeccCcccc
Q 014736          213 HGAENPVIYRDFKTSNILLDSDFTAKLSDFGLAKM  247 (419)
Q Consensus       213 H~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~~  247 (419)
                      .....++||+|+.+.|||++++  ..++||+-+..
T Consensus       188 ~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         188 EDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             SCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            1224579999999999999753  46899988774

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.18  E-value=0.0007  Score=63.01  Aligned_cols=80  Identities=15%  Similarity=0.157  Sum_probs=51.4

Q ss_pred             CCeecccCceEEEEEEEcCcccc-cccccEEEEEEeccCCcccHHHHHHHHHHHcCCCcccc-cceeeEEEeCCeeEEEE
Q 014736           96 NYLLGEGGFGTVHKGYIDDDLRQ-GLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRHPHL-VRLIGYCCEDEERLLVY  173 (419)
Q Consensus        96 ~~~lg~G~fg~Vy~a~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~  173 (419)
                      ++.|+-|--=.+|++...+.... ....+.|.+++....  .......+|..+++.+.-.++ .++++++.    -++||
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence            34677788889999876543211 233466888887632  223345578888888753344 56777663    26899


Q ss_pred             EecCCCCh
Q 014736          174 EFMPRGSL  181 (419)
Q Consensus       174 e~~~~g~L  181 (419)
                      ||++|..|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.14  E-value=0.00035  Score=62.89  Aligned_cols=156  Identities=15%  Similarity=0.020  Sum_probs=84.3

Q ss_pred             CCHHHHHHHhcCCCCCCeec-----ccCceEEEEEEEcCcccccccccEEEEEEeccCCcccHHHHHHHHHHHcCCCc--
Q 014736           81 FQLSELRAITQNFSSNYLLG-----EGGFGTVHKGYIDDDLRQGLKAQAVAVKLLDIEGLQGHREWLAEVIFLGQLRH--  153 (419)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg-----~G~fg~Vy~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--  153 (419)
                      .+..+++.+..+|.++++..     .|---+.|+....+        ..+++|+.+...  ...++..|++++..|..  
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~--------g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g   72 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK--------DPLILTLYEKRV--EKNDLPFFLGLMQHLAAKG   72 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS--------CCEEEEEECC-----CCHHHHHHHHHHHHHHTT
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC--------CcEEEEEcCCCC--CHHHHHHHHHHHHhhhhcc
Confidence            45678888889998866543     45556788875332        359999986432  12333445666655532  


Q ss_pred             ---cccccee---eEEEeCCeeEEEEEecCCCChhhhh--------------h---hccC----CCC-------------
Q 014736          154 ---PHLVRLI---GYCCEDEERLLVYEFMPRGSLENHL--------------F---KRIS----VSL-------------  193 (419)
Q Consensus       154 ---pnIv~~~---~~~~~~~~~~lv~e~~~~g~L~~~l--------------~---~~~~----~~~-------------  193 (419)
                         |..+...   .+....+..+.++.++.+......-              .   ....    ...             
T Consensus        73 ~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (316)
T d2ppqa1          73 LSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSE  152 (316)
T ss_dssp             CCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHG
T ss_pred             ccccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHH
Confidence               2222221   1223345667777777664332100              0   0000    000             


Q ss_pred             -----CHHHHHHHHHHHHHHHHHhhc--CCCCeeecCCCCCcEEEcCCCcEEEeccCccc
Q 014736          194 -----PWGTRLKIAIGAAKGLAFLHG--AENPVIYRDFKTSNILLDSDFTAKLSDFGLAK  246 (419)
Q Consensus       194 -----~~~~~~~i~~qi~~al~~lH~--~~~~ivH~Dlkp~NIll~~~~~~kl~DfGla~  246 (419)
                           ........+..+...+.-.+-  ...|+||+|+.+.||+++++...-|+||+.+.
T Consensus       153 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         153 ERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             GGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhhhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence                 000112223333333333331  35689999999999999988777899998876